Citrus Sinensis ID: 017139

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370------
Protein Sequence
MEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSAGT
Secondary Structure (PSIPRED)
ccccccccccccccccEEEEEEEcccccccccEEEEEEEEEEcccccEEEEEEEEcccccEEEEEEcccccHHHHHHHHHHHHcccccEEEEcEEEccccccccEEEEEEEEccccHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEcccccccccccccccEEEEEEEcccHHHHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccHHHHcccHHHHHHccHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEccccccccEEEEEEEccccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHccHHHHHHccccccccccc
Coil and Loop (DISEMBL)
MEMSAAVIQGNDAVTGHIISttiggkngepkqTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLmdhpnvislkhcffsttskDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAyihtvpgvchrdvkpqnllvdplthqvklcdfgsakvlvkgEANISYICSryyrapelifgateyttsiDIWSAGCVLAELllgqplfpgenaVDQLVEIIKVLgtptreeircmnpnytdfrfpqikahpwhkvfhkrmppeAIDLASRLlqyspslrctaleacahpffdelrepnarlpngrpfpplfnfkqelagasPELINRLIpehvrrqtglsmphsagt
Flexible Loop (DISEMBL)
MEMSAAVIqgndavtgHIISttiggkngepkQTISYMAERVVGTGSFGIVFQAKCletgetvaikkvlqdrrYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLgtptreeiRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEhvrrqtglsmphsagt
Low Complexity Region (SEG)
MEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSAGT
Disordered region (IsUnstruct)
*********GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR*************PLFNFKQ*L******LINRL*******************
Disordered Region (DISOPRED)
******************ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR*************
Disordered Region (DISEMBL)
********QGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR************
Disordered Region (DISPRO)
************AVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQT**********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSAGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	376	2.2.26 [Sep-21-2011]
Q39010	412	Shaggy-related protein ki	yes	no	0.994	0.907	0.935	0.0
Q39012	407	Shaggy-related protein ki	no	no	0.989	0.914	0.935	0.0
Q39011	380	Shaggy-related protein ki	no	no	0.997	0.986	0.906	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	0.968	0.887	0.838	0.0
P43289	409	Shaggy-related protein ki	no	no	0.968	0.889	0.816	0.0
P43288	405	Shaggy-related protein ki	no	no	0.968	0.898	0.819	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	0.968	0.889	0.808	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	0.968	0.885	0.810	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.976	0.892	0.796	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.976	0.892	0.790	1e-180

>sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2

 Score =  739 bits (1909), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/374 (93%), Positives = 362/374 (96%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 38  EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 97

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRV
Sbjct: 98  VAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRV 157

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           LKHY+S NQRMP+ YVKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDF
Sbjct: 158 LKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDF 217

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGEANISYICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 218 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGEN 277

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           +VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 278 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 337

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQEL+GASPELINRLIPEH
Sbjct: 338 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEH 397

Query: 362 VRRQTGLSMPHSAG 375
           VRRQ     P  AG
Sbjct: 398 VRRQMNGGFPFQAG 411

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1

 Score =  732 bits (1890), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/372 (93%), Positives = 359/372 (96%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 36  EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 95

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRV
Sbjct: 96  VAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRV 155

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           L+HY+S NQRMP+ YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF
Sbjct: 156 LRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 215

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGE NISYICSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 216 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGEN 275

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           +VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 276 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 335

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQEL GAS ELINRLIPEH
Sbjct: 336 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEH 395

Query: 362 VRRQTGLSMPHS 373
           VRRQ    + +S
Sbjct: 396 VRRQMSTGLQNS 407

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2

 Score =  728 bits (1879), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/375 (90%), Positives = 361/375 (96%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EM AAV+ G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6   EMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMR+MDHPNV+ LKHCFFSTTSKDELFLNLVMEYVPE++YRV
Sbjct: 66  VAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRV 125

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           LKHYSS NQRMPL+YVKLY YQIFRGLAYIH V GVCHRD+KPQNLLVDPLTHQVK+CDF
Sbjct: 126 LKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDF 185

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAK LVKGEANISYICSR+YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLL 305

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE+AG+SPEL+N+LIP+H
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDH 365

Query: 362 VRRQTGLSMPHSAGT 376
           ++RQ GLS  + +GT
Sbjct: 366 IKRQLGLSFLNQSGT 380

Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  655 bits (1690), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 306/365 (83%), Positives = 333/365 (91%), Gaps = 1/365 (0%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EM AAV+ GN   TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLETGET
Sbjct: 40  EMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGET 99

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET+YRV
Sbjct: 100 VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRV 159

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
            KHYS  NQRMP+IYVKLYTYQI R LAYIH   GVCHRD+KPQNLLV+P THQVKLCDF
Sbjct: 160 SKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDF 219

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+
Sbjct: 220 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGES 279

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SRLL
Sbjct: 280 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLL 339

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
           QYSP+LR TA+EA  HPFFDELR+PN RLPNGR  PPLFNFK QEL GAS EL+++LIP+
Sbjct: 340 QYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPD 399

Query: 361 HVRRQ 365
           H R+Q
Sbjct: 400 HARKQ 404

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  647 bits (1670), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 298/365 (81%), Positives = 333/365 (91%), Gaps = 1/365 (0%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EM A ++ GN   TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct: 39  EMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 98

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET++RV
Sbjct: 99  VAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 158

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           +KHY+ +NQRMPL+YVKLYTYQIFR L+YIH   GVCHRD+KPQNLLV+P THQVKLCDF
Sbjct: 159 IKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 218

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGES 278

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct: 279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 338

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
           QYSP+LRC AL++  HPFFDELR+PNARLPNGR  PPLFNFK  EL G   E++ +L+PE
Sbjct: 339 QYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPE 398

Query: 361 HVRRQ 365
           H R+Q
Sbjct: 399 HARKQ 403

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  644 bits (1661), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 299/365 (81%), Positives = 331/365 (90%), Gaps = 1/365 (0%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EM A V+ GN   TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct: 35  EMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 94

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET++RV
Sbjct: 95  VAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 154

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           +KHY+ +NQRMPLIYVKLYTYQIFR L+YIH   GVCHRD+KPQNLLV+P THQVKLCDF
Sbjct: 155 IKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 214

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 215 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGES 274

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct: 275 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 334

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
           QYSP+LR  AL+   HPFFDELR+PNARLPNGR  PPLFNFK  EL G   E++ +L+PE
Sbjct: 335 QYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPE 394

Query: 361 HVRRQ 365
           H R+Q
Sbjct: 395 HARKQ 399

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  639 bits (1649), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 295/365 (80%), Positives = 330/365 (90%), Gaps = 1/365 (0%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           E+ AA++ GN   TGHII TTIGG++G+PKQTISYMAER+VG GSFG+VFQAKCLETGET
Sbjct: 39  EIEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGET 98

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQD+RYKNRELQ MRL+DHPNV+ LKHCFFSTT KDE++LNLV+EYVPET++RV
Sbjct: 99  VAIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRV 158

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           +KHY+ +NQRMPLI VKLYTYQIFR L+YIH   GVCHRD+KPQNLLV+P THQVKLCDF
Sbjct: 159 IKHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDF 218

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+
Sbjct: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGES 278

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            VDQLVEIIKVLGTPTREEI+CMNPNY +F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct: 279 GVDQLVEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 338

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
           QYSP+LRCTALEA  H FFDELR+PN RLPNGR  PPLFNFK  EL G S E + +L+PE
Sbjct: 339 QYSPNLRCTALEAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPE 398

Query: 361 HVRRQ 365
           H R+Q
Sbjct: 399 HARKQ 403

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  637 bits (1642), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 296/365 (81%), Positives = 327/365 (89%), Gaps = 1/365 (0%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EM A V+ GN   TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct: 41  EMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 100

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET++RV
Sbjct: 101 VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 160

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           +KHYS +NQRMP+IYVKLYTYQIFR L+YIH   GVCHRD+KPQNLLV+P THQVKLCDF
Sbjct: 161 IKHYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 220

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WS GCVLAELLLGQPLFPGE 
Sbjct: 221 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGER 280

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMP EA+DL SRLL
Sbjct: 281 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLL 340

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
           QYSP+LRC AL+   HPFFDELR+PNARLP GR  PPLFNFK  EL G   E + +L+PE
Sbjct: 341 QYSPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPE 400

Query: 361 HVRRQ 365
           H R+Q
Sbjct: 401 HARKQ 405

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  633 bits (1632), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 294/369 (79%), Positives = 330/369 (89%), Gaps = 2/369 (0%)

Query: 2   EMSAA-VIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE 60
           EM AA ++ GN   TGHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLETGE
Sbjct: 39  EMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 98

Query: 61  TVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYR 120
           TVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET+ R
Sbjct: 99  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSR 158

Query: 121 VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 180
           V++HY+ MNQRMP+IYVKLY+YQI R LAYIH   GVCHRD+KPQNLLV+P THQ+K+CD
Sbjct: 159 VIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICD 218

Query: 181 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
           FGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVL ELLLGQPLFPGE
Sbjct: 219 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGE 278

Query: 241 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           + VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRL
Sbjct: 279 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 338

Query: 301 LQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIP 359
           LQYSP+LR TALEA  HPF+D++R+PN RLPNGR  PPLFNFK  EL G   E++ +L+P
Sbjct: 339 LQYSPNLRSTALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVP 398

Query: 360 EHVRRQTGL 368
            H R+Q  L
Sbjct: 399 PHARKQCAL 407

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  630 bits (1626), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 291/368 (79%), Positives = 325/368 (88%), Gaps = 1/368 (0%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EM A V+ GN    GH+I TTIGGKNG+PKQTISYMAER VG GSFG+VFQAKCLETGET
Sbjct: 40  EMEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGET 99

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQD+RYKNRELQ MRL+DHPNV++LKHCFFSTT KDEL+LNLV+E+VPET++RV
Sbjct: 100 VAIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRV 159

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           ++HYS MNQRMPLIYVKLY+YQI R LAYIH   GV HRD+KPQNLLV+P THQ+KLCDF
Sbjct: 160 IRHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDF 219

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGE NISYICSRYYRAPELIFGATEYT++IDIWSAGCVL ELLLGQPLFPG +
Sbjct: 220 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGAS 279

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRLL
Sbjct: 280 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLL 339

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
           QYSP+LR TALEA  HPFFDELR+PN RLPNGR  PPLFNFK  EL G   E++ +L+P 
Sbjct: 340 QYSPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPS 399

Query: 361 HVRRQTGL 368
           H R+Q  L
Sbjct: 400 HARKQCSL 407

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	376
356543100	420	PREDICTED: shaggy-related protein kinase	0.997	0.892	0.941	0.0
356517324	419	PREDICTED: shaggy-related protein kinase	0.997	0.894	0.941	0.0
357452871	423	Shaggy-related protein kinase [Medicago	0.986	0.877	0.946	0.0
359483773	380	PREDICTED: shaggy-related protein kinase	0.997	0.986	0.941	0.0
449463108	425	PREDICTED: shaggy-related protein kinase	0.997	0.882	0.925	0.0
15224593	412	Shaggy-related protein kinase zeta [Arab	0.994	0.907	0.935	0.0
297843440	410	hypothetical protein ARALYDRAFT_470656 [	0.989	0.907	0.938	0.0
297826527	412	hypothetical protein ARALYDRAFT_902112 [	0.994	0.907	0.933	0.0
21593135	412	putative shaggy-like protein kinase dzet	0.994	0.907	0.930	0.0
359485302	411	PREDICTED: shaggy-related protein kinase	0.992	0.907	0.933	0.0

>gi|356543100|ref|XP_003540001.1| PREDICTED: shaggy-related protein kinase zeta-like [Glycine max]

 Score =  750 bits (1936), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/375 (94%), Positives = 365/375 (97%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           +MSA VI+GNDAVTGHIISTTIGGKNGEPK+TISYMAERVVGTGSFG+VFQAKCLETGE 
Sbjct: 46  DMSATVIEGNDAVTGHIISTTIGGKNGEPKETISYMAERVVGTGSFGVVFQAKCLETGEA 105

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS+DELFLNLVMEYVPE+MYRV
Sbjct: 106 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPESMYRV 165

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           +KHY++MNQRMPLIYVKLYTYQIFRGLAYIHT  GVCHRDVKPQNLLV PLTHQVKLCDF
Sbjct: 166 IKHYTTMNQRMPLIYVKLYTYQIFRGLAYIHTALGVCHRDVKPQNLLVHPLTHQVKLCDF 225

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGE+NISYICSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 226 GSAKVLVKGESNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGEN 285

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            VDQLVEIIKVLGTPTREEIRCMNPNYT+FRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 286 QVDQLVEIIKVLGTPTREEIRCMNPNYTEFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 345

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQELAGASPELINRLIPEH
Sbjct: 346 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELAGASPELINRLIPEH 405

Query: 362 VRRQTGLSMPHSAGT 376
           +RRQ GLS PHSAGT
Sbjct: 406 IRRQMGLSFPHSAGT 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356517324|ref|XP_003527338.1| PREDICTED: shaggy-related protein kinase zeta-like [Glycine max]

 Score =  747 bits (1928), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/375 (94%), Positives = 363/375 (96%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           +MSA VI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFG+VFQAKCLETGE 
Sbjct: 45  DMSATVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGVVFQAKCLETGEA 104

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE+MYRV
Sbjct: 105 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPESMYRV 164

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           +KHY++MNQRMPLIYVKLYTYQIFRGLAYIHT   VCHRDVKPQNLLV PLTHQVKLCDF
Sbjct: 165 IKHYTTMNQRMPLIYVKLYTYQIFRGLAYIHTALRVCHRDVKPQNLLVHPLTHQVKLCDF 224

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGE+NISYICSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 225 GSAKVLVKGESNISYICSRYYRAPELIFGATEYTPSIDIWSAGCVLAELLLGQPLFPGEN 284

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 285 QVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 344

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFFDELREPNARLPNG P PPLFNFKQELAGASPELINRLIPEH
Sbjct: 345 QYSPSLRCTALEACAHPFFDELREPNARLPNGHPLPPLFNFKQELAGASPELINRLIPEH 404

Query: 362 VRRQTGLSMPHSAGT 376
           +RRQ GLS PHSAG+
Sbjct: 405 IRRQMGLSFPHSAGS 419

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357452871|ref|XP_003596712.1| Shaggy-related protein kinase [Medicago truncatula] gi|355485760|gb|AES66963.1| Shaggy-related protein kinase [Medicago truncatula]

 Score =  746 bits (1926), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/371 (94%), Positives = 364/371 (98%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EMSA+V+  NDAVTGHIISTTIGGKNGEPK+TISYMAERVVGTGSFGIVFQAKCLETGE 
Sbjct: 51  EMSASVVDSNDAVTGHIISTTIGGKNGEPKRTISYMAERVVGTGSFGIVFQAKCLETGEA 110

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQD+RYKNRELQLMR+MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPETMYRV
Sbjct: 111 VAIKKVLQDKRYKNRELQLMRVMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETMYRV 170

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           LKHY+++NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF
Sbjct: 171 LKHYNNINQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 230

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 231 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 290

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 291 QVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 350

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRC+ALEACAHPFFDELREPNARLPNGRP PPLFNFKQEL+GASPELIN+LIPEH
Sbjct: 351 QYSPSLRCSALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELINKLIPEH 410

Query: 362 VRRQTGLSMPH 372
           VRRQTGL  P+
Sbjct: 411 VRRQTGLGFPY 421

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483773|ref|XP_003633016.1| PREDICTED: shaggy-related protein kinase eta-like [Vitis vinifera] gi|297740523|emb|CBI30705.3| unnamed protein product [Vitis vinifera]

 Score =  744 bits (1920), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/375 (94%), Positives = 364/375 (97%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           E+SA V+ GND VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6   EISAPVVDGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPETMYRV
Sbjct: 66  VAIKKVLQDRRYKNRELQLMRTMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETMYRV 125

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           LKHYS+  QRMPLIYVKLYTYQIFRGLAYIH+VPGVCHRD+KPQNLLVDPLTHQVKLCDF
Sbjct: 126 LKHYSNAKQRMPLIYVKLYTYQIFRGLAYIHSVPGVCHRDLKPQNLLVDPLTHQVKLCDF 185

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGEANISYICSR+YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPSYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 305

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQEL+GASPEL+N+LIPEH
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPEH 365

Query: 362 VRRQTGLSMPHSAGT 376
           VRRQ GLS  H AGT
Sbjct: 366 VRRQIGLSFFHPAGT 380

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449463108|ref|XP_004149276.1| PREDICTED: shaggy-related protein kinase zeta-like [Cucumis sativus] gi|449505439|ref|XP_004162470.1| PREDICTED: shaggy-related protein kinase zeta-like [Cucumis sativus]

 Score =  739 bits (1909), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/375 (92%), Positives = 362/375 (96%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVG+GSFGIVFQAKCLETGET
Sbjct: 50  EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGSGSFGIVFQAKCLETGET 109

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQD+RYKNRELQLMRLMDHPNV+SLKHCFFSTTSKDELFLNLVMEYVP+ MY V
Sbjct: 110 VAIKKVLQDKRYKNRELQLMRLMDHPNVVSLKHCFFSTTSKDELFLNLVMEYVPQNMYHV 169

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           LKHY+SMNQRMPLIYVKLYTYQIFRGLAYIH+VPGVCHRDVKPQNLLVD LTHQVK+CDF
Sbjct: 170 LKHYNSMNQRMPLIYVKLYTYQIFRGLAYIHSVPGVCHRDVKPQNLLVDTLTHQVKICDF 229

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVL+KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 230 GSAKVLIKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 289

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW+KVFHKRMPPEAIDLASRLL
Sbjct: 290 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWYKVFHKRMPPEAIDLASRLL 349

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFFDELRE N RLPN RP PPLFNFKQELAGASPELI+RL+PE+
Sbjct: 350 QYSPSLRCTALEACAHPFFDELREANVRLPNNRPLPPLFNFKQELAGASPELISRLLPEY 409

Query: 362 VRRQTGLSMPHSAGT 376
           VRRQ GL + H   +
Sbjct: 410 VRRQIGLGLQHQQAS 424

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15224593|ref|NP_180655.1| Shaggy-related protein kinase zeta [Arabidopsis thaliana] gi|147744570|sp|Q39010.2|KSG6_ARATH RecName: Full=Shaggy-related protein kinase zeta; AltName: Full=ASK-zeta gi|3201623|gb|AAC20732.1| putative shaggy-like protein kinase dzeta [Arabidopsis thaliana] gi|17381128|gb|AAL36376.1| putative shaggy protein kinase dzeta [Arabidopsis thaliana] gi|20453108|gb|AAM19796.1| At2g30980/F7F1.19 [Arabidopsis thaliana] gi|20465727|gb|AAM20332.1| putative shaggy protein kinase dzeta [Arabidopsis thaliana] gi|330253376|gb|AEC08470.1| Shaggy-related protein kinase zeta [Arabidopsis thaliana]

 Score =  739 bits (1909), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/374 (93%), Positives = 362/374 (96%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 38  EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 97

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRV
Sbjct: 98  VAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRV 157

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           LKHY+S NQRMP+ YVKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDF
Sbjct: 158 LKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDF 217

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGEANISYICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 218 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGEN 277

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           +VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 278 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 337

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQEL+GASPELINRLIPEH
Sbjct: 338 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEH 397

Query: 362 VRRQTGLSMPHSAG 375
           VRRQ     P  AG
Sbjct: 398 VRRQMNGGFPFQAG 411

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297843440|ref|XP_002889601.1| hypothetical protein ARALYDRAFT_470656 [Arabidopsis lyrata subsp. lyrata] gi|297335443|gb|EFH65860.1| hypothetical protein ARALYDRAFT_470656 [Arabidopsis lyrata subsp. lyrata]

 Score =  738 bits (1906), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/372 (93%), Positives = 361/372 (97%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 39  EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 98

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRV
Sbjct: 99  VAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRV 158

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           L+HY+S NQRMP+ YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF
Sbjct: 159 LRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 218

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGEANISYICSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 219 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGEN 278

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           +VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 279 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 338

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQEL GAS EL+NRLIPEH
Sbjct: 339 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELGGASVELVNRLIPEH 398

Query: 362 VRRQTGLSMPHS 373
           VRRQ G  + +S
Sbjct: 399 VRRQMGTGLQNS 410

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297826527|ref|XP_002881146.1| hypothetical protein ARALYDRAFT_902112 [Arabidopsis lyrata subsp. lyrata] gi|297326985|gb|EFH57405.1| hypothetical protein ARALYDRAFT_902112 [Arabidopsis lyrata subsp. lyrata]

 Score =  736 bits (1901), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/374 (93%), Positives = 361/374 (96%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 38  EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 97

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRV
Sbjct: 98  VAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRV 157

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           LKHY+S NQRMP+ YVKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDF
Sbjct: 158 LKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDF 217

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGEANISYICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 218 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGEN 277

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           +VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 278 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 337

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFF+ELRE NARLPNGRP PPLFNFKQEL+GASPELINRLIPEH
Sbjct: 338 QYSPSLRCTALEACAHPFFNELREANARLPNGRPLPPLFNFKQELSGASPELINRLIPEH 397

Query: 362 VRRQTGLSMPHSAG 375
           VRRQ     P  AG
Sbjct: 398 VRRQMNGGFPFQAG 411

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|21593135|gb|AAM65084.1| putative shaggy-like protein kinase dzeta [Arabidopsis thaliana]

 Score =  736 bits (1900), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/374 (93%), Positives = 362/374 (96%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 38  EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 97

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRV
Sbjct: 98  VAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRV 157

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           LKHY+S NQRMP+ YVKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDF
Sbjct: 158 LKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDF 217

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGEANISYICSRYYR+PELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 218 GSAKVLVKGEANISYICSRYYRSPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGEN 277

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           +VD+LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 278 SVDRLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 337

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQEL+GASPELINRLIPEH
Sbjct: 338 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEH 397

Query: 362 VRRQTGLSMPHSAG 375
           VRRQ     P  AG
Sbjct: 398 VRRQMNGGFPFQAG 411

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485302|ref|XP_002281788.2| PREDICTED: shaggy-related protein kinase zeta-like [Vitis vinifera]

 Score =  735 bits (1898), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/375 (93%), Positives = 363/375 (96%), Gaps = 2/375 (0%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           EMSAAVI+GND VTGHIISTTIGGKNGEPKQTISYMAER+VGTGSFGIVFQAKCLETGET
Sbjct: 39  EMSAAVIEGNDPVTGHIISTTIGGKNGEPKQTISYMAERIVGTGSFGIVFQAKCLETGET 98

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
           VAIKKVLQDRRYKNRELQL+RLMDHPNV++LKHCFFSTTS+DELFLNLVMEYVPETMYRV
Sbjct: 99  VAIKKVLQDRRYKNRELQLLRLMDHPNVVTLKHCFFSTTSRDELFLNLVMEYVPETMYRV 158

Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
           LKHYS+ NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN+LVDPLTHQVKLCDF
Sbjct: 159 LKHYSNANQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNVLVDPLTHQVKLCDF 218

Query: 182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV AELLLGQPLFPGE+
Sbjct: 219 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVFAELLLGQPLFPGES 278

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
           AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA+DLASRLL
Sbjct: 279 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEALDLASRLL 338

Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           QYSPSLRCTA+   AH FFDELREPNARLPNGRP PPLFNFKQELA ASPEL++RLIPEH
Sbjct: 339 QYSPSLRCTAVS--AHSFFDELREPNARLPNGRPLPPLFNFKQELAAASPELLHRLIPEH 396

Query: 362 VRRQTGLSMPHSAGT 376
           VRRQ GLS PH AGT
Sbjct: 397 VRRQVGLSFPHPAGT 411

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	376
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.994	0.907	0.935	4e-193
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.976	0.901	0.948	5.3e-191
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.997	0.986	0.906	7.7e-190
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.968	0.887	0.838	8.2e-170
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.968	0.889	0.816	5.8e-169
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.968	0.898	0.819	4.1e-168
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.976	0.777	0.769	5.1e-161
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.976	0.871	0.736	1.2e-154
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.965	0.828	0.717	5e-147
ZFIN|ZDB-GENE-990714-4	421	gsk3b "glycogen synthase kinas	0.944	0.843	0.651	1.5e-129

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1871 (663.7 bits), Expect = 4.0e-193, P = 4.0e-193
 Identities = 350/374 (93%), Positives = 362/374 (96%)

Query:     2 EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
             EMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct:    38 EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 97

Query:    62 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
             VAIKKVLQDRRYKNRELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRV
Sbjct:    98 VAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRV 157

Query:   122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
             LKHY+S NQRMP+ YVKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDF
Sbjct:   158 LKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDF 217

Query:   182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
             GSAKVLVKGEANISYICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct:   218 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGEN 277

Query:   242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
             +VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct:   278 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 337

Query:   302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
             QYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQEL+GASPELINRLIPEH
Sbjct:   338 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEH 397

Query:   362 VRRQTGLSMPHSAG 375
             VRRQ     P  AG
Sbjct:   398 VRRQMNGGFPFQAG 411

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1851 (656.6 bits), Expect = 5.3e-191, P = 5.3e-191
 Identities = 350/369 (94%), Positives = 359/369 (97%)

Query:     2 EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
             EMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct:    36 EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 95

Query:    62 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
             VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRV
Sbjct:    96 VAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRV 155

Query:   122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
             L+HY+S NQRMP+ YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF
Sbjct:   156 LRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 215

Query:   182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
             GSAKVLVKGE NISYICSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct:   216 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGEN 275

Query:   242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
             +VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct:   276 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 335

Query:   302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
             QYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQEL GAS ELINRLIPEH
Sbjct:   336 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEH 395

Query:   362 VRRQ--TGL 368
             VRRQ  TGL
Sbjct:   396 VRRQMSTGL 404

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1840 (652.8 bits), Expect = 7.7e-190, P = 7.7e-190
 Identities = 340/375 (90%), Positives = 361/375 (96%)

Query:     2 EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
             EM AAV+ G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct:     6 EMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65

Query:    62 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
             VAIKKVLQDRRYKNRELQLMR+MDHPNV+ LKHCFFSTTSKDELFLNLVMEYVPE++YRV
Sbjct:    66 VAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRV 125

Query:   122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
             LKHYSS NQRMPL+YVKLY YQIFRGLAYIH V GVCHRD+KPQNLLVDPLTHQVK+CDF
Sbjct:   126 LKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDF 185

Query:   182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
             GSAK LVKGEANISYICSR+YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct:   186 GSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245

Query:   242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
             AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLL
Sbjct:   246 AVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLL 305

Query:   302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
             QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE+AG+SPEL+N+LIP+H
Sbjct:   306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDH 365

Query:   362 VRRQTGLSMPHSAGT 376
             ++RQ GLS  + +GT
Sbjct:   366 IKRQLGLSFLNQSGT 380

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1651 (586.2 bits), Expect = 8.2e-170, P = 8.2e-170
 Identities = 306/365 (83%), Positives = 333/365 (91%)

Query:     2 EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
             EM AAV+ GN   TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLETGET
Sbjct:    40 EMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGET 99

Query:    62 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
             VAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET+YRV
Sbjct:   100 VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRV 159

Query:   122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
              KHYS  NQRMP+IYVKLYTYQI R LAYIH   GVCHRD+KPQNLLV+P THQVKLCDF
Sbjct:   160 SKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDF 219

Query:   182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
             GSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+
Sbjct:   220 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGES 279

Query:   242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
              VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SRLL
Sbjct:   280 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLL 339

Query:   302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
             QYSP+LR TA+EA  HPFFDELR+PN RLPNGR  PPLFNFK QEL GAS EL+++LIP+
Sbjct:   340 QYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPD 399

Query:   361 HVRRQ 365
             H R+Q
Sbjct:   400 HARKQ 404

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1643 (583.4 bits), Expect = 5.8e-169, P = 5.8e-169
 Identities = 298/365 (81%), Positives = 333/365 (91%)

Query:     2 EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
             EM A ++ GN   TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct:    39 EMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 98

Query:    62 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
             VAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET++RV
Sbjct:    99 VAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 158

Query:   122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
             +KHY+ +NQRMPL+YVKLYTYQIFR L+YIH   GVCHRD+KPQNLLV+P THQVKLCDF
Sbjct:   159 IKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 218

Query:   182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
             GSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct:   219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGES 278

Query:   242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
              VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct:   279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 338

Query:   302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
             QYSP+LRC AL++  HPFFDELR+PNARLPNGR  PPLFNFK  EL G   E++ +L+PE
Sbjct:   339 QYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPE 398

Query:   361 HVRRQ 365
             H R+Q
Sbjct:   399 HARKQ 403

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1635 (580.6 bits), Expect = 4.1e-168, P = 4.1e-168
 Identities = 299/365 (81%), Positives = 331/365 (90%)

Query:     2 EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
             EM A V+ GN   TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct:    35 EMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 94

Query:    62 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
             VAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET++RV
Sbjct:    95 VAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 154

Query:   122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
             +KHY+ +NQRMPLIYVKLYTYQIFR L+YIH   GVCHRD+KPQNLLV+P THQVKLCDF
Sbjct:   155 IKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 214

Query:   182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
             GSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct:   215 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGES 274

Query:   242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
              VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct:   275 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 334

Query:   302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
             QYSP+LR  AL+   HPFFDELR+PNARLPNGR  PPLFNFK  EL G   E++ +L+PE
Sbjct:   335 QYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPE 394

Query:   361 HVRRQ 365
             H R+Q
Sbjct:   395 HARKQ 399

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1568 (557.0 bits), Expect = 5.1e-161, P = 5.1e-161
 Identities = 284/369 (76%), Positives = 326/369 (88%)

Query:     2 EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
             +M   V+ G+   TG +I+TT+GG++G+PKQTISYMA+RVVGTGSFG+VFQAKCLETGE 
Sbjct:   104 DMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQ 163

Query:    62 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
             VAIKKVLQD+RYKNRELQ+MRL DHPNV+ L+H FFSTT KDEL+LNLV+EYVPET+YR 
Sbjct:   164 VAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRA 223

Query:   122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
              KHY+ MNQ MP+I+V+LYTYQI R L Y+H V GVCHRD+KPQNLLV+P THQ+K+CDF
Sbjct:   224 SKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDF 283

Query:   182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
             GSAK+LV GE NISYICSRYYRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFPGE+
Sbjct:   284 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGES 343

Query:   242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
              +DQLVEIIK+LGTPTREEIRCMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct:   344 GIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 403

Query:   302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
             QYSP+LRCTALEACAHPFFD+LR+PN  LPNGR  PPLFNF  QELAGAS EL  RLIP 
Sbjct:   404 QYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPA 463

Query:   361 HVRRQTGLS 369
             H +  TG S
Sbjct:   464 HCQG-TGSS 471

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1508 (535.9 bits), Expect = 1.2e-154, P = 1.2e-154
 Identities = 271/368 (73%), Positives = 317/368 (86%)

Query:     7 VIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKK 66
             +I G  A  GH+I TT+ G+NG+ +QT+SY++E VVGTGSFG+VFQAKC ETGE VAIKK
Sbjct:    54 IIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKK 113

Query:    67 VLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYS 126
             VLQD+RYKNRELQ+M+++DHPN ++LKH FFS T  +E++LNLV+E+VPET+ RV + YS
Sbjct:   114 VLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYS 173

Query:   127 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 186
               NQ MPLIYVKLYTYQI R LAYIH   G+CHRD+KPQNLLV+P THQ+K+CDFGSAKV
Sbjct:   174 RTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKV 233

Query:   187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 246
             LVKGE N+SYICSRYYRAPELIFGA+EYTT+IDIWS GCV+AELLLGQPLFPGE+ VDQL
Sbjct:   234 LVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 293

Query:   247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 306
             VEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL  R  QYSP+
Sbjct:   294 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPN 353

Query:   307 LRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPEHVRRQ 365
             LRCTALEAC HP FDELR+PN RLPNGRP PPLFNFK QEL+G  PE++NRL+PEH R+Q
Sbjct:   354 LRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQ 413

Query:   366 TGLSMPHS 373
                   HS
Sbjct:   414 NLFMALHS 421

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1436 (510.6 bits), Expect = 5.0e-147, P = 5.0e-147
 Identities = 261/364 (71%), Positives = 310/364 (85%)

Query:     2 EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
             +M   +I+GN   +G II+T   G N +  +TISY AE V+GTGSFG+VFQAKCLET E 
Sbjct:    75 DMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEK 134

Query:    62 VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRV 121
             VAIKKVLQD+RYKNRELQ+MR++DHPNV+ LKH FFSTT KDEL+LNLV+EYVPET+YR 
Sbjct:   135 VAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRA 194

Query:   122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
              + Y+ MNQ MPLIY++LYTYQI R + Y+H V GVCHRD+KPQNLLV+ +TH+VK+CDF
Sbjct:   195 SRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDF 254

Query:   182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
             GSAK+L+ GE NISYICSRYYRAPELIFGATEYT++ID+WS GCV+AEL LG PLFPGE 
Sbjct:   255 GSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGET 314

Query:   242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
             +VDQLVEIIK+LGTP REEI+ MNP Y DF+FPQIKA PWHK+F +++ PEA+DLASRLL
Sbjct:   315 SVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLL 374

Query:   302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPE 360
             QYSP+LRCTALEACAHPFFD+LR+P A LPNGR  PPLF+F  QELAGAS EL +RLIPE
Sbjct:   375 QYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPE 434

Query:   361 HVRR 364
             H R+
Sbjct:   435 HARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

ZFIN|ZDB-GENE-990714-4 gsk3b "glycogen synthase kinase 3 beta" [Danio rerio (taxid:7955)]

 Score = 1271 (452.5 bits), Expect = 1.5e-129, P = 1.5e-129
 Identities = 234/359 (65%), Positives = 290/359 (80%)

Query:    16 GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
             G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct:    34 GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 93

Query:    74 KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
             KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct:    94 KNRELQIMRKLDHCNIVRLRYFFYSSGDKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153

Query:   133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
             P++YVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct:   154 PMVYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query:   193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
             N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct:   213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272

Query:   253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
             LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct:   273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332

Query:   313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMP 371
             EACAH FFDELREPN +LPNGR  P LFNF  +   ++P L + LIP H R Q G S P
Sbjct:   333 EACAHSFFDELREPNVKLPNGREKPSLFNFTTQELSSNPTLASILIPAHARNQAGASTP 391

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0001947 "heart looping" evidence=IMP

GO:0003146 "heart jogging" evidence=IMP

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.8164	0.9680	0.8899	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.8191	0.9680	0.8987	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5677	0.9148	0.8888	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.9354	0.9893	0.9140	no	no
A8X5H5	GSK3_CAEBR	2, ., 7, ., 1, 1, ., 2, 6	0.6710	0.8111	0.8495	N/A	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.9358	0.9946	0.9077	yes	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.9066	0.9973	0.9868	no	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.7364	0.9760	0.8717	no	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5233	0.8457	0.8594	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6710	0.8111	0.8425	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.7445	0.9760	0.8738	no	no
O23145	KSG2_ARATH	2, ., 7, ., 1, 1, ., 1	0.7170	0.9654	0.8422	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.8082	0.9680	0.8899	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6464	0.9521	0.8523	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6205	0.8936	0.7194	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8109	0.9680	0.8856	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7907	0.9760	0.8929	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7967	0.9760	0.8929	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7685	0.9627	0.7735	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6464	0.9521	0.8523	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8383	0.9680	0.8878	no	no
Q91757	GSK3B_XENLA	2, ., 7, ., 1, 1, ., 2, 6	0.6488	0.9361	0.8380	N/A	no
Q5YJC2	GSK3B_SPECI	2, ., 7, ., 1, 1, ., 1	0.6436	0.9521	0.8523	N/A	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6464	0.9521	0.8523	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	376
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-134
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-92
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-87
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-85
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-85
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-81
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-79
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-77
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-75
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-75
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-75
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-71
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-70
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-70
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-70
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-68
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-65
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-62
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-62
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-61
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-60
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-58
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-58
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-58
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-58
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-58
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-58
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-57
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-57
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-57
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-57
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-57
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-57
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-57
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-56
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-55
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-52
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-52
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-52
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-50
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-50
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-49
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-49
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-49
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-49
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-48
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-48
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-46
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-45
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-45
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-45
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-44
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-43
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-41
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-41
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-40
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-40
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-39
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-39
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-38
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-37
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-37
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-36
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-36
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-35
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-33
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-33
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-33
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-32
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-30
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-29
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-29
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-29
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-29
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-28
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-28
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-27
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-26
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-25
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-24
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-23
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-23
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-22
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-22
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-22
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-21
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-20
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-20
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-20
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-20
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-19
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-18
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-18
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-17
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-17
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-16
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-16
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-16
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-16
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-15
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-14
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-13
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-06
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	9e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-04
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	0.002
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.003

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  391 bits (1005), Expect = e-134
 Identities = 171/333 (51%), Positives = 239/333 (71%), Gaps = 6/333 (1%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 94
           SY    ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL +M+ ++H N+I LK 
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 95  CFFSTTSKDE---LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
            +++   K     +FLN+VME++P+T+++ +KHY+  N  +PL  VKLY+YQ+ R LAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   +CHRD+KPQNLL+DP TH +KLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           T YTT ID+WS GC++AE++LG P+F G+++VDQLV II+VLGTPT ++++ MNPNY D 
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
           +FP +K     KVF K  P +AI+  S+ L+Y P  R   +EA A PFFD+LR+P  +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365

Query: 332 NG-RPFPPLFNF-KQELAGASPELINRLIPEHV 362
                 P LFNF   E+   S     ++IP+  
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCT 398

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  280 bits (719), Expect = 1e-92
 Identities = 116/324 (35%), Positives = 181/324 (55%), Gaps = 20/324 (6%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y   + +G+G++G+V  A    TG  VAIKK+      L D +   RE++L+R + H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           I L       + +D   + +V E +   +++V+K      Q +   +++ + YQI RGL 
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLK 117

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAP 205
           Y+H+   V HRD+KP N+LV+     +K+CDFG A+ +   E        Y+ +R+YRAP
Sbjct: 118 YLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM- 264
           EL+  ++ YT +IDIWS GC+ AELL  +PLFPG + +DQL  I++VLGTP+ E+++ + 
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235

Query: 265 NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
           +    ++    P+    P  K+F     PEAIDL  ++L + P  R TA EA AHP+  +
Sbjct: 236 SEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294

Query: 323 LREPNARLPNGRPFPPLFNFKQEL 346
           L +P        PF   F    EL
Sbjct: 295 LHDPEDEPVAKPPFDFDFFDDDEL 318

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  264 bits (677), Expect = 5e-87
 Identities = 109/293 (37%), Positives = 170/293 (58%), Gaps = 31/293 (10%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHPNVISLK 93
           +G G++G+V++A+  +TGE VA+KK+  D   +         RE+ L++ + HPN++ L 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                  ++ +L+L  V EY        LK Y       +    +K   YQ+ RGLAY H
Sbjct: 65  DVI---HTERKLYL--VFEY----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 209
           +   + HRD+KPQN+L++     +KL DFG A+    G    +Y   + + +YRAPE++ 
Sbjct: 116 SH-RILHRDLKPQNILINR-DGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILL 171

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMNPN 267
           G+  Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++LGTPT E        P+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           Y    FP+       KV   R+ PE IDL S++LQY+P+ R +A EA  HP+F
Sbjct: 232 YKP-TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  260 bits (667), Expect = 2e-85
 Identities = 115/293 (39%), Positives = 164/293 (55%), Gaps = 25/293 (8%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLK 93
             +G G+ GIVF+AK  ETGETVA+KKV   R          RE++ ++   HP V+ L 
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             F   +        LVMEY+P  +  VL+      + +P   VK Y   + +G+AY+H 
Sbjct: 66  DVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 210
             G+ HRD+KP NLL+      +K+ DFG A++    E    Y   + +R+YRAPEL++G
Sbjct: 118 N-GIMHRDLKPANLLISA-DGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYG 174

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 267
           A +Y   +D+W+ GC+ AELL G PLFPGEN ++QL  + + LGTP  E    +  + P+
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PD 233

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           Y    FP+ K  P  ++F     PEA+DL   LL Y PS R +A EA  HP+F
Sbjct: 234 YNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  259 bits (664), Expect = 3e-85
 Identities = 110/294 (37%), Positives = 166/294 (56%), Gaps = 20/294 (6%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKN---RELQLMRLMDHPNV 89
           Y     +G G++G+V++A+   TGE VAIKK+              RE++L++ ++HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           I L   F          L LV E++   +Y+++K      + +P   +K Y YQ+ +GLA
Sbjct: 61  IKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLA 112

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 208
           + H+  G+ HRD+KP+NLL++     +KL DFG A+           Y+ +R+YRAPEL+
Sbjct: 113 FCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 267
            G   Y+T +DIWS GC+ AELL  +PLFPG++ +DQL +I + LGTP  E         
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 268 -YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
               F FP+    P  K+F     P+A+DL S++L Y P  R TA +A AHP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  249 bits (638), Expect = 1e-81
 Identities = 102/291 (35%), Positives = 148/291 (50%), Gaps = 43/291 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 90
           Y     +G GSFG V+ A+  +TG+ VAIK +      +DR    RE+++++ + HPN++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
            L   F     +DE  L LVMEY     ++ +LK       R+     + Y  QI   L 
Sbjct: 61  RLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           Y+H+  G+ HRD+KP+N+L+D     VKL DFG A+ L  GE   +++ +  Y APE++ 
Sbjct: 112 YLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G   Y  ++DIWS G +L ELL G+P FPG++   QL+E+ K +G P             
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPP------- 218

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                              + PEA DL  +LL   P  R TA EA  HPFF
Sbjct: 219 ---------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  242 bits (621), Expect = 5e-79
 Identities = 100/289 (34%), Positives = 145/289 (50%), Gaps = 39/289 (13%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 92
            R +G+GSFG V++AK   TG+ VA+K + +            RE++++R + HPN++ L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              F     KD L+L  VMEY        L  Y S    +     K    QI RGL Y+H
Sbjct: 64  IDAF---EDKDHLYL--VMEYCEGG---DLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGA 211
           +  G+ HRD+KP+N+L+D     VK+ DFG AK L+K   +  +++ + +Y APE++ G 
Sbjct: 116 SN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             Y   +D+WS G +L ELL G+P F GEN +DQL  I ++LG P               
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                    + +        EA DL  + L   PS R TA E   HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  238 bits (611), Expect = 5e-77
 Identities = 110/296 (37%), Positives = 169/296 (57%), Gaps = 32/296 (10%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ-LMRLMDHPNVIS 91
           + +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++ L +L +HPN++ 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           LK  F      DEL+   V EY+   +Y+++K      +      ++   YQI +GLA+I
Sbjct: 63  LKEVF---RENDELYF--VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHI 115

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H   G  HRD+KP+NLLV      VK+ DFG A+ +        Y+ +R+YRAPE++  +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-------IRCM 264
           T Y++ +DIW+ GC++AEL   +PLFPG + +DQL +I  VLGTPT+++          +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                 FRFPQ      H++      PEAIDL   +L++ P  R TA +A  HP+F
Sbjct: 234 G-----FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  235 bits (601), Expect = 2e-75
 Identities = 104/297 (35%), Positives = 162/297 (54%), Gaps = 25/297 (8%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDH 86
           Y   + +G G++ +V++A+  ETG  VAIKK+    R +          RE++L++ + H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           PN+I L   F     K    +NLV E++   + +V+K     +  +    +K Y     R
Sbjct: 62  PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRYYRAP 205
           GL Y+H    + HRD+KP NLL+      +KL DFG A+        +++ + +R+YRAP
Sbjct: 114 GLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           EL+FGA  Y   +D+WS GC+ AELLL  P  PG++ +DQL +I + LGTPT E    + 
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231

Query: 266 --PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
             P+Y +F+       P  ++F      +A+DL  RLL  +P+ R TA +A  HP+F
Sbjct: 232 SLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  233 bits (597), Expect = 5e-75
 Identities = 103/291 (35%), Positives = 163/291 (56%), Gaps = 21/291 (7%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 94
           VVG G++G+V + +   TGE VAIKK  +    ++      RE++++R + H N+++LK 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            F     K  L+L  V EYV  T+  +L+        +P   V+ Y +Q+ + +AY H+ 
Sbjct: 68  AF---RRKGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYRAPELIFGAT 212
             + HRD+KP+N+LV   +  +KLCDFG A+ L    A+    Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTD 270
            Y   +D+W+ GC++AELL G+PLFPG++ +DQL  I K LG   P+ +E+   NP +  
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 271 FRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
             FP+        + +  ++   A+D     L+  P  R T  E   HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  233 bits (596), Expect = 8e-75
 Identities = 93/293 (31%), Positives = 159/293 (54%), Gaps = 26/293 (8%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G V++A+  +TGE VA+KK+  +   +       RE++L++ + HPN++ LK  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
               TSK +  + +V EY+   +  +L        +     +K Y  Q+  GL Y+H+  
Sbjct: 67  ---VTSKGKGSIYMVFEYMDHDLTGLLDSPEV---KFTESQIKCYMKQLLEGLQYLHSN- 119

Query: 156 GVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 210
           G+ HRD+K  N+L++   +   +KL DFG A+   K   +  Y   + + +YR PEL+ G
Sbjct: 120 GILHRDIKGSNILIN---NDGVLKLADFGLARPYTK-RNSADYTNRVITLWYRPPELLLG 175

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 267
           AT Y   +D+WS GC+LAEL LG+P+F G   ++QL +I ++ G+PT E    +  + P 
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PW 234

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           + + +  +       + F   + P A+DL  +LL   P  R +A +A  H +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  225 bits (576), Expect = 4e-71
 Identities = 111/329 (33%), Positives = 177/329 (53%), Gaps = 32/329 (9%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 88
           Y     +G G++G+V  A    TG  VAIKK+          R    RE++++R   H N
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--REIKILRRFKHEN 64

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +I +       + +    + +V E +   +Y+++K      Q +   +++ + YQI RGL
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRA 204
            YIH+   V HRD+KP NLL++     +K+CDFG A++      +      Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE++  +  YT +IDIWS GC+LAE+L  +PLFPG++ + QL  I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 265 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF-- 319
            +    ++    P     PW+K+F     P+A+DL  ++L ++P  R T  EA AHP+  
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296

Query: 320 --FDELREPNARLPNGRPFPPLFNFKQEL 346
              D   EP A      PFP  F    +L
Sbjct: 297 QYHDPSDEPVAE----EPFPFDFELFDDL 321

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  224 bits (573), Expect = 1e-70
 Identities = 109/306 (35%), Positives = 169/306 (55%), Gaps = 28/306 (9%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 87
           Y     VG+G++G V  A   +TG  VAIKK+ +         R Y  REL+L++ MDH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 88  NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           NVI L   F   +S ++   + LV   +   +  ++K      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAP 205
           GL YIH+  G+ HRD+KP N+ V+    ++K+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLAR---HTDDEMTGYVATRWYRAP 184

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I+ ++GTP  E ++ ++
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244

Query: 266 P----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
                NY     PQ+    + +VF     P AIDL  ++L   P  R TA EA AHP+  
Sbjct: 245 SESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302

Query: 322 ELREPN 327
           E  +P 
Sbjct: 303 EYHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  223 bits (570), Expect = 3e-70
 Identities = 106/309 (34%), Positives = 171/309 (55%), Gaps = 31/309 (10%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD--RRYKNRELQ-LMRLMDH 86
           Y   + +G G++GIV++A    T E VA+KK+        D  R +  RE+  L  L DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           PN++ L +   +   KD   + LV EY+   ++ V++     +     ++ +   YQ+ +
Sbjct: 67  PNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRANILED-----VHKRYIMYQLLK 118

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------YICSR 200
            L YIH+   V HRD+KP N+L++     VKL DFG A+ L + E N        Y+ +R
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
           +YRAPE++ G+T YT  +D+WS GC+L E+LLG+PLFPG + ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 261 IRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
           I  +   +        P     P  ++   +   +A+DL  +LL ++P+ R TA EA  H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 318 PFFDELREP 326
           P+  +   P
Sbjct: 296 PYVAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  222 bits (568), Expect = 5e-70
 Identities = 118/333 (35%), Positives = 188/333 (56%), Gaps = 21/333 (6%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y+  + +G G++GIV  AK  ET E VAIKK+        D +   RE++L+R +DH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           I++K        +    + +V E +   ++++++     +Q +   + + + YQ+ RGL 
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLK 122

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 208
           YIH+   V HRD+KP NLL++     +K+CDFG A+    KG+    Y+ +R+YRAPEL+
Sbjct: 123 YIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-NPN 267
              +EYTT+ID+WS GC+ AELL  +PLFPG++ V QL  I ++LG+P+ E++  + N  
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 268 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
              +    P      + ++F     P AIDL  ++L + PS R T  EA AHP+   L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299

Query: 326 PNARLPNGRPFPPLFNFKQELAGASPELINRLI 358
           P+       PF   F+F+++    + E I  LI
Sbjct: 300 PSDEPVCQTPFS--FDFEED--ALTEEDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  218 bits (558), Expect = 1e-68
 Identities = 114/344 (33%), Positives = 182/344 (52%), Gaps = 32/344 (9%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRLMDHPN 88
            Y     +G+G++G+V  A    +G+ VAIKK      V    +   REL+++R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 89  VISLKHCFFSTTSKDELFLN--LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           +I+++            F +  +VM+ +   ++ ++  +S  +Q +   +++ + YQ+ R
Sbjct: 66  IIAIRDIL---RPPGADFKDVYVVMDLMESDLHHII--HS--DQPLTEEHIRYFLYQLLR 118

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRY 201
           GL YIH+   V HRD+KP NLLV+     +++ DFG A+ L             Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           YRAPEL+    EYTT+ID+WS GC+ AE+L  + LFPG+N V QL  I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 262 RCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
             +       Y     P+ +  PW K+F K   PEA+DL S++LQ+ P  R T  +A  H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294

Query: 318 PFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 361
           PF  +  +P+    +    PP F+F  E    S E +   I + 
Sbjct: 295 PFLAQYHDPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  208 bits (532), Expect = 3e-65
 Identities = 103/291 (35%), Positives = 163/291 (56%), Gaps = 26/291 (8%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  +   +       RE+ L++ ++HPN++ L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             S     E  L LV E++       LK Y  SS    +    +K Y YQ+ +G+AY H+
Sbjct: 67  VHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 212
              V HRD+KPQNLL+D     +KL DFG A+   V        + + +YRAPE++ G+ 
Sbjct: 118 -HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 269
           +Y+T +DIWS GC+ AE++  +PLFPG++ +DQL  I + LGTP  +    +  + P+Y 
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
              FP+       KV    +  + +DL S++L Y P+ R +A  A  HP+F
Sbjct: 235 P-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  201 bits (514), Expect = 1e-62
 Identities = 100/289 (34%), Positives = 151/289 (52%), Gaps = 25/289 (8%)

Query: 43  GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMR-LMDHPNVISLKH 94
           G G+F  V +A+  +TG+  AIK + +   +K+       RE+Q +R L  HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVKLYTYQIFRGLAYIH 152
             F   +     L LV E +   +Y ++K      ++ PL    VK Y YQ+ + L ++H
Sbjct: 66  VLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
              G+ HRD+KP+N+L+      +KL DFGS + +        YI +R+YRAPE +    
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-NYTDF 271
            Y   +DIW+ GCV  E+L   PLFPG N +DQ+ +I  VLGTP  E ++      + ++
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            FP  K     K+       E +DL  +LL Y P  R TA +A  HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  201 bits (512), Expect = 3e-62
 Identities = 110/291 (37%), Positives = 172/291 (59%), Gaps = 23/291 (7%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKH 94
           +VG GS+G+V + K  ETG+ VAIKK L+       ++   RE+++++ + H N+++L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F     K  L+L  V E+V  T+   L+ Y + +++      V+ Y +QI RG+ + H+
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGAT 212
              + HRD+KP+N+LV   +  VKLCDFG A+ L   GE    Y+ +R+YRAPEL+ G T
Sbjct: 119 -HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTD 270
           +Y  ++DIW+ GC++ E+L G+PLFPG++ +DQL  IIK LG   P  +EI   NP +  
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236

Query: 271 FRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            R P++K   P  K F K +    +DLA + L+  P  R ++ +   H FF
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  198 bits (506), Expect = 7e-61
 Identities = 121/326 (37%), Positives = 182/326 (55%), Gaps = 27/326 (8%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y  + V+G GS+G+V  A    TGE VAIKK+      + D     RE++L+RL+ HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           + +KH     + ++   + +V E +   +++V+K     N  +   + + + YQ+ R L 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANI---SYICSRYYRAP 205
           YIHT   V HRD+KP+N+L +    ++K+CDFG A+V        I    Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 206 ELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-R 262
           EL  G+  ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL  I  +LGTP+ E I R
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPF 319
             N     +     K  P    F ++ P   P A+ L  RLL + P  R TA EA A P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 320 FDELREPNARLPNGRPFPPL-FNFKQ 344
           F  L +   R P+ +P   L F F++
Sbjct: 293 FKGLAKVE-REPSAQPITKLEFEFER 317

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  198 bits (504), Expect = 1e-60
 Identities = 114/306 (37%), Positives = 170/306 (55%), Gaps = 29/306 (9%)

Query: 33  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLM 84
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK        VL  R Y  REL+L++ +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHL 66

Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
            H N+ISL   F S        +  V E +   ++R+L       Q     +++ + YQI
Sbjct: 67  RHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQI 117

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
            RGL Y+H+  GV HRD+KP N+L++     +K+CDFG A++  +      Y+ +RYYRA
Sbjct: 118 LRGLKYVHSA-GVVHRDLKPSNILINE-NCDLKICDFGLARI--QDPQMTGYVSTRYYRA 173

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE++    +Y   +DIWSAGC+ AE+L G+PLFPG++ V+Q   I  +LGTP  + I  +
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233

Query: 265 NPNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
               T  RF    P+ +  P+ + F K   P AIDL  ++L + P  R +A EA AHP+ 
Sbjct: 234 CSENT-LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Query: 321 DELREP 326
               +P
Sbjct: 292 APYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  190 bits (485), Expect = 3e-58
 Identities = 97/293 (33%), Positives = 159/293 (54%), Gaps = 19/293 (6%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G V++A+   TG+ VA+KK   +   +       RE+ L++++     I     
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 96  FFSTTSKD-ELFLNLVMEYVPETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
                 K+ +  L LV EY+   + + +  +     + +P   +K + YQ+ +G+A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 212
             GV HRD+KPQNLLVD     +K+ D G  +   +  ++    I + +YRAPE++ G+T
Sbjct: 129 H-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y+T +DIWS GC+ AE+   QPLFPG++ + QL+ I K+LGTPT +      P  +  R
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243

Query: 273 ----FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
               FPQ K     +     + PE +DL  ++L+Y P+ R +A  A  HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  189 bits (483), Expect = 4e-58
 Identities = 106/290 (36%), Positives = 164/290 (56%), Gaps = 24/290 (8%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHCF 96
           +G G++  V++ +   TGE VA+K++  D          RE+ LM+ + H N++ L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR---MPLIYVKLYTYQIFRGLAYIHT 153
             T +K    L LV EY    M + LK Y   +     +    VK +TYQ+ +G+A+ H 
Sbjct: 67  IHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 212
              V HRD+KPQNLL++    ++KL DFG A+   +      + + + +YRAP+++ G+ 
Sbjct: 119 -NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTD 270
            Y+TSIDIWS GC++AE++ G+PLFPG N  DQL++I +++GTPT      ++  P Y  
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236

Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
             FP+       ++F     P  IDL  RLLQ +P LR +A +A  HP+F
Sbjct: 237 -TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  190 bits (483), Expect = 7e-58
 Identities = 107/303 (35%), Positives = 167/303 (55%), Gaps = 29/303 (9%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
           Y     +G G++G+V++A+   T ET+A+KK+  ++  +       RE+ L++ M H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSM-----NQRMPLIYVKLYTYQI 144
           + L+    S     E  L LV EY+   +    KH  S      N R+    +K Y YQI
Sbjct: 64  VRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL----IKTYLYQI 111

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYR 203
            RG+AY H+   V HRD+KPQNLL+D  T+ +KL DFG A+   +        + + +YR
Sbjct: 112 LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE++ G+  Y+T +DIWS GC+ AE++  +PLFPG++ +D+L +I ++LGTP  E    
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230

Query: 264 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
           +   P+Y    FP+        V    + P  +DL S++L+  PS R TA  A  H +F 
Sbjct: 231 VTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288

Query: 322 ELR 324
           +L 
Sbjct: 289 DLG 291

Length = 294

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  190 bits (484), Expect = 8e-58
 Identities = 109/297 (36%), Positives = 160/297 (53%), Gaps = 32/297 (10%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++GIV++A+   +GE VA+KKV  D           RE+ L+  + HPN++ LK  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                  D +FL  VMEY  + +  +L    +M        VK    Q+ RGL Y+H   
Sbjct: 75  VVGK-HLDSIFL--VMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHE-N 127

Query: 156 GVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGAT 212
            + HRD+K  NLL   LT +  +K+ DFG A+        ++  + + +YRAPEL+ G T
Sbjct: 128 FIIHRDLKVSNLL---LTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI----RCMNPNY 268
            YTT+ID+W+ GC+LAELL  +PL PG++ ++QL  II++LGTP  E I      + P  
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDL-PLV 242

Query: 269 TDFRFPQIKAHPWHKVFHKRMP--PEA-IDLASRLLQYSPSLRCTALEACAHPFFDE 322
             F  P+    P++ + HK  P   EA + L + LL Y P  R TA EA    +F E
Sbjct: 243 GKFTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  191 bits (486), Expect = 8e-58
 Identities = 110/306 (35%), Positives = 169/306 (55%), Gaps = 29/306 (9%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLMDHP 87
           Y + + VG+G++G V  A    TGE VAIKK        +   R Y  REL L++ M H 
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHE 74

Query: 88  NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           NVI L   F S  S DE     LVM Y+   + +++ H  S ++      V+   YQ+  
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLC 128

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAP 205
           GL YIH+  G+ HRD+KP NL V+    ++K+ DFG A+     +A ++ Y+ +R+YRAP
Sbjct: 129 GLKYIHSA-GIIHRDLKPGNLAVNE-DCELKILDFGLAR---HADAEMTGYVVTRWYRAP 183

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E+I     Y  ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P  E ++ + 
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243

Query: 266 ----PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
                +Y     P+     +  +F  +  P+A+DL  ++L+     R TA EA  HP+FD
Sbjct: 244 DKAAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301

Query: 322 ELREPN 327
             R+ +
Sbjct: 302 SFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  189 bits (482), Expect = 9e-58
 Identities = 100/294 (34%), Positives = 165/294 (56%), Gaps = 34/294 (11%)

Query: 45  GSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHCFFS 98
           G++G+V++A+  +TGE VA+KK+  ++  +       RE+ ++  + HPN++++K     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 99  TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 158
           +   D++++  VMEYV   +  +++    M Q      VK    Q+  G+A++H    + 
Sbjct: 76  SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128

Query: 159 HRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGATE 213
           HRD+K  NLL   L +   +K+CDFG A+    G     Y   + + +YRAPEL+ GA E
Sbjct: 129 HRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183

Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           Y+T+ID+WS GC+ AELL  +PLFPG++ +DQL +I K+LGTPT +      P +++   
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPG 239

Query: 274 PQIKAHPWH------KVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + K    +      K F    +     DL +RLL Y P+ R +A +A  HP+F
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  188 bits (479), Expect = 2e-57
 Identities = 96/303 (31%), Positives = 153/303 (50%), Gaps = 46/303 (15%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD---HPN 88
           +G G++G V++A+ L TG  VA+KKV    R             RE+ L++ ++   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           ++ L        +  EL L LV E+V + +   L         +P   +K    Q+ RG+
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            ++H+   + HRD+KPQN+LV     QVK+ DFG A++     A  S + + +YRAPE++
Sbjct: 121 DFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
             ++ Y T +D+WS GC+ AEL   +PLF G +  DQL +I  V+G P+ EE        
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE-------- 229

Query: 269 TDFRFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAH 317
               +P+  + P    F              +  E +DL  ++L ++P  R +A EA  H
Sbjct: 230 ----WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284

Query: 318 PFF 320
           P+F
Sbjct: 285 PYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  187 bits (478), Expect = 3e-57
 Identities = 102/299 (34%), Positives = 158/299 (52%), Gaps = 26/299 (8%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRLMDHPNV 89
           +Y     +G GS+  V++ +   TG+ VA+K++ L+          RE  L++ + H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 148
           ++L     +  +     L LV EY    +   LK Y       + +  V+L+ +Q+ RGL
Sbjct: 66  VTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAP 205
           AY H    V HRD+KPQNLL+     ++KL DFG A+   K   + +Y   + + +YR P
Sbjct: 117 AYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARA--KSVPSKTYSNEVVTLWYRPP 172

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIR-- 262
           +++ G+TEY+TS+D+W  GC+  E+  G+PLFPG  +  DQL +I +VLGTPT E     
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
             NP +  + FP     P      +    P   +LA + LQY P  R +A EA  HP+F
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  188 bits (478), Expect = 3e-57
 Identities = 106/295 (35%), Positives = 163/295 (55%), Gaps = 34/295 (11%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N++ L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             S     +  L LV EY  + +    K++ S N  +    VK + +Q+ +GLA+ H+  
Sbjct: 68  LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-H 118

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISY---ICSRYYRAPELIF 209
            V HRD+KPQNLL++    ++KL DFG A+   + V+      Y   + + +YR P+++F
Sbjct: 119 NVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVR-----CYSAEVVTLWYRPPDVLF 172

Query: 210 GATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 266
           GA  Y+TSID+WSAGC+ AEL   G+PLFPG +  DQL  I ++LGTPT E    ++  P
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232

Query: 267 NYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           +Y  +  +P   +     V   ++     DL   LL  +P  R +A EA  HP+F
Sbjct: 233 DYKPYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  187 bits (477), Expect = 4e-57
 Identities = 98/291 (33%), Positives = 158/291 (54%), Gaps = 25/291 (8%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHC 95
           +G GS+G+VF+ +  ETG+ VAIKK ++       ++   RE+++++ + HPN+++L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           F     + +  L+LV EY   T+   L+      + +P   +K   +Q  + + + H   
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-H 119

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGATEY 214
              HRDVKP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178

Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTDFR 272
              +D+W+ GCV AELL GQPL+PG++ VDQL  I K LG   P  ++I   N  +  F+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN-QF--FK 235

Query: 273 FPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPFF 320
              I      +    + P     A+      LQ  P+ R +  E   HP+F
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  189 bits (481), Expect = 5e-57
 Identities = 107/300 (35%), Positives = 168/300 (56%), Gaps = 28/300 (9%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHPNVISLK 93
           VG+G++G V  A    TG  VAIKK+           R Y  REL+L++ M H NVI L 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMKHENVIGLL 80

Query: 94  HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
             F    S D      LVM ++   + +++KH      R     ++   YQ+ +GL YIH
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIH 135

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 211
              G+ HRD+KP NL V+    ++K+ DFG A+   + ++ ++ Y+ +R+YRAPE+I   
Sbjct: 136 AA-GIIHRDLKPGNLAVNE-DCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVILNW 190

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----N 267
             YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV GTP++E ++ +      N
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
           Y   + P+ +   +  +      P A+++  ++L      R TA EA AHP+F+E  +P 
Sbjct: 251 YVK-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  188 bits (480), Expect = 5e-57
 Identities = 107/306 (34%), Positives = 167/306 (54%), Gaps = 31/306 (10%)

Query: 42  VGTGSFGIVFQAKCLET--GETVAIKKV--------LQDRRYKNRELQLMR-LMDHPNVI 90
           +G G++GIV  A+  ET   ETVAIKK+        L  R    REL+L+R    H N+ 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKNIT 65

Query: 91  SLKHCFFSTTSK-DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
            L           +EL+L    E +   ++++++      Q +   + + + YQI  GL 
Sbjct: 66  CLYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLK 119

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK----VLVKGEANIS-YICSRYYRA 204
           YIH+   V HRD+KP NLLV+    ++K+CDFG A+       +    ++ Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RC 263
           PE++     YT +ID+WS GC+LAELL  +P+F G++ VDQL +I++VLGTP  E + R 
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237

Query: 264 MNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
            +P   ++    P I   P+  +F     P A+DL  +LL + P+ R +  EA  HP+  
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296

Query: 322 ELREPN 327
              +P+
Sbjct: 297 IWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  186 bits (475), Expect = 8e-57
 Identities = 104/296 (35%), Positives = 167/296 (56%), Gaps = 36/296 (12%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             +        L LV E+    +++ LK +  +S    +PL  +K Y +Q+ +GLA+ H+
Sbjct: 68  IHTENK-----LYLVFEF----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 212
              V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G  
Sbjct: 119 -HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT--- 269
            Y+T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP       + P  T   
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTSLP 232

Query: 270 DFR--FPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFF 320
           D++  FP+     + KV    +PP   +  DL S++L Y P+ R +A  A AHPFF
Sbjct: 233 DYKPSFPKWARQDFSKV----VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  185 bits (471), Expect = 8e-56
 Identities = 108/317 (34%), Positives = 157/317 (49%), Gaps = 46/317 (14%)

Query: 42  VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 92
           +G G++G V++AK      G+  AIKK   D+           RE+ L+R + H NV+SL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM-PLIYVKLYTYQIFRGLAYI 151
              F     K    + L+ +Y    +++++K +    +   P   VK   +QI  G+ Y+
Sbjct: 68  VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 152 HTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSA-------KVLVKGEANISYICSRY 201
           H+   V HRD+KP N+LV    P    VK+ D G A       K L   +  +  I   +
Sbjct: 125 HS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKV 252
           YRAPEL+ GA  YT +IDIW+ GC+ AELL  +P+F G  A          DQL  I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 253 LGTPTREE---IRCMNPNY----TDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQY 303
           LGTPT ++   I+ M P Y     DF+     ++   K   K      +  DL  +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299

Query: 304 SPSLRCTALEACAHPFF 320
            P+ R TA EA  HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  181 bits (461), Expect = 5e-55
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 44/290 (15%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRLMDHPNVISLK 93
            ++G GSFG V+ A   +TGE +A+K V L     +      RE++++  + HPN++   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             + S   +++  LN+ +EYV       L        ++P   ++ YT QI  GLAY+H+
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSG---GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---VKGEANISYICSRYYRAPELIFG 210
             G+ HRD+K  N+LVD     VKL DFG AK L     GE   S   + Y+ APE+I G
Sbjct: 120 -NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
             EY  + DIWS GC + E+  G+P +         +  I   G P              
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------------- 222

Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
              P+I  H         +  EA D   + L+  P  R TA E   HPF 
Sbjct: 223 ---PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  183 bits (467), Expect = 5e-55
 Identities = 92/326 (28%), Positives = 166/326 (50%), Gaps = 38/326 (11%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKN--RELQLMRLMDHPNVIS 91
           YM  R +G GS G+VF A   +  + VA+KK++    +  K+  RE++++R +DH N++ 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 92  LKHCFFSTTSKDELFLN---------LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
           +      + S     +          +V EY+   +  VL+        +   + +L+ Y
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI----C 198
           Q+ RGL YIH+   V HRD+KP N+ ++     +K+ DFG A+++    ++  Y+     
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180

Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVLGT 255
           +++YR+P L+     YT +ID+W+AGC+ AE+L G+PLF G + ++Q+   +E + V+  
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240

Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPW--HKVFHKRMP---PEAIDLASRLLQYSPSLRCT 310
             R E+  + P++       ++       +     +P   PEA+D   ++L ++P  R T
Sbjct: 241 EDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293

Query: 311 ALEACAHPFFDELREPNARLPNGRPF 336
           A EA  HP+      P     +  PF
Sbjct: 294 AEEALMHPYMSCYSCPFDEPVSLHPF 319

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (441), Expect = 1e-52
 Identities = 71/247 (28%), Positives = 121/247 (48%), Gaps = 40/247 (16%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHCF 96
           +G G FG V+ A+  +TG+ VAIK + ++          RE+++++ ++HPN++ L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                +DE  L LVMEY    ++  +LK       ++    +     QI  GL Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN- 111

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEY 214
           G+ HRD+KP+N+L+D    +VKL DFG +K+L   ++ +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-FRF 273
           +   DIWS G +L EL              +L ++I+          + +  +       
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 274 PQIKAHP 280
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  176 bits (447), Expect = 1e-52
 Identities = 95/292 (32%), Positives = 160/292 (54%), Gaps = 27/292 (9%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVIS 91
           +G G++G+V++ +  +TG+ VA+KK+    R ++          RE+ L++ + HPN++ 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L+          E  L L+ E++   + + L       Q M    VK Y YQI +G+ + 
Sbjct: 64  LQDVLM-----QESRLYLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFC 117

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFG 210
           H+   V HRD+KPQNLL+D     +KL DFG A+   +        + + +YRAPE++ G
Sbjct: 118 HS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNY 268
           +  Y+T +DIWS G + AE+   +PLF G++ +DQL  I ++LGTPT +    +   P+Y
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            +  FP+ K     +   K +  + +DL  ++L Y P+ R +A +A  HP+F
Sbjct: 236 KN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  178 bits (450), Expect = 3e-52
 Identities = 97/342 (28%), Positives = 143/342 (41%), Gaps = 46/342 (13%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHP 87
           SY   R +G GSFG V+ A+  +    VA+K + +             RE+Q++  ++HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
             I   + FF    +DE  L LVMEYV       L         +          QI   
Sbjct: 58  PNIVKLYDFF----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-------SYICSR 200
           L Y+H+  G+ HRD+KP+N+L+D     VKL DFG AK+L    +         + + + 
Sbjct: 114 LEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 201 YYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGT 255
            Y APE++ G +    ++S DIWS G  L ELL G P F GE    A  Q ++II  L T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
           P                     A P      + +   A DL  +LL   P  R ++    
Sbjct: 233 P-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Query: 316 AHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRL 357
           +H     L+   + L +          +  L  +   LI+ L
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315

Length = 384

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  170 bits (433), Expect = 4e-50
 Identities = 103/315 (32%), Positives = 150/315 (47%), Gaps = 51/315 (16%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV---------LQDRRYKN---------RELQLMRL 83
           +G G++G V +A    TG+ VAIKKV          +DR+            REL++M  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           + H N++ L   +      D  F+NLVM+     M   LK       R+    VK    Q
Sbjct: 77  IKHENIMGLVDVY---VEGD--FINLVMDI----MASDLKKVVDRKIRLTESQVKCILLQ 127

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-----VLVKGEANISYIC 198
           I  GL  +H      HRD+ P N+ ++      K+ DFG A+           +    + 
Sbjct: 128 ILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 199 SR----------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248
            R          +YRAPEL+ GA +Y  ++D+WS GC+ AELL G+PLFPGEN +DQL  
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245

Query: 249 IIKVLGTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 305
           I ++LGTP  +   + + + P YT+F   + K     K        +AIDL   LL+ +P
Sbjct: 246 IFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLNP 301

Query: 306 SLRCTALEACAHPFF 320
             R +A EA  H +F
Sbjct: 302 LERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  169 bits (428), Expect = 7e-50
 Identities = 108/294 (36%), Positives = 164/294 (55%), Gaps = 28/294 (9%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 94
           VVG G++G+V + +  ET E VAIKK       +       REL+++R +   N++ LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            F     + +L+L  V EYV + M  +L+    M   +P   V+ Y YQ+ + + + H  
Sbjct: 68  AF---RRRGKLYL--VFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK- 118

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANIS-YICSRYYRAPELIFGAT 212
             + HRD+KP+NLL+      +KLCDFG A+ L +G  AN + Y+ +R+YR+PEL+ GA 
Sbjct: 119 NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NPNYTD 270
            Y  ++D+WS GC+L EL  GQPLFPGE+ +DQL  I KVLG    E+++    NP +  
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 271 FRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            RFP +  HP  +   +R    +    +DL   LL+ +P+ R    +   HP F
Sbjct: 237 LRFPAV-NHP--QSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  170 bits (432), Expect = 1e-49
 Identities = 109/330 (33%), Positives = 171/330 (51%), Gaps = 51/330 (15%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A    TG+ VAIKK+   R ++N        REL LM+L++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHK 75

Query: 88  NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRV----LKHYSSMNQRMPLIYVKLYTY 142
           N+I L + F    S +E   + LVME +   + +V    L H     +RM  +      Y
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH-----ERMSYL-----LY 125

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
           Q+  G+ ++H+  G+ HRD+KP N++V    T  +K+ DFG A+          Y+ +RY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRY 182

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           YRAPE+I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  +II+ LGTP+ E +
Sbjct: 183 YRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241

Query: 262 RCMNP---NYTDFRFPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPS 306
             + P   NY + R P+   + + ++F            +K    +A DL S++L   P 
Sbjct: 242 SRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300

Query: 307 LRCTALEACAHPF----FDELREPNARLPN 332
            R +  +A  HP+    +D   E  A  P 
Sbjct: 301 KRISVDDALQHPYINVWYDP-SEVEAPPPA 329

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  169 bits (429), Expect = 1e-49
 Identities = 93/309 (30%), Positives = 150/309 (48%), Gaps = 45/309 (14%)

Query: 43  GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVISL 92
           G G+FG V++A+ ++TG  VA+KK+L      N          RE+++++ + HPNV+ L
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHPNVVPL 72

Query: 93  KHCFFS---TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
                     + +    + +V  Y+   +  +L    S+      I  K Y  Q+  G+ 
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQI--KCYMLQLLEGIN 129

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---------VKGEANISY---I 197
           Y+H    + HRD+K  N+L+D     +K+ DFG A+             G     Y   +
Sbjct: 130 YLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            +R+YR PEL+ G   YTT++DIW  GCV AE+   +P+  G++ +DQL  I K+ GTPT
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247

Query: 258 REEIRCMNPNYTDF-RFPQIKAHPWH-----KVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
            E      P +        + +   +     + F  ++ PE +DL S+LL   P  R TA
Sbjct: 248 EETW----PGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTA 302

Query: 312 LEACAHPFF 320
            +A  HP+F
Sbjct: 303 SDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  170 bits (432), Expect = 2e-49
 Identities = 113/379 (29%), Positives = 174/379 (45%), Gaps = 59/379 (15%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKK---VLQD-----RRYKNRELQLMRLMDHPNVI 90
           +R +G G+FG+V+       G+ VA+KK   V Q+     R +  REL+++    H NV+
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVL 62

Query: 91  S--------LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
           S            F      +E+++      V E M   L       Q +   +VK++ Y
Sbjct: 63  SALDILQPPHIDPF------EEIYV------VTELMQSDLHKIIVSPQPLSSDHVKVFLY 110

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI--SYICSR 200
           QI RGL Y+H+  G+ HRD+KP NLLV+     +K+CDFG A+V    E+      + ++
Sbjct: 111 QILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
           YYRAPE++ G+  YT+++DIWS GC+ AELL  + LF  ++ + QL  I  +LGTP+ E 
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228

Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAH 317
           +R                 P   V +        EA+ L  R+L + P  R +A +A AH
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288

Query: 318 PFFDELR-------------EPNARL-------PNGRPFPPLFNFKQELAGASPELINRL 357
           P+ DE R                 R+           PF   +           E +++ 
Sbjct: 289 PYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQF 348

Query: 358 IPEHVR-RQTGLS-MPHSA 374
           I E  +  +  L   P SA
Sbjct: 349 ILEQQQGNRVPLCINPQSA 367

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  168 bits (427), Expect = 4e-49
 Identities = 103/311 (33%), Positives = 165/311 (53%), Gaps = 21/311 (6%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y     VG+G++G V  A      + VA+KK+      L   R   REL+L++ M H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 90  ISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           I L   F   TS +    + LV   +   +  ++K      Q++   +V+   YQ+ RGL
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGL 131

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            YIH+  G+ HRD+KP N+ V+    ++++ DFG A+     +    Y+ +R+YRAPE++
Sbjct: 132 KYIHSA-GIIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYVATRWYRAPEIM 187

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++V+GTP+ E ++ ++  +
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247

Query: 269 TDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
                   P +      K+F +   P AIDL  ++L      R +A EA AHP+F +  +
Sbjct: 248 ARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306

Query: 326 PNARLPNGRPF 336
           P    P   P+
Sbjct: 307 PEDE-PEAEPY 316

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  167 bits (423), Expect = 1e-48
 Identities = 105/308 (34%), Positives = 165/308 (53%), Gaps = 27/308 (8%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHPNVISLK 93
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 82

Query: 94  HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
             F    S +E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 83  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 137

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +   + HRD+KP NL V+    ++K+ DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 138 SA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 268
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+ 
Sbjct: 254 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 311

Query: 329 RLPNGRPF 336
             P   P+
Sbjct: 312 E-PVADPY 318

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  164 bits (415), Expect = 9e-48
 Identities = 97/308 (31%), Positives = 166/308 (53%), Gaps = 23/308 (7%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
           +Y+    +G G++  V++ +   T   VA+K++  +          RE+ L++ + H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           ++L     +  S     L LV EY+ + + + L    +    + +  VKL+ +Q+ RGL 
Sbjct: 67  VTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISYICSRYYRAPE 206
           Y H    V HRD+KPQNLL++    ++KL DFG A+   +  K  +N   + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSN--EVVTLWYRPPD 174

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 264
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG    +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324
           N  +  + +P+ +A   H     R+  +  +L S+LLQ+    R +A EA  HP+F  L 
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 325 EPNARLPN 332
           E   +LP+
Sbjct: 294 ERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  159 bits (404), Expect = 3e-46
 Identities = 98/298 (32%), Positives = 164/298 (55%), Gaps = 21/298 (7%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+ L++ + H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           ++L     +  S     L LV EY+ + + + +    ++   M +  VK++ YQI RGLA
Sbjct: 67  VTLHDIVHTDKS-----LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 208
           Y H    V HRD+KPQNLL++    ++KL DFG A+   V  +   + + + +YR P+++
Sbjct: 119 YCHRRK-VLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 267
            G++EY+T ID+W  GC+  E+  G+PLFPG    D+L  I ++LGTPT E    ++ N 
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236

Query: 268 -YTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
            + ++ FP+ K  P   + H  R+  E I+L ++ LQY    R +A EA  H +F  L
Sbjct: 237 EFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  156 bits (396), Expect = 2e-45
 Identities = 85/287 (29%), Positives = 131/287 (45%), Gaps = 46/287 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRLMDHPNVISLKHC 95
             +G G FG V++A+   TG+ VAIK + L+ +  K     E+Q+++   HPN++     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
           +     KDEL+  +VME+    ++  +LK     NQ +    +     ++ +GL Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 155 PGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
            G+ HRD+K  N+L   LT   +VKL DFG +  L   +A  + + + Y+ APE+I G  
Sbjct: 118 -GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y    DIWS G    EL  G+P +     +  L +I    G P               R
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-------------LR 218

Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            P      W   F         D   + LQ +P  R TA +   HPF
Sbjct: 219 NP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  157 bits (398), Expect = 2e-45
 Identities = 102/299 (34%), Positives = 159/299 (53%), Gaps = 26/299 (8%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNV 89
           SY+    +G GS+  V++      G+ VA+K +             RE  L++ + H N+
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY---VKLYTYQIFR 146
           + L     +  +     L  V EY    M+  L  Y  M Q    ++   V+L+ +Q+ R
Sbjct: 66  VLLHDIIHTKET-----LTFVFEY----MHTDLAQY--MIQHPGGLHPYNVRLFMFQLLR 114

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 205
           GLAYIH    + HRD+KPQNLL+  L  ++KL DFG A+   +  +   S + + +YR P
Sbjct: 115 GLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCM 264
           +++ GAT+Y++++DIW AGC+  E+L GQP FPG  +  +QL +I  VLG PT +    +
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232

Query: 265 N--PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           +  PNY    F   K      V+ +   PP+A DLAS++L   P  R +A +A  HP+F
Sbjct: 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  157 bits (397), Expect = 2e-45
 Identities = 99/297 (33%), Positives = 162/297 (54%), Gaps = 25/297 (8%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+ L++ + H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           ++L H    T    E  L LV EY+   + + L +  ++   M +  VK++ +Q+ RGL+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISYICSRYYRAPE 206
           Y H    + HRD+KPQNLL++    ++KL DFG A+   V  K  +N   + + +YR P+
Sbjct: 118 YCHKRK-ILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSN--EVVTLWYRPPD 173

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CM 264
           ++ G+TEY+T ID+W  GC+L E+  G+P+FPG    ++L  I ++LGTPT E       
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 265 NPNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           N  +  + FPQ +A P   + H  R+  + IDL S LL Y    R +A  A  H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  153 bits (388), Expect = 3e-44
 Identities = 88/292 (30%), Positives = 138/292 (47%), Gaps = 55/292 (18%)

Query: 42  VGTGSFGIVFQAKCLETGETVAI----KKVLQDRR---YKNRELQLMRLMDHPNVISLKH 94
           +G GSFG V   +  +TG+  A+    KK +  R+   +   E  ++  ++HP ++ L +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 95  CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
            F     + E  L LV+EY P  E ++  L      ++       + Y  +I   L Y+H
Sbjct: 61  AF-----QTEEKLYLVLEYAPGGE-LFSHLSKEGRFSEER----ARFYAAEIVLALEYLH 110

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGA 211
           ++ G+ +RD+KP+N+L+D   H +KL DFG AK L    +  +  C +  Y APE++ G 
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             Y  ++D WS G +L E+L G+P F  E+   ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFF 320
           RFP            + + PEA DL S LLQ  P+ R  +  A    AHPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  152 bits (386), Expect = 1e-43
 Identities = 91/303 (30%), Positives = 150/303 (49%), Gaps = 39/303 (12%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 94
            +G G++G V++A+  +TGE VA+KKV  D   +       RE++++R ++H N+++LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 95  CFFSTTS-----KDELFLNLVMEYVPETMYRVLK----HYSSMNQRMPLIYVKLYTYQIF 145
                       KD+    LV EY+   +  +L+    H+S  +       +K +  Q+ 
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYR 203
            GL Y H      HRD+K  N+L++    Q+KL DFG A++    E+    + + + +YR
Sbjct: 127 EGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
            PEL+ G   Y  +ID+WS GC+L EL   +P+F     + QL  I ++ G+P       
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA---- 240

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKR-------MPPEAIDLASRLLQYSPSLRCTALEACA 316
           + P+    + P        K + +R       +P  A+DL   +L   PS RCTA EA  
Sbjct: 241 VWPDVI--KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298

Query: 317 HPF 319
            P+
Sbjct: 299 SPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  147 bits (373), Expect = 1e-41
 Identities = 90/300 (30%), Positives = 143/300 (47%), Gaps = 30/300 (10%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH- 94
           +G G+FG VF+A+  +T + VA+KKVL +   +       RE+++++L+ H NV++L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 95  CFFSTT--SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           C    T  ++ +    LV E+    +  +L   S+ N +  L  +K     +  GL YIH
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISY---ICSRYYRAPEL 207
               + HRD+K  N+L+      +KL DFG A+     K      Y   + + +YR PEL
Sbjct: 137 R-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           + G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    + P 
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE----VWPG 250

Query: 268 ------YTDFRFPQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                 +     PQ  K     ++      P A+DL  +LL   P+ R  A  A  H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  144 bits (367), Expect = 5e-41
 Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 44/293 (15%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y   + +G GSFG V+  +    G+   +K++       ++R     E+++++ ++HPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           I     F     +++  L +VMEY     + + +K      +  P   +  +  Q+   L
Sbjct: 62  IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPEL 207
            Y+H+   + HRD+KPQN+ +      VKL DFG +KVL    +   + + + YY +PEL
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
                 Y    DIWS GCVL EL   +  F GEN + +L    K+L    + +   +   
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KGQYPPIPSQ 226

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           Y                       E  +L S LLQ  P  R +  +    PF 
Sbjct: 227 Y---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  145 bits (367), Expect = 6e-41
 Identities = 90/320 (28%), Positives = 136/320 (42%), Gaps = 77/320 (24%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRE-LQLMRLMDH 86
           +   +++G GSF  V  AK  ET +  AI K+L  R+        Y   E   L RL  H
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           P +I L + F     +DE  L  V+EY P   + + ++ Y S++++      + Y  +I 
Sbjct: 62  PGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEIL 112

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRY 201
             L Y+H+  G+ HRD+KP+N+L+D   H +K+ DFG+AKVL                  
Sbjct: 113 LALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 202 -----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
                            Y +PEL+        S D+W+ GC++ ++L G+P F G N   
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229

Query: 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
              +I+K                  ++ FP               PP+A DL  +LL   
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260

Query: 305 PSLRCTALEAC----AHPFF 320
           P  R    E      AHPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  141 bits (358), Expect = 6e-40
 Identities = 90/290 (31%), Positives = 140/290 (48%), Gaps = 48/290 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---------NRELQLMRLMDHPNVI 90
            ++G+GSFG V++   L+ G+  A+K+V      +          +E+ L+  + HPN++
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
                 +  T ++E  L + +E VP  ++ ++LK Y S  +  P+I  +LYT QI  GL 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE--PVI--RLYTRQILLGLE 116

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           Y+H      HRD+K  N+LVD     VKL DFG AK +V+     S+  S Y+ APE+I 
Sbjct: 117 YLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
               Y  + DIWS GC + E+  G+P +   + ++ +  + K+  +     I        
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                     P H      +  EA D   + LQ  PSLR TA E   HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  142 bits (360), Expect = 8e-40
 Identities = 100/303 (33%), Positives = 158/303 (52%), Gaps = 28/303 (9%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRLMDHPNV 89
           SY     +G GS+  V++ K    G+ VA+K + LQ+         RE  L++ + H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRGL 148
           + L     +  +     L LV EYV   + + + KH   ++       VKL+ +Q+ RGL
Sbjct: 66  VLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPEL 207
           +YIH    + HRD+KPQNLL+   T ++KL DFG A+   V      + + + +YR P++
Sbjct: 117 SYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMN- 265
           + G+TEY+T +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    ++ 
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234

Query: 266 -PNYTDFRFPQIKA----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            P++   RF           W+K+ +      A DLAS+LLQ  P  R +A  A +H +F
Sbjct: 235 LPHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEYF 291

Query: 321 DEL 323
            +L
Sbjct: 292 SDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  143 bits (362), Expect = 1e-39
 Identities = 101/314 (32%), Positives = 164/314 (52%), Gaps = 35/314 (11%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A     G  VA+KK+   R ++N        REL L++ ++H 
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 88  NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    S +E   + LVME +   + +V+ H    ++RM  +      YQ+  
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLC 134

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 135 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ EL+ G  +F G + +DQ  ++I+ LGTP+ E +  + P
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251

Query: 267 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 312
              NY + R PQ     + ++F   + P           +A DL S++L   P  R +  
Sbjct: 252 TVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310

Query: 313 EACAHPFFDELREP 326
           EA  HP+     +P
Sbjct: 311 EALRHPYITVWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  140 bits (355), Expect = 4e-39
 Identities = 87/292 (29%), Positives = 142/292 (48%), Gaps = 24/292 (8%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLM---DHPN 88
           +G G++G V++A+   +G  VA+K V    R +           RE+ L++ +   DHPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           ++ L     ++ +  E  + LV E+V + +   L         +P   +K    Q  RGL
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGL 121

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            ++H    + HRD+KP+N+LV     QVKL DFG A++     A    + + +YRAPE++
Sbjct: 122 DFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
             +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  ++    +   
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTL 237

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
               F      P   V    +      L   +L ++P  R +A  A  HPFF
Sbjct: 238 PRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  139 bits (350), Expect = 6e-38
 Identities = 101/314 (32%), Positives = 166/314 (52%), Gaps = 35/314 (11%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 88  NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    S +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYLL-----YQMLC 130

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 131 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 267 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 312
              NY + R P+     + K+F   + P           +A DL S++L   P+ R +  
Sbjct: 248 TVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 313 EACAHPFFDELREP 326
           EA  HP+ +   +P
Sbjct: 307 EALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  138 bits (349), Expect = 1e-37
 Identities = 101/326 (30%), Positives = 168/326 (51%), Gaps = 41/326 (12%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 88  NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYLL-----YQMLC 137

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254

Query: 267 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F   + P           +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313

Query: 313 EACAHPFFD------ELREPNARLPN 332
           EA  HP+ +      E   P  ++P+
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPD 339

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  134 bits (340), Expect = 3e-37
 Identities = 94/296 (31%), Positives = 142/296 (47%), Gaps = 59/296 (19%)

Query: 45  GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRLMDHPNVISLKHCFF 97
           G++G VF AK   TG+  AIK +   D   KN+      E  ++     P V+ L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 98  STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
           S   K  L+L  VMEY+P   +  +L++  S+++ +     ++Y  +I   L Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISY--------ICSRYYRAPEL 207
           + HRD+KP N+L+D   H +KL DFG +KV LV+ + N++         + +  Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           I G   ++ ++D WS GC+L E L+G P F GE                  EEI   N  
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP----------------EEI-FQNIL 214

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFF 320
                +P+             +  EAIDL S+LL   P  R  A    E   HPFF
Sbjct: 215 NGKIEWPEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  133 bits (337), Expect = 1e-36
 Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 50/292 (17%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRLMDHPNVISLKHC 95
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++++ L+ HPN++     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
           +     ++++   + MEY    T+  +L+H   +++ +    +++YT Q+  GLAY+H+ 
Sbjct: 65  YGVEVHREKV--YIFMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHS- 117

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYRAPELIF 209
            G+ HRD+KP N+ +D     +KL DFG A  L       GE   S   +  Y APE+I 
Sbjct: 118 HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 210 GAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           G     +  + DIWS GCV+ E+  G+  +   +   Q++  +     P           
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP---------- 226

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                 P             ++ PE  D   R L+  P  R TA E   HPF
Sbjct: 227 -----IPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  131 bits (332), Expect = 6e-36
 Identities = 83/292 (28%), Positives = 130/292 (44%), Gaps = 54/292 (18%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHC 95
           V+G GS G+V++ +   TG+  A+KK+  D   + R     EL+ +R  + P V+     
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
           F+         +++V+EY+   ++  +LK    + + +    +     QI +GL Y+HT 
Sbjct: 68  FYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTK 118

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPELIF 209
             + HRD+KP NLL++    +VK+ DFG +KVL     N    C+ +     Y +PE I 
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPN 267
           G + Y+ + DIWS G  L E  LG+ P  P       +L++ I            C  P 
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                              +   PE  D  S  LQ  P  R +A E   HPF
Sbjct: 221 P----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  131 bits (330), Expect = 1e-35
 Identities = 97/294 (32%), Positives = 157/294 (53%), Gaps = 27/294 (9%)

Query: 42  VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMRLMD---HPNVIS 91
           +G G++G VF+A+ L+ G   VA+K+V      +       RE+ ++R ++   HPNV+ 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 92  L-KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   C  S T + E  L LV E+V + +   L         +P   +K   +Q+ RGL +
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
           +H+   V HRD+KPQN+LV   + Q+KL DFG A++     A  S + + +YRAPE++  
Sbjct: 126 LHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
           ++ Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G P  E+     P   D
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR--D 236

Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLL----QYSPSLRCTALEACAHPFF 320
              P+   H       ++   +  +L   LL     ++P+ R +A  A +HP+F
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 2e-35
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 54/291 (18%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM---------DHPNVIS 91
           ++G G+FG+V++   LETG+ VAIK++      K +E  L  +M          HPN++ 
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQI---SLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
                     +    L +++EY    ++ +++K +    + +    V +Y YQ+ +GLAY
Sbjct: 64  YIGSI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAY 114

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 209
           +H   GV HRD+K  N+L       VKL DFG A  L     +  S + + Y+ APE+I 
Sbjct: 115 LHE-QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE 172

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
             +  +T+ DIWS GC + ELL G P +   N +  L  I++             + +  
Sbjct: 173 M-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-------------DDHP- 217

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
               P            + + PE  D   +  Q  P+LR TA +   HP+ 
Sbjct: 218 --PLP------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  125 bits (315), Expect = 2e-33
 Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 47/291 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKH 94
             +G G+ G+V +     TG+ +A+K +  +     ++   REL ++   + P ++    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            F++        +++ MEY+        K    +  R+P   +      + +GL Y+H  
Sbjct: 67  AFYNNGD-----ISICMEYMDGGSLD--KILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 214
             + HRDVKP N+LV+    Q+KLCDFG +  LV   A  +++ +  Y APE I G  +Y
Sbjct: 120 HKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176

Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIRCMNPNYT 269
           +   DIWS G  L EL  G+  +P EN       + L  I+               P   
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
               P++ +  +         P+  D  +  L   P  R +  E   HPF 
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  126 bits (317), Expect = 2e-33
 Identities = 104/316 (32%), Positives = 158/316 (50%), Gaps = 44/316 (13%)

Query: 42  VGTGSFGIVFQAKCLE--TGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFF 97
           VG G++G V++AK  +       A+K++          RE+ L+R + HPNVISL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 98  STTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQR---MPLIYVKLYTYQIFRGLAYIH 152
           S   +    + L+ +Y    ++ ++K +  S  N++   +P   VK   YQI  G+ Y+H
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 153 TVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL---VKGEANIS-YICSRYYRAP 205
               V HRD+KP N+LV    P   +VK+ D G A++    +K  A++   + + +YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 256
           EL+ GA  YT +IDIW+ GC+ AELL  +P+F               DQL  I  V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244

Query: 257 TR---EEIRCMNPNYT---DFR------FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
                E+I+ M  + T   DFR         IK    HKV   +   +A  L  +LL   
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301

Query: 305 PSLRCTALEACAHPFF 320
           P  R T+ +A   P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  125 bits (314), Expect = 5e-33
 Identities = 102/314 (32%), Positives = 160/314 (50%), Gaps = 40/314 (12%)

Query: 42  VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFF 97
           VG G++G V++AK  +  +    A+K++          RE+ L+R + HPNVI+L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 98  STTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQR---MPLIYVKLYTYQIFRGLAYIH 152
           S + +    + L+ +Y    ++ ++K +  S  N++   +P   VK   YQI  G+ Y+H
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 153 TVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL---VKGEANIS-YICSRYYRAP 205
               V HRD+KP N+LV    P   +VK+ D G A++    +K  A++   + + +YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 256
           EL+ GA  YT +IDIW+ GC+ AELL  +P+F               DQL  I  V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 257 TR---EEIRCMNPNY----TDFRFPQIKAHPWHKVFHK-RMPPEA--IDLASRLLQYSPS 306
                E+IR M P Y     DFR          K   K ++ P++    L  +LL   P+
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303

Query: 307 LRCTALEACAHPFF 320
            R T+ +A   P+F
Sbjct: 304 KRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  122 bits (308), Expect = 3e-32
 Identities = 83/296 (28%), Positives = 137/296 (46%), Gaps = 60/296 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 92
           + +GTGSFG V   +   +G+  A+K     K+++ ++ +    E ++++ + HP +++L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
              F     +D+  L LVMEYVP  E     L  +   + R P    + Y  Q+   L Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 209
           +H++  + +RD+KP+NLL+D   + +K+ DFG AK +         +C +  Y APE+I 
Sbjct: 117 LHSL-DIVYRDLKPENLLLDSDGY-IKITDFGFAKRVKG---RTYTLCGTPEYLAPEIIL 171

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
               Y  ++D W+ G ++ E+L G P F  +N   Q+ E  K+L                
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--------------G 213

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 320
             RFP                P+A DL   LLQ   + R   L+        HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  121 bits (304), Expect = 5e-32
 Identities = 89/291 (30%), Positives = 133/291 (45%), Gaps = 58/291 (19%)

Query: 45  GSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           G+FG V+ AK   TG+  AIK      ++   +  N + +   +M   + P V  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 97  FSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           +S  SKD L+L  VMEY+      ++ + L         +P  + K Y  ++  G+  +H
Sbjct: 64  YSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLH 114

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
              G+ HRD+KP+NLL+D   H +KL DFG ++    G  N  ++ +  Y APE I G  
Sbjct: 115 Q-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
           +     D WS GCV+ E L G P F  E   D + + I           R +N       
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNI---------LSRRIN------- 211

Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 320
                   W +   +   PEA+DL +RLL   P+ R  A    E  +HPFF
Sbjct: 212 --------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  116 bits (292), Expect = 3e-30
 Identities = 75/288 (26%), Positives = 121/288 (42%), Gaps = 49/288 (17%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFFS 98
            +G GS+G V++A   ETG+ VAIK V  +   +   +E+ +++  D P ++     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 99  TTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            T      L +VMEY     V + M          N+ +    +    YQ  +GL Y+H+
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIM-------KITNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFGAT 212
                HRD+K  N+L++    Q KL DFG +  L    A   + I + ++ APE+I    
Sbjct: 118 N-KKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y    DIWS G    E+  G+P +   + +  +  I                P      
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KP------ 215

Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            P   + P      ++  PE  D   + L   P  R +A++   HPF 
Sbjct: 216 -PPTLSDP------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  116 bits (293), Expect = 4e-30
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 56/292 (19%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVL---QDRRYKNRELQLMRLMDHPNVISLKHCFF 97
            +G G+ G V++A    TG+ VAIKK+    Q++     E+ +M+   HPN++     + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 98  STTSKDELFLNLVMEYVPETMYR------VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
                DEL+  +VMEY    M        + +++  MN+   + YV     ++ +GL Y+
Sbjct: 86  ---VGDELW--VVMEY----MDGGSLTDIITQNFVRMNEPQ-IAYVCR---EVLQGLEYL 132

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELI 208
           H+   V HRD+K  N+L   L+    VKL DFG A  L K ++   S + + Y+ APE+I
Sbjct: 133 HSQ-NVIHRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
               +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P  +         
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKN-------- 238

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                       W   F         D  ++ L   P  R +A E   HPF 
Sbjct: 239 ---------PEKWSPEF--------KDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 1e-29
 Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 22/240 (9%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLM---RLMDHPNVISL 92
           ++G G++G V++ K + TG  VA+K +  D    +     RE+ L+   R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +          L ++MEY      R L     + ++    Y+ +   ++   L YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELIFGA 211
            V GV HRD+K  N+LV   T  VKLCDFG A +L +  +   +++ + Y+ APE+I   
Sbjct: 119 KV-GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             Y T  DIWS G  + E+  G P +   +A   ++ I K    P R E    +    +F
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRLEDNGYSKLLREF 234

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  113 bits (286), Expect = 2e-29
 Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 50/293 (17%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHPNVISLKH 94
           +G G FG V   K      T A+K V    + +   +     E +++   +HP ++ L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 95  CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             F    KD+ ++ ++MEY     ++ +L+     ++       + Y   +     Y+H 
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARFYIACVVLAFEYLHN 111

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
             G+ +RD+KP+NLL+D     VKL DFG AK L  G+   ++  +  Y APE+I     
Sbjct: 112 R-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168

Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           Y  S+D WS G +L ELL G+P F GE+  D +             +I   N       F
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKLE---F 215

Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 321
           P              +   A DL  +LL+ +P  R   L+        H +F+
Sbjct: 216 PNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  113 bits (285), Expect = 3e-29
 Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 51/297 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNV 89
           + +GTG+F   +QA+ ++TG  +A+K+V   R   +          +E++LM  ++HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           I +       T +D  F NL +E++   ++  +L  Y +  +    + +  YT Q+ RGL
Sbjct: 66  IRM----LGATCEDSHF-NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYR 203
           +Y+H    + HRDVK  NLL+D    ++++ DFG+A  L       GE     + +  + 
Sbjct: 117 SYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE++ G  +Y  S D+WS GCV+ E+   +P +  E   + L  I K         I  
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                     P I  H         + P   D+  R L+  P  R  + E   HP F
Sbjct: 226 ATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (285), Expect = 3e-29
 Identities = 63/236 (26%), Positives = 110/236 (46%), Gaps = 44/236 (18%)

Query: 39  ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
            + +G G+FG V++             VA+K + +D   +      RE ++MR +DHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRG 147
           + L       T ++ L   +VMEY+P      L  Y   +  + + L  +  +  QI RG
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---- 203
           + Y+ +     HRD+  +N LV      VK+ DFG ++ L   +         YY+    
Sbjct: 116 MEYLESKN-FIHRDLAARNCLVGE-NLVVKISDFGLSRDLYDDD---------YYKVKGG 164

Query: 204 -------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
                  APE +    ++T+  D+WS G +L E+  LG+  +PG +   +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  113 bits (284), Expect = 5e-29
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 22/225 (9%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLKH 94
            +G GSFG V + +    G+ +  K++       ++++    E+ ++R + HPN++    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 95  CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH- 152
                +++    L +VMEY     + ++++      + +   ++     Q+   L   H 
Sbjct: 67  RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 153 -TVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPE 206
            + PG  V HRD+KP N+ +D   + VKL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
            +   + Y    DIWS GC++ EL    P F   N   QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 1e-28
 Identities = 94/313 (30%), Positives = 143/313 (45%), Gaps = 54/313 (17%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           VG G +G VF AK  +TGE VA+K++       L + R+   E  ++       ++ L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F     +D+ +L L MEYVP   +R +L +   +++     + + Y  ++F  +  +H 
Sbjct: 69  AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
           + G  HRD+KP+N L+D   H +KL DFG +K +V   AN S + S  Y APE++ G   
Sbjct: 120 L-GYIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KG 174

Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           Y  ++D WS GC+L E L G P F G    +    +     T  R       P Y D RF
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF 227

Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-----DELREPNA 328
                          +  EA DL ++L+        +  +   HPFF     +ELRE   
Sbjct: 228 --------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKP 273

Query: 329 RLPNGRPFPPLFN 341
                 PF P   
Sbjct: 274 ------PFVPELE 280

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 1e-28
 Identities = 95/345 (27%), Positives = 141/345 (40%), Gaps = 88/345 (25%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----LM---DHPNVISLK 93
           V+G G+FG V+  +  +TG+  A+K + +    K  ++  +R    ++   D P ++ L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 94  HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           +  F    +DE  L LVMEY+P   +  +L          P    + Y  ++   L  +H
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH 118

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY----------- 201
            + G  HRD+KP N+L+D   H +KL DFG  K + K +    Y+   +           
Sbjct: 119 KL-GFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 202 -------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
                              Y APE++ G T Y    D WS G +L E+L G P F  +  
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234

Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
              L E        T  +I  +N      RFP              + PEAIDL  RLL 
Sbjct: 235 ---LQE--------TYNKI--INWK-ESLRFPP----------DPPVSPEAIDLICRLLC 270

Query: 303 YSPSLR-CTALEACAHPFF-----DELREPNARLPNGRPFPPLFN 341
             P  R  +  E  +HPFF     + LRE         PF P  +
Sbjct: 271 -DPEDRLGSFEEIKSHPFFKGIDWENLRETKP------PFVPELS 308

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  111 bits (280), Expect = 2e-28
 Identities = 89/308 (28%), Positives = 143/308 (46%), Gaps = 67/308 (21%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYK-----NRELQLMR 82
           ++   ++G+GSFG V+      +GE +A+K+V         +DR+        RE+ L++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYT 141
            + H N++          S D   LN+ +EYVP  ++  +L +Y +  + +    V+ + 
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI------- 194
            QI +GL Y+H   G+ HRD+K  N+LVD     +K+ DFG +K   K EAN        
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISK---KLEANSLSTKTNG 167

Query: 195 ---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
              S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFK 223

Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           +    +                P+I ++         +  EAID   +  +   + R TA
Sbjct: 224 IGENAS----------------PEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258

Query: 312 LEACAHPF 319
            E   HPF
Sbjct: 259 AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  111 bits (279), Expect = 2e-28
 Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 79/309 (25%)

Query: 39  ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
            + +G G+FG V++ K      +    VA+K + +D   +      RE ++MR +DHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 148
           + L       T ++ L+  +VMEY+       L  Y      ++ L  +  +  QI RG+
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+ +   + HRD+  +N LV      VK+ DFG ++ L   +         YYR     
Sbjct: 116 EYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDD---------YYRKRGGK 164

Query: 204 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 256
                 APE +    ++T+  D+WS G +L E+  LG+  +PG +  ++++E +K     
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK----- 217

Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                         +R PQ              PPE  DL  +     P  R T      
Sbjct: 218 ------------NGYRLPQP----------PNCPPELYDLMLQCWAEDPEDRPT------ 249

Query: 317 HPFFDELRE 325
              F EL E
Sbjct: 250 ---FSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  108 bits (272), Expect = 2e-27
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 17/216 (7%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR---ELQLMRLMDHPN 88
           +  E+ +G G F +V++A CL  G  VA+KKV    + D + +     E+ L++ +DHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           VI     F      +   LN+V+E      + R++KH+    + +P   +  Y  Q+   
Sbjct: 64  VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 206
           L ++H+   + HRD+KP N+ +   T  VKL D G  +    K  A  S + + YY +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
            I     Y    DIWS GC+L E+   Q  F G+  
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 6e-27
 Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 53/295 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVI 90
           +++G G+FG V+    ++TG  +A+K+V  D               E+QL++ + H  ++
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
               C      +D+  L++ MEY+P  ++   LK Y ++ + +     + YT QI  G+ 
Sbjct: 68  QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRYYRAP 205
           Y+H+   + HRD+K  N+L D     VKL DFG++K L      G    S   + Y+ +P
Sbjct: 119 YLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E+I G   Y    D+WS GC + E+L  +P +      + +  I K+   PT        
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                   PQ+ +H         + P+A +   R    +   R +A E   H F 
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  106 bits (267), Expect = 1e-26
 Identities = 79/303 (26%), Positives = 139/303 (45%), Gaps = 53/303 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------------ELQLM 81
           ++   ++G G++G V+ A  + TGE +A+K+V        R              E++ +
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLY 140
           + +DH N++             E +L++ +EYVP  ++   L+ Y    +++    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV---LVKGEANISYI 197
           T Q+  GLAY+H+  G+ HRD+K  NLLVD      K+ DFG +K    +   + N+S  
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 198 CSRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
            S ++ APE+I   ++ Y+  +DIWS GCV+ E+  G+  +  E A+  + ++       
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL------- 224

Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                             +  A P        + P A+D  +     +P  R TA E   
Sbjct: 225 ----------------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Query: 317 HPF 319
           HPF
Sbjct: 269 HPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  106 bits (266), Expect = 2e-26
 Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 46/293 (15%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHC 95
           V+G G+  +V+ A CL   E VAIK++  ++   +     +E+Q M   +HPNV+   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F     DEL+  LVM Y+   ++  ++K  Y        +I   L   ++ +GL Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 154 VPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVLVKG-----EANISYICSRYYRAPEL 207
             G  HRD+K  N+L+       VK+ DFG +  L  G     +   +++ +  + APE+
Sbjct: 121 -NGQIHRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +     Y    DIWS G    EL  G   +     +  L+  ++             N  
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-------------ND- 223

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                 P ++    +K + K        + S  LQ  PS R TA E   H FF
Sbjct: 224 -----PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  106 bits (267), Expect = 2e-26
 Identities = 89/313 (28%), Positives = 139/313 (44%), Gaps = 57/313 (18%)

Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ 79
             +P++  + + E  +G GSFG V+ A+ + T E VAIKK+    +  N       +E++
Sbjct: 10  KDDPEKLFTDLRE--IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL 139
            ++ + HPN I  K C+    +       LVMEY   +   +L+ +     + PL  V++
Sbjct: 68  FLQQLRHPNTIEYKGCYLREHTA-----WLVMEYCLGSASDILEVH-----KKPLQEVEI 117

Query: 140 --YTYQIFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISY 196
               +   +GLAY+H+     HRD+K  N LL +P    VKL DFGSA   +   AN S+
Sbjct: 118 AAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SF 171

Query: 197 ICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
           + + Y+ APE+I    E  Y   +D+WS G    EL   +P     NA+  L  I +   
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--- 228

Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
                     N +      P + ++ W   F        +D     LQ  P  R ++ E 
Sbjct: 229 ----------NDS------PTLSSNDWSDYFRN-----FVDSC---LQKIPQDRPSSEEL 264

Query: 315 CAHPFFDELREPN 327
             H F    R P 
Sbjct: 265 LKHRFVLRERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  106 bits (267), Expect = 3e-26
 Identities = 87/302 (28%), Positives = 130/302 (43%), Gaps = 62/302 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRY-----KNRELQLMRLMDHPNV 89
           +V+G GSFG V  A+   T E  A+K      +LQD        + R L L     HP +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
             L H  F T  KD LF   VMEYV   + M+ + +     + R      + Y  +I  G
Sbjct: 59  TQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLG 108

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 206
           L ++H   G+ +RD+K  N+L+D   H +K+ DFG  K  + G    S  C +  Y APE
Sbjct: 109 LQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++     Y  ++D W+ G +L E+L GQ  F G++  D+L + I                
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL--------------- 209

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 321
              + R+P            + +  EA  +    L  +P  R   L         HPFF 
Sbjct: 210 -EDEVRYP------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Query: 322 EL 323
           E+
Sbjct: 257 EI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  104 bits (262), Expect = 5e-26
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 18/217 (8%)

Query: 43  GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 96
           G GS+G V++ K L   +  A+K+V L     K R     E++++  ++HPN+IS K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 97  FSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                     L +VMEY P   + + +       + +P   +     Q+ RGL  +H   
Sbjct: 69  LDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122

Query: 156 GVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 214
            + HRD+K  N LLV      VK+ D G +KVL K  A  + I + +Y APE ++    Y
Sbjct: 123 KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178

Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
           +   DIWS GC+L E+    P F   +  D   ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  102 bits (256), Expect = 5e-25
 Identities = 89/300 (29%), Positives = 140/300 (46%), Gaps = 53/300 (17%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVISLKHC 95
           +G GS GIV  A    TG  VA+KK+  D R + R      E+ +MR   HPN++ +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
           + S    DEL++  VME++    +  ++ H      RM    +      + + L+++H  
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA- 133

Query: 155 PGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGA 211
            GV HRD+K  ++L   LT   +VKL DFG  A+V  +     S + + Y+ APE+I   
Sbjct: 134 QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SR 189

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             Y T +DIWS G ++ E++ G+P +  E  +  +            + IR   P     
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP----- 232

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
             P++K    HKV      P       R+L   P+ R TA E   HPF  +   P++ +P
Sbjct: 233 --PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  101 bits (253), Expect = 1e-24
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 43/223 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           + +G G+FG V++      GE     VA+K + +    +       E  +M+ + HPN++
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 149
            L       T  + L+  +V EY+P      L  +     +++ L  +     QI +G+ 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+ +   V HRD+  +N LV      VK+ DFG ++ + + +         YYR      
Sbjct: 117 YLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165

Query: 204 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                 APE +    ++T+  D+WS G +L E+  LG+  +PG
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207

Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (252), Expect = 1e-24
 Identities = 73/290 (25%), Positives = 129/290 (44%), Gaps = 46/290 (15%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRLMDHPNVISL 92
           RV+G G+FG V   +  +T +  A+K     K ++    +N   E ++++ ++HP +++L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
            + F     +DE  + LV++ +   +   L+++ S   +     VK +  +I   L Y+H
Sbjct: 66  WYSF-----QDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRD+KP N+L+D   H V + DF  A  +       S   +  Y APE++    
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y+ ++D WS G    E L G+  + G +                R++IR          
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK-------- 213

Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEACAHPFF 320
             Q  A   +         EAID  ++LL+  P  R      +   HP+F
Sbjct: 214 --QETADVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 88/294 (29%), Positives = 135/294 (45%), Gaps = 58/294 (19%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 97
           +G+G++G V++A+ + TGE VAIK +      D     +E+ +++   HPN++     F 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AYFG 67

Query: 98  STTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
           S   +D+L+  +VMEY      + +Y+V +   S  Q   + YV     +  +GLAY+H 
Sbjct: 68  SYLRRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV---CRETLKGLAYLHE 119

Query: 154 VPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELIFG 210
             G  HRD+K  N+L   LT    VKL DFG +  L    A   S+I + Y+ APE+   
Sbjct: 120 T-GKIHRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-- 173

Query: 211 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           A E    Y    DIW+ G    EL   QP  P  +     +  ++ L   ++        
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP--PMFD-----LHPMRALFLISKS------- 219

Query: 267 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
              +F  P++K    W  VFH        D   + L   P  R TA +   HPF
Sbjct: 220 ---NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =   99 bits (249), Expect = 3e-24
 Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y   RVVG G+FGIV   +     + V IK++        +R     E Q+++L+ HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           I     F    +     L +VMEY P  T+   ++     N  +    +  +  QI   L
Sbjct: 62  IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            ++HT   + HRD+K QN+L+D     VK+ DFG +K+L       + + +  Y +PEL 
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
            G   Y    DIW+ GCVL EL   +  F   N
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 99.1 bits (247), Expect = 2e-23
 Identities = 93/313 (29%), Positives = 142/313 (45%), Gaps = 57/313 (18%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
           +V+G GSFG V  A+   T E  AIK + +D   ++ +++        L    +HP    
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP---F 57

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L H F +  +K+ LF   VMEY+   + M+    H  S + R      + Y  +I  GL 
Sbjct: 58  LTHLFCTFQTKEHLFF--VMEYLNGGDLMF----HIQS-SGRFDEARARFYAAEIICGLQ 110

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           ++H   G+ +RD+K  N+L+D   H +K+ DFG  K  + GE   S  C +  Y APE++
Sbjct: 111 FLHK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL 168

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
            G  +Y  S+D WS G +L E+L+GQ  F GE+  D+L + I         +        
Sbjct: 169 KG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSI-------LNDR------- 212

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACAHPFFDELREPN 327
                      P    F + +  EA D  S+L +  P+ R     +   HPFF   R  +
Sbjct: 213 -----------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGID 255

Query: 328 ARLPNGRPFPPLF 340
                 R  PP F
Sbjct: 256 WERLEKREIPPPF 268

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 50/230 (21%)

Query: 40  RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVIS 91
           + +G G+FG V++ K          VA+K + +D   + R     E ++M+ + HPNV+ 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY---------SSMNQRMPLIYVKLYTY 142
           L       T ++ L+  LV+EY+       L  Y         S     + L  +  +  
Sbjct: 61  LLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
           QI +G+ Y+ +   V HRD+  +N LV      VK+ DFG ++ +   +         YY
Sbjct: 113 QIAKGMEYLASKKFV-HRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD---------YY 161

Query: 203 R------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
           R            APE +     +T+  D+WS G +L E+  LG   +PG
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 97.2 bits (242), Expect = 3e-23
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 22/220 (10%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-LQ--DRRYKN---RELQLMRLMDHPNVISLKHC 95
           +G GSFG+VF+          A+K++ L   +RR +     E +++  +D   +I     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
           F      D+  LN+VMEY     ++++LK      + +P   V  +  QI  GLA++H+ 
Sbjct: 68  FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS- 119

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPELIFGA 211
             + HRD+K  NL +D     VK+ D G AK+L   +      + + + YY +PEL    
Sbjct: 120 KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELC-ED 175

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
             Y    D+W+ G VL E   G+  F   N    +++II+
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 98.5 bits (245), Expect = 3e-23
 Identities = 95/337 (28%), Positives = 151/337 (44%), Gaps = 68/337 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
           +V+G GSFG V  A+    GE  A+K + +D    + +++        L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L +C F T  K+ LF   VME++   + M+ +         R  L     Y  +I  GL 
Sbjct: 61  L-YCTFQT--KEHLFF--VMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQ 110

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           ++H+  G+ +RD+K  N+++D   H +K+ DFG  K  V G+   S  C +  Y APE++
Sbjct: 111 FLHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
            G  +YT S+D WS G +L E+L+GQ  F G++  D+L E I+V  TP            
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------ 213

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 327
               +P+     W       +  E+ D+  +L +  P+ R   +     HPFF  +   N
Sbjct: 214 ---HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---N 255

Query: 328 ARLPNGRPFPPLF-----------NFKQELAGASPEL 353
                 R   P F           NF +E     P L
Sbjct: 256 WTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRL 292

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 97.4 bits (242), Expect = 5e-23
 Identities = 73/220 (33%), Positives = 110/220 (50%), Gaps = 24/220 (10%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 92
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ + HPN I  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           + C+       E    LVMEY   +   +L+ +    Q + +  V   T+   +GLAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132

Query: 153 TVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           +   + HRDVK  N LL +P    VKL DFGSA ++    AN  ++ + Y+ APE+I   
Sbjct: 133 S-HNMIHRDVKAGNILLSEP--GLVKLGDFGSASIM--APAN-XFVGTPYWMAPEVILAM 186

Query: 212 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
            E  Y   +D+WS G    EL   +P     NA+  L  I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 97.3 bits (242), Expect = 6e-23
 Identities = 94/336 (27%), Positives = 147/336 (43%), Gaps = 66/336 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
           +++G GSFG VF A+   T +  AIK + +D    + +++        L    +HP    
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 57

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L H + +  +K+ LF   VMEY+   + M+    H  S + +  L     Y  +I  GL 
Sbjct: 58  LTHLYCTFQTKENLFF--VMEYLNGGDLMF----HIQSCH-KFDLPRATFYAAEIICGLQ 110

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           ++H+  G+ +RD+K  N+L+D   H +K+ DFG  K  + G+A     C +  Y APE++
Sbjct: 111 FLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
            G  +Y TS+D WS G +L E+L+GQ  F G +  +              + IR  NP Y
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY 215

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 327
             +                 +  EA D+  +L    P  R     +   HPFF E+    
Sbjct: 216 PRW-----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW-- 256

Query: 328 ARLPNGR---PFPPLF-------NFKQELAGASPEL 353
           + L       PF P         NF +E     P L
Sbjct: 257 SALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRL 292

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.5 bits (241), Expect = 6e-23
 Identities = 74/296 (25%), Positives = 112/296 (37%), Gaps = 57/296 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 90
           +     +G GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
                F   +      L ++MEY        L     +++     Y+     ++  GL Y
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGKLDET----YIAFILREVLLGLEY 113

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-------YYR 203
           +H   G  HRD+K  N+L+      VKL DFG     V G+   S +  R       ++ 
Sbjct: 114 LHE-EGKIHRDIKAANILLSE-EGDVKLADFG-----VSGQLT-STMSKRNTFVGTPFWM 165

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE+I   + Y    DIWS G    EL  G+P     + +  L  I K            
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------ 212

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            NP       P ++ + + K F         D  S  L   P  R +A E   H F
Sbjct: 213 NNP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 96.3 bits (240), Expect = 9e-23
 Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 37/296 (12%)

Query: 43  GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 102
           G G++G+V + + + TG  +A+K++   R   N + Q   LMD    +    C ++ T  
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRI---RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 103 DELFLN----LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 158
             LF      + ME +  ++ +  K        +P   +      I + L Y+H+   V 
Sbjct: 67  GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVI 126

Query: 159 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE---YT 215
           HRDVKP N+L++    QVKLCDFG +  LV   A       + Y APE I        Y 
Sbjct: 127 HRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYD 185

Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275
              D+WS G  + EL  G+  FP ++      ++ +V+  P+                PQ
Sbjct: 186 VKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS----------------PQ 227

Query: 276 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
           + A        ++  PE  D  ++ L+ +   R    E   HPFF+     N  + 
Sbjct: 228 LPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 96.7 bits (240), Expect = 1e-22
 Identities = 98/326 (30%), Positives = 144/326 (44%), Gaps = 61/326 (18%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 92
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN I  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           K C+       E    LVMEY   +   +L+ +    Q + +  +   T+   +GLAY+H
Sbjct: 91  KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142

Query: 153 TVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           +   + HRD+K  N LL +P   QVKL DFGSA +     AN S++ + Y+ APE+I   
Sbjct: 143 S-HNMIHRDIKAGNILLTEP--GQVKLADFGSASIA--SPAN-SFVGTPYWMAPEVILAM 196

Query: 212 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
            E  Y   +D+WS G    EL   +P     NA+  L  I +             N +  
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NES-- 241

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 329
               P ++++ W   F         +     LQ  P  R T+ E   H F   LRE    
Sbjct: 242 ----PTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMFV--LRE---- 283

Query: 330 LPNGRPFPPLFNFKQELAGASPELIN 355
               RP   L +  Q    A  EL N
Sbjct: 284 ----RPETVLIDLIQRTKDAVRELDN 305

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 24/218 (11%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLKH 94
           +G GSFG V+ A    T E VA+KK+    +  N       +E++ ++ + HPN I  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
           C+    +       LVMEY   +   +L+ +    Q + +  +   T+   +GLAY+H+ 
Sbjct: 89  CYLKEHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHS- 139

Query: 155 PGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
             + HRD+K  N LL +P   QVKL DFGSA       AN S++ + Y+ APE+I    E
Sbjct: 140 HNMIHRDIKAGNILLTEP--GQVKLADFGSASKS--SPAN-SFVGTPYWMAPEVILAMDE 194

Query: 214 --YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
             Y   +D+WS G    EL   +P     NA+  L  I
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 87/295 (29%), Positives = 125/295 (42%), Gaps = 52/295 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRLMDHPNV 89
           Y+  RV+G G+FG     +  E    V  K+V L       RR    E+ ++ L+ HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           I+  + F    +     L + MEY    T+Y  +       Q      V  Y +QI   +
Sbjct: 62  IAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYIC--SRYYRA 204
           +YIH   G+ HRD+K  N+    LT    +KL DFG +K+L   E +++     + YY +
Sbjct: 115 SYIHKA-GILHRDIKTLNIF---LTKAGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMS 169

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PEL  G  +Y    DIW+ GCVL ELL  +  F   N ++ +V+I              +
Sbjct: 170 PELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------------V 214

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
             NYT                      E I L   LLQ  P  R TA E    P 
Sbjct: 215 QGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.8 bits (233), Expect = 5e-22
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 31/213 (14%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYK--NRELQLMRLMDHPNVI 90
           V+G G++G V+       G+ +A+K+V  D        + Y+    E+ L++ + H N++
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
                 +  T  D+  +++ ME+VP  ++  +L  +  +    P      YT QI  G+A
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGPL----PEPVFCKYTKQILDGVA 116

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI-------CSRYY 202
           Y+H    V HRD+K  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 117 YLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 235
            APE+I   + Y    DIWS GC + E+  G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 94.0 bits (234), Expect = 7e-22
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 24/209 (11%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           VGTG+FG V   +   +    A+K +       L+  ++ + E ++++ + HP +I L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 95  CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
                T  D+ FL ++MEYVP   ++  L++    +    L     Y  +I   L Y+H+
Sbjct: 68  ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----FYASEIVCALEYLHS 119

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGAT 212
              + +RD+KP+N+L+D   H +KL DFG AK L         +C +  Y APE+I  + 
Sbjct: 120 K-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI-QSK 173

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
            +  ++D W+ G ++ E+L+G P F  +N
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 94.4 bits (235), Expect = 7e-22
 Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 35/299 (11%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHC 95
            +G G+ G+V +     +G  +A K +  +     R    REL+++   + P ++     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
           F+S        +++ ME++   ++ +VLK       R+P   +   +  + RGL Y+   
Sbjct: 68  FYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK 118

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 214
             + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175

Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----TREEIRCMNPNYT 269
           T   DIWS G  L E+ +G+   P  +A     E+  + G P      +E  R ++ +  
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPP 231

Query: 270 DFRFPQ--------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           D   P         I   P  K+       E  D   + L+ +P  R    E   HPF 
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 48/299 (16%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN--RELQLMRLMDHPNVISLKHCF 96
           +G G++G V++     TG T+A+K++   L + ++     EL ++     P ++     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
           F   +     + + MEY+       L       + +P   ++  TY + +GL ++     
Sbjct: 69  FIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI-----FGA 211
           + HRDVKP N+LV+    QVKLCDFG +  LV   A  +  C  Y  APE I        
Sbjct: 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIRCMNPNY 268
             YT   D+WS G  + E+ LG+  +P E   N   QL  I+   G P       +   Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
           +                      +A D  ++ L   P+ R T  +   HP+  + +  +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 25/212 (11%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNR-ELQLMR-LMDHPNVISLKHCF 96
           V+G G++G V++A+  +TG+ VAIK   +++D   + + E  ++R   +HPN+ +    F
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 97  F---STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                  + D+L+  LVME     ++  ++K      +R+   ++     +  RGLAY+H
Sbjct: 73  IKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 153 TVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIF 209
               V HRD+K QN+L   LT   +VKL DFG SA++        ++I + Y+ APE+I 
Sbjct: 131 E-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185

Query: 210 GATE------YTTSIDIWSAGCVLAELLLGQP 235
            A +      Y    D+WS G    EL  G+P
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 70/247 (28%), Positives = 112/247 (45%), Gaps = 51/247 (20%)

Query: 40  RVVGTGSFGIVFQAKCLE-----TGETVAIKK-----VLQDRRYKNRELQLMRLMDHPNV 89
           + +G G FG V      +     TGE VA+K        Q R    RE++++R +DH N+
Sbjct: 10  KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 148
           +  K             L L+MEY+P      L+ Y   ++ ++ L  + L++ QI +G+
Sbjct: 69  VKYKGV---CEKPGGRSLRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----------VKGEANISYIC 198
            Y+ +     HRD+  +N+LV+     VK+ DFG AKVL            GE+ I    
Sbjct: 123 DYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---- 176

Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FPGENAVD 244
             +Y APE +  +   + S D+WS G  L EL            + L       G+  V 
Sbjct: 177 -FWY-APECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233

Query: 245 QLVEIIK 251
           +L+E++K
Sbjct: 234 RLLELLK 240

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 47/302 (15%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G V + K + TG  +A K V        R+   RELQ+M     P ++S    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVS----F 68

Query: 97  FSTTSKDELFLN-----LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           +        FLN     + ME++   ++ R+ K    +    P+  +      +  GL Y
Sbjct: 69  YGA------FLNENNICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTY 118

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
           ++ V  + HRD+KP N+LV+    Q+KLCDFG +  L+   A+ +++ +  Y +PE I G
Sbjct: 119 LYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQG 176

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
             +YT   D+WS G  + EL LG+ P        D   + + +L                
Sbjct: 177 G-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-------------- 221

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-HPFFDELREPNA 328
                QI   P  ++     P +  D     L   P+ R T  + CA  PF   LR  N 
Sbjct: 222 ---LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278

Query: 329 RL 330
            L
Sbjct: 279 DL 280

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 92.2 bits (229), Expect = 4e-21
 Identities = 82/311 (26%), Positives = 137/311 (44%), Gaps = 65/311 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRLMDHPNVISL 92
           +++  G++G V+  +  ET +  A+KK+  Q+   +N+      E  ++   ++P V+S+
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
             C F T       L +VMEYV       +LK+  ++    P+   ++Y  +    L Y+
Sbjct: 67  -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALEYL 117

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY--------------- 196
           H   G+ HRD+KP NLL+  + H +KL DFG +K+ +       Y               
Sbjct: 118 HNY-GIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 197 IC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           +C +  Y APE+I     Y   +D W+ G +L E L+G   F G+   +   ++I     
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230

Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TAL 312
              ++I    P   +                  +P +A DL SRLL+ +P  R     A 
Sbjct: 231 ---DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAF 268

Query: 313 EACAHPFFDEL 323
           E   H FF  L
Sbjct: 269 EVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.0 bits (226), Expect = 5e-21
 Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 17/208 (8%)

Query: 39  ERVV-GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK---NRELQLMRLMDHPNVISLK 93
           ERVV G G++GIV+ A+ L T   +AIK++  +D RY    + E+ L   + H N++   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
                       F  + ME VP      L    +  +      I    YT QI  GL Y+
Sbjct: 72  GSDSENG-----FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELI-F 209
           H    + HRD+K  N+LV+  +  VK+ DFG++K L        ++  +  Y APE+I  
Sbjct: 125 HDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLF 237
           G   Y    DIWS GC + E+  G+P F
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 91.9 bits (228), Expect = 6e-21
 Identities = 96/338 (28%), Positives = 144/338 (42%), Gaps = 70/338 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQD-----RRYKNRELQLMRLMDHPNV 89
           RV+G GSFG V  A+  E+G   A+K      +LQD        + R L L R  +HP +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
             L  CF +    D LF   VME+V   + M+ + K     ++R      + Y  +I   
Sbjct: 59  TQLYCCFQTP---DRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSA 108

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 206
           L ++H   G+ +RD+K  N+L+D   H  KL DFG  K  +      S  C +  Y APE
Sbjct: 109 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            I     Y  S+D W+ G +L E+L G   F  EN  D L E I        +E+     
Sbjct: 167 -ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----- 213

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEA----CAHPFF 320
                            V+   +  +A+D+    +  +P++R     L        HPFF
Sbjct: 214 -----------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256

Query: 321 DELREPNARLPNGR----PFPPLFNFKQELAGASPELI 354
            EL   +    N R    PF P    +++++   P+ I
Sbjct: 257 KEL---DWEKLNRRQIEPPFRPRIKSREDVSNFDPDFI 291

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.9 bits (225), Expect = 7e-21
 Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHP 87
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+ L++ ++HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           NVI     F      ++  LN+V+E      + R++KH+    + +P   V  Y  Q+  
Sbjct: 63  NVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 205
            L ++H+   V HRD+KP N+ +   T  VKL D G  +    K  A  S + + YY +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 65/293 (22%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 90
           +V+G GSFG V  AK    G+  A+ KVLQ +    ++ Q         L++ + HP ++
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L H  F T  K    L  V++YV   E  + + +  S    R      + Y  +I   L
Sbjct: 60  GL-HYSFQTADK----LYFVLDYVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 207
            Y+H++  + +RD+KP+N+L+D   H V L DFG  K  ++     S  C +  Y APE+
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +     Y  ++D W  G VL E+L G P F   +   ++ +   +L  P R     + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218

Query: 268 YT-----------------------DFRFPQIKAHP------WHKVFHKRMPP 291
            +                       DF   +IK H       W  + +K++ P
Sbjct: 219 ISVSARHLLEGLLQKDRTKRLGAKDDFL--EIKNHVFFSSINWDDLVNKKITP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 27/236 (11%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLMDHPNVI 90
           +++G G+FG V+     +TG  +A+K+V  D               E+QL++ + H  ++
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
               C      +    L++ ME++P  ++   LK Y ++ + +     + YT QI  G++
Sbjct: 68  QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRYYRAP 205
           Y+H+   + HRD+K  N+L D     VKL DFG++K L    + G    S   + Y+ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           E+I G   Y    DIWS GC + E+L  +P +      + +  I K+   PT   +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 83/312 (26%), Positives = 132/312 (42%), Gaps = 52/312 (16%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 93
           +G G FG V   +   TG+  A KK L  +R K R        E +++  +    ++SL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIH 152
           + F    +KD+L L + +    +  Y    H  ++ +   P      Y  QI  GL ++H
Sbjct: 60  YAF---ETKDDLCLVMTLMNGGDLKY----HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
               + +RD+KP+N+L+D   + V++ D G A  L  G+       +  Y APE++ G  
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y  S+D ++ GC L E++ G+  F       Q  E ++      +EE++          
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR-------- 209

Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 327
                       +  +  PEA DL   LLQ  P  R      +A E   HP F +L    
Sbjct: 210 ---TLEMA--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR- 263

Query: 328 ARLPNGRPFPPL 339
            RL  G   PP 
Sbjct: 264 -RLEAGMLEPPF 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 89.1 bits (221), Expect = 3e-20
 Identities = 90/322 (27%), Positives = 144/322 (44%), Gaps = 62/322 (19%)

Query: 40  RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRR---YKNRELQ-LMRLMDHP 87
           RV+GTG++G VF  + +   + G+  A+K      ++Q  +   +   E Q L  +   P
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +++L H  F T +K    L+L+++YV      +  H     +      V++Y  +I   
Sbjct: 66  FLVTL-HYAFQTDTK----LHLILDYVNGG--ELFTHLYQ-REHFTESEVRVYIAEIVLA 117

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYRAP 205
           L ++H + G+ +RD+K +N+L+D   H V L DFG +K  +  E     S+  +  Y AP
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 206 ELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           E+I G +  +  ++D WS G +  ELL G   F  +   +   EI +          R +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------RIL 225

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFF- 320
                       K+ P    F K M  EA D   +LL+  P  R     A E   HPFF 
Sbjct: 226 ------------KSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Query: 321 ----DELREPNARLPNGRPFPP 338
               D+L     R+P   PF P
Sbjct: 271 GIDWDDLAA--KRIP--APFKP 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 50/283 (17%)

Query: 43  GTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFF 97
           G G+ G V + +   TG   A+K +  D     ++   REL++ +    P ++     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69

Query: 98  STTSKDELFLNLVMEYVP----ETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
             +S     + + MEY      +++Y +V K    + ++  L  +      + +GL+Y+H
Sbjct: 70  DESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAPELI 208
           +   + HRD+KP N+L+     QVKLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 S-RKIIHRDIKPSNILLT-RKGQVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPT------- 257
            G   Y+ + D+WS G  L E+   +  FP E        +L+  I  +  P        
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 258 ----REEIR-----CMNPNYTDFRFP-QIKAHPWHKVFHKRMP 290
                EE +     C+  + T    P  +  HPW K   K+  
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 91/304 (29%), Positives = 132/304 (43%), Gaps = 64/304 (21%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQD-----RRYKNRELQLMRLMDHPNV 89
           +V+G GSFG V  A+   T E  AIK      +LQD        + R L L     HP +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +L HC F T  KD LF   VMEYV   + M+++ +       R      + Y  ++   
Sbjct: 59  TAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLA 108

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 206
           L ++H   GV +RD+K  N+L+D   H  KL DFG  K  +      +  C +  Y APE
Sbjct: 109 LMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            I    EY  S+D W+ G ++ E++ GQP F  +N  D L E I                
Sbjct: 167 -ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL--------------- 209

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC-----AHPF 319
            + D  +P      W       +  EA+ +    +  +P+ R  C A +        HPF
Sbjct: 210 -HDDVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256

Query: 320 FDEL 323
           F E+
Sbjct: 257 FKEI 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 89/354 (25%), Positives = 134/354 (37%), Gaps = 99/354 (27%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 92
           +V+G G+FG V   +  +TG   A+KK+ + +   K +      E  ++   D+P V+ L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
            + F     +DE +L L+MEY+P   M  +L    +  +     Y+     +    +  I
Sbjct: 67  YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA----ETILAIDSI 117

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL--------------VKGEANISYI 197
           H + G  HRD+KP NLL+D   H +KL DFG    L                    + +I
Sbjct: 118 HKL-GYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 198 CSRY-------------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLL 232
                                        Y APE +F  T Y    D WS G ++ E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEMLV 234

Query: 233 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE 292
           G P F  +N  +   +I              +N   T  +FP              + PE
Sbjct: 235 GYPPFCSDNPQETYRKI--------------INWKET-LQFPD----------EVPLSPE 269

Query: 293 AIDLASRLLQYSPSLRC---TALEACAHPFF-----DELREPNARLPNGRPFPP 338
           A DL  RL       R       E  +HPFF     + +RE  A      P  P
Sbjct: 270 AKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------PIIP 316

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (220), Expect = 6e-20
 Identities = 92/319 (28%), Positives = 140/319 (43%), Gaps = 56/319 (17%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLKH 94
           +G GSFG V Q +  +T    A+K + +       E+        ++  ++ P ++ LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
             FS  S ++L+L L      E     L H+     R  L   + YT ++   L  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLHKF 112

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATE 213
             V +RD+KP+N+L+D   H + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 113 -NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           YT ++D W+ G +L E+L G P F  EN V+++    K+L  P               RF
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEP--------------LRF 212

Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREPNARL 330
           P                 +A DL   LL   P+ R     A E   HPFF +L     +L
Sbjct: 213 PD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW--KKL 258

Query: 331 PNGRPFPPLFNFKQELAGA 349
                 PP   FK  ++ A
Sbjct: 259 LMKGIQPP---FKPAVSSA 274

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.2 bits (218), Expect = 6e-20
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 17/215 (7%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHP 87
           ++  E+ +G G F  V++A CL   + VA+KKV    + D + +    +E+ L++ ++HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           NVI     F          LN+V+E      + +++K++    + +P   V  Y  Q+  
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 205
            + ++H+   V HRD+KP N+ +   T  VKL D G  +    K  A  S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 87.7 bits (217), Expect = 7e-20
 Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 22/218 (10%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLK 93
           + +G GSFG ++ AK     E   IK++      ++++    +E+ L+  M HPN+++  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 94  HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
             F S      LF+  VMEY    + M R+ +    +     ++    +  QI  GL +I
Sbjct: 65  --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIF 209
           H    + HRD+K QN+ +       KL DFG A+ L      ++Y C  + YY +PE I 
Sbjct: 118 HDRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
               Y    DIWS GCVL EL   +  F G N + QLV
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 88.2 bits (218), Expect = 7e-20
 Identities = 91/315 (28%), Positives = 148/315 (46%), Gaps = 47/315 (14%)

Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 82
           G+P++ +    +  +G GS GIV  A    TG+ VA+KK +  R+ + REL      +MR
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMR 74

Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
              H NV+ +   + S    DEL++  VME++       +  ++ MN+      +     
Sbjct: 75  DYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCL 125

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRY 201
            + R L+Y+H   GV HRD+K  ++L+     ++KL DFG  A+V  +     S + + Y
Sbjct: 126 SVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           + APE+I     Y T +DIWS G ++ E++ G+P +  E               P  + +
Sbjct: 184 WMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---------------PPLQAM 227

Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
           R +  N      P++K    HKV    +    +DL   +L   PS R TA E   HPF  
Sbjct: 228 RRIRDNLP----PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFLK 276

Query: 322 ELREPNARLPNGRPF 336
               P+  +P  R +
Sbjct: 277 LAGPPSCIVPLMRQY 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 69/242 (28%), Positives = 119/242 (49%), Gaps = 27/242 (11%)

Query: 34  ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLM 84
           I++   +++G G+FG V+    ++TG  +A K+V  D               E+QL++ +
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
            H  ++    C      + E  L + MEY+P  ++   LK Y ++ + +     + YT Q
Sbjct: 62  QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICS 199
           I  G++Y+H+   + HRD+K  N+L D     VKL DFG++K L    + G    S   +
Sbjct: 115 ILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            Y+ +PE+I G   Y    D+WS GC + E+L  +P +    A   +  I K+   PT  
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTNP 228

Query: 260 EI 261
           ++
Sbjct: 229 QL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 65/236 (27%), Positives = 117/236 (49%), Gaps = 27/236 (11%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLMDHPNVI 90
           +++G G+FG V+     +TG  +A+K+V  D   +           E+QL++ + H  ++
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
               C      K    L++ +EY+P  ++   LK Y ++ + +     + YT QI +G++
Sbjct: 68  QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK----VLVKGEANISYICSRYYRAP 205
           Y+H+   + HRD+K  N+L D     VKL DFG++K    + + G    S   + Y+ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           E+I G   Y    D+WS  C + E+L  +P +    A   +  I K+   PT+  +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 90/312 (28%), Positives = 144/312 (46%), Gaps = 51/312 (16%)

Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 82
           G+P+  +    +  +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR
Sbjct: 16  GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 72

Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
              H NV+ +   + S    DEL++  VME++       +  ++ MN+      +     
Sbjct: 73  DYQHENVVEM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 123

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICS 199
            + + L+ +H   GV HRD+K  ++L   LTH  +VKL DFG  A+V  +     S + +
Sbjct: 124 AVLKALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179

Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 223

Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            ++ +  N      P++K    HKV      P       RLL   P+ R TA E   HPF
Sbjct: 224 AMKMIRDNLP----PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 272

Query: 320 FDELREPNARLP 331
             +   P+  +P
Sbjct: 273 LAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 85.5 bits (211), Expect = 9e-19
 Identities = 81/296 (27%), Positives = 135/296 (45%), Gaps = 45/296 (15%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISLKHCF 96
           +G GS GIV  A+   +G  VA+K ++  R+ + REL      +MR   H NV+ +   +
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---Y 84

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            S    +EL++  +ME++       +   + +N+      +      + + L Y+H+  G
Sbjct: 85  KSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHS-QG 137

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
           V HRD+K  ++L+  L  +VKL DFG  A++        S + + Y+ APE+I   T Y 
Sbjct: 138 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYG 195

Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275
           T +DIWS G ++ E++ G+P +  ++ V  +  +        R+              P 
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------PP 234

Query: 276 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
            K    HK+      P   D   R+L   P  R TA E   HPF  +   P   +P
Sbjct: 235 PKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 26/212 (12%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH------- 94
           +G+G+ G V++ +  +TG  +A+K++   RR  N+E     LMD  +V+   H       
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMD-LDVVLKSHDCPYIVK 78

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP-LIYVKLYTYQIFRGLAYIHT 153
           C+    +  ++F+   ME +   + ++LK    +   +P  I  K+ T  I + L Y+  
Sbjct: 79  CYGYFITDSDVFI--CMELMSTCLDKLLKR---IQGPIPEDILGKM-TVAIVKALHYLKE 132

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFGAT 212
             GV HRDVKP N+L+D  +  VKLCDFG +  LV  +A   S  C+ Y  APE I    
Sbjct: 133 KHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPD 190

Query: 213 ---EYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
              +Y    D+WS G  L EL  GQ  FP +N
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ--FPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 70/249 (28%), Positives = 124/249 (49%), Gaps = 20/249 (8%)

Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 83
           G+PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+ +MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             HPN+++    +      DEL++  VMEY+       +   + M++      +     +
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 202
             + L ++H+   V HRD+K  N+L+  +   VKL DFG  A++  +     + + + Y+
Sbjct: 124 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +   
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPE 239

Query: 263 CMNPNYTDF 271
            ++  + DF
Sbjct: 240 KLSAIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 84/312 (26%), Positives = 134/312 (42%), Gaps = 50/312 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 91
           RV+G G FG V   +   TG+  A KK L+ +R K R        E Q++  ++   V+S
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L + +    +KD L L L +    +  + +   Y+  N          Y  +I  GL  +
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H    + +RD+KP+N+L+D   H +++ D G A  + +GE     + +  Y APE++   
Sbjct: 119 HR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             YT S D W  GC++ E++ G+  F          E +K      REE+          
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVE--------- 214

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--C---TALEACAHPFFDELREP 326
              ++K     + + ++    A  +  +LL   P  R  C    A E  AHPFF      
Sbjct: 215 --RRVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF- 269

Query: 327 NARLPNGRPFPP 338
             RL  G   PP
Sbjct: 270 -KRLEAGMLEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 94/363 (25%), Positives = 151/363 (41%), Gaps = 108/363 (29%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-------MDHPNVISL 92
           +V+G G+FG V   +  +TG+  A+K +L+   +K  +L  ++         D P V+SL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            + F     +D  +L L+ME++P  + M  ++K Y + ++ +     + Y  +    +  
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDV----TRFYMAECVLAIEA 116

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG------------SAKVLVKGEANISYIC 198
           +H + G  HRD+KP N+L+D   H +KL DFG              + L++G++N + I 
Sbjct: 117 VHKL-GFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174

Query: 199 SRY------------------------------------YRAPELIFGATEYTTSIDIWS 222
           +R                                     Y APE IF    Y    D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233

Query: 223 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
            G ++ E L+G P F  EN+ +   +II       RE +           FP    H   
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIINW-----RETL----------YFPD-DIH--- 274

Query: 283 KVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFF-----DELREPNARLPNGRP 335
                 +  EA DL  RL+  + +   R  A E  +HPFF     D +R+  A      P
Sbjct: 275 ------LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA------P 322

Query: 336 FPP 338
           F P
Sbjct: 323 FIP 325

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 22/221 (9%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+V + +   +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK      +R+P   +   +  + RGLAY+    
Sbjct: 73  YSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180

Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
              DIWS G  L EL +G+   P  +A     E+  + G P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 82/284 (28%), Positives = 130/284 (45%), Gaps = 47/284 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 90
           +V+G GSFG V  AK    G+  A+K VLQ +   NR+ Q         L++ + HP ++
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L H  F TT K    L  V+++V   E  + + +  S      P    + Y  +I   L
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASAL 109

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPEL 207
            Y+H++  + +RD+KP+N+L+D   H V L DFG  K  + + +   ++  +  Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII-KVL----GTPTR---- 258
           I     Y  ++D W  G VL E+L G P F   +  +    I+ K L    G        
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI 226

Query: 259 -----EEIRCMNPNYTDFRFPQIKAHP------WHKVFHKRMPP 291
                E+ R       +  F +I+ HP      W  +  K++PP
Sbjct: 227 LEELLEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 84.0 bits (207), Expect = 3e-18
 Identities = 72/249 (28%), Positives = 125/249 (50%), Gaps = 20/249 (8%)

Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 83
           G+PK+   Y     +G G+ G VF A  + TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           + +PN+++    F      DELF+  VMEY+       +   + M++      +     +
Sbjct: 73  LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQ----IAAVCRE 123

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 202
             + L ++H    V HRD+K  N+L+  +   VKL DFG  A++  +     + + + Y+
Sbjct: 124 CLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +   
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPE 239

Query: 263 CMNPNYTDF 271
            ++P + DF
Sbjct: 240 KLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 25/221 (11%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 93
           V+G GSFG V  A+   T E  AIK + +D   ++ +++       ++ L D P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 94  HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 150
           H  F T  +    L  VMEYV   + MY    H   + + + P      Y  +I  GL +
Sbjct: 67  HSCFQTVDR----LYFVMEYVNGGDLMY----HIQQVGKFKEP--QAVFYAAEISVGLFF 116

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELIF 209
           +H   G+ +RD+K  N+++D   H +K+ DFG  K  +V G    ++  +  Y APE+I 
Sbjct: 117 LHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII- 173

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
               Y  S+D W+ G +L E+L GQP F GE+  D+L + I
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 30/233 (12%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHC----- 95
           +G G+FG V +     +G  +A+K++    R    E +  RL MD   V+    C     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 96  FFSTTSKD-------ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           F+    ++       EL     M+   +  Y+ +  Y  +   +P   +        + L
Sbjct: 68  FYGALFREGDCWICMEL-----MDISLDKFYKYV--YEVLKSVIPEEILGKIAVATVKAL 120

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            Y+     + HRDVKP N+L+D     +KLCDFG +  LV   A       R Y APE I
Sbjct: 121 NYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179

Query: 209 --FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 258
                  Y    D+WS G  L E+  G+  +P  N+V DQL +++K  G P  
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 82.9 bits (205), Expect = 7e-18
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 23/220 (10%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 93
           V+G GSFG V  A+   T E  AIK + +D   ++ +++       ++ L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 94  HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           H  F T   D L+   VMEYV   + MY + +       +    +   Y  +I  GL ++
Sbjct: 67  HSCFQTM--DRLYF--VMEYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFL 117

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 210
           H+  G+ +RD+K  N+++D   H +K+ DFG  K  + G       C +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              Y  S+D W+ G +L E+L GQP F GE+  D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 93/342 (27%), Positives = 148/342 (43%), Gaps = 68/342 (19%)

Query: 40  RVVGTGSFGIVF--------------QAKCLETGETVAIKKVLQDRRYKNRELQLMRLMD 85
           +V+GTG++G VF                K L+    V   K ++  R +   L+ +R   
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
            P +++L H  F T +K    L+L+++YV    M+  L    + ++      V+ Y+ +I
Sbjct: 64  SPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE----VRFYSGEI 114

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISYICSRYY 202
              L ++H + G+ +RD+K +N+L+D   H V L DFG +K  +  + E   S+  +  Y
Sbjct: 115 ILALEHLHKL-GIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE+I G   +  ++D WS G ++ ELL G   F  E   +   E+       +R  ++
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILK 225

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----H 317
           C  P                  F   + PEA DL  +LL+  P  R  A    A     H
Sbjct: 226 CDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267

Query: 318 PFFDELR-EPNARLPNGRPFPP-------LFNFKQELAGASP 351
           PFF  L  E  A      PF P       + NF +E     P
Sbjct: 268 PFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEP 309

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 79/317 (24%), Positives = 133/317 (41%), Gaps = 60/317 (18%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLK 93
           +VG G FG V   +   TG+  A+K + +          +   E  ++ + + P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 94  HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           + F     +D+  L LVMEY P  + +  + ++    ++ M     + Y  ++   +  +
Sbjct: 68  YAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY--ICSRYYRAPELI- 208
           H + G  HRD+KP+N+L+D   H +KL DFGSA  L   +   S   + +  Y APE++ 
Sbjct: 119 HQM-GYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 209 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
                G   Y    D WS G +  E++ G+  F    +      I+              
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222

Query: 265 NPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
             N+  F +FP+            ++  + +DL   LL      R      C HPFF ++
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269

Query: 324 REPNAR--LPNGRPFPP 338
              N R  LP   PF P
Sbjct: 270 DWNNIRNSLP---PFVP 283

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 80.4 bits (198), Expect = 2e-17
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 35/211 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           Y   RVVG GSFG     + + + +  A+K++   +         +E  L+  M HPN++
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT--------Y 142
           + K  F     + +  L +VMEY              + Q++ L   KL+          
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDG---------GDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVK-GEANISYICS 199
           Q+  G+ +IH    V HRD+K +N+    LT   +VKL DFGSA++L   G    +Y+ +
Sbjct: 108 QMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163

Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAEL 230
            YY  PE I+    Y    DIWS GC+L EL
Sbjct: 164 PYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 63/299 (21%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRLMDHPNV 89
           +++G G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +LK+ F    + D L    VMEY    E  + + +       R      + Y  +I   
Sbjct: 58  TALKYSF---QTHDRLCF--VMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 206
           L Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C +  Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEI     
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEI----- 212

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
                RFP            + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 213 -----RFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 73  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 123

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 124 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180

Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENA 242
              DIWS G  L E+ +G+   P  +A
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDA 207

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 84/350 (24%), Positives = 148/350 (42%), Gaps = 80/350 (22%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 91
           RV+G GS+  V   +  +T    A+K + ++    + ++  ++          +HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF  T S+  LF   V+E+V   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 61  LHSCF-QTESR--LFF--VIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 208
           ++H   G+ +RD+K  N+L+D   H +KL D+G  K  +  G+   ++  +  Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII--KVLGTPTR 258
            G  +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I  K +  P  
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-- 225

Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-- 316
                        R   +KA    K F  + P E              L C         
Sbjct: 226 -------------RSLSVKASSVLKGFLNKDPKE-------------RLGCHPQTGFRDI 259

Query: 317 --HPFFD----ELREPNARLPNGRPFPP-------LFNFKQELAGASPEL 353
             HPFF     +L E    LP   P+ P       L NF  +      +L
Sbjct: 260 KSHPFFRNIDWDLLEQKQVLP---PYKPNIESDRDLDNFDPQFTDEPVQL 306

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.8 bits (197), Expect = 6e-17
 Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 38/210 (18%)

Query: 42  VGTGSFGIVFQAKCL------ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVIS 91
           +G G+FG V    C        TGE VA+KK+        R   RE+++++ + H N++ 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 150
            K   +S   ++   L LVMEY+P   Y  L+ Y   ++ R+    + LY  QI +G+ Y
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL--------VK--GEANISYICSR 200
           + +   V HRD+  +N+LV+     VK+ DFG  KVL        V+  GE+ I      
Sbjct: 124 LGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI------ 175

Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAEL 230
           ++ APE +   ++++ + D+WS G VL EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 79.7 bits (196), Expect = 6e-17
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 47/288 (16%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 97
           +G+G++G V++A+ + TGE  AIK +     +D     +E+ +M+   H N+++    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 98  STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 157
           S   +D+L++   ME+      + + H +       + YV   T Q   GL Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127

Query: 158 CHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE--- 213
            HRD+K  N+L+    H VKL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 214 -YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y    DIW+ G    EL   QP     + +  L  + K                 ++F+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----------------SNFQ 227

Query: 273 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            P++K    W   FH              L  +P  R TA +   HPF
Sbjct: 228 PPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.5 bits (196), Expect = 7e-17
 Identities = 75/294 (25%), Positives = 130/294 (44%), Gaps = 43/294 (14%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHC 95
           ++G G+ G V++A  L T   +A+K +  D     ++    EL+++   D P +I     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           FF      E  +++  E++      V +       ++P   +      + +GL Y+ ++ 
Sbjct: 68  FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK 115

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    QVKLCDFG +  LV   A  +Y+ +  Y APE I G  +Y 
Sbjct: 116 -ILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171

Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPNYTDFRFP 274
              D+WS G    EL LG+  +P         +I K  G+    ++ +C+     D   P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP---------QIQKNQGSLMPLQLLQCI----VDEDPP 218

Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
            +    + + F        +   ++ ++  P  R        HPF  +  + NA
Sbjct: 219 VLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 84/358 (23%), Positives = 147/358 (41%), Gaps = 66/358 (18%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE----------LQLMRLMDHPNVIS 91
           +G G+FG V+Q +  +T    A+K + +      +E          L    L + P ++ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           LK   FS  +  +L+L  V +Y+   E  + + K       R      K Y  ++   L 
Sbjct: 61  LK---FSFQTDSDLYL--VTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALE 110

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           ++H    + +RD+KP+N+L+D   H + LCDFG +K  +      +  C +  Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                YT  +D WS G ++ E+  G   F  E+               T++  R  N  +
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---------------TQQMYR--NIAF 211

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELR 324
              RFP+             +  E       LL  +P  R      A+E   HPFF ++ 
Sbjct: 212 GKVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI- 259

Query: 325 EPNARLPNGR----PFPPLFNFKQELAGASPELINRLIPEH--VRRQTGLSMPHSAGT 376
             +  L + +    PF P+ +  ++++   PE  N  +     V  +    +P +  T
Sbjct: 260 --DWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSSLLNAGIVPWEDVPGLPGANST 315

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 41/214 (19%)

Query: 40  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           RV+G G FG V    +      TGE VA+K + ++   +N      E+ +++ + H N++
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
             K C    + +    L L+MEYVP    R  + KH  ++ Q +      L+  QI  G+
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE-- 206
           AY+H+   + HRD+  +N+L+D     VK+ DFG AK + +G          YYR  E  
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170

Query: 207 ---LIFGATE------YTTSIDIWSAGCVLAELL 231
              + + A E      ++ + D+WS G  L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 82/300 (27%), Positives = 131/300 (43%), Gaps = 61/300 (20%)

Query: 40  RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQ---------DRRYKNRELQLMRLMDHP 87
           +V+G G +G VFQ + +   +TG+  A+K VL+         D  +   E  ++  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            ++ L    F T  K    L L++EY+    ++  L+      +         Y  +I  
Sbjct: 61  FIVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT----ACFYLSEISL 111

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAP 205
            L ++H   G+ +RD+KP+N+L+D   H VKL DFG  K  +         C    Y AP
Sbjct: 112 ALEHLHQQ-GIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E I   + +  ++D WS G ++ ++L G P F  EN    + +I+K          +   
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNL 219

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
           P Y                    + PEA DL  +LL+ +PS R       A E  +HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 78.6 bits (193), Expect = 2e-16
 Identities = 82/308 (26%), Positives = 142/308 (46%), Gaps = 46/308 (14%)

Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 83
           G+PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+ +MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             +PN+++    +      DEL++  VMEY+       +   + M++      +     +
Sbjct: 73  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 202
             + L ++H+   V HRD+K  N+L+  +   VKL DFG  A++  +     + + + Y+
Sbjct: 124 CLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +   
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQ--- 236

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
             NP                    +R+     D  +R L+     R +A E   HPF  +
Sbjct: 237 --NP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL-K 273

Query: 323 LREPNARL 330
           L +P + L
Sbjct: 274 LAKPLSSL 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 88/343 (25%), Positives = 142/343 (41%), Gaps = 77/343 (22%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL----------MDHPNVI 90
           V+G G FG V  A+  +TGE  AIK + +       E++ +              HP ++
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +L  CF    ++D +    VMEY    + M  +     S  +         Y   +  GL
Sbjct: 66  NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHTDVFSEPR------AVFYAACVVLGL 114

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 207
            Y+H    + +RD+K  NLL+D     VK+ DFG  K  +      S  C +  + APE+
Sbjct: 115 QYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   T YT ++D W  G ++ E+L+G+  FPG++  +    I+        +E+R     
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEVR----- 219

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF-- 320
                      +P        +  EAI +  RLL+ +P  R  + E  A      PFF  
Sbjct: 220 -----------YPRF------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262

Query: 321 ---DELREPNARLPNGRPFPP-------LFNFKQELAGASPEL 353
              D+L     ++    PF P       + NF +E    +P L
Sbjct: 263 INWDDLL--ARKIKP--PFVPTIKGPEDVSNFDEEFTSEAPVL 301

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 47/285 (16%)

Query: 40  RVVGTGSFGIVFQAKCL---ETGETVAIK-------KVLQDRRYKNRELQLMRLMDHPNV 89
           +V+G GSFG VF  + +   + G+  A+K       KV +DR     E  ++  ++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFI 60

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           + L H  F T  K    L L+++++   +   R+ K      +      VK Y  ++   
Sbjct: 61  VKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALA 110

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPE 206
           L ++H++ G+ +RD+KP+N+L+D   H +KL DFG +K  +  E      C    Y APE
Sbjct: 111 LDHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP------TRE 259
           ++     +T S D WS G ++ E+L G   F G++  + +  I+K  LG P       + 
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227

Query: 260 EIRCM---NPNYTDFRFPQ----IKAHP------WHKVFHKRMPP 291
            +R +   NP       P     IK HP      W+K++ + + P
Sbjct: 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 92
           +V+G G+FG V   +   + +  A+K + +    K         E  +M   +   ++ L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
            H  F    +D+ +L +VMEY+P   +  ++ +Y      +P  + + YT ++   L  I
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAI 158

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPE 206
           H++ G  HRDVKP N+L+D   H +KL DFG+    +K +AN    C        Y +PE
Sbjct: 159 HSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213

Query: 207 LIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
           ++    G   Y    D WS G  L E+L+G   F  ++ V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 24/222 (10%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
           +V+G GSFG V  A+     +  A+K + +    K +E +        L++ + HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L H  F T  K    L  V++Y+   E  Y + +    +  R      + Y  +I   L 
Sbjct: 61  L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           Y+H++  + +RD+KP+N+L+D   H V L DFG  K  ++     S  C +  Y APE++
Sbjct: 111 YLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
                Y  ++D W  G VL E+L G P F   N  +    I+
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 81/286 (28%), Positives = 127/286 (44%), Gaps = 51/286 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 90
           +V+G GSFG V  AK    G   A+K VLQ +    ++ Q         L++ + HP ++
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L H  F T  K    L  V++YV   E  + + +    +  R      + Y  ++   +
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 207
            Y+H++  + +RD+KP+N+L+D   H V L DFG  K  V+ E   S  C +  Y APE 
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII----------------K 251
           +     Y  ++D W  G VL E+L G P F   + V Q+ + I                 
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225

Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAH------PWHKVFHKRMPP 291
           +L     ++ R       DF   +IK H       W  ++HKR+ P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 77.5 bits (190), Expect = 4e-16
 Identities = 68/249 (27%), Positives = 124/249 (49%), Gaps = 20/249 (8%)

Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 83
           G+PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             +PN+++    +      DEL++  VMEY+       +   + M++      +     +
Sbjct: 74  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 124

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 202
             + L ++H+   V HRD+K  N+L+  +   VKL DFG  A++  +     + + + Y+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +   
Sbjct: 183 MAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 240

Query: 263 CMNPNYTDF 271
            ++  + DF
Sbjct: 241 KLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 83/297 (27%), Positives = 128/297 (43%), Gaps = 66/297 (22%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYK-----NRELQLMRLMDHPNVISLK 93
           +GTGSFG V  AK   TGE  AI K L+ R   + K      +E  ++  + HP ++++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAI-KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             F     +DE  +  ++E+V      +  H      R P    K Y  ++     Y+H+
Sbjct: 85  CSF-----QDENRVYFLLEFV--VGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS 136

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
              + +RD+KP+NLL+D   H VK+ DFG AK +   +   +   +  Y APE+I  +  
Sbjct: 137 K-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKG 191

Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--EEI---RCMNPNY 268
           +  ++D W+ G +L E + G P F  +              TP R  E+I   R   PN+
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILAGRLKFPNW 237

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 320
            D R                    A DL   LLQ   + R   L+        HP+F
Sbjct: 238 FDGR--------------------ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.9 bits (189), Expect = 6e-16
 Identities = 86/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 91
           RV+G G FG V   +   TG+  A K+ L+ +R K R        E Q++  ++   V++
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L + +    +KD L L L +    +  + +   Y+  N          Y  +I  GL  +
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H      +RD+KP+N+L+D   H +++ D G A  + +GE+    + +  Y APE++   
Sbjct: 119 HR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             YT S D W  GC++ E++ GQ  F G        E +K      REE+        D 
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV--------DR 215

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFDELREP 326
           R  + +     +V+  +   EA  +   LL   P  R  C    A E   HPFF  +   
Sbjct: 216 RVLETE-----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN-- 268

Query: 327 NARLPNGRPFPPL 339
             RL  G   PP 
Sbjct: 269 FKRLEAGMLDPPF 281

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 7e-16
 Identities = 77/302 (25%), Positives = 126/302 (41%), Gaps = 70/302 (23%)

Query: 43  GTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKHC 95
           G G+FG V++A+  ETG   A K +       L+D      E+ ++    HPN++ L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 96  FFSTTSKDELFLNLVMEYVP--------ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           +F    +++L++  ++E+            + R L              ++    Q+   
Sbjct: 71  YFY---ENKLWI--LIEFCDGGALDSIMLELERGLTEP----------QIRYVCRQMLEA 115

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPE 206
           L ++H+   V HRD+K  N+L+  L   VKL DFG SAK     +   ++I + Y+ APE
Sbjct: 116 LNFLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173

Query: 207 LI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREE 260
           ++    F    Y    DIWS G  L EL   +P  P  + ++ +  ++K+L +  PT + 
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEPPTLD- 229

Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                P              W   F+        D     L   P  R TA E   HPF 
Sbjct: 230 ----QP------------SKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFV 265

Query: 321 DE 322
            +
Sbjct: 266 SD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 79/306 (25%), Positives = 140/306 (45%), Gaps = 59/306 (19%)

Query: 40  RVVGTGSFGIVFQAKCL---ETGETVAIK-----------KVLQDRRYKNRELQLMRLMD 85
           +V+GTG++G VF  + +   ++G+  A+K           K  +  R + + L+ +R   
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 63

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
            P +++L H  F T +K    L+L+++Y+      +  H S   +R     V++Y+ +I 
Sbjct: 64  SPFLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEVQIYSGEIV 115

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRY-YR 203
             L ++H + G+ +RD+K +N+L+D   H V L DFG +K   + E   +Y  C    Y 
Sbjct: 116 LALEHLHKL-GIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 204 APELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
           AP+++ G    +  ++D WS G ++ ELL G   F  +   +   EI + +         
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--------- 224

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAH 317
                        +K+ P    + + M   A D+  RLL   P  R       A E   H
Sbjct: 225 -------------LKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268

Query: 318 PFFDEL 323
           PFF ++
Sbjct: 269 PFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 27/229 (11%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPN 88
           Y   +V+G G+FG V   +   T +  A+K + +       D  +   E  +M   + P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           V+ L + F     +D+ +L +VMEY+P   +  ++ +Y      +P  + + YT ++   
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 204
           L  IH++ G  HRDVKP N+L+D   H +KL DFG+   + K E  +   + + +  Y +
Sbjct: 155 LDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 211

Query: 205 PELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 61/230 (26%), Positives = 114/230 (49%), Gaps = 32/230 (13%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 91
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF    ++  LF   V+EYV   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 61  LHSCF---QTESRLFF--VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           Y+H   G+ +RD+K  N+L+D   H +KL D+G  K  ++     S  C +  Y APE++
Sbjct: 111 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 250
            G  +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 169 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 21/203 (10%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 97
           VG+G++G V++A+ L TGE  A+K +      D     +E+ +++   H N+++    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 98  STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 157
           S  S+++L+  + MEY      + + H +     + + YV   T Q   GLAY+H+  G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127

Query: 158 CHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE--- 213
            HRD+K  N+L+      VKL DFG +AK+        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184

Query: 214 -YTTSIDIWSAGCVLAELLLGQP 235
            Y    DIW+ G    EL   QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 25/228 (10%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPN 88
           Y   +V+G G+FG V   +   + +  A+K + +       D  +   E  +M   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           V+ L  C F    +D+ +L +VMEY+P   +  ++ +Y      +P  + K YT ++   
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANI-SYICSRYYRAP 205
           L  IH++ G+ HRDVKP N+L+D   H +KL DFG+  K+   G     + + +  Y +P
Sbjct: 155 LDAIHSM-GLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212

Query: 206 ELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           E++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 28/229 (12%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y+  + +G GSFG     K  E G+   IK++       ++R    +E+ ++  M HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY----VKLYTYQIF 145
           +  +  F    +     L +VM+Y           Y  +N +  +++    +  +  QI 
Sbjct: 62  VQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKG-EANISYICSRYY 202
             L ++H    + HRD+K QN+    LT    +KL DFG A+VL    E   + I + YY
Sbjct: 112 LALKHVHDRK-ILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
            +PE I     Y    DIW+ GCVL E+   +  F   N  + +++II+
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 66/236 (27%), Positives = 118/236 (50%), Gaps = 32/236 (13%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDH--------PNVIS 91
           RV+G GS+  V   +  +  +  A+K V ++  + + ++  ++   H        P ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF  TTS+    L LV+EYV   + M+ + +      +++P  + + Y  +I   L 
Sbjct: 61  LHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 208
           ++H   G+ +RD+K  N+L+D   H +KL D+G  K  L  G+   ++  +  Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEIIKVLGTPTR 258
            G  EY  S+D W+ G ++ E++ G+  F      P  N  D L ++I  L  P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 93
           V+G GSFG V  A+   T E  AIK + +D   ++ +++       ++ L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 94  HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           H  F T  +    L  VMEYV   + MY++         R    +   Y  +I  GL ++
Sbjct: 67  HSCFQTMDR----LYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELIFG 210
           H+  G+ +RD+K  N+++D   H +K+ DFG  K  +  G    ++  +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              Y  S+D W+ G +L E+L GQ  F GE+  D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 46/288 (15%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPNV 89
           ++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+   D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           + + + F    + D+L   L +    +  Y + +H       M     + Y  +I  GL 
Sbjct: 60  VCMSYAF---HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           ++H    V +RD+KP N+L+D   H V++ D G A    K + + S + +  Y APE++ 
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPG-----ENAVDQLVEIIKV------------ 252
               Y +S D +S GC+L +LL G   F       ++ +D++   + V            
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228

Query: 253 -----LGTPTREEIRCMNPNYTDFR-FPQIKAHPWHKVFHKRMPPEAI 294
                L       + C+     + +  P  ++  W  VF ++ PP  I
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLI 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 62/299 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRLMDHPNV 89
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +LK+ F    + D L    VMEY    E  + + +       R      + Y  +I   
Sbjct: 58  TALKYSF---QTHDRLCF--VMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 206
           L Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +K  A +   C +  Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 84/313 (26%), Positives = 134/313 (42%), Gaps = 50/313 (15%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 91
           RV+G G FG V   +   TG+  A KK L+ +R K R        E Q++  ++   V+S
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L + +    +KD L L L +    +  + +   Y              Y  +I  GL  +
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H    + +RD+KP+N+L+D   H +++ D G A  + +G+     + +  Y APE++   
Sbjct: 119 HQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             YT S D W+ GC+L E++ GQ  F       Q  + IK      REE+  +       
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL------- 216

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326
               +K     + + ++  P+A  L   LL   P  R       A E   HP F ++   
Sbjct: 217 ----VKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268

Query: 327 NARLPNGRPFPPL 339
             RL  G   PP 
Sbjct: 269 FKRLEAGMLEPPF 281

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 68/253 (26%), Positives = 118/253 (46%), Gaps = 29/253 (11%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 96
           +G G+FG V++AK  ETG  +A  KV++ +  +       E++++   +HP ++ L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
           +         L +++E+ P      +          P I  ++   Q+   L Y+H++  
Sbjct: 79  YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLEALQYLHSMK- 130

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGAT--- 212
           + HRD+K  N+L+  L   +KL DFG SAK +   +   S+I + Y+ APE++   T   
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 213 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMNPN 267
             Y    DIWS G  L E+   +P     N +  L++I K     L  P++      +  
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-----WSME 244

Query: 268 YTDFRFPQIKAHP 280
           + DF    +  HP
Sbjct: 245 FRDFLKTALDKHP 257

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 73.1 bits (179), Expect = 9e-15
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPN 88
           +Y   RVVG GS+G V   +    G+   IKK+       ++R+   +E QL+  + HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           +++ +    S   +D L L +VM +     +Y  LK      + +P   V  +  QI   
Sbjct: 61  IVAYRE---SWEGEDGL-LYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 206
           L Y+H    + HRD+K QN+ +   T+ +K+ D G A+VL  + +   + I + YY +PE
Sbjct: 115 LQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172

Query: 207 LIFGATEYTTSIDIWSAGCVLAEL 230
           L F    Y    D+W+ GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 57/255 (22%), Positives = 115/255 (45%), Gaps = 38/255 (14%)

Query: 42  VGTGSFGIVFQAKCLETGET-VAIKKVL-------QDRRYKNR-------ELQLMR-LMD 85
           +G+G+FG V++ +    G+  +A+K++        +D+R +++       E+ +++  + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSM---NQRMPLIYVKLYTY 142
           HPN++     F      D L++  VM+ +        +H++S+    QR     +     
Sbjct: 68  HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
           Q+   L Y+H    + HRD+ P N+++     +V + DFG AK         S + +  Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI- 261
             PE++     Y    D+W+ GC+L ++   QP F   N +    +I++ +  P  E + 
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238

Query: 262 ---------RCMNPN 267
                     C+ P+
Sbjct: 239 SEDVTDVITSCLTPD 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 20/205 (9%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 93
           +G G FG V   +   TG+  A KK L  +R K +        E +++  ++ P +++L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIH 152
           + F S T      L LVM  +     +   H  ++ +R + +  V  Y+ QI  G+ ++H
Sbjct: 60  YAFESKTH-----LCLVMSLMNGGDLKY--HIYNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++  + +RD+KP+N+L+D      +L D G A  L  G+       +  Y APE I    
Sbjct: 113 SM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKEE 169

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLF 237
            Y+  +D ++ GC + E++ G+  F
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 89/344 (25%), Positives = 148/344 (43%), Gaps = 58/344 (16%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLM---RLMDHPNVISLKH 94
           ++G G+FG V +A   +  E  A+K V    +Y      E+Q M   R  D  +   L  
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 95  C--FFSTTSKDELFLNLVM-EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              +F   +     + +VM +Y P  +  ++KH    + R    ++    +Q    L Y 
Sbjct: 196 IQRYFQNETGH---MCIVMPKYGPCLLDWIMKH-GPFSHR----HLAQIIFQTGVALDYF 247

Query: 152 HTVPGVCHRDVKPQNLL-------VDPLTHQ--------VKLCDFGSAKVLVKGEANISY 196
           HT   + H D+KP+N+L       VDP+T++        V++CD G      +  +  + 
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAI 305

Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT- 255
           + +R+YR+PE++ G   +  S D+WS GC++ EL  G+ L+   + ++ L  + K LG  
Sbjct: 306 VSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364

Query: 256 PTREEIRCMNPN----YTDFRFPQIKAHPWH--KVFHKRMPPEAI------DLASRLLQY 303
           P+    RC        Y      +    P H  ++   R   E I      DL   LL Y
Sbjct: 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424

Query: 304 SPSLRCTALEACAHP----FFDELRE-PNARLPNGRPF---PPL 339
               R  A +   HP    ++ E R+ PN   P+ R      P+
Sbjct: 425 DRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRPTPI 466

Length = 467

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 73/303 (24%), Positives = 127/303 (41%), Gaps = 46/303 (15%)

Query: 45  GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 104
           GS G VF A      + V +K  +  +     E  L++ ++HP+VI +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG----- 129

Query: 105 LFLNLVMEYVPETMYRVLKHYSS--------MNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
                           VL HYSS         ++ +P+    +   QI  GL Y+H    
Sbjct: 130 -----------AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR- 177

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 216
           + HRDVK +N+ ++ +  QV + D G+A+  V   A +    +    APE +    +Y +
Sbjct: 178 IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNS 235

Query: 217 SIDIWSAGCVLAELLL----------GQPLFPGENAVDQLVEIIKVLGT-----PTREEI 261
             DIWSAG VL E+L             P    ++    L++II  L       P     
Sbjct: 236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295

Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           R +   + ++   + + +  +  F +  +P +   L  ++L +  ++R +A E   +P F
Sbjct: 296 R-LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354

Query: 321 DEL 323
            +L
Sbjct: 355 AQL 357

Length = 357

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 43/216 (19%)

Query: 42  VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLK 93
           +G G+FG V +   L        VA+K + Q+          RE  +M  +DHP ++ L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
                   K E  + LVME  P      L  Y    + +P+  +K   +Q+  G+AY+ +
Sbjct: 62  ----IGVCKGEPLM-LVMELAPLG---PLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113

Query: 154 VPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--------- 203
              V HRD+  +N LLV+   HQ K+ DFG ++ L  G        S YYR         
Sbjct: 114 KHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPL 162

Query: 204 ---APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 235
              APE I     +++  D+WS G  L E    G  
Sbjct: 163 KWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 70/265 (26%), Positives = 123/265 (46%), Gaps = 37/265 (13%)

Query: 40  RVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYKNR-------ELQLMRLMDHPNVIS 91
           R +GTGSFG V  A    E    VAIK+  + +  K +       E +++  ++HP  ++
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   F     KDE +L LV+E+V    +     +   N+R P      Y  QI     Y+
Sbjct: 96  LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 210
            ++  + +RD+KP+NLL+D     +K+ DFG AKV+   +     +C +  Y APE++  
Sbjct: 148 QSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202

Query: 211 ATEYTTSIDIWSAGCVLAELLLG-------QPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
              +  + D W+ G  + E+L+G       +PL   +  ++ ++   K L    +  ++ 
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK 261

Query: 264 MNPNYTDFRF-------PQIKAHPW 281
           +  +    R+         +K HPW
Sbjct: 262 LLSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 68/326 (20%), Positives = 108/326 (33%), Gaps = 52/326 (15%)

Query: 40  RVVGTGSFG--IVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVIS 91
            ++G       IV  AK   T   VA+KK+  D   K        E+   R + HPN++ 
Sbjct: 4   TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTYQIFRGLA 149
               F       EL++  V   +       L   H+    + +P + +      +   L 
Sbjct: 64  YVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHF---PEGLPELAIAFILKDVLNALD 115

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELI 208
           YIH+  G  HR VK  ++L+     +V L     +  ++K G+               L 
Sbjct: 116 YIHSK-GFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 209 FGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---- 256
           + + E        Y    DI+S G    EL  G   F    A   L+E  KV GT     
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLL 231

Query: 257 ----------TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 306
                     +  + R  N +                 + +             LQ  P 
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPN-------NRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284

Query: 307 LRCTALEACAHPFFDELREPNARLPN 332
            R +A +   H FF + +  N  L +
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 79/324 (24%), Positives = 130/324 (40%), Gaps = 79/324 (24%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRLMDHPNVISL 92
           +++G G  G VF  +   TG+  A+K    K +  R    R   E +++  +DHP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F + T     +L LVM+Y P   ++R+L+      + +     + Y  ++   L Y+
Sbjct: 67  YASFQTET-----YLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYL 119

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDF-------------------GSAKVLVKGEA 192
           H + G+ +RD+KP+N+L+    H + L DF                   GS +  V    
Sbjct: 120 HLL-GIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 193 NISYICS-----------RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           + ++                Y APE+I G   + +++D W+ G +L E+L G   F G N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
             +    I+K                  +  FP              +   A DL  +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269

Query: 302 QYSPSLRC----TALEACAHPFFD 321
              PS R      A E   HPFF 
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 89/343 (25%), Positives = 139/343 (40%), Gaps = 97/343 (28%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 91
           + +G G+FG V  A  ++T    A+K  L+ +   NR        E  ++   D+  V+ 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   ++S   KD L+   VM+Y+P   M  +L       + +   Y+   T  I      
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ES 116

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG---------SAKVLVKGE---------- 191
           +H + G  HRD+KP N+L+D L   +KL DFG         ++K   KG           
Sbjct: 117 VHKM-GFIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174

Query: 192 ------ANI-----------------------SYICSRYYRAPELIFGATEYTTSIDIWS 222
                 +N                        S + +  Y APE++     YT   D WS
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWS 233

Query: 223 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
            G +L E+L+GQP F              +  TPT  +++ +N   T    PQ+K     
Sbjct: 234 VGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK----- 274

Query: 283 KVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDEL 323
                 + PEA+DL ++L   +     R  A +  AHPFF E+
Sbjct: 275 ------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 26/224 (11%)

Query: 40  RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE     VAIK + ++   K       E  +M  +DHP+V+
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     S+       + L+ + +P  +  +L +  +    +   Y+  +  QI +G++Y
Sbjct: 73  RLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 125 LEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 248
           I     YT   D+WS G  + EL+  G   + G  AV+   L+E
Sbjct: 183 IL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 18/206 (8%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-----RLMDHPN---VIS 91
           RV+G G FG V   +   TG+  A KK L+ +R K R+ + M     R+++  N   V+S
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L + +    +KD L L L +    +  + +   Y+  N          Y  ++  GL  +
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
                + +RD+KP+N+L+D   H +++ D G A  + +GE     + +  Y APE+I   
Sbjct: 119 QR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLF 237
            +YT S D W  GC++ E++ GQ  F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPNV 89
           ++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+   D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           + + + F +    D+L   L +    +  Y + +H     + M     + Y  +I  GL 
Sbjct: 60  VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           ++H    V +RD+KP N+L+D   H V++ D G A    K + + S + +  Y APE++ 
Sbjct: 112 HMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
             T Y +S D +S GC+L +LL G   F      D+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 39/249 (15%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 96
           +G G+FG V++A+  ETG  +A  KV+  +  +       E+ ++   DHPN++ L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 97  FSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +   +     L +++E+     V   M  + +  +          +++   Q    L Y+
Sbjct: 72  YYENN-----LWILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYL 119

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFG 210
           H    + HRD+K  N+L   L   +KL DFG SAK     +   S+I + Y+ APE++  
Sbjct: 120 HE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 211 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 262
            T     Y    D+WS G  L E+   +P     N +  L++I K     L  P+R    
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 233

Query: 263 CMNPNYTDF 271
             +  + DF
Sbjct: 234 -WSSEFKDF 241

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 68.0 bits (166), Expect = 5e-13
 Identities = 67/296 (22%), Positives = 131/296 (44%), Gaps = 50/296 (16%)

Query: 36  YMAERVVGTGSFGIVF--QAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDH 86
           Y+ ++ +G GSFG V+  + K     E + + K +        +    N+E QL+  +DH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           P ++     F ++  + + F  ++ EY     +   L+      + +    V  +  Q+ 
Sbjct: 62  PAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI--SYICSRYYR 203
            G+ Y+H    + HRD+K +N+ +    + +K+ DFG +++L+ G  ++  ++  + YY 
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLM-GSCDLATTFTGTPYYM 172

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           +PE +     Y +  DIWS GC+L E+      F G+N    L  +++++  PT      
Sbjct: 173 SPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT------ 222

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
             P+  +                     +   +   +L   PSLR +A E   +PF
Sbjct: 223 --PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 19/209 (9%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRLMDHPNVISLKHCF 96
            VVG G++G V++ + ++TG+  AIK   V +D   +   E+ +++   H   I+  +  
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 97  FSTTS----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           F   S     D+L+  LVME+        L   +  N  +   ++     +I RGLA++H
Sbjct: 82  FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLH 138

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK--GEANISYICSRYYRAPELIF- 209
               V HRD+K QN+L+     +VKL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 139 -AHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 195

Query: 210 ---GATEYTTSIDIWSAGCVLAELLLGQP 235
                  Y    DIWS G    E+  G P
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 57/296 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 92
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           K+ F    + D L    VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 61  KYAF---QTHDRLCF--VMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 110

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 209
           +H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C +  Y APE + 
Sbjct: 111 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 213

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 70.2 bits (171), Expect = 6e-13
 Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 37/248 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR--ELQLMRLMDHPNV 89
           Y   + +G G FG VF  K   T E    K +    L++R       E+ +MR + H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +     F +  ++    L ++ME+     + R ++    M  ++    +   T Q+   L
Sbjct: 75  VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 149 AYIHTVPG------VCHRDVKPQNLL-------VDPLTHQV---------KLCDFGSAKV 186
           AY H +        V HRD+KPQN+        +  +T Q          K+ DFG +K 
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 187 LVKGEANISYIC--SRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
           +  G  ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   N  
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249

Query: 244 DQLVEIIK 251
            QL+  +K
Sbjct: 250 SQLISELK 257

Length = 1021

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 16/221 (7%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFST 99
           +V+G G+FG V   K   T    A+K + +    K  E    R  +  NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 100 T----SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           T     +DE +L LVM+Y       +L   S    R+P    + Y  ++   +  IH + 
Sbjct: 65  TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELIF---- 209
            V HRD+KP N+L+D   H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           G  +Y    D WS G  + E+L G+  F  E+ V+   +I+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 28/221 (12%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LM--DHPNVISL 92
           +V+G G+FG V   K   TG+  A+K + +    K  E    R     L+  D   + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 93  KHCFFSTTSKDELFLNLVMEY-VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
            + F     +DE  L LVM+Y V   +  +L   S    R+P    + Y  ++   +  +
Sbjct: 67  HYAF-----QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKG--EANIS-----YICSRYYR 203
           H + G  HRD+KP N+L+D   H ++L DFGS  ++L  G  ++N++     YI     +
Sbjct: 119 HQL-GYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
           A E   G   Y    D WS G  + E+L G+  F  E+ V+
Sbjct: 177 AME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 33/219 (15%)

Query: 40  RVVGTGSFGIVFQAK-CLETGE--TVAIKKVLQDRRYKNREL-----QLMRLMDHPNVIS 91
           R +G G FG V+Q        E   VA+K          RE       +MR  DHP+++ 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 150
           L        +++ ++  +VME  P      L+ Y  +N+  + L  + LY+YQ+   LAY
Sbjct: 72  L----IGVITENPVW--IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122

Query: 151 IHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRA 204
           + +   V HRD+  +N+LV  P    VKL DFG ++ L   E    Y  S+      + A
Sbjct: 123 LESKRFV-HRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176

Query: 205 PELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 241
           PE I     +T++ D+W  G C+   L+LG +P    +N
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 24/221 (10%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 92
           +++G G+FG V   +   +G+  A+K + ++      E+       ++++   HP + SL
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           K+ F    +KD L    VMEYV   E  + + +       R      + Y  +I   L Y
Sbjct: 61  KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 209
           +H+   + +RD+K +NL++D   H +K+ DFG  K  +   A +   C +  Y APE + 
Sbjct: 111 LHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 29/209 (13%)

Query: 40  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++++R + H N++
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 149
             K      T      + L+ME++P      LK Y   N+ ++ L     Y  QI +G+ 
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLKYAVQICKGMD 123

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-------YY 202
           Y+ +   V HRD+  +N+LV+   HQVK+ DFG  K +   E +  Y   +       ++
Sbjct: 124 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFW 178

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +  +  Y  S D+WS G  L ELL
Sbjct: 179 YAPECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 68/233 (29%), Positives = 107/233 (45%), Gaps = 31/233 (13%)

Query: 20  STTIGGKNGEPKQTISYMA-ERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----R 71
           S++       P    S    ERV  +G+G+ G V++     TG   A+K +  +     R
Sbjct: 57  SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR 116

Query: 72  RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR 131
           R   RE++++R ++HPNV+   H  F    + ++ L        E M       + +   
Sbjct: 117 RQICREIEILRDVNHPNVVKC-HDMFDHNGEIQVLL--------EFMDGGSLEGTHIADE 167

Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG- 190
             L  V     QI  G+AY+H    V HRD+KP NLL++     VK+ DFG +++L +  
Sbjct: 168 QFLADV---ARQILSGIAYLHRRHIV-HRDIKPSNLLINS-AKNVKIADFGVSRILAQTM 222

Query: 191 EANISYICSRYYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 238
           +   S + +  Y +PE I      GA +     DIWS G  + E  LG+  FP
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 45/225 (20%)

Query: 79  QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYV 137
           QLM+  D+PN I L +    TT K  +   L+M+Y+ +  ++ +LK       ++    V
Sbjct: 63  QLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLFDLLK----KEGKLSEAEV 111

Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           K    Q+   L  +H    + H D+K +N+L D    ++ LCD+G  K+ +         
Sbjct: 112 KKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTP------ 163

Query: 198 CSRY-----YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI--- 249
            S Y     Y +PE I G   Y  S D W+ G +  ELL G+   P +   D+ +++   
Sbjct: 164 -SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDLESL 219

Query: 250 ----------IKVLGTPTREEIRCM---NPNYTDFRFPQIKAHPW 281
                     IK +     + ++ M   N NY    + +I  HP+
Sbjct: 220 LKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264

Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLM-RLMDHPN 88
           + +G G+FG V +A      ++     VA+K +        R     EL++M  L +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFR 146
           +++L     + T    + +  + EY     Y  L ++    +   L    L  ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEANISYICS 199
           G+A++ +   + HRD+  +N+L+      VK+CDFG A+        +VKG A +     
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207

Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
             + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 208 -KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 55/247 (22%)

Query: 42  VGTGSFGIVFQAKCLETGE-----TVAIKKVLQDRRYKN-----RELQLMRLM-DHPNVI 90
           +G G+FG V +A+ +         TVA+K +  D   K+      E+++M+++  H N+I
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 91  SLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLIYV 137
           +L       T +  L++  V+EY              P   Y          + +    +
Sbjct: 80  NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
             + YQ+ RG+ ++ +   + HRD+  +N+LV    H +K+ DFG A+       +I +I
Sbjct: 135 VSFAYQVARGMEFLASKKCI-HRDLAARNVLVTE-DHVMKIADFGLAR-------DIHHI 185

Query: 198 CSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 244
              YYR            APE +F    YT   D+WS G +L E+  LG   +PG   V+
Sbjct: 186 --DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 241

Query: 245 QLVEIIK 251
           +L +++K
Sbjct: 242 ELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 73/284 (25%), Positives = 114/284 (40%), Gaps = 46/284 (16%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 96
           +G GSFG VF+     T + VAIK + L++   +     +E+ ++   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
              T      L ++MEY+       L      ++      +K    +I +GL Y+H+   
Sbjct: 72  LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIFGATEYT 215
           + HRD+K  N+L+      VKL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 123 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179

Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275
           +  DIWS G    EL  G+P  P  +                      M+P    F  P+
Sbjct: 180 SKADIWSLGITAIELAKGEP--PNSD----------------------MHPMRVLFLIPK 215

Query: 276 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                    F K       +     L   PS R TA E   H F
Sbjct: 216 NNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 62.4 bits (151), Expect = 4e-11
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 26/204 (12%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 96
           +G GSFG VF+     T + VAIK + L++   +     +E+ ++   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTY--QIFRGLAYIH 152
              T      L ++MEY        L   S+++  +  PL   ++ T   +I +GL Y+H
Sbjct: 72  LKDTK-----LWIIMEY--------LGGGSALDLLEPGPLDETQIATILREILKGLDYLH 118

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 211
           +   + HRD+K  N+L+     +VKL DFG A  L   +   + ++ + ++ APE+I   
Sbjct: 119 SEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQ 175

Query: 212 TEYTTSIDIWSAGCVLAELLLGQP 235
           + Y +  DIWS G    EL  G+P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 32/200 (16%)

Query: 45  GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 104
           G+ G  F     +T E V IK     R     E  ++R ++HP++I LK  F  T +K  
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK-- 156

Query: 105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 164
            F  L++      +Y     Y +  + + +  +      + R + Y+H    + HRD+K 
Sbjct: 157 -FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKA 210

Query: 165 QNLLVDPLTHQVKLC--DFGSAKVLVKGEANISYICSRYY--------RAPELIFGATEY 214
           +N+ ++   H   +C  DFG+A   V   AN      +YY         APEL+     Y
Sbjct: 211 ENIFIN---HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPY 260

Query: 215 TTSIDIWSAGCVLAELLLGQ 234
             ++DIWSAG VL E+    
Sbjct: 261 GPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRLMDHPNVISLKHCFF 97
           +VG G++G V++ + ++TG+  AIK   V  D   +  +E+ +++   H   I+  +  F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 98  STTS----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
              +     D+L+  LVME+        L   +  N  +   ++     +I RGL+++H 
Sbjct: 73  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK--GEANISYICSRYYRAPELIF-- 209
              V HRD+K QN+L+     +VKL DFG +  L +  G  N ++I + Y+ APE+I   
Sbjct: 130 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186

Query: 210 --GATEYTTSIDIWSAGCVLAELLLGQP 235
                 Y    D+WS G    E+  G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 22/224 (9%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LMDHPN--VISL 92
           +V+G G+FG V   K     +  A+K + +    K  E    R     L++  N  + +L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
            + F     +DE  L LVM+Y       +L   S    R+P    + Y  ++   +  +H
Sbjct: 67  HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELIF- 209
            +  V HRD+KP N+L+D +   ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 120 QLHYV-HRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 210 ---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              G  +Y    D WS G  + E+L G+  F  E+ V+   +I+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 26/220 (11%)

Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDH 86
           P++++    ER +G G FG V+      T + VA+K +           +E Q+M+ + H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMP-LIYVKLYTYQI 144
             ++ L    ++  S++E    +V EY+ + ++   LK       R+P L+ +     QI
Sbjct: 61  DKLVQL----YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY--- 201
             G+AY+ +     HRD+  +N+LV       K+ DFG A+++   E   +   +++   
Sbjct: 113 AEGMAYLESR-NYIHRDLAARNILVGE-NLVCKIADFGLARLIEDDEYT-AREGAKFPIK 169

Query: 202 YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
           + APE   +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 30/206 (14%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 96
           +G GSFG V++     T E VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP----LIYVKLYTYQIFRGLAYIH 152
              T      L ++MEY        L   S+++   P      Y+     +I +GL Y+H
Sbjct: 72  LKGTK-----LWIIMEY--------LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIF 209
           +   + HRD+K  N+L   L+ Q  VKL DFG A  L   +    +++ + ++ APE+I 
Sbjct: 119 SERKI-HRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI- 173

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQP 235
             + Y    DIWS G    EL  G+P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 50/242 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----LMDHPNVISLKHC 95
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    ++   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
           F+S   +D+L L L+ME++P   M  +L    ++ +       + Y  +    +  IH +
Sbjct: 67  FYSF--QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE----TQFYIAETVLAIDSIHQL 120

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG------------------------ 190
            G  HRD+KP NLL+D   H VKL DFG    L K                         
Sbjct: 121 -GFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 191 ------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 238
                       +   S + +  Y APE +F  T Y    D WS G ++ E+L+G P F 
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 239 GE 240
            E
Sbjct: 238 SE 239

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 83/320 (25%), Positives = 128/320 (40%), Gaps = 64/320 (20%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 93
           +G G FG V   +   TG+  A KK L  +R K R        E +++  +    ++SL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI---YVKLYTYQIFRGLAY 150
           + F + T      L LVM  +     R   H  ++++  P         YT QI  GL +
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRY--HIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 209
           +H    + +RD+KP+N+L+D   + V++ D G A  L  G++    Y  +  + APEL+ 
Sbjct: 113 LHQ-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLF--PGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           G  EY  S+D ++ G  L E++  +  F   GE          KV     ++ I   +  
Sbjct: 171 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDSVT 219

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-------CTALEACAHPFF 320
           Y D                 +  P +      LL   P  R       C  L    HP F
Sbjct: 220 YPD-----------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLR--THPLF 260

Query: 321 DELREPNARLPNGRPFPPLF 340
            +L   N R       PP F
Sbjct: 261 RDL---NWRQLEAGMLPPPF 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 18/219 (8%)

Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLM 84
           P  + ++     +G G++G VF+    + G   A+K +L      + E++     L  L 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72

Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DHPNV+     ++    K+   L LV+E     ++  ++K +    +RM    +    ++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFG-SAKVLVKGEANISYICSR 200
              GL ++H V    HRDVK  N+L   LT +  VKL DFG SA++        + + + 
Sbjct: 133 ALMGLQHLH-VNKTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188

Query: 201 YYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQP 235
           ++ APE+I       + Y    D+WS G    EL  G P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 49/238 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQ-----DRRYKNRELQLMRLMDHPNV 89
           + +G G FG V +A            TVA+K + +     + R    E  L++ ++HP+V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL---------- 139
           I L    +   S+D   L L++EY     Y  L+ +   ++++   Y+            
Sbjct: 66  IKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 140 --------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 185
                         + +QI RG+ Y+  +  V HRD+  +N+LV     ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKMKISDFGLSR 175

Query: 186 VLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            + + ++ +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 52/243 (21%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LMDHPNVISLKH 94
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R     L++      +K 
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVK- 65

Query: 95  CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F+S   K  L+L  +ME++P   M  +L    ++++       + Y  +    +  IH 
Sbjct: 66  MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA----TQFYIAETVLAIDAIHQ 119

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFG------------------------------- 182
           + G  HRD+KP NLL+D   H VKL DFG                               
Sbjct: 120 L-GFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 183 ---SAKVLVKGEANISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 237
               A+   K    ++Y  + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 238 PGE 240
             E
Sbjct: 237 CSE 239

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 70/278 (25%), Positives = 109/278 (39%), Gaps = 46/278 (16%)

Query: 57  ETGETVAIKKVLQD-----RRYK--NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 109
            TG  VAIK +  D      +     RE  L   + HPN+++L      +       L  
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFA 56

Query: 110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 169
           V EYVP    R L+   + +  +P         Q+   LA  H   G+ HRD+KPQN++V
Sbjct: 57  VFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112

Query: 170 DP--LTHQVKLCDFGSAKVLVKGEANI--------SYICSRYYRAPELIFGATEYTTSID 219
               +    K+ DFG   +L                 + +  Y APE + G    T + D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSD 171

Query: 220 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ-IKA 278
           +++ G +  E L GQ +  G +    + EI+           + ++P   D   P  I  
Sbjct: 172 LYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--DVSLPPWIAG 215

Query: 279 HPWHKVFHKRM---PPEAIDLASRLLQYSPSLRCTALE 313
           HP  +V  K +   P +    A  L +   +L   AL 
Sbjct: 216 HPLGQVLRKALNKDPRQRAASAPALAERFRALELCALV 253

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 75/275 (27%)

Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIK--------KVLQDRRYKN 75
            P   + ++ E  +G G+FG V++ +        +  +VAIK        KV Q+ R   
Sbjct: 2   IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--- 56

Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ----- 130
           +E +LM  + HPN++    C     +K++    ++ EY+    +  L  +   N      
Sbjct: 57  QEAELMSDLQHPNIV----CLLGVCTKEQP-TCMLFEYLA---HGDLHEFLVRNSPHSDV 108

Query: 131 ---------RMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 179
                    +  L          QI  G+ Y+ +     HRD+  +N LV      VK+ 
Sbjct: 109 GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKIS 166

Query: 180 DFGSAKVLVKGEANISYICSRYYR------------APELI-FGATEYTTSIDIWSAGCV 226
           DFG ++ +   +         YYR             PE I +G  ++TT  DIWS G V
Sbjct: 167 DFGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVV 215

Query: 227 LAELL-LG-QPLFPGENAVDQLVEIIK---VLGTP 256
           L E+   G QP +   N   +++E+I+   +L  P
Sbjct: 216 LWEIFSYGLQPYYGFSN--QEVIEMIRSRQLLPCP 248

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 18/221 (8%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISLKHCF 96
           +G G++G V++    + G   A+K +L      + E++     L  L +HPNV+     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +         L LV+E     ++  ++K      QR+    +    Y    GL ++H   
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147

Query: 156 GVCHRDVKPQNLLVDPLTHQ--VKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGAT 212
            + HRDVK  N+L   LT +  VKL DFG SA++        + + + ++ APE+I    
Sbjct: 148 RIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204

Query: 213 EYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
           +Y  S     D+WS G    EL  G P     + V  L +I
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 24/169 (14%)

Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEA 192
           Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+        + KG+A
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
            +       + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +
Sbjct: 242 RLPL----KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDE 289

Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
                 +E  R   P+YT     Q     WH    +R  P   +L   L
Sbjct: 290 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 44/244 (18%)

Query: 45  GSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS 101
           GS G VF   C + G+      I K +   +   RE+ +++ + H  +I+L H +     
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155

Query: 102 KDELFLNLVMEYVPETMYRVLKH----YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 157
           + +  + +VM           K     Y   +  +PL        ++   LAY+H   G+
Sbjct: 156 RWKSTVCMVM--------PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGI 206

Query: 158 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPELIFGAT 212
            HRDVK +N+ +D   + V L DFG+A  L       +  C  +       +PEL+    
Sbjct: 207 IHRDVKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALD 262

Query: 213 EYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
            Y    DIWSAG VL E+ +    LF  +          K   +  R  IRCM  +    
Sbjct: 263 PYCAKTDIWSAGLVLFEMSVKNVTLFGKQV---------KSSSSQLRSIIRCMQVH--PL 311

Query: 272 RFPQ 275
            FPQ
Sbjct: 312 EFPQ 315

Length = 392

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 35/227 (15%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR----ELQLMRLMDHPNVISLKH 94
           ER +G+G FG V++         VAIK +  D   K +    E+Q ++ + H ++ISL  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYR-VLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYI 151
             F+  S  E         + E M +  L  +  S   Q +P+  +     Q+  G+AY+
Sbjct: 68  --FAVCSVGEPVY-----IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Query: 152 HTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVL-----VKGEANISYICSRYYRAP 205
                  HRD+  +N+LV + L    K+ DFG A+++     +  +  I Y     + AP
Sbjct: 121 EE-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY----KWTAP 173

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 248
           E       ++T  D+WS G +L E+   GQ  +PG N     DQ+  
Sbjct: 174 EAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 73/270 (27%), Positives = 110/270 (40%), Gaps = 69/270 (25%)

Query: 30  PKQTISYMAERVVGTGSFGIVFQAKC--LETGET---VAIKKVLQD------RRYKNREL 78
            + TI     R +G G+FG VF  +C  LE       VA+ K L++      R+   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59

Query: 79  QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-------SMNQ 130
           +L+    H N++         T  D     +V EY+    + + L+ +        S + 
Sbjct: 60  ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 131 RM-PLIYVKLY--TYQIFRGLAYI---HTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGS 183
            M  L   +L     QI  G+ Y+   H V    HRD+  +N LV   L   VK+ DFG 
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV----HRDLATRNCLVGYDLV--VKIGDFGM 168

Query: 184 AKVLVKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL 231
           ++ +        Y    YYR             PE I     +TT  D+WS G VL E+ 
Sbjct: 169 SRDV--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIF 218

Query: 232 L--GQPLFPGENAVDQLVEIIK---VLGTP 256
               QP +   N  ++++E I    +L  P
Sbjct: 219 TYGKQPWYGLSN--EEVIECITQGRLLQRP 246

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 15/168 (8%)

Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 199
           Y++Q+ RG+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 200 RY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT 255
           R    + APE IF    YTT  D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288

Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP-PEAIDLASRLLQ 302
             ++  R   P        +I    W     +R      +++   LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 21/215 (9%)

Query: 36  YMAERVVGTGSFGIVFQA-KCLETGETVAIKKV-LQDRR---YKNRELQLMRLMDHPNVI 90
           Y+   +VG       F A +  +  E V  K V L D R   Y   EL  +   DH  ++
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 91  SLKHCFFSTTSKDELFLNLVMEY-VPETMYRVLKHYSSMNQRMPL--IYVKLYTYQIFRG 147
             KH F    S D+L L  +MEY     + + +K    + + +P     V L  YQI   
Sbjct: 129 --KH-FDDFKSDDKLLL--IMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLA 181

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---VKGEANISYICSRYYRA 204
           L  +H+   + HRD+K  N+ + P T  +KL DFG +K     V  +   S+  + YY A
Sbjct: 182 LDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
           PEL +    Y+   D+WS G +L ELL     F G
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273

Length = 478

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRYKNRELQLMRLMDHPNVISLKH 94
             +G G+FG V++   L+    VA+K          +R   +E ++++  DHPN++ L  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
                  K  +++  VME VP      L        R+ +  +   +     G+ Y+ + 
Sbjct: 58  -IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-------APE- 206
               HRD+  +N LV    + +K+ DFG    + + E    Y  S   +       APE 
Sbjct: 112 KNCIHRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEA 166

Query: 207 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
           L +G   YT+  D+WS G +L E   LG   +PG
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 29/212 (13%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRLMDHPNVI 90
           +V+G+G+FG V++   +  GETV I    K+L +       ++      +M  MDHP+++
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     S T      + LV + +P    +  V +H  ++  ++ L +      QI +G+
Sbjct: 73  RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC----VQIAKGM 122

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A 
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLL--GQP 235
           E I    ++T   D+WS G  + EL+   G+P
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 64/285 (22%)

Query: 40  RVVGTGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDRRYKNRELQLMRLMDHPN 88
             +G+G+FG V++    +     +G   VA+K        Q+++   +E  LM   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-------TMYRVLKHYSSMNQRMPLIYVKLYT 141
           ++ L                ++ME +            RV +    +     L+ + L  
Sbjct: 61  IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL-- 113

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----VKLCDFGSAKVLVKGEANISYI 197
             + +G  Y+  +  + HRD+  +N LV    +     VK+ DFG A+ + K        
Sbjct: 114 -DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-------- 163

Query: 198 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 243
            S YYR            APE L+ G   +TT  D+WS G ++ E+L LGQ  +P  N  
Sbjct: 164 -SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220

Query: 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 288
           + L  +            R   P     +  Q+  + W +   +R
Sbjct: 221 EVLQHV--------TAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 91  SLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 148
            L   C  ST       + L+ + +P   +  L  Y   ++  +   Y+  +  QI +G+
Sbjct: 73  RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     V HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 123 NYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 55/235 (23%)

Query: 39  ERVVGTGSFGIVFQ--AKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPN 88
            R +G GSFG+V++  AK +  GE    VAIK V     +++R     E  +M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--------SSMNQRMPLIYVKLY 140
           V+ L        S  +  L +VME + +     LK Y         +     P    K  
Sbjct: 71  VVRL----LGVVSTGQPTL-VVMELMAKGD---LKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 141 TY--QIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYI 197
               +I  G+AY+       HRD+  +N +V + LT  VK+ DFG  +       +I   
Sbjct: 123 QMAAEIADGMAYLAAKK-FVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE- 171

Query: 198 CSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            + YYR            APE +     +TT  D+WS G VL E+  L +  + G
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 20/247 (8%)

Query: 12  DAVTGHIIST---TIGGKNGEPK-QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV 67
           DA+ G +  T   T        K Q   Y   RV+G+G+ G V  AK +  GE  A+K V
Sbjct: 6   DAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVV 65

Query: 68  ------LQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE---LFLNLVMEYVPETM 118
                   D+     E+  +   D  +++     F     ++    L + LV++Y     
Sbjct: 66  DMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGD 125

Query: 119 YRV-LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 177
            R  +K  +  N+        L   Q+   + ++H+   + HRD+K  N+L+      VK
Sbjct: 126 LRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVK 183

Query: 178 LCDFGSAKVL---VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 234
           L DFG +K+    V  +   ++  + YY APE I+    Y+   D++S G +L ELL  +
Sbjct: 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLK 242

Query: 235 PLFPGEN 241
             F GEN
Sbjct: 243 RPFDGEN 249

Length = 496

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 26/208 (12%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 90
           E V+G G FG V + +    G+    VAIK +      + RR    E  +M   DHPN+I
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 149
            L+     T S+  + +   ME         L  +   N  +  +I +      I  G+ 
Sbjct: 69  HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------YYR 203
           Y+  +  V HRD+  +N+LV+      K+ DFG ++ L    ++ +Y  S        + 
Sbjct: 121 YLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL 231
           APE I    ++T++ D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 52/228 (22%), Positives = 98/228 (42%), Gaps = 37/228 (16%)

Query: 42  VGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLK 93
           +G GSFG+V + +   +G     VA+K +  D+         +E  +M  +DH N+I L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 94  HCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
               +          +V E  P     + + +    +        +  +  Y  QI  G+
Sbjct: 63  GVVLTHPLM------MVTELAPLGSLLDRLRKDALGH------FLISTLCDYAVQIANGM 110

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+ +   + HRD+  +N+L+     +VK+ DFG  + L + E +  Y+   + +     
Sbjct: 111 RYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAW 166

Query: 204 -APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 249
            APE +   T ++ + D+W  G  L E+   G+  + G +    L +I
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 20/150 (13%)

Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 199
           Y++Q+ RG+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   +  Y+  
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYK---DPDYVRK 232

Query: 200 RYYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKV 252
              R      APE IF    YTT  D+WS G +L E+  LG   +PG       V+I + 
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284

Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
                +E  R   P Y       I    WH
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWH 314

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 47/284 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRLMDHPNVIS 91
           RV+G G FG V+    +++       A+K +     L++     +E  +M+   HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP----LIYVKLYTYQIFRG 147
           L           E      +  +P   +  L+++       P    LI   L   Q+ +G
Sbjct: 61  L----LGICLPSE---GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKG 110

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 207
           + Y+ +   V HRD+  +N ++D  +  VK+ DFG A+ +   E    Y     +   +L
Sbjct: 111 MEYLASKKFV-HRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----YYSVHNHTGAKL 164

Query: 208 --IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258
              + A E      +TT  D+WS G +L EL+  G P +P  ++ D  V +++  G    
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLL 222

Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
           +   C +P Y      ++    WH     R  P   +L SR+ Q
Sbjct: 223 QPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 15/108 (13%)

Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEA 192
           ++ Q+ +G+ ++       HRDV  +N+L+       K+CDFG A+        +VKG A
Sbjct: 217 FSSQVAQGMDFL-ASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            +       + APE IF    YT   D+WS G +L E+  LG+  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 26/152 (17%)

Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAK-------VLVKG 190
           ++YQ+ +G++++       HRD+  +N+L   LTH    K+CDFG A+        +VKG
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIRNDSNYVVKG 274

Query: 191 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 249
            A +       + APE IF    YT   D+WS G +L E+  LG   +PG     +  ++
Sbjct: 275 NARLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329

Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 281
           IK       E  R ++P         I    W
Sbjct: 330 IK-------EGYRMLSPECAPSEMYDIMKSCW 354

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 44/217 (20%)

Query: 41  VVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 90
            +G G FG VF AK      E GET+ + K LQ  + +N      REL + R + H NV+
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYT--YQI 144
            L         + E    +++EY      +   R  K      +  PL   +      QI
Sbjct: 72  RL----LGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR- 203
             G+ ++     V HRD+  +N LV     +VK+    S   L K   N     S YY+ 
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLVSS-QREVKV----SLLSLSKDVYN-----SEYYKL 175

Query: 204 ----------APELIFGATEYTTSIDIWSAGCVLAEL 230
                     APE +    +++T  D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 19/161 (11%)

Query: 45  GSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQL------MRLMDHPNVISLKHCFF 97
           G+FG V+  +     +  A+K V + D   KN   Q+      + L   P ++ L   ++
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71

Query: 98  STTSKDELFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
           S  S + ++L  VMEY+     + L H Y   ++ M + Y+     ++   L Y+H   G
Sbjct: 72  SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR-HG 124

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + HRD+KP N+L+    H +KL DFG +KV +  E N+  I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 54/281 (19%)

Query: 42  VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 88
           +G G FG V  A+ L       +   TVA+K +  D   K+      E+++M+++  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL--------KHYSSMNQRMP---LIYV 137
           +I+L     + T    L++  ++EY  +   R            YS    R+P   + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 138 KLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
            L   TYQ+ RG+ Y+ +   + HRD+  +N+LV    + +K+ DFG    L +   NI 
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVTE-NNVMKIADFG----LARDVNNID 191

Query: 196 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 247
           Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249

Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 288
           +++K  G    +   C N  Y   R        WH +   R
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 32/210 (15%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 90
           E+V+G G FG V   +    G+    VAIK +      + RR    E  +M   DHPN+I
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            L+     T SK  +   +V EY+     +   R  KH    + +  +I +      I  
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYMENGSLDAFLR--KH----DGQFTVIQLVGMLRGIAS 117

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----Y 201
           G+ Y+  + G  HRD+  +N+LV+      K+ DFG ++VL + +   +Y          
Sbjct: 118 GMKYLSDM-GYVHRDLAARNILVNS-NLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIR 174

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           + APE I    ++T++ D+WS G V+ E++
Sbjct: 175 WTAPEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRY--KNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I    KVL++      N+E+     +M  +  P V 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 149
            L     ++T      + LV + +P   Y  L  Y   N+ R+    +  +  QI +G++
Sbjct: 73  RLLGICLTST------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPE 206
           Y+  V  V HRD+  +N+LV    H VK+ DFG A++L   E        +    + A E
Sbjct: 124 YLEEVRLV-HRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 207 LIFGATEYTTSIDIWSAGCVLAELL 231
            I     +T   D+WS G  + EL+
Sbjct: 182 SIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 11/106 (10%)

Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANIS-- 195
           +TYQ+ RG+ ++ +   V HRD+  +N+L   L     VK+CDFG A+ ++     +S  
Sbjct: 242 FTYQVARGMEFLASKNCV-HRDLAARNVL---LAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 196 -YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                  + APE IF    YTT  D+WS G +L E+  LG   +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 31/209 (14%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 90
           E+V+G G FG V + +    G+    VAIK +      + R     E  +M   DHPN+I
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
            L+       +K    + ++ EY+   ++ + L+      +      V +    I  G+ 
Sbjct: 69  RLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM-LRGIASGMK 120

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQV-KLCDFGSAKVLVKGEANISY------ICSRYY 202
           Y+  +    HRD+  +N+LV+  ++ V K+ DFG ++ L   ++  +Y      I  R+ 
Sbjct: 121 YLSEM-NYVHRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE I    ++T++ D+WS G V+ E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 21/152 (13%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 92
           + +G G+FG V   + ++T    A+K + + D   +N+      E  ++   D+  V+ L
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
              ++S   KD L+   VM+Y+P  + M  +++              + Y  ++   +  
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIES 116

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 182
           +H + G  HRD+KP N+L+D   H +KL DFG
Sbjct: 117 VHKM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 69/243 (28%), Positives = 98/243 (40%), Gaps = 62/243 (25%)

Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 79
           P+  I Y   R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 3   PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 80  LMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYV-PETMYRVLKHYSSMNQ------- 130
           LM   DHPN++ L   C           + L+ EY+    +   L+H S   Q       
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKP------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114

Query: 131 ---------RMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 179
                     +PL   +      Q+  G+AY+     V HRD+  +N LV      VK+ 
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIA 172

Query: 180 DFGSAKVLVKGEANISYICSRYYRA------------PELIFGATEYTTSIDIWSAGCVL 227
           DFG ++       NI    + YY+A            PE IF    YTT  D+W+ G VL
Sbjct: 173 DFGLSR-------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVL 222

Query: 228 AEL 230
            E+
Sbjct: 223 WEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 54/192 (28%), Positives = 83/192 (43%), Gaps = 35/192 (18%)

Query: 77  ELQLMRLMDHPNVISL--KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           E +L+R + HP V++L         T        LV+      +Y  L    +  + + L
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC-------LVLPKYRSDLYTYL---GARLRPLGL 259

Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
             V     Q+   + YIH   G+ HRD+K +N+LV+     + L DFG+A    +G    
Sbjct: 260 AQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG---- 312

Query: 195 SYICSRYY--------RAPELIFGATEYTTSIDIWSAGCVLAEL------LLGQPLFPGE 240
           S+    +Y         APE++ G   YT S+DIWSAG V+ E       L         
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371

Query: 241 NAVD-QLVEIIK 251
              D Q++ II+
Sbjct: 372 RPYDAQILRIIR 383

Length = 461

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 79/315 (25%), Positives = 131/315 (41%), Gaps = 70/315 (22%)

Query: 42  VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRLMD-HPN 88
           +G G FG V +A+         +   TVA+K +  +   K+      E++LM+L+  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 89  VISLK---------HCFFSTTSKDEL--FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 137
           +I+L          +      +K  L  FL       P+  + + K          L + 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-----QLSFK 134

Query: 138 KLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
            L +  YQ+ RG+ Y+ +   + HRD+  +N+LV    + +K+ DFG    L +G  +I 
Sbjct: 135 DLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVTE-DNVMKIADFG----LARGVHDID 188

Query: 196 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 247
           Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L 
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELF 246

Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR----------------MPP 291
           +++       RE  R   P+        +    WH V  +R                +  
Sbjct: 247 KLL-------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299

Query: 292 EAIDLASRLLQYSPS 306
           E +DL+    QYSPS
Sbjct: 300 EYLDLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 26/211 (12%)

Query: 40  RVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
           R +G G FG V++   L    T VA+K +            E Q+M+ + HP +I L   
Sbjct: 12  RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66

Query: 96  FFSTTSKDE--LFLNLVMEYVPETMYRVLKHYSSMNQRMP-LIYVKLYTYQIFRGLAYIH 152
            ++  + +E    +  +M+Y   ++   L+  +    ++P LI +     Q+  G+AY+ 
Sbjct: 67  -YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLE 120

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIF 209
               + HRD+  +N+LV    +  K+ DFG A+V+ +     +   +++   + APE   
Sbjct: 121 AQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL 177

Query: 210 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
               ++   D+WS G +L E++  G+  +PG
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 81/316 (25%), Positives = 132/316 (41%), Gaps = 71/316 (22%)

Query: 42  VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 88
           +G G FG V  A+ +   +       TVA+K +  D   K+      E+++M+++  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL--------KHYSSMNQRMP---LIYV 137
           +I+L     + T    L++  ++EY  +   R            YS    ++P   L + 
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 138 KLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
            L +  YQ+ RG+ Y+ +   + HRD+  +N+LV    + +K+ DFG    L +   NI 
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVTE-DNVMKIADFG----LARDVHNID 188

Query: 196 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 247
           Y            + APE +F    YT   D+WS G +L E+  LG   +PG   V++L 
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF 246

Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-----------------MP 290
           +++K       E  R   P         I    WH V  +R                   
Sbjct: 247 KLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299

Query: 291 PEAIDLASRLLQYSPS 306
            E +DL+    QYSP 
Sbjct: 300 DEYLDLSVPFEQYSPG 315

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 98
           +G G +G V++    +   TVA+K + +D        +E  +M+ + HPN++ L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 69

Query: 99  TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTVPG 156
             +++  F  ++ E++    Y  L  Y     R  +  V L     QI   + Y+     
Sbjct: 70  VCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KN 124

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 213
             HRD+  +N LV    H VK+ DFG ++ L+ G+   ++  +++   + APE +    +
Sbjct: 125 FIHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNK 181

Query: 214 YTTSIDIWSAGCVLAEL-LLGQPLFPG 239
           ++   D+W+ G +L E+   G   +PG
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 16/169 (9%)

Query: 128 MNQRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 185
           +N+   L Y+ L  ++YQ+  G+ ++ +   V HRD+  +N+L+      VK+CDFG A+
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLAR 287

Query: 186 VLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGEN 241
            +++    IS         + APE IF    YTT  D+WS G +L E+  LG   +P   
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346

Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 290
             +Q    IK          R   P +      +I    W + F  R  
Sbjct: 347 MNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 57/220 (25%), Positives = 84/220 (38%), Gaps = 69/220 (31%)

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY- 201
           QI   L  +H+  G+ HRDVKPQN++    +   K+ D G+A  L  G   I+YI   + 
Sbjct: 263 QILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 202 ----YRAPELIFGATEYTTS----------------------IDIWSAGCVLAELLLGQP 235
               Y APE    +T+ T S                       DI+SAG     L+  Q 
Sbjct: 319 LDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQM 372

Query: 236 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---- 291
            FP   +   L++         R+  R       D+         W K+   R  P    
Sbjct: 373 AFPNLRSDSNLIQF-------NRQLKRN------DYDLVA-----WRKLVEPRASPDLRR 414

Query: 292 --EAIDLASR--------LLQYSPSLRCTALEACAHPFFD 321
             E +DL           ++++    R +A  A AHP+FD
Sbjct: 415 GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 40/189 (21%)

Query: 63  AIKKVLQDRRYKNRELQLMRLMDHPNVISL-------KHCFFSTTSKDELFLN-LVMEYV 114
           A     +D     +E++++  +  PN+  L                 +   LN  + ++V
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114

Query: 115 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 174
            ET    L   S       L+Y+     QI  G+ Y+ ++  V HRD+  +N LV    +
Sbjct: 115 AET--SGLACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLATRNCLVGKN-Y 167

Query: 175 QVKLCDFGSAKVLVKGEANISYICSRYY----RAP--------ELIFGATEYTTSIDIWS 222
            +K+ DFG ++ L        Y    YY    RAP        E +    ++TT  D+W+
Sbjct: 168 TIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWA 217

Query: 223 AGCVLAELL 231
            G  L E+L
Sbjct: 218 FGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 56/291 (19%)

Query: 40  RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 90
           R++G G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNVI
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ------RMPLIYVKLYTYQI 144
            L      + +K  L + +V+  +P   +  L  +  M++       +PL  +  +   I
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR- 203
             G+ Y+ +     HRD+  +N +++     V + DFG +K +  G+         YYR 
Sbjct: 123 ASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGD---------YYRQ 171

Query: 204 --APELIFG--ATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENAVDQLVEIIK 251
             A +L     A E      YTT  D+W+ G  + E++  GQ  + G EN+     EI  
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYN 226

Query: 252 VL--GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
            L  G   ++   C+   Y      ++    W      R  P    L  +L
Sbjct: 227 YLIKGNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 23/218 (10%)

Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDH 86
           P++T+     + +G G FG V+          VAIK + Q          E  LM+ + H
Sbjct: 4   PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           P ++ L    ++  +++ +++  + EY+   ++   LK  +    ++ +  +     QI 
Sbjct: 61  PRLVRL----YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIA 112

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYR 203
            G+A+I       HRD++  N+LV       K+ DFG A+++   E  A         + 
Sbjct: 113 EGMAFIE-RKNYIHRDLRAANILVSETLC-CKIADFGLARLIEDNEYTAREGAKFPIKWT 170

Query: 204 APELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
           APE I +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 171 APEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 65/246 (26%)

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           PN++ L H +    S+D +FL  V+++        L  + S    +P   VK +  ++  
Sbjct: 45  PNMVCL-HKYI--VSEDSVFL--VLQHAEGGK---LWSHISKFLNIPEECVKRWAAEMVV 96

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK---GEANISYICSRYYR 203
            L  +H    VC RD+ P N+L+D   H ++L  F     +     GEA         Y 
Sbjct: 97  ALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYC 149

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE + G +E T + D WS G +L ELL G+ L                        + C
Sbjct: 150 APE-VGGISEETEACDWWSLGAILFELLTGKTL------------------------VEC 184

Query: 264 MNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---- 315
            +P+    +T    P+             +  EA  L  +LLQ++P+ R  A  A     
Sbjct: 185 -HPSGINTHTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231

Query: 316 -AHPFF 320
            +HPFF
Sbjct: 232 KSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 25/225 (11%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRLMDHPNVI 90
           S    + +G G FG V+       G T VA+K +            E Q+M+ + H  ++
Sbjct: 7   SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
            L    ++  S++ +++  V EY+ + ++   LK       ++P + V +   Q+  G+A
Sbjct: 65  QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116

Query: 150 YIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPE 206
           YI  +  + HRD++  N+LV D L    K+ DFG A+++   E  A         + APE
Sbjct: 117 YIERMNYI-HRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Query: 207 L-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 249
             ++G   +T   D+WS G +L EL+  G+  +PG N  + L ++
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 58/234 (24%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRL---MDHPNVISL 92
           R++G G  G V+ A        VA+KK+ +D       K R L+  ++   + HP ++ +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPL---------------IY 136
               +S  S  +  +   M Y+   T+  +LK   S+ Q+  L               I+
Sbjct: 68  ----YSICSDGDP-VYYTMPYIEGYTLKSLLK---SVWQKESLSKELAEKTSVGAFLSIF 119

Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVK 189
            K     I   + Y+H+  GV HRD+KP N+L+  L  +V + D+G+A         L+ 
Sbjct: 120 HK-----ICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 190 GEANISYICSRY------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 231
            + +   IC               Y APE + G    + S DI++ G +L ++L
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 66/255 (25%), Positives = 102/255 (40%), Gaps = 54/255 (21%)

Query: 39  ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRLMDHPNV 89
           +R +G G+FG VF A+C     T     VA+K +    L  R+   RE +L+  + H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLIY 136
           +      F     D   L +V EY+             P+ M  V          + L  
Sbjct: 70  VK-----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 196
           +     QI  G+ Y+ +   V HRD+  +N LV      VK+ DFG ++ +         
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSRDVYS------- 175

Query: 197 ICSRYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP-GEN 241
             + YYR             PE I    ++TT  D+WS G +L E+     QP F     
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232

Query: 242 AVDQLVEIIKVLGTP 256
            V + +   +VL  P
Sbjct: 233 EVIECITQGRVLERP 247

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 27/155 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 92
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E  ++   D+  V+ L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM---PLIYVKLYTYQIFRG 147
              ++S   KD L+   VM+Y+P  + M        S+  RM   P    + Y  ++   
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPGGDMM--------SLLIRMGIFPEDLARFYIAELTCA 113

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 182
           +  +H + G  HRD+KP N+L+D   H +KL DFG
Sbjct: 114 VESVHKM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 21/208 (10%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM---DHPNVISLKHC 95
           ++G G+FG VF+   L+    VA+K   +D  +  K + L   R++   DHPN++ L   
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
               T +  ++  +VME VP   +  L         +    +  +      G+AY+ +  
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-K 112

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGAT 212
              HRD+  +N LV    + +K+ DFG ++    G    + +  I  ++     L +G  
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG-- 169

Query: 213 EYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            Y++  D+WS G +L E   LG   +PG
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 61/268 (22%), Positives = 117/268 (43%), Gaps = 35/268 (13%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVISLKHCFF 97
           +G+G FG+V+    LE  + VAIK +    + +  +   E Q+M  + HP ++ L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 98  STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
             +      + LV E++    +   L+       +  L+ + L    +  G+AY+ +   
Sbjct: 70  ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL---DVCEGMAYLES-SN 120

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 213
           V HRD+  +N LV      VK+ DFG  + ++  +   S   +++   + +PE +F  ++
Sbjct: 121 VIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFSK 177

Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           Y++  D+WS G ++ E +  +   P EN  +   E+++ +        R   P       
Sbjct: 178 YSSKSDVWSFGVLMWE-VFSEGKTPYENRSNS--EVVETINA----GFRLYKPRLASQSV 230

Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLL 301
            ++  H W      +  PE     S LL
Sbjct: 231 YELMQHCW------KERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           ++V+G G FG VF+      G     VAIK +      K R     E  +M    H N+I
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L+     T  K  + +   ME     + + L+ +        L+ +      I  G+ Y
Sbjct: 70  RLEGVV--TKFKPAMIITEYME--NGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMKY 122

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 205
           +  +  V HRD+  +N+LV+    + K+ DFG ++VL + +   +Y  S       + AP
Sbjct: 123 LSDMNYV-HRDLAARNILVNS-NLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAP 179

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T++ D+WS G V+ E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 83/331 (25%), Positives = 135/331 (40%), Gaps = 85/331 (25%)

Query: 30  PKQTISYMAERVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQ 79
            ++ I+ + E  +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLI 135
           +M+     +V+ L        SK +  L +VME +     ++  R L+  +  N   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 136 YVK---LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            ++       +I  G+AY++    V HRD+  +N +V      VK+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMVAH-DFTVKIGDFGMTRDIYETD- 173

Query: 193 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFP 238
                   YYR            APE +     +TTS D+WS G VL E+  L  QP   
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQG 224

Query: 239 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 298
             N  +Q+++ +             M+  Y D         P         P    DL  
Sbjct: 225 LSN--EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255

Query: 299 RLLQYSPSLRCTALEACA------HPFFDEL 323
              Q++P +R T LE         HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 51/197 (25%), Positives = 81/197 (41%), Gaps = 26/197 (13%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRLMDHPNVISLKHCFFS 98
           +G G FG V        G+ VA+K +  D         E  +M  + HPN++ L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 99  TTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
                   L +V EY+ +     L  Y  S     + L     +   +  G+ Y+     
Sbjct: 72  GNP-----LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 213
           V HRD+  +N+LV       K+ DFG AK     EA+      +    + APE +    +
Sbjct: 124 V-HRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175

Query: 214 YTTSIDIWSAGCVLAEL 230
           ++T  D+WS G +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 31/208 (14%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRLMDHPNVI 90
           +++G+G FG V +   +  G+++ I    K +QDR  +         +  M  +DH  ++
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 91  SLKH-CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            L   C  ++       L LV +  P    +  V +H  S++ +  L +      QI +G
Sbjct: 73  RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKG 121

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----ICSRYYR 203
           + Y+     + HR++  +N+L+      V++ DFG A +L   +    Y       ++  
Sbjct: 122 MYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL 231
              ++FG   YT   D+WS G  + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 37/126 (29%), Positives = 49/126 (38%), Gaps = 38/126 (30%)

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           Y APE++   T YT   D WS G +L E+L+GQP F  +              TP   ++
Sbjct: 210 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQL 254

Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFH----KRMPPEAIDLASRLLQYSPSLRC---TALEA 314
           + +N               W    H     ++  EA DL  RL       R     A E 
Sbjct: 255 KVIN---------------WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEI 298

Query: 315 CAHPFF 320
            AHPFF
Sbjct: 299 KAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 50/223 (22%)

Query: 42  VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISL 92
           +G G+FG VF A+C     E  + +   K L++     R+   RE +L+ ++ H +++  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK------HYSSMNQRMPLIYVKL-----Y 140
              F+   ++    L +V EY+    + R L+         +  + +    + L      
Sbjct: 72  ---FYGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 200
             QI  G+ Y+ ++  V HRD+  +N LV      VK+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYLASLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD--------- 176

Query: 201 YYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 231
           YYR             PE I    ++TT  DIWS G VL E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 39/230 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ-------LMRLMDHPNV 89
           +++G G FG V + + L   +   +K   K ++   +   E++        M+  DHPNV
Sbjct: 5   KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 90  ISLKHCFFSTTSKDELFLNLV----MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           + L    F  +S  ++   +V    M++     + +      + +++PL  +  +   I 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
            G+ Y+       HRD+  +N ++      V + DFG +K +  G+         YYR  
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 206 ELI-----FGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 242
            +      + A E      YT+  D+W+ G  + E+   GQ  +PG EN 
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 64/286 (22%)

Query: 42  VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 88
           +G G FG V  A+ +   +        VA+K +  D   K+      E+++M+++  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLI 135
           +I+L     + T    L++  ++EY              P  M           +++   
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
            +    YQ+ RG+ Y+ +   + HRD+  +N+LV    + +K+ DFG A+       +I 
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTE-DNVMKIADFGLAR-------DIH 191

Query: 196 YICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 242
           +I   YY+            APE +F    YT   D+WS G +L E+  LG   +PG   
Sbjct: 192 HI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-P 247

Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 288
           V++L +++K  G    +   C N  Y   R        WH V  +R
Sbjct: 248 VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 41/220 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 90
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+++ +L  HPN+I
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP----------------ETMYRVLKHYSSMNQRMPL 134
           +L         +   +L L +EY P                +  + +    +S      L
Sbjct: 72  NLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGE 191
           ++   +   + RG+ Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK  
Sbjct: 127 LH---FAADVARGMDYLSQKQFI-HRDLAARNILVGE-NYVAKIADFGLSRGQEVYVK-- 179

Query: 192 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
             +  +  R+     L +    YTT+ D+WS G +L E++
Sbjct: 180 KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 31/123 (25%)

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTR 258
           Y APE++   T YT   D WS G +L E+L+GQP F  +  ++  +++I     L  P +
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272

Query: 259 EEIRCMNPNYTDF-----RFP----------QIKAHPWHKVFHKRMPPEAIDLASRLLQY 303
            +   ++P  +D      R P          +IKAHP+ K          ID +S L Q 
Sbjct: 273 AK---LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFK---------TIDFSSDLRQQ 320

Query: 304 SPS 306
           S  
Sbjct: 321 SAP 323

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 45/195 (23%), Positives = 93/195 (47%), Gaps = 18/195 (9%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 98
           +GTG FG+V   K       VAIK + +    ++    E ++M  + H  ++ L   +  
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 99  TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 158
            T +  +++  V EY+      +L +     +R     +      +  G+AY+ +   + 
Sbjct: 68  CTKQRPIYI--VTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI- 122

Query: 159 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEYT 215
           HRD+  +N LVD     VK+ DFG ++ ++  E   S + S++   +  PE +   ++++
Sbjct: 123 HRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE-VLLYSKFS 179

Query: 216 TSIDIWSAGCVLAEL 230
           +  D+W+ G ++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 60/262 (22%), Positives = 95/262 (36%), Gaps = 56/262 (21%)

Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV----MEYVPETMYRVLKHYSSMNQR 131
            E   M+  DHPNV+ L      T   +     +V    M++     + +        Q 
Sbjct: 49  SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY 108

Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 191
           +P   +  +   I  G+ Y+ +     HRD+  +N +++     V + DFG +K +  G+
Sbjct: 109 LPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNGD 166

Query: 192 ANISYICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENAV 243
               Y   R  + P + + A E      YTT  D+WS G  + E+   GQ  +PG EN+ 
Sbjct: 167 ---YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS- 221

Query: 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 303
               EI   L    R                             + PP+ +D       Y
Sbjct: 222 ----EIYDYLRQGNR----------------------------LKQPPDCLDGL-----Y 244

Query: 304 SPSLRCTALEACAHPFFDELRE 325
           S    C  L     P F+ LR 
Sbjct: 245 SLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 7e-05
 Identities = 23/54 (42%), Positives = 34/54 (62%), Gaps = 2/54 (3%)

Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +K    Q+  GL  +H + G+ HRD+KP+NLLV  +  QVK+ DFG+A  +  G
Sbjct: 311 IKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362

Length = 507

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 64/311 (20%), Positives = 121/311 (38%), Gaps = 49/311 (15%)

Query: 58  TGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 111
           TGE V ++++  +        +   EL + +L +HPN++  +  F    + +EL++    
Sbjct: 24  TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI---ADNELWVVTSF 80

Query: 112 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 171
                    +  H+      + + Y+      + + L YIH + G  HR VK  ++L+  
Sbjct: 81  MAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIHHM-GYVHRSVKASHILIS- 135

Query: 172 LTHQVKLCDFGSAKVLVK--GEANISYICSRY------YRAPELIFGATE-YTTSIDIWS 222
           +  +V L    S   ++       + +   +Y      + +PE++    + Y    DI+S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195

Query: 223 AGCVLAELLLGQPLFPGENAVDQLVEIIK-----VLGTPT--REEIR------------C 263
            G    EL  G   F    A   L+E +      +L T T   EE+              
Sbjct: 196 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLG 255

Query: 264 MNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
            +   +  R    +  +HP+++ F     P       + LQ +P  R +A     H FF 
Sbjct: 256 ESTTVSTPRPSNGESSSHPYNRTF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311

Query: 322 EL-REPNARLP 331
           ++ R  +  LP
Sbjct: 312 QIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 23/207 (11%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 98
           +G G FG V+      T + VAIK +           +E Q+M+ + H  ++ L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 99  TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 157
             S++ +++  V E++ + ++   LK       ++P + V +   QI  G+AYI  +  +
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIERMNYI 124

Query: 158 CHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPEL-IFGATE 213
            HRD++  N+LV D L    K+ DFG A+++   E  A         + APE  ++G   
Sbjct: 125 -HRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--R 179

Query: 214 YTTSIDIWSAGCVLAELLL-GQPLFPG 239
           +T   D+WS G +L EL+  G+  +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 44/229 (19%)

Query: 33  TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMR 82
           T+ +M E  +G   FG V++         E  + VAIK  L+D+     R + +   +MR
Sbjct: 6   TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62

Query: 83  L-MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPET---MYRVLKHYSS----------- 127
             + HPN++    C     +K++  L+++  Y   +    + V++   S           
Sbjct: 63  SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 128 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKV 186
            +   P  +V + T QI  G+ ++ +   V H+D+  +N+LV D L   VK+ D G  + 
Sbjct: 118 KSTLEPADFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFRE 173

Query: 187 LVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +       S +  R+     +++G  +++   DIWS G VL E+ 
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 46/222 (20%), Positives = 89/222 (40%), Gaps = 35/222 (15%)

Query: 27  NGEPKQTIS---YMAERVVGTGSFGIVFQAKCLE---------------TGETVAIKKVL 68
            G P   I+   +  ++++G G FG V++ +C                   ET+ ++ ++
Sbjct: 2   EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61

Query: 69  QDRRY-KNRELQLMRL--MDHPNVISLKHC-FFSTTSKDELFLNLVMEYVPETMYRVLKH 124
            +  Y  ++      +  +DH  +     C  F        F+  ++E + E    + K 
Sbjct: 62  YNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI--LLEKLVENTKEIFKR 119

Query: 125 YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 184
               N+   LI  K     +   L YIH   G+ H D+KP+N++VD   ++  + D+G A
Sbjct: 120 IKCKNK--KLI--KNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDG-NNRGYIIDYGIA 173

Query: 185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV 226
              +    +I      Y +  + +   T Y   +D  +  CV
Sbjct: 174 SHFIIHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210

Length = 294

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 55/254 (21%)

Query: 39  ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNV 89
           +R +G G+FG VF A+C     E  + +   K L+D     R+  +RE +L+  + H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY-------SSMNQRMPLIYVKLY- 140
           +     F+    + +  + +V EY+    + + L+ +       +  N+   L   ++  
Sbjct: 70  VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 141 -TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 199
              QI  G+ Y+ +   V HRD+  +N LV      VK+ DFG ++ +   +        
Sbjct: 125 IAQQIAAGMVYLASQHFV-HRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTD-------- 174

Query: 200 RYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 245
            YYR             PE I    ++TT  D+WS G VL E+     QP +   N  ++
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230

Query: 246 LVEII---KVLGTP 256
           ++E I   +VL  P
Sbjct: 231 VIECITQGRVLQRP 244

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 43/221 (19%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 90
           E V+G G+FG V +A   + G     AIK + +     D R    EL+++ +L  HPN+I
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK------LYTYQI 144
           +L         ++  +L + +EY P          S + +  P    +      L + Q+
Sbjct: 67  NL-----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 145 FR-------GLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY 196
            +       G+ Y+     + HRD+  +N+LV + L    K+ DFG    L +GE    Y
Sbjct: 122 LQFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLA--SKIADFG----LSRGEE--VY 172

Query: 197 ICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAELL 231
           +     R P + + A E      YTT  D+WS G +L E++
Sbjct: 173 VKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 39/214 (18%)

Query: 42  VGTGSFGIVFQAKCLETGETVA--IKKVLQDRRYKNRELQLM------RLMDHPNVIS-L 92
           +G G FG V   +    G + A  + K L+     + +L  +      R ++HPNV+  L
Sbjct: 3   IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM------PLIYVKLYTYQIFR 146
             C  S          LV+E+ P      LK+Y   N+ M        +  ++   ++  
Sbjct: 62  GQCIESIP------YLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111

Query: 147 GLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---Y 202
           GL ++H    + H D+  +N  L   L+  VK+ D+G A      +  I+  C      +
Sbjct: 112 GLLWLHQADFI-HSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 203 RAPEL--IFGA----TEYTTSIDIWSAGCVLAEL 230
            APEL  I G      + T   +IWS G  + EL
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 27/188 (14%)

Query: 62  VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 116
           VA+K +  D     R     E+++M  + +PN+I L          D+  L ++ EY+  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL----LGVCVSDDP-LCMITEYMEN 101

Query: 117 ---TMY---RVLKHYSSMNQRMPLIYVKLYTY---QIFRGLAYIHTVPGVCHRDVKPQNL 167
                +   R ++   +    +P + +    Y   QI  G+ Y+ ++  V HRD+  +N 
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV-HRDLATRNC 160

Query: 168 LVDPLTHQVKLCDFGSAKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSA 223
           LV    + +K+ DFG ++ L  G+       + +  R+     ++ G  ++TT+ D+W+ 
Sbjct: 161 LVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAF 217

Query: 224 GCVLAELL 231
           G  L E+ 
Sbjct: 218 GVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 29/121 (23%)

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
           QI  G+ Y+ ++  V HRD+  +N LV      +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 203 R------------APELIFGATEYTTSIDIWSAGCVLAELLL---GQPLFPGENAVDQLV 247
           R            A E I    ++TT+ D+W+ G  L E+L+    QP   GE   +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251

Query: 248 E 248
           E
Sbjct: 252 E 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	376
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.83
smart00090	237	RIO RIO-like kinase.	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
KOG1243	690	consensus Protein kinase [General function predict	99.5
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.31
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.09
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.04
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.87
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.8
PRK09902	216	hypothetical protein; Provisional	98.69
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.69
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.6
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.55
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.52
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.39
PF01636	239	APH: Phosphotransferase enzyme family This family	98.36
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.24
PLN02876	822	acyl-CoA dehydrogenase	98.01
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.99
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.93
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.93
KOG2270	520	consensus Serine/threonine protein kinase involved	97.88
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.77
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.72
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.72
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.67
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.61
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.55
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.47
PRK10593	297	hypothetical protein; Provisional	97.44
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.43
PRK05231	319	homoserine kinase; Provisional	97.36
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.32
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.24
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.24
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.96
PLN02236	344	choline kinase	96.92
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.86
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.81
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.65
PRK12396	409	5-methylribose kinase; Reviewed	96.56
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.34
PLN02756	418	S-methyl-5-thioribose kinase	96.24
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.1
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.04
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.56
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.35
PTZ00384	383	choline kinase; Provisional	95.19
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.18
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.84
KOG2269	531	consensus Serine/threonine protein kinase [Signal	94.41
PHA03111	444	Ser/Thr kinase; Provisional	94.38
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	93.9
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.1
PTZ00296	442	choline kinase; Provisional	92.57

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.9e-72  Score=485.76  Aligned_cols=360  Identities=71%  Similarity=1.194  Sum_probs=342.5

Q ss_pred             cccceEeeccCCCCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecc
Q 017139           14 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLK   93 (376)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~   93 (376)
                      ..+.+..++..+....++..-.|.-.+.+|.|+||.||+|....+++.+|||++..+.+...+|.++|+.++|||||++.
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~   83 (364)
T KOG0658|consen    4 ESGHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLL   83 (364)
T ss_pred             cceeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEE
Confidence            45667777778877777888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC
Q 017139           94 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT  173 (376)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~  173 (376)
                      .+|....+.+..++.+||||++.+|.+.++++...+..++...++-+.+||++||.|||+ .||+||||||+|+|+|.+.
T Consensus        84 ~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~t  162 (364)
T KOG0658|consen   84 YFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDT  162 (364)
T ss_pred             EEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCC
Confidence            999877766567888999999999999999988889999999999999999999999999 7999999999999999988


Q ss_pred             CcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017139          174 HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL  253 (376)
Q Consensus       174 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  253 (376)
                      +.+||||||.|+....+.++.++.||++|+|||++.+...|+.+.||||.||++.||+-|++.|+|.+..+++..|++.+
T Consensus       163 g~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l  242 (364)
T KOG0658|consen  163 GVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL  242 (364)
T ss_pred             CeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCC
Q 017139          254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG  333 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~  333 (376)
                      |+|+.+++..+++++.+..+|+++..+|...+....++++.+|+.++|.++|.+|.++.|+|.||||..++.++.+++.+
T Consensus       243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g  322 (364)
T KOG0658|consen  243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNG  322 (364)
T ss_pred             CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhhhhcCCHHHHhhhcHHHHHhhcCCCCCCCC
Q 017139          334 RPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSA  374 (376)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (376)
                      .+.|++++|........++....++|++.+++.+....+.+
T Consensus       323 ~~lp~lf~f~~~e~~~~~~~~~~l~p~~~~~~~~~~~~~~~  363 (364)
T KOG0658|consen  323 RPLPPLFNFKRAELGISPELVNVLIPEHLREQEKDKILCES  363 (364)
T ss_pred             CcCCCccCchHHHhccchHHHHhhccHhhhhhccccccccC
Confidence            99999999999999999999999999999999888776654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-61  Score=433.85  Aligned_cols=283  Identities=37%  Similarity=0.661  Sum_probs=256.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc-----hHHHHHHHHhCC-CCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLMRLMD-HPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|.+.++||.|.||.||+|+.+.+|+.||||++++....     ..||+.-|++++ ||||+++.+++.+    .+.
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----NDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----cCc
Confidence            457899999999999999999999999999999998765322     237999999999 9999999999842    222


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+|||||+.+|+++++.+   +..|++..++.|+.||+.||+|+|+ +|+.|||+||+|||+.. ...+||+|||+|+
T Consensus        84 ~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~-~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   84 ILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISG-NDVIKIADFGLAR  158 (538)
T ss_pred             eEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecc-cceeEeccccccc
Confidence            79999999999999999874   6889999999999999999999999 89999999999999996 7789999999999


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc-
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-  264 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  264 (376)
                      ...+..+.+.++.|+||+|||+++....|+.+.|+|++|||++|+++-++.|+|.+..+++.+|++.+|+|....|... 
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            9999999999999999999999998888999999999999999999999999999999999999999999998877542 


Q ss_pred             -CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          265 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       265 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                       ......+.+|.....++...++. .++++.++|.+||.|||++||||+++|+||||+...
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence             23345678899888888888887 999999999999999999999999999999997643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.3e-61  Score=405.84  Aligned_cols=282  Identities=35%  Similarity=0.655  Sum_probs=247.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      +.|+.+.++|+|+||.||+|+++.||+.||||++.....      ...+|+.+|++++|+|+|.++++|     .....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            579999999999999999999999999999999976543      345899999999999999999999     777789


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|+|||+.++++.+..+   ...++...++.+++|++.|+.|||+ ++++||||||+|||++. ++.+||||||+|+..
T Consensus        77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~-~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQ-NGVVKLCDFGFARTL  151 (396)
T ss_pred             EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEec-CCcEEeccchhhHhh
Confidence            999999999888888764   5679999999999999999999999 79999999999999997 889999999999998


Q ss_pred             c-cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc--
Q 017139          188 V-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--  264 (376)
Q Consensus       188 ~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--  264 (376)
                      . ++...+.++.|+||+|||++.+...|++.+||||+||++.||++|.+.|++..+.+++..|.+.+|...+....-+  
T Consensus       152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            7 5566677888999999999999888999999999999999999999999999999999999999999887655543  


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ++-+.-.++|.......-+.-..+++.-+.||+++||..||++|++.+++|.||||.++..
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence            4555566777665543333333467889999999999999999999999999999976543

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-59  Score=409.49  Aligned_cols=321  Identities=37%  Similarity=0.657  Sum_probs=271.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ..|...+.||.|+||.|+.|.++.+|+.||||++...      .+...+|+.+|+.++|+||+.+.+++.........-+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4566689999999999999999999999999998632      2344589999999999999999999876444556679


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+|+|+|+.+|...++.    ++.+++..++.+++|++.||+|+|+ .+++||||||+|+|++. +..+||+|||+|+..
T Consensus       102 YiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~-~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  102 YLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNA-DCDLKICDFGLARYL  175 (359)
T ss_pred             EEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeecc-CCCEEeccccceeec
Confidence            99999998888887775    4559999999999999999999999 79999999999999997 888999999999988


Q ss_pred             cc---CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VK---GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ..   ....+.++.|.||+|||++.....|+.+.||||+|||+.||++|++.|+|.+..+++..+...+|+|+.+.+...
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            64   334467788999999999998888999999999999999999999999999999999999999999999988876


Q ss_pred             CcC-CcCc--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCC
Q 017139          265 NPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN  341 (376)
Q Consensus       265 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~  341 (376)
                      ... ...+  ..|.....+|...|+ +.++.+.||+.+||.+||.+|+|++|+|+||||..+.++...+.....+.   .
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~---~  331 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFD---S  331 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCc---c
Confidence            522 1122  577788888888888 79999999999999999999999999999999999988764432222111   1


Q ss_pred             chhhhhcCCHHHHhhhcHHHHHhhcC
Q 017139          342 FKQELAGASPELINRLIPEHVRRQTG  367 (376)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (376)
                      +.  .. .+.+.+..++.+++..-.+
T Consensus       332 ~~--~~-~~~~~~r~~i~~e~~~~~~  354 (359)
T KOG0660|consen  332 FE--HE-LTEEELRELIYKEILDFHP  354 (359)
T ss_pred             cc--cc-ccHHHHHHHHHHHHHhhCc
Confidence            22  22 5678888888888765544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-59  Score=413.84  Aligned_cols=258  Identities=31%  Similarity=0.499  Sum_probs=215.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+..           ....+|+++|+.++|||||+++++|    
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----  245 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----  245 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence            4567899999999999999999999999999999996532           1224899999999999999999999    


Q ss_pred             CCCceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEE
Q 017139          101 SKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVK  177 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~k  177 (376)
                       +...+.|+||||++|+ |.+.    .-.++.+.+...+-++.|++.|+.|||+ +||+||||||+|||++.+  +..+|
T Consensus       246 -~~~ds~YmVlE~v~GGeLfd~----vv~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  246 -EVPDSSYMVLEYVEGGELFDK----VVANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             -ecCCceEEEEEEecCccHHHH----HHhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEE
Confidence             5555589999999975 3333    3346789999999999999999999999 799999999999999742  36799


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhCCC--CCCccchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLG  254 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~  254 (376)
                      |+|||+|+...+.....+.+|||.|.|||++.+..  .+..++|+||+||++|.+++|.+||.+..... ..++|.+.  
T Consensus       320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G--  397 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG--  397 (475)
T ss_pred             ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC--
Confidence            99999999988777788999999999999996533  24458899999999999999999998765544 44444431  


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                     .|        .+....+.++++++++||++||.+||++|||++|+|+||||+...
T Consensus       398 ---------------~y--------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  398 ---------------RY--------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ---------------cc--------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence                           11        112234567899999999999999999999999999999998653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.7e-58  Score=384.08  Aligned_cols=279  Identities=38%  Similarity=0.683  Sum_probs=243.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|...++||+|.||.||+|++..+|+.||||++....      ....+|++.|+.++|+||+.++++|     .....+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            57999999999999999999999999999999996542      2345899999999999999999999     555558


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      .||+||++.+|...++.   ....++...++.++.+++.||+|||+ +.|+||||||.|+|+++ ++.+||+|||+++..
T Consensus        77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISS-DGQLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcC-CCcEEeecccchhcc
Confidence            89999999999888876   46779999999999999999999999 89999999999999997 889999999999988


Q ss_pred             ccCCCcc-eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEANI-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .+..... ..+.|.||+|||++.|...|+..+||||.|||+.||+-|.+.|+|.++.+++..++..+|+|..+.|+.+..
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            7554433 347799999999999999999999999999999999999999999999999999999999999999988764


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      -.....+......+....|+ ..+.++.||+.+||.+||.+|+|+.|+|+||||+..
T Consensus       232 lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             cccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence            33332333333444444444 578889999999999999999999999999999974

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-58  Score=401.36  Aligned_cols=258  Identities=31%  Similarity=0.516  Sum_probs=224.3

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ....++|+++++||+|+||+||+++.+.+++.||+|++.+..       .....|..+|..++||+||+++..|     +
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q   95 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q   95 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence            456789999999999999999999999999999999986643       2334699999999999999999998     6


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|+||+.| .|...|.    .++.++|..++.++.+|+.||.|||+ +||+||||||+|||+|. +|.++|+||
T Consensus        96 t~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~-~GHi~LtDF  169 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDE-QGHIKLTDF  169 (357)
T ss_pred             cCCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecC-CCcEEEecc
Confidence            77779999999997 4444444    46889999999999999999999999 79999999999999996 888999999


Q ss_pred             CCcccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |+|+.... +....+.+||+.|||||++.+.. |+.++|+||||+++|+|++|.+||.+.+.......+.+.-.      
T Consensus       170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------  242 (357)
T KOG0598|consen  170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------  242 (357)
T ss_pred             ccchhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------
Confidence            99985544 44556779999999999998764 99999999999999999999999999998888888776310      


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC----CHHHHhCCCccccccCCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELREPN  327 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~ell~hp~~~~~~~~~  327 (376)
                                            ...+..++.+++++|+++|++||++|.    ++.++-+||||+.++|..
T Consensus       243 ----------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  243 ----------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence                                  112334899999999999999999996    688999999999999874

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-57  Score=419.30  Aligned_cols=253  Identities=32%  Similarity=0.549  Sum_probs=223.8

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      .|.. .+|...+.||+|||+.||.+++..+|+.||+|++.+.       .....+|+++.+.|+|||||+++++|     
T Consensus        14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----   87 (592)
T KOG0575|consen   14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----   87 (592)
T ss_pred             cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----
Confidence            3344 6799999999999999999999999999999999653       23345799999999999999999999     


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      ++..++|||.|+|. ++|.++++.    ...++|.+++.++.||+.||.|||+ ++|+|||||..|+|++. +..|||+|
T Consensus        88 EDs~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~-~~~VKIgD  161 (592)
T KOG0575|consen   88 EDSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNE-NMNVKIGD  161 (592)
T ss_pred             ecCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecC-cCcEEecc
Confidence            88888999999999 566666653    5789999999999999999999999 79999999999999996 77899999


Q ss_pred             cCCccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          181 FGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       181 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ||+|.....+ +...+.+|||.|.|||++... ..+..+||||+||++|.|++|++||...+-.+.+..|..        
T Consensus       162 FGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~--------  232 (592)
T KOG0575|consen  162 FGLATQLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL--------  232 (592)
T ss_pred             cceeeeecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh--------
Confidence            9999888754 677889999999999999754 489999999999999999999999999888888887766        


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                               .++.            +|..+|.+++|||.+||+.||.+|||++++|.|+||+.-
T Consensus       233 ---------~~Y~------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  233 ---------NEYS------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             ---------cCcc------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence                     2333            445789999999999999999999999999999999543

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-56  Score=427.67  Aligned_cols=330  Identities=51%  Similarity=0.962  Sum_probs=283.5

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecC---CCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTT---SKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~---~~~~~~~~  108 (376)
                      ..++|.+++.||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++||||+++++++....   .....+++
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            346799999999999999999999999999999999877777778999999999999999998875432   13345788


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||||++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+++...
T Consensus       144 lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        144 VVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             EEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            999999999888887766667889999999999999999999999 7999999999999998656679999999998766


Q ss_pred             cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          189 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       189 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      .........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+++.++.+..+.+..+.+.+
T Consensus       223 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~  302 (440)
T PTZ00036        223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY  302 (440)
T ss_pred             CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence            55555567889999999998776668999999999999999999999999999999999999999999999988888888


Q ss_pred             cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCC-CCCCCCCCCchhh-h
Q 017139          269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN-GRPFPPLFNFKQE-L  346 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~  346 (376)
                      ..+.++......+...++...+.++++||.+||++||.+|+|+.|+|+||||..+.++....+. ....+.+++|... .
T Consensus       303 ~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (440)
T PTZ00036        303 ADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEI  382 (440)
T ss_pred             hcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHH
Confidence            8888888877788888888899999999999999999999999999999999998776444332 2356677788753 3


Q ss_pred             hcCCHHHHhhhcHHHH
Q 017139          347 AGASPELINRLIPEHV  362 (376)
Q Consensus       347 ~~~~~~~~~~~~~~~~  362 (376)
                      ....++....+++...
T Consensus       383 ~~~~~~~~~~~~~~~~  398 (440)
T PTZ00036        383 KEMSDACRRKIIPKCT  398 (440)
T ss_pred             hhCCHHHHHHHhhHHH
Confidence            3667777777666543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-57  Score=391.86  Aligned_cols=285  Identities=31%  Similarity=0.548  Sum_probs=248.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      +..++|+.+..|++|.||.||+|+++.+++.||+|+++-+..      ...+|+.+|..++|||||.+.++.....   -
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~  149 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---M  149 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---c
Confidence            566899999999999999999999999999999999965431      2348999999999999999999886533   2


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+|||||+.+|.+++...   .++|...+++.++.|++.|++|||. +.|+||||||+|+|++. .|.+||+|||+|
T Consensus       150 d~iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~-~G~lKiaDFGLA  224 (419)
T KOG0663|consen  150 DKIYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSH-KGILKIADFGLA  224 (419)
T ss_pred             ceeeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeecc-CCcEEecccchh
Confidence            338899999999988888763   4789999999999999999999999 79999999999999995 888999999999


Q ss_pred             cccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +.+.+... .+..+.|.||+|||++++...|+.+.|+||+|||+.||+++.+.|++....+++.+|++.+|+|+..-|+.
T Consensus       225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            99876644 45567799999999999999999999999999999999999999999999999999999999999988876


Q ss_pred             cCc--CCcCccCCCCCCCCcccccccC-CChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          264 MNP--NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       264 ~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ...  .+....++...-.+++..|+.. +++...+|++.+|.+||.+|+||+|.|.|+||.+.
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence            542  2233455555555566666554 78999999999999999999999999999999974

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-57  Score=408.37  Aligned_cols=285  Identities=35%  Similarity=0.597  Sum_probs=242.4

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .|...+.|+..++||+|.||.||+|++..+|+.||+|++..+.      ....+|+.+|++|+||||+++.+.....   
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---  188 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---  188 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---
Confidence            4567789999999999999999999999999999999996553      3446899999999999999999988653   


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ....+|+|+|||+.+|.-++..   ..-.|++.+++.++.||+.||+|||+ +||+|||||.+|||||. ++.+||+|||
T Consensus       189 ~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn-~G~LKiaDFG  263 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDN-NGVLKIADFG  263 (560)
T ss_pred             CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcC-CCCEEecccc
Confidence            3456999999999988777764   34579999999999999999999999 89999999999999995 8999999999


Q ss_pred             CccccccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          183 SAKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       183 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      +|++.....  ..++.+.|.||+|||+++|...|+.++|+||+||||.||++|++.|++.+..+++..|.+.+|.|....
T Consensus       264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            999765543  456778899999999999999999999999999999999999999999999999999999999999998


Q ss_pred             HhhcCcC-CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          261 IRCMNPN-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       261 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      |....-. +..+.-...-...+.+. -..+++.+.+|+..||+.||++|.||.++|+|+||..
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            8722211 11111111112222333 3468999999999999999999999999999999943

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-57  Score=408.23  Aligned_cols=256  Identities=33%  Similarity=0.589  Sum_probs=227.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      +...+|.+++.||.|+|++|++|+++.+++.||||++.+.       ..+..+|.+.|..| .||.|++++..|     +
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence            4457999999999999999999999999999999988543       24455799999999 899999999998     6


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ++..+|+|+||++ |+|+++++++    +.|++.-.+.++.||+.||+|||+ +|||||||||+|||+|. ++++||+||
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~-dmhikITDF  218 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDK-DGHIKITDF  218 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcC-CCcEEEeec
Confidence            6666999999999 6888888875    779999999999999999999999 79999999999999997 889999999


Q ss_pred             CCccccccCCC--------------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 017139          182 GSAKVLVKGEA--------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV  247 (376)
Q Consensus       182 g~~~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  247 (376)
                      |.|+.+.....              ..+++||..|.+||++... ..++.+|+|+||||+|+|+.|.+||.+.+....++
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence            99987753211              1458999999999999654 58999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                      +|++..                 |            .|++++++.++|||+++|..||++|+|+++|.+||||.+++|.+
T Consensus       298 kI~~l~-----------------y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  298 KIQALD-----------------Y------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHHhc-----------------c------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            998842                 1            15568899999999999999999999999999999999999876

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-56  Score=391.22  Aligned_cols=255  Identities=31%  Similarity=0.560  Sum_probs=215.1

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .+.+.++.||+|..|+||+|+++.+++.+|+|++...     .+...+|+++++..+|||||++|++|+....    .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3678899999999999999999999999999999433     2334589999999999999999999965432    488


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+||||+| +|...++.    .++++|..+..++.+++.||.|||+..+|+||||||+|||+++ .+.|||||||.+...
T Consensus       155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGVSGIL  229 (364)
T ss_pred             eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccccHHh
Confidence            99999995 66665554    3779999999999999999999994369999999999999997 889999999999887


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhcCCCCHHHHh
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-----NAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      .+. ...+++||..|||||.+.+.. |+.++||||||++++|+++|++||...     +..+.+..|+.   .+++    
T Consensus       230 vnS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP----  300 (364)
T KOG0581|consen  230 VNS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP----  300 (364)
T ss_pred             hhh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC----
Confidence            766 667899999999999998765 999999999999999999999999874     33444444433   1111    


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccC-CChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                                           .+|.. +|+++++||..||++||.+|+|+.|+++|||+++....+
T Consensus       301 ---------------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  301 ---------------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             ---------------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence                                 13333 799999999999999999999999999999999765543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-55  Score=371.70  Aligned_cols=256  Identities=29%  Similarity=0.486  Sum_probs=225.3

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      .|...++|++.+.||.|+||+|.+++++.+|..||+|++.+...       ....|..+|+.+.||+++++.+.+     
T Consensus        39 ~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----  113 (355)
T KOG0616|consen   39 NPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----  113 (355)
T ss_pred             CCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----
Confidence            34667899999999999999999999999999999999976532       223689999999999999999888     


Q ss_pred             CCceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+..++|+||||++|+ |.++++    ..+++++..++.++.||+.||+|||+ .+|++|||||+|||+|+ +|.+||+|
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~-~G~iKitD  187 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQ-NGHIKITD  187 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeecc-CCcEEEEe
Confidence            7777899999999975 444443    46889999999999999999999999 79999999999999997 88899999


Q ss_pred             cCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          181 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       181 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ||+|+....  ...+.+|||.|+|||++.... |+.++|+|||||++|||+.|.+||.+.+....+.+|++.        
T Consensus       188 FGFAK~v~~--rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~--------  256 (355)
T KOG0616|consen  188 FGFAKRVSG--RTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG--------  256 (355)
T ss_pred             ccceEEecC--cEEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC--------
Confidence            999987643  367889999999999997655 999999999999999999999999999999999988873        


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN  327 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~~  327 (376)
                               ++            .||..++++++|||+++|++|-.+|.     ...++.+||||+.+.|..
T Consensus       257 ---------~v------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  257 ---------KV------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             ---------cc------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence                     22            25567899999999999999999994     567999999999998864

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.8e-54  Score=374.31  Aligned_cols=291  Identities=34%  Similarity=0.677  Sum_probs=244.6

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCC-eeecceeeeecCC-CCc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPN-VISLKHCFFSTTS-KDE  104 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~-Iv~~~~~~~~~~~-~~~  104 (376)
                      ...|..+++||+|+||+||+|+.+.+|+.||+|++..+..      ...+|+.+++.++|+| |+.+++++.+... ...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            5568889999999999999999999999999999865433      2358999999999999 9999999865441 233


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+++|+||++-+|..++.........++...++.++.||+.||+|||+ ++|+||||||+|||+++ ++.+||+|||+|
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~-~G~lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISS-SGVLKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECC-CCcEeeeccchH
Confidence            4689999999998888887754333567778999999999999999999 79999999999999997 889999999999


Q ss_pred             cccc-cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +... +.......++|.+|+|||++.+...|+...||||+|||++||+++++.|++....+++..|.+.+|+|..+.|+.
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            9776 334466778899999999999998899999999999999999999999999999999999999999999988876


Q ss_pred             cCcC--CcCccCCCCC-CCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          264 MNPN--YTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       264 ~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                      ...-  +.. .++... ...+.... +..+++..+++.+||+.+|.+|.|+..+|.||||.......
T Consensus       248 v~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  248 VSSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             ccccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence            5422  111 333333 22333333 34557999999999999999999999999999999876554

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.8e-54  Score=389.54  Aligned_cols=268  Identities=33%  Similarity=0.535  Sum_probs=224.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|.++++||+|+||.||+|+.+.||..||+|++++..-       ....|.++|...++|.||+++..|     ++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            56899999999999999999999999999999999976542       234688999999999999999999     888


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      .++||||||++| ++-.+|..    ...|++..++.++.+++.|++.||+ .|++||||||+|+|||. .|.+||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~-~GHiKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDA-KGHIKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecC-CCCEeeccccc
Confidence            889999999997 44444443    5889999999999999999999999 69999999999999997 88899999999


Q ss_pred             cccccc-----------------------CCC-------------------------cceeeccccccChhhhhCCCCCC
Q 017139          184 AKVLVK-----------------------GEA-------------------------NISYICSRYYRAPELIFGATEYT  215 (376)
Q Consensus       184 ~~~~~~-----------------------~~~-------------------------~~~~~~t~~y~aPE~~~~~~~~~  215 (376)
                      |.....                       ...                         ..+.+|||-|+|||++.+.. |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            843211                       000                         02467999999999999876 99


Q ss_pred             ccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHH
Q 017139          216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID  295 (376)
Q Consensus       216 ~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (376)
                      ..+|+||||||+|||+.|.+||.+.++.+...+|+..-..               +.+|.          ...++++++|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~----------~~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPE----------EVDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCC----------cCcccHHHHH
Confidence            9999999999999999999999999999999988763111               11111          1246899999


Q ss_pred             HHHhhcCCCCCCCCC---HHHHhCCCccccccCCCCCCCCCCCCCC
Q 017139          296 LASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPNGRPFPP  338 (376)
Q Consensus       296 li~~~L~~dP~~R~t---~~ell~hp~~~~~~~~~~~~~~~~~~~~  338 (376)
                      ||.+||+ ||.+|..   ++||.+||||+.++|...+-.. .+|.|
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~-apfvP  465 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMP-APFVP  465 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCC-CCCCC
Confidence            9999999 9999985   8999999999999998766443 34444

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-54  Score=399.34  Aligned_cols=284  Identities=30%  Similarity=0.515  Sum_probs=237.7

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccch-------HHHHHHHHhCC-CCCeeecceeeeecCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMD-HPNVISLKHCFFSTTS  101 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~e~~~l~~l~-h~~Iv~~~~~~~~~~~  101 (376)
                      +...++|++.++||+|+||+|++|..+.+++.||||+++++....       ..|..++...+ ||+++.++.+|     
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----  438 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----  438 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence            345689999999999999999999999999999999998765433       35677777664 99999999999     


Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...++|+||||+.|+.   +.+ ....+.+++..++.|+.+|+.||+|||+ +||||||||.+|||+|. +|.+||+||
T Consensus       439 QT~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~-eGh~kiADF  512 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDT-EGHVKIADF  512 (694)
T ss_pred             ccCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcc-cCcEEeccc
Confidence            77777999999999874   222 2335789999999999999999999999 89999999999999997 788999999


Q ss_pred             CCccccc-cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |+++..- .+....+.+|||.|+|||++.+.. |+.++|+|||||+||+|+.|..||++.+.++....|+..        
T Consensus       513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--------  583 (694)
T KOG0694|consen  513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--------  583 (694)
T ss_pred             ccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Confidence            9998765 455667889999999999997654 999999999999999999999999999999999888762        


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCCCC-CCCCCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNA-RLPNGR  334 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~~~-~~~~~~  334 (376)
                               +..            +|..+|.++.++++++|.+||.+|..     ++++..||||+.++|... .....+
T Consensus       584 ---------~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P  642 (694)
T KOG0694|consen  584 ---------EVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP  642 (694)
T ss_pred             ---------CCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence                     222            45678999999999999999999986     478999999999998642 112233


Q ss_pred             CCCCC-------CCchhhhhcCCHHHH
Q 017139          335 PFPPL-------FNFKQELAGASPELI  354 (376)
Q Consensus       335 ~~~~~-------~~~~~~~~~~~~~~~  354 (376)
                      |+.|.       -||++++++..+.+-
T Consensus       643 Pf~P~i~~~~D~snFd~eFt~e~p~Lt  669 (694)
T KOG0694|consen  643 PFVPTIKGPEDVSNFDEEFTSEKPALT  669 (694)
T ss_pred             CCCcccCChhhhcccchhhhcCCCccC
Confidence            44443       478888887666554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-53  Score=395.29  Aligned_cols=251  Identities=34%  Similarity=0.543  Sum_probs=224.9

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      |.+++.||.|+-|.|-+|++..||+..|||++.+.       ....++|+-+|+.+.|||++.+++++     ++..++|
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~ly   88 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHLY   88 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceEE
Confidence            99999999999999999999999999999999776       44567899999999999999999999     7777899


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|.||++| .|.+++.    ..+++++....+++.||+.|+.|||. .+|+||||||+|+|++. .+.+||+|||+|...
T Consensus        89 lvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~-~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDV-KNNIKIADFGMASLE  162 (786)
T ss_pred             EEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhc-ccCEeeeccceeecc
Confidence            99999996 4444444    46889999999999999999999999 59999999999999997 555999999999998


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .++....+.||+|.|.|||++.|..+.+.++||||+|||||.|++|+.||.+.+....+.++.+.               
T Consensus       163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G---------------  227 (786)
T KOG0588|consen  163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG---------------  227 (786)
T ss_pred             cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC---------------
Confidence            88888889999999999999999988899999999999999999999999988777777666541               


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                        .|.            +|..+|+++++||.+||.+||++|+|.+|++.|||+......
T Consensus       228 --~f~------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  228 --VFE------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             --ccc------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence              222            446799999999999999999999999999999999887654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-53  Score=374.78  Aligned_cols=256  Identities=29%  Similarity=0.526  Sum_probs=221.0

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ....++|.+.+.||.|+||+||+|+++.++..||||.+.+..      .....|+.+|+.++|||||.++++.     +.
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~   80 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----ED   80 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ec
Confidence            345678999999999999999999999999999999996653      2345799999999999999999999     66


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--C---CcEE
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--T---HQVK  177 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~---~~~k  177 (376)
                      +.++|+|||||+ |+|..++..    .+.+++..++.++.||+.||++||+ ++|+||||||+|||++..  +   -.+|
T Consensus        81 ~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LK  155 (429)
T KOG0595|consen   81 DDFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLK  155 (429)
T ss_pred             CCeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEE
Confidence            667999999999 577777765    4689999999999999999999999 899999999999999752  1   4699


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |+|||+|+...+.....+.+|+|.|||||++... .|+.++|+||+|+|+|++++|++||...+..+.+..+.+...   
T Consensus       156 IADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~---  231 (429)
T KOG0595|consen  156 IADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE---  231 (429)
T ss_pred             ecccchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc---
Confidence            9999999999988888899999999999999754 599999999999999999999999999998888774433111   


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                             ....++..++..+.+++...|+.+|..|.+..+-+.||++..
T Consensus       232 -----------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  232 -----------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             -----------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                                   111234457888889999999999999999999999999864

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.6e-52  Score=390.15  Aligned_cols=278  Identities=36%  Similarity=0.629  Sum_probs=230.9

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchH---HHHHHHHhCC-C-----CCeeecceeeeecCCCCce
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMD-H-----PNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~e~~~l~~l~-h-----~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +|.|.+.||+|+||+|.+|.+..|++.||||+++....+..   .|+.+|..++ |     -|+|+++++|     -...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence            79999999999999999999999999999999987765544   5888888887 3     4899999999     5555


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec-CCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~-~~~~~~kl~Dfg~~  184 (376)
                      ++|||+|.++-+|+++++....  ..++...++.++.||+.||.+||+ .||||+||||||||+. .....|||+|||.+
T Consensus       262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence            6999999999999999998654  459999999999999999999999 6999999999999995 33457999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....  ....+++.+++|+|||+++|.+ |+.+.||||||||++||++|.+.|+|.+..+++..|++.+|.|+...+...
T Consensus       339 c~~~--q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFES--QRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccC--CcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            8643  3333888999999999999876 999999999999999999999999999999999999999999998877643


Q ss_pred             CcCCcCc-----------------------------------cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC
Q 017139          265 NPNYTDF-----------------------------------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC  309 (376)
Q Consensus       265 ~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  309 (376)
                      ......+                                   ..|. ....+...+...-...+.|||++||.+||.+|+
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~-~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPP-GSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCC-CCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence            2211110                                   0110 111222222223335679999999999999999


Q ss_pred             CHHHHhCCCcccccc
Q 017139          310 TALEACAHPFFDELR  324 (376)
Q Consensus       310 t~~ell~hp~~~~~~  324 (376)
                      |+.++|+||||+...
T Consensus       495 tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  495 TPAQALNHPFLTGTS  509 (586)
T ss_pred             CHHHHhcCccccccc
Confidence            999999999998543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-54  Score=364.63  Aligned_cols=256  Identities=29%  Similarity=0.495  Sum_probs=215.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ...+|.|+++||.|+||.||+|.+..+|..+|.|.+.-+      +...-.|+.+|+.|+|||||++++.-+.   +++.
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~e   93 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNE   93 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccch
Confidence            345799999999999999999999999999999988532      2334479999999999999999883322   4444


Q ss_pred             eEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHc--CC-CceeccCCCCCeeecCCCCcEEEEec
Q 017139          106 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT--VP-GVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       106 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~--~~-~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .++||||||+ |+|...+++++.....++|..+|+++.|++.||..||+  -+ -|+||||||.||+++. +|.+||+||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDf  172 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDF  172 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccc
Confidence            5899999999 79999999999999999999999999999999999998  21 2899999999999996 889999999


Q ss_pred             CCccccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |+++...+... ..+.+|||+||+||.+.+.+ |+.+|||||+||++|||+.-++||.+.+-.+...+|.+.--.|    
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~----  247 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP----  247 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC----
Confidence            99998865543 45789999999999998765 9999999999999999999999999997666666665531111    


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccc-cCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                              +| ..+|.++..+|..|+++||..||+.     +|++.++..
T Consensus       248 ------------------------~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  248 ------------------------LPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             ------------------------CcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence                                    12 3578999999999999999999986     566655433

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-54  Score=356.71  Aligned_cols=260  Identities=30%  Similarity=0.461  Sum_probs=223.0

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecc------cccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|.+.++||+|+|+.|+++.+..+|+.+|+|++..      +....++|+.+.+.|+||||+++++.+     ...
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~   82 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE   82 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence            456789999999999999999999999999999998742      234567899999999999999999988     777


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEec
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDF  181 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Df  181 (376)
                      .+.|+|+|++.| +|...+-..    ...+|..+..++.||+.||.|||. +||+|||+||+|+++-+  .+.-+||+||
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeeccc
Confidence            889999999997 555555442    557899999999999999999999 89999999999999943  2446999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |+|.....+..-....|||.|||||++...+ |+..+|||+.|||||-|+.|.+||.+.+....+++|++.-        
T Consensus       158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~--------  228 (355)
T KOG0033|consen  158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA--------  228 (355)
T ss_pred             ceEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc--------
Confidence            9999887666666788999999999997665 9999999999999999999999999999888888887731        


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                               +.++        ...++.+++++++||++||..||++|+|+.|+|+|||+++-..-
T Consensus       229 ---------yd~~--------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~  276 (355)
T KOG0033|consen  229 ---------YDYP--------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERV  276 (355)
T ss_pred             ---------cCCC--------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHH
Confidence                     1111        12446789999999999999999999999999999999875443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-52  Score=383.60  Aligned_cols=253  Identities=33%  Similarity=0.511  Sum_probs=218.4

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc---------ccchHHHHHHHHhCC-CCCeeecceeeeecC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMD-HPNVISLKHCFFSTT  100 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~  100 (376)
                      ...+.|.+++.||+|+||+|++|.+..+++.||+|++.+.         .....+|+.+++++. ||||+++++++.   
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~---   90 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA---   90 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence            4566899999999999999999999999999999976543         123347999999999 999999999994   


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                        ....+|+|||||.| .|.+.+..    .+++.|..++.++.|++.|++|||+ +||+||||||+|||++.+.+++||+
T Consensus        91 --t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   91 --TPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             --cCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEe
Confidence              34449999999996 66666654    5789999999999999999999999 7999999999999999743889999


Q ss_pred             ecCCcccc-ccCCCcceeeccccccChhhhhCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          180 DFGSAKVL-VKGEANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       180 Dfg~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |||++... .......+.+||+.|+|||++.+.. +-+.++||||+||+||.|++|..||...+.......+.+      
T Consensus       164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------  237 (370)
T KOG0583|consen  164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------  237 (370)
T ss_pred             ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence            99999988 4666778899999999999998766 457899999999999999999999999777777766544      


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCC-ChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM-PPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                 ..+.            ++..+ |+++++|+.+||..||.+|+|+.++++||||+.
T Consensus       238 -----------~~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  238 -----------GEFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -----------CCcc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                       1222            33456 999999999999999999999999999999996

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.5e-50  Score=366.82  Aligned_cols=278  Identities=33%  Similarity=0.639  Sum_probs=230.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +.++|++.+.||.|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++     .....
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~   77 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERC   77 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCe
Confidence            3567999999999999999999999999999999885432     2344799999999999999999988     44556


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +++||||++++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus        78 ~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~  152 (288)
T cd07871          78 LTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARA  152 (288)
T ss_pred             EEEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEECcCcceee
Confidence            899999999988777654   23457899999999999999999999 79999999999999996 78899999999876


Q ss_pred             cccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ..... ......+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+..+.+....
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         153 KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             ccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            43322 22345678999999998765668999999999999999999999999999999999999999999888776543


Q ss_pred             c--CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          266 P--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       266 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      .  .+..+.++.....++... ...++.+++|||++||++||.+|||++|+|+||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cchhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            2  223333443333333322 24678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-51  Score=362.59  Aligned_cols=276  Identities=27%  Similarity=0.435  Sum_probs=229.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..+.|++++.||.|.-|+||+|+...++..+|+|++.+..       ...+.|.+||..++||+++.+|+.|     +.+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~  149 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD  149 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence            3467899999999999999999999999999999996543       2334699999999999999999999     788


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+.|+|||||+|+-+..+.+ .+.+..+++..++.++.+++.||+|||. -|||+|||||+||||.. +|.|.|+||.++
T Consensus       150 ~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvre-dGHIMLsDFDLS  226 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVRE-DGHIMLSDFDLS  226 (459)
T ss_pred             ceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEec-CCcEEeeecccc
Confidence            88999999999754444443 3457889999999999999999999999 49999999999999996 888999999886


Q ss_pred             ccccc-----------------------------------C----------------------CCcceeeccccccChhh
Q 017139          185 KVLVK-----------------------------------G----------------------EANISYICSRYYRAPEL  207 (376)
Q Consensus       185 ~~~~~-----------------------------------~----------------------~~~~~~~~t~~y~aPE~  207 (376)
                      .....                                   .                      ....+.+||-+|.|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            32210                                   0                      01125678999999999


Q ss_pred             hhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCccccccc
Q 017139          208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK  287 (376)
Q Consensus       208 ~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (376)
                      +.+.. .+.++|+|+|||.+|||+.|..||.+.+..+.+.+++..                 +..+|..          .
T Consensus       307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~----------~  358 (459)
T KOG0610|consen  307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE----------P  358 (459)
T ss_pred             eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------C
Confidence            98765 899999999999999999999999999999999988763                 1222221          2


Q ss_pred             CCChhHHHHHHhhcCCCCCCCCC----HHHHhCCCccccccCCCCCCCCCCCCCCCCCch
Q 017139          288 RMPPEAIDLASRLLQYSPSLRCT----ALEACAHPFFDELREPNARLPNGRPFPPLFNFK  343 (376)
Q Consensus       288 ~~~~~~~~li~~~L~~dP~~R~t----~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~  343 (376)
                      .++..++|||+++|.+||++|+.    |.||.+||||+.++|...+....+.+|...+..
T Consensus       359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~  418 (459)
T KOG0610|consen  359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG  418 (459)
T ss_pred             cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence            46889999999999999999998    999999999999999976665555555554443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-51  Score=363.94  Aligned_cols=259  Identities=32%  Similarity=0.535  Sum_probs=210.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..+|..++.||+|+||.||++.+..+|+.+|+|.+...    .....+|+.+|+.++|||||+.++.....   +...++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~---~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR---ENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc---cCeeeE
Confidence            56799999999999999999999999999999998665    34467899999999999999998864221   114688


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|||+++ +|.+.+..+.   ..+++..++.+..||+.||+|||+ +||+||||||+|||++..++.+||+|||++...
T Consensus        93 i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            99999995 7767666532   269999999999999999999999 899999999999999964578999999998876


Q ss_pred             cc----CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHHHh
Q 017139          188 VK----GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ..    ........||+.|||||++......++++|||||||++.||+||..||... ...+.+..+....         
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~---------  239 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED---------  239 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------
Confidence            53    223446789999999999975322345999999999999999999999873 3333222222110         


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                        ....++..+|.++++||.+||.+||.+||||+++|+|||.+....
T Consensus       240 ------------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 ------------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ------------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                              011356679999999999999999999999999999999986443

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=363.07  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=214.6

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------------------cchHHHHHHHHhCCCCCeeec
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------RYKNRELQLMRLMDHPNVISL   92 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------------~~~~~e~~~l~~l~h~~Iv~~   92 (376)
                      +..++|++.+.||+|.||+|-+|++..+++.||||++.+..                  ....+|+.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            67789999999999999999999999999999999985432                  123479999999999999999


Q ss_pred             ceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC
Q 017139           93 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL  172 (376)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~  172 (376)
                      +++.-   +.....+|+|+|||..+   .+.........+++.+++.|+..++.||+|||. +||+||||||+|+|++. 
T Consensus       174 iEvLD---DP~s~~~YlVley~s~G---~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~-  245 (576)
T KOG0585|consen  174 IEVLD---DPESDKLYLVLEYCSKG---EVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSS-  245 (576)
T ss_pred             EEeec---CcccCceEEEEEeccCC---ccccCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcC-
Confidence            99873   35566699999999954   222222223339999999999999999999999 79999999999999996 


Q ss_pred             CCcEEEEecCCcccccc------CCCcceeeccccccChhhhhC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 017139          173 THQVKLCDFGSAKVLVK------GEANISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV  243 (376)
Q Consensus       173 ~~~~kl~Dfg~~~~~~~------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  243 (376)
                      ++.+||+|||.+.....      .......+|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||.+....
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            79999999999876622      222335789999999999876   233577899999999999999999999999988


Q ss_pred             HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      +...+|+..                 ...+|.          .+.+.++++|||.+||++||.+|+++.++..|||...-
T Consensus       326 ~l~~KIvn~-----------------pL~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  326 ELFDKIVND-----------------PLEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHHHhcC-----------------cccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            888888762                 222222          12468999999999999999999999999999999764

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-49  Score=367.93  Aligned_cols=318  Identities=36%  Similarity=0.642  Sum_probs=239.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++......+...+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5999999999999999999999999999999886421      2244799999999999999999988655444445689


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||||+++|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANA-DCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEccCccccccc
Confidence            9999999888777654    4569999999999999999999999 79999999999999996 7889999999987643


Q ss_pred             cCCC----cceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          189 KGEA----NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       189 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ....    .....+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            3221    1245689999999998542 3588999999999999999999999999888888888888888887765543


Q ss_pred             cCcCCcC-c--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCC
Q 017139          264 MNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF  340 (376)
Q Consensus       264 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~  340 (376)
                      ....... +  ........++...+ ..+++++.++|.+||+.||++|||++++++||||+.+...... +...+... .
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~-~~~~~~~~-~  311 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE-PSAQPITK-L  311 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc-cccCcccc-c
Confidence            3211000 0  00000111111112 2468899999999999999999999999999999987665322 22232222 2


Q ss_pred             CchhhhhcCCHHHHhhhcHHH
Q 017139          341 NFKQELAGASPELINRLIPEH  361 (376)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~  361 (376)
                      .+.-+....+.+.+...+.++
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~  332 (338)
T cd07859         312 EFEFERRRLTKEDVRELIYRE  332 (338)
T ss_pred             cccHHHHhcCHHHHHHHHHHH
Confidence            233233344555555554444

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.2e-51  Score=371.11  Aligned_cols=249  Identities=30%  Similarity=0.546  Sum_probs=217.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc------hHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+.      ..+|+++++.++||||+.+++.|     +....+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            5799999999999999999999999999999998665432      45899999999999999999999     666779


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|+|||.|+|..++..    .+.++|+.++.++.+++.||.|||+ ++|.|||+||.|||+.+ ++.+|+||||+|+.+
T Consensus        77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEK-GGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecC-CCceeechhhhhhhc
Confidence            99999999987777765    6789999999999999999999999 79999999999999997 888999999999988


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..+.. ..+..|||.|||||+..+. .|+..+|+||+|||+||+++|++||...........|..-   +.         
T Consensus       151 ~~~t~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v---------  217 (808)
T KOG0597|consen  151 STNTSVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV---------  217 (808)
T ss_pred             ccCceeeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC---------
Confidence            76543 3466799999999999865 5999999999999999999999999887666655555441   11         


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                       ..+..++.++.+|++.+|.+||.+|+|..+++.|||+++-
T Consensus       218 -----------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  218 -----------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             -----------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                             0234689999999999999999999999999999999764

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2e-49  Score=362.12  Aligned_cols=283  Identities=33%  Similarity=0.555  Sum_probs=220.0

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....     ....+|+.+++.++||||+++++++     .+...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            467999999999999999999999999999999986432     2345799999999999999999988     445568


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+||||+++++.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECCCCcceec
Confidence            99999999988777754   23568999999999999999999999 79999999999999996 788999999998754


Q ss_pred             ccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          188 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       188 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ... .......+++.|+|||++.+...++.++|+||+||++|+|++|..||.+.. ..+.+..+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            322 222345678999999998766668899999999999999999999998754 445666676666766655443221


Q ss_pred             cC--CcCccCCCCCCCCcccccc-cCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          266 PN--YTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       266 ~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ..  +..-.+.......+...+. ...+.++.+||.+||++||++|||+.++++||||+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            10  0000000001111111111 135678999999999999999999999999999987643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=351.82  Aligned_cols=276  Identities=26%  Similarity=0.444  Sum_probs=225.5

Q ss_pred             cCCCCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeee
Q 017139           23 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFF   97 (376)
Q Consensus        23 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~   97 (376)
                      .......|...+.|++..+||.|.-++||+|++..+++.||||++..+.     ..+.+|+..++.++||||++++.+|.
T Consensus        15 ~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   15 SSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             ccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            3345556777789999999999999999999999999999999996432     44568999999999999999999995


Q ss_pred             ecCCCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcE
Q 017139           98 STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV  176 (376)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~  176 (376)
                      ...     .+|+||.||. |++.++++.+-.  ..+.|..+..|+.+++.||.|||. +|.||||||+.||||+. +|.|
T Consensus        95 v~~-----~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~-dG~V  165 (516)
T KOG0582|consen   95 VDS-----ELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDS-DGTV  165 (516)
T ss_pred             ecc-----eeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcC-CCcE
Confidence            544     3999999999 588888887644  459999999999999999999999 79999999999999996 8899


Q ss_pred             EEEecCCccccccCCCc-----ceeeccccccChhhh-hCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017139          177 KLCDFGSAKVLVKGEAN-----ISYICSRYYRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  250 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~-~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  250 (376)
                      ||+|||.+..+......     .+..||++|||||++ .....|+.++||||||++..||++|..||....+...+..-+
T Consensus       166 kLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL  245 (516)
T KOG0582|consen  166 KLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL  245 (516)
T ss_pred             EEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence            99999987665443321     456789999999994 444569999999999999999999999999988877765443


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      +  +.|+......                 ....-.+.++..++.+|..||.+||++||||+++|+|+||+.....
T Consensus       246 q--n~pp~~~t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  246 Q--NDPPTLLTSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             c--CCCCCccccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            3  4443211100                 0011123567899999999999999999999999999999876553

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-50  Score=368.12  Aligned_cols=250  Identities=29%  Similarity=0.495  Sum_probs=214.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ..|....+||+|+.|.||.|+...+++.||||.+....    .....|+.+|+..+|+|||.+++.|+..     ..+++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence            47899999999999999999999999999999986443    3345799999999999999999998554     33899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      ||||++| +|.+.+..     ..++|.++..|+.+++.||+|||. +||+|||||.+|||++. ++.+||+|||+|....
T Consensus       348 VMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~-~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTM-DGSVKLTDFGFCAQIS  420 (550)
T ss_pred             EEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEecc-CCcEEEeeeeeeeccc
Confidence            9999996 55444443     559999999999999999999999 79999999999999997 8889999999988776


Q ss_pred             cCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ... ...+.+|||+|||||++... .|++++||||||+++.||+-|.+||-..+....+..|.. .|+|...        
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk--------  490 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK--------  490 (550)
T ss_pred             cccCccccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC--------
Confidence            554 56688999999999999654 599999999999999999999999998877766665544 3433311        


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                       .++.+|++++|||.+||+.|+.+|++|.|||+||||+.
T Consensus       491 -----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  491 -----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             -----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                             34579999999999999999999999999999999953

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-50  Score=316.06  Aligned_cols=278  Identities=35%  Similarity=0.644  Sum_probs=237.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .|...++||+|.||+||+|++..+++.||+|.+..+.      ....+|+-+++.++|.|||+++++.     ..+..+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence            4777889999999999999999999999999986543      2345899999999999999999988     4455588


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|+|||..+|..++..   .++.++.+.++.++.|++.||.++|+ +++.||||||.|.|++. ++.+|++|||+++...
T Consensus        78 lvfe~cdqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~-ngelkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINR-NGELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEecc-CCcEEecccchhhhcC
Confidence            9999999876655543   57889999999999999999999999 79999999999999997 8899999999999775


Q ss_pred             cCCCc-ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          189 KGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       189 ~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      -.-.. ...+.|.+|++|.++.+..-|+...|+||.|||+.|+.. |++.|++.+..+++.+|...+|.|..+.|+.+..
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            44332 344569999999999998889999999999999999995 9999999999999999999999999999987764


Q ss_pred             CCcCccCCCCCC-CCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      -.....+|.... ..|.++.| +++...+|+++++|.-+|.+|++++++++||||...
T Consensus       233 lpdyk~yp~ypattswsqivp-~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVP-KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCCCcccCCccccchHHHHhh-hhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            433333443332 34555444 578889999999999999999999999999999864

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-48  Score=354.06  Aligned_cols=276  Identities=37%  Similarity=0.700  Sum_probs=221.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|.+.+.||+|+||.||+|++..+++.+|+|++....      ....+|+.+++.++||||+++++++     ..+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            46999999999999999999999999999999986432      2234799999999999999999988     455668


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+||||++++++..+..   ....+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~  150 (287)
T cd07848          76 YLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISH-NDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccCcccc
Confidence            99999999887666543   24568999999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          188 VKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       188 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  ......+++.|+|||++.+.. ++.++|+||+||++|+|++|++||.+.+..+.+..+....+..+.+.+....
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            4322  223456899999999997654 8999999999999999999999999988888887777777776665554322


Q ss_pred             cC--CcCccCCCCC-CCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          266 PN--YTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       266 ~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ..  +.....+... ...+...+...+|.++.+||++||++||++|||++++|+||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            11  1111111111 1112223344578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-48  Score=354.50  Aligned_cols=280  Identities=34%  Similarity=0.587  Sum_probs=222.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcC-CCcEEEEEEecccc------cchHHHHHHHHhC---CCCCeeecceeeeecCCCC
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~~Iv~~~~~~~~~~~~~  103 (376)
                      .+|++.+.||+|+||.||+|++.. +++.||+|.+....      ....+|+.+++.+   +||||+++++++.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            369999999999999999999864 46889999885432      1233577777665   6999999999885444345


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+++||||++++|.+.+...  ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcC-CCCEEEccccc
Confidence            5668999999999888777643  23458999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +.............+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            9876554444556789999999999664 489999999999999999999999999999999999998888777665543


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ... .....+......+... +...+++.+++++.+||+.||++|||+.++|+||||
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVA-LPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhc-ccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            211 1111111111222222 223578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2e-48  Score=363.71  Aligned_cols=287  Identities=32%  Similarity=0.551  Sum_probs=225.4

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~  103 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..... ..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            34578999999999999999999999999999999986431      223468999999999999999998753322 12


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+|+||||+++++...+.      ..+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~  169 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGL  169 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEecCCC
Confidence            34578999999998776653      347889999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ++............+|+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+.+..+.+..+....
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            9765444444556789999999999765 489999999999999999999999999988888888888888877654432


Q ss_pred             cCcCCcCc--cCCCCCCCCcc-----------cccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          264 MNPNYTDF--RFPQIKAHPWH-----------KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       264 ~~~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      .......+  ..+......+.           .......++++++||.+||+.||++|||+.|+|+||||..+..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence            21110000  00000000000           11122357889999999999999999999999999999876554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.4e-48  Score=362.85  Aligned_cols=288  Identities=32%  Similarity=0.551  Sum_probs=228.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~  103 (376)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... ..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            45678999999999999999999999999999999986432      223468999999999999999988743321 23


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+|+||||+++++...+.      ..+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~  172 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGL  172 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECC-CCcEEEEeCCC
Confidence            34578999999998777664      247888999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ++............+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....++...+.+..+.+..
T Consensus       173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9876544444556789999999999765 489999999999999999999999999999999999999888887765544


Q ss_pred             cCcCCcCc--cCCCCCC-----------CCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          264 MNPNYTDF--RFPQIKA-----------HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       264 ~~~~~~~~--~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                      .......+  ..+....           .++........+.++++||.+||+.||++|||++++|+||||..+..+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  328 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  328 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence            33221110  0000000           1111112223467899999999999999999999999999998765554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.9e-48  Score=354.50  Aligned_cols=283  Identities=34%  Similarity=0.648  Sum_probs=230.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|.+.+.||+|+||.||+|++..+++.+|+|.+....     ....+|+.+++.++||||+++++++     ..+..
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~   78 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKS   78 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCe
Confidence            4567999999999999999999999999999999886432     2344799999999999999999988     44455


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +++||||+++++...+..   .+..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        79 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~  153 (309)
T cd07872          79 LTLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARA  153 (309)
T ss_pred             EEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcccccee
Confidence            899999999988776654   23568899999999999999999999 79999999999999996 77899999999875


Q ss_pred             cccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ..... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+.+..+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             cCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            43322 22344678999999998766668999999999999999999999999999888999999999988887765443


Q ss_pred             cC--CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          266 PN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       266 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ..  +..+.++.....++.. ....+++++++||.+||+.||.+|||++|+++||||+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             chhhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            21  1222233222222222 12357899999999999999999999999999999987653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=358.12  Aligned_cols=260  Identities=30%  Similarity=0.498  Sum_probs=222.5

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCC-CCCeeecceeeeecC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMD-HPNVISLKHCFFSTT  100 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~  100 (376)
                      .....+.|.+.+.||.|.||.||+|+++.+|+.+|+|.+.+...       ...+|+.+|+.+. ||||+.+++.|    
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~----  105 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF----  105 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence            34456789999999999999999999999999999999965432       4568999999998 99999999999    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC---CcE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT---HQV  176 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~---~~~  176 (376)
                       ++...+++|||+|.| .|.+.+...     .+++..+..++.|++.+++|||+ .|++||||||+|+|+....   +.+
T Consensus       106 -e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~i  178 (382)
T KOG0032|consen  106 -EDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRI  178 (382)
T ss_pred             -EcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcE
Confidence             555579999999995 555555543     39999999999999999999999 7999999999999996432   479


Q ss_pred             EEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          177 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      |++|||++............+||+.|+|||++... .|+..+|+||+|+++|.|++|.+||.+.+......++....-  
T Consensus       179 k~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--  255 (382)
T KOG0032|consen  179 KLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--  255 (382)
T ss_pred             EEeeCCCceEccCCceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--
Confidence            99999999988776667788999999999999654 599999999999999999999999999988877776665211  


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                             .+....+..++..+++||++||..||.+|+|+.++|+|||++....
T Consensus       256 -----------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  256 -----------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             -----------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence                                   1122244568999999999999999999999999999999987633

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.9e-48  Score=362.77  Aligned_cols=283  Identities=33%  Similarity=0.562  Sum_probs=224.8

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..........+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999999999999999885431      2345799999999999999999988543322223689


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +||||+.++|...+..    ...+++..++.++.||+.||.|||+ +|++||||||+|||++. ++.+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNS-NCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECC-CCCEEeccccceeecc
Confidence            9999999887766643    4679999999999999999999999 79999999999999996 7889999999987654


Q ss_pred             cCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          189 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       189 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...  ......+++.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.+|.+..+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  123346789999999997766689999999999999999999999999999999999999999888766543221


Q ss_pred             CCcCccCCCCCCC-Cc--ccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYTDFRFPQIKAH-PW--HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ............. .+  ...+....++++.+||.+||++||.+|||+.++|+||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            1100000000000 00  001234568899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-50  Score=337.53  Aligned_cols=260  Identities=30%  Similarity=0.471  Sum_probs=221.4

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      ..|.-.+.||.|..+.|-++.++.+|..+|+|++....            ....+|+.+|+++ .||+|+++.++|    
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----   92 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----   92 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec----
Confidence            45777889999999999999999999999999884321            1123689999987 699999999999    


Q ss_pred             CCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          101 SKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                       +.+.++++|+|.|+ |.|.+++.    ..-.+++...+.|+.|++.|++|||. ++||||||||+|||++. +.++||+
T Consensus        93 -es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILldd-n~~i~is  165 (411)
T KOG0599|consen   93 -ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDD-NMNIKIS  165 (411)
T ss_pred             -cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecc-ccceEEe
Confidence             88888999999999 56555554    45779999999999999999999999 79999999999999995 8889999


Q ss_pred             ecCCccccccCCCcceeeccccccChhhhhC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          180 DFGSAKVLVKGEANISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       180 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      |||++.....+......+|||.|+|||.+..     .+.|+..+|+|++|+|+|.|+.|.+||........+..|++..-
T Consensus       166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky  245 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY  245 (411)
T ss_pred             ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence            9999999988888889999999999999854     34588999999999999999999999988877777777766322


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR  329 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~  329 (376)
                      ....                         .-+.++|...+|||.+||++||.+|+|++|+|+||||..+-....+
T Consensus       246 qF~s-------------------------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r  295 (411)
T KOG0599|consen  246 QFRS-------------------------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR  295 (411)
T ss_pred             ccCC-------------------------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence            2111                         1234689999999999999999999999999999999877655444

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.9e-48  Score=359.23  Aligned_cols=287  Identities=32%  Similarity=0.563  Sum_probs=228.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~  103 (376)
                      ...++|.+.+.||+|+||.||+|.+..+++.+|+|++....      ....+|+.+++.++||||+++++++..... ..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999999999999999986432      223468999999999999999998754322 22


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+|+||||+++++...+.      ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~-~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECC-CCCEEEeeCcc
Confidence            34578999999998776654      248889999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ++............+|+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+++.++.+..+.+..
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9876554444566789999999999765 489999999999999999999999999998888888888888887765544


Q ss_pred             cCcCCc----------CccCCCCCC---CCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          264 MNPNYT----------DFRFPQIKA---HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       264 ~~~~~~----------~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ..+...          ...++....   .+.........+.++++||.+||..||++|||+.|+|+||||..+..+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            332211          111111000   011111223456789999999999999999999999999999876544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-47  Score=347.84  Aligned_cols=279  Identities=30%  Similarity=0.545  Sum_probs=221.9

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhC---CCCCeeecceeeeecCCCCce
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5999999999999999999999999999999886431      1233577777665   799999999988654444566


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .++++|||++++|...+....  ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccCccc
Confidence            789999999998877776432  3458999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ............++..|+|||++.+. .++.++|+||+||++|+|++|.+||.+....+.+..+....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            76544444456779999999999765 48999999999999999999999999988888888888887777655543211


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      .. ....+......++.. ....++.++.++|.+||++||++|||+.+++.||||
T Consensus       236 ~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TL-PRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cc-cccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00 000111111111111 223578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-48  Score=353.19  Aligned_cols=250  Identities=28%  Similarity=0.416  Sum_probs=210.4

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence            47999999999999999999999999999999985421       2345699999999999999999887     55567


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~-~~~~kl~Dfg~~~  149 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDK-EGHIKLTDFGFAK  149 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEEecCcch
Confidence            9999999985 66666553    4578999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .....  .....|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....            
T Consensus       150 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------  214 (291)
T cd05612         150 KLRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK------------  214 (291)
T ss_pred             hccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence            65432  2345689999999998765 48999999999999999999999999887766665554310            


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                       ..++..+++.+++||++||+.||.+|++     ++++++||||+.+++.
T Consensus       215 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         215 -----------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             -----------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                             0133456889999999999999999995     9999999999987664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.2e-47  Score=348.20  Aligned_cols=285  Identities=32%  Similarity=0.612  Sum_probs=230.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ...++|++.+.||.|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++     ....
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~   77 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEK   77 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCC
Confidence            35678999999999999999999999999999999885432     2344799999999999999999998     4455


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+||||++++|...+...   ...+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus        78 ~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~  152 (301)
T cd07873          78 SLTLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLAR  152 (301)
T ss_pred             eEEEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECC-CCcEEECcCcchh
Confidence            68999999999887776542   4568899999999999999999999 79999999999999996 7789999999987


Q ss_pred             ccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+....+...++.+....+...
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (301)
T cd07873         153 AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI  232 (301)
T ss_pred             ccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence            643322 2223456889999999876666889999999999999999999999999888888888888888777666543


Q ss_pred             Cc--CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          265 NP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ..  .+..+.++....... ......+++++++||.+||+.||.+|||++++++||||+.+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         233 LSNEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             hccccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence            21  122222232221111 12334678999999999999999999999999999999887644

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5e-48  Score=356.64  Aligned_cols=253  Identities=28%  Similarity=0.432  Sum_probs=211.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|.+.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .+
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~   89 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QD   89 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ec
Confidence            34578999999999999999999999999999999986432       2245799999999999999999988     45


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      +..+|+|||||.| +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~Dfg  163 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDN-KGHVKVTDFG  163 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECC-CCCEEEeecc
Confidence            5568999999986 66555543    4678999999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++......  .....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+.......+...  .       
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~-------  231 (329)
T PTZ00263        164 FAKKVPDR--TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--R-------  231 (329)
T ss_pred             CceEcCCC--cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--C-------
Confidence            99765332  23467899999999997654 799999999999999999999999887766555544331  0       


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                              .            .++..++..+++||.+||+.||.+|++     ++++++||||++..+.
T Consensus       232 --------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        232 --------L------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             --------c------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                    0            123347889999999999999999997     7999999999886554

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-49  Score=345.31  Aligned_cols=249  Identities=26%  Similarity=0.454  Sum_probs=221.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .-.+|++.+.||+|.||+|-+|.....|+.||||.+.++..       .+.+|++++..|+||||+.++++|     ++.
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENk  125 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENK  125 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCC
Confidence            34689999999999999999999999999999999876542       345899999999999999999999     666


Q ss_pred             eeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+.|||||.. |.|++++..    .+.+++.+.++++.||.+|+.|||. ++++|||||.+|||+|. ++++||+|||+
T Consensus       126 dKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~-N~NiKIADFGL  199 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQ-NNNIKIADFGL  199 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecC-CCCeeeeccch
Confidence            66899999998 577777765    5789999999999999999999999 89999999999999997 77899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +..+.......+++|+|.|.+||++.+.++-++.+|.||||++||.|+.|..||.+.+....+.+|...           
T Consensus       200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G-----------  268 (668)
T KOG0611|consen  200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG-----------  268 (668)
T ss_pred             hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-----------
Confidence            999888888889999999999999998887799999999999999999999999999988877776552           


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                            .|+-             ..-+.++.-||+.||-+||++|.|++++-+|=|++
T Consensus       269 ------aYrE-------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  269 ------AYRE-------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ------cccC-------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                  1111             13477899999999999999999999999996664

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-49  Score=322.56  Aligned_cols=252  Identities=29%  Similarity=0.464  Sum_probs=221.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|++++.||.|-||.||+|+.+.++..||+|++.+..       ....+|+++...|+||||++++++|     -+.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence            4578999999999999999999999999999999986543       3445799999999999999999999     555


Q ss_pred             eeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+++||.+ |.++..|...  ...++++...+.++.|++.||.|||. ++++||||||+|+|++. .+.+||+|||.
T Consensus        95 ~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~-~~~lkiAdfGw  170 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGS-AGELKIADFGW  170 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCC-CCCeeccCCCc
Confidence            66999999998 6777777642  35679999999999999999999999 89999999999999997 88899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +.... .....+.+||.-|.+||...+.. ++..+|+|++|++.||++.|.+||.+....+.+++|.+.           
T Consensus       171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-----------  237 (281)
T KOG0580|consen  171 SVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-----------  237 (281)
T ss_pred             eeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----------
Confidence            87654 55667889999999999997654 899999999999999999999999999888888888773           


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                            ++.            +|..++.++.|+|.+||.++|.+|.+..|++.|||+...
T Consensus       238 ------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 ------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                  122            446789999999999999999999999999999998753

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.5e-48  Score=356.10  Aligned_cols=246  Identities=27%  Similarity=0.441  Sum_probs=203.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     .....+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            47999999999999999999999999986432       1234688999999999999999888     45556899999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-C
Q 017139          113 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-G  190 (376)
Q Consensus       113 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-~  190 (376)
                      |+++ +|...+..    +..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCC
Confidence            9996 55555443    4678999999999999999999999 79999999999999996 77899999999875432 2


Q ss_pred             CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          191 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       191 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  211 (323)
T ss_pred             CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence            233456789999999999764 4899999999999999999999999887765555443321                 0


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                  ..++..+++++.+||.+||+.||++||     ++.++++||||+.+.+.
T Consensus       212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         212 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                        013456799999999999999999999     89999999999987664

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-47  Score=346.85  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=208.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++|+||+++.+++     .++..+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            3889999999999999999999999999999885432       1234689999999999999999888     445568


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++|||||++ +|...+...  ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus        76 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDD-RGHIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeCCCcEE
Confidence            999999986 555444331  23468999999999999999999999 79999999999999996 77899999999987


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...........|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......          
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05631         152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------  220 (285)
T ss_pred             cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------
Confidence            5444444456789999999999765 48999999999999999999999998765433332222211100          


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                     ...++..+++++.+||++||+.||.+|++     ++++++||||..+++.
T Consensus       221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence                           01134467999999999999999999997     8999999999988765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-47  Score=353.62  Aligned_cols=285  Identities=35%  Similarity=0.623  Sum_probs=227.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~  105 (376)
                      .++|.+.+.||.|+||+||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            468999999999999999999999999999999986432      223469999999999999999988743221 2234


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+++++++++|...+.     ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus        94 ~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~  166 (343)
T cd07878          94 EVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNE-DCELRILDFGLAR  166 (343)
T ss_pred             cEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECC-CCCEEEcCCccce
Confidence            578999999888766654     2569999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  ......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+....
T Consensus       167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            6543  23355789999999999775568999999999999999999999999988888888888888887766554332


Q ss_pred             cCCcCc---cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          266 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       266 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                      ......   ..+......+... ....++.+.+||.+||..||.+|||+.++|+||||.....+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             hhhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence            211110   1111111111111 234678899999999999999999999999999999876553

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-48  Score=351.22  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=233.2

Q ss_pred             CCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        27 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      ....+..+-|.+.+.||+|-|+.|-+|++..+|+.||||++.+..      ..+.+|+..++.++|||||++|++.    
T Consensus        11 i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi----   86 (864)
T KOG4717|consen   11 IYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI----   86 (864)
T ss_pred             ccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh----
Confidence            344455667999999999999999999999999999999997653      2334799999999999999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                       .....+|+|+|.-++ +|.+++...   ...+.|...++++.||+.|+.|||++ ++|||||||+|+.+-..-|-+||+
T Consensus        87 -DTQTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLT  161 (864)
T KOG4717|consen   87 -DTQTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLT  161 (864)
T ss_pred             -cccceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEee
Confidence             555569999999885 888888763   46799999999999999999999995 899999999998876667889999


Q ss_pred             ecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          180 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       180 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      |||++..+.++....+.+|+..|.|||++++..+..+++||||||||||.|++|++||...++.+.+..|+.+-      
T Consensus       162 DFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK------  235 (864)
T KOG4717|consen  162 DFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK------  235 (864)
T ss_pred             eccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc------
Confidence            99999999999999999999999999999998877889999999999999999999999999999998888742      


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                                 |.            .|..++.+++|||..||..||.+|.+.+++..|+|++.++.+.
T Consensus       236 -----------Yt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  236 -----------YT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             -----------cc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence                       22            4467899999999999999999999999999999999987664

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-49  Score=336.88  Aligned_cols=256  Identities=29%  Similarity=0.431  Sum_probs=219.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchH-------HHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      -.++|..+++||+|.||+|-+|+.+.+++.||||+++++....+       .|-.+|+..+||++..+...|     +..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence            34789999999999999999999999999999999987654443       467899999999999998888     666


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+||||.+|+   .+....+....+++...+.+-.+|++||.|||+ ++||+||||.+|.|+|+ +|.+||+|||+|
T Consensus       241 drlCFVMeyanGG---eLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDk-DGHIKitDFGLC  315 (516)
T KOG0690|consen  241 DRLCFVMEYANGG---ELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDK-DGHIKITDFGLC  315 (516)
T ss_pred             ceEEEEEEEccCc---eEeeehhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheecc-CCceEeeecccc
Confidence            6799999999975   222223346789999999999999999999999 89999999999999997 888999999999


Q ss_pred             ccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +..-. .....+.+|||.|+|||++... .|+.++|+|.+||++|||++|+.||...+.......|+..           
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------  383 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------  383 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence            86544 3445678999999999999654 5999999999999999999999999998887776666542           


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCCC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN  327 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~~  327 (376)
                            ++            .||..++++++.|+..+|.+||.+|..     +.|+.+|+||..++|..
T Consensus       384 ------d~------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 ------DL------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             ------hc------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                  11            156789999999999999999999984     78999999999999874

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-47  Score=360.19  Aligned_cols=278  Identities=23%  Similarity=0.349  Sum_probs=213.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....  ....+|+++++.++||||+++++++     ......++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEEEEe
Confidence            3579999999999999999999999999999997643  2356799999999999999999988     34455889999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC--
Q 017139          113 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--  190 (376)
Q Consensus       113 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~--  190 (376)
                      ++.++|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......  
T Consensus       164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcC-CCCEEEEeCCcccccccccc
Confidence            999887776654    3568999999999999999999999 79999999999999996 778999999998754322  


Q ss_pred             CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCCHHHHhh
Q 017139          191 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-------NAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       191 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...       +....+..++...|.++.+....
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            222345789999999999764 4899999999999999999999887543       23456677777777654321100


Q ss_pred             cCcC----C----cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          264 MNPN----Y----TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       264 ~~~~----~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ....    +    ............|...  ..++.++.+||.+||++||.+|||++|+|+||||+.+..+
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            0000    0    0000000000111111  1357789999999999999999999999999999876443

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.6e-47  Score=355.67  Aligned_cols=256  Identities=28%  Similarity=0.418  Sum_probs=207.0

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.+..       ....+|+.+++.++||||+++++.+     .+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            47999999999999999999999999999999986432       2334688999999999999999988     55566


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+|||||+| +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus        76 ~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~-~~~vkL~DFGla~  149 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDS-KGHVKLSDFGLCT  149 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCCEEEeeccCcc
Confidence            9999999986 56555543    4679999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCC------------------------------------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHH
Q 017139          186 VLVKGE------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAE  229 (376)
Q Consensus       186 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~  229 (376)
                      ......                                    .....+||+.|+|||++.+. .++.++|+|||||++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~e  228 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE  228 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHH
Confidence            542210                                    01235789999999999765 48999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCC---
Q 017139          230 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS---  306 (376)
Q Consensus       230 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---  306 (376)
                      |++|..||.+.+..+....+......               ..+|.          ...++++++++|.+|+. +|.   
T Consensus       229 ll~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~  282 (363)
T cd05628         229 MLIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRI  282 (363)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcC
Confidence            99999999988877766665542110               00110          01368899999999876 444   


Q ss_pred             CCCCHHHHhCCCccccccCCC
Q 017139          307 LRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       307 ~R~t~~ell~hp~~~~~~~~~  327 (376)
                      .||+++|+++||||+.+++..
T Consensus       283 ~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         283 GAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCCHHHHhCCCCCCCCCHHH
Confidence            458999999999999987754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.5e-47  Score=346.93  Aligned_cols=278  Identities=32%  Similarity=0.561  Sum_probs=211.2

Q ss_pred             eeeeccCCceEEEEEEEc--CCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           39 ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      +++||+|+||.||+|++.  .+++.||+|.+....  ....+|+.+++.++||||+++++++..   ..+..+|++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEecc
Confidence            468999999999999975  467899999986543  234579999999999999999998754   3345688999999


Q ss_pred             cchHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec---CCCCcEEEEecCCccc
Q 017139          115 PETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKV  186 (376)
Q Consensus       115 ~g~l~~~l~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~---~~~~~~kl~Dfg~~~~  186 (376)
                      ++++...+.....     ....+++..++.++.||+.||+|||+ +||+||||||+|||++   ..++.+||+|||+++.
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9988877754321     12358999999999999999999999 7999999999999994   2356899999999976


Q ss_pred             cccCC----CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 017139          187 LVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL  253 (376)
Q Consensus       187 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~~~~~~  253 (376)
                      .....    ......+|+.|+|||++.+...++.++|+||+||++|+|++|.+||.....         ...+..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            54322    123456799999999997766689999999999999999999999975432         35677788888


Q ss_pred             CCCCHHHHhhcCcCCc------Cc---cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          254 GTPTREEIRCMNPNYT------DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      |.+....+.....-..      .+   .........+........+.++.+||.+||++||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            8877766554321100      00   0000000000011112346679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-48  Score=332.17  Aligned_cols=289  Identities=35%  Similarity=0.602  Sum_probs=231.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCc----EEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      .....|++.+.||+|.||.||+|....++.    .+|||++....      ...-+|+.+++.++|||++.+..+|+.  
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~--   98 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS--   98 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc--
Confidence            445689999999999999999997665533    69999996552      234589999999999999999999864  


Q ss_pred             CCCceeEEEEeecccchHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC---CCcE
Q 017139          101 SKDELFLNLVMEYVPETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---THQV  176 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g~l~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~---~~~~  176 (376)
                        .+..+++++||.+-+|++.++.... ....++...++.|+.||+.|+.|||+ +-|+||||||.|||+..+   .|+|
T Consensus        99 --~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen   99 --HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             --cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCee
Confidence              2556999999999999999976543 34678999999999999999999999 899999999999999752   3899


Q ss_pred             EEEecCCccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC---------ChH
Q 017139          177 KLCDFGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---------NAV  243 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---------~~~  243 (376)
                      ||+|||+++...+.-.    ....+.|.||+|||++++...|+++.|+|++|||+.||++-.+.|.+.         -..
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            9999999998765432    234566999999999999999999999999999999999999999754         245


Q ss_pred             HHHHHHHHhcCCCCHHHHhhcCcCCcCc--cCCCCC-----CCCccccc--ccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          244 DQLVEIIKVLGTPTREEIRCMNPNYTDF--RFPQIK-----AHPWHKVF--HKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                      +++.+|++.+|.|....|+.+..- .++  ....+.     ...++..+  .+.-++.+.+|+.+||++||-+|+|++++
T Consensus       256 dQl~rIf~vLG~Pt~~~Wp~lkk~-Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  256 DQLDRIFEVLGTPTDKDWPDLKKM-PEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHcCCCccccchhhhhC-cchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence            889999999999999888755321 111  011111     11111111  12345669999999999999999999999


Q ss_pred             hCCCccccccC
Q 017139          315 CAHPFFDELRE  325 (376)
Q Consensus       315 l~hp~~~~~~~  325 (376)
                      |+|+||+.-..
T Consensus       335 leh~yF~~d~l  345 (438)
T KOG0666|consen  335 LEHPYFTEDPL  345 (438)
T ss_pred             hcccccccCCC
Confidence            99999987433

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-47  Score=353.27  Aligned_cols=252  Identities=29%  Similarity=0.448  Sum_probs=209.8

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCC-cEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..++|.+.+.||+|+||.||+|.+..++ ..||+|.+....       ....+|+.+++.++||||+++++++     .+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence            4578999999999999999999876655 689999885431       2234699999999999999999998     44


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+|||||.+ +|.+.+..    +..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~ikL~DFG  176 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDK-DGFIKMTDFG  176 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEecCC
Confidence            5568999999985 66666543    4679999999999999999999999 79999999999999986 7889999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++.....  ......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+....         
T Consensus       177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------  244 (340)
T PTZ00426        177 FAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------  244 (340)
T ss_pred             CCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence            9976532  23456789999999999764 48999999999999999999999999887766555554311         


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                          ..++..+++++.++|++||+.||.+|+     +++++++||||+++.+.
T Consensus       245 --------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        245 --------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                                013345788999999999999999996     89999999999987654

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-46  Score=340.07  Aligned_cols=276  Identities=35%  Similarity=0.574  Sum_probs=219.0

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||.|+||.||+|.+..+|+.+|+|.+....      ....+|+.+++.++||||+++++++     .+...++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            5899999999999999999999999999999885431      2345799999999999999999988     4455689


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +++||++++|...+..   ....+++..++.++.||+.||.|||+ +|++|+||||+||+++. ++.+||+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINK-NGELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcC-CCcEEECccchhhccC
Confidence            9999999988776654   24569999999999999999999999 79999999999999996 7889999999987653


Q ss_pred             cCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          189 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       189 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ... ......++..|+|||.+.+...++.++|+|||||++|+|++|..| |.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            322 122345688999999987766679999999999999999998877 566666777777887777776665543322


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ......++..............+++++.++|.+||+.||.+|||+++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111111111111111122334688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-47  Score=351.13  Aligned_cols=258  Identities=30%  Similarity=0.466  Sum_probs=211.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++....       .....|+++++.++||||+++++++     .+...
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            36999999999999999999999999999999986432       2234688999999999999999888     55556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+|||||+| +|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kL~Dfg~a~  149 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDA-SGHIKLTDFGLSK  149 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEEEeCcCCc
Confidence            8999999985 66666643    4578999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  ......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+........        
T Consensus       150 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------  218 (333)
T cd05600         150 GIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------  218 (333)
T ss_pred             cccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--------
Confidence            6543  33456789999999999765 589999999999999999999999998877666655443211000        


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                             .+..      ......++.++.++|.+||..+|++|++++++++||||+...+.
T Consensus       219 -------~~~~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         219 -------RPVY------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             -------CCCC------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence                   0000      00012468999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=327.98  Aligned_cols=264  Identities=28%  Similarity=0.426  Sum_probs=213.0

Q ss_pred             ccccceEee-eeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEE
Q 017139           31 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        31 ~~~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..+++|.+. ++||-|-.|+|..|.++.+++.+|+|++.. .....+|+++--.. .|||||.++++|.... .+...+.
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLL  135 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLL  135 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeE
Confidence            467899885 689999999999999999999999997744 44556788875544 6999999999985443 4566788


Q ss_pred             EEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEecCCcc
Q 017139          109 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAK  185 (376)
Q Consensus       109 lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Dfg~~~  185 (376)
                      +|||+++|+ |.+-+...  ..+.++|.++..|+.||+.|+.|||+ .+|.||||||+|+|...  .+..+||+|||+|+
T Consensus       136 iVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             eeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEeccccccc
Confidence            999999975 44434332  34669999999999999999999999 59999999999999953  34579999999999


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCCHHHH
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV----DQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~  261 (376)
                      .........+.+.||+|.|||++ +...|+..+|+||+||++|-|++|.+||++....    ....+|...         
T Consensus       213 ~t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g---------  282 (400)
T KOG0604|consen  213 ETQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG---------  282 (400)
T ss_pred             ccCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc---------
Confidence            88777777788889999999998 5556999999999999999999999999876532    222223221         


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                              .|.||.        .-+..+|++++|+|+++|..+|++|.|++++++|||+.....
T Consensus       283 --------qy~FP~--------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  283 --------QYEFPE--------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             --------CccCCC--------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence                    122221        123458999999999999999999999999999999987543

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-47  Score=355.83  Aligned_cols=255  Identities=31%  Similarity=0.504  Sum_probs=207.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence            46999999999999999999999999999999986431       2234699999999999999999988     55566


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+|||||+| +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~  149 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDA-KGHIKLSDFGLCT  149 (364)
T ss_pred             EEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEeecccce
Confidence            9999999985 55555543    4569999999999999999999999 79999999999999996 7889999999986


Q ss_pred             ccccCC---------------------------------------CcceeeccccccChhhhhCCCCCCccchhHHHHHH
Q 017139          186 VLVKGE---------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV  226 (376)
Q Consensus       186 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  226 (376)
                      ......                                       .....+||+.|+|||++.+. .++.++|+|||||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~i  228 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVI  228 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhH
Confidence            542211                                       01124689999999998654 48999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCC
Q 017139          227 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS  306 (376)
Q Consensus       227 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  306 (376)
                      +|+|++|..||.+.+..+....+.....               ...++.          ...+++++++||.+||. +|.
T Consensus       229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~  282 (364)
T cd05599         229 MYEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAE  282 (364)
T ss_pred             HHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHh
Confidence            9999999999998877666555543110               001110          11468999999999997 999


Q ss_pred             CCCC---HHHHhCCCccccccCC
Q 017139          307 LRCT---ALEACAHPFFDELREP  326 (376)
Q Consensus       307 ~R~t---~~ell~hp~~~~~~~~  326 (376)
                      +|++   ++++++||||+..++.
T Consensus       283 ~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         283 RRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             hcCCCCCHHHHhcCCCcCCCCHH
Confidence            9998   9999999999987664

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-47  Score=356.60  Aligned_cols=255  Identities=30%  Similarity=0.482  Sum_probs=205.1

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.+..       ....+|+++++.++||||+++++++     .+..+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            47999999999999999999999999999999985432       2234689999999999999999988     55667


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+|||||+| +|...+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus        76 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~-~~~~kl~DfGla~  149 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDR-GGHIKLSDFGLST  149 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEEeeccccc
Confidence            9999999985 66666553    4678999999999999999999999 79999999999999996 7889999999985


Q ss_pred             ccccCC------------------------------------------------CcceeeccccccChhhhhCCCCCCcc
Q 017139          186 VLVKGE------------------------------------------------ANISYICSRYYRAPELIFGATEYTTS  217 (376)
Q Consensus       186 ~~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~  217 (376)
                      ......                                                .....+||+.|+|||++.+. .++.+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  228 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQE  228 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCc
Confidence            321100                                                00124689999999999765 48999


Q ss_pred             chhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHH
Q 017139          218 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA  297 (376)
Q Consensus       218 ~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  297 (376)
                      +|+|||||++|+|++|.+||.+.+..+....+.....               ...+|.          ...++.++++||
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli  283 (377)
T cd05629         229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLI  283 (377)
T ss_pred             eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHH
Confidence            9999999999999999999988877666655543110               001110          124688999999


Q ss_pred             HhhcCCCCCCC---CCHHHHhCCCccccccCC
Q 017139          298 SRLLQYSPSLR---CTALEACAHPFFDELREP  326 (376)
Q Consensus       298 ~~~L~~dP~~R---~t~~ell~hp~~~~~~~~  326 (376)
                      .+||+ +|.+|   +++.++++||||+..++.
T Consensus       284 ~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~  314 (377)
T cd05629         284 RRLIT-NAENRLGRGGAHEIKSHPFFRGVDWD  314 (377)
T ss_pred             HHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            99998 67665   599999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-46  Score=344.31  Aligned_cols=320  Identities=34%  Similarity=0.625  Sum_probs=241.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|.+....     ....+|+.+++.++||||+++++++..........
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3468999999999999999999999999999999885321     12346899999999999999998875444344556


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|+++||+++++...+..     ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~  155 (336)
T cd07849          83 VYIVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-NCDLKICDFGLARI  155 (336)
T ss_pred             EEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEECcccceee
Confidence            899999999987766643     569999999999999999999999 79999999999999996 78899999999876


Q ss_pred             cccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          187 LVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       187 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ......    .....+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+.......+...++.+..+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            543221    1234678899999988665568999999999999999999999999988888888888888887776654


Q ss_pred             hcCcCCcCc---cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCC
Q 017139          263 CMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPL  339 (376)
Q Consensus       263 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~  339 (376)
                      .........   ..+.....++.. ....+++++.++|.+||+.||++|||+.++++||||+.+..+.....  ...+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~--~~~~~~  312 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPV--AEEPFP  312 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCccc--CCCCCC
Confidence            332211100   011111111211 12346889999999999999999999999999999998866522211  112234


Q ss_pred             CCchhhhhcCCHHHHhhhcHHHH
Q 017139          340 FNFKQELAGASPELINRLIPEHV  362 (376)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~  362 (376)
                      ++|... .....+.+.+++.+++
T Consensus       313 ~~~~~~-~~~~~~~~~~~~~~~~  334 (336)
T cd07849         313 FDFELF-DDLPKEKLKELIFEEI  334 (336)
T ss_pred             hhhccc-cccCHHHHHHHHHHHh
Confidence            444432 3444555556555544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-46  Score=360.84  Aligned_cols=282  Identities=23%  Similarity=0.358  Sum_probs=212.5

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCC------CCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDH------PNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h------~~Iv~~~~~~~~~~~~~  103 (376)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....   .....|+.+++.+.|      .+++++++++.    .+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~----~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ----NE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE----cC
Confidence            468999999999999999999999999999999986432   223457777777655      45788877763    23


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC---------
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---------  174 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~---------  174 (376)
                      ...+|+|||+++++|.+.+..    ...+++..++.|+.||+.||+|||+..||+||||||+|||++..+.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            346889999998888877764    3579999999999999999999997139999999999999985322         


Q ss_pred             ------cEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017139          175 ------QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE  248 (376)
Q Consensus       175 ------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  248 (376)
                            .+||+|||.+....  .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  49999999875432  233456789999999999765 489999999999999999999999999998888888


Q ss_pred             HHHhcCCCCHHHHhhcCcC-----CcCc--cCCCCCCCCcccc-----cc-cCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          249 IIKVLGTPTREEIRCMNPN-----YTDF--RFPQIKAHPWHKV-----FH-KRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~-----~~-~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                      +.+.+|.++..........     +...  ..+......+...     .. ...++.+.|||.+||++||.+|||++|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            8888887765433211000     0000  0000000000000     00 01246688999999999999999999999


Q ss_pred             CCCccccccC
Q 017139          316 AHPFFDELRE  325 (376)
Q Consensus       316 ~hp~~~~~~~  325 (376)
                      +||||.....
T Consensus       437 ~Hp~~~~~~~  446 (467)
T PTZ00284        437 THPYVLKYYP  446 (467)
T ss_pred             cCccccccCC
Confidence            9999987543

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-46  Score=353.37  Aligned_cols=255  Identities=29%  Similarity=0.471  Sum_probs=203.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .|++++.||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .+...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            5899999999999999999999999999999986432       2234689999999999999999988     445569


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+|||||+| +|.+.+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~-~~~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDL-DGHIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECC-CCCEEEeeCcCCcc
Confidence            999999986 66555543    4568999999999999999999999 79999999999999996 78899999998753


Q ss_pred             cccCC------------------------------------------------CcceeeccccccChhhhhCCCCCCccc
Q 017139          187 LVKGE------------------------------------------------ANISYICSRYYRAPELIFGATEYTTSI  218 (376)
Q Consensus       187 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  218 (376)
                      .....                                                ...+..||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence            21000                                                01235689999999999764 489999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHH
Q 017139          219 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS  298 (376)
Q Consensus       219 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  298 (376)
                      |||||||++|+|++|..||...+..+....+......               ..++          ....+++++++||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIP----------PQVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCC----------CCCCCCHHHHHHHH
Confidence            9999999999999999999887765555444321110               0011          11247899999999


Q ss_pred             hhcCC--CCCCCCCHHHHhCCCccccccCC
Q 017139          299 RLLQY--SPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       299 ~~L~~--dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      +||..  +|..|++++++++||||+++.+.
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCChh
Confidence            96654  45559999999999999987664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.2e-46  Score=336.99  Aligned_cols=276  Identities=34%  Similarity=0.647  Sum_probs=218.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||+|++|.||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++     .++..+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence            5899999999999999999999999999999885431      2345799999999999999999998     4445689


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +||||++++|...+.... .+..+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcC-CCcEEECcccceeecC
Confidence            999999988777765432 24678999999999999999999999 79999999999999996 7889999999987543


Q ss_pred             cCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+....+....+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            222 1223456889999999876656789999999999999999999999998887777777777766655444321110


Q ss_pred             CcCc--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          268 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       268 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                       .++  .++....... ......+++++.++|.+||+.||++|||+.+++.||||
T Consensus       233 -~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 -PDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             -HHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence             000  0111111111 11233579999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-47  Score=352.28  Aligned_cols=256  Identities=33%  Similarity=0.531  Sum_probs=211.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++....       .....|+.++..++||||+++++++     .++.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            47999999999999999999999999999999986432       2345689999999999999999888     55667


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||+++ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~-~~~~kL~Dfg~~~  149 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDA-DGHIKLADFGLCK  149 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEeecCCCCc
Confidence            9999999985 66666654    3679999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCC------------------------------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCC
Q 017139          186 VLVKGE------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP  235 (376)
Q Consensus       186 ~~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~  235 (376)
                      ......                              ......||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCC
Confidence            654432                              22345689999999999765 58999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-HHHH
Q 017139          236 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEA  314 (376)
Q Consensus       236 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~el  314 (376)
                      ||...+.......+......               ..++          ....+++++.+||.+||. ||.+|++ ++++
T Consensus       229 Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~l  282 (350)
T cd05573         229 PFYSDTLQETYNKIINWKES---------------LRFP----------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEI  282 (350)
T ss_pred             CCCCCCHHHHHHHHhccCCc---------------ccCC----------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence            99988766665555431110               0111          111368999999999998 9999999 9999


Q ss_pred             hCCCccccccCCC
Q 017139          315 CAHPFFDELREPN  327 (376)
Q Consensus       315 l~hp~~~~~~~~~  327 (376)
                      ++||||+.+.+..
T Consensus       283 l~hp~~~~~~~~~  295 (350)
T cd05573         283 KSHPFFKGIDWEN  295 (350)
T ss_pred             hcCCCcCCCCHHH
Confidence            9999999887654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6e-46  Score=344.10  Aligned_cols=320  Identities=35%  Similarity=0.620  Sum_probs=244.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .++|.+.+.||.|+||+||+|++..+++.||||.+....      ....+|+.+++.++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357999999999999999999999999999999885421      22346899999999999999999875443333456


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|+|+||+.++|...+..    ...+++..++.++.|++.||.|||+ ++++|+||||+||+++. ++.+||+|||++..
T Consensus        84 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNA-NCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcCccccc
Confidence            899999999887766653    4679999999999999999999999 79999999999999996 77899999999876


Q ss_pred             cccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .... .......++..|+|||.+.....++.++|+|||||++|+|++|.+||.+.+.......+....+.+..+.+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            5433 222345678899999998654458999999999999999999999999888888888888888877766553222


Q ss_pred             cCCc-Cc--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCCc
Q 017139          266 PNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF  342 (376)
Q Consensus       266 ~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~  342 (376)
                      .... .+  ..+......+. .....+++++.++|.+||+.||++|||++++++||||..+..+..... .   +..+.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~-~---~~~~~~  312 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV-C---QTPFSF  312 (337)
T ss_pred             chhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc-C---CCccch
Confidence            1110 00  01111111111 123468999999999999999999999999999999998876653322 1   223344


Q ss_pred             hhhhhcCCHHHHhhhcHHHHH
Q 017139          343 KQELAGASPELINRLIPEHVR  363 (376)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~  363 (376)
                      +-+..+.+.+.+.+++-.++.
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~  333 (337)
T cd07858         313 DFEEDALTEEDIKELIYNEML  333 (337)
T ss_pred             hhhhhhcCHHHHHHHHHHHHh
Confidence            444444677788877765543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.8e-46  Score=351.37  Aligned_cols=259  Identities=26%  Similarity=0.441  Sum_probs=211.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++     .+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~  114 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QD  114 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence            45678999999999999999999999999999999985421       2234689999999999999999888     55


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ..++|+|||||+| +|...+..     ..+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~~kL~DfG  187 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG  187 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcC-CCCEEEEecc
Confidence            6669999999985 66655543     458899999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCC--CcceeeccccccChhhhhCCC---CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          183 SAKVLVKGE--ANISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       183 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      ++.......  ......||+.|+|||++.+..   .++.++|+|||||++|+|++|..||.+.+.......+......  
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--  265 (370)
T cd05596         188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS--  265 (370)
T ss_pred             ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc--
Confidence            987654332  223457899999999986432   3788999999999999999999999988776666555431110  


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCC--CCCHHHHhCCCccccccCC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP  326 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~~~~~~~~  326 (376)
                                   ..++.          ...++.++++||.+||+.+|.+  |+|++++++||||+...+.
T Consensus       266 -------------~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         266 -------------LTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             -------------CCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence                         01110          1247899999999999999998  9999999999999875543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=345.10  Aligned_cols=243  Identities=31%  Similarity=0.522  Sum_probs=200.7

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        42 Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .+...+|+|||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            799999999999999999999999986431       1234688999999999999999888     4455689999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC-CC
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EA  192 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~-~~  192 (376)
                      ++ +|...+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+++..... ..
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCCc
Confidence            86 55555543    4578999999999999999999999 79999999999999996 788999999998754322 22


Q ss_pred             cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCcc
Q 017139          193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR  272 (376)
Q Consensus       193 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .....||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+...                    
T Consensus       150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--------------------  208 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--------------------  208 (312)
T ss_pred             cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--------------------
Confidence            3345789999999999765 4899999999999999999999999887766555544321                    


Q ss_pred             CCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC---CHHHHhCCCccccccC
Q 017139          273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELRE  325 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~ell~hp~~~~~~~  325 (376)
                               ...++..+++++.++|.+||..||.+||   ++.++++||||.+..+
T Consensus       209 ---------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         209 ---------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence                     0013446789999999999999999997   5899999999998644

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-46  Score=354.15  Aligned_cols=254  Identities=29%  Similarity=0.475  Sum_probs=205.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      +|++++.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .+...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            5899999999999999999999999999999986532       2345699999999999999999998     445569


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+|||||++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEeECCCCcc
Confidence            999999986 56665543    3568999999999999999999999 79999999999999996 78899999999753


Q ss_pred             cccC------------------------------------------------CCcceeeccccccChhhhhCCCCCCccc
Q 017139          187 LVKG------------------------------------------------EANISYICSRYYRAPELIFGATEYTTSI  218 (376)
Q Consensus       187 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~  218 (376)
                      ....                                                .......||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001134689999999999765 489999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHH
Q 017139          219 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS  298 (376)
Q Consensus       219 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  298 (376)
                      |||||||++|+|++|.+||.+.+..+....+......               ...|          ....+++++.++|.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHH
Confidence            9999999999999999999988776655554431110               0011          11357899999999


Q ss_pred             hhcCCCCCCCCC---HHHHhCCCccccccCC
Q 017139          299 RLLQYSPSLRCT---ALEACAHPFFDELREP  326 (376)
Q Consensus       299 ~~L~~dP~~R~t---~~ell~hp~~~~~~~~  326 (376)
                      +|+ .||.+|++   ++++++||||+.+.+.
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            986 59999997   9999999999987654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-47  Score=347.82  Aligned_cols=254  Identities=29%  Similarity=0.470  Sum_probs=223.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .++|..++++|+|+||.+++++++.++..|++|++.-.      +.....|..+++++.|||||.+.+.|.    .++.+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~   78 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL   78 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence            46799999999999999999999999999999998543      234567999999999999999999983    34445


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      ++|||+||+| ++.+.+....  +..++++.+..|+.|++.|+.|||+ ++|+|||||+.|||+++ ++.|||+|||+|+
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk-~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTK-DKKVKLGDFGLAK  154 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccc-cCceeecchhhhh
Confidence            9999999996 6777776644  5779999999999999999999999 89999999999999997 6668999999999


Q ss_pred             ccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...+.. ...+.+||+.|++||++.+. .|+.++|||||||++|||++-+++|.+.+-.....++.+....|        
T Consensus       155 ~l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P--------  225 (426)
T KOG0589|consen  155 ILNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP--------  225 (426)
T ss_pred             hcCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC--------
Confidence            988776 66788999999999999765 49999999999999999999999999999888888887754332        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                          .+...+.+++.+|+.||..+|..||++.++|.+|.+...
T Consensus       226 --------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  226 --------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             --------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                                345679999999999999999999999999999998743

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-45  Score=343.84  Aligned_cols=286  Identities=33%  Similarity=0.594  Sum_probs=226.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~  104 (376)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++..... .+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999999999999999985431      123369999999999999999998753322 223


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+||||+.+++...+..      .+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~-~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCccc
Confidence            45789999999988776653      28899999999999999999999 79999999999999996 778999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .............+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+...++.+..+.....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             eeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            876544444455678899999999765 4899999999999999999999999999888888888888888876554433


Q ss_pred             CcCCcCcc--CCCCCCCCccccc------------ccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          265 NPNYTDFR--FPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~~--~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ......+.  .+.....++...+            +...+++++++|.+||+.||++|||+.++|.||||+.+-.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence            22111110  0000011111111            22456789999999999999999999999999999876554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.5e-47  Score=355.32  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=204.8

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      +|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++.+     .++..+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            699999999999999999999999999999998542       12345799999999999999999988     555679


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+|||||+| +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECC-CCCEEEEeCCCCcc
Confidence            999999985 66666654    4568999999999999999999999 79999999999999996 78899999999742


Q ss_pred             cccC--------------------------------------------CCcceeeccccccChhhhhCCCCCCccchhHH
Q 017139          187 LVKG--------------------------------------------EANISYICSRYYRAPELIFGATEYTTSIDIWS  222 (376)
Q Consensus       187 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  222 (376)
                      ....                                            .......||+.|+|||++.+. .++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence            2100                                            001134689999999999765 4899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcC
Q 017139          223 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ  302 (376)
Q Consensus       223 lG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  302 (376)
                      |||++|+|++|..||.+.+..+....+......               ..++          ....+++++.++|.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh-
Confidence            999999999999999988766555444321100               0011          11247899999999977 


Q ss_pred             CCCCCCC---CHHHHhCCCccccccCC
Q 017139          303 YSPSLRC---TALEACAHPFFDELREP  326 (376)
Q Consensus       303 ~dP~~R~---t~~ell~hp~~~~~~~~  326 (376)
                      .+|.+|+   +++++++||||+.+...
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~~~  310 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGIDFA  310 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence            5999999   99999999999987554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-46  Score=344.64  Aligned_cols=246  Identities=30%  Similarity=0.507  Sum_probs=201.4

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|+++.+++.||+|++.+..       .....|..++..+ +||||+++++++     .+...+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999986432       1223566777665 799999999988     4555689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-  189 (376)
                      |||++ +|...+..    ...+++..++.++.|++.||.|||+ +|++||||||+|||++. ++.+||+|||++..... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCcC
Confidence            99996 55544443    4679999999999999999999999 79999999999999996 78899999999875432 


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------------  212 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------------  212 (320)
T ss_pred             CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2233345689999999998654 48999999999999999999999999888776665554310                


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH------HHHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~ell~hp~~~~~~~~  326 (376)
                                   ..++..++.++.++|.+||+.||.+|+++      +++++||||+.+.+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         213 -------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence                         01234578999999999999999999998      899999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.9e-46  Score=348.75  Aligned_cols=258  Identities=27%  Similarity=0.441  Sum_probs=209.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|++..+++.+|+|++.+.       .....+|+.+++.++||||+++++++     .+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~  114 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QD  114 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----Ec
Confidence            4557899999999999999999999999999999998542       12344789999999999999999988     55


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      +..+|+|||||+| +|.+.+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~-~~~~kL~DFG  187 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDK-HGHLKLADFG  187 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEEecc
Confidence            5669999999985 66666543     458899999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCCC--cceeeccccccChhhhhCCC---CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          183 SAKVLVKGEA--NISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       183 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      ++........  .....||+.|+|||++.+..   .++.++|+||+||++|+|++|..||.+.+.......+....... 
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-  266 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL-  266 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc-
Confidence            9986543222  23567899999999986532   37889999999999999999999999887766666655421110 


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCC--CCCHHHHhCCCccccccC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE  325 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~~~~~~~  325 (376)
                                    .++          ....++..+++++.+||+.++.+  |++++++++||||+...+
T Consensus       267 --------------~~p----------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         267 --------------NFP----------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             --------------CCC----------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence                          011          01246889999999999866654  899999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-46  Score=347.11  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=201.8

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .++..+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986532       1234688999999999999999888     45556899999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC-
Q 017139          113 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-  190 (376)
Q Consensus       113 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~-  190 (376)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..... 
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECC-CCcEEEecCcCCccCCCcc
Confidence            9986 55444433    4679999999999999999999999 79999999999999996 788999999998754322 


Q ss_pred             CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          191 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       191 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D  211 (328)
T ss_pred             cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence            222345689999999999765 4899999999999999999999999887665544433220                 0


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                  ..++..+++++.+||.+||.+||++|+     ++.++++||||...++.
T Consensus       212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         212 ------------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             ------------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                        013456799999999999999999997     89999999999886553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-46  Score=347.53  Aligned_cols=258  Identities=27%  Similarity=0.468  Sum_probs=210.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            46999999999999999999999999999999986532       2345788999999999999999887     45556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||+++ +|.+.+...   ...+++..++.++.|++.||.|||+ .||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~a~  150 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDR-TGHIKLADFGSAA  150 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECC-CCCEEeccCCCCe
Confidence            8999999975 666666542   3579999999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccCCCc--ceeeccccccChhhhhC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          186 VLVKGEAN--ISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       186 ~~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      ........  ....||+.|+|||++..     ...++.++|||||||++|+|++|..||...+....+..+......   
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~---  227 (330)
T cd05601         151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF---  227 (330)
T ss_pred             ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc---
Confidence            65443322  23468999999999863     334788999999999999999999999888776666555432100   


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                                  ..++          ....+++++.+||.+||+ ||++|||++++++||||+.+++..
T Consensus       228 ------------~~~~----------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         228 ------------LKFP----------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             ------------cCCC----------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence                        0011          112478999999999998 999999999999999999877654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-46  Score=346.04  Aligned_cols=246  Identities=26%  Similarity=0.437  Sum_probs=202.7

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     ..+..+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            47999999999999999999999999986432       1223688999999999999999988     44556899999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC-
Q 017139          113 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-  190 (376)
Q Consensus       113 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~-  190 (376)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcC-CCCEEecccHHhccccCCC
Confidence            9986 55444433    4578999999999999999999999 79999999999999996 788999999998753322 


Q ss_pred             CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          191 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       191 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E  211 (323)
T ss_pred             CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            222345689999999998665 4899999999999999999999999887766555544321                 0


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                      .            .++..+++++.++|.+||..||++|+     ++.++++||||.+..+.
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             C------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            0            13346799999999999999999998     89999999999887654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.9e-46  Score=343.43  Aligned_cols=251  Identities=29%  Similarity=0.457  Sum_probs=205.2

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCC-CeeecceeeeecCCCCcee
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHP-NVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~-~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +|++.+.||+|+||.||+|++..+++.||+|++....       .....|..++..+.|+ +|+.+++++     .+...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            5899999999999999999999999999999986432       1233577888888765 577887777     44456


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+|||||+| +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDA-EGHIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcC-CCCEEEeecCcce
Confidence            8999999985 55555543    4568999999999999999999999 79999999999999996 7789999999987


Q ss_pred             cccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .... ........||+.|+|||++.+.. ++.++|+||+||++|+|++|+.||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            5322 22333567899999999997654 8999999999999999999999999888776665554311           


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH-----HHHhCCCccccccCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~~~~~~~~  326 (376)
                                        ..++..+++++.+++.+||.+||.+|+++     +++++||||+.+++.
T Consensus       218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                              01334578999999999999999999986     899999999987664

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-46  Score=334.95  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=208.5

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .|++.+.||+|+||.||++.+..+++.||+|++....       ....+|+.+++.++||||+++++++     .....+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            4899999999999999999999999999999986432       1234689999999999999999888     445569


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+||||+.+ +|...+...  ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDD-YGHIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECC-CCCEEEeeCCCcee
Confidence            999999985 555444331  23568999999999999999999999 79999999999999996 78899999999987


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...........|++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+.......          
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----------  220 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence            6444443455789999999999764 48999999999999999999999998876544433333211100          


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                     ...++..++..+.+||.+||..||++||     +++++++||||...++.
T Consensus       221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                           0112345789999999999999999999     89999999999886554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.5e-45  Score=334.29  Aligned_cols=286  Identities=34%  Similarity=0.554  Sum_probs=226.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|++.+.||.|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++|+||+++++++..   ....
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCC
Confidence            4578999999999999999999999999999999885432      123469999999999999999998743   2234


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+++||||+.++|.+.+...   ...+++..++.++.|++.||.|||+ .|++||||+|+||+++. ++.+||+|||.+.
T Consensus        82 ~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~kL~dfg~~~  156 (309)
T cd07845          82 SIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTD-KGCLKIADFGLAR  156 (309)
T ss_pred             eEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccceee
Confidence            57899999999887777643   3568999999999999999999999 79999999999999996 7789999999988


Q ss_pred             ccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            664432 2223345788999999876666899999999999999999999999999999999999988887776554432


Q ss_pred             CcC--CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          265 NPN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ...  ...+..+......+... ....++++.++|.+||.+||++|||++++++||||++...+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             hcccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            211  11111111111111111 12368899999999999999999999999999999865433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.7e-46  Score=342.34  Aligned_cols=249  Identities=28%  Similarity=0.464  Sum_probs=202.9

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHH---HhCCCCCeeecceeeeecCCCCce
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM---RLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l---~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      |++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.++   +.++||||+++++++     ....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            788999999999999999999999999999986432       1222454444   566899999999988     4455


Q ss_pred             eEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+|+|||||+|+ |...+.     ...+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDT-EGFVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCcEEeCcccCC
Confidence            689999999974 433332     3569999999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ...... .......|++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+....          
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------  217 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------  217 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            753322 223356789999999998764 48999999999999999999999999887766665544310          


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                         ..++..++.++.++|.+||+.||++||     ++.++++||||+++.+.
T Consensus       218 -------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         218 -------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence                               013345789999999999999999999     69999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.3e-45  Score=337.39  Aligned_cols=278  Identities=31%  Similarity=0.560  Sum_probs=209.0

Q ss_pred             eeeeccCCceEEEEEEEcC--CCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           39 ERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      +.+||+|+||.||+|++..  ++..||+|.+....  ....+|+.+++.++||||+++++++..   ..+..+++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEeee
Confidence            4689999999999999754  56889999886543  234579999999999999999998754   3345688999999


Q ss_pred             cchHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec---CCCCcEEEEecCCccc
Q 017139          115 PETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKV  186 (376)
Q Consensus       115 ~g~l~~~l~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~---~~~~~~kl~Dfg~~~~  186 (376)
                      ++++...+.....     ....+++..++.++.||+.||.|||+ +||+||||||+||++.   ..++.+||+|||+++.
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            9988877753221     22358899999999999999999999 7999999999999994   2356899999999986


Q ss_pred             cccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhc
Q 017139          187 LVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQLVEIIKVL  253 (376)
Q Consensus       187 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---------~~~~~~~~~~~~  253 (376)
                      ......    .....+|+.|+|||++.+...++.++||||+||++|+|++|.+||....         ....+..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            543321    2345678999999999775668999999999999999999999997543         235566677777


Q ss_pred             CCCCHHHHhhcCcC--CcCc-------cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          254 GTPTREEIRCMNPN--YTDF-------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       254 ~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      +.+....+......  +...       .+................+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            77766655432211  0000       0000000001111122346679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.2e-46  Score=334.38  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=201.3

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        42 Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ||+|+||+||+|.+..+++.||+|.+....       .....|+.+++.++|+||+++.+++     .....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999986432       1224688999999999999998887     4455689999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC-
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-  192 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~-  192 (376)
                      ++ +|...+......+..+++..+..++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCccceecCCCCcc
Confidence            85 5655554434445679999999999999999999999 79999999999999986 78899999999876543322 


Q ss_pred             cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCcc
Q 017139          193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR  272 (376)
Q Consensus       193 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .....|++.|+|||.+.+. .++.++|+|||||++|+|++|..||...........+.......                
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  216 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------  216 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence            2345689999999999765 48999999999999999999999998654332222222111000                


Q ss_pred             CCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                               ...++..+++++.+++.+||+.||++|+     +++++++||||+.+.+.
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence                     0013346789999999999999999999     88999999999987665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.2e-46  Score=345.24  Aligned_cols=256  Identities=30%  Similarity=0.472  Sum_probs=202.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEecccc--------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           35 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      +|++.+.||+|+||.||+|++.   .+++.||+|++.+..        .....|+.+++.+ +||||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4899999999999999999874   478999999985421        1234688899999 589999999888     5


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .+..+|+|||||++ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDS-EGHVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECC-CCCEEEeeC
Confidence            55668999999986 66565543    4668999999999999999999999 79999999999999996 778999999


Q ss_pred             CCccccccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          182 GSAKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       182 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      |+++......  ......||+.|+|||++.+...++.++|||||||++|+|++|..||...........+......    
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  225 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----  225 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence            9987653322  2234578999999999976555789999999999999999999999754322111111111000    


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                           ....++..+++.+.++|.+||+.||++|+     +++++++||||+...+.
T Consensus       226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         226 ---------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                                 00113345789999999999999999999     88899999999987554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.3e-46  Score=342.14  Aligned_cols=246  Identities=29%  Similarity=0.476  Sum_probs=202.0

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|++..+++.||+|++....       .....|.+++..+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            46999999999999999999999999986532       1123577777755 799999999998     4455689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      |||++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEeecccceecccC
Confidence            99986 55544443    4678999999999999999999999 79999999999999996 788999999998754322


Q ss_pred             -CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          191 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       191 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                       .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------  212 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------  212 (321)
T ss_pred             CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223345689999999998654 48999999999999999999999999888777666554310                


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-------CHHHHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-------TALEACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-------t~~ell~hp~~~~~~~~  326 (376)
                                   ..++..+++++.++|.+||+.||++|+       +++++++||||..+++.
T Consensus       213 -------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         213 -------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence                         012334689999999999999999999       99999999999887654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.7e-45  Score=331.83  Aligned_cols=286  Identities=33%  Similarity=0.593  Sum_probs=222.7

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+. ||||+++++++..........
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46999999999999999999999999999999875432      23456999999995 699999999886544334456


Q ss_pred             EEEEeecccchHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSM-NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .|+||||+++++...+...... ...+++..++.++.||+.||.|||+ +|++||||+|+||+++.+++.+||+|||.+.
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8899999999888877654332 4568999999999999999999999 7999999999999999657889999999987


Q ss_pred             ccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....+..+....+.+....+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            553321 2223356888999999876555789999999999999999999999998888888888777766665443321


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                      ........++......... ..+.++.++.+||.+||..||++||++++++.||||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            1111111111111111111 1235789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.1e-46  Score=341.19  Aligned_cols=251  Identities=29%  Similarity=0.436  Sum_probs=205.8

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhC-CCCCeeecceeeeecCCCCcee
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +|.+.+.||+|+||.||+|++..+++.||+|++.+...       ....|..++..+ .|++|+++++++     .+...
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            58999999999999999999999999999999865321       123466666666 588999998888     44556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||+++ +|...+..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECC-CCcEEEccCCCce
Confidence            8999999985 65555543    4568999999999999999999999 79999999999999996 7889999999987


Q ss_pred             cccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .... ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            5432 2223355689999999999765 48999999999999999999999999888776666655421           


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH-----HHHhCCCccccccCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~~~~~~~~  326 (376)
                                        ..++..++.++.+++.+||+.||++|+++     .++++||||+.+++.
T Consensus       218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                              01334578999999999999999999984     899999999987764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.9e-46  Score=344.46  Aligned_cols=247  Identities=28%  Similarity=0.439  Sum_probs=201.0

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +.||+|+||.||+|++..+|+.||+|++....       .....|..+++.++||||+++++++     .....+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986532       1223588899999999999999888     45556899999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-C
Q 017139          113 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-G  190 (376)
Q Consensus       113 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-~  190 (376)
                      |+++ +|...+.    ....+++..++.++.||+.||.|||+.+||+||||||+|||++. ++.+||+|||++..... .
T Consensus        76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeecCCCC
Confidence            9996 4444443    24579999999999999999999996249999999999999996 78899999999875432 2


Q ss_pred             CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          191 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       191 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~  212 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  212 (325)
T ss_pred             cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            223345689999999999765 4899999999999999999999999887765554443221                 0


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                      .            .++..+++++.++|.+||++||++|+     ++.++++||||+...+.
T Consensus       213 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         213 I------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             C------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            0            13346789999999999999999997     89999999999986554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-45  Score=344.62  Aligned_cols=278  Identities=25%  Similarity=0.406  Sum_probs=207.5

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|+.....  ...|+.+++.++||||+++++++.     .....++|||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--TLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLP  137 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--cHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEE
Confidence            457999999999999999999999999999999754432  346999999999999999999884     4445889999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC
Q 017139          113 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA  192 (376)
Q Consensus       113 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~  192 (376)
                      ++.++|...+..   ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++........
T Consensus       138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEecCccccccccCcc
Confidence            999988877754   34678999999999999999999999 79999999999999996 77899999999976544444


Q ss_pred             cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCC-CCCCCCC---------hHHHHHHHHHhcCCCCHHHHh
Q 017139          193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGEN---------AVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       193 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      .....||+.|+|||++.+. .++.++|+|||||++|+|+++. .+|....         ....+..++..++..+.....
T Consensus       213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            4456789999999999765 4899999999999999999854 4444321         123344444444433221110


Q ss_pred             hcCcCC-cC-ccCCCCCCCCc---ccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          263 CMNPNY-TD-FRFPQIKAHPW---HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       263 ~~~~~~-~~-~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ...... .. .........++   ...-...++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            000000 00 00000000000   001112568889999999999999999999999999999863

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.6e-46  Score=347.30  Aligned_cols=256  Identities=28%  Similarity=0.430  Sum_probs=207.0

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....       .....|+.++..++||||+++++.+     .+...
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            46999999999999999999999999999999985421       2234688999999999999999988     55566


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+|||||+| +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~-~~~vkL~DfG~~~  149 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDA-KGHVKLSDFGLCT  149 (360)
T ss_pred             EEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEeeccCCc
Confidence            9999999986 56665543    4679999999999999999999999 79999999999999996 7889999999986


Q ss_pred             ccccCC------------------------------------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHH
Q 017139          186 VLVKGE------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAE  229 (376)
Q Consensus       186 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~  229 (376)
                      ......                                    .....+||+.|+|||++.+. .++.++|+|||||++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilye  228 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE  228 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeee
Confidence            442110                                    01235689999999999765 48999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC
Q 017139          230 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC  309 (376)
Q Consensus       230 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  309 (376)
                      |++|..||.+.+.......+.....               ...+|.          ...++++++++|.+|+ .||.+|+
T Consensus       229 l~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~  282 (360)
T cd05627         229 MLIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFC-TDSENRI  282 (360)
T ss_pred             cccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhc-cChhhcC
Confidence            9999999998877666655543100               000110          0136889999999987 4999998


Q ss_pred             ---CHHHHhCCCccccccCCC
Q 017139          310 ---TALEACAHPFFDELREPN  327 (376)
Q Consensus       310 ---t~~ell~hp~~~~~~~~~  327 (376)
                         +++++++||||+++++..
T Consensus       283 ~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         283 GSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             CCCCHHHHhcCCCCCCCCHHH
Confidence               489999999999987754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.5e-45  Score=339.04  Aligned_cols=275  Identities=27%  Similarity=0.446  Sum_probs=206.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||.||+|++..++..+|+|.+....     ....+|+++++.++||||+++++++.     ++..+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence            468999999999999999999999999999999886542     23457999999999999999999884     34458


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+..+|+||||||+||+++. ++.+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~  153 (331)
T cd06649          79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ  153 (331)
T ss_pred             EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEccCccccc
Confidence            899999996 66666543    3568999999999999999999998336999999999999996 77899999999876


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh----
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR----  262 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----  262 (376)
                      .... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+... +.   +.+......    
T Consensus       154 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~~---~~~~~~~~~~~~~  227 (331)
T cd06649         154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-IF---GRPVVDGEEGEPH  227 (331)
T ss_pred             cccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-Hh---cccccccccCCcc
Confidence            5332 23345689999999999765 48999999999999999999999998766544322 21   111100000    


Q ss_pred             hcCcCCcC-------c---cCC---------CCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          263 CMNPNYTD-------F---RFP---------QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       263 ~~~~~~~~-------~---~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ...+....       .   ..+         .+............+++++++||.+||++||++|||++++++||||+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence            00000000       0   000         0000000000112468899999999999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-45  Score=339.27  Aligned_cols=246  Identities=29%  Similarity=0.493  Sum_probs=201.2

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||+||+|.+..+++.||+|++.+..       .....|..+++.+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999986532       1223577788777 699999999988     4455689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-  189 (376)
                      |||+| +|...+..    ...+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECC-CCcEEecccCCCeecCcC
Confidence            99986 55544443    4579999999999999999999999 79999999999999996 77899999999865322 


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ........|++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2223345689999999999765 4899999999999999999999999887766555444321                 


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH-----HHHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~~~~~~~~  326 (376)
                                  ...++..++.++.+||.+||..||++||++     .++++||||+...+.
T Consensus       212 ------------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         212 ------------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                        001334578999999999999999999999     999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.6e-46  Score=342.81  Aligned_cols=246  Identities=28%  Similarity=0.455  Sum_probs=199.2

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHH-HHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~-~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||+||+|++..+|+.||+|++.....       ....|. .+++.++||||+++++.+     .+...+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            479999999999999999999999999864321       111233 356789999999999888     4455689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||+++ +|...+..    +..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeccCCCcccccC
Confidence            99996 55555443    4678999999999999999999999 79999999999999996 788999999998754322


Q ss_pred             -CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          191 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       191 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                       .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP----------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223345689999999998765 48999999999999999999999999887766655544310                


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH----HHHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~~~~~~~~  326 (376)
                                   ..++..++.++.++|.+||+.||.+||++    .++++||||..+.+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~  260 (323)
T cd05575         213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD  260 (323)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence                         00223578999999999999999999998    699999999887654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=341.35  Aligned_cols=251  Identities=27%  Similarity=0.444  Sum_probs=208.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...|+..+.||+|+||.||+|.+..+++.||+|++..+..     ..++|+.+|..++++||.++|+.|+....     +
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----L   86 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----L   86 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----H
Confidence            3468889999999999999999999999999999965432     34579999999999999999999965444     9


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +++||||.| ++.++++.    +..+.+..+..++.+++.||.|||. ++.+|||||+.|||+.. ++.+||+|||.+..
T Consensus        87 wiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~-~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSE-SGDVKLADFGVAGQ  160 (467)
T ss_pred             HHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEec-cCcEEEEecceeee
Confidence            999999996 55555543    4556899999999999999999999 79999999999999997 68899999999877


Q ss_pred             cccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ...... ..+++|||+|||||++.+ ..|+.++||||||++.+||++|.+|+....+...+..|-+.             
T Consensus       161 l~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~-------------  226 (467)
T KOG0201|consen  161 LTNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS-------------  226 (467)
T ss_pred             eechhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC-------------
Confidence            655433 368899999999999985 45999999999999999999999999877664333222210             


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                 .    -..+....++.+++|+..||.+||+.||+|.+||.|+|++..
T Consensus       227 -----------~----PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  227 -----------A----PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             -----------C----CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                       0    001223578999999999999999999999999999999764

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-45  Score=338.47  Aligned_cols=260  Identities=28%  Similarity=0.431  Sum_probs=207.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+..       ....+|..+++.++|+||+++++++     .++..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            47999999999999999999999999999999986421       2244688899999999999999988     55566


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||+.| +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~  150 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDK-NGHIRLADFGSCL  150 (331)
T ss_pred             EEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECC-CCCEEEEECCcee
Confidence            9999999975 66666643   24568999999999999999999999 79999999999999986 7889999999987


Q ss_pred             ccccCCCc--ceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          186 VLVKGEAN--ISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       186 ~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ........  ....||+.|+|||++..    ...++.++|+||+||++|+|++|..||.+.+..+....+......    
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~----  226 (331)
T cd05597         151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH----  226 (331)
T ss_pred             ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc----
Confidence            65433222  23468999999999863    234788999999999999999999999887766665554432110    


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCC--CCCHHHHhCCCccccccCCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN  327 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~~~~~~~~~  327 (376)
                                 +.++.         ....++.+++++|++||+.++.+  |++++++++||||...++..
T Consensus       227 -----------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~  276 (331)
T cd05597         227 -----------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN  276 (331)
T ss_pred             -----------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence                       00110         11247899999999999765554  78999999999998876643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-45  Score=334.81  Aligned_cols=245  Identities=31%  Similarity=0.457  Sum_probs=200.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcE-EEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~-~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ....+.+.||+|+||+||++...  |+. ||+|++....      ..+.+|+.+|.+++|||||++++++....    ..
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~  114 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GS  114 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----Cc
Confidence            45566777999999999999984  455 9999986543      35668999999999999999999984322    15


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-ceeccCCCCCeeecCCCC-cEEEEecCC
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-VCHRDVKPQNLLVDPLTH-QVKLCDFGS  183 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~-ivH~dlkp~Nill~~~~~-~~kl~Dfg~  183 (376)
                      ++|||||+++ +|..++...  ....++...+..++.||+.||+|||+ ++ ||||||||+|||++. ++ .+||+|||+
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~-~~~~~KI~DFGl  190 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDL-KGKTLKIADFGL  190 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcC-CCCEEEECCCcc
Confidence            8899999995 666666543  46789999999999999999999999 79 999999999999997 65 899999999


Q ss_pred             ccccccC-CCcceeeccccccChhhhhC-CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          184 AKVLVKG-EANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       184 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      ++..... .......||+.|||||++.+ ...|+.++||||||+++|||+||..||.+.........+.....+|.    
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~----  266 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP----  266 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence            9877654 33444789999999999974 24599999999999999999999999999888555555544322222    


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                             ++...++.+..++.+||..||.+||+..+++
T Consensus       267 -----------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~  297 (362)
T KOG0192|consen  267 -----------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIV  297 (362)
T ss_pred             -----------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence                                   3345789999999999999999999998775

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.1e-45  Score=342.13  Aligned_cols=258  Identities=28%  Similarity=0.439  Sum_probs=208.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|++..+++.+|+|++....       ....+|+.+++.++||||+++++++     .+
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~  114 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD  114 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence            34578999999999999999999999999999999985421       2234688999999999999999988     55


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      +.++|+|||||+| +|...+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~-~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECC-CCCEEEEeCC
Confidence            5669999999985 66655543     458899999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCCC--cceeeccccccChhhhhCCC---CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          183 SAKVLVKGEA--NISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       183 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      ++........  .....||+.|+|||++.+..   .++.++|+|||||++|+|++|..||.+.+.......+....... 
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-  266 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-  266 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc-
Confidence            9976543322  23567899999999986532   37889999999999999999999999887766666554421110 


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCC--CCCHHHHhCCCccccccC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE  325 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~~~~~~~  325 (376)
                                    .++          ....++.+++++|.+||..++.+  |++++++++||||++..+
T Consensus       267 --------------~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         267 --------------TFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             --------------cCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                          011          11357999999999999854443  789999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-45  Score=339.24  Aligned_cols=247  Identities=29%  Similarity=0.487  Sum_probs=201.6

Q ss_pred             eeeeccCCceEEEEEEEc---CCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           39 ERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++.||+|+||.||+|++.   .+++.||+|++....        .....|+.+++.++||||+++++++     ..+..+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence            368999999999999874   468899999986421        1234689999999999999999988     445568


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+||||+++ +|...+..    ...+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus        76 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~  149 (323)
T cd05584          76 YLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDA-QGHVKLTDFGLCKE  149 (323)
T ss_pred             EEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEeeCcCCee
Confidence            999999996 55555543    4668899999999999999999999 79999999999999996 78899999999875


Q ss_pred             cccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .... .......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....            
T Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~------------  216 (323)
T cd05584         150 SIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK------------  216 (323)
T ss_pred             cccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence            4322 223345689999999998764 47899999999999999999999999887766555544310            


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                       ..++..+++++.++|.+||++||++|+     +++++++||||+...+.
T Consensus       217 -----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~  265 (323)
T cd05584         217 -----------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD  265 (323)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                             013345789999999999999999999     89999999999876553

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.1e-45  Score=337.33  Aligned_cols=246  Identities=29%  Similarity=0.492  Sum_probs=198.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHh-CCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~-l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|++..+|+.||+|.+....       .....|..++.. ++||||+++++++     .+..++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999986432       122346666654 5899999999988     5556799999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-  189 (376)
                      |||.+ +|...+..    +..+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+++.... 
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEeCccCCCeecccC
Confidence            99986 55555543    4678999999999999999999999 79999999999999996 77899999999875322 


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ........|++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~--------------  212 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T--------------  212 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence            2223356689999999999765 4899999999999999999999999887766555443221  0              


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH-HHHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~ell~hp~~~~~~~~  326 (376)
                                   ..++..++.+++++|.+||+.||++|+++ +++++||||+...+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         213 -------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence                         01233478899999999999999999998 588999999887653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.4e-45  Score=337.35  Aligned_cols=307  Identities=35%  Similarity=0.656  Sum_probs=237.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|.+.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.... .....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            68999999999999999999999999999999986532      12346899999999999999998774433 345568


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+||||+.++|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNE-DCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEecccccceee
Confidence            89999999877666543    4569999999999999999999999 79999999999999996 888999999998765


Q ss_pred             ccCCC-----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          188 VKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      .....     .....++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+....+..+....|.++...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     1234678899999998665558999999999999999999999999988888888888888888776654


Q ss_pred             hcCcCCcCc---cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCC
Q 017139          263 CMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPL  339 (376)
Q Consensus       263 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~  339 (376)
                      .........   .++.....++.. +....+.++.++|.+||+.||++|||+++++.||||.+...+....    ...+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~----~~~~~  312 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP----TCPPP  312 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc----cCCCC
Confidence            322111000   112222222222 2235789999999999999999999999999999999877664332    12344


Q ss_pred             CCchhhhhcCCHH
Q 017139          340 FNFKQELAGASPE  352 (376)
Q Consensus       340 ~~~~~~~~~~~~~  352 (376)
                      ++++-+....+.+
T Consensus       313 ~~~~~~~~~~~~~  325 (334)
T cd07855         313 FDFDFEAIELSRE  325 (334)
T ss_pred             CCCChhhhhcChh
Confidence            5555444333333

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.8e-45  Score=339.55  Aligned_cols=247  Identities=25%  Similarity=0.471  Sum_probs=196.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|..+++.+ +||||+++++++     .+...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            47999999999999999999999999986532       1234688888888 799999999988     4555689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc-c
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-K  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~-~  189 (376)
                      |||+| +|...+..    ...+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||++.... .
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEECcCccccccccC
Confidence            99986 55444433    4679999999999999999999999 79999999999999996 7889999999987532 2


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHhcCCCCHHHH
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~  261 (376)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||.....        .+.+.+.+..         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            2333456789999999999764 489999999999999999999999963211        1111111110         


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC------HHHHhCCCccccccCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~ell~hp~~~~~~~~  326 (376)
                             ..            ..++..++.++.++|.+||++||.+|++      ++++++||||..+.+.
T Consensus       220 -------~~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         220 -------KQ------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             -------CC------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence                   00            0133457899999999999999999987      7899999999887654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.2e-44  Score=325.90  Aligned_cols=277  Identities=34%  Similarity=0.644  Sum_probs=215.0

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     .....+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            47999999999999999999999999999999885432      2234699999999999999999988     445568


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++||||++++++..+..   ....+++..++.++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++...
T Consensus        76 ~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~  150 (286)
T cd07847          76 HLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITK-QGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcC-CCcEEECccccceec
Confidence            99999999876555433   34568999999999999999999999 79999999999999996 778999999999876


Q ss_pred             ccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .... ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+....+............
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            5433 223455788999999987655578999999999999999999999998887777776666555443322111110


Q ss_pred             C--CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 N--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      .  +.....+..............++..+.+||.+||+.||++|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0  01111111111111111223578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.5e-45  Score=336.79  Aligned_cols=246  Identities=31%  Similarity=0.499  Sum_probs=198.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHh-CCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~-l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|++..+++.||+|++.....       ....|..++.. .+||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            479999999999999999999999999865321       12235555554 4899999999888     4455689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||++| +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCC
Confidence            99986 55555443    4579999999999999999999999 79999999999999996 788999999998754332


Q ss_pred             -CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          191 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       191 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                       .......||+.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------------  212 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR----------------  212 (316)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             2333557899999999997654 8999999999999999999999999887766555443210                


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH-HHHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~ell~hp~~~~~~~~  326 (376)
                                   ..++..++.++.++|.+||..||++|+++ .++++||||..+.+.
T Consensus       213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05592         213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWE  257 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHH
Confidence                         01334578899999999999999999986 588899999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.1e-45  Score=330.04  Aligned_cols=280  Identities=34%  Similarity=0.609  Sum_probs=225.0

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+.....      ...+|+.+++.++||||+++++++...   +...
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence            4679999999999999999999999999999998854321      224699999999999999999987542   2256


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|+||||++++|...+...   ...+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||++..
T Consensus        81 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~~l~d~g~~~~  155 (293)
T cd07843          81 IYMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNN-RGILKICDFGLARE  155 (293)
T ss_pred             EEEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCcEEEeecCceee
Confidence            8999999998887776542   2368999999999999999999999 79999999999999996 78899999999887


Q ss_pred             cccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .... .......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||......+....+....+.+....+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            6544 223345578889999998765557899999999999999999999999998888888888888877776655332


Q ss_pred             c--CCcCccCCCCCCCCcccccccC-CChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          266 P--NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       266 ~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      .  ..............+...++.. +++.+.++|++||+.||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            1  1111111112222233334444 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-44  Score=327.85  Aligned_cols=276  Identities=41%  Similarity=0.745  Sum_probs=225.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     .....+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            5899999999999999999999999999999986543      2344789999999999999999988     4455689


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +||||+.++|.+.+...   ...+++..++.++.||+.||+|||+ .|++|+||+|+||+++. ++.++|+|||.+....
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISA-DGVLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcC-CCcEEEeeeeeccccc
Confidence            99999977887776542   3669999999999999999999999 79999999999999996 7889999999988665


Q ss_pred             cCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          189 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       189 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ....  .....++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+..+....+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            4332  33456788999999987665578999999999999999999999999888888888888888887766554321


Q ss_pred             --CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          267 --NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       267 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                        .+....++.....++... ....+.++.++|.+||..||++|||++++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEI-FPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHh-CCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              122222232222223222 235678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-44  Score=326.12  Aligned_cols=275  Identities=36%  Similarity=0.640  Sum_probs=217.9

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      |++.+.||+|+||.||+|.+..+++.+|+|++.....     ...+|+.+++++. |+||+++++++.+.   ....+++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            7889999999999999999999999999998865321     1235778888885 99999999988532   2245899


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      ||||+++++.+.+...   ...+++..++.++.|++.||+|||+ +|++|+||+|+||+++.  +.+||+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD--DILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC--CCeEEEeccccccccc
Confidence            9999999887776542   3568999999999999999999999 79999999999999995  7899999999987655


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC-C
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN-Y  268 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  268 (376)
                      ........++..|+|||.+.....++.++|+||+||++|+|++|.+||.+.+..+....+....+.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444445567899999998765555789999999999999999999999999888888888887777766443222111 1


Q ss_pred             cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ..+.++......... ....++.++.++|.+||.+||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            112222211111111 123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-45  Score=335.92  Aligned_cols=246  Identities=30%  Similarity=0.509  Sum_probs=199.2

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHh-CCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~-l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|.+..+++.||+|++....       .....|..+++. ++||||+++++++     .+...+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999986532       122346666665 5899999999988     4445689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-  189 (376)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..... 
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEccCCcceECCCC
Confidence            99985 66555543    3568999999999999999999999 79999999999999996 77899999999875322 


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~--------------  212 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--N--------------  212 (316)
T ss_pred             CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence            2233456789999999998765 4899999999999999999999999887766555443221  0              


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHH-HHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-ell~hp~~~~~~~~  326 (376)
                                   ..++..++.+++++|.+||+.||++|+++. ++++||||+.+.+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         213 -------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence                         012234688999999999999999999996 89999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=366.09  Aligned_cols=269  Identities=28%  Similarity=0.472  Sum_probs=227.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|.|+++||+|+||.|.+++++.+++.||+|++.+.       ...+..|.++|-.-+.+=|+.++..|     +++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            347899999999999999999999999999999998763       23456789999888999999999988     888


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      .++|+||||++| +|..++..+    .++++..+++|+.+|+.||.-||++ |+|||||||+|||+|. .|.+||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~-~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDK-SGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecc-cCcEeeccchh
Confidence            999999999995 777777664    3799999999999999999999995 9999999999999997 88899999999


Q ss_pred             ccccccCCC--cceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          184 AKVLVKGEA--NISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       184 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |-.+..++.  ....+|||-|.+||++..    ...|++.+|+||+||++|||+.|..||+...-.+.+.+|+..-    
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----  297 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----  297 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence            987765544  345689999999999853    2458999999999999999999999999998888888887631    


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC---HHHHhCCCccccccCCCCCCCCCC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPNGR  334 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~~~~~~~~~~~~~~~~  334 (376)
                                 ..+.||..          ..+|+++++||.++++ +|+.|..   ++++.+||||.++.|...+-..++
T Consensus       298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP  355 (1317)
T KOG0612|consen  298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP  355 (1317)
T ss_pred             -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence                       11222211          2489999999999998 8999998   999999999999999766544333


Q ss_pred             CCC
Q 017139          335 PFP  337 (376)
Q Consensus       335 ~~~  337 (376)
                      .+|
T Consensus       356 ~vP  358 (1317)
T KOG0612|consen  356 VVP  358 (1317)
T ss_pred             CCC
Confidence            333

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2e-44  Score=327.65  Aligned_cols=283  Identities=35%  Similarity=0.614  Sum_probs=221.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+....      ....+|+++++.++||||+++++++     .+...+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            57999999999999999999999999999999885432      2345799999999999999999998     444568


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+||||+++++...+...  ....+++..++.++.||+.||+|||+ +|++|+||+|+||+++..++.+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            999999998877776542  22346888999999999999999999 799999999999999865678999999998765


Q ss_pred             ccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||...+..+.+.++....+.+....+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            3322 122345688999999987655678999999999999999999999998888888888877777776555432111


Q ss_pred             CCc-CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          267 NYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       267 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ... ...++..... ........+++++.++|.+||+.||++||++.++++||||++++.
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        234 LPDYKSAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             chhhhhhcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            000 0001110000 011123457889999999999999999999999999999987653

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.9e-46  Score=340.90  Aligned_cols=245  Identities=29%  Similarity=0.467  Sum_probs=197.8

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHH-HHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~-~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||+||+|++..+|+.+|+|++.....       ....|. .+++.++||||+++++.+     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            469999999999999999999999999864321       112233 356789999999999888     4455689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-  189 (376)
                      ||++| +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEeecCCcccCCCC
Confidence            99996 5544443    34679999999999999999999999 79999999999999996 77899999999875432 


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ........|++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~----------------  212 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP----------------  212 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            2233456789999999999765 48999999999999999999999999887666655544310                


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH----HHHhCCCccccccC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE  325 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~~~~~~~  325 (376)
                                   ..++...+.++.++|.+||+.||.+||++    .+++.||||....+
T Consensus       213 -------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         213 -------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             -------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence                         01223578899999999999999999986    58999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.3e-45  Score=336.46  Aligned_cols=260  Identities=26%  Similarity=0.410  Sum_probs=208.0

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||++++..+++.+|+|++.+..       .....|+.++..++|+||+++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            47999999999999999999999999999999985421       1234688899999999999999888     45556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||+.+ +|.+.+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~-~~~~kL~DfG~a~  150 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSCL  150 (332)
T ss_pred             EEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEeecchhe
Confidence            8999999985 66666654   23568999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCC--cceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          186 VLVKGEA--NISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       186 ~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      .......  .....||+.|+|||++.+    ...++.++|+|||||++|+|++|..||.+.+..+....+.....     
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----  225 (332)
T cd05623         151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-----  225 (332)
T ss_pred             ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-----
Confidence            5433222  223568999999999862    33478999999999999999999999998877766665543110     


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCC--CCCHHHHhCCCccccccCCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN  327 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~~~~~~~~~  327 (376)
                                .+.++.         ....+++++++||.+||+.++++  |++++++++||||..+++..
T Consensus       226 ----------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~  276 (332)
T cd05623         226 ----------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN  276 (332)
T ss_pred             ----------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence                      001110         11357899999999999776555  68999999999999877653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.6e-45  Score=334.61  Aligned_cols=251  Identities=29%  Similarity=0.448  Sum_probs=204.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCcee
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +|.+.+.||+|+||.||+|++..+|+.||+|++.+..       .....|..++..+. |++|+++++++     .+...
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            4788999999999999999999999999999986532       12335777887776 46777888877     44456


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||++| +|...+..    ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~-~~~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDS-EGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEecccccc
Confidence            8999999985 55555443    4679999999999999999999999 79999999999999996 7789999999987


Q ss_pred             ccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+.....          
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----------  218 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----------  218 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence            543222 23345689999999999764 489999999999999999999999998877666665554110          


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                         .++..++.++.+++.+||+.||.+|++     .+++++||||+.+++.
T Consensus       219 -------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~  266 (323)
T cd05615         219 -------------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD  266 (323)
T ss_pred             -------------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence                               133457899999999999999999997     4789999999988653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-44  Score=327.71  Aligned_cols=281  Identities=36%  Similarity=0.645  Sum_probs=222.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc---------hHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---------KNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+......         ...|+++++.++|+||+++++++     .+..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence            488999999999999999999999999999998654322         23688999999999999999998     4455


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+++||||+.++|.+.+...   ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIAS-DGVLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcC-CCCEEEccceeee
Confidence            68999999977777776542   1369999999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....... .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            7654322 223456788999999866556789999999999999999999999988888888888777777766555432


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ...............+... .....+.++.++|.+||.+||++|||+.+++.||||++...+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence            2111111111111111111 224568899999999999999999999999999999975444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=325.69  Aligned_cols=277  Identities=35%  Similarity=0.654  Sum_probs=217.5

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||.|++|.||+|.+..+++.||+|.+....     ....+|+++++.++|+||+++++++     .++...
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence            467999999999999999999999999999999985432     2234699999999999999999988     455568


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+||||++++|.+.+...   ...+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||+++..
T Consensus        79 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~  153 (291)
T cd07844          79 TLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISE-RGELKLADFGLARAK  153 (291)
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcC-CCCEEECcccccccc
Confidence            999999999887766542   3468999999999999999999999 79999999999999996 778999999998754


Q ss_pred             ccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.. ..+.+..+.+..+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence            3221 11223467889999998765557899999999999999999999998765 566677777777777666554332


Q ss_pred             cC--CcCccCCCCCCCCcccccccCCC--hhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          266 PN--YTDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       266 ~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ..  +.....+.....+....+ ..++  .++.++|.+||++||++|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            21  111111111111111111 1344  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-44  Score=349.14  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=214.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC---C
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---K  102 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~---~  102 (376)
                      ..++|.+.+.||+|+||+||+|++..+|+.||||++....      ....+|+.++..++|+||+++++.+.....   .
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            3468999999999999999999999999999999985432      223468889999999999998877643221   1


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ....+++||||++ |+|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~-~~~vkL~DF  187 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDF  187 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeC-CCCEEEEec
Confidence            2235789999998 47877777655556789999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccC---CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          182 GSAKVLVKG---EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       182 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      |+++.....   .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.....    
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~----  262 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----  262 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC----
Confidence            998765432   223346789999999999765 489999999999999999999999988776655554433100    


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                              ..++..+++++.+++.+||+.||.+||++.++++|||++.+.
T Consensus       263 ------------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        263 ------------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                                    013346789999999999999999999999999999997653

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-44  Score=327.56  Aligned_cols=276  Identities=34%  Similarity=0.636  Sum_probs=218.5

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||.|++|.||+|++..+++.||||.+..+.      .....|++++++++||||+++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            4899999999999999999999999999999886432      2345799999999999999999988     4455689


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +||||++++|...+...  ....+++..++.++.|++.||+|||+ .|++|+||+|+||+++. ++.+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEeeccchhhcc
Confidence            99999998877766542  24568999999999999999999999 79999999999999996 7889999999987654


Q ss_pred             cCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .... .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+...++.+..+.+....+......
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            3222 223446788999998876555788999999999999999999999998888888888888877765443321100


Q ss_pred             C-cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          268 Y-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       268 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      . ....++......... ....++++++++|.+||+.||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0 000111111111111 123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-45  Score=344.08  Aligned_cols=280  Identities=23%  Similarity=0.332  Sum_probs=212.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC--CCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ..+|.+++.||.|+||.||+|....  +++.||+|.+... ....+|+++++.++||||+++++++     .....+|++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence            3579999999999999999997643  5678999988654 3445799999999999999999988     445568999


Q ss_pred             eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          111 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       111 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||++.++|...+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.++|+|||++......
T Consensus       165 ~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~-~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDE-PENAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEccCccccccCcc
Confidence            9999998877773    24679999999999999999999999 79999999999999996 788999999998765433


Q ss_pred             CC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCHHHHhhc
Q 017139          191 EA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       191 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ..   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..   ....+..+++.++..+.+.....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   2245689999999999765 48999999999999999999999997653   34556666666554332211000


Q ss_pred             Cc----CCcCccCCCCCCCCcccc-cccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          265 NP----NYTDFRFPQIKAHPWHKV-FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       265 ~~----~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ..    .+..+............. ....++.++.++|.+||.+||++|||+.++|+||||++..+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence            00    000000000000000011 11246788999999999999999999999999999986433

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-45  Score=336.63  Aligned_cols=247  Identities=26%  Similarity=0.482  Sum_probs=194.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|++..+++.||+|++.+..       .....|..++..+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            47999999999999999999999999986532       1233577777665 899999999988     4445689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-  189 (376)
                      ||+++ +|...+.    ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCCEEEeeCCccccccCC
Confidence            99996 5544443    24679999999999999999999999 79999999999999996 78899999999875432 


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHhcCCCCHHHH
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--------AVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~  261 (376)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||....        ....+.+.+..         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            2223356789999999999765 48999999999999999999999995311        11111111110         


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC------HHHHhCCCccccccCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~ell~hp~~~~~~~~  326 (376)
                             .            ...++..++.++.++|++||..||++|++      .+++++||||+.+++.
T Consensus       220 -------~------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~  271 (329)
T cd05618         220 -------K------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  271 (329)
T ss_pred             -------C------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence                   0            00134567899999999999999999998      5799999999987653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.6e-45  Score=340.22  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=199.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ...++|.+.+.||+|+||.||+|++..+++.||||++....     ....+|+++++.++|+||+++++++     ..+.
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~  145 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG  145 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence            34578999999999999999999999999999999985432     2345799999999999999999988     5556


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+|||||.++.+.   .    .....+..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus       146 ~~~lv~e~~~~~~L~---~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DfG~~~  216 (353)
T PLN00034        146 EIQVLLEFMDGGSLE---G----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSR  216 (353)
T ss_pred             eEEEEEecCCCCccc---c----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEcccccce
Confidence            689999999975321   1    2345678888999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCC-CcceeeccccccChhhhhCC----CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          186 VLVKGE-ANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       186 ~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ...... ......|+..|+|||.+...    ...+.++|||||||++|+|++|+.||......+....+.......    
T Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----  292 (353)
T PLN00034        217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----  292 (353)
T ss_pred             ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence            654322 22345789999999987431    224568999999999999999999997433222111111110000    


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                           ....+..++.++++||.+||+.||++|||+.|+++||||..-.
T Consensus       293 ---------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        293 ---------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             ---------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence                                 0012235788999999999999999999999999999998753

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-45  Score=338.59  Aligned_cols=247  Identities=28%  Similarity=0.464  Sum_probs=202.7

Q ss_pred             eeeeccCCceEEEEEEEc---CCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           39 ERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ++.||+|+||.||++++.   .+|+.||+|++....      .....|+++++.++||||+++++++     .++..+|+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l   75 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYL   75 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEE
Confidence            367999999999999873   578999999986432      2234689999999999999999988     44556899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      ||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus        76 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          76 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGLSKESI  149 (318)
T ss_pred             EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECC-CCcEEEeeccCCcccC
Confidence            9999985 66555543    4678999999999999999999999 79999999999999996 7789999999987654


Q ss_pred             cC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .. .......|++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+....              
T Consensus       150 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------  214 (318)
T cd05582         150 DHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------  214 (318)
T ss_pred             CCCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            43 223356789999999998764 47899999999999999999999999887766665544310              


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                         .            .++..+++++.++|++||+.||++||+     ++++++||||..+.+.
T Consensus       215 ---~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         215 ---L------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             ---C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence               0            123457899999999999999999999     7789999999887554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-44  Score=344.18  Aligned_cols=275  Identities=25%  Similarity=0.347  Sum_probs=206.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....  ....+|+++++.++|+||+++++++.     .....++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEEEEEE
Confidence            4579999999999999999999999999999996432  23457999999999999999999873     3445889999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC
Q 017139          113 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA  192 (376)
Q Consensus       113 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~  192 (376)
                      ++.++|...+...   ...+++..++.|+.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++.......
T Consensus       241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECC-CCCEEEcccCCceecccccc
Confidence            9999888777542   3469999999999999999999999 79999999999999996 77899999999876533221


Q ss_pred             ---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCC-C------ChHHHHHHHHHhcCCCCHHH--
Q 017139          193 ---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-E------NAVDQLVEIIKVLGTPTREE--  260 (376)
Q Consensus       193 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~------~~~~~~~~~~~~~~~~~~~~--  260 (376)
                         .....||+.|+|||++.+.. ++.++|||||||++|+|++|..|+.. .      .....+.++++..+....+.  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence               22356899999999997654 89999999999999999998765432 1      11244555555433221110  


Q ss_pred             ------HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          261 ------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       261 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                            .............+......|...  ..++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                  000000000001111111122221  146789999999999999999999999999999964

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-44  Score=329.82  Aligned_cols=282  Identities=36%  Similarity=0.619  Sum_probs=215.6

Q ss_pred             ceEeeeeeccCCceEEEEEEEcC--CCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +|.+.+.||+|+||.||+|.+..  +++.||+|.+....       ....+|+.+++.++||||+++++++..   ....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            48999999999999999999988  89999999987632       233469999999999999999998843   2235


Q ss_pred             eEEEEeecccchHHHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC---CCCcEEEEec
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMN-QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP---LTHQVKLCDF  181 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~---~~~~~kl~Df  181 (376)
                      .+++||||+++++...+....... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.   .++.+||+||
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            689999999998887776544333 378999999999999999999999 79999999999999984   2577999999


Q ss_pred             CCccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 017139          182 GSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVE  248 (376)
Q Consensus       182 g~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---------~~~~~  248 (376)
                      |++........    .....++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..         ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99876543322    223456888999999877666899999999999999999999999765432         35566


Q ss_pred             HHHhcCCCCHHHHhhcCcC--CcC----ccCCCCCCCCcccccc--cCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          249 IIKVLGTPTREEIRCMNPN--YTD----FRFPQIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ++..++.+....+......  +..    ..............+.  ...+.++.+++.+||..||++|||+.++++||||
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            6666666665544321111  000    0000000011111111  2578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-44  Score=360.53  Aligned_cols=266  Identities=27%  Similarity=0.384  Sum_probs=214.5

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      +...++|.+.+.||.|+||+||+|++..+++.+|+|.+....      .....|+.+++.++||||++++++|..   ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~   85 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KA   85 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cC
Confidence            456679999999999999999999999999999999886432      224469999999999999999998854   33


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC------CCceeccCCCCCeeecCC----
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV------PGVCHRDVKPQNLLVDPL----  172 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~------~~ivH~dlkp~Nill~~~----  172 (376)
                      ...+|||||||++ +|...+.........+++..++.|+.||+.||.|||+.      ++|+||||||+|||++..    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            4468899999985 78888776555557799999999999999999999983      139999999999999631    


Q ss_pred             ------------CCcEEEEecCCccccccCCCcceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 017139          173 ------------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPG  239 (376)
Q Consensus       173 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~  239 (376)
                                  ...+||+|||++.............||+.|+|||++.+. ..++.++||||||||+|+|++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                        235899999999876544444456789999999998643 3478999999999999999999999987


Q ss_pred             CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                      .+....+...+.....                 +           .....+.++.+||.+||.++|.+||++.++|.|||
T Consensus       246 ~~~~~qli~~lk~~p~-----------------l-----------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~  297 (1021)
T PTZ00266        246 ANNFSQLISELKRGPD-----------------L-----------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI  297 (1021)
T ss_pred             CCcHHHHHHHHhcCCC-----------------C-----------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence            6655544433331100                 0           01235889999999999999999999999999999


Q ss_pred             cccccCC
Q 017139          320 FDELREP  326 (376)
Q Consensus       320 ~~~~~~~  326 (376)
                      ++.+..+
T Consensus       298 ik~i~~p  304 (1021)
T PTZ00266        298 IKNVGPP  304 (1021)
T ss_pred             HhhcCCC
Confidence            9877544

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.1e-44  Score=326.42  Aligned_cols=252  Identities=24%  Similarity=0.385  Sum_probs=198.9

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        42 Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ||+|+||.||++.+..+|+.||+|.+....       .....|+++++.++||||+++++++     .++..+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            799999999999999999999999885421       1233589999999999999999888     5556689999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCc
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN  193 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~  193 (376)
                      +| +|...+...  ....+++..+..++.|++.||+|||+ .|++||||||+||+++. ++.++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCCcee
Confidence            85 555555432  23458899999999999999999999 79999999999999996 778999999998776544444


Q ss_pred             ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccC
Q 017139          194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF  273 (376)
Q Consensus       194 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ....++..|+|||++.+.. ++.++|+||+||++|+|++|..||.+.........+....-..             ... 
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~-  216 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-------------EVK-  216 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-------------ccc-
Confidence            4556899999999997655 8999999999999999999999997654322222221110000             000 


Q ss_pred             CCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH----HHHhCCCccccccCCC
Q 017139          274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREPN  327 (376)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~~~~~~~~~  327 (376)
                                .....+++++.++|.+||++||.+||++    ++++.||||+.++++.
T Consensus       217 ----------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~  264 (277)
T cd05607         217 ----------FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR  264 (277)
T ss_pred             ----------cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence                      0112478899999999999999999999    6788999999877653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-46  Score=330.42  Aligned_cols=264  Identities=27%  Similarity=0.390  Sum_probs=221.2

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      .|...+.|+.-++||+|+||.||-+..+.||+.||.|.+.+.+.       ....|..+|..++.++||.+-..|     
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----  254 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----  254 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence            45566789999999999999999999999999999998854432       233689999999999999998777     


Q ss_pred             CCceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      +....+|+|+..|+|+ |.-.+-+  -.+..+++..++.++.+|+.||++||+ .+||+|||||+|||+|. .|.+.|+|
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd-~GhvRISD  330 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDD-HGHVRISD  330 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeecc-CCCeEeec
Confidence            5555599999999975 3222222  234589999999999999999999999 79999999999999995 88899999


Q ss_pred             cCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          181 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       181 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      +|+|............+||..|||||++.+.. |+...|+|||||++|+|+.|+.||..........++-++.-..    
T Consensus       331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~----  405 (591)
T KOG0986|consen  331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED----  405 (591)
T ss_pred             cceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc----
Confidence            99999988888888889999999999997765 9999999999999999999999998776554444443322211    


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN  327 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~~  327 (376)
                                           ...+++++|++++++++.+|++||.+|..     ++++.+||||+.++|..
T Consensus       406 ---------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  406 ---------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             ---------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence                                 12356789999999999999999999984     67999999999999864

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-45  Score=340.16  Aligned_cols=245  Identities=27%  Similarity=0.487  Sum_probs=196.5

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEecccccc-------hHHHHHHHHhC---CCCCeeecceeeeecCCCCceeEEEEe
Q 017139           42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRLM---DHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        42 Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~e~~~l~~l---~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      ||+|+||+||+|++..+++.||+|++......       ...|..++...   .||||+++++++     .+...+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            79999999999999999999999998643211       12355555544   699999999988     4555689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCC
Confidence            99985 55555443    4679999999999999999999999 79999999999999996 778999999998754322


Q ss_pred             -CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          191 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       191 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                       .......||+.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------  212 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------  212 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             23345678999999999876555899999999999999999999999887766555444321                 


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC----CHHHHhCCCccccccC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELRE  325 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~ell~hp~~~~~~~  325 (376)
                      ...++           ...+++++.++|.+||..||.+||    +++++++||||....+
T Consensus       213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence            00111           123688999999999999999998    7999999999987654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.7e-45  Score=324.46  Aligned_cols=252  Identities=35%  Similarity=0.587  Sum_probs=205.1

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccch------HHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      |++++.||+|+||+||+|++..+++.||+|++.......      .+|+.+++.++||||+++++++..     ...+++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            899999999999999999999999999999997654222      248899999999999999999843     555889


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc-
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-  187 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~-  187 (376)
                      ||||+++ +|.+.+.    ....+++..+..++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~-~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDE-NGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEEST-TSEEEESSGTTTEEST
T ss_pred             ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccccc
Confidence            9999997 7777776    24678999999999999999999999 79999999999999995 888999999998763 


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ..........++..|+|||++.....++.++|+||+|+++|+|++|..||......+....+.+...........     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence            223334456779999999998734458999999999999999999999999875444444443332211111100     


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                       .....++++.++|.+||+.||++|||+.++++||||
T Consensus       225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                             001123799999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.9e-45  Score=334.95  Aligned_cols=260  Identities=26%  Similarity=0.389  Sum_probs=207.7

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||++++..+++.||+|++.+..       .....|..++..++|+||+++++++     .+..+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            57999999999999999999999999999999986421       1234678899999999999999988     55567


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||+.| +|...+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~-~~~~kl~DfG~a~  150 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDM-NGHIRLADFGSCL  150 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcC-CCCEEEEecccee
Confidence            9999999985 66666654   23568999999999999999999999 79999999999999996 7789999999987


Q ss_pred             ccccCCCc--ceeeccccccChhhhhCC----CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          186 VLVKGEAN--ISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       186 ~~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ........  ....|++.|+|||++.+.    ..++.++|+||+||++|+|++|..||.+.+..+....+.......   
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---  227 (331)
T cd05624         151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF---  227 (331)
T ss_pred             eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc---
Confidence            65433222  234689999999998642    347889999999999999999999998887766655544311100   


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCC--CCCHHHHhCCCccccccCCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN  327 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~~~~~~~~~  327 (376)
                                  .++.         ....++++++++|.+||+.++++  |++++++++||||+..++..
T Consensus       228 ------------~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~  276 (331)
T cd05624         228 ------------QFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN  276 (331)
T ss_pred             ------------cCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence                        0110         11246899999999999976655  56899999999999877654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.8e-44  Score=324.04  Aligned_cols=276  Identities=35%  Similarity=0.667  Sum_probs=222.0

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      +|++.+.||.|++|.||+|++..+|+.||+|.+....     ....+|+.+++.++||||+++++++.     +...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence            5899999999999999999999999999999886542     23346899999999999999999984     3445889


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      ||||++++|.+.+.... ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCcEEEeecchhhhhcC
Confidence            99999998877776532 23568999999999999999999999 79999999999999996 78899999999875533


Q ss_pred             CC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          190 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       190 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      .. ......++..|++||.+.+...++.++|+|||||++|+|++|..||.+.+..+....+......+....+.... ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            22 12234568889999998766567899999999999999999999999988888888888887777776655433 11


Q ss_pred             cCc--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          269 TDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       269 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ..+  .++......... +...++.++.++|.+||+.||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            111  122221112211 223568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.1e-44  Score=326.01  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=204.6

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....       .....|+.+++.++|++|+.+++.+     ..+..+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence            3788999999999999999999999999999885432       1234689999999999999998887     444568


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+||||+.| +|...+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++..
T Consensus        76 ~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~  151 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDD-HGHIRISDLGLAVH  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeccceee
Confidence            999999985 665555432  23468999999999999999999999 79999999999999996 77899999999876


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...........|+..|+|||++.+.. ++.++|+||+||++|+|++|..||..................           
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-----------  219 (285)
T cd05630         152 VPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-----------  219 (285)
T ss_pred             cCCCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----------
Confidence            54443334457899999999997654 899999999999999999999999865432111111110000           


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                    ....++..+++++.+|+.+||+.||++|+|     ++++++||||+++.+.
T Consensus       220 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         220 --------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             --------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                          001133457889999999999999999999     9999999999876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.7e-44  Score=332.02  Aligned_cols=287  Identities=30%  Similarity=0.543  Sum_probs=217.1

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCC-------
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTS-------  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-------  101 (376)
                      ..+|.+.+.||.|+||.||+|.+..+|+.||+|++....    ....+|+++++.++||||+++++++.....       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367999999999999999999999999999999885432    234568999999999999999987643221       


Q ss_pred             --CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          102 --KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       102 --~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                        .+...+|+||||++++|.+.+..     ..+++..++.++.||+.||.|||+ .|++||||||+||+++..+..+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEEC
Confidence              11235789999999877665542     468999999999999999999999 7999999999999998657789999


Q ss_pred             ecCCccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          180 DFGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       180 Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      |||.+........    .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+....+......
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999876432211    122356888999998766556889999999999999999999999988877777666665444


Q ss_pred             CCHHHHhhcCcCCcCccC--CCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          256 PTREEIRCMNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ..................  ......+... +...++.++.+||.+||+.||.+|||+++++.||||+.+..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence            333222211110000000  0001111111 223578899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.3e-45  Score=335.12  Aligned_cols=246  Identities=26%  Similarity=0.429  Sum_probs=199.1

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chH-HHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKN-RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~-~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|++..+++.||+|++.....       ... ++..+++.++||||+++++++     .....+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            479999999999999999999999999864321       111 223456788999999999888     4455689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-  189 (376)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEEccCCCCcccccC
Confidence            99996 55555543    4668899999999999999999999 79999999999999996 77899999999875432 


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------------  212 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP----------------  212 (325)
T ss_pred             CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------------
Confidence            2233456789999999999764 48999999999999999999999999887766665554310                


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHH----HHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL----EACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----ell~hp~~~~~~~~  326 (376)
                                   ..++..++..+.++|.+||+.||.+|+++.    ++++|+||...++.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~  260 (325)
T cd05602         213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD  260 (325)
T ss_pred             -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence                         002345789999999999999999999876    89999999877653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=325.36  Aligned_cols=270  Identities=29%  Similarity=0.454  Sum_probs=224.6

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchH-------HHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      -.+..+|.++.+||.|+||+|.+|..+.+.+.||||+++++.....       .|..+|... +-|++++++.+|     
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----  419 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----  419 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----
Confidence            3455689999999999999999999999999999999987654332       466676655 467899999998     


Q ss_pred             CCceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      +.-..+|+||||+.|+ |--.+.+    -+.+.|..+..++.+|+-||-+||+ +||++||||.+||+++. ++.+||+|
T Consensus       420 QTmDRLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~-eGHiKi~D  493 (683)
T KOG0696|consen  420 QTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIAD  493 (683)
T ss_pred             hhhhheeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEecc-CCceEeee
Confidence            4445599999999974 4333443    4678888999999999999999999 89999999999999997 78899999


Q ss_pred             cCCccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          181 FGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       181 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ||+++...-+ ....+.+|||.|+|||++.- +.|+.++|+||+||+||||+.|++||.+.+..+..+.|.+.       
T Consensus       494 FGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------  565 (683)
T KOG0696|consen  494 FGMCKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------  565 (683)
T ss_pred             cccccccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------
Confidence            9999765433 44567899999999999964 45999999999999999999999999999999999988873       


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH-----HHHhCCCccccccCCC-CCCCCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN-ARLPNG  333 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~~~~~~~~~-~~~~~~  333 (376)
                                            ...+|+.+|.++.++++..|.+.|.+|..+     .++..||||+.++|.. ++....
T Consensus       566 ----------------------nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiq  623 (683)
T KOG0696|consen  566 ----------------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQ  623 (683)
T ss_pred             ----------------------cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCC
Confidence                                  223667899999999999999999999864     5899999999999863 344445


Q ss_pred             CCCCCCC
Q 017139          334 RPFPPLF  340 (376)
Q Consensus       334 ~~~~~~~  340 (376)
                      +|+.|..
T Consensus       624 PPfkPk~  630 (683)
T KOG0696|consen  624 PPFKPKI  630 (683)
T ss_pred             CCCCCcc
Confidence            5666654

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-44  Score=346.46  Aligned_cols=254  Identities=27%  Similarity=0.355  Sum_probs=210.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCC-CcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..|.+.+.||+|++|.||+|.+..+ ++.+|+|.+....    ....+|+.+++.++||||+++++++     .....+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEE
Confidence            4599999999999999999998877 7889999764432    2345699999999999999999998     4445689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||++| +|.+.+.........+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~~~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECC-CCcEEEEeCcCceec
Confidence            99999984 7777776655556679999999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....   ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......         
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------  289 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------  289 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            4332   13345689999999998664 4899999999999999999999999887776655554431100         


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                         .++..++.++.++|.+||..||++||++++++.|||++..
T Consensus       290 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 -------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                               1233578899999999999999999999999999999754

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-44  Score=331.81  Aligned_cols=288  Identities=38%  Similarity=0.686  Sum_probs=232.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||.|++|.||+|++..+++.||+|++....      ....+|+.+++.++|+||+++.+++..........+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5899999999999999999999999999999886532      2345799999999999999999988554323334689


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      ++|||++++|.+.+..    ...+++..++.++.||+.||++||+ +||+|+||||+||+++. ++.++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~-~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNS-NCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcccCceEeec
Confidence            9999999877666653    3479999999999999999999999 79999999999999996 7889999999998765


Q ss_pred             cCC----CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          189 KGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       189 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...    ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+....+.+..+.+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            543    2334567889999999977646899999999999999999999999999999999999998888887665422


Q ss_pred             CcC-CcCc--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCC
Q 017139          265 NPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR  329 (376)
Q Consensus       265 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~  329 (376)
                      ... ...+  ..+.....++... ...++.++.++|.+||++||++|||++++++||||+++..+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence            111 1111  0111112222222 23478999999999999999999999999999999998776433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-45  Score=337.70  Aligned_cols=260  Identities=29%  Similarity=0.438  Sum_probs=223.4

Q ss_pred             CCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        28 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++..+.|.+.+.||+|.|++|.+|++..++..||||.+.+..-      ...+|+++++.++|||||+++.+..+   
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t---  126 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET---  126 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee---
Confidence            456778889999999999999999999999999999999876532      24589999999999999999999844   


Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                        ...+|+||||+.++   .+..|...++++.+...+.++.|+++|++|||+ ++|+|||||++|||++. +.++||+||
T Consensus       127 --~~~lylV~eya~~g---e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~-~mnikIaDf  199 (596)
T KOG0586|consen  127 --EATLYLVMEYASGG---ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDE-NMNIKIADF  199 (596)
T ss_pred             --cceeEEEEEeccCc---hhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccc-ccceeeecc
Confidence              44499999999964   344444457888889999999999999999999 89999999999999996 777999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |++..........+.+|++.|.|||++.+..+.++.+|+||+|+++|.|+.|..||.+.+-.+.....+.          
T Consensus       200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----------  269 (596)
T KOG0586|consen  200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----------  269 (596)
T ss_pred             ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------
Confidence            9999998888888999999999999999888789999999999999999999999998765544433322          


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                             ..+++|            --++.++.++|+++|..+|.+|++.+++..|.|.......
T Consensus       270 -------gk~rIp------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 -------GKYRIP------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             -------eeeccc------------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                   122222            2478999999999999999999999999999999876655

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.8e-45  Score=334.05  Aligned_cols=246  Identities=28%  Similarity=0.438  Sum_probs=197.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHH-HHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e-~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|++..+++.||+|++.+...       ...+| ..+++.++||||+++++++     .+...+|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            479999999999999999999999999854321       11223 3467889999999999888     4455689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-  189 (376)
                      |||+| +|...+.    ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++..... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEccCCCCccCCCC
Confidence            99996 5544443    24678999999999999999999999 79999999999999996 78899999999875322 


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ........|++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P-------------  212 (321)
T ss_pred             CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence            2223345689999999998654 4899999999999999999999999888766555544321   0             


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH----HHHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~~~~~~~~  326 (376)
                                   ..++...+.++.++|.+||+.||.+|+++    .++++||||..+++.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence                         01234568899999999999999999976    499999999887654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-46  Score=343.68  Aligned_cols=258  Identities=23%  Similarity=0.367  Sum_probs=214.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .+-|.|+..||.|+||+||+|..+.++-..|.|++.....    ...-|+++|..++||+||++++.|+..+.     ++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eE
Confidence            3568999999999999999999998888888898743321    12258999999999999999999865554     89


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |+.|||+|+-.+.+.-  ..+..+++.+++.+++|+|.||.|||+ ++|+|||||..|||+.. +|.++|+|||.+....
T Consensus       106 iliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~Tl-dGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTL-DGDIRLADFGVSAKNK  181 (1187)
T ss_pred             EEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEe-cCcEeeecccccccch
Confidence            9999999875544432  346889999999999999999999999 79999999999999996 8889999999864432


Q ss_pred             -cCCCcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          189 -KGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       189 -~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                       ......+++|||+|||||+..+    ...|+.++||||||++|.+|+.+.+|-...+....+..+.+.           
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-----------  250 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-----------  250 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-----------
Confidence             2344568999999999999743    345999999999999999999999999888888777766552           


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                     .|.....|.+.+..+.||+++||.+||..||+++++|+||||++...
T Consensus       251 ---------------ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  251 ---------------EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             ---------------CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence                           11222245567899999999999999999999999999999986543

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-44  Score=331.94  Aligned_cols=247  Identities=25%  Similarity=0.448  Sum_probs=196.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|..++..+ .||||+.+++++     .+...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999996532       1234677888777 699999999988     4455689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc-
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-  189 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-  189 (376)
                      |||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeC-CCCEEEeccccceeccCC
Confidence            99986 55544443    4579999999999999999999999 79999999999999996 77899999999875322 


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCHHHHhh
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||....      ..+...+....           
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  217 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-----------  217 (327)
T ss_pred             CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-----------
Confidence            2233456789999999999765 48999999999999999999999996421      11222222110           


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC------HHHHhCCCccccccCC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~ell~hp~~~~~~~~  326 (376)
                           ..            ..++..++..+.++|.+||..||++|++      .+++++||||+.+++.
T Consensus       218 -----~~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         218 -----KP------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             -----CC------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence                 00            0133457899999999999999999998      4699999999988765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.5e-43  Score=324.05  Aligned_cols=285  Identities=29%  Similarity=0.510  Sum_probs=217.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCC---
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS---  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~---  101 (376)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|.+.....      ...+|+.+++.++||||+++++++.....   
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            456789999999999999999999999999999998854321      22468999999999999999998754321   


Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ......++||||+.+++...+..   ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df  163 (310)
T cd07865          89 RYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITK-DGILKLADF  163 (310)
T ss_pred             CCCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECC-CCcEEECcC
Confidence            22345789999999987777654   23468999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCC-----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          182 GSAKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       182 g~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      |++........     .....++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+.......+....+..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99876543221     1234567889999998765557889999999999999999999999888777777777766655


Q ss_pred             CHHHHhhcCc--CCcCccCCCCCCCCccccc-ccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          257 TREEIRCMNP--NYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       257 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      +.+.++....  .+....++..........+ +...+..+.++|.+||..||.+|||++++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            5443322110  0011111111110111111 11246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-46  Score=324.12  Aligned_cols=281  Identities=28%  Similarity=0.513  Sum_probs=219.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHhCCC--C----CeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRLMDH--P----NVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~e~~~l~~l~h--~----~Iv~~~~~~~~~~~~~  103 (376)
                      ..+|.+++.||+|.||+|-.+.+..++..||||+++.-.++   ..-|+++|..+.+  |    -++.+.++|     +-
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            57899999999999999999999999999999998654333   3458899998842  2    266666767     66


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC------------
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------------  171 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~------------  171 (376)
                      .+..|||+|.++.++.+.+....  ..+++...++.|..|++.++++||+ .+++|.||||+|||+.+            
T Consensus       163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence            77799999999989999888643  4678999999999999999999999 69999999999999832            


Q ss_pred             -------CCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 017139          172 -------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD  244 (376)
Q Consensus       172 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  244 (376)
                             .+..|+|+|||.|+...  ....+.+.|..|+|||++++-+ ++.++||||+||||+|+.+|...|+.+++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                   13369999999998643  3346778899999999999865 9999999999999999999999999999999


Q ss_pred             HHHHHHHhcCCCCHHHHhhcC-c--------CCcCccCCC----CC--CCCcccccc--cCCChhHHHHHHhhcCCCCCC
Q 017139          245 QLVEIIKVLGTPTREEIRCMN-P--------NYTDFRFPQ----IK--AHPWHKVFH--KRMPPEAIDLASRLLQYSPSL  307 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~----~~--~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~  307 (376)
                      .+.-+..++|..+...+.... .        .|.+..-..    ..  ..+......  +..-.++.|||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            998888888977665554331 0        011100000    00  001111110  011235889999999999999


Q ss_pred             CCCHHHHhCCCcccccc
Q 017139          308 RCTALEACAHPFFDELR  324 (376)
Q Consensus       308 R~t~~ell~hp~~~~~~  324 (376)
                      |+|+.|+|.||||+.+.
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998753

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.4e-43  Score=320.10  Aligned_cols=277  Identities=35%  Similarity=0.608  Sum_probs=212.1

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+....     ....+|+.+++.++|+||+++++++     .+....
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeE
Confidence            467999999999999999999999999999999985432     1235799999999999999999988     444568


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+||||+.+++...+..   ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||+++..
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~  153 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISY-LGELKLADFGLARAK  153 (291)
T ss_pred             EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcC-CCcEEEecccccccc
Confidence            89999999887766543   23457888899999999999999999 79999999999999996 788999999998754


Q ss_pred             ccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .... ......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+ ..+.+..+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            3222 22334568899999998765557889999999999999999999997654 345666666666766655433221


Q ss_pred             --cCCcCccCCCCCCCCccccccc--CCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          266 --PNYTDFRFPQIKAHPWHKVFHK--RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       266 --~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                        +.+.....+......... .+.  ..+.++.+++.+||..||++|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRV-VWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hcccccchhccccCCcchhh-hccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              111111111100000111 111  236789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-43  Score=328.86  Aligned_cols=316  Identities=34%  Similarity=0.611  Sum_probs=237.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~  104 (376)
                      ..++|.+.+.||+|++|.||+|++..+++.||+|++....      ....+|+.+++.++||||+++.+++..... ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3467999999999999999999999999999999885421      223368999999999999999887743222 223


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+++|+||++++|.+.+..     ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++
T Consensus        93 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~-~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNE-DCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEcccccc
Confidence            45889999998888777653     569999999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ......  .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+.+..+....+.+....+...
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            765332  234567889999999876555789999999999999999999999998888888888888777776554433


Q ss_pred             CcCCc-Cc--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCC
Q 017139          265 NPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN  341 (376)
Q Consensus       265 ~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~  341 (376)
                      ..... .+  ..+......+.. ....+++++.++|.+||+.||++|||+.++++||||+++..+...     +..+.++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~-----~~~~~~~  317 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE-----PVAPPYD  317 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc-----ccccccC
Confidence            21100 00  011111111111 123468999999999999999999999999999999987655321     2233333


Q ss_pred             chhhhhcCCHHHHhhhcHHHH
Q 017139          342 FKQELAGASPELINRLIPEHV  362 (376)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~  362 (376)
                      ..-.-.+.....+..++..++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~  338 (343)
T cd07851         318 QSFESRDLTVDEWKELVYKEI  338 (343)
T ss_pred             cchhhhhcCHHHHHHHhHHHH
Confidence            332333345555555555443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-44  Score=331.05  Aligned_cols=278  Identities=26%  Similarity=0.420  Sum_probs=204.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||.|+||.||+|.+..++..+|+|.+....     ....+|+++++.++||||+++++++.     ++..+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence            468999999999999999999999999999999886542     23457999999999999999999984     44568


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+||||+.+ +|.+.+..    ...+++..+..++.|++.||.|||+..+++|+||||+|||++. ++.+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~  153 (333)
T cd06650          79 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEeeCCcchh
Confidence            999999985 66666653    4568999999999999999999997237999999999999986 77899999999875


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh--cCCCCHHHHhhc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV--LGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~  264 (376)
                      .... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||......+.. .+...  .+.+........
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcc
Confidence            5332 22345688999999999764 4899999999999999999999999876543322 11110  011100000000


Q ss_pred             CcC-------CcCccCC---------CCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          265 NPN-------YTDFRFP---------QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       265 ~~~-------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ...       +.....+         ..............++.++++||.+||++||++|||+.+++.||||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence            000       0000000         0000000000112367889999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.2e-44  Score=330.67  Aligned_cols=289  Identities=34%  Similarity=0.674  Sum_probs=228.1

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      +...++|++.+.||+|+||.||+|.+..+++.+|+|++....      ....+|+.+++.+ +||||+++++++..   .
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~   79 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---E   79 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---C
Confidence            356678999999999999999999999899999999885421      2234699999999 99999999998733   2


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      +...+|+||||++++|...+..     ..+++..++.++.|++.||.|||+ +||+|+||+|+||+++. ++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~-~~~~kl~d~g  152 (337)
T cd07852          80 NDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNS-DCRVKLADFG  152 (337)
T ss_pred             CCceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeecc
Confidence            3445889999999887766653     267888999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCC------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          183 SAKVLVKGE------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       183 ~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      .+.......      ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+....+....+....+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            987654322      12234678899999988665567899999999999999999999999988888888888888777


Q ss_pred             CHHHHhhcCcCCcCcc---CCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCC
Q 017139          257 TREEIRCMNPNYTDFR---FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR  329 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~  329 (376)
                      ..+.+..+........   .+..........+ ..++.++.++|.+||+.||++|||+.++++||||+.+..+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~  307 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE  307 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCC
Confidence            7665543322111111   1111111222222 2378999999999999999999999999999999998665433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.4e-44  Score=321.30  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=204.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHH-HHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~-~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+.....     ....|.. .++.++||||+++++++.     .+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence            479999999999999999999999999999998865421     1123444 467779999999999884     34458


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~-~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |++|||++++|.+.+.........+++..++.++.|++.||+|||+ + +++||||||+||+++. ++.+||+|||++..
T Consensus        76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~~~  153 (283)
T cd06617          76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINR-NGQVKLCDFGISGY  153 (283)
T ss_pred             EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecccccc
Confidence            9999999998888877655555789999999999999999999998 6 9999999999999996 78899999999876


Q ss_pred             cccCCCcceeeccccccChhhhhCC---CCCCccchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCHHHHh
Q 017139          187 LVKGEANISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ...........++..|+|||.+.+.   ..++.++|+|||||++|+|++|..||.... ..+.+........  .     
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~-----  226 (283)
T cd06617         154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--P-----  226 (283)
T ss_pred             cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--C-----
Confidence            5443333345678889999988542   236889999999999999999999996532 2333333222100  0     


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                               .+           ....+|.++.++|.+||..||++||++++++.||||.....
T Consensus       227 ---------~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         227 ---------QL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             ---------CC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence                     00           11246889999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-43  Score=327.68  Aligned_cols=296  Identities=35%  Similarity=0.612  Sum_probs=228.6

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCC--CcEEEEEEecccc------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCce
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +|++.+.||+|+||.||+|.+..+  +..||+|.+....      ....+|+.+++.+ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            589999999999999999999888  8999999886421      2234688999988 5999999988654322 2334


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+++||++++|...+..    ...+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~-~~~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNA-DCELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcC-CCCEEeCcCCCce
Confidence            5789999999887776653    4678999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCC-----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          186 VLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       186 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      .......     .....++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+..++..++.+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6543211     22346788999999987655689999999999999999999999999988889999999988887665


Q ss_pred             HhhcCcCCc-C--ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCC
Q 017139          261 IRCMNPNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP  337 (376)
Q Consensus       261 ~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~  337 (376)
                      +........ .  .........++.. .....+..+.+++.+||+.||.+|||+.+++.||||+.+.++.....+..+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~  312 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFD  312 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccccccccc
Confidence            443321100 0  0011111111111 12346889999999999999999999999999999999877644433444333


Q ss_pred             C
Q 017139          338 P  338 (376)
Q Consensus       338 ~  338 (376)
                      .
T Consensus       313 ~  313 (332)
T cd07857         313 F  313 (332)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.7e-43  Score=322.56  Aligned_cols=283  Identities=31%  Similarity=0.562  Sum_probs=220.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC---C
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---K  102 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~---~  102 (376)
                      ..++|++.+.||.|+||.||+|.+..+++.+|+|++....      ....+|+++++.++||||+++++++.....   .
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            4689999999999999999999999999999999885321      234579999999999999999988754321   2


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ....+++||||+.+++...+..   ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||
T Consensus        86 ~~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg  160 (311)
T cd07866          86 KRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFG  160 (311)
T ss_pred             cCceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECcCc
Confidence            3456789999999887666653   24579999999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCCC------------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017139          183 SAKVLVKGEA------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  250 (376)
Q Consensus       183 ~~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  250 (376)
                      ++........            .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9876543221            1223567889999998765558899999999999999999999999998888888888


Q ss_pred             HhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          251 KVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ...+.+....+.....  ................. ....+++++.++|.+||+.||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            8777666554432211  00000000000111111 112456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-43  Score=321.06  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=208.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .|++.+.||.|+||+||+|.+..+++.+|+|.+....       ....+|+++++.++|+||+.+.+++     ..+..+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence            3788999999999999999999999999999885432       1234689999999999999998888     445568


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |++|||+.+ +|...+..  .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~-~~~~kl~Dfg~~~~  151 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDD-YGHIRISDLGLAVK  151 (285)
T ss_pred             EEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECC-CCCEEEecCCccee
Confidence            999999996 55444432  123469999999999999999999999 79999999999999996 67899999999876


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...........|+..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.........+........         
T Consensus       152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05632         152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------  221 (285)
T ss_pred             cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------
Confidence            5443333456789999999999765 489999999999999999999999988766554444433211110         


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                      ..++..++.++.+|+.+||..||++||+     +++++.||||+.....
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         222 ----------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                            0123457889999999999999999999     8899999999987544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-43  Score=320.17  Aligned_cols=277  Identities=36%  Similarity=0.668  Sum_probs=214.7

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||+++++++     .+...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            46999999999999999999999899999999875432      1234789999999999999999998     555668


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+||||++++++..+..   ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~  150 (286)
T cd07846          76 YLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCcEEEEeeeeeeec
Confidence            99999999865554433   23458999999999999999999999 79999999999999996 788999999998765


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....++..|+|||.+.+...++.++|+|||||++|+|++|.+||......+....+....+......-.....
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence            43322 23355788999999987655578899999999999999999999998887777777766655443222111110


Q ss_pred             C--CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 N--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      .  ......+..............++..+.+|+.+||..||++||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0  01111121111111111234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=311.87  Aligned_cols=325  Identities=31%  Similarity=0.526  Sum_probs=254.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCC-Cc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~-~~  104 (376)
                      ...+|.-++.+|.|+- .|..|.+...++.||+|++...      .+...+|..++..++|+||++++.+|...... ..
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            4457999999999998 8888999999999999988543      34556899999999999999999988543322 23


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+|||++..+|...+.      ..++...+..++.|++.|++|||+ .||+||||||+||+++. +..+||.|||++
T Consensus        94 ~e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~-~~~lKi~dfg~a  165 (369)
T KOG0665|consen   94 QEVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNS-DCTLKILDFGLA  165 (369)
T ss_pred             HhHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecc-hhheeeccchhh
Confidence            3478999999999887776      336778899999999999999999 79999999999999996 889999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +.....-..+.++.|.+|+|||++.+.. +...+||||+|||+.||++|...|+|.+..++..++.+.+|.|.......+
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            8876665677888999999999998866 999999999999999999999999999999999999999999999988766


Q ss_pred             CcCCcCc--cCCCCCCCCccccccc-----------CCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCC
Q 017139          265 NPNYTDF--RFPQIKAHPWHKVFHK-----------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP  331 (376)
Q Consensus       265 ~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~  331 (376)
                      .+....+  ..|+.....+...+++           .-+..++|++.+||..||++|.+++++|+|||++-|-...+.. 
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~-  323 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVE-  323 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccccc-
Confidence            5432222  1111111222222221           1234689999999999999999999999999999553333221 


Q ss_pred             CCCCCCCCCCchhhhhcCCHHHHhhhcHHHHHhhcCCC
Q 017139          332 NGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLS  369 (376)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (376)
                       .+ .|+.+.-.-++.+.+++.+..++.+++.+.-.++
T Consensus       324 -ap-~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~~  359 (369)
T KOG0665|consen  324 -AP-PPEIYDKQLDEREHTIEEWKELIFKEVQRFEEFN  359 (369)
T ss_pred             -CC-CCchhhhhcccccCCHHHHHHHHHHHHHhhcccc
Confidence             11 1222222223444568888888888877665543

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=317.30  Aligned_cols=248  Identities=29%  Similarity=0.498  Sum_probs=202.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ++|.+.+.||+|++|.||+|.+..+++.+|+|.+....         ....+|+++++.++||||+++++++     .++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            46999999999999999999999999999999875432         1244688999999999999999988     444


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++|+||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~-~~~~~l~dfg~  150 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA  150 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccc
Confidence            579999999986 56555543    3568899999999999999999999 79999999999999995 78899999999


Q ss_pred             ccccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          184 AKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       184 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      +.........    ....++..|+|||.+.+.. ++.++|+||+||++|+|++|..||...+.......+.....     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----  224 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-----  224 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC-----
Confidence            8755332211    2345678899999997654 89999999999999999999999987665544433322100     


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                            ...++..++.++.++|.+||..||.+|||+.++++||||
T Consensus       225 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 ----------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ----------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                  112344678999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-43  Score=319.43  Aligned_cols=277  Identities=35%  Similarity=0.665  Sum_probs=220.4

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+++++.++|+||+++++++..     ...+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence            46999999999999999999999999999999875421      234579999999999999999999843     4458


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +++|||++++++..+..   ....+++..++.++.||+.||.|||+ +|++|+||+|+||+++. ++.+||+|||++...
T Consensus        76 ~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~  150 (288)
T cd07833          76 YLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSE-SGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEEeeeccccc
Confidence            99999999876665543   24568999999999999999999999 79999999999999996 888999999998776


Q ss_pred             ccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          188 VKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       188 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  ......++..|+|||++.+...++.++|+||||+++|+|++|.+||.+....+.+..+....+...........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence            5443  33345678899999999776468999999999999999999999999888777777777766665554433222


Q ss_pred             c--CCcCccCCCC-CCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          266 P--NYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       266 ~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      .  .+.....+.. ....+...++..++.++.+||++||..||++|||+++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            1  1111111111 11112223445568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=319.35  Aligned_cols=275  Identities=34%  Similarity=0.632  Sum_probs=217.8

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      |++.+.||.|++|.||+|.+..+|+.||+|++....      .....|+++++.++|||++++++++     .+....|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            678899999999999999999999999999886432      2244699999999999999999988     44566899


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      +|||++++|...+....  ...+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCcEEEeecccccccCC
Confidence            99999888777765422  1468999999999999999999999 79999999999999997 88899999999875532


Q ss_pred             CC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          190 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       190 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      .. ......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+....+.++.+..+.+....+.......
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            22 22233568889999988665557899999999999999999999999988888888888877777766543221110


Q ss_pred             c-CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          269 T-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       269 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      . ...++........ .....++.++.++|.+||+.||++|||+++++.||||
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0 0011111111111 1234678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-43  Score=324.56  Aligned_cols=282  Identities=36%  Similarity=0.650  Sum_probs=221.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~~  106 (376)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            57999999999999999999999999999999886431      123479999999999999999998754321 12234


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|+|+||+..++....      ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~-~~~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNE-DCELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCCCCcC
Confidence            6899999987654432      2468999999999999999999999 79999999999999996 78899999999876


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...  ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            432  223456788999999987655588999999999999999999999999888888888888777777665543321


Q ss_pred             CCcC-c--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          267 NYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       267 ~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      .... +  ..+......+...+ ...+.++.+||.+||+.||.+||++++++.||||+.+.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            1100 0  11111111111111 2468899999999999999999999999999999988754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-43  Score=323.44  Aligned_cols=261  Identities=29%  Similarity=0.477  Sum_probs=212.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||+|.+..+++.+|+|.+.....       ....|+++++.++||||+++++.+     .+...
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence            469999999999999999999999999999999865432       234689999999999999999988     55566


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .|+||||+.| +|.+.+...  .+..+++..++.++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~  151 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHE-SGHIMLSDFDLSK  151 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcC-CCCEEEeecchhh
Confidence            8999999986 666655432  24678999999999999999999999 79999999999999996 7789999999986


Q ss_pred             ccccCCC------------------------------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCC
Q 017139          186 VLVKGEA------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP  235 (376)
Q Consensus       186 ~~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~  235 (376)
                      .......                              .....|+..|+|||.+.+.. ++.++|+|||||++|+|++|..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~  230 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTT  230 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCC
Confidence            5432211                              11235788899999997654 7999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC----H
Q 017139          236 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT----A  311 (376)
Q Consensus       236 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~  311 (376)
                      ||.+.+....+..+....                 ..++          ....++.++.++|.+||..||++|||    +
T Consensus       231 pf~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~  283 (316)
T cd05574         231 PFKGSNRDETFSNILKKE-----------------VTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGA  283 (316)
T ss_pred             CCCCCchHHHHHHHhcCC-----------------ccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence            998887766555443210                 0011          01126889999999999999999999    9


Q ss_pred             HHHhCCCccccccCCCCCCC
Q 017139          312 LEACAHPFFDELREPNARLP  331 (376)
Q Consensus       312 ~ell~hp~~~~~~~~~~~~~  331 (376)
                      +++++||||+...++..+..
T Consensus       284 ~~ll~~~~~~~~~~~~~~~~  303 (316)
T cd05574         284 AEIKQHPFFRGVNWALIRHT  303 (316)
T ss_pred             HHHHcCchhhcCChhhcccC
Confidence            99999999999888766653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.6e-43  Score=326.31  Aligned_cols=281  Identities=35%  Similarity=0.557  Sum_probs=221.0

Q ss_pred             ccccceEe-eeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------------------chHHHHHHHHhCCCCCeee
Q 017139           31 KQTISYMA-ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------YKNRELQLMRLMDHPNVIS   91 (376)
Q Consensus        31 ~~~~~y~~-~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------------------~~~~e~~~l~~l~h~~Iv~   91 (376)
                      ...++|.. .+.||.|+||.||+|.+..+++.||+|++.....                  ...+|+++++.++|+||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            34567875 5779999999999999999999999998854321                  2347899999999999999


Q ss_pred             cceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC
Q 017139           92 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP  171 (376)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~  171 (376)
                      +++++     ....++++||||+.++|.+.+..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.
T Consensus        85 ~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~  154 (335)
T PTZ00024         85 LVDVY-----VEGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINS  154 (335)
T ss_pred             eeEEE-----ecCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECC
Confidence            99988     34456899999999988777754    4568999999999999999999999 79999999999999996


Q ss_pred             CCCcEEEEecCCccccccC---------------CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCC
Q 017139          172 LTHQVKLCDFGSAKVLVKG---------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL  236 (376)
Q Consensus       172 ~~~~~kl~Dfg~~~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p  236 (376)
                       ++.++|+|||.+......               .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+|
T Consensus       155 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p  233 (335)
T PTZ00024        155 -KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL  233 (335)
T ss_pred             -CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence             778999999998765411               1112234578899999987655578999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHhcCCCCHHHHhhcCcC--CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          237 FPGENAVDQLVEIIKVLGTPTREEIRCMNPN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       237 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                      |.+.+..+.+..+....+.+....+......  +..+  ......... ......+.++.++|.+||+.||++|||++++
T Consensus       234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             CCCCCHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            9999988888888888877766544322110  0000  000000111 1123468899999999999999999999999


Q ss_pred             hCCCccccccC
Q 017139          315 CAHPFFDELRE  325 (376)
Q Consensus       315 l~hp~~~~~~~  325 (376)
                      |.||||+....
T Consensus       311 l~~~~~~~~~~  321 (335)
T PTZ00024        311 LKHEYFKSDPL  321 (335)
T ss_pred             hcCcccCCCCC
Confidence            99999986543

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.5e-43  Score=318.26  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=208.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|.+....   ....+|+.+++.+ +|||++++++++..........+
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            3678999999999999999999999999999999986532   2334688888888 89999999999865443344568


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++..
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~-~~~~kl~dfg~~~~  177 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQ  177 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEeecccchh
Confidence            899999985 6666665544455679999999999999999999999 79999999999999986 77899999999876


Q ss_pred             cccCC-CcceeeccccccChhhhhCCC----CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          187 LVKGE-ANISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       187 ~~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      ..... ......++..|+|||.+....    .++.++|+|||||++|+|++|+.||...+....+..+.+..  +.    
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~----  251 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--PP----  251 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--CC----
Confidence            54322 122345788899999875432    25789999999999999999999998776655544332210  00    


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                                          ....+..++..+.++|.+||+.||++||++.++++||||+
T Consensus       252 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 --------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             --------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                                0001234677899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-46  Score=308.48  Aligned_cols=286  Identities=31%  Similarity=0.522  Sum_probs=230.5

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeec---CCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFST---TSK  102 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~---~~~  102 (376)
                      ....|.-..++|+|.||.||+|+++.+|+.||+|++.-+.      ....+|+++|..++|+|++.+++++-+.   ...
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3456888999999999999999999999999999764321      2234899999999999999998876332   334


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      +...+|+|+.+|+.+|.-++..   ...+++...+..++.+++.||.|+|+ ..|+|||+|+.|+||+. ++.+||+|||
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~-dgilklADFG  169 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITK-DGILKLADFG  169 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcC-CceEEeeccc
Confidence            4567899999999888777765   34679999999999999999999999 79999999999999996 8899999999


Q ss_pred             CccccccCC-----CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          183 SAKVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       183 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      +++......     ..+..+.|.+|++||.+++...|+++.|+|..|||+.+|.++.+.|++++...++..|....|...
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            997664321     123455699999999999999999999999999999999999999999999999999999999988


Q ss_pred             HHHHhhcCc--CCcCccCCCCCCCCccccc----ccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          258 REEIRCMNP--NYTDFRFPQIKAHPWHKVF----HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       258 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      .+-|+....  -+..+..+.+.......+-    +-.-.+++.||+.++|..||.+|++++++|+|.||..
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            887765431  1222212212111111110    0112468999999999999999999999999999964

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.4e-43  Score=323.59  Aligned_cols=285  Identities=34%  Similarity=0.585  Sum_probs=223.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~  105 (376)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            478999999999999999999999999999999986432      223468999999999999999988753321 2234


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+++++++++|...+..     ..+++..++.++.|++.||+|||+ .|++||||||+||+++. ++.+||+|||++.
T Consensus        96 ~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~dfg~~~  168 (345)
T cd07877          96 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR  168 (345)
T ss_pred             cEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcC-CCCEEEecccccc
Confidence            5789999998887665543     468999999999999999999999 79999999999999996 7789999999987


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+....+..+....+.+.........
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            6432  22345678899999998765558899999999999999999999999888888888888877777665554332


Q ss_pred             cCCcCc---cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          266 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       266 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                      ......   ..+......+.. .....++++.++|.+||+.||.+|+++.++++||||+++..+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence            211000   001111111111 1124688999999999999999999999999999999876654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=319.24  Aligned_cols=274  Identities=39%  Similarity=0.740  Sum_probs=222.4

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+.....      ...+|+.+++.++|+||+++++++     .+...+++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence            6788999999999999999999999999999865432      234688999999999999999988     44456899


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |+||+++++.+.+...   ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECC-CCcEEEeeeeeeEecCC
Confidence            9999999887776552   3578999999999999999999999 79999999999999996 77899999999876654


Q ss_pred             CC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc--
Q 017139          190 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP--  266 (376)
Q Consensus       190 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  266 (376)
                      .. ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.+..+....+....+.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            43 223355788899999987664689999999999999999999999999988888888888888777665554333  


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ......++....... ......++.++.++|.+||.+||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            111122222222222 11234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.3e-45  Score=299.61  Aligned_cols=284  Identities=32%  Similarity=0.599  Sum_probs=235.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .+++|++++++|+|-|+.||.|.+..+++.++||+++.-. +...+|+.+|+.+. ||||+++.++.-+.   ......+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccCchh
Confidence            4678999999999999999999999999999999997643 45678999999997 99999999988543   3344679


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |+||++..-...+      -+.++...++.++.|++.||.|||+ .||.|||+||.|+++|.....++|+|+|+|.+...
T Consensus       113 iFE~v~n~Dfk~l------y~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQL------YPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHH------hhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9999997522222      3568889999999999999999999 69999999999999998788899999999999988


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCHHHHh-----h
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIR-----C  263 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-----~  263 (376)
                      .......+.+.+|..||++...+.|+..-|+|||||++..|+..+.|| .|.++.+++.+|.+.+|+......-     .
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            887778888999999999988888999999999999999999987665 7889999999999999986543321     1


Q ss_pred             cCcCCcCccCCCCCCCCccccccc----CCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      +.+.+.++ .......+|...++.    -+++++.||+.++|..|..+|+||.|++.||||..+...
T Consensus       266 Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  266 LDPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             CChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence            22222221 223344556555543    257999999999999999999999999999999876544

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=319.06  Aligned_cols=253  Identities=27%  Similarity=0.435  Sum_probs=208.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +-|.++.+||+|+||.||+|.++.+|..+|||.+..+.  +...+|+.++++++.|++|++++.|+-..+     ++|||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeeh
Confidence            35788999999999999999999999999999986554  445589999999999999999999965444     99999


Q ss_pred             eccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      |||+ |+..+.++.   .+.++++.++..++..-+.||+|||.+ .-+|||||..|||++. ++..||+|||.+....+.
T Consensus       108 EYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  108 EYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNT-DGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             hhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcc-cchhhhhhccccchhhhh
Confidence            9999 565555554   368899999999999999999999995 7899999999999997 888999999998765443


Q ss_pred             -CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          191 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       191 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                       ....+.+|||.|||||++.... |...+||||||++..||+.|++||.+..+...+.      ..|+...        .
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------MIPT~PP--------P  247 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------MIPTKPP--------P  247 (502)
T ss_pred             HHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeE------eccCCCC--------C
Confidence             3456789999999999997655 8999999999999999999999998765432221      1111000        0


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      .++            -|+..|.++.|||++||.++|++|.|+-++++|||+++.
T Consensus       248 TF~------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  248 TFK------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             CCC------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            011            123468899999999999999999999999999999864

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.9e-43  Score=319.36  Aligned_cols=250  Identities=30%  Similarity=0.499  Sum_probs=208.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+....       ....+|++++++++||||+++++++     .+...
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            46999999999999999999999999999999885432       2244689999999999999999988     44556


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||++ ++|.+.+..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++.
T Consensus        76 ~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~dfg~~~  149 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDS-DGYIKITDFGFAK  149 (290)
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEeeCCCcc
Confidence            899999996 576666654    3679999999999999999999999 79999999999999996 7789999999988


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .....  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+...  .          
T Consensus       150 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~----------  214 (290)
T cd05580         150 RVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K----------  214 (290)
T ss_pred             ccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C----------
Confidence            76444  3345678999999998654 4789999999999999999999999887755444443321  0          


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                       ..++..++..++++|.+||+.||.+|+     +++++++||||+.+.+.
T Consensus       215 -----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         215 -----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             -----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                             013345688999999999999999999     99999999999987754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-42  Score=321.91  Aligned_cols=286  Identities=36%  Similarity=0.650  Sum_probs=222.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC-Cc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~-~~  104 (376)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++...... ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3467999999999999999999999999999999885432      1234699999999999999999988543221 12


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+++||||+++++...+..     ..+++..++.++.|++.||+|||+ .||+||||||+||+++. ++.++|+|||++
T Consensus        93 ~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~-~~~~kl~dfg~~  165 (343)
T cd07880          93 HDFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA  165 (343)
T ss_pred             ceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccc
Confidence            34689999997777665542     568999999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ......  .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+.+..+.+..+.....
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            765332  223456889999999876445789999999999999999999999988887788777776666554433322


Q ss_pred             CcCCc-C--ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          265 NPNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       265 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                      ..... .  ...+......+ ..+...+++++.++|.+||+.||++|||+.+++.||||+.+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             cchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence            21100 0  00111111111 112346788999999999999999999999999999999886653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.6e-43  Score=317.36  Aligned_cols=264  Identities=24%  Similarity=0.349  Sum_probs=209.4

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCCCCc
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .+...++|++.+.||+|+||.||+|.+..+++.+|+|++....   .....|+.+++.+ +||||+++++++.......+
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            4456788999999999999999999999999999999875432   2345688889998 69999999998865544556


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++||||++| +|.+.+.........+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.++|+|||+
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~  170 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTT-EGGVKLVDFGV  170 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECC-CCCEEEccCCc
Confidence            678999999985 6766666544455678999999999999999999999 79999999999999996 77799999999


Q ss_pred             ccccccCC-CcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          184 AKVLVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +....... ......+++.|+|||++..    ...++.++|+||+||++|+|++|..||...+....+..+...  .+  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~--  246 (286)
T cd06638         171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP--  246 (286)
T ss_pred             eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC--
Confidence            87654322 2234467899999998743    233788999999999999999999999876544333221110  00  


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                            .....+...+.++.+++.+||+.||++|||+.++++||||
T Consensus       247 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 ----------------------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ----------------------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                  0001123457789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=297.25  Aligned_cols=257  Identities=26%  Similarity=0.363  Sum_probs=205.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .+|+|.+.||+|||+.||+++...++..||+|++....    ....+|++..+.++|||+++++++............||
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            48999999999999999999999999999999986554    33457999999999999999999877665556677899


Q ss_pred             Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--ceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          110 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       110 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~--ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +++|.. |+|++.+......+..+++.++..|+.+|++||++||+ ..  ++||||||.|||+.. ++.++|.|||.+..
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSD-SGLPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecC-CCceEEEeccCccc
Confidence            999987 78999999888888899999999999999999999999 68  999999999999996 78899999999875


Q ss_pred             cccCCC----------cceeeccccccChhhhhCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          187 LVKGEA----------NISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       187 ~~~~~~----------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      ..-.-.          -....||..|+|||++.-.  ...+.++|||||||++|.|+.|..||...-         +.-|
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~Gg  249 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGG  249 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCC
Confidence            432111          1234579999999998432  236889999999999999999999995321         1000


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ...      ..-....+.+|.          ...+|+.+.++|+.||++||.+||++.+++.+
T Consensus       250 Sla------LAv~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 SLA------LAVQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eEE------EeeeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            000      000001122222          12479999999999999999999999999864

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-43  Score=314.16  Aligned_cols=263  Identities=28%  Similarity=0.410  Sum_probs=210.0

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCC-CCc
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTS-KDE  104 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~-~~~  104 (376)
                      |..+++|++.+.||.|++|.||+|.+..+++.+++|++....   ....+|+.+++.+ +|+||+++++++..... ...
T Consensus         2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            566789999999999999999999999999999999986543   2345788999998 79999999999865443 345


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+||||+++ +|.+.+......+..+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~-~~~~~l~d~~~  159 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTK-NAEVKLVDFGV  159 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEcc-CCeEEECCCcc
Confidence            678999999996 6666665544345779999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCC-CcceeeccccccChhhhhCC----CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          184 AKVLVKGE-ANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +....... ......++..|+|||.+...    ..++.++|+|||||++|+|++|..||..........++.....    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----  235 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP----  235 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC----
Confidence            87653322 22345678899999987532    2367889999999999999999999986655544444332100    


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                     +       ....+..++.++.++|.+||..||++|||+.++++|||+
T Consensus       236 ---------------~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 ---------------P-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ---------------C-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                           0       000112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-43  Score=315.84  Aligned_cols=275  Identities=39%  Similarity=0.713  Sum_probs=221.9

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      |.+.+.||.|++|.||+|+...+++.++||.+.....     ...+|+..++.++ |+||+++++++     .++...++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence            6889999999999999999999999999998865432     2235888899998 99999999988     44556899


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      ||||+++++.+.+....  ...+++..+..++.|++.+|.|||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSG-PEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCCEEEeecccceeccC
Confidence            99999888877776532  3578999999999999999999999 79999999999999996 78899999999987655


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc--C
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP--N  267 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  267 (376)
                      ........++..|+|||.+.+...++.++|+||||+++++|++|.+||......+....+....+.+....+.....  .
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            54445566788999999886655689999999999999999999999999988888888888888877654432211  0


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ...+.++..........++ ..+.++.++|.+||+.||++|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            1111222222222222222 347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-43  Score=317.23  Aligned_cols=277  Identities=32%  Similarity=0.614  Sum_probs=217.9

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      |.+.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+++++.++|||++++++++...   +....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            788999999999999999999999999999997652      1234689999999999999999988432   1256899


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      ||||+++++...+...   ...+++..++.++.||+.||+|||+ .|++|+||+|+||+++. ++.++|+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINN-DGVLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcC-CCCEEEccccceeeccC
Confidence            9999998877766542   2578999999999999999999999 79999999999999996 88899999999876654


Q ss_pred             CC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          190 GE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       190 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ..  ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+....+..+.+..+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            33  1233456788999998766555789999999999999999999999998888888888887777665554332211


Q ss_pred             --CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          268 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                        .................+...+++++.+++.+||..||++||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00000000000011122222348899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=315.46  Aligned_cols=304  Identities=28%  Similarity=0.434  Sum_probs=240.1

Q ss_pred             ceEeeccCC----CCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHhCC----
Q 017139           17 HIISTTIGG----KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMD----   85 (376)
Q Consensus        17 ~~~~~~~~~----~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~e~~~l~~l~----   85 (376)
                      ....|..+|    +.|++...++|.+.++||.|-|++||+|.+..+.+.||+|+.+....+.   ..|+++|+.++    
T Consensus        57 ~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp  136 (590)
T KOG1290|consen   57 DPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDP  136 (590)
T ss_pred             ChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCC
Confidence            334566666    5666666789999999999999999999999999999999997765443   36899998873    


Q ss_pred             ----CCCeeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceecc
Q 017139           86 ----HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD  161 (376)
Q Consensus        86 ----h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~d  161 (376)
                          ..+||++++.|-... ....++|+|+|+++..|+.++....  .+.++...++.|+.|||.||.|||+-.||+|.|
T Consensus       137 ~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTD  213 (590)
T KOG1290|consen  137 NDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTD  213 (590)
T ss_pred             CCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccC
Confidence                357999999986554 6778899999999999999998753  467999999999999999999999867999999


Q ss_pred             CCCCCeeecCCC--------------------------------------------------------------------
Q 017139          162 VKPQNLLVDPLT--------------------------------------------------------------------  173 (376)
Q Consensus       162 lkp~Nill~~~~--------------------------------------------------------------------  173 (376)
                      |||+|||+...+                                                                    
T Consensus       214 lKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~  293 (590)
T KOG1290|consen  214 LKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEG  293 (590)
T ss_pred             CCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccc
Confidence            999999983100                                                                    


Q ss_pred             --------------------------------------------------------------------------------
Q 017139          174 --------------------------------------------------------------------------------  173 (376)
Q Consensus       174 --------------------------------------------------------------------------------  173 (376)
                                                                                                      
T Consensus       294 ~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~  373 (590)
T KOG1290|consen  294 IEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGT  373 (590)
T ss_pred             ccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccc
Confidence                                                                                            


Q ss_pred             -----------------CcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCC
Q 017139          174 -----------------HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL  236 (376)
Q Consensus       174 -----------------~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p  236 (376)
                                       -++||+|||-|.....  ..+.-+.|..|+|||++.+.. |++.+||||++|++|||+||...
T Consensus       374 ~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyL  450 (590)
T KOG1290|consen  374 IASNPLVNPDIPLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYL  450 (590)
T ss_pred             cccccccCCCCCCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCcee
Confidence                             0356666666654321  223446688899999999876 99999999999999999999999


Q ss_pred             CCCC------ChHHHHHHHHHhcCCCCHHHHhhc-------CcCCcCccCCCCCCCCcccccccC------CChhHHHHH
Q 017139          237 FPGE------NAVDQLVEIIKVLGTPTREEIRCM-------NPNYTDFRFPQIKAHPWHKVFHKR------MPPEAIDLA  297 (376)
Q Consensus       237 f~~~------~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li  297 (376)
                      |...      .+.+.++.|++.+|..++.....-       +..-.-..+..++.+++..++.+.      -..++.|||
T Consensus       451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL  530 (590)
T KOG1290|consen  451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL  530 (590)
T ss_pred             ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence            9532      467889999999999887755321       222222256666777776665542      235688999


Q ss_pred             HhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          298 SRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       298 ~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      .-||+++|.+|+||.++|+|||+..+-.+
T Consensus       531 ~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  531 SPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHHhcCccccccHHHHhcCccccCCCCC
Confidence            99999999999999999999999876543

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-43  Score=317.94  Aligned_cols=260  Identities=25%  Similarity=0.419  Sum_probs=204.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++     ..+..+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence            47999999999999999999999999999999886432     2234689999999999999999988     4455689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|...+.. ......+++..+..++.|++.||.|||+..|++|+||||+||+++. ++.++|+|||.+...
T Consensus        76 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~  153 (286)
T cd06622          76 MCMEYMDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEeecCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCcccc
Confidence            99999997 55444443 2223479999999999999999999996249999999999999996 788999999998755


Q ss_pred             ccCCCcceeeccccccChhhhhCCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          188 VKGEANISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ... ......+++.|+|||.+.+..     .++.++|+|||||++|+|++|..||...........+........     
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  227 (286)
T cd06622         154 VAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-----  227 (286)
T ss_pred             cCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-----
Confidence            322 222345788899999985432     257899999999999999999999976554433333222111100     


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                                          ..++..++.++.++|.+||..||++||+++++++||||......
T Consensus       228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 --------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             --------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                                01233578999999999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.6e-43  Score=325.02  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=193.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.++..+ +||||+++++++.   
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---   81 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT---   81 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec---
Confidence            3468999999999999999999752     345789999986432     2244689999999 8999999998773   


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhh----------------------------------------------------
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSS----------------------------------------------------  127 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~----------------------------------------------------  127 (376)
                       ..+..+++|||||++ +|.+.+.....                                                    
T Consensus        82 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          82 -KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             -CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence             223357899999995 77766654211                                                    


Q ss_pred             ------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC---cceeec
Q 017139          128 ------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYIC  198 (376)
Q Consensus       128 ------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~  198 (376)
                            ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.......   .....+
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCCCC
Confidence                  12357888999999999999999999 79999999999999996 78899999999976533221   112334


Q ss_pred             cccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCC
Q 017139          199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK  277 (376)
Q Consensus       199 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+.. +..                     
T Consensus       239 ~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~---------------------  295 (338)
T cd05102         239 PLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR---------------------  295 (338)
T ss_pred             CccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC---------------------
Confidence            6789999998765 48999999999999999997 99999876544333332221 000                     


Q ss_pred             CCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          278 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                           ...+...++++.+++.+||+.||++|||+.++++
T Consensus       296 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 -----MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                 0023356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-43  Score=318.60  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=199.0

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+..+.     .....|+++++.++||||+++++++.     .....+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEE
Confidence            36889999999999999999999999999999986542     22346899999999999999999984     344588


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +||||++++.+...       ..+++..+..++.|++.||.|||+ .||+|+||||+||+++. ++.++|+|||++....
T Consensus        76 lv~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~~~~  146 (279)
T cd06619          76 ICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLV  146 (279)
T ss_pred             EEEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECC-CCCEEEeeCCcceecc
Confidence            99999997543322       347888899999999999999999 79999999999999996 7889999999987653


Q ss_pred             cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCHHHHhhcC
Q 017139          189 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ---LVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       189 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .. ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||........   ............        
T Consensus       147 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------  216 (279)
T cd06619         147 NS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------  216 (279)
T ss_pred             cc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------
Confidence            32 23345788999999998765 489999999999999999999999965322110   001111100000        


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                             .+        .......++++.+++.+||+.||++||+++++++||||...+..
T Consensus       217 -------~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         217 -------PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             -------CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence                   00        00112467899999999999999999999999999999876443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.9e-42  Score=315.78  Aligned_cols=283  Identities=30%  Similarity=0.513  Sum_probs=219.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC----
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS----  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~----  101 (376)
                      ..++|++.+.||.|+||.||+|.+..+|+.||+|.+....      ....+|+++++.++||||+++++++....+    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4568999999999999999999999999999999986432      123468999999999999999988744320    


Q ss_pred             -CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 -KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 -~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                       .+...+++|+||+++++...+...   ...+++..++.++.|++.||.|||+ .||+|+||+|+||+++. ++.+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~kl~d  159 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLAD  159 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCcEEeCc
Confidence             123378999999999877666542   3568999999999999999999999 79999999999999996 78899999


Q ss_pred             cCCccccccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          181 FGSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       181 fg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      ||++........  .....++..|+|||.+.+...++.++|+|||||++|+|++|++||...+..+.+..+.+..+.+..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            999876543321  122345778999998866555789999999999999999999999988888888888887777665


Q ss_pred             HHHhhcCcC--CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          259 EEIRCMNPN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       259 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ..++.....  +............+. .....++..+.++|.+||..||++||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            544322110  000000000000111 1223468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-42  Score=315.94  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=204.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .+.|++++.||.|+||.||+|++..+++.+++|.+.....    ...+|+.+++.++||||+++++++.     .+..+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEE
Confidence            3679999999999999999999999999999999865432    2346889999999999999999884     344589


Q ss_pred             EEeecccchHH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g~l~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||++++.+ ..+..   ....+++..++.++.|++.+|.|||+ +|++||||+|+||+++. ++.++|+|||++...
T Consensus        86 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~  160 (292)
T cd06644          86 IMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTL-DGDIKLADFGVSAKN  160 (292)
T ss_pred             EEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcC-CCCEEEccCccceec
Confidence            99999997543 33322   23568999999999999999999999 79999999999999986 788999999988654


Q ss_pred             ccC-CCcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          188 VKG-EANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ... .......+++.|+|||.+.+    ...++.++|+|||||++|+|++|.+||...+......++....  ++     
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~-----  233 (292)
T cd06644         161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP-----  233 (292)
T ss_pred             cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc-----
Confidence            322 22234567889999998852    2336789999999999999999999998766544443332210  00     


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                                         ....+..++.++.++|.+||..||++||+++++++||||..+...
T Consensus       234 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         234 -------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             -------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                               001223568899999999999999999999999999999876554

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=334.78  Aligned_cols=248  Identities=27%  Similarity=0.485  Sum_probs=205.5

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecccc
Q 017139           41 VVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE  116 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g  116 (376)
                      +||+|.||+||.|++..+...+|||.+...    .+...+|+.+-++++|.|||++.+++     .+++++-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            799999999999999999999999998543    34456899999999999999999997     667788899999996


Q ss_pred             -hHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC-
Q 017139          117 -TMYRVLKHYSSMNQRM--PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-  192 (376)
Q Consensus       117 -~l~~~l~~~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~-  192 (376)
                       +|.+++.. .-  +++  .|..+..+-.||+.||+|||+ +.|||||||-+|+|++...|.+||+|||.++....-.+ 
T Consensus       657 GSLSsLLrs-kW--GPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRS-KW--GPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHh-cc--CCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             55555544 22  344  788899999999999999999 79999999999999999899999999999887655433 


Q ss_pred             cceeeccccccChhhhhC-CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc
Q 017139          193 NISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF  271 (376)
Q Consensus       193 ~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ..++.||..|||||++.. ...|++++|||||||++.||+||++||.........  +.+ .|..               
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFk-VGmy---------------  794 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFK-VGMY---------------  794 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhh-hcce---------------
Confidence            346789999999999954 345999999999999999999999999765443221  111 1110               


Q ss_pred             cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                              ..+..+|..++.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus       795 --------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  795 --------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             --------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                    11333667789999999999999999999999999999999865

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.1e-43  Score=322.64  Aligned_cols=278  Identities=21%  Similarity=0.313  Sum_probs=198.6

Q ss_pred             eeeeeccC--CceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           38 AERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        38 ~~~~Lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ++++||+|  +|++||++.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     .+..+|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence            46789999  78899999999999999999986432      23456899999999999999999884     4445899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      ||||+++ +|.+++....  ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEec-CCcEEEcccchhhccc
Confidence            9999985 6666664322  2458999999999999999999999 79999999999999996 7789999998654332


Q ss_pred             cCCC--------cceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC----
Q 017139          189 KGEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT----  255 (376)
Q Consensus       189 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~----  255 (376)
                      ....        .....++..|+|||++.+. ..++.++|+|||||++|+|++|..||................-.    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            1111        1123456779999998653 34889999999999999999999999876544433332221000    


Q ss_pred             ---CCHHHHhhcC------cCCcCccC----CCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          256 ---PTREEIRCMN------PNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       256 ---~~~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                         ...+.+....      ........    ...........+...+++++.+||.+||++||++|||++++++||||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence               0000000000      00000000    0000000011123356789999999999999999999999999999987


Q ss_pred             cc
Q 017139          323 LR  324 (376)
Q Consensus       323 ~~  324 (376)
                      +.
T Consensus       313 ~~  314 (327)
T cd08227         313 IK  314 (327)
T ss_pred             cc
Confidence            54

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-44  Score=324.10  Aligned_cols=253  Identities=26%  Similarity=0.425  Sum_probs=195.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..|++.++||.||.+.||+|...+. +.||+|++....      .....|+.+|..|+ |.+|++++++-     -.+.+
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~  434 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY  434 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence            4799999999999999999996544 566766654322      22347999999985 89999999987     44677


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|+||||-+-+|...|..+.   ..++.-.++.+..|++.|+.++|. +||||.||||.|+|+-  .|.+||+|||.|..
T Consensus       435 lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV--kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  435 LYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV--KGRLKLIDFGIANA  508 (677)
T ss_pred             EEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE--eeeEEeeeechhcc
Confidence            99999998889888887743   234445889999999999999999 7999999999999997  67899999999988


Q ss_pred             cccCCC---cceeeccccccChhhhhCCC----------CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017139          187 LVKGEA---NISYICSRYYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL  253 (376)
Q Consensus       187 ~~~~~~---~~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  253 (376)
                      ...+..   ..+.+||+.||+||.+....          .++.++||||||||||+|+.|++||.....  ...++... 
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI-  585 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAI-  585 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhh-
Confidence            766544   34678999999999984321          257899999999999999999999975432  22222221 


Q ss_pred             CCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ..|.           .++.+|.+.           -..++.++++.||.+||.+|||+.++|+|||++-.
T Consensus       586 ~~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  586 TDPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             cCCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            1111           112223221           12239999999999999999999999999999763

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=312.86  Aligned_cols=274  Identities=38%  Similarity=0.698  Sum_probs=224.4

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      |++.+.||+|++|.||+|++..+++.+|+|++....      .....|+.+++.++|+||+++++++     .+...+++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence            677899999999999999999999999999986542      1234688999999999999999988     34456899


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      ||||++++|.+.+...   ...+++..+..++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINR-DGVLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcC-CCCEEEecCCcccccCC
Confidence            9999999888777652   1469999999999999999999999 79999999999999996 78899999999876544


Q ss_pred             CC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          190 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       190 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      .. ......++..|+|||.+.+...++.++|+|||||++|++++|.+||.+.+..+.+..+....+.+....+.......
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 22234457789999998766468999999999999999999999999999888888898888888877665443221


Q ss_pred             -cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          269 -TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       269 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                       ....++..........++ .++.++.++|.+||..||++||++++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             222334333333333333 358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-42  Score=312.05  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=202.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCCC-CceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK-DELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~-~~~~~  107 (376)
                      .+.|++.+.||+|+||.||+|.+..+++.+|+|.+....   .....|+.+++.+ +|+||+++++++...... ....+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            457999999999999999999999999999999986543   2345688888888 699999999988654322 23568


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |++|||+++ +|.+.+...  ....+++..+..++.|++.||+|||+ ++|+|+||+|+||+++. ++.++|+|||++..
T Consensus        85 ~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~-~~~~~l~Dfg~~~~  160 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECC-CCCEEEccCCCcee
Confidence            899999985 666655542  23568999999999999999999999 79999999999999996 77899999999876


Q ss_pred             cccC-CCcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          187 LVKG-EANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       187 ~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      .... .......+++.|+|||++.+    ...++.++|+||+||++|+|++|..||...............         
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---------  231 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---------  231 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---------
Confidence            5332 22334567889999999853    224788999999999999999999999765544333222110         


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                        .........++.++.+|+.+||..||.+|||+.+++.||||
T Consensus       232 ------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 ------------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ------------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                              00001123467899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=327.09  Aligned_cols=252  Identities=31%  Similarity=0.551  Sum_probs=212.7

Q ss_pred             ceEe--eeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           35 SYMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        35 ~y~~--~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      -|+|  .++||+|.||+||-|+++.+|+.||||++.+-      ......|+.+|+.+.||.||.+...|     +....
T Consensus       563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~er  637 (888)
T KOG4236|consen  563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPER  637 (888)
T ss_pred             HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCce
Confidence            4555  47899999999999999999999999998543      34456799999999999999998777     44445


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC--CcEEEEecCCc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSA  184 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~--~~~kl~Dfg~~  184 (376)
                      +++|||-+.|++++.+...  ..+++++...+.++.||+.||.|||. ++|+|+||||+|||+.+.+  -.+||||||+|
T Consensus       638 vFVVMEKl~GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  638 VFVVMEKLHGDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             EEEEehhhcchHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccce
Confidence            8899999999988887753  45789999999999999999999999 7999999999999997433  26999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +...+..-..+.+|||.|+|||++.... |...-|+||.|||+|.-+.|.+||....+ .+++++               
T Consensus       715 RiIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN---------------  778 (888)
T KOG4236|consen  715 RIIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN---------------  778 (888)
T ss_pred             eecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhHHhhc---------------
Confidence            9998888888999999999999998655 89999999999999999999999975433 233322               


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                           ..+.+|.   .||     +.+++++.|||+.+|++.-.+|.|++..|.|||+++.
T Consensus       779 -----AaFMyPp---~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  779 -----AAFMYPP---NPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             -----cccccCC---Cch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                 1222221   233     3579999999999999999999999999999999875

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.3e-42  Score=306.77  Aligned_cols=249  Identities=27%  Similarity=0.440  Sum_probs=202.8

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||.|++|.||++.+..+++.+|+|.+....      .....|+++++.++|+|++++++.+.    ..+..+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4999999999999999999999999999999985432      22346889999999999999987762    2345688


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|||+++ +|.+.+...  ....+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~-~~~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEec-CCcEEEecccceEEe
Confidence            99999985 666666542  24568999999999999999999999 79999999999999996 788999999998766


Q ss_pred             ccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .... ......+++.|+|||++.+. .++.++|+||+||++|+|++|..||...+.......+.....            
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------  219 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------  219 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            4332 22344678899999998664 488999999999999999999999987765554444332100            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                      ...+..+++++.+++.+||+.||++|||+.++++||||
T Consensus       220 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 ----------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ----------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                            00223578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.4e-42  Score=318.58  Aligned_cols=281  Identities=38%  Similarity=0.720  Sum_probs=221.5

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|.+.+.||.|+||.||+|.+..+++.+|+|++...      ......|+++++.++||||+++.+++..    ...
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~   83 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS----PLE   83 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----CCC
Confidence            456899999999999999999999999999999987542      1234479999999999999999998743    223


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+++||++++|...+..     ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||.+.
T Consensus        84 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~-~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINE-NCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECC-CCCEEeCcccccc
Confidence            4789999998887666543     468888899999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.........+.+.++.++.+......
T Consensus       157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            5432  22345678889999988664558999999999999999999999999988877777778888877755543221


Q ss_pred             cCC-cCc--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          266 PNY-TDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       266 ~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ..- .++  ..+.....+... ....++.++.++|.+||+.||++|||+++++.||||.....+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSE-KFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             chhhHHHHhhccccCCCcHHH-HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence            110 000  011111111111 123578899999999999999999999999999999877665

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2e-42  Score=309.72  Aligned_cols=256  Identities=28%  Similarity=0.426  Sum_probs=204.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ++|++.+.||.|+||+||+|.+..++..+|+|++....     ....+|+.+++.++|+||+++++.+     .....++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence            47999999999999999999999899999999886432     2345789999999999999999887     3445588


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|||++++ +|.+.+... .....+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus        76 iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~  152 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSS-YPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGE-DGSVKIADFGVSASL  152 (267)
T ss_pred             EEEeccCCCcHHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccchHHHh
Confidence            99999986 555555432 123568999999999999999999999 79999999999999996 778999999998766


Q ss_pred             ccCCCc-----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          188 VKGEAN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ......     ....++..|+|||.+.....++.++|+|||||++|+|++|..||...+............  +.     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-----  225 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PP-----  225 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC--CC-----
Confidence            543222     334578899999998765458999999999999999999999998776654444433310  00     


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                             .  ++.       ......+++++.+++.+||..||++|||+.+++.||||
T Consensus       226 -------~--~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         226 -------S--LET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -------C--cCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                   0  000       00123578899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-43  Score=313.65  Aligned_cols=251  Identities=27%  Similarity=0.416  Sum_probs=205.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ++|.+.+.||.|++|.||+|.+..+++.+|+|.+....     ....+|+.+++.++|+||+++++++.     ++..+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence            46999999999999999999999999999999986543     22456899999999999999999884     345689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|+||+++ +|.+.+..     ..+++..++.++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~  148 (274)
T cd06609          76 IIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL  148 (274)
T ss_pred             EEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEcccccceee
Confidence            99999986 66555543     378999999999999999999999 79999999999999996 788999999998776


Q ss_pred             ccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ... .......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+.....            
T Consensus       149 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------  215 (274)
T cd06609         149 TSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------------  215 (274)
T ss_pred             cccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC------------
Confidence            543 2233456788899999997654 89999999999999999999999987665444333222100            


Q ss_pred             CCcCccCCCCCCCCcccccccC-CChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                      ..+... +++++.+++.+||..||++|||++++++||||++...
T Consensus       216 ----------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         216 ----------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             ----------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence                            001122 6889999999999999999999999999999987433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-44  Score=298.34  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=214.0

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccch-----HHHHHH-HHhCCCCCeeecceeeeecCCC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQL-MRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~e~~~-l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .+...++..++..||.|..|+|++++.+.+|...|||.+.+.....     ...+++ ++..++|+||+.+++|....+ 
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-  165 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-  165 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-
Confidence            3456677888899999999999999999999999999997653221     123333 334458999999999976554 


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                          ++|.||.|..-...+++.   ..++++|..+-++...++.||.||.+-+||+|||+||+|||+|. .|++||||||
T Consensus       166 ----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~GniKlCDFG  237 (391)
T KOG0983|consen  166 ----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGNIKLCDFG  237 (391)
T ss_pred             ----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc-CCCEEeeccc
Confidence                789999988555555554   34679999999999999999999997679999999999999996 8899999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCHH
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~  259 (376)
                      .+....+....+...|-+.|||||.+.-  ...|+.++||||||++++||+||+.||.+.+ +.+.+..++..  .|+  
T Consensus       238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP--  313 (391)
T KOG0983|consen  238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPP--  313 (391)
T ss_pred             ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCC--
Confidence            9999988888888999999999999843  3458899999999999999999999999854 45666666552  111  


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                            ......++|+++++|+..||++|+.+||.-.++|+|||+.....
T Consensus       314 ----------------------~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  314 ----------------------LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             ----------------------CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence                                  00122357999999999999999999999999999999987543

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=328.87  Aligned_cols=248  Identities=30%  Similarity=0.482  Sum_probs=211.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .|.=++.||.|+||.||.|++..+.+.||||++.-..+       .+.+|+..|+.++|||++.+.+||+-...     .
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence            46667899999999999999999999999999965432       23479999999999999999999964433     7


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|||||-|+-.+++.-.   ..++.+..+..|+.+.+.||.|||+ .+.||||||..|||++. .+.|||+|||.|...
T Consensus       102 WLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse-~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSE-PGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecC-CCeeeeccccchhhc
Confidence            899999999776776553   3679999999999999999999999 69999999999999995 889999999998765


Q ss_pred             ccCCCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          188 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                         .+..+++|||+|||||+++.  ...|+.++||||||++..+|+-.++|....+....+..|...- .          
T Consensus       177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-s----------  242 (948)
T KOG0577|consen  177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S----------  242 (948)
T ss_pred             ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-C----------
Confidence               34568999999999999853  3459999999999999999999999999999888887776521 1          


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                              |.+..        ...|..+..||..||++-|.+|||++++|.|+|...
T Consensus       243 --------PtLqs--------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  243 --------PTLQS--------NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             --------CCCCC--------chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence                    11111        235889999999999999999999999999999965

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=314.01  Aligned_cols=255  Identities=26%  Similarity=0.384  Sum_probs=205.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+.....    ...+|+++++.++||||+++++.+     ..+..+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence            4679999999999999999999998999999999864322    234689999999999999999988     3445689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+|+||+|+||+++. ++.++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~-~~~~~l~d~g~~~~~  153 (280)
T cd06611          79 ILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTL-DGDVKLADFGVSAKN  153 (280)
T ss_pred             EEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECC-CCCEEEccCccchhh
Confidence            99999996 55555443   23569999999999999999999999 79999999999999996 788999999987654


Q ss_pred             ccCC-CcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          188 VKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      .... ......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||...+.......+...  .+      
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------  225 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP------  225 (280)
T ss_pred             cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC------
Confidence            3322 2234567899999999752    233678999999999999999999999877665544433221  00      


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                 +       ....+..++.++.++|.+||+.||++||++.++++||||...
T Consensus       226 -----------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         226 -----------P-------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             -----------C-------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                       0       000123568899999999999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.9e-42  Score=307.27  Aligned_cols=252  Identities=25%  Similarity=0.429  Sum_probs=207.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+....      .....|+++++.++||||+++++++..   .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            5899999999999999999999999999999885432      123358899999999999999987753   3345688


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH-----cCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH-----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-----~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ++|||+++ +|.+.+.........+++..++.++.||+.||.|||     + .+++|+||+|+||+++. ++.+||+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~-~~~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDA-NNNVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEec-CCCEEEeccc
Confidence            99999985 777777765555678999999999999999999999     8 69999999999999996 7889999999


Q ss_pred             CccccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          183 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       183 ~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      ++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------  226 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--------  226 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------
Confidence            9887654433 33456799999999986644 8899999999999999999999998876444333322110        


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                          ...++...+.++.+++.+||..+|++||++.++++|||+
T Consensus       227 --------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         227 --------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             --------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                                011334578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-42  Score=316.06  Aligned_cols=279  Identities=25%  Similarity=0.393  Sum_probs=204.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....     ....+|+++++.++||||+++++++     .++..+|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence            46999999999999999999999999999999886442     1234699999999999999999998     4455689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+..+++|+||||+||+++. ++.+||+|||++...
T Consensus        76 lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~  150 (308)
T cd06615          76 ICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL  150 (308)
T ss_pred             EEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCcccc
Confidence            99999986 66666553    3668999999999999999999997248999999999999996 778999999998755


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh--hcC
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMN  265 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  265 (376)
                      ... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.... ................  ...
T Consensus       151 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         151 IDS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             ccc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCccccc
Confidence            332 22345678999999998654 488999999999999999999999976653322 2222211100000000  000


Q ss_pred             cCCcC----cc----CCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          266 PNYTD----FR----FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       266 ~~~~~----~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ....+    ..    ................++.++.+|+.+||..||++|||+.++++||||.+...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  295 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL  295 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence            00000    00    00000000000011136788999999999999999999999999999987533

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.1e-42  Score=306.69  Aligned_cols=249  Identities=31%  Similarity=0.455  Sum_probs=206.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....      .....|+.+++.++||||+++++.+     .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            5999999999999999999999999999999986432      2344689999999999999999887     4455689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+...  ....+++..+..++.|++.+|+|||+ +|++|+||+|+||+++.+++.+||+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999986 676666542  23558999999999999999999999 799999999999999865677899999999876


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ..........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-------------  218 (256)
T ss_pred             CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence            555444456678899999998654 478999999999999999999999988766555444332100             


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                     ..++..++.++.+++.+||..||++|||+.++++||||
T Consensus       219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                           01233578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=303.28  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=204.2

Q ss_pred             ccceEee-eeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCC-CCCeeecceeeeecCCCCcee
Q 017139           33 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        33 ~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .+-|.+. +.||+|+|+.|--|....+|..||||++.+..    ....+|++++...+ |+||+.++++|     +++..
T Consensus        76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~  150 (463)
T KOG0607|consen   76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTR  150 (463)
T ss_pred             HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccce
Confidence            3456553 68999999999999999999999999997653    33457999999884 99999999999     77777


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC--cEEEEecCC
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGS  183 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~--~~kl~Dfg~  183 (376)
                      +|+|||-+.| .|+..+..    ...+++.++.+++.+|+.||.+||. +||.||||||+|||...-+.  -+|||||.+
T Consensus       151 FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccc
Confidence            9999999996 66666554    4679999999999999999999999 89999999999999864232  489999988


Q ss_pred             ccccccC--------CCcceeeccccccChhhhh----CCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH--------
Q 017139          184 AKVLVKG--------EANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--------  243 (376)
Q Consensus       184 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--------  243 (376)
                      .......        ....+.+|+..|||||+..    ....|+.++|.||||+|+|-|++|.+||.++-..        
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            7543221        2234567888999999862    2345899999999999999999999999865211        


Q ss_pred             -------HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          244 -------DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       244 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                             ..+..|.+                 ..|.+|.   .     -+..+|.+++|+|+.+|..|+..|.++.++++
T Consensus       306 ~Cr~CQ~~LFesIQE-----------------GkYeFPd---k-----dWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQE-----------------GKYEFPD---K-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccHHHHHHHHHHHhc-----------------cCCcCCh---h-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                   11112211                 1122221   1     12357999999999999999999999999999


Q ss_pred             CCccccccCC
Q 017139          317 HPFFDELREP  326 (376)
Q Consensus       317 hp~~~~~~~~  326 (376)
                      |||++.+...
T Consensus       361 hPw~~~~~~e  370 (463)
T KOG0607|consen  361 HPWVQRCAPE  370 (463)
T ss_pred             Cccccccchh
Confidence            9999887554

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-42  Score=313.56  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=203.6

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..+|++.+.||+|+||.||+|.+..+++.+|+|.+....    ....+|+.+++.+.|+||+++++.+.     ....+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEE
Confidence            357999999999999999999999999999999886543    23346889999999999999999884     344589


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|...+..     ..+++..+..++.|++.||.|||+ .||+|+||||+||+++. ++.++|+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~~~  166 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI  166 (296)
T ss_pred             EeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEECccccchhc
Confidence            99999985 66665542     458899999999999999999999 79999999999999986 788999999998765


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+.. .+.+          
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~----------  234 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP----------  234 (296)
T ss_pred             cccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCC----------
Confidence            33221 2234678899999998654 478999999999999999999999987765443332221 0100          


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                     ....+..++..+.+++.+||..||++|||+.++++||||...
T Consensus       235 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         235 ---------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             ---------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                           001223578899999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-42  Score=310.67  Aligned_cols=252  Identities=29%  Similarity=0.517  Sum_probs=201.2

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      +|+..+.||+|+||.||+|.+..+++.+|+|++....          ....+|+.+++.++|+||+++++++     .+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            4888999999999999999999999999999886432          2334689999999999999999998     455


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++|+||+.| +|.+.+..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++..+||+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            568999999996 56665543    3568999999999999999999999 79999999999999986556799999999


Q ss_pred             ccccccCCC-----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          184 AKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +........     .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+.+....   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  226 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---  226 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence            876643321     1234568899999998654 4889999999999999999999999755433222222211000   


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                                           .....++..+++++.+++.+||..||++||++.++++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                 000113345789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=337.84  Aligned_cols=249  Identities=25%  Similarity=0.424  Sum_probs=199.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCC-CCCeeecce-eeeecCCCC-cee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMD-HPNVISLKH-CFFSTTSKD-ELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~-h~~Iv~~~~-~~~~~~~~~-~~~  106 (376)
                      -+++|.+.|.+|||+.||+|.+...|..||+|++....    ....+|+++|+.|+ |+|||.+++ ......+.. ...
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            46789999999999999999999888999999885442    33458999999997 999999999 443332333 467


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--ceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~--ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      +.|+||||. |+|.+++..+..  ..|++.++.+|++++++|+.+||.+ .  |||||||-|||||+. ++..||||||.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~-~g~~KLCDFGS  192 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSA-DGNYKLCDFGS  192 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcC-CCCEEeCcccc
Confidence            889999999 699999987765  4499999999999999999999994 6  999999999999996 78899999999


Q ss_pred             ccccccCCCc----------ceeeccccccChhhhh--CCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017139          184 AKVLVKGEAN----------ISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  251 (376)
Q Consensus       184 ~~~~~~~~~~----------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  251 (376)
                      +.........          ....-|+.|+|||.+.  .+..++.++|||+|||+||.|+....||........+    .
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----n  268 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----N  268 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----e
Confidence            8654333211          1234589999999973  3345899999999999999999999999765332111    1


Q ss_pred             hcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                       ..|.+|..          .+++..+++||..||+.||++||++-+++.+
T Consensus       269 -----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  269 -----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             -----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                             23334421          3578999999999999999999999887653

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-42  Score=309.66  Aligned_cols=278  Identities=35%  Similarity=0.622  Sum_probs=216.2

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhC---CCCCeeecceeeeecCCCCcee
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLM---DHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l---~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      |++.+.||+|+||.||+|++..+++.+|+|.+.....      ...+|+.+++.+   +||||+++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6889999999999999999998899999999864321      233577776665   5999999999986554434456


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++++|||++++|.+.+....  ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||.+..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~-~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEcc-CCCEEEeccCccee
Confidence            89999999988877665422  2358999999999999999999999 79999999999999997 68899999999887


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...........++..|+|||.+.+.. ++.++|+||+||++|+|++|.+||.+....+.+..+....+.+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            65544444456788899999997654 89999999999999999999999999888888888877666554433221110


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                       .....++......+.. ....+++.+.++|.+||+.||++||+++++++||||
T Consensus       236 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 -LPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             -cchhhcccccccchhh-hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence             0000111111111111 122467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.3e-42  Score=312.54  Aligned_cols=253  Identities=28%  Similarity=0.454  Sum_probs=204.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..+|++.+.||.|++|.||+|.+..+++.|++|.+.....    ...+|+.+++.++||||+++++.+     .....+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEE
Confidence            3579999999999999999999999999999998854322    234688999999999999999988     3445689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|+||+++ +|...+.     ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~~~  165 (296)
T cd06655          93 VVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQI  165 (296)
T ss_pred             EEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccchhc
Confidence            99999986 5544443     2468999999999999999999999 79999999999999986 788999999998765


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+... +.+.         
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------  234 (296)
T cd06655         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------  234 (296)
T ss_pred             ccccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc---------
Confidence            43322 2234578899999998654 4789999999999999999999999887765544433221 1100         


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                      ...+..+++.+.++|.+||..||++||++.+++.||||+...
T Consensus       235 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 ----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             ----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                            012235788999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-42  Score=309.42  Aligned_cols=250  Identities=29%  Similarity=0.479  Sum_probs=198.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .+|.+.+.||+|+||.||+|.+..++..||+|.+....         ....+|+.+++.++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            46999999999999999999999999999999875321         124468899999999999999988743   224


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++++||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~-~~~~~l~dfg~  152 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA  152 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCCC
Confidence            568899999985 66666643    3568899999999999999999999 79999999999999986 77899999999


Q ss_pred             ccccccCC----CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          184 AKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       184 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      +.......    ......++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.............     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-----  226 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-----  226 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-----
Confidence            87543211    11234568889999998764 489999999999999999999999987655444433221100     


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                                            ...++..+++.+++++ +||..||++||+++++++||||+
T Consensus       227 ----------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ----------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ----------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                  0112345688899999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-42  Score=309.40  Aligned_cols=246  Identities=31%  Similarity=0.533  Sum_probs=199.9

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+....             ....+|+.+++.++||||+++++++     
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS-----   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence            4889999999999999999999999999999885432             1234688999999999999999987     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+..+.+++|||+++ +|...+..    ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~-~~~~~l~d  149 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISD  149 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcC-CCCEEecc
Confidence            344558899999986 66666543    3568899999999999999999999 79999999999999986 78899999


Q ss_pred             cCCccccccCCC-------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017139          181 FGSAKVLVKGEA-------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL  253 (376)
Q Consensus       181 fg~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  253 (376)
                      ||.++.......       .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA  228 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence            999876642211       1123468889999998654 47899999999999999999999998766544433322200


Q ss_pred             CCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                                  ...++..++.++.++|.+||+.||.+||++.++++||||
T Consensus       229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                        011234578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.2e-42  Score=304.29  Aligned_cols=248  Identities=27%  Similarity=0.396  Sum_probs=203.7

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...      .....+|+++++.++||||+++++++     .+...+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence            488999999999999999999999999999988532      22334688899999999999999988     4455689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+...  ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~-~~~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeC-CCCEEEcccccceec
Confidence            99999985 776666542  24678999999999999999999999 79999999999999996 778999999998765


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+.....            
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  218 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------  218 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            44322 23446788999999987654 88999999999999999999999988776554444332110            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                      ..++..++.++.+++.+||+.+|++||++.+++.|||+
T Consensus       219 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 ----------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                            01223468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.5e-42  Score=314.23  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=204.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...+|++++.||+|+||.||+|.+..+++.||+|.+.....    ...+|+.+++.++|+||+++++++     .....+
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   91 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDEL   91 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEE
Confidence            34679999999999999999999999999999999864332    234688999999999999999988     445568


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+||||+++ +|.+.+..     ..+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++..
T Consensus        92 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~~  164 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ  164 (297)
T ss_pred             EEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEECcCccceE
Confidence            999999986 55555532     458899999999999999999999 79999999999999986 78899999999876


Q ss_pred             cccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ...... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+.......+.. .+.+         
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~---------  233 (297)
T cd06656         165 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP---------  233 (297)
T ss_pred             ccCCccCcCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC---------
Confidence            543322 2234678899999998654 478999999999999999999999977654332221111 0100         


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                      ....+..++..+.+++.+||..||++||+++++++||||+....
T Consensus       234 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         234 ----------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             ----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence                            01123357888999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.8e-42  Score=310.78  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=202.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCC-CCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTS-KDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~-~~~~~  106 (376)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|.+....   .....|+.+++.+ +|+||+++++++..... .....
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            3468999999999999999999999999999999885543   2334678888888 79999999998854322 23567


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|++|||+++ +|.+.+...  ....+++..++.++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~-~~~~~l~dfg~~~  169 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSA  169 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCcchh
Confidence            8999999986 666666542  23568899999999999999999999 79999999999999996 7789999999987


Q ss_pred             ccccC-CCcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          186 VLVKG-EANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       186 ~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ..... .......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||...........+... ..     
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~-----  243 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PP-----  243 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC-CC-----
Confidence            54322 22334567889999998753    234788999999999999999999999766544333222110 00     


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                           .......++.++.+||.+||..||.+|||+.+++.||||
T Consensus       244 ---------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 ---------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ---------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                 001123478899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.8e-42  Score=307.90  Aligned_cols=247  Identities=28%  Similarity=0.471  Sum_probs=198.5

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      +|++++.||.|+||.||+|.+ .+++.+|+|.+....          ....+|+++++.++|+||+++++++     .+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            588999999999999999986 578899999875432          2244689999999999999999988     445


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++++||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++. ++.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECC-CCeEEeccchh
Confidence            668999999986 66555543    3568999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccC-------CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          184 AKVLVKG-------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       184 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      +......       .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....+. 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence            8754221       111234578899999998654 4789999999999999999999999876654433332221110 


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                               ...++..++.++.++|.+||+.||++||++.++++||||
T Consensus       227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                     011334578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-42  Score=306.30  Aligned_cols=248  Identities=34%  Similarity=0.545  Sum_probs=202.8

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +|+..+.||+|+||.||+|.+..+++.|++|.+....         ....+|+.+++.++|+||+++++++     .+..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            4888999999999999999998899999999885432         2344689999999999999999987     4445


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+|+++||+++ +|.+.+..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||.+
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccc
Confidence            68999999986 66665543    3568899999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .............++..|+|||.+.....++.++|+|||||++|+|++|..||...........+......         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  220 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---------  220 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence            77654443445667889999999865434789999999999999999999999876644444332221000         


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                        ..++..+++++.+++.+||+.||++||++.+++.|||+
T Consensus       221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                              01234578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.7e-42  Score=314.05  Aligned_cols=263  Identities=24%  Similarity=0.357  Sum_probs=203.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|...+.||+|+||.||++.+..+++.+|+|.+....     ....+|+.++.++. |+||+++++++..     ....
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~   78 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDC   78 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcE
Confidence            45778899999999999999999999999999986432     22346888888885 9999999998743     3447


Q ss_pred             EEEeecccchHHHHHHhh-hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +++|||+++++..+.... ......+++..+..++.|++.||+|||+..+++||||||+||+++. ++.+||+|||++..
T Consensus        79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~  157 (288)
T cd06616          79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQ  157 (288)
T ss_pred             EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecchhHH
Confidence            899999997665544321 2234679999999999999999999997249999999999999996 77899999999876


Q ss_pred             cccCCCcceeeccccccChhhhhCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...........++..|+|||.+.+.  ..++.++|+||+||++|+|++|..||.....  ....+.+......       
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~-------  228 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP-------  228 (288)
T ss_pred             hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC-------
Confidence            5544444445678899999998765  3588999999999999999999999976542  1222222111000       


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                               +.+     ....+..++.++.+|+.+||+.||++|||+++++.||||+....
T Consensus       229 ---------~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         229 ---------PIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             ---------CcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence                     000     00112347889999999999999999999999999999987544

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4e-42  Score=307.18  Aligned_cols=246  Identities=30%  Similarity=0.502  Sum_probs=200.5

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        42 Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ||.|++|.||+|.+..+++.+|+|++....       ....+|+.+++.++||||+++++.+     .++..+|++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            699999999999999999999999986432       2344688999999999999999987     4445589999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCc
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN  193 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~  193 (376)
                      ++ +|.+.+..    ...+++..+..++.||+.||+|||+ +|++|+||+|+||+++. ++.++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCccccc
Confidence            85 66666654    3458999999999999999999999 79999999999999996 788999999999876554333


Q ss_pred             ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCHHHHhhcCcCCcCc
Q 017139          194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVLGTPTREEIRCMNPNYTDF  271 (376)
Q Consensus       194 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||....  .......+.....                 
T Consensus       150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  211 (262)
T cd05572         150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-----------------  211 (262)
T ss_pred             ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence            445678899999998654 48999999999999999999999998765  3333333321000                 


Q ss_pred             cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                ...++...+.++.++|.+||..||++|++     +.|+++||||+++++.
T Consensus       212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence                      01133345889999999999999999999     9999999999987654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.3e-42  Score=308.07  Aligned_cols=246  Identities=27%  Similarity=0.451  Sum_probs=203.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+.+..       ....+|++++++++||||+++++++     .+...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            5899999999999999999999999999999986432       2344689999999999999999888     556669


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++|+||+.| +|...+..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~-~~~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDE-QGHVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcC-CCCEEEeecccccc
Confidence            999999986 55555543    3578999999999999999999999 79999999999999996 78899999999887


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCHHHHhhc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.  .+.+......            
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence            65544444566788999999986644 89999999999999999999999987664  2222211110            


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH--HHHhCCCcc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA--LEACAHPFF  320 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~ell~hp~~  320 (376)
                                      ....++..++.++.++|.+||..||.+||+.  .|+++||||
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            0111334578999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5e-42  Score=309.98  Aligned_cols=253  Identities=25%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      -|++.+.||.|+||.||+|.+..++..+++|.+....    ....+|+++++.++||||+++++++.     .....++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence            4788999999999999999999999999999885432    22346889999999999999999884     34458899


Q ss_pred             eecccchHH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g~l~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||++++.+ ..+..   ....+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          81 IEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTR  155 (282)
T ss_pred             EEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcc-CCCEEEccccccccccc
Confidence            999997543 33332   23568999999999999999999999 79999999999999986 78899999999865433


Q ss_pred             CC-CcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          190 GE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       190 ~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .. ......++..|+|||++..    ...++.++|+||+||++|+|++|.+||...+.......+......         
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~---------  226 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP---------  226 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC---------
Confidence            21 2234567889999999742    234678999999999999999999999887765555444331100         


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                       ....+..++.++.++|.+||..||++||+++++++||||+..
T Consensus       227 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         227 -----------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             -----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                             001223568899999999999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.9e-42  Score=310.14  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=200.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+.....    ...+|+.+++.++||||+++++.+     .....+
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~   81 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKL   81 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEE
Confidence            34689999999999999999999999999999998865422    234688999999999999999988     344558


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~  155 (267)
T cd06645          82 WICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTD-NGHVKLADFGVSAQ  155 (267)
T ss_pred             EEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcceeeeE
Confidence            999999986 66665543    4579999999999999999999999 79999999999999996 77899999999865


Q ss_pred             cccCC-CcceeeccccccChhhhh--CCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          187 LVKGE-ANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       187 ~~~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ..... ......|+..|+|||.+.  ....++.++|+|||||++|+|++|..||..................        
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~--------  227 (267)
T cd06645         156 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ--------  227 (267)
T ss_pred             ccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC--------
Confidence            53322 223456889999999874  2234788999999999999999999999765543333222111000        


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                               .+..       .....++..+.++|.+||+.||++|||++++++|||
T Consensus       228 ---------~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         228 ---------PPKL-------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ---------CCcc-------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                     0000       001136788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.9e-42  Score=305.38  Aligned_cols=250  Identities=28%  Similarity=0.452  Sum_probs=202.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      ++|++.+.||+|+||.||+|....+++.+++|.+....  ....+|+++++.++||||+++++++.     ....+|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEEE
Confidence            57999999999999999999999889999999986543  34557999999999999999999884     445689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECC-CCcEEEcccccchhcccC
Confidence            99996 55555533   24678999999999999999999999 79999999999999996 778999999998866543


Q ss_pred             C-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          191 E-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       191 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      . ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+....                
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------  215 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP----------------  215 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC----------------
Confidence            3 22334578899999998665 48999999999999999999999998765443322211100                


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                         .+       ....+..++.++.++|.+||+.||++|||+.+++.||||
T Consensus       216 ---~~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 ---PP-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ---CC-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence               00       000123467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.9e-42  Score=309.25  Aligned_cols=251  Identities=28%  Similarity=0.409  Sum_probs=200.2

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        42 Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ||+|+||+||+|.+..+|+.||+|.+....       .....|+++++.++||||+++++.+     .....+|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999885421       1224689999999999999999888     4455689999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCc
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN  193 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~  193 (376)
                      ++ +|.+.+....  ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEccCcchhhhccCCcc
Confidence            95 6665655422  2468999999999999999999999 79999999999999996 778999999998765443333


Q ss_pred             ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccC
Q 017139          194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF  273 (376)
Q Consensus       194 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ....++..|+|||.+.+.. ++.++|+||+||++|+|++|..||...........+......                  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence            4456788899999987655 899999999999999999999999776542222222111000                  


Q ss_pred             CCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCCC
Q 017139          274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN  327 (376)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~~  327 (376)
                             ....++..+++++.++|.+||+.||++||     ++.++++||||..+++..
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence                   00113345789999999999999999999     899999999999887753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-42  Score=310.19  Aligned_cols=252  Identities=26%  Similarity=0.398  Sum_probs=198.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .++|++.+.||+|+||.||+|++..+++.+|+|++....    ....+|+.+++.++||||+++++.+.     ....++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence            457999999999999999999999999999999886432    23457899999999999999999884     344588


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+..    ...+++..+..++.|++.||+|||+ .||+|+||+|+||+++. ++.++|+|||++...
T Consensus        83 iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~  156 (267)
T cd06646          83 ICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTD-NGDVKLADFGVAAKI  156 (267)
T ss_pred             EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEECcCccceee
Confidence            99999996 56555543    3568999999999999999999999 79999999999999986 778999999998765


Q ss_pred             ccCC-CcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGE-ANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .... ......+++.|+|||.+..  ...++.++|+||+||++|+|++|..||...+.......+...            
T Consensus       157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------  224 (267)
T cd06646         157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------  224 (267)
T ss_pred             cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------------
Confidence            4322 2234567889999998742  233678999999999999999999999655433222111110            


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                           .+..+..       .....++..+.++|.+||+.||++|||++++++|+|
T Consensus       225 -----~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 -----NFQPPKL-------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -----CCCCCCC-------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                 0000000       011246889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-42  Score=305.95  Aligned_cols=253  Identities=28%  Similarity=0.418  Sum_probs=202.6

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .++|++.+.||.|+||.||+|.+..+++.+++|.+....    ....+|+++++.++||||+++++++     .+...+|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   76 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLW   76 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEE
Confidence            368999999999999999999999999999999986542    3345789999999999999999988     3445589


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|||+++ +|...+..   ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||.+...
T Consensus        77 l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~  151 (262)
T cd06613          77 IVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTE-DGDVKLADFGVSAQL  151 (262)
T ss_pred             EEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECC-CCCEEECccccchhh
Confidence            99999996 55444433   23578999999999999999999999 79999999999999996 788999999998765


Q ss_pred             ccCC-CcceeeccccccChhhhhCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .... ......++..|+|||.+.+.  ..++.++|+|||||++|+|++|.+||...+.......+....-.+.       
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  224 (262)
T cd06613         152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP-------  224 (262)
T ss_pred             hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------
Confidence            4332 22345678889999998654  1478899999999999999999999988765554443322100000       


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                                       .......++.++.+++.+||..||.+|||+.+++.|||
T Consensus       225 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 -----------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             -----------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                             00012245788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=324.30  Aligned_cols=248  Identities=31%  Similarity=0.467  Sum_probs=203.5

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHh-CCCCCeeecceeeeecCCCCceeE
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~-l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .+...++|.+...+|.|+|+.|-.+.+..+++.+++|++.+......+|+.++.. -+||||+++++.+     .+....
T Consensus       317 ~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~  391 (612)
T KOG0603|consen  317 TAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI  391 (612)
T ss_pred             cCCcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence            3346788999999999999999999999999999999998876666677765554 4799999999998     777789


Q ss_pred             EEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+|||.+.|+ +++-+.    ....+. ..+..|+.+|+.|+.|||+ +|++||||||+|||++.+.+.++|+|||.++.
T Consensus       392 ~~v~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             eeeehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            9999999975 222222    223333 6777899999999999999 79999999999999953478899999999986


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ....  ..+.+-|..|.|||++. ...|+.++||||||++||+|++|+.||......   .++..+++.+.         
T Consensus       466 ~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~---------  530 (612)
T KOG0603|consen  466 LERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK---------  530 (612)
T ss_pred             Cchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc---------
Confidence            6444  23345588899999997 456999999999999999999999999877665   33344433332         


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                        +...+|.+++|||++||++||.+|+++.+++.||||
T Consensus       531 ------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 ------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                              224689999999999999999999999999999999

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-41  Score=307.79  Aligned_cols=263  Identities=26%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....     ...+|+++++.++||||+++++++..   .....+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence            469999999999999999999999999999998865322     34579999999999999999998754   3344588


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~  155 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTR-KGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEec-CCeEEEeeccccccc
Confidence            99999985 6766665544456778999999999999999999999 79999999999999996 778999999998754


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCCCCHHHHh
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ..... ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.....     .+....+..    .....+ 
T Consensus       156 ~~~~~-~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~-  228 (287)
T cd06621         156 VNSLA-GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL-  228 (287)
T ss_pred             ccccc-ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-
Confidence            33221 234568889999998654 489999999999999999999999976521     111111111    000000 


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                 +   ..   .......++.+.++|.+||..||++|||+.|++.||||++...
T Consensus       229 -----------~---~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         229 -----------K---DE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             -----------c---cC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence                       0   00   0000124678999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-42  Score=337.14  Aligned_cols=284  Identities=19%  Similarity=0.275  Sum_probs=198.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCc-EEEEE------------------Eeccc---ccchHHHHHHHHhCCCCCee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGE-TVAIK------------------KVLQD---RRYKNRELQLMRLMDHPNVI   90 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~-~~aiK------------------~~~~~---~~~~~~e~~~l~~l~h~~Iv   90 (376)
                      .++|++.+.||+|+||+||+|..+.... ..+.|                  .+...   .....+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999987654322 22222                  11111   12235799999999999999


Q ss_pred             ecceeeeecCCCCceeEEEEeecccchHHHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee
Q 017139           91 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV  169 (376)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill  169 (376)
                      ++++++     ......|+|++++.+++...+.... ..........++.++.||+.||+|||+ +||+||||||+|||+
T Consensus       227 ~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            999998     3444588999999988877765422 112334567788999999999999999 799999999999999


Q ss_pred             cCCCCcEEEEecCCccccccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCC-CCC--CChHH
Q 017139          170 DPLTHQVKLCDFGSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPG--ENAVD  244 (376)
Q Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~--~~~~~  244 (376)
                      +. ++.+||+|||++........  .....|+..|+|||++.+. .++.++|||||||++|+|++|..+ |..  .....
T Consensus       301 ~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NC-DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CC-CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            96 78899999999986644322  2345789999999999765 489999999999999999998754 432  23445


Q ss_pred             HHHHHHHhcCCCCHHHHhh---cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          245 QLVEIIKVLGTPTREEIRC---MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                      .+.+++...+....+....   .........+...............++.++.++|.+||++||.+|||+.|+|+||||.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            5656555544322211000   0000000000000000000111124678899999999999999999999999999998


Q ss_pred             ccc
Q 017139          322 ELR  324 (376)
Q Consensus       322 ~~~  324 (376)
                      ...
T Consensus       459 ~~~  461 (501)
T PHA03210        459 AEE  461 (501)
T ss_pred             cCC
Confidence            754

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-41  Score=302.42  Aligned_cols=248  Identities=26%  Similarity=0.433  Sum_probs=204.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+....      ....+|+.+++.++||||+++.+++     .+....+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            5999999999999999999999999999999885431      2345689999999999999999988     5556789


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEEeeccceeec
Confidence            99999985 666665432  23467899999999999999999999 79999999999999996 778999999998765


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+..+....+....  .          
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------  218 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--Y----------  218 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--C----------
Confidence            43322 12345788899999986654 7899999999999999999999998777666655543311  0          


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                      ...+..++.++.++|.+||+.+|++||++.++++||||
T Consensus       219 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 ----------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ----------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                            00233568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=316.72  Aligned_cols=243  Identities=26%  Similarity=0.374  Sum_probs=200.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ..+.+++.||+|-||.||.|..+.+ ..||+|.+....   ....+|+++|+.|+|+|||++++++....     -+|||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIV  279 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIV  279 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEE
Confidence            3456688999999999999998543 378999886532   33458999999999999999999984333     48999


Q ss_pred             eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||++ |+|+++|+.  ..+..+...+...++.||++|++||++ +++|||||...|||++. +..+||+|||+|+...+
T Consensus       280 tE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDE-DLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeecc-CceEEEcccccccccCC
Confidence            99999 788888886  346779999999999999999999999 79999999999999996 88999999999995433


Q ss_pred             CCCcce--eeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          190 GEANIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       190 ~~~~~~--~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      +.-...  ..-..-|.|||.+... .++.+||||||||+||||+| |+.||.+.+..+.+..+.+...            
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR------------  422 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR------------  422 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc------------
Confidence            322111  1225569999999765 49999999999999999998 9999999999888887765322            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                            .|          -|...|+++-+++..||..+|++|||.+.+.
T Consensus       423 ------lp----------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  423 ------LP----------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             ------CC----------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                  22          2456899999999999999999999998653

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.6e-42  Score=311.74  Aligned_cols=255  Identities=28%  Similarity=0.415  Sum_probs=203.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      +.|.....||.|+||.||++.+..+++.||||.+....    ....+|+.+++.++|+||+++++.+     ......|+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEE
Confidence            45666788999999999999999999999999885432    2344688999999999999999988     34455899


Q ss_pred             Eeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      ||||++++ |.+.+.     ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus        97 v~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~~  169 (292)
T cd06658          97 VMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVS  169 (292)
T ss_pred             EEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccCcchhhcc
Confidence            99999874 444332     2468999999999999999999999 79999999999999996 7889999999987543


Q ss_pred             cCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......+........          
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  238 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV----------  238 (292)
T ss_pred             cccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----------
Confidence            222 22345678999999998654 489999999999999999999999987766554443332111000          


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                                      .....++..+.+++.+||..||++|||++++++||||+....+.
T Consensus       239 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         239 ----------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             ----------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence                            01124688999999999999999999999999999999766554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-41  Score=304.76  Aligned_cols=250  Identities=30%  Similarity=0.483  Sum_probs=198.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .+|++.+.||+|+||.||.|.+..+++.||+|.+....         ....+|+.+++.+.||||+++++++..   ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence            46999999999999999999999999999999875321         123468999999999999999987632   223


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..++++|||+++ +|.+.+..    ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~Dfg~  152 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGA  152 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecC-CCCEEECcCcc
Confidence            468899999985 66655543    3458899999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCC----CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          184 AKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       184 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      +.......    ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+......+...   .+.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--  226 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--  226 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC--
Confidence            87543211    12234578899999998764 489999999999999999999999987655444433221   110  


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                                            ....+..++..+.++|.+|+. +|++||+++++++|||+.
T Consensus       227 ----------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ----------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ----------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                  111334568889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-41  Score=301.47  Aligned_cols=248  Identities=33%  Similarity=0.506  Sum_probs=205.5

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||.|+||.||.+++..+++.+++|.+....      ....+|+++++.++|+||+++++++     .+...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence            5999999999999999999999999999999875432      2344799999999999999999998     4445689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++||||++ +|.+.+....  ...+++..+..++.|++.+|.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTK-AGLIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeC-CCCEEECcCcceEEc
Confidence            99999985 7776665422  3568999999999999999999999 79999999999999996 778999999998765


Q ss_pred             ccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .... ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+..+....+...  ...         
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------  219 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT---------  219 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence            4433 223456789999999987654 789999999999999999999999887766666555431  110         


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                       ..+..++.++.+++.+||..||++||++.++++|||+
T Consensus       220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                             0113468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=321.83  Aligned_cols=258  Identities=25%  Similarity=0.411  Sum_probs=227.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..+..++..||-|+||.|=+++.+.....+|+|++++...       ....|..+|.....|+||++|..|     .++.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k  493 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK  493 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence            3467788899999999999998877666799998865432       223588999999999999999999     8899


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ++|++||-|-| .++..+..    .+.|++...+.++..++.|++|||+ +||++|||||+|++++. +|-+||.|||+|
T Consensus       494 yvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~-~Gy~KLVDFGFA  567 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDN-RGYLKLVDFGFA  567 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeecc-CCceEEeehhhH
Confidence            99999999975 67777765    5789999999999999999999999 89999999999999996 888999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +....+....+++|||.|.|||+++... .+.++|.||||+++|||++|.+||.+.++...+..|++.+..         
T Consensus       568 Kki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------  637 (732)
T KOG0614|consen  568 KKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------  637 (732)
T ss_pred             HHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---------
Confidence            9999999999999999999999998765 899999999999999999999999999999999988874221         


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCCCCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNAR  329 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~~~~  329 (376)
                                        ..+|+.++..+.+||+++...+|.+|..     +.++..|-||...+|...+
T Consensus       638 ------------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr  689 (732)
T KOG0614|consen  638 ------------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR  689 (732)
T ss_pred             ------------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence                              1156789999999999999999999986     7899999999999987533

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-41  Score=311.06  Aligned_cols=255  Identities=29%  Similarity=0.479  Sum_probs=204.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||++.+..+++.|++|.+....       ....+|+++++.++||||+++++.+     ..+..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            46999999999999999999999999999999886542       1233688999999999999999887     44556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +++||||++| +|.+.+..    ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||+++
T Consensus        76 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~-~~~~~l~dfg~~~  149 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSK  149 (305)
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECC-CCCEEEeeCCCcc
Confidence            8999999986 66666543    3568999999999999999999999 79999999999999986 7889999999886


Q ss_pred             ccccCC----------------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017139          186 VLVKGE----------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI  249 (376)
Q Consensus       186 ~~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~  249 (376)
                      ......                ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~  228 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV  228 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            421100                01123467789999998654 4899999999999999999999999887766555544


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC---HHHHhCCCccccccCC
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP  326 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~~~~~~~~  326 (376)
                      ......                 .+.         ....++.++.++|.+||..||++||+   +.++++||||...++.
T Consensus       229 ~~~~~~-----------------~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         229 ISDDIE-----------------WPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             HhcccC-----------------CCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence            331100                 000         11246889999999999999999998   7899999999876654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=300.14  Aligned_cols=292  Identities=33%  Similarity=0.554  Sum_probs=231.3

Q ss_pred             CCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        28 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      -+|...-+.+-.+.||.|+||.||.+.+..+|+.||+|++..-.      +..-+|.++|..++|.|++...++.-...-
T Consensus        47 h~Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~  126 (449)
T KOG0664|consen   47 HPPQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP  126 (449)
T ss_pred             CCccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence            34555666777899999999999999999999999999985432      233479999999999999998887632221


Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .-...+|+++|.+..+|...+    -..+.++.+.++-+++||+.||+|||+ .+|.||||||.|.|+++ +..+|||||
T Consensus       127 dfFqEiYV~TELmQSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNS-NCvLKICDF  200 (449)
T KOG0664|consen  127 SFFQELYVLTELMQSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNS-NCILKICDF  200 (449)
T ss_pred             hHHHHHHHHHHHHHhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEecc-CceEEeccc
Confidence            112236788888876654444    346889999999999999999999999 79999999999999997 889999999


Q ss_pred             CCccccccCCCc--ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          182 GSAKVLVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       182 g~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      |+++....+...  +..+.|.+|+|||++.+...|+.+.||||.|||+.||+..+..|...++.+++..|.+.+|+|+-+
T Consensus       201 GLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E  280 (449)
T KOG0664|consen  201 GLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE  280 (449)
T ss_pred             ccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence            999987554432  334569999999999999899999999999999999999999999999999999999999999999


Q ss_pred             HHhhcCcCCcCccCCCCCCCCccccc-----ccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVF-----HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      .+....++........-...+-...+     +..-..+..+++.++|.+||++|++.++++.|++..+.+.
T Consensus       281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence            88754443322211111111111111     1234457889999999999999999999999999977643

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=320.36  Aligned_cols=236  Identities=27%  Similarity=0.425  Sum_probs=202.3

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeeccc-ch
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ET  117 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~  117 (376)
                      ++-||+|+.|.||+++.  .++.||||++..   ..+.+++-|+.|+||||+.+.+++     .....+|||||||. |-
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            45699999999999987  678999997743   345689999999999999999999     55666999999999 67


Q ss_pred             HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCcceee
Q 017139          118 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI  197 (376)
Q Consensus       118 l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  197 (376)
                      |+..|+.    +..++......|..+|+.|+.|||. +.|||||||.-||||.. +..|||+|||.++...+.....+++
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISY-DDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeec-cceEEeccccchHhhhhhhhhhhhh
Confidence            8887775    6789999999999999999999999 79999999999999996 7789999999999887777778899


Q ss_pred             ccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCC
Q 017139          198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK  277 (376)
Q Consensus       198 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ||..|||||++... .++.++|||||||+||||+||..||.+.+....+    -..                       .
T Consensus       273 GTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGV-----------------------G  324 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGV-----------------------G  324 (904)
T ss_pred             hhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeE----Eec-----------------------c
Confidence            99999999999765 4999999999999999999999999876543221    111                       2


Q ss_pred             CCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCC
Q 017139          278 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP  318 (376)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  318 (376)
                      ...++...|...+..++-||++||.-.|..||+..++|.|-
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            22334446677899999999999999999999999999884

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-41  Score=307.28  Aligned_cols=247  Identities=26%  Similarity=0.379  Sum_probs=191.3

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHH---hCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMR---LMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~---~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .||+|+||.||+|.+..+++.+|+|.+.+...       ...+|..+++   ...||||+.+++.+     .....+++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence            48999999999999999999999998854321       1123333333   34799999998888     334458899


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+++ +|...+..    ...+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECC-CCCEEEccCCcceeccc
Confidence            999996 55544443    4569999999999999999999999 79999999999999996 77899999999865433


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .. .....++..|+|||.+.+...++.++|+||+||++|+|++|..||......  .........               
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------  213 (279)
T cd05633         150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------  213 (279)
T ss_pred             cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc---------------
Confidence            22 233468999999999865455789999999999999999999999754322  111111100               


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCCC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN  327 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~~  327 (376)
                                   ....++..++.++.++|.+||..||++|+     |+.++++||||+.+++..
T Consensus       214 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         214 -------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             -------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence                         01113445789999999999999999999     699999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1e-41  Score=304.96  Aligned_cols=251  Identities=30%  Similarity=0.507  Sum_probs=201.4

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+.....     ...+|+++++.++||||+++++.+     .....++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence            468999999999999999999999999999998865432     234688999999999999999988     4446689


Q ss_pred             EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +++||++ ++|.+.+...   ...+++..+..++.|++.||+|||+..|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~  151 (265)
T cd06605          76 ICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQL  151 (265)
T ss_pred             EEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccchhh
Confidence            9999999 4776666542   2678999999999999999999999239999999999999996 778999999998765


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCCHHHHh
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ...... ...++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+     ..+....+...   ..     
T Consensus       152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~-----  221 (265)
T cd06605         152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PP-----  221 (265)
T ss_pred             HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CC-----
Confidence            332222 26678899999998665 58999999999999999999999997652     11222221110   00     


Q ss_pred             hcCcCCcCccCCCCCCCCccccccc-CCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                 +         ..+. .++.++.++|.+||..||++|||+.+++.||||+.+
T Consensus       222 -----------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         222 -----------P---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             -----------C---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                       0         0111 268899999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-41  Score=303.73  Aligned_cols=252  Identities=31%  Similarity=0.535  Sum_probs=199.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--------------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+....              ....+|+.+++.++||||+++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            5999999999999999999999999999999874311              1234688999999999999999987    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                       .....+++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~  150 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDA-DGICKIS  150 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcC-CCeEEEe
Confidence             444568899999985 66665544    3578999999999999999999999 79999999999999996 7889999


Q ss_pred             ecCCccccccCC---CcceeeccccccChhhhhCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          180 DFGSAKVLVKGE---ANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       180 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      |||++.......   ......++..|+|||.+.... .++.++|+||||+++|++++|..||...+.......+......
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  230 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA  230 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence            999987653321   122345688899999986543 3788999999999999999999999765544333322111000


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                             ..+.......++.++.++|.+||..||++|||++++++||||
T Consensus       231 -----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         231 -----------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -----------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                   000111223468999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=303.36  Aligned_cols=246  Identities=33%  Similarity=0.526  Sum_probs=195.0

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHH-HHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~-~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||.|+||.||+|.+..+++.||+|.+.....       ....|.. +....+|+||+++++++     ..+..+|+|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            579999999999999999999999999864321       1122333 33455899999999988     4455689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEeecccceeccc-
Confidence            99986 66655543    3568999999999999999999999 79999999999999996 77899999999875433 


Q ss_pred             CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          191 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       191 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                        .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+......               
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------  211 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN---------------  211 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC---------------
Confidence              22345788899999987654 899999999999999999999999887765554443321000               


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC---HHHHhCCCccccccC
Q 017139          271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELRE  325 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~~~~~~~  325 (376)
                                +.......++.++.++|.+||+.||++||+   ++|++.||||++++|
T Consensus       212 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         212 ----------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ----------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence                      011122347899999999999999999995   579999999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.6e-41  Score=309.14  Aligned_cols=250  Identities=30%  Similarity=0.452  Sum_probs=202.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+++++.++||||+++++++..     ...
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence            46999999999999999999999999999999885432       123468899999999999999999843     344


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      .|+||||+.|++.+.+...   ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++..
T Consensus        90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~-~~~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTE-PGTVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECC-CCCEEEeecCccee
Confidence            8899999999877766532   3468999999999999999999999 79999999999999996 78899999999875


Q ss_pred             cccCCCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          187 LVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....   ....+++.|+|||.+.+  ...++.++|+||||+++|+|++|..||.+.+.......+... ..+        
T Consensus       165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~--------  232 (307)
T cd06607         165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP--------  232 (307)
T ss_pred             cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCC--------
Confidence            4322   24567889999998742  234788999999999999999999999877655544332211 000        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                .        ......+.++.++|.+||..||++||++.+++.||||..-
T Consensus       233 ----------~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         233 ----------T--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             ----------C--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                      0        0112357889999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.1e-41  Score=302.40  Aligned_cols=249  Identities=27%  Similarity=0.374  Sum_probs=193.3

Q ss_pred             ccceEeeeee--ccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVV--GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~L--g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|.+.+.+  |+|+||.||++.+..+++.+|+|.+....... .|......+ +||||+++++++.     ....+|+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~i   86 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-IEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVL   86 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-hhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEE
Confidence            3467777666  99999999999999999999999986543221 233333323 7999999999983     3446899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      ||||+++ +|.+.+..    +..+++..++.++.|++.||.|||+ .|++||||+|+||+++.+++.++|+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         87 IMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            9999985 77666654    3479999999999999999999999 7999999999999999744389999999987653


Q ss_pred             cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ..   ....++..|+|||++.+.. ++.++|+||+||++|+|++|..||........ ...+......            
T Consensus       162 ~~---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------  225 (267)
T PHA03390        162 TP---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------------  225 (267)
T ss_pred             CC---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc------------
Confidence            22   2346788999999997654 89999999999999999999999985543321 1111111100            


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-HHHHhCCCcccc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDE  322 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~ell~hp~~~~  322 (376)
                                    .....+.+++.+.+||.+||+.||.+|++ .+++|+||||++
T Consensus       226 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        226 --------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                          00122357999999999999999999996 599999999963

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-41  Score=318.01  Aligned_cols=249  Identities=22%  Similarity=0.332  Sum_probs=192.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC-----CcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      .++|.+.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.+ +|+||+++++++     
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-----  111 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-----  111 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence            45899999999999999999986543     3579999986542     2234699999999 899999999988     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSS-----------------------------------------------------  127 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~-----------------------------------------------------  127 (376)
                      .....+++|||||++ +|.+.+.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            444558999999984 77766643210                                                     


Q ss_pred             -------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCc-
Q 017139          128 -------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-  193 (376)
Q Consensus       128 -------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~-  193 (376)
                                   ...++++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++........ 
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeC-CCeEEEeeceeeeeccCCccee
Confidence                         12357889999999999999999999 79999999999999995 788999999998765433221 


Q ss_pred             --ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          194 --ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       194 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                        ....++..|+|||++.+. .++.++|||||||++|+|++ |..||..................               
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~---------------  333 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ---------------  333 (374)
T ss_pred             eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC---------------
Confidence              112235679999998654 48999999999999999997 99999876544433333321000               


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                  ...+..+++++.+++.+||+.||++|||+.++++
T Consensus       334 ------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         334 ------------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ------------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        0022346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.8e-41  Score=299.80  Aligned_cols=249  Identities=28%  Similarity=0.436  Sum_probs=202.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||.|+||.||+|.++.+|..+|+|.+...      .....+|+.+++.++|+||+++++.+     .....++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            589999999999999999999999999999998543      22345799999999999999999988     4555689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|+||+++ +|.+.+...  ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++..+||+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999985 666666432  23457999999999999999999999 799999999999999875566899999998765


Q ss_pred             ccCCCc-ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...... ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            433221 234578889999988654 48899999999999999999999998776555444332210             


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                            .         ......++.++.++|.+||..+|++|||+.++++||||
T Consensus       219 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  0         00123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.1e-42  Score=309.11  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=201.4

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +.|...+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++     .++..+|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceE
Confidence            45888899999999999999999999999999886432     2345799999999999999999988     4455689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+.     ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~  151 (277)
T cd06642          79 IIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSE-QGDVKLADFGVAGQL  151 (277)
T ss_pred             EEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeC-CCCEEEccccccccc
Confidence            99999996 5544443     2568999999999999999999999 79999999999999986 788999999998765


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...              
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------  216 (277)
T cd06642         152 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------  216 (277)
T ss_pred             cCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------------
Confidence            43322 2234578889999998665 4889999999999999999999999765543333221110              


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                    ....+...++.++.++|.+||..+|++||++.++++||||..+.
T Consensus       217 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 --------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             --------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                          00012234678999999999999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.4e-41  Score=304.90  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=193.1

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEecccccc-------hHHHH---HHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNREL---QLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~e~---~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .||+|+||.||+|.+..+++.||+|.+.+....       ...|.   .+++...||||+.+++++     .+...+|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            489999999999999999999999988653211       11232   344456899999998888     445568999


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+.| +|...+.    ....+++..++.++.|++.||.|||+ .+++||||||+||+++. ++.++|+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECC-CCCEEEccCcCccccCc
Confidence            999986 4444443    24679999999999999999999999 79999999999999996 77899999999875433


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCCHHHHhhcCcC
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      . ......|+..|+|||.+.+...++.++|+||+||++|+|++|..||........  .......               
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  213 (278)
T cd05606         150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------  213 (278)
T ss_pred             c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc---------------
Confidence            2 223456899999999987554588999999999999999999999987632211  1111100               


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCCC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN  327 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~~  327 (376)
                                   ....++..++.++.+++.+||..||++|+     ++.++++||||+...+..
T Consensus       214 -------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         214 -------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             -------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence                         00113345689999999999999999999     999999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2e-41  Score=305.24  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=202.1

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..|+..+.||.|+||.||+|.+..+++.+|+|.+....     ....+|+.+++.++||||+++++++     .++..+|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEE
Confidence            35888999999999999999999999999999886432     2344688999999999999999998     4455699


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||++| +|.+.+..     ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++. ++.++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~~~  151 (277)
T cd06640          79 IIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSE-QGDVKLADFGVAGQL  151 (277)
T ss_pred             EEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcC-CCCEEEcccccceec
Confidence            99999986 66555542     468899999999999999999999 79999999999999996 778999999998765


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... .            
T Consensus       152 ~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~------------  217 (277)
T cd06640         152 TDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-N------------  217 (277)
T ss_pred             cCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-C------------
Confidence            43322 2234568889999998655 4799999999999999999999999876654433222110 0            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                     ...+...++..+.+++.+||..||++||+++++++||||...
T Consensus       218 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         218 ---------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             ---------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence                           001223467889999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.3e-41  Score=299.52  Aligned_cols=251  Identities=31%  Similarity=0.489  Sum_probs=205.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ++|.+.+.||.|++|.||+|.+..+++.|++|++....     .....|+..+..++|+||+++++++     .....++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEE
Confidence            36899999999999999999999999999999986653     2345788999999999999999988     4445689


Q ss_pred             EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-CCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          109 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       109 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +||||++ ++|.+.+..    ...+++..++.++.|++.||.|||+ . |++|+||+|+||+++. ++.++|+|||.+..
T Consensus        76 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~-~~~~~l~df~~~~~  149 (264)
T cd06623          76 IVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINS-KGEVKIADFGISKV  149 (264)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECC-CCCEEEccCcccee
Confidence            9999999 466666654    3678999999999999999999998 6 9999999999999996 78899999999887


Q ss_pred             cccCCCcc-eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCHHHHh
Q 017139          187 LVKGEANI-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       187 ~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ........ ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+   ..+....+... ..       
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~-------  220 (264)
T cd06623         150 LENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PP-------  220 (264)
T ss_pred             cccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-CC-------
Confidence            65443332 45678899999998665 58899999999999999999999997764   22222222210 00       


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccC-CChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                          ...+.. ++..+.++|.+||..+|++||++.++++||||+..+
T Consensus       221 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 --------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             --------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                                001223 688999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=6.7e-43  Score=315.74  Aligned_cols=282  Identities=32%  Similarity=0.534  Sum_probs=228.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCC------CCCeeecceeeeecCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMD------HPNVISLKHCFFSTTSK  102 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~------h~~Iv~~~~~~~~~~~~  102 (376)
                      .-.+|.+....|+|-|++|.+|.+..-|+.||||++.....   .-.+|+++|+.|+      .-|+++++..|     .
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~  504 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----K  504 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----h
Confidence            33689999999999999999999999999999999977643   3347999999996      35889998888     6


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...++|+|+|.+.-+|.++|+.+.. +-.|....++.++.|++.||..|.. .||+|.||||+|||++.....+||||||
T Consensus       505 hknHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hcceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCc
Confidence            6677999999999999999998754 5678999999999999999999999 6999999999999999888899999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      .|.....+. .+.+..+.+|+|||+++|-. |+...|+||+||+||||.||+..|+|.++-+++...+..-|..+...+.
T Consensus       583 SA~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  583 SASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            998765444 34667788999999999875 9999999999999999999999999999999999999999988876664


Q ss_pred             hc-------CcCCc--CccCCCC----CCCCcccccc-----------cCCC-------hhHHHHHHhhcCCCCCCCCCH
Q 017139          263 CM-------NPNYT--DFRFPQI----KAHPWHKVFH-----------KRMP-------PEAIDLASRLLQYSPSLRCTA  311 (376)
Q Consensus       263 ~~-------~~~~~--~~~~~~~----~~~~~~~~~~-----------~~~~-------~~~~~li~~~L~~dP~~R~t~  311 (376)
                      ..       ....+  ......+    ....+..+-|           ..++       ..+++||.+||..||++|.|+
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            21       11110  0000000    0000000000           0122       358899999999999999999


Q ss_pred             HHHhCCCcccc
Q 017139          312 LEACAHPFFDE  322 (376)
Q Consensus       312 ~ell~hp~~~~  322 (376)
                      .++|.||||+.
T Consensus       741 nqAL~HpFi~~  751 (752)
T KOG0670|consen  741 NQALKHPFITE  751 (752)
T ss_pred             HHHhcCCcccC
Confidence            99999999974

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.5e-41  Score=298.03  Aligned_cols=250  Identities=30%  Similarity=0.462  Sum_probs=207.0

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||.|+||.||+|.+..+++.+++|++.....      ...+|+++++.++|||++++.+.+.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence            58999999999999999999999999999999865432      3446899999999999999999884     335688


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|+|++++ +|...+......+..+++..+..++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~-~~~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcC-CCcEEECCccceeec
Confidence            99999986 7777776644345789999999999999999999999 79999999999999996 788999999998766


Q ss_pred             ccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .... ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.............            
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  220 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------  220 (258)
T ss_pred             ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------
Confidence            4443 223456788999999986654 88999999999999999999999987765544444332110            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                      ..++..++.++.+++.+||..||++|||+.++|+||||
T Consensus       221 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         221 ----------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                            01223578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.4e-41  Score=303.79  Aligned_cols=240  Identities=17%  Similarity=0.197  Sum_probs=192.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      ..+|+|+++.||+|..  +|+.||+|.+....       ....+|+.++++++||||+++++++.... .+...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5799999999999987  78999999986542       22347999999999999999999885421 22345889999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCC
Q 017139          113 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE  191 (376)
Q Consensus       113 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~  191 (376)
                      ||++ +|.+.+..    ...+++.....++.|++.||.|||+..+++||||||+||+++. ++.+||+|||+++..... 
T Consensus       103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKIICHGLEKILSSP-  176 (283)
T ss_pred             eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEcccchHhhhccc-
Confidence            9996 56666543    4568899999999999999999997338999999999999996 788999999998765332 


Q ss_pred             CcceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          192 ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       192 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                       .....++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......+.             
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------  242 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK-------------  242 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Confidence             2345678899999998652 3589999999999999999999999998877666555443211110             


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                    ++...++++.+++.+||+.||++|||++++++
T Consensus       243 --------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 --------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             --------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                          22346889999999999999999999999874

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.9e-41  Score=315.19  Aligned_cols=249  Identities=22%  Similarity=0.335  Sum_probs=193.2

Q ss_pred             cceEeeeeeccCCceEEEEEEE-----cCCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           34 ISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|++....     ....+|+.+++.+ +||||+++++++     .
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----~  109 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----T  109 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----c
Confidence            4899999999999999999974     3456789999986432     2234699999999 899999999988     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhh------------------------------------------------------
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSS------------------------------------------------------  127 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~------------------------------------------------------  127 (376)
                      +....++|||||++ +|.+.+.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            44558899999994 77777654211                                                      


Q ss_pred             -----------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          128 -----------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       128 -----------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                                       ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEEC-CCcEEEecCccceeccCc
Confidence                             12357888999999999999999999 79999999999999996 778999999998765433


Q ss_pred             CCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          191 EAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       191 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...   ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||..........+.+.....           
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  335 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR-----------  335 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc-----------
Confidence            221   122335679999999765 48999999999999999998 89999876554444333321000           


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                      ...+...+.++.+++.+||+.||++|||+.++++.
T Consensus       336 ----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 ----------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                            00123457899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.2e-41  Score=306.68  Aligned_cols=253  Identities=20%  Similarity=0.260  Sum_probs=191.7

Q ss_pred             cceEeeeeeccCCceEEEEEEEcC----------------CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeec
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISL   92 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~   92 (376)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|.+....     ....+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            579999999999999999998642                34479999886532     234479999999999999999


Q ss_pred             ceeeeecCCCCceeEEEEeecccc-hHHHHHHhhhh---------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 017139           93 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS---------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPG  156 (376)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~---------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~  156 (376)
                      ++++.     +...+++||||+.+ +|.+.+.....               ....+++..++.++.||+.||.|||+ +|
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~  158 (304)
T cd05096          85 LGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN  158 (304)
T ss_pred             EEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence            99884     33448999999985 77776654211               11346788899999999999999999 79


Q ss_pred             ceeccCCCCCeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-
Q 017139          157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-  232 (376)
Q Consensus       157 ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-  232 (376)
                      |+||||||+|||++. ++.+||+|||+++.......   .....++..|+|||++.+. .++.++|+|||||++|+|++ 
T Consensus       159 ivH~dlkp~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 FVHRDLATRNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccccCcchhheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHc
Confidence            999999999999996 78899999999876533221   1123346789999998765 48999999999999999987 


Q ss_pred             -CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH
Q 017139          233 -GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA  311 (376)
Q Consensus       233 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  311 (376)
                       +..||...+..+....+.........                     ......+...+..+.+++.+||..||++|||+
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGR---------------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhccc---------------------cccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence             56788877665554443321110000                     00001123468899999999999999999999


Q ss_pred             HHHh
Q 017139          312 LEAC  315 (376)
Q Consensus       312 ~ell  315 (376)
                      +++.
T Consensus       296 ~~i~  299 (304)
T cd05096         296 SDIH  299 (304)
T ss_pred             HHHH
Confidence            9984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.2e-41  Score=306.16  Aligned_cols=254  Identities=28%  Similarity=0.451  Sum_probs=202.7

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ..|.....||.|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++++.     .+..+|+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~i   95 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWV   95 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEE
Confidence            34556678999999999999999999999999985422    23446889999999999999999883     3455899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||+++ +|...+.     ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++....
T Consensus        96 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~~  168 (297)
T cd06659          96 LMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQIS  168 (297)
T ss_pred             EEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEcc-CCcEEEeechhHhhcc
Confidence            9999996 5544432     2568999999999999999999999 79999999999999996 7889999999987543


Q ss_pred             cCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+.+..+...   +.          
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~----------  234 (297)
T cd06659         169 KDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP----------  234 (297)
T ss_pred             cccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC----------
Confidence            322 22345678999999998664 4899999999999999999999999877665554433211   00          


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                            +       .......++.++.++|.+||+.||++||+++++++||||.+...+
T Consensus       235 ------~-------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         235 ------P-------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             ------C-------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence                  0       000123468899999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.8e-41  Score=304.70  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=203.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ..++|.+.+.||+|+||.||++.+..++..+|+|.+.....    ....|+.+++.++||||+++++.+.     .....
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~   91 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDEL   91 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcE
Confidence            34789999999999999999999988999999998854322    2346888999999999999999884     34458


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+|+||+++ +|.+.+..     ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++..
T Consensus        92 ~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~~  164 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ  164 (293)
T ss_pred             EEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcC-CCCEEEccCcceec
Confidence            899999985 66555543     457889999999999999999999 79999999999999996 77899999998865


Q ss_pred             cccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ...... .....+++.|+|||.+.+. .++.++|+|||||++|++++|..||...+.......+.. .+.+         
T Consensus       165 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~---------  233 (293)
T cd06647         165 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP---------  233 (293)
T ss_pred             ccccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC---------
Confidence            543322 2234578889999998654 478999999999999999999999987665433322111 0000         


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                      ....+..++..+.++|.+||..||++||++.+++.||||+..+.
T Consensus       234 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         234 ----------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             ----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence                            00012346789999999999999999999999999999987553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.2e-41  Score=297.51  Aligned_cols=245  Identities=28%  Similarity=0.452  Sum_probs=199.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+....     .....|+.+++.++|+||+++++.+     .+...+|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            5899999999999999999999999999999875322     2334688899999999999999988     45556899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||+++ ++.+.+...  ....+++..++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQ-NGKVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECC-CCcEEEcccCcceeec
Confidence            9999985 666655432  24568999999999999999999999 79999999999999986 7889999999987654


Q ss_pred             cCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.....             
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  217 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-------------  217 (255)
T ss_pred             ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-------------
Confidence            3322 2345678899999998664 489999999999999999999999987765554444332100             


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                     ..++..++..+.++|.+||+.||++|||+.++++-
T Consensus       218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                           01233568899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=301.74  Aligned_cols=251  Identities=28%  Similarity=0.477  Sum_probs=200.6

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCC---CCCeeecceeeeecCCCCcee
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~---h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .|.+.+.||.|+||.||+|.+..+++.+|+|.+....     ....+|+.+++.+.   |||++++++++     .++..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence            4888999999999999999999999999999885432     23446888888886   99999999987     34456


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+||||+++ +|.+.+..     ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTN-TGNVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcC-CCCEEEccCCcee
Confidence            8999999986 55554432     368999999999999999999999 79999999999999996 8889999999987


Q ss_pred             ccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....... .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------  217 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------  217 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence            6644332 234467889999999876555789999999999999999999999876543322111100            


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                             ..+.        .....++.++.+++.+||..||++||++.+++.||||++..
T Consensus       218 -------~~~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         218 -------KPPR--------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             -------CCCC--------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                   0000        01113678999999999999999999999999999997643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.7e-40  Score=301.02  Aligned_cols=258  Identities=24%  Similarity=0.322  Sum_probs=199.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+.....     ...+|..+++.++||||+++++++     
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----   78 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-----   78 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            45789999999999999999997652     345799998764432     233588899999999999999987     


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSSM------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH  174 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~  174 (376)
                      .+....|+||||++ |+|.+.+......      ...++...+..++.|++.||.|||+ +|++||||||+||+++. ++
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~-~~  156 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DF  156 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcC-CC
Confidence            33445889999998 5777777653211      2345677888999999999999999 79999999999999996 78


Q ss_pred             cEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017139          175 QVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII  250 (376)
Q Consensus       175 ~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  250 (376)
                      .++|+|||+++.......   .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            899999999875433221   11223466799999986544 8999999999999999998 789998876655444332


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC------CCcccccc
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDELR  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~------hp~~~~~~  324 (376)
                      .. +.+                           ..+...++.+.+++.+||+.||++|||+.++++      ||||+.+.
T Consensus       236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         236 DG-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             cC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            21 000                           012345789999999999999999999999976      99998875


Q ss_pred             C
Q 017139          325 E  325 (376)
Q Consensus       325 ~  325 (376)
                      +
T Consensus       288 ~  288 (288)
T cd05061         288 F  288 (288)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.8e-40  Score=304.30  Aligned_cols=250  Identities=30%  Similarity=0.449  Sum_probs=202.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +.|...+.||+|+||.||+|++..+++.+++|++....       ....+|+++++.++|||++++++++.     +...
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   95 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHT   95 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCE
Confidence            34777889999999999999999999999999986432       12346889999999999999999984     4455


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      .|+||||+.+++.+.+..   ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++..
T Consensus        96 ~~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~-~~~~kL~dfg~~~~  170 (313)
T cd06633          96 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASK  170 (313)
T ss_pred             EEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECC-CCCEEEeecCCCcc
Confidence            889999999987777654   24568999999999999999999999 79999999999999986 77899999998864


Q ss_pred             cccCCCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          187 LVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ..   ......++..|+|||.+..  ...++.++|+|||||++|+|++|..||...+.......+.... .+        
T Consensus       171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~--------  238 (313)
T cd06633         171 SS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP--------  238 (313)
T ss_pred             cC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC--------
Confidence            32   2234567889999999742  2347889999999999999999999998877655554443210 00        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                        ......++..+++|+.+||+.+|.+||++.+++.||||+..
T Consensus       239 ------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         239 ------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                              00112457789999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.8e-40  Score=297.59  Aligned_cols=248  Identities=28%  Similarity=0.477  Sum_probs=194.0

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeec
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY  113 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~  113 (376)
                      ....||+|+||.||+|.+..++..+|+|.+....    ....+|+.+++.++|+||+++++++     ..+..+++|+||
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~   86 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFMEQ   86 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEec
Confidence            3458999999999999999999999999886543    2345789999999999999999987     444568999999


Q ss_pred             ccc-hHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          114 VPE-TMYRVLKHYSSMNQRM--PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       114 ~~g-~l~~~l~~~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      +++ +|...+...   ...+  ++..+..++.||+.||.|||+ +||+||||||+||+++..++.++|+|||.+......
T Consensus        87 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          87 VPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             CCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            985 666666542   1234  788889999999999999999 799999999999999865678999999998765332


Q ss_pred             CC-cceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          191 EA-NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       191 ~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      .. .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||.................              
T Consensus       163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------  228 (268)
T cd06624         163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--------------  228 (268)
T ss_pred             CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc--------------
Confidence            22 2234578899999998543 2378899999999999999999999975433211110000000              


Q ss_pred             cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                  ....++..+++++.+++.+||+.+|++|||+.+++.||||
T Consensus       229 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 ------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                        0111344578899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-41  Score=303.72  Aligned_cols=259  Identities=29%  Similarity=0.453  Sum_probs=199.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||+||++.+..+++.||+|++....     ....+|+++++.++||||+++++++     .....+
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEE
Confidence            468999999999999999999999999999999876442     2344789999999999999999998     444568


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++||||+++ +|...+..    .+.+++..++.++.|++.||.|||+..+++|+||+|+||+++. ++.++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl~~~  153 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGE  153 (284)
T ss_pred             EEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCcccc
Confidence            999999996 55444433    3568999999999999999999996348999999999999995 78899999999865


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHhcCCCCHHHHh
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ----LVEIIKVLGTPTREEIR  262 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~  262 (376)
                      ..... .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||........    ...+...        +.
T Consensus       154 ~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~  223 (284)
T cd06620         154 LINSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--------LQ  223 (284)
T ss_pred             hhhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH--------HH
Confidence            43222 2245678999999998655 588999999999999999999999986544211    0000000        00


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ..... .   .+.        .....++.++.+|+.+||..||++|||++|+++||||.+-
T Consensus       224 ~~~~~-~---~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         224 QIVQE-P---PPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHhhc-c---CCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            00000 0   000        0011267889999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.6e-41  Score=310.96  Aligned_cols=278  Identities=21%  Similarity=0.318  Sum_probs=198.4

Q ss_pred             eeeccC--CceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      ..||.|  +||+||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++     .....+++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            456666  99999999999999999999986432      2345688888999999999999998     4445589999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||+.+ ++.+.+....  ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISG-DGLVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeC-CCcEEEechHHHhhhhcc
Confidence            99995 6666665532  3458999999999999999999999 79999999999999996 778999999865433221


Q ss_pred             CCc--------ceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH--
Q 017139          191 EAN--------ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--  259 (376)
Q Consensus       191 ~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--  259 (376)
                      ...        ....++..|+|||++.+. ..++.++|+||+||++|+|++|..||.+.................+..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            111        011235569999998653 347899999999999999999999998876655544433321110000  


Q ss_pred             -------HHhhcCcCCc----Ccc-----CCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          260 -------EIRCMNPNYT----DFR-----FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       260 -------~~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                             .+......+.    +..     ........+.......++.++.+|+.+||+.||++|||++++|+||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                   0000000000    000     000011111222233467889999999999999999999999999999876


Q ss_pred             cCC
Q 017139          324 REP  326 (376)
Q Consensus       324 ~~~  326 (376)
                      ...
T Consensus       315 ~~~  317 (328)
T cd08226         315 KEQ  317 (328)
T ss_pred             HHh
Confidence            553

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.5e-40  Score=294.30  Aligned_cols=249  Identities=29%  Similarity=0.448  Sum_probs=205.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+....      ....+|+++++.++|+||+++++++.     +....|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence            5899999999999999999999999999999986432      12336888999999999999999883     445689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|...+.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVA-NDLVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEec-CCcEEEeeccchhhh
Confidence            99999985 7777776654445778999999999999999999999 79999999999999996 778999999999876


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+.......+....              
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--------------  217 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            544 33345678899999998664 47889999999999999999999998877654443332210              


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                           ++         ..+..++.++++++.+||..+|++||++.++++||++
T Consensus       218 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         218 -----YP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -----CC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                 00         0223468899999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-40  Score=298.15  Aligned_cols=245  Identities=19%  Similarity=0.215  Sum_probs=192.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .++|++.+.||+|+||.||+|...   ..+..||+|.+....     ....+|+.+++.++||||+++++++.     ..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence            457999999999999999999865   346689999886542     12346899999999999999999883     34


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++||||+++ +|.+.+..   ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.++++|||.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~-~~~~~l~dfg~  153 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNS-DLVCKISGFRR  153 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcC-CCcEEECCCcc
Confidence            458999999996 45444443   23568999999999999999999999 79999999999999996 78899999998


Q ss_pred             ccccccCCCcc--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          184 AKVLVKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       184 ~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      +..........  ...++..|+|||.+.+. .++.++|+||+||++|++++ |..||.+.+..+.+..+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-----  227 (266)
T cd05064         154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL-----  227 (266)
T ss_pred             cccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-----
Confidence            76543222111  22335689999998664 48999999999999999775 99999887766655544321100     


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                             ..+..++..+.+++.+||+.+|++||+++++++
T Consensus       228 -----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         228 -----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                   023457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.8e-40  Score=299.05  Aligned_cols=253  Identities=29%  Similarity=0.460  Sum_probs=202.9

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      +|...+.||.|++|.||++.+..+++.+++|++....    ....+|+.+++.++||||+++++++.     .....+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence            4666789999999999999999999999999875332    22346889999999999999999884     34458899


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      +||+.| +|.+.+..     ..+++..+..++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcC-CCcEEEcccccchhhcc
Confidence            999985 66555543     468999999999999999999999 79999999999999996 78899999998765433


Q ss_pred             CCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          190 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       190 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ... .....+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||...+.......+... ..+.           
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~-----------  234 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK-----------  234 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC-----------
Confidence            221 22346788999999986644 889999999999999999999999877665555443321 0000           


Q ss_pred             cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                                    ......++..+.+++.+||+.||++|||+.++++||||++...+
T Consensus       235 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         235 --------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             --------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                          00112368899999999999999999999999999999886653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.4e-40  Score=295.86  Aligned_cols=250  Identities=31%  Similarity=0.535  Sum_probs=198.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+.....      ....|+++++.++|+||+++++.+     .+...++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            59999999999999999999999999999999865433      234689999999999999999987     4445689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|+||+++ +|.+.+..    +..+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccccccccc
Confidence            99999985 55555543    3558899999999999999999999 79999999999999996 788999999998776


Q ss_pred             ccCCCcc-----eeeccccccChhhhhCCC--CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          188 VKGEANI-----SYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       188 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      .......     ...++..|+|||.+.+..  .++.++|+||||+++|++++|..||...+........... +...   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---  225 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---  225 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence            4332211     245688999999986532  2788999999999999999999999765432222211111 1000   


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                 .+|          ....+++.+.++|.+||+.||++|||+.+++.|||+
T Consensus       226 -----------~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -----------PIP----------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------CCC----------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                       011          012358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=296.71  Aligned_cols=249  Identities=28%  Similarity=0.489  Sum_probs=200.1

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .+|.+.+.||+|+||.||+|.+..+++.+|+|.+....         ....+|+.+++.++|+||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            46999999999999999999999999999999874321         123468999999999999999998743   233


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++++||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~  152 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA  152 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcccc
Confidence            457899999985 56555543    3558899999999999999999999 79999999999999996 77899999999


Q ss_pred             ccccccC----CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          184 AKVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       184 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ++.....    .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||..........++..   .+.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--  226 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT--  226 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC--
Confidence            8765321    111234578899999998764 478999999999999999999999987665554443321   111  


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                            ...++..+++++.++|.+||. +|.+||++.+++.|||.
T Consensus       227 ----------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 ----------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ----------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                  112445688999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-40  Score=300.12  Aligned_cols=248  Identities=27%  Similarity=0.409  Sum_probs=200.7

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      -|.+.+.||.|+||.||+|.+..+++.+|+|.+....     ....+|+.+++.++||||+++++++     .++..+|+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence            4788999999999999999999999999999875432     2344688999999999999999988     44556899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      ||||+++ +|...+.     ...+++..+..++.|++.++.+||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECC-CCCEEEeecccceecc
Confidence            9999996 5554443     2468999999999999999999999 79999999999999996 7889999999987654


Q ss_pred             cCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .... .....++..|+|||.+.+. ..+.++|+||+||++|+|++|..||...........+... ..            
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------  218 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------  218 (277)
T ss_pred             cchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC------------
Confidence            3221 2234578889999998654 4788999999999999999999999876554433332110 00            


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                     ..+...++.++.+++.+||..||++||++.++++||||.+.
T Consensus       219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         219 ---------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                           01223568899999999999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.4e-41  Score=300.99  Aligned_cols=246  Identities=33%  Similarity=0.597  Sum_probs=203.4

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCce
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ++|.+.+.||+|+||.||+|.+..+++.+|+|++....       ....+|.++++.+. ||||+++++++     .+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            46999999999999999999999999999999886521       23346888999998 99999999988     4555


Q ss_pred             eEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+++|||++. ++|.+.+..    ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~-~~~~~l~df~~~  149 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDK-DMHIKITDFGTA  149 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEecCCccc
Confidence            6899999995 577766654    3479999999999999999999999 79999999999999986 778999999998


Q ss_pred             cccccCCC---------------------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 017139          185 KVLVKGEA---------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV  243 (376)
Q Consensus       185 ~~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  243 (376)
                      ........                     .....++..|+|||.+... .++.++|+||||++++++++|..||...+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY  228 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            76543221                     1234567889999998654 4889999999999999999999999887755


Q ss_pred             HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH----HHHhCCCc
Q 017139          244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPF  319 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~  319 (376)
                      ..+..+...                             ...++..+++.+.++|.+||+.||++||++    +++++|||
T Consensus       229 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         229 LTFQKILKL-----------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             HHHHHHHhc-----------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence            554444321                             011334568899999999999999999999    99999999


Q ss_pred             c
Q 017139          320 F  320 (376)
Q Consensus       320 ~  320 (376)
                      |
T Consensus       280 ~  280 (280)
T cd05581         280 F  280 (280)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-40  Score=297.28  Aligned_cols=249  Identities=28%  Similarity=0.436  Sum_probs=197.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++..     ...
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence            57999999999999999999999999999999875321       123468999999999999999998843     345


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +++++||+++ +|...+.........+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcC-CCCEEECccccce
Confidence            8899999995 6766666544445668999999999999999999999 79999999999999986 7789999999987


Q ss_pred             ccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhh
Q 017139          186 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       186 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ....... .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||..... .......+...+.++      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  227 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------  227 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence            6543322 12345788899999987654 78999999999999999999999965432 122222222111111      


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                          ......+..+.+++.+||+.||++||++.++++
T Consensus       228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                                012246788999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-40  Score=297.88  Aligned_cols=245  Identities=33%  Similarity=0.555  Sum_probs=198.9

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        42 Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ||.|+||.||+|++..+|+.+++|.+.....       ...+|+++++.++||||+++++.+     .....+|++|||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            6899999999999999999999999865432       344688999999999999999887     4556689999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCC--
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--  191 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~--  191 (376)
                      .+ +|.+.+..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcC-CCCEEEEecccchhcccCccc
Confidence            85 66666654    2468999999999999999999999 79999999999999996 7889999999987654332  


Q ss_pred             -------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          192 -------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       192 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                             ......++..|+|||...... .+.++|+||||+++|++++|..||...+..+....+...  ..        
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------  218 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KI--------  218 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc--------
Confidence                   122345678899999986654 789999999999999999999999887766555444321  00        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH---HHHhCCCccccccC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFFDELRE  325 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~ell~hp~~~~~~~  325 (376)
                             ..+.          ...++..+.+++.+||+.+|++|||+   .++|+||||++++|
T Consensus       219 -------~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         219 -------EWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             -------CCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                   0000          01248899999999999999999999   99999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.7e-40  Score=295.63  Aligned_cols=245  Identities=22%  Similarity=0.344  Sum_probs=197.0

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .+|.+.+.||+|+||.||+|.+..+++.+|+|.+..+..   ...+|+++++.++||||+++++++     ..+..++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEE
Confidence            469999999999999999999999999999999875532   244699999999999999999987     344458899


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+++ +|.+.+...  ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCcEEeCCCcccccccc
Confidence            999985 666666432  23568999999999999999999999 79999999999999986 78899999999876543


Q ss_pred             CCCcc--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          190 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       190 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .....  ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+....             
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  222 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-------------  222 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            32211  12235679999998654 48999999999999999998 999998876655444332210             


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                     ....+..++.++.++|.+||+.||++|||+.++++
T Consensus       223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                           00123457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-40  Score=297.72  Aligned_cols=249  Identities=24%  Similarity=0.448  Sum_probs=199.2

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +|.+.+.||+|+||.||++.+..++..+++|.+....         .....|+.+++.++||||+++++++     .+..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence            5999999999999999999998887777777654311         1233588899999999999999988     3344


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..++||||+++ +|...+.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++  ++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~--~~~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLK--NNLLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEee--cCCEeecccCce
Confidence            58899999985 7766666555556789999999999999999999999 7999999999999997  356999999998


Q ss_pred             cccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ........ .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.........+...  ..       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~-------  222 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PT-------  222 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CC-------
Confidence            76543322 2244578889999988654 4788999999999999999999999776654444333221  00       


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                         ..++..++.++.++|.+||..||++||++.++++||||
T Consensus       223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 -------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                               01234568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.8e-40  Score=300.72  Aligned_cols=260  Identities=26%  Similarity=0.398  Sum_probs=201.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|.+.....     ...+|..++... .||||+++++++     .+.
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~   86 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD   86 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence            455789999999999999999999998899999999865321     122355545444 599999999998     444


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|++|||+++.+..++...   ...+++..+..++.|++.||.|||+..||+||||+|+||+++. ++.+||+|||++
T Consensus        87 ~~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg~~  162 (296)
T cd06618          87 SDVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGIS  162 (296)
T ss_pred             CeEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECccccc
Confidence            558999999988766665442   3478999999999999999999996249999999999999995 788999999998


Q ss_pred             cccccCCCcceeeccccccChhhhhCC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHH
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~  260 (376)
                      .............++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||..... .+.+..+..... +    
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~----  237 (296)
T cd06618         163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-P----  237 (296)
T ss_pred             hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-C----
Confidence            765444333344567889999998643   2368899999999999999999999976432 223332222100 0    


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                 ..+          ....++.++.+|+.+||..||++||+++++++||||.....
T Consensus       238 -----------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         238 -----------SLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             -----------CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence                       000          01136789999999999999999999999999999986533

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-40  Score=300.99  Aligned_cols=248  Identities=23%  Similarity=0.313  Sum_probs=197.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCC-----cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      .+|++.+.||+|+||.||+|.+...+     ..+|+|.+.....     ...+|+.+++.++||||+++++++     .+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence            47999999999999999999986655     6799998864432     235689999999999999999988     34


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD  170 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~  170 (376)
                      ....|++|||+++ +|.+.+.....            ....+++..+..++.|++.||.|||+ +|++|+||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence            4458899999984 77777654321            11568889999999999999999999 7999999999999999


Q ss_pred             CCCCcEEEEecCCccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017139          171 PLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL  246 (376)
Q Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  246 (376)
                      . ++.++|+|||++.......   ......+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+..
T Consensus       159 ~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 E-GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             C-CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            6 7789999999987543322   12234457889999998654 48999999999999999998 99999887766555


Q ss_pred             HHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ..+......                            ..+..++.++.+|+.+||+.||.+||++.+++++
T Consensus       237 ~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            444331100                            0234578999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-40  Score=304.21  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=194.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcE--EEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||.||+|.+..++..  +++|.+....     ....+|++++.++ +||||+++++++     ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~   79 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH   79 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence            456899999999999999999998877764  5777665322     1234688999999 899999999988     45


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD  170 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~  170 (376)
                      +..+|+||||+++ +|.+.+.....            ....+++..++.++.|++.||+|||+ +|++||||||+|||++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~  158 (303)
T cd05088          80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG  158 (303)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEec
Confidence            5568999999984 77777654321            12468899999999999999999999 7999999999999999


Q ss_pred             CCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017139          171 PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI  249 (376)
Q Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~  249 (376)
                      . ++.+||+|||++.............++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+
T Consensus       159 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  236 (303)
T cd05088         159 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  236 (303)
T ss_pred             C-CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            6 778999999998643221111222335679999998654 48999999999999999998 99999877655444332


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ....                            ....+...++++.+++.+||+.||++||++++++++
T Consensus       237 ~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         237 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             hcCC----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1100                            000123468899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.5e-40  Score=290.92  Aligned_cols=248  Identities=30%  Similarity=0.499  Sum_probs=202.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      +|++.+.||+|++|.||++.+..+++.+++|++....    ....+|+.+++.++|+|++++++++     ..+...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence            4889999999999999999999899999999986654    3455799999999999999999988     334558899


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      +||+++ +|.+.+...   ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTS-DGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEcc-CCeEEEeeccccccccc
Confidence            999995 665555442   2578999999999999999999999 79999999999999996 78899999999877655


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+........... ..+.            
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------  216 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG------------  216 (253)
T ss_pred             cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC------------
Confidence            43334566788999999987654 789999999999999999999999877554444332221 0000            


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                         .          .....++..+.++|.+||+.||++|||+.+++.|||
T Consensus       217 ---~----------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 ---L----------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ---c----------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence               0          001124789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.1e-42  Score=315.84  Aligned_cols=254  Identities=28%  Similarity=0.425  Sum_probs=205.1

Q ss_pred             cccce-EeeeeeccCCceEEEEEEEcCCCcEEEEEEecc-----c---ccchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           32 QTISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----D---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        32 ~~~~y-~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~---~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ..++| +...+||+|+|-+||+|.|..+|-.||--.+..     .   ...+..|+.+|+.|+||||+++++++.+.   
T Consensus        37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---  113 (632)
T KOG0584|consen   37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---  113 (632)
T ss_pred             CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---
Confidence            34556 456799999999999999999999888654421     1   24456799999999999999999998663   


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CCceeccCCCCCeeecCCCCcEEEEe
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+..+.+|+|.+. |+|..+++.    .+......++.|+.||+.||.|||++ ..|+|||||-+||||+...|.|||+|
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD  189 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD  189 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence            3466889999998 555555544    57788899999999999999999984 35999999999999999889999999


Q ss_pred             cCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHH
Q 017139          181 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTRE  259 (376)
Q Consensus       181 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~  259 (376)
                      +|+|........ ...+|||.|||||.+.  ..|+..+||||||+.++||+|+..||..-.+.. .+.++..  |..+..
T Consensus       190 LGLAtl~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~s  264 (632)
T KOG0584|consen  190 LGLATLLRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAA  264 (632)
T ss_pred             hhHHHHhhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHH
Confidence            999987654433 3489999999999996  359999999999999999999999998755444 4444433  222111


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                               +.+--.+++++||.+||.. .+.|+|+.|||.||||+.-
T Consensus       265 -------------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 -------------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -------------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                                     2223478999999999999 9999999999999999863

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-40  Score=308.31  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=193.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      .++|++++.||.|+||.||+|.+..     +++.||+|++....     ....+|+.+++++ +|+||+++++++..   
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~---   82 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK---   82 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence            4589999999999999999997543     45789999886432     1233688999999 89999999997743   


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSS-----------------------------------------------------  127 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~-----------------------------------------------------  127 (376)
                       .+..++++|||+++ +|.+.+.....                                                     
T Consensus        83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence             33457899999995 66666643211                                                     


Q ss_pred             ----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC---cceeeccc
Q 017139          128 ----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSR  200 (376)
Q Consensus       128 ----~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~  200 (376)
                          ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.++|+|||++........   .....++.
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                02368899999999999999999999 79999999999999996 77899999999986533221   12234467


Q ss_pred             cccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCC
Q 017139          201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH  279 (376)
Q Consensus       201 ~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+.....                        
T Consensus       240 ~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------  294 (337)
T cd05054         240 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR------------------------  294 (337)
T ss_pred             cccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC------------------------
Confidence            89999998765 48999999999999999998 99999875544433333221000                        


Q ss_pred             CcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          280 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       280 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                         ...+...++++.+++.+||+.+|++||+++++++|
T Consensus       295 ---~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         295 ---MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               00123467899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.4e-40  Score=301.72  Aligned_cols=248  Identities=31%  Similarity=0.456  Sum_probs=202.6

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .|...+.||+|+||.||+|++..++..+|+|.+....       ....+|+++++.++|||++++++++.     ++...
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeE
Confidence            4888999999999999999999999999999986432       12346889999999999999999884     34458


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++||||+.|++.+.+..   ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~-~~~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECC-CCCEEEecCCCcccc
Confidence            89999999987776653   24568999999999999999999999 79999999999999986 788999999988654


Q ss_pred             ccCCCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          188 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ..   .....+++.|+|||.+..  ...++.++|+|||||++|+|++|..||...+.......+......+         
T Consensus       176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  243 (317)
T cd06635         176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------  243 (317)
T ss_pred             CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence            32   234567889999999742  2347889999999999999999999998776655555444321100         


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                        .....+++.+.+++.+||+.+|.+||++.++++|||+..
T Consensus       244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                              011246788999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.6e-40  Score=300.16  Aligned_cols=252  Identities=29%  Similarity=0.431  Sum_probs=200.2

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      |....+||+|+||.||++....+++.+|+|++....    ....+|+.+++.++|+||+++++++     ......++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEE
Confidence            444578999999999999999999999999875322    2234688999999999999999988     3445689999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||+++ +|.+.+.     ...+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||++......
T Consensus        97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657          97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEcccccceecccc
Confidence            99997 4444332     2468999999999999999999999 79999999999999996 778999999988655432


Q ss_pred             C-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          191 E-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       191 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      . ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.........+......              
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--------------  234 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP--------------  234 (292)
T ss_pred             cccccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc--------------
Confidence            2 22345678899999988654 4789999999999999999999999877665544433221100              


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                                  .......+++++.+++.+||+.||.+||++.+++.||||.....+
T Consensus       235 ------------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         235 ------------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             ------------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence                        000112468899999999999999999999999999999886543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.9e-40  Score=302.28  Aligned_cols=250  Identities=29%  Similarity=0.441  Sum_probs=202.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..|...+.||.|+||.||+|++..+++.+|+|.+....       ....+|+++++.++|+|++++.+++..     ...
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence            45888999999999999999999999999999885321       123368899999999999999998843     445


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      .++||||+.|++...+..   ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++..
T Consensus        90 ~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~  164 (308)
T cd06634          90 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI  164 (308)
T ss_pred             eEEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECC-CCcEEECCccccee
Confidence            889999999887766643   23568999999999999999999999 79999999999999986 78899999999876


Q ss_pred             cccCCCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          187 LVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...   .....+++.|+|||.+.+  ...++.++|+|||||++|+|++|..||...+..+....+..... +        
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~--------  232 (308)
T cd06634         165 MAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P--------  232 (308)
T ss_pred             ecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C--------
Confidence            432   224467889999999752  23478899999999999999999999987665544443332100 0        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                        .......+..+.++|.+||..+|++||++++++.|||+...
T Consensus       233 ------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         233 ------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                              00122468889999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-40  Score=300.71  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=201.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEecccc--------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           35 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      +|++.+.||.|+||.||+|++.   .+|+.||+|++....        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4899999999999999999975   478999999986421        2234688999999 589999999888     5


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .+..+|+||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECC-CCCEEEeeC
Confidence            55668999999995 66555543    4568899999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCC--CcceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          182 GSAKVLVKGE--ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       182 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      |++.......  ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+.+.....  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            9987654322  12245578899999998643 236789999999999999999999997543322222222211000  


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                             ...++..+++.+.+++.+||..||++|+     ++++++.||||+..++.
T Consensus       228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence                                   0012345788999999999999999997     88999999999988764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.6e-40  Score=328.29  Aligned_cols=250  Identities=24%  Similarity=0.335  Sum_probs=193.4

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++..+.       ....+|+.+++.++||||+++++++     .++..
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence            57999999999999999999999999999999986532       1234689999999999999999988     44456


Q ss_pred             EEEEeecccc-hHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSS-------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                      .|++|||++| +|.+.+.....       ....++...+..++.||+.||+|||+ +||+||||||+||+++. ++.++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~-dg~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGL-FGEVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcC-CCCEEE
Confidence            8999999986 67666654211       12345667788999999999999999 79999999999999996 778999


Q ss_pred             EecCCccccccCC-------------------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 017139          179 CDFGSAKVLVKGE-------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG  239 (376)
Q Consensus       179 ~Dfg~~~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  239 (376)
                      +|||++.......                   ......||+.|+|||.+.+.. ++.++|+||+||++|+|++|..||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999997652110                   011246899999999987654 89999999999999999999999977


Q ss_pred             CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .+.......  .....+.  .                      ......+++.+.+++.+||+.||++|++..+.+.+
T Consensus       234 ~~~~ki~~~--~~i~~P~--~----------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        234 KKGRKISYR--DVILSPI--E----------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             cchhhhhhh--hhccChh--h----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            543322211  1000000  0                      00113578899999999999999999987665543

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.2e-40  Score=300.50  Aligned_cols=248  Identities=22%  Similarity=0.295  Sum_probs=193.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCc--EEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCCCce
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ++|++.+.||+|+||.||+|....++.  .+++|.+....     ....+|+.++.++ +||||+++++++     .+..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            579999999999999999999877765  46888775321     2344688999888 799999999987     4445


Q ss_pred             eEEEEeeccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC
Q 017139          106 FLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL  172 (376)
Q Consensus       106 ~~~lv~e~~~-g~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~  172 (376)
                      .+|++|||++ ++|.+.+.....            ....+++..++.++.|++.||+|||+ +|++||||||+||+++. 
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-  154 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGE-  154 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECC-
Confidence            6899999998 477777754221            12358899999999999999999999 79999999999999986 


Q ss_pred             CCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017139          173 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK  251 (376)
Q Consensus       173 ~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  251 (376)
                      ++.+||+|||++..............+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+....+..
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             CCeEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            778999999998643222111122234569999998654 48999999999999999997 9999988776655544332


Q ss_pred             hcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ...                            ...+..++.++.+|+.+||..||.+|||++++++.
T Consensus       234 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            100                            01223578899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.1e-40  Score=291.05  Aligned_cols=250  Identities=34%  Similarity=0.526  Sum_probs=202.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||+|++|.||+|.+..+++.+++|++....      ....+|+.++++++||||+++++.+...   ....++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence            4889999999999999999999999999999986543      2345789999999999999999888432   125688


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +++||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEcccccEEec
Confidence            99999964 66655554    2379999999999999999999999 79999999999999996 788999999998876


Q ss_pred             ccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .....   .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+....  .......          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc----------
Confidence            55543   34456788999999986554 89999999999999999999999987662211  1111100          


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                    ......++..++.++.++|.+||+.||++||++.++++||||
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                          000111344568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-40  Score=297.89  Aligned_cols=248  Identities=23%  Similarity=0.338  Sum_probs=196.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .++|.+.+.||+|+||.||+|.+..     +++.||+|.+....     ....+|+++++.++|+||+++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   78 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT-----   78 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence            4579999999999999999998753     36789999986543     23457999999999999999999884     


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhh----------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYS----------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP  171 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~----------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~  171 (376)
                      .....++||||+++ +|.+.+....          .....+++..+..++.|++.||.+||+ +|++||||||+||+++.
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~  157 (280)
T cd05049          79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY  157 (280)
T ss_pred             cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC
Confidence            33558999999985 6766665431          123458899999999999999999999 79999999999999996


Q ss_pred             CCCcEEEEecCCccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017139          172 LTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV  247 (376)
Q Consensus       172 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  247 (376)
                       ++.+||+|||++.......   ......+++.|+|||++.+.. ++.++|+|||||++|+|++ |..||...+..+...
T Consensus       158 -~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         158 -DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             -CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence             7889999999987543222   122334567899999997654 8999999999999999998 999998777665544


Q ss_pred             HHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .+...  ..                          ...+..++..+.+++.+||+.||++||++.|+++
T Consensus       236 ~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         236 CITQG--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHcC--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            43321  00                          0122357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=341.55  Aligned_cols=256  Identities=28%  Similarity=0.473  Sum_probs=207.4

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      +..-+|.....+|.|.||.||-|.+..+|+..|+|.+.-.      .....+|..++..++|||+|+++++-..     .
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-----R 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-----R 1306 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-----H
Confidence            3445788899999999999999999999999999977432      2344579999999999999999988643     3


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..++|.||||.| +|.+++.+    +...++...+.+..|++.|+.|||+ +|||||||||.||+++. ++.+|++|||.
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~-~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDF-NGLIKYGDFGS 1380 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeec-CCcEEeecccc
Confidence            337899999995 56555554    4557788888999999999999999 79999999999999996 77999999999


Q ss_pred             ccccccCC-----CcceeeccccccChhhhhCCC--CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          184 AKVLVKGE-----ANISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       184 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      |....+..     ......||+.|||||++.+..  ....+.|||||||++.||+||+.||...+..=++.-.+.....|
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence            98775542     234678999999999996643  35678999999999999999999998765432222222211111


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                                 .+|.++|.+.+|||.+||..||.+|+++.|+|.|-|-+...
T Consensus      1461 ---------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1461 ---------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             ---------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence                                       25667999999999999999999999999999998876543

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.6e-40  Score=295.39  Aligned_cols=250  Identities=22%  Similarity=0.300  Sum_probs=194.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++|++.+.||+|+||.||+|.+..     ++..+|+|++.....     ...+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            45689999999999999999998642     356799998854321     234688999999999999999987     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSSM------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH  174 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~  174 (376)
                      ......++||||+++ +|.+.+......      ...++...+..++.|++.||.|||+ .|++|+||||+||+++. ++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~-~~  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DF  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcC-CC
Confidence            445568899999985 677666542211      2346778889999999999999999 79999999999999996 78


Q ss_pred             cEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017139          175 QVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII  250 (376)
Q Consensus       175 ~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  250 (376)
                      .++|+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+.......+.
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            899999999875433221   1122346789999998764 48999999999999999999 789998876655444333


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .. +.+                           ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         236 EG-GLL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cC-CcC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21 000                           0223467899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-41  Score=311.67  Aligned_cols=265  Identities=28%  Similarity=0.450  Sum_probs=210.9

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      |..++.||-|+||.|.++...++...||+|.+.+...       ..+.|.+||..-+.+-||+++..|     ++...+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnLY  705 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNLY  705 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCceE
Confidence            7888999999999999999999999999998865432       234689999999999999999888     6677799


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||+|++| ++-.+|..    -+-|.|..++.++.++..|+++.|.+ |+|||||||+|||||. +|.|||+|||+|.-+
T Consensus       706 FVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDr-dGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDR-DGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEcc-CCceeeeeccccccc
Confidence            99999996 55555544    46799999999999999999999995 9999999999999997 888999999998533


Q ss_pred             c---------cC-----------------CC-----------------cceeeccccccChhhhhCCCCCCccchhHHHH
Q 017139          188 V---------KG-----------------EA-----------------NISYICSRYYRAPELIFGATEYTTSIDIWSAG  224 (376)
Q Consensus       188 ~---------~~-----------------~~-----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  224 (376)
                      .         ++                 ..                 ..+.+||+.|+|||++.... |+..+|+||.|
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~g  858 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVG  858 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhh
Confidence            1         00                 00                 01457899999999997654 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCC
Q 017139          225 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS  304 (376)
Q Consensus       225 ~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  304 (376)
                      ||||+|+.|++||...+..+.-.+++..                ..         .++..+-.++|+++.++|.++.+ +
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~kv~nw----------------~~---------~l~~~~~~~ls~e~~~li~kLc~-s  912 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQYKVINW----------------RN---------FLHIPYQGNLSKEALDLIQKLCC-S  912 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcceeeeeeh----------------hh---------ccccccccccCHHHHHHHHHHhc-C
Confidence            9999999999999877655443333221                00         01112335789999999988765 7


Q ss_pred             CCCCCC---HHHHhCCCccccccCCCCCCCCCCCCCC
Q 017139          305 PSLRCT---ALEACAHPFFDELREPNARLPNGRPFPP  338 (376)
Q Consensus       305 P~~R~t---~~ell~hp~~~~~~~~~~~~~~~~~~~~  338 (376)
                      ++.|..   ++++..||||+.+++...+.....++|.
T Consensus       913 ad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~  949 (1034)
T KOG0608|consen  913 ADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPR  949 (1034)
T ss_pred             hhhhhcccchhhhhcCccccccchHhhhhccCCcCcc
Confidence            888884   6789999999999887766555555553

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.1e-40  Score=295.75  Aligned_cols=247  Identities=29%  Similarity=0.467  Sum_probs=196.4

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||+|.+..+++.+|+|.+....       ....+|+.+++.++||||+++++++.     ++..
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence            57999999999999999999999999999999875421       22346899999999999999999884     3445


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      ++++|||+++ +|.+.+.........+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEECcchhhh
Confidence            8899999985 7777776554455678999999999999999999999 79999999999999996 7789999999987


Q ss_pred             ccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHHHHh
Q 017139          186 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       186 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  262 (376)
                      ....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+....  .....+... .        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--------  224 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-D--------  224 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-C--------
Confidence            6543322 22446788999999986544 789999999999999999999999764322  111111110 0        


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                .+        ...+...++++.+++.+||..||++|||+.+++
T Consensus       225 ----------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~  259 (267)
T cd08229         225 ----------YP--------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVY  259 (267)
T ss_pred             ----------CC--------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHH
Confidence                      00        001234688999999999999999999999775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=289.50  Aligned_cols=246  Identities=33%  Similarity=0.577  Sum_probs=203.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+.....      ...+|+++++.++|||++++++++.     +...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            58999999999999999999999999999999865542      2347889999999999999999873     345689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|||+++ +|.+.+..    ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTK-DGVVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECC-CCCEEEeccccceec
Confidence            99999986 56555543    3678999999999999999999999 79999999999999996 788999999998876


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+...........              
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------  214 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------  214 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence            54332 23456788999999986654 789999999999999999999999876654444332210              


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                    ....++..++..+.+++.+||..+|++|||+.+++.||||
T Consensus       215 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 --------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                          0111344678999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.2e-40  Score=296.47  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=194.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      .++|.+.+.||+|+||+||++.+.     .++..+|+|.+....    ....+|+++++.++||||+++++++     ..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VE   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence            357999999999999999999863     345679999886542    2345799999999999999999988     44


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYS---------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT  173 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~---------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~  173 (376)
                      ...+++||||+++ +|.+.+....         .....+++..++.++.|++.||+|||+ +|++||||||+||+++. +
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~-~  156 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-N  156 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc-C
Confidence            4558999999984 7766665432         122358999999999999999999999 79999999999999996 7


Q ss_pred             CcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017139          174 HQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI  249 (376)
Q Consensus       174 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~  249 (376)
                      +.+||+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+....+
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            8899999999875533221   1123346789999998654 48999999999999999998 99999887766555444


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                      ....  .                          ...+...+.++.+++.+||+.||.+|||+.+++
T Consensus       236 ~~~~--~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~  273 (288)
T cd05093         236 TQGR--V--------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH  273 (288)
T ss_pred             HcCC--c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            3310  0                          001234688999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-40  Score=294.26  Aligned_cols=249  Identities=24%  Similarity=0.311  Sum_probs=196.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++|++.+.||+|+||.||+|.+...     +..||+|.+.....     ...+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----   78 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----
Confidence            346899999999999999999998644     37899999864432     234688999999999999999988     


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSS------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH  174 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~  174 (376)
                      ......++||||++ ++|...+.....      ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~-~~  156 (277)
T cd05032          79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAE-DL  156 (277)
T ss_pred             cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcC-CC
Confidence            44456899999998 577777654322      12347888999999999999999999 79999999999999996 78


Q ss_pred             cEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017139          175 QVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII  250 (376)
Q Consensus       175 ~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  250 (376)
                      .+||+|||+++.......   .....++..|+|||.+.+.. ++.++|+|||||++|++++ |..||.+.+..+....+.
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  235 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI  235 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence            899999999876543221   22334577899999986544 8999999999999999998 999998877655544333


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .. +.                           ..++...+.++.+++.+||+.+|++|||+.++++
T Consensus       236 ~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         236 DG-GH---------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             cC-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            10 00                           0123346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.3e-40  Score=327.35  Aligned_cols=142  Identities=25%  Similarity=0.399  Sum_probs=123.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      .++|.+.+.||.|+||.||+|.+..+++.||||++....       .....|+.+++.++||||++++.++     ....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence            578999999999999999999999999999999986542       3345788999999999999999887     4445


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+|+||||+.| +|..++..    ...+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~-~g~vkL~DFGls  151 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISN-EGHIKLTDFGLS  151 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcC-CCCEEEEeCCCC
Confidence            68999999975 66666643    3568899999999999999999999 79999999999999986 788999999987


Q ss_pred             c
Q 017139          185 K  185 (376)
Q Consensus       185 ~  185 (376)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.7e-40  Score=296.71  Aligned_cols=257  Identities=30%  Similarity=0.463  Sum_probs=207.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..+.|++.+.||+|++|.||+|.+..+++.+++|++.....   ....|+++++.++|+||+++++++..     ....|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-----GDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEE
Confidence            45569999999999999999999998899999999876542   34578999999999999999998843     35589


Q ss_pred             EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +++||++ ++|.+.+....   ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSK-DGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcC-CCCEEECccchhhhh
Confidence            9999999 57777766521   379999999999999999999999 79999999999999996 778999999987654


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... +.+.         
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~---------  235 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP---------  235 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC---------
Confidence            33221 2234567889999998654 4899999999999999999999999877665444433221 0000         


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                      ......++.++.++|.+||+.+|.+|||+.+++.||||++..+
T Consensus       236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         236 ----------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             ----------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence                            0011236889999999999999999999999999999998443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=8.5e-40  Score=318.93  Aligned_cols=282  Identities=22%  Similarity=0.278  Sum_probs=185.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCC----CcEEEEEEecccccchHHHHHHH---HhCCCCCeeecceeeeecC-CCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDRRYKNRELQLM---RLMDHPNVISLKHCFFSTT-SKD  103 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~----~~~~aiK~~~~~~~~~~~e~~~l---~~l~h~~Iv~~~~~~~~~~-~~~  103 (376)
                      ..++|.+.+.||+|+||.||+|.+..+    +..||+|++.....   .|..+.   +...+.++..+...+.... ...
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            567999999999999999999999988    99999998754322   222222   2223333443333322211 144


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhh----------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSS----------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN  166 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~----------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~N  166 (376)
                      +..+++||||+++ +|.+.+.....                .........+..++.||+.||.|||+ +||+||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence            5568899999985 66666643210                01112344577899999999999999 799999999999


Q ss_pred             eeecCCCCcEEEEecCCccccccC--CCcceeeccccccChhhhhCCC---------------------CCCccchhHHH
Q 017139          167 LLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRYYRAPELIFGAT---------------------EYTTSIDIWSA  223 (376)
Q Consensus       167 ill~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diwsl  223 (376)
                      ||++.+++.+||+|||+++.....  .......+++.|+|||.+....                     .++.++||||+
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            999865678999999999755332  2223567899999999763221                     13445699999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCC
Q 017139          224 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY  303 (376)
Q Consensus       224 G~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  303 (376)
                      ||++|+|+++..++  .+....+...+...+..............    .+...   .........+..+.+||.+||++
T Consensus       366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPRA----SPDLR---RGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhcccc----chhhh---hhhhhccccchHHHHHHHHHccC
Confidence            99999999976554  33344444444443332211111111000    00000   00001112345677999999999


Q ss_pred             CCCCCCCHHHHhCCCccccccCC
Q 017139          304 SPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       304 dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ||++|||+.++|+||||+.....
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCCcc
Confidence            99999999999999999876553

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-39  Score=290.42  Aligned_cols=243  Identities=21%  Similarity=0.297  Sum_probs=193.1

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ++|++.+.||+|+||.||+|... .+..+|+|.+....   .....|+.+++.++||||+++++++     .....+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence            56999999999999999999875 45679999876442   2345699999999999999999987     444558999


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+++ +|.+.+...   ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSS-TGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcC-CCeEEECCCCCccccCC
Confidence            999985 666655431   2458899999999999999999999 79999999999999996 78899999999876533


Q ss_pred             CCCcc--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          190 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       190 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .....  ...++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+......           
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-----------  220 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-----------  220 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence            22211  22335579999998654 48999999999999999999 99999887766665554331000           


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                       ..+...+.++.+++.+||+.||++||+++++++
T Consensus       221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             012235778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-39  Score=290.71  Aligned_cols=248  Identities=31%  Similarity=0.491  Sum_probs=197.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|.+...       .....+|+++++.++|+||+++++++.     +...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence            5799999999999999999999999999999987531       223447899999999999999999883     3455


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .++||||+++ +|...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~-~~~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECC-CCcEEEeccceee
Confidence            8899999985 7777776654455678999999999999999999999 79999999999999996 7789999999987


Q ss_pred             ccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCHHHHh
Q 017139          186 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       186 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.....  .+....+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  224 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD---------  224 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC---------
Confidence            654332 22345678899999998654 489999999999999999999999965431  11111111100         


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                .+        ......++.++.++|.+||..+|++|||+.++++
T Consensus       225 ----------~~--------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         225 ----------YP--------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ----------CC--------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                      00        0011246789999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.1e-39  Score=299.40  Aligned_cols=275  Identities=22%  Similarity=0.303  Sum_probs=194.4

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .+++.+|.|  |.||.+++..+++.||+|++....      ....+|+++++.++|+||+++++++     .+....+++
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~   77 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVV   77 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEE
Confidence            344444444  556666777799999999986541      2345799999999999999999988     344458999


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+++ ++.+.+...  ....+++..+..++.|++.||+|||+ +||+|+||||+||+++. ++.+||+|||.+.....
T Consensus        78 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          78 SPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             EeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEec-CCceEEecCccceeecc
Confidence            999995 565665543  23458899999999999999999999 79999999999999995 78899999998865432


Q ss_pred             CCC--------cceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH-
Q 017139          190 GEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-  259 (376)
Q Consensus       190 ~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  259 (376)
                      ...        .....++..|+|||++.+. ..++.++|+||+||++|+|++|..||..........+...  +..... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~  231 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCLL  231 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcccc
Confidence            211        1233457789999998653 3478999999999999999999999987655443322221  110000 


Q ss_pred             ---HHhhcCcCCc----CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          260 ---EIRCMNPNYT----DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       260 ---~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                         ..........    ....+ .............++.++.+|+.+||++||++|||++++|+||||+.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         232 DKSTYPLYEDSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             ccCchhhhcCCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence               0000000000    00000 00111122233345678999999999999999999999999999997763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-39  Score=307.54  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=192.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeccccc-----chHHHHHHHHhCC-CCCeeecceeeeecCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTS  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~  101 (376)
                      .++|++++.||+|+||.||+|.+...     +..||+|++.....     ...+|+++++.+. ||||+++++++     
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-----  110 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-----  110 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence            46899999999999999999987433     34699999865322     2346999999996 99999999988     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSS-----------------------------------------------------  127 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~-----------------------------------------------------  127 (376)
                      .+...+|+|||||++ +|.+.+.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            445558999999984 77766654211                                                     


Q ss_pred             ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCee
Q 017139          128 ---------------------------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL  168 (376)
Q Consensus       128 ---------------------------------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nil  168 (376)
                                                             ....+++..+..++.|++.||+|||+ ++|+|+||||+||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence                                                   12357888899999999999999999 79999999999999


Q ss_pred             ecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 017139          169 VDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD  244 (376)
Q Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  244 (376)
                      ++. ++.+||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus       270 l~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         270 LAQ-GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EeC-CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            996 77899999999876543222   1233456789999998764 48999999999999999997 999998765443


Q ss_pred             HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .....+.....                           ...+..++.++.+++.+||+.||++|||+.++.+
T Consensus       348 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYNKIKSGYR---------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHhcCCC---------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            33332221000                           0022356889999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-39  Score=290.18  Aligned_cols=245  Identities=19%  Similarity=0.273  Sum_probs=193.5

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++.+.||+|+||.||+|.+.. +..+|+|.+.....   ...+|+.+++.++||||+++++++     .....+++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   76 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYI   76 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEE
Confidence            4579999999999999999998754 45699998865432   245799999999999999999987     33445789


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||+.+ +|.+.+...   ...+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||.++...
T Consensus        77 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~~~  151 (256)
T cd05113          77 VTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVL  151 (256)
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCCEEECCCccceecC
Confidence            9999985 566655432   2368999999999999999999999 79999999999999996 7889999999987654


Q ss_pred             cCCCcc--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          189 KGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       189 ~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ......  ...++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...+..+....+......          
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  220 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------  220 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------
Confidence            332211  123456799999986544 8999999999999999998 99999877765544444331100          


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                        ..+...+..+.+++.+||..||.+||++.+++.+
T Consensus       221 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                              0122357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-39  Score=293.46  Aligned_cols=250  Identities=20%  Similarity=0.281  Sum_probs=195.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .++|.+.+.||+|++|.||+|.+..     ++..||+|.+....     ....+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-----   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence            4679999999999999999999987     77889999876432     12346889999999999999999873     


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC--CcE
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQV  176 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~--~~~  176 (376)
                      +....++||||+.| +|.+.+.....   ....+++..+..++.||+.||+|||+ ++++|+||||+||+++..+  ..+
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence            33347899999975 77777655321   12358999999999999999999999 7999999999999997522  369


Q ss_pred             EEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 017139          177 KLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV  252 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  252 (376)
                      ||+|||+++.......   ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999876532211   11222345799999997654 8999999999999999997 99999887765544332221


Q ss_pred             cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                       ..                           ..++..++..+.+++.+||+.||++|||+.++++|
T Consensus       238 -~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 -GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             00                           01234578899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-39  Score=290.92  Aligned_cols=244  Identities=25%  Similarity=0.344  Sum_probs=194.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++.++||+|+||.||+|... ++..||+|.+....   ....+|+.+++.++|+||+++++++     .+....++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence            467999999999999999999864 56779999876533   2334699999999999999999887     44455889


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||+++ +|.+.+...  ....+++..+..++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSE-SLMCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecC-CCcEEECCCccceecC
Confidence            9999974 777666542  24568889999999999999999999 79999999999999996 7889999999998654


Q ss_pred             cCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          189 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       189 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+.......+.....           
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------  222 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-----------  222 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            3221  1122345679999998654 48899999999999999998 9999988766555544432110           


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                             .+          ....++.++.+++.+||..||++||+++++.
T Consensus       223 -------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  255 (261)
T cd05072         223 -------MP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQ  255 (261)
T ss_pred             -------CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence                   00          1234688999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=288.40  Aligned_cols=238  Identities=34%  Similarity=0.581  Sum_probs=196.6

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        42 Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ||.|+||.||++.+..+++.+|+|.+.....       ....|+.+++.++||||+++++.+     ..+..+|++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            6999999999999998999999998865422       345688999999999999999887     5566699999999


Q ss_pred             c-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC-CC
Q 017139          115 P-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EA  192 (376)
Q Consensus       115 ~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~-~~  192 (376)
                      + ++|.+.+..    ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||.+...... ..
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcC-CCcEEEeecCcceecccCCCc
Confidence            5 577666654    3468999999999999999999999 79999999999999996 778999999998765443 22


Q ss_pred             cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCcc
Q 017139          193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR  272 (376)
Q Consensus       193 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .....++..|+|||.+.+.. .+.++|+||||+++|++++|..||...+.......+..  ..                 
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~-----------------  209 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DP-----------------  209 (250)
T ss_pred             ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CC-----------------
Confidence            33456788899999986544 78899999999999999999999987765443333322  00                 


Q ss_pred             CCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH---HHHhCCCcc
Q 017139          273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF  320 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~ell~hp~~  320 (376)
                                ..++..++.++.+++++||..||++||++   +++++||||
T Consensus       210 ----------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 ----------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                      01334568899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=291.89  Aligned_cols=251  Identities=21%  Similarity=0.278  Sum_probs=194.5

Q ss_pred             eEeeeeeccCCceEEEEEEEcCC---CcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017139           36 YMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL  105 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~  105 (376)
                      |.+++.||+|+||.||+|....+   +..+|+|.+..+..      ...+|+.+++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            57889999999999999997654   47899999865422      23468899999999999999988754332 2344


Q ss_pred             eEEEEeecccc-hHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ..+++|||+++ +|...+....  .....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECC-CCeEEECCcc
Confidence            57899999985 6666664432  123468999999999999999999999 79999999999999996 7789999999


Q ss_pred             CccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          183 SAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       183 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +++........   ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.... .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~---  233 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-R---  233 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C---
Confidence            98865433211   112335679999998654 48999999999999999999 899998877655444333210 0   


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                              ...+...+.++.+++.+||..||++|||+.+++.+
T Consensus       234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    00223568899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=289.37  Aligned_cols=242  Identities=26%  Similarity=0.393  Sum_probs=196.9

Q ss_pred             eeeccCCceEEEEEEEcCC---CcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|.+...   +..+++|.+.....     ...+|+++++.++|+||+++++++     .....++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEEE
Confidence            4799999999999999866   88999999865432     344689999999999999999988     3455689999


Q ss_pred             eccc-chHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          112 EYVP-ETMYRVLKHYSSM-----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       112 e~~~-g~l~~~l~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      ||++ ++|.+.+......     ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~-~~~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGE-DLVVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECC-CCcEEEccccccc
Confidence            9996 5777776653221     3779999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          186 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       186 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      ......   ......++..|+|||.+... .++.++|+||+||++|+|++ |..||......+....+...         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------  223 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---------  223 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence            765432   22344567889999998765 48999999999999999999 69999888665555444321         


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                         .....+..+++++.+++.+||+.||++|||+.+++++
T Consensus       224 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 -------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                               0011234568999999999999999999999999865

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-39  Score=289.28  Aligned_cols=238  Identities=21%  Similarity=0.312  Sum_probs=186.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      +.||+|+||.||+|.+..+++.+|+|.+....     ....+|+++++.++||||+++++++     .....+++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence            46899999999999999999999999875432     2345789999999999999999988     3444589999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCc
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN  193 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~  193 (376)
                      ++ +|.+.+..   ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++.........
T Consensus        76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcC-CCcEEECccccCccccccccc
Confidence            86 55555543   23468899999999999999999999 79999999999999996 778999999998754322111


Q ss_pred             c---eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          194 I---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       194 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      .   ....+..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...........+.....               
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---------------  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---------------  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------
Confidence            1   111245699999986654 8999999999999999998 8999976655443332222100               


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                   ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         0123346889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=286.06  Aligned_cols=262  Identities=25%  Similarity=0.444  Sum_probs=210.6

Q ss_pred             CCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhC-CCCCeeecceeeee
Q 017139           27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM-DHPNVISLKHCFFS   98 (376)
Q Consensus        27 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l-~h~~Iv~~~~~~~~   98 (376)
                      ..-.....+|.++++||+|+|++|.+++.+.+.+.||+|++++...       -.+.|..+...- +||++|.++.||  
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--  320 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--  320 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--
Confidence            3344455789999999999999999999999999999999865422       223566666554 799999999999  


Q ss_pred             cCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139           99 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                         +.+..+++|.||++|+  +++.+. .....++++.++.+..+|+.||.|||+ +||++||||.+|+|++. .+.+||
T Consensus       321 ---qtesrlffvieyv~gg--dlmfhm-qrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvllda-eghikl  392 (593)
T KOG0695|consen  321 ---QTESRLFFVIEYVNGG--DLMFHM-QRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKL  392 (593)
T ss_pred             ---cccceEEEEEEEecCc--ceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEcc-CCceee
Confidence               6666799999999975  222221 234679999999999999999999999 89999999999999997 778999


Q ss_pred             EecCCccccc-cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCC-------CCChHHHHHHHH
Q 017139          179 CDFGSAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-------GENAVDQLVEII  250 (376)
Q Consensus       179 ~Dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~-------~~~~~~~~~~~~  250 (376)
                      +|+|.++... +.....+++|||.|.|||++.+. .|+..+|+|+||++++||+.|+.||.       ..+..+.+.+++
T Consensus       393 tdygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi  471 (593)
T KOG0695|consen  393 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI  471 (593)
T ss_pred             cccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence            9999997654 34456678899999999999875 49999999999999999999999994       223344444433


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC------HHHHhCCCcccccc
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELR  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~ell~hp~~~~~~  324 (376)
                      -.                ..++            +|..+|-.+..+++.-|.+||.+|..      ..++..||||+.++
T Consensus       472 le----------------kqir------------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  472 LE----------------KQIR------------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             hh----------------hccc------------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            21                0111            34557778889999999999999975      57999999999998


Q ss_pred             CCC
Q 017139          325 EPN  327 (376)
Q Consensus       325 ~~~  327 (376)
                      |..
T Consensus       524 wd~  526 (593)
T KOG0695|consen  524 WDL  526 (593)
T ss_pred             HHH
Confidence            863

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-39  Score=299.33  Aligned_cols=245  Identities=24%  Similarity=0.362  Sum_probs=191.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcE----EEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..+|++.+.||+|+||.||+|++..+++.    ||+|.+....     ....+|+.+++.++||||+++++++...    
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC----
Confidence            35799999999999999999998766664    8999886432     2334688999999999999999987431    


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                        ..++++||+. |+|.+.+...   ...+++..+..++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        82 --~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~-~~~~kl~DfG  154 (316)
T cd05108          82 --TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKT-PQHVKITDFG  154 (316)
T ss_pred             --CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecC-CCcEEEcccc
Confidence              2568999998 4676666542   3468889999999999999999999 79999999999999986 7789999999


Q ss_pred             CccccccCCCcce---eeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          183 SAKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       183 ~~~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +++..........   ..++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+. ..+......   
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~---  229 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGER---  229 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCC---
Confidence            9987654332221   2235679999998664 48999999999999999997 9999987655443 233221100   


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                    .+          .+...+.++.+++.+||..||++||++.+++.+
T Consensus       230 --------------~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         230 --------------LP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             --------------CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                          00          122457789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.6e-39  Score=295.31  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=195.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      .++|.+.+.||+|+||.||++.....     ...+|+|.+.....     ...+|+++++.+ +|+||+++++++     
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----   85 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC-----   85 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----
Confidence            46899999999999999999997643     36899998865322     234688999999 899999999987     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCee
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL  168 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nil  168 (376)
                      ..+..++++|||+.+ +|...+....            .....+++..+..++.|++.||+|||+ +||+||||||+||+
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil  164 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL  164 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence            444558999999984 7777765421            234578999999999999999999999 79999999999999


Q ss_pred             ecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 017139          169 VDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD  244 (376)
Q Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  244 (376)
                      ++. ++.+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+
T Consensus       165 ~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            986 78899999999986543321   1122235679999998654 48999999999999999997 999998776655


Q ss_pred             HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ....+.....                            ...+...+.++.+|+.+||..||++|||+.+++++
T Consensus       243 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            4443322100                            00223468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=289.39  Aligned_cols=244  Identities=19%  Similarity=0.286  Sum_probs=193.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+.....   ...+|+++++.++||||+++++++     ......|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence            35899999999999999999875 466899998865432   344699999999999999999887     444568999


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+++ +|.+.+...   ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+++...+
T Consensus        78 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          78 TEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLD  152 (256)
T ss_pred             EecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECC-CCcEEECCcccceeccc
Confidence            999985 666666532   2468999999999999999999999 79999999999999996 78899999999876543


Q ss_pred             CCCcc--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          190 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       190 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .....  ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.....            
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------  219 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc------------
Confidence            22111  11224479999998764 48999999999999999998 8999987766555444322100            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                      ...+...+.++.+++.+||..+|++|||+.++++.
T Consensus       220 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 ----------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                            01223468899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.8e-39  Score=293.38  Aligned_cols=249  Identities=21%  Similarity=0.308  Sum_probs=194.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEc----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      .++|++.+.||+|+||+||+|...    .++..+++|.+....     ....+|+.+++.++||||+++++++     ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~   78 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQ   78 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ec
Confidence            467999999999999999999853    356789999886432     2345799999999999999999987     33


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhh-------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYS-------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV  169 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~-------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill  169 (376)
                      ....|+||||+++ +|.+.+....             .....+++..+..++.|++.||.|||+ +|++|+||||+||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili  157 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILI  157 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEE
Confidence            4458899999985 6666664211             012357888999999999999999999 799999999999999


Q ss_pred             cCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017139          170 DPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ  245 (376)
Q Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~  245 (376)
                      +. ++.+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+....
T Consensus       158 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~  235 (283)
T cd05090         158 GE-QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV  235 (283)
T ss_pred             cC-CCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            96 77899999999976533221   2233446679999998654 48999999999999999998 9999988765544


Q ss_pred             HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ...+.... .+                           ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       236 ~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         236 IEMVRKRQ-LL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHcCC-cC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            44332210 00                           0234578899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.5e-40  Score=295.24  Aligned_cols=248  Identities=21%  Similarity=0.267  Sum_probs=195.0

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ..+|.+.+.||.|+||.||+|.+..+     ++.||+|++.....     ...+|+.++..++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~   78 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----T   78 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----c
Confidence            34689999999999999999987543     57899999875432     234688899999999999999988     3


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV  169 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill  169 (376)
                      .....++++||+.+ +|...+....            .....+++..+..++.|++.||.|||+ +|++||||||+||++
T Consensus        79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~  157 (283)
T cd05091          79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLV  157 (283)
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEe
Confidence            44458899999985 6665653211            113458888999999999999999999 799999999999999


Q ss_pred             cCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017139          170 DPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ  245 (376)
Q Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~  245 (376)
                      +. ++.+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+....+.
T Consensus       158 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  235 (283)
T cd05091         158 FD-KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  235 (283)
T ss_pred             cC-CCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            85 77899999999876533221   12233467899999986554 8999999999999999998 8899988776665


Q ss_pred             HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ...+......                            .++...+.++.+++.+||+.||++||++.++++
T Consensus       236 ~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         236 IEMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            5544432110                            123457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=289.08  Aligned_cols=244  Identities=23%  Similarity=0.320  Sum_probs=194.1

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.+....   ....+|+.+++.++||||+++++++     .....+|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeee
Confidence            457999999999999999999865 45789999986543   2345789999999999999999987     34445889


Q ss_pred             Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||++ ++|.+.+....  +..+++..+..++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||++....
T Consensus        79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~  154 (261)
T cd05068          79 VTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGE-NNICKVADFGLARVIK  154 (261)
T ss_pred             eeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcC-CCCEEECCcceEEEcc
Confidence            999996 57777665422  3568999999999999999999999 79999999999999996 7789999999998765


Q ss_pred             cCCCcc--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          189 KGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       189 ~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ......  ....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+.......+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05068         155 EDIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM----------  223 (261)
T ss_pred             CCcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            322111  11223579999988654 48999999999999999999 99999887766555444321100          


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                        ..+...+..+.+++.+||+.||++||++.+++
T Consensus       224 ------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~  255 (261)
T cd05068         224 ------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQ  255 (261)
T ss_pred             ------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence                              01234688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-41  Score=314.52  Aligned_cols=206  Identities=27%  Similarity=0.402  Sum_probs=171.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecC-CCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT-SKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~-~~~~~~~  107 (376)
                      .-|...+.||+|+||.||+++++.+|+.||||.+....     ...-+|++++++++|+|||++.++--+.. ..-....
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            44888999999999999999999999999999986632     23347999999999999999987642111 0002234


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC---CCcEEEEecCC
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---THQVKLCDFGS  183 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~---~~~~kl~Dfg~  183 (376)
                      .+|||||.| +|...+.. -.....+++.+++.++..+..||.|||+ +||+||||||.||++-..   ....||+|||.
T Consensus        93 vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             eEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            699999996 66666654 3345679999999999999999999999 899999999999998421   33689999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN  241 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  241 (376)
                      |+...++....+.+||+.|.+||++..+..|+..+|.|||||++|+.+||..||-...
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9999999989999999999999999755679999999999999999999999996543

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.9e-39  Score=292.08  Aligned_cols=258  Identities=27%  Similarity=0.359  Sum_probs=190.0

Q ss_pred             cce-EeeeeeccCCceEEEEEE----EcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           34 ISY-MAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        34 ~~y-~~~~~Lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ++| .+.+.||+|+||+||++.    ...++..+|+|.+....     ....+|+++++.++||||+++++++..   ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence            456 899999999999998865    33568899999986542     233469999999999999999987643   23


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...++++|||+++ +|.+.+..     ..+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg  152 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFG  152 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcC-CCcEEEeecc
Confidence            4458899999996 55555543     459999999999999999999999 79999999999999996 7789999999


Q ss_pred             CccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCC
Q 017139          183 SAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPT  257 (376)
Q Consensus       183 ~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~  257 (376)
                      ++........    .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||......  ....... .+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~  229 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMT  229 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccc
Confidence            9876543222    1122346679999998654 4899999999999999999999998654321  1111110 00000


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ...+...            .........+...+.++.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         230 VVRLIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000000            0000111134467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4e-39  Score=287.92  Aligned_cols=243  Identities=26%  Similarity=0.334  Sum_probs=191.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ++|++.++||+|+||.||+|.+..+ ..+|+|++.....   ...+|+++++.++||||+++++.+     .+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-----SE-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-----CC-CCcEEE
Confidence            5799999999999999999998665 4599999875332   345799999999999999998765     22 236899


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+++ +|.+.+...  ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~-~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcC-CCcEEeccCCceeeccc
Confidence            999985 776666532  23457899999999999999999999 79999999999999996 77899999999876543


Q ss_pred             CCCc--ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          190 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       190 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ....  ....++..|+|||...+. .++.++|+|||||++|+|++ |..||.+....+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------  222 (262)
T ss_pred             cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-----------
Confidence            3221  123346679999988654 48999999999999999999 88999877665554433221000           


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                       ..+..++..+.+++.+||+.||++||++.++++
T Consensus       223 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 -----------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                             012346889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-39  Score=290.70  Aligned_cols=246  Identities=23%  Similarity=0.323  Sum_probs=198.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...+|++.+.||.|+||.||+|.+.. ++.+|+|.+.....    ....|+.+++.++||||+++++++     .+...+
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCe
Confidence            34579999999999999999999877 88999999865533    345688999999999999999887     344458


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++||||+++ +|.+.+...  ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||.+..
T Consensus        78 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~-~~~~kl~d~g~~~~  153 (261)
T cd05148          78 YIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGE-DLVCKVADFGLARL  153 (261)
T ss_pred             EEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcC-CceEEEccccchhh
Confidence            899999985 777777643  24568999999999999999999999 79999999999999996 78899999999876


Q ss_pred             cccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          187 LVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...... .....++..|+|||.+... .++.++|+||||+++|+|++ |..||.+.+..+.+..+......         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------  223 (261)
T cd05148         154 IKEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------  223 (261)
T ss_pred             cCCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---------
Confidence            543221 1123346679999998654 48899999999999999998 89999887766665554431100         


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                         ..+...++.+.+++.+||+.||++|||+.++++
T Consensus       224 -------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 -------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                               022356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-39  Score=288.00  Aligned_cols=246  Identities=23%  Similarity=0.294  Sum_probs=193.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC---CcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .++|++.+.||+|+||.||+|.+..+   ...+|+|.+.....     ...+|+.+++.++||||+++++.+     .+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence            35799999999999999999998654   45799998865432     233588999999999999999987     344


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..++++|||+++ +|.+.+..   ....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||+
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~-~~~~~l~dfg~  152 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGL  152 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCCEEECccch
Confidence            558899999986 66666543   23478999999999999999999999 79999999999999996 77899999999


Q ss_pred             ccccccCCCc-c--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          184 AKVLVKGEAN-I--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       184 ~~~~~~~~~~-~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      +......... .  ...++..|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+......    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----  227 (266)
T cd05033         153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL----  227 (266)
T ss_pred             hhcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            9876422211 1  12235679999998654 48999999999999999998 99999776655544433321000    


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                              ..+...++.+.+++.+||+.||++||++.+++++
T Consensus       228 ------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         228 ------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    0123568899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-39  Score=294.01  Aligned_cols=256  Identities=29%  Similarity=0.469  Sum_probs=198.0

Q ss_pred             ceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEecccc--------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           35 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      +|.+.+.||.|+||.||+|++.   .+++.+|+|.+.+..        .....|+.++.++ +||||+++++.+     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4899999999999999999864   467889999886421        2234688999999 599999999887     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .+..+|+||||+++ +|...+..    ...+++..++.++.|++.+|.|||+ .|++|+||+|+||+++. ++.++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDS-EGHVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEEEC
Confidence            45568999999986 55555443    3568999999999999999999999 79999999999999996 778999999


Q ss_pred             CCccccccCCC--cceeeccccccChhhhhCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          182 GSAKVLVKGEA--NISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       182 g~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      |++........  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+.......+.+.....  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--  227 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--  227 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence            99876543322  22345788999999986532 36789999999999999999999996543222222221110000  


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC---HHHHhCCCccccccCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP  326 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~hp~~~~~~~~  326 (376)
                                             ....+..++.++.++|.+||+.||++|||   +.++|+||||+.+.++
T Consensus       228 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         228 -----------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             -----------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                                   00123346889999999999999999998   5678999999998775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4e-39  Score=289.37  Aligned_cols=251  Identities=20%  Similarity=0.254  Sum_probs=191.7

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCc--EEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCcee
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF  106 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~~  106 (376)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.+....      ....+|..+++.++||||++++++++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3578899999999999999887775  58999875431      223468899999999999999987643321 12234


Q ss_pred             EEEEeecccc-hHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          107 LNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      .+++|||+.+ +|...+....  .....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcC-CCCEEECCCCc
Confidence            7899999984 6665553221  123458999999999999999999999 79999999999999986 77899999999


Q ss_pred             ccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          184 AKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       184 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ++.......   .....+++.|++||.+.+. .++.++|+|||||++|+|++ |..||.+....+....+.....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-----  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            987543321   1122346789999998654 48999999999999999999 8999987766544443322100     


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                             ...+..++..+.++|.+||+.||++|||+++++++
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                   00223467889999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.5e-39  Score=293.39  Aligned_cols=255  Identities=19%  Similarity=0.229  Sum_probs=195.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCC----------------cEEEEEEecccc-----cchHHHHHHHHhCCCCCeee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETG----------------ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVIS   91 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~----------------~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~   91 (376)
                      ..+|++++.||+|+||.||+|.+...+                ..+|+|.+....     ....+|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            467999999999999999999876543                468999886543     23346899999999999999


Q ss_pred             cceeeeecCCCCceeEEEEeecccc-hHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCC
Q 017139           92 LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS-------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK  163 (376)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlk  163 (376)
                      +++++     ..+..++++|||+.+ +|...+.....       ....+++..++.++.|++.||.|||+ +|++|+|||
T Consensus        84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk  157 (296)
T cd05051          84 LLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA  157 (296)
T ss_pred             EEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence            99988     334558899999985 67776655331       12368999999999999999999999 799999999


Q ss_pred             CCCeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh--CCCCCC
Q 017139          164 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP  238 (376)
Q Consensus       164 p~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~  238 (376)
                      |+||+++. ++.++|+|||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++  |..||.
T Consensus       158 p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         158 TRNCLVGK-NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             hhceeecC-CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            99999996 78899999999876433221   1233456789999998654 48999999999999999998  778887


Q ss_pred             CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          239 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ..+..+.+...........                     .......+...+.++.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         236 HLTDQQVIENAGHFFRDDG---------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CcChHHHHHHHHhcccccc---------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            7666555544433211100                     00000122346789999999999999999999999953

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.9e-39  Score=292.46  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=194.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..+|.+.+.||+|+||.||+|++..     ++..+++|.+....    ....+|+.+++.++||||+++++++     ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GD   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----cc
Confidence            3569999999999999999998643     45569999886543    2355789999999999999999988     44


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD  170 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~  170 (376)
                      ...+++||||+++ +|.+.+....            .....+++..++.++.||+.||+|||+ +|++||||||+||+++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~  157 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVG  157 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEc
Confidence            4558999999984 7776665422            122458999999999999999999999 7999999999999999


Q ss_pred             CCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017139          171 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL  246 (376)
Q Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  246 (376)
                      . ++.++|+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+..
T Consensus       158 ~-~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  235 (291)
T cd05094         158 A-NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI  235 (291)
T ss_pred             c-CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            6 78899999999876543221   2234457789999998764 48999999999999999999 99999877665544


Q ss_pred             HHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ..+...  ..                 +         ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~--~~-----------------~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         236 ECITQG--RV-----------------L---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHhCC--CC-----------------C---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            432210  00                 0         012346789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.4e-39  Score=286.02  Aligned_cols=243  Identities=21%  Similarity=0.305  Sum_probs=192.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .++|.+.+.||+|+||.||++..  .|..+|+|.+..+..  ....|+.+++.++|+|+++++++++.    .+..++++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv   78 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIV   78 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEE
Confidence            35799999999999999999976  478899998865433  34579999999999999999987642    33347899


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+++ +|.+.+...  ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          79 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcC-CCcEEecCCccceeccc
Confidence            999985 777766542  22458899999999999999999999 79999999999999996 78899999999875433


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ..  ....++..|+|||++.+. .++.++|+|||||++|+|++ |..||...+..+....+.+..               
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------  216 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------  216 (256)
T ss_pred             cC--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence            22  223345679999998654 48999999999999999997 999998766544443332210               


Q ss_pred             cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                   ....+..+++.+.+++.+||..||++|||+.++++
T Consensus       217 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 -------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                         00123457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.3e-39  Score=292.56  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=194.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeec
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFST   99 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~   99 (376)
                      ...++|.+.+.||+|+||.||+|.+.     .++..+|+|.+.....     ...+|+.+++++ +||||+++++++   
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---  108 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC---  108 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE---
Confidence            45578999999999999999999853     3456899998865422     244699999999 799999999988   


Q ss_pred             CCCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          100 TSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                        .....++++|||++ ++|.+.+...  ....+++..+..++.|++.||+|||+ ++++|+||||+||+++. ++.++|
T Consensus       109 --~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l  182 (302)
T cd05055         109 --TIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTH-GKIVKI  182 (302)
T ss_pred             --ecCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcC-CCeEEE
Confidence              33445899999998 4676666532  12348999999999999999999999 79999999999999985 778999


Q ss_pred             EecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017139          179 CDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       179 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      +|||++........   .....++..|+|||.+.+.. ++.++|+||+||++|+|++ |..||.+....+..........
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~  261 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY  261 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence            99999876543321   11233467899999986654 8999999999999999998 9999987765544443332100


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                 ....+...++++.+++.+||..+|++|||+.++++
T Consensus       262 ---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         262 ---------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                       00012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.5e-39  Score=294.33  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=192.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-------CCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeec
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFST   99 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~   99 (376)
                      .++|.+.+.||+|+||.||+|++..       +...+|+|.+..+..     ....|+.+++.+ +||||+++++++   
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~---   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC---   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence            4789999999999999999998643       235699998875422     234588899988 799999999988   


Q ss_pred             CCCCceeEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCC
Q 017139          100 TSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN  166 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~N  166 (376)
                        .....+|+||||+++ +|.+.+.....            ....+++..+..++.|++.||+|||+ +|++||||||+|
T Consensus        94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N  170 (307)
T cd05098          94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  170 (307)
T ss_pred             --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence              444458899999985 77777765321            12358889999999999999999999 799999999999


Q ss_pred             eeecCCCCcEEEEecCCccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 017139          167 LLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA  242 (376)
Q Consensus       167 ill~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  242 (376)
                      |+++. ++.+||+|||.+.........   ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+.
T Consensus       171 ill~~-~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         171 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             eEEcC-CCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            99996 778999999998765432111   112234679999998764 48999999999999999998 8899977665


Q ss_pred             HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .+....+... .                           ....+...+.++.+++.+||..+|++|||+.+++++
T Consensus       249 ~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         249 EELFKLLKEG-H---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHcC-C---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            4433332210 0                           001233568899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=310.99  Aligned_cols=268  Identities=27%  Similarity=0.393  Sum_probs=220.8

Q ss_pred             CCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           26 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        26 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      ...-|...+-|+|.+++|.|.+|+||+++.+.+++..|+|+...+..   ..+.|.++++.. .|||++.++++|.-...
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            33456667789999999999999999999999999999999865543   344677888877 59999999999977666


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      ..+..++||||||+| +..++++...  +.++.|..+..|++.++.||.+||. +.++|||||-.|||++. ++.|||+|
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~-e~~VKLvD  166 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTE-NAEVKLVD  166 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEec-cCcEEEee
Confidence            667789999999995 6666666655  7889999999999999999999999 79999999999999997 77899999


Q ss_pred             cCCccccccC-CCcceeeccccccChhhhhCCC----CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          181 FGSAKVLVKG-EANISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       181 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      ||.+...... ....+.+|||+|||||++....    .|+..+|+||||++..||.-|.+|+-+..+...+..|..    
T Consensus       167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR----  242 (953)
T KOG0587|consen  167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----  242 (953)
T ss_pred             eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC----
Confidence            9988665443 3456788999999999996543    267789999999999999999999987766544433221    


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                            ..|....-+++.+.++.+||..||.+|-.+||+..++|.|||+++.
T Consensus       243 ----------------------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  243 ----------------------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ----------------------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                                  1112222345678899999999999999999999999999999843

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.4e-39  Score=290.91  Aligned_cols=246  Identities=23%  Similarity=0.353  Sum_probs=190.7

Q ss_pred             ceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+.....     ...+|+.+++.++||||+++++.+     ...
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence            48899999999999999998753     235688888764432     244689999999999999999987     444


Q ss_pred             eeEEEEeeccc-chHHHHHHhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCC
Q 017139          105 LFLNLVMEYVP-ETMYRVLKHYS--------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK  163 (376)
Q Consensus       105 ~~~~lv~e~~~-g~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlk  163 (376)
                      ...++++||+. ++|.+.+....                    .....+++..+..++.|++.||+|||+ +|++|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence            45889999999 46666665421                    112458899999999999999999999 799999999


Q ss_pred             CCCeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 017139          164 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG  239 (376)
Q Consensus       164 p~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~  239 (376)
                      |+||+++. ++.+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+
T Consensus       155 p~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            99999986 78899999999876533221   1122346689999998654 48999999999999999998 9999987


Q ss_pred             CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ..............                            ....+..++.++.+++.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTGY----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            76554333222100                            00123457889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.9e-39  Score=284.99  Aligned_cols=243  Identities=24%  Similarity=0.324  Sum_probs=192.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+.....   ...+|+.+++.++|+||+++++++     .+ ...++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-----SE-EPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-----CC-CCcEE
Confidence            468999999999999999999865 556799998865322   345799999999999999998876     22 22679


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||+++ +|.+.+...  ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~-~~~~~l~dfg~~~~~~  153 (260)
T cd05070          78 VTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGD-GLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeC-CceEEeCCceeeeecc
Confidence            9999985 676666532  23568999999999999999999999 79999999999999996 7889999999997654


Q ss_pred             cCCCc--ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          189 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       189 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+.....           
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------  221 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-----------  221 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            32211  122345679999998654 48999999999999999999 8999988776655544432100           


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                       ...+...+..+.+++.+||..||++|||+++++
T Consensus       222 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         222 -----------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             -----------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                             012235688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=284.06  Aligned_cols=242  Identities=24%  Similarity=0.354  Sum_probs=194.1

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|.+.+.||.|+||.||+|..  .|+.+|+|.+.....   ...+|+.+++.++|+||+++++++.     +....++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEE
Confidence            35799999999999999999987  478999999976644   3446899999999999999999883     3445889


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      ||||+++ +|.+.+...  ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.++...
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~-~~~~~l~d~g~~~~~~  153 (256)
T cd05039          78 VTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSE-DLVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeC-CCCEEEcccccccccc
Confidence            9999994 777766542  12368999999999999999999999 79999999999999996 7889999999998763


Q ss_pred             cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ....  ....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+....              
T Consensus       154 ~~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------  216 (256)
T cd05039         154 QGQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY--------------  216 (256)
T ss_pred             cccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            2222  23345679999998654 48899999999999999997 999998776554433322110              


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                    ....+...++++.++|.+||..+|++|||+.+++.
T Consensus       217 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 --------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             --------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                          00122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-38  Score=292.15  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=193.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcC-------CCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFS   98 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~   98 (376)
                      ..++|.+.+.||+|+||.||+|++..       ....+|+|.+.....     ....|+.+++.+ +||||+++++++  
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC--   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE--
Confidence            34689999999999999999998642       345799998864322     234688899988 699999999988  


Q ss_pred             cCCCCceeEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCC
Q 017139           99 TTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ  165 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~  165 (376)
                         .+...+|++|||+++ +|...+.....            ....+++..+..++.|++.||.|||+ +|++||||||+
T Consensus        88 ---~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~  163 (314)
T cd05099          88 ---TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAAR  163 (314)
T ss_pred             ---ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccce
Confidence               344558999999984 77777765321            23458899999999999999999999 79999999999


Q ss_pred             CeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 017139          166 NLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN  241 (376)
Q Consensus       166 Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  241 (376)
                      ||+++. ++.+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+..
T Consensus       164 Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         164 NVLVTE-DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eEEEcC-CCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            999986 77899999999976543211   1112234579999998664 48999999999999999999 899998776


Q ss_pred             hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ..+....+.....                            ...+..++.++.+++.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         242 VEELFKLLREGHR----------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            6554443322100                            0022356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.3e-39  Score=298.18  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=190.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEE-----cCCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      .++|++.+.||.|+||.||+|.+     ..+++.||||.+....     ....+|+.++..+ +||||+++++++..   
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---   82 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence            35799999999999999999985     3467899999986532     1234699999999 68999999987742   


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSS-----------------------------------------------------  127 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~-----------------------------------------------------  127 (376)
                       .+..++++||||++ +|.+.+.....                                                     
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence             23457899999995 67666643210                                                     


Q ss_pred             ----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC---cc
Q 017139          128 ----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NI  194 (376)
Q Consensus       128 ----------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~  194 (376)
                                ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++........   ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcC-CCcEEEEecccccccccCcchhhcC
Confidence                      01246788889999999999999999 79999999999999996 77899999999876432211   11


Q ss_pred             eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccC
Q 017139          195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF  273 (376)
Q Consensus       195 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||............+.....+                 
T Consensus       240 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  301 (343)
T cd05103         240 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----------------  301 (343)
T ss_pred             CCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-----------------
Confidence            22345679999998664 48999999999999999997 999997754433332222110000                 


Q ss_pred             CCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                ..+...++++.+++.+||+.||++|||+.++++|
T Consensus       302 ----------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         302 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      0122357889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-38  Score=283.69  Aligned_cols=242  Identities=24%  Similarity=0.316  Sum_probs=191.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ++|.+.+.||+|++|.||+|.+..+ ..+|+|.+.....   ...+|+.+++.++|||++++++++     .+ ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-----SE-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE-----cC-CCcEEE
Confidence            5799999999999999999987655 4699998765432   234699999999999999998876     22 236799


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~-~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGD-NLVCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCeEEECCCccceEccC
Confidence            999985 777777542  23457899999999999999999999 79999999999999996 78899999999976533


Q ss_pred             CCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          190 GEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       190 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...  .....++..|+|||...+. .++.++|+|||||++|+|++ |..||.+....+....+.... .+          
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~----------  222 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RM----------  222 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC----------
Confidence            221  1123346679999988654 48999999999999999999 999998877665554433210 00          


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                       ..+...+..+.+++.+||.+||++||++++++
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  254 (260)
T cd05069         223 -----------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQ  254 (260)
T ss_pred             -----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHH
Confidence                             12235688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-39  Score=291.49  Aligned_cols=255  Identities=20%  Similarity=0.246  Sum_probs=192.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCC--------------cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETG--------------ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLK   93 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~--------------~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~   93 (376)
                      .++|++.+.||+|+||.||+|.+..++              ..||+|.+.....     ...+|+++++.++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            357999999999999999999875432              3589998865422     234699999999999999999


Q ss_pred             eeeeecCCCCceeEEEEeecccc-hHHHHHHhhhh--------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCC
Q 017139           94 HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS--------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP  164 (376)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~--------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp  164 (376)
                      +++     ......++||||+.+ +|.+.+.....        ....+++..+..++.|++.||+|||+ +|++|+||||
T Consensus        84 ~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp  157 (295)
T cd05097          84 GVC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT  157 (295)
T ss_pred             EEE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence            988     344458899999985 66666643211        11246888999999999999999999 7999999999


Q ss_pred             CCeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh--CCCCCCC
Q 017139          165 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG  239 (376)
Q Consensus       165 ~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~  239 (376)
                      +||+++. ++.+||+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++  |..||..
T Consensus       158 ~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         158 RNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhEEEcC-CCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            9999995 77899999999876533221   1122336689999998654 48999999999999999998  6788887


Q ss_pred             CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .+..+....+.+.......                     ......+...++.+.+|+.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         236 LSDEQVIENTGEFFRNQGR---------------------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cChHHHHHHHHHhhhhccc---------------------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            7665555443331100000                     0000012346789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=284.49  Aligned_cols=246  Identities=25%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...++|++.+.||+|+||.||+|.+. +++.+|+|.+.....   ...+|+.+++.++|+||+++++++     .....+
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPI   76 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCce
Confidence            34578999999999999999999975 457899998875432   345799999999999999999887     344458


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++||||+++ +|.+.+...  .+..+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~  152 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGE-NLVCKIADFGLARL  152 (261)
T ss_pred             EEEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcC-CCCEEECcccccee
Confidence            999999985 676666542  23568999999999999999999999 79999999999999996 78899999999876


Q ss_pred             cccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          187 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       187 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ......  .....++..|+|||.+.+. .++.++|+||+||++|+|++ |+.||.+.+....+..+......        
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------  223 (261)
T cd05034         153 IEDDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM--------  223 (261)
T ss_pred             ccchhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            543211  1122335679999998754 48999999999999999998 99999887766666554332110        


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                          ..+...+.++.+++.+||+.||++||++++++
T Consensus       224 --------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  255 (261)
T cd05034         224 --------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQ  255 (261)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence                                11234578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.2e-39  Score=300.89  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=195.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeccccc-----chHHHHHHHHhCC-CCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~  100 (376)
                      ..++|.+.+.||+|+||.||+|++.     .+++.||+|++.....     ...+|+.++.++. ||||+++++++.   
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---  111 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT---  111 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc---
Confidence            3467899999999999999999864     3456899999965422     2346999999997 999999999883   


Q ss_pred             CCCceeEEEEeeccc-chHHHHHHhhhh----------------------------------------------------
Q 017139          101 SKDELFLNLVMEYVP-ETMYRVLKHYSS----------------------------------------------------  127 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~----------------------------------------------------  127 (376)
                        ....+++|||||. |+|.+.+.....                                                    
T Consensus       112 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         112 --KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             --cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence              3345899999999 477777754211                                                    


Q ss_pred             ------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCC
Q 017139          128 ------------------------------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ  165 (376)
Q Consensus       128 ------------------------------------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~  165 (376)
                                                                ....+++..++.++.|++.||+|||+ ++++||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~  268 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR  268 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence                                                      11246777889999999999999999 79999999999


Q ss_pred             CeeecCCCCcEEEEecCCccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 017139          166 NLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN  241 (376)
Q Consensus       166 Nill~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  241 (376)
                      |||++. ++.+||+|||+++......   ......++..|+|||.+.+. .++.++|+|||||++|+|++ |..||....
T Consensus       269 NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         269 NVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             eEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999996 7889999999987643222   12234567889999998654 48999999999999999998 899998765


Q ss_pred             hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ..+.....+.....                           ...+..++.++.+++.+||..||.+||++.+++..
T Consensus       347 ~~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         347 MNEQFYNAIKRGYR---------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             chHHHHHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55544433321000                           01233568899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.5e-39  Score=289.37  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=193.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .+|.+.+.||+|+||.||+|.+.     .++..+|+|.+....    ....+|+++++.++|+||+++++++     .+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence            57899999999999999999753     346689999876432    2345789999999999999999887     334


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSS-----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL  172 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~  172 (376)
                      ..++++|||+++ +|.+.+.....           ....+++..+..++.|++.||+|||+ +|++|+||||+||+++. 
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~-  157 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQ-  157 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcC-
Confidence            458899999985 77666654321           11358899999999999999999999 79999999999999996 


Q ss_pred             CCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017139          173 THQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE  248 (376)
Q Consensus       173 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~  248 (376)
                      ++.+||+|||++........   .....+++.|+|||.+.+.. ++.++|+|||||++|+|++ |.+||......+....
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            78899999999875433221   12233467899999987654 8999999999999999998 9999987766655544


Q ss_pred             HHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      +.....                            ...+..+++.+.+++.+||+.||.+||++++++.
T Consensus       237 ~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            332100                            0122356889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-41  Score=296.93  Aligned_cols=266  Identities=24%  Similarity=0.396  Sum_probs=210.0

Q ss_pred             CCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----------cchHHHHHHHHhCCCCCeeecce
Q 017139           26 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKH   94 (376)
Q Consensus        26 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h~~Iv~~~~   94 (376)
                      +.-+|...++|-++..||+|||+.||+|.+....+.||+|+-....           +..-+|..+-+.|+||.||++++
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            3457888999999999999999999999999999999999753221           12237999999999999999999


Q ss_pred             eeeecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CCceeccCCCCCeeecCC
Q 017139           95 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPL  172 (376)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~~ivH~dlkp~Nill~~~  172 (376)
                      +|..    +...+|-|+|||+| +|..+|+.    +..+++.+++.|+.||+.||.||.+. ..|+|-||||.|||+-..
T Consensus       535 yfsl----DtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G  606 (775)
T KOG1151|consen  535 YFSL----DTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG  606 (775)
T ss_pred             eeee----ccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC
Confidence            9853    33348899999998 55555554    67799999999999999999999973 359999999999999532


Q ss_pred             --CCcEEEEecCCccccccCCCc--------ceeeccccccChhhhhC---CCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 017139          173 --THQVKLCDFGSAKVLVKGEAN--------ISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPG  239 (376)
Q Consensus       173 --~~~~kl~Dfg~~~~~~~~~~~--------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~  239 (376)
                        .|.+||+|||+++.+..+...        ....||.||++||.+.-   .+.++.++||||+|||+|..+.|+.||..
T Consensus       607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence              357999999999988654332        34578999999998732   34578999999999999999999999976


Q ss_pred             CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                      +.....+.+--.++.             ..+..||.          .+.+++++++||++||++--.+|+.+.++..|||
T Consensus       687 nqsQQdILqeNTIlk-------------AtEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpy  743 (775)
T KOG1151|consen  687 NQSQQDILQENTILK-------------ATEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPY  743 (775)
T ss_pred             chhHHHHHhhhchhc-------------ceeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence            654433322111111             12222221          1358999999999999999999999999999999


Q ss_pred             ccc
Q 017139          320 FDE  322 (376)
Q Consensus       320 ~~~  322 (376)
                      |.-
T Consensus       744 llP  746 (775)
T KOG1151|consen  744 LLP  746 (775)
T ss_pred             ccc
Confidence            964

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.2e-39  Score=286.97  Aligned_cols=228  Identities=26%  Similarity=0.340  Sum_probs=181.3

Q ss_pred             CCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecccc-hHHHHHH
Q 017139           45 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK  123 (376)
Q Consensus        45 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~  123 (376)
                      |.+|.||+|++..+++.||+|.+...... .+|...+....||||+++++++     .+...++++|||++| +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~-~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY-SRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhh-hhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence            88999999999999999999999765433 3455555566799999999988     444568999999995 6666665


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCcceeecccccc
Q 017139          124 HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR  203 (376)
Q Consensus       124 ~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~  203 (376)
                      .    ...+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++++|||.+......  .....++..|+
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEecccchhccccc--cccCCcCcccc
Confidence            4    2458999999999999999999999 79999999999999996 778999999987654332  12334567799


Q ss_pred             ChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCccc
Q 017139          204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK  283 (376)
Q Consensus       204 aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      |||.+.+. .++.++|+||+||++|+|++|..||......     +..                ..            ..
T Consensus       150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~----------------~~------------~~  195 (237)
T cd05576         150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----INT----------------HT------------TL  195 (237)
T ss_pred             CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc----------------cc------------cc
Confidence            99988554 4789999999999999999999887533210     000                00            00


Q ss_pred             ccccCCChhHHHHHHhhcCCCCCCCCCH-----HHHhCCCcc
Q 017139          284 VFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFF  320 (376)
Q Consensus       284 ~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~~  320 (376)
                      .++..+++.+.++|.+||+.||++|+++     +++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1334578899999999999999999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-38  Score=284.13  Aligned_cols=244  Identities=24%  Similarity=0.319  Sum_probs=193.5

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++.++||+|+||.||+|... +++.+|+|.+.....   ...+|+.+++.++|+||+++++++.     + ..+++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEE
Confidence            467999999999999999999854 578899999875443   3356999999999999999988752     1 23789


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||+.+ +|.+.+...  .+..+++..+..++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~  153 (260)
T cd05067          78 ITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSE-TLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcC-CCCEEEccCcceeecC
Confidence            9999985 676666432  24568999999999999999999999 79999999999999996 7789999999987654


Q ss_pred             cCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          189 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       189 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  .....++..|+|||.+.+. .++.++|+||||+++|++++ |..||.+.+..+....+......          
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------  222 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----------  222 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----------
Confidence            2221  1123346689999998654 48899999999999999999 99999887765554443221110          


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                        ..+...+.++.+++.+||..||++|||++++++
T Consensus       223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                              022346889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-38  Score=287.43  Aligned_cols=245  Identities=22%  Similarity=0.308  Sum_probs=191.5

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCc----EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...+|++.+.||+|+||+||+|.+..+++    .||+|.+....     ....+|..+++.++||||+++++++..    
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC----
Confidence            34679999999999999999999877776    48999885432     223468889999999999999988732    


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                        ...++++||++ |+|.+.+..   ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+||
T Consensus        81 --~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~-~~~~kL~df  153 (279)
T cd05109          81 --STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKS-PNHVKITDF  153 (279)
T ss_pred             --CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcC-CCcEEECCC
Confidence              12668999998 577666654   23568999999999999999999999 79999999999999985 778999999


Q ss_pred             CCccccccCCCcc---eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          182 GSAKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       182 g~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |+++.........   ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.......... .+.....++
T Consensus       154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~  231 (279)
T cd05109         154 GLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLP  231 (279)
T ss_pred             CceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC
Confidence            9998664332221   12335679999998655 48999999999999999998 999997765544333 222111100


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                 .+...+.++.+++.+||..||++||++.+++.
T Consensus       232 ---------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 ---------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ---------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                       12346889999999999999999999999983

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-38  Score=291.42  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=195.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-------CCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFS   98 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~   98 (376)
                      ..++|.+.+.||+|+||.||+|++.       .++..+|+|.+....     ....+|+.+++.+ +||||+++++++  
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--   90 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--   90 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence            4578999999999999999999753       234579999886432     2345789999999 899999999988  


Q ss_pred             cCCCCceeEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCC
Q 017139           99 TTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ  165 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~  165 (376)
                         .....+|++|||+++ +|.+.+.....            ....++...+..++.|++.||.|||+ +|++||||||+
T Consensus        91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~  166 (304)
T cd05101          91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR  166 (304)
T ss_pred             ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence               344558899999985 77777765321            12457888899999999999999999 79999999999


Q ss_pred             CeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 017139          166 NLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN  241 (376)
Q Consensus       166 Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  241 (376)
                      ||+++. ++.+||+|||+++.......   .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+..
T Consensus       167 Nili~~-~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         167 NVLVTE-NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             eEEEcC-CCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999986 78899999999986643221   1123346779999998664 48999999999999999998 889998776


Q ss_pred             hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ..+....+.... .                           ...+...+.++.+++.+||..+|++|||+.++++.
T Consensus       245 ~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKEGH-R---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            655444332210 0                           00123568899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=282.90  Aligned_cols=264  Identities=25%  Similarity=0.341  Sum_probs=207.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc-----hHHHHH-HHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQ-LMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~e~~-~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++.+-+..||.|+||+|++..++.+|+..|||.+......     +..|.+ +++.-+.||||++++..+.+++     .
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c  138 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C  138 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence            4444566899999999999999999999999999755432     223444 3455579999999999876554     7


Q ss_pred             EEEeecccchHHHHHHh-hhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|.||.|+-++..+.+. +.-....++|..+-.|....+.||.||.+..+|+|||+||+|||++. .|.+||||||.+..
T Consensus       139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeecccchHh
Confidence            89999999877655543 33345679999999999999999999997558999999999999997 88899999999988


Q ss_pred             cccCCCcceeeccccccChhhhhCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ..+.-..+...|-..|||||.+..... |+.+||+||||++|||++||.+|+.+-+. .+++.++..  |.|+.-.... 
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~~~-  294 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLFDK-  294 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecCcc-
Confidence            877777777788889999999965444 89999999999999999999999977543 233333322  2222110000 


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                                          ---.++..+..+|..||.+|-+.||.-.+++.+||++.....
T Consensus       295 --------------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  295 --------------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             --------------------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence                                001378899999999999999999999999999999876443

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-38  Score=284.07  Aligned_cols=234  Identities=25%  Similarity=0.335  Sum_probs=184.2

Q ss_pred             eeccCCceEEEEEEE--cCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           41 VVGTGSFGIVFQAKC--LETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      .||+|+||.||+|..  ..++..+|+|++.....      ....|+.+++.++||||+++++++     .++ ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence            689999999999964  45678999998854322      234688999999999999998876     222 3679999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCC
Q 017139          113 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE  191 (376)
Q Consensus       113 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~  191 (376)
                      |+++ +|.+.+..    ...+++..+..++.|++.||+|||+ +|++||||||.||+++. ++.+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcC-CCeEEECCCccccccCCCC
Confidence            9995 56665543    3568999999999999999999999 79999999999999996 7789999999987664332


Q ss_pred             Cc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          192 AN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       192 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..    ....++..|+|||.+... .++.++|+|||||++|+|++ |..||.+.+..+....+.+.. .           
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~-----------  216 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-R-----------  216 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-C-----------
Confidence            21    112235689999988644 48899999999999999998 999998876655444332210 0           


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                      ...+..+++++.++|.+||+.||++||+++++.
T Consensus       217 ----------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~  249 (257)
T cd05116         217 ----------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVE  249 (257)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHH
Confidence                            012345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-38  Score=284.86  Aligned_cols=249  Identities=21%  Similarity=0.376  Sum_probs=197.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcC-CCcEEEEEEecccc--------------cchHHHHHHHH-hCCCCCeeecceeeee
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR--------------RYKNRELQLMR-LMDHPNVISLKHCFFS   98 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~--------------~~~~~e~~~l~-~l~h~~Iv~~~~~~~~   98 (376)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....              .....|..++. .++||||+++++++  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            48899999999999999999987 67899999875321              01224666665 47999999999988  


Q ss_pred             cCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139           99 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                         .++...+++|||+++ +|.+.+.........+++..++.++.|++.+|.|||+..|++|+||+|+||+++. ++.++
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~~~  154 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVT  154 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCcEE
Confidence               455568999999985 6766665544456679999999999999999999995258999999999999996 77899


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |+|||.+.............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+......+ 
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  232 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-  232 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence            99999998765544444566788999999997644 8999999999999999999999998776554444333211110 


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                                ......++++.+++.+||+.||++||++.|+..+
T Consensus       233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                      0112467899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=286.50  Aligned_cols=241  Identities=24%  Similarity=0.338  Sum_probs=185.8

Q ss_pred             eeeccCCceEEEEEEEcCCCc--EEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|++..++.  .+++|.+....     ....+|++++..+ +||||+++++++     .....++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEE
Confidence            368999999999999988776  46888776422     2334689999999 799999999988     4445589999


Q ss_pred             eccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          112 EYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       112 e~~~-g~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                      ||++ ++|.+.+.....            ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~-~~~~kl  153 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKI  153 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcC-CCeEEE
Confidence            9998 577777765321            12358899999999999999999999 79999999999999996 788999


Q ss_pred             EecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          179 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       179 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      +|||++..............+..|+|||++... .++.++|+|||||++|+|++ |..||.+.+..+....+....    
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----  228 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----  228 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----
Confidence            999998643221111122235679999998654 48999999999999999997 999998766554444332100    


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                    ..          ..+...+.++.+++.+||..||.+|||++++++
T Consensus       229 --------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 --------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             --------------CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                          00          012346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1e-38  Score=289.31  Aligned_cols=248  Identities=25%  Similarity=0.304  Sum_probs=194.5

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||.||+|.+..     ++..+|+|.+....     ....+|+.+++.++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence            4679999999999999999998753     57889999886542     2344689999999999999999987     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhh------------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCC
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYS------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK  163 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~------------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlk  163 (376)
                      .+..++++|||+++ +|.+.+....                  .....+++..++.++.|++.||.|||+ +|++|||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~  157 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA  157 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence            44458899999995 7777775421                  112347888999999999999999999 799999999


Q ss_pred             CCCeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 017139          164 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG  239 (376)
Q Consensus       164 p~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~  239 (376)
                      |+||+++. ++.++|+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+
T Consensus       158 p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         158 TRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             HhheEecC-CCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999986 78899999999875432211   1122345679999998665 48999999999999999997 8889987


Q ss_pred             CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ....+....+.....                            ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         236 MAHEEVIYYVRDGNV----------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            776655543322100                            0012346889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-38  Score=285.87  Aligned_cols=245  Identities=25%  Similarity=0.345  Sum_probs=192.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..+|++.+.||+|+||.||+|.+..++.   .+|+|.+....     .....|+.+++.++||||+++++++     ..+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS   77 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            3579999999999999999999875543   69999886432     2345688999999999999999987     344


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+||||+++ +|.+.+..   ....+++..+..++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~-~~~~~l~dfg~  152 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNS-NLVCKVSDFGL  152 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECC-CCeEEeCCCCc
Confidence            458899999985 66655543   23468999999999999999999999 79999999999999986 77899999999


Q ss_pred             ccccccCCCcc----eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          184 AKVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +..........    ...++..|+|||.+.+. .++.++|+|||||++|++++ |..||...+..+....+.+...    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----  227 (267)
T cd05066         153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----  227 (267)
T ss_pred             ccccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc----
Confidence            98764432211    11224579999999654 48999999999999999886 9999987766554444332110    


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                    .+          .+..+++.+.+++.+||+.+|.+||++.++++
T Consensus       228 --------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 --------------LP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             --------------CC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                          00          12346889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-38  Score=285.10  Aligned_cols=244  Identities=22%  Similarity=0.312  Sum_probs=192.7

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ++|+..+.||+|+||.||+|.+..++.   .+|+|.+....     .....|+.+++.++||||+++.+++     .+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence            478999999999999999999876654   69999886442     2234688999999999999999988     4444


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..++||||+++ +|...+..   ....+++..+..++.|++.||+|||+ .|++|+||||+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNS-NLECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcC-CCcEEECCCccc
Confidence            58899999996 55555543   23568999999999999999999999 79999999999999996 778999999998


Q ss_pred             cccccCCCcc----eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          185 KVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       185 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ..........    ....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+......+   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---  230 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---  230 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence            7654332211    11124569999998654 47999999999999999997 999998777655554443211100   


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                               .+...+.++.+++.+||+.||++||++.++++
T Consensus       231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                     11246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.6e-39  Score=286.01  Aligned_cols=242  Identities=26%  Similarity=0.382  Sum_probs=188.8

Q ss_pred             EeeeeeccCCceEEEEEEEc----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           37 MAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .+.+.||.|+||.||+|...    ..+..|+||.+....     ....+|++.++.++||||+++++++....     .+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PL   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----cc
Confidence            46789999999999999987    346789999995432     23446899999999999999999986322     28


Q ss_pred             EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++|||||+ |+|.+.+...  ....+++..+..|+.||+.||.|||+ ++++|++|+++||+++. ++.+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDS-NGQVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEET-TTEEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccc
Confidence            89999998 5788888763  24678999999999999999999999 79999999999999996 78999999999987


Q ss_pred             cccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          187 LVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       187 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ......   .....+...|+|||.+.... ++.++||||||+++||+++ |..||...+..+....+.+...        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence            632222   12334577899999997655 8999999999999999999 7899988877776665533110        


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                          ...+..++..+.++|.+||..||++|||+.++++
T Consensus       224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                1123457899999999999999999999999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=289.75  Aligned_cols=254  Identities=18%  Similarity=0.211  Sum_probs=184.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCC---CcEEEEEEecccccchHH---------------HHHHHHhCCCCCeeeccee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKNR---------------ELQLMRLMDHPNVISLKHC   95 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~---------------e~~~l~~l~h~~Iv~~~~~   95 (376)
                      ++|.+.+.||+|+||+||+|.+..+   +..+|+|+..........               +...+..+.|++|++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5799999999999999999998877   667788865332222111               2223445689999999887


Q ss_pred             eeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc
Q 017139           96 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ  175 (376)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~  175 (376)
                      ..... ....+.+++++++..++...+...    ...++..++.++.|++.||+|||+ ++|+||||||+|||++. ++.
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~-~~~  164 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDG-NNR  164 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCc
Confidence            64332 223456789998887766555432    335788899999999999999999 79999999999999986 778


Q ss_pred             EEEEecCCccccccCC--------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 017139          176 VKLCDFGSAKVLVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV  247 (376)
Q Consensus       176 ~kl~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  247 (376)
                      ++|+|||+++......        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999987653221        11234689999999998765 48999999999999999999999998764322222


Q ss_pred             HHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ...+.      +.+......               .......++++.++++.|+..+|++||+.+++++
T Consensus       244 ~~~~~------~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKC------DFIKRLHEG---------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHH------HHHHHhhhh---------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11110      000000000               0011245789999999999999999999999863

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.3e-38  Score=282.09  Aligned_cols=239  Identities=24%  Similarity=0.341  Sum_probs=190.0

Q ss_pred             eeeccCCceEEEEEEEcC-CCc--EEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|++|.||+|.+.. +++  .+|+|.+.....     ...+|+.++++++||||+++++.+.     + ..+++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence            468999999999999865 333  699999876544     3446999999999999999999873     3 5588999


Q ss_pred             eccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||++ ++|.+.+.....  ..+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEec-CCEEEecccccccccccc
Confidence            9997 577776665321  568999999999999999999999 79999999999999996 788999999998876442


Q ss_pred             CCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          191 EAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       191 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ...    ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+......          
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  219 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER----------  219 (257)
T ss_pred             ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc----------
Confidence            211    123456789999998654 48999999999999999998 99999877766655544331000          


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                       ...+...+..+.+++.+||+.+|++||++.++++
T Consensus       220 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 -----------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                             0012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.9e-38  Score=284.57  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=192.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      .+|.+.+.||+|+||.||+|.+..+++   .||+|.+....     .....|+.+++.++||||+++++++     .++.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            469999999999999999999887765   59999886532     2334689999999999999999987     4445


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+++||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~-~~~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcC-CCcEEECCCccc
Confidence            58899999986 55555543   23568999999999999999999999 79999999999999986 778999999998


Q ss_pred             cccccCCCcce---ee---ccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          185 KVLVKGEANIS---YI---CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       185 ~~~~~~~~~~~---~~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      ...........   ..   .+..|+|||.+.+. .++.++|+||+||++|++++ |..||...+..+....+.....   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~---  229 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR---  229 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc---
Confidence            76543222111   11   13469999998654 48999999999999999886 9999987766554444322100   


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                     .+          .+..++..+.+++.+||..+|++||++++++.
T Consensus       230 ---------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         230 ---------------LP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ---------------CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           00          12346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.3e-38  Score=284.94  Aligned_cols=249  Identities=22%  Similarity=0.280  Sum_probs=194.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      .+|.+.+.||.|+||.||+|+.+.     +.+.+++|.+.....     ...+|+.+++.++|+||+++++++     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            679999999999999999999754     346799998855432     245799999999999999999987     44


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSM-----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                      ....|+||||++ ++|.+.+......     ...+++..+..++.|++.||+|||+ +||+|+||||+||+++. ++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSS-QREVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeC-CCcEE
Confidence            556899999998 4777776543211     1268999999999999999999999 79999999999999996 77899


Q ss_pred             EEecCCccccccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017139          178 LCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       178 l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      ++|||++.......  ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+.... 
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-  235 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-  235 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-
Confidence            99999986543221  122334567799999986544 7899999999999999998 889997765544443332110 


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                                +....+..++..+.+++.+||..||++|||+.+++++
T Consensus       236 --------------------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 --------------------------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --------------------------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                      0001223578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-39  Score=319.65  Aligned_cols=256  Identities=31%  Similarity=0.460  Sum_probs=192.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeee----------
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFS----------   98 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~----------   98 (376)
                      .+|+..+.||+||||.||+|+++-+|+.||||++....     ....+|+.++.+|+|||||+++..+..          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            56888999999999999999999999999999996552     224479999999999999998744310          


Q ss_pred             --------------------------------------------cC---------C------------------------
Q 017139           99 --------------------------------------------TT---------S------------------------  101 (376)
Q Consensus        99 --------------------------------------------~~---------~------------------------  101 (376)
                                                                  ..         +                        
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                        00         0                        


Q ss_pred             --------------------C-------CceeEEEEeecccchHHHHHHhhhhcCCCC-CHHHHHHHHHHHHHHHHHhHc
Q 017139          102 --------------------K-------DELFLNLVMEYVPETMYRVLKHYSSMNQRM-PLIYVKLYTYQIFRGLAYIHT  153 (376)
Q Consensus       102 --------------------~-------~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l-~~~~~~~i~~qil~aL~~LH~  153 (376)
                                          .       ...++||-||||+.+++..+...   +... .....|+++.||+.||.|+|+
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~---N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR---NHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh---cccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                0       00567999999998766665542   2222 467789999999999999999


Q ss_pred             CCCceeccCCCCCeeecCCCCcEEEEecCCccccc-------------------cCCCcceeeccccccChhhhhCCC--
Q 017139          154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-------------------KGEANISYICSRYYRAPELIFGAT--  212 (376)
Q Consensus       154 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--  212 (376)
                       .|||||||||.|||+++ ++.|||+|||+|....                   +....++.+||..|+|||++.+..  
T Consensus       716 -~giIHRDLKP~NIFLd~-~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  716 -QGIIHRDLKPRNIFLDS-RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             -CceeeccCCcceeEEcC-CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence             69999999999999996 7789999999997621                   112345678999999999997655  


Q ss_pred             CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChh
Q 017139          213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE  292 (376)
Q Consensus       213 ~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (376)
                      .|+.++|+||||+|++||+.   ||...  .+.. .++..+....               +|..      .-|...--+.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa-~iL~~LR~g~---------------iP~~------~~f~~~~~~~  846 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTS--MERA-SILTNLRKGS---------------IPEP------ADFFDPEHPE  846 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCch--HHHH-HHHHhcccCC---------------CCCC------cccccccchH
Confidence            59999999999999999994   45422  2222 2222211111               1110      1122223456


Q ss_pred             HHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          293 AIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       293 ~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                      -..+|..||+.||++||||.|+|++.||-
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            67999999999999999999999999997

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-38  Score=293.50  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=193.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC-------CcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeec
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFST   99 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~   99 (376)
                      ..+|++++.||+|+||.||+|.+...       +..+|+|.+....     ....+|+++++.+ +||||+++++++   
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC---   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE---
Confidence            35799999999999999999986432       2368999876432     2344689999999 799999999988   


Q ss_pred             CCCCceeEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCC
Q 017139          100 TSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN  166 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~N  166 (376)
                        .....++++|||+++ +|.+.+.....            ....++...+..++.|++.||.|||+ +|++||||||+|
T Consensus        88 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  164 (334)
T cd05100          88 --TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN  164 (334)
T ss_pred             --ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence              344458899999985 77777664321            23457888899999999999999999 799999999999


Q ss_pred             eeecCCCCcEEEEecCCccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 017139          167 LLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA  242 (376)
Q Consensus       167 ill~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  242 (376)
                      |+++. ++.+||+|||+++........   ....++..|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+.
T Consensus       165 ill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         165 VLVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEEcC-CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99996 778999999998765432211   122234679999998664 48999999999999999998 8999988766


Q ss_pred             HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .+....+.....                            ...+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         243 EELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            554443322100                            01223568899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=281.26  Aligned_cols=236  Identities=27%  Similarity=0.383  Sum_probs=185.6

Q ss_pred             eeeccCCceEEEEEEEcCCC---cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|....++   ..+|+|.+.....     ...+|+.+++.++||||+++++++     ..+ .+++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~-~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-----KGE-PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----cCC-ceEEEE
Confidence            47999999999999876554   7899999865543     234688999999999999999876     222 368999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||+++ +|.+.+..    ...+++..+..++.|++.||+|||. .|++|+||||+||+++. ++.+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcC-CCcEEeccccccceeecC
Confidence            99985 67666654    3478999999999999999999999 79999999999999996 788999999998866433


Q ss_pred             CCcc----eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          191 EANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       191 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....    ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+... ..          
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~----------  216 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ER----------  216 (257)
T ss_pred             CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-Cc----------
Confidence            2211    11124579999998654 48999999999999999998 99999877665444333221 00          


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                       ...+..++..+.+++.+||..||++||++.++++
T Consensus       217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             0122356889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-38  Score=285.07  Aligned_cols=250  Identities=20%  Similarity=0.265  Sum_probs=194.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcC----CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ..++|.+.+.||+|+||.||+|.+..    ++..+++|.+....     ....+|+.+++.++||||+++++++...   
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence            45789999999999999999999876    35789999886442     2234688999999999999999976432   


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSM----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                       ....++++||++ ++|...+......    ...+++..+..++.|++.||+|||+ ++++|+||||+||+++. ++.+|
T Consensus        81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~k  157 (280)
T cd05043          81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDE-ELQVK  157 (280)
T ss_pred             -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcC-CCcEE
Confidence             344789999998 5777766543222    1568999999999999999999999 79999999999999986 78899


Q ss_pred             EEecCCccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 017139          178 LCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL  253 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  253 (376)
                      |+|||+++........   ....++..|+|||.+.+. .++.++|||||||++|++++ |..||...+..+....+....
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  236 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY  236 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence            9999999765332211   122345679999998665 48999999999999999998 999998776654333222110


Q ss_pred             CCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                        ..          ..+..+++++.+++.+||..||++|||+.++++
T Consensus       237 ------------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 ------------------RL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ------------------CC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                              00          012246789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.7e-38  Score=280.50  Aligned_cols=243  Identities=27%  Similarity=0.396  Sum_probs=194.3

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCC----cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +++.+.||.|+||.||+|.+...+    ..+|+|.+.....     ....|+.+++.++|+||+++++++.     +...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence            356789999999999999998766    8999999865432     3446899999999999999999883     3455


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+++|||+++ +|.+.+....  ...+++..+..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~  151 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGE-NLVVKISDFGLSR  151 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEcc-CCeEEEcccCCce
Confidence            8999999985 6666665421  1228999999999999999999999 79999999999999996 7789999999997


Q ss_pred             ccccCCCcc--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          186 VLVKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       186 ~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      .........  ...+++.|+|||.+.+ ..++.++|+||+||++|+|++ |.+||...+.......+.....        
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------  222 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------  222 (258)
T ss_pred             ecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------
Confidence            665442221  1235678999999854 458999999999999999998 8899988766655554433110        


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                          ...+...+.++.+++.+||..||++|||+.++++
T Consensus       223 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 --------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             --------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                                0122346889999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.6e-38  Score=285.34  Aligned_cols=244  Identities=19%  Similarity=0.290  Sum_probs=187.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCc----EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      .++|++.+.||.|+||.||+|.+..+++    .+++|.+....     .....|+..++.++||||+++++++.     +
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~   80 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G   80 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C
Confidence            4679999999999999999999987776    47777764322     12234666778899999999998762     2


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      . ..++++||++ |+|.+.+..   ....+++..+..++.||+.||.|||+ +|++|+||||+||+++. ++.+||+|||
T Consensus        81 ~-~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~-~~~~kl~Dfg  154 (279)
T cd05111          81 A-SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFG  154 (279)
T ss_pred             C-ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEEcCCc
Confidence            2 2668999998 577766654   23568999999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          183 SAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       183 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +++.......   .....++..|+|||.+.+. .++.++|+|||||++|++++ |..||.+........ ++.....+. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~-  231 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEKGERLA-  231 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC-
Confidence            9976543322   1123456689999998654 48999999999999999998 999998776544322 222100000 


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                .+...+.++.+++.+||..||++|||+.++++
T Consensus       232 --------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 --------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             --------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                      11235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.3e-38  Score=280.14  Aligned_cols=244  Identities=20%  Similarity=0.315  Sum_probs=192.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .+|++.+.||.|+||.||+|.+. ++..+|+|.+....   ....+|+++++.++||||+++++++     ......++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence            46999999999999999999875 46789999886542   2345799999999999999999887     444558999


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+.+ +|.+.+..   ....+++..++.++.|++.||++||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcC-CCeEEECCCcceeeccc
Confidence            999986 55444432   23458899999999999999999999 79999999999999985 77899999999875533


Q ss_pred             CCCc--ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          190 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       190 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+.+...            
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------  219 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC------------
Confidence            2211  122345679999998654 48899999999999999998 9999987776555544322100            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                      ...+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus       220 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 ----------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                            00122357899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.5e-39  Score=286.95  Aligned_cols=236  Identities=19%  Similarity=0.235  Sum_probs=180.9

Q ss_pred             eeeccCCceEEEEEEEcCCCc-------EEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           40 RVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~-------~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +.||.|+||.||+|.+...+.       .+++|.+.....    ....|..+++.++||||+++++++..     ....+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence            469999999999999866544       388887754332    23468889999999999999998843     33478


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC-------cEEEEe
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QVKLCD  180 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~-------~~kl~D  180 (376)
                      +||||+++ +|...+...   ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++.       .++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999986 565555432   3468999999999999999999999 79999999999999986333       279999


Q ss_pred             cCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          181 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       181 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ||.+.....   .....++..|+|||.+.+...++.++|+|||||++|+|++| ..||...+....... ...       
T Consensus       152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~-------  220 (258)
T cd05078         152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YED-------  220 (258)
T ss_pred             cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHc-------
Confidence            998865432   22345688899999997655578999999999999999998 466665544332221 110       


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                            ...++...+.++.+++.+||+.||++|||++++++.
T Consensus       221 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ----------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                  001223456789999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.5e-38  Score=287.87  Aligned_cols=254  Identities=20%  Similarity=0.270  Sum_probs=190.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcC----------------CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeec
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISL   92 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~   92 (376)
                      ++|++.+.||+|+||.||+|.+..                ++..+|+|.+....     ....+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            469999999999999999986532                34579999886542     234479999999999999999


Q ss_pred             ceeeeecCCCCceeEEEEeecccc-hHHHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCC
Q 017139           93 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSM-------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP  164 (376)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~-------~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp  164 (376)
                      ++++.     ....++++|||+++ +|.+.+......       ...+++..+..++.|++.||+|||+ +|++|+||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp  158 (296)
T cd05095          85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT  158 (296)
T ss_pred             EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence            99883     33448999999984 777766543211       2347788899999999999999999 7999999999


Q ss_pred             CCeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh--CCCCCCC
Q 017139          165 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG  239 (376)
Q Consensus       165 ~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~  239 (376)
                      +||+++. ++.++|+|||++........   ......+..|++||...+. .++.++|+|||||++|+|++  |..||..
T Consensus       159 ~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            9999986 78899999999876533221   1122335679999988665 48999999999999999998  7789977


Q ss_pred             CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .+..+...........           .......+          .+...++.+.+|+.+||+.||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~-----------~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFRD-----------QGRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHhh-----------ccccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6655444332211000           00000000          12346789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.5e-38  Score=279.77  Aligned_cols=236  Identities=23%  Similarity=0.294  Sum_probs=183.7

Q ss_pred             eeccCCceEEEEEEEc--CCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeec
Q 017139           41 VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY  113 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~  113 (376)
                      .||+|+||.||+|.+.  ..+..+|+|++.....     ...+|+.+++.++||||+++++++     +. ..+++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EA-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----cC-CCeEEEEEe
Confidence            4899999999999765  3456799998865432     244789999999999999999876     22 237899999


Q ss_pred             ccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC
Q 017139          114 VPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA  192 (376)
Q Consensus       114 ~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~  192 (376)
                      +++ +|.+.+..   ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++........
T Consensus        76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcC-CCcEEeccCCccccccCCcc
Confidence            985 66555543   23568999999999999999999999 79999999999999986 77899999999875533322


Q ss_pred             c----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          193 N----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       193 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .    ....++..|+|||.+... .++.++|+|||||++|++++ |..||.+....+....+... ..            
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~------------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-KR------------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CC------------
Confidence            1    111225679999998654 48999999999999999996 99999887765544333221 00            


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                     ...+...++++.+++.+||..||++||+..++.+
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0123456899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=296.48  Aligned_cols=261  Identities=26%  Similarity=0.365  Sum_probs=191.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .+++|.-...||+|+||.||+|... +|..||||++....    .....|+.++.+++|||+|++++++.....    ..
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~  147 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR  147 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence            4477888889999999999999964 44899999886543    346789999999999999999999943221    47


Q ss_pred             EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC--CceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          108 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--GVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       108 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      +||+||++ |+|.+.+......  .++|..+.+|+.+++.||+|||+..  .|+||||||+|||+|. +...||+|||+|
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~aKlsDFGLa  224 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNAKLSDFGLA  224 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCEEccCccCc
Confidence            89999999 6877777653222  8899999999999999999999843  3999999999999995 899999999999


Q ss_pred             ccccc-CCCccee-eccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHH-hcCCCCHH
Q 017139          185 KVLVK-GEANISY-ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIK-VLGTPTRE  259 (376)
Q Consensus       185 ~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~~~~-~~~~~~~~  259 (376)
                      +.... ....... .||..|+|||++... ..+.++||||||+++.|++||+.+.....  ....+..+.. .....   
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---  300 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---  300 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---
Confidence            76554 3332333 789999999999754 48999999999999999999998876532  1111222211 11110   


Q ss_pred             HHhhcCcCCcCccCCCCCCCCccccccc-CCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                             ...++.-|.+..    ..++. ..-..+..+..+|++.+|.+||+..+++
T Consensus       301 -------~~~eiiD~~l~~----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv  346 (361)
T KOG1187|consen  301 -------KLREIVDPRLKE----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV  346 (361)
T ss_pred             -------chhheeCCCccC----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence                   111111111110    00110 0112366777999999999999999874

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-38  Score=284.33  Aligned_cols=260  Identities=25%  Similarity=0.349  Sum_probs=189.5

Q ss_pred             cceEeeeeeccCCceEEEEEEE----cCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           34 ISYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      .+|++.+.||+|+||.||+|..    ..+++.||+|.+.....    ...+|+++++.++||||+++++++..   .+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence            4799999999999999999974    45788999999865432    34579999999999999999887643   2334


Q ss_pred             eEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+++||||++ ++|.+.+...   ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVES-ENRVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECC-CCeEEECCCccc
Confidence            5889999998 4777666532   3458999999999999999999999 79999999999999986 778999999999


Q ss_pred             cccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCHH
Q 017139          185 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-TPTRE  259 (376)
Q Consensus       185 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~  259 (376)
                      .........    ....++..|+|||.+.+. .++.++|+|||||++|+|++|..|+...... ....+..... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence            865433221    111234469999998654 4899999999999999999998776543211 1110000000 00000


Q ss_pred             HHh-hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          260 EIR-CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       260 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .+. .....             .....+..++.++.+++.+||..+|++|||+.++++
T Consensus       234 ~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 HLIELLKNN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHhcC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            000 00000             000123457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-38  Score=278.27  Aligned_cols=237  Identities=24%  Similarity=0.346  Sum_probs=186.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ++||.|+||.||+|.+.. ++.||+|.+.....     ....|+++++.++|+||+++++++     .+....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence            479999999999999877 99999998865432     345689999999999999999988     4444588999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCc
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN  193 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~  193 (376)
                      ++ +|.+.+..   ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||.+.........
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcC-CCcEEEeeccccccccCCcce
Confidence            85 56555543   23468899999999999999999999 79999999999999996 778999999998755322111


Q ss_pred             ---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 017139          194 ---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  269 (376)
Q Consensus       194 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                         .....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+.....               
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~---------------  213 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR---------------  213 (251)
T ss_pred             eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence               112224569999998654 48999999999999999999 8899987765443333221100               


Q ss_pred             CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                   ...+...+.++.+++.+||..+|++|||++++++
T Consensus       214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         0123356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.1e-38  Score=281.02  Aligned_cols=244  Identities=27%  Similarity=0.376  Sum_probs=191.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC---CcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .++|.+.+.||.|+||.||+|.+...   ...+++|......     .....|+.+++.++||||+++++++.     +.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----EN   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----CC
Confidence            35699999999999999999987544   3468999876443     13446899999999999999998773     22


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                       ..|+||||+++ +|.+.+...   ...+++..++.++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||+
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~  153 (270)
T cd05056          80 -PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSS-PDCVKLGDFGL  153 (270)
T ss_pred             -CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEec-CCCeEEccCce
Confidence             26799999985 676666542   3458999999999999999999999 79999999999999996 77899999999


Q ss_pred             ccccccCCCcc--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          184 AKVLVKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       184 ~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      +..........  ...++..|+|||.+... .++.++|+|||||++|++++ |..||.+.+..+....+.....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------  226 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER------  226 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc------
Confidence            87654432211  12234579999998654 48999999999999999996 9999988776655544322100      


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                            ...+..++.++.+++.+||..+|++|||+.+++.
T Consensus       227 ----------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         227 ----------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  0123457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.3e-38  Score=279.43  Aligned_cols=243  Identities=24%  Similarity=0.347  Sum_probs=191.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|.+.+.||+|+||.||+|.+. .+..+|+|.+.....   ...+|+.+++.++|+||+++++++..      ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence            367999999999999999999864 456799998865432   34469999999999999999888732      34789


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||+++ +|.+.+...  ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~  153 (260)
T cd05073          78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCCcceeecc
Confidence            9999984 777776542  24567888999999999999999999 79999999999999996 7889999999987653


Q ss_pred             cCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          189 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       189 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  .....++..|+|||.+... .++.++|+|||||++|++++ |..||.+.+.......+.....           
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------  221 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-----------  221 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------
Confidence            3221  1122345679999998654 48999999999999999998 9999987765544443322100           


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                             .          ..+...+.++.+++.+||+.||++||++.+++
T Consensus       222 -------~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  254 (260)
T cd05073         222 -------M----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQ  254 (260)
T ss_pred             -------C----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                   0          01234688999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.5e-38  Score=277.55  Aligned_cols=237  Identities=24%  Similarity=0.369  Sum_probs=185.4

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ++||+|+||.||+|... ++..+|+|.+.....     ...+|+++++.++||||+++++++.     .....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence            47899999999999854 688999998765432     2346899999999999999999873     344588999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCc
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN  193 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~  193 (376)
                      ++ +|.+.+..   ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++.........
T Consensus        75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcC-CCeEEECCCccceeccccccc
Confidence            85 55555533   23458899999999999999999999 79999999999999986 788999999998754332211


Q ss_pred             c--eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          194 I--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       194 ~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .  ...++..|+|||.+.+. .++.++|+||||+++|++++ |..||.+.........+....                 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-----------------  211 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-----------------  211 (250)
T ss_pred             cCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            1  12235679999998654 48899999999999999998 999998776554443332210                 


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                 ....+..++.++.+++.+||..+|++||++.++++
T Consensus       212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                       00122356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.1e-38  Score=280.86  Aligned_cols=246  Identities=21%  Similarity=0.291  Sum_probs=183.6

Q ss_pred             eeeccCCceEEEEEEEcC--CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +.||+|+||.||+|....  ....+++|.+.....     ...+|+.+++.++||||+++++.+     .....+|+|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence            368999999999996533  345788887754321     234688899999999999999988     34445899999


Q ss_pred             cccc-hHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          113 YVPE-TMYRVLKHYSSM-NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       113 ~~~g-~l~~~l~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      |+++ +|.+.+...... ....++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecC-CCcEEEeccccccccccc
Confidence            9985 777766553321 2345678888999999999999999 79999999999999996 788999999998654322


Q ss_pred             CC---cceeeccccccChhhhhC------CCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          191 EA---NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       191 ~~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ..   .....++..|+|||++..      ...++.++|+|||||++|+|++ |..||......+.+..........    
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~----  229 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK----  229 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc----
Confidence            11   122334667999999743      2246889999999999999999 789998777666555444321110    


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                  .+       ....+..++..+.+++..|+ .||++|||++++++
T Consensus       230 ------------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         230 ------------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ------------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                        00       01123457888999999998 59999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-38  Score=281.53  Aligned_cols=244  Identities=25%  Similarity=0.337  Sum_probs=192.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCc----EEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ..++|.+.+.||+|+||.||+|.+..+|+    .+|+|.+.....     ...+|+.+++.++||||+++++++..    
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence            34679999999999999999999877665    589998765432     23468999999999999999998743    


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                        ...++||||+++ +|.+.+..   ....+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.+||+||
T Consensus        81 --~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kL~df  153 (279)
T cd05057          81 --SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKT-PQHVKITDF  153 (279)
T ss_pred             --CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcC-CCeEEECCC
Confidence              347899999984 66666654   23458999999999999999999999 79999999999999986 778999999


Q ss_pred             CCccccccCCCcce---eeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          182 GSAKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       182 g~~~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |.++..........   ..++..|+|||.+... .++.++|+|||||++|++++ |..||.+....+....+.... .  
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~--  229 (279)
T cd05057         154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-R--  229 (279)
T ss_pred             cccccccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-C--
Confidence            99976543322111   1224579999998654 48999999999999999998 999998876655444333210 0  


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                               ...+...+.++.+++.+||..||++||++.+++
T Consensus       230 -------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~  262 (279)
T cd05057         230 -------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELI  262 (279)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence                                     001234577899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.2e-38  Score=284.04  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=188.3

Q ss_pred             ceEeeeeeccCCceEEEEEEE----cCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           35 SYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      -|.+.+.||+|+||.||+|+.    ..++..||+|.+....     ....+|+.+++.++||||+++++++..   .+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence            478999999999999999984    4568899999986432     234579999999999999999987743   2234


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+++||||++| +|.+.+..   ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~-~~~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcC-CCCEEECCCccc
Confidence            57899999985 66665543   23458999999999999999999999 79999999999999986 778999999998


Q ss_pred             cccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH-
Q 017139          185 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-  259 (376)
Q Consensus       185 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  259 (376)
                      .........    ....++..|+|||.+.+. .++.++|+|||||++|+|+++..|+.....  ..   .+..+....+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~  230 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQM  230 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccc
Confidence            765433221    123456679999998664 489999999999999999998876533211  00   0111100000 


Q ss_pred             ----HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          260 ----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       260 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                          ........             .....+..++.++.+|+.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 TVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                00000000             0001234578999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=298.02  Aligned_cols=245  Identities=21%  Similarity=0.310  Sum_probs=190.7

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++..+...||+|.||+||+|++-.   .||||++..+.      +.++.|+.+++.=+|.||+-+.+++.     ... +
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p~-~  462 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NPP-L  462 (678)
T ss_pred             HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CCc-e
Confidence            456778899999999999999854   59999986543      34557999999999999999999883     333 3


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      .||+-+|+| +|+.+++..   ...|.....+.|+.|++.|+.|||. ++|||||||..|||+.. ++.|||+|||++..
T Consensus       463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~-~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHE-DLKVKIGDFGLATV  537 (678)
T ss_pred             eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEcc-CCcEEEecccceee
Confidence            799999998 777777653   3679999999999999999999999 89999999999999995 78999999999865


Q ss_pred             ccc---CCCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          187 LVK---GEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       187 ~~~---~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      -.-   ........|...|||||+++.  ...|+..+|||||||++|||++|..||...+.+..+..+=+..+.+...  
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s--  615 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS--  615 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch--
Confidence            322   112223446778999999853  3358999999999999999999999998554443332221111111111  


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                            ....+.+.++++|+..||.+++++||...+||.
T Consensus       616 ----------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  616 ----------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ----------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                  122356789999999999999999999988875

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-38  Score=280.46  Aligned_cols=237  Identities=17%  Similarity=0.185  Sum_probs=177.1

Q ss_pred             eeeccCCceEEEEEEEcCC------------CcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           40 RVVGTGSFGIVFQAKCLET------------GETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~------------~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      +.||+|+||.||+|+....            ...+++|.+.....    ...+|+.+++.++||||+++++++.     +
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence            4689999999999985422            23588888754332    2345788999999999999999873     3


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC------cEE
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH------QVK  177 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~------~~k  177 (376)
                      +...++||||++++.+..+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.      .++
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeE
Confidence            3447899999996543333221  23568999999999999999999999 79999999999999975221      389


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      ++|||++......   ....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+... ....    
T Consensus       153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~----  224 (262)
T cd05077         153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG----  224 (262)
T ss_pred             eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc----
Confidence            9999998654322   23456788999998865556899999999999999998 5888887654332211 1110    


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                .   ..            .....+.++.+++.+||+.||.+||+..+++++
T Consensus       225 ----------~---~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 ----------Q---CM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ----------C---cc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                      0   00            111236789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-38  Score=282.97  Aligned_cols=235  Identities=19%  Similarity=0.229  Sum_probs=177.9

Q ss_pred             eeccCCceEEEEEEEcCC------------------------CcEEEEEEeccccc----chHHHHHHHHhCCCCCeeec
Q 017139           41 VVGTGSFGIVFQAKCLET------------------------GETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISL   92 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~~~------------------------~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~   92 (376)
                      .||+|+||.||+|....+                        ...+++|++.....    ...+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999975321                        23588888754322    23467889999999999999


Q ss_pred             ceeeeecCCCCceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC
Q 017139           93 KHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP  171 (376)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~  171 (376)
                      ++++.     +....++|||||+++ |...+..   ....+++..+..++.|++.||+|||+ +||+||||||+||+++.
T Consensus        82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEE-----eCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence            99884     334588999999975 4334332   24568999999999999999999999 79999999999999974


Q ss_pred             C------CCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHH-hCCCCCCCCChHH
Q 017139          172 L------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD  244 (376)
Q Consensus       172 ~------~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~  244 (376)
                      .      ...+|++|||.+......   ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||......+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            2      124899999987644222   22356778999998866556899999999999999995 6999998765443


Q ss_pred             HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ... .....                             ..++...++++.++|.+||+.+|++|||+.+++++
T Consensus       230 ~~~-~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KER-FYEKK-----------------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHH-HHHhc-----------------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            322 11100                             00122346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-37  Score=278.66  Aligned_cols=246  Identities=20%  Similarity=0.232  Sum_probs=182.5

Q ss_pred             eeeccCCceEEEEEEEc--CCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +.||+|+||.||+|...  .++..+|+|.+.....     ...+|+.+++.++||||+++++++     .+...+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence            46899999999999864  3456799998865432     334689999999999999999987     44445889999


Q ss_pred             ccc-chHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          113 YVP-ETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       113 ~~~-g~l~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      |++ |+|.+.+..... .....++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEECCccccccccCc
Confidence            999 477666654322 22346677888999999999999999 79999999999999996 788999999998754332


Q ss_pred             CC---cceeeccccccChhhhhCCC------CCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          191 EA---NISYICSRYYRAPELIFGAT------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       191 ~~---~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ..   .....++..|+|||++.+..      .++.++|+|||||++|+|++ |..||......+...........     
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----  228 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----  228 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence            21   12234577899999985321      25789999999999999996 99999876655443322211000     


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                 ..+       ...+....++.+.+++.+|+ .+|++|||+++++.
T Consensus       229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                       000       00112245788999999998 68999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.3e-38  Score=281.58  Aligned_cols=241  Identities=24%  Similarity=0.328  Sum_probs=187.3

Q ss_pred             eeeccCCceEEEEEEEcCCC------cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           40 RVVGTGSFGIVFQAKCLETG------ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      +.||+|+||.||+|++....      +.+|+|.+....     ....+|+.+++.++||||+++++++     ......+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeE
Confidence            46899999999999986543      689999875432     2334689999999999999999988     3344588


Q ss_pred             EEeecccc-hHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC-----cEEEE
Q 017139          109 LVMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLC  179 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~-----~~kl~  179 (376)
                      +||||+++ +|.+.+.....   ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++     .++|+
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~~~~~~l~  153 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSE-KGYDADRVVKIG  153 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEec-CCCCCCcceEEC
Confidence            99999984 77777754322   23457889999999999999999999 79999999999999986 44     79999


Q ss_pred             ecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017139          180 DFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       180 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      |||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+... ..
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~  231 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR  231 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc
Confidence            9999875533211   1123446789999998765 48999999999999999998 99999877665544433210 00


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                 ...+..++..+.++|.+||..+|++||+++++++
T Consensus       232 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 ---------------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ---------------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                       0122356889999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-37  Score=277.42  Aligned_cols=241  Identities=23%  Similarity=0.351  Sum_probs=190.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ..+|++.+.||+|+||.||++..  +++.+|+|.+..+.  ....+|+.+++.++||||+++++++..     +. .+++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~-~~~v   76 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----NG-LYIV   76 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----CC-cEEE
Confidence            35799999999999999999864  78899999886542  234578999999999999999988732     22 6899


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          77 MELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSE-DGVAKVSDFGLARVGSM  152 (254)
T ss_pred             EECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCcEEECCCccceeccc
Confidence            999985 777776542  23458899999999999999999999 79999999999999986 77899999999875432


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      .  ......+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.+..               
T Consensus       153 ~--~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------  214 (254)
T cd05083         153 G--VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---------------  214 (254)
T ss_pred             c--CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------------
Confidence            2  1122335679999998654 48999999999999999997 999998876655443332210               


Q ss_pred             cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                         .          ...+..++..+.+++.+||+.+|++||++++++.
T Consensus       215 ---~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         215 ---R----------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ---C----------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               0          0012356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.6e-37  Score=283.49  Aligned_cols=245  Identities=23%  Similarity=0.336  Sum_probs=190.0

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCc----EEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      .++|++.+.||+|+||.||+|.+..+|+    .+|+|.+.....     ...+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence            4578999999999999999999887776    468887765432     23468899999999999999998732     


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      . ..++++||++ |+|.+.+..   ....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.+||+|||
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~-~~~~kL~Dfg  154 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKS-PNHVKITDFG  154 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecC-CCceEEcccc
Confidence            1 2568999998 566666543   23468899999999999999999999 79999999999999985 7789999999


Q ss_pred             CccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          183 SAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       183 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +++........   ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+.. .++.....+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~--  230 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERL--  230 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC--
Confidence            99865433221   123346789999998654 48999999999999999997 99999876543332 222211100  


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                     +          .+...+..+.+++.+||..||++||+++++++.
T Consensus       231 ---------------~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         231 ---------------P----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ---------------C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           0          112357789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.3e-37  Score=276.44  Aligned_cols=239  Identities=23%  Similarity=0.362  Sum_probs=180.8

Q ss_pred             eeeccCCceEEEEEEEcC---CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           40 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      +.||+|+||.||+|.+..   .+..+|+|.+....     ....+|+.+++.++||||+++++++..    .+...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence            468999999999998754   34579999875422     233468889999999999999986642    233477999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||+.+ +|...+...   ...+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||+++.....
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCccccccccCC
Confidence            99984 666666532   2446777888999999999999999 79999999999999996 778999999998754332


Q ss_pred             CC-----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          191 EA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       191 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ..     .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+...  .+        
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~--------  220 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR--------  220 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence            11     1122346689999998654 48999999999999999999 56778766655444332211  00        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                        ...+...+..+.+++.+||..+|++||++.+++.
T Consensus       221 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         221 ------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                              0012345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.9e-37  Score=275.37  Aligned_cols=246  Identities=20%  Similarity=0.252  Sum_probs=182.6

Q ss_pred             eeeccCCceEEEEEEEcCC--CcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +.||+|+||.||++.....  ...+++|.+....     ....+|+.+++.++||||+++++.+     .+...+|+|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEe
Confidence            3699999999999975433  2356777665432     2334678889999999999999988     44455899999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCC
Q 017139          113 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE  191 (376)
Q Consensus       113 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~  191 (376)
                      |+++ +|.+.+.........+++..++.++.||+.||+|||+ ++++||||||+|||++. ++.++|+|||++.......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcC-CccEEecccccccccCcch
Confidence            9995 7777776533334557778889999999999999999 79999999999999996 7789999999976432211


Q ss_pred             ---CcceeeccccccChhhhhCC------CCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          192 ---ANISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       192 ---~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                         ......++..|+|||++...      ..++.++|+|||||++|+|++ |..||...+..+.+..+.......     
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-----  228 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK-----  228 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc-----
Confidence               12244568889999987431      125778999999999999997 578888777666555544321100     


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                        .+...+...+++.+.+++..|+ .+|++||+++++++
T Consensus       229 ------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         229 ------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                              0011122346788999999999 68999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=291.64  Aligned_cols=243  Identities=25%  Similarity=0.353  Sum_probs=195.0

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCc---E-EEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGE---T-VAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~---~-~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      +-.+.++||+|+||.||+|..+..+.   . ||+|......       ...-.|+++++.++|||||+++++......  
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P--  235 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP--  235 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc--
Confidence            33456899999999999998876432   3 8999886422       223469999999999999999998865544  


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                         +++|||+|.| +|.++|+..   ...++..+...++.+.+.||+|||+ ++++||||-..|+|++. ++.+||+|||
T Consensus       236 ---l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~-~~~vKISDFG  307 (474)
T KOG0194|consen  236 ---LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSK-KGVVKISDFG  307 (474)
T ss_pred             ---cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecC-CCeEEeCccc
Confidence               8999999996 777777763   2369999999999999999999999 89999999999999996 6778999999


Q ss_pred             CccccccCCCccee-eccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          183 SAKVLVKGEANISY-ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       183 ~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      +++........... .-...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....+.....      
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~------  380 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY------  380 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc------
Confidence            98865422222211 235679999999765 59999999999999999998 8899999998888877754211      


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                           ....+...+.++..++.+|+..||++|||..++.
T Consensus       381 ---------------------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~  414 (474)
T KOG0194|consen  381 ---------------------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK  414 (474)
T ss_pred             ---------------------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence                                 1113345688999999999999999999998875

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-37  Score=275.62  Aligned_cols=233  Identities=19%  Similarity=0.195  Sum_probs=179.6

Q ss_pred             eeeccCCceEEEEEEEcCCC----------cEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           40 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~----------~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ....+|+.+++.++||||+++++++..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            46899999999999998776          358888775443   234578899999999999999998743      23


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC-------cEEE
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QVKL  178 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~-------~~kl  178 (376)
                      .++||||+++ +|...+...   ...+++..+..++.||+.||+|||+ +||+||||||+||+++. ++       .+||
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl  149 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVAR-YGLNEGYVPFIKL  149 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEec-CccccCCceeEEe
Confidence            6899999996 555555432   2268999999999999999999999 79999999999999986 44       6999


Q ss_pred             EecCCccccccCCCcceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017139          179 CDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       179 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      +|||++.....   .....++..|+|||.+.+. ..++.++|+|||||++|+|++ |..||...+.......... .   
T Consensus       150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~---  222 (259)
T cd05037         150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-Q---  222 (259)
T ss_pred             CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-C---
Confidence            99999876543   2234556789999998765 358899999999999999999 5888876543222211110 0   


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                  .              ..+......+.+++.+||+.||++|||+.++++
T Consensus       223 ------------~--------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 ------------H--------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ------------C--------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                        0              011112378999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.9e-37  Score=275.96  Aligned_cols=250  Identities=22%  Similarity=0.302  Sum_probs=189.7

Q ss_pred             eEeeeeeccCCceEEEEEEEcC---CCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCC-ce
Q 017139           36 YMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKD-EL  105 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~-~~  105 (376)
                      |.+.+.||+|+||.||+|....   +++.+|||.+..+..      ...+|+.+++.++||||+++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            6788999999999999998653   578999998865421      2346899999999999999999875433222 22


Q ss_pred             eEEEEeecccc-hHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ..++++||+.+ +|...+....  .....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~-~~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcC-CCCEEECccc
Confidence            35788999984 5555543221  122357889999999999999999999 79999999999999986 7789999999


Q ss_pred             CccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          183 SAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       183 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +++.......   .....+++.|++||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+....+... ...  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~--  234 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRL--  234 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcC--
Confidence            9886543221   1223345679999998654 47899999999999999999 89999877665444333321 000  


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                               ..+...+..+.+++.+||..+|++||++.++++
T Consensus       235 -------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         235 -------------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     011246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.6e-38  Score=300.61  Aligned_cols=244  Identities=24%  Similarity=0.331  Sum_probs=200.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      +-...+.||+|+||+||+|+.-.     ....||||.++...     ..+++|++++..++|||||++++++.     .+
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~~  561 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----EG  561 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----cC
Confidence            45668899999999999998643     34579999997654     34668999999999999999999994     33


Q ss_pred             eeEEEEeeccc-chHHHHHHhhhh------cC----CCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC
Q 017139          105 LFLNLVMEYVP-ETMYRVLKHYSS------MN----QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT  173 (376)
Q Consensus       105 ~~~~lv~e~~~-g~l~~~l~~~~~------~~----~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~  173 (376)
                      .-+|+|+|||. |+|.++|.....      .+    .+++..+...|+.||+.|++||-+ +.+|||||-..|+||+. +
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge-~  639 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGE-N  639 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceecc-c
Confidence            34899999999 788888876432      12    338899999999999999999999 79999999999999996 8


Q ss_pred             CcEEEEecCCccccccCCCcc---eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017139          174 HQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI  249 (376)
Q Consensus       174 ~~~kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~  249 (376)
                      ..|||+|||+++..-..+-..   ...-...|||||.+.-+ .++.+|||||+||+|||+++ |..||.+..+.+.++.+
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence            899999999998643222111   12235679999999755 59999999999999999997 99999999998888776


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                      .+..-                            ...|++.|.++.+|+..||+.+|.+||+..||
T Consensus       719 ~~g~l----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  719 RAGQL----------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HcCCc----------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            55210                            11456789999999999999999999999987

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.6e-37  Score=275.80  Aligned_cols=260  Identities=25%  Similarity=0.344  Sum_probs=190.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcC----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ++|.+.+.||+|+||.||+|....    +++.+|+|.+.....     ...+|+++++.++||||+++++++..   .+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            468889999999999999998643    478999999875543     34578999999999999999887633   234


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      .+.+++|||+++ +|.+.+...   ...+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVES-EDLVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEccccc
Confidence            568899999985 776666542   2358999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-hcCCCCH
Q 017139          184 AKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK-VLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~-~~~~~~~  258 (376)
                      +.........    ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.........  +.. ..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~  232 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIV  232 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccH
Confidence            9876532221    112335569999998655 4899999999999999999999998654321100  000 0000000


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ..+......  ...          ...+...+.++.+++.+||..||++|||+.++++
T Consensus       233 ~~~~~~~~~--~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         233 TRLLELLKE--GER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHc--CCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000000  000          0012345788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=8.6e-38  Score=277.21  Aligned_cols=284  Identities=28%  Similarity=0.475  Sum_probs=215.9

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcC---CCcEEEEEEecccc--cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR--RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~--~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      -|...+.|.++++||.|.|++||++.+..   ..+.||+|.+....  .....|.++|..+ .+.||+++.+++     .
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----R  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----c
Confidence            45667889999999999999999999887   78899999885443  3456799999988 589999999998     6


Q ss_pred             CceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .+..+.+|+||++.. ..++..       .++...++.+++.++.||.++|. +|||||||||+|+|.+...+.-.|+||
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEec
Confidence            777799999999953 222322       36788899999999999999999 899999999999999987888999999


Q ss_pred             CCcccccc----------------C-----------------------------CCcceeeccccccChhhhhCCCCCCc
Q 017139          182 GSAKVLVK----------------G-----------------------------EANISYICSRYYRAPELIFGATEYTT  216 (376)
Q Consensus       182 g~~~~~~~----------------~-----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~  216 (376)
                      |+|.....                .                             .......||+.|+|||++...+..++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            99862100                0                             00113468999999999988887899


Q ss_pred             cchhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCHHHHhhcCcC------------------CcCccCCCCC
Q 017139          217 SIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIRCMNPN------------------YTDFRFPQIK  277 (376)
Q Consensus       217 ~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~  277 (376)
                      ++||||.|+|+..+++++.||- ..++.+.+.++...+|...-.........                  +.......+.
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            9999999999999999999874 45666777777777665433222211111                  1111001111


Q ss_pred             C----CCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          278 A----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       278 ~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      .    ..+.....+..+..+.||+.+||+.||.+|+|++++|.||||.....
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            1    01233333455678999999999999999999999999999986543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.1e-36  Score=287.16  Aligned_cols=274  Identities=23%  Similarity=0.292  Sum_probs=183.4

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEc----------------CCCcEEEEEEecccccc------------------hHH
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCL----------------ETGETVAIKKVLQDRRY------------------KNR   76 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~----------------~~~~~~aiK~~~~~~~~------------------~~~   76 (376)
                      ...++|.+.++||+|+||+||+|...                ..++.||||++......                  ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45679999999999999999999752                24567999998543211                  123


Q ss_pred             HHHHHHhCCCCCe-----eecceeeeecCC---CCceeEEEEeecccc-hHHHHHHhhhh--------------------
Q 017139           77 ELQLMRLMDHPNV-----ISLKHCFFSTTS---KDELFLNLVMEYVPE-TMYRVLKHYSS--------------------  127 (376)
Q Consensus        77 e~~~l~~l~h~~I-----v~~~~~~~~~~~---~~~~~~~lv~e~~~g-~l~~~l~~~~~--------------------  127 (376)
                      |+.++..++|.++     +++++++.....   ......++||||+++ +|.+.+.....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            5666677766554     555555532211   123447899999995 66666643110                    


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCcce--eeccccccCh
Q 017139          128 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--YICSRYYRAP  205 (376)
Q Consensus       128 ~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~t~~y~aP  205 (376)
                      ....+++..++.++.|++.+|.|||+ .+|+||||||+||+++. ++.+||+|||++...........  ..+++.|+||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            11234667889999999999999999 79999999999999996 77899999999875543322222  2347899999


Q ss_pred             hhhhCCCC-------------------C--CccchhHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          206 ELIFGATE-------------------Y--TTSIDIWSAGCVLAELLLGQP-LFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       206 E~~~~~~~-------------------~--~~~~DiwslG~il~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      |.+.....                   +  ....|+||+||++|+|++|.. ||.+......-   .+... .....|..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~-~~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYD-NDLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhcc-chHHHHHh
Confidence            98753211                   1  124799999999999999875 77543221110   00000 00001110


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCC---CCCCCHHHHhCCCcccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP---SLRCTALEACAHPFFDE  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~R~t~~ell~hp~~~~  322 (376)
                      ..            ...+........++.++||+.+||..+|   .+|+|++|+|+||||..
T Consensus       456 ~~------------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        456 YK------------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hc------------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            00            0011111234578999999999999876   68999999999999953

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=300.50  Aligned_cols=248  Identities=21%  Similarity=0.364  Sum_probs=200.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCc-----EEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...-+..+.||+|+||.||.|......-     .||+|.+.+...     .+.+|..+++.++|||||+++++.++... 
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC-
Confidence            3566788999999999999998865433     399999876533     33479999999999999999999976443 


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                          .+|++|||. |+|..+|+..+.   ....++......++.+|+.|++||++ +++|||||...|+|++. ...+||
T Consensus       770 ----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~-~r~VKI  843 (1025)
T KOG1095|consen  770 ----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDE-RRVVKI  843 (1025)
T ss_pred             ----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecc-cCcEEE
Confidence                789999999 578888876321   14568999999999999999999999 79999999999999997 788999


Q ss_pred             EecCCccccccCCCcc---eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017139          179 CDFGSAKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       179 ~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      +|||+|+..-...-..   ...-...|||||.+... .++.++|||||||++||+++ |..||.+.++.+.+....+. |
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-g  921 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-G  921 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC-C
Confidence            9999998432221111   11124569999999764 59999999999999999998 99999999988887755542 1


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      +.                           ..|...+..+.+++.+||+.+|++||+...+++
T Consensus       922 RL---------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 RL---------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             cc---------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            11                           134568899999999999999999999998885

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=292.49  Aligned_cols=249  Identities=31%  Similarity=0.430  Sum_probs=190.6

Q ss_pred             eEeeeeeccCCceE-EEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEee
Q 017139           36 YMAERVVGTGSFGI-VFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        36 y~~~~~Lg~G~~g~-V~~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      |.-.+++|.|+.|+ ||+|..  .|+.||||++..... ..++|+.+|+.- +||||+++++.-     .+..++||+.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence            34456789999985 599987  789999999876654 778999999988 599999987654     77888999999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC----CCCcEEEEecCCccccc
Q 017139          113 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       113 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~----~~~~~kl~Dfg~~~~~~  188 (376)
                      .|..+|.+++...............+.++.|++.||++||+ -+||||||||.||||+.    ...+++|+|||+++...
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            99999999987631111122224457788999999999999 59999999999999975    23579999999999876


Q ss_pred             cCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          189 KGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       189 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      .+..    .....||..|+|||.+.... -..++||||+||++|..++| ..||...-.  .-.+|+..  ...      
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~--~~~------  731 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTG--NYT------  731 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcC--ccc------
Confidence            5433    33456899999999997765 57799999999999999985 899965422  11222220  000      


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                               .-.         +......++.|||.+||.+||..||+|.++|.||||=
T Consensus       732 ---------L~~---------L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  732 ---------LVH---------LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             ---------eee---------eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                     000         1111122899999999999999999999999999993

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.2e-35  Score=258.58  Aligned_cols=238  Identities=39%  Similarity=0.653  Sum_probs=191.9

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecccc-hHH
Q 017139           46 SFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMY  119 (376)
Q Consensus        46 ~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~  119 (376)
                      +||.||+|.+..+|+.+|+|++....     ....+|++.++.++|+||+++++++.     .....++++||+++ +|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence            58999999999899999999986543     34457999999999999999999884     33558899999997 777


Q ss_pred             HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCcceeecc
Q 017139          120 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS  199 (376)
Q Consensus       120 ~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t  199 (376)
                      +.+..    ...++...++.++.+++.++.+||+ .+++|+||+|+||+++. ++.++|+|||.+.............++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCC
Confidence            66654    2338899999999999999999999 79999999999999996 688999999999877655444566778


Q ss_pred             ccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCC
Q 017139          200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH  279 (376)
Q Consensus       200 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      ..|++||.+.+. .++.++|+||+|++++++++|..||..........+.........                      
T Consensus       150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------  206 (244)
T smart00220      150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF----------------------  206 (244)
T ss_pred             cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Confidence            899999998654 478899999999999999999999987433333333322100000                      


Q ss_pred             CcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          280 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       280 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                         ......++.++.+++.+||..||++||++.++++||||
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence               00011167899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-36  Score=275.05  Aligned_cols=242  Identities=22%  Similarity=0.375  Sum_probs=200.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .+.++.++||.|.||.||.+.++...-.||||.++.+.-   .+.+|+.+++.++|||+|++++++..+..     +|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-----FYIi  341 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-----FYII  341 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC-----eEEE
Confidence            356778899999999999999999999999999987743   34579999999999999999999854433     8899


Q ss_pred             eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      +|||. |+|+++|.....  ..++.-.+..++.||..|++||.. +++|||||-..|+|+.. ++.+|++|||+++.+..
T Consensus       342 TEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgE-nhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccc-cceEEeeccchhhhhcC
Confidence            99987 899999987543  457777888999999999999999 89999999999999996 88899999999998854


Q ss_pred             CCCcceeec---cccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          190 GEANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       190 ~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      +. .+...|   ..-|.|||-+.- ..++.++|||+|||+|||++| |..||++.+-.+.+..+.+-             
T Consensus       418 DT-YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-------------  482 (1157)
T KOG4278|consen  418 DT-YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-------------  482 (1157)
T ss_pred             Cc-eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-------------
Confidence            42 223333   556999998854 458999999999999999998 89999998766555443331             


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                           |+..          -++++++.+.+|+..||+|+|++||+..|+
T Consensus       483 -----yRM~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  483 -----YRMD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             -----cccc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                 1111          245789999999999999999999998876

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=242.24  Aligned_cols=215  Identities=22%  Similarity=0.401  Sum_probs=178.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc-----hHHHHHHHHh-CCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLMRL-MDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~e~~~l~~-l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..-++..-...||+|+||.|-+.++..+|...|+|.+......     ..+|+++..+ ..+|++|.+++.++...+   
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd---  119 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD---  119 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc---
Confidence            3445666677899999999999999999999999998644322     2235554433 368999999998865554   


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                        ++|.||.+.-+|..+-.+....++.++|..+-+|+..++.||.|||+.-.++|||+||+|||+|. ++.+|+||||.+
T Consensus       120 --vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 --VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKICDFGIS  196 (282)
T ss_pred             --EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEEcccccc
Confidence              89999999999888888888889999999999999999999999998557999999999999997 889999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhC---CCCCCccchhHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIK  251 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~~~~~~  251 (376)
                      ....+.-..+...|-..|||||.+..   ...|+.++||||||+++.||++++.||.. .++.+++.++++
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            88877666665667778999999843   23589999999999999999999999975 466777777765

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=273.76  Aligned_cols=239  Identities=30%  Similarity=0.444  Sum_probs=191.6

Q ss_pred             eEeeeeeccCCceEEEEEEEcCC--C--cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           36 YMAERVVGTGSFGIVFQAKCLET--G--ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~--~--~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .+..++||.|-||.||.|....-  |  -.||||.-+.+.     ..+..|..+++.++||||+++++++....      
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P------  464 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------  464 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc------
Confidence            34567899999999999987532  3  358999876543     23346899999999999999999984321      


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+||||.++ |.|.++++..   ...++......++.||+.||.|||+ +.+|||||-..|||+.+ ...+||+|||+++
T Consensus       465 ~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsS-p~CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSS-PQCVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecC-cceeeecccchhh
Confidence            789999999 7777777663   4678889999999999999999999 89999999999999997 6679999999999


Q ss_pred             ccccCCCcceeec--cccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          186 VLVKGEANISYIC--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       186 ~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ...++.-.....|  ..-|||||.+.-. .++.++|||.|||.+||+++ |..||.+..+.+.+..+.+.-         
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe---------  609 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE---------  609 (974)
T ss_pred             hccccchhhccccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC---------
Confidence            8876654443344  4569999998544 48999999999999999986 999999887665554333210         


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                                         ....|++.|+.+..|..+||++||.+||+..++
T Consensus       610 -------------------RlP~P~nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  610 -------------------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             -------------------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence                               112456789999999999999999999987654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=268.69  Aligned_cols=250  Identities=21%  Similarity=0.279  Sum_probs=198.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ....++++||+|-||.|.+|.- ..+..||+|+++.+.     ..+.+|+++|.+++||||+.+.+++.....     ++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence            5678999999999999999985 346899999997653     345689999999999999999999965444     89


Q ss_pred             EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|+||++ |+|..++.....  ..+.-....+|+.||+.|++||.+ -++|||||.+.|+|++. ++++||+|||.++..
T Consensus       612 mI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~-e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDG-EFTIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecC-cccEEecCccccccc
Confidence            9999998 677777765422  224455566799999999999999 59999999999999996 889999999999865


Q ss_pred             ccCCCcc---eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          188 VKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL--LGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       188 ~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      -.++...   ..+-...|||+|.+.-. +++.++|+|+||+++||++  +...||....+.+...+.-..+..+.+.-+ 
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~-  765 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV-  765 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee-
Confidence            4433221   22336789999999765 4999999999999999987  478999888777776665554433332211 


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                          ...|.-.+..+.+++.+||..|-.+||+.+++.
T Consensus       766 --------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  766 --------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             --------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence                                112345788899999999999999999999983

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=272.24  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=204.0

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCC-Cc--EEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLET-GE--TVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~-~~--~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ++..+.+.||+|+||.|++|.+... |+  .||||.+..+..     .+.+|+.+|..|+|+|++++|++..+..     
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp-----  184 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP-----  184 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence            4566788999999999999988653 33  599999876543     3558999999999999999999986522     


Q ss_pred             eEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                       .-+|||+++ |+|++-|..  .....|.......++.||+.|+.||.+ +++|||||-..|+|+-. ...|||+|||+.
T Consensus       185 -~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllas-prtVKI~DFGLm  259 (1039)
T KOG0199|consen  185 -AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLAS-PRTVKICDFGLM  259 (1039)
T ss_pred             -hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecc-cceeeeecccce
Confidence             559999999 688777776  345678888899999999999999999 89999999999999986 778999999999


Q ss_pred             cccccCCCcceeec----cccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          185 KVLVKGEANISYIC----SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       185 ~~~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      +.....+.......    ...|.|||.+... .++.++|+|++||++|||++ |..||.+....+.++.+-+...-+   
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp---  335 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP---  335 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC---
Confidence            98876665543322    4469999999765 49999999999999999998 899999999888887665321110   


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                               -++..++++.++++.||+.+|.+|||...|...-+...
T Consensus       336 -------------------------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  336 -------------------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             -------------------------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence                                     23457899999999999999999999998865555443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.6e-34  Score=300.91  Aligned_cols=253  Identities=22%  Similarity=0.310  Sum_probs=182.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeec
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY  113 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~  113 (376)
                      ..|...+.||+|+||.||+|++..++..||+|++.........|++.++.++||||+++++++..     ....|+||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeC
Confidence            34566778999999999999999999999999987665555678999999999999999999843     3447899999


Q ss_pred             ccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH---cCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          114 VPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH---TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       114 ~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      +++ +|.+.+.       .+++..+..++.|++.||+|||   + .+|+||||||+||+++. +...++. ||.......
T Consensus       765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECC-CCceEEE-ecccccccc
Confidence            985 6666653       2788899999999999999999   5 59999999999999986 6666665 665443221


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                         .....+++.|+|||++.+. .++.++|||||||++|||++|+.||..... ........+......  ..       
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~-------  901 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--HL-------  901 (968)
T ss_pred             ---CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc--ch-------
Confidence               1233678999999998754 489999999999999999999999953211 111111111100000  00       


Q ss_pred             cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ..+.-+.+...   ...+.....++.+++.+||+.||++|||+.++++.
T Consensus       902 ~~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        902 DMWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             hheeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00000100000   00111123467889999999999999999999754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=278.05  Aligned_cols=244  Identities=25%  Similarity=0.370  Sum_probs=203.5

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCc---EEEEEEeccc-----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .-.|.++||.|.||.|++++.+..|+   .||||.++..     +..+..|+.||-+++||||+++.++...     ..-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Cce
Confidence            45788999999999999999887764   6999999643     3445579999999999999999998833     333


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +-||+|||+ |+|..+|+..   .+.|+..++.-+++.|+.|++||-++ ++|||||...|||+|+ +-..|++|||+++
T Consensus       705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNs-nLvCKVsDFGLSR  779 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR  779 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeecc-ceEEEecccccee
Confidence            789999999 5777777763   35699999999999999999999995 9999999999999997 8899999999999


Q ss_pred             ccccCC-Ccceeec---cccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          186 VLVKGE-ANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       186 ~~~~~~-~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ...++. ...+..|   ...|.|||.+.-. +++.+||+||+|+++||.++ |..||-...+.+.+..+.+-..-|+   
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp---  855 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP---  855 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC---
Confidence            876554 2223332   5679999999654 59999999999999999885 9999999999999988876433332   


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                               |.+.|..+.+|...||++|-.+||...+|+++
T Consensus       856 -------------------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  856 -------------------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             -------------------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                                     34678999999999999999999999988753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=262.99  Aligned_cols=206  Identities=29%  Similarity=0.427  Sum_probs=179.1

Q ss_pred             CCCCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchH------------HHHHHHHhCC---CCC
Q 017139           24 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------------RELQLMRLMD---HPN   88 (376)
Q Consensus        24 ~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------~e~~~l~~l~---h~~   88 (376)
                      .+-.+++...-+|+..+.||.|+||+|++|.++.+...|+||.+.+.+...+            .|+++|..++   |+|
T Consensus       551 ~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N  630 (772)
T KOG1152|consen  551 IGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN  630 (772)
T ss_pred             ccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence            3455667777889999999999999999999999999999999877654332            4999999998   999


Q ss_pred             eeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCee
Q 017139           89 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL  168 (376)
Q Consensus        89 Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nil  168 (376)
                      |++++++|     +++.++||+||.-..++  .|..+......++|.....|+.|+..|+++||+ .||+|||||-+|+.
T Consensus       631 IlKlLdfF-----Eddd~yyl~te~hg~gI--DLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvi  702 (772)
T KOG1152|consen  631 ILKLLDFF-----EDDDYYYLETEVHGEGI--DLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVI  702 (772)
T ss_pred             hhhhhhee-----ecCCeeEEEecCCCCCc--chhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEE
Confidence            99999999     88889999999876431  334455567889999999999999999999999 69999999999999


Q ss_pred             ecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 017139          169 VDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG  239 (376)
Q Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  239 (376)
                      +++ +|.+||+|||.+... ..++...+.||..|.|||++.+..+.+..-|||++|+++|.++....||+.
T Consensus       703 vd~-~g~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  703 VDS-NGFVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             Eec-CCeEEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            997 788999999998754 445566889999999999998888779999999999999999999989864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=268.94  Aligned_cols=258  Identities=26%  Similarity=0.371  Sum_probs=206.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .-.++|..+..+|+|.||.||+|+++.+++..|+|+++..    ....++|+-+++..+||||+.+++.|..     ...
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dk   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDK   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcC
Confidence            3457899999999999999999999999999999998643    3456679999999999999999998843     334


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++|+||||+|+.++.+-+   ..+++++.++..++++.+.+|+|||+ .|-+|||||-.||+++. .+.+|++|||.+-.
T Consensus        87 lwicMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd-~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTD-EGDVKLADFGVSAQ  161 (829)
T ss_pred             cEEEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecc-cCceeecccCchhh
Confidence            889999999754444433   35789999999999999999999999 69999999999999995 88899999998754


Q ss_pred             cc-cCCCcceeeccccccChhhh--hCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          187 LV-KGEANISYICSRYYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       187 ~~-~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      .. .-....+++||++|||||+.  .....|...+|+|++|++..|+.--++|-....+...+..+-+..-.|+      
T Consensus       162 itati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp------  235 (829)
T KOG0576|consen  162 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP------  235 (829)
T ss_pred             hhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC------
Confidence            43 33455689999999999986  2233589999999999999999988888665555544444433211111      


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                 .++       =..+.++-+-+|++.+|.++|.+|||++-+|.|||...
T Consensus       236 -----------~lk-------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  236 -----------TLK-------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             -----------ccc-------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                       111       01245778889999999999999999999999999854

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-33  Score=233.67  Aligned_cols=261  Identities=21%  Similarity=0.287  Sum_probs=187.6

Q ss_pred             CCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhC-CCCCeeecceeeeecCCCC
Q 017139           28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLM-DHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        28 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ......+.|.|.+.||+|.||.+.+|+++.+...+++|.+.....   .+.+|...--.| .|.||+..+++.+.    .
T Consensus        18 ~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t   93 (378)
T KOG1345|consen   18 KKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----T   93 (378)
T ss_pred             cccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhh----c
Confidence            334456889999999999999999999999999999999876543   233454433333 48999999887653    3


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee-cCCCCcEEEEec
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDF  181 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill-~~~~~~~kl~Df  181 (376)
                      ..++.+++||++ |+|.+-+..     ..+.|...+.++.|+++|+.|||+ +++||||||.+|||+ +.+..++|||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             CceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeec
Confidence            346889999999 665554443     568899999999999999999999 899999999999998 444568999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCC----CCCCccchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCC
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTP  256 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~  256 (376)
                      |+.+....--..  .--+-.|.+||+....    -...+.+|+|.||+++|.++||.+||+.....+ .+.+..+..+..
T Consensus       168 G~t~k~g~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  168 GLTRKVGTTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK  245 (378)
T ss_pred             ccccccCceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence            998754322111  1124558899987432    225778999999999999999999997432221 122222221111


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCC---CCHHHHhCCCcccc
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDE  322 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~t~~ell~hp~~~~  322 (376)
                      ..             ..|.         .-..+++.+..+.++-|..+|.+|   .++......-|...
T Consensus       246 ~~-------------~~P~---------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  246 NP-------------ALPK---------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             Cc-------------cCch---------hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            10             0000         113578999999999999999999   45555555566543

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=6e-31  Score=259.23  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=189.8

Q ss_pred             eEeeeeeccCCceEEEEEEEcC-------CCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           36 YMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      ..+.+.||+|+||+|++|....       ....||+|.+.....     ....|+++++.+ .|+||+.+.+++..    
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~----  373 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ----  373 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence            3566799999999999997531       145799998865433     344688999888 59999999998843    


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhh---hc-------C--CCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYS---SM-------N--QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV  169 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~---~~-------~--~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill  169 (376)
                       ...+++|+|||. |+|..++++.+   ..       .  ..++......++.||+.|++||++ .+++||||-..|||+
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLI  451 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEe
Confidence             455889999999 78888888755   11       1  238999999999999999999999 799999999999999


Q ss_pred             cCCCCcEEEEecCCccccccCCCcce--ee--ccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC-hH
Q 017139          170 DPLTHQVKLCDFGSAKVLVKGEANIS--YI--CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN-AV  243 (376)
Q Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~--~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~-~~  243 (376)
                      .. +..+||+|||+++..........  ..  -...|||||.+.. ..|+.++||||+|+++||+++ |..||++.. ..
T Consensus       452 ~~-~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  452 TK-NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             cC-CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            96 78899999999986544333221  11  1334999999976 559999999999999999998 889998855 33


Q ss_pred             HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                      +.. +.++.....                           ..|...+.++.++++.||..+|++||+..++.
T Consensus       530 ~l~-~~l~~G~r~---------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  530 ELL-EFLKEGNRM---------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             HHH-HHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            333 333211111                           13346789999999999999999999998875

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=240.93  Aligned_cols=192  Identities=28%  Similarity=0.401  Sum_probs=156.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHh--CCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~--l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      +...+.+.+|+|.||.||+|..  +++.||||++.... .....|.++.+.  ++|+||+++++.--... .....++||
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLV  286 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLV  286 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEE
Confidence            4567789999999999999987  66999999997543 344567777664  58999999877532211 224568899


Q ss_pred             eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--------CCceeccCCCCCeeecCCCCcEEEEec
Q 017139          111 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--------PGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       111 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ++|-+ |+|.++|+.     ..+++....+|+..++.||+|||+-        ..|+|||||..|||+.. +....|+||
T Consensus       287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-DlTccIaDF  360 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-DLTCCIADF  360 (534)
T ss_pred             eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-CCcEEeecc
Confidence            99998 799999886     6799999999999999999999973        35999999999999995 889999999


Q ss_pred             CCccccccCCC---cceeeccccccChhhhhCCCCCC-----ccchhHHHHHHHHHHHhCC
Q 017139          182 GSAKVLVKGEA---NISYICSRYYRAPELIFGATEYT-----TSIDIWSAGCVLAELLLGQ  234 (376)
Q Consensus       182 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~lltg~  234 (376)
                      |+|........   ....+||..|||||++.+..++.     .+.||||+|.++|||++.-
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            99987764332   33578999999999998766555     3689999999999999754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=236.20  Aligned_cols=270  Identities=24%  Similarity=0.329  Sum_probs=189.1

Q ss_pred             cCCCCcccceEeeccCCCCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHH--hCC
Q 017139            9 QGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMR--LMD   85 (376)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~--~l~   85 (376)
                      +|++.+.+-++..+++.         +-++.+.+|+|.||.||+|..  -|+.||||+|... +..-.+|.++.+  .|+
T Consensus       195 SGSGSGlplLVQRTiar---------qI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLR  263 (513)
T KOG2052|consen  195 SGSGSGLPLLVQRTIAR---------QIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLR  263 (513)
T ss_pred             CCCCCCchhHhHHhhhh---------eeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhc
Confidence            34444444444555544         488999999999999999998  6789999999653 333345666555  579


Q ss_pred             CCCeeecceeeeecCCCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------CCc
Q 017139           86 HPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------PGV  157 (376)
Q Consensus        86 h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-------~~i  157 (376)
                      |+||+.+++.=.... ..-..++||++|-+ |+|.++|..     ..++.+...+++..++.||++||..       ..|
T Consensus       264 HENILgFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaI  337 (513)
T KOG2052|consen  264 HENILGFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAI  337 (513)
T ss_pred             cchhhhhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchh
Confidence            999999887543222 34567899999998 899998876     6688888999999999999999962       248


Q ss_pred             eeccCCCCCeeecCCCCcEEEEecCCccccccC-----CCcceeeccccccChhhhhCCCCC-----CccchhHHHHHHH
Q 017139          158 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-----EANISYICSRYYRAPELIFGATEY-----TTSIDIWSAGCVL  227 (376)
Q Consensus       158 vH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwslG~il  227 (376)
                      .|||||..|||+.+ ++...|+|+|+|-...+.     ......+||..|||||++....+.     -..+||||||.++
T Consensus       338 AHRDlKSKNILVKk-n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl  416 (513)
T KOG2052|consen  338 AHRDLKSKNILVKK-NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL  416 (513)
T ss_pred             hccccccccEEEcc-CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence            99999999999996 888999999999765543     234577899999999999653321     2358999999999


Q ss_pred             HHHHh----C------CCCCCCCC-hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHH
Q 017139          228 AELLL----G------QPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL  296 (376)
Q Consensus       228 ~~llt----g------~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  296 (376)
                      ||++.    |      ++||.+.- .+...+++.+.....      ...+..+         ..|..   ...=..+..+
T Consensus       417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~------~~RP~ip---------nrW~s---~~~l~~m~kl  478 (513)
T KOG2052|consen  417 WEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQ------KLRPNIP---------NRWKS---DPALRVMAKL  478 (513)
T ss_pred             HHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeec------ccCCCCC---------ccccc---CHHHHHHHHH
Confidence            99984    2      37886431 111222222211110      0000000         01100   0011346688


Q ss_pred             HHhhcCCCCCCCCCHHHH
Q 017139          297 ASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       297 i~~~L~~dP~~R~t~~el  314 (376)
                      ++.||..||.-|.||--+
T Consensus       479 MkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  479 MKECWYANPAARLTALRI  496 (513)
T ss_pred             HHHhhcCCchhhhHHHHH
Confidence            999999999999998654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=252.77  Aligned_cols=240  Identities=26%  Similarity=0.352  Sum_probs=192.8

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCc----EEEEEEeccc-----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .+..++||+|+||+||++.....|+    +||||++...     .....+|+-.+..++|||++++++++..+.      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            4557899999999999999877665    5888887543     234457889999999999999999884332      


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +-||++|++ |.|+++++.   ....+.......|+.||++||.|||. ++++||||-..|+|+.+ -..+||+|||+++
T Consensus       772 ~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVks-P~hvkitdfgla~  846 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKS-PNHVKITDFGLAK  846 (1177)
T ss_pred             HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecC-CCeEEEEecchhh
Confidence            559999999 678888776   34678889999999999999999999 79999999999999996 6679999999999


Q ss_pred             ccccCCCcceeec---cccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          186 VLVKGEANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       186 ~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      ....+.......+   .+-|||-|.+... .|+.++||||+||++||++| |..|+.+....+.-..+.+-         
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g---------  916 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG---------  916 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc---------
Confidence            8877665544333   5568898988654 59999999999999999998 99999887655443322220         


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                             .+            ...|+..+.++.-++.+||..|+..||++.++.
T Consensus       917 -------eR------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  917 -------ER------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             -------cc------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence                   00            112345788999999999999999999998864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1e-29  Score=218.22  Aligned_cols=208  Identities=37%  Similarity=0.618  Sum_probs=175.0

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeeccc-
Q 017139           42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-  115 (376)
Q Consensus        42 Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~-  115 (376)
                      ||+|++|.||++....+++.+++|++.....     ...+|+..++.+.|++|+++++++     ......++++|+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence            6899999999999988899999999976654     466899999999999999999988     33356889999999 


Q ss_pred             chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCC-Ccc
Q 017139          116 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANI  194 (376)
Q Consensus       116 g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~-~~~  194 (376)
                      ++|.+.+...   ...++...++.++.+++.+|++||+ .|++|+||+|.||+++..++.++|+|||.+....... ...
T Consensus        76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~  151 (215)
T cd00180          76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK  151 (215)
T ss_pred             CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence            5776666542   1468899999999999999999999 7999999999999998535789999999987654332 123


Q ss_pred             eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCC
Q 017139          195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP  274 (376)
Q Consensus       195 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      ...+...|++||.+......+.++|+|++|++++++                                            
T Consensus       152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            455688899999986543578999999999999999                                            


Q ss_pred             CCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCC
Q 017139          275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP  318 (376)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  318 (376)
                                      ..+.+++.+|++.||++||+++++++|+
T Consensus       188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                            1456999999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4.9e-31  Score=269.52  Aligned_cols=206  Identities=17%  Similarity=0.180  Sum_probs=145.5

Q ss_pred             hCCC-CCeeecceeeeecC--CCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCcee
Q 017139           83 LMDH-PNVISLKHCFFSTT--SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH  159 (376)
Q Consensus        83 ~l~h-~~Iv~~~~~~~~~~--~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH  159 (376)
                      .++| .||+++++.|-...  ......+++++|+++++|.+.+..   ....+++..++.++.||+.||.|||+ +||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence            4455 57777777652111  112234678899999998888753   23569999999999999999999999 79999


Q ss_pred             ccCCCCCeeecC------------------CCCcEEEEecCCccccccCC-----------------CcceeeccccccC
Q 017139          160 RDVKPQNLLVDP------------------LTHQVKLCDFGSAKVLVKGE-----------------ANISYICSRYYRA  204 (376)
Q Consensus       160 ~dlkp~Nill~~------------------~~~~~kl~Dfg~~~~~~~~~-----------------~~~~~~~t~~y~a  204 (376)
                      |||||+|||++.                  .++.+|++|||+++......                 ......||++|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999953                  13456667777665321100                 0012357889999


Q ss_pred             hhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccc
Q 017139          205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV  284 (376)
Q Consensus       205 PE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (376)
                      ||++.+.. ++.++|||||||++|||++|.+|+....  .....+.... .++ .                         
T Consensus       184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~-------------------------  233 (793)
T PLN00181        184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-Q-------------------------  233 (793)
T ss_pred             hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-h-------------------------
Confidence            99987654 8999999999999999999988875322  1111111110 000 0                         


Q ss_pred             cccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          285 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       285 ~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      . ....+...+++.+||++||.+||++.++++||||...
T Consensus       234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            0 0114456789999999999999999999999999764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.9e-29  Score=217.57  Aligned_cols=200  Identities=34%  Similarity=0.594  Sum_probs=166.2

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      |.+.+.||.|++|.||++.+..+++.+++|.+....     ....+|++.++.++|+|++++++++.     .....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence            677899999999999999999889999999987542     34457899999999999999999873     33458899


Q ss_pred             eecccc-hHHHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~-l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|++++ +|.+.+...    .. +++..++.++.+++.++.+||+ ++++|+||+|.||+++. ++.++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGM-DGLVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeCceeeEec
Confidence            999997 777666542    23 8899999999999999999999 79999999999999996 6889999999988765


Q ss_pred             cCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCC-CChHHHH
Q 017139          189 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQL  246 (376)
Q Consensus       189 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~  246 (376)
                      ...  ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+....+
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~  210 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLL  210 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence            543  334556788899999884334578899999999999999999999977 4444333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.2e-28  Score=206.69  Aligned_cols=167  Identities=21%  Similarity=0.177  Sum_probs=125.5

Q ss_pred             chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCcce
Q 017139          116 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS  195 (376)
Q Consensus       116 g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~  195 (376)
                      |+|.+.+...   +..+++..++.++.|++.||.|||+ ++      ||+|||++. ++.+|+  ||.+......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTW-DGLLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcC-ccceee--ccceEeeccc----c
Confidence            4666666542   4569999999999999999999999 67      999999986 777888  9998765432    2


Q ss_pred             eeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhcCcCCcCccCC
Q 017139          196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFP  274 (376)
Q Consensus       196 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      ..|++.|+|||++.+. .++.++|||||||++|+|++|..||...... ..+..+..........               
T Consensus        64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  127 (176)
T smart00750       64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---------------  127 (176)
T ss_pred             CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence            3678999999999765 4899999999999999999999999765433 2233332211110000               


Q ss_pred             CCCCCCcccccccCCCh--hHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          275 QIKAHPWHKVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       275 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                             ....+..++.  ++.+++.+||..||.+||++.+++.|+|+..
T Consensus       128 -------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 -------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                   0000112233  6999999999999999999999999999853

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-27  Score=208.55  Aligned_cols=247  Identities=20%  Similarity=0.247  Sum_probs=190.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCC-----cEEEEEEecccccch-----HHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~-----~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      .+++....+-+|.||.||.|..+...     +.+.+|.+.......     ..|.-++..+.|||+.++.++...    +
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie----~  359 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE----D  359 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----c
Confidence            57777888999999999999765432     346666665544333     256777778889999999888753    3


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSM----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                      ..+.+.++.+.+ |+|..++...+..    .+.++-.++..++.|+..|++|||+ +|++|.||-..|++|+. .-.+||
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd-~LqVkl  437 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDD-QLQVKL  437 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehh-heeEEe
Confidence            444678888888 7887777643321    3456777888999999999999999 79999999999999995 789999


Q ss_pred             EecCCccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017139          179 CDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       179 ~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      +|=.+++...+..-+   ...-....||+||.+... .|+.++|+||||+++|||+| |+.|+...++.+...-+.+.  
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG--  514 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG--  514 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc--
Confidence            999998876543321   112224569999999765 49999999999999999998 99999998888776655441  


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                      +++          ..|-+.|.++..++..||..+|++||+.+++.
T Consensus       515 ----------------yRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  515 ----------------YRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             ----------------cee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence                            111          12346899999999999999999999999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.2e-28  Score=240.20  Aligned_cols=261  Identities=24%  Similarity=0.347  Sum_probs=191.5

Q ss_pred             cce-EeeeeeccCCceEEEEEEEcCCCcEEEEEEecc----cccc------hHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           34 ISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        34 ~~y-~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~~~~------~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ..| .....+|.|++|.|+.+......+.++.|.+..    ....      ...|.-+-..+.|||++.....+....  
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--  394 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--  394 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--
Confidence            335 457899999999999988877777777775541    1111      113444556788999988776663221  


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                        . .+-.||||+++|...+..    ...++...+..++.|++.||+|||+ .||.|||+|++|+++.. ++.+||+|||
T Consensus       395 --~-~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~-~g~lki~Dfg  465 (601)
T KOG0590|consen  395 --G-ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTE-NGILKIIDFG  465 (601)
T ss_pred             --c-chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEec-CCceEEeecC
Confidence              1 334499999977766664    3578888999999999999999999 69999999999999996 7799999999


Q ss_pred             CccccccCCC-----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCC
Q 017139          183 SAKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV-EIIKVLGTP  256 (376)
Q Consensus       183 ~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~  256 (376)
                      .+........     ....+|+..|+|||++.+........||||.|+++..|.+|+.||......+... ....     
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-----  540 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-----  540 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-----
Confidence            9876644322     3456789999999999877655667999999999999999999997554332211 0000     


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                                  ...  .....  -...+...++...+.+|.+||++||.+|+|++++++.+||+.+...
T Consensus       541 ------------~~~--~~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  541 ------------SDQ--RNIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             ------------ccc--ccccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence                        000  00000  0011234578899999999999999999999999999999987654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-28  Score=228.73  Aligned_cols=237  Identities=28%  Similarity=0.404  Sum_probs=192.9

Q ss_pred             eeccCCceEEEEEEEc---CCCcEEEEEEeccc------ccchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEEE
Q 017139           41 VVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ++|.|+||.|+++...   ..|..||+|+..+.      ......|..++...+ ||++++++..+     +.+..++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence            4799999999987542   45778999987542      223335888888887 99999999988     555558999


Q ss_pred             eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          111 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       111 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      +++..|+   .+.........+.+...+.+...++.+++++|+ .||+|||+|++||+++. +|.+++.|||+++.....
T Consensus        76 ld~~rgg---~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   76 LDFLRGG---DLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhcccc---hhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecc-cCccccCCchhhhHhHhh
Confidence            9999975   233334446778899999999999999999999 69999999999999996 888999999999877655


Q ss_pred             CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          191 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       191 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ...   +||..|||||++.   ....++|.||+|+++++|++|..||.+    +....|.+..                 
T Consensus       151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-----------------  203 (612)
T KOG0603|consen  151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-----------------  203 (612)
T ss_pred             hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------
Confidence            443   8899999999986   368899999999999999999999987    4555554421                 


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH-----HHHhCCCccccccCC
Q 017139          271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP  326 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~~~~~~~~  326 (376)
                                  ..+|..++..+++++..++..+|..|...     .++++|+||..++|.
T Consensus       204 ------------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  204 ------------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ------------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                        11345678899999999999999999854     799999999999887

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3.8e-25  Score=203.02  Aligned_cols=251  Identities=20%  Similarity=0.191  Sum_probs=188.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCC-cEEEEEEecccc----cchHHHHHHHHhCCC----CCeeecceeeeecCCCCce
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR----RYKNRELQLMRLMDH----PNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~----~~~~~e~~~l~~l~h----~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +|.+.+.||+|+||.||.|.+..++ +.+|+|......    .....|..+++.+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            8999999999999999999988775 678999775532    146679999998873    57777766652    3555


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC----CcEEEEec
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT----HQVKLCDF  181 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~----~~~kl~Df  181 (376)
                      +.|+||+.++.+|.++.....  .+.++...+..++.|++.+|++||+ .|++||||||+|+.+....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999988776543  5789999999999999999999999 7999999999999997533    56999999


Q ss_pred             CCcc--ccccCC--------C-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017139          182 GSAK--VLVKGE--------A-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  250 (376)
Q Consensus       182 g~~~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  250 (376)
                      |+++  ......        . .....||..|.++....+.. .+.+.|+||++.++.+++.|..||.+...........
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  321111        1 12355899999999887654 8999999999999999999999997765433332222


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      +......               ...         +....+.++.++...+-..+...+|....+...
T Consensus       251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            2110000               000         112245677777777777888999988766543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=6.4e-26  Score=187.80  Aligned_cols=205  Identities=23%  Similarity=0.329  Sum_probs=165.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCC-CCeeecceeeeecCCCCceeE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h-~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...+.|.++++||+|+||.+|.|....+|+.||||.-+...  .....|..+.+.+++ ..|..+..+.     .+..+-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccc
Confidence            44567999999999999999999999999999999886654  345579999998875 4555555554     445556


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEecCCcc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAK  185 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Dfg~~~  185 (376)
                      .+||+.++.+|.+++.-.   ...++...+.-++-|++.-++|+|. ++++||||||+|+|+.-  ..+.+.++|||+++
T Consensus        87 vlVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   87 VLVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchh
Confidence            799999999988877653   3568999999999999999999999 89999999999999853  23579999999998


Q ss_pred             ccccCC--------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 017139          186 VLVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ  245 (376)
Q Consensus       186 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~  245 (376)
                      ...+..        ......||..|.+--...+.. -+.+.|+-|+|.++..+.-|..||++......
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk  229 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATK  229 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence            765432        233567899999877766544 58889999999999989999999998755433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=4e-25  Score=202.63  Aligned_cols=173  Identities=19%  Similarity=0.280  Sum_probs=127.2

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcC-CCcEEEEEEeccc---------ccchHHHHHHHHhCCCCCeeecceeeee
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFS   98 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~   98 (376)
                      .+...++|.+.+.||+|+||+||+|.+.. +++.+|||++...         .....+|+++++.++|+|++..+..+  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            44567889999999999999999999876 6788899986432         12356899999999999998533211  


Q ss_pred             cCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccC-CCCCeeecCCCCcEE
Q 017139           99 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV-KPQNLLVDPLTHQVK  177 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dl-kp~Nill~~~~~~~k  177 (376)
                       .     ..|+|||||+|..+....    .   ..   ...++.|++.+|.|||+ +||+|||| ||+|||++. ++.+|
T Consensus        91 -~-----~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~-~~~ik  152 (365)
T PRK09188         91 -G-----KDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGP-DGEAA  152 (365)
T ss_pred             -C-----CcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcC-CCCEE
Confidence             1     268999999975333221    0   11   14678899999999999 79999999 999999985 67899


Q ss_pred             EEecCCccccccCCCc---------ceeeccccccChhhhhCC-----CCCCccchhH
Q 017139          178 LCDFGSAKVLVKGEAN---------ISYICSRYYRAPELIFGA-----TEYTTSIDIW  221 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~---------~~~~~t~~y~aPE~~~~~-----~~~~~~~Diw  221 (376)
                      |+|||+++........         ....+++.|.|||.+...     ...+..+|-|
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9999999876543221         234457778899887422     1234456666

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.4e-23  Score=192.55  Aligned_cols=260  Identities=35%  Similarity=0.504  Sum_probs=194.8

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCC-CeeecceeeeecCCCCceeE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHP-NVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~-~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....       ...+|..++..+.|+ +|+++.+.+     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            788999999999999999987   7889998854432       245788899999988 799999988     333337


Q ss_pred             EEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +++++++.+. +...+...... ..+++.....++.|++.++.++|+ .+++|||+||+||+++..+..++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            8999999974 43233221100 379999999999999999999999 79999999999999997333799999999875


Q ss_pred             cccCC-------CcceeeccccccChhhhhCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcC
Q 017139          187 LVKGE-------ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG  254 (376)
Q Consensus       187 ~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~  254 (376)
                      .....       ......++..|++||.+.+.  ..++...|+||+|++++++++|..||.....   .......+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            54432       23567889999999999763  4588999999999999999999999887764   333333333322


Q ss_pred             CC-CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          255 TP-TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       255 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      .+ .....           .+.         ........+.+++.+++..+|..|.+..+...++|......
T Consensus       232 ~~~~~~~~-----------~~~---------~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         232 TPSLASPL-----------SPS---------NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             Cccccccc-----------Ccc---------ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            22 00000           000         00112357899999999999999999999988877765433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=7.8e-26  Score=221.05  Aligned_cols=227  Identities=28%  Similarity=0.459  Sum_probs=171.0

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      -..-.+|..++.+..|+||.||.++++.+.+.+|+ ++.++......   ++.....|++|                   
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn---ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN---ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc---cccccCCccee-------------------
Confidence            34456799999999999999999999999999999 45444332221   22222222222                   


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                            |+=...++.    -+.++..        ++.+++|||+ .||+|||+||+|.+|.. -+.+|++|||+.+....
T Consensus       136 ------gDc~tllk~----~g~lPvd--------mvla~Eylh~-ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 ------GDCATLLKN----IGPLPVD--------MVLAVEYLHS-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             ------chhhhhccc----CCCCcch--------hhHHhHhhcc-CCeecCCCCCCcceeee-cccccccchhhhhhhhh
Confidence                  221112222    2334433        2679999999 69999999999999997 78899999999865421


Q ss_pred             C----------------CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017139          190 G----------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL  253 (376)
Q Consensus       190 ~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  253 (376)
                      .                -.....+|||.|.|||++..+. |+..+|+|++|+|+|+.+.|..||.+.+.++.+.+++...
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            1                0112457899999999997654 9999999999999999999999999999999988887743


Q ss_pred             CCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC---CHHHHhCCCccccccCC
Q 017139          254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREP  326 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~ell~hp~~~~~~~~  326 (376)
                      ...+.+                          ...++++++++|.++|..+|..|.   .+-++.+|+||+.++|.
T Consensus       275 i~wpE~--------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  275 IEWPEE--------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cccccc--------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            322211                          234789999999999999999996   45688899999999887

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=5.2e-24  Score=184.17  Aligned_cols=206  Identities=21%  Similarity=0.327  Sum_probs=168.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecc--cccchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      -.|.++++||.|+||..+.+++.-+++.||||.-..  +...+..|....+.|. .++|..++.+-     +...+-.+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhh
Confidence            369999999999999999999999999999997643  3345567888888885 67887765443     555566799


Q ss_pred             eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec----CCCCcEEEEecCCccc
Q 017139          111 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKV  186 (376)
Q Consensus       111 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~----~~~~~~kl~Dfg~~~~  186 (376)
                      +|.++.+|.+++...   +..|+...+..++.|++.-++++|+ +.+|+|||||+|+||.    .+.+.|.|+|||+|+.
T Consensus       103 idLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  103 IDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            999999998877653   4679999999999999999999999 8999999999999995    3345799999999988


Q ss_pred             cccCCC--------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHH
Q 017139          187 LVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEI  249 (376)
Q Consensus       187 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~~  249 (376)
                      ..+...        ..+..||..||+--..++.. -+.+.|+-|||-+++..+-|..||.+..   ..+.+++|
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            765433        34667899999987777755 6899999999999999999999998754   34444444

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8.5e-25  Score=193.26  Aligned_cols=195  Identities=23%  Similarity=0.346  Sum_probs=142.5

Q ss_pred             CCCCeeecceeeeec----------------------CCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHH
Q 017139           85 DHPNVISLKHCFFST----------------------TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY  142 (376)
Q Consensus        85 ~h~~Iv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~  142 (376)
                      +|||||.+...|.++                      .......+|+||...+.+|..++..     ...+....+-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            599999998877322                      2234567899999999888877764     4456666778999


Q ss_pred             HHHHHHHHhHcCCCceeccCCCCCeeecCCC---CcEEEEecCCccccccCCC-------cceeeccccccChhhhhCCC
Q 017139          143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVKGEA-------NISYICSRYYRAPELIFGAT  212 (376)
Q Consensus       143 qil~aL~~LH~~~~ivH~dlkp~Nill~~~~---~~~kl~Dfg~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~  212 (376)
                      |+++|+.|||+ +|+.|||+|.+|||+.-++   -.+.|+|||+|-.......       ....-|+..-||||+....+
T Consensus       349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999999 7999999999999984322   2578999999865443211       12334677899999985432


Q ss_pred             C-----CCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCccccccc
Q 017139          213 E-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK  287 (376)
Q Consensus       213 ~-----~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (376)
                      .     .-.++|.|+.|.+.||++....||++......-..                  +|.+-..|.         +++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r------------------~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR------------------TYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh------------------hhhhhhCCC---------Ccc
Confidence            1     12378999999999999999999987432211000                  011112222         556


Q ss_pred             CCChhHHHHHHhhcCCCCCCCCCHH
Q 017139          288 RMPPEAIDLASRLLQYSPSLRCTAL  312 (376)
Q Consensus       288 ~~~~~~~~li~~~L~~dP~~R~t~~  312 (376)
                      .+++.+++++..+|+.||++|+++.
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCcc
Confidence            8899999999999999999999864

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=8.6e-25  Score=192.20  Aligned_cols=237  Identities=25%  Similarity=0.302  Sum_probs=145.1

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchH-------HHHHHHHhCC----------CCCeeecceeee
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMD----------HPNVISLKHCFF   97 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~e~~~l~~l~----------h~~Iv~~~~~~~   97 (376)
                      .+..++.||.|+++.||.|.+..+|+.+|+|++........       +|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            57889999999999999999999999999999854332211       1111111111          111222222211


Q ss_pred             ec-------CCCCce-----eEEEEeecccchHHHHHHhhhhcCC---CCCHHHHHHHHHHHHHHHHHhHcCCCceeccC
Q 017139           98 ST-------TSKDEL-----FLNLVMEYVPETMYRVLKHYSSMNQ---RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV  162 (376)
Q Consensus        98 ~~-------~~~~~~-----~~~lv~e~~~g~l~~~l~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dl  162 (376)
                      ..       ...+..     ..+++|+-+.++|...+........   .+.......+..|++..+++||+ .|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence            11       001111     2368888888888777654322222   23344445666899999999999 79999999


Q ss_pred             CCCCeeecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCC-------CCCCccchhHHHHHHHHHHHhCCC
Q 017139          163 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQP  235 (376)
Q Consensus       163 kp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~  235 (376)
                      +|+|++++. +|.++|+||+...........  ...+..|.|||.....       ..++.+.|.|+||+++|.|.+|..
T Consensus       172 ~~~nfll~~-~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQ-DGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-T-TS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcC-CCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            999999997 788999999977654322111  2335779999987432       236888999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCC
Q 017139          236 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR  308 (376)
Q Consensus       236 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  308 (376)
                      ||..........                       +        .+.. .. ++|+.+++||.++|++||.+|
T Consensus       249 Pf~~~~~~~~~~-----------------------~--------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPE-----------------------W--------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSG-----------------------G--------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccccc-----------------------c--------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            997553210000                       0        0111 12 579999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-24  Score=213.24  Aligned_cols=241  Identities=29%  Similarity=0.437  Sum_probs=173.7

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chH--HHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~--~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +|..++.||++.|=+|.+|++. .| .|+||++.+...      ..+  +|++ ...+++||.+.+....     ..+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            6888999999999999999974 34 499999865431      111  2444 5677999999987665     44555


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      -|+|-+|...+|++-+..    ..-+.+.+.+.|+.||+.||..+|. .||+|||||.+|||+.+ -+.+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTS-WNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITS-WNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEee-echhhhhcccccCC
Confidence            779999998887776654    4567788888999999999999999 69999999999999996 77899999986543


Q ss_pred             cc--c-CCCcce-e----eccccccChhhhhCCC----------CCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017139          187 LV--K-GEANIS-Y----ICSRYYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV  247 (376)
Q Consensus       187 ~~--~-~~~~~~-~----~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  247 (376)
                      .-  + +....+ +    ....+|.|||.+....          ..+++.||||+||+++||++ |++||.-    .++-
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence            31  1 111111 1    1244699999984411          15778999999999999997 7999941    1111


Q ss_pred             HHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ...... ....+..                       +.+--+..++.+|..|++.||++|.+|++.|+-
T Consensus       246 aYr~~~-~~~~e~~-----------------------Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQL-----------------------LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccC-ccCHHHH-----------------------HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111100 1111110                       111125588999999999999999999999875

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=5.5e-23  Score=173.59  Aligned_cols=135  Identities=16%  Similarity=0.207  Sum_probs=103.4

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------------------------------chHHHHHHHHhCCCCC
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRLMDHPN   88 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------------------------------~~~~e~~~l~~l~h~~   88 (376)
                      ...||+|++|.||+|.+. +|+.||+|++.....                              ....|...+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 899999999864321                              0123888999998877


Q ss_pred             eeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh-HcCCCceeccCCCCCe
Q 017139           89 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI-HTVPGVCHRDVKPQNL  167 (376)
Q Consensus        89 Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~~~ivH~dlkp~Ni  167 (376)
                      +.....+.     ...  .+|||||++|+.+....   .....+++..+..++.|++.+|.++ |+ .||+||||||+||
T Consensus        81 v~~p~~~~-----~~~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL-----LKS--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE-----ecC--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence            74433222     111  36999999975322111   1235789999999999999999999 68 7999999999999


Q ss_pred             eecCCCCcEEEEecCCcccc
Q 017139          168 LVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       168 ll~~~~~~~kl~Dfg~~~~~  187 (376)
                      +++  ++.++|+|||++...
T Consensus       150 li~--~~~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYH--DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEE--CCcEEEEEccccccC
Confidence            998  457999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.5e-22  Score=173.00  Aligned_cols=170  Identities=12%  Similarity=0.131  Sum_probs=124.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cc---------hHHHHHHHHhCCCCCeeecceeeeec
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RY---------KNRELQLMRLMDHPNVISLKHCFFST   99 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~---------~~~e~~~l~~l~h~~Iv~~~~~~~~~   99 (376)
                      .++|++.++||.|+||.||++..  ++..+|+|.+....    ..         .++|+..+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            46899999999999999999765  46789999985431    11         35788899999999999998886543


Q ss_pred             CCC---CceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc
Q 017139          100 TSK---DELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ  175 (376)
Q Consensus       100 ~~~---~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~  175 (376)
                      ...   .....+++|||++|. |.+. .       .+++.    .+.+++.+|..||+ .|++|||++|+||+++. ++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~-~-------~~~~~----~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~-~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDM-P-------EISED----VKAKIKASIESLHQ-HGMVSGDPHKGNFIVSK-NG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHh-h-------hccHH----HHHHHHHHHHHHHH-cCCccCCCChHHEEEeC-CC-
Confidence            211   123478999999984 4332 1       13332    35599999999999 79999999999999986 66 


Q ss_pred             EEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHH
Q 017139          176 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL  231 (376)
Q Consensus       176 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  231 (376)
                      ++|+|||.............           +.... .++.++|+||||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~d~-----------~vler-~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKDR-----------IDLER-HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHHH-----------HHHHh-HhcccccccceeEeehHHH
Confidence            99999998865432221111           22333 3668899999999877544

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=3.2e-21  Score=161.29  Aligned_cols=181  Identities=17%  Similarity=0.100  Sum_probs=132.1

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc--------chHHHHHHHHhCC-CCCeeecceeeeecCCCCceeE
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++..|++|+||+|+.+..  .+..++.+.+.....        ...+|+++|+++. |+++.+++++.     .    .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----E
Confidence            4678999999999998765  677888777755432        3568999999995 47788876641     1    6


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccC-CCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV-KPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dl-kp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |++|||+.|..+....         +.. ...++.|++.+|+++|+ +||+|||| ||+|||++. ++.++|+|||++..
T Consensus        74 ~lvmeyI~G~~L~~~~---------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~-~g~i~LIDFG~A~~  141 (218)
T PRK12274         74 HLDRSYLAGAAMYQRP---------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQE-DGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEeeecCccHHhhh---------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcC-CCCEEEEECCCcee
Confidence            7999999985322111         001 13467899999999999 79999999 799999986 77899999999985


Q ss_pred             cccCCCc--------------ceeeccccccChhhhhCCCCCC-ccchhHHHHHHHHHHHhCCCCCCCC
Q 017139          187 LVKGEAN--------------ISYICSRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGE  240 (376)
Q Consensus       187 ~~~~~~~--------------~~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~  240 (376)
                      .......              .....++.|++|+...--...+ ...++++.|+-+|.++|+..|+-+.
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            5433311              0112377788888653222233 5678999999999999999887554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.4e-21  Score=164.12  Aligned_cols=137  Identities=17%  Similarity=0.193  Sum_probs=105.7

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------------------------------chHHHHHHHHhCCCC
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRLMDHP   87 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------------------------------~~~~e~~~l~~l~h~   87 (376)
                      +.+.||+|++|.||+|.+. +|+.||||++.....                              ....|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999999865421                              113578888899998


Q ss_pred             CeeecceeeeecCCCCceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCC
Q 017139           88 NVISLKHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN  166 (376)
Q Consensus        88 ~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~N  166 (376)
                      ++.....+...     .  .|+||||++|+ +......    ...+++..+..++.|++.+|.+||+..||+||||||+|
T Consensus        80 ~i~~p~~~~~~-----~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N  148 (190)
T cd05145          80 GVPVPEPILLK-----K--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN  148 (190)
T ss_pred             CCCCceEEEec-----C--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence            87554433311     1  36999999975 2222111    24578888999999999999999982399999999999


Q ss_pred             eeecCCCCcEEEEecCCccccc
Q 017139          167 LLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       167 ill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |+++  ++.++|+|||++....
T Consensus       149 Ill~--~~~~~liDFG~a~~~~  168 (190)
T cd05145         149 ILYH--DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EEEE--CCCEEEEEcccceecC
Confidence            9998  5679999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=2.6e-20  Score=185.69  Aligned_cols=194  Identities=23%  Similarity=0.343  Sum_probs=150.0

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHhCC---CCCeeecceeeeecCCCCce
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRLMD---HPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~l~~l~---h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +...+.|.|.+.||+|+||+||+|.... |+.||+|+-..... ...-=.+++.+|+   -+-|..+..++...+.    
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~----  768 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA----  768 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc----
Confidence            3455789999999999999999999877 99999998765432 1111234455555   2344555444432222    


Q ss_pred             eEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec------CCCCcEEE
Q 017139          106 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD------PLTHQVKL  178 (376)
Q Consensus       106 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~------~~~~~~kl  178 (376)
                       -++|+||.+ |+|++++.    ....+++..+..++.|++..++.||. .+|||+||||+|+||.      .+...++|
T Consensus       769 -S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 -SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             -ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEE
Confidence             459999999 78888776    46779999999999999999999999 6999999999999994      22346999


Q ss_pred             EecCCccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCC
Q 017139          179 CDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP  235 (376)
Q Consensus       179 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~  235 (376)
                      +|||.+.-+.-..   .....+.|..+-++|...|.. |+...|.|.|+.+++.|+.|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            9999987654332   334556788999999997765 9999999999999999999973

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=1.1e-19  Score=154.79  Aligned_cols=135  Identities=17%  Similarity=0.235  Sum_probs=101.2

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHhC-----CCCCeeecceeeeecCCCCcee-
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLM-----DHPNVISLKHCFFSTTSKDELF-  106 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l-----~h~~Iv~~~~~~~~~~~~~~~~-  106 (376)
                      .-.+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     .||||+++++++.+..  +... 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence            3357899999999995  6666666 69988643    23456899999999     5799999999985532  2234 


Q ss_pred             EEEEeeccc---chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH-HHhHcCCCceeccCCCCCeeecCC---CCcEEEE
Q 017139          107 LNLVMEYVP---ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL-AYIHTVPGVCHRDVKPQNLLVDPL---THQVKLC  179 (376)
Q Consensus       107 ~~lv~e~~~---g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL-~~LH~~~~ivH~dlkp~Nill~~~---~~~~kl~  179 (376)
                      +.+|+||++   ++|.+.+..     ..+++.  ..++.|++.++ +|||+ ++|+||||||+|||++..   +..++|+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            347899955   577777754     235555  35677888888 99999 799999999999999742   3479999


Q ss_pred             ecCCc
Q 017139          180 DFGSA  184 (376)
Q Consensus       180 Dfg~~  184 (376)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.4e-20  Score=158.89  Aligned_cols=239  Identities=17%  Similarity=0.243  Sum_probs=177.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .+..+.-+|.+...|..|+++.  .|..+++|++.-.      .+.+..|.-.|+.+.||||+.+++.+-     ....+
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppnl  262 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPNL  262 (448)
T ss_pred             hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCCc
Confidence            4556677899999999999998  4556777876422      344557888899999999999999883     33447


Q ss_pred             EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceec-cCCCCCeeecCCCCcEEEE--ecCC
Q 017139          108 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR-DVKPQNLLVDPLTHQVKLC--DFGS  183 (376)
Q Consensus       108 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~-dlkp~Nill~~~~~~~kl~--Dfg~  183 (376)
                      .++..|++ |+|+..+....  +-..+..+..+++.+++.|+.|||++..++-| -|....+++|. +.+.+|.  |--+
T Consensus       263 v~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kf  339 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKF  339 (448)
T ss_pred             eEeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheeccccee
Confidence            89999999 78888887532  34466677888999999999999997666655 58888999985 6555544  3322


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCC--CccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEY--TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      +..      .....-.|.|++||.+...+..  -.++|+|||++++|||.|...||..-.+.+.-.++.-          
T Consensus       340 sfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----------  403 (448)
T KOG0195|consen  340 SFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----------  403 (448)
T ss_pred             eee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------
Confidence            211      1123347889999999654432  3478999999999999999999988776654433321          


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                       +.+...+|+++++.+..|++-|+.-||.+||..+.++
T Consensus       404 -----------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 -----------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -----------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                             1223346778999999999999999999999887653

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=7.5e-20  Score=159.70  Aligned_cols=140  Identities=16%  Similarity=0.133  Sum_probs=105.4

Q ss_pred             ceEeeeeeccCCceEEEEEE-EcCCCcEEEEEEeccccc----------------------------chHHHHHHHHhCC
Q 017139           35 SYMAERVVGTGSFGIVFQAK-CLETGETVAIKKVLQDRR----------------------------YKNRELQLMRLMD   85 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~-~~~~~~~~aiK~~~~~~~----------------------------~~~~e~~~l~~l~   85 (376)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|++.....                            ....|..+++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 677899999998864321                            1246888898887


Q ss_pred             CCCeeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-ceeccCCC
Q 017139           86 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-VCHRDVKP  164 (376)
Q Consensus        86 h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~-ivH~dlkp  164 (376)
                      +. .+.+...+..   .   ..++||||++|..+....   .....+....+..++.|++.+|.+||+ +| ++||||||
T Consensus       109 ~~-~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp  177 (237)
T smart00090      109 EA-GVPVPKPIAW---R---RNVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE  177 (237)
T ss_pred             hc-CCCCCeeeEe---c---CceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence            53 3333333311   1   146999999984322211   123446666778999999999999999 79 99999999


Q ss_pred             CCeeecCCCCcEEEEecCCcccc
Q 017139          165 QNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       165 ~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||+++  ++.++|+|||.+...
T Consensus       178 ~NIli~--~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH--DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE--CCCEEEEEChhhhcc
Confidence            999998  567999999998653

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=2.5e-20  Score=171.27  Aligned_cols=179  Identities=30%  Similarity=0.455  Sum_probs=131.7

Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ..++||.|+.|.- +|.+.+ .........+......++.|+..|++|    +|.+|+|+||.||++.. +..+||.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl-~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~-d~q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWL-RRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSD-DDQLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHh-hCCCcccccchhHHHHHHHhhccchhh----ccchhhhcccccccccc-chhhhhhhhh
Confidence            3468899999995 444444 334445667777888999999999999    48999999999999985 6689999999


Q ss_pred             CccccccCC-------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017139          183 SAKVLVKGE-------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       183 ~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      +........       ..+...||.+||+||.+.+.. |+.++||||||+|++|++. =...|.....   +..+..  |
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~r~--g  475 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIAT---LTDIRD--G  475 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhhhc--C
Confidence            988776655       456778999999999998765 9999999999999999997 2222211111   111100  1


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                      ..++.                         +..+ .++-.+|+.+||...|.+||++.+.-.|+|.
T Consensus       476 ~ip~~-------------------------~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  476 IIPPE-------------------------FLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CCChH-------------------------Hhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            11111                         1111 3455699999999999999988887777775

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.3e-18  Score=162.73  Aligned_cols=203  Identities=27%  Similarity=0.398  Sum_probs=148.7

Q ss_pred             HHhCCCCCeeecceeeeecCCCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCc-e
Q 017139           81 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV-C  158 (376)
Q Consensus        81 l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~i-v  158 (376)
                      |+.+.|.|+.++++..+..     ...++|.+||. |+|.+.+..   ....++......++.+|+.||.|||.. .| .
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS-PIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC-ccee
Confidence            3568899999999998655     34889999999 677777765   456788888999999999999999984 55 9


Q ss_pred             eccCCCCCeeecCCCCcEEEEecCCccccccC---CCcceeeccccccChhhhhCCCC------CCccchhHHHHHHHHH
Q 017139          159 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAE  229 (376)
Q Consensus       159 H~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwslG~il~~  229 (376)
                      |+.|+..|++++. ...+||+|||+.......   .......-..-|.|||.+.....      .+.+.|+||+|++++|
T Consensus        72 hg~l~s~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   72 HGALKSSNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeccccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            9999999999996 899999999998766421   11112223556999999865311      3667999999999999


Q ss_pred             HHhCCCCCCCCChH----HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCC
Q 017139          230 LLLGQPLFPGENAV----DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP  305 (376)
Q Consensus       230 lltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  305 (376)
                      +++...||......    +....+.+....+.+..+..                      ....++++..++..||.-+|
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~----------------------~~e~~~~l~~l~~~cw~e~P  208 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL----------------------LNELPPELLLLVARCWEEIP  208 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh----------------------hhhcchHHHHHHHHhcccCh
Confidence            99999999763322    22222222011111111100                      01345689999999999999


Q ss_pred             CCCCCHHHHh
Q 017139          306 SLRCTALEAC  315 (376)
Q Consensus       306 ~~R~t~~ell  315 (376)
                      .+||+++++-
T Consensus       209 ~~rPs~~~i~  218 (484)
T KOG1023|consen  209 EKRPSIEQIR  218 (484)
T ss_pred             hhCccHHHHH
Confidence            9999998874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=2.3e-19  Score=175.31  Aligned_cols=256  Identities=23%  Similarity=0.321  Sum_probs=191.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC-CcEEEEEEecccc---c---chHHHHHHHHhCC-CCCeeecceeeeecCCCCc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR---R---YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~---~---~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...|.+.+.||+|+|+.|-.+....+ ...+|.|.+....   .   ....|..+-+.+. |+|++.+++..     .+.
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence            34688999999999999988876443 3456666654332   1   1224666766776 99999998877     556


Q ss_pred             eeEEEEeecccch-HHHHHHhhhhcCC-CCCHHHHHHHHHHHHHHHHHhH-cCCCceeccCCCCCeeecCCCC-cEEEEe
Q 017139          105 LFLNLVMEYVPET-MYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAYIH-TVPGVCHRDVKPQNLLVDPLTH-QVKLCD  180 (376)
Q Consensus       105 ~~~~lv~e~~~g~-l~~~l~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH-~~~~ivH~dlkp~Nill~~~~~-~~kl~D  180 (376)
                      .+.+++++|..|+ +..-+.   .... ..+......++.|+..++.|+| . .++.|+|+||+|.+++. .+ .+++.|
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~-s~~~l~~~d  168 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDE-SGSALKIAD  168 (601)
T ss_pred             cccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhcc-CCCcccCCC
Confidence            6688999998764 222221   1222 5667778889999999999999 8 79999999999999996 55 899999


Q ss_pred             cCCcccccc-CCC---cceeec-cccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          181 FGSAKVLVK-GEA---NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       181 fg~~~~~~~-~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      ||+|..... ...   ....+| ++.|+|||...+.....+..|+||+|+++..+++|..|+......+....       
T Consensus       169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-------  241 (601)
T KOG0590|consen  169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-------  241 (601)
T ss_pred             chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-------
Confidence            999987765 332   234567 99999999997755578999999999999999999999865543321100       


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                      .+... ........+..++....+++.++|..+|+.|.+.+++-.+||+..
T Consensus       242 ----------------~~~~~-~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  242 ----------------SWKSN-KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ----------------eeccc-ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                            00000 011223345678999999999999999999999999999999988

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=3.1e-17  Score=141.57  Aligned_cols=129  Identities=20%  Similarity=0.314  Sum_probs=101.1

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      +.||+|++|.||+|..  .|..+++|+.....            ....+|+.++..+.|++|.....++...     ...
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence            5799999999999987  77789999764321            1234688899999999887766655332     236


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +++|||++| +|.+.+...       .. ....++.+++.+|.+||+ .|++|+|++|.||+++  ++.++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence            799999987 555554321       11 677899999999999999 7999999999999998  56799999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=1.9e-17  Score=141.32  Aligned_cols=132  Identities=18%  Similarity=0.158  Sum_probs=99.0

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--------------------------cchHHHHHHHHhCCCCC
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------RYKNRELQLMRLMDHPN   88 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------------------~~~~~e~~~l~~l~h~~   88 (376)
                      .|.+.+.||+|+||.||++... +|+.+|||++....                          .....|..++..+.+++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3888999999999999999864 79999999865322                          01345777888887764


Q ss_pred             e--eecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCC
Q 017139           89 V--ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN  166 (376)
Q Consensus        89 I--v~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~N  166 (376)
                      +  ...++    .     ...++||||++|..+..+..         ......++.+++.++.++|+ .|++|+||+|+|
T Consensus        95 i~v~~~~~----~-----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N  155 (198)
T cd05144          95 FPVPKPID----W-----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN  155 (198)
T ss_pred             CCCCceee----c-----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence            3  22221    1     12579999999843322211         02356788899999999999 799999999999


Q ss_pred             eeecCCCCcEEEEecCCcccc
Q 017139          167 LLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       167 ill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+++. ++.++|+|||.+...
T Consensus       156 ill~~-~~~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDD-DEKIYIIDWPQMVST  175 (198)
T ss_pred             EEEcC-CCcEEEEECCccccC
Confidence            99996 788999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=1.4e-16  Score=136.25  Aligned_cols=125  Identities=21%  Similarity=0.317  Sum_probs=93.9

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .||+|++|.||++..  +|..+++|......            ....+|.++++.+.|+++....-++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            379999999999984  67889999864321            12236889999998887655444433221     257


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +||||++| ++.+.+..    .. .      .++.+++.+|.+||+ .|++|+|++|.||+++  ++.++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~----~~-~------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEE----GN-D------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhh----cH-H------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence            99999987 44444322    11 0      678899999999999 7999999999999998  56799999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=3.1e-16  Score=153.63  Aligned_cols=133  Identities=20%  Similarity=0.251  Sum_probs=99.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------------ccchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------------RRYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      ...|...+.||+|+||.||++....  ..+++|+....            .....+|+++++.++|++++....+.... 
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-  408 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-  408 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence            3455678899999999999998743  34454443211            01234699999999999988766554332 


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                          ...++||||++| +|.+.+.            ....++.+++.+|.+||+ .|++||||||+||+++  ++.++|+
T Consensus       409 ----~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~li  469 (535)
T PRK09605        409 ----EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLI  469 (535)
T ss_pred             ----CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEE
Confidence                225799999987 5544443            245788999999999999 7999999999999994  6679999


Q ss_pred             ecCCcccc
Q 017139          180 DFGSAKVL  187 (376)
Q Consensus       180 Dfg~~~~~  187 (376)
                      |||+++..
T Consensus       470 DFGla~~~  477 (535)
T PRK09605        470 DFGLGKYS  477 (535)
T ss_pred             eCcccccC
Confidence            99998753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=6e-16  Score=130.87  Aligned_cols=131  Identities=24%  Similarity=0.207  Sum_probs=90.6

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecccccch----------------------------HHHHHHHHhCCCCC--
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRLMDHPN--   88 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------------------------~~e~~~l~~l~h~~--   88 (376)
                      .+.||+|+||+||+|.+. +|+.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999976 89999999886532111                            12334444443322  


Q ss_pred             eeecceeeeecCCCCceeEEEEeecccchH-H-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCC
Q 017139           89 VISLKHCFFSTTSKDELFLNLVMEYVPETM-Y-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN  166 (376)
Q Consensus        89 Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l-~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~N  166 (376)
                      +.+.+.+         ...++||||++|+. . ..+....     . ...++.++.+++.++.++|...||+|+||||+|
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            2222211         11579999999721 1 1122111     1 155788999999999999983499999999999


Q ss_pred             eeecCCCCcEEEEecCCcccc
Q 017139          167 LLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       167 ill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+++  ++.++|+|||.+...
T Consensus       146 ili~--~~~~~liDfg~a~~~  164 (187)
T cd05119         146 ILVD--DGKVYIIDVPQAVEI  164 (187)
T ss_pred             EEEE--CCcEEEEECcccccc
Confidence            9998  667999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=3.2e-16  Score=146.94  Aligned_cols=252  Identities=24%  Similarity=0.249  Sum_probs=190.9

Q ss_pred             ccccceEeeeeecc--CCceEEEEEEE--cCCCcEEEEEEecc------cccchHHHHHHHHhC-CCCCeeecceeeeec
Q 017139           31 KQTISYMAERVVGT--GSFGIVFQAKC--LETGETVAIKKVLQ------DRRYKNRELQLMRLM-DHPNVISLKHCFFST   99 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~--G~~g~V~~~~~--~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~   99 (376)
                      .....+.+.+.+|.  |.+|.||.+.+  ..++..+|+|.-..      ......+|+.-.+.+ .|++.++.+..+   
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~---  187 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW---  187 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc---
Confidence            34456777889999  99999999999  88899999997322      223334566665555 488888866666   


Q ss_pred             CCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHH----HHHHhHcCCCceeccCCCCCeeecCCCCc
Q 017139          100 TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR----GLAYIHTVPGVCHRDVKPQNLLVDPLTHQ  175 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~----aL~~LH~~~~ivH~dlkp~Nill~~~~~~  175 (376)
                        ++...+|+-+|+|+.++......   ....+++..++.++.+...    ||.++|+ .+++|-|+||.||++..+...
T Consensus       188 --e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  188 --EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             --ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccce
Confidence              66667899999999765554433   3455888999999999999    9999999 799999999999999874378


Q ss_pred             EEEEecCCccccccCCCcc-e-----eeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC--ChHHHHH
Q 017139          176 VKLCDFGSAKVLVKGEANI-S-----YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAVDQLV  247 (376)
Q Consensus       176 ~kl~Dfg~~~~~~~~~~~~-~-----~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~--~~~~~~~  247 (376)
                      .+++|||+.....+..... .     ..+..-|++||+..+  -++...|++++|.++.+..+|..++...  +.+.++.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            9999999988776554222 1     145667999999854  4799999999999999999987666544  3333222


Q ss_pred             HHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      .+.                              .-..+-...+.++...+..|++.+|-.|++++.+++|+++...
T Consensus       340 ~~~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  340 QGY------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ccc------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            211                              0111223456777789999999999999999999999998753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=6.6e-15  Score=128.85  Aligned_cols=134  Identities=18%  Similarity=0.233  Sum_probs=95.9

Q ss_pred             eeeec-cCCceEEEEEEEcCCCcEEEEEEecccc-----------------cchHHHHHHHHhCCCCCe--eecceeeee
Q 017139           39 ERVVG-TGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRLMDHPNV--ISLKHCFFS   98 (376)
Q Consensus        39 ~~~Lg-~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------------~~~~~e~~~l~~l~h~~I--v~~~~~~~~   98 (376)
                      ...|| .|+.|+||.+..  .+..++||.+....                 ....+|+.++..+.|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34677 888899998876  47789999774211                 123469999999998875  444444322


Q ss_pred             cCCCCceeEEEEeecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcE
Q 017139           99 TTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV  176 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~  176 (376)
                      .. ......++|||+++|  +|...+..     ..+++..    +.||+.+|.+||+ +||+|+||||+|||++. ++.+
T Consensus       114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~-~~~v  181 (239)
T PRK01723        114 RH-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDP-DGKF  181 (239)
T ss_pred             ec-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcC-CCCE
Confidence            11 111123599999996  55555432     3455543    4689999999999 79999999999999986 6689


Q ss_pred             EEEecCCccc
Q 017139          177 KLCDFGSAKV  186 (376)
Q Consensus       177 kl~Dfg~~~~  186 (376)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=7e-15  Score=119.42  Aligned_cols=131  Identities=19%  Similarity=0.248  Sum_probs=102.5

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHhCCC--CCeeecceeeeecCCCCceeEEEEeec
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEY  113 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h--~~Iv~~~~~~~~~~~~~~~~~~lv~e~  113 (376)
                      +++.||.|.++.||++....  ..+++|.......  ...+|...++.+.+  .++.+++..+     ......+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence            46789999999999999743  7899998866543  46679999999976  4777776655     333457899999


Q ss_pred             ccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--CCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          114 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       114 ~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +.|.....+          +......++.+++.+|..||..  .+++|+|++|+||+++. ++.++++|||.+..
T Consensus        75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence            987422111          4455667888999999999984  26999999999999996 78899999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=6e-16  Score=152.53  Aligned_cols=263  Identities=24%  Similarity=0.267  Sum_probs=191.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..+.+.+.+.+-+|+++.++.+.-..+|-..++|......       .....+..++-...+|.++.....+     ...
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence            5577888999999999999999888888667776543221       2222333443344556666543332     122


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      .-.+++++|.++ ++...+..    .+..+++..+..+..+..++++||. ..+.|+|++|.|++... ++..+++|||.
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~-~gh~~l~~~~t  950 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAY-DGHRPLTDFGT  950 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcc-cCCcccCcccc
Confidence            226799999975 55555543    3456777788888899999999999 57999999999999986 77899999984


Q ss_pred             cccccc---------------------C-----------CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHH
Q 017139          184 AKVLVK---------------------G-----------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL  231 (376)
Q Consensus       184 ~~~~~~---------------------~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  231 (376)
                      ......                     .           .......+|+-|.+||...+.. .+..+|+|++|+++++.+
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence            321100                     0           0112346799999999998765 789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH
Q 017139          232 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA  311 (376)
Q Consensus       232 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  311 (376)
                      +|.+||...........+.......+                         . -+...+.++++++.++|..+|.+|..+
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~~~~~~p-------------------------~-g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDIPWP-------------------------E-GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             cCCCCCCCcchhhhhhccccCCCCCC-------------------------C-CccccChhhhhhhhhhhccCchhccCc
Confidence            99999999888877766654211111                         1 223468899999999999999999988


Q ss_pred             H---HHhCCCccccccCCCCCCCC
Q 017139          312 L---EACAHPFFDELREPNARLPN  332 (376)
Q Consensus       312 ~---ell~hp~~~~~~~~~~~~~~  332 (376)
                      .   ++-.||||+...|.......
T Consensus      1084 ~~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred             ccccccccCCccCCCCcccccccc
Confidence            7   88999999999887654433

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=4.7e-15  Score=128.99  Aligned_cols=208  Identities=16%  Similarity=0.206  Sum_probs=147.6

Q ss_pred             HHHhCCCCCeeecceeeeecCCCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CCc
Q 017139           80 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGV  157 (376)
Q Consensus        80 ~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~~i  157 (376)
                      -+-.+.|.|||+++.++-+...++.....+++||+. |++...|+........+....+++|+.||+.||.|||+. .-|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            344567999999999886666556677889999998 788888888777788899999999999999999999985 358


Q ss_pred             eeccCCCCCeeecCCCCcEEEEecCCcccccc-----CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh
Q 017139          158 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL  232 (376)
Q Consensus       158 vH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt  232 (376)
                      +|+++..+-|++.. ++-+|+.--........     ........+.++|.+||.=.. .+.+.++|||++|....+|..
T Consensus       200 ihgnlTc~tifiq~-ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQH-NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccCCcchhheeecC-CceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHH
Confidence            99999999999995 66666653221111000     011112345678899986432 236778999999999999998


Q ss_pred             CCCCCC-CCChH---HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCC
Q 017139          233 GQPLFP-GENAV---DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR  308 (376)
Q Consensus       233 g~~pf~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  308 (376)
                      |..--. +....   +.....+.                                   .--..--++++.+||+-.|..|
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~-----------------------------------~len~lqr~~i~kcl~~eP~~r  322 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVII-----------------------------------GLENGLQRGSITKCLEGEPNGR  322 (458)
T ss_pred             heeccCCCcceeehhhhhhhhee-----------------------------------eccCccccCcCcccccCCCCCC
Confidence            874322 21111   11111100                                   0011223588999999999999


Q ss_pred             CCHHHHhCCCcccccc
Q 017139          309 CTALEACAHPFFDELR  324 (376)
Q Consensus       309 ~t~~ell~hp~~~~~~  324 (376)
                      |++.+++-||.+-++.
T Consensus       323 p~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  323 PDARLLLFHPLLFEVH  338 (458)
T ss_pred             cchhhhhcCceeeecc
Confidence            9999999999986653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.50  E-value=7.3e-13  Score=125.85  Aligned_cols=187  Identities=22%  Similarity=0.276  Sum_probs=133.1

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +....-|.+ ...+-++.+..-.|..+.++.++.+........    ...+.++-|+.++||||+++++.+     +.+.
T Consensus         9 ~~~~fpY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~   82 (690)
T KOG1243|consen    9 SSSQFPYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEG   82 (690)
T ss_pred             ccccCCccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccC
Confidence            334444666 444444444332466677888888887755433    245677889999999999999988     5556


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|||+|-+.. |...++.       ++...+...+.||+.||.+||.-++++|++|..+.|+++. .|..||++|.++.
T Consensus        83 ~~ylvTErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~  153 (690)
T KOG1243|consen   83 TLYLVTERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVS  153 (690)
T ss_pred             ceEEEeecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEe
Confidence            79999999874 3345554       3366777889999999999984378999999999999997 8899999999875


Q ss_pred             ccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCC
Q 017139          186 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ  234 (376)
Q Consensus       186 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~  234 (376)
                      ....... .....---.|..|+.+...   .-..|.|.|||++++++.|.
T Consensus       154 ~~~~~~~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  154 KASGFNAPAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccccCCcccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCcc
Confidence            5432221 1122223346677755221   24579999999999999993

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.45  E-value=7.3e-12  Score=115.70  Aligned_cols=234  Identities=18%  Similarity=0.227  Sum_probs=163.8

Q ss_pred             CCCccccceEeeeeec---cCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           28 GEPKQTISYMAERVVG---TGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        28 ~~~~~~~~y~~~~~Lg---~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      +-|.....|.-+..|-   .---.+.|+|....+|..|++|++..++.    ..-.-+++++.+.|+|+|++.++|.+. 
T Consensus       267 ~~p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~-  345 (655)
T KOG3741|consen  267 GIPSLVESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY-  345 (655)
T ss_pred             cCCcchhhhhceeecccccccccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhh-
Confidence            3444444444433322   22345789999999999999999944321    223578999999999999999998733 


Q ss_pred             CCCceeEEEEeecccc--hHHHHHHhh-----------hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCe
Q 017139          101 SKDELFLNLVMEYVPE--TMYRVLKHY-----------SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL  167 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g--~l~~~l~~~-----------~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Ni  167 (376)
                      ..++..+++|++|.++  +|++.....           -..+...+|..+|.++.|+..||.++|+ .|+.-+-|.|.+|
T Consensus       346 tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kI  424 (655)
T KOG3741|consen  346 TFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKI  424 (655)
T ss_pred             ccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHe
Confidence            3567779999999984  666654332           1234568899999999999999999999 7999999999999


Q ss_pred             eecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-hHHHH
Q 017139          168 LVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQL  246 (376)
Q Consensus       168 ll~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~  246 (376)
                      +++. ..+++|...|......++.           .  |.+.+    -.+-|.-.||.+++.|.||..--...+ .....
T Consensus       425 lv~G-~~RIriS~C~i~Dvl~~d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~  486 (655)
T KOG3741|consen  425 LVTG-KMRIRISGCGIMDVLQEDP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH  486 (655)
T ss_pred             EeeC-cceEEEecccceeeecCCC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHH
Confidence            9985 5588998888766554433           1  11211    234599999999999999964321122 11111


Q ss_pred             HHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ...                                   +...++.+++++|.-+...++++ -++.+++.|
T Consensus       487 ~~~-----------------------------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  487 LTR-----------------------------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHH-----------------------------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            111                                   11346888999998888888876 577777644

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=8.9e-13  Score=126.85  Aligned_cols=142  Identities=18%  Similarity=0.221  Sum_probs=90.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc----------------------------------------
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY----------------------------------------   73 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------------------------------------   73 (376)
                      .+|.. +.||+|++|+||+|+.+.+|+.||||+.......                                        
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35666 7999999999999999888999999998643100                                        


Q ss_pred             ----hHHHHHHHHhC----CCCCeeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcC---CCCCHHHHHHHHH
Q 017139           74 ----KNRELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN---QRMPLIYVKLYTY  142 (376)
Q Consensus        74 ----~~~e~~~l~~l----~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~---~~l~~~~~~~i~~  142 (376)
                          ..+|...+.++    .+.+.+.+..++.+-+    ...++||||+.|.-...+......+   ..+.+..+..++.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence                01233222222    2444455555553221    1256999999984222221111111   1355555555555


Q ss_pred             HHHHHHHHhHcCCCceeccCCCCCeeecCCCC----cEEEEecCCcccccc
Q 017139          143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVKLCDFGSAKVLVK  189 (376)
Q Consensus       143 qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~----~~kl~Dfg~~~~~~~  189 (376)
                      |++       . .|++|+|++|.||+++. ++    .++++|||++.....
T Consensus       275 Qif-------~-~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF-------R-DGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH-------h-CCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECCH
Confidence            554       4 69999999999999986 55    899999999876543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=2.1e-12  Score=122.77  Aligned_cols=137  Identities=20%  Similarity=0.242  Sum_probs=88.3

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecccccc--------------------------------------------h
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------------K   74 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------------------------------~   74 (376)
                      .+.||+|++|+||+|+. .+|+.||||+.......                                            .
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            46899999999999986 47899999987543100                                            0


Q ss_pred             HHHHHHHHhC----CCCCeeecceeeeecCCCCceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHH-HH
Q 017139           75 NRELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFR-GL  148 (376)
Q Consensus        75 ~~e~~~l~~l----~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~-aL  148 (376)
                      .+|...+.++    ++.+-+.+..++....    ...++||||++|. +.+.... ..  ....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~-~~--~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAAL-DE--AGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHH-Hh--cCCC---HHHHHHHHHHHHH
Confidence            1233333333    2333344444442211    1257999999974 3333221 11  1122   2345555554 46


Q ss_pred             HHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       149 ~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      ..+|. .|++|+|++|.||+++. ++.++++|||++....
T Consensus       271 ~ql~~-~g~~H~D~hPgNilv~~-~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLR-DGFFHADLHPGNIFVLK-DGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHh-CCceeCCCCcccEEECC-CCcEEEEeCCCeeECC
Confidence            78899 79999999999999986 7889999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.40  E-value=2e-12  Score=108.34  Aligned_cols=132  Identities=20%  Similarity=0.215  Sum_probs=92.9

Q ss_pred             eeeeccCCceEEEEEEEcC------CCcEEEEEEecc--------------ccc------------c----hHHHHHHHH
Q 017139           39 ERVVGTGSFGIVFQAKCLE------TGETVAIKKVLQ--------------DRR------------Y----KNRELQLMR   82 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~------~~~~~aiK~~~~--------------~~~------------~----~~~e~~~l~   82 (376)
                      ...||.|--+.||.|....      .+..+|||+.+.              +.+            .    .++|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998653      357899997631              100            0    126888888


Q ss_pred             hCCCC--CeeecceeeeecCCCCceeEEEEeecccch-HH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh-HcCCCc
Q 017139           83 LMDHP--NVISLKHCFFSTTSKDELFLNLVMEYVPET-MY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI-HTVPGV  157 (376)
Q Consensus        83 ~l~h~--~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-l~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~~~i  157 (376)
                      ++..-  ++..++.+.     .    .+|||||++++ +. ..++.     ..+++.....+..+++.+|..| |+ .|+
T Consensus        82 rl~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~-~gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE-CNL  146 (197)
T ss_pred             HHHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence            87543  333333321     1    56999999863 11 12221     2355566778889999999998 88 799


Q ss_pred             eeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          158 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       158 vH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|+||++.||+++  ++.+.|+|||.+...
T Consensus       147 VHGDLs~~NIL~~--~~~v~iIDF~qav~~  174 (197)
T cd05146         147 VHADLSEYNMLWH--DGKVWFIDVSQSVEP  174 (197)
T ss_pred             ecCCCCHHHEEEE--CCcEEEEECCCceeC
Confidence            9999999999997  456999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=2.7e-13  Score=127.48  Aligned_cols=249  Identities=20%  Similarity=0.166  Sum_probs=173.6

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEc-CCCcEEEEEEecccccch------HHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYK------NRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~------~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      ....+|..+..||.|.|+.|+.+... .++..|++|.+.+.....      ..|+.+...+ .|.|++.....+.     
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-----  336 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-----  336 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----
Confidence            34567899999999999999988765 677889999876543222      2355555544 5888888776663     


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      .....|+--|||.+...++-.   .....+.+...+.+..|++.++.++|+ ..++|+|++|+||++..+++..++.|||
T Consensus       337 ~~r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             ccccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccc
Confidence            333356999999864333322   223557888899999999999999999 7999999999999998544889999999


Q ss_pred             CccccccCCCcceeecccccc-ChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          183 SAKVLVKGEANISYICSRYYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      .+....-  ..........+. .+|++.....+..+.|++|||..+.+.++|...-........+.   .  +       
T Consensus       413 ~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~---~--~-------  478 (524)
T KOG0601|consen  413 CWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR---S--G-------  478 (524)
T ss_pred             cccccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee---c--c-------
Confidence            8864211  111222233344 36666555668899999999999999999875432222111110   0  0       


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                ..+          .......+++.+.+.++..|+..|+.+.++..|+-|..
T Consensus       479 ----------~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  479 ----------DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ----------ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                      000          01123467889999999999999999999988887754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=4.4e-12  Score=105.31  Aligned_cols=126  Identities=15%  Similarity=0.188  Sum_probs=90.0

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeeccc
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP  115 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~  115 (376)
                      .+.|+.|.++.||++..  .++.+++|......   ....+|+.+++.+.+.+++...-.+ .   .+.  .++|||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~-~---~~~--~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF-D---PET--GVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE-e---CCC--CeEEEEecC
Confidence            46789999999999986  47889999875543   3356799999988765554322222 1   111  359999999


Q ss_pred             chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCc-----eeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          116 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV-----CHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       116 g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~i-----vH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |......        .   .....++.+++.+|..||+ .++     +|+|++|.||+++  ++.++++|||.+..
T Consensus        75 G~~l~~~--------~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence            8421110        0   1123456789999999999 575     9999999999998  45699999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=1.1e-12  Score=125.15  Aligned_cols=156  Identities=19%  Similarity=0.301  Sum_probs=114.1

Q ss_pred             HHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC--------ccee--eccccccChhhhhCCCC
Q 017139          144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA--------NISY--ICSRYYRAPELIFGATE  213 (376)
Q Consensus       144 il~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~--~~t~~y~aPE~~~~~~~  213 (376)
                      +..||.|+|...++||++|.|++|.++. ++..||+.|+++........        ....  .-...|.|||++.+. -
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~  185 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T  185 (700)
T ss_pred             ccchhhhhccCcceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence            3489999998789999999999999997 78899999998765543111        1111  125569999999764 4


Q ss_pred             CCccchhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChh
Q 017139          214 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE  292 (376)
Q Consensus       214 ~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (376)
                      .+.++|++|+||++|.+. .|+..+.+..............+.                         -...+..+++++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~p~e  240 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-------------------------GAFGYSNNLPSE  240 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-------------------------ccccccccCcHH
Confidence            789999999999999999 566666554333222211111000                         011133578999


Q ss_pred             HHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          293 AIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       293 ~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      +++-+.++|..|+..||++..++..|||.+..-.
T Consensus       241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~  274 (700)
T KOG2137|consen  241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK  274 (700)
T ss_pred             HHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence            9999999999999999999999999999875443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.31  E-value=3.6e-11  Score=97.08  Aligned_cols=140  Identities=19%  Similarity=0.237  Sum_probs=97.4

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEec-cc-----------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~-~~-----------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ....+-+|+-+.|+++..  .|+.+.||.-. +.           +....+|+.+|.++.--.|.-..-++.+.+.    
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            567889999999999987  78888888532 21           1233468888877654344333333333222    


Q ss_pred             eEEEEeecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcE--EEEec
Q 017139          106 FLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV--KLCDF  181 (376)
Q Consensus       106 ~~~lv~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~--kl~Df  181 (376)
                       -+|+|||++|  ++..++....  ...........++..|-..+.-||. ++|+|+||..+||++.++++.+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence             4599999998  5555554422  2223333446788889999999999 8999999999999998655544  89999


Q ss_pred             CCcccc
Q 017139          182 GSAKVL  187 (376)
Q Consensus       182 g~~~~~  187 (376)
                      |++...
T Consensus       161 gls~~s  166 (229)
T KOG3087|consen  161 GLSSVS  166 (229)
T ss_pred             cchhcc
Confidence            998653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=2.9e-10  Score=92.35  Aligned_cols=127  Identities=18%  Similarity=0.305  Sum_probs=84.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ..+++|+-+.+|.+..  -|..+++|.=.+..            ....+|+.++..+.--.|....=+.++   .+.  -
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD---~~~--~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD---PDN--G   74 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc---CCC--C
Confidence            4578999999999865  44556777432211            122358888877654333222222222   222  3


Q ss_pred             EEEeecccchHHH-HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g~l~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      .|+|||++|.+.. .+..    .       ...++..+-.-+.-||. .||+|+||.++||+++.  +.+.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~----~-------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~--~~i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEE----A-------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSG--GRIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHh----c-------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEeC--CcEEEEECCcccc
Confidence            4999999996544 3332    1       13456677778889999 89999999999999984  4499999999875


Q ss_pred             c
Q 017139          187 L  187 (376)
Q Consensus       187 ~  187 (376)
                      .
T Consensus       141 s  141 (204)
T COG3642         141 S  141 (204)
T ss_pred             c
Confidence            3

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.16  E-value=2.9e-09  Score=96.56  Aligned_cols=258  Identities=16%  Similarity=0.160  Sum_probs=157.9

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEecccccch--HHHHHHHHhCCCCCeeeccee---eeecCCCCceeEEEEee
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK--NRELQLMRLMDHPNVISLKHC---FFSTTSKDELFLNLVME  112 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~e~~~l~~l~h~~Iv~~~~~---~~~~~~~~~~~~~lv~e  112 (376)
                      ..+.||+|+-+.+|-.-.   -...+.|+........  ++-..+.+.-.||-+-.-+..   .+... .....+.++|.
T Consensus        15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflmP   90 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLMP   90 (637)
T ss_pred             CCccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEecc
Confidence            467899999999986542   2234567775543222  122333334456543321100   01111 22333678899


Q ss_pred             cccc--hHHHHHH--hhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          113 YVPE--TMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       113 ~~~g--~l~~~l~--~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      .++|  ....+..  ..........+....+++..++.+..-||. .|.+-+|+.++|+|++. ++.+.|.|-..-....
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd-~~~V~LVdsDsfqi~~  168 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSD-DSKVVLVDSDSFQINA  168 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeec-CceEEEEcccceeecc
Confidence            8886  2222221  222334557888999999999999999999 79999999999999985 7889998765544444


Q ss_pred             cCCCcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          189 KGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       189 ~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ++......+|.+.|.+||...-    ...-+...|.|.||+++++++.| +.||.+....      . -.+.|....+..
T Consensus       169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~------~-~ap~p~E~~Ia~  241 (637)
T COG4248         169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI------S-DAPNPLETDIAH  241 (637)
T ss_pred             CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc------C-CCCCcchhhhhc
Confidence            5555566778999999997531    12246789999999999999986 9999764210      0 000000101110


Q ss_pred             cC----cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCC--CCCCCCCHHH
Q 017139          264 MN----PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY--SPSLRCTALE  313 (376)
Q Consensus       264 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dP~~R~t~~e  313 (376)
                      ..    +....-..|.....+|     .-++++++.+..+|++.  ++.-|||++.
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             ceeeechhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            00    0001111222222333     34789999999999984  3568999753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.09  E-value=8.5e-10  Score=92.21  Aligned_cols=121  Identities=26%  Similarity=0.320  Sum_probs=75.6

Q ss_pred             EEEEEEEcCCCcEEEEEEecccc------------------------------cchHHHHHHHHhCCCCC--eeecceee
Q 017139           49 IVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRELQLMRLMDHPN--VISLKHCF   96 (376)
Q Consensus        49 ~V~~~~~~~~~~~~aiK~~~~~~------------------------------~~~~~e~~~l~~l~h~~--Iv~~~~~~   96 (376)
                      .||.|.. .+|+.+|+|+.....                              ....+|...|..+..-+  +.+++.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888886 567799999873210                              01136899999997654  44443322


Q ss_pred             eecCCCCceeEEEEeeccc--chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHH-hHcCCCceeccCCCCCeeecCCC
Q 017139           97 FSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY-IHTVPGVCHRDVKPQNLLVDPLT  173 (376)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~--g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~-LH~~~~ivH~dlkp~Nill~~~~  173 (376)
                           .    .+|||||++  |.....+...     .++......++.+++..+.. +|. .||+|+||++.||+++. +
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~-~  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDD-G  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEET-T
T ss_pred             -----C----CEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeec-c
Confidence                 1    359999999  6433333331     12233456677788885555 578 79999999999999985 4


Q ss_pred             CcEEEEecCCcccc
Q 017139          174 HQVKLCDFGSAKVL  187 (376)
Q Consensus       174 ~~~kl~Dfg~~~~~  187 (376)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             7999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=7.6e-09  Score=91.69  Aligned_cols=133  Identities=11%  Similarity=0.093  Sum_probs=89.1

Q ss_pred             EEEEEEEcCCCcEEEEEEecccc---------------cchHHHHHHHHhCCCCCeeec--ceeeeecCCCCceeEEEEe
Q 017139           49 IVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRLMDHPNVISL--KHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        49 ~V~~~~~~~~~~~~aiK~~~~~~---------------~~~~~e~~~l~~l~h~~Iv~~--~~~~~~~~~~~~~~~~lv~  111 (376)
                      .|+++..  .|+.|.||......               ....+|...+..+..-+|...  +.+...........-++||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            4555543  56778888653221               125578888888754444333  2232211111123356999


Q ss_pred             ecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC------CCCcEEEEecCC
Q 017139          112 EYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------LTHQVKLCDFGS  183 (376)
Q Consensus       112 e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~------~~~~~kl~Dfg~  183 (376)
                      |++++  +|.+++....  ....+......++.++...+.-||. .||+|+||++.|||++.      ++..+.|+||+.
T Consensus       115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            99997  4666654322  2345667788999999999999999 79999999999999974      246799999998


Q ss_pred             ccc
Q 017139          184 AKV  186 (376)
Q Consensus       184 ~~~  186 (376)
                      +..
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            753

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.04  E-value=4.9e-09  Score=90.85  Aligned_cols=140  Identities=19%  Similarity=0.197  Sum_probs=92.8

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccc-----ccchHHHHHHHHhCCCCC--eeecceeeeecCCCCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~--Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +.|+.|..+.||++... +|+.+++|.....     ......|.++++.+.+.+  +.+++.+..  ........++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~--~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCE--DPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECC--CCCccCCceEEEE
Confidence            57899999999999874 3688999987653     234568999999987644  344444331  1111124579999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--------------------------------------
Q 017139          113 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--------------------------------------  154 (376)
Q Consensus       113 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------------------------------------  154 (376)
                      |++|.......   . ...+++.....++.+++.+|..||+.                                      
T Consensus        81 ~i~G~~l~~~~---~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          81 RVDGRVLRDRL---L-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EeCCEecCCCC---C-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            99974211110   0 02355555556666666666666631                                      


Q ss_pred             -----------------CCceeccCCCCCeeecCC-CCcEEEEecCCccc
Q 017139          155 -----------------PGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKV  186 (376)
Q Consensus       155 -----------------~~ivH~dlkp~Nill~~~-~~~~kl~Dfg~~~~  186 (376)
                                       ..++|+|++|.||+++.+ ++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             246999999999999853 35588999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.87  E-value=1.7e-08  Score=87.06  Aligned_cols=131  Identities=21%  Similarity=0.177  Sum_probs=90.7

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc--------------------------ccchHHHHHHHHhCCCC--
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------------------------RRYKNRELQLMRLMDHP--   87 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------------------------~~~~~~e~~~l~~l~h~--   87 (376)
                      +.++..||.|--|.||.|.+. .|..+|||.=...                          +...++|.+.|..|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567789999999999999964 7899999953110                          12234788899888654  


Q ss_pred             CeeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCe
Q 017139           88 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL  167 (376)
Q Consensus        88 ~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Ni  167 (376)
                      .+.+.++         .+...+|||+++|-.   +..     -+++......++..|+.-+...-. .|++|+|+++-||
T Consensus       172 ~VP~P~~---------~nRHaVvMe~ieG~e---L~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIA---------WNRHAVVMEYIEGVE---LYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI  233 (304)
T ss_pred             CCCCccc---------cccceeeeehcccce---eec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence            4444432         233679999999842   211     111233444555555555555556 6999999999999


Q ss_pred             eecCCCCcEEEEecCCccc
Q 017139          168 LVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       168 ll~~~~~~~kl~Dfg~~~~  186 (376)
                      +++. ++.+.++||-.+..
T Consensus       234 lV~~-dg~~~vIDwPQ~v~  251 (304)
T COG0478         234 LVTE-DGDIVVIDWPQAVP  251 (304)
T ss_pred             EEec-CCCEEEEeCccccc
Confidence            9996 77899999987654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.80  E-value=8.8e-10  Score=104.60  Aligned_cols=246  Identities=20%  Similarity=0.196  Sum_probs=165.3

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCC-eeecceeeeecCCCCceeEEEEeec
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPN-VISLKHCFFSTTSKDELFLNLVMEY  113 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~-Iv~~~~~~~~~~~~~~~~~~lv~e~  113 (376)
                      -|...+-+++|+++++++.+...+.... .+.+... ....-++++|..++||| .+..++-     .+.+.+..+++++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhhh
Confidence            4567788999999999999876555444 6666554 33445899999999999 3333222     2667778899999


Q ss_pred             ccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCc
Q 017139          114 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN  193 (376)
Q Consensus       114 ~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~  193 (376)
                      |+++-..... .......+.+.+...++..-..+|+++|+ ..=+|+|    ||+..  ++..+..||+...........
T Consensus       316 ~s~~rs~~~~-~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  316 CSTGRSSALE-MTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGS--EEEVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hcCCcccccc-CChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccc--ccccccccccCCcccCccccc
Confidence            9864000000 01112334455566677777889999998 4458888    88776  456899999998776655556


Q ss_pred             ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccC
Q 017139          194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF  273 (376)
Q Consensus       194 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .+..+++.++|||+..... +....|.|++|.-..++.-|.+|-.....      .....|..+              ..
T Consensus       388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~------~~~~~g~~p--------------~s  446 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA------VLPMIGNGP--------------NS  446 (829)
T ss_pred             ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc------ccCCCCCCC--------------Cc
Confidence            6788899999999886654 88899999999887788888777544110      000001000              00


Q ss_pred             CCC-CCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          274 PQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       274 ~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      +.+ ....|...+++       ++...|+...|..|+...+++-|.+|...
T Consensus       447 ~~L~~~~aw~~~~~~-------~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  447 PMLTDKSAWSPVFHR-------DFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cccchhhhcCccccc-------CCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            111 11223222222       67889999999999999999999999765

>PRK09902 hypothetical protein; Provisional

Probab=98.69  E-value=7.5e-07  Score=75.11  Aligned_cols=137  Identities=12%  Similarity=0.084  Sum_probs=95.2

Q ss_pred             ccCCceEEEEEEEcCCCcEEEEEEecc----------cccchHHHHHHHHhCCCCCee--ecceeeeecCCCCceeEEEE
Q 017139           43 GTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRLMDHPNVI--SLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        43 g~G~~g~V~~~~~~~~~~~~aiK~~~~----------~~~~~~~e~~~l~~l~h~~Iv--~~~~~~~~~~~~~~~~~~lv  110 (376)
                      |+||.+-|++...  .|+.+-+|.-..          ......+|...++.+..-+|.  ++. ++-.........-+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            5689999998765  445688886531          223456899998888644433  332 2211222334456799


Q ss_pred             eecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc--EEEEecCCccc
Q 017139          111 MEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKV  186 (376)
Q Consensus       111 ~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~--~kl~Dfg~~~~  186 (376)
                      +|-++|  +|.+.+...  .-.+.++.....++.++..++.-||+ .|+.|+|+-+.||+++. ++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence            998885  665555432  12345777778999999999999999 79999999999999984 344  99999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.69  E-value=2.1e-07  Score=79.74  Aligned_cols=107  Identities=19%  Similarity=0.277  Sum_probs=74.8

Q ss_pred             hHHHHHHHHhCCCCCeee--cceeeeecCCCCceeEEEEeecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 017139           74 KNRELQLMRLMDHPNVIS--LKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA  149 (376)
Q Consensus        74 ~~~e~~~l~~l~h~~Iv~--~~~~~~~~~~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~  149 (376)
                      ..+|...+..+..-.|..  .+.+..... .....-++|+|++++  +|.+.+...    ...+......++.++...+.
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHH
Confidence            456888777775433332  233322211 112345799999997  455555442    22666777889999999999


Q ss_pred             HhHcCCCceeccCCCCCeeecCCC--CcEEEEecCCccc
Q 017139          150 YIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAKV  186 (376)
Q Consensus       150 ~LH~~~~ivH~dlkp~Nill~~~~--~~~kl~Dfg~~~~  186 (376)
                      -||. +||+|+|+++.|||++.++  ..+.++||+.++.
T Consensus       133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999 7999999999999998633  2699999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.63  E-value=9e-07  Score=74.93  Aligned_cols=137  Identities=15%  Similarity=0.225  Sum_probs=83.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchH-------------HHHHHHHhCCCCCeeecceeeee-
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RELQLMRLMDHPNVISLKHCFFS-   98 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------------~e~~~l~~l~h~~Iv~~~~~~~~-   98 (376)
                      .++|.+.+++-......|.+..-  +|+.+.+|.........+             +++..+..+....+..+-..++. 
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45788889998888777766654  778999998755432222             23333333322222111111100 


Q ss_pred             --cCCCCceeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc
Q 017139           99 --TTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ  175 (376)
Q Consensus        99 --~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~  175 (376)
                        -...-....+++|||++|- |.+..        .+++    .+...+..++.-||+ .|+.|+|.+|.|++++. + .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~-~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSN-N-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEEC-C-c
Confidence              0001123356899999983 22211        1222    233467778999999 79999999999999983 4 4


Q ss_pred             EEEEecCCccc
Q 017139          176 VKLCDFGSAKV  186 (376)
Q Consensus       176 ~kl~Dfg~~~~  186 (376)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.60  E-value=1.4e-07  Score=90.57  Aligned_cols=138  Identities=21%  Similarity=0.234  Sum_probs=83.5

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccccc--------------------------------------------hH
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------------KN   75 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------------------------------~~   75 (376)
                      ..|+.++-|+||+|+.. +|+.||||+.......                                            ..
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            68999999999999965 4999999987432100                                            01


Q ss_pred             HHHHHHHhC----CCCCeeecceeeeecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 017139           76 RELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY  150 (376)
Q Consensus        76 ~e~~~l~~l----~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~  150 (376)
                      +|..-+.++    ....-+.+..++..-.+    .-.++|||++| .+.+.... ..  ..++...+...+.++..  ..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l-~~--~g~d~k~ia~~~~~~f~--~q  280 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTT----RRVLTMEWIDGIKISDIAAL-KS--AGIDRKELAELLVRAFL--RQ  280 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccC----CcEEEEEeeCCEecccHHHH-Hh--cCCCHHHHHHHHHHHHH--HH
Confidence            244333333    23333444555532211    14599999998 33333211 11  33443333322222221  22


Q ss_pred             hHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       151 LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      +-. .|++|.|.+|.||+++. ++.+.+.|||+.....+
T Consensus       281 ~~~-dgffHaDpHpGNi~v~~-~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLR-DGFFHADPHPGNILVRS-DGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHh-cCccccCCCccceEEec-CCcEEEEcCcceecCCH
Confidence            222 59999999999999997 78899999999866543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.55  E-value=9.2e-07  Score=75.71  Aligned_cols=134  Identities=18%  Similarity=0.166  Sum_probs=87.6

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecccccc----------------------------hHHHHHHHHhCCCC--C
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY----------------------------KNRELQLMRLMDHP--N   88 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------------------------~~~e~~~l~~l~h~--~   88 (376)
                      ...|++|--+.||+|.. .++..+|+|++...-..                            ..+|..-|+++..-  .
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34888999999999984 56889999988432100                            12466677776433  3


Q ss_pred             eeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCee
Q 017139           89 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL  168 (376)
Q Consensus        89 Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nil  168 (376)
                      +.+.+.+.     .    -.|||||++...   .-.-.-..-.+.......+..+++..+.-|-...++||+||+.-|||
T Consensus       132 vP~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL  199 (268)
T COG1718         132 VPEPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL  199 (268)
T ss_pred             CCCceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence            33333332     1    349999998420   00000011223333566777788888877665359999999999999


Q ss_pred             ecCCCCcEEEEecCCcccc
Q 017139          169 VDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       169 l~~~~~~~kl~Dfg~~~~~  187 (376)
                      +.  ++.+.|+|||.+...
T Consensus       200 ~~--~~~p~iID~~QaV~~  216 (268)
T COG1718         200 VH--DGEPYIIDVSQAVTI  216 (268)
T ss_pred             EE--CCeEEEEECcccccc
Confidence            98  567999999988654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.52  E-value=5e-07  Score=91.78  Aligned_cols=205  Identities=21%  Similarity=0.302  Sum_probs=137.0

Q ss_pred             HHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHc
Q 017139           75 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT  153 (376)
Q Consensus        75 ~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~  153 (376)
                      +.|...+..+.|+|++.+..+-+.....+ ....+..++|.. ++...+.+    -..++....+.+..+++.||.++|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            35677788889999999877664432222 233455677775 44444443    4668889999999999999999999


Q ss_pred             CCCceeccCCCC---CeeecCCCCcEEEE--ecCCccccccCCCcceeeccccccChhhhhCCCCCCc--cchhHHHHHH
Q 017139          154 VPGVCHRDVKPQ---NLLVDPLTHQVKLC--DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT--SIDIWSAGCV  226 (376)
Q Consensus       154 ~~~ivH~dlkp~---Nill~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~--~~DiwslG~i  226 (376)
                       ....|.-|..+   +.-.+. .+...++  ||+...................+.++|...... ...  ..|+|++|..
T Consensus       305 -~~l~~v~L~~s~~~~~~~~~-e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  305 -LSLEHVVLSASSSKESTVDG-EGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLL  381 (1351)
T ss_pred             -hccceeEEecccccccccCc-cceeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHHH
Confidence             55555555444   222332 3445555  888887766666555666677788888774432 333  3699999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCC
Q 017139          227 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS  306 (376)
Q Consensus       227 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  306 (376)
                      ...+..|..+-....      .....                                .+........+++.+|+.-+++
T Consensus       382 ~~~~~~~~~i~~~~~------~~~~~--------------------------------l~~~~~~~~~d~~~~~~~~~~~  423 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSA------VPVSL--------------------------------LDVLSTSELLDALPKCLDEDSE  423 (1351)
T ss_pred             HhhhhhcCccccccc------chhhh--------------------------------hccccchhhhhhhhhhcchhhh
Confidence            999998764421110      00000                                0011122678999999999999


Q ss_pred             CCCCHHHHhCCCccccccC
Q 017139          307 LRCTALEACAHPFFDELRE  325 (376)
Q Consensus       307 ~R~t~~ell~hp~~~~~~~  325 (376)
                      +|+++.+++.|||.+.-..
T Consensus       424 ~Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  424 ERLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             hccchhhhhhchhcccccc
Confidence            9999999999999976433

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.39  E-value=1.7e-06  Score=83.10  Aligned_cols=137  Identities=20%  Similarity=0.260  Sum_probs=84.8

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecccccc-----------------------------------------hHHH
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----------------------------------------KNRE   77 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----------------------------------------~~~e   77 (376)
                      .+.||..+.|+|++|+.+. |+.||||+-+...+.                                         ..+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            4689999999999999765 999999976432100                                         0023


Q ss_pred             HH----HHHhCCCCC---eeecceeeeecCCCCceeEEEEeecccch---HHHHHHhhhhcCCCCCHHHHHHHHHHHHHH
Q 017139           78 LQ----LMRLMDHPN---VISLKHCFFSTTSKDELFLNLVMEYVPET---MYRVLKHYSSMNQRMPLIYVKLYTYQIFRG  147 (376)
Q Consensus        78 ~~----~l~~l~h~~---Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~---l~~~l~~~~~~~~~l~~~~~~~i~~qil~a  147 (376)
                      ++    +.+.+.|-+   -|.+..++..-.    ..-.|+||||+|-   -.+.+..     ..++...+..-+.+...-
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~  315 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLE  315 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHH
Confidence            22    223344545   233444443221    1256999999972   2233332     445555544444443321


Q ss_pred             HHHhHcCCCceeccCCCCCeeecC---CCCcEEEEecCCccccc
Q 017139          148 LAYIHTVPGVCHRDVKPQNLLVDP---LTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       148 L~~LH~~~~ivH~dlkp~Nill~~---~~~~~kl~Dfg~~~~~~  188 (376)
                        -|-. .|++|+|=+|.||++++   .+..+.+.|||+.....
T Consensus       316 --qIf~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  316 --QIFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             --HHHh-cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence              2223 58999999999999984   36789999999987553

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.36  E-value=3.4e-06  Score=73.51  Aligned_cols=75  Identities=19%  Similarity=0.199  Sum_probs=49.6

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCe--eecceeeeecCCCCceeEEEEeecc
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~I--v~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....+  .+++...  .........+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            4689999999999999744  58999987655  2344578888887754333  3443322  1113334478999999


Q ss_pred             cch
Q 017139          115 PET  117 (376)
Q Consensus       115 ~g~  117 (376)
                      +|.
T Consensus        78 ~g~   80 (239)
T PF01636_consen   78 PGR   80 (239)
T ss_dssp             SSE
T ss_pred             ccc
Confidence            873

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.24  E-value=1.7e-05  Score=68.79  Aligned_cols=69  Identities=16%  Similarity=0.087  Sum_probs=45.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCe--eecceeeeecCCCCceeEEEEeeccc
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVMEYVP  115 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~I--v~~~~~~~~~~~~~~~~~~lv~e~~~  115 (376)
                      ..||+|..+.||+.    .+..+++|......  ....+|.++++.+..-.+  .+.+++.     ++.....+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            57899999999974    24567889875532  234679999988764333  3333333     23333678999999


Q ss_pred             ch
Q 017139          116 ET  117 (376)
Q Consensus       116 g~  117 (376)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            83

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.01  E-value=7.8e-05  Score=77.20  Aligned_cols=77  Identities=18%  Similarity=0.188  Sum_probs=50.2

Q ss_pred             eeeeccCCceEEEEEEEcCCC--cEEEEEEeccc-----ccchHHHHHHHHhCC-CCCe--eecceeeeecCCCCceeEE
Q 017139           39 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQD-----RRYKNRELQLMRLMD-HPNV--ISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~--~~~aiK~~~~~-----~~~~~~e~~~l~~l~-h~~I--v~~~~~~~~~~~~~~~~~~  108 (376)
                      ++.|+.|.++.+|+......+  ..+++|+....     .....+|..+++.+. |+++  .+++.++.+  .......|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d--~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD--ASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC--CCcCCCce
Confidence            577899999999998765432  46788876432     234568999999995 6664  333333311  11123467


Q ss_pred             EEeecccch
Q 017139          109 LVMEYVPET  117 (376)
Q Consensus       109 lv~e~~~g~  117 (376)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            999999874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.99  E-value=0.00011  Score=61.74  Aligned_cols=127  Identities=24%  Similarity=0.347  Sum_probs=86.1

Q ss_pred             ccceEeeeeeccCCc-eEEEEEEEcCCCcEEEEEEecc---c------------cc----------chHHHHH---HHHh
Q 017139           33 TISYMAERVVGTGSF-GIVFQAKCLETGETVAIKKVLQ---D------------RR----------YKNRELQ---LMRL   83 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~-g~V~~~~~~~~~~~~aiK~~~~---~------------~~----------~~~~e~~---~l~~   83 (376)
                      ..+++..+.||.|.- |.||+++.  .|+.||+|.+..   .            ..          .+..|-.   .|+.
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            368999999999999 99999987  778999999421   0            00          0112333   3444


Q ss_pred             CCCCCe--eecceeeeecCC-------------CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH
Q 017139           84 MDHPNV--ISLKHCFFSTTS-------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL  148 (376)
Q Consensus        84 l~h~~I--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL  148 (376)
                      ..+.++  |+.++++.....             .......||.||....-            .++...+    .++++-|
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~~----~~~~~dl  177 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRDI----PQMLRDL  177 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhHH----HHHHHHH
Confidence            556666  888887754321             11223457888776531            2333333    4677788


Q ss_pred             HHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       149 ~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|. .||+-+|+++.|..    ++  ||+|||.+
T Consensus       178 ~~~~k-~gI~~~Dv~~~ny~----~G--~lvDfs~~  206 (207)
T PF13095_consen  178 KILHK-LGIVPRDVKPRNYR----GG--KLVDFSSS  206 (207)
T ss_pred             HHHHH-CCeeeccCcccccc----CC--EEEecccC
Confidence            99999 69999999999985    33  89999964

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.93  E-value=0.00015  Score=63.86  Aligned_cols=70  Identities=17%  Similarity=0.103  Sum_probs=42.4

Q ss_pred             eeccCCc-eEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHhCCC-CCeeecceeeeecCCCCceeEEEEeecccch
Q 017139           41 VVGTGSF-GIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPET  117 (376)
Q Consensus        41 ~Lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~h-~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~  117 (376)
                      .|..|.. +.||++..  .+..+.+|+.... .....+|+.+++.+.. --+.+++.+.     ......++|||+++|.
T Consensus         5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEEEeeCCc
Confidence            3444555 78898875  3467888877543 1235578988888753 2233333333     1223356999999873

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.93  E-value=7.7e-05  Score=60.67  Aligned_cols=126  Identities=19%  Similarity=0.292  Sum_probs=84.9

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecc
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      .+.+.|++|.+|.||++..  .|..+|+|+-..+.  ..++.|+++|..++-.++-+-.-.+ .   +    -++.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhhh
Confidence            5578899999999999987  56689999876553  4567899999998876665533222 1   1    23669999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCC-C-CeeecCCCCcEEEEecCCccc
Q 017139          115 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP-Q-NLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       115 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp-~-Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      .| .|.+....       .+...+    ..++.+---|-. .||-|+.|+- . ||+++  ++.+.|+||..|+.
T Consensus        95 ~G~~L~~~~~~-------~~rk~l----~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At~  155 (201)
T COG2112          95 DGRPLGKLEIG-------GDRKHL----LRVLEKAYKLDR-LGIEHGELSRPWKNVLVN--DRDVYIIDFDSATF  155 (201)
T ss_pred             cCcchhhhhhc-------ccHHHH----HHHHHHHHHHHH-hccchhhhcCCceeEEec--CCcEEEEEccchhh
Confidence            98 43322211       122223    345555445556 5999998863 3 56665  44799999999874

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.88  E-value=8.3e-05  Score=67.35  Aligned_cols=137  Identities=17%  Similarity=0.191  Sum_probs=93.3

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------c------------------------cchHHHHHHHHhCCC
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------R------------------------RYKNRELQLMRLMDH   86 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~------------------------~~~~~e~~~l~~l~h   86 (376)
                      .+-.+|..|--+.||.|. ..+|..+|||+++-.      +                        ...++|+.-|+++..
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            456688999999999998 467888999986321      1                        011357777888875


Q ss_pred             CCeeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCC
Q 017139           87 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN  166 (376)
Q Consensus        87 ~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~N  166 (376)
                      -.|....-+.+-       ...|||++++..-   +-.-.-..-.++...++.+-.|++.-+.-|-+..++||.||+--|
T Consensus       226 aGIP~PePIlLk-------~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCPEPILLK-------NHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCCCceeee-------cceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            554332222211       1459999998421   111111234566667777777888888877655799999999999


Q ss_pred             eeecCCCCcEEEEecCCccc
Q 017139          167 LLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       167 ill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|+-  +|.+.|+|.+-+..
T Consensus       296 ~Lyh--dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  296 LLYH--DGKLYIIDVSQSVE  313 (520)
T ss_pred             heEE--CCEEEEEEcccccc
Confidence            9996  67799999987643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.77  E-value=0.00033  Score=59.23  Aligned_cols=128  Identities=20%  Similarity=0.280  Sum_probs=82.1

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecccc--------------------cchHHHHHHHHhCC------CCCeeec
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------RYKNRELQLMRLMD------HPNVISL   92 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------------~~~~~e~~~l~~l~------h~~Iv~~   92 (376)
                      ...||+|+.-.||.--   .....+||+.....                    ....+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3578999999998543   34457889886655                    23345666555555      7889999


Q ss_pred             ceeeeecCCCCceeEEEEeeccc---chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee
Q 017139           93 KHCFFSTTSKDELFLNLVMEYVP---ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV  169 (376)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~---g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill  169 (376)
                      ++...+.     .-..+|+|.+.   |.....+..+.. ...+++ .....+.   .-.++|-+ ++|+.+|++|.||++
T Consensus        83 ~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~~L~---~f~~~l~~-~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETN-----LGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQALD---EFKRYLLD-HHIVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecC-----CceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHHHHH---HHHHHHHH-cCCeecCCCcccEEE
Confidence            9988443     33778888764   433333333332 345666 4443333   34556777 689999999999999


Q ss_pred             cCCC--C-cEEEEe
Q 017139          170 DPLT--H-QVKLCD  180 (376)
Q Consensus       170 ~~~~--~-~~kl~D  180 (376)
                      ...+  . .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            5322  2 466665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.72  E-value=0.00042  Score=60.63  Aligned_cols=31  Identities=39%  Similarity=0.546  Sum_probs=25.3

Q ss_pred             CCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       155 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      .+++|+|+.+.||+++. +....|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~-~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQD-GRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEEC-CCEEEEEeCcccCc
Confidence            35899999999999984 55567999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.72  E-value=0.00075  Score=58.98  Aligned_cols=69  Identities=17%  Similarity=0.319  Sum_probs=44.5

Q ss_pred             eeeeccCCceEEEEEEEcC-CCcEEEEEEecccc---cchHHHHHHHHhCCCCCeee-cceeeeecCCCCceeEEEEeec
Q 017139           39 ERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVIS-LKHCFFSTTSKDELFLNLVMEY  113 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~-~~~~~~~~~~~~~~~~~lv~e~  113 (376)
                      .+.|..|-...+|++.... .++.|++|+.....   ....+|..+++.+...+++. ++...     .+    .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence            4678888889999997543 35688899775432   12346888888886544433 22211     11    279999


Q ss_pred             ccc
Q 017139          114 VPE  116 (376)
Q Consensus       114 ~~g  116 (376)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            886

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.67  E-value=0.00039  Score=61.70  Aligned_cols=134  Identities=19%  Similarity=0.242  Sum_probs=73.3

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecccc
Q 017139           41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE  116 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g  116 (376)
                      .+..|-.+.+|++.  .+++.+++|.......    ...+|..+++.+....+++-.-.. .   .    -++||||++|
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~-~---~----~~~v~e~i~G   72 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV-N---E----HWLLVEWLEG   72 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE-e---C----CEEEEEeccC
Confidence            45678888899887  3567888887644322    246788899988654443221111 1   1    2489999987


Q ss_pred             hHHH---------------HHHhhhh---cCCCCCHH-HHHHHHHHH---------HHHHHHhHc-------CCCceecc
Q 017139          117 TMYR---------------VLKHYSS---MNQRMPLI-YVKLYTYQI---------FRGLAYIHT-------VPGVCHRD  161 (376)
Q Consensus       117 ~l~~---------------~l~~~~~---~~~~l~~~-~~~~i~~qi---------l~aL~~LH~-------~~~ivH~d  161 (376)
                      ....               .+...-.   ...+++.. .+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            3211               1111000   11112211 111221111         111221211       02489999


Q ss_pred             CCCCCeeecCCCCcEEEEecCCccc
Q 017139          162 VKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       162 lkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +.|.||+++. ++ +.|+||..+..
T Consensus       153 l~~~Nil~~~-~~-~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTP-QG-LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeC-CC-CEEEeccccCc
Confidence            9999999985 44 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.61  E-value=0.00017  Score=67.97  Aligned_cols=173  Identities=20%  Similarity=0.255  Sum_probs=110.1

Q ss_pred             HHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 017139           75 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV  154 (376)
Q Consensus        75 ~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~  154 (376)
                      .....+++.+.|+|.....++--.    ......+|||+++-++.+.+....     +-..       +++       . 
T Consensus        30 lgr~~~lktl~~~~l~~yl~~~r~----~~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~-   85 (725)
T KOG1093|consen   30 LGRFQYLKSLQHDNLCQYLDFSRG----KHERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A-   85 (725)
T ss_pred             hhhhHHHHhhcCccceeeEeeecC----ccceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------c-
Confidence            346788999999999988776421    122267999999998888776521     1100       111       1 


Q ss_pred             CCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCC
Q 017139          155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ  234 (376)
Q Consensus       155 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~  234 (376)
                      +++.|-     |+        ++.+| .++..               |  |      ...++++||||+|.++.++.-|.
T Consensus        86 ~~~~~~-----~~--------~~~td-~~~t~---------------~--~------~~~~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   86 HGVLHL-----NI--------IYITD-HFLTK---------------Y--P------SPIGPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             ccccee-----hh--------hhccc-ccccc---------------C--C------CCCCcchhhhhHHHHHHHHHHhh
Confidence            233222     22        23333 00000               0  1      01235999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          235 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       235 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                      ..+......+.+..+.+....+.....-.+                .+ .+.-.++....++..+|+-..|..||...++
T Consensus       129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~----------------e~-~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  129 SLEAELTESEYLEILLKYYTDDQELLSTAM----------------EH-LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHHHHHHHHHHHHhccCchhHHHHHH----------------HH-HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            998887777777666664433322111100                00 1222457788899999999999999999999


Q ss_pred             hCCCccccccC
Q 017139          315 CAHPFFDELRE  325 (376)
Q Consensus       315 l~hp~~~~~~~  325 (376)
                      ..|+-|.++..
T Consensus       192 ~k~~i~~ev~~  202 (725)
T KOG1093|consen  192 SKRCSFTEVYK  202 (725)
T ss_pred             hcCccHHHHHh
Confidence            99999988744

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.55  E-value=4.2e-05  Score=80.23  Aligned_cols=213  Identities=16%  Similarity=0.023  Sum_probs=140.3

Q ss_pred             HHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 017139           77 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP  155 (376)
Q Consensus        77 e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~  155 (376)
                      |++.++...|+++...+.-...   ......|..++||. |.+.+.+.........+....+.....+.+.+..-+|+..
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4445556788888776544322   33444678999998 5666777666555666666666655555577777777653


Q ss_pred             C----ceeccCCCCCeeecCCCCcEEEEecCCccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHH
Q 017139          156 G----VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL  230 (376)
Q Consensus       156 ~----ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  230 (376)
                      +    -+|++||+-|.++.. +..+|+.++|+.+...+. .......|++.|+.|++... ..++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVt-ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVT-NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceec-CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence            4    478999999999986 777999999999843322 33345678889999998754 3478889999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC
Q 017139          231 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT  310 (376)
Q Consensus       231 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  310 (376)
                      ..|..+|..     .++...+.           .-.+...+.++            ...|.++-.....+|-+.-..||.
T Consensus      1434 s~~n~~fi~-----flq~~Lkg-----------iidn~tf~sIe------------~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFIF-----FLQPALKG-----------IIDNHTFFSIE------------KLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             hcccHHHHH-----HHHHHHcC-----------ccccccccccc------------ccCCCcccHHHHHHHHHHhhhcch
Confidence            998887732     22222221           11111111111            122444445555556666678898


Q ss_pred             HHHHhCCCcccc
Q 017139          311 ALEACAHPFFDE  322 (376)
Q Consensus       311 ~~ell~hp~~~~  322 (376)
                      -...+.-+.|.-
T Consensus      1486 q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1486 QYISLSRDHFAV 1497 (2724)
T ss_pred             hhhhcccccccc
Confidence            888888777754

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.47  E-value=0.0029  Score=59.44  Aligned_cols=71  Identities=23%  Similarity=0.324  Sum_probs=46.3

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecc-----------cccchHHHHHHHHhCC---CCCeeecceeeeecCCCCc
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----------~~~~~~~e~~~l~~l~---h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .+.||.|.+..||++.....++.++||.-..           .......|.+.|+.+.   ..++.+++++-     ++.
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC
Confidence            4689999999999999864446899997431           1112345777777763   23455554432     222


Q ss_pred             eeEEEEeecccc
Q 017139          105 LFLNLVMEYVPE  116 (376)
Q Consensus       105 ~~~~lv~e~~~g  116 (376)
                        .++|||++++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              4599999875

>PRK10593 hypothetical protein; Provisional

Probab=97.44  E-value=0.0037  Score=56.75  Aligned_cols=76  Identities=5%  Similarity=-0.024  Sum_probs=49.3

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhCCCC---CeeecceeeeecCCCCceeEEEEe
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHP---NVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~---~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      .-.+.||.|..+.||..... ++ .+++|.....  ......|...++.+...   .+.++++++...  .....-++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEE
Confidence            34678999999999998642 23 4677775442  23567899999988542   445555443211  1223367999


Q ss_pred             ecccc
Q 017139          112 EYVPE  116 (376)
Q Consensus       112 e~~~g  116 (376)
                      |+++|
T Consensus        93 E~i~G   97 (297)
T PRK10593         93 ERLRG   97 (297)
T ss_pred             eccCC
Confidence            99886

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.43  E-value=0.00012  Score=65.32  Aligned_cols=133  Identities=17%  Similarity=0.176  Sum_probs=86.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecc----------c----------------ccchHHHHHHHHhCCC-C
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------D----------------RRYKNRELQLMRLMDH-P   87 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~----------~----------------~~~~~~e~~~l~~l~h-~   87 (376)
                      -|.++..||-|--+.+|.+-+ ..|++.++|.-..          .                +....+|...|+.|.. -
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            367888999999999999986 4578888884311          1                1122368888887743 2


Q ss_pred             C-eeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCC
Q 017139           88 N-VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN  166 (376)
Q Consensus        88 ~-Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~N  166 (376)
                      + +.+.+         +....++|||++.|--...+.+      ...   ...+...+..-+.-|-. +|+||+|+.-=|
T Consensus       172 fpVPkpi---------D~~RH~Vvmelv~g~Pl~~v~~------v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFN  232 (465)
T KOG2268|consen  172 FPVPKPI---------DHNRHCVVMELVDGYPLRQVRH------VED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFN  232 (465)
T ss_pred             CCCCCcc---------cccceeeHHHhhcccceeeeee------cCC---hHHHHHHHHHHHHHHHH-cCceecccchhe
Confidence            2 23332         2333789999998731111111      112   22334444455556667 799999999999


Q ss_pred             eeecCCCCcEEEEecCCccccc
Q 017139          167 LLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       167 ill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |+++. ++.++++||--+....
T Consensus       233 imv~d-d~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  233 IMVKD-DDKIVVIDFPQMVSTS  253 (465)
T ss_pred             eEEec-CCCEEEeechHhhccC
Confidence            99995 7779999998765443

>PRK05231 homoserine kinase; Provisional

Probab=97.36  E-value=0.0028  Score=58.13  Aligned_cols=30  Identities=30%  Similarity=0.331  Sum_probs=25.4

Q ss_pred             CCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       155 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .++||+|+.|.||+++. +...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEG-DRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEEC-CceEEEEeccccc
Confidence            48999999999999984 5545899999875

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.32  E-value=0.00091  Score=56.19  Aligned_cols=98  Identities=22%  Similarity=0.219  Sum_probs=74.0

Q ss_pred             HHHHHHHhCCC-CCeeecceeeeecCCCCceeEEEEeecccc-hHHHH---HHhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 017139           76 RELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRV---LKHYSSMNQRMPLIYVKLYTYQIFRGLAY  150 (376)
Q Consensus        76 ~e~~~l~~l~h-~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~---l~~~~~~~~~l~~~~~~~i~~qil~aL~~  150 (376)
                      .|.-+++.+.+ +++.++++.+     .    .++|.||.+. +++..   +.+    --..++..+.+|+.+++..+++
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~~   74 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLEE   74 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHHH
Confidence            47888888876 6899998877     2    3579999984 33211   111    1236788899999999999999


Q ss_pred             hHcC--CCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          151 IHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       151 LH~~--~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++..  ..+.-.|++++|+-++. ++++|++|...+...
T Consensus        75 l~~~~~~~~~lcDv~~~nfgv~~-~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   75 LDHGPLGFFYLCDVSPDNFGVND-DGRLKLIDLDDVFVE  112 (188)
T ss_pred             HhcCCCCcEEEeecchHHeEEeC-CCcEEEEechhcchh
Confidence            9972  13566899999999995 788999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.24  E-value=0.0041  Score=56.80  Aligned_cols=146  Identities=15%  Similarity=0.066  Sum_probs=76.3

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCC--eeecceeeeec-CCCCceeEEEEe
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPN--VISLKHCFFST-TSKDELFLNLVM  111 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~--Iv~~~~~~~~~-~~~~~~~~~lv~  111 (376)
                      ...+.++.|....+|++.. . +..+++|+....  ......|.+++..|....  +.+++...-.. ....+...++++
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             eeccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            3466778888889998874 3 336788877543  223345677777774322  22322211000 001234467999


Q ss_pred             ecccchH-----H-------HHH---Hhhhhc-CCC----CCHHHHH---------------HHHHHHHHHHHHhHc---
Q 017139          112 EYVPETM-----Y-------RVL---KHYSSM-NQR----MPLIYVK---------------LYTYQIFRGLAYIHT---  153 (376)
Q Consensus       112 e~~~g~l-----~-------~~l---~~~~~~-~~~----l~~~~~~---------------~i~~qil~aL~~LH~---  153 (376)
                      +|++|..     .       ..+   +..... ...    .......               .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            9987621     0       111   110000 000    0000000               001112233444432   


Q ss_pred             ---CCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          154 ---VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       154 ---~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                         ..+++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDG-DSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence               158999999999999986 5556899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.24  E-value=0.0039  Score=56.51  Aligned_cols=144  Identities=14%  Similarity=0.025  Sum_probs=76.2

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecc-cccchHHHHHHHHhCCCCC--eeecceeeeec-CCCCceeEEEEeecc
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRLMDHPN--VISLKHCFFST-TSKDELFLNLVMEYV  114 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~e~~~l~~l~h~~--Iv~~~~~~~~~-~~~~~~~~~lv~e~~  114 (376)
                      .+.+..|....+|++..  .+..+++|+... .......|..+++.+.+.+  +.+++...-.. ........++|++++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            56788888889998864  345788998764 2233456888888775433  33332210000 001123357899999


Q ss_pred             cchHH------------HHH---Hhhhhc-CCC----CCHHHHHH------------HHHHHHHHHHHhHc------CCC
Q 017139          115 PETMY------------RVL---KHYSSM-NQR----MPLIYVKL------------YTYQIFRGLAYIHT------VPG  156 (376)
Q Consensus       115 ~g~l~------------~~l---~~~~~~-~~~----l~~~~~~~------------i~~qil~aL~~LH~------~~~  156 (376)
                      +|...            ..+   +..... ...    ........            ....+..++.++..      ..+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            86211            111   110000 000    00000000            01112223333332      137


Q ss_pred             ceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       157 ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      ++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus       177 l~HgD~~~~Nil~~~-~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDG-DELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeC-CceEEEeehhhhc
Confidence            999999999999985 6656899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.96  E-value=0.019  Score=52.27  Aligned_cols=69  Identities=17%  Similarity=0.249  Sum_probs=42.8

Q ss_pred             eeeeccCCceEEEEEEEcC------CCcEEEEEEecccc---cchHHHHHHHHhCCCCCeee-cceeeeecCCCCceeEE
Q 017139           39 ERVVGTGSFGIVFQAKCLE------TGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVIS-LKHCFFSTTSKDELFLN  108 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~-~~~~~~~~~~~~~~~~~  108 (376)
                      ++.|..|-...+|++....      .++.+++|+.....   ....+|..+++.+....+.+ ++..+     .+    .
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~----~   73 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF-----PN----G   73 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe-----CC----C
Confidence            3566777777888887533      25789999876542   23457888888886544432 22222     11    1


Q ss_pred             EEeecccc
Q 017139          109 LVMEYVPE  116 (376)
Q Consensus       109 lv~e~~~g  116 (376)
                      +|+||++|
T Consensus        74 ~v~e~i~G   81 (302)
T cd05156          74 RIEEFIPS   81 (302)
T ss_pred             chhheeCC
Confidence            57888775

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=96.92  E-value=0.019  Score=53.29  Aligned_cols=141  Identities=16%  Similarity=0.241  Sum_probs=76.3

Q ss_pred             eEeeeeeccCCceEEEEEEEcC----CCcEEEEEEeccccc---chHHHHHHHHhCCCCCeee-cceeeeecCCCCceeE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVIS-LKHCFFSTTSKDELFL  107 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~-~~~~~~~~~~~~~~~~  107 (376)
                      ..-...|..|-...+|++....    .++.|++|+......   ....|..+++.+..-++.+ +++.+     .+.   
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~g---  109 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PNG---  109 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-----CCc---
Confidence            3344566668888999987432    246899998754322   2346888888886544432 33333     211   


Q ss_pred             EEEeecccch-HH--------------HHHHhhhhcC---C--CCCHHHHHHHHHHH-----------------HHHHHH
Q 017139          108 NLVMEYVPET-MY--------------RVLKHYSSMN---Q--RMPLIYVKLYTYQI-----------------FRGLAY  150 (376)
Q Consensus       108 ~lv~e~~~g~-l~--------------~~l~~~~~~~---~--~l~~~~~~~i~~qi-----------------l~aL~~  150 (376)
                       .|++|++|. +.              ..+...-...   .  ......+..++.++                 ...+..
T Consensus       110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence             467777642 11              0111100001   0  11122222332211                 111111


Q ss_pred             ----h----HcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          151 ----I----HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       151 ----L----H~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                          +    +. ..++|+|+++.||+++..++.+.++||..+..
T Consensus       189 L~~~~~~~~~~-~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        189 LEKELSGDDQE-IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHhcccCCC-ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                1    12 25899999999999985456799999998754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.86  E-value=0.015  Score=53.63  Aligned_cols=30  Identities=20%  Similarity=0.334  Sum_probs=25.9

Q ss_pred             ceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       157 ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++|+|+.+.||+++.+++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            699999999999975456799999998754

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.81  E-value=0.024  Score=51.71  Aligned_cols=29  Identities=31%  Similarity=0.618  Sum_probs=24.8

Q ss_pred             CCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       155 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+++|+|+.+.||+++.  +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence            47899999999999984  458999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.65  E-value=0.037  Score=51.06  Aligned_cols=69  Identities=23%  Similarity=0.249  Sum_probs=42.2

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEecc-----------cccchHHHHHHHHhCC--CC-CeeecceeeeecCCCCcee
Q 017139           41 VVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRLMD--HP-NVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----------~~~~~~~e~~~l~~l~--h~-~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .+|.|....||++.....++.++||.-..           +......|...|+...  .| ++.+++++      ..+ .
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~------D~e-~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF------DTE-M   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE------ccc-c
Confidence            57999999999999754446899995321           1122335777777664  24 34444332      111 2


Q ss_pred             EEEEeecccc
Q 017139          107 LNLVMEYVPE  116 (376)
Q Consensus       107 ~~lv~e~~~g  116 (376)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            4499999863

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.56  E-value=0.02  Score=53.50  Aligned_cols=71  Identities=20%  Similarity=0.263  Sum_probs=45.0

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecc----------cccchHHHHHHHHhCC--CCC-eeecceeeeecCCCCce
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRLMD--HPN-VISLKHCFFSTTSKDEL  105 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~----------~~~~~~~e~~~l~~l~--h~~-Iv~~~~~~~~~~~~~~~  105 (376)
                      .+.||.|--..||++.+...++.++||.-..          +......|.+.|+...  .|. +.+++. +     ..+ 
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-----D~e-  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-----DSV-  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-----CcH-
Confidence            6788999999999999854457899995321          1122345788887764  343 444433 2     112 


Q ss_pred             eEEEEeecccc
Q 017139          106 FLNLVMEYVPE  116 (376)
Q Consensus       106 ~~~lv~e~~~g  116 (376)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            24489999863

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.34  E-value=0.07  Score=48.49  Aligned_cols=30  Identities=30%  Similarity=0.551  Sum_probs=26.2

Q ss_pred             ceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       157 ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|+|+.+.|++++. +.-+-|.||+.+..-
T Consensus       200 lvHGD~~~gNlii~~-~~~~gVlDwe~~~lG  229 (321)
T COG3173         200 LVHGDYRPGNLIIDP-GRPTGVLDWELATLG  229 (321)
T ss_pred             eeeCCcccCCEEEeC-CCeeEEEeccccccC
Confidence            899999999999997 555999999998754

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.24  E-value=0.073  Score=50.05  Aligned_cols=70  Identities=19%  Similarity=0.241  Sum_probs=45.0

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEecc-----------cccchHHHHHHHHhCC---CCCeeecceeeeecCCCC
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----------~~~~~~~e~~~l~~l~---h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..+.||.|....||++.+  .+..++||.-..           +......|...|+.+.   ..++.+++.+.     ++
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence            467889999999999986  345688996531           2222335667776654   23555565543     32


Q ss_pred             ceeEEEEeecccc
Q 017139          104 ELFLNLVMEYVPE  116 (376)
Q Consensus       104 ~~~~~lv~e~~~g  116 (376)
                      .  -+++||++++
T Consensus       109 ~--~vlvME~L~~  119 (418)
T PLN02756        109 M--ALIGMRYLEP  119 (418)
T ss_pred             C--CEEEEeecCC
Confidence            2  3488999976

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.10  E-value=0.11  Score=46.49  Aligned_cols=31  Identities=32%  Similarity=0.500  Sum_probs=24.8

Q ss_pred             CceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       156 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      .++|+|++|.||+++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999985333457999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.04  E-value=0.076  Score=48.49  Aligned_cols=31  Identities=19%  Similarity=0.248  Sum_probs=26.7

Q ss_pred             CCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       155 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      .+++|+|+.+.|++++. ++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~-~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDE-TRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcC-CCCEEEEEhhhccc
Confidence            47999999999999986 66789999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.56  E-value=0.032  Score=51.83  Aligned_cols=61  Identities=25%  Similarity=0.270  Sum_probs=40.4

Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT  173 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~  173 (376)
                      .++-+|..| ++...++.     ...+++.++.++.-...|+--|--..+++|.|+.|.||++..+.
T Consensus       321 vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             eeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            366667776 65555554     34555666666666666655444335899999999999996433

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.35  E-value=0.06  Score=49.31  Aligned_cols=77  Identities=18%  Similarity=0.226  Sum_probs=56.9

Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .+..+.|++|++-++.+. .++       ....+++..++.+.+..+.-+..--..-|||+...||||+  .|.|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is-~ik-------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPIS-IIK-------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceee-eee-------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence            566778899998766532 222       2345667788888888777776522578999999999998  667999999


Q ss_pred             CCccccc
Q 017139          182 GSAKVLV  188 (376)
Q Consensus       182 g~~~~~~  188 (376)
                      -+++...
T Consensus       366 klsRl~~  372 (488)
T COG5072         366 KLSRLSY  372 (488)
T ss_pred             eeeeccc
Confidence            9998543

>PTZ00384 choline kinase; Provisional

Probab=95.19  E-value=0.47  Score=44.64  Aligned_cols=28  Identities=29%  Similarity=0.346  Sum_probs=23.7

Q ss_pred             CceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       156 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      ..+|.|+-+.||+.+  +..+.++||..|.
T Consensus       228 VfCHNDL~~gNIL~~--~~~l~lID~EYA~  255 (383)
T PTZ00384        228 LFCHNDLFFTNILDF--NQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeccCCcccEEec--CCCEEEEEecccc
Confidence            579999999999986  4459999998775

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.18  E-value=0.13  Score=46.24  Aligned_cols=72  Identities=14%  Similarity=0.146  Sum_probs=42.7

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHhCC---CCCeeecceeeeecCCCCceeEEEEee
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~---h~~Iv~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +-.+.++.|....+|+..  .+++.+.+|+-... ......|.+-|+.|.   --.+.+++.+...   .+.  -|+|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~---~~~--~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY---DDD--AFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE----SSC--CEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee---cCC--ceEEEE
Confidence            345678999999999887  57888999987643 334667998888884   2334455554322   122  379999


Q ss_pred             ccc
Q 017139          113 YVP  115 (376)
Q Consensus       113 ~~~  115 (376)
                      |++
T Consensus        93 ~l~   95 (288)
T PF03881_consen   93 FLE   95 (288)
T ss_dssp             ---
T ss_pred             eec
Confidence            986

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.84  E-value=0.17  Score=43.30  Aligned_cols=84  Identities=17%  Similarity=0.226  Sum_probs=54.9

Q ss_pred             HHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-
Q 017139           75 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-  153 (376)
Q Consensus        75 ~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-  153 (376)
                      ..+..++.++.  .|+++.      . .+...+.++.|+|..--  .          ..   . .++.-=+.+|...|+ 
T Consensus       106 ~nky~v~Armh--GilrL~------N-Dn~~~yGvIlE~Cy~~~--i----------~~---~-N~i~agi~~L~~fH~~  160 (308)
T PF07387_consen  106 FNKYRVFARMH--GILRLK------N-DNNYKYGVILERCYKIK--I----------NF---S-NFITAGIKDLMDFHSE  160 (308)
T ss_pred             hhhhhHHHHhh--heeEee------c-CCCceeEEEEeeccCcc--c----------ch---h-HHHHHhHHHHHHhhcc
Confidence            34666766653  466654      1 34445779999997420  0          00   1 122222567888883 


Q ss_pred             CCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       154 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+.+|+|..|+||+-|+ .|.+||.|-+.-
T Consensus       161 ~~~~lHGD~np~NiM~D~-~G~lKlVDP~~L  190 (308)
T PF07387_consen  161 NQHCLHGDCNPDNIMCDK-FGYLKLVDPVCL  190 (308)
T ss_pred             CCCeecCCCChhheeecC-CCCEEecChhhh
Confidence            357999999999999997 778999997753

The function of this family is unknown.

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=94.41  E-value=0.037  Score=49.82  Aligned_cols=132  Identities=22%  Similarity=0.231  Sum_probs=86.0

Q ss_pred             EeeeeeccCCceEEEEEEEc-------C---CCcEEEEEEeccc--------------ccch----------------HH
Q 017139           37 MAERVVGTGSFGIVFQAKCL-------E---TGETVAIKKVLQD--------------RRYK----------------NR   76 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~-------~---~~~~~aiK~~~~~--------------~~~~----------------~~   76 (376)
                      .|..+|..|--+.|+-|.--       .   ....+|||+++-.              .++.                ++
T Consensus       255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk  334 (531)
T KOG2269|consen  255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK  334 (531)
T ss_pred             hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence            45678889999999887421       1   2346899976321              0111                12


Q ss_pred             HHHHHHhC-----CCCCeeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh
Q 017139           77 ELQLMRLM-----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI  151 (376)
Q Consensus        77 e~~~l~~l-----~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~L  151 (376)
                      |..-|.++     .+|-+|.+..            ..+||-|++..   .+..-.-.+-.++....+..-.|++.++.-|
T Consensus       335 EmhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~l  399 (531)
T KOG2269|consen  335 EMHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRL  399 (531)
T ss_pred             HHHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHH
Confidence            33333343     3677777644            34899998732   1112222345588888888888999888876


Q ss_pred             HcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       152 H~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      -.-.-+||.||+--|+|...  +.+-++|..-+.
T Consensus       400 Y~Ec~LVHADlSEyN~Lw~~--gKvw~IDVsQsv  431 (531)
T KOG2269|consen  400 YKECLLVHADLSEYNLLWTP--GKVWVIDVSQSV  431 (531)
T ss_pred             HHhhheeecchhhhhheecC--CceEEEechhcc
Confidence            54267999999999999984  478899977653

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.38  E-value=0.067  Score=48.31  Aligned_cols=63  Identities=19%  Similarity=0.240  Sum_probs=36.8

Q ss_pred             EEeecccchHHHHHH-hhhhcCCCCCHHHHHHHHHHHHHHHHHhHc---CCCceeccCCCCCeeecC
Q 017139          109 LVMEYVPETMYRVLK-HYSSMNQRMPLIYVKLYTYQIFRGLAYIHT---VPGVCHRDVKPQNLLVDP  171 (376)
Q Consensus       109 lv~e~~~g~l~~~l~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~~~ivH~dlkp~Nill~~  171 (376)
                      ||++...++..+.-. .....+-.--.+.++.++.|++.-.-.+-.   ...++|.||||+|||+-.
T Consensus       252 IIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  318 (444)
T PHA03111        252 IIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD  318 (444)
T ss_pred             EEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence            777776543222211 111112222345678888898765533322   136899999999999853

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=93.90  E-value=0.075  Score=50.44  Aligned_cols=30  Identities=20%  Similarity=0.274  Sum_probs=23.4

Q ss_pred             ceeccCCCCCeeecCCCC----cEEEEecCCccc
Q 017139          157 VCHRDVKPQNLLVDPLTH----QVKLCDFGSAKV  186 (376)
Q Consensus       157 ivH~dlkp~Nill~~~~~----~~kl~Dfg~~~~  186 (376)
                      ++|+||...|||.+.++.    -..|+||-.+..
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~  303 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR  303 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence            699999999999987443    456888877654

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.10  E-value=0.11  Score=47.14  Aligned_cols=62  Identities=21%  Similarity=0.253  Sum_probs=35.4

Q ss_pred             EEeecccchHHHHHHh-hhhcCCCCCHHHHHHHHHHHHHHHHHhHc---CCCceeccCCCCCeeec
Q 017139          109 LVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHT---VPGVCHRDVKPQNLLVD  170 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~~~ivH~dlkp~Nill~  170 (376)
                      ||++...++..+.-.. ....+-.--.+.++.++.|++.-.--+-.   ...++|.||||+|||+-
T Consensus       248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  313 (434)
T PF05445_consen  248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIF  313 (434)
T ss_pred             EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEe
Confidence            7888766543222111 11122223345677888887654311211   14689999999999984

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PTZ00296 choline kinase; Provisional

Probab=92.57  E-value=2.9  Score=40.18  Aligned_cols=70  Identities=14%  Similarity=0.167  Sum_probs=42.7

Q ss_pred             eeeeeccCCceEEEEEEEcCC--------CcEEEEEEeccccc---chHHHHHHHHhCCCCCeee-cceeeeecCCCCce
Q 017139           38 AERVVGTGSFGIVFQAKCLET--------GETVAIKKVLQDRR---YKNRELQLMRLMDHPNVIS-LKHCFFSTTSKDEL  105 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~--------~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~-~~~~~~~~~~~~~~  105 (376)
                      -.+.|..|-.-.+|++.....        ++.|.+++.-....   ....|..+++.+...+|-+ +++.+     .+  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~g--  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----SG--  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----CC--
Confidence            566778888889999875422        56788888754321   2345788887776544433 33332     11  


Q ss_pred             eEEEEeecccc
Q 017139          106 FLNLVMEYVPE  116 (376)
Q Consensus       106 ~~~lv~e~~~g  116 (376)
                        +.|.||++|
T Consensus       182 --g~I~efi~g  190 (442)
T PTZ00296        182 --GRIEEWLYG  190 (442)
T ss_pred             --CEEEEeeCC
Confidence              256777765

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	376
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-142
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-142
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-142
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-142
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-142
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-142
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-141
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-141
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-141
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-140
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-140
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-140
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-139
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-139
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-138
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-138
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-138
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-137
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-137
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-137
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-135
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-133
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-91
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-83
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-46
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-45
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-45
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-45
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-44
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-44
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-44
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-44
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-44
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-44
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-44
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-44
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-44
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-44
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-44
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-44
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-44
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-44
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-44
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-44
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-44
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-44
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-44
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-44
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-44
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-44
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-44
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-43
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-43
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-43
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-43
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-43
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-43
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-43
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-43
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-43
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-43
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-43
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-43
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-43
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-43
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-43
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-43
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-43
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-43
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-43
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-43
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-43
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-43
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-43
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-42
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-42
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-42
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-42
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-42
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-42
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-42
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-42
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-42
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-42
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-42
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-42
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-42
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-42
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-42
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-42
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-42
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-42
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-42
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-41
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-41
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-40
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-40
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-40
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-40
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-40
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-39
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-39
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-39
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-39
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-39
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-39
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-39
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-39
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-39
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-39
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-39
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-39
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-39
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-39
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-39
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-39
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-39
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-39
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-39
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-39
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-39
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-39
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-39
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-39
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-39
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-39
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-39
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-39
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-39
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-39
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-39
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-39
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-39
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-39
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-39
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-39
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-39
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-39
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-39
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-39
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-39
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-39
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-39
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-39
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-39
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-39
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-39
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-39
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-38
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-38
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-38
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-38
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-38
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-38
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-38
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-38
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-38
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-38
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-38
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-38
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-38
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-38
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-38
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-38
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-37
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-35
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-35
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-35
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-35
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-35
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-35
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-35
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-34
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-34
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-34
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-34
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-34
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-34
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-34
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-34
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-34
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-34
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-34
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-34
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-34
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-34
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-34
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-34
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-34
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-34
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-34
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-34
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-34
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-34
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-34
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-34
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-33
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-33
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-33
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-33
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-33
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-33
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-33
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-33
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-33
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-33
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-33
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-33
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-33
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-33
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-33
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-33
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-32
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-32
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-32
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-32
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		6e-32
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		6e-32
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		6e-32
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-32
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		6e-32
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-32
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-31
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-31
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-31
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-31
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-31
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-31
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-31
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-31
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-31
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-30
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-29
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-29
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-28
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-28
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-28
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-28
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-28
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-28
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-28
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-27
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-26
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-26
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-26
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-26
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-26
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-26
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-26
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-26
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-26
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		9e-26
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-25
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-25
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-25
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-25
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-23
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-22
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-22
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-22
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-22
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-21
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-21
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-21
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-21
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-21
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-21
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-21
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-21
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-21
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-21
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-21
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-21
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-21
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-21
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-21
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-21
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-21
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-20
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-19
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-19
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-19
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-19
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-19
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-18
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-18
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-18
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-18
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-18
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-18
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-18
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-18
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-18
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-18
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-18
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-18
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-18
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-18
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-18
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-17
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-17
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-17
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-17
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-17
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-17
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-17
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-17
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-17
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-17
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-17
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-17
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-17
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-17
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-16
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-16
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-16
3soa_A	444	Full-Length Human Camkii Length = 444		1e-16
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-16
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-16
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-16
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-16
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-16
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-16
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-16
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-16
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-16
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-16
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-16
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-16
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-16
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-16
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-16
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-16
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-15
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-15
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-15
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-15
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-15
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-15
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-15
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-14
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-14
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-14
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-14
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-14
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		8e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-13
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-13
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-13
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-13
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		8e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-12
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-11
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		8e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-11
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		8e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-10
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		6e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-05
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		2e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-04

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  501 bits (1291), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 234/362 (64%), Positives = 290/362 (80%), Gaps = 4/362 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 34  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 93
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 94  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 372
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P 
Sbjct: 333 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 392
Query: 373 SA 374
           +A
Sbjct: 393 NA 394

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  501 bits (1291), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 234/362 (64%), Positives = 290/362 (80%), Gaps = 4/362 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 36  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 95
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 96  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 155
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 156 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 214
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 215 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 274
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 275 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 334
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 372
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P 
Sbjct: 335 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 394
Query: 373 SA 374
           +A
Sbjct: 395 NA 396

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  501 bits (1290), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 234/362 (64%), Positives = 290/362 (80%), Gaps = 4/362 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 28  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 87
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 88  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 147
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 148 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 206
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 207 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 266
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 267 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 326
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 372
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P 
Sbjct: 327 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 386
Query: 373 SA 374
           +A
Sbjct: 387 NA 388

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  501 bits (1290), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 234/362 (64%), Positives = 290/362 (80%), Gaps = 4/362 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 38  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 97
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 98  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 157
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 158 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 216
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 217 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 276
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 277 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 336
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 372
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P 
Sbjct: 337 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 396
Query: 373 SA 374
           +A
Sbjct: 397 NA 398

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  501 bits (1289), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 234/362 (64%), Positives = 290/362 (80%), Gaps = 4/362 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 79  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 138
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 139 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 198
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 199 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 257
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 258 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 317
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 318 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 377
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 372
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P 
Sbjct: 378 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 437
Query: 373 SA 374
           +A
Sbjct: 438 NA 439

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  500 bits (1287), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 232/351 (66%), Positives = 285/351 (81%), Gaps = 2/351 (0%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +
Sbjct: 16  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 75
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +P+IYVKLY YQ
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 135
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+SYICSRYYR
Sbjct: 136 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 194
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR 
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 254
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDEL
Sbjct: 255 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 314
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSA 374
           R+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P +A
Sbjct: 315 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNA 365

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  498 bits (1283), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 233/362 (64%), Positives = 289/362 (79%), Gaps = 4/362 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 34  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 93
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 94  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+S ICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 213 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 372
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P 
Sbjct: 333 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 392
Query: 373 SA 374
           +A
Sbjct: 393 NA 394

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  498 bits (1282), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 233/359 (64%), Positives = 288/359 (80%), Gaps = 4/359 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 13  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 72
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 73  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 132
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 133 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 191
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 192 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 251
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 252 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 311
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMP 371
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P
Sbjct: 312 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTP 370

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  498 bits (1281), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 233/363 (64%), Positives = 289/363 (79%), Gaps = 4/363 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 12  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 71
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 72  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 190
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+S ICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 250
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 251 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 310
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 372
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P 
Sbjct: 311 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 370
Query: 373 SAG 375
           +A 
Sbjct: 371 NAA 373

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  495 bits (1275), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 232/359 (64%), Positives = 287/359 (79%), Gaps = 4/359 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 12  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 71
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 72  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 190
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+S ICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 250
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 251 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 310
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMP 371
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P
Sbjct: 311 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTP 369

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  495 bits (1275), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 232/359 (64%), Positives = 287/359 (79%), Gaps = 4/359 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 8   GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 67
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 68  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 127
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 128 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 186
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+S ICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 187 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 246
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 247 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 306
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMP 371
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P
Sbjct: 307 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTP 365

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 232/359 (64%), Positives = 287/359 (79%), Gaps = 4/359 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 19  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 78
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 79  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 138
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 139 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 197
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+S ICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 198 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 257
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 258 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 317
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMP 371
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P
Sbjct: 318 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTP 376

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  491 bits (1264), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 228/340 (67%), Positives = 280/340 (82%), Gaps = 2/340 (0%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+SYICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR 363
           R+PN +LPNGR  P LFNF  +   ++P L   LIP H R
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  489 bits (1260), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 280/342 (81%), Gaps = 2/342 (0%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+S ICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQ 365
           R+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 351

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  489 bits (1259), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 229/351 (65%), Positives = 284/351 (80%), Gaps = 4/351 (1%)
Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 4   GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 63
Query: 74  KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 64  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 123
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 124 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 182
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+S ICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 183 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 242
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 243 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 302
Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR 363
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R
Sbjct: 303 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 353

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  488 bits (1257), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 227/340 (66%), Positives = 279/340 (82%), Gaps = 2/340 (0%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+S ICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR 363
           R+PN +LPNGR  P LFNF  +   ++P L   LIP H R
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  488 bits (1256), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 227/340 (66%), Positives = 279/340 (82%), Gaps = 2/340 (0%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +
Sbjct: 12  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 71
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +P+IYVKLY YQ
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+S ICSRYYR
Sbjct: 132 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 190
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR 
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 250
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDEL
Sbjct: 251 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 310
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR 363
           R+PN +LPNGR  P LFNF  +   ++P L   LIP H R
Sbjct: 311 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 350

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  486 bits (1250), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 227/342 (66%), Positives = 278/342 (81%), Gaps = 2/342 (0%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ + +KNRELQ+MR +
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+SYICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNYT+F FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQ 365
           R+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 351

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  486 bits (1250), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/340 (66%), Positives = 278/340 (81%), Gaps = 2/340 (0%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DH N++ L++ F+S+   KD ++LNLV++YVPET+YRV +HYS   Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+S ICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR 363
           R+PN +LPNGR  P LFNF  +   ++P L   LIP H R
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  486 bits (1250), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/340 (66%), Positives = 278/340 (81%), Gaps = 2/340 (0%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ + +KNRELQ+MR +
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+SYICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR 363
           R+PN +LPNGR  P LFNF  +   ++P L   LIP H R
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  479 bits (1233), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 224/340 (65%), Positives = 275/340 (80%), Gaps = 2/340 (0%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ + +KNRELQ+MR +
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           DH N++ L++ F+S+   KDE++LNLV++YVP T+YRV +HYS   Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+S ICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNYT+F FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR 363
           R+PN +LPNGR  P LFNF  +   ++P L   LIP H R
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  470 bits (1209), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 217/342 (63%), Positives = 276/342 (80%), Gaps = 4/342 (1%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           GK GE ++ I+Y   +V+G GSFG+VFQAK +E+ E VAIKKVLQD+R+KNRELQ+MR++
Sbjct: 32  GKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIV 89
Query: 85  DHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
            HPNV+ LK  F+S    KDE+FLNLV+EYVPET+YR  +HY+ + Q MP++ +KLY YQ
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           + R LAYIH++ G+CHRD+KPQNLL+DP +  +KL DFGSAK+L+ GE N+S ICSRYYR
Sbjct: 150 LLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYR 208
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APELIFGAT YTT+IDIWS GCV+AEL+ GQPLFPGE+ +DQLVEIIKVLGTP+RE+I+ 
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           MNPNY + +FPQI+ HP+ KVF  R PP+AIDL SRLL+Y+PS R TA+EA  HPFFDEL
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328
Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQ 365
           R   AR+PNGR  PPLFN+ +E     P+LI+RL+P+H   +
Sbjct: 329 RTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAE 370

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  331 bits (849), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 164/369 (44%), Positives = 238/369 (64%), Gaps = 44/369 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHC 95
           Y   + +GTGSFGIV +   +E+G+  A+KKVLQD RYKNREL +M+++DH N+I L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 96  FFSTTSKD---------------------------------ELFLNLVMEYVPETMYRVL 122
           F++T  ++                                   +LN++MEYVP+T+++VL
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 123 KHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 182
           K +    + +P+  + +Y YQ+FR + +IH++ G+CHRD+KPQNLLV+   + +KLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
           SAK L+  E +++ ICSR+YRAPEL+ GATEYT SID+WS GCV  EL+LG+PLF GE +
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
           +DQLV II+++GTPT+E++  MNP+YT+ RFP +KA  W K+  +  P  AIDL  ++L+
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 303 YSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPFPPLFNFK-QELAGASPE 352
           Y P LR    EA AHPFFD LR         N+  P+G  +  P LFNF   EL+     
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 353 LINRLIPEH 361
           ++NR++P++
Sbjct: 368 VLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  304 bits (778), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 150/322 (46%), Positives = 211/322 (65%), Gaps = 10/322 (3%)
Query: 31  KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR---LMDHP 87
           K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R++NRELQ+M+   ++ HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 88  NVISLKHCFFSTTSKD--ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           N++ L+  F++   +D  +++LN+VMEYVP+T++R  ++Y       P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 146 RGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
           R +  +H     VCHRD+KP N+LV+     +KLCDFGSAK L   E N++YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PELIFG   YTT++DIWS GC+ AE++LG+P+F G+N+  QL EI++VLG P+RE +R +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 265 NPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
           NP++TD      K  PW  VF     +   EA DL S LLQY P  R    EA  HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 322 ELREPNARLPNGRPFP-PLFNF 342
           EL +P  +LPN +  P  LF F
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRF 341

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 116/347 (33%), Positives = 189/347 (54%), Gaps = 27/347 (7%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNR---ELQLMRLMDHPNVI 90
           Y   + +G G++G+V  A        VAIKK+   + + Y  R   E+Q++    H NVI
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            ++    ++T +    + +V + +   +Y++LK     +Q++   ++  + YQI RGL Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFLYQILRGLKY 159
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----ICSRYYRAPE 206
           IH+   V HRD+KP NLL++  T  +K+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 264
           ++  +  YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 265 --NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
               NY     P      W K+F K    +A+DL  R+L ++P+ R T  EA AHP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 323 LREPNARLPNGRPFPPLFNFKQELAGASPELINRLI-PEHVRRQTGL 368
             +P        P    F F  EL     E +  LI  E  R Q G+
Sbjct: 336 YYDPTDEPVAEEP----FTFAMELDDLPKERLKELIFQETARFQPGV 378

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 110/336 (32%), Positives = 180/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + LV   +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 284 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 341
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 342 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 373

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 266 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 323
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 324 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 355

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 271
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 272 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 329
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 330 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 361

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 284 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 341
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 342 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 373

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 111/339 (32%), Positives = 181/339 (53%), Gaps = 32/339 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNR---ELQLMRLMDHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R   E++++    H N+I +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC-MNPNYTDF 271
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C +N    ++
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNY 265
Query: 272 --RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP----FFDELRE 325
               P     PW+++F      +A+DL  ++L ++P  R    +A AHP    ++D   E
Sbjct: 266 LLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDE 324
Query: 326 PNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
           P A  P        F F  EL     E +  LI E   R
Sbjct: 325 PIAEAP--------FKFDMELDDLPKEKLKELIFEETAR 355

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 261
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 262 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 319
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 320 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 351

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 269 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 327 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 358

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 269
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 270 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 327
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 328 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 359

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 260
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 261 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 318
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 319 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 350

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 112/340 (32%), Positives = 180/340 (52%), Gaps = 34/340 (10%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNR---ELQLMRLMDHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R   E++++    H N+I +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP----FFDELR 324
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP    ++D   
Sbjct: 266 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSD 323
Query: 325 EPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
           EP A  P        F F  EL     E +  LI E   R
Sbjct: 324 EPIAEAP--------FKFDMELDDLPKEKLKELIFEETAR 355

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 108/315 (34%), Positives = 170/315 (53%), Gaps = 27/315 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLMDH 86
           +Y++   VG+G++G V  A    +GE VAIKK        +   R Y  REL L++ M H
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQH 100
Query: 87  PNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
            NVI L   F   +S    +   LVM ++   + +++    S  +      ++   YQ+ 
Sbjct: 101 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEK------IQYLVYQML 154
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRA 204
           +GL YIH+  GV HRD+KP NL V+    ++K+ DFG A+     +A ++ Y+ +R+YRA
Sbjct: 155 KGLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLAR---HADAEMTGYVVTRWYRA 209
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE+I     Y  ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P  E ++ +
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269
Query: 265 NPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
           N           PQ     + ++F  R  P+A DL  ++L+     R TA +A  HPFF+
Sbjct: 270 NDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328
Query: 322 ELREPNARLPNGRPF 336
             R+P       +PF
Sbjct: 329 PFRDPEEETEAQQPF 343

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 180/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P +E++ C+      NY
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNY 261
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 262 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 319
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 320 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 351

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 108/315 (34%), Positives = 169/315 (53%), Gaps = 27/315 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLMDH 86
           +Y++   VG+G++G V  A    +GE VAIKK        +   R Y  REL L++ M H
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQH 82
Query: 87  PNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
            NVI L   F   +S    +   LVM ++   + ++      M  +     ++   YQ+ 
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI------MGLKFSEEKIQYLVYQML 136
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRA 204
           +GL YIH+  GV HRD+KP NL V+    ++K+ DFG A+     +A ++ Y+ +R+YRA
Sbjct: 137 KGLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLAR---HADAEMTGYVVTRWYRA 191
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE+I     Y  ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P  E ++ +
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251
Query: 265 NPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
           N           PQ     + ++F  R  P+A DL  ++L+     R TA +A  HPFF+
Sbjct: 252 NDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310
Query: 322 ELREPNARLPNGRPF 336
             R+P       +PF
Sbjct: 311 PFRDPEEETEAQQPF 325

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 108/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAI+K+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 108/345 (31%), Positives = 184/345 (53%), Gaps = 30/345 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNV 89
            +  + ++G G++G+V  A    TGE VAIKK+    +        RE+++++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           I++    F+    D  F N    Y+ + + +   H     Q +   +++ + YQ  R + 
Sbjct: 72  ITI----FNIQRPDS-FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----------YIC 198
            +H    V HRD+KP NLL++     +K+CDFG A+++ +  A+ S           Y+ 
Sbjct: 127 VLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-T 257
           +R+YRAPE++  + +Y+ ++D+WS GC+LAEL L +P+FPG +   QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 258 REEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
             ++RC+ +P   ++    P   A P  K+F  R+ P+ IDL  R+L + P+ R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 315 CAHPFFDELREPNARLPNGRPFPP-LFNFKQELAGASPELINRLI 358
             HP+     +PN   P G P PP  F F       + + + +LI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 108/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----ICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 108/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----ICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 269 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 327 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 358

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 106/345 (30%), Positives = 184/345 (53%), Gaps = 30/345 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNV 89
            +  + ++G G++G+V  A    TGE VAIKK+    +        RE+++++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           I++    F+    D  F N    Y+ + + +   H     Q +   +++ + YQ  R + 
Sbjct: 72  ITI----FNIQRPDS-FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----------ISYIC 198
            +H    V HRD+KP NLL++     +K+CDFG A+++ +  A+           + ++ 
Sbjct: 127 VLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-T 257
           +R+YRAPE++  + +Y+ ++D+WS GC+LAEL L +P+FPG +   QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 258 REEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
             ++RC+ +P   ++    P   A P  K+F  R+ P+ IDL  R+L + P+ R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 315 CAHPFFDELREPNARLPNGRPFPP-LFNFKQELAGASPELINRLI 358
             HP+     +PN   P G P PP  F F       + + + +LI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 179/336 (53%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE----IRCMNPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E+    I     NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNY 263
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 105/315 (33%), Positives = 176/315 (55%), Gaps = 28/315 (8%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------REL 78
           G  G P+   ++     +G G++G+V++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 79  QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK 138
            L++ ++HPN++ L     +        L LV E++ + + + +   +S    +PL  +K
Sbjct: 61  SLLKELNHPNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIK 113
Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYI 197
            Y +Q+ +GLA+ H+   V HRD+KPQNLL++     +KL DFG A+   V        +
Sbjct: 114 SYLFQLLQGLAFCHS-HRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEV 171
Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            + +YRAPE++ G   Y+T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP 
Sbjct: 172 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 231
Query: 258 REEIRCMNPNYTDFR--FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTA 311
            E +     +  D++  FP+     W +  F K +PP   +   L S++L Y P+ R +A
Sbjct: 232 -EVVWPGVTSMPDYKPSFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285
Query: 312 LEACAHPFFDELREP 326
             A AHPFF ++ +P
Sbjct: 286 KAALAHPFFQDVTKP 300

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 105/315 (33%), Positives = 176/315 (55%), Gaps = 28/315 (8%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------REL 78
           G  G P+   ++     +G G++G+V++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 79  QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK 138
            L++ ++HPN++ L     +        L LV E++ + + + +   +S    +PL  +K
Sbjct: 61  SLLKELNHPNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIK 113
Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYI 197
            Y +Q+ +GLA+ H+   V HRD+KPQNLL++     +KL DFG A+   V        +
Sbjct: 114 SYLFQLLQGLAFCHS-HRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEV 171
Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            + +YRAPE++ G   Y+T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP 
Sbjct: 172 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 231
Query: 258 REEIRCMNPNYTDFR--FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTA 311
            E +     +  D++  FP+     W +  F K +PP   +   L S++L Y P+ R +A
Sbjct: 232 -EVVWPGVTSMPDYKPSFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285
Query: 312 LEACAHPFFDELREP 326
             A AHPFF ++ +P
Sbjct: 286 KAALAHPFFQDVTKP 300

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/307 (34%), Positives = 173/307 (56%), Gaps = 28/307 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 75  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 126
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 127 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 244
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P  
Sbjct: 245 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 299
Query: 329 RLPNGRP 335
            L   RP
Sbjct: 300 HLRLERP 306

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 107/345 (31%), Positives = 183/345 (53%), Gaps = 30/345 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNV 89
            +  + ++G G++G+V  A    TGE VAIKK+    +        RE+++++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           I++    F+    D  F N    Y+ + + +   H     Q +   +++ + YQ  R + 
Sbjct: 72  ITI----FNIQRPDS-FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----------YIC 198
            +H    V HRD+KP NLL++     +K+CDFG A+++ +  A+ S            + 
Sbjct: 127 VLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-T 257
           +R+YRAPE++  + +Y+ ++D+WS GC+LAEL L +P+FPG +   QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 258 REEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
             ++RC+ +P   ++    P   A P  K+F  R+ P+ IDL  R+L + P+ R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 315 CAHPFFDELREPNARLPNGRPFPP-LFNFKQELAGASPELINRLI 358
             HP+     +PN   P G P PP  F F       + + + +LI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E+V + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHTENK-----LYLVFEHVDQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 73  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 124
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 125 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 242
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 243 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 75  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 126
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 127 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 185
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 244
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 245 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 73  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 124
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 125 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 242
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 243 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 169/298 (56%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E+V + +   +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHTENK-----LYLVFEHVHQDLKTFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/297 (34%), Positives = 163/297 (54%), Gaps = 21/297 (7%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
           Y     VG G++G+V++AK    G  VA+K++  D   +       RE+ L++ + HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +SL     S     E  L LV E++ + + +VL    +  Q      +K+Y YQ+ RG+A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQ---IKIYLYQLLRGVA 133
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 208
           + H    + HRD+KPQNLL++     +KL DFG A+   +   +    + + +YRAP+++
Sbjct: 134 HCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 266
            G+ +Y+TS+DIWS GC+ AE++ G+PLFPG    DQL +I  +LGTP   E   +   P
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
            +    F   +  PW  +       E IDL S +L + P+ R +A +A  HP+F +L
Sbjct: 252 LWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 108/336 (32%), Positives = 178/336 (52%), Gaps = 26/336 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRLM---DHPNVISLKHCF 96
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPELIFGAT 212
           V HRD+KP NLL++  T  +K+ DFG A+V      +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE----IRCMNPNY 268
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E+    I     NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNY 263
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                 P    F F  EL     E +  LI E   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/297 (34%), Positives = 163/297 (54%), Gaps = 21/297 (7%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
           Y     VG G++G+V++AK    G  VA+K++  D   +       RE+ L++ + HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +SL     S     E  L LV E++ + + +VL    +  Q      +K+Y YQ+ RG+A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQ---IKIYLYQLLRGVA 133
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 208
           + H    + HRD+KPQNLL++     +KL DFG A+   +   +    + + +YRAP+++
Sbjct: 134 HCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 266
            G+ +Y+TS+DIWS GC+ AE++ G+PLFPG    DQL +I  +LGTP   E   +   P
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
            +    F   +  PW  +       E IDL S +L + P+ R +A +A  HP+F +L
Sbjct: 252 LWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 106/319 (33%), Positives = 172/319 (53%), Gaps = 24/319 (7%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRLMDHPNVISLKHC 95
           +G G++G+V  A+   TG+ VAIKK      V+ + +   REL++++   H N+I++K  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 96  FFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
              T    E   + +V++ +   +++++      +Q + L +V+ + YQ+ RGL Y+H+ 
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA 177
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRYYRAPELIF 209
             V HRD+KP NLLV+    ++K+ DFG A+ L    A        Y+ +R+YRAPEL+ 
Sbjct: 178 -QVIHRDLKPSNLLVNE-NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 235
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              EYT +ID+WS GC+  E+L  + LFPG+N V QL  I+ VLGTP+   I+ +     
Sbjct: 236 SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 295
Query: 270 DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
                  P  +  PW  V+      +A+ L  R+L++ PS R +A  A  HPF  +  +P
Sbjct: 296 RAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354
Query: 327 NARLPNGRPFPPLFNFKQE 345
           +       PF   F F +E
Sbjct: 355 DDEPDCAPPFD--FAFDRE 371

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GL++ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLSFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 169/298 (56%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + +   +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHTENK-----LYLVFEFLHQDLKTFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 106/320 (33%), Positives = 172/320 (53%), Gaps = 24/320 (7%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRLMDHPNVISLKH 94
            +G G++G+V  A+   TG+ VAIKK      V+ + +   REL++++   H N+I++K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 95  CFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
               T    E   + +V++ +   +++++      +Q + L +V+ + YQ+ RGL Y+H+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRYYRAPELI 208
              V HRD+KP NLLV+    ++K+ DFG A+ L    A        Y+ +R+YRAPEL+
Sbjct: 178 A-QVIHRDLKPSNLLVNE-NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
               EYT +ID+WS GC+  E+L  + LFPG+N V QL  I+ VLGTP+   I+ +    
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 295
Query: 269 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
                   P  +  PW  V+      +A+ L  R+L++ PS R +A  A  HPF  +  +
Sbjct: 296 VRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 354
Query: 326 PNARLPNGRPFPPLFNFKQE 345
           P+       PF   F F +E
Sbjct: 355 PDDEPDCAPPFD--FAFDRE 372

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 73  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 124
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KP+NLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 125 RVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 242
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 243 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KP+NLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPENLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 169/298 (56%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++   + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHTENK-----LYLVFEFLSMDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KP+NLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPENLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 168/298 (56%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++   +   +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 73  IHTENK-----LYLVFEFLSMDLKDFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 124
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 125 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 242
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 243 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 169/298 (56%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+ K+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 169/298 (56%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+ K+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 169/298 (56%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++   + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHTENK-----LYLVFEFLSMDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KP+NLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 168/298 (56%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++   +   +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHTENK-----LYLVFEFLSMDLKDFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 169/298 (56%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + +   +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKDFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KP+NLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPENLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 101/294 (34%), Positives = 167/294 (56%), Gaps = 28/294 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + + +   +S    +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 272
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 273 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF +
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  167 bits (423), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 160/289 (55%), Gaps = 19/289 (6%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQ---DRRYKN---RELQLMRLMDHPNVISLKH 94
           +VG GS+G+V + +  +TG  VAIKK L+   D+  K    RE++L++ + H N+++L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL-- 89
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
                  K +    LV E+V  T+   L+ + +    +    V+ Y +QI  G+ + H+ 
Sbjct: 90  ---LEVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHS- 142
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGATE 213
             + HRD+KP+N+LV   +  VKLCDFG A+ L   GE     + +R+YRAPEL+ G  +
Sbjct: 143 HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDF 271
           Y  ++D+W+ GC++ E+ +G+PLFPG++ +DQL  I+  LG   P  +E+   NP +   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           R P+IK     +  + ++    IDLA + L   P  R    E   H FF
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 112/333 (33%), Positives = 177/333 (53%), Gaps = 30/333 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  +  +++G  +A+KK       ++  +R   R
Sbjct: 41  ELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYR 99
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F   TS +E   + LV   +   +  ++K      Q++   
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 154
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 155 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 210
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + ++QL +I+++ GT
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGT 270
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P    I  M      NY +   PQ+    +  VF     P A+DL  ++L      R TA
Sbjct: 271 PPASVISRMPSHEARNYIN-SLPQMPKRNFADVF-IGANPLAVDLLEKMLVLDTDKRITA 328
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQ 344
            EA AHP+F +  +P+   P   P+   F  +Q
Sbjct: 329 SEALAHPYFSQYHDPDDE-PESEPYDQSFESRQ 360

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/319 (33%), Positives = 167/319 (52%), Gaps = 31/319 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVISL 92
           +G G F  V++A+   T + VAIKK+    R +          RE++L++ + HPN+I L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              F   ++     ++LV +++   +  ++K  S +   +   ++K Y     +GL Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLH 129
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 209
               + HRD+KP NLL+D     +KL DFG AK    G  N +Y   + +R+YRAPEL+F
Sbjct: 130 Q-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI--RCMNPN 267
           GA  Y   +D+W+ GC+LAELLL  P  PG++ +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 268 YTDFR-FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           Y  F+ FP I   P H +F      + +DL   L  ++P  R TA +A    +F     P
Sbjct: 246 YVTFKSFPGI---PLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301
Query: 327 NARLPNGRPFPPLFNFKQE 345
                  RP  P+   K++
Sbjct: 302 TPGCQLPRPNCPVETLKEQ 320

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 162/306 (52%), Gaps = 19/306 (6%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLK 93
           R VG+G++G V  A      + VA+KK+      L   R   REL+L++ + H NVI L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 94  HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
             F   TS ++   + LV   +   +  ++K     +Q +   +V+   YQ+ RGL YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----SQALSDEHVQFLVYQLLRGLKYIH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRD+KP N+ V+    ++++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNE-DSELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 273 FPQIKAHPWHKV--FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
              +   P   +    +   P AIDL  R+L      R +A EA AH +F +  +P    
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE- 323
Query: 331 PNGRPF 336
           P   P+
Sbjct: 324 PEAEPY 329

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 161/306 (52%), Gaps = 19/306 (6%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLK 93
           R VG+G++G V  A      + VA+KK+      L   R   REL+L++ + H NVI L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 94  HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
             F   TS ++   + LV   +   +  ++K      Q +   +V+   YQ+ RGL YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRD+KP N+ V+    ++++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNE-DSELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 273 FPQIKAHPWHKV--FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
              +   P   +    +   P AIDL  R+L      R +A EA AH +F +  +P    
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE- 323
Query: 331 PNGRPF 336
           P   P+
Sbjct: 324 PEAEPY 329

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 163/298 (54%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHPNVISLK 93
           VG+G++G V  A    TG  VAIKK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHENVIGLL 90
Query: 94  HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
             F    + D+     LVM ++   + +++KH      R     ++   YQ+ +GL YIH
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR-----IQFLVYQMLKGLRYIH 145
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFGA 211
              G+ HRD+KP NL V+    ++K+ DFG A+   + ++ +   + +R+YRAPE+I   
Sbjct: 146 AA-GIIHRDLKPGNLAVNE-DCELKILDFGLAR---QADSEMXGXVVTRWYRAPEVILNW 200
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----N 267
             YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP  E ++ +      N
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
           Y     P+++   +  +      P A++L  ++L      R TA EA AHP+F+ L +
Sbjct: 261 YMK-GLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/299 (34%), Positives = 160/299 (53%), Gaps = 30/299 (10%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N++ L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             S        L LV E+  + +    K++ S N  +    VK + +Q+ +GL + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++    ++KL +FG A+   +      + + + +YR P+++FGA  Y
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 215 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           +TSID+WSAGC+ AEL   G+PLFPG +  DQL  I ++LGTPT E+   M       + 
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------KL 233
Query: 274 PQIKAHPWHKVFHK------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           P  K +P +           ++     DL   LL+ +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 102/299 (34%), Positives = 159/299 (53%), Gaps = 30/299 (10%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N++ L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             S        L LV E+  + +    K++ S N  +    VK + +Q+ +GL + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            V HRD+KPQNLL++    ++KL DFG A+   +      + + + +YR P+++FGA  Y
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 215 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           +TSID+WSAGC+ AEL    +PLFPG +  DQL  I ++LGTPT E+   M       + 
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------KL 233
Query: 274 PQIKAHPWHKVFHK------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           P  K +P +           ++     DL   LL+ +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 161/306 (52%), Gaps = 19/306 (6%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLK 93
           R VG+G++G V  A      + VA+KK+      L   R   REL+L++ + H NVI L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 94  HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
             F   TS ++   + LV   +   +  ++K      Q +   +V+   YQ+ RGL YIH
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 140
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRD+KP N+ V+    ++++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 141 SA-GIIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 196
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 273 FPQIKAHPWHKV--FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
              +   P   +    +   P AIDL  R+L      R +A EA AH +F +  +P    
Sbjct: 257 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE- 315
Query: 331 PNGRPF 336
           P   P+
Sbjct: 316 PEAEPY 321

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 97/307 (31%), Positives = 168/307 (54%), Gaps = 21/307 (6%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
           +Y+    +G G++  V++ K   T   VA+K++  +          RE+ L++ + H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           ++L     +  S     L LV EY+ + + + L    ++   + +  VKL+ +Q+ RGLA
Sbjct: 63  VTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNI---INMHNVKLFLFQLLRGLA 114
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 208
           Y H    V HRD+KPQNLL++    ++KL DFG A+   +  +   + + + +YR P+++
Sbjct: 115 YCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NP 266
            G+T+Y+T ID+W  GC+  E+  G+PLFPG    +QL  I ++LGTPT E    +  N 
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232
Query: 267 NYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
            +  + +P+ +A     + H  R+  +  DL ++LLQ+    R +A +A  HPFF  L E
Sbjct: 233 EFKTYNYPKYRAEAL--LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290
Query: 326 PNARLPN 332
              +LP+
Sbjct: 291 RIHKLPD 297

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 100/339 (29%), Positives = 173/339 (51%), Gaps = 57/339 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLM-RLMDHPN 88
           Y   + +G G++GIV+++    TGE VA+KK+        D +   RE+ ++  L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +++L +   +   +D   + LV +Y+   ++ V++     N   P ++ +   YQ+ + +
Sbjct: 71  IVNLLNVLRADNDRD---VYLVFDYMETDLHAVIR----ANILEP-VHKQYVVYQLIKVI 122
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV---KGEANI----------- 194
            Y+H+  G+ HRD+KP N+L++   H VK+ DFG ++  V   +   NI           
Sbjct: 123 KYLHS-GGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 195 --------SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 246
                    Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG + ++QL
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH-------------PWHKVFHKRMPP-- 291
             II V+  P+ E++  +   +       +K                W  +  K  P   
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 292 ---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
              EA+DL  +LLQ++P+ R +A +A  HPF      PN
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 112/335 (33%), Positives = 176/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++  A  Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DXELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 32  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 90
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 145
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 146 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 201
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 261
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 262 PGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 319
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 320 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 353

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 18  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 76
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 131
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 132 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTG 187
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 248 PGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 305
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 306 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 339

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 112/336 (33%), Positives = 175/336 (52%), Gaps = 32/336 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 14  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-- 71
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 126
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +   
Sbjct: 127 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DSELKILDFGLARH--TDDEMT 182
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 242
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 243 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRIT 300
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
           A +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 301 AAQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 335

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 18  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 76
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 131
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 132 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DSELKILDFGLARH--TDDEMTG 187
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 248 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 305
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 306 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 339

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 112/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   PF   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPFDQSFESRDLL 333

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 31  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 89
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 144
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 145 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 200
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 260
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 261 PGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 318
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 319 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 352

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 112/336 (33%), Positives = 175/336 (52%), Gaps = 32/336 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 23  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-- 80
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 135
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +   
Sbjct: 136 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DXELKILDFGLARH--TDDEMT 191
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 251
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 252 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRIT 309
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
           A +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 310 AAQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 344

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 22  ELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 80
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 81  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 135
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 136 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 191
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 251
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 252 PGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 309
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 310 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 343

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 17  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 75
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 130
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 131 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DXELKILDFGLARH--TDDEMTG 186
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 247 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 304
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 305 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 338

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 8   ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 66
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 121
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 122 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 177
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 238 PGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 295
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 296 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 329

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 95/301 (31%), Positives = 163/301 (54%), Gaps = 30/301 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPN 88
            Y     +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           ++ L     +        L LV E++ + + ++L         +  +  K +  Q+  G+
Sbjct: 62  IVKLYDVIHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGI 113
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPEL 207
           AY H    V HRD+KPQNLL++    ++K+ DFG A+   +        I + +YRAP++
Sbjct: 114 AYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------EI 261
           + G+ +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +      E+
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
              +PN+T +     +  PW   F K +    IDL S++L+  P+ R TA +A  H +F 
Sbjct: 232 PKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
Query: 322 E 322
           E
Sbjct: 286 E 286

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      +G+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 17  ELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 75
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 130
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 131 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DXELKILDFGLARH--TDDEMTG 186
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 247 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 304
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 305 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 338

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 19  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 77
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 132
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 133 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTG 188
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 249 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 306
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 307 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 340

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 112/336 (33%), Positives = 175/336 (52%), Gaps = 32/336 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 24  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY-- 81
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 136
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +   
Sbjct: 137 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMT 192
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 252
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 253 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRIT 310
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
           A +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 311 AAQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 345

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 32  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 90
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 145
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 146 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 201
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 261
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 262 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 319
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 320 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 353

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 112/336 (33%), Positives = 175/336 (52%), Gaps = 32/336 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 23  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-- 80
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 135
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +   
Sbjct: 136 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMT 191
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 251
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 252 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRIT 309
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
           A +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 310 AAQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 344

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 18  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 76
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 131
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 132 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 187
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 248 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 305
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 306 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 339

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 14  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 72
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 127
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 128 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 183
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 244 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 301
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 302 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 335

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 94/301 (31%), Positives = 163/301 (54%), Gaps = 30/301 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPN 88
            Y     +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           ++ L     +        L LV E++ + + ++L         +  +  K +  Q+  G+
Sbjct: 62  IVKLYDVIHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGI 113
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPEL 207
           AY H    V HRD+KPQNLL++    ++K+ DFG A+   +        + + +YRAP++
Sbjct: 114 AYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------EI 261
           + G+ +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +      E+
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
              +PN+T +     +  PW   F K +    IDL S++L+  P+ R TA +A  H +F 
Sbjct: 232 PKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
Query: 322 E 322
           E
Sbjct: 286 E 286

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 31  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 89
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 144
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 145 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 200
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 260
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 261 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 318
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 319 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 352

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 94/301 (31%), Positives = 163/301 (54%), Gaps = 30/301 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPN 88
            Y     +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           ++ L     +        L LV E++ + + ++L         +  +  K +  Q+  G+
Sbjct: 62  IVKLYDVIHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGI 113
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPEL 207
           AY H    V HRD+KPQNLL++    ++K+ DFG A+   +        + + +YRAP++
Sbjct: 114 AYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------EI 261
           + G+ +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +      E+
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
              +PN+T +     +  PW   F K +    IDL S++L+  P+ R TA +A  H +F 
Sbjct: 232 PKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
Query: 322 E 322
           E
Sbjct: 286 E 286

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 109/326 (33%), Positives = 172/326 (52%), Gaps = 32/326 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-- 69
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K     +Q++  
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----SQKLTD 124
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG  +     +   
Sbjct: 125 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DSELKILDFGLCRH--TDDEMT 180
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 240
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 241 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRIT 298
Query: 311 ALEACAHPFFDELREPNARLPNGRPF 336
           A +A AH +F +  +P+   P   P+
Sbjct: 299 AAQALAHAYFAQYHDPDDE-PVADPY 323

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 18  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 76
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 131
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 132 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTG 187
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 248 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 305
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 306 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 339

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 24  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 82
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 137
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 138 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 193
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 254 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 311
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 312 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 345

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 24  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 82
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 137
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 138 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 193
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 254 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 311
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 312 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 345

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 14  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 72
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 127
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 128 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 183
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 244 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 301
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 302 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 335

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 19  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 77
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 132
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 133 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 188
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 249 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 306
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 307 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 340

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 35  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 93
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 148
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 149 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMXG 204
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 264
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 265 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 322
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 323 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 356

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 35  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 93
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 148
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 149 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 204
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 264
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 265 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 322
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 323 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 356

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 17  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 75
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 130
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 131 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 186
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 247 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 304
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 305 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 338

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 11  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 69
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 70  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 124
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 125 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 180
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 240
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 241 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 298
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 299 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 332

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 10  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 68
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 69  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 123
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 124 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 179
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 239
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 240 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 297
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 298 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 331

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 17  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 75
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 130
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 131 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 186
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 247 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 304
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 305 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 338

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 14  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 72
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 127
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 128 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 183
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 244 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 301
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 302 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 335

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 8   ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 66
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 121
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 122 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 177
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 238 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 295
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 296 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 329

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 9   ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 67
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 122
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 123 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 178
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 238
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 239 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 296
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 297 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 330

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 96/293 (32%), Positives = 161/293 (54%), Gaps = 19/293 (6%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHC 95
           +G GS+G+VF+ +  +TG+ VAIKK L+       ++   RE+++++ + HPN+++L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           F     + +  L+LV EY   T+   L  Y    + +P   VK  T+Q  + + + H   
Sbjct: 71  F-----RRKRRLHLVFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHK-H 121
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGATEY 214
              HRDVKP+N+L+   +  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDFR 272
              +D+W+ GCV AELL G PL+PG++ VDQL  I K LG   P  +++   N  ++  +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
            P  +     ++    +   A+ L    L   P+ R T  +   HP+F+ +RE
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 111/335 (33%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 9   ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 67
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 122
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 123 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 178
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 238
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 239 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 296
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 297 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 330

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMAG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           ++ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 110/326 (33%), Positives = 172/326 (52%), Gaps = 32/326 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 19  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-- 76
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 131
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +   
Sbjct: 132 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMT 187
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 248 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRIT 305
Query: 311 ALEACAHPFFDELREPNARLPNGRPF 336
           A +A AH +F +  +P+   P   P+
Sbjct: 306 AAQALAHAYFAQYHDPDDE-PVADPY 330

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 109/325 (33%), Positives = 172/325 (52%), Gaps = 30/325 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 19  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 77
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 132
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 133 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTG 188
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 249 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 306
Query: 312 LEACAHPFFDELREPNARLPNGRPF 336
            +A AH +F +  +P+   P   P+
Sbjct: 307 AQALAHAYFAQYHDPDDE-PVADPY 330

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 8   ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 66
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 121
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 122 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMAG 177
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           ++ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 238 PGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 295
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 296 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 329

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMAG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           ++ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 107/316 (33%), Positives = 169/316 (53%), Gaps = 29/316 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPN 327
            +A AH +F +  +P+
Sbjct: 300 AQALAHAYFAQYHDPD 315

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 108/317 (34%), Positives = 169/317 (53%), Gaps = 31/317 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-- 69
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 124
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +   
Sbjct: 125 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMT 180
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 240
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 241 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRIT 298
Query: 311 ALEACAHPFFDELREPN 327
           A +A AH +F +  +P+
Sbjct: 299 AAQALAHAYFAQYHDPD 315

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 108/317 (34%), Positives = 169/317 (53%), Gaps = 31/317 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-- 69
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 124
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +   
Sbjct: 125 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMT 180
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 240
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 241 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRIT 298
Query: 311 ALEACAHPFFDELREPN 327
           A +A AH +F +  +P+
Sbjct: 299 AAQALAHAYFAQYHDPD 315

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 175/335 (52%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ D+G A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDYGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 174/335 (51%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 8   ELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 66
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K       ++   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CAKLTDD 121
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 122 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 177
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 238 PGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 295
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 296 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 329

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 111/336 (33%), Positives = 174/336 (51%), Gaps = 32/336 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 32  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-- 89
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 144
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +   
Sbjct: 145 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMX 200
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
             + +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 201 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 260
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 261 TPGAELLKKISSESARNYIQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRIT 318
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
           A +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 319 AAQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 353

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 174/335 (51%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DF  A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFYLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 174/335 (51%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
            + +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 174/335 (51%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+  FG A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILGFGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 111/336 (33%), Positives = 174/336 (51%), Gaps = 32/336 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-- 69
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 124
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ D G A+     +   
Sbjct: 125 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDAGLARH--TDDEMT 180
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 240
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 241 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRIT 298
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
           A +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 299 AAQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 111/336 (33%), Positives = 174/336 (51%), Gaps = 32/336 (9%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKN 75
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK+ +         R Y  
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-- 69
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           REL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++  
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTD 124
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ D G A+     +   
Sbjct: 125 DHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDGGLARH--TDDEMT 180
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++G
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 240
Query: 255 TPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           TP  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R T
Sbjct: 241 TPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRIT 298
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
           A +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 299 AAQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  154 bits (388), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 110/335 (32%), Positives = 174/335 (51%), Gaps = 30/335 (8%)
Query: 29  EPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNR 76
           E  +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  +R   R
Sbjct: 12  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYR 70
Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           EL+L++ M H NVI L   F    S +E   + LV   +   +  ++K      Q++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDD 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +V+   YQI RGL YIH+   + HRD+KP NL V+    ++K+ D G A+     +    
Sbjct: 126 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDRGLARH--TDDEMTG 181
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           Y+ +R+YRAPE++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GT
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 256 PTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
           P  E ++ ++     NY      Q+    +  VF     P A+DL  ++L      R TA
Sbjct: 242 PGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 299
Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
            +A AH +F +  +P+   P   P+   F  +  L
Sbjct: 300 AQALAHAYFAQYHDPDDE-PVADPYDQSFESRDLL 333

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 98/298 (32%), Positives = 157/298 (52%), Gaps = 28/298 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHCF 96
           +G G++  V++     TG  VA+K+V  D          RE+ LM+ + H N++ L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTYQIFRGLAYIHTV 154
            +        L LV E++   + + +   +  N  + + L  VK + +Q+ +GLA+ H  
Sbjct: 73  HTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE- 126
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATE 213
             + HRD+KPQNLL++    Q+KL DFG A+   +      S + + +YRAP+++ G+  
Sbjct: 127 NKILHRDLKPQNLLINK-RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDF 271
           Y+TSIDIWS GC+LAE++ G+PLFPG N  +QL  I  ++GTP       +   P Y   
Sbjct: 186 YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN-- 243
Query: 272 RFPQIKAHP---WHKVF--HKRMPPEA--IDLASRLLQYSPSLRCTALEACAHPFFDE 322
             P I+  P     +V   H + P +   +D    LLQ +P +R +A +A  HP+F E
Sbjct: 244 --PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 168/311 (54%), Gaps = 40/311 (12%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVIS 91
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++++R +DH N++ 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 92  LKHCFFSTTSK--DELF----LN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
           +      + S+  D++     LN   +V EY+   +  VL+    + +     + +L+ Y
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE-----HARLFMY 127
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-----KGEANISYI 197
           Q+ RGL YIH+   V HRD+KP NL ++     +K+ DFG A+++      KG  +   +
Sbjct: 128 QLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS-EGL 185
Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVLG 254
            +++YR+P L+     YT +ID+W+AGC+ AE+L G+ LF G + ++Q+   +E I V+ 
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 255 TPTREEIRCMNPNY--TDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRC 309
              R+E+  + P Y   D   P       HK   + +P    EA+D   ++L +SP  R 
Sbjct: 246 EEDRQELLSVIPVYIRNDMTEP-------HKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
Query: 310 TALEACAHPFF 320
           TA EA +HP+ 
Sbjct: 299 TAEEALSHPYM 309

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 167/315 (53%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM++++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERMSYL-----LYQMLV 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYL-----LYQMLX 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 315 ALQHPYINVWYDP 327

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 167/315 (53%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM++++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYL-----LYQMLX 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 315 ALQHPYINVWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYL-----LYQMLX 130
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 131 GIKHLHSA-GIIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 308 ALQHPYINVWYDP 320

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 97/300 (32%), Positives = 151/300 (50%), Gaps = 27/300 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMR-LMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K  RE++++  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 158/312 (50%), Gaps = 30/312 (9%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN------------RELQL 80
           Y  +R + +GS+G V  A     G  VAIK+V   + D R  N            RE++L
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 81  MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI--YVK 138
           +    HPN++ L+  F          L LV E +   + +V+      +QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            + Y I  GL  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G    +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 259 EEIRCM-NPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
           E++    +P+  D+       + A  W  V      P A+DL +++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVV-PTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 315 CAHPFFDELREP 326
             HP+F+ L +P
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 158/312 (50%), Gaps = 30/312 (9%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN------------RELQL 80
           Y  +R + +GS+G V  A     G  VAIK+V   + D R  N            RE++L
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 81  MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI--YVK 138
           +    HPN++ L+  F          L LV E +   + +V+      +QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            + Y I  GL  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G    +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 259 EEIRCM-NPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
           E++    +P+  D+       + A  W  V      P A+DL +++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVV-PTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 315 CAHPFFDELREP 326
             HP+F+ L +P
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 98/315 (31%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM++++H 
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERMSYL-----LYQMLV 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS G ++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 315 ALQHPYINVWYDP 327

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 106/332 (31%), Positives = 170/332 (51%), Gaps = 41/332 (12%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------REL 78
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +       RE+
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 79  QLMRLMD---HPNVISL-KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            ++R ++   HPNV+ L   C  S T + E  L LV E+V + +   L         +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
             +K   +Q+ RGL ++H+   V HRD+KPQN+LV   + Q+KL DFG A++     A  
Sbjct: 120 ETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALT 177
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
           S + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR--MPPEAI---------DLASRLLQY 303
            P  E+            +P+  A P  + FH +   P E           DL  + L +
Sbjct: 237 LPGEED------------WPRDVALP-RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 283
Query: 304 SPSLRCTALEACAHPFFDELREPNARLPNGRP 335
           +P+ R +A  A +HP+F +L      L +  P
Sbjct: 284 NPAKRISAYSALSHPYFQDLERCKENLDSHLP 315

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 104/320 (32%), Positives = 167/320 (52%), Gaps = 41/320 (12%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------REL 78
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +       RE+
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 79  QLMRLMD---HPNVISL-KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            ++R ++   HPNV+ L   C  S T + E  L LV E+V + +   L         +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
             +K   +Q+ RGL ++H+   V HRD+KPQN+LV   + Q+KL DFG A++     A  
Sbjct: 120 ETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALT 177
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
           S + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR--MPPEAI---------DLASRLLQY 303
            P  E+            +P+  A P  + FH +   P E           DL  + L +
Sbjct: 237 LPGEED------------WPRDVALP-RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 283
Query: 304 SPSLRCTALEACAHPFFDEL 323
           +P+ R +A  A +HP+F +L
Sbjct: 284 NPAKRISAYSALSHPYFQDL 303

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 98/315 (31%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM++++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERMSYL-----LYQMLV 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS G ++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 101/313 (32%), Positives = 162/313 (51%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A     G  VA+KK+   R ++N        REL L++ ++H 
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V+ H    ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ EL+ G  +F G + +DQ  ++I+ LGTP+ E +  + P
Sbjct: 196 VILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP 254
Query: 267 ---NYTDFR--FPQIKAH--------PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R  +P IK          P      K    +A DL S++L   P  R +  E
Sbjct: 255 TVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDE 314
Query: 314 ACAHPFFDELREP 326
           A  HP+     +P
Sbjct: 315 ALRHPYITVWYDP 327

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 315 ALQHPYINVWYDP 327

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 138
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 197 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 256 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 315
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 316 ALQHPYINVWYDP 328

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 138
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 197 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 256 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 315
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 316 ALQHPYINVWYDP 328

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 99/307 (32%), Positives = 155/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  LM  PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGGPNIVKL 91
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 142
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 255
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/292 (31%), Positives = 152/292 (52%), Gaps = 24/292 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G V++A    T ETVAIK++  +   +       RE+ L++ + H N+I LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                      L+L+ EY        LK Y   N  + +  +K + YQ+  G+ + H+  
Sbjct: 102 IHHNHR-----LHLIFEYAEND----LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 156 GVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVLVKGEANISY-ICSRYYRAPELIFG 210
              HRD+KPQNLL+       T  +K+ DFG A+         ++ I + +YR PE++ G
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNY 268
           +  Y+TS+DIWS  C+ AE+L+  PLFPG++ +DQL +I +VLG P       +   P++
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
               FP+ +     +V    +  E +DL + +L+  P  R +A  A  HP+F
Sbjct: 272 KQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 175
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 234 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 353 ALQHPYINVWYDP 365

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 98/308 (31%), Positives = 163/308 (52%), Gaps = 33/308 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 314 ACAHPFFD 321
           A  HP+ +
Sbjct: 315 ALQHPYIN 322

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 315 ALQHPYINVWYDP 327

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 136
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 137 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 194
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 195 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 253
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 254 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 313
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 314 ALQHPYINVWYDP 326

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 175
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 234 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 353 ALQHPYINVWYDP 365

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 130
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 131 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 308 ALQHPYINVWYDP 320

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 131
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 132 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 189
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 190 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 248
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 249 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 308
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 309 ALQHPYINVWYDP 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 165/313 (52%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++     ++RM  +      YQ+  
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 131
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 132 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 189
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 190 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 248
Query: 267 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 249 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 308
Query: 314 ACAHPFFDELREP 326
           A  HP+ +   +P
Sbjct: 309 ALQHPYINVWYDP 321

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 103/317 (32%), Positives = 165/317 (52%), Gaps = 41/317 (12%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------REL 78
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +       RE+
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 79  QLMRLMD---HPNVISL-KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            ++R ++   HPNV+ L   C  S T + E  L LV E+V + +   L         +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
             +K   +Q+ RGL ++H+   V HRD+KPQN+LV   + Q+KL DFG A++     A  
Sbjct: 120 ETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALT 177
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
           S + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR--MPPEAI---------DLASRLLQY 303
            P  E+            +P+  A P  + FH +   P E           DL  + L +
Sbjct: 237 LPGEED------------WPRDVALP-RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 283
Query: 304 SPSLRCTALEACAHPFF 320
           +P+ R +A  A +HP+F
Sbjct: 284 NPAKRISAYSALSHPYF 300

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 98/315 (31%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 139
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+        + ++ +RYYRAPE
Sbjct: 140 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPE 197
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 198 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 256
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 257 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 315
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 316 EALQHPYINVWYDPS 330

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 165/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 138
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 197 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 256 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 315 EALQHPYINVWYDPS 329

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 165/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/313 (31%), Positives = 161/313 (51%), Gaps = 33/313 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A     G  VA+KK+   R ++N        REL L++ ++H 
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V+ H    ++RM  +      YQ+  
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLC 135
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 136 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTASTNFMMTPYVVTRYYRAPE 193
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ EL+ G  +F G + +DQ  ++I+ LGTP+ E +  + P
Sbjct: 194 VILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP 252
Query: 267 ---NYTDFR--FPQIKAH--------PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
              NY + R  +P I           P      K    +A DL S++L   P  R +  E
Sbjct: 253 TVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDE 312
Query: 314 ACAHPFFDELREP 326
           A  HP+     +P
Sbjct: 313 ALRHPYITVWYDP 325

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 154/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  L   PN++ L
Sbjct: 53  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 112
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 113 LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTD----YDIRYYIYELLKALDYCH 163
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 164 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNAYLNKY 276
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 277 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 336
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 337 PYFQQVR 343

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 100/310 (32%), Positives = 153/310 (49%), Gaps = 27/310 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E VA+K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+L+D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 321 DELREPNARL 330
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 154/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  L   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 91
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 142
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 255
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 154/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  L   PN++ L
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 92
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 93  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 143
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 144 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 256
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 257 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 317 PYFQQVR 323

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 154/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  L   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 91
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 142
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 255
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 154/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  L   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 91
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 142
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 255
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 154/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  L   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 91
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 142
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 255
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 154/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  L   PN++ L
Sbjct: 34  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 93
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 94  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 144
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 145 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 257
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 258 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 317
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 318 PYFQQVR 324

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 154/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  L   PN++ L
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 92
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 93  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 143
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 144 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 256
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 257 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 317 PYFQQVR 323

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 154/307 (50%), Gaps = 33/307 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  L   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 91
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK     +L+ EYV  T ++VL  Y ++        ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 142
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 255
Query: 272 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 317
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 318 PFFDELR 324
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 165/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 142
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 143 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 200
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++D+WS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 201 VILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 259
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 260 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 318
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 319 EALQHPYINVWYDPS 333

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 165/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 131
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 132 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 189
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++D+WS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 190 VILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 248
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 249 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 307
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 308 EALQHPYINVWYDPS 322

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 106/359 (29%), Positives = 182/359 (50%), Gaps = 36/359 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F   + P           +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN-ARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSM 370
           EA  HP+ +   +P+ A  P  +      + ++       ELI + + +  +R T L++
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLPKRPTTLNL 372

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 98/310 (31%), Positives = 153/310 (49%), Gaps = 27/310 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L+      Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLR------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 321 DELREPNARL 330
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 98/310 (31%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 321 DELREPNARL 330
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 98/310 (31%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 102
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 103 ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 153
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 154 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 269
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 270 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329
Query: 321 DELREPNARL 330
             + +  AR+
Sbjct: 330 YTVVKDQARM 339

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 98/310 (31%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 321 DELREPNARL 330
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 98/310 (31%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 321 DELREPNARL 330
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 98/310 (31%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 321 DELREPNARL 330
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 98/310 (31%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 321 DELREPNARL 330
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 98/310 (31%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 96
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 97  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 147
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 263
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
Query: 321 DELREPNARL 330
             + +  AR+
Sbjct: 324 YTVVKDQARM 333

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 164/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP    ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
              NY + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRNYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 98/309 (31%), Positives = 151/309 (48%), Gaps = 27/309 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 321 DELREPNAR 329
             + +  AR
Sbjct: 325 YTVVKDQAR 333

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 147/300 (49%), Gaps = 27/300 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 147/300 (49%), Gaps = 27/300 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 147/300 (49%), Gaps = 27/300 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 96  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 146
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 147 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 262
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 147/300 (49%), Gaps = 27/300 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  L   PN+I+L
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 96
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 97  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 147
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++ G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 269
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 263
Query: 270 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/315 (30%), Positives = 164/315 (52%), Gaps = 35/315 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+I L + F    S +E   + +VME +   + +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLC 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++D+WS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 312
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFDELREPN 327
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 95/301 (31%), Positives = 146/301 (48%), Gaps = 29/301 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E   V I K ++ ++ K     L  L    N+I L
Sbjct: 39  DYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKL 98
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK      LV EY+  T ++ L       Q +    ++ Y Y++ + L Y H
Sbjct: 99  IDTVKDPVSKTPA---LVFEYINNTDFKQLY------QILTDFDIRFYMYELLKALDYCH 149
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+     +     + SRY++ PEL+    
Sbjct: 150 S-KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 208
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC-------- 263
            Y  S+D+WS GC+LA ++   +P F G++  DQLV I KVLGT   EE+          
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHID 265
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
           ++P++ D    Q     W    H      + PEA+DL  +LL+Y    R TA EA  HP+
Sbjct: 266 LDPHFNDI-LGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324
Query: 320 F 320
           F
Sbjct: 325 F 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 95/301 (31%), Positives = 146/301 (48%), Gaps = 29/301 (9%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKNRELQLMRLMDHPNVISL 92
            Y   R +G G +  VF+A  +   E   V I K ++ ++ K     L  L    N+I L
Sbjct: 44  DYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKL 103
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   SK      LV EY+  T ++ L       Q +    ++ Y Y++ + L Y H
Sbjct: 104 IDTVKDPVSKTPA---LVFEYINNTDFKQLY------QILTDFDIRFYMYELLKALDYCH 154
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +  G+ HRDVKP N+++D    +++L D+G A+     +     + SRY++ PEL+    
Sbjct: 155 S-KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 213
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC-------- 263
            Y  S+D+WS GC+LA ++   +P F G++  DQLV I KVLGT   EE+          
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHID 270
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
           ++P++ D    Q     W    H      + PEA+DL  +LL+Y    R TA EA  HP+
Sbjct: 271 LDPHFNDI-LGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329
Query: 320 F 320
           F
Sbjct: 330 F 330

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 114/400 (28%), Positives = 175/400 (43%), Gaps = 84/400 (21%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRLMDHPNV 89
           Y    ++GTGS+G V +A        VAIKK+L+      D +   RE+ ++  ++H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 90  ISLKHCFFSTTSK--DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           + +         +  DEL++  V+E       ++ +    + +    +++K   Y +  G
Sbjct: 115 VKVLDIVIPKDVEKFDELYV--VLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVG 168
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------------ 195
           + Y+H+  G+ HRD+KP N LV+     VK+CDFG A+ +   E   S            
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 196 ----------------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-------- 231
                           ++ +R+YRAPELI     YT +ID+WS GC+ AELL        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 232 ---LGQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCMNPNY 268
                 PLFPG +                      DQL  I  +LGTP+ E+I  +    
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 269 TDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPFFDELR- 324
              R+ +I          +R P    +AI L  R+L ++P+ R T  E  AHPFF E+R 
Sbjct: 347 AK-RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405
Query: 325 ---EPNARLPNGRPFPPLFNFKQ-ELAGASPELINRLIPE 360
              E NA      PF    N  + +L  A  + I R  PE
Sbjct: 406 AEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 99/295 (33%), Positives = 147/295 (49%), Gaps = 40/295 (13%)
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQR-- 131
           RE+ L+R + HPNVISL+  F S   +    + L+ +Y    ++ ++K +  S  N++  
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 132 -MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL 187
            +P   VK   YQI  G+ Y+H    V HRD+KP N+LV    P   +VK+ D G A++ 
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 188 ---VKGEANIS-YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
              +K  A++   + + +YRAPEL+ GA  YT +IDIW+ GC+ AELL  +P+F      
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 244 ---------DQLVEIIKVLGTPTR---EEIRCMNPNYT---DFRFPQ------IKAHPWH 282
                    DQL  I  V+G P     E+I+ M  + T   DFR         IK    H
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 283 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP 337
           KV   +   +A  L  +LL   P  R T+ +A   P+F E   P + +  G   P
Sbjct: 303 KV---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIP 354

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 143/292 (48%), Gaps = 24/292 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD---HPN 88
           +G G++G V++A+   +G  VA+K V    R  N          RE+ L+R ++   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           V+ L     ++ +  E+ + LV E+V + +   L         +P   +K    Q  RGL
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGL 125
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            ++H    + HRD+KP+N+LV      VKL DFG A++     A    + + +YRAPE++
Sbjct: 126 DFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
             +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  E+    + + 
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-EDDWPRDVSL 241
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
               FP     P   V  + M      L   +L ++P  R +A  A  H + 
Sbjct: 242 PRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 143/292 (48%), Gaps = 24/292 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD---HPN 88
           +G G++G V++A+   +G  VA+K V    R  N          RE+ L+R ++   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           V+ L     ++ +  E+ + LV E+V + +   L         +P   +K    Q  RGL
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGL 125
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            ++H    + HRD+KP+N+LV      VKL DFG A++     A    + + +YRAPE++
Sbjct: 126 DFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
             +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  E+    + + 
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-EDDWPRDVSL 241
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
               FP     P   V  + M      L   +L ++P  R +A  A  H + 
Sbjct: 242 PRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/333 (27%), Positives = 164/333 (49%), Gaps = 53/333 (15%)
Query: 30  PKQTISYMAE--RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDH- 86
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  ++R+  +  + +R+++H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 87  -----PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
                 N +++ H   + T ++ + +    E +   +Y ++K        +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTF--ELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-VKLCDFGSAKVLVKGEANISYICSR 200
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE+  DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 261 IRCMNPNYTDFRFPQIKAHPWH------------------KVFHKRMPPEA--------- 293
            + ++ +     F   K +P +                  +    R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 294 ------IDLASRLLQYSPSLRCTALEACAHPFF 320
                 +D   + L++ P++R T  +A  HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 143/292 (48%), Gaps = 24/292 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD---HPN 88
           +G G++G V++A+   +G  VA+K V    R  N          RE+ L+R ++   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           V+ L     ++ +  E+ + LV E+V + +   L         +P   +K    Q  RGL
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGL 125
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            ++H    + HRD+KP+N+LV      VKL DFG A++     A    + + +YRAPE++
Sbjct: 126 DFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL 183
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
             +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  E+    + + 
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-EDDWPRDVSL 241
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
               FP     P   V  + M      L   +L ++P  R +A  A  H + 
Sbjct: 242 PRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/333 (27%), Positives = 164/333 (49%), Gaps = 53/333 (15%)
Query: 30  PKQTISYMAE--RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDH- 86
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  ++R+  +  + +R+++H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 87  -----PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
                 N +++ H   + T ++ + +    E +   +Y ++K        +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTF--ELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-VKLCDFGSAKVLVKGEANISYICSR 200
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE+  DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 261 IRCMNPNYTDFRFPQIKAHPWH------------------KVFHKRMPPEA--------- 293
            + ++ +     F   K +P +                  +    R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 294 ------IDLASRLLQYSPSLRCTALEACAHPFF 320
                 +D   + L++ P++R T  +A  HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 101/356 (28%), Positives = 166/356 (46%), Gaps = 77/356 (21%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPN 88
           +Y+ + ++G GS+G V+ A    T + VAIKKV      L D +   RE+ ++  +    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 89  VISLKHCFF--STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           +I L            DEL++  V+E     + ++ K    + +     ++K   Y +  
Sbjct: 87  IIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLL 140
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANI----------- 194
           G  +IH   G+ HRD+KP N L++     VK+CDFG A+ +  + + NI           
Sbjct: 141 GENFIHE-SGIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 195 -----------SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQ-------- 234
                      S++ +R+YRAPELI     YT SIDIWS GC+ AELL + Q        
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 235 --PLFPGENAV-----------------DQLVEIIKVLGTPTREEIRCMN-PNYTDFRFP 274
             PLFPG +                   DQL  I  ++GTPT ++++ +N P    +   
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY--- 315
Query: 275 QIKAHPWHKVFHKR-----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
            IK  P  K  + +     +  + I+L   +L+++P+ R T  +A  HP+  ++R+
Sbjct: 316 -IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 143/295 (48%), Gaps = 27/295 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RELQLMRLMD--- 85
           +G G++G V++A+   +G  VA+K V    R  N             RE+ L+R ++   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           HPNV+ L     ++ +  E+ + LV E+V + +   L         +P   +K    Q  
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFL 130
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
           RGL ++H    + HRD+KP+N+LV      VKL DFG A++     A    + + +YRAP
Sbjct: 131 RGLDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E++  +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  E+    +
Sbjct: 189 EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-EDDWPRD 246
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            +     FP     P   V  + M      L   +L ++P  R +A  A  H + 
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 101/360 (28%), Positives = 158/360 (43%), Gaps = 78/360 (21%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPN 88
           +Y  + ++G GS+G V+ A      + VAIKKV      L D +   RE+ ++  +    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 89  VISLKHCFF--STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           +I L            DEL++  V+E     + ++ K    + ++    +VK   Y +  
Sbjct: 89  IIRLHDLIIPEDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLL 142
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI------------ 194
           G  +IH   G+ HRD+KP N L++     VK+CDFG A+  +  + +I            
Sbjct: 143 GEKFIHE-SGIIHRDLKPANCLLNQ-DCSVKICDFGLART-INSDKDIHIVNDLEEKEEN 199
Query: 195 ---------------SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ----- 234
                          S++ +R+YRAPELI     YT SIDIWS GC+ AELL        
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 235 ------PLFPGENAV-----------------DQLVEIIKVLGTPTREEIRCMNP----N 267
                 PLFPG +                   DQL  I  V+GTP  E+++C+       
Sbjct: 260 NPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIK 319
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
           Y    FP        K +   +  E IDL   +L+++   R T  +A +HP+  ++R+ N
Sbjct: 320 YIKL-FPTRDGIDLSKKY-SSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKEN 377

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/333 (27%), Positives = 161/333 (48%), Gaps = 53/333 (15%)
Query: 30  PKQTISYMAE--RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDH- 86
           P   ++Y  E  +V+G G FG V +A   +  + VA+K V  ++R+  +  + +R+++H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 87  -----PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
                 N +++ H   + T ++ + +    E +   +Y ++K        +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTF--ELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-VKLCDFGSAKVLVKGEANISYICSR 200
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +     I SR
Sbjct: 207 HSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSR 263
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE+  DQL  +I++LG P +  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ-- 320
Query: 261 IRCMNPNYTDFRFPQIKAHPWH------------------KVFHKRMPPEA--------- 293
            + ++ +     F   K +P +                  +    R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 294 ------IDLASRLLQYSPSLRCTALEACAHPFF 320
                 +D   + L++ P++R T  +A  HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 137/295 (46%), Gaps = 49/295 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 88  NVISLKHCFFSTTSKDELFLNLVME-YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N++ L   F     +D+ +  LV E Y    ++  +       +R   +       Q+  
Sbjct: 111 NIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLS 161
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRA 204
           G+ Y+H    + HRD+KP+NLL++  +    +++ DFG +      +     I + YY A
Sbjct: 162 GITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 221 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 265
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
              YT F  PQ     W KV        A DL  ++L Y PS+R +A +A  H +
Sbjct: 266 -GKYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 137/295 (46%), Gaps = 49/295 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 88  NVISLKHCFFSTTSKDELFLNLVME-YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N++ L   F     +D+ +  LV E Y    ++  +       +R   +       Q+  
Sbjct: 110 NIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLS 160
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRA 204
           G+ Y+H    + HRD+KP+NLL++  +    +++ DFG +      +     I + YY A
Sbjct: 161 GITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 219
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 220 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 264
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
              YT F  PQ     W KV        A DL  ++L Y PS+R +A +A  H +
Sbjct: 265 -GKYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 149/302 (49%), Gaps = 34/302 (11%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++L+ H NV++L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 96  FFSTTS---KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
             +  S   + +  + LV ++    +  +L   S++  +  L  +K     +  GL YIH
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV--LVKGEANISY---ICSRYYRAPEL 207
               + HRD+K  N+L+      +KL DFG A+   L K      Y   + + +YR PEL
Sbjct: 143 R-NKILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           + G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    + PN
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE----VWPN 256
Query: 268 YTDF----RFPQIKAHPWHKVFHKRMP-----PEAIDLASRLLQYSPSLRCTALEACAHP 318
             ++    +   +K     +    R+      P A+DL  +LL   P+ R  + +A  H 
Sbjct: 257 VDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 319 FF 320
           FF
Sbjct: 315 FF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 148/299 (49%), Gaps = 28/299 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++L+ H NV++L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 96  FFSTTS-----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
             +  S     K  ++L  V ++    +  +L   S++  +  L  +K     +  GL Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV--LVKGEANISY---ICSRYYRAP 205
           IH    + HRD+K  N+L+      +KL DFG A+   L K      Y   + + +YR P
Sbjct: 141 IHR-NKILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           EL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            NY  +   ++      KV  +       P A+DL  +LL   P+ R  + +A  H FF
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 130/242 (53%), Gaps = 22/242 (9%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMR 82
           KNGE K    Y  + ++G GSFG V +A      E VAIK +   + + N+   E++L+ 
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 83  LMDHPN------VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
           LM+  +      ++ LK  F          L LV E +   +Y +L++ +     + L  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRNH-----LCLVFEMLSYNLYDLLRNTNFRGVSLNL-- 139
Query: 137 VKLYTYQIFRGLAYIHTVP-GVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            + +  Q+   L ++ T    + H D+KP+N LL +P    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
             I SR+YR+PE++ G   Y  +ID+WS GC+L E+  G+PLF G N VDQ+ +I++VLG
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 255 TP 256
            P
Sbjct: 257 IP 258

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 137/295 (46%), Gaps = 49/295 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 88  NVISLKHCFFSTTSKDELFLNLVME-YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N++ L   F     +D+ +  LV E Y    ++  +       +R   +       Q+  
Sbjct: 87  NIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLS 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRA 204
           G+ Y+H    + HRD+KP+NLL++  +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
              YT F  PQ     W KV        A DL  ++L Y PS+R +A +A  H +
Sbjct: 242 -GKYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 130/242 (53%), Gaps = 22/242 (9%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMR 82
           KNGE K    Y  + ++G GSFG V +A      E VAIK +   + + N+   E++L+ 
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 83  LMDHPN------VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
           LM+  +      ++ LK  F          L LV E +   +Y +L++ +     + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNH-----LCLVFEMLSYNLYDLLRNTNFRGVSLNL-- 158
Query: 137 VKLYTYQIFRGLAYIHTVP-GVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            + +  Q+   L ++ T    + H D+KP+N LL +P    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
             I SR+YR+PE++ G   Y  +ID+WS GC+L E+  G+PLF G N VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 255 TP 256
            P
Sbjct: 276 IP 277

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 149/304 (49%), Gaps = 38/304 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++L+ H NV++L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 96  FFSTTS-----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
             +  S     K  ++L  V ++    +  +L   S++  +  L  +K     +  GL Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV--LVKGEANISY---ICSRYYRAP 205
           IH    + HRD+K  N+L+      +KL DFG A+   L K      Y   + + +YR P
Sbjct: 141 IHR-NKILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           EL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    + 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE----VW 254
Query: 266 PNYTDF----RFPQIKAHPWHKVFHKRMP-----PEAIDLASRLLQYSPSLRCTALEACA 316
           PN  ++    +   +K     +    R+      P A+DL  +LL   P+ R  + +A  
Sbjct: 255 PNVDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 317 HPFF 320
           H FF
Sbjct: 313 HDFF 316

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 130/242 (53%), Gaps = 22/242 (9%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMR 82
           KNGE K    Y  + ++G GSFG V +A      E VAIK +   + + N+   E++L+ 
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 83  LMDHPN------VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
           LM+  +      ++ LK  F          L LV E +   +Y +L++ +     + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNH-----LCLVFEMLSYNLYDLLRNTNFRGVSLNL-- 158
Query: 137 VKLYTYQIFRGLAYIHTVP-GVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            + +  Q+   L ++ T    + H D+KP+N LL +P    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
             I SR+YR+PE++ G   Y  +ID+WS GC+L E+  G+PLF G N VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 255 TP 256
            P
Sbjct: 276 IP 277

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 105/359 (29%), Positives = 164/359 (45%), Gaps = 53/359 (14%)
Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLM-RL 83
           GEP +   Y+  R +G G F  V+ AK +     VA+K V  D+ Y      E++L+ R+
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 84  MDHPNV----ISLKHCF-----FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            D  N     +   H       F+    + + + +V E + E +  ++K Y   ++ +PL
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 130
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLCDFGSAKVLVK 189
           IYVK  + Q+  GL Y+H   G+ H D+KP+N+L++ +       Q+K+ D G+A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWY 188
Query: 190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAV----- 243
            E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF P E        
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRF---------PQIKAHPWHKV------FHKR 288
           D + +II++LG      +R  N  YT   F          ++K  P   V      F K 
Sbjct: 248 DHIAQIIELLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 289 MPPEAIDLASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPFPPLF 340
              E  D  S +LQ  P  R  A     HP+       +E+R P+  L  +G   P  F
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 105/359 (29%), Positives = 164/359 (45%), Gaps = 53/359 (14%)
Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLM-RL 83
           GEP +   Y+  R +G G F  V+ AK +     VA+K V  D+ Y      E++L+ R+
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 84  MDHPNV----ISLKHCF-----FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            D  N     +   H       F+    + + + +V E + E +  ++K Y   ++ +PL
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 130
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLCDFGSAKVLVK 189
           IYVK  + Q+  GL Y+H   G+ H D+KP+N+L++ +       Q+K+ D G+A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWY 188
Query: 190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAV----- 243
            E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF P E        
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRF---------PQIKAHPWHKV------FHKR 288
           D + +II++LG      +R  N  YT   F          ++K  P   V      F K 
Sbjct: 248 DHIAQIIELLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 289 MPPEAIDLASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPFPPLF 340
              E  D  S +LQ  P  R  A     HP+       +E+R P+  L  +G   P  F
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 148/299 (49%), Gaps = 28/299 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++L+ H NV++L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 96  FFSTTS-----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
             +  S     K  ++L  V ++    +  +L   S++  +  L  +K     +  GL Y
Sbjct: 85  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV--LVKGEANISY---ICSRYYRAP 205
           IH    + HRD+K  N+L+      +KL DFG A+   L K      Y   + + +YR P
Sbjct: 140 IHR-NKILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           EL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    ++
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            NY  +   ++      KV  +       P A+DL  +LL   P+ R  + +A  H FF
Sbjct: 258 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 137/295 (46%), Gaps = 49/295 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 88  NVISLKHCFFSTTSKDELFLNLVME-YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N++ L   F     +D+ +  LV E Y    ++  +       +R   +       Q+  
Sbjct: 93  NIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLS 143
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRA 204
           G+ Y+H    + HRD+KP+NLL++  +    +++ DFG +      +     I + YY A
Sbjct: 144 GITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 203 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 247
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
              YT F  PQ     W KV        A DL  ++L Y PS+R +A +A  H +
Sbjct: 248 -GKYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 133/295 (45%), Gaps = 49/295 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 88  NVISLKHCFFSTTSKDELFLNLVME-YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+  L   F     +D+ +  LV E Y    ++  +       +R   +       Q+  
Sbjct: 87  NIXKLYEFF-----EDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLS 137
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRA 204
           G+ Y H    + HRD+KP+NLL++  +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYXHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIA 196
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
              YT F  PQ     W KV        A DL  + L Y PS R +A +A  H +
Sbjct: 242 -GKYT-FELPQ-----WKKV-----SESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 140/308 (45%), Gaps = 49/308 (15%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLK 93
           ++G GSFG V + K   T +  A+K V+     KN       RE++L++ +DHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
                ++S    F  +   Y    ++  +      ++      +K    Q+F G+ Y+H 
Sbjct: 88  EILEDSSS----FYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHK 139
Query: 154 VPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
              + HRD+KP+N+L++       +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             Y    D+WSAG +L  LL G P F G+N  D    I+K          R     Y  F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILK----------RVETGKYA-F 241
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
             PQ     W  +       +A DL  ++L + PSLR TA +   HP+   +++ ++  P
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 332 NGRPFPPL 339
                P L
Sbjct: 289 TISDLPSL 296

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLK 93
           ++G GSFG V + K   T +  A+K V+     KN       RE++L++ +DHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
              F        F  +   Y    ++  +      ++      +K    Q+F G+ Y+H 
Sbjct: 87  ---FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHK 139
Query: 154 VPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
              + HRD+KP+N+L++       +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             Y    D+WSAG +L  LL G P F G+N  D    I+K          R     Y  F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILK----------RVETGKYA-F 241
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
             PQ     W     + +  +A DL  ++L + PSLR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLK 93
           ++G GSFG V + K   T +  A+K V+     KN       RE++L++ +DHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
              F        F  +   Y    ++  +      ++      +K    Q+F G+ Y+H 
Sbjct: 87  ---FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHK 139
Query: 154 VPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
              + HRD+KP+N+L++       +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             Y    D+WSAG +L  LL G P F G+N  D    I+K          R     Y  F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILK----------RVETGKYA-F 241
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
             PQ     W     + +  +A DL  ++L + PSLR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 94  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 145
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN S++ +  Y +PEL
Sbjct: 146 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-SFVGTAQYVSPEL 202
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 203 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 246
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+            +  P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 247 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292
Query: 322 ELREPN 327
            +   N
Sbjct: 293 SVTWEN 298

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 145/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 98  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 149
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN S++ +  Y +PEL
Sbjct: 150 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-SFVGTAQYVSPEL 206
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 207 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 250
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 251 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296
Query: 322 ELREPN 327
            +   N
Sbjct: 297 SVTWEN 302

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSAXKSS-DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--------------- 249
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 322 ELREPN 327
            +   N
Sbjct: 296 SVTWEN 301

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 143/306 (46%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 101
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L  CF      ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 102 LYFCF---QDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 153
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 154 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 210
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 211 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 254
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 255 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 300
Query: 322 ELREPN 327
            +   N
Sbjct: 301 SVTWEN 306

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 145/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 146
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN +++ +  Y +PEL
Sbjct: 147 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-AFVGTAQYVSPEL 203
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 204 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 247
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 322 ELREPN 327
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--------------- 249
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 322 ELREPN 327
            +   N
Sbjct: 296 SVTWEN 301

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 145/307 (47%), Gaps = 62/307 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   +F+    ++L+  L   Y     + + ++   S ++       + YT +I   L Y
Sbjct: 97  L---YFTFQDDEKLYFGL--SYAKNGCLLKYIRKIGSFDETC----TRFYTAEIVSALEY 147
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPE 206
           +H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN S++ +  Y +PE
Sbjct: 148 LHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-SFVGTAQYVSPE 204
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           L+   +   +S D+W+ GC++ +L+ G P F   N      +IIK+              
Sbjct: 205 LLTEKSASKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------------- 249
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFF 320
              ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF
Sbjct: 250 ---EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294
Query: 321 DELREPN 327
           + +   N
Sbjct: 295 ESVTWEN 301

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 249
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 322 ELREPN 327
            +   N
Sbjct: 296 SVTWEN 301

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 249
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 322 ELREPN 327
            +   N
Sbjct: 296 SVTWEN 301

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 146
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 147 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 203
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 204 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 247
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 322 ELREPN 327
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 249
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 322 ELREPN 327
            +   N
Sbjct: 296 SVTWEN 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 146
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 147 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 203
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 204 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 247
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 322 ELREPN 327
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 143/306 (46%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 94  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 145
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 146 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 202
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 203 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 246
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+            +  P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 247 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292
Query: 322 ELREPN 327
            +   N
Sbjct: 293 SVTWEN 298

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 98  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 149
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 150 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 206
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 207 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 250
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 251 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296
Query: 322 ELREPN 327
            +   N
Sbjct: 297 SVTWEN 302

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 71
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 72  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 123
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 124 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 180
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 181 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 224
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 225 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 270
Query: 322 ELREPN 327
            +   N
Sbjct: 271 SVTWEN 276

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 143/306 (46%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 78
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 79  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 130
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 131 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 187
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 188 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 231
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+            +  P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 232 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 277
Query: 322 ELREPN 327
            +   N
Sbjct: 278 SVTWEN 283

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 73
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 74  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 125
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 126 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 182
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 183 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 226
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 227 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 272
Query: 322 ELREPN 327
            +   N
Sbjct: 273 SVTWEN 278

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 73  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 125 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 181
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 182 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 225
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 226 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
Query: 322 ELREPN 327
            +   N
Sbjct: 272 SVTWEN 277

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 74
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 75  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 126
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 127 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 183
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 184 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 227
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 228 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 273
Query: 322 ELREPN 327
            +   N
Sbjct: 274 SVTWEN 279

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 96/339 (28%), Positives = 148/339 (43%), Gaps = 62/339 (18%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDH 86
            ++  +++G GSFG VF A+  +T +  AIK + +D    + +++        L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           P    L H F +  +K+ LF   VMEY+   + MY    H  S + +  L     Y  +I
Sbjct: 78  P---FLTHMFCTFQTKENLFF--VMEYLNGGDLMY----HIQSCH-KFDLSRATFYAAEI 127
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYR 203
             GL ++H+  G+ +RD+K  N+L+D   H +K+ DFG  K  + G+A  +  C    Y 
Sbjct: 128 ILGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYI 185
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE++ G  +Y  S+D WS G +L E+L+GQ  F G++  +                IR 
Sbjct: 186 APEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRM 232
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDE 322
            NP Y                  + +  EA DL  +L    P  R     +   HP F E
Sbjct: 233 DNPFYP-----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275
Query: 323 LR-EPNARLPNGRPFPPLF-------NFKQELAGASPEL 353
           +  E   R     PF P         NF +E     P L
Sbjct: 276 INWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 314

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 143/306 (46%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF     A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 146
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 147 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 203
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 204 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 247
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 322 ELREPN 327
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 141/306 (46%), Gaps = 60/306 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMDHPNVIS 91
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 99
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   +F+    ++L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 100 L---YFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETC----TRFYTAEIVSALEYL 151
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV----KGEANISYICSRYYRAPEL 207
           H   G+ HRD+KP+N+L++   H +++ DFG+AKVL     +  AN  ++ +  Y +PEL
Sbjct: 152 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 208
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 209 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 252
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 321
             ++ FP                P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 253 --EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 298
Query: 322 ELREPN 327
            +   N
Sbjct: 299 SVTWEN 304

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 96/334 (28%), Positives = 146/334 (43%), Gaps = 62/334 (18%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
           +++G GSFG VF A+  +T +  AIK + +D    + +++        L    +HP    
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 80
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L H F +  +K+ LF   VMEY+   + MY    H  S + +  L     Y  +I  GL 
Sbjct: 81  LTHMFCTFQTKENLFF--VMEYLNGGDLMY----HIQSCH-KFDLSRATFYAAEIILGLQ 133
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELI 208
           ++H+  G+ +RD+K  N+L+D   H +K+ DFG  K  + G+A  +  C    Y APE++
Sbjct: 134 FLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
            G  +Y  S+D WS G +L E+L+GQ  F G++  +                IR  NP Y
Sbjct: 192 LG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPFY 238
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELR-EP 326
                             + +  EA DL  +L    P  R     +   HP F E+  E 
Sbjct: 239 P-----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 281
Query: 327 NARLPNGRPFPPLF-------NFKQELAGASPEL 353
             R     PF P         NF +E     P L
Sbjct: 282 LERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 315

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 90/323 (27%), Positives = 152/323 (47%), Gaps = 51/323 (15%)
Query: 30  PKQTISYMAERV--VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLM 81
            K  +S M +RV  +G+G++G V   +   T    AIK + +     +       E+ ++
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVME-YVPETMYRVLKHYSSMNQRMPLIYVKLY 140
           +L+DHPN++ L + FF    +D+    LVME Y    ++  + H    N+    + +K  
Sbjct: 91  KLLDHPNIMKL-YDFF----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-- 143
Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYIC 198
             Q+  G+ Y+H    + HRD+KP+NLL++       +K+ DFG + V    +     + 
Sbjct: 144 --QVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           + YY APE++    +Y    D+WS G +L  LL G P F G+   DQ  EI++       
Sbjct: 201 TAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQ--TDQ--EILR------- 247
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
              +     YT F  P+     W     K +   A DL  ++LQ+    R +A +A  HP
Sbjct: 248 ---KVEKGKYT-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293
Query: 319 FFDELREPNARLPNGRPFPPLFN 341
           +   ++E  ++  +G   P L N
Sbjct: 294 W---IKEMCSKKESGIELPSLAN 313

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 122/254 (48%), Gaps = 29/254 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHP 87
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+ L++ ++HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           NVI     F          LN+V+E      + R++KH+    + +P   V  Y  Q+  
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 205
            L ++H+   V HRD+KP N+ +   T  VKL D G  +    K  A  S + + YY +P
Sbjct: 148 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 206 ELIFGATEYTTSIDIWSAGCVLAEL-LLGQPLFPGENAVDQLVEIIKVLGTP------TR 258
           E I     Y    DIWS GC+L E+  L  P +  +  +  L + I+    P        
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264
Query: 259 EEIR-----CMNPN 267
           EE+R     C+NP+
Sbjct: 265 EELRQLVNMCINPD 278

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 137/307 (44%), Gaps = 40/307 (13%)
Query: 22  TIGGKNGEPK-QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL 80
           +IG +N E K   +  + E  +G G++G+V + + + +G+ +A+K++   R   N + Q 
Sbjct: 40  SIGNQNFEVKADDLEPIME--LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQK 94
Query: 81  MRLMDHPNVISLKHCFFSTTSKDELF----LNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             LMD    +    C F+ T    LF    + + ME +  ++ +  K      Q +P   
Sbjct: 95  RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI 154
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 196
           +      I + L ++H+   V HRDVKP N+L++ L  QVK+CDFG +  LV   A    
Sbjct: 155 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYLVDSVAKTID 213
Query: 197 ICSRYYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
              + Y APE I        Y+   DIWS G  + EL + +  FP ++            
Sbjct: 214 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDS-----------W 260
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
           GTP ++               Q+   P  ++   +   E +D  S+ L+ +   R T  E
Sbjct: 261 GTPFQQ-------------LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 307
Query: 314 ACAHPFF 320
              HPFF
Sbjct: 308 LMQHPFF 314

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 114/232 (49%), Gaps = 24/232 (10%)
Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLM 81
           +P++  S + E  +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ +
Sbjct: 51  DPEKLFSDLRE--IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 108
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
           + + HPN I  + C+       E    LVMEY   +   +L+ +    Q + +  V   T
Sbjct: 109 QKLRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---T 160
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
           +   +GLAY+H+   + HRDVK  N+L+      VKL DFGSA ++        ++ + Y
Sbjct: 161 HGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAPAN---XFVGTPY 215
Query: 202 YRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
           + APE+I    E  Y   +D+WS G    EL   +P     NA+  L  I +
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 114/232 (49%), Gaps = 24/232 (10%)
Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLM 81
           +P++  S + E  +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ +
Sbjct: 12  DPEKLFSDLRE--IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
           + + HPN I  + C+    +       LVMEY   +   +L+ +    Q + +  V   T
Sbjct: 70  QKLRHPNTIQYRGCYLREHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAV---T 121
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
           +   +GLAY+H+   + HRDVK  N+L+      VKL DFGSA ++        ++ + Y
Sbjct: 122 HGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAPAN---XFVGTPY 176
Query: 202 YRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
           + APE+I    E  Y   +D+WS G    EL   +P     NA+  L  I +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 37/286 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS 101
           +G G++G+V + + + +G+ +A+K++   R   N + Q   LMD    +    C F+ T 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 102 KDELF----LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 157
              LF    + + ME +  ++ +  K      Q +P   +      I + L ++H+   V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 158 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI---FGATEY 214
            HRDVKP N+L++ L  QVK+CDFG +  LV   A       + Y APE I        Y
Sbjct: 132 IHRDVKPSNVLINALG-QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
           +   DIWS G  + EL + +  FP ++            GTP ++               
Sbjct: 191 SVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------LK 224
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           Q+   P  ++   +   E +D  S+ L+ +   R T  E   HPFF
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYK---NRELQLMRLMDHPNVISLKHCF 96
           V+G G++GIV+  + L     +AIK++ + D RY    + E+ L + + H N++     F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
                 +  F+ + ME VP      L        +     +  YT QI  GL Y+H    
Sbjct: 89  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ- 142
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIF-GATEY 214
           + HRD+K  N+L++  +  +K+ DFG++K L        ++  +  Y APE+I  G   Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 215 TTSIDIWSAGCVLAELLLGQPLF 237
             + DIWS GC + E+  G+P F
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF 225

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 137/307 (44%), Gaps = 48/307 (15%)
Query: 24  GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQ 79
           G   G+  Q   Y  E  +G GS+G V  A    T    A KK+    ++D     +E++
Sbjct: 1   GSTKGDINQY--YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIE 58
Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYV 137
           +M+ +DHPN+I L   F     +D   + LVME     E   RV+ H     +      +
Sbjct: 59  IMKSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIM 112
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL--VDPLTHQVKLCDFGSAKVLVKGEANIS 195
           K     +   +AY H +  V HRD+KP+N L   D     +KL DFG A     G+   +
Sbjct: 113 K----DVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
            + + YY +P+++ G   Y    D WSAG ++  LL G P F      + +++I +  GT
Sbjct: 168 KVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT 223
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
                          F FP+     W  V      P+A  L  RLL  SP  R T+L+A 
Sbjct: 224 ---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260
Query: 316 AHPFFDE 322
            H +F++
Sbjct: 261 EHEWFEK 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 137/307 (44%), Gaps = 48/307 (15%)
Query: 24  GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQ 79
           G   G+  Q   Y  E  +G GS+G V  A    T    A KK+    ++D     +E++
Sbjct: 18  GSTKGDINQY--YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIE 75
Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYV 137
           +M+ +DHPN+I L   F     +D   + LVME     E   RV+ H     +      +
Sbjct: 76  IMKSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIM 129
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL--VDPLTHQVKLCDFGSAKVLVKGEANIS 195
           K     +   +AY H +  V HRD+KP+N L   D     +KL DFG A     G+   +
Sbjct: 130 K----DVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 184
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
            + + YY +P+++ G   Y    D WSAG ++  LL G P F      + +++I +  GT
Sbjct: 185 KVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT 240
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
                          F FP+     W  V      P+A  L  RLL  SP  R T+L+A 
Sbjct: 241 ---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 277
Query: 316 AHPFFDE 322
            H +F++
Sbjct: 278 EHEWFEK 284

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYK---NRELQLMRLMDHPNVISLKHCF 96
           V+G G++GIV+  + L     +AIK++ + D RY    + E+ L + + H N++     F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
                 +  F+ + ME VP      L        +     +  YT QI  GL Y+H    
Sbjct: 75  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ- 128
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIF-GATEY 214
           + HRD+K  N+L++  +  +K+ DFG++K L        ++  +  Y APE+I  G   Y
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 215 TTSIDIWSAGCVLAELLLGQPLF 237
             + DIWS GC + E+  G+P F
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPF 211

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+   +   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F  +T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HS-KKVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      D    I +V                 +F
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EF 223
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 134/310 (43%), Gaps = 62/310 (20%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-------- 76
           GK GE     SY   R +G+G++G V   K        AIK + + +  K R        
Sbjct: 32  GKIGE-----SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 77  ---------ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME-YVPETMYRVLKHYS 126
                    E+ L++ +DHPN+I L   F     +D+ +  LV E Y    ++  + +  
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRH 141
Query: 127 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSA 184
             ++      +K    QI  G+ Y+H    + HRD+KP+N+L++       +K+ DFG +
Sbjct: 142 KFDECDAANIMK----QILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
               K       + + YY APE++    +Y    D+WS G ++  LL G P F G+N  D
Sbjct: 197 SFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254
Query: 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
            + ++ K                Y DF       + W     K +  EA +L   +L Y 
Sbjct: 255 IIKKVEK-------------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYD 289
Query: 305 PSLRCTALEA 314
            + RCTA EA
Sbjct: 290 YNKRCTAEEA 299

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 85/332 (25%), Positives = 151/332 (45%), Gaps = 64/332 (19%)
Query: 42  VGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFS 98
           +G G+FG V +  C++    G  VA+K V    RY       +++++H N     +  F 
Sbjct: 22  LGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTD-PNSTFR 78
Query: 99  TTSKDELF-----LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
                E F     + +V E +  + Y  +K    +  R+   +++   YQI + + ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 154 VPGVCHRDVKPQNLL---------------------VDPLTHQVKLCDFGSAKVLVKGEA 192
              + H D+KP+N+L                     ++P    +K+ DFGSA      E 
Sbjct: 137 -NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           + + + +R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP  ++ + L  + ++
Sbjct: 191 HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 253 LGTPTREEI------RCMNPNYTDF-------RFPQIKAHPW------HKVFHKRMPPEA 293
           LG   +  I      +  + +  D+       R+      P         V H+R+    
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL---- 305
Query: 294 IDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
            DL  ++L+Y P+ R T  EA  HPFFD L++
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 117/227 (51%), Gaps = 24/227 (10%)
Query: 39  ERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVIS 91
           ER+  +G G+ G+V + +   +G  +A K +  +     R    RELQ++   + P ++ 
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 78
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
               F+S        +++ ME++   ++ +VLK      +R+P   +   +  + RGLAY
Sbjct: 79  FYGAFYSDGE-----ISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAY 129
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
           +     + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y APE + G
Sbjct: 130 LREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERLQG 187
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            T Y+   DIWS G  L EL +G+   P  +A     E+  + G P 
Sbjct: 188 -THYSVQSDIWSMGLSLVELAVGRYPIPPPDA----KELEAIFGRPV 229

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 151 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 207
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 142 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 198
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 199 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 240
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 241 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 142/306 (46%), Gaps = 56/306 (18%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 82
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
            ++HP +I +K+ F      ++ ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 127
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI-SYICS 199
           Q+   + Y+H   G+ HRD+KP+N+L+        +K+ DFG +K+L  GE ++   +C 
Sbjct: 128 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 184
Query: 200 R-YYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 234
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 235 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 280
Query: 317 HPFFDE 322
           HP+  +
Sbjct: 281 HPWLQD 286

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 142/306 (46%), Gaps = 56/306 (18%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 82
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
            ++HP +I +K+ F      ++ ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI-SYICS 199
           Q+   + Y+H   G+ HRD+KP+N+L+        +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 200 R-YYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 317 HPFFDE 322
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 142/306 (46%), Gaps = 56/306 (18%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 82
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
            ++HP +I +K+ F      ++ ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI-SYICS 199
           Q+   + Y+H   G+ HRD+KP+N+L+        +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 200 R-YYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 317 HPFFDE 322
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 142/306 (46%), Gaps = 56/306 (18%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 82
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
            ++HP +I +K+ F      ++ ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI-SYICS 199
           Q+   + Y+H   G+ HRD+KP+N+L+        +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 200 R-YYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 317 HPFFDE 322
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 142/306 (46%), Gaps = 56/306 (18%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 82
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
            ++HP +I +K+ F      ++ ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 120
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI-SYICS 199
           Q+   + Y+H   G+ HRD+KP+N+L+        +K+ DFG +K+L  GE ++   +C 
Sbjct: 121 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 177
Query: 200 R-YYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 227
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 228 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 273
Query: 317 HPFFDE 322
           HP+  +
Sbjct: 274 HPWLQD 279

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 124 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 181 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 222
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 181
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/228 (32%), Positives = 115/228 (50%), Gaps = 20/228 (8%)
Query: 30  PKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMR 82
           P QT     M ER+ GTG FG V +    +TGE VAIK+  Q+   KNR     E+Q+M+
Sbjct: 9   PTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 83  LMDHPNVISLKHC--FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY--VK 138
            ++HPNV+S +         + ++L L L MEY      R  K+ +       L    ++
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLR--KYLNQFENCCGLKEGPIR 124
Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV--KLCDFGSAKVLVKGEANISY 196
                I   L Y+H    + HRD+KP+N+++ P   ++  K+ D G AK L +GE    +
Sbjct: 125 TLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAV 243
           + +  Y APEL+    +YT ++D WS G +  E + G +P  P    V
Sbjct: 184 VGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/228 (32%), Positives = 115/228 (50%), Gaps = 20/228 (8%)
Query: 30  PKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMR 82
           P QT     M ER+ GTG FG V +    +TGE VAIK+  Q+   KNR     E+Q+M+
Sbjct: 10  PTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 68
Query: 83  LMDHPNVISLKHC--FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY--VK 138
            ++HPNV+S +         + ++L L L MEY      R  K+ +       L    ++
Sbjct: 69  KLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLR--KYLNQFENCCGLKEGPIR 125
Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV--KLCDFGSAKVLVKGEANISY 196
                I   L Y+H    + HRD+KP+N+++ P   ++  K+ D G AK L +GE    +
Sbjct: 126 TLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 184
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAV 243
           + +  Y APEL+    +YT ++D WS G +  E + G +P  P    V
Sbjct: 185 VGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 231

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/332 (25%), Positives = 150/332 (45%), Gaps = 64/332 (19%)
Query: 42  VGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFS 98
           +G G+FG V +  C++    G  VA+K V    RY       +++++H N     +  F 
Sbjct: 22  LGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTD-PNSTFR 78
Query: 99  TTSKDELF-----LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
                E F     + +V E +  + Y  +K    +  R+   +++   YQI + + ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 154 VPGVCHRDVKPQNLL---------------------VDPLTHQVKLCDFGSAKVLVKGEA 192
              + H D+KP+N+L                     ++P    +K+ DFGSA      E 
Sbjct: 137 -NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           + + +  R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP  ++ + L  + ++
Sbjct: 191 HSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 253 LGTPTREEI------RCMNPNYTDF-------RFPQIKAHPW------HKVFHKRMPPEA 293
           LG   +  I      +  + +  D+       R+      P         V H+R+    
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL---- 305
Query: 294 IDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
            DL  ++L+Y P+ R T  EA  HPFFD L++
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 227
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 126 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGR 181
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HS-KRVIHRDIKPENLLLGS-NGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G P F      +    I +V                 +F
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++ S R T  E   HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 151 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 207
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 186
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/313 (28%), Positives = 143/313 (45%), Gaps = 53/313 (16%)
Query: 28  GEPKQTISYMAERV-VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LM 81
           G+P+   SY+   + +G GS GIV  A    +G+ VA+KK +  R+ + REL      +M
Sbjct: 25  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIM 80
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
           R   H NV+ + + +      DEL++  VME++       +  ++ MN+      +    
Sbjct: 81  RDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVC 131
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYIC 198
             + + L+ +H   GV HRD+K  ++L   LTH  +VKL DFG  A+V  +       + 
Sbjct: 132 LAVLQALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKXLVG 187
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           + Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  
Sbjct: 188 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPL 231
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
           + ++ +  N            P  K  HK + P       RLL   P+ R TA E   HP
Sbjct: 232 KAMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHP 280
Query: 319 FFDELREPNARLP 331
           F  +   P + +P
Sbjct: 281 FLAKAGPPASIVP 293

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE I G 
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGR 186
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 187 X-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/313 (28%), Positives = 143/313 (45%), Gaps = 53/313 (16%)
Query: 28  GEPKQTISYMAERV-VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LM 81
           G+P+   SY+   + +G GS GIV  A    +G+ VA+KK +  R+ + REL      +M
Sbjct: 20  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIM 75
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
           R   H NV+ + + +      DEL++  VME++       +  ++ MN+      +    
Sbjct: 76  RDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVC 126
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYIC 198
             + + L+ +H   GV HRD+K  ++L   LTH  +VKL DFG  A+V  +       + 
Sbjct: 127 LAVLQALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKXLVG 182
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           + Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  
Sbjct: 183 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPL 226
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
           + ++ +  N            P  K  HK + P       RLL   P+ R TA E   HP
Sbjct: 227 KAMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHP 275
Query: 319 FFDELREPNARLP 331
           F  +   P + +P
Sbjct: 276 FLAKAGPPASIVP 288

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/313 (28%), Positives = 143/313 (45%), Gaps = 53/313 (16%)
Query: 28  GEPKQTISYMAERV-VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LM 81
           G+P+   SY+   + +G GS GIV  A    +G+ VA+KK +  R+ + REL      +M
Sbjct: 16  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIM 71
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
           R   H NV+ + + +      DEL++  VME++       +  ++ MN+      +    
Sbjct: 72  RDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVC 122
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYIC 198
             + + L+ +H   GV HRD+K  ++L   LTH  +VKL DFG  A+V  +       + 
Sbjct: 123 LAVLQALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKXLVG 178
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           + Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  
Sbjct: 179 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPL 222
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
           + ++ +  N            P  K  HK + P       RLL   P+ R TA E   HP
Sbjct: 223 KAMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHP 271
Query: 319 FFDELREPNARLP 331
           F  +   P + +P
Sbjct: 272 FLAKAGPPASIVP 284

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/313 (28%), Positives = 143/313 (45%), Gaps = 53/313 (16%)
Query: 28  GEPKQTISYMAERV-VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LM 81
           G+P+   SY+   + +G GS GIV  A    +G+ VA+KK +  R+ + REL      +M
Sbjct: 27  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIM 82
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
           R   H NV+ + + +      DEL++  VME++       +  ++ MN+      +    
Sbjct: 83  RDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVC 133
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYIC 198
             + + L+ +H   GV HRD+K  ++L   LTH  +VKL DFG  A+V  +       + 
Sbjct: 134 LAVLQALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKXLVG 189
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           + Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  
Sbjct: 190 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPL 233
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
           + ++ +  N            P  K  HK + P       RLL   P+ R TA E   HP
Sbjct: 234 KAMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHP 282
Query: 319 FFDELREPNARLP 331
           F  +   P + +P
Sbjct: 283 FLAKAGPPASIVP 295

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 126 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 182
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 88/312 (28%), Positives = 141/312 (45%), Gaps = 50/312 (16%)
Query: 29  EPKQTISYMAERV-VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 82
           +P    SY+   + +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR
Sbjct: 68  DPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 126
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
              H NV+ + + +      DEL++  VME++       +  ++ MN+      +     
Sbjct: 127 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 177
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICS 199
            + + L+ +H   GV HRD+K  ++L   LTH  +VKL DFG  A+V  +       + +
Sbjct: 178 AVLQALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKXLVGT 233
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 234 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 277
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            ++ +  N            P  K  HK + P       RLL   P+ R TA E   HPF
Sbjct: 278 AMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPF 326
Query: 320 FDELREPNARLP 331
             +   P + +P
Sbjct: 327 LAKAGPPASIVP 338

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRLMDHP 87
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RL+ HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           ++I L   +    SKDE+ +  V+EY    ++  +     M+++      + +  QI   
Sbjct: 65  HIIKL---YDVIKSKDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 115
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 207
           + Y H    + HRD+KP+NLL+D   + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 116 VEYCHR-HKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           I G       +D+WS G +L  +L  +  F  E+
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 88/312 (28%), Positives = 141/312 (45%), Gaps = 50/312 (16%)
Query: 29  EPKQTISYMAERV-VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-----QLMR 82
           +P    SY+   + +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR
Sbjct: 145 DPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 203
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
              H NV+ + + +      DEL++  VME++       +  ++ MN+      +     
Sbjct: 204 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 254
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICS 199
            + + L+ +H   GV HRD+K  ++L   LTH  +VKL DFG  A+V  +       + +
Sbjct: 255 AVLQALSVLHAQ-GVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKXLVGT 310
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 311 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 354
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            ++ +  N            P  K  HK + P       RLL   P+ R TA E   HPF
Sbjct: 355 AMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPF 403
Query: 320 FDELREPNARLP 331
             +   P + +P
Sbjct: 404 LAKAGPPASIVP 415

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRLMDHP 87
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RL+ HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           ++I L   +    SKDE+ +  V+EY    ++  +     M+++      + +  QI   
Sbjct: 75  HIIKL---YDVIKSKDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 125
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 207
           + Y H    + HRD+KP+NLL+D   + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 126 VEYCHR-HKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           I G       +D+WS G +L  +L  +  F  E+
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRLMDHP 87
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RL+ HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           ++I L   +    SKDE+ +  V+EY    ++  +     M+++      + +  QI   
Sbjct: 74  HIIKL---YDVIKSKDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 124
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 207
           + Y H    + HRD+KP+NLL+D   + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 125 VEYCHR-HKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           I G       +D+WS G +L  +L  +  F  E+
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRLMDHP 87
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RL+ HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           ++I L   +    SKDE+ +  V+EY    ++  +     M+++      + +  QI   
Sbjct: 69  HIIKL---YDVIKSKDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 119
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 207
           + Y H    + HRD+KP+NLL+D   + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 120 VEYCHR-HKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           I G       +D+WS G +L  +L  +  F  E+
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 127 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 183
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 64/295 (21%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-------SAKVLVKGEANISYICSRYYRA 204
           H+   V HRD+KP+NLL+     ++K+ DFG       S +  + G  +        Y  
Sbjct: 126 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLP 175
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE+I G   +   +D+WS G +  E L+G+P F      +    I +V            
Sbjct: 176 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                +F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 -----EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 184
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HS-KRVIHRDIKPENLLLGS-NGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G P F      +    I +V                 +F
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++ S R T  E   HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  +    +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 122 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 179 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 220
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 221 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 136 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 186
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 187 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 243
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENA 242
              DIWS G  L E+ +G+   P  +A
Sbjct: 244 VQSDIWSMGLSLVEMAVGRYPIPPPDA 270

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 31/277 (11%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 93  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 143
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 144 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 200
Query: 216 TSIDIWSAGCVLAELLLGQ-PLFPGEN--AVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
              DIWS G  L E+ +G+ P+  G    A+ +L++ I V   P +      +  + DF 
Sbjct: 201 VQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFV 259
Query: 273 FPQIKAHPWHK---------VFHKRMPPEAIDLASRL 300
              +  +P  +          F KR   E +D A  L
Sbjct: 260 NKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 296

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G 
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P  T+YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G 
Sbjct: 127 HS-KRVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 183
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 119/250 (47%), Gaps = 27/250 (10%)
Query: 15  TGHIISTTIGGKNGEPK-QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           TG++   TIGG+  + +   +  + E  +G+G+ G V++ +  +TG  +A+K++   RR 
Sbjct: 10  TGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM---RRS 61
Query: 74  KNRELQLMRLMDHPNVIS------LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSS 127
            N+E     LMD   V+       +  CF +  +  ++F+   ME +     ++ K    
Sbjct: 62  GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLKKR--- 116
Query: 128 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 187
           M   +P   +   T  I + L Y+    GV HRDVKP N+L+D    Q+KLCDFG +  L
Sbjct: 117 MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFGISGRL 175
Query: 188 VKGEANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
           V  +A         Y APE I        +Y    D+WS G  L EL  GQ  FP +N  
Sbjct: 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FPYKNCK 233
Query: 244 DQLVEIIKVL 253
                + KVL
Sbjct: 234 TDFEVLTKVL 243

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 138/296 (46%), Gaps = 44/296 (14%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVI 90
           ++ +R +G+G+FG V   +   +G    IK + +DR          E+++++ +DHPN+I
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            +   F     +D   + +VME     E + R++    +  + +   YV     Q+   L
Sbjct: 84  KIFEVF-----EDYHNMYIVMETCEGGELLERIVS-AQARGKALSEGYVAELMKQMMNAL 137
Query: 149 AYIHTVPGVCHRDVKPQNLLV-DPLTHQ-VKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           AY H+   V H+D+KP+N+L  D   H  +K+ DFG A++    E + +   +  Y APE
Sbjct: 138 AYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +     + T   DIWSAG V+  LL G   F G +       + +V    T +E     P
Sbjct: 197 VF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-------LEEVQQKATYKE-----P 242
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
           NY       ++  P        + P+A+DL  ++L   P  R +A +   H +F +
Sbjct: 243 NYA------VECRP--------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 142/306 (46%), Gaps = 56/306 (18%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 82
           Y+  + +G+G+ G V  A   +T + VAI+ ++  R++                E+++++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
            ++HP +I +K+ F      ++ ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 246
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI-SYICS 199
           Q+   + Y+H   G+ HRD+KP+N+L+        +K+ DFG +K+L  GE ++   +C 
Sbjct: 247 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 303
Query: 200 R-YYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 353
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 354 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 399
Query: 317 HPFFDE 322
           HP+  +
Sbjct: 400 HPWLQD 405

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 130/295 (44%), Gaps = 48/295 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 87
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           ++I L +   ST S  ++F+  VMEYV       L  Y   N R+     +    QI  G
Sbjct: 77  HIIKL-YQVISTPS--DIFM--VMEYVSGGE---LFDYICKNGRLDEKESRRLFQQILSG 128
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 207
           + Y H    V HRD+KP+N+L+D   +  K+ DFG + ++  GE       S  Y APE+
Sbjct: 129 VDYCHR-HMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRXSCGSPNYAAPEV 186
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           I G       +DIWS+G +L  LL G   F  ++              PT  +  C    
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------------VPTLFKKICDGIF 233
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
           YT    PQ             + P  I L   +LQ  P  R T  +   H +F +
Sbjct: 234 YT----PQY------------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENA 242
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 148/316 (46%), Gaps = 49/316 (15%)
Query: 28  GEPKQTISYMAERV-VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LM 81
           G+P++   Y+A  + +G GS GIV  A    TG+ VA+KK +  R+ + REL      +M
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIM 96
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
           R   H NV+ +   + S    DEL++  VME++       +  ++ MN+      +    
Sbjct: 97  RDYHHDNVVDM---YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVC 147
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSR 200
             + R L+Y+H   GV HRD+K  ++L+     ++KL DFG  A+V  +       + + 
Sbjct: 148 LSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSKEVPKRKXLVGTP 205
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
           Y+ APE+I     Y T +DIWS G ++ E++ G+P +  E  +  +              
Sbjct: 206 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM------------RR 252
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           IR   P       P++K    HKV    +    +DL   +L   PS R TA E   HPF 
Sbjct: 253 IRDSLP-------PRVK--DLHKV--SSVLRGFLDL---MLVREPSQRATAQELLGHPFL 298
Query: 321 DELREPNARLPNGRPF 336
                P+  +P  R +
Sbjct: 299 KLAGPPSCIVPLMRQY 314

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 142/306 (46%), Gaps = 56/306 (18%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 82
           Y+  + +G+G+ G V  A   +T + VAI+ ++  R++                E+++++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
            ++HP +I +K+ F      ++ ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 260
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI-SYICS 199
           Q+   + Y+H   G+ HRD+KP+N+L+        +K+ DFG +K+L  GE ++   +C 
Sbjct: 261 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 317
Query: 200 R-YYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 367
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 368 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 413
Query: 317 HPFFDE 322
           HP+  +
Sbjct: 414 HPWLQD 419

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 135/296 (45%), Gaps = 51/296 (17%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-------ELQLMRLMDHPN 88
           Y   + +G+G++G V   K   TG   AIK + +              E+ +++ +DHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSS--MNQRMPLIYVKLYTYQIFR 146
           ++ L   F     +D+    LVME     +YR  + +    + Q+   +   +   Q+  
Sbjct: 66  IMKLYEFF-----EDKRNYYLVME-----VYRGGELFDEIILRQKFSEVDAAVIMKQVLS 115
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFG-SAKVLVKGEANISYICSRYYR 203
           G  Y+H    + HRD+KP+NLL++  +    +K+ DFG SA   V G+     + + YY 
Sbjct: 116 GTTYLHK-HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK-ERLGTAYYI 173
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE++    +Y    D+WS G +L  LL G P F G+   DQ  EI+K          R 
Sbjct: 174 APEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQ--TDQ--EILK----------RV 217
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
               ++ F  P      W +V       EA  L   +L Y PS R +A EA  HP+
Sbjct: 218 EKGKFS-FDPP-----DWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 101 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 151
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 152 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 208
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENA 242
              DIWS G  L E+ +G+   P  +A
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDA 235

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 129/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P   +Y+ L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 32  QTISYMAERV--VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-------ELQLMR 82
           Q +S   +RV  +G+G++G V   K   TG   AIK + +              E+ +++
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSS--MNQRMPLIYVKLY 140
            +DHPN++ L   F     +D+    LVME     +YR  + +    + Q+   +   + 
Sbjct: 77  QLDHPNIMKLYEFF-----EDKRNYYLVME-----VYRGGELFDEIILRQKFSEVDAAVI 126
Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYIC 198
             Q+  G  Y+H    + HRD+KP+NLL++  +    +K+ DFG +     G      + 
Sbjct: 127 MKQVLSGTTYLHK-HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLG 185
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           + YY APE++    +Y    D+WS G +L  LL G P F G+   DQ     ++L    +
Sbjct: 186 TAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEK 236
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
            +     P++T                  ++  EA  L   +L Y PS R +A EA  HP
Sbjct: 237 GKFSFDPPDWT------------------QVSDEAKQLVKLMLTYEPSKRISAEEALNHP 278
Query: 319 F 319
           +
Sbjct: 279 W 279

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENA 242
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENA 242
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENA 242
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENA 242
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   T      + L++EY P   +Y+ L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H+   V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGR 186
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             +   +D+WS G +  E L+G+P F      +    I +V                 +F
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 93/337 (27%), Positives = 147/337 (43%), Gaps = 68/337 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRY-----KNRELQLMRLMDHPNV 89
           RV+G GSFG V  A+  ETG+  A+K      +LQD        + R L L R  +HP +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
             L  CF    + D LF   VME+V   + M+ + K     ++R      + Y  +I   
Sbjct: 87  TQLFCCF---QTPDRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISA 136
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPE 206
           L ++H   G+ +RD+K  N+L+D   H  KL DFG  K  +  G    ++  +  Y APE
Sbjct: 137 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            I     Y  ++D W+ G +L E+L G   F  EN  D L E I        +E+     
Sbjct: 195 -ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----- 241
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFF 320
                            V+   +  +A  +    +  +P++R  +L          HPFF
Sbjct: 242 -----------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
Query: 321 DELREPNARLPNGR---PFPPLFNFKQELAGASPELI 354
            E+    A+L + +   PF P    +++++   P+ I
Sbjct: 285 KEIDW--AQLNHRQIEPPFRPRIKSREDVSNFDPDFI 319

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 92/322 (28%), Positives = 144/322 (44%), Gaps = 52/322 (16%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLKHC 95
           +G G+F +V +   +  G+  A K +       +D +   RE ++ RL+ HPN++ L H 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 88
Query: 96  FFSTTSKDELFLNLVM--EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             S      L  +LV   E   + + R  ++YS  +    +        QI   + + H 
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHCHQ 139
Query: 154 VPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIF 209
           + GV HRD+KP+NLL+        VKL DFG A + V+GE  A   +  +  Y +PE + 
Sbjct: 140 M-GVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VL 196
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
               Y   +D+W+ G +L  LL+G P F  E+   +L + IK                  
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA--------------GAY 241
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 329
           DF  P+     W  V      PEA DL +++L  +PS R TA EA  HP+        + 
Sbjct: 242 DFPSPE-----WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASC 291
Query: 330 LPNGRPFPPL--FNFKQELAGA 349
           +        L  FN +++L GA
Sbjct: 292 MHRQETVDCLKKFNARRKLKGA 313

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 92/331 (27%), Positives = 149/331 (45%), Gaps = 52/331 (15%)
Query: 33  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDH 86
           T  Y     +G G+F +V +   + TG+  A K +       +D +   RE ++ RL+ H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 87  PNVISLKHCFFSTTSKDELFLNLVM--EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L H   S      L  +LV   E   + + R  ++YS  +    +        QI
Sbjct: 63  PNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGE--ANISYICSR 200
              + + H + G+ HRD+KP+NLL+   +    VKL DFG A + V+G+  A   +  + 
Sbjct: 113 LESVNHCH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
            Y +PE +     Y   +D+W+ G +L  LL+G P F  E+   +L + IK         
Sbjct: 171 GYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA-------- 220
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                    DF  P+     W  V      PEA DL +++L  +P+ R TA EA  HP+ 
Sbjct: 221 ------GAYDFPSPE-----WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264
Query: 321 DELREPNARLPNGRPFPPL--FNFKQELAGA 349
            +     + +        L  FN +++L GA
Sbjct: 265 CQRSTVASMMHRQETVDCLKKFNARRKLKGA 295

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 92/331 (27%), Positives = 149/331 (45%), Gaps = 52/331 (15%)
Query: 33  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDH 86
           T  Y     +G G+F +V +   + TG+  A K +       +D +   RE ++ RL+ H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 87  PNVISLKHCFFSTTSKDELFLNLVM--EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L H   S      L  +LV   E   + + R  ++YS  +    +        QI
Sbjct: 63  PNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGE--ANISYICSR 200
              + + H + G+ HRD+KP+NLL+   +    VKL DFG A + V+G+  A   +  + 
Sbjct: 113 LESVNHCH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
            Y +PE +     Y   +D+W+ G +L  LL+G P F  E+   +L + IK         
Sbjct: 171 GYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA-------- 220
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                    DF  P+     W  V      PEA DL +++L  +P+ R TA EA  HP+ 
Sbjct: 221 ------GAYDFPSPE-----WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264
Query: 321 DELREPNARLPNGRPFPPL--FNFKQELAGA 349
            +     + +        L  FN +++L GA
Sbjct: 265 CQRSTVASMMHRQETVDCLKKFNARRKLKGA 295

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEY+P   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGGDMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEY+P   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGGDMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 27/252 (10%)
Query: 19  ISTTIGGKNGEPKQTISYMAE-RVVGTGSFGIVFQAKCL---ETGETVAIKKV------L 68
           IS T   K G  K   S+    +V+G GSFG VF  + +   ++G   A+K +      +
Sbjct: 12  ISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKV 71
Query: 69  QDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYS 126
           +DR     E  ++  ++HP V+ L H  F T  K    L L+++++   +   R+ K   
Sbjct: 72  RDRVRTKMERDILADVNHPFVVKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVM 126
Query: 127 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 186
              +      VK Y  ++  GL ++H++ G+ +RD+KP+N+L+D   H +KL DFG +K 
Sbjct: 127 FTEED-----VKFYLAELALGLDHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKE 179
Query: 187 LVKGEANISYICSRY-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
            +  E      C    Y APE++     ++ S D WS G ++ E+L G   F G++  + 
Sbjct: 180 AIDHEKKAYSFCGTVEYMAPEVV-NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKET 238
Query: 246 LVEIIKV-LGTP 256
           +  I+K  LG P
Sbjct: 239 MTLILKAKLGMP 250

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 133/289 (46%), Gaps = 36/289 (12%)
Query: 30  PKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           P+Q   + AE +     +G G++G V +     +G+ +A+K++   R   + + Q   LM
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI---RSTVDEKEQKQLLM 69
Query: 85  DHPNVISLKHCFFSTTSKDELFLN----LVMEYVPETMYRVLKH-YSSMNQRMPLIYVKL 139
           D   V+    C +       LF      + ME +  +  +  K+ YS ++  +P   +  
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 199
            T    + L ++     + HRD+KP N+L+D  +  +KLCDFG +  LV   A       
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 200 RYYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGT 255
           R Y APE I  +     Y    D+WS G  L EL  G+  +P  N+V DQL +++K  G 
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GD 246
Query: 256 P---TREEIRCMNPNYTDF-------------RFPQIKAHPWHKVFHKR 288
           P   +  E R  +P++ +F             ++ ++  HP+  ++ +R
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 95/343 (27%), Positives = 149/343 (43%), Gaps = 84/343 (24%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ----DRRYKNRELQLMRLMDH 86
           Y  +  +G GS+G+V  A   +T    AIK     K+ Q    D      E++LM+ + H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 87  PNVISLKHCFFSTTSKDELFLNLVME-------------YVPETMYR----VLK------ 123
           PN+  L   +     +DE ++ LVME             ++ ++  +    V+K      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 124 ---HYSSMNQ-----RMPLIYV---KLYTY---QIFRGLAYIHTVPGVCHRDVKPQNLLV 169
              +  ++N      R  L +V   KL +    QIF  L Y+H   G+CHRD+KP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLF 201
Query: 170 DP-LTHQVKLCDFGSAKVLVK---GE--ANISYICSRYYRAPELIFGATE-YTTSIDIWS 222
               + ++KL DFG +K   K   GE     +   + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 223 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           AG +L  LL+G   FPG N  D + +++        +++   NPNY              
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN------------- 301
Query: 283 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
                 + P A DL S LL  +   R  A+ A  HP+  +  +
Sbjct: 302 -----VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEY P   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NL++D   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 136/308 (44%), Gaps = 45/308 (14%)
Query: 23  IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNREL 78
           +  K G      +     ++G G FG V + +   TG  +A K +    ++D+     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 79  QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY 136
            +M  +DH N+I L   F    SK+++ L  VMEYV   E   R++    ++ +   +++
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIVL--VMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +K    QI  G+ ++H +  + H D+KP+N+L V+    Q+K+ DFG A+     E    
Sbjct: 193 MK----QICEGIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 196 YICSRYYRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
              +  + APE++ +    + T  D+WS G +   LL G   F G+N  + L  I+    
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
               EE +                          +  EA +  S+LL    S R +A EA
Sbjct: 306 DLEDEEFQ-------------------------DISEEAKEFISKLLIKEKSWRISASEA 340
Query: 315 CAHPFFDE 322
             HP+  +
Sbjct: 341 LKHPWLSD 348

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 18/199 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 96
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           +S        +++ ME++   ++ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 77  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 127
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
            + HRDVKP N+LV+    ++KLCDFG +  L+   AN  ++ +R Y +PE + G T Y+
Sbjct: 128 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-THYS 184
Query: 216 TSIDIWSAGCVLAELLLGQ 234
              DIWS G  L E+ +G+
Sbjct: 185 VQSDIWSMGLSLVEMAVGR 203

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--L 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y  ++ +G G+F  V  A+ + TG  VA+K +  D+   N        RE+++M++++H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L         + E  L LVMEY    E    ++ H      RM     +    QI
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 123
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
              + Y H    + HRD+K +NLL+D     +K+ DFG +     G    ++  S  Y A
Sbjct: 124 VSAVQYCHQ-KYIVHRDLKAENLLLDG-DMNIKIADFGFSNEFTVGNKLDTFCGSPPYAA 181
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           PEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L++ F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L++ F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L++ F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 88
           Y+    +G GSFG V  A   +T + VA+K + +    K+       RE+  ++L+ HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +I L     + T      + +V+EY    ++     Y    +RM     + +  QI   +
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            Y H    + HRD+KP+NLL+D     VK+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHR-HKIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
            G       +D+WS G VL  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 125/257 (48%), Gaps = 32/257 (12%)
Query: 13  AVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAI--KKVLQ- 69
           A+T H+     G +  +P Q   +   +V+G GSFG VF  K +   +   +   KVL+ 
Sbjct: 9   AITHHVKE---GHEKADPSQ---FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK 62
Query: 70  ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV--PETMYRV 121
                 DR     E  ++  ++HP ++ L H  F T  K    L L+++++   +   R+
Sbjct: 63  ATLKVRDRVRTKMERDILVEVNHPFIVKL-HYAFQTEGK----LYLILDFLRGGDLFTRL 117
Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
            K      +      VK Y  ++   L ++H++ G+ +RD+KP+N+L+D   H +KL DF
Sbjct: 118 SKEVMFTEED-----VKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGH-IKLTDF 170
Query: 182 GSAKVLVKGEANISYICSRY-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
           G +K  +  E      C    Y APE++     +T S D WS G ++ E+L G   F G+
Sbjct: 171 GLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 241 NAVDQLVEIIKV-LGTP 256
           +  + +  I+K  LG P
Sbjct: 230 DRKETMTMILKAKLGMP 246

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 19  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 79  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 129
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 130 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--L 184
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 185 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 236

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 92/353 (26%), Positives = 149/353 (42%), Gaps = 55/353 (15%)
Query: 3   MSAAVIQGNDAVTGHIISTTIGGKN-----GEPKQTISYMAERVVGTGSFGIVFQAKCLE 57
           MSAA+ + +   + H+   +   K       +P+    YM  R +G G F   ++   ++
Sbjct: 6   MSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMD 65
Query: 58  TGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 110
           T E  A K V +    K       + E+ + + +D+P+V+   H FF    +D+ F+ +V
Sbjct: 66  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF-HGFF----EDDDFVYVV 120
Query: 111 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 170
           +E       R L       + +     + +  Q  +G+ Y+H    V HRD+K  NL ++
Sbjct: 121 LEIC---RRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN-NRVIHRDLKLGNLFLN 176
Query: 171 PLTHQVKLCDFGSA-KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAE 229
                VK+ DFG A K+   GE   +   +  Y APE +     ++  +DIWS GC+L  
Sbjct: 177 D-DMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPE-VLCKKGHSFEVDIWSLGCILYT 234
Query: 230 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM 289
           LL+G+P F                      E  C+   Y      +IK + +    H  +
Sbjct: 235 LLVGKPPF----------------------ETSCLKETYI-----RIKKNEYSVPRH--I 265
Query: 290 PPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG-RPFPPLFN 341
            P A  L  R+L   P+LR +  E     FF     P  RLP      PP F+
Sbjct: 266 NPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP-MRLPTSCLTVPPRFS 317

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEY P   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NL++D   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 125/257 (48%), Gaps = 32/257 (12%)
Query: 13  AVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAI--KKVLQ- 69
           A+T H+     G +  +P Q   +   +V+G GSFG VF  K +   +   +   KVL+ 
Sbjct: 10  AITHHVKE---GHEKADPSQ---FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK 63
Query: 70  ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV--PETMYRV 121
                 DR     E  ++  ++HP ++ L H  F T  K    L L+++++   +   R+
Sbjct: 64  ATLKVRDRVRTKMERDILVEVNHPFIVKL-HYAFQTEGK----LYLILDFLRGGDLFTRL 118
Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
            K      +      VK Y  ++   L ++H++ G+ +RD+KP+N+L+D   H +KL DF
Sbjct: 119 SKEVMFTEED-----VKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGH-IKLTDF 171
Query: 182 GSAKVLVKGEANISYICSRY-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
           G +K  +  E      C    Y APE++     +T S D WS G ++ E+L G   F G+
Sbjct: 172 GLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 230
Query: 241 NAVDQLVEIIKV-LGTP 256
           +  + +  I+K  LG P
Sbjct: 231 DRKETMTMILKAKLGMP 247

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 125/257 (48%), Gaps = 32/257 (12%)
Query: 13  AVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAI--KKVLQ- 69
           A+T H+     G +  +P Q   +   +V+G GSFG VF  K +   +   +   KVL+ 
Sbjct: 9   AITHHVKE---GHEKADPSQ---FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK 62
Query: 70  ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV--PETMYRV 121
                 DR     E  ++  ++HP ++ L H  F T  K    L L+++++   +   R+
Sbjct: 63  ATLKVRDRVRTKMERDILVEVNHPFIVKL-HYAFQTEGK----LYLILDFLRGGDLFTRL 117
Query: 122 LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 181
            K      +      VK Y  ++   L ++H++ G+ +RD+KP+N+L+D   H +KL DF
Sbjct: 118 SKEVMFTEED-----VKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGH-IKLTDF 170
Query: 182 GSAKVLVKGEANISYICSRY-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
           G +K  +  E      C    Y APE++     +T S D WS G ++ E+L G   F G+
Sbjct: 171 GLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 241 NAVDQLVEIIKV-LGTP 256
           +  + +  I+K  LG P
Sbjct: 230 DRKETMTMILKAKLGMP 246

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEY P   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NL++D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 92/353 (26%), Positives = 148/353 (41%), Gaps = 55/353 (15%)
Query: 3   MSAAVIQGNDAVTGHIISTTIGGKN-----GEPKQTISYMAERVVGTGSFGIVFQAKCLE 57
           MSAA+ + +   + H+   +   K       +P+    YM  R +G G F   ++   ++
Sbjct: 6   MSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMD 65
Query: 58  TGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 110
           T E  A K V +    K       + E+ + + +D+P+V+   H FF    +D+ F+ +V
Sbjct: 66  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF-HGFF----EDDDFVYVV 120
Query: 111 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 170
           +E       R L       + +     + +  Q  +G+ Y+H    V HRD+K  NL ++
Sbjct: 121 LEIC---RRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN-NRVIHRDLKLGNLFLN 176
Query: 171 PLTHQVKLCDFGSA-KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAE 229
                VK+ DFG A K+   GE       +  Y APE +     ++  +DIWS GC+L  
Sbjct: 177 D-DMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE-VLCKKGHSFEVDIWSLGCILYT 234
Query: 230 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM 289
           LL+G+P F                      E  C+   Y      +IK + +    H  +
Sbjct: 235 LLVGKPPF----------------------ETSCLKETYI-----RIKKNEYSVPRH--I 265
Query: 290 PPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG-RPFPPLFN 341
            P A  L  R+L   P+LR +  E     FF     P  RLP      PP F+
Sbjct: 266 NPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP-MRLPTSCLTVPPRFS 317

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 93
           V+G GSFG V  A    T E  AIK + +D   ++ +++       ++ L+D P  ++  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 94  HCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           H  F T  +    L  VMEYV   + MY + +      +   + Y      +I  GL ++
Sbjct: 86  HSCFQTVDR----LYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAA----EISIGLFFL 136
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELIFG 210
           H   G+ +RD+K  N+++D   H +K+ DFG  K  ++ G     +  +  Y APE+I  
Sbjct: 137 HK-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-A 193
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              Y  S+D W+ G +L E+L GQP F GE+  D+L + I
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 93/322 (28%), Positives = 144/322 (44%), Gaps = 52/322 (16%)
Query: 42  VGTGSFGIVFQ-AKCLETGETVAI-----KKVLQDRRYKNRELQLMRLMDHPNVISLKHC 95
           +G G+F +V +  K L   E  A+     K   +D +   RE ++ RL+ HPN++ L H 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 77
Query: 96  FFSTTSKDELFLNLVM--EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             S      L  +LV   E   + + R  ++YS  +    +        QI   + + H 
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHCHQ 128
Query: 154 VPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIF 209
           + GV HR++KP+NLL+        VKL DFG A + V+GE  A   +  +  Y +PE + 
Sbjct: 129 M-GVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VL 185
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
               Y   +D+W+ G +L  LL+G P F  E+   +L + IK                  
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA--------------GAY 230
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 329
           DF  P+     W  V      PEA DL +++L  +PS R TA EA  HP+        + 
Sbjct: 231 DFPSPE-----WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASC 280
Query: 330 LPNGRPFPPL--FNFKQELAGA 349
           +        L  FN +++L GA
Sbjct: 281 MHRQETVDCLKKFNARRKLKGA 302

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEY P   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFXEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NL++D   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 124/281 (44%), Gaps = 39/281 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKK--VLQDRRYKNRELQLMRLMDHPNVISLKHCFFST 99
           +G GS+G V++A   ETG+ VAIK+  V  D +   +E+ +M+  D P+V+     +F  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 100 TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 159
           T      L +VMEY       V       N+ +    +        +GL Y+H +  + H
Sbjct: 97  TD-----LWIVMEYCGAG--SVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI-H 148
Query: 160 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGATEYTTSI 218
           RD+K  N+L++   H  KL DFG A  L    A  +  I + ++ APE+I     Y    
Sbjct: 149 RDIKAGNILLNTEGH-AKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI-QEIGYNCVA 206
Query: 219 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKA 278
           DIWS G    E+  G+P +   + +  +  I      PT       NP  T FR P++  
Sbjct: 207 DIWSLGITAIEMAEGKPPYADIHPMRAIFMI------PT-------NPPPT-FRKPEL-- 250
Query: 279 HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
             W   F         D   + L  SP  R TA +   HPF
Sbjct: 251 --WSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 114 RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 164
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 165 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 219
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 220 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 37/286 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS 101
           +G G++G+V + + + +G+  A+K++   R   N + Q   L D         C F+ T 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI---RATVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 102 KDELF----LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 157
              LF    + +  E    ++ +  K      Q +P   +      I + L ++H+   V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 158 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI---FGATEY 214
            HRDVKP N+L++ L  QVK CDFG +  LV   A       + Y APE I        Y
Sbjct: 159 IHRDVKPSNVLINALG-QVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGY 217
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
           +   DIWS G    EL + +  FP ++            GTP ++               
Sbjct: 218 SVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ-------------LK 251
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           Q+   P  ++   +   E +D  S+ L+ +   R T  E   HPFF
Sbjct: 252 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 137/300 (45%), Gaps = 50/300 (16%)
Query: 31  KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----RELQLMRLMDH 86
           ++T  +M   V+G+G+F  VF  K   TG+  A+K + +   +++     E+ +++ + H
Sbjct: 8   RKTFIFM--EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
            N+++L+  + STT        LVM+ V   E   R+L+      +   L+       Q+
Sbjct: 66  ENIVTLEDIYESTTH-----YYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQV 115
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISYICSR-Y 201
              + Y+H   G+ HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    
Sbjct: 116 LSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPG 172
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           Y APE +     Y+ ++D WS G +   LL G P F  E    +L E IK          
Sbjct: 173 YVAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK---------- 220
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
                 Y +F  P          F   +   A D    LL+  P+ R T  +A +HP+ D
Sbjct: 221 ----EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 92/353 (26%), Positives = 148/353 (41%), Gaps = 55/353 (15%)
Query: 3   MSAAVIQGNDAVTGHIISTTIGGKN-----GEPKQTISYMAERVVGTGSFGIVFQAKCLE 57
           MSAA+ + +   + H+   +   K       +P+    YM  R +G G F   ++   ++
Sbjct: 6   MSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMD 65
Query: 58  TGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 110
           T E  A K V +    K       + E+ + + +D+P+V+   H FF    +D+ F+ +V
Sbjct: 66  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF-HGFF----EDDDFVYVV 120
Query: 111 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 170
           +E       R L       + +     + +  Q  +G+ Y+H    V HRD+K  NL ++
Sbjct: 121 LEIC---RRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN-NRVIHRDLKLGNLFLN 176
Query: 171 PLTHQVKLCDFGSA-KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAE 229
                VK+ DFG A K+   GE       +  Y APE +     ++  +DIWS GC+L  
Sbjct: 177 D-DMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPE-VLCKKGHSFEVDIWSLGCILYT 234
Query: 230 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM 289
           LL+G+P F                      E  C+   Y      +IK + +    H  +
Sbjct: 235 LLVGKPPF----------------------ETSCLKETYI-----RIKKNEYSVPRH--I 265
Query: 290 PPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG-RPFPPLFN 341
            P A  L  R+L   P+LR +  E     FF     P  RLP      PP F+
Sbjct: 266 NPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP-MRLPTSCLTVPPRFS 317

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++M++++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L         + E  L LVMEY    E    ++ H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
              + Y H    + HRD+K +NLL+D     +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           PEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++M++++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L         + E  L LVMEY    E    ++ H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
              + Y H    + HRD+K +NLL+D     +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           PEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 149/311 (47%), Gaps = 60/311 (19%)
Query: 37  MAERVVGTGSFG-IVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM----DHPNVIS 91
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++L+    DHPNVI 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTY-QIFRGL 148
               ++ + + D  FL + +E     +  ++  K+ S  N ++   Y  +    QI  G+
Sbjct: 92  ----YYCSETTDR-FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTH------------QVKLCDFGSAKVLVKGEANISY 196
           A++H++  + HRD+KPQN+LV   +             ++ + DFG  K L  G+     
Sbjct: 147 AHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 197 ICSR-----YYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
             +       +RAPEL+  +T+   T SIDI+S GCV    +L +   P  +   +   I
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNI 264
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
           I+  G  + +E++C++                     + +  EA DL S+++ + P  R 
Sbjct: 265 IR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRP 302
Query: 310 TALEACAHPFF 320
           TA++   HP F
Sbjct: 303 TAMKVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 149/311 (47%), Gaps = 60/311 (19%)
Query: 37  MAERVVGTGSFG-IVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM----DHPNVIS 91
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++L+    DHPNVI 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTY-QIFRGL 148
               ++ + + D  FL + +E     +  ++  K+ S  N ++   Y  +    QI  G+
Sbjct: 92  ----YYCSETTDR-FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTH------------QVKLCDFGSAKVLVKGEANISY 196
           A++H++  + HRD+KPQN+LV   +             ++ + DFG  K L  G+     
Sbjct: 147 AHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 197 ICSR-----YYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
             +       +RAPEL+  +T+   T SIDI+S GCV    +L +   P  +   +   I
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNI 264
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
           I+  G  + +E++C++                     + +  EA DL S+++ + P  R 
Sbjct: 265 IR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRP 302
Query: 310 TALEACAHPFF 320
           TA++   HP F
Sbjct: 303 TAMKVLRHPLF 313

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEY P   M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NL++D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P +  L+  F     KD   L +VMEY P   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLTKLEFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NL++D   + +K+ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 137/317 (43%), Gaps = 57/317 (17%)
Query: 22  TIGGKNGEPKQTISYMAERV---------VGTGSFGIVFQAKCLETGETVAIK----KVL 68
           ++  +NGE   +    AE +         +GTG+F  V  A+   TG+  A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 69  QDRRYK-NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KH 124
           + +      E+ ++R + H N+++L+  + S        L LVM+ V   E   R++ K 
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESPN-----HLYLVMQLVSGGELFDRIVEKG 115
Query: 125 YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL--CDFG 182
           + +      LI       Q+   + Y+H + G+ HRD+KP+NLL      + K+   DFG
Sbjct: 116 FYTEKDASTLIR------QVLDAVYYLHRM-GIVHRDLKPENLLYYSQDEESKIMISDFG 168
Query: 183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
            +K+  KG+   +   +  Y APE +     Y+ ++D WS G +   LL G P F  EN 
Sbjct: 169 LSKMEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 227
Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
                +I+K        E    +P + D                  +   A D    L++
Sbjct: 228 SKLFEQILKA-------EYEFDSPYWDD------------------ISDSAKDFIRNLME 262
Query: 303 YSPSLRCTALEACAHPF 319
             P+ R T  +A  HP+
Sbjct: 263 KDPNKRYTCEQAARHPW 279

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHA 136
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 137 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 191
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 192 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 243

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P +  L+  F     KD   L +VMEY P   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLTKLEFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NL++D   + +K+ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y   + +G G+F  V  A+ + TG  VAIK +  D+   N        RE+++M++++H
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 70
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L         + E  L L+MEY    E    ++ H      RM     +    QI
Sbjct: 71  PNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQI 120
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
              + Y H    + HRD+K +NLL+D     +K+ DFG +     G    ++  S  Y A
Sbjct: 121 VSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGKLDTFCGSPPYAA 178
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           PEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 93/331 (28%), Positives = 146/331 (44%), Gaps = 52/331 (15%)
Query: 33  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDH 86
           T  Y     +G G+F +V +   L TG   A K +       +D +   RE ++ RL+ H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 87  PNVISLKHCFFSTTSKDELFLNLVM--EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
            N++ L H   S      L  +LV   E   + + R  ++YS  +    +        QI
Sbjct: 63  SNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGE--ANISYICSR 200
              + + H + GV HRD+KP+NLL+        VKL DFG A + V+G+  A   +  + 
Sbjct: 113 LEAVLHCHQM-GVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
            Y +PE +     Y   +DIW+ G +L  LL+G P F  E+   +L + IK         
Sbjct: 171 GYLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA-------- 220
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                    DF  P+     W  V      PEA +L +++L  +P+ R TA EA  HP+ 
Sbjct: 221 ------GAYDFPSPE-----WDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPWV 264
Query: 321 DELREPNARLPNGRPFPPL--FNFKQELAGA 349
            +     + +        L  FN +++L GA
Sbjct: 265 CQRSTVASMMHRQETVECLKKFNARRKLKGA 295

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 49/312 (15%)
Query: 27  NGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----L 80
            G+P+  + SY+    +G GS GIV  A+   +G  VA+K ++  R+ + REL      +
Sbjct: 40  QGDPRLLLDSYVK---IGEGSTGIVCLAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVI 95
Query: 81  MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLY 140
           MR   H NV+ +   + S    +EL++  +ME++       +     +N+      +   
Sbjct: 96  MRDYQHFNVVEM---YKSYLVGEELWV--LMEFLQGGALTDIVSQVRLNEEQ----IATV 146
Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICS 199
              + + LAY+H   GV HRD+K  ++L+  L  +VKL DFG  A++          + +
Sbjct: 147 CEAVLQALAYLHA-QGVIHRDIKSDSILL-TLDGRVKLSDFGFCAQISKDVPKRKXLVGT 204
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            Y+ APE+I   + Y T +DIWS G ++ E++ G+P +  ++ V  +            +
Sbjct: 205 PYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------K 251
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            +R   P       P++K    HKV      P   D   R+L   P  R TA E   HPF
Sbjct: 252 RLRDSPP-------PKLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPF 297
Query: 320 FDELREPNARLP 331
             +   P   +P
Sbjct: 298 LLQTGLPECLVP 309

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYVP   M+  L+       R    + 
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHA 136
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 137 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 191
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 192 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 243

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P +  L+  F     KD   L +VMEY P   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLTKLEFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFXEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NL++D   + +K+ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 118/234 (50%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    R +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            + + ++ P ++ L+  F     KD   L +V+EY P   M+  L+       R    + 
Sbjct: 94  RIQQAVNFPFLVKLEFSF-----KDNSNLYMVLEYAPGGEMFSHLRRIG----RFSEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +K+ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 60/299 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISL 92
           R +GTGSFG V   +    G   A+K +       L+   + N E  ++ ++ HP +I +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F     +D   + ++M+Y+    ++ +L+     +QR P    K Y  ++   L Y+
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYL 122
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSR-YYRAPELIF 209
           H+   + +RD+KP+N+L+D   H +K+ DFG AK +     +++Y +C    Y APE++ 
Sbjct: 123 HS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV- 175
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
               Y  SID WS G ++ E+L G   F   N +    +I+                   
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----------------A 218
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFDEL 323
           + RFP                 +  DL SRL+    S R   L+        HP+F E+
Sbjct: 219 ELRFPPF------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K  ETG   A+K + + +  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEY P   M+  L+       R    + 
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHA 144
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NL++D   + +K+ DFG AK  VKG      +
Sbjct: 145 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGRT--WXL 199
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 200 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 131/291 (45%), Gaps = 53/291 (18%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISLK 93
           ++G GSF  V++A+ + TG  VAIK + +   YK         E+++   + HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 94  HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIY--VKLYTYQIFRGLAY 150
           + F     +D  ++ LV+E      M R LK     N+  P      + + +QI  G+ Y
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNRYLK-----NRVKPFSENEARHFMHQIITGMLY 127
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIF 209
           +H+  G+ HRD+   NLL+      +K+ DFG A  L +  E + +   +  Y +PE I 
Sbjct: 128 LHS-HGILHRDLTLSNLLLTR-NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IA 184
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
             + +    D+WS GC+   LL+G+P F  +   + L +++                   
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------LA 227
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           D+  P              +  EA DL  +LL+ +P+ R +      HPF 
Sbjct: 228 DYEMPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 86/322 (26%), Positives = 136/322 (42%), Gaps = 50/322 (15%)
Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLM 81
           +P+    YM  R +G G F   ++   ++T E  A K V +    K       + E+ + 
Sbjct: 21  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
           + +D+P+V+   H FF    +D+ F+ +V+E       R L       + +     + + 
Sbjct: 81  KSLDNPHVVGF-HGFF----EDDDFVYVVLEICRR---RSLLELHKRRKAVTEPEARYFM 132
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISYICSR 200
            Q  +G+ Y+H    V HRD+K  NL ++     VK+ DFG A K+   GE       + 
Sbjct: 133 RQTIQGVQYLHN-NRVIHRDLKLGNLFLND-DMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 191 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 227
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
             C+   Y      +IK + +    H  + P A  L  R+L   P+LR +  E     FF
Sbjct: 228 TSCLKETYI-----RIKKNEYSVPRH--INPVASALIRRMLHADPTLRPSVAELLTDEFF 280
Query: 321 DELREPNARLPNG-RPFPPLFN 341
                P  RLP      PP F+
Sbjct: 281 TSGYAP-MRLPTSCLTVPPRFS 301

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y   + +G G+F  V  A+ + TG+ VA++ +  D+   N        RE+++M++++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L         + E  L LVMEY    E    ++ H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
              + Y H    + HRD+K +NLL+D     +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           PEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++M++++H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           PN++ L         + E  L LVMEY     ++  L  +  M ++      +    QI 
Sbjct: 66  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR----QIV 116
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
             + Y H    + HRD+K +NLL+D     +K+ DFG +     G    ++  S  Y AP
Sbjct: 117 SAVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 174
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           EL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++M++++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L         + E  L LVMEY    E    ++ H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
              + Y H    + HRD+K +NLL+D     +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           PEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 120/234 (51%), Gaps = 29/234 (12%)
Query: 30  PKQTISYMAE----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           P Q  +++ +    + +GTGSFG V   K +ETG   A+K + + +  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 80  -LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
            +++ ++ P ++ L+  F     KD   L +VMEYV    M+  L+       R    + 
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHA 143
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           + Y  QI     Y+H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXL 198
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           C    Y APE+I  +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 126/294 (42%), Gaps = 48/294 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYK-NRELQLMRLMDHPNVI 90
           Y    V+GTG+F  V  A+   T + VAIK    K L+ +      E+ ++  + HPN++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRG 147
           +L   + S        L L+M+ V   E   R++ K + +      LI+      Q+   
Sbjct: 80  ALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDA 128
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL--CDFGSAKVLVKGEANISYICSRYYRAP 205
           + Y+H + G+ HRD+KP+NLL   L    K+   DFG +K+   G    +   +  Y AP
Sbjct: 129 VKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E +     Y+ ++D WS G +   LL G P F  EN      +I+K        E    +
Sbjct: 188 E-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------EYEFDS 239
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
           P + D                  +   A D    L++  P  R T  +A  HP+
Sbjct: 240 PYWDD------------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y   + +G G+F  V  A+ + TG  VAIK +  D+   N        RE+++M++++H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L         + E  L L+MEY    E    ++ H      RM     +    QI
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQI 123
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
              + Y H    + HRD+K +NLL+D     +K+ DFG +     G    ++  +  Y A
Sbjct: 124 VSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           PEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y   + +G G+F  V  A+ + TG+ VA++ +  D+   N        RE+++M++++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L         + E  L LVMEY    E    ++ H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
              + Y H    + HRD+K +NLL+D     +K+ DFG +     G     +  S  Y A
Sbjct: 123 VSAVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDEFCGSPPYAA 180
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           PEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 24  GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------- 75
           G K+    +   Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           RE+Q ++L  HP++I L     + T        +VMEYV       L  Y   + R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGE---LFDYICKHGRVEEM 111
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             +    QI   + Y H    V HRD+KP+N+L+D      K+ DFG + ++  GE   +
Sbjct: 112 EARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRT 169
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
              S  Y APE+I G       +DIWS G +L  LL G   F  E+ 
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 98/359 (27%), Positives = 153/359 (42%), Gaps = 81/359 (22%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKC-LETG--ETVAIKKVLQDRR--YKNRELQLMRLM 84
           P+ +  +  E  +G G+F  V+ A   L+ G  E +A+K ++          ELQ + + 
Sbjct: 17  PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 85  D-HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY--VKLYT 141
               NV+ +K+CF     +    + + M Y        L+H S ++    L +  V+ Y 
Sbjct: 77  GGQDNVMGVKYCF-----RKNDHVVIAMPY--------LEHESFLDILNSLSFQEVREYM 123
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK----------VLVKGE 191
             +F+ L  IH   G+ HRDVKP N L +    +  L DFG A+            V+ E
Sbjct: 124 LNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSE 182
Query: 192 A-------NISYIC-SRY-----------YRAPELIFGATEYTTSIDIWSAGCVLAELLL 232
           A       N   IC SR            +RAPE++      TT+ID+WSAG +   LL 
Sbjct: 183 AQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242
Query: 233 GQ-PLFPGENAVDQLVEIIKVLGTPTREEIR-----------------------CMNPNY 268
           G+ P +   + +  L +I+ + G  +RE I+                       C     
Sbjct: 243 GRYPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRG 300
Query: 269 TDFRFPQ----IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
            D   P+    I+ H  +      +P EA DL  +LL  +P+ R TA EA  HPFF ++
Sbjct: 301 MDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 138/296 (46%), Gaps = 45/296 (15%)
Query: 34  ISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDRRYKNRELQLMR-LMDHPNVIS 91
           +S +  R V   + G  F  K +E T E ++ +++ + R    RE  ++R +  HP++I+
Sbjct: 106 VSSVVRRCVHRAT-GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   + S++     F+ LV + + +  ++  L    +++++      +     +   +++
Sbjct: 165 LIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEK----ETRSIMRSLLEAVSF 215
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
           +H    + HRD+KP+N+L+D    Q++L DFG +  L  GE       +  Y APE++  
Sbjct: 216 LH-ANNIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273
Query: 211 ATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           + +     Y   +D+W+ G +L  LL G P F     +  L  I++        + +  +
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME-------GQYQFSS 326
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
           P + D R   +K                 DL SRLLQ  P  R TA +A  HPFF+
Sbjct: 327 PEWDD-RSSTVK-----------------DLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 19/227 (8%)
Query: 24  GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------- 75
           G K+    +   Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
           RE+Q ++L  HP++I L     + T        +VMEYV       L  Y   + R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGE---LFDYICKHGRVEEM 111
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             +    QI   + Y H    V HRD+KP+N+L+D      K+ DFG + ++  GE    
Sbjct: 112 EARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRD 169
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
              S  Y APE+I G       +DIWS G +L  LL G   F  E+ 
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 40  RVVGTGSFGIVFQAK--------CLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVIS 91
           +V+G GSFG V  A+         ++  +  AI K  +++   +    L++ + HP ++ 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L    FS  + D+L+   V++Y+   E  Y + +    +  R      + Y  +I   L 
Sbjct: 104 LH---FSFQTADKLYF--VLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 153
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELI 208
           Y+H++  + +RD+KP+N+L+D   H V L DFG  K  ++  +  S  C    Y APE +
Sbjct: 154 YLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYLAPE-V 210
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
                Y  ++D W  G VL E+L G P F   N  +    I+
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 148/328 (45%), Gaps = 62/328 (18%)
Query: 40  RVVGTGSFGIVFQAKCL---ETGETVAIK--------KVLQDRRYKNRELQLMRLMDHPN 88
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E  ++  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           ++ L + F  T  K    L L++EY+    ++  L+      +     Y+     +I   
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYLSGGELFMQLEREGIFMEDTACFYLA----EISMA 133
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 206
           L ++H   G+ +RD+KP+N++++   H VKL DFG  K  +  G    ++  +  Y APE
Sbjct: 134 LGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++   + +  ++D WS G ++ ++L G P F GEN    + +I+K               
Sbjct: 192 ILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-------------- 236
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFD 321
                   ++   P+       +  EA DL  +LL+ + + R       A E  AHPFF 
Sbjct: 237 --------KLNLPPY-------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281
Query: 322 EL--REPNARLPNGRPFPPLFNFKQELA 347
            +   E  AR     PF PL   +++++
Sbjct: 282 HINWEELLARKVE-PPFKPLLQSEEDVS 308

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 137/326 (42%), Gaps = 45/326 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMDHPNVISLKHCFFS 98
           +G+G+FG+    +  ++ E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 99  TTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            T      L +VMEY    E   R+         R      + +  Q+  G++Y H +  
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAM-Q 135
Query: 157 VCHRDVKPQNLLVDPL-THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
           VCHRD+K +N L+D     ++K+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYD 194
Query: 216 TSI-DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
             + D+WS G  L  +L+G   F          + I           R +N  Y    + 
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------RILNVQYAIPDYV 244
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 334
            I              PE   L SR+    P+ R +  E   H +F  L+   A L N  
Sbjct: 245 HIS-------------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDN 289
Query: 335 PFPPLFNFKQELAGASPELINRLIPE 360
                F+ + +  G S E I ++I E
Sbjct: 290 TMTTQFD-ESDQPGQSIEEIMQIIAE 314

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 139/303 (45%), Gaps = 48/303 (15%)
Query: 27  NGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMR 82
           +G  +  +S  +  E  +G G+  IV++ K   T +  A+K  K   D++    E+ ++ 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KHYSSMNQRMPLIYVKL 139
            + HPN+I LK  F + T      ++LV+E V   E   R++ K Y S  +R     VK 
Sbjct: 104 RLSHPNIIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGYYS--ERDAADAVK- 155
Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTHQ-VKLCDFGSAKVLVKGEANISYI 197
              QI   +AY+H   G+ HRD+KP+NLL   P     +K+ DFG +K+ V+ +  +  +
Sbjct: 156 ---QILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTV 210
Query: 198 CSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           C    Y APE++ G   Y   +D+WS G +   LL G   F  E   DQ +         
Sbjct: 211 CGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM--------- 259
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
            R  + C      ++ F      PW       +   A DL  +L+   P  R T  +A  
Sbjct: 260 FRRILNC------EYYF----ISPW----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305
Query: 317 HPF 319
           HP+
Sbjct: 306 HPW 308

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 149/315 (47%), Gaps = 64/315 (20%)
Query: 37  MAERVVGTGSFG-IVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM----DHPNVIS 91
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++L+    DHPNVI 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTY-QIFRGL 148
               ++ + + D  FL + +E     +  ++  K+ S  N ++   Y  +    QI  G+
Sbjct: 74  ----YYCSETTDR-FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTH------------QVKLCDFGSAKVLVKGEANISY 196
           A++H++  + HRD+KPQN+LV   +             ++ + DFG  K L  G+++   
Sbjct: 129 AHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 197 ICSR-----YYRAPELIFGATEYTT------SIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
             +       +RAPEL+  +    T      SIDI+S GCV    +L +   P  +   +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSR 246
Query: 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 305
              II+  G  + +E++C++                     + +  EA DL S+++ + P
Sbjct: 247 ESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDP 284
Query: 306 SLRCTALEACAHPFF 320
             R TA++   HP F
Sbjct: 285 LKRPTAMKVLRHPLF 299

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 110/211 (52%), Gaps = 34/211 (16%)
Query: 40  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVIS 91
           R +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++ 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAY 150
            K   +S   ++   L L+ME++P   Y  L+ Y     +R+  I +  YT QI +G+ Y
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLP---YGSLREYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSR 200
           + T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      
Sbjct: 133 LGTKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------ 184
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           ++ APE +   ++++ + D+WS G VL EL 
Sbjct: 185 FWYAPESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 135/303 (44%), Gaps = 47/303 (15%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 97
           +GTG+FG+V +     TG   A K V+     D+    +E+Q M ++ HP +++L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 98  STTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
               +D+  + ++ E++   E   +V   ++ M++   + Y++    Q+ +GL ++H   
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHE-N 274
Query: 156 GVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TE 213
              H D+KP+N++     ++++KL DFG    L   ++      +  + APE+  G    
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           Y T  D+WS G +   LL G   F GEN  + L              ++  + N  D  F
Sbjct: 335 YYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAF 380
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NARLP 331
             I               +  D   +LL   P+ R T  +A  HP+      P  ++++P
Sbjct: 381 SGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 427
Query: 332 NGR 334
           + R
Sbjct: 428 SSR 430

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 112/230 (48%), Gaps = 27/230 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHP 87
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E  +M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            V+ L + F     +D+ +L +VMEY+P   +  ++ +Y      +P  + + YT ++  
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVL 184
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            L  IH++ G  HRDVKP N+L+D   H +KL DFG+   + K E  +   + + +  Y 
Sbjct: 185 ALDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYI 241
Query: 204 APELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 114/219 (52%), Gaps = 23/219 (10%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 128 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 178
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG A  +   +  Y APE+I  +
Sbjct: 179 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-S 233
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 136/309 (44%), Gaps = 47/309 (15%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVIS 91
           Y     +GTG+FG+V +     TG   A K V+     D+    +E+Q M ++ HP +++
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L   F     +D+  + ++ E++   E   +V   ++ M++   + Y++    Q+ +GL 
Sbjct: 113 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 163
Query: 150 YIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
           ++H      H D+KP+N++     ++++KL DFG    L   ++      +  + APE+ 
Sbjct: 164 HMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 222
Query: 209 FGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
            G    Y T  D+WS G +   LL G   F GEN  + L              ++  + N
Sbjct: 223 EGKPVGYYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWN 268
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP- 326
             D  F  I               +  D   +LL   P+ R T  +A  HP+      P 
Sbjct: 269 MDDSAFSGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 315
Query: 327 -NARLPNGR 334
            ++++P+ R
Sbjct: 316 RDSQIPSSR 324

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 85  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 138
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 139 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 190
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 191 YAPESL-TESKFSVASDVWSFGVVLYELF 218

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 84  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 137
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 138 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 189
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 190 YAPESL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCF 96
           V+G G FG   +    ETGE + +K+++    + +R   +E+++MR ++HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
                KD+  LN + EY+     R +    SM+ + P      +   I  G+AY+H++  
Sbjct: 73  IGVLYKDKR-LNFITEYIKGGTLRGI--IKSMDSQYPWSQRVSFAKDIASGMAYLHSM-N 128
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---------------ISYICSRY 201
           + HRD+   N LV      V + DFG A+++V  +                  + + + Y
Sbjct: 129 IIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           + APE+I G + Y   +D++S G VL E++
Sbjct: 188 WMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 109 GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 163 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 214
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 215 YAPESL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 112/230 (48%), Gaps = 27/230 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHP 87
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E  +M   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            V+ L + F     +D+ +L +VMEY+P   +  ++ +Y      +P  + + YT ++  
Sbjct: 130 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVL 179
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            L  IH++ G  HRDVKP N+L+D   H +KL DFG+   + K E  +   + + +  Y 
Sbjct: 180 ALDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYI 236
Query: 204 APELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 78  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 132 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 183
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 184 YAPESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 48/294 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVI 90
           Y    V+GTG+F  V  A+   T + VAIK + ++           E+ ++  + HPN++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRG 147
           +L   + S        L L+M+ V   E   R++ K + +      LI+      Q+   
Sbjct: 80  ALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDA 128
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL--CDFGSAKVLVKGEANISYICSRYYRAP 205
           + Y+H + G+ HRD+KP+NLL   L    K+   DFG +K+   G    +   +  Y AP
Sbjct: 129 VKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E +     Y+ ++D WS G +   LL G P F  EN      +I+K        E    +
Sbjct: 188 E-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------EYEFDS 239
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
           P + D                  +   A D    L++  P  R T  +A  HP+
Sbjct: 240 PYWDD------------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 78  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 132 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI------FW 183
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 184 YAPESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 145/328 (44%), Gaps = 62/328 (18%)
Query: 40  RVVGTGSFGIVFQAKCL---ETGETVAIK--------KVLQDRRYKNRELQLMRLMDHPN 88
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E  ++  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           ++ L + F  T  K    L L++EY+    ++  L+      +     Y+     +I   
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYLSGGELFMQLEREGIFMEDTACFYLA----EISMA 133
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPE 206
           L ++H   G+ +RD+KP+N++++   H VKL DFG  K  +         C    Y APE
Sbjct: 134 LGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++   + +  ++D WS G ++ ++L G P F GEN    + +I+K               
Sbjct: 192 ILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-------------- 236
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFD 321
                   ++   P+       +  EA DL  +LL+ + + R       A E  AHPFF 
Sbjct: 237 --------KLNLPPY-------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281
Query: 322 EL--REPNARLPNGRPFPPLFNFKQELA 347
            +   E  AR     PF PL   +++++
Sbjct: 282 HINWEELLARKVE-PPFKPLLQSEEDVS 308

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 83  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 136
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 137 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 188
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 189 YAPESL-TESKFSVASDVWSFGVVLYELF 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 81  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 135 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 186
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 187 YAPESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 78  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 132 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 183
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 184 YAPESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y  +  +R+  I +  YT QI +G+ Y+ 
Sbjct: 81  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG 134
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 135 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 186
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 187 YAPESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 77  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 130
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 131 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 182
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 183 YAPESL-TESKFSVASDVWSFGVVLYELF 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 96  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 150 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 201
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 202 YAPESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 76  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 129
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 130 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 181
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 182 YAPESL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 96  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 150 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 201
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 202 YAPESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 82  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 135
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HRD+  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 136 TKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 187
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 188 YAPESL-TESKFSVASDVWSFGVVLYELF 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 124/249 (49%), Gaps = 20/249 (8%)
Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 83
           G+PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             +PN+++    +      DEL++  VMEY+       +   + M++      +     +
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 124
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 202
             + L ++H+   V HRD+K  N+L+  +   VKL DFG  A++  +     + + + Y+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +   
Sbjct: 183 MAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 240
Query: 263 CMNPNYTDF 271
            ++  + DF
Sbjct: 241 KLSAIFRDF 249

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 48/294 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVI 90
           Y    V+GTG+F  V  A+   T + VAIK + ++           E+ ++  + HPN++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRG 147
           +L   + S        L L+M+ V   E   R++ K + +      LI+      Q+   
Sbjct: 80  ALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDA 128
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL--CDFGSAKVLVKGEANISYICSRYYRAP 205
           + Y+H + G+ HRD+KP+NLL   L    K+   DFG +K+   G    +   +  Y AP
Sbjct: 129 VKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E +     Y+ ++D WS G +   LL G P F  EN      +I+K        E    +
Sbjct: 188 E-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------EYEFDS 239
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
           P + D                  +   A D    L++  P  R T  +A  HP+
Sbjct: 240 PYWDD------------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 112/230 (48%), Gaps = 27/230 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHP 87
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E  +M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            V+ L + F     +D+ +L +VMEY+P   +  ++ +Y      +P  + + YT ++  
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVL 184
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            L  IH++ G  HRDVKP N+L+D   H +KL DFG+   + K E  +   + + +  Y 
Sbjct: 185 ALDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYI 241
Query: 204 APELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 48/294 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVI 90
           Y    V+GTG+F  V  A+   T + VAIK + ++           E+ ++  + HPN++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRG 147
           +L   + S        L L+M+ V   E   R++ K + +      LI+      Q+   
Sbjct: 80  ALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDA 128
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL--CDFGSAKVLVKGEANISYICSRYYRAP 205
           + Y+H + G+ HRD+KP+NLL   L    K+   DFG +K+   G    +   +  Y AP
Sbjct: 129 VKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E +     Y+ ++D WS G +   LL G P F  EN      +I+K        E    +
Sbjct: 188 E-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------EYEFDS 239
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
           P + D                  +   A D    L++  P  R T  +A  HP+
Sbjct: 240 PYWDD------------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 62/299 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRLMDHPNV 89
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +LK+ F +        L  VMEY    E  + + +       R      + Y  +I   
Sbjct: 72  TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 121
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPE 206
           L Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +K  A +   C    Y APE
Sbjct: 122 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 180
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 228
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 229 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 62/299 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRLMDHPNV 89
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +LK+ F +        L  VMEY    E  + + +       R      + Y  +I   
Sbjct: 73  TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 122
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPE 206
           L Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +K  A +   C    Y APE
Sbjct: 123 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 182 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 229
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 230 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 62/299 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRLMDHPNV 89
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 213
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +LK+ F +        L  VMEY    E  + + +       R      + Y  +I   
Sbjct: 214 TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 263
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPE 206
           L Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +K  A +   C    Y APE
Sbjct: 264 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 322
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 323 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 370
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 371 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 62/299 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRLMDHPNV 89
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +LK+ F +        L  VMEY    E  + + +       R      + Y  +I   
Sbjct: 71  TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 120
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPE 206
           L Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +K  A +   C    Y APE
Sbjct: 121 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 179
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 180 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 227
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 228 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 62/299 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRLMDHPNV 89
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +LK+ F +        L  VMEY    E  + + +       R      + Y  +I   
Sbjct: 211 TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 260
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPE 206
           L Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +K  A +   C    Y APE
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 320 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 367
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 368 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 123/249 (49%), Gaps = 20/249 (8%)
Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 83
           G+PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             +PN+++    +      DEL++  VMEY+       +   + M++      +     +
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 124
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 202
             + L ++H+   V HRD+K  N+L+  +   VKL DFG  A++  +       + + Y+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVGTPYW 182
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +   
Sbjct: 183 MAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 240
Query: 263 CMNPNYTDF 271
            ++  + DF
Sbjct: 241 KLSAIFRDF 249

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 123/249 (49%), Gaps = 20/249 (8%)
Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 83
           G+PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             +PN+++    +      DEL++  VMEY+       +   + M++      +     +
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 124
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 202
             + L ++H+   V HRD+K  N+L+  +   VKL DFG  A++  +       + + Y+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 182
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +   
Sbjct: 183 MAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 240
Query: 263 CMNPNYTDF 271
            ++  + DF
Sbjct: 241 KLSAIFRDF 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 123/249 (49%), Gaps = 20/249 (8%)
Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 83
           G+PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             +PN+++    +      DEL++  VMEY+       +   + M++      +     +
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 125
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 202
             + L ++H+   V HRD+K  N+L+  +   VKL DFG  A++  +       + + Y+
Sbjct: 126 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 183
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +   
Sbjct: 184 MAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 241
Query: 263 CMNPNYTDF 271
            ++  + DF
Sbjct: 242 KLSAIFRDF 250

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 147/315 (46%), Gaps = 64/315 (20%)
Query: 37  MAERVVGTGSFG-IVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM----DHPNVIS 91
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++L+    DHPNVI 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTY-QIFRGL 148
               ++ + + D  FL + +E     +  ++  K+ S  N ++   Y  +    QI  G+
Sbjct: 74  ----YYCSETTDR-FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTH------------QVKLCDFGSAKVLVKGEANISY 196
           A++H++  + HRD+KPQN+LV   +             ++ + DFG  K L  G+     
Sbjct: 129 AHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 187
Query: 197 ICSR-----YYRAPELIFGATEYTT------SIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
             +       +RAPEL+  +    T      SIDI+S GCV    +L +   P  +   +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSR 246
Query: 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 305
              II+  G  + +E++C++                     + +  EA DL S+++ + P
Sbjct: 247 ESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDP 284
Query: 306 SLRCTALEACAHPFF 320
             R TA++   HP F
Sbjct: 285 LKRPTAMKVLRHPLF 299

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 267 PLKKGAKRP 275

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 135/326 (41%), Gaps = 45/326 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMDHPNVISLKHCFFS 98
           +G+G+FG+    +  ++ E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 99  TTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            T      L +VMEY    E   R+         R      + +  Q+  G++Y H +  
Sbjct: 86  PTH-----LAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAMQ- 134
Query: 157 VCHRDVKPQNLLVDPL-THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
           VCHRD+K +N L+D     ++K+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYD 193
Query: 216 TSI-DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
             + D+WS G  L  +L+G   F          + I           R +N  Y    + 
Sbjct: 194 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------RILNVQYAIPDYV 243
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 334
            I              PE   L SR+    P+ R +  E   H +F  L+   A L N  
Sbjct: 244 HIS-------------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDN 288
Query: 335 PFPPLFNFKQELAGASPELINRLIPE 360
                F    +  G S E I ++I E
Sbjct: 289 TMTTQFAASDQ-PGQSIEEIMQIIAE 313

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 212
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 113/230 (49%), Gaps = 32/230 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 91
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP ++ 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF  T S+    L  V+EYV   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 86  LHSCF-QTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 135
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELI 208
           Y+H   G+ +RD+K  N+L+D   H +KL D+G  K  ++     S  C    Y APE++
Sbjct: 136 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 193
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 250
            G  +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 194 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 242

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 113/230 (49%), Gaps = 32/230 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 91
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP ++ 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF  T S+    L  V+EYV   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 71  LHSCF-QTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 120
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELI 208
           Y+H   G+ +RD+K  N+L+D   H +KL D+G  K  ++     S  C    Y APE++
Sbjct: 121 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 178
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 250
            G  +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 179 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 39/285 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMDHPNVISLKHCFFS 98
           +G+G+FG+    +   T E VA+K + +         RE+   R + HPN++  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 99  TTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            T      L ++MEY    E   R+         R      + +  Q+  G++Y H++  
Sbjct: 88  PT-----HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSM-Q 136
Query: 157 VCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
           +CHRD+K +N L+D     ++K+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYD 195
Query: 216 TSI-DIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTR--EEIRCMNPN---- 267
             I D+WS G  L  +L+G  P    E   D    I ++L       ++IR ++P     
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-ISPECCHL 254
Query: 268 ---------YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 303
                     T    P+IK H W   F K +P + ++ ++   Q+
Sbjct: 255 ISRIFVADPATRISIPEIKTHSW---FLKNLPADLMNESNTGSQF 296

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 146/326 (44%), Gaps = 64/326 (19%)
Query: 40  RVVGTGSFGIVFQAKCL---ETGETVAIK-----------KVLQDRRYKNRELQLMRLMD 85
           +V+GTG++G VF  + +   +TG+  A+K           K  +  R + + L+ +R   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 117
Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
            P +++L + F + T      L+L+++Y+      +  H S   +R     V++Y  +I 
Sbjct: 118 SPFLVTLHYAFQTETK-----LHLILDYI--NGGELFTHLSQ-RERFTEHEVQIYVGEIV 169
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRY-YR 203
             L ++H + G+ +RD+K +N+L+D   H V L DFG +K  V  E   +Y  C    Y 
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 204 APELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
           AP+++ G  + +  ++D WS G ++ ELL G   F  +   +   EI       +R  ++
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILK 280
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAH 317
              P      +PQ             M   A DL  RLL   P  R       A E   H
Sbjct: 281 SEPP------YPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322
Query: 318 PFFDELREPN---ARLPNGRPFPPLF 340
            FF ++   +    ++P   PF P+ 
Sbjct: 323 LFFQKINWDDLAAKKVPA--PFKPVI 346

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 116/230 (50%), Gaps = 32/230 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 91
           RV+G GS+  V   +  +T    A++ V ++    + ++  ++          +HP ++ 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 92  LKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF  T S+    L  V+EYV   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 118 LHSCF-QTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELI 208
           Y+H   G+ +RD+K  N+L+D   H +KL D+G  K  ++ G+   ++  +  Y APE++
Sbjct: 168 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 250
            G  +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 226 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 113/230 (49%), Gaps = 32/230 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 91
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP ++ 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 92  LKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF  T S+    L  V+EYV   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 75  LHSCF-QTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELI 208
           Y+H   G+ +RD+K  N+L+D   H +KL D+G  K  ++     S  C    Y APE++
Sbjct: 125 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 182
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 250
            G  +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 183 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 267 PLKKGAKRP 275

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFAEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 128 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 178
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 179 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 232
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 116 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 116 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 116 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 116 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 132/289 (45%), Gaps = 52/289 (17%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   VA+K + + +  K        RE+++   + HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMN-QRMPLIYVKLYTYQIFRGLAY 150
            + F+     D   + L++EY P   +Y+ L+   + + QR   I  +L        L Y
Sbjct: 89  YNYFY-----DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELAD-----ALMY 138
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
            H    V HRD+KP+NLL+  L  ++K+ DFG + V        +   +  Y  PE+I G
Sbjct: 139 CHG-KKVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
              +   +D+W  G +  ELL+G P F   +  +    I+KV                 D
Sbjct: 196 RM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-----------------D 237
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            +FP              +P  A DL S+LL+++PS R    +  AHP+
Sbjct: 238 LKFPA------------SVPTGAQDLISKLLRHNPSERLPLAQVSAHPW 274

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPI-QIYEKI 250

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 92/336 (27%), Positives = 147/336 (43%), Gaps = 62/336 (18%)
Query: 33  TISYMAERVVGTGSFGIV-----------FQAKCLETGETVAIKKVLQDRRYKNRELQLM 81
           T  Y     +G G+F +V           + AK + T +  A     +D +   RE ++ 
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKLEREARIC 84
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVM--EYVPETMYRVLKHYSSMNQRMPLIYVKL 139
           RL+ HPN++ L H   S      L  +LV   E   + + R  ++YS  +    +     
Sbjct: 85  RLLKHPNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI----- 136
Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGE--ANIS 195
             +QI   + +IH    + HRD+KP+NLL+        VKL DFG A + V+GE  A   
Sbjct: 137 --HQILESVNHIHQ-HDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFG 192
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           +  +  Y +PE +     Y   +DIW+ G +L  LL+G P F  E+   +L + IK    
Sbjct: 193 FAGTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA--- 247
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
                         DF  P+     W  V      PEA +L +++L  +P+ R TA +A 
Sbjct: 248 -----------GAYDFPSPE-----WDTV-----TPEAKNLINQMLTINPAKRITADQAL 286
Query: 316 AHPFFDELREPNARLPNGRPFPPL--FNFKQELAGA 349
            HP+  +     + +        L  FN +++L GA
Sbjct: 287 KHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGA 322

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFS-- 98
           ++G+G FG VF+AK    G+T  IK+V  +     RE++ +  +DH N++    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 99  ----TTSKDE-------LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
               T+SK+        LF+   ME+  +             +   ++ ++L+  QI +G
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQ--MEFCDKGTLEQWIEKRRGEKLDKVLALELFE-QITKG 134
Query: 148 LAYIHTVPGVCHRDVKPQNL-LVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           + YIH+   + +RD+KP N+ LVD  T QVK+ DFG    L           +  Y +PE
Sbjct: 135 VDYIHS-KKLINRDLKPSNIFLVD--TKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPE 191
Query: 207 LIFGATEYTTSIDIWSAGCVLAELL 231
            I  + +Y   +D+++ G +LAELL
Sbjct: 192 QI-SSQDYGKEVDLYALGLILAELL 215

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 34/220 (15%)
Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKN--RELQLMRLMDHPNVI 90
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E +L  ++ HPN+I
Sbjct: 12  EEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L+       +     L LVME+     + RVL       +R+P   +  +  QI RG+ 
Sbjct: 70  ALRGVCLKEPN-----LCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 150 YIH---TVPGVCHRDVKPQNLLV-------DPLTHQVKLCDFGSAKVLVKGEANISYICS 199
           Y+H    VP + HRD+K  N+L+       D     +K+ DFG A+   +    +S   +
Sbjct: 120 YLHDEAIVP-IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGA 177
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
             + APE+I  A+ ++   D+WS G +L ELL G+  F G
Sbjct: 178 YAWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 94  EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 144
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 145 HSLD-LIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 198
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 237

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 23/219 (10%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG        +  Y APE+I  +
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT-WXLAGTPEYLAPEIIL-S 212
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 23/219 (10%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG        +  Y APE+I  +
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT-WXLXGTPEYLAPEIIL-S 212
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              +S   ++   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 79  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 132
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK----------GEANISYICSRYY 202
           T   + HR++  +N+LV+   ++VK+ DFG  KVL +          GE+ I      ++
Sbjct: 133 TKRYI-HRNLATRNILVEN-ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI------FW 184
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
            APE +   ++++ + D+WS G VL EL 
Sbjct: 185 YAPESL-TESKFSVASDVWSFGVVLYELF 212

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVIS 91
           Y+  + +G G F  V   + L  G   A+K++L    QDR    RE  + RL +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 92  L-KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L  +C     +K E +L L+  +   T++  ++        +    +      I RGL  
Sbjct: 91  LVAYCLRERGAKHEAWL-LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS---AKVLVKGEANISYI-------CSR 200
           IH   G  HRD+KP N+L+      V L D GS   A + V+G      +       C+ 
Sbjct: 150 IHA-KGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 201 YYRAPELIFGATEYTT---SIDIWSAGCVLAELLLGQ 234
            YRAPEL F    +       D+WS GCVL  ++ G+
Sbjct: 208 SYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 124/249 (49%), Gaps = 20/249 (8%)
Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 83
           G+PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             +PN+++    +      DEL++  VMEY+       +   + M++      +     +
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 125
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 202
             + L ++H+   V HR++K  N+L+  +   VKL DFG  A++  +     + + + Y+
Sbjct: 126 CLQALEFLHS-NQVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 183
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +   
Sbjct: 184 MAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 241
Query: 263 CMNPNYTDF 271
            ++  + DF
Sbjct: 242 KLSAIFRDF 250

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 267 PLKKGAKRP 275

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 25/229 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHP 87
            Y   +V+G G+FG V   +   + +  A+K + +       D  +   E  +M   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            V+ L  C F    +D+ +L +VMEY+P   +  ++ +Y      +P  + K YT ++  
Sbjct: 136 WVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVL 185
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANI-SYICSRYYRA 204
            L  IH++ G+ HRDVKP N+L+D   H +KL DFG+  K+   G  +  + + +  Y +
Sbjct: 186 ALDAIHSM-GLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYIS 243
Query: 205 PELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 244 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 102 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 152
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 153 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 206
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 245

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 116 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 113
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 114 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 215
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 216 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 266 PLKKGAKRP 274

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NL++D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIII- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 129/311 (41%), Gaps = 61/311 (19%)
Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQL 80
           N   K + +Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI 81
Query: 81  MRLMDHPNVI---------SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR 131
            R + HPN++         S  +  F   +  ELF ++V            + YS  +  
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----------EFYSEADAS 131
Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVK 189
             +        QI   +AY H+  G+ HR++KP+NLL+        VKL DFG A  +  
Sbjct: 132 HCI-------QQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
            EA   +  +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E+   +L   
Sbjct: 184 SEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQ 241
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
           IK                  D+  P+     W  V      PEA  L   +L  +P  R 
Sbjct: 242 IKA--------------GAYDYPSPE-----WDTV-----TPEAKSLIDSMLTVNPKKRI 277
Query: 310 TALEACAHPFF 320
           TA +A   P+ 
Sbjct: 278 TADQALKVPWI 288

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/326 (25%), Positives = 136/326 (41%), Gaps = 45/326 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMDHPNVISLKHCFFS 98
           +G+G+FG+    +  ++ E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 99  TTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            T      L +VMEY    E   R+         R      + +  Q+  G++Y H +  
Sbjct: 87  PTH-----LAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAM-Q 135
Query: 157 VCHRDVKPQNLLVDPL-THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
           VCHRD+K +N L+D     ++K+C FG +K  V      S + +  Y APE++    EY 
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYD 194
Query: 216 TSI-DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
             + D+WS G  L  +L+G   F          + I           R +N  Y    + 
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------RILNVQYAIPDYV 244
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 334
            I              PE   L SR+    P+ R +  E   H +F  L+   A L N  
Sbjct: 245 HIS-------------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDN 289
Query: 335 PFPPLFNFKQELAGASPELINRLIPE 360
                F+ + +  G S E I ++I E
Sbjct: 290 TMTTQFD-ESDQPGQSIEEIMQIIAE 314

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 62/288 (21%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 62/288 (21%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 51/275 (18%)
Query: 59  GETVAIKKVLQDRRYKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE- 116
           G + + ++V + R    +E+ ++R +  HPN+I LK  + + T     F  LV + + + 
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG 109
Query: 117 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL----AYIHTVPGVCHRDVKPQNLLVDPL 172
            ++  L    +++++         T +I R L      +H +  + HRD+KP+N+L+D  
Sbjct: 110 ELFDYLTEKVTLSEKE--------TRKIMRALLEVICALHKL-NIVHRDLKPENILLDD- 159
Query: 173 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVL 227
              +KL DFG +  L  GE   S   +  Y APE+I  +       Y   +D+WS G ++
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 228 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 287
             LL G P F     +  L  I              M+ NY      Q  +  W      
Sbjct: 220 YTLLAGSPPFWHRKQMLMLRMI--------------MSGNY------QFGSPEWDD---- 255
Query: 288 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                  DL SR L   P  R TA EA AHPFF +
Sbjct: 256 -YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 62/288 (21%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 62/288 (21%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 116 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 255

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 62/288 (21%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 113/220 (51%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ ++  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPI-QIYEKI 250

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 46/232 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISLKH 94
           RV+  G F  V++A+ + +G   A+K++L +   KNR +      + +L  HPN++    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF-- 91
Query: 95  CFFSTTSKDEL------FLNLVMEYVPETMYRVLKHYSSMNQRMPL---IYVKLYTYQIF 145
           C  ++  K+E       FL L+ E     +   LK    M  R PL     +K++ YQ  
Sbjct: 92  CSAASIGKEESDTGQAEFL-LLTELCKGQLVEFLK---KMESRGPLSCDTVLKIF-YQTC 146
Query: 146 RGLAYIH-TVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSA---------------KVL 187
           R + ++H   P + HRD+K +NLL   L++Q  +KLCDFGSA               + L
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLL---LSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 188 VKGEANISYICSRYYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLF 237
           V  E  I+   +  YR PE+I  +         DIW+ GC+L  L   Q  F
Sbjct: 204 V--EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/313 (23%), Positives = 135/313 (43%), Gaps = 58/313 (18%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  +    +A+K + + +  K        RE+++   + HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
            + F      D   + L++E+ P   +Y+ L+ +   +++    +++    ++   L Y 
Sbjct: 81  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 131
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H    V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 132 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           T +   +D+W AG +  E L+G P F   +  +    I+ V                 D 
Sbjct: 189 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 230
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
           +FP              +   + DL S+LL+Y P  R        HP+     + N+R  
Sbjct: 231 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR-- 272
Query: 332 NGRPFPPLFNFKQ 344
             R  PP++   Q
Sbjct: 273 --RVLPPVYQSTQ 283

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/313 (23%), Positives = 135/313 (43%), Gaps = 58/313 (18%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  +    +A+K + + +  K        RE+++   + HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
            + F      D   + L++E+ P   +Y+ L+ +   +++    +++    ++   L Y 
Sbjct: 80  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 130
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           H    V HRD+KP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 131 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
           T +   +D+W AG +  E L+G P F   +  +    I+ V                 D 
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 229
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
           +FP              +   + DL S+LL+Y P  R        HP+     + N+R  
Sbjct: 230 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR-- 271
Query: 332 NGRPFPPLFNFKQ 344
             R  PP++   Q
Sbjct: 272 --RVLPPVYQSTQ 282

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 96
           E VVG G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN++ L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV- 154
            +          LVMEY    ++Y VL H +         +   +  Q  +G+AY+H++ 
Sbjct: 71  LNPVC-------LVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 155 -PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
              + HRD+KP NLL+      +K+CDFG+A  +     N     S  + APE +F  + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSN 179
Query: 214 YTTSIDIWSAGCVLAELL 231
           Y+   D++S G +L E++
Sbjct: 180 YSEKCDVFSWGIILWEVI 197

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 96
           E VVG G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN++ L    
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV- 154
            +          LVMEY    ++Y VL H +         +   +  Q  +G+AY+H++ 
Sbjct: 72  LNPVC-------LVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 155 -PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
              + HRD+KP NLL+      +K+CDFG+A  +     N     S  + APE +F  + 
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSN 180
Query: 214 YTTSIDIWSAGCVLAELL 231
           Y+   D++S G +L E++
Sbjct: 181 YSEKCDVFSWGIILWEVI 198

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK--------NRELQLMRLMDHP 87
           Y+   ++G GS+G V +    ET    A+K + + +  +         +E+QL+R + H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           NVI L    ++   +    + +VMEY    M  +L   S   +R P+     Y  Q+  G
Sbjct: 67  NVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLD--SVPEKRFPVCQAHGYFCQLIDG 121
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR---YYRA 204
           L Y+H+  G+ H+D+KP NLL+      +K+   G A+ L    A+ +   S+    ++ 
Sbjct: 122 LEYLHS-QGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 205 PELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-------LGTP 256
           PE+  G   ++   +DIWSAG  L  +  G   F G+N       I K         G P
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPP 239
Query: 257 TREEIRCMNPNYTDFRFP--QIKAHPWHKVFHKRMPP 291
             + ++ M       RF   QI+ H W   F K+ PP
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSW---FRKKHPP 273

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 125/283 (44%), Gaps = 45/283 (15%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMD-HPNVISLK 93
           + ++ +G GSF I  +    ++ +  A+K ++  R   N  +E+  ++L + HPN++ L 
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVK-IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 94  HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
             F      D+L   LVME +   E   R+ K           I  KL +      ++++
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHM 122
Query: 152 HTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           H V GV HRD+KP+NLL        ++K+ DFG A++       +   C + +Y APEL+
Sbjct: 123 HDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCMN 265
                Y  S D+WS G +L  +L GQ  F   +        VEI+K +            
Sbjct: 182 -NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK---------- 230
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
               DF F   +   W     K +  EA DL   LL   P+ R
Sbjct: 231 ---GDFSF---EGEAW-----KNVSQEAKDLIQGLLTVDPNKR 262

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 137/320 (42%), Gaps = 50/320 (15%)
Query: 42  VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFS 98
           +G G+FG V   +CL+       VA+K +    +Y+      + ++        ++ F  
Sbjct: 59  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 116
Query: 99  TTSKDELFLN----LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
               D    +    +  E + +  +  LK   +  Q  PL +V+   YQ+   L ++H  
Sbjct: 117 VLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQPYPLPHVRHMAYQLCHALRFLHE- 173
Query: 155 PGVCHRDVKPQNLLV-----DPLTHQVKLC-------------DFGSAKVLVKGEANISY 196
             + H D+KP+N+L      + L ++ K C             DFGSA      E + + 
Sbjct: 174 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 231
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-- 254
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG  
Sbjct: 232 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 290
Query: 255 -----TPTREEIR------CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI---DLASRL 300
                  TR++          + N +D R+ +    P  K +  +   E +   DL  R+
Sbjct: 291 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRM 349
Query: 301 LQYSPSLRCTALEACAHPFF 320
           L++ P+ R T  EA  HPFF
Sbjct: 350 LEFDPAQRITLAEALLHPFF 369

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 46/295 (15%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVA-----IKKVLQDRRYKNRELQLMRLMDHPNVI 90
           YM    +G G FGIV   +C+ET          +K    D+    +E+ ++ +  H N++
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L   F    S +EL +  + E++   +   R+      +N+R  + YV    +Q+   L
Sbjct: 65  HLHESF---ESMEELVM--IFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 207
            ++H+   + H D++P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +      +T+ D+WS G ++  LL G   F  E    Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
           YT           + +   K +  EA+D   RLL      R TA EA  HP+  +
Sbjct: 220 YT-----------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 133/315 (42%), Gaps = 74/315 (23%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV---------LVKGEANISY 196
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V         L K    + Y
Sbjct: 116 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           +      APEL+     +   +D+WS G VL  +L G+   P +   D   E        
Sbjct: 174 V------APELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------- 217
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                      Y+D++  +   +PW     K++    + L  ++L  +PS R T  +   
Sbjct: 218 -----------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKK 261
Query: 317 HPFFDELREPNARLP 331
             ++++  +  A+ P
Sbjct: 262 DRWYNKPLKKGAKRP 276

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 112/220 (50%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C    Y AP +I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPAIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 133/315 (42%), Gaps = 74/315 (23%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV---------LVKGEANISY 196
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V         L K    + Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           +      APEL+     +   +D+WS G VL  +L G+   P +   D   E        
Sbjct: 173 V------APELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------- 216
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                      Y+D++  +   +PW     K++    + L  ++L  +PS R T  +   
Sbjct: 217 -----------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKK 260
Query: 317 HPFFDELREPNARLP 331
             ++++  +  A+ P
Sbjct: 261 DRWYNKPLKKGAKRP 275

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 26/259 (10%)
Query: 5   AAVIQGNDA---VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
           A + QG  A    T + IS      N +  +   +    V+G GSFG V  ++   T E 
Sbjct: 309 AKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDEL 368
Query: 62  VAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 114
            A+K + +D   ++ +++       ++ L   P  ++  H  F T  +    L  VMEYV
Sbjct: 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR----LYFVMEYV 424
Query: 115 --PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 172
              + MY +         R    +   Y  +I  GL ++ +  G+ +RD+K  N+++D  
Sbjct: 425 NGGDLMYHI-----QQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSE 478
Query: 173 THQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
            H +K+ DFG  K  +         C    Y APE+I     Y  S+D W+ G +L E+L
Sbjct: 479 GH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEML 536
Query: 232 LGQPLFPGENAVDQLVEII 250
            GQ  F GE+  D+L + I
Sbjct: 537 AGQAPFEGEDE-DELFQSI 554

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 133/309 (43%), Gaps = 62/309 (20%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G+ G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266
Query: 323 LREPNARLP 331
             +  A+ P
Sbjct: 267 PLKKGAKRP 275

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 137/320 (42%), Gaps = 50/320 (15%)
Query: 42  VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFS 98
           +G G+FG V   +CL+       VA+K +    +Y+      + ++        ++ F  
Sbjct: 27  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 99  TTSKDELFLN----LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
               D    +    +  E + +  +  LK   +  Q  PL +V+   YQ+   L ++H  
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQPYPLPHVRHMAYQLCHALRFLHE- 141
Query: 155 PGVCHRDVKPQNLLV-----DPLTHQVKLC-------------DFGSAKVLVKGEANISY 196
             + H D+KP+N+L      + L ++ K C             DFGSA      E + + 
Sbjct: 142 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 199
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-- 254
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG  
Sbjct: 200 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 255 -----TPTREEIR------CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI---DLASRL 300
                  TR++          + N +D R+ +    P  K +  +   E +   DL  R+
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRM 317
Query: 301 LQYSPSLRCTALEACAHPFF 320
           L++ P+ R T  EA  HPFF
Sbjct: 318 LEFDPAQRITLAEALLHPFF 337

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 137/320 (42%), Gaps = 50/320 (15%)
Query: 42  VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFS 98
           +G G+FG V   +CL+       VA+K +    +Y+      + ++        ++ F  
Sbjct: 36  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 93
Query: 99  TTSKDELFLN----LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
               D    +    +  E + +  +  LK   +  Q  PL +V+   YQ+   L ++H  
Sbjct: 94  VLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQPYPLPHVRHMAYQLCHALRFLHE- 150
Query: 155 PGVCHRDVKPQNLLV-----DPLTHQVKLC-------------DFGSAKVLVKGEANISY 196
             + H D+KP+N+L      + L ++ K C             DFGSA      E + + 
Sbjct: 151 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 208
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-- 254
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG  
Sbjct: 209 VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 267
Query: 255 -----TPTREEIR------CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI---DLASRL 300
                  TR++          + N +D R+ +    P  K +  +   E +   DL  R+
Sbjct: 268 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRM 326
Query: 301 LQYSPSLRCTALEACAHPFF 320
           L++ P+ R T  EA  HPFF
Sbjct: 327 LEFDPAQRITLAEALLHPFF 346

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/325 (24%), Positives = 132/325 (40%), Gaps = 43/325 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMDHPNVISLKHCFFS 98
           +G+G+FG+    +  ++ E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 99  TTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            T      L +VMEY    E   R+         R      + +  Q+  G++Y H +  
Sbjct: 87  PTH-----LAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAM-Q 135
Query: 157 VCHRDVKPQNLLVDPL-THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
           VCHRD+K +N L+D     ++K+C FG +K  V        + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275
              D+WS G  L  +L+G   F          + I           R +N  Y    +  
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------RILNVQYAIPDYVH 245
Query: 276 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 335
           I              PE   L SR+    P+ R +  E   H +F  L+   A L N   
Sbjct: 246 IS-------------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNT 290
Query: 336 FPPLFNFKQELAGASPELINRLIPE 360
               F+ + +  G S E I ++I E
Sbjct: 291 MTTQFD-ESDQPGQSIEEIMQIIAE 314

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 62/288 (21%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ +  +++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG--EANISYICSRY-Y 202
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V      E  ++ +C    Y
Sbjct: 116 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 255

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 51/275 (18%)
Query: 59  GETVAIKKVLQDRRYKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE- 116
           G + + ++V + R    +E+ ++R +  HPN+I LK  + + T     F  LV + + + 
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG 109
Query: 117 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL----AYIHTVPGVCHRDVKPQNLLVDPL 172
            ++  L    +++++         T +I R L      +H +  + HRD+KP+N+L+D  
Sbjct: 110 ELFDYLTEKVTLSEKE--------TRKIMRALLEVICALHKL-NIVHRDLKPENILLDD- 159
Query: 173 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVL 227
              +KL DFG +  L  GE       +  Y APE+I  +       Y   +D+WS G ++
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 228 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 287
             LL G P F     +  L  I              M+ NY      Q  +  W      
Sbjct: 220 YTLLAGSPPFWHRKQMLMLRMI--------------MSGNY------QFGSPEWDD---- 255
Query: 288 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                  DL SR L   P  R TA EA AHPFF +
Sbjct: 256 -YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLKH 94
           +G G    V+ A+       VAIK +    R K        RE+     + H N++S+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
                  +D+ +  LVMEY+       L  Y   +  + +     +T QI  G+ + H +
Sbjct: 77  --IDVDEEDDCYY-LVMEYIEGP---TLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAPELIFG 210
             + HRD+KPQN+L+D     +K+ DFG AK L   E +++     + +  Y +PE   G
Sbjct: 131 R-IVHRDIKPQNILIDS-NKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 211 -ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
            AT+  T  DI+S G VL E+L+G+P F GE AV
Sbjct: 187 EATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 51/275 (18%)
Query: 59  GETVAIKKVLQDRRYKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE- 116
           G + + ++V + R    +E+ ++R +  HPN+I LK  + + T     F  LV + + + 
Sbjct: 42  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG 96
Query: 117 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL----AYIHTVPGVCHRDVKPQNLLVDPL 172
            ++  L    +++++         T +I R L      +H +  + HRD+KP+N+L+D  
Sbjct: 97  ELFDYLTEKVTLSEKE--------TRKIMRALLEVICALHKL-NIVHRDLKPENILLDD- 146
Query: 173 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVL 227
              +KL DFG +  L  GE       +  Y APE+I  +       Y   +D+WS G ++
Sbjct: 147 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 206
Query: 228 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 287
             LL G P F     +  L  I              M+ NY      Q  +  W      
Sbjct: 207 YTLLAGSPPFWHRKQMLMLRMI--------------MSGNY------QFGSPEWDD---- 242
Query: 288 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                  DL SR L   P  R TA EA AHPFF +
Sbjct: 243 -YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 133/315 (42%), Gaps = 74/315 (23%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV---------LVKGEANISY 196
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V         L K    + Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           +      APEL+     +   +D+WS G VL  +L G+   P +   D   E        
Sbjct: 173 V------APELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE-------- 216
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                      Y+D++  +   +PW     K++    + L  ++L  +PS R T  +   
Sbjct: 217 -----------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKK 260
Query: 317 HPFFDELREPNARLP 331
             ++++  +  A+ P
Sbjct: 261 DRWYNKPLKKGAKRP 275

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFS-- 98
           ++G+G FG VF+AK    G+T  I++V  +     RE++ +  +DH N++    C+    
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 99  ---TTSKDEL-------------------FLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
               TS D L                    L + ME+  +             +   ++ 
Sbjct: 79  YDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 138
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL-LVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           ++L+  QI +G+ YIH+   + HRD+KP N+ LVD  T QVK+ DFG    L        
Sbjct: 139 LELFE-QITKGVDYIHS-KKLIHRDLKPSNIFLVD--TKQVKIGDFGLVTSLKNDGKRTR 194
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
              +  Y +PE I  + +Y   +D+++ G +LAELL
Sbjct: 195 SKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 112/220 (50%), Gaps = 25/220 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K + + +  K ++++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           +  F     KD   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
           H++  + +RD+KP+NLL+D   + +++ DFG AK  VKG      +C      APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEALAPEIIL- 211
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 133/315 (42%), Gaps = 74/315 (23%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV---------LVKGEANISY 196
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V         L K    + Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           +      APEL+     +   +D+WS G VL  +L G+   P +   D   E        
Sbjct: 173 V------APELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------- 216
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                      Y+D++  +   +PW     K++    + L  ++L  +PS R T  +   
Sbjct: 217 -----------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKK 260
Query: 317 HPFFDELREPNARLP 331
             ++++  +  A+ P
Sbjct: 261 DRWYNKPLKKGAKRP 275

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDH 86
           +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++ ++++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           PN++ L         + E  L LV EY    E    ++ H     +     +      QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF-----RQI 122
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
              + Y H    + HRD+K +NLL+D     +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQ-KFIVHRDLKAENLLLDA-DXNIKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           PEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 126/306 (41%), Gaps = 61/306 (19%)
Query: 31  KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRLM 84
           K + +Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R +
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 85  DHPNVI---------SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
            HPN++         S  +  F   +  ELF ++V            + YS  +    + 
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCI- 111
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEAN 193
                  QI   +AY H+  G+ HR++KP+NLL+        VKL DFG A  +   EA 
Sbjct: 112 ------QQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164
Query: 194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
             +  +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E+      +I    
Sbjct: 165 HGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---- 219
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                           D+  P+     W  V      PEA  L   +L  +P  R TA +
Sbjct: 220 -----------KAGAYDYPSPE-----WDTV-----TPEAKSLIDSMLTVNPKKRITADQ 258
Query: 314 ACAHPF 319
           A   P+
Sbjct: 259 ALKVPW 264

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 48/303 (15%)
Query: 33  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LMRLMDHPNVIS 91
           T  Y  +  +G GS+ +  +     T    A+K + + +R    E++ L+R   HPN+I+
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGL 148
           LK  +      D  ++ +V E +   E + ++L+  + S  +   +++       I + +
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT------ITKTV 129
Query: 149 AYIHTVPGVCHRDVKPQNLL-VDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRA 204
            Y+H   GV HRD+KP N+L VD   +   +++CDFG AK L      +   C +  + A
Sbjct: 130 EYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           PE +     Y  + DIWS G +L  +L G  P   G +  D   EI+  +G+        
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIGSG------- 238
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF---F 320
                   +F  +    W+ V        A DL S++L   P  R TA     HP+   +
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
Query: 321 DEL 323
           D+L
Sbjct: 285 DQL 287

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 126/307 (41%), Gaps = 61/307 (19%)
Query: 31  KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRLM 84
           K + +Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R +
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 85  DHPNVI---------SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
            HPN++         S  +  F   +  ELF ++V            + YS  +    + 
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCI- 110
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEAN 193
                  QI   +AY H+  G+ HR++KP+NLL+        VKL DFG A  +   EA 
Sbjct: 111 ------QQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 163
Query: 194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
             +  +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E+      +I    
Sbjct: 164 HGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---- 218
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                           D+  P+     W  V      PEA  L   +L  +P  R TA +
Sbjct: 219 -----------KAGAYDYPSPE-----WDTV-----TPEAKSLIDSMLTVNPKKRITADQ 257
Query: 314 ACAHPFF 320
           A   P+ 
Sbjct: 258 ALKVPWI 264

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 128/306 (41%), Gaps = 58/306 (18%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F IV + +   TG+  A  K ++ RR  +           RE+ ++R + HPN+I
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   F + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 72  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 122
Query: 150 YIHTVPGVCHRDVKPQNLLV------DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           Y+H+   + H D+KP+N+++      +P   ++KL DFG A  +  G    +   +  + 
Sbjct: 123 YLHS-KRIAHFDLKPENIMLLDKNVPNP---RIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE++          D+WS G +   LL G   F GE   + L  I  V           
Sbjct: 179 APEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----------- 226
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
              NY DF           + +       A D   RLL   P  R T  ++  H +   +
Sbjct: 227 ---NY-DF----------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
Query: 324 REPNAR 329
           R  N R
Sbjct: 273 RRRNVR 278

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 126/307 (41%), Gaps = 61/307 (19%)
Query: 31  KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRLM 84
           K + +Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R +
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 85  DHPNVI---------SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI 135
            HPN++         S  +  F   +  ELF ++V            + YS  +    + 
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCI- 111
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEAN 193
                  QI   +AY H+  G+ HR++KP+NLL+        VKL DFG A  +   EA 
Sbjct: 112 ------QQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164
Query: 194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
             +  +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E+      +I    
Sbjct: 165 HGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---- 219
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                           D+  P+     W  V      PEA  L   +L  +P  R TA +
Sbjct: 220 -----------KAGAYDYPSPE-----WDTV-----TPEAKSLIDSMLTVNPKKRITADQ 258
Query: 314 ACAHPFF 320
           A   P+ 
Sbjct: 259 ALKVPWI 265

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 86/367 (23%), Positives = 155/367 (42%), Gaps = 63/367 (17%)
Query: 12  DAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVL 68
           D   GH+I   +G    E  + +S      +G G+FG V Q  C++    G  VA+K + 
Sbjct: 17  DDAEGHLI-YHVGDWLQERYEIVS-----TLGEGTFGRVVQ--CVDHRRGGARVALKIIK 68
Query: 69  QDRRYKNR---ELQLMRLM-----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYR 120
              +YK     E+ ++  +     D+ N+      +F         + +  E +  + + 
Sbjct: 69  NVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGH----MCISFELLGLSTFD 124
Query: 121 VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----- 175
            LK  + +    P+  V+   +Q+ + + ++H    + H D+KP+N+L     ++     
Sbjct: 125 FLKDNNYLP--YPIHQVRHMAFQLCQAVKFLHD-NKLTHTDLKPENILFVNSDYELTYNL 181
Query: 176 -------------VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWS 222
                        V++ DFGSA      E + + + +R+YRAPE+I     ++   D+WS
Sbjct: 182 EKKRDERSVKSTAVRVVDFGSATF--DHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWS 238
Query: 223 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR-------------CMNPNYT 269
            GC++ E  +G  LF   +  + L  + ++LG      IR               + N +
Sbjct: 239 IGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTS 298
Query: 270 DFRFPQIKAHPWHKVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFDELR-EP 326
             R+ +    P  +          +  DL   +L+Y P+ R T  EA  HPFF  LR EP
Sbjct: 299 AGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEP 358
Query: 327 NARLPNG 333
             +L + 
Sbjct: 359 PNKLWDS 365

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 93
           V+G GSFG V  ++   T E  A+K + +D   ++ +++       ++ L   P  ++  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 94  HCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           H  F T  +    L  VMEYV   + MY +         R    +   Y  +I  GL ++
Sbjct: 87  HSCFQTMDR----LYFVMEYVNGGDLMYHI-----QQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIFG 210
            +  G+ +RD+K  N+++D   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 138 QS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 194
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              Y  S+D W+ G +L E+L GQ  F GE+  D+L + I
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 233

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y+  + +G GSFG     K  E G    IK++       ++R    RE+ ++  M HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           +  +  F    S     L +VM+Y    +   R+      + Q   ++    +  QI   
Sbjct: 86  VQYRESFEENGS-----LYIVMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLA 137
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANISYICSRYYRAPE 206
           L ++H    + HRD+K QN+ +      V+L DFG A+VL    E   + I + YY +PE
Sbjct: 138 LKHVHDRK-ILHRDIKSQNIFLTK-DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
            I     Y    DIW+ GCVL EL   +  F   +  + +++II
Sbjct: 196 -ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 135/291 (46%), Gaps = 42/291 (14%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRLMDHPNVISL 92
           R +G GSFG V   +  +T +  A+K     K ++    +N  +ELQ+M+ ++HP +++L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
            + F     +DE  + +V++ +   +   L+++   N       VKL+  ++   L Y+ 
Sbjct: 81  WYSF-----QDEEDMFMVVDLL---LGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG-- 210
               + HRD+KP N+L+D   H V + DF  A +L +     +   ++ Y APE+     
Sbjct: 133 N-QRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--------TREEI- 261
              Y+ ++D WS G    ELL G+  +   ++     EI+    T         ++E + 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEMVS 249
Query: 262 ---RCMNPNYTDFRFPQ---IKAHP------WHKVFHKRMPPEAIDLASRL 300
              + + PN  D RF Q   ++  P      W  VF KR+ P  I    RL
Sbjct: 250 LLKKLLEPN-PDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRL 299

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
            Y  + V+G+G+  +V  A C    E VAIK++  ++   +     +E+Q M    HPN+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIY----VKLYTYQI 144
           +S    + S   KDEL+  LVM+ +   ++  ++KH  +  +    +     +     ++
Sbjct: 76  VSY---YTSFVVKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG------EANISYIC 198
             GL Y+H   G  HRDVK  N+L+      V++ DFG +  L  G      +   +++ 
Sbjct: 131 LEGLEYLHK-NGQIHRDVKAGNILLGE-DGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 233
           +  + APE++     Y    DIWS G    EL  G
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
            Y  + V+G+G+  +V  A C    E VAIK++  ++   +     +E+Q M    HPN+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIY----VKLYTYQI 144
           +S    + S   KDEL+  LVM+ +   ++  ++KH  +  +    +     +     ++
Sbjct: 71  VSY---YTSFVVKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG------EANISYIC 198
             GL Y+H   G  HRDVK  N+L+      V++ DFG +  L  G      +   +++ 
Sbjct: 126 LEGLEYLHK-NGQIHRDVKAGNILLGE-DGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 233
           +  + APE++     Y    DIWS G    EL  G
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 74/294 (25%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVI---- 90
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 91  -----SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV---------LVKGEANISY 196
            G+ Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V         L K    + Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           +      APEL+     +   +D+WS G VL  +L G+   P +   D   E        
Sbjct: 173 V------APELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------- 216
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
                      Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -----------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 128/309 (41%), Gaps = 50/309 (16%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKH 94
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            FF    +D  F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 135
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISYICSRYYRAPELIFGATE 213
             V HRD+K  NL ++    +VK+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 136 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP-N 332
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP  
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 283
Query: 333 GRPFPPLFN 341
               PP F+
Sbjct: 284 CLTIPPXFS 292

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 139/320 (43%), Gaps = 54/320 (16%)
Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN------ 75
            GE  Q  S M+   +G+G+FG V+ A   E  + V +K     KVL+D   ++      
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 76  -RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN----- 129
             E+ ++  ++H N+I +   F     +++ F  LVME          KH S ++     
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVME----------KHGSGLDLFAFI 121
Query: 130 QRMPLIYVKLYTY---QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 186
            R P +   L +Y   Q+   + Y+  +  + HRD+K +N+++      +KL DFGSA  
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVIAE-DFTIKLIDFGSAAY 179
Query: 187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD- 244
           L +G+   ++  +  Y APE++ G       +++WS G  L  L+  + P    E  V+ 
Sbjct: 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239
Query: 245 ----------QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ---IKAHPWHKVFHKRMPP 291
                     +L+ ++  L  P  E    +    TD    Q   +  + W +VF    P 
Sbjct: 240 AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPE 299
Query: 292 EAIDLASRLLQYSPSLRCTA 311
             +  A+ L   + SL   A
Sbjct: 300 SGVLSAASLEMGNRSLSDVA 319

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 124/298 (41%), Gaps = 49/298 (16%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKH 94
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            FF    +D  F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 88  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 139
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISYICSRYYRAPELIFGATE 213
             V HRD+K  NL ++    +VK+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 140 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 197
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 231
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP
Sbjct: 232 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLP 285

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 124/298 (41%), Gaps = 49/298 (16%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKH 94
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            FF    +D  F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 135
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISYICSRYYRAPELIFGATE 213
             V HRD+K  NL ++    +VK+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 136 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLP 281

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/326 (25%), Positives = 133/326 (40%), Gaps = 45/326 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMDHPNVISLKHCFFS 98
           +G G+FG+    +  +  E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 99  TTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
            T      L +VMEY    E   R+         R      + +  Q+  G++Y H +  
Sbjct: 87  PTH-----LAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYAHAM-Q 135
Query: 157 VCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
           V HRD+K +N L+D     ++K+ DFG +K  V      S + +  Y APE++    EY 
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL-KKEYD 194
Query: 216 TSI-DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
             + D+WS G  L  +L+G   F          + I           R +N  Y    + 
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------RILNVQYAIPDYV 244
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 334
            I              PE   L SR+    P+ R +  E   H +F  L+   A L N  
Sbjct: 245 HIS-------------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDN 289
Query: 335 PFPPLFNFKQELAGASPELINRLIPE 360
                F+ + +  G S E I ++I E
Sbjct: 290 TMTTQFD-ESDQPGQSIEEIMQIIAE 314

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 28  GEPKQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYK 74
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 75  NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            RE Q    ++HP ++++     + T    L   +VMEYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
           I V     Q    L + H   G+ HRDVKP N+L+   T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQ-NGIIHRDVKPANILIS-ATNAVKVVDFGIARAIADSGNSV 173
Query: 195 ----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
               + I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 174 XQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 41/294 (13%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LMRLMDHPNVISLKH 94
           Y+ +  +G GS+    +     T    A+K + + +R  + E++ L+R   HPN+I+LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 95  CFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
            +      D   + LV E +   E + ++L+      +    +      + I + + Y+H
Sbjct: 89  VY-----DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLH 138
Query: 153 TVPGVCHRDVKPQNLL-VDPLTHQ--VKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           +  GV HRD+KP N+L VD   +   +++CDFG AK L      +   C +  + APE +
Sbjct: 139 S-QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                Y    DIWS G +L  +L G   F      D   EI+  +G+             
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSG------------ 243
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
              +F  +    W+ V        A DL S++L   P  R TA +   HP+  +
Sbjct: 244 ---KF-TLSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 41/291 (14%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LMRLMDHPNVISLKH 94
           Y+ +  +G GS+    +     T    A+K + + +R  + E++ L+R   HPN+I+LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 95  CFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
            +      D   + LV E +   E + ++L+      +    +   L+T  I + + Y+H
Sbjct: 89  VY-----DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV---LHT--IGKTVEYLH 138
Query: 153 TVPGVCHRDVKPQNLL-VDPLTHQ--VKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           +  GV HRD+KP N+L VD   +   +++CDFG AK L      +   C +  + APE +
Sbjct: 139 S-QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                Y    DIWS G +L  +L G   F      D   EI+  +G+             
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSG------------ 243
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
              +F  +    W+ V        A DL S++L   P  R TA +   HP+
Sbjct: 244 ---KFT-LSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 121/247 (48%), Gaps = 26/247 (10%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQL 80
           ++ +P +    + E  +G G+FG V++AK  ETG  +A  KV++ +  +       E+++
Sbjct: 5   RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 61
Query: 81  MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLY 140
           +   DHP ++ L   ++         L +++E+ P      +     +++ +    +++ 
Sbjct: 62  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVV 114
Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICS 199
             Q+   L ++H+   + HRD+K  N+L+  L   ++L DFG SAK L   +   S+I +
Sbjct: 115 CRQMLEALNFLHS-KRIIHRDLKAGNVLM-TLEGDIRLADFGVSAKNLKTLQKRDSFIGT 172
Query: 200 RYYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---- 251
            Y+ APE++       T Y    DIWS G  L E+   +P     N +  L++I K    
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 232
Query: 252 VLGTPTR 258
            L TP++
Sbjct: 233 TLLTPSK 239

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 121/247 (48%), Gaps = 26/247 (10%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQL 80
           ++ +P +    + E  +G G+FG V++AK  ETG  +A  KV++ +  +       E+++
Sbjct: 13  RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 69
Query: 81  MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLY 140
           +   DHP ++ L   ++         L +++E+ P      +     +++ +    +++ 
Sbjct: 70  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVV 122
Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICS 199
             Q+   L ++H+   + HRD+K  N+L+  L   ++L DFG SAK L   +   S+I +
Sbjct: 123 CRQMLEALNFLHS-KRIIHRDLKAGNVLM-TLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 200 RYYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---- 251
            Y+ APE++       T Y    DIWS G  L E+   +P     N +  L++I K    
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240
Query: 252 VLGTPTR 258
            L TP++
Sbjct: 241 TLLTPSK 247

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 93/333 (27%), Positives = 143/333 (42%), Gaps = 66/333 (19%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKV----------LQDRRYKNRELQLMRLMDHPNVI 90
           V+G G+F +V +    ETG+  A+K V          L     K RE  +  ++ HP+++
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIV 89
Query: 91  SLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKL----YTYQI 144
            L      T S D + L +V E++   +  + ++K   +       +Y +     Y  QI
Sbjct: 90  EL----LETYSSDGM-LYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQI 139
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI---SYICS 199
              L Y H    + HRDVKP+N+L+    +   VKL DFG A  L  GE+ +     + +
Sbjct: 140 LEALRYCHD-NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGT 196
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I + G     
Sbjct: 197 PHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI-IKGKYK-- 250
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
               MNP              W  +        A DL  R+L   P+ R T  EA  HP+
Sbjct: 251 ----MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPW 289
Query: 320 FDELREPNA---RLPNGRPFPPLFNFKQELAGA 349
             E R+  A    LP        FN +++L GA
Sbjct: 290 LKE-RDRYAYKIHLPETVEQLRKFNARRKLKGA 321

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 130/301 (43%), Gaps = 44/301 (14%)
Query: 42  VGTGSFGIVFQAKCLE--TGETVAIKKVLQ----DRRYKNRELQLMRLMDHPNVISLKHC 95
           +G+G+FG+V   +C+E  TG     K +      D+     E+ +M  + HP +I+L   
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           F     +D+  + L++E++  +   +    ++ + +M    V  Y  Q   GL ++H   
Sbjct: 117 F-----EDKYEMVLILEFL--SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-H 168
Query: 156 GVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 214
            + H D+KP+N++ +      VK+ DFG A  L   E       +  + APE++      
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPV 227
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
               D+W+ G +   LL G   F GE+ ++ L  +            RC      D+ F 
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-----------RC------DWEFD 270
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD-ELREPNARLPNG 333
           +         F   + PEA D    LLQ  P  R T  +A  HP+   +     +R+P+ 
Sbjct: 271 E-------DAF-SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 322
Query: 334 R 334
           R
Sbjct: 323 R 323

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 48/303 (15%)
Query: 33  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LMRLMDHPNVIS 91
           T  Y  +  +G GS+ +  +     T    A+K + + +R    E++ L+R   HPN+I+
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGL 148
           LK  +      D  ++ +V E     E + ++L+  + S  +   +++       I + +
Sbjct: 81  LKDVY-----DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFT------ITKTV 129
Query: 149 AYIHTVPGVCHRDVKPQNLL-VDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRA 204
            Y+H   GV HRD+KP N+L VD   +   +++CDFG AK L      +   C +  + A
Sbjct: 130 EYLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVA 188
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           PE +     Y  + DIWS G +L   L G  P   G +  D   EI+  +G+        
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD--DTPEEILARIGSG------- 238
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF---F 320
                   +F  +    W+ V        A DL S+ L   P  R TA     HP+   +
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHW 284
Query: 321 DEL 323
           D+L
Sbjct: 285 DQL 287

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 58/308 (18%)
Query: 29  EPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QL 80
           +PK T++ +   +++G G+FG V   +   TG   A+K + ++      E+       ++
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 63
Query: 81  MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVK 138
           ++   HP + +LK+ F +        L  VMEY    E  + + +      +R      +
Sbjct: 64  LQNTRHPFLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----AR 113
Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            Y  +I   L Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C
Sbjct: 114 FYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFC 171
Query: 199 SR-YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
               Y APE +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +     
Sbjct: 172 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM----- 224
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTAL 312
            EEIR                      F + + PEA  L + LL+  P  R       A 
Sbjct: 225 -EEIR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 261
Query: 313 EACAHPFF 320
           E   H FF
Sbjct: 262 EVMEHRFF 269

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFF 97
           V+G G+FG V +A+        AIKK+       +    E+ L+  ++H  V+     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 98  S--------TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
                    T  K +  L + MEY        L H  ++NQ+    Y +L+  QI   L+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE-YWRLFR-QILEALS 130
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEANI-------- 194
           YIH+  G+ HRD+KP N+ +D  +  VK+ DFG AK       +L     N+        
Sbjct: 131 YIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           S I +  Y A E++ G   Y   ID++S G +  E++
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 123/298 (41%), Gaps = 49/298 (16%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKH 94
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            FF    +D  F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 108 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 159
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISYICSRYYRAPELIFGATE 213
             V HRD+K  NL ++    +VK+ DFG A KV   GE       +  Y APE +     
Sbjct: 160 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 217
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 251
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP
Sbjct: 252 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLP 305

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFF 97
           V+G G+FG V +A+        AIKK+       +    E+ L+  ++H  V+     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 98  S--------TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
                    T  K +  L + MEY        L H  ++NQ+    Y +L+  QI   L+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-YWRLFR-QILEALS 130
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEANI-------- 194
           YIH+  G+ HRD+KP N+ +D  +  VK+ DFG AK       +L     N+        
Sbjct: 131 YIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           S I +  Y A E++ G   Y   ID++S G +  E++
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 123/298 (41%), Gaps = 49/298 (16%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKH 94
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            FF    +D  F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 106 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 157
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISYICSRYYRAPELIFGATE 213
             V HRD+K  NL ++    +VK+ DFG A KV   GE       +  Y APE +     
Sbjct: 158 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 215
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 249
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP
Sbjct: 250 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLP 303

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 28  GEPKQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYK 74
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 75  NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            RE Q    ++HP ++++     + T    L   +VMEYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
           I V     Q    L + H   G+ HRDVKP N+++   T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSV 173
Query: 195 S----YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
           +     I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 127/309 (41%), Gaps = 50/309 (16%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKH 94
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            FF    +D  F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 82  GFF----EDNDFVFVVLELCRR---RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 133
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISYICSRYYRAPELIFGATE 213
             V HRD+K  NL ++    +VK+ DFG A KV   GE       +  Y APE +     
Sbjct: 134 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 191
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 225
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP-N 332
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP  
Sbjct: 226 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 281
Query: 333 GRPFPPLFN 341
               PP F+
Sbjct: 282 CLTIPPRFS 290

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRL 83
            +   R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+  
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKH--YSSMNQRMPLIYVKLYT 141
            D P ++ + + F +    D+L   L +    +  Y + +H  +S  + R        Y 
Sbjct: 248 GDCPFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLSQHGVFSEADMR-------FYA 297
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
            +I  GL ++H    V +RD+KP N+L+D   H V++ D G A    K + + S + +  
Sbjct: 298 AEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 354
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
           Y APE++     Y +S D +S GC+L +LL G   F      D+
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 398

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 127/306 (41%), Gaps = 58/306 (18%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F IV + +   TG+  A  K ++ RR  +           RE+ ++R + HPN+I
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   F + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 93  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 143
Query: 150 YIHTVPGVCHRDVKPQNLLV------DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           Y+H+   + H D+KP+N+++      +P   ++KL DFG A  +  G    +   +  + 
Sbjct: 144 YLHS-KRIAHFDLKPENIMLLDKNVPNP---RIKLIDFGIAHKIEAGNEFKNIFGTPEFV 199
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE++          D+WS G +   LL G   F GE   + L  I  V           
Sbjct: 200 APEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----------- 247
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
              NY DF           + +       A D   RLL   P  R    ++  H +   +
Sbjct: 248 ---NY-DF----------DEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAI 293
Query: 324 REPNAR 329
           R  N R
Sbjct: 294 RRRNVR 299

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRL 83
            +   R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKH--YSSMNQRMPLIYVKLYT 141
            D P ++ + + F +    D+L   L +    +  Y + +H  +S  + R        Y 
Sbjct: 249 GDCPFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
            +I  GL ++H    V +RD+KP N+L+D   H V++ D G A    K + + S + +  
Sbjct: 299 AEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
           Y APE++     Y +S D +S GC+L +LL G   F      D+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 57/296 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 92
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 93  KHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIF 209
           +H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C    Y APE + 
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VL 177
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 30/209 (14%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVISLKHC 95
           +G GSFG V +A+    G  VA+K +++   +  R      E+ +M+ + HPN++     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            F         L++V EY+   ++YR+L H S   +++         Y + +G+ Y+H  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 155 -PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY------YRAPEL 207
            P + HRD+K  NLLVD   + VK+CDFG +++         ++ S+       + APE+
Sbjct: 157 NPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWMAPEV 210
Query: 208 IFGATEYTTSIDIWSAGCVLAEL-LLGQP 235
           +        S D++S G +L EL  L QP
Sbjct: 211 LRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 57/296 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 92
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 93  KHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIF 209
           +H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C    Y APE + 
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VL 177
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 57/296 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 92
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 93  KHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIF 209
           +H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C    Y APE + 
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VL 177
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 88/323 (27%), Positives = 142/323 (43%), Gaps = 48/323 (14%)
Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLM 81
           +P    ++   RV+G G FG V   +   TG+  A KK+ + R  K         E Q++
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
             ++   V+SL + +    +KD L L L +    +  + +   Y       P      Y 
Sbjct: 239 EKVNSRFVVSLAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYA 292
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
            +I  GL  +H    + +RD+KP+N+L+D   H +++ D G A  + +G+     + +  
Sbjct: 293 AEICCGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           Y APE++     YT S D W+ GC+L E++ GQ  F       Q  + IK      REE+
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEV 397
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACA 316
             +           +K  P  + + +R  P+A  L S+LL   P+ R      +A E   
Sbjct: 398 ERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 317 HPFFDELREPNARLPNGRPFPPL 339
           HP F +L     RL  G   PP 
Sbjct: 445 HPLFKKLN--FKRLGAGMLEPPF 465

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 57/296 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 92
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 93  KHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 74  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 123
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIF 209
           +H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C    Y APE + 
Sbjct: 124 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 180
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 226
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 227 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 28  GEPKQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYK 74
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 75  NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            RE Q    ++HP ++++     + T    L   +VMEYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
           I V     Q    L + H   G+ HRDVKP N+++   T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSV 173
Query: 195 S----YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
           +     I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRL 83
            +   R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKH--YSSMNQRMPLIYVKLYT 141
            D P ++ + + F +    D+L   L +    +  Y + +H  +S  + R        Y 
Sbjct: 249 GDCPFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
            +I  GL ++H    V +RD+KP N+L+D   H V++ D G A    K + + S + +  
Sbjct: 299 AEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
           Y APE++     Y +S D +S GC+L +LL G   F      D+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRL 83
            +   R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKH--YSSMNQRMPLIYVKLYT 141
            D P ++ + + F +    D+L   L +    +  Y + +H  +S  + R        Y 
Sbjct: 249 GDCPFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
            +I  GL ++H    V +RD+KP N+L+D   H V++ D G A    K + + S + +  
Sbjct: 299 AEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
           Y APE++     Y +S D +S GC+L +LL G   F      D+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 57/296 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 92
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 93  KHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIF 209
           +H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C    Y APE + 
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 177
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 25/231 (10%)
Query: 28  GEPKQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYK 74
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 75  NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            RE Q    ++HP ++++     + T    L   +VMEYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
           I V     Q    L + H   G+ HRDVKP N+++   T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSV 173
Query: 195 S----YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
           +     I +  Y +PE   G +    S D++S GCVL E+L G+P F G++
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 57/296 (19%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 92
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 93  KHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-YYRAPELIF 209
           +H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C    Y APE + 
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 177
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVISLKHC 95
           +G GSFG V +A+    G  VA+K +++   +  R      E+ +M+ + HPN++     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            F         L++V EY+   ++YR+L H S   +++         Y + +G+ Y+H  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 155 -PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANISYICSRYYRAPELIFGAT 212
            P + HR++K  NLLVD   + VK+CDFG +++      ++ S   +  + APE++    
Sbjct: 157 NPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 213 EYTTSIDIWSAGCVLAEL-LLGQP 235
               S D++S G +L EL  L QP
Sbjct: 216 SNEKS-DVYSFGVILWELATLQQP 238

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 28  GEPKQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYK 74
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 75  NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            RE Q    ++HP ++++     + T    L   +VMEYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
           I V     Q    L + H   G+ HRDVKP N+++   T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSV 173
Query: 195 S----YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
           +     I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 88/323 (27%), Positives = 142/323 (43%), Gaps = 48/323 (14%)
Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLM 81
           +P    ++   RV+G G FG V   +   TG+  A KK+ + R  K         E Q++
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
             ++   V+SL + +    +KD L L L +    +  + +   Y       P      Y 
Sbjct: 239 EKVNSRFVVSLAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYA 292
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
            +I  GL  +H    + +RD+KP+N+L+D   H +++ D G A  + +G+     + +  
Sbjct: 293 AEICCGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           Y APE++     YT S D W+ GC+L E++ GQ  F       Q  + IK      REE+
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEV 397
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACA 316
             +           +K  P  + + +R  P+A  L S+LL   P+ R      +A E   
Sbjct: 398 ERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 317 HPFFDELREPNARLPNGRPFPPL 339
           HP F +L     RL  G   PP 
Sbjct: 445 HPLFKKLN--FKRLGAGMLEPPF 465

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 28  GEPKQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYK 74
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 18  GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 77
Query: 75  NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
            RE Q    ++HP ++++     + T    L   +VMEYV     R + H          
Sbjct: 78  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 135
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
           I V     Q    L + H   G+ HRDVKP N+++   T+ VK+ DFG A+ +     ++
Sbjct: 136 IEVIADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSV 190
Query: 195 S----YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
           +     I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 191 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 144 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 197
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 198 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ 257
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            + +  +  IR C+    +D   F +I+ HPW
Sbjct: 258 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 144 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 197
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 198 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ 257
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            + +  +  IR C+    +D   F +I+ HPW
Sbjct: 258 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRLMDHPNVIS 91
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + HPN+I+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   + + T      + L++E V    ++  L    S+++     ++K    QI  G+ Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 151 IHTVPGVCHRDVKPQN-LLVD---PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           +HT   + H D+KP+N +L+D   P+ H +KL DFG A  +  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-------------- 233
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                      ++ + + F  +    A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 145 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 198
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 199 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ 258
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            + +  +  IR C+    +D   F +I+ HPW
Sbjct: 259 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 145 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 198
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 199 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ 258
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            + +  +  IR C+    +D   F +I+ HPW
Sbjct: 259 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 35  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 94  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 151 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 204
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 264
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            + +  +  IR C+    +D   F +I+ HPW
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 74  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 131 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 184
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 185 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 244
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            + +  +  IR C+    +D   F +I+ HPW
Sbjct: 245 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 159 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 212
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 213 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 272
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            + +  +  IR C+    +D   F +I+ HPW
Sbjct: 273 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 40  RVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNV 89
           R +G G FG V    C +     TGE VA+K +  D     R    +E+ ++R + H ++
Sbjct: 37  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           I  K C     +     L LVMEYVP    R  + +H   + Q +      L+  QI  G
Sbjct: 96  IKYKGCCEDAGAAS---LQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEG 146
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-------EANISYICSR 200
           +AY+H    + HRD+  +N+L+D     VK+ DFG AK + +G       E   S +   
Sbjct: 147 MAYLHAQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV--- 201
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           ++ APE +     Y  S D+WS G  L ELL
Sbjct: 202 FWYAPECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 132 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 185
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 186 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 245
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            + +  +  IR C+    +D   F +I+ HPW
Sbjct: 246 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 144 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 197
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 198 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 257
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            + +  +  IR C+    +D   F +I+ HPW
Sbjct: 258 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 35/211 (16%)
Query: 40  RVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNV 89
           R +G G FG V    C +     TGE VA+K +  D     R    +E+ ++R + H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           I  K C      + E  L LVMEYVP    R  + +H   + Q +      L+  QI  G
Sbjct: 79  IKYKGC---CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEG 129
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------- 200
           +AY+H+   + HR++  +N+L+D     VK+ DFG AK + +G     Y   R       
Sbjct: 130 MAYLHSQHYI-HRNLAARNVLLDN-DRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 184
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           ++ APE +     Y  S D+WS G  L ELL
Sbjct: 185 FWYAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 138/301 (45%), Gaps = 51/301 (16%)
Query: 34  ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD-HPNVIS 91
           IS+  + V+G G+ G +      +  + VA+K++L +   + +RE+QL+R  D HPNVI 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETM--YRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
                +  T KD  F  + +E    T+  Y   K ++ +    P+  ++    Q   GLA
Sbjct: 83  -----YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQ----QTTSGLA 132
Query: 150 YIHTVPGVCHRDVKPQNLLVD-PLTH---QVKLCDFGSAKVLVKGEANISYIC----SRY 201
           ++H++  + HRD+KP N+L+  P  H   +  + DFG  K L  G  + S       +  
Sbjct: 133 HLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 202 YRAPELIFGATEY--TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
           + APE++    +   T ++DI+SAGCV    ++ +   P   ++ +   I+  LG  +  
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS-- 246
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + C++P                    K     A +L  +++   P  R +A     HPF
Sbjct: 247 -LDCLHPE-------------------KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 320 F 320
           F
Sbjct: 287 F 287

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 145 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 198
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 199 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ 258
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            +    +  IR C+    +D   F +I+ HPW
Sbjct: 259 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 145 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 198
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 199 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ 258
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            +    +  IR C+    +D   F +I+ HPW
Sbjct: 259 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 144 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 197
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 198 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ 257
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            +    +  IR C+    +D   F +I+ HPW
Sbjct: 258 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 40  RVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNV 89
           R +G G FG V    C +     TGE VA+K +  D     R    +E+ ++R + H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           I  K C      + E  L LVMEYVP    R  + +H   + Q +      L+  QI  G
Sbjct: 79  IKYKGC---CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEG 129
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------- 200
           +AY+H    + HR++  +N+L+D     VK+ DFG AK + +G     Y   R       
Sbjct: 130 MAYLHAQHYI-HRNLAARNVLLDN-DRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 184
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           ++ APE +     Y  S D+WS G  L ELL
Sbjct: 185 FWYAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 74  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 131 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 184
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 185 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 244
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            +    +  IR C+    +D   F +I+ HPW
Sbjct: 245 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 159 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 212
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 213 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 272
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            +    +  IR C+    +D   F +I+ HPW
Sbjct: 273 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 132 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 185
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 186 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 245
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            +    +  IR C+    +D   F +I+ HPW
Sbjct: 246 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 48  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 107 PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 163
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 164 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 217
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 218 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 277
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            +    +  IR C+    +D   F +I+ HPW
Sbjct: 278 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 309

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 233
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 234 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 233
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 234 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 40  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++++R + H N++
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-YTYQIFRGLA 149
             K      T      + L+ME++P      LK Y   N+    +  +L Y  QI +G+ 
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR----YYRAP 205
           Y+ +   V HRD+  +N+LV+   HQVK+ DFG  K +   +   +    R    ++ AP
Sbjct: 141 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E +  +  Y  S D+WS G  L ELL
Sbjct: 199 ECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 40  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++++R + H N++
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-YTYQIFRGLA 149
             K      T      + L+ME++P      LK Y   N+    +  +L Y  QI +G+ 
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPKNKNKINLKQQLKYAVQICKGMD 128
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR----YYRAP 205
           Y+ +   V HRD+  +N+LV+   HQVK+ DFG  K +   +   +    R    ++ AP
Sbjct: 129 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E +  +  Y  S D+WS G  L ELL
Sbjct: 187 ECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 111/246 (45%), Gaps = 33/246 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----LQLMRLMDHPNVISLKHCF 96
           +G G+FG V++A+  ET   +A  KV+  +  +  E     + ++   DHPN++ L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI--YVKLYTYQIFRGLAYIHTV 154
           +   +     L +++E+        +     +    PL    +++   Q    L Y+H  
Sbjct: 104 YYENN-----LWILIEFCAGGAVDAV----MLELERPLTESQIQVVCKQTLDALNYLHD- 153
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE 213
             + HRD+K  N+L   L   +KL DFG SAK     +   S+I + Y+ APE++   T 
Sbjct: 154 NKIIHRDLKAGNILF-TLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 214 ----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMN 265
               Y    D+WS G  L E+   +P     N +  L++I K     L  P+R      +
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR-----WS 267
Query: 266 PNYTDF 271
            N+ DF
Sbjct: 268 SNFKDF 273

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 111/246 (45%), Gaps = 33/246 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----LQLMRLMDHPNVISLKHCF 96
           +G G+FG V++A+  ET   +A  KV+  +  +  E     + ++   DHPN++ L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI--YVKLYTYQIFRGLAYIHTV 154
           +   +     L +++E+        +     +    PL    +++   Q    L Y+H  
Sbjct: 104 YYENN-----LWILIEFCAGGAVDAV----MLELERPLTESQIQVVCKQTLDALNYLHD- 153
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE 213
             + HRD+K  N+L   L   +KL DFG SAK     +   S+I + Y+ APE++   T 
Sbjct: 154 NKIIHRDLKAGNILF-TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 214 ----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMN 265
               Y    D+WS G  L E+   +P     N +  L++I K     L  P+R      +
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR-----WS 267
Query: 266 PNYTDF 271
            N+ DF
Sbjct: 268 SNFKDF 273

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 25/272 (9%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----- 79
           GK  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 80  -----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
                L++ +      VI L   F      D   L L      + ++  +    ++ + +
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
                + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K   
Sbjct: 132 ----ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 185
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 251
              +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   +
Sbjct: 186 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 245
Query: 252 VLGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
            +    +  IR C+     D   F +I+ HPW
Sbjct: 246 RVSXECQHLIRWCLALRPXDRPTFEEIQNHPW 277

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 130/303 (42%), Gaps = 28/303 (9%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           K  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL       
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 80  ----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 133
               L++ +      VI L   F      D   L L      + ++  +    ++ + + 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL- 116
Query: 134 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 193
               + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K    
Sbjct: 117 ---ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 171
Query: 194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKV 252
             +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 231
Query: 253 LGTPTREEIR-CMNPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
           + +  +  IR C+    +D   F +I+ HPW +     +P E  ++    L   PS +  
Sbjct: 232 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAA 288
Query: 311 ALE 313
           ALE
Sbjct: 289 ALE 291

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRLMDHPNVISLKHCFF 97
           +VG G++G V++ + ++TG+  AIK   V  D   +  +E+ +++   H   I+  +  F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 98  STTS----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
              +     D+L+  LVME+        L   +  N  +   ++     +I RGL+++H 
Sbjct: 91  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 147
Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK--GEANISYICSRYYRAPELIF-- 209
              V HRD+K QN+L+     +VKL DFG +  L +  G  N ++I + Y+ APE+I   
Sbjct: 148 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 204
Query: 210 ---GATEYTTSIDIWSAGCVLAELLLGQP 235
               AT Y    D+WS G    E+  G P
Sbjct: 205 ENPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 33/229 (14%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F IV + +   TG+  A  K ++ RR  +           RE+ ++R + HPN+I
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   F + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 79  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 129
Query: 150 YIHTVPGVCHRDVKPQNLLV------DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           Y+H+   + H D+KP+N+++      +P   ++KL DFG A  +  G    +   +  + 
Sbjct: 130 YLHS-KRIAHFDLKPENIMLLDKNVPNP---RIKLIDFGIAHKIEAGNEFKNIFGTPEFV 185
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           APE++          D+WS G +   LL G   F GE   + L  I  V
Sbjct: 186 APEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L++E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 56/275 (20%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 91  SL---------------KHCFFSTTSKDELFL----NLVMEYVPETMYRVLKHYSSMNQR 131
           +L               + C F   S    +L    N  + Y PE +Y+           
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKPEDLYKDF--------- 144
Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 191
           + L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLSE-KNVVKICDFGLARDIXKDP 202
Query: 192 ANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 247
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           +I +      +E  R   P+YT     Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRLMDHPNVIS 91
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   + + T      + L++E V    ++  L    S+++     ++K    QI  G+ Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 151 IHTVPGVCHRDVKPQN-LLVD---PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           +HT   + H D+KP+N +L+D   P+ H +KL DFG A  +  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-------------- 233
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                      ++ + + F       A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRLMDHPNVIS 91
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   + + T      + L++E V    ++  L    S+++     ++K    QI  G+ Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 151 IHTVPGVCHRDVKPQN-LLVD---PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           +HT   + H D+KP+N +L+D   P+ H +KL DFG A  +  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-------------- 233
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                      ++ + + F  +    A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 40  RVVGTGSFGIVFQAKCLE-----TGETVAIKKVL-----QDRRYKNRELQLMRLMDHPNV 89
           R +G G FG V    C +     TGE VA+K +      Q R    RE++++R + H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           +  K C      + E  + LVMEYVP    R  + +H   + Q +      L+  QI  G
Sbjct: 73  VKYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 123
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------- 200
           +AY+H    + HR +  +N+L+D     VK+ DFG AK + +G     Y   R       
Sbjct: 124 MAYLHAQHYI-HRALAARNVLLDN-DRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 178
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           ++ APE +     Y  S D+WS G  L ELL
Sbjct: 179 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 40  RVVGTGSFGIVFQAKCLE-----TGETVAIKKVL-----QDRRYKNRELQLMRLMDHPNV 89
           R +G G FG V    C +     TGE VA+K +      Q R    RE++++R + H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           +  K C      + E  + LVMEYVP    R  + +H   + Q +      L+  QI  G
Sbjct: 74  VKYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 124
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------- 200
           +AY+H    + HR +  +N+L+D     VK+ DFG AK + +G     Y   R       
Sbjct: 125 MAYLHAQHYI-HRALAARNVLLDN-DRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 179
Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           ++ APE +     Y  S D+WS G  L ELL
Sbjct: 180 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 130/299 (43%), Gaps = 50/299 (16%)
Query: 58  TGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV--- 114
             + ++IK    D  +KN ELQ++  + +   ++   C    T+ DE+++  + EY+   
Sbjct: 77  NNDKISIKSKYDD--FKN-ELQIITDIKNEYCLT---CEGIITNYDEVYI--IYEYMEND 128
Query: 115 -----PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 169
                 E  + + K+Y+     +P+  +K     +    +YIH    +CHRDVKP N+L+
Sbjct: 129 SILKFDEYFFVLDKNYTCF---IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185
Query: 170 DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT-TSIDIWSAGCVLA 228
           D    +VKL DFG ++ +V  +   S   +  +  PE     + Y    +DIWS G  L 
Sbjct: 186 DK-NGRVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243
Query: 229 ELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 288
            +      F  + +   LVE+   + T   E             +P  + H  + + +K+
Sbjct: 244 VMFYNVVPFSLKIS---LVELFNNIRTKNIE-------------YPLDRNHFLYPLTNKK 287
Query: 289 -------MPPEAIDLASRLLQYSPSLRCTALEACAHPFF-----DELREPNARLPNGRP 335
                  +  E ID     L+ +P+ R T+ +A  H +      ++LRE +  L   R 
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRK 346

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 29  EPKQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHP 87
           E ++ + +M  +  VG GSFG V + K  +TG   A+KKV  +  ++  EL     +  P
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSP 110
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            ++ L         ++  ++N+ ME +   ++ +++K    + +   L Y+     Q   
Sbjct: 111 RIVPL-----YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALE 161
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY----- 201
           GL Y+HT   + H DVK  N+L+     +  LCDFG A  L       S +   Y     
Sbjct: 162 GLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 202 -YRAPELIFGATEYTTSIDIWSAGCVLAELLLG 233
            + APE++ G       +DIWS+ C++  +L G
Sbjct: 221 THMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 29  EPKQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHP 87
           E ++ + +M  +  VG GSFG V + K  +TG   A+KKV  +  ++  EL     +  P
Sbjct: 68  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSP 126
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            ++ L         ++  ++N+ ME +   ++ +++K    + +   L Y+     Q   
Sbjct: 127 RIVPL-----YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALE 177
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY----- 201
           GL Y+HT   + H DVK  N+L+     +  LCDFG A  L       S +   Y     
Sbjct: 178 GLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 236
Query: 202 -YRAPELIFGATEYTTSIDIWSAGCVLAELLLG 233
            + APE++ G       +DIWS+ C++  +L G
Sbjct: 237 THMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 268

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRLMDHPNVIS 91
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   + + T      + L++E V    ++  L    S+++     ++K    QI  G+ Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 151 IHTVPGVCHRDVKPQN-LLVD---PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           +HT   + H D+KP+N +L+D   P+ H +KL DFG A  +  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-------------- 233
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                      ++ + + F  +    A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 94  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 147
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 148 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 205
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 206 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 252
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 253 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHPNVI 90
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L   + + T      + L+ E V    ++  L    S+ +     ++K    QI  G+ 
Sbjct: 78  TLHEVYENKTD-----VILIGELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 150 YIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 25/271 (9%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           K  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL       
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 80  ----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 133
               L++ +      VI L   F      D   L L      + ++  +    ++ + + 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL- 116
Query: 134 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 193
               + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K    
Sbjct: 117 ---ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 171
Query: 194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKV 252
             +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 231
Query: 253 LGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
           + +  +  IR C+    +D   F +I+ HPW
Sbjct: 232 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/335 (22%), Positives = 144/335 (42%), Gaps = 58/335 (17%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRLMDHPNVIS 91
           +++  R +G G+FG V   + ++  +  A+K V   ++Y      E  +++ + + ++ +
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTYQIFRGLA 149
                +         + L+ E +  ++Y ++   +Y+  +    +  +KLY  +I + L 
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFH----IEDIKLYCIEILKALN 151
Query: 150 YIHTVPGVCHRDVKPQNLLVDP------------------------LTHQVKLCDFGSAK 185
           Y+  +  + H D+KP+N+L+D                          +  +KL DFG A 
Sbjct: 152 YLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
              K + + S I +R YRAPE+I     +  S D+WS GCVLAEL  G  LF     ++ 
Sbjct: 211 F--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267
Query: 246 LVEIIKVL----------GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH--KRMPPEA 293
           L  +  ++           T T    + +N +     +P+  A   + + H  K +P   
Sbjct: 268 LAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPE-NASSINSIKHVKKCLPLYK 325
Query: 294 I-------DLASRLLQYSPSLRCTALEACAHPFFD 321
           I       D    +LQ  P+LR +  E   H F +
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 25/271 (9%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           K  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL       
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 80  ----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 133
               L++ +      VI L   F      D   L L      + ++  +    ++ + + 
Sbjct: 60  MEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL- 115
Query: 134 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 193
               + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K    
Sbjct: 116 ---ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 170
Query: 194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKV 252
             +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 171 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 230
Query: 253 LGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
           + +  +  IR C+    +D   F +I+ HPW
Sbjct: 231 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 25/271 (9%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           K  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL       
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 80  ----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 133
               L++ +      VI L   F      D   L L      + ++  +    ++ + + 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL- 116
Query: 134 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 193
               + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K    
Sbjct: 117 ---ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 171
Query: 194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKV 252
             +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 231
Query: 253 LGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
           + +  +  IR C+    +D   F +I+ HPW
Sbjct: 232 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRLMDHPNVIS 91
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   + + T      + L++E V    ++  L    S+++     ++K    QI  G+ Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 151 IHTVPGVCHRDVKPQN-LLVD---PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           +HT   + H D+KP+N +L+D   P+ H +KL DFG A  +  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-------------- 233
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                      ++ + + F       A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVISLKHCF 96
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTY--QIFRGLAYIH 152
              T      L ++MEY        L   S+++  +  PL   ++ T   +I +GL Y+H
Sbjct: 75  LKDTK-----LWIIMEY--------LGGGSALDLLEPGPLDETQIATILREILKGLDYLH 121
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIFGA 211
           +   + HRD+K  N+L+     +VKL DFG A  L   +    +++ + ++ APE+I   
Sbjct: 122 SEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQ 178
Query: 212 TEYTTSIDIWSAGCVLAELLLGQP 235
           + Y +  DIWS G    EL  G+P
Sbjct: 179 SAYDSKADIWSLGITAIELARGEP 202

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVISLKHCF 96
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D P V      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTY--QIFRGLAYIH 152
              T      L ++MEY        L   S+++  +  PL   ++ T   +I +GL Y+H
Sbjct: 90  LKDTK-----LWIIMEY--------LGGGSALDLLEPGPLDETQIATILREILKGLDYLH 136
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 211
           +   + HRD+K  N+L+     +VKL DFG A  L   +   + ++ + ++ APE+I   
Sbjct: 137 SEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQ 193
Query: 212 TEYTTSIDIWSAGCVLAELLLGQP 235
           + Y +  DIWS G    EL  G+P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEP 217

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 86  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 139
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 140 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 197
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 198 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 244
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 245 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 130 YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 183
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 184 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 241
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 242 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 288
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 289 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 124 YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 178 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 282
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 283 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 52/293 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRLMDHPNVIS 91
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   + + T      + L++E V    ++  L    S+++     ++K    QI  G+ Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 151 IHTVPGVCHRDVKPQN-LLVD---PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           +HT   + H D+KP+N +L+D   P+ H +KL DFG A  +  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-------------- 233
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                      ++ + + F       A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 119/268 (44%), Gaps = 19/268 (7%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL------- 78
           K  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL       
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 79  -QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIY 136
            +++ L    +  S          + + F+ ++    P + ++  +    ++ + +    
Sbjct: 60  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEEL---- 115
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 196
            + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K      +
Sbjct: 116 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 173
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGT 255
             +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 233
Query: 256 PTREEIR-CMNPNYTDF-RFPQIKAHPW 281
             +  IR C+    +D   F +I+ HPW
Sbjct: 234 ECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 33/246 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----LQLMRLMDHPNVISLKHCF 96
           +G G+FG V++A+  ET   +A  KV+  +  +  E     + ++   DHPN++ L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI--YVKLYTYQIFRGLAYIHTV 154
           +   +     L +++E+        +     +    PL    +++   Q    L Y+H  
Sbjct: 104 YYENN-----LWILIEFCAGGAVDAV----MLELERPLTESQIQVVCKQTLDALNYLHD- 153
Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE 213
             + HRD+K  N+L   L   +KL DFG SAK     +    +I + Y+ APE++   T 
Sbjct: 154 NKIIHRDLKAGNILF-TLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 214 ----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMN 265
               Y    D+WS G  L E+   +P     N +  L++I K     L  P+R      +
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR-----WS 267
Query: 266 PNYTDF 271
            N+ DF
Sbjct: 268 SNFKDF 273

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 78  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 132 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 189
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 236
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 237 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 80  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 134 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 191
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 238
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 239 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 79  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 132
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 133 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 190
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 191 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 237
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 238 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVISLKHCF 96
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTY--QIFRGLAYIH 152
              T      L ++MEY        L   S+++  +  PL   ++ T   +I +GL Y+H
Sbjct: 75  LKDTK-----LWIIMEY--------LGGGSALDLLEPGPLDETQIATILREILKGLDYLH 121
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 211
           +   + HRD+K  N+L+     +VKL DFG A  L   +   + ++ + ++ APE+I   
Sbjct: 122 SEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQ 178
Query: 212 TEYTTSIDIWSAGCVLAELLLGQP 235
           + Y +  DIWS G    EL  G+P
Sbjct: 179 SAYDSKADIWSLGITAIELARGEP 202

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 84  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 137
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 138 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 195
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 196 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 242
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 243 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVISLKHCF 96
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D P V      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTY--QIFRGLAYIH 152
              T      L ++MEY        L   S+++  +  PL   ++ T   +I +GL Y+H
Sbjct: 95  LKDTK-----LWIIMEY--------LGGGSALDLLEPGPLDETQIATILREILKGLDYLH 141
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIFGA 211
           +   + HRD+K  N+L+     +VKL DFG A  L   +    +++ + ++ APE+I   
Sbjct: 142 SEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQ 198
Query: 212 TEYTTSIDIWSAGCVLAELLLGQP 235
           + Y +  DIWS G    EL  G+P
Sbjct: 199 SAYDSKADIWSLGITAIELARGEP 222

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 85  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 138
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 139 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 196
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 197 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 243
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 244 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 29  EPKQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHP 87
           E ++ + +M  +  +G GSFG V + K  +TG   A+KKV  +  ++  EL     +  P
Sbjct: 66  EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSP 124
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            ++ L         ++  ++N+ ME +   ++ +++K    + +   L Y+     Q   
Sbjct: 125 RIVPL-----YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALE 175
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY----- 201
           GL Y+HT   + H DVK  N+L+     +  LCDFG A  L       S +   Y     
Sbjct: 176 GLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 234
Query: 202 -YRAPELIFGATEYTTSIDIWSAGCVLAELLLG 233
            + APE++ G       +DIWS+ C++  +L G
Sbjct: 235 THMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 266

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 80  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 134 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 191
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 238
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 239 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 116/271 (42%), Gaps = 25/271 (9%)
Query: 26  KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------ 79
           K  EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL       
Sbjct: 24  KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 80  ----LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 133
               L++ +      VI L   F      D   L L      + ++  +    ++ + + 
Sbjct: 83  MEVVLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL- 138
Query: 134 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 193
               + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K    
Sbjct: 139 ---ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 193
Query: 194 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKV 252
             +  +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 194 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 253
Query: 253 LGTPTREEIR-CMNPNYTDF-RFPQIKAHPW 281
           +    +  IR C+    +D   F +I+ HPW
Sbjct: 254 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 284

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 78  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +      + YY APE + 
Sbjct: 132 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE-VL 189
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 236
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 237 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 126/319 (39%), Gaps = 51/319 (15%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-------DHPNVISL 92
           +V+G G+F  V   K  +TG+  A+K + +    K  E+   R         D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              F     +DE +L LVMEY       +L   S   +R+P    + Y  +I   +  +H
Sbjct: 127 HFAF-----QDENYLYLVMEYY--VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEA-NISYICSRYYRAPELIFG 210
            + G  HRD+KP N+L+D   H ++L DFGS  K+   G   ++  + +  Y +PE++  
Sbjct: 180 RL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 211 ATEYTT------SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
                         D W+ G    E+  GQ  F  ++  +   +I+              
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-------------- 283
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDE 322
                       K H    +  + +P EA D   RLL    +   R  A +   HPFF  
Sbjct: 284 ----------HYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFG 333
Query: 323 LREPNARLPNGRPFPPLFN 341
           L     R  +  PF P F 
Sbjct: 334 LDWDGLR-DSVPPFTPDFE 351

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVISLKHCF 96
           +G GSFG V++     T E VAIK +       +     +E+ ++   D P +      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP----LIYVKLYTYQIFRGLAYIH 152
             +T      L ++MEY        L   S+++   P      Y+     +I +GL Y+H
Sbjct: 87  LKSTK-----LWIIMEY--------LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 133
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 211
           +   + HRD+K  N+L+      VKL DFG A  L   +   + ++ + ++ APE+I   
Sbjct: 134 SERKI-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQ 190
Query: 212 TEYTTSIDIWSAGCVLAELLLGQP 235
           + Y    DIWS G    EL  G+P
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEP 214

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 32/238 (13%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFF 97
           V+G G+FG V +A+        AIKK+       +    E+ L+  ++H  V+     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 98  S--------TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
                    T  K +  L +  EY        L H  ++NQ+    Y +L+  QI   L+
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE-YWRLFR-QILEALS 130
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEANI-------- 194
           YIH+  G+ HR++KP N+ +D  +  VK+ DFG AK       +L     N+        
Sbjct: 131 YIHS-QGIIHRNLKPXNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           S I +  Y A E++ G   Y   ID +S G +  E +   P   G   V+ L ++  V
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKLRSV 244

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 199
           Y++Q+ RG+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLSSRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 200 RY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT 255
           R    + APE IF    Y+T  D+WS G +L E+  LG   +PG       V++ +   +
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFCS 313
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
             RE +R   P Y+     QI    WH+   +R  P   +L  +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 17/220 (7%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRL 83
           P +   Y     +GTGS+G   + +    G+ +  K++        +++    E+ L+R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTY 142
           + HPN++         T+     L +VMEY     +  V+   +   Q +   +V     
Sbjct: 62  LKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 143 QIFRGLAYIHTVPG----VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-NISYI 197
           Q+   L   H        V HRD+KP N+ +D     VKL DFG A++L   E     ++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDEDFAKEFV 177
Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 237
            + YY +PE +     Y    DIWS GC+L EL    P F
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 112/261 (42%), Gaps = 24/261 (9%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----------LMRLMD 85
           Y    ++G+G FG V+    +     VAIK V +DR     EL           L++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 86  H--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
                VI L   F      D   L L      + ++  +    ++ + +     + + +Q
Sbjct: 66  SGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ 118
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYS 176
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIR 262
            PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  IR
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIR 236
Query: 263 -CMNPNYTDF-RFPQIKAHPW 281
            C+    +D   F +I+ HPW
Sbjct: 237 WCLALRPSDRPTFEEIQNHPW 257

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 116/268 (43%), Gaps = 25/268 (9%)
Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------- 79
           EP ++  Y    ++G+G FG V+    +     VAIK V +DR     EL          
Sbjct: 3   EPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 61
Query: 80  -LMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
            L++ +      VI L   F      D   L L      + ++  +    ++ + +    
Sbjct: 62  VLLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL---- 114
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 196
            + + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K      +
Sbjct: 115 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 172
Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGT 255
             +R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 173 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 232
Query: 256 PTREEIR-CMNPNYTDF-RFPQIKAHPW 281
             +  IR C+    +D   F +I+ HPW
Sbjct: 233 ECQHLIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 112/261 (42%), Gaps = 24/261 (9%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----------LMRLMD 85
           Y    ++G+G FG V+    +     VAIK V +DR     EL           L++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 86  H--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
                VI L   F      D   L L      + ++  +    ++ + +     + + +Q
Sbjct: 66  SGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ 118
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYS 176
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIR 262
            PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  IR
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIR 236
Query: 263 -CMNPNYTDF-RFPQIKAHPW 281
            C+    +D   F +I+ HPW
Sbjct: 237 WCLALRPSDRPTFEEIQNHPW 257

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS 101
           +G GSFG V + +  +TG   A+KKV  +  ++  EL     +  P ++ L         
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV-FRAEELMACAGLTSPRIVPLY-----GAV 154
Query: 102 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 160
           ++  ++N+ ME +   ++ +++K    + +   L Y+     Q   GL Y+H+   + H 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 209
Query: 161 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY------YRAPELIFGATEY 214
           DVK  N+L+        LCDFG A  L       S +   Y      + APE++ G +  
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-C 268
Query: 215 TTSIDIWSAGCVLAELLLG 233
              +D+WS+ C++  +L G
Sbjct: 269 DAKVDVWSSCCMMLHMLNG 287

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRL 83
           P +   Y     +GTGS+G   + +    G+ +  K++        +++    E+ L+R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTY 142
           + HPN++         T+     L +VMEY     +  V+   +   Q +   +V     
Sbjct: 62  LKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 143 QIFRGLAYIHTVPG----VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-NISYI 197
           Q+   L   H        V HRD+KP N+ +D     VKL DFG A++L    +   +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFV 177
Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 237
            + YY +PE +     Y    DIWS GC+L EL    P F
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRL 83
           P +   Y     +GTGS+G   + +    G+ +  K++        +++    E+ L+R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTY 142
           + HPN++         T+     L +VMEY     +  V+   +   Q +   +V     
Sbjct: 62  LKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 143 QIFRGLAYIHTVPG----VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-NISYI 197
           Q+   L   H        V HRD+KP N+ +D     VKL DFG A++L    +   +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 237
            + YY +PE +     Y    DIWS GC+L EL    P F
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 91/333 (27%), Positives = 139/333 (41%), Gaps = 66/333 (19%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKV----------LQDRRYKNRELQLMRLMDHPNVI 90
           V+G G F +V +    ETG+  A+K V          L     K RE  +  ++ HP+++
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIV 91
Query: 91  SLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKL----YTYQI 144
            L      T S D + L +V E++   +  + ++K   +       +Y +     Y  QI
Sbjct: 92  EL----LETYSSDGM-LYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQI 141
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI---SYICS 199
              L Y H    + HRDVKP  +L+    +   VKL  FG A  L  GE+ +     + +
Sbjct: 142 LEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGT 198
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I + G     
Sbjct: 199 PHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI-IKGKYK-- 252
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
               MNP              W  +        A DL  R+L   P+ R T  EA  HP+
Sbjct: 253 ----MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPW 291
Query: 320 FDELREPNA---RLPNGRPFPPLFNFKQELAGA 349
             E R+  A    LP        FN +++L GA
Sbjct: 292 LKE-RDRYAYKIHLPETVEQLRKFNARRKLKGA 323

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TG  VA+K++       +R   RE+Q+++ +    ++  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              +    +    L LVMEY+P    R  + +H + ++    L    LY+ QI +G+ Y+
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLL----LYSSQICKGMEYL 130
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-------VKGEANISYICSRYYRA 204
            +   V HRD+  +N+LV+   H VK+ DFG AK+L       V  E   S I   ++ A
Sbjct: 131 GSRRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYA 185
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELL 231
           PE +     ++   D+WS G VL EL 
Sbjct: 186 PESL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 91/333 (27%), Positives = 139/333 (41%), Gaps = 66/333 (19%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKV----------LQDRRYKNRELQLMRLMDHPNVI 90
           V+G G F +V +    ETG+  A+K V          L     K RE  +  ++ HP+++
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIV 89
Query: 91  SLKHCFFSTTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKL----YTYQI 144
            L      T S D + L +V E++   +  + ++K   +       +Y +     Y  QI
Sbjct: 90  EL----LETYSSDGM-LYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQI 139
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANI---SYICS 199
              L Y H    + HRDVKP  +L+    +   VKL  FG A  L  GE+ +     + +
Sbjct: 140 LEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGT 196
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I + G     
Sbjct: 197 PHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI-IKGKYK-- 250
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
               MNP              W  +        A DL  R+L   P+ R T  EA  HP+
Sbjct: 251 ----MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPW 289
Query: 320 FDELREPNA---RLPNGRPFPPLFNFKQELAGA 349
             E R+  A    LP        FN +++L GA
Sbjct: 290 LKE-RDRYAYKIHLPETVEQLRKFNARRKLKGA 321

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 91
           +V+G G+FG V   K L+  + V   K+L       R        E  ++   D   + +
Sbjct: 80  KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L + F     +D+  L LVM+Y       +L   S    R+P    + Y  ++   +  +
Sbjct: 139 LHYAF-----QDDNNLYLVMDYY--VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELI- 208
           H +  V HRD+KP N+L+D   H ++L DFGS  K++  G    S  + +  Y +PE++ 
Sbjct: 192 HQLHYV-HRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 209 ---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
               G   Y    D WS G  + E+L G+  F  E+ V+   +I+ 
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TG  VA+K++       +R   RE+Q+++ +    ++  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              +    +    L LVMEY+P    R  + +H + ++    L    LY+ QI +G+ Y+
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLL----LYSSQICKGMEYL 131
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-------VKGEANISYICSRYYRA 204
            +   V HRD+  +N+LV+   H VK+ DFG AK+L       V  E   S I   ++ A
Sbjct: 132 GSRRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYA 186
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELL 231
           PE +     ++   D+WS G VL EL 
Sbjct: 187 PESL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TG  VA+K++       +R   RE+Q+++ +    ++  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              +    +    L LVMEY+P    R  + +H + ++    L    LY+ QI +G+ Y+
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLL----LYSSQICKGMEYL 143
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-------VKGEANISYICSRYYRA 204
            +   V HRD+  +N+LV+   H VK+ DFG AK+L       V  E   S I   ++ A
Sbjct: 144 GSRRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYA 198
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELL 231
           PE +     ++   D+WS G VL EL 
Sbjct: 199 PESL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 111/261 (42%), Gaps = 24/261 (9%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ----------LMRLMD 85
           Y    ++G+G FG V+    +     VAIK V +DR     EL           L++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 86  H--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
                VI L   F      D   L L      + ++  +    ++ + +     + + +Q
Sbjct: 66  SGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ 118
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYS 176
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIR 262
            PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  IR
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIR 236
Query: 263 -CMNPNYTDF-RFPQIKAHPW 281
            C+    +D   F +I+ HPW
Sbjct: 237 WCLALRPSDRPTFEEIQNHPW 257

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 42  VGTGSFGIV----FQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLK 93
           +G G+FG V    +      TG  VA+K++       +R   RE+Q+++ +    ++  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              +     +   L LVMEY+P    R  + +H + ++    L    LY+ QI +G+ Y+
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLRDFLQRHRARLDASRLL----LYSSQICKGMEYL 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-------VKGEANISYICSRYYRA 204
            +   V HRD+  +N+LV+   H VK+ DFG AK+L       V  E   S I   ++ A
Sbjct: 128 GSRRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYA 182
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELL 231
           PE +     ++   D+WS G VL EL 
Sbjct: 183 PESL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 16/222 (7%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFST 99
           +V+G G+FG V   K   T    A+K + +    K  E    R  +  +V+    C + T
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 153
Query: 100 T----SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                 +DE  L LVM+Y       +L   S    ++P    + Y  ++   +  IH + 
Sbjct: 154 ALHYAFQDENHLYLVMDYYVGG--DLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELI----F 209
            V HRD+KP N+L+D   H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 212 YV-HRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
           G  +Y    D WS G  + E+L G+  F  E+ V+   +I+ 
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 311

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 46/306 (15%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----RELQ-LMRLMDHPNVIS 91
           +   ++G G++  V  A  L+ G+  A+K + +   +      RE++ L +   + N++ 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           L   F     +D+    LV E +   ++   ++     N+R     V+     +   L +
Sbjct: 76  LIEFF-----EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVR----DVAAALDF 126
Query: 151 IHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDF--GSAKVLVKGEANISY------ICSR 200
           +HT  G+ HRD+KP+N+L +       VK+CDF  GS   L      I+         S 
Sbjct: 127 LHT-KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 201 YYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD---QLVEIIKVL 253
            Y APE++      AT Y    D+WS G VL  +L G P F G    D      E+ +V 
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVC 245
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                E I+     + D  +  I +             EA DL S+LL      R +A +
Sbjct: 246 QNKLFESIQEGKYEFPDKDWAHISS-------------EAKDLISKLLVRDAKQRLSAAQ 292
Query: 314 ACAHPF 319
              HP+
Sbjct: 293 VLQHPW 298

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 16/222 (7%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFST 99
           +V+G G+FG V   K   T    A+K + +    K  E    R  +  +V+    C + T
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 137
Query: 100 T----SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                 +DE  L LVM+Y       +L   S    ++P    + Y  ++   +  IH + 
Sbjct: 138 ALHYAFQDENHLYLVMDYYVGG--DLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELI----F 209
            V HRD+KP N+L+D   H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 196 YV-HRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
           G  +Y    D WS G  + E+L G+  F  E+ V+   +I+ 
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 89/366 (24%), Positives = 140/366 (38%), Gaps = 88/366 (24%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM--------DHP 87
           Y   R +G G F  V+ +  ++  + VA+K V     Y    L  +RL+        + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 88  N---VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           N   V+ L   F   +  +   + +V E +   + + +    S  Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWI--IKSNYQGLPLPCVKKIIQQV 155
Query: 145 FRGLAYIHTVPGVCHRDVKPQNL------------------------------------- 167
            +GL Y+HT   + H D+KP+N+                                     
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 168 -----LVDPL------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 216
                LV+PL        +VK+ D G+A  + K       I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSG-YNT 272
Query: 217 SIDIWSAGCVLAELLLGQPLF---PGENAV---DQLVEIIKVLGTPTREEIRCMNPNYTD 270
             DIWS  C+  EL  G  LF    GE      D +  II++LG   R+ I  +   Y+ 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYSK 330
Query: 271 FRFPQ-------IKAHPW--------HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
             F +        K  PW           + +       D    +L+  P  R TA E  
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
Query: 316 AHPFFD 321
            HP+ +
Sbjct: 391 RHPWLN 396

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLM 81
           P + +   ++RV+G G FG+V+  + ++  +     AIK +     +Q      RE  LM
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-Y 140
           R ++HPNV++L            + L       P   +  L  +    QR P +   + +
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 200
             Q+ RG+ Y+     V HRD+  +N ++D  +  VK+ DFG A+ ++  E   S    R
Sbjct: 130 GLQVARGMEYLAEQKFV-HRDLAARNCMLDE-SFTVKVADFGLARDILDRE-YYSVQQHR 186
Query: 201 YYRAPELIFGATE------YTTSIDIWSAGCVLAELL 231
           + R P + + A E      +TT  D+WS G +L ELL
Sbjct: 187 HARLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 89/366 (24%), Positives = 140/366 (38%), Gaps = 88/366 (24%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM--------DHP 87
           Y   R +G G F  V+ +  ++  + VA+K V     Y    L  +RL+        + P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 88  N---VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           N   V+ L   F   +  +   + +V E +   + + +    S  Q +PL  VK    Q+
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWI--IKSNYQGLPLPCVKKIIQQV 139
Query: 145 FRGLAYIHTVPGVCHRDVKPQNL------------------------------------- 167
            +GL Y+HT   + H D+KP+N+                                     
Sbjct: 140 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 199
Query: 168 -----LVDPL------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 216
                LV+PL        +VK+ D G+A  + K       I +R YR+ E++ G+  Y T
Sbjct: 200 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSG-YNT 256
Query: 217 SIDIWSAGCVLAELLLGQPLF---PGENAV---DQLVEIIKVLGTPTREEIRCMNPNYTD 270
             DIWS  C+  EL  G  LF    GE      D +  II++LG   R+ I  +   Y+ 
Sbjct: 257 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYSK 314
Query: 271 FRFPQ-------IKAHPW--------HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
             F +        K  PW           + +       D    +L+  P  R TA E  
Sbjct: 315 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 374
Query: 316 AHPFFD 321
            HP+ +
Sbjct: 375 RHPWLN 380

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 91  SL---------------KHCFF---STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           +L               + C F   ST  + +    +  +  PE +Y+           +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF---------L 136
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIXKDPD 194
Query: 193 NISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           I +      +E  R   P+YT     Q     WH
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 91  SL---------------KHCFF---STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           +L               + C F   ST  + +    +  +  PE +Y+           +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF---------L 136
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIXKDPD 194
Query: 193 NISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           I +      +E  R   P+YT     Q     WH
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 44/268 (16%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMP----------LIYVK 138
           +L        +K    L +++E+     +  L  Y  S  N+ +P          L ++ 
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCK---FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K    +    
Sbjct: 148 CYSFQVAKGMEFLASRKXI-HRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGD 205
Query: 199 SRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 254
           +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +   
Sbjct: 206 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFC 257
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWH 282
              +E  R   P+YT     Q     WH
Sbjct: 258 RRLKEGTRMRAPDYTTPEMYQTMLDCWH 285

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 91  SL---------------KHCFF---STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           +L               + C F   ST  + +    +  +  PE +Y+           +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF---------L 145
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIXKDPD 203
Query: 193 NISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 255
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           I +      +E  R   P+YT     Q     WH
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 91  SL---------------KHCFF---STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           +L               + C F   ST  + +    +  +  PE +Y+           +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF---------L 145
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIYKDPD 203
Query: 193 NISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 255
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           I +      +E  R   P+YT     Q     WH
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS 101
           +G GSFG V + +  +TG   A+KKV  +  ++  EL     +  P ++ L         
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV-FRAEELMACAGLTSPRIVPLY-----GAV 135
Query: 102 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 160
           ++  ++N+ ME +   ++ +++K    + +   L Y+     Q   GL Y+H+   + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 190
Query: 161 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY------YRAPELIFGATEY 214
           DVK  N+L+        LCDFG A  L         +   Y      + APE++ G +  
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-C 249
Query: 215 TTSIDIWSAGCVLAELLLG 233
              +D+WS+ C++  +L G
Sbjct: 250 DAKVDVWSSCCMMLHMLNG 268

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 55/275 (20%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 91  SL---------------KHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQR 131
           +L               + C F   S      +   E+VP    E +Y+           
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLST--YLRSKRNEFVPYKTPEDLYKDF--------- 144
Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 191
           + L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIXKDP 202
Query: 192 ANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 247
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           +I +      +E  R   P+YT     Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 75/289 (25%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHC 95
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++L+       ++  
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLK-----CVRES 87
Query: 96  FFSTTSKDELFLNLVMEYVPETM--------YRVLKHY------SSMNQRMPLIYVKLYT 141
             S  +KD + + L+ ++    M        + VL H+       S  Q +P+  VK   
Sbjct: 88  DPSDPNKD-MVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSII 146
Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQN----------------------------------- 166
            Q+ +GL Y+H+   + H D+KP+N                                   
Sbjct: 147 RQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVST 206
Query: 167 -----LLVDPLTHQ------VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 215
                LLV+PL  +      VK+ D G+A  + K       I +R YR+ E++ GA  Y+
Sbjct: 207 APAADLLVNPLDPRNADKIRVKIADLGNACWVHK--HFTEDIQTRQYRSIEVLIGAG-YS 263
Query: 216 TSIDIWSAGCVLAELLLGQPLF---PGENAV---DQLVEIIKVLGTPTR 258
           T  DIWS  C+  EL  G  LF    GE+     D +  II++LG+  R
Sbjct: 264 TPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPR 312

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 106/222 (47%), Gaps = 22/222 (9%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 90
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE ++++ ++H N++
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
            L      TT++ ++   L+ME+ P  ++Y VL+  S+    +P     +    +  G+ 
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMN 126
Query: 150 YIHTVPGVCHRDVKPQNLL--VDPLTHQV-KLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           ++    G+ HR++KP N++  +      V KL DFG+A+ L   E  +S   +  Y  P+
Sbjct: 127 HLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 207 LIFGAT-------EYTTSIDIWSAGCVLAELLLGQ-PLFPGE 240
           +   A        +Y  ++D+WS G        G  P  P E
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 91  SL---------------KHCFF---STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           +L               + C F   ST  + +    +  +  PE +Y+           +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF---------L 136
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIYKDPD 194
Query: 193 NISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           I +      +E  R   P+YT     Q     WH
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 91  SL---------------KHCFF---STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           +L               + C F   ST  + +    +  +  PE +Y+           +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF---------L 136
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIYKDPD 194
Query: 193 NISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           I +      +E  R   P+YT     Q     WH
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 91  SL---------------KHCFF---STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           +L               + C F   ST  + +    +  +  PE +Y+           +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF---------L 145
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIYKDPD 203
Query: 193 NISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 255
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           I +      +E  R   P+YT     Q     WH
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 91  SL---------------KHCFF---STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           +L               + C F   ST  + +    +  +  PE +Y+           +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF---------L 182
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   
Sbjct: 183 TLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIYKDPD 240
Query: 193 NISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 292
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           I +      +E  R   P+YT     Q     WH
Sbjct: 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVISLKHCF 96
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D   V      +
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
              +      L ++MEY+       L      ++      +K    +I +GL Y+H+   
Sbjct: 91  LKGSK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 141
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIFGATEYT 215
           + HRD+K  N+L+      VKL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 142 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 198
Query: 216 TSIDIWSAGCVLAELLLGQP 235
           +  DIWS G    EL  G+P
Sbjct: 199 SKADIWSLGITAIELAKGEP 218

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 91  SL---------------KHCFF---STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           +L               + C F   ST  + +    +  +  PE +Y+           +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF---------L 147
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + K   
Sbjct: 148 TLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIYKDPD 205
Query: 193 NISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 257
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           I +      +E  R   P+YT     Q     WH
Sbjct: 258 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 291

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 9/207 (4%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDHPNVISLKHCFFSTT 100
           +G GS+G VF+ +  E G   A+K+ +   R  K+R  +L  +  H  V     C     
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 101 SKDE-LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 159
           + +E   L L  E    ++    +H  +    +P   V  Y       LA++H+  G+ H
Sbjct: 125 AWEEGGILYLQTELCGPSLQ---QHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVH 180
Query: 160 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSID 219
            DVKP N+ + P   + KL DFG    L    A         Y APEL+ G+  Y T+ D
Sbjct: 181 LDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS--YGTAAD 237
Query: 220 IWSAGCVLAELLLGQPLFPGENAVDQL 246
           ++S G  + E+     L  G     QL
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 30/231 (12%)
Query: 28  GEPKQTIS---YMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDRRYKNRE---- 77
           G P+  I+    +  R++G G FG V++       GE   VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 78  -LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLI 135
              +M+ +DHP+++ L          +E    ++ME  P   Y  L HY   N+  + ++
Sbjct: 75  EAVIMKNLDHPHIVKLIGII------EEEPTWIIMELYP---YGELGHYLERNKNSLKVL 125
Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---A 192
            + LY+ QI + +AY+ ++  V HRD+  +N+LV      VKL DFG ++ +   +   A
Sbjct: 126 TLVLYSLQICKAMAYLESINCV-HRDIAVRNILVAS-PECVKLGDFGLSRYIEDEDYYKA 183
Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGEN 241
           +++ +  + + +PE I     +TT+ D+W     + E+L    QP F  EN
Sbjct: 184 SVTRLPIK-WMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 125/305 (40%), Gaps = 61/305 (20%)
Query: 25  GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-------- 76
           G +G+  Q   Y  +  +G GS+G+V  A   E   T    KVL  ++   +        
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYN-ENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 77  -----------------------ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 113
                                  E+ +++ +DHPNV+ L        ++D L++  V E 
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL-DDPNEDHLYM--VFEL 119
Query: 114 V---PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 170
           V   P      LK  S    R        Y   + +G+ Y+H    + HRD+KP NLLV 
Sbjct: 120 VNQGPVMEVPTLKPLSEDQAR-------FYFQDLIKGIEYLH-YQKIIHRDIKPSNLLVG 171
Query: 171 PLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGATEYTT--SIDIWSAGCVL 227
              H +K+ DFG +      +A +S  + +  + APE +    +  +  ++D+W+ G  L
Sbjct: 172 EDGH-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 228 AELLLGQPLFPGENAVDQLVEI-IKVLGTPTREEI---------RCMNPN-YTDFRFPQI 276
              + GQ  F  E  +    +I  + L  P + +I         R ++ N  +    P+I
Sbjct: 231 YCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
Query: 277 KAHPW 281
           K HPW
Sbjct: 291 KLHPW 295

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 95  CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F   ++K +L   +V ++    ++Y  L    +  +   LI +     Q  RG+ Y+H 
Sbjct: 72  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHASETKFEMKKLIDI---ARQTARGMDYLH- 125
Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF- 209
              + HRD+K  N+ +    + VK+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 126 AKSIIHRDLKSNNIFLHE-DNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 210 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++E++
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 37/293 (12%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K  LQD     RE++L  R    P+++ +   
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +V E +        + +S +  R    + +    +I + +     Y+
Sbjct: 124 YENLYAGRKCLL-IVXECLDGG-----ELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE + 
Sbjct: 178 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           G  +Y  S D WS G +   LL G P F   + +         +    +  IR       
Sbjct: 236 GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL--------AISPGXKTRIR-----XG 282
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+  +
Sbjct: 283 QYEFPNPE---WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPWIXQ 327

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQ-------LMRLMDHPNVISLK 93
           +G GSF  V+  K L+T  TV +    LQDR+    E Q        ++ + HPN++   
Sbjct: 34  IGRGSFKTVY--KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             + ST    +  + +       T+   LK +     ++    ++ +  QI +GL ++HT
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV----LRSWCRQILKGLQFLHT 147
Query: 154 -VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
             P + HRD+K  N+ +   T  VK+ D G A  L +     + I +  + APE      
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EE 204
Query: 213 EYTTSIDIWSAG-CVLAELLLGQPLFPGENAV 243
           +Y  S+D+++ G C L       P    +NA 
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYPYSECQNAA 236

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 40  RVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDRRYKNRE-----LQLMRLMDHPNVIS 91
           R++G G FG V++       GE   VA+K   +D    N+E       +M+ +DHP+++ 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAY 150
           L         ++  +  ++ME  P   Y  L HY   N+  + ++ + LY+ QI + +AY
Sbjct: 74  L----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPEL 207
           + ++  V HRD+  +N+LV      VKL DFG ++ +   +   A+++ +  + + +PE 
Sbjct: 125 LESINCV-HRDIAVRNILVAS-PECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPES 181
Query: 208 IFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGEN 241
           I     +TT+ D+W     + E+L    QP F  EN
Sbjct: 182 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM---------DHPNVISL 92
           +G G FG+VF+AK        AIK++    R  NREL   ++M         +HP ++  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 93  KHCFFSTTSKDEL-------FLNLVMEYV-PETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
            + +    + ++L       +L + M+    E +   +    ++ +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF-LQI 127
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA------------ 192
              + ++H+  G+ HRD+KP N+    +   VK+ DFG    + + E             
Sbjct: 128 AEAVEFLHS-KGLMHRDLKPSNIFF-TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 193 -NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
            +   + ++ Y +PE I G + Y+  +DI+S G +L ELL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 27/216 (12%)
Query: 40  RVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDRRYKNRE-----LQLMRLMDHPNVIS 91
           R++G G FG V++       GE   VA+K   +D    N+E       +M+ +DHP+++ 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAY 150
           L          +E    ++ME  P   Y  L HY   N+  + ++ + LY+ QI + +AY
Sbjct: 78  LIGII------EEEPTWIIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPEL 207
           + ++  V HRD+  +N+LV      VKL DFG ++ +   +   A+++ +  + + +PE 
Sbjct: 129 LESINCV-HRDIAVRNILVAS-PECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPES 185
Query: 208 IFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGEN 241
           I     +TT+ D+W     + E+L    QP F  EN
Sbjct: 186 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 105/222 (47%), Gaps = 22/222 (9%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 90
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE ++++ ++H N++
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
            L      TT++ ++   L+ME+ P  ++Y VL+  S+    +P     +    +  G+ 
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMN 126
Query: 150 YIHTVPGVCHRDVKPQNLL--VDPLTHQV-KLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           ++    G+ HR++KP N++  +      V KL DFG+A+ L   E  +    +  Y  P+
Sbjct: 127 HLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 207 LIFGAT-------EYTTSIDIWSAGCVLAELLLGQ-PLFPGE 240
           +   A        +Y  ++D+WS G        G  P  P E
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 21/246 (8%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDH-PNV 89
           +  + +G G F +V Q     TG+  A K + + RR ++       E+ ++ L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           I+L H  +  TS+    + L++EY    E     L   + M     +I +     QI  G
Sbjct: 92  INL-HEVYENTSE----IILILEYAAGGEIFSLCLPELAEMVSENDVIRL---IKQILEG 143
Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
           + Y+H    + H D+KPQN+L+  +     +K+ DFG ++ +         + +  Y AP
Sbjct: 144 VYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E I      TT+ D+W+ G +   LL     F GE+  +  + I +V    + E    ++
Sbjct: 203 E-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261
Query: 266 PNYTDF 271
              TDF
Sbjct: 262 QLATDF 267

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 23/175 (13%)
Query: 112 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 171
           E  PE +Y+           + L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+  
Sbjct: 186 EEAPEDLYKDF---------LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE 235
Query: 172 LTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLA 228
             + VK+CDFG A+ + K    +    +R    + APE IF    YT   D+WS G +L 
Sbjct: 236 -KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLW 293
Query: 229 ELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           E+  LG   +PG       V+I +      +E  R   P+YT     Q     WH
Sbjct: 294 EIFSLGASPYPG-------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 341

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 23/175 (13%)
Query: 112 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 171
           E  PE +Y+           + L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+  
Sbjct: 184 EEAPEDLYKDF---------LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE 233
Query: 172 LTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLA 228
             + VK+CDFG A+ + K    +    +R    + APE IF    YT   D+WS G +L 
Sbjct: 234 -KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLW 291
Query: 229 ELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           E+  LG   +PG       V+I +      +E  R   P+YT     Q     WH
Sbjct: 292 EIFSLGASPYPG-------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 339

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 23/175 (13%)
Query: 112 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 171
           E  PE +Y+           + L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+  
Sbjct: 177 EEAPEDLYKDF---------LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE 226
Query: 172 LTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLA 228
             + VK+CDFG A+ + K    +    +R    + APE IF    YT   D+WS G +L 
Sbjct: 227 -KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLW 284
Query: 229 ELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           E+  LG   +PG       V+I +      +E  R   P+YT     Q     WH
Sbjct: 285 EIFSLGASPYPG-------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 332

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 23/175 (13%)
Query: 112 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 171
           E  PE +Y+           + L ++  Y++Q+ +G+ ++ +   + HRD+  +N+L+  
Sbjct: 179 EEAPEDLYKDF---------LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE 228
Query: 172 LTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLA 228
             + VK+CDFG A+ + K    +    +R    + APE IF    YT   D+WS G +L 
Sbjct: 229 -KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLW 286
Query: 229 ELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           E+  LG   +PG       V+I +      +E  R   P+YT     Q     WH
Sbjct: 287 EIFSLGASPYPG-------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRLMDHPNVI 90
           +V+G+G+FG V++   +  GETV I    K+L +       ++      +M  MDHP+++
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     S T      + LV + +P    +  V +H  ++  ++ L     +  QI +G+
Sbjct: 104 RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN----WCVQIAKGM 153
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A 
Sbjct: 154 MYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T   D+WS G  + EL+
Sbjct: 212 ECIH-YRKFTHQSDVWSYGVTIWELM 236

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 5/145 (3%)
Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 199
           + +Q+   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTR 258
           R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 259 EEIR-CMNPNYTDF-RFPQIKAHPW 281
             IR C+    +D   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 114/250 (45%), Gaps = 31/250 (12%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-RELQLMRLMDHPNVISLKHCFFST 99
           ++G G +G V++    E    V +      + + N + +  + LM+H N+          
Sbjct: 20  LIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERV 79
Query: 100 TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT------ 153
           T+   +   LVMEY P      L  Y S++    +   +L  + + RGLAY+HT      
Sbjct: 80  TADGRMEYLLVMEYYPNG---SLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTELPRGD 135
Query: 154 --VPGVCHRDVKPQNLLVDPLTHQVKLCDFG-----SAKVLVK-GE---ANISYICSRYY 202
              P + HRD+  +N+LV      V + DFG     +   LV+ GE   A IS + +  Y
Sbjct: 136 HYKPAISHRDLNSRNVLVKNDGTCV-ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 203 RAPELIFGATEYTT------SIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVEIIKVLG 254
            APE++ GA            +D+++ G +  E+ +    LFPGE+  + Q+    +V  
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254
Query: 255 TPTREEIRCM 264
            PT E+++ +
Sbjct: 255 HPTFEDMQVL 264

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRLMDHPNVI 90
           +V+G+G+FG V++   +  GETV I    K+L +       ++      +M  MDHP+++
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     S T      + LV + +P    +  V +H  ++  ++ L     +  QI +G+
Sbjct: 81  RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN----WCVQIAKGM 130
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A 
Sbjct: 131 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T   D+WS G  + EL+
Sbjct: 189 ECIH-YRKFTHQSDVWSYGVTIWELM 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 95  CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F   ++K +L   +V ++    ++Y  L    +  +   LI +     Q  RG+ Y+H 
Sbjct: 84  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHASETKFEMKKLIDI---ARQTARGMDYLH- 137
Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA--KVLVKGEANISYIC-SRYYRAPELIF- 209
              + HRD+K  N+ +    + VK+ DFG A  K    G      +  S  + APE+I  
Sbjct: 138 AKSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 210 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 44/268 (16%)
Query: 42  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRLMDHPNVI 90
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMP----------LIYVK 138
           +L        +K    L +++E+     +  L  Y  S  N+ +P          L ++ 
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCK---FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+ DFG A+ + K    +    
Sbjct: 148 XYSFQVAKGMEFLASRKXI-HRDLAARNILLSE-KNVVKIXDFGLARDIYKDPDYVRKGD 205
Query: 199 SRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 254
           +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +   
Sbjct: 206 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFX 257
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWH 282
              +E  R   P+YT     Q     WH
Sbjct: 258 RRLKEGTRMRAPDYTTPEMYQTMLDCWH 285

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 38/221 (17%)
Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKK-VLQDRRYK----------NRELQLMRLMDHP 87
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+ +M  ++HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY-VKL-YTYQ 143
           N++ L     +          +VME+VP  +  +R+L      ++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLL------DKAHPIKWSVKLRLMLD 130
Query: 144 IFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLC----DFGSAKVLVKGEANISYIC 198
           I  G+ Y+    P + HRD++  N+ +  L     +C    DFG+++  V   + +  + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL--LG 188
Query: 199 SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLF 237
           +  + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 189 NFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+M+ +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNR--ELQ 79
             +P     ++  RV+G G FG VF  +   TG+  A KK+ + R      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY--- 136
           ++  +    ++SL + F + T      L LVM  +     R   H  ++++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-S 195
              YT QI  GL ++H    + +RD+KP+N+L+D     V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKG 348
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           Y  +  + APEL+ G  EY  S+D ++ G  L E++
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+M+ +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNR--ELQ 79
             +P     ++  RV+G G FG VF  +   TG+  A KK+ + R      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY--- 136
           ++  +    ++SL + F + T      L LVM  +     R   H  ++++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-S 195
              YT QI  GL ++H    + +RD+KP+N+L+D     V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKG 348
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           Y  +  + APEL+ G  EY  S+D ++ G  L E++
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNR--ELQ 79
             +P     ++  RV+G G FG VF  +   TG+  A KK+ + R      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY--- 136
           ++  +    ++SL + F + T      L LVM  +     R   H  ++++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-S 195
              YT QI  GL ++H    + +RD+KP+N+L+D     V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKG 348
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           Y  +  + APEL+ G  EY  S+D ++ G  L E++
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYKNRELQLMRLMDHPNVISLK 93
           +G G FG+V++     T  TVA+KK+         + ++  ++E+++M    H N++ L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY-VKLYTYQ-IFRGLAYI 151
              FS+   D   L LV  Y+P     +L   S ++   PL + ++    Q    G+ ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPELI 208
           H    + HRD+K  N+L+D      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLDE-AFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQP 235
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYKNRELQLMRLMDHPNVISLK 93
           +G G FG+V++     T  TVA+KK+         + ++  ++E+++M    H N++ L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY-VKLYTYQ-IFRGLAYI 151
              FS+   D   L LV  Y+P     +L   S ++   PL + ++    Q    G+ ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPELI 208
           H    + HRD+K  N+L+D      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLDE-AFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQP 235
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNR--ELQ 79
             +P     ++  RV+G G FG VF  +   TG+  A KK+ + R      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY--- 136
           ++  +    ++SL + F + T      L LVM  +     R   H  ++++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-S 195
              YT QI  GL ++H    + +RD+KP+N+L+D     V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKG 348
Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           Y  +  + APEL+ G  EY  S+D ++ G  L E++
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N+  L  
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 85
Query: 95  CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             +ST  +    L +V ++    ++Y  L    +  +   LI +     Q  RG+ Y+H 
Sbjct: 86  MGYSTAPQ----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDI---ARQTARGMDYLH- 137
Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA--KVLVKGEANISYIC-SRYYRAPELIF- 209
              + HRD+K  N+ +    + VK+ DFG A  K    G      +  S  + APE+I  
Sbjct: 138 AKSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 210 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+M+ +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYKNRELQLMRLMDHPNVISLK 93
           +G G FG+V++     T  TVA+KK+         + ++  ++E+++M    H N++ L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY-VKLYTYQ-IFRGLAYI 151
              FS+   D   L LV  Y+P     +L   S ++   PL + ++    Q    G+ ++
Sbjct: 90  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 143
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPELI 208
           H    + HRD+K  N+L+D      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 144 HENHHI-HRDIKSANILLDE-AFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQP 235
            G  E T   DI+S G VL E++ G P
Sbjct: 202 RG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRLMDHPNVISLKHCF 96
           +G+GSFG V++ K       V I KV+     Q + ++N E+ ++R   H N++     F
Sbjct: 44  IGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL----LF 97
Query: 97  FSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
               +KD L   +V ++    ++Y+ L    +  Q   LI +   T Q   G+ Y+H   
Sbjct: 98  MGYMTKDNL--AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ---GMDYLHA-K 151
Query: 156 GVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVK--GEANISY-ICSRYYRAPELIFGA 211
            + HRD+K  N+ + + LT  VK+ DFG A V  +  G   +     S  + APE+I   
Sbjct: 152 NIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 212 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
               ++   D++S G VL EL+ G+  +   N  DQ++ ++
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+M+ +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 38/221 (17%)
Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKK-VLQDRRYK----------NRELQLMRLMDHP 87
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+ +M  ++HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY-VKL-YTYQ 143
           N++ L     +          +VME+VP  +  +R+L      ++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLL------DKAHPIKWSVKLRLMLD 130
Query: 144 IFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLC----DFGSAKVLVKGEANISYIC 198
           I  G+ Y+    P + HRD++  N+ +  L     +C    DFG ++  V   + +  + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL--LG 188
Query: 199 SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLF 237
           +  + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 189 NFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+M+ +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+M+ +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 81  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+M+ +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 84  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 133
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 134 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 192 ESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+M+ +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+M+ +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 129/304 (42%), Gaps = 40/304 (13%)
Query: 29  EPKQ---TISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           EPK+   T  Y ++++V+G G  G V +     TG+  A+K +    + +       +  
Sbjct: 20  EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQAS 79
Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
             P+++ +   + +        L ++ME +        + +S + +R    + +    +I
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLL-IIMECMEGG-----ELFSRIQERGDQAFTEREAAEI 133
Query: 145 FRGLA----YIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYIC 198
            R +     ++H+   + HRDVKP+NLL         +KL DFG AK   +  A  +   
Sbjct: 134 MRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCY 191
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           + YY APE + G  +Y  S D+WS G ++  LL G P F             + +    +
Sbjct: 192 TPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMK 242
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
             IR        + FP  +   W +V       +A  L   LL+  P+ R T  +   HP
Sbjct: 243 RRIR-----LGQYGFPNPE---WSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHP 289
Query: 319 FFDE 322
           + ++
Sbjct: 290 WINQ 293

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 114/248 (45%), Gaps = 51/248 (20%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNRE-----LQ 79
           P++ + +   +V+G+G+FG V  A      +T     VA+K + +      RE     L+
Sbjct: 43  PRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 80  LM-RLMDHPNVISL--------------KHCFFSTT-----SKDELFLNLVMEYVPETMY 119
           +M +L  H N+++L              ++C +        SK E F    +EY  +   
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ--- 157
Query: 120 RVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-- 175
           + L+    +N    L +  L  + YQ+ +G+ ++       HRD+  +N+LV   TH   
Sbjct: 158 KRLEEEEDLN---VLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLV---THGKV 210
Query: 176 VKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL- 231
           VK+CDFG A+ ++     +    +R    + APE +F    YT   D+WS G +L E+  
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFS 269
Query: 232 LGQPLFPG 239
           LG   +PG
Sbjct: 270 LGVNPYPG 277

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 129/304 (42%), Gaps = 40/304 (13%)
Query: 29  EPKQ---TISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM 84
           EPK+   T  Y ++++V+G G  G V +     TG+  A+K +    + +       +  
Sbjct: 1   EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQAS 60
Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
             P+++ +   + +        L ++ME +        + +S + +R    + +    +I
Sbjct: 61  GGPHIVCILDVYENMHHGKRCLL-IIMECMEGG-----ELFSRIQERGDQAFTEREAAEI 114
Query: 145 FRGLA----YIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYIC 198
            R +     ++H+   + HRDVKP+NLL         +KL DFG AK   +  A  +   
Sbjct: 115 MRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCY 172
Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           + YY APE + G  +Y  S D+WS G ++  LL G P F             + +    +
Sbjct: 173 TPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMK 223
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
             IR        + FP  +   W +V       +A  L   LL+  P+ R T  +   HP
Sbjct: 224 RRIR-----LGQYGFPNPE---WSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHP 270
Query: 319 FFDE 322
           + ++
Sbjct: 271 WINQ 274

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 95  CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F   ++K +L   +V ++    ++Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 95  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 149
Query: 154 VPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 209
              + HRD+K  N+ + + LT  VK+ DFG A V  +   +  +     S  + APE+I 
Sbjct: 150 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 210 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 95  CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F   ++K +L   +V ++    ++Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 150
Query: 154 VPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 209
              + HRD+K  N+ + + LT  VK+ DFG A V  +   +  +     S  + APE+I 
Sbjct: 151 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 210 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 95  CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F   ++K +L   +V ++    ++Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 70  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 124
Query: 154 VPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 209
              + HRD+K  N+ + + LT  VK+ DFG A V  +   +  +     S  + APE+I 
Sbjct: 125 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 210 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRLMDHPNVI 90
           +V+G+G FG V +   +  GE++ I    KV++D+  +         +  +  +DH +++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L      ++      L LV +Y+P    +  V +H  ++  ++ L     +  QI +G+
Sbjct: 97  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 146
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+    G+ HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A 
Sbjct: 147 YYLEE-HGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 206 ELI-FGATEYTTSIDIWSAGCVLAELL 231
           E I FG  +YT   D+WS G  + EL+
Sbjct: 205 ESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            F   ++K +L   +V ++   +   +  H   +  +  +I +     Q  +G+ Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA- 127
Query: 155 PGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 210
             + HRD+K  N+ + + LT  VK+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 128 KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 211 ATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            F   ++K +L   +V ++   +   +  H   +  +  +I +     Q  +G+ Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA- 127
Query: 155 PGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 210
             + HRD+K  N+ + + LT  VK+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 128 KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 211 ATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            F   ++K +L   +V ++   +   +  H   +  +  +I +     Q  +G+ Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA- 122
Query: 155 PGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 210
             + HRD+K  N+ + + LT  VK+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 123 KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 211 ATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 37/220 (16%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMD---------- 85
           Y    ++G G FG VF    L     VAIK +      +NR L    L D          
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-----PRNRVLGWSPLSDSVTCPLEVAL 87
Query: 86  ---------HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
                    HP VI L   F       E F+ ++   +P         +  + ++ PL  
Sbjct: 88  LWKVGAGGGHPGVIRLLDWF----ETQEGFMLVLERPLPAQ-----DLFDYITEKGPLGE 138
Query: 137 --VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
              + +  Q+   + + H+  GV HRD+K +N+L+D      KL DFGS   L+  E   
Sbjct: 139 GPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT 196
Query: 195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 234
            +  +R Y  PE I     +     +WS G +L +++ G 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRLMDHPNVI 90
           +V+G+G FG V +   +  GE++ I    KV++D+  +         +  +  +DH +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L      ++      L LV +Y+P    +  V +H  ++  ++ L     +  QI +G+
Sbjct: 79  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 128
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+    G+ HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A 
Sbjct: 129 YYLEE-HGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 206 ELI-FGATEYTTSIDIWSAGCVLAELL 231
           E I FG  +YT   D+WS G  + EL+
Sbjct: 187 ESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 81  RLLGICLTST------VQLITQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+ + +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 83  RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+ + +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 88  RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 140 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+ + +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 81  RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 133 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 97/194 (50%), Gaps = 21/194 (10%)
Query: 79  QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYV 137
           Q +  + HP+++ + +    T    +    +VMEYV  +++ R      S  Q++P+   
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR------SKGQKLPVAEA 184
Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
             Y  +I   L+Y+H++ G+ + D+KP+N+++     Q+KL D G+   +     +  Y+
Sbjct: 185 IAYLLEILPALSYLHSI-GLVYNDLKPENIML--TEEQLKLIDLGAVSRI----NSFGYL 237
Query: 198 -CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE---IIKVL 253
             +  ++APE++   T  T + DI++ G  LA L L  P   G   VD L E   ++K  
Sbjct: 238 YGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKTY 294
Query: 254 GTPTREEIRCMNPN 267
            +  R   R ++P+
Sbjct: 295 DSYGRLLRRAIDPD 308

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 38/221 (17%)
Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKK-VLQDRRYK----------NRELQLMRLMDHP 87
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+ +M  ++HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY-VKL-YTYQ 143
           N++ L     +          +VME+VP  +  +R+L      ++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLL------DKAHPIKWSVKLRLMLD 130
Query: 144 IFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLC----DFGSAKVLVKGEANISYIC 198
           I  G+ Y+    P + HRD++  N+ +  L     +C    DF  ++  V   + +  + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL--LG 188
Query: 199 SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLF 237
           +  + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 189 NFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 30/223 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 95  CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F   ++K +L   +V ++    ++Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLH- 149
Query: 154 VPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSA--KVLVKGEANISYIC-SRYYRAPELIF 209
              + HRD+K  N+ + + LT  VK+ DFG A  K    G      +  S  + APE+I 
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 210 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 30/223 (13%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 95  CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F   ++K +L   +V ++    ++Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 88  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 142
Query: 154 VPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSA--KVLVKGEANISYIC-SRYYRAPELIF 209
              + HRD+K  N+ + + LT  VK+ DFG A  K    G      +  S  + APE+I 
Sbjct: 143 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 210 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 88  RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 137
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 138 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 196 ESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 87  RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 136
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 137 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 195 ESILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+ + +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 84  RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 136 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 91  RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 140
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 141 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 199 ESILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+ + +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 83  RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+ + +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 106 RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 158 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 216 ILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 81  RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+ +G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+M+ +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 88  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 137
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 138 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 196 ESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 84  RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 133
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 134 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 192 ESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------LMRLMDHPN 88
           ++  + ++G G FG V++ + L  G  VA+K+ L++ R +  ELQ      ++ +  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQI--F 145
           ++ L+   F  T  + L   LV  Y+   ++   L+       + PL + K     +   
Sbjct: 89  LLRLRG--FCMTPTERL---LVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSA 141
Query: 146 RGLAYIHT--VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-- 201
           RGLAY+H    P + HRDVK  N+L+D     V + DFG AK++   + ++         
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIG 200
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 237
           + APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 201 HIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 98
           +G G FG V++    +   TVA+K + +D        +E  +M+ + HPN++ L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 74
Query: 99  TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLY-TYQIFRGLAYIHTVPGV 157
             +++  F  ++ E++  T   +L +    N++     V LY   QI   + Y+      
Sbjct: 75  VCTREPPFY-IITEFM--TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNF 130
Query: 158 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEY 214
            HRD+  +N LV    H VK+ DFG ++ L+ G+   ++  +++   + APE +    ++
Sbjct: 131 IHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL-AYNKF 187
Query: 215 TTSIDIWSAGCVLAEL-LLGQPLFPG 239
           +   D+W+ G +L E+   G   +PG
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 84  RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 133
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 134 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 192 ESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ------LMRLMDHPN 88
           ++  + ++G G FG V++ + L  G  VA+K+ L++ R +  ELQ      ++ +  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQI--F 145
           ++ L+   F  T  + L   LV  Y+   ++   L+       + PL + K     +   
Sbjct: 97  LLRLRG--FCMTPTERL---LVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSA 149
Query: 146 RGLAYIHT--VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-- 201
           RGLAY+H    P + HRDVK  N+L+D     V + DFG AK++   + ++         
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIG 208
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 237
           + APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 209 HIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            F   ++K +L   +V ++   +   +  H   +  +  +I +     Q  +G+ Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA- 122
Query: 155 PGVCHRDVKPQNLLV-DPLTHQVKLCDFGSA--KVLVKGEANISYIC-SRYYRAPELIFG 210
             + HRD+K  N+ + + LT  VK+ DFG A  K    G      +  S  + APE+I  
Sbjct: 123 KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 211 ATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 43  GTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYKNRELQLMRLMDHPNVISLKH 94
           G G FG+V++     T  TVA+KK+         + ++  ++E+++     H N++ L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY-VKLYTYQ-IFRGLAYIH 152
             FS+   D   L LV  Y P     +L   S ++   PL +  +    Q    G+ ++H
Sbjct: 87  LGFSSDGDD---LCLVYVYXPNG--SLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 209
               + HRD+K  N+L+D      K+ DFG A+   K    +     + +  Y APE + 
Sbjct: 142 ENHHI-HRDIKSANILLDE-AFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR 199
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQP 235
           G  E T   DI+S G VL E++ G P
Sbjct: 200 G--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+ + +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 81  RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 133 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 94
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N+  L  
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
             +ST  +    L +V ++   +   +  H   +  +  +I +     Q  +G+ Y+H  
Sbjct: 70  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA- 122
Query: 155 PGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 210
             + HRD+K  N+ + + LT  VK+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 123 KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 211 ATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+ + +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 75  RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I     YT   D+WS G  + EL+
Sbjct: 185 ILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   + + R       N+E+     +M  +D+P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 115 RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 164
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 165 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 223 ESILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 34  ISYMA-ERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLM 84
           +SY+  E V+G G FG V + +    G+    VAIK +      + RR    E  +M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQ 143
           +HPN+I L+     T S   + L   ME         L  +  +N  +  +I +      
Sbjct: 73  EHPNIIRLEGVV--TNSMPVMILTEFME------NGALDSFLRLNDGQFTVIQLVGMLRG 124
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 200
           I  G+ Y+  +  V HRD+  +N+LV+      K+ DFG ++ L +  ++ +Y  S    
Sbjct: 125 IASGMRYLAEMSYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 201 ---YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
               + APE I    ++T++ D WS G V+ E++
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI  G+
Sbjct: 78  RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAEGM 127
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 128 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 186 ESILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME       R        +  + L  + LY YQ+   LAY+
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV   T  VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRL--MDHPNVISLKHCFF 97
           V   G FG V++A+ L   E VA+K   +QD++    E ++  L  M H N++       
Sbjct: 31  VKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 98  STTSKDELFLNLVMEYVPETMYRVLK-HYSSMNQRMPLIYVKLYTYQIFRGLAYIH-TVP 155
             TS D     +   +   ++   LK +  S N+   L ++      + RGLAY+H  +P
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNE---LCHI---AETMARGLAYLHEDIP 142
Query: 156 G--------VCHRDVKPQNLLVDPLTHQVKLC--DFGSAKVLVKGEA---NISYICSRYY 202
           G        + HRD+K +N+L   L + +  C  DFG A     G++       + +R Y
Sbjct: 143 GLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 203 RAPELIFGATEYTTS----IDIWSAGCVLAEL 230
            APE++ GA  +       ID+++ G VL EL
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 39  ERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 90
           E+++G+G  G V   +    G+    VAIK +      + RR    E  +M   DHPN+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
            L+       ++  L + +V EY+   ++   L+ +      M L+ +      +  G+ 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRA 204
           Y+  + G  HRD+  +N+LVD      K+ DFG ++VL + + + +Y  +       + A
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTA 222
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELL 231
           PE I   T ++++ D+WS G V+ E+L
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVIS-------- 91
           +V+G+G+FG V++   +  GE V I   ++  R          ++D   V++        
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 92  --LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
             L  C  ST       + LV + +P     +L H      R+    +  +  QI +G++
Sbjct: 83  RLLGICLTST-------VQLVTQLMPYGC--LLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPE 206
           Y+  V  + HRD+  +N+LV    H VK+ DFG A++L   E        +    + A E
Sbjct: 134 YLEDVR-LVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 207 LIFGATEYTTSIDIWSAGCVLAELL 231
            I     +T   D+WS G  + EL+
Sbjct: 192 SIL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME       R        +  + L  + LY YQ+   LAY+
Sbjct: 456 L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV   T  VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 39  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           ERV+G G FG V   +    G+    VAIK +      K R     E  +M   DHPN+I
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L+     T SK  + +   ME    ++   LK     + +  +I +      I  G+ Y
Sbjct: 87  HLEGVV--TKSKPVMIVTEYME--NGSLDTFLKKN---DGQFTVIQLVGMLRGISAGMKY 139
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 205
           +  + G  HRD+  +N+L++      K+ DFG ++VL + +   +Y          + AP
Sbjct: 140 LSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 196
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T++ D+WS G V+ E++
Sbjct: 197 EAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 82/190 (43%), Gaps = 25/190 (13%)
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFG-SAKVLVKGEAN------- 193
           +   L ++H   G+ HRD+KP+N+L +       VK+CDFG  + + + G+ +       
Sbjct: 120 VASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPEL 178
Query: 194 ISYICSRYYRAPELIFGATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
           ++   S  Y APE++   +E    Y    D+WS G +L  LL G P F G    D   + 
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD- 237
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
            +    P  + +   +     + FP      W       +   A DL S+LL      R 
Sbjct: 238 -RGEACPACQNMLFESIQEGKYEFPD---KDW-----AHISCAAKDLISKLLVRDAKQRL 288
Query: 310 TALEACAHPF 319
           +A +   HP+
Sbjct: 289 SAAQVLQHPW 298

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           E+V+G G FG V   +    G+    VAIK +      K R     E  +M   DHPN+I
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L+     T  K  + +   ME      +         + R  +I +      I  G+ Y
Sbjct: 94  HLEGVV--TKCKPVMIITEYMENGSLDAF-----LRKNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 205
           +  +  V HRD+  +N+LV+      K+ DFG ++VL + +   +Y          + AP
Sbjct: 147 LSDMSAV-HRDLAARNILVNS-NLVCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T++ D+WS G V+ E++
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DA 142
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG A+VL + 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLARVL-ED 199
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEXMENGSLDSF-LRKH----DA 142
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG ++VL + 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM-GAVHRDLAARNILINS-NLVCKVSDFGLSRVL-ED 199
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME    T+  +          + L  + LY YQ+   LAY+
Sbjct: 81  L----IGVITENPVW--IIMELC--TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV      VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 133 ESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 187
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 188 SI-NFRRFTSASDVWMFGVCMWEILM 212

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+ +G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 88  RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 137
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 138 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 196 ESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DA 142
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG ++VL + 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM-GFVHRDLAARNILINS-NLVCKVSDFGLSRVL-ED 199
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME    T+  +          + L  + LY YQ+   LAY+
Sbjct: 78  L----IGVITENPVW--IIMELC--TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 129
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV      VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 130 ESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 184
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 185 SI-NFRRFTSASDVWMFGVCMWEILM 209

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME    T+  +          + L  + LY YQ+   LAY+
Sbjct: 79  L----IGVITENPVW--IIMELC--TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 130
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV      VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 131 ESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 185
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 186 SI-NFRRFTSASDVWMFGVCMWEILM 210

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME    T+  +          + L  + LY YQ+   LAY+
Sbjct: 73  L----IGVITENPVW--IIMELC--TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV      VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 125 ESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 179
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 180 SI-NFRRFTSASDVWMFGVCMWEILM 204

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QLMRLMDHPNVI 90
           +V+ +G+FG V++   +  GE V I   +++ R       N+E+     +M  +D+P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L     ++T      + L+ + +P    +  V +H  ++  +    Y+  +  QI +G+
Sbjct: 81  RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 205
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I     YT   D+WS G  + EL+
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME    T+  +          + L  + LY YQ+   LAY+
Sbjct: 104 L----IGVITENPVW--IIMELC--TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 155
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV      VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 156 ESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 210
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 211 SI-NFRRFTSASDVWMFGVCMWEILM 235

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME    T+  +          + L  + LY YQ+   LAY+
Sbjct: 76  L----IGVITENPVW--IIMELC--TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV      VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME    T+  +          + L  + LY YQ+   LAY+
Sbjct: 76  L----IGVITENPVW--IIMELC--TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV      VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DA 142
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG ++VL + 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-ED 199
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEXMENGSLDSF-LRKH----DA 142
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG ++VL + 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-ED 199
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DA 142
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG ++VL + 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-ED 199
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DA 142
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG ++VL + 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-ED 199
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 40  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME       R        +  + L  + LY YQ+   LAY+
Sbjct: 456 L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAPE 206
            +   V HRD+  +N+LV      VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL 232
            I     +T++ D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DA 142
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG ++VL + 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-ED 199
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DA 142
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG  +VL + 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVL-ED 199
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 39  ERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 90
           E+++G+G  G V   +    G+    VAIK +      + RR    E  +M   DHPN+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
            L+       ++  L + +V EY+   ++   L+ +      M L+ +      +  G+ 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANISYICSRY---YRAP 205
           Y+  + G  HRD+  +N+LVD      K+ DFG ++VL    +A  +    +    + AP
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I   T ++++ D+WS G V+ E+L
Sbjct: 224 EAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 29  EPKQTISYMA----------ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN 75
           +P QT+   A          ++VVG G FG V   +     +   +VAIK +      K 
Sbjct: 28  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 87
Query: 76  R-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           R     E  +M   DHPN+I L+     T SK  + +   ME      + + KH    + 
Sbjct: 88  RRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DA 140
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 190
           +  +I +      I  G+ Y+  + G  HRD+  +N+L++      K+ DFG ++VL + 
Sbjct: 141 QFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-ED 197
Query: 191 EANISYICSR-----YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           +   +Y          + +PE I    ++T++ D+WS G VL E++
Sbjct: 198 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 46/245 (18%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVL----------QDRRYKNRELQLM-RLMDHPN 88
           + +G G+FG V +A     G+  A+ KV            ++     EL++M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 89  VISL--------------KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           +++L              ++C +         LN +    P  +        +  +++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGD------LLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VL 187
             +  ++ Q+ +G+A++ +     HRDV  +N+L+    H  K+ DFG A+        +
Sbjct: 166 RDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDSNYI 223
Query: 188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQL 246
           VKG A +       + APE IF    YT   D+WS G +L E+  LG   +PG     + 
Sbjct: 224 VKGNARLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 278
Query: 247 VEIIK 251
            +++K
Sbjct: 279 YKLVK 283

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           E+V+G G FG V   +    G+    VAIK +      K R     E  +M   DHPN+I
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L+     T  K  + +   ME      +         + R  +I +      I  G+ Y
Sbjct: 79  HLEGVV--TKCKPVMIITEYMENGSLDAF-----LRKNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 205
           +  +  V HRD+  +N+LV+      K+ DFG ++VL + +   +Y          + AP
Sbjct: 132 LSDMSYV-HRDLAARNILVNS-NLVCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T++ D+WS G V+ E++
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           E+V+G G FG V   +    G+    VAIK +      K R     E  +M   DHPN+I
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L+     T  K  + +   ME      +         + R  +I +      I  G+ Y
Sbjct: 73  HLEGVV--TKCKPVMIITEYMENGSLDAF-----LRKNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 205
           +  +  V HRD+  +N+LV+      K+ DFG ++VL + +   +Y          + AP
Sbjct: 126 LSDMSYV-HRDLAARNILVNS-NLVCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T++ D+WS G V+ E++
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           ++VVG G FG V   +     +   +VAIK +      K R     E  +M   DHPN+I
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L+     T SK  + +   ME      + + KH    + +  +I +      I  G+ Y
Sbjct: 81  RLEGVV--TKSKPVMIVTEXMENGSLDSF-LRKH----DAQFTVIQLVGMLRGIASGMKY 133
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 205
           +  + G  HRD+  +N+L++      K+ DFG ++VL + +   +Y          + +P
Sbjct: 134 LSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T++ D+WS G VL E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 121/291 (41%), Gaps = 46/291 (15%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 82
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 83  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 134
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ ++ +   V HRD+  +N ++D     VK+ DFG A+ ++  E +  
Sbjct: 135 DLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMLDKEFDSV 192
Query: 196 YICSRY-----YRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 249
           +  +       + A E +    ++TT  D+WS G +L EL+  G P +P  N  D  V +
Sbjct: 193 HNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           +        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 252 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           ++VVG G FG V   +     +   +VAIK +      K R     E  +M   DHPN+I
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L+     T SK  + +   ME      + + KH    + +  +I +      I  G+ Y
Sbjct: 98  RLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DAQFTVIQLVGMLRGIASGMKY 150
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 205
           +  + G  HRD+  +N+L++      K+ DFG ++VL + +   +Y          + +P
Sbjct: 151 LSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 207
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T++ D+WS G VL E++
Sbjct: 208 EAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 40  RVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNV 89
           + +G G FG V +A         G T    K+L++       R    E  +++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL---------- 139
           I L    +   S+D   L L++EY     Y  L+ +   ++++   Y+            
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAK---YGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 140 --------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 185
                         + +QI +G+ Y+  +  + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEM-SLVHRDLAARNILVAE-GRKMKISDFGLSR 198
Query: 186 VLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            + + ++ +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 54/248 (21%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVL----------QDRRYKNRELQLM-RLMDHPN 88
           + +G G+FG V +A     G+  A+ KV            ++     EL++M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 89  VISL--------------KHCFFSTTSKDELFLNLVMEYVPETMYRVLK---HYSSMNQR 131
           +++L              ++C +         LN +         RVL+    ++  N  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGD------LLNFL-----RRKSRVLETDPAFAIANST 160
Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK------ 185
           +    +  ++ Q+ +G+A++ +     HRDV  +N+L+    H  K+ DFG A+      
Sbjct: 161 LSTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDS 218
Query: 186 -VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 243
             +VKG A +       + APE IF    YT   D+WS G +L E+  LG   +PG    
Sbjct: 219 NYIVKGNARLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273
Query: 244 DQLVEIIK 251
            +  +++K
Sbjct: 274 SKFYKLVK 281

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 48/292 (16%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 80
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 81  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 132
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 133 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEXXSV 190
Query: 196 Y------ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 248
           +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  N  D  V 
Sbjct: 191 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 248
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 249 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 40  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRLMDHPNVIS 91
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L        +++ ++  ++ME       R        +  + L  + LY YQ+   LAY+
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL--------VKGEANISYICSRYYR 203
            +   V HRD+  +N+LV      VKL DFG ++ +         KG+  I ++      
Sbjct: 128 ESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM------ 179
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLL 232
           APE I     +T++ D+W  G  + E+L+
Sbjct: 180 APESI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           ++VVG G FG V   +     +   +VAIK +      K R     E  +M   DHPN+I
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L+     T SK  + +   ME      + + KH    + +  +I +      I  G+ Y
Sbjct: 81  RLEGVV--TKSKPVMIVTEYMENGSLDSF-LRKH----DAQFTVIQLVGMLRGIASGMKY 133
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 205
           +  + G  HRD+  +N+L++      K+ DFG ++VL + +   +Y          + +P
Sbjct: 134 LSDM-GYVHRDLAARNILINS-NLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
           E I    ++T++ D+WS G VL E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 40  RVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNV 89
           + +G G FG V +A         G T    K+L++       R    E  +++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL---------- 139
           I L    +   S+D   L L++EY     Y  L+ +   ++++   Y+            
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAK---YGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 140 --------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 185
                         + +QI +G+ Y+  +  + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK-LVHRDLAARNILVAE-GRKMKISDFGLSR 198
Query: 186 VLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            + + ++ +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 34  ISYMA-ERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLM 84
           +SY+  E V+G G FG V + +    G+    VAIK +      + RR    E  +M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQ 143
           +HPN+I L+     T S   + L   ME         L  +  +N  +  +I +      
Sbjct: 75  EHPNIIRLEGVV--TNSMPVMILTEFME------NGALDSFLRLNDGQFTVIQLVGMLRG 126
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 200
           I  G+ Y+  +  V HRD+  +N+LV+      K+ DFG ++ L +  ++ +   S    
Sbjct: 127 IASGMRYLAEMSYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 201 ---YYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
               + APE I    ++T++ D WS G V+ E++
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 34/231 (14%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYK-----NRELQ 79
           P+  I Y+  R +G G+FG VFQA+       E    VA+K + ++          RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKH------YSSMNQRM- 132
           LM   D+PN++ L            LF  +    + E +  +  H      +S ++ R  
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 133 -------PLIYVK--LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 183
                  PL   +      Q+  G+AY+     V HRD+  +N LV      VK+ DFG 
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIADFGL 220
Query: 184 AKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
           ++ +   +   A+ +      +  PE IF    YTT  D+W+ G VL E+ 
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIF 270

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 45  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 99
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 100 GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 151
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 152 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---- 205
Query: 196 YICSRYYRAPEL--------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 246
           Y         +L             ++TT  D+WS G +L EL+  G P +P  N  D  
Sbjct: 206 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 265
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           V ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 266 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 309

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 46  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 100
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 101 GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 152
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 153 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---- 206
Query: 196 YICSRYYRAPEL--------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 246
           Y         +L             ++TT  D+WS G +L EL+  G P +P  N  D  
Sbjct: 207 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 266
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           V ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 267 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 310

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           ERV+G G FG V   +    G+    VAIK +      K R     E  +M   DHPNV+
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L+     T  K  + +   ME      + + KH    + +  +I +      I  G+ Y
Sbjct: 108 HLEGVV--TRGKPVMIVIEFMENGALDAF-LRKH----DGQFTVIQLVGMLRGIAAGMRY 160
Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANISYICSRY---YRAPE 206
           +  + G  HRD+  +N+LV+      K+ DFG ++V+    EA  +    +    + APE
Sbjct: 161 LADM-GYVHRDLAARNILVNS-NLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPE 218
Query: 207 LIFGATEYTTSIDIWSAGCVLAELL 231
            I    ++T++ D+WS G V+ E++
Sbjct: 219 AI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 79
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 80  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 131
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 132 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---- 185
Query: 196 YICSRYYRAPEL--------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 246
           Y         +L             ++TT  D+WS G +L EL+  G P +P  N  D  
Sbjct: 186 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 245
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           V ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 246 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 48/292 (16%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 19  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 73
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 74  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 125
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---- 191
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 126 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEYYSV 183
Query: 192 --ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 248
                + +  ++     L     ++TT  D+WS G +L EL+  G P +P  N  D  V 
Sbjct: 184 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 241
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 242 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 283

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 58/291 (19%)
Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHC 95
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA----YI 151
           + +  +  +  L +VME +        + +S +  R    + +    +I + +     Y+
Sbjct: 80  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           H++  + HRDVKP+NLL         +KL DFG AK    GE                  
Sbjct: 134 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE------------------ 173
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 174 ---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 217
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 218 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 82  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 133
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 134 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---- 187
Query: 196 YICSRYYRAPEL--------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 246
           Y         +L             ++TT  D+WS G +L EL+  G P +P  N  D  
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 247
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           V ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 248 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 48/292 (16%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 24  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---- 191
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 131 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEYYSV 188
Query: 192 --ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 248
                + +  ++     L     ++TT  D+WS G +L EL+  G P +P  N  D  V 
Sbjct: 189 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 247 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 288

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 40  RVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNV 89
           + +G G FG V +A         G T    K+L++       R    E  +++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL---------- 139
           I L    +   S+D   L L++EY     Y  L+ +   ++++   Y+            
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAK---YGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 140 --------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 185
                         + +QI +G+ Y+  +  + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK-LVHRDLAARNILVAE-GRKMKISDFGLSR 198
Query: 186 VLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            + + ++ +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 81/190 (42%), Gaps = 25/190 (13%)
Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFG-SAKVLVKGEAN------- 193
           +   L ++H   G+ HRD+KP+N+L +       VK+CDF   + + + G+ +       
Sbjct: 120 VASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 194 ISYICSRYYRAPELIFGATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
           ++   S  Y APE++   +E    Y    D+WS G +L  LL G P F G    D   + 
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD- 237
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
            +    P  + +   +     + FP      W       +   A DL S+LL      R 
Sbjct: 238 -RGEACPACQNMLFESIQEGKYEFPD---KDW-----AHISCAAKDLISKLLVRDAKQRL 288
Query: 310 TALEACAHPF 319
           +A +   HP+
Sbjct: 289 SAAQVLQHPW 298

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 32/235 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVL----------QDRRYKNRELQLM-RLMDHPN 88
           + +G G+FG V +A     G+  A+ KV            ++     EL++M  L  H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR--MPLIYVKL--YTYQI 144
           +++L      T     L +     Y     +   K  + +++    PL    L  ++ Q+
Sbjct: 104 IVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEANISYI 197
            +G+A++ +     HRDV  +N+L+    H  K+ DFG A+        +VKG A +   
Sbjct: 162 AQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDSNYIVKGNARLPV- 218
Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
               + APE IF    YT   D+WS G +L E+  LG   +PG     +  +++K
Sbjct: 219 ---KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 269

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 48/292 (16%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 86  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 192
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ ++ +   V HRD+  +N ++D     VK+ DFG A+ +   E +  
Sbjct: 193 DLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSV 250
Query: 196 Y------ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 248
           +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  N  D  V 
Sbjct: 251 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 309 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 350

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 82  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 133
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 134 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---- 187
Query: 196 YICSRYYRAPEL--------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 246
           Y         +L             ++TT  D+WS G +L EL+  G P +P  N  D  
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 247
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           V ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 248 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 48/292 (16%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 32  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 86
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 87  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 138
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ ++ +   V HRD+  +N ++D     VK+ DFG A+ +   E +  
Sbjct: 139 DLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSV 196
Query: 196 Y------ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 248
           +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  N  D  V 
Sbjct: 197 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 254
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 255 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 296

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 104/252 (41%), Gaps = 62/252 (24%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVL----------QDRRYKNRELQLM-RLMDHPN 88
           + +G G+FG V +A     G+  A+ KV            ++     EL++M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 89  VISL--------------KHCFFSTTSKDELFLNLVMEYVPE-------TMYRVLKHYSS 127
           +++L              ++C +          + V+E  P           R L H+SS
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 128 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-- 185
                          Q+ +G+A++ +     HRDV  +N+L+    H  K+ DFG A+  
Sbjct: 172 ---------------QVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDI 214
Query: 186 -----VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                 +VKG A +       + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 215 MNDSNYIVKGNARLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269
Query: 240 ENAVDQLVEIIK 251
                +  +++K
Sbjct: 270 ILVNSKFYKLVK 281

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 22  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 77  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 128
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 129 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---- 182
Query: 196 YICSRYYRAPEL--------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 246
           Y         +L             ++TT  D+WS G +L EL+  G P +P  N  D  
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           V ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 243 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 286

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 32/235 (13%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVL----------QDRRYKNRELQLM-RLMDHPN 88
           + +G G+FG V +A     G+  A+ KV            ++     EL++M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR--MPLIYVKL--YTYQI 144
           +++L      T     L +     Y     +   K  + +++    PL    L  ++ Q+
Sbjct: 112 IVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEANISYI 197
            +G+A++ +     HRDV  +N+L+    H  K+ DFG A+        +VKG A +   
Sbjct: 170 AQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDSNYIVKGNARLPV- 226
Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
               + APE IF    YT   D+WS G +L E+  LG   +PG     +  +++K
Sbjct: 227 ---KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 277

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 80
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 81  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 132
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ Y+ +   V HRD+  +N ++D     VK+ DFG A+ +   E    
Sbjct: 133 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---- 186
Query: 196 YICSRYYRAPEL--------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 246
           Y         +L             ++TT  D+WS G +L EL+  G P +P  N  D  
Sbjct: 187 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 246
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           V ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 247 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 82
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 83  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 134
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ ++ +   V HRD+  +N ++D     VK+ DFG A+ +   E +  
Sbjct: 135 DLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSV 192
Query: 196 YICSRY-----YRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 249
           +  +       + A E +    ++TT  D+WS G +L EL+  G P +P  N  D  V +
Sbjct: 193 HNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           +        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 252 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 39  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           E+V+G G FG V        G+    VAIK +      K R     E  +M   DHPNVI
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 149
            L+     +T      + ++ E++       L  +   N  +  +I +      I  G+ 
Sbjct: 98  HLEGVVTKSTP-----VMIITEFMENG---SLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------YYR 203
           Y+  +  V HRD+  +N+LV+      K+ DFG ++ L    ++ +Y  +        + 
Sbjct: 150 YLADMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL 231
           APE I    ++T++ D+WS G V+ E++
Sbjct: 208 APEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 48/292 (16%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 82  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 133
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ ++ +   V HRD+  +N ++D     VK+ DFG A+ +   E +  
Sbjct: 134 DLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSV 191
Query: 196 Y------ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 248
           +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  N  D  V 
Sbjct: 192 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 250 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 48/292 (16%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 82  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 133
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ ++ +   V HRD+  +N ++D     VK+ DFG A+ +   E +  
Sbjct: 134 DLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSV 191
Query: 196 Y------ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 248
           +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  N  D  V 
Sbjct: 192 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 250 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 48/292 (16%)
Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------E 77
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 79
Query: 78  LQLMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
             +M+   HPNV+SL   C  S  S         +  +P   +  L+++       P + 
Sbjct: 80  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 131
Query: 137 VKL-YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
             + +  Q+ +G+ ++ +   V HRD+  +N ++D     VK+ DFG A+ +   E +  
Sbjct: 132 DLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSV 189
Query: 196 Y------ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 248
           +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  N  D  V 
Sbjct: 190 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 247
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           ++        +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 248 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 107/261 (40%), Gaps = 71/261 (27%)
Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVL----------QDRRYKNRELQLM-RLMDHPN 88
           + +G G+FG V +A     G+  A+ KV            ++     EL++M  L  H N
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 89  VISL--------------KHC-------FFSTTSKDELFLNLVMEYVPETM--------- 118
           +++L              ++C       F    ++  L  +L     PE +         
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 119 YRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 178
            R L H+SS               Q+ +G+A++ +     HRDV  +N+L+    H  K+
Sbjct: 157 LRDLLHFSS---------------QVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKI 199
Query: 179 CDFGSAK-------VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
            DFG A+        +VKG A +       + APE IF    YT   D+WS G +L E+ 
Sbjct: 200 GDFGLARDIMNDSNYIVKGNARLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIF 254
Query: 232 -LGQPLFPGENAVDQLVEIIK 251
            LG   +PG     +  +++K
Sbjct: 255 SLGLNPYPGILVNSKFYKLVK 275

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 105/264 (39%), Gaps = 81/264 (30%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM---------DHPNVISL 92
           +G G FG+VF+AK        AIK++    R  NREL   ++M         +HP ++  
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 93  KHCFFSTTSK------DELFL-NLVMEY---------VPETMYRVLKHYSSMNQ------ 130
            + +  T  +      DE++L +   ++          P    R +  +S+ N       
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 131 RMPLIY-----------------------------VKLYTY-QIFRGLAYIHTVPGVCHR 160
             P +Y                             V L+ + QI   + ++H+  G+ HR
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-KGLMHR 188
Query: 161 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-------------ANISYICSRYYRAPEL 207
           D+KP N+    +   VK+ DFG    + + E              +   + ++ Y +PE 
Sbjct: 189 DLKPSNIFF-TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ 247
Query: 208 IFGATEYTTSIDIWSAGCVLAELL 231
           I G   Y+  +DI+S G +L ELL
Sbjct: 248 IHG-NNYSHKVDIFSLGLILFELL 270

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 75/347 (21%), Positives = 128/347 (36%), Gaps = 60/347 (17%)
Query: 41  VVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISL 92
           V+G G      V  A+   TGE V ++++  +        +   EL + +L +HPN++  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           +  F    + +EL++             +  H+      + + Y+      + + L YIH
Sbjct: 76  RATFI---ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 153 TVPGVCHRDVKPQNLLV--------DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
            + G  HR VK  ++L+          L   + +   G  + +V      S     +   
Sbjct: 130 HM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--------- 255
             L      Y    DI+S G    EL  G   F    A   L+E  K+ GT         
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLNGTVPCLLDTST 246
Query: 256 ---------PTR--------EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 298
                    P+R        + +    P  ++   P   +HP+H+ F     P       
Sbjct: 247 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTF----SPHFHHFVE 299
Query: 299 RLLQYSPSLRCTALEACAHPFFDEL-REPNARLPN-GRPFPPLFNFK 343
           + LQ +P  R +A     H FF ++ R  +  LP   RP  P+ NF+
Sbjct: 300 QCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 346

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 39  ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 90
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+++ +L  HPN+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP----------------ETMYRVLKHYSSMNQRMPL 134
           +L         +   +L L +EY P                +  + +    +S      L
Sbjct: 90  NL-----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGE 191
           ++   +   + RG+ Y+ +     HRD+  +N+LV    +  K+ DFG ++   V VK  
Sbjct: 145 LH---FAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVK-- 197
Query: 192 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
             +  +  R+     L +    YTT+ D+WS G +L E++
Sbjct: 198 KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 235

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 100/248 (40%), Gaps = 55/248 (22%)
Query: 39  ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRLMDHPNV 89
           +R +G G+FG VF A+C     T     VA+K +    L  R+   RE +L+  + H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLIY 136
           +      F     D   L +V EY+             P+ M  V          + L  
Sbjct: 80  VK-----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 196
           +     QI  G+ Y+ +   V HRD+  +N LV      VK+ DFG ++           
Sbjct: 135 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSR---------DV 183
Query: 197 ICSRYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENA 242
             + YYR             PE I    ++TT  D+WS G +L E+     QP F   N 
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
Query: 243 VDQLVEII 250
             +++E I
Sbjct: 243 --EVIECI 248

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 39  ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 90
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+++ +L  HPN+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP----------------ETMYRVLKHYSSMNQRMPL 134
           +L         +   +L L +EY P                +  + +    +S      L
Sbjct: 80  NL-----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGE 191
           ++   +   + RG+ Y+ +     HRD+  +N+LV    +  K+ DFG ++   V VK  
Sbjct: 135 LH---FAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVK-- 187
Query: 192 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
             +  +  R+     L +    YTT+ D+WS G +L E++
Sbjct: 188 KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 37  MAERVVGTGSFGIVFQA--KCLETGETVAIKKVLQ-----DRRYKNRELQLMRLMDHPNV 89
           +A+  +G G+FG V Q   +  +    VAIK + Q     D     RE Q+M  +D+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV---PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           + L          + L   LVME     P   + V K      + +P+  V    +Q+  
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSM 121
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY----- 201
           G+ Y+       HRD+  +N+L+    H  K+ DFG +K L    A+ SY  +R      
Sbjct: 122 GMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKAL---GADDSYYTARSAGKWP 176
Query: 202 --YRAPELIFGATEYTTSIDIWSAGCVLAELL 231
             + APE I    ++++  D+WS G  + E L
Sbjct: 177 LKWYAPECI-NFRKFSSRSDVWSYGVTMWEAL 207

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 75/347 (21%), Positives = 128/347 (36%), Gaps = 60/347 (17%)
Query: 41  VVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISL 92
           V+G G      V  A+   TGE V ++++  +        +   EL + +L +HPN++  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           +  F    + +EL++             +  H+      + + Y+      + + L YIH
Sbjct: 92  RATFI---ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 153 TVPGVCHRDVKPQNLLV--------DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
            + G  HR VK  ++L+          L   + +   G  + +V      S     +   
Sbjct: 146 HM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--------- 255
             L      Y    DI+S G    EL  G   F    A   L+E  K+ GT         
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLNGTVPCLLDTST 262
Query: 256 ---------PTR--------EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 298
                    P+R        + +    P  ++   P   +HP+H+ F     P       
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTF----SPHFHHFVE 315
Query: 299 RLLQYSPSLRCTALEACAHPFFDEL-REPNARLPN-GRPFPPLFNFK 343
           + LQ +P  R +A     H FF ++ R  +  LP   RP  P+ NF+
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 37  MAERVVGTGSFGIVFQA--KCLETGETVAIKKVLQ-----DRRYKNRELQLMRLMDHPNV 89
           +A+  +G G+FG V Q   +  +    VAIK + Q     D     RE Q+M  +D+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYV---PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           + L          + L   LVME     P   + V K      + +P+  V    +Q+  
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSM 447
Query: 147 GLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---- 201
           G+ Y+       HR++  +N LLV+   H  K+ DFG +K L    A+ SY  +R     
Sbjct: 448 GMKYLEE-KNFVHRNLAARNVLLVN--RHYAKISDFGLSKAL---GADDSYYTARSAGKW 501
Query: 202 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 231
              + APE I    ++++  D+WS G  + E L
Sbjct: 502 PLKWYAPECI-NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 79/344 (22%), Positives = 133/344 (38%), Gaps = 68/344 (19%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPN 88
           Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L +L  H +
Sbjct: 58  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTYQIFR 146
            I   + +  T    + ++ +VME     +   LK   S++  +R      K Y   +  
Sbjct: 117 KIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWER------KSYWKNMLE 166
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            +  IH   G+ H D+KP N L+  +   +KL DFG A  +     ++   S + +  Y 
Sbjct: 167 AVHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 204 APELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
            PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  ++
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 281
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRCT 310
                      +PN+ +  FP I              PE  DL   L   L+  P  R +
Sbjct: 282 -----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRIS 314
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELI 354
             E  AHP+      P  ++  G      +   Q +   SP  I
Sbjct: 315 IPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSI 358

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 39  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           E+V+G G FG V        G+    VAIK +      K R     E  +M   DHPNVI
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 149
            L+     +T      + ++ E++       L  +   N  +  +I +      I  G+ 
Sbjct: 72  HLEGVVTKSTP-----VMIITEFMENG---SLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------YYR 203
           Y+  +  V HR +  +N+LV+      K+ DFG ++ L    ++ +Y  +        + 
Sbjct: 124 YLADMNYV-HRALAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL 231
           APE I    ++T++ D+WS G V+ E++
Sbjct: 182 APEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 39  ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 90
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+++ +L  HPN+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP----------------ETMYRVLKHYSSMNQRMPL 134
           +L         +   +L L +EY P                +  + +    +S      L
Sbjct: 87  NL-----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGE 191
           ++   +   + RG+ Y+ +     HR++  +N+LV    +  K+ DFG ++   V VK  
Sbjct: 142 LH---FAADVARGMDYL-SQKQFIHRNLAARNILVGE-NYVAKIADFGLSRGQEVYVK-- 194
Query: 192 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
             +  +  R+     L +    YTT+ D+WS G +L E++
Sbjct: 195 KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 232

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL----QLMRLM 84
           EP+    +   R +G+GSFG ++    ++T E VAIK  L++ + K+ +L    ++ R++
Sbjct: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRIL 59
Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
                I     F      + L ++L+   + +        ++  ++++ L  V +   Q+
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDL-------FNFCSRKLSLKTVLMLADQM 112
Query: 145 FRGLAYIHTVPGVCHRDVKPQNLL--VDPLTHQVKLCDFGSAK 185
              + ++H+     HRD+KP N L  +    +QV + DFG AK
Sbjct: 113 INRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 79/344 (22%), Positives = 133/344 (38%), Gaps = 68/344 (19%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPN 88
           Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L +L  H +
Sbjct: 58  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTYQIFR 146
            I   + +  T    + ++ +VME     +   LK   S++  +R      K Y   +  
Sbjct: 117 KIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWER------KSYWKNMLE 166
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            +  IH   G+ H D+KP N L+  +   +KL DFG A  +     ++   S + +  Y 
Sbjct: 167 AVHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 204 APELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
            PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  ++
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 281
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRCT 310
                      +PN+ +  FP I              PE  DL   L   L+  P  R +
Sbjct: 282 -----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRIS 314
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELI 354
             E  AHP+      P  ++  G      +   Q +   SP  I
Sbjct: 315 IPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSI 358

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 79/344 (22%), Positives = 133/344 (38%), Gaps = 68/344 (19%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPN 88
           Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L +L  H +
Sbjct: 14  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTYQIFR 146
            I   + +  T    + ++ +VME     +   LK   S++  +R      K Y   +  
Sbjct: 73  KIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWER------KSYWKNMLE 122
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            +  IH   G+ H D+KP N L+  +   +KL DFG A  +     ++   S + +  Y 
Sbjct: 123 AVHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 204 APELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
            PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  ++
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 237
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRCT 310
                      +PN+ +  FP I              PE  DL   L   L+  P  R +
Sbjct: 238 -----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRIS 270
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELI 354
             E  AHP+      P  ++  G      +   Q +   SP  I
Sbjct: 271 IPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSI 314

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/323 (23%), Positives = 127/323 (39%), Gaps = 68/323 (21%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPN 88
           Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L +L  H +
Sbjct: 58  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTYQIFR 146
            I   + +  T    + ++ +VME     +   LK   S++  +R      K Y   +  
Sbjct: 117 KIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWER------KSYWKNMLE 166
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            +  IH   G+ H D+KP N L+  +   +KL DFG A  +     ++   S + +  Y 
Sbjct: 167 AVHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 204 APELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
            PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  ++
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 281
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRCT 310
                      +PN+ +  FP I              PE  DL   L   L+  P  R +
Sbjct: 282 -----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRIS 314
Query: 311 ALEACAHPFFDELREPNARLPNG 333
             E  AHP+      P  ++  G
Sbjct: 315 IPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 79/344 (22%), Positives = 133/344 (38%), Gaps = 68/344 (19%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPN 88
           Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L +L  H +
Sbjct: 11  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTYQIFR 146
            I   + +  T    + ++ +VME     +   LK   S++  +R      K Y   +  
Sbjct: 70  KIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWER------KSYWKNMLE 119
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            +  IH   G+ H D+KP N L+  +   +KL DFG A  +     ++   S + +  Y 
Sbjct: 120 AVHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 204 APELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
            PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  ++
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 234
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRCT 310
                      +PN+ +  FP I              PE  DL   L   L+  P  R +
Sbjct: 235 -----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRIS 267
Query: 311 ALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELI 354
             E  AHP+      P  ++  G      +   Q +   SP  I
Sbjct: 268 IPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSI 311

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/323 (23%), Positives = 126/323 (39%), Gaps = 68/323 (21%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPN 88
           Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L +L  H +
Sbjct: 30  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            I   + +  T    + ++ +VME     +   LK   S++      Y K         L
Sbjct: 89  KIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK-------NML 137
Query: 149 AYIHTVP--GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
             +HT+   G+ H D+KP N L+  +   +KL DFG A  +     ++   S + +  Y 
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 204 APELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
            PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  ++
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 253
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRCT 310
                      +PN+ +  FP I              PE  DL   L   L+  P  R +
Sbjct: 254 -----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRIS 286
Query: 311 ALEACAHPFFDELREPNARLPNG 333
             E  AHP+      P  ++  G
Sbjct: 287 IPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 75/323 (23%), Positives = 127/323 (39%), Gaps = 68/323 (21%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPN 88
           Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L +L  H +
Sbjct: 10  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTYQIFR 146
            I   + +  T    + ++ +VME     +   LK   S++  +R      K Y   +  
Sbjct: 69  KIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWER------KSYWKNMLE 118
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            +  IH   G+ H D+KP N L+  +   +KL DFG A  +     ++   S + +  Y 
Sbjct: 119 AVHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 204 APELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
            PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  ++
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 233
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRCT 310
                      +PN+ +  FP I              PE  DL   L   L+  P  R +
Sbjct: 234 -----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRIS 266
Query: 311 ALEACAHPFFDELREPNARLPNG 333
             E  AHP+      P  ++  G
Sbjct: 267 IPELLAHPYVQIQTHPVNQMAKG 289

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 42  VGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN---RELQLMRLMDHPNVIS 91
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  +DH N+I 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L     +   K      +V E  P    + R+ KH         L  +  Y  Q+  G+ 
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 129
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+ +   + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 130 YLESKRFI-HRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 185
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 251
           APE +   T ++ + D W  G  L E+   GQ  + G N    L +I K
Sbjct: 186 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 159 HRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANI--SYICSRYYRAPELIFGATEY 214
           HRDVKP+N+LV  D   +   L DFG A      +     + + + YY APE  F  +  
Sbjct: 157 HRDVKPENILVSADDFAY---LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHA 212
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGEN 241
           T   DI++  CVL E L G P + G+ 
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQ 239

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 42  VGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN---RELQLMRLMDHPNVIS 91
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  +DH N+I 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L     +   K      +V E  P    + R+ KH         L  +  Y  Q+  G+ 
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 135
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+ +   + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 136 YLESKRFI-HRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 191
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
           APE +   T ++ + D W  G  L E+   GQ  + G N    L +I K
Sbjct: 192 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 75/323 (23%), Positives = 126/323 (39%), Gaps = 68/323 (21%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPN 88
           Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L +L  H +
Sbjct: 30  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTYQIFR 146
            I   + +  T    + ++ +VME     +   LK   S++  +R      K Y   +  
Sbjct: 89  KIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWER------KSYWKNMLE 138
Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYR 203
            +  IH   G+ H D+KP N L+  +   +KL DFG A  +      +   S + +  Y 
Sbjct: 139 AVHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 204 APELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
            PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  ++
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 253
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRCT 310
                      +PN+ +  FP I              PE  DL   L   L+  P  R +
Sbjct: 254 -----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRIS 286
Query: 311 ALEACAHPFFDELREPNARLPNG 333
             E  AHP+      P  ++  G
Sbjct: 287 IPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 42  VGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN---RELQLMRLMDHPNVIS 91
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  +DH N+I 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L     +   K      +V E  P    + R+ KH         L  +  Y  Q+  G+ 
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 125
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+ +   + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 126 YLESKRFI-HRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 181
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
           APE +   T ++ + D W  G  L E+   GQ  + G N    L +I K
Sbjct: 182 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 42  VGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN---RELQLMRLMDHPNVIS 91
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  +DH N+I 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L     +   K      +V E  P    + R+ KH         L  +  Y  Q+  G+ 
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 129
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+ +   + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 130 YLESKRFI-HRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 185
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
           APE +   T ++ + D W  G  L E+   GQ  + G N    L +I K
Sbjct: 186 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 42  VGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN---RELQLMRLMDHPNVIS 91
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  +DH N+I 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L     +   K      +V E  P    + R+ KH         L  +  Y  Q+  G+ 
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 125
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+ +   + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 126 YLESKRFI-HRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 181
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
           APE +   T ++ + D W  G  L E+   GQ  + G N    L +I K
Sbjct: 182 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 42  VGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN---RELQLMRLMDHPNVIS 91
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  +DH N+I 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L     +   K      +V E  P    + R+ KH         L  +  Y  Q+  G+ 
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 135
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR----YYRAP 205
           Y+ +   + HRD+  +NLL+      VK+ DFG  + L + + +      R     + AP
Sbjct: 136 YLESKRFI-HRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 251
           E +   T ++ + D W  G  L E+   GQ  + G N    L +I K
Sbjct: 194 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 45  GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRL--MDHPNVISLKHCFFSTTS 101
           G FG V++A+ +   + VA+K   LQD++    E ++     M H N++     F +   
Sbjct: 26  GRFGCVWKAQLM--NDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQ----FIAAEK 79
Query: 102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT------ 153
           +     NL +E    T +      +   +   + + +L      + RGL+Y+H       
Sbjct: 80  RGS---NLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 154 ----VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPE 206
                P + HRD K +N+L+      V L DFG A     G+        + +R Y APE
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE 195
Query: 207 LIFGATEYTTS----IDIWSAGCVLAELL 231
           ++ GA  +       ID+++ G VL EL+
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 42  VGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN---RELQLMRLMDHPNVIS 91
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  +DH N+I 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L     +   K      +V E  P    + R+ KH         L  +  Y  Q+  G+ 
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 125
Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR----YYRAP 205
           Y+ +   + HRD+  +NLL+      VK+ DFG  + L + + +      R     + AP
Sbjct: 126 YLESKRFI-HRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 251
           E +   T ++ + D W  G  L E+   GQ  + G N    L +I K
Sbjct: 184 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKN-RELQLMRLMDHPNVISLKHCF 96
           +G G+FG VF  +       VA+K   +    D + K  +E ++++   HPN++ L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
              T K  ++  +VME V    +  L    +   R+ +  +         G+ Y+ +   
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDF--LTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE--- 213
           + HRD+  +N LV    + +K+ DFG    + + EA+  Y  S   R   + + A E   
Sbjct: 235 I-HRDLAARNCLVTE-KNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 214 ---YTTSIDIWSAGCVLAELL-LGQPLFP 238
              Y++  D+WS G +L E   LG   +P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYP 317

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 129/312 (41%), Gaps = 65/312 (20%)
Query: 40  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 94
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R    +  ++  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 95  C-----FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMP---LIYVKLYTY 142
           C          SK +  L +VME +     ++  R L+  +  N   P   L  +     
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICS 199
           +I  G+AY++    V HRD+  +N +V      VK+ DFG  + + + +        +  
Sbjct: 138 EIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVEIIKVLGTPT 257
             + APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++ +       
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFV------- 245
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA- 316
                 M+  Y D         P         P    DL     Q++P++R T LE    
Sbjct: 246 ------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNL 285
Query: 317 -----HPFFDEL 323
                HP F E+
Sbjct: 286 LKDDLHPSFPEV 297

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 50/223 (22%)
Query: 42  VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISL 92
           +G G+FG VF A+C     E  + +   K L++     R+   RE +L+ ++ H +++  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 107
Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRM---------PLIYVKLYTY 142
              FF   ++    L +V EY+    + R L+ +    + +         PL   +L   
Sbjct: 108 ---FFGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 143 --QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 200
             Q+  G+ Y+  +  V HRD+  +N LV      VK+ DFG ++ +           + 
Sbjct: 164 ASQVAAGMVYLAGLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYS---------TD 212
Query: 201 YYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 231
           YYR             PE I    ++TT  D+WS G VL E+ 
Sbjct: 213 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 254

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 65/312 (20%)
Query: 40  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 94
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R    +  ++  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 95  C-----FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMP---LIYVKLYTY 142
           C          SK +  L +VME +     ++  R L+  +  N   P   L  +     
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICS 199
           +I  G+AY++    V HRD+  +N +V      VK+ DFG  + + + +        +  
Sbjct: 138 EIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVEIIKVLGTPT 257
             + APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++ +       
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFV------- 245
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA- 316
                 M+  Y D         P         P    DL     Q++P +R T LE    
Sbjct: 246 ------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 285
Query: 317 -----HPFFDEL 323
                HP F E+
Sbjct: 286 LKDDLHPSFPEV 297

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVIS-LKHCF 96
           VG G +G V++   L  GE+VA+K +   R     ++  E+    L+ H N++  +    
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVK-IFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDM 72
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT--- 153
            S  S  +L+L +   +   ++Y  L+  +      P + ++L       GLA++H    
Sbjct: 73  TSRNSSTQLWL-ITHYHEHGSLYDFLQRQT----LEPHLALRLAVSAAC-GLAHLHVEIF 126
Query: 154 ----VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-----ANISYICSRYYRA 204
                P + HRD K +N+LV     Q  + D G A +  +G       N   + ++ Y A
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKS-NLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 205 PELI--------FGATEYTTSIDIWSAGCVLAEL 230
           PE++        F + ++T   DIW+ G VL E+
Sbjct: 186 PEVLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 65/312 (20%)
Query: 40  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 94
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R    +  ++  +V+    
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 75
Query: 95  C-----FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMP---LIYVKLYTY 142
           C          SK +  L +VME +     ++  R L+  +  N   P   L  +     
Sbjct: 76  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICS 199
           +I  G+AY++    V HRD+  +N +V      VK+ DFG  + + + +        +  
Sbjct: 135 EIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVEIIKVLGTPT 257
             + APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++ +       
Sbjct: 193 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFV------- 242
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA- 316
                 M+  Y D         P         P    DL     Q++P +R T LE    
Sbjct: 243 ------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 282
Query: 317 -----HPFFDEL 323
                HP F E+
Sbjct: 283 LKDDLHPSFPEV 294

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKN-RELQLMRLMDHPNVISLKHCF 96
           +G G+FG VF  +       VA+K   +    D + K  +E ++++   HPN++ L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
              T K  ++  +VME V    +  L    +   R+ +  +         G+ Y+ +   
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDF--LTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPE-LIFGAT 212
           + HRD+  +N LV    + +K+ DFG ++    G    S    +    + APE L +G  
Sbjct: 235 I-HRDLAARNCLVTE-KNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG-- 290
Query: 213 EYTTSIDIWSAGCVLAELL-LGQPLFP 238
            Y++  D+WS G +L E   LG   +P
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYP 317

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 50/223 (22%)
Query: 42  VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISL 92
           +G G+FG VF A+C     E  + +   K L++     R+   RE +L+ ++ H +++  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 78
Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRM---------PLIYVKLYTY 142
              FF   ++    L +V EY+    + R L+ +    + +         PL   +L   
Sbjct: 79  ---FFGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 143 --QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 200
             Q+  G+ Y+  +  V HRD+  +N LV      VK+ DFG ++ +           + 
Sbjct: 135 ASQVAAGMVYLAGLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYS---------TD 183
Query: 201 YYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 231
           YYR             PE I    ++TT  D+WS G VL E+ 
Sbjct: 184 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 225

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 55/254 (21%)
Query: 39  ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNV 89
           +R +G G+FG VF A+C     E  + +   K L+D     R+  +RE +L+  + H ++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY-------SSMNQRMPLIYVKLY- 140
           +     F+    + +  + +V EY+    + + L+ +       +  N    L   ++  
Sbjct: 78  VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 141 -TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 199
              QI  G+ Y+ +   V HRD+  +N LV      VK+ DFG ++             +
Sbjct: 133 IAQQIAAGMVYLASQHFV-HRDLATRNCLVGE-NLLVKIGDFGMSR---------DVYST 181
Query: 200 RYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 245
            YYR             PE I    ++TT  D+WS G VL E+     QP +   N  ++
Sbjct: 182 DYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 238
Query: 246 LVEII---KVLGTP 256
           ++E I   +VL  P
Sbjct: 239 VIECITQGRVLQRP 252

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 129/321 (40%), Gaps = 83/321 (25%)
Query: 40  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 94
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R    +  ++  +V+    
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 77
Query: 95  C-----FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMP---LIYVKLYTY 142
           C          SK +  L +VME +     ++  R L+  +  N   P   L  +     
Sbjct: 78  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
           +I  G+AY++    V HRD+  +N +V      VK+ DFG  + + +         + YY
Sbjct: 137 EIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TDYY 185
Query: 203 R------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVE 248
           R            APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLK 242
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
            +             M+  Y D         P         P    DL     Q++P +R
Sbjct: 243 FV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMR 275
Query: 309 CTALEACA------HPFFDEL 323
            T LE         HP F E+
Sbjct: 276 PTFLEIVNLLKDDLHPSFPEV 296

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 50/223 (22%)
Query: 42  VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISL 92
           +G G+FG VF A+C     E  + +   K L++     R+   RE +L+ ++ H +++  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 84
Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRM---------PLIYVKLYTY 142
              FF   ++    L +V EY+    + R L+ +    + +         PL   +L   
Sbjct: 85  ---FFGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 143 --QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 200
             Q+  G+ Y+  +  V HRD+  +N LV      VK+ DFG ++ +           + 
Sbjct: 141 ASQVAAGMVYLAGLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYS---------TD 189
Query: 201 YYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 231
           YYR             PE I    ++TT  D+WS G VL E+ 
Sbjct: 190 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 231

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL----QLMRLMDHP-NVI 90
           Y   R +G+GSFG ++    + +GE VAIK  L+  + K+ +L    +  ++M     + 
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIK--LECVKTKHPQLHIESKFYKMMQGGVGIP 68
Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           S+K C       +  +  +VME +  ++  +   ++  +++  L  V L   Q+   + Y
Sbjct: 69  SIKWC-----GAEGDYNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 151 IHTVPGVCHRDVKPQNLL--VDPLTHQVKLCDFGSAK 185
           IH+     HRDVKP N L  +    + V + DFG AK
Sbjct: 121 IHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 101/248 (40%), Gaps = 57/248 (22%)
Query: 20  STTIGGKNGEPKQTISYMAERV-----VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK 74
           S T G  +G P      +A ++     VG G +G V++      GE VA+K +   R  K
Sbjct: 18  SCTSGSGSGLPFLVQRTVARQITLLECVGKGRYGEVWRGSW--QGENVAVK-IFSSRDEK 74
Query: 75  N--RELQLMR--LMDHPNVIS-LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN 129
           +  RE +L    ++ H N++  +     S  S  +L+L              + HY  M 
Sbjct: 75  SWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL--------------ITHYHEMG 120
Query: 130 QRMPLIYVKLYTYQ----------IFRGLAYIHT-------VPGVCHRDVKPQNLLVDPL 172
                 Y++L T            I  GLA++H         P + HRD+K +N+LV   
Sbjct: 121 SLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK- 177
Query: 173 THQVKLCDFGSAKVLVKGE-----ANISYICSRYYRAPELI-----FGATEYTTSIDIWS 222
             Q  + D G A +  +        N   + ++ Y APE++         +    +DIW+
Sbjct: 178 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 237
Query: 223 AGCVLAEL 230
            G VL E+
Sbjct: 238 FGLVLWEV 245

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 101/250 (40%), Gaps = 46/250 (18%)
Query: 40  RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR------ELQLMRLMDHPNVI 90
           +++G G FG V +    +   T   VA+K +  D   +        E   M+   HPNVI
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 91  SLKHCFFSTTSK---DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            L       +S+     + +   M+Y     Y +     +  + +PL  +  +   I  G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 148 LAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           + Y+       HRD+  +N +L D +T  V + DFG +K +  G+    Y   R  + P 
Sbjct: 160 MEYLSN-RNFLHRDLAARNCMLRDDMT--VCVADFGLSKKIYSGDY---YRQGRIAKMP- 212
Query: 207 LIFGATE------YTTSIDIWSAGCVLAE--------------------LLLGQPLFPGE 240
           + + A E      YT+  D+W+ G  + E                    LL G  L   E
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE 272
Query: 241 NAVDQLVEII 250
           + +D+L EI+
Sbjct: 273 DCLDELYEIM 282

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 83/321 (25%), Positives = 130/321 (40%), Gaps = 83/321 (25%)
Query: 40  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNV 89
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMP---LIYVKLYTY 142
           + L        SK +  L +VME +     ++  R L+  +  N   P   L  +     
Sbjct: 83  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
           +I  G+AY++    V HRD+  +N +V      VK+ DFG  + + +         + YY
Sbjct: 138 EIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TAYY 186
Query: 203 R------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVE 248
           R            APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLK 243
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
            +             M+  Y D         P         P    DL     Q++P +R
Sbjct: 244 FV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMR 276
Query: 309 CTALEACA------HPFFDEL 323
            T LE         HP F E+
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEV 297

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 129/321 (40%), Gaps = 83/321 (25%)
Query: 40  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 94
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R    +  ++  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 95  C-----FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMP---LIYVKLYTY 142
           C          SK +  L +VME +     ++  R L+  +  N   P   L  +     
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
           +I  G+AY++    V HRD+  +N +V      VK+ DFG  + + +         + YY
Sbjct: 138 EIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TDYY 186
Query: 203 R------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVE 248
           R            APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLK 243
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
            +             M+  Y D         P         P    DL     Q++P +R
Sbjct: 244 FV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMR 276
Query: 309 CTALEACA------HPFFDEL 323
            T LE         HP F E+
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEV 297

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 52/221 (23%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--LMDHPNVIS-LKHCF 96
           VG G +G V++      GE VA+K +   R  K+  RE +L    ++ H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW--QGENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ----------IFR 146
            S  S  +L+L              + HY  M       Y++L T            I  
Sbjct: 73  TSRHSSTQLWL--------------ITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIAS 116
Query: 147 GLAYIHT-------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-----ANI 194
           GLA++H         P + HRD+K +N+LV     Q  + D G A +  +        N 
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 195 SYICSRYYRAPELI-----FGATEYTTSIDIWSAGCVLAEL 230
             + ++ Y APE++         +    +DIW+ G VL E+
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 52/221 (23%)
Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--LMDHPNVIS-LKHCF 96
           VG G +G V++      GE VA+K +   R  K+  RE +L    ++ H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW--QGENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ----------IFR 146
            S  S  +L+L              + HY  M       Y++L T            I  
Sbjct: 73  TSRHSSTQLWL--------------ITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIAS 116
Query: 147 GLAYIHT-------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-----ANI 194
           GLA++H         P + HRD+K +N+LV     Q  + D G A +  +        N 
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 195 SYICSRYYRAPELI-----FGATEYTTSIDIWSAGCVLAEL 230
             + ++ Y APE++         +    +DIW+ G VL E+
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 104/240 (43%), Gaps = 43/240 (17%)
Query: 21  TTIGGKNGEP---KQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--- 72
           TT G  +G P   ++TI  + + +  +G G FG V++ K    GE VA+K +   R    
Sbjct: 24  TTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVK-IFSSREERS 80
Query: 73  -YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE---LFLNLVMEYVPE-TMYRVLKHYSS 127
            ++  E+    ++ H N++     F +  +KD      L LV +Y    +++  L  Y+ 
Sbjct: 81  WFREAEIYQTVMLRHENILG----FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 136
Query: 128 MNQRMPLIYVKLYTYQIFRGLAYIHT-------VPGVCHRDVKPQNLLVDPLTHQVKLCD 180
             + M  I + L T     GLA++H         P + HRD+K +N+LV        + D
Sbjct: 137 TVEGM--IKLALSTAS---GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIAD 190
Query: 181 FGSAKVLVKGEANISY-----ICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAEL 230
            G A         I       + ++ Y APE++  +      E     DI++ G V  E+
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 43/240 (17%)
Query: 21  TTIGGKNGEP---KQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN 75
           TT G  +G P   ++TI  + + +  +G G FG V++ K    GE VA+K +   R  ++
Sbjct: 11  TTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVK-IFSSREERS 67
Query: 76  --RELQLMR--LMDHPNVISLKHCFFSTTSKDE---LFLNLVMEYVPE-TMYRVLKHYSS 127
             RE ++ +  ++ H N++     F +  +KD      L LV +Y    +++  L  Y+ 
Sbjct: 68  WFREAEIYQTVMLRHENILG----FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 123
Query: 128 MNQRMPLIYVKLYTYQIFRGLAYIHT-------VPGVCHRDVKPQNLLVDPLTHQVKLCD 180
             + M  I + L T     GLA++H         P + HRD+K +N+LV        + D
Sbjct: 124 TVEGM--IKLALSTAS---GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIAD 177
Query: 181 FGSAKVLVKGEANISY-----ICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAEL 230
            G A         I       + ++ Y APE++  +      E     DI++ G V  E+
Sbjct: 178 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 130/321 (40%), Gaps = 83/321 (25%)
Query: 40  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 94
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R    +  ++  +V+    
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 79
Query: 95  C-----FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMP---LIYVKLYTY 142
           C          SK +  L +VME +     ++  R L+  +  N   P   L  +     
Sbjct: 80  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
           +I  G+AY++    V HR++  +N +V      VK+ DFG  + + +         + YY
Sbjct: 139 EIADGMAYLNAKKFV-HRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TDYY 187
Query: 203 R------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVE 248
           R            APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++
Sbjct: 188 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLK 244
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
            +             M+  Y D         P         P    DL     Q++P++R
Sbjct: 245 FV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMR 277
Query: 309 CTALEACA------HPFFDEL 323
            T LE         HP F E+
Sbjct: 278 PTFLEIVNLLKDDLHPSFPEV 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 130/321 (40%), Gaps = 83/321 (25%)
Query: 40  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 94
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R    +  ++  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 95  C-----FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMP---LIYVKLYTY 142
           C          SK +  L +VME +     ++  R L+  +  N   P   L  +     
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
           +I  G+AY++    V HR++  +N +V      VK+ DFG  + + +         + YY
Sbjct: 138 EIADGMAYLNAKKFV-HRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TDYY 186
Query: 203 R------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVE 248
           R            APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLK 243
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
            +             M+  Y D         P         P    DL     Q++P++R
Sbjct: 244 FV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMR 276
Query: 309 CTALEACA------HPFFDEL 323
            T LE         HP F E+
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEV 297

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 31/262 (11%)
Query: 40  RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN------RELQLMRLMDHPNVI 90
           R++G G FG V +A+  +   +   VA+K +  D    +      RE   M+  DHP+V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 91  SLKHCFFSTTSKDELFLNLV----MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            L      + +K  L + +V    M++     + +          +PL  +  +   I  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 147 GLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---Y 202
           G+ Y+ +     HRD+  +N +L + +T  V + DFG ++ +  G+       S+    +
Sbjct: 149 GMEYLSS-RNFIHRDLAARNCMLAEDMT--VCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG-ENAVDQLVEIIKVL--GTPTR 258
            A E +     YT   D+W+ G  + E++  GQ  + G ENA     EI   L  G   +
Sbjct: 206 LALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----EIYNYLIGGNRLK 259
Query: 259 EEIRCMNPNYTDFRFPQIKAHP 280
           +   CM   Y D  +    A P
Sbjct: 260 QPPECMEEVY-DLMYQCWSADP 280

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	376
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-101
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-99
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-94
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-92
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-92
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-92
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-91
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-91
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-90
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-90
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-90
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-89
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-89
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-88
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-88
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-87
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-86
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-86
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-86
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-80
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-64
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-63
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-62
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-60
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-59
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-58
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-58
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-58
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-57
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-56
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-55
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-54
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-54
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-54
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-53
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-52
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-52
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-52
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-52
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-51
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-51
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-51
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-51
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-51
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-50
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-50
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-50
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-50
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-50
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-50
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-49
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-49
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-49
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-49
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-49
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-49
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-49
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-48
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-48
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-47
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-47
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-47
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-47
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-47
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-47
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-47
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-47
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-46
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-46
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-46
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-46
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-46
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-46
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-45
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-45
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-45
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-45
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-45
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-44
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-44
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-43
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-43
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-42
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-42
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-42
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-41
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-41
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-41
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-41
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-41
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-41
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-41
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-41
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-41
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-40
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-40
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-40
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-40
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-40
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-39
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-39
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-39
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-39
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-39
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-39
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-38
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-38
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-38
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-38
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-38
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-38
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-37
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-37
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-36
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-36
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-36
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-36
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-36
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-36
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-35
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-35
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-35
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-34
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-34
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-34
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-34
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-33
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-32
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-31
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-31
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-30
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-28
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-19
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-17
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-15
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-14
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-14
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  634 bits (1636), Expect = 0.0
 Identities = 234/364 (64%), Positives = 290/364 (79%), Gaps = 4/364 (1%)

Query: 16  GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G  ++T +   G+  +  Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+
Sbjct: 34  GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 93

Query: 74  KNRELQLMRLMDHPNVISLKHCFFSTTSK-DELFLNLVMEYVPETMYRVLKHYSSMNQRM 132
           KNRELQ+MR +DH N++ L++ F+S+  K DE++LNLV++YVPET+YRV +HYS   Q +
Sbjct: 94  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153

Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P+IYVKLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE 
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
           N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272

Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
           LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T L
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332

Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 372
           EACAH FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R Q   S P 
Sbjct: 333 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 392

Query: 373 SAGT 376
           +A  
Sbjct: 393 NATA 396

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  630 bits (1626), Expect = 0.0
 Identities = 220/365 (60%), Positives = 282/365 (77%), Gaps = 4/365 (1%)

Query: 2   EMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
            ++   +   D     I      GK GE ++ I+Y   +V+G GSFG+VFQAK +E+ E 
Sbjct: 9   PLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE- 66

Query: 62  VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DELFLNLVMEYVPETMYR 120
           VAIKKVLQD+R+KNRELQ+MR++ HPNV+ LK  F+S   K DE+FLNLV+EYVPET+YR
Sbjct: 67  VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR 126

Query: 121 VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 180
             +HY+ + Q MP++ +KLY YQ+ R LAYIH++ G+CHRD+KPQNLL+DP +  +KL D
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLID 185

Query: 181 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
           FGSAK+L+ GE N+SYICSRYYRAPELIFGAT YTT+IDIWS GCV+AEL+ GQPLFPGE
Sbjct: 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245

Query: 241 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
           + +DQLVEIIKVLGTP+RE+I+ MNPNY + +FPQI+ HP+ KVF  R PP+AIDL SRL
Sbjct: 246 SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRL 305

Query: 301 LQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPE 360
           L+Y+PS R TA+EA  HPFFDELR   AR+PNGR  PPLFN+ +E     P+LI+RL+P+
Sbjct: 306 LEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQ 365

Query: 361 HVRRQ 365
           H   +
Sbjct: 366 HAEAE 370

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  598 bits (1544), Expect = 0.0
 Identities = 155/358 (43%), Positives = 221/358 (61%), Gaps = 13/358 (3%)

Query: 16  GHIISTTIGGKNGEP--KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           G ++S        E   K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 74  KNRELQLMRLM---DHPNVISLKHCFFSTTSK--DELFLNLVMEYVPETMYRVLKHYSSM 128
           +NRELQ+M+ +    HPN++ L+  F++   +   +++LN+VMEYVP+T++R  ++Y   
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 129 NQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 187
               P I +K++ +Q+ R +  +H     VCHRD+KP N+LV+     +KLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
              E N++YICSRYYRAPELIFG   YTT++DIWS GC+ AE++LG+P+F G+N+  QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYS 304
           EI++VLG P+RE +R +NP++TD      K  PW  VF     +   EA DL S LLQY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 305 PSLRCTALEACAHPFFDELREPNARLPNGRPFPP-LFNF-KQELAGASPELINRLIPE 360
           P  R    EA  HP+FDEL +P  +LPN +  P  LF F   E+   S     +L+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  576 bits (1487), Expect = 0.0
 Identities = 166/381 (43%), Positives = 240/381 (62%), Gaps = 44/381 (11%)

Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHP 87
           G    +  Y   + +GTGSFGIV +   +E+G+  A+KKVLQD RYKNREL +M+++DH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 88  NVISLKHCFFSTTSK---------------------------------DELFLNLVMEYV 114
           N+I L   F++T  +                                    +LN++MEYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 115 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 174
           P+T+++VLK +    + +P+  + +Y YQ+FR + +IH++ G+CHRD+KPQNLLV+   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179

Query: 175 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 234
            +KLCDFGSAK L+  E +++YICSR+YRAPEL+ GATEYT SID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 235 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 294
           PLF GE ++DQLV II+++GTPT+E++  MNP+YT+ RFP +KA  W K+  +  P  AI
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 295 DLASRLLQYSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPFPPLFNF-KQ 344
           DL  ++L+Y P LR    EA AHPFFD LR         N+  P+G  +  P LFNF   
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359

Query: 345 ELAGASPELINRLIPEHVRRQ 365
           EL+     ++NR++P++    
Sbjct: 360 ELSIIPGNVLNRILPKNFSPN 380

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  301 bits (774), Expect = e-101
 Identities = 99/313 (31%), Positives = 157/313 (50%), Gaps = 22/313 (7%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G GS+G+VF+ +  +TG+ VAIKK L+            RE+++++ + HPN+++L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
           F          L+LV EY   T+   L       + +P   VK  T+Q  + + + H   
Sbjct: 71  FRRKRR-----LHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
              HRDVKP+N+L+      +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 272
              +D+W+ GCV AELL G PL+PG++ VDQL  I K LG       ++   N  ++  +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 273 FPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
            P  +   P    F   +   A+ L    L   P+ R T  +   HP+F+ +RE    L 
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLA 298

Query: 332 NGRPFPPLFNFKQ 344
                P    + Q
Sbjct: 299 KEHDKPAENLYFQ 311

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  295 bits (758), Expect = 7e-99
 Identities = 97/295 (32%), Positives = 152/295 (51%), Gaps = 21/295 (7%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           VG GS+G+V + +  +TG  VAIKK L+    K       RE++L++ + H N+++L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                        LV E+V  T+   L+        +    V+ Y +QI  G+ + H+  
Sbjct: 93  CKKKKR-----WYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 214
            + HRD+KP+N+LV   +  VKLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 272
             ++D+W+ GC++ E+ +G+PLFPG++ +DQL  I+  LG       E+   NP +   R
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 273 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
            P+IK   P  + +  ++    IDLA + L   P  R    E   H FF      
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  291 bits (748), Expect = 2e-97
 Identities = 86/313 (27%), Positives = 155/313 (49%), Gaps = 30/313 (9%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRLMDHPNV 89
           YM  + +G G  G+VF A   +  + VAIKK+ L D          RE++++R +DH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 90  ISLKHCFFSTTSKDELFLN---------LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLY 140
           + +      + S+    +          +V EY+   +  VL+        +   + +L+
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLF 125

Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----Y 196
            YQ+ RGL YIH+   V HRD+KP NL ++     +K+ DFG A+++    ++       
Sbjct: 126 MYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           + +++YR+P L+     YT +ID+W+AGC+ AE+L G+ LF G + ++Q+  I++ +   
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244

Query: 257 TREEIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
             E+ + +      +          P  ++    +  EA+D   ++L +SP  R TA EA
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 315 CAHPFFDELREPN 327
            +HP+      P 
Sbjct: 304 LSHPYMSIYSFPM 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  290 bits (745), Expect = 7e-97
 Identities = 102/327 (31%), Positives = 168/327 (51%), Gaps = 35/327 (10%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMD 85
           +Y+    +G G++  V++ K   T   VA+K++    R ++         RE+ L++ + 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQI 144
           H N+++L     +  S     L LV EY    + + LK Y       + +  VKL+ +Q+
Sbjct: 59  HANIVTLHDIIHTEKS-----LTLVFEY----LDKDLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRY 201
            RGLAY H    V HRD+KPQNLL++    ++KL DFG A+   K     +Y   + + +
Sbjct: 110 LRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARA--KSIPTKTYDNEVVTLW 165

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-- 259
           YR P+++ G+T+Y+T ID+W  GC+  E+  G+PLFPG    +QL  I ++LGTPT E  
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225

Query: 260 -EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
             I      +  + +P+ +A         R+  +  DL ++LLQ+    R +A +A  HP
Sbjct: 226 PGILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283

Query: 319 FFDELREPNARLPNGRPFPPLFNFKQE 345
           FF  L E   +LP+      L   + +
Sbjct: 284 FFLSLGERIHKLPDTTSIFALKEIQLQ 310

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  291 bits (747), Expect = 8e-97
 Identities = 102/346 (29%), Positives = 182/346 (52%), Gaps = 34/346 (9%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 88
           +  + ++G G++G+V  A    TGE VAIKK+          R    RE+++++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +I++ +     + ++   + ++ E +   ++RV+       Q +   +++ + YQ  R +
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAV 125

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----------YI 197
             +H    V HRD+KP NLL++     +K+CDFG A+++ +  A+ S           ++
Sbjct: 126 KVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            +R+YRAPE++  + +Y+ ++D+WS GC+LAEL L +P+FPG +   QL+ I  ++GTP 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243

Query: 258 REEI--RCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
            +       +P   ++    P   A P  K+F + + P+ IDL  R+L + P+ R TA E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKE 302

Query: 314 ACAHPFFDELREPNARLPNGRPFPPL-FNFKQELAGASPELINRLI 358
           A  HP+     +PN   P G P PP  F F       + + + +LI
Sbjct: 303 ALEHPYLQTYHDPN-DEPEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  289 bits (743), Expect = 2e-96
 Identities = 93/303 (30%), Positives = 152/303 (50%), Gaps = 23/303 (7%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMR-LMDHPNVISLK 93
           Y   R +G G +  VF+A  +   E V +K +   ++ K  RE++++  L   PN+I+L 
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 97

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
                  S+      LV E+V  T ++ L       Q +    ++ Y Y+I + L Y H+
Sbjct: 98  DIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
           + G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+     
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207

Query: 214 YTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC-----MNPN 267
           Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT    +        ++P 
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267

Query: 268 YTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
           + D    +     W +  H      + PEA+D   +LL+Y    R TA EA  HP+F  +
Sbjct: 268 FND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

Query: 324 REP 326
            + 
Sbjct: 327 VKD 329

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  287 bits (736), Expect = 4e-95
 Identities = 95/332 (28%), Positives = 158/332 (47%), Gaps = 33/332 (9%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------------RELQL 80
           Y  +R + +GS+G V        G  VAIK+V                       RE++L
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 81  MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVK 138
           +    HPN++ L+  F          L LV E +   + +V+       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137

Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            + Y I  GL  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195

Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G    +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255

Query: 259 EEIRCM-NP---NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
           E++    +P   +Y       + A  W  V      P A+DL +++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314

Query: 315 CAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
             HP+F+ L +P   L  G      F+F + +
Sbjct: 315 LRHPYFESLFDPL-DLTEGLSER--FHFDESV 343

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  284 bits (728), Expect = 5e-94
 Identities = 103/312 (33%), Positives = 157/312 (50%), Gaps = 33/312 (10%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVISL 92
           +G G F  V++A+   T + VAIKK+    R +          RE++L++ + HPN+I L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
              F   ++     ++LV +++   +  ++K     +  +   ++K Y     +GL Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 209
               + HRD+KP NLL+D     +KL DFG AK    G  N +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---RCMNP 266
           GA  Y   +D+W+ GC+LAELLL  P  PG++ +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
           +Y    F      P H +F      + +DL   L  ++P  R TA +A    +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299

Query: 327 NARLPNGRPFPP 338
                   P P 
Sbjct: 300 GPTPGCQLPRPN 311

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  283 bits (725), Expect = 2e-93
 Identities = 107/337 (31%), Positives = 178/337 (52%), Gaps = 28/337 (8%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 88
           Y     +G G++G+V  A        VAIKK+          R    RE++++    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +I +     + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRA 204
            YIH+   V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE++  +  YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259

Query: 265 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
            N    ++    P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

Query: 322 ELREPNARLPNGRPFPPLFNFKQELAGASPELINRLI 358
           +  +P+   P        F F  EL     E +  LI
Sbjct: 319 QYYDPS-DEP---IAEAPFKFDMELDDLPKEKLKELI 351

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  281 bits (720), Expect = 9e-93
 Identities = 106/335 (31%), Positives = 169/335 (50%), Gaps = 29/335 (8%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 87
           Y++   VG+G++G V  A    +GE VAIKK+           R Y  REL L++ M H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 88  NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           NVI L   F   +S    +   LVM ++   + +++        +     ++   YQ+ +
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           GL YIH+  GV HRD+KP NL V+    ++K+ DFG A+          Y+ +R+YRAPE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARHA--DAEMTGYVVTRWYRAPE 193

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 265
           +I     Y  ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P  E ++ + +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253

Query: 266 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
                +    PQ     + ++F  R  P+A DL  ++L+     R TA +A  HPFF+  
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLI 358
           R+P             F+   E    + +   + I
Sbjct: 313 RDPE----EETEAQQPFDDSLEHEKLTVDEWKQHI 343

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  280 bits (719), Expect = 2e-92
 Identities = 103/318 (32%), Positives = 169/318 (53%), Gaps = 25/318 (7%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 87
           Y   + VG+G++G V  A    TG  VAIKK+           R Y  REL+L++ M H 
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84

Query: 88  NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           NVI L   F    + D+     LVM ++   + +++K     ++++    ++   YQ+ +
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           GL YIH   G+ HRD+KP NL V+    ++K+ DFG A+          Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPE 195

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 265
           +I     YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP  E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255

Query: 266 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
               ++    P+++   +  +      P A++L  ++L      R TA EA AHP+F+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

Query: 324 REPNARLPNGRPFPPLFN 341
            +     P  + +   F+
Sbjct: 315 HDTEDE-PQVQKYDDSFD 331

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  279 bits (715), Expect = 2e-92
 Identities = 95/313 (30%), Positives = 154/313 (49%), Gaps = 41/313 (13%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G V++A    T ETVAIK++  +   +       RE+ L++ + H N+I LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                      L+L+ EY        LK Y   N  + +  +K + YQ+  G+ + H+  
Sbjct: 102 IHHNHR-----LHLIFEY----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151

Query: 156 GVCHRDVKPQNLLVDPLTH----QVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 208
              HRD+KPQNLL+          +K+ DFG A+    G     +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMN 265
            G+  Y+TS+DIWS  C+ AE+L+  PLFPG++ +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
           P++    FP+ +     +V    +  E +DL + +L+  P  R +A  A  HP+F     
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325

Query: 326 PNARLPNGRPFPP 338
                     F P
Sbjct: 326 ---------DFDP 329

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  276 bits (709), Expect = 1e-91
 Identities = 101/294 (34%), Positives = 163/294 (55%), Gaps = 27/294 (9%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           VG G++G+V++AK    G  VA+K++  D   +       RE+ L++ + HPN++SL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             S        L LV E++ + + +VL         +    +K+Y YQ+ RG+A+ H   
Sbjct: 88  IHSERC-----LTLVFEFMEKDLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 212
            + HRD+KPQNLL++     +KL DFG A+    G    SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINS-DGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 269
           +Y+TS+DIWS GC+ AE++ G+PLFPG    DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
              F   +  PW  +       E IDL S +L + P+ R +A +A  HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  275 bits (705), Expect = 2e-91
 Identities = 94/294 (31%), Positives = 159/294 (54%), Gaps = 28/294 (9%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N++ L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             +        L LV E++ + + ++L         +  +  K +  Q+  G+AY H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 212
            V HRD+KPQNLL++    ++K+ DFG A+    G     Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLINR-EGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 269
           +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
              F   +  PW     K +    IDL S++L+  P+ R TA +A  H +F E 
Sbjct: 236 PN-FTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  275 bits (706), Expect = 2e-90
 Identities = 105/335 (31%), Positives = 170/335 (50%), Gaps = 29/335 (8%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 87
           Y     VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 88  NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           NVI L   F    S +E   + LV   +   +  ++K      Q++   +V+   YQI R
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILR 143

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           GL YIH+   + HRD+KP NL V+    ++K+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARHT--ADEMTGYVATRWYRAPE 199

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 265
           ++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ + +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259

Query: 266 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
            +  ++     Q+    +  VF     P A+DL  ++L      R TA +A AH +F + 
Sbjct: 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLI 358
            +P+       P    ++   E      +    L 
Sbjct: 319 HDPDD-----EPVADPYDQSLESRDLLIDEWKSLT 348

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  275 bits (704), Expect = 3e-90
 Identities = 98/331 (29%), Positives = 160/331 (48%), Gaps = 38/331 (11%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+           R Y  REL LM+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVKLYTYQI 144
           N+I L + F    S +E   + +VME +   + +V+        +M L    +    YQ+
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------QMELDHERMSYLLYQM 136

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 204
             G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE+I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253

Query: 265 NPNYTDF--RFPQIKAHPWHKVFHKRMP-----------PEAIDLASRLLQYSPSLRCTA 311
            P    +    P+   + + K+F   +             +A DL S++L    S R + 
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313

Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFNF 342
            EA  HP+ +   +P+       P  P    
Sbjct: 314 DEALQHPYINVWYDPS-EAEAPPPKIPDKQL 343

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  272 bits (698), Expect = 5e-90
 Identities = 95/320 (29%), Positives = 158/320 (49%), Gaps = 41/320 (12%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVISL 92
           +G G++  V++     TG  VA+K+V    +  +         RE+ LM+ + H N++ L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAY 150
                +        L LV E++   + + +   +  +  + + L  VK + +Q+ +GLA+
Sbjct: 69  YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPEL 207
            H    + HRD+KPQNLL++    Q+KL DFG A+    G    ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           + G+  Y+TSIDIWS GC+LAE++ G+PLFPG N  +QL  I  ++GTP  E +    P+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLW---PS 235

Query: 268 YTDF-----RFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
            T          Q       +V        +    +D    LLQ +P +R +A +A  HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

Query: 319 FFDELREPNARLPNGRPFPP 338
           +F E     A +   R    
Sbjct: 296 WFAEYYHH-ASMGGSRSHHH 314

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  270 bits (692), Expect = 2e-89
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 28/298 (9%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 95
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N++ L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
             S        L LV E+  + + +      S N  +    VK + +Q+ +GL + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 212
            V HRD+KPQNLL++    ++KL +FG A+    G     Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLINR-NGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 213 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNY 268
            Y+TSID+WSAGC+ AEL   G+PLFPG +  DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
             +            V   ++     DL   LL+ +P  R +A EA  HP+F +   P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  275 bits (705), Expect = 4e-89
 Identities = 99/345 (28%), Positives = 171/345 (49%), Gaps = 36/345 (10%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 87
           Y   + +G+G+ GIV  A        VAIKK+ +         R Y  REL LM+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 88  NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N+ISL + F    + +E   + LVME +   + +V++        +    +    YQ+  
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 175

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           G+ ++H+  G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 234 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292

Query: 267 NYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALE 313
              ++    P+     + K+F           +K    +A DL S++L   P+ R +  +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352

Query: 314 ACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLI 358
           A  HP+ +   +P        P P +++ + +    + E    LI
Sbjct: 353 ALQHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELI 394

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  270 bits (693), Expect = 3e-88
 Identities = 93/360 (25%), Positives = 169/360 (46%), Gaps = 61/360 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---QD-----RRYKNRELQLMRLM-DH 86
           Y   + +G G++GIV+++    TGE VA+KK+    Q+     R +  RE+ ++  +  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
            N+++L +   +   +D   + LV +Y+   ++ V++        +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD---VYLVFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----------- 195
            + Y+H+  G+ HRD+KP N+L++     VK+ DFG ++  V      +           
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 196 -----------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG + ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 245 QLVEIIKVLGTPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMP----------- 290
           QL  II V+  P+ E++  + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 291 ----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 346
                EA+DL  +LLQ++P+ R +A +A  HPF      PN             N   + 
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  272 bits (697), Expect = 5e-88
 Identities = 101/381 (26%), Positives = 159/381 (41%), Gaps = 79/381 (20%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRLMDHP 87
           Y    ++GTGS+G V +A        VAIKK+L+         R    RE+ ++  ++H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           +V+ +         +    L +V+E       ++ +        +  +++K   Y +  G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVG 168

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------------ 195
           + Y+H+  G+ HRD+KP N LV+     VK+CDFG A+ +   E   S            
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 196 ----------------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL------- 232
                           ++ +R+YRAPELI     YT +ID+WS GC+ AELL        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286

Query: 233 ----GQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCM-NPN 267
                 PLFPG +                      DQL  I  +LGTP+ E+I  +   +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346

Query: 268 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
              +   FP+ +     + F      +AI L  R+L ++P+ R T  E  AHPFF E+R 
Sbjct: 347 AKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405

Query: 326 PNARLPNGRPFPPLFNFKQEL 346
                         FN    +
Sbjct: 406 AEVETNATEKVRLPFNDWMNM 426

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  264 bits (676), Expect = 9e-87
 Identities = 84/302 (27%), Positives = 141/302 (46%), Gaps = 35/302 (11%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RE---LQLMRLMDHPNV 89
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRG 147
           + L     ++ +  E+ + LV E+    + + L+ Y   +    +P   +K    Q  RG
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEH----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRA 204
           L ++H    + HRD+KP+N+LV      VKL DFG A++       ++    + + +YRA
Sbjct: 133 LDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIY---SYQMALTPVVVTLWYRA 187

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE++  +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  ++    
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW--- 243

Query: 265 NPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
            P         FP     P   V    M      L   +L ++P  R +A  A  H +  
Sbjct: 244 -PRDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

Query: 322 EL 323
           + 
Sbjct: 302 KD 303

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  265 bits (679), Expect = 1e-86
 Identities = 87/320 (27%), Positives = 142/320 (44%), Gaps = 36/320 (11%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVIS 91
           +G G+FG VF+A+  +TG+ VA+KKV      +N          RE+++++L+ H NV++
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80

Query: 92  LK---HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRG 147
           L        S  ++ +  + LV ++        L    S++  +  L  +K     +  G
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV--LVKGEANISY---ICSRYY 202
           L YIH    + HRD+K  N+L+      +KL DFG A+   L K      Y   + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 259
           R PEL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E   
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254

Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
            +      Y      + +              P A+DL  +LL   P+ R  + +A  H 
Sbjct: 255 NVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313

Query: 319 FFDELREPNARLPNGRPFPP 338
           FF    +P      G     
Sbjct: 314 FFWS--DPMPSDLKGMLSTH 331

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  264 bits (677), Expect = 1e-86
 Identities = 96/316 (30%), Positives = 155/316 (49%), Gaps = 37/316 (11%)

Query: 42  VGTGSFGIVFQAK-CLETGETVAIKKVLQDRRYKN-------RE---LQLMRLMDHPNVI 90
           +G G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNV+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGL 148
            L      + +  E  L LV E+    + + L  Y        +P   +K   +Q+ RGL
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEH----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAP 205
            ++H+   V HRD+KPQN+LV   + Q+KL DFG A++       ++    + + +YRAP
Sbjct: 134 DFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 188

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E++  ++ Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G P  E+     
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---- 243

Query: 266 PNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
           P         F    A P  K     +     DL  + L ++P+ R +A  A +HP+F +
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302

Query: 323 LREPNARLPNGRPFPP 338
           L      L +    PP
Sbjct: 303 LERCKENLDS--HLPP 316

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  266 bits (682), Expect = 4e-86
 Identities = 96/373 (25%), Positives = 159/373 (42%), Gaps = 71/373 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQD--RRYKNRELQLMRLMDHP 87
           Y+ + ++G GS+G V+ A    T + VAIKKV      L D  R    RE+ ++  +   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +I L              L +V+E     + ++ K        +   ++K   Y +  G
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLG 141

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------------ 195
             +IH   G+ HRD+KP N L++     VK+CDFG A+ +   +                
Sbjct: 142 ENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199

Query: 196 -----------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ---------- 234
                      ++ +R+YRAPELI     YT SIDIWS GC+ AELL             
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259

Query: 235 -PLFPG-----------------ENAVDQLVEIIKVLGTPTREEIRCM-NPNYTDF--RF 273
            PLFPG                 ++  DQL  I  ++GTPT ++++ +  P    +   F
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319

Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 333
           P  K     + +   +  + I+L   +L+++P+ R T  +A  HP+  ++R+      + 
Sbjct: 320 PHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFST 378

Query: 334 RPFPPLFNFKQEL 346
           +     F+    L
Sbjct: 379 KKIILPFDDWMVL 391

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  249 bits (637), Expect = 9e-80
 Identities = 92/333 (27%), Positives = 152/333 (45%), Gaps = 40/333 (12%)

Query: 42  VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFF 97
           VG G++G V++AK  +    +  A+K++       +  RE+ L+R + HPNVISL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 98  STTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           S   +    + L+ +Y    ++ ++K +     +    ++P   VK   YQI  G+ Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 153 TVPGVCHRDVKPQNLLVDPLTH---QVKLCDFGSAKVLVKGEANISYICSR----YYRAP 205
               V HRD+KP N+LV        +VK+ D G A++       ++ +       +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVEIIKVLGTP 256
           EL+ GA  YT +IDIW+ GC+ AELL  +P+F               DQL  I  V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264

Query: 257 TRE---------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 307
             +         E   +  ++    +       + +    +   +A  L  +LL   P  
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324

Query: 308 RCTALEACAHPFFDELREP--NARLPNGRPFPP 338
           R T+ +A   P+F E   P  +       P+P 
Sbjct: 325 RITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPK 357

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  209 bits (533), Expect = 5e-64
 Identities = 94/342 (27%), Positives = 155/342 (45%), Gaps = 60/342 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM------DH 86
           Y   +V+G GSFG V +A   +  + VA+K V  ++R+      E++++  +      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 87  PNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
            NVI +   F         F N   +  E +   +Y ++K      Q   L  V+ + + 
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHS 208

Query: 144 IFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
           I + L  +H    + H D+KP+N LL       +K+ DFGS+      +   +YI SR+Y
Sbjct: 209 ILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
           RAPE+I GA  Y   ID+WS GC+LAELL G PL PGE+  DQL  +I++LG P+++ + 
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 263 -----------CMNPNYTDF---------------RFPQIKAHPWHKVFHKRMPPEA--- 293
                         P Y                  R  +++  P  + +   +       
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 294 -IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 334
            +D   + L++ P++R T  +A  HP+    R    + P G 
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWL---RRRLPKPPTGE 423

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  204 bits (521), Expect = 7e-63
 Identities = 85/339 (25%), Positives = 145/339 (42%), Gaps = 42/339 (12%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM-----DHP 87
           Y+  R +G G F  V+ AK +     VA+K V  D+ Y      E++L++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 88  NVISLKHC-----FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
           + +   H       F+    + + + +V E + E +  ++K Y   ++ +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYI 197
           Q+  GL Y+H   G+ H D+KP+N+L++ +        +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 251
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  +         D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 252 VLGTPTREEIR-------CMNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLAS 298
           +LG      +R         N         ++K  P   V  ++         E  D  S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 299 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP 337
            +LQ  P  R  A     HP+  +           R   
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  203 bits (519), Expect = 2e-62
 Identities = 93/336 (27%), Positives = 147/336 (43%), Gaps = 62/336 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM------DH 86
           Y  + ++G GSFG V +A      E VAIK +   + + N    E++L+ LM        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 87  PNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             ++ LK  F         F N   LV E +   +Y +L++ +   + + L   + +  Q
Sbjct: 116 YYIVHLKRHFM--------FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQ 165

Query: 144 IFRGLAYIHTV-PGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
           +   L ++ T    + H D+KP+N LL +P    +K+ DFGS+     G+    YI SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF 223

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           YR+PE++ G   Y  +ID+WS GC+L E+  G+PLF G N VDQ+ +I++VLG P    +
Sbjct: 224 YRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282

Query: 262 R-----------CMNPNYTDFRFPQIKAH---PWHKVFH-----KRMPPEA--------- 293
                         +  +   +    K     P  +  H     +   P           
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342

Query: 294 -------IDLASRLLQYSPSLRCTALEACAHPFFDE 322
                   DL  R+L Y P  R     A  H FF +
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  195 bits (499), Expect = 6e-60
 Identities = 79/337 (23%), Positives = 136/337 (40%), Gaps = 60/337 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRLM------D 85
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q++  +       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 86  HPNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
               + +   F               +V E +  + Y  +K          L +++   Y
Sbjct: 76  TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAY 125

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQN-LLVD-----------------PLTHQVKLCDFGSA 184
           QI + + ++H+   + H D+KP+N L V                   +   +K+ DFGSA
Sbjct: 126 QICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
                 E + + + +R+YRAPE+I     ++   D+WS GC+L E  LG  +FP  ++ +
Sbjct: 185 --TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241

Query: 245 QLVEIIKVLGTPTREEIR-CMNPNY-TDFRFPQIKAHPWHKVFHKRMPP----------- 291
            L  + ++LG   +  I+      Y    R    +     +   +   P           
Sbjct: 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301

Query: 292 --EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
                DL  ++L+Y P+ R T  EA  HPFFD L++ 
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  195 bits (498), Expect = 1e-59
 Identities = 75/338 (22%), Positives = 137/338 (40%), Gaps = 66/338 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM-----DHP 87
           ++  R +G G+FG V   + ++  +  A+K V   ++Y      E  +++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 88  NVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           N++     F        ++ +   L+ E +  ++Y ++   +       +  +KLY  +I
Sbjct: 97  NIVKYHGKF--------MYYDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEI 146

Query: 145 FRGLAYIHTVPGVCHRDVKPQN-LLVDPLTH-----------------------QVKLCD 180
            + L Y+  +  + H D+KP+N LL DP                           +KL D
Sbjct: 147 LKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 181 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
           FG A    K + + S I +R YRAPE+I     +  S D+WS GCVLAEL  G  LF   
Sbjct: 206 FGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 241 NAVDQLVEIIKVLGTPTREEIR---------CMNPNYTDFRFPQIKAHPWHKVFHKRMPP 291
             ++ L  +  ++    +  +           +N +     +P+  +        K+  P
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 292 EA--------IDLASRLLQYSPSLRCTALEACAHPFFD 321
                      D    +LQ  P+LR +  E   H F +
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  193 bits (492), Expect = 1e-58
 Identities = 77/346 (22%), Positives = 129/346 (37%), Gaps = 60/346 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRLM------D 85
           Y     +G G+FG V +      G   VA+K +    +Y+     E+ +++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 86  HPNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
               + +   F         F     +  E + +  +  LK  +   Q  PL +V+   Y
Sbjct: 81  KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAY 130

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTH-----------------QVKLCDFGSA 184
           Q+   L ++H    + H D+KP+N L V+                      +++ DFGSA
Sbjct: 131 QLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
                 E + + + +R+YR PE+I     +    D+WS GC+L E   G  LF      +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

Query: 245 QLVEIIKVLGTPTREEIRCM---------NPNYTDFRFPQIKAHPWHKVFHKRMPPEA-- 293
            LV + K+LG      I               + +            K     M  ++  
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306

Query: 294 ----IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 335
                DL  R+L++ P+ R T  EA  HPFF  L          R 
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  189 bits (483), Expect = 7e-58
 Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 62/320 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRLMDHPN- 88
           Y   + +G+G    VFQ    E  +  AIK V      ++   +   E+  +  +   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 89  -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +I L           + ++ +VME     +   LK      + +     K Y   +   
Sbjct: 89  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 204
           +  IH   G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 205 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 253
           PE I             ++ +   D+WS GC+L  +  G+  F    N + +L  II   
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 253

Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                      +PN+    FP I               +  D+    L+  P  R +  E
Sbjct: 254 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 289

Query: 314 ACAHPFFDELREPNARLPNG 333
             AHP+      P  ++  G
Sbjct: 290 LLAHPYVQIQTHPVNQMAKG 309

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  192 bits (489), Expect = 7e-58
 Identities = 74/360 (20%), Positives = 125/360 (34%), Gaps = 62/360 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPN- 88
           Y   + +G+G    VFQ    E  +  AIK V  +            E+  +  +   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 89  -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +I L           + ++ +VME     +   LK      + +     K Y   +   
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 204
           +  IH   G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 205 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 253
           PE I             ++ +   D+WS GC+L  +  G+  F    N + +L  II   
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 281

Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                      +PN+    FP I               +  D+    L+  P  R +  E
Sbjct: 282 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 317

Query: 314 ACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHS 373
             AHP+      P  ++  G      +   Q +   SP  I +         +G    +S
Sbjct: 318 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 377

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  189 bits (482), Expect = 9e-58
 Identities = 69/307 (22%), Positives = 112/307 (36%), Gaps = 68/307 (22%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQ-LMRLMDHP 87
           S+     +G GS+G VF+ +  E G   A+K+ +      +DR  K  E+    ++  HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
             + L+  +     ++   L L  E    ++ +  + +      +P   V  Y       
Sbjct: 118 CCVRLEQAW-----EEGGILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLA 169

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 207
           LA++H+  G+ H DVKP N+ + P   + KL DFG    L    A         Y APEL
Sbjct: 170 LAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +     Y T+ D++S G  + E+     L  G                            
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHG---------------------------- 257

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPP--------EAIDLASRLLQYSPSLRCTALEACAHPF 319
                        W ++    +PP        E   +   +L+  P LR TA    A P 
Sbjct: 258 ----------GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307

Query: 320 FDELREP 326
               R+P
Sbjct: 308 L---RQP 311

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  189 bits (483), Expect = 1e-57
 Identities = 74/360 (20%), Positives = 125/360 (34%), Gaps = 62/360 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPN- 88
           Y   + +G+G    VFQ    E  +  AIK V  +            E+  +  +   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 89  -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +I L           + ++ +VME     +   LK      + +     K Y   +   
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 204
           +  IH   G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 205 PELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 253
           PE I             ++ +   D+WS GC+L  +  G+  F    N + +L  II   
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 234

Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                      +PN+    FP I               +  D+    L+  P  R +  E
Sbjct: 235 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 270

Query: 314 ACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHS 373
             AHP+      P  ++  G      +   Q +   SP  I +         +G    +S
Sbjct: 271 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  188 bits (480), Expect = 2e-57
 Identities = 68/324 (20%), Positives = 108/324 (33%), Gaps = 53/324 (16%)

Query: 27  NGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRE 77
                  +      Y+  + +G G F  V   + L  G   A+K++L    QDR    RE
Sbjct: 17  LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76

Query: 78  LQLMRLMDHPNVISLKHCFF-STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLI 135
             + RL +HPN++ L         +K E +  L++ +    T++  ++        +   
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134

Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG----- 190
            +      I RGL  IH   G  HRD+KP N+L+     Q  L D GS            
Sbjct: 135 QILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSR 192

Query: 191 -----EANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
                +   +  C+  YRAPEL             D+WS GCVL  ++ G+  +      
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252

Query: 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 303
              V +  V                     PQ            R       L + ++  
Sbjct: 253 GDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTV 286

Query: 304 SPSLRCTALEACAHPFFDELREPN 327
            P  R       +     +   P 
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPG 310

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  187 bits (477), Expect = 2e-56
 Identities = 47/333 (14%), Positives = 91/333 (27%), Gaps = 57/333 (17%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHP 87
                  +  G   +VF  + +E  E  A+K                +        +   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 88  NVISLKHCFFSTTSKDELFLN---------------------LVMEYVP---ETMYRVLK 123
           +    +         D + +                      L+M       E ++  L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 124 HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 183
                     ++ + + T Q+ R  A + +  G+ H    P NL + P   ++ L D  +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSA 240

Query: 184 AKVLVKGEANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
              +  G    +      Y   E +      +T +++ W  G  +  +      F     
Sbjct: 241 LWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
             +       L  P  +                             +P     L  R L 
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338

Query: 303 YSPSLRCTALEACAHPFFDELR-EPNARLPNGR 334
           +    R   LEA   P F +L+ E ++ L  G+
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  189 bits (481), Expect = 3e-56
 Identities = 70/301 (23%), Positives = 124/301 (41%), Gaps = 51/301 (16%)

Query: 34  ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-LMDHPNVIS 91
           IS+  + V+G G+ G +   + +     VA+K++L +   + +RE+QL+R   +HPNVI 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
                     KD  F  + +E    T+   V +   +     P+  ++    Q   GLA+
Sbjct: 83  YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 151 IHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVLVKGEANISY---IC-SRYY 202
           +H++  + HRD+KP N+L+         +  + DFG  K L  G  + S    +  +  +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 203 RAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259
            APE++    +   T ++DI+SAGCV   ++  G   F                    + 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----------------QR 236

Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
           +   +               P      K     A +L  +++   P  R +A     HPF
Sbjct: 237 QANILLGAC-SLDCLH----PE-----KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

Query: 320 F 320
           F
Sbjct: 287 F 287

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  182 bits (465), Expect = 1e-55
 Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 45/299 (15%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y     +GTGS+G   + +    G+ +  K++        +++    E+ L+R + HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +         T+     L +VMEY     +  V+   +   Q +   +V     Q+   L
Sbjct: 68  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 149 AYIH----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYR 203
              H        V HRD+KP N+ +D     VKL DFG A++L    +       + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           +PE +     Y    DIWS GC+L EL    P F   +   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                 + +F +I           R   E  ++ +R+L      R +  E   +P   E
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  184 bits (469), Expect = 1e-54
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 60/323 (18%)

Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-LM 84
           N E       ++E+++G GS G V   +    G  VA+K++L D       E++L+    
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66

Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKH--YSSMNQRMPLIYVKLYT 141
           DHPNVI   +C        + FL + +E         V          +           
Sbjct: 67  DHPNVIRY-YCSE----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVD------------PLTHQVKLCDFGSAKVLVK 189
            QI  G+A++H++  + HRD+KPQN+LV                 ++ + DFG  K L  
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 190 GEANISY----IC-SRYYRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLF 237
           G+++          +  +RAPEL+  +         T SIDI+S GCV   +L  G+  F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 238 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 297
             +    +   II+                   F   ++K      +       EA DL 
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276

Query: 298 SRLLQYSPSLRCTALEACAHPFF 320
           S+++ + P  R TA++   HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  180 bits (459), Expect = 2e-54
 Identities = 70/312 (22%), Positives = 113/312 (36%), Gaps = 59/312 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISL 92
           +    V+G G+FG V +A+        AIKK+       +    E+ L+  ++H  V+  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 93  KHCF--------FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
              +          T  K +  L + MEY    T+Y ++    S N             Q
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLFRQ 124

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 200
           I   L+YIH+  G+ HRD+KP N+ +D  +  VK+ DFG AK + +    +         
Sbjct: 125 ILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 201 ------------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248
                        Y A E++ G   Y   ID++S G +  E++   P   G       V 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236

Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
           I+K L +                 FP     P    F          +   L+ + P+ R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275

Query: 309 CTALEACAHPFF 320
             A       + 
Sbjct: 276 PGARTLLNSGWL 287

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  181 bits (460), Expect = 2e-54
 Identities = 53/302 (17%), Positives = 113/302 (37%), Gaps = 23/302 (7%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 90
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE ++++ ++H N++
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L      TT++    L  +ME+ P       + +  ++    +P     +    +  G+
Sbjct: 71  KLFAIEEETTTR-HKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
            ++    G+ HR++KP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 206 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           ++   A        +Y  ++D+WS G        G   F       +  E++  + T   
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
                      +         P      + +      + + +L+          +  A  
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

Query: 319 FF 320
             
Sbjct: 305 SD 306

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  175 bits (447), Expect = 7e-53
 Identities = 60/297 (20%), Positives = 111/297 (37%), Gaps = 50/297 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHC 95
           +    ++G+G FG VF+AK    G+T  IK+V  +     RE++ +  +DH N++    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 96  F-----------FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           +            +++      L + ME+  + T+ + ++      +++  +       Q
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQ 130

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           I +G+ YIH+   + +RD+KP N+ +   T QVK+ DFG    L           +  Y 
Sbjct: 131 ITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           +PE I    +Y   +D+++ G +LAELL                ++              
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                               +       +   L  +LL   P  R    E       
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  177 bits (450), Expect = 1e-52
 Identities = 71/318 (22%), Positives = 120/318 (37%), Gaps = 47/318 (14%)

Query: 17  HIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQ 69
           H  S    G      Q++  Y+  + +G GSFG     K  E G    IK++       +
Sbjct: 6   HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 70  DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSM 128
           +R    RE+ ++  M HPN++  +  F     ++   L +VM+Y     +++ +      
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESF-----EENGSLYIVMDYCEGGDLFKRINAQK-- 118

Query: 129 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 188
                   +  +  QI   L ++H    + HRD+K QN+ +      V+L DFG A+VL 
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLN 176

Query: 189 KGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
                      + YY +PE+      Y    DIW+ GCVL EL   +  F   + +  LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234

Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 307
             I             ++ +Y                       +   L S+L + +P  
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267

Query: 308 RCTALEACAHPFFDELRE 325
           R +        F  +  E
Sbjct: 268 RPSVNSILEKGFIAKRIE 285

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  175 bits (447), Expect = 1e-52
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 44/294 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 88
           +  E+ +G G F  V++A CL  G  VA+KKV        + R    +E+ L++ ++HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           VI     F      ++  LN+V+E      + R++KH+    + +P   V  Y  Q+   
Sbjct: 94  VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 206
           L ++H+   V HRD+KP N+ +   T  VKL D G  +    K  A  S + + YY +PE
Sbjct: 149 LEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMN 265
            I     Y    DIWS GC+L E+   Q  F G+   +  L + I           +C  
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------EQC-- 253

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                  +P + +             E   L +  +   P  R           
Sbjct: 254 ------DYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  179 bits (457), Expect = 2e-52
 Identities = 86/322 (26%), Positives = 137/322 (42%), Gaps = 53/322 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 88
           Y  +RV+G GSFG V   K   TG+  A+K +         D+    RE+QL++ +DHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQI 144
           ++ L   F     +D+ +  LV E     E    ++    +S +              Q+
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYY 202
             G+ Y+H    + HRD+KP+NLL++  +    +++ DFG +      +     I + YY
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K           
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----------- 241

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                   + F       W KV        A DL  ++L Y PS+R +A +A  H +   
Sbjct: 242 ------GKYTFE---LPQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287

Query: 323 LREPNARLPNGRPFPPLFNFKQ 344
             +    +        + N +Q
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQ 309

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  179 bits (457), Expect = 4e-52
 Identities = 79/341 (23%), Positives = 136/341 (39%), Gaps = 55/341 (16%)

Query: 19  ISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD 70
           +  T G      K  +S  Y   + +G+G++G V   +   T    AIK +         
Sbjct: 20  LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79

Query: 71  RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYS 126
                 E+ +++L+DHPN++ L   F     +D+    LVME     E    ++    ++
Sbjct: 80  NSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN 134

Query: 127 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSA 184
            +          +   Q+  G+ Y+H    + HRD+KP+NLL++       +K+ DFG +
Sbjct: 135 EV-------DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186

Query: 185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
            V    +     + + YY APE++    +Y    D+WS G +L  LL G P F G+   D
Sbjct: 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--D 242

Query: 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
           Q  EI+         ++      +            W  V        A DL  ++LQ+ 
Sbjct: 243 Q--EIL--------RKVEKGKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFD 279

Query: 305 PSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF-NFKQ 344
              R +A +A  HP+  E+                  N ++
Sbjct: 280 SQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  179 bits (455), Expect = 5e-52
 Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 53/322 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRLMDHPNV 89
           Y    ++G GSFG V + K   T +  A+K +       +D     RE++L++ +DHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 145
           + L         +D     +V E     E    ++K   +S                Q+F
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYR 203
            G+ Y+H    + HRD+KP+N+L++       +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE++ G   Y    D+WSAG +L  LL G P F G+N  D L  +              
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
                  + F       W  +       +A DL  ++L + PSLR TA +   HP+  + 
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

Query: 324 REPNARLPNGRPFPPLF-NFKQ 344
                 + +         N +Q
Sbjct: 284 SSETPTISDLPSLESAMTNIRQ 305

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  172 bits (439), Expect = 2e-51
 Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 54/306 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRLMDHPNVISLKHC 95
            V+G G++GIV+  + L     +AIK++  +D RY      E+ L + + H N++     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 96  FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
            +  +  +  F+ + ME VP      + R    +  +      I    YT QI  GL Y+
Sbjct: 84  -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTI--GFYTKQILEGLKYL 138

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFG 210
           H    + HRD+K  N+L++  +  +K+ DFG++K L        ++  +  Y APE+I  
Sbjct: 139 HD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197

Query: 211 ATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
               Y  + DIWS GC + E+  G+P F       +L E    +                
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM---------------- 235

Query: 270 DFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
            F+    K HP        +P     EA     +  +  P  R  A +     F     +
Sbjct: 236 -FKVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

Query: 326 PNARLP 331
                P
Sbjct: 288 KKKTQP 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  175 bits (445), Expect = 2e-51
 Identities = 60/355 (16%), Positives = 130/355 (36%), Gaps = 32/355 (9%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 90
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE ++++ ++H N++
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L      TT++    L  +ME+ P       + +  ++    +P     +    +  G+
Sbjct: 71  KLFAIEEETTTR-HKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
            ++    G+ HR++KP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 206 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           ++   A        +Y  ++D+WS G        G   F       +  E++  + T   
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
                      +         P      + +      + + +L+          +     
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ----- 299

Query: 319 FFDELREP-NARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 372
           FF E  +  +  + +      +   K  +          +  E V +QT +   +
Sbjct: 300 FFAETSDILHRMVIHVFSLQQMTAHKIYI---HSYNTATIFHELVYKQTKIISSN 351

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  171 bits (436), Expect = 3e-51
 Identities = 85/308 (27%), Positives = 128/308 (41%), Gaps = 54/308 (17%)

Query: 28  GEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM 81
           G  K  I+  Y  E  +G GS+G V  A    T    A K      ++D     +E+++M
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYV 137
           + +DHPN+I L   F     +D   + LVME     E   RV+    +            
Sbjct: 61  KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108

Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANIS 195
                 +   +AY H +  V HRD+KP+N L    +    +KL DFG A     G+  + 
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMR 166

Query: 196 YIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
               + YY +P+++ G   Y    D WSAG ++  LL G P F      + +++I +   
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-- 222

Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
                           F FP      W  V      P+A  L  RLL  SP  R T+L+A
Sbjct: 223 ---------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259

Query: 315 CAHPFFDE 322
             H +F++
Sbjct: 260 LEHEWFEK 267

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  170 bits (433), Expect = 8e-51
 Identities = 76/324 (23%), Positives = 133/324 (41%), Gaps = 60/324 (18%)

Query: 17  HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ 69
           H    + G +N   + TI   ++ +R +G+G+FG V   +   +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 70  DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL----- 122
                  E+++++ +DHPN+I +   F     +D   + +VME     E + R++     
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 123 -KHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLC 179
            K  S         YV     Q+   LAY H+   V H+D+KP+N+L    +    +K+ 
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKII 169

Query: 180 DFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 238
           DFG A++    E + +    +  Y APE+     + T   DIWSAG V+  LL G   F 
Sbjct: 170 DFGLAELFKSDE-HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFT 226

Query: 239 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 298
           G +  +   +                     +  +               + P+A+DL  
Sbjct: 227 GTSLEEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLK 260

Query: 299 RLLQYSPSLRCTALEACAHPFFDE 322
           ++L   P  R +A +   H +F +
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFKQ 284

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  176 bits (448), Expect = 8e-51
 Identities = 76/332 (22%), Positives = 130/332 (39%), Gaps = 63/332 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------------KVLQDRRYKNREL 78
           Y   R +G+G++G V   K        AIK                  + +       E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 79  QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPL 134
            L++ +DHPN+I L   F     +D+ +  LV E+    E   +++    +         
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146

Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEA 192
                   QI  G+ Y+H    + HRD+KP+N+L++       +K+ DFG +    K   
Sbjct: 147 -DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
               + + YY APE++    +Y    D+WS G ++  LL G P F G+N  DQ  +II  
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-- 256

Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
                 +++      +          + W  +       EA +L   +L Y  + RCTA 
Sbjct: 257 ------KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAE 297

Query: 313 EACAHPFFDELREPNARLPNGRPFPPLFNFKQ 344
           EA    +  +      +         L N ++
Sbjct: 298 EALNSRWIKKYANNINKSDQKTLCGALSNMRK 329

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  171 bits (436), Expect = 1e-50
 Identities = 67/313 (21%), Positives = 118/313 (37%), Gaps = 48/313 (15%)

Query: 16  GHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRY 73
           G +++  +   + E ++ +     +  VG GSFG V + K  +TG   A+KKV L+   +
Sbjct: 39  GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--F 96

Query: 74  KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRM 132
           +  EL     +  P ++ L         ++  ++N+ ME +   ++ +++K        +
Sbjct: 97  RVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMG----CL 147

Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
           P      Y  Q   GL Y+HT   + H DVK  N+L+     +  LCDFG A  L     
Sbjct: 148 PEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206

Query: 193 NISYICSR------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 246
             S +          + APE++ G       +DIWS+ C++  +L G   +         
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265

Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 306
           ++I      P                  +I              P         L+  P 
Sbjct: 266 LKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKEPV 299

Query: 307 LRCTALEACAHPF 319
            R +A+E      
Sbjct: 300 HRASAMELRRKVG 312

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  170 bits (433), Expect = 1e-50
 Identities = 64/318 (20%), Positives = 122/318 (38%), Gaps = 60/318 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 90
           +   + +G G FG+VF+AK        AIK++        R    RE++ +  ++HP ++
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 91  SLKHCFF-------STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTY 142
              + +           S  +++L + M+    E +   +    ++ +R           
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-- 200
           QI   + ++H+  G+ HRD+KP N+        VK+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 201 -----------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
                       Y +PE I G   Y+  +DI+S G +L ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
           ++                  + +FP +           +  P    +   +L  SP  R 
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272

Query: 310 TALEACAHPFFDELREPN 327
            A+    +  F++L  P 
Sbjct: 273 EAINIIENAVFEDLDFPG 290

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  170 bits (432), Expect = 5e-50
 Identities = 83/348 (23%), Positives = 132/348 (37%), Gaps = 84/348 (24%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---------QDRRYKNRELQLMRLMDH 86
           Y  +  +G GS+G+V  A   +T    AIK +          +D      E++LM+ + H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKL----- 139
           PN+  L   +     +DE ++ LVME       + ++         +  +  VK      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 140 ------------------------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 169
                                            QIF  L Y+H   G+CHRD+KP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201

Query: 170 D-PLTHQVKLCDFGSAKVLVKGEANISYIC-----SRYYRAPELIFGATE-YTTSIDIWS 222
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 223 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
           AG +L  LL+G   FPG N  D + +++                      F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 283 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
            +      P A DL S LL  +   R  A+ A  HP+  +  +   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  170 bits (433), Expect = 5e-50
 Identities = 70/358 (19%), Positives = 137/358 (38%), Gaps = 53/358 (14%)

Query: 11  NDAVTGHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK---- 65
            D ++ +     +     E  + I+ Y   R +  G F  +   +  +  +  A+K    
Sbjct: 7   KDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEK 64

Query: 66  -KVLQDRRYKN----------------RELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 108
             + + R +                   ELQ++  + +   ++ +      T+ DE+++ 
Sbjct: 65  SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII---TNYDEVYI- 120

Query: 109 LVMEYVP-----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 163
            + EY+      +          +    +P+  +K     +    +YIH    +CHRDVK
Sbjct: 121 -IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179

Query: 164 PQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEY-TTSIDIW 221
           P N+L+D    +VKL DFG ++ +V  +   S    +  +  PE     + Y    +DIW
Sbjct: 180 PSNILMDK-NGRVKLSDFGESEYMVDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVDIW 236

Query: 222 SAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 281
           S G  L  +      F  + ++ +L   I+       + I    P   +  F     +  
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIR------TKNIEY--PLDRN-HFLYPLTNKK 287

Query: 282 HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-----DELREPNARLPNGR 334
               +  +  E ID     L+ +P+ R T+ +A  H +      ++LRE +  L   R
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  171 bits (436), Expect = 8e-50
 Identities = 76/306 (24%), Positives = 133/306 (43%), Gaps = 56/306 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRL 83
           Y+  + +G+G+ G V  A   +T + VAI+    +       +          E+++++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYT 141
           ++HP +I +K+ F      D     +V+E +   E   +V+ +     +R+     KLY 
Sbjct: 197 LNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC- 198
           YQ+   + Y+H   G+ HRD+KP+N+L+        +K+ DFG +K+L +    +  +C 
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303

Query: 199 SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           +  Y APE++       Y  ++D WS G +L   L G P F        L + I   G  
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360

Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                         + F       W +V       +A+DL  +LL   P  R T  EA  
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399

Query: 317 HPFFDE 322
           HP+  +
Sbjct: 400 HPWLQD 405

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  168 bits (427), Expect = 8e-50
 Identities = 77/326 (23%), Positives = 127/326 (38%), Gaps = 52/326 (15%)

Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 81
           +P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+ + 
Sbjct: 10  DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLY 140
           R + H +V+     F      D +F  +V+E     ++  + K      + +     + Y
Sbjct: 70  RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR----RKALTEPEARYY 120

Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYIC- 198
             QI  G  Y+H    V HRD+K  NL ++    +VK+ DFG + KV   GE     +C 
Sbjct: 121 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGER-KKVLCG 177

Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
           +  Y APE++     ++  +D+WS GC++  LL+G+P F      +  + I K       
Sbjct: 178 TPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------ 230

Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
                      ++  P              + P A  L  ++LQ  P+ R T  E     
Sbjct: 231 -----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDE 267

Query: 319 FFDELREPNARLPNGRPFPPLFNFKQ 344
           FF     P          PP F+   
Sbjct: 268 FFTSGYIPARLPITCLTIPPRFSIAP 293

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  168 bits (427), Expect = 2e-49
 Identities = 78/333 (23%), Positives = 132/333 (39%), Gaps = 60/333 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRL 83
           Y+  + +G+G+ G V  A   +T + VAIK    +       +          E+++++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKL 139
           ++HP +I +K+ F      D     +V+E +   E   +V+          +       L
Sbjct: 72  LNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-------L 118

Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYI 197
           Y YQ+   + Y+H   G+ HRD+KP+N+L+        +K+ DFG +K+L +    +  +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176

Query: 198 C-SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
           C +  Y APE++       Y  ++D WS G +L   L G P F        L + I   G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235

Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
                           + F       W +V       +A+DL  +LL   P  R T  EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272

Query: 315 CAHPFFDELREPNARLPNGRPFPPLFNFKQELA 347
             HP+  +                     Q LA
Sbjct: 273 LRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  166 bits (422), Expect = 4e-49
 Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 52/302 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  ++   +A+K     ++ +        RE+++   + HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F      D   + L++EY P  T+YR L+       +        Y  ++   L+Y 
Sbjct: 75  YGYF-----HDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 125

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 210
           H+   V HRD+KP+NLL+     ++K+ DFG +            +C +  Y  PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCGTLDYLPPEMIEG 181

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 223

Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
           F FP      +       +   A DL SRLL+++PS R    E   HP+        +  
Sbjct: 224 FTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271

Query: 331 PN 332
            N
Sbjct: 272 QN 273

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  167 bits (425), Expect = 4e-49
 Identities = 79/347 (22%), Positives = 124/347 (35%), Gaps = 67/347 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR-LMDHPNVI 90
               RV+  G F  V++A+ + +G   A+K++L    +  R   +E+  M+ L  HPN++
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 91  SLKHCFF-----STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
                       S T + E    L+ E     +   LK   S    +    V    YQ  
Sbjct: 90  QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTC 146

Query: 146 RGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-------------E 191
           R + ++H   P + HRD+K +NLL+      +KLCDFGSA  +                E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 192 ANISYICSRYYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
             I+   +  YR PE+I  +         DIW+ GC+L  L   Q  F     +      
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259

Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
                       R +N  Y     P           H         L   +LQ +P  R 
Sbjct: 260 ------------RIVNGKY---SIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294

Query: 310 TALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINR 356
           +  E        E+        N  P  P+    ++  G     ++R
Sbjct: 295 SIAEVVHQLQ--EIAAA----RNVNPKSPITELLEQNGGYGSATLSR 335

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  166 bits (422), Expect = 5e-49
 Identities = 60/290 (20%), Positives = 116/290 (40%), Gaps = 42/290 (14%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 94
            +G GSF  V++    ET   VA  ++   +  K+       E ++++ + HPN++    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 95  CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            + ST    +  + LV E +   T+   LK +    + M +  ++ +  QI +GL ++HT
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147

Query: 154 -VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
             P + HRD+K  N+ +   T  VK+ D G A +     A  + I +  + APE+     
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--EE 204

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
           +Y  S+D+++ G  + E+   +  +       Q+   +      T               
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------TSGVKPASFDKVAI-- 256

Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                             PE  ++    ++ +   R +  +   H FF E
Sbjct: 257 ------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  174 bits (442), Expect = 5e-49
 Identities = 77/366 (21%), Positives = 139/366 (37%), Gaps = 33/366 (9%)

Query: 24  GGKNGEPKQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----R 76
           GG++          +  +  +GTG FG V +    +TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELFLN-LVMEYVP--ETMYRVLKH--YSSMNQR 131
           E+Q+M+ ++HPNV+S +             L  L MEY    +    + +      + + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121

Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVK 189
                +      I   L Y+H    + HRD+KP+N+++ P   +   K+ D G AK L +
Sbjct: 122 PIRTLLS----DISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176

Query: 190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
           GE    ++ +  Y APEL+    +YT ++D WS G +  E + G   F       Q    
Sbjct: 177 GELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235

Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI---DLASRLLQYSPS 306
           ++     + E I   +      +F  +   P     +      A         +L +   
Sbjct: 236 VR---EKSNEHIVVYDDLTGAVKFSSVLPTP-----NHLSGILAGKLERWLQCMLMWHQR 287

Query: 307 LRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQT 366
            R T  +      F  L    +          + + +      +     + +   +++ T
Sbjct: 288 QRGTDPQNPNVGCFQALDSILSLKL--LSVMNMVSGRVHTYPVTENENLQNLKSWLQQDT 345

Query: 367 GLSMPH 372
           G+    
Sbjct: 346 GIPEEE 351

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  167 bits (425), Expect = 5e-49
 Identities = 74/326 (22%), Positives = 124/326 (38%), Gaps = 50/326 (15%)

Query: 29  EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 81
           +P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+ + 
Sbjct: 36  DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 95

Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLY 140
           R + H +V+     F      D +F  +V+E     ++  + K      + +     + Y
Sbjct: 96  RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR----RKALTEPEARYY 146

Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-S 199
             QI  G  Y+H    V HRD+K  NL ++    +VK+ DFG A  +         +C +
Sbjct: 147 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGT 204

Query: 200 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
             Y APE++     ++  +D+WS GC++  LL+G+P F      +  + I K        
Sbjct: 205 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 256

Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                     ++  P              + P A  L  ++LQ  P+ R T  E     F
Sbjct: 257 ----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEF 294

Query: 320 FDELREPNARLPNGRPFPPLFNFKQE 345
           F     P          PP F+    
Sbjct: 295 FTSGYIPARLPITCLTIPPRFSIAPS 320

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  168 bits (428), Expect = 5e-49
 Identities = 76/317 (23%), Positives = 124/317 (39%), Gaps = 44/317 (13%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRLMDHPNVIS 91
           Y     +G+G+FG+V +     TG     K        D+     E+ +M  + HP +I+
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L   F     +D+  + L++E++   E   R+      M++      V  Y  Q   GL 
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163

Query: 150 YIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
           ++H    + H D+KP+N++        VK+ DFG A  L   E       +  + APE I
Sbjct: 164 HMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                     D+W+ G +   LL G   F GE+ ++ L  + +                 
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPN 327
            D+ F       +  V      PEA D    LLQ  P  R T  +A  HP+   +     
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316

Query: 328 ARLPNGRPFPPLFNFKQ 344
           +R+P+ R        K+
Sbjct: 317 SRIPSSRYNKIRQKIKE 333

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  165 bits (421), Expect = 6e-49
 Identities = 82/320 (25%), Positives = 135/320 (42%), Gaps = 54/320 (16%)

Query: 17  HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQD 70
           H    + G +N   + T +  Y    ++G GSFG V + K   T +  A+K       ++
Sbjct: 3   HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62

Query: 71  RRYKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--H 124
           +      RE++L++ +DHPN++ L         +D     +V E     E    ++K   
Sbjct: 63  KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 125 YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG 182
           +S                Q+F G+ Y+H    + HRD+KP+N+L++       +K+ DFG
Sbjct: 118 FSEH-------DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG 169

Query: 183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
            +    +       I + YY APE++ G   Y    D+WSAG +L  LL G P F G+N 
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227

Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
            D L  +                     + F       W  +       +A DL  ++L 
Sbjct: 228 YDILKRVET-----------------GKYAFD---LPQWRTI-----SDDAKDLIRKMLT 262

Query: 303 YSPSLRCTALEACAHPFFDE 322
           + PSLR TA +   HP+  +
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  163 bits (416), Expect = 3e-48
 Identities = 72/303 (23%), Positives = 129/303 (42%), Gaps = 50/303 (16%)

Query: 28  GEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 79
               + I  +    ++G GSF  V++A+ + TG  VAIK    K +           E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVK 138
           +   + HP+++ L + F      + ++  LV+E      M R LK+     +       +
Sbjct: 64  IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLKNR---VKPFSENEAR 115

Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            + +QI  G+ Y+H+  G+ HRD+   NLL+      +K+ DFG A  L         +C
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLC 173

Query: 199 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            +  Y +PE+    + +    D+WS GC+   LL+G+P F  +   + L +++       
Sbjct: 174 GTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----- 227

Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
                       D+  P      +       +  EA DL  +LL+ +P+ R +      H
Sbjct: 228 ------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263

Query: 318 PFF 320
           PF 
Sbjct: 264 PFM 266

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  164 bits (416), Expect = 4e-48
 Identities = 49/323 (15%), Positives = 93/323 (28%), Gaps = 80/323 (24%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQ----LMRLMDHPN 88
           +     +G+G FG VF+      G   AIK+    L     +   L+       L  H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           V+     +      ++  + +  EY    ++   +     +        +K    Q+ RG
Sbjct: 73  VVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDP------------------LTHQVKLCDFGSAKVLVK 189
           L YIH+   + H D+KP N+ +                         K+ D G    +  
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
            +          + A E++     +    DI++    +      +PL             
Sbjct: 187 PQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233

Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP-------EAIDLASRLLQ 302
                                          WH++   R+P        E  +L   ++ 
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265

Query: 303 YSPSLRCTALEACAHPFFDELRE 325
             P  R +A+    H        
Sbjct: 266 PDPERRPSAMALVKHSVLLSASR 288

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  163 bits (414), Expect = 2e-47
 Identities = 71/310 (22%), Positives = 129/310 (41%), Gaps = 46/310 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVA---IKKVLQDRRYKNRELQLMRLMDHPNVISL 92
           YM    +G G FGIV +     + +T     +K    D+    +E+ ++ +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
              F     +    L ++ E++   +   R+      +N+R     +  Y +Q+   L +
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117

Query: 151 IHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           +H+   + H D++P+N++     +  +K+ +FG A+ L  G+ N   +  +  Y APE +
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPE-V 174

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                 +T+ D+WS G ++  LL G   F  E   +Q  +II        E I      +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-- 326
            +  F +I               EA+D   RLL      R TA EA  HP+  +  E   
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269

Query: 327 NARLPNGRPF 336
              +   +  
Sbjct: 270 TKVIRTLKHR 279

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  164 bits (416), Expect = 2e-47
 Identities = 68/355 (19%), Positives = 113/355 (31%), Gaps = 83/355 (23%)

Query: 20  STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----------KVL 68
              +  + GE  +T   +   V+G        +A   ETGE+  +             + 
Sbjct: 61  PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118

Query: 69  QDRRYKNR---------------------ELQLMRLMDHPNVISLKHCFFSTTSKDELFL 107
           Q +    R                        L++      +I ++            FL
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178

Query: 108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 167
              M+   +T   VL  +SS ++ +        T Q+ R LA +H   G+ H  ++P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDI 237

Query: 168 LVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI----------FGATEYTTS 217
           ++D     V L  F      V+  A +    SR +  PEL              T  T S
Sbjct: 238 VLDQ-RGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293

Query: 218 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 277
            D W+ G V+  +         + A+               E I         FR     
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALG------------GSEWI---------FRSC--- 329

Query: 278 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-NARLP 331
                    K +P     L    L+Y    R   L+A   P +++LR   +A LP
Sbjct: 330 ---------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  161 bits (410), Expect = 2e-47
 Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 52/296 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 92
           R +G G FG V+ A+  +    +A+K     ++ ++       RE+++   + HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
            + +F    +    + L++E+ P   +Y+ L+     + R        +  ++   L Y 
Sbjct: 80  -YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 210
           H    V HRD+KP+NLL+     ++K+ DFG +             C +  Y  PE+I G
Sbjct: 131 HE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CGTLDYLPPEMIEG 186

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
              +   +D+W AG +  E L+G P F   +  +    I+ V                 D
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------D 228

Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
            +FP     P+       +   + DL S+LL+Y P  R        HP+       
Sbjct: 229 LKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  168 bits (426), Expect = 3e-47
 Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 43/303 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVIS 91
           Y     +GTG+FG+V +     TG   A K V      D+    +E+Q M ++ HP +++
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L   F     +D+  + ++ E++   E   +V   ++ M++   + Y++    Q+ +GL 
Sbjct: 219 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 150 YIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
           ++H      H D+KP+N++     ++++KL DFG    L   ++      +  + APE+ 
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
            G        D+WS G +   LL G   F GEN  +            T   ++  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
            D  F  I               +  D   +LL   P+ R T  +A  HP+      P  
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

Query: 329 RLP 331
              
Sbjct: 423 DSQ 425

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  160 bits (407), Expect = 6e-47
 Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 53/298 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRLMDHPNV 89
           Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R + HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 145
           + L         ++E F  LV + V   E    ++    YS  +             QI 
Sbjct: 68  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 202
             +AY H+  G+ HR++KP+NLL+        VKL DFG A  +   EA       +  Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGY 173

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            +PE +     Y+  +DIW+ G +L  LL+G P F  E+      +I             
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---------- 222

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                   + +P   +  W  V      PEA  L   +L  +P  R TA +A   P+ 
Sbjct: 223 -------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  161 bits (409), Expect = 6e-47
 Identities = 71/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRLMDHPNVIS 91
           ++   V+G+G+F  VF  K   TG+  A+K               E+ +++ + H N+++
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRG 147
           L+  +     +      LVM+ V   E   R+L+   Y+   ++   + ++    Q+   
Sbjct: 71  LEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRA 204
           + Y+H   G+ HRD+KP+NLL        ++ + DFG +K+   G   +S  C +  Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVA 175

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE +     Y+ ++D WS G +   LL G P F  E       +I +             
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324
                 + F    +  W  +        A D    LL+  P+ R T  +A +HP+ D   
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269

Query: 325 EPNARL 330
             +  +
Sbjct: 270 ALHRDI 275

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  161 bits (410), Expect = 6e-47
 Identities = 70/327 (21%), Positives = 124/327 (37%), Gaps = 59/327 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 85
           Y     +G+G F +V + +   TG   A K          +    R    RE+ +++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 141
           HPNVI+L   +     +++  + L++E V   E    + +    +             + 
Sbjct: 73  HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFL 120

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            QI  G+ Y+H++  + H D+KP+N+++   +    ++K+ DFG A  +  G      I 
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178

Query: 199 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            +  + APE I          D+WS G +   LL G   F G+   + L  +  V     
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232

Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
                    NY +F         +           A D   RLL   P  R T  ++  H
Sbjct: 233 ---------NY-EFEDE-----YFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272

Query: 318 PFFDELREPNARLPNGRPFPPLFNFKQ 344
           P+    ++    L        +  FK+
Sbjct: 273 PWIKP-KDTQQALSRKASAVNMEKFKK 298

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  160 bits (406), Expect = 8e-47
 Identities = 72/312 (23%), Positives = 119/312 (38%), Gaps = 58/312 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 85
           Y     +G+G F IV + +   TG+  A K          +    R    RE+ ++R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 141
           HPN+I+L   F     +++  + L++E V   E    + +    +             + 
Sbjct: 67  HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFL 114

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            QI  G+ Y+H+   + H D+KP+N+++   +    ++KL DFG A  +  G      I 
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172

Query: 199 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            +  + APE I          D+WS G +   LL G   F GE   + L  I  V     
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226

Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
                       ++ F       +           A D   RLL   P  R T  ++  H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266

Query: 318 PFFDELREPNAR 329
            +   +R  N R
Sbjct: 267 SWIKAIRRRNVR 278

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  161 bits (410), Expect = 1e-46
 Identities = 77/335 (22%), Positives = 124/335 (37%), Gaps = 60/335 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK---------KVLQDRRYKNRELQLMRLMDH 86
           Y    V+G G F +V +    ETG+  A+K                   RE  +  ++ H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY----VKLY 140
           P+++ L   +       +  L +V E++   +  + ++K   +        Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135

Query: 141 TYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYI 197
             QI   L Y H    + HRDVKP  +L+   +  +  VKL  FG A  L +        
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 198 C-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
             + ++ APE +     Y   +D+W  G +L  LL G   F G    ++L E I      
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII----- 245

Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                         ++        W  +        A DL  R+L   P+ R T  EA  
Sbjct: 246 -----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALN 286

Query: 317 HPFFDELREPNARLPNGRPFPPL--FNFKQELAGA 349
           HP+  E      ++        L  FN +++L GA
Sbjct: 287 HPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  159 bits (405), Expect = 2e-46
 Identities = 76/311 (24%), Positives = 123/311 (39%), Gaps = 64/311 (20%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-------------KVLQDRRYKNRELQ-LM 81
           Y  + ++G G   +V +     T +  A+K             +V + R    +E+  L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYV 137
           ++  HPN+I LK  +     +   F  LV + +   E    + +    S    R      
Sbjct: 79  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------ 127

Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
                 +   +  +H +  + HRD+KP+N+L+D     +KL DFG +  L  GE  +  +
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LREV 183

Query: 198 C-SRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
           C +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I+ 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243

Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
                             +++F    +  W             DL SR L   P  R TA
Sbjct: 244 G-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTA 278

Query: 312 LEACAHPFFDE 322
            EA AHPFF +
Sbjct: 279 EEALAHPFFQQ 289

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  161 bits (409), Expect = 2e-46
 Identities = 86/347 (24%), Positives = 136/347 (39%), Gaps = 60/347 (17%)

Query: 17  HIISTTIGGKNGEPKQTIS---------YMAERVVGTGSFGIVFQAKCLETGETVAIK-- 65
           H+ S T G + G   + +          Y  +  +G G+F +V +     TG   A K  
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 66  --KVLQDRRYKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMY 119
             K L  R ++   RE ++ R + HPN++ L         ++E F  LV + V   E   
Sbjct: 63  NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFE 117

Query: 120 RVLK--HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQ 175
            ++    YS  +             QI   +AY H+  G+ HR++KP+NLL+        
Sbjct: 118 DIVAREFYSEADAS-------HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAA 169

Query: 176 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 235
           VKL DFG A  +   EA   +  +  Y +PE +     Y+  +DIW+ G +L  LL+G P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYP 228

Query: 236 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 295
            F  E+      +I                     + +P   +  W  V      PEA  
Sbjct: 229 PFWDEDQHRLYAQIKAG-----------------AYDYP---SPEWDTV-----TPEAKS 263

Query: 296 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 342
           L   +L  +P  R TA +A   P+        + +        L  F
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKF 310

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  160 bits (406), Expect = 3e-46
 Identities = 73/330 (22%), Positives = 118/330 (35%), Gaps = 59/330 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 85
           Y     +G+G F IV + +   TG   A K          +    R    RE+ ++R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 141
           H NVI+L   +     ++   + L++E V   E    + +    S             + 
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            QI  G+ Y+HT   + H D+KP+N+++   +     +KL DFG A  +  G      I 
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 199 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            +  + APE I          D+WS G +   LL G   F G+   + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233

Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
                        + F       +           A D   +LL      R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 318 PFFDELREPNARLPNGRPFPPLFNFKQELA 347
           P+     +    +        L NF+++  
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFRKQYV 302

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  160 bits (407), Expect = 3e-46
 Identities = 73/317 (23%), Positives = 124/317 (39%), Gaps = 49/317 (15%)

Query: 14  VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
           V  H I   +   + +      Y  +  +G GS+ +  +     T    A+K + + +R 
Sbjct: 4   VGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61

Query: 74  KNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSM 128
              E++++ R   HPN+I+LK  +      D  ++ +V E +   E + ++L+   +S  
Sbjct: 62  PTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSER 116

Query: 129 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAK 185
                        + I + + Y+H   GV HRD+KP N+L          +++CDFG AK
Sbjct: 117 EASA-------VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 186 VLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
            L      +   C +  + APE +     Y  + DIWS G +L  +L G   F       
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227

Query: 245 QLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 303
               + ++  G                F         W+ V        A DL S++L  
Sbjct: 228 PEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHV 264

Query: 304 SPSLRCTALEACAHPFF 320
            P  R TA     HP+ 
Sbjct: 265 DPHQRLTAALVLRHPWI 281

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  162 bits (413), Expect = 3e-46
 Identities = 75/300 (25%), Positives = 119/300 (39%), Gaps = 52/300 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
           Y     +G G+F +V +   +  G+  A   +   +          RE ++ RL+ HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 145
           + L          +E    L+ + V   E    ++   +YS                QI 
Sbjct: 73  VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------DASHCIQQIL 120

Query: 146 RGLAYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISYIC-SRYY 202
             + + H + GV HR++KP+NLL    L    VKL DFG A  +   +        +  Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            +PE +     Y   +D+W+ G +L  LL+G P F  E+      +I             
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                   + FP   +  W  V      PEA DL +++L  +PS R TA EA  HP+   
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  160 bits (407), Expect = 4e-46
 Identities = 74/330 (22%), Positives = 120/330 (36%), Gaps = 59/330 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 85
           Y     +G+G F IV + +   TG   A K          +    R    RE+ ++R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 141
           HPN+I+L   +     ++   + L++E V   E    + +    S             + 
Sbjct: 74  HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 198
            QI  G+ Y+HT   + H D+KP+N+++   +     +KL DFG A  +  G      I 
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 199 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
            +  + APE I          D+WS G +   LL G   F G+   + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233

Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
                        + F       + +         A D   +LL      R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 318 PFFDELREPNARLPNGRPFPPLFNFKQELA 347
           P+     +    +        L NFK++  
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENFKKQYV 302

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  159 bits (403), Expect = 1e-45
 Identities = 74/316 (23%), Positives = 123/316 (38%), Gaps = 39/316 (12%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFF 97
           ++V+G G  G V +     TG+  A+K +L D     +E+    +    P+++ +    +
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91

Query: 98  STTSKDELFLNLVMEYVP--ETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
                 +  L ++ME +   E   R   +   +  +R            I   + ++H+ 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----AAEIMRDIGTAIQFLHSH 147

Query: 155 PGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGA 211
             + HRDVKP+NLL         +KL DFG AK   +    +   C + YY APE + G 
Sbjct: 148 -NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGP 203

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
            +Y  S D+WS G ++  LL G P F           + +          R     Y  F
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----------RIRLGQY-GF 252

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE-PNARL 330
             P      W +V       +A  L   LL+  P+ R T  +   HP+ ++    P   L
Sbjct: 253 PNP-----EWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302

Query: 331 PNGRPFPPLFNFKQEL 346
              R      +   E+
Sbjct: 303 HTARVLQEDKDHWDEV 318

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  159 bits (405), Expect = 1e-45
 Identities = 77/333 (23%), Positives = 141/333 (42%), Gaps = 46/333 (13%)

Query: 23  IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNREL 78
           +  K G      +     ++G G FG V + +   TG  +A K    + ++D+     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 79  QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY 136
            +M  +DH N+I L   F     + +  + LVMEYV   E   R++    ++ +   +++
Sbjct: 138 SVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANIS 195
           +K    QI  G+ ++H +  + H D+KP+N+L V+    Q+K+ DFG A+     E  + 
Sbjct: 193 MK----QICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK 246

Query: 196 YIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
               +  + APE +      +   D+WS G +   LL G   F G+N  + L  I+    
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303

Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
                        + D          +  +       EA +  S+LL    S R +A EA
Sbjct: 304 ------------RW-DLEDE-----EFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340

Query: 315 CAHPFFDELREPNARLPNGRPFPPLFNFKQELA 347
             HP+  +  + ++RL   +      + +  + 
Sbjct: 341 LKHPWLSD-HKLHSRLSAQKKKNRGSDAQDFVT 372

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  159 bits (403), Expect = 2e-45
 Identities = 75/308 (24%), Positives = 127/308 (41%), Gaps = 63/308 (20%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK------------KVLQDRRYKNRELQLMR- 82
           Y  + V+G G   +V +     TG   A+K            ++ + R    RE  ++R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVK 138
           +  HP++I+L   +     +   F+ LV + +   E    + +    S    R       
Sbjct: 156 VAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR------- 203

Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 198
                +   ++++H    + HRD+KP+N+L+D    Q++L DFG +  L  GE  +  +C
Sbjct: 204 SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEK-LRELC 260

Query: 199 -SRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
            +  Y APE++  + +     Y   +D+W+ G +L  LL G P F     +  L  I++ 
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320

Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
                             ++F    +  W             DL SRLLQ  P  R TA 
Sbjct: 321 -----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAE 355

Query: 313 EACAHPFF 320
           +A  HPFF
Sbjct: 356 QALQHPFF 363

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  158 bits (402), Expect = 5e-45
 Identities = 78/293 (26%), Positives = 116/293 (39%), Gaps = 43/293 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKH 94
            +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 95  CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY----VKLYTYQIFRGL 148
             +         L +VME +   E   R+         R    +           I   +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQAFTEREASEIMKSIGEAI 174

Query: 149 AYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
            Y+H++  + HRDVKP+NLL     P    +KL DFG AK      +  +   + YY AP
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E + G  +Y  S D+WS G ++  LL G P F   + +     +            R   
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------RIRM 281

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
             Y +F  P      W +V       E   L   LL+  P+ R T  E   HP
Sbjct: 282 GQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 323

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  157 bits (398), Expect = 7e-45
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 50/303 (16%)

Query: 27  NGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR 82
           +G  +  +S  +  E  +G G+  IV++ K   T +  A+K + +    K    E+ ++ 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103

Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVK 138
            + HPN+I LK  F     +    ++LV+E V   E   R+++  +YS   +R     VK
Sbjct: 104 RLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYS---ERDAADAVK 155

Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISY 196
               QI   +AY+H   G+ HRD+KP+NLL   P     +K+ DFG +K++      +  
Sbjct: 156 ----QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209

Query: 197 IC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           +C +  Y APE I     Y   +D+WS G +   LL G   F  E     +   I     
Sbjct: 210 VCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL---- 264

Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
                  C      ++ F    +  W +V        A DL  +L+   P  R T  +A 
Sbjct: 265 ------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQAL 304

Query: 316 AHP 318
            HP
Sbjct: 305 QHP 307

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  155 bits (393), Expect = 1e-44
 Identities = 80/323 (24%), Positives = 131/323 (40%), Gaps = 51/323 (15%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN---RELQLMRLMDHP 87
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+QL+R + H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           NVI L    ++   +    + +VMEY    M  +L       +R P+     Y  Q+  G
Sbjct: 67  NVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDG 121

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRA 204
           L Y+H+  G+ H+D+KP NLL+      +K+   G A+ L    A+        S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 205 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           PE+  G   ++   +DIWSAG  L  +  G   F G+N + +L E I             
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIG------------ 226

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
                  +  P                P   DL   +L+Y P+ R +  +   H +F + 
Sbjct: 227 ----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

Query: 324 REPNARLPNGRPFPPLFNFKQEL 346
             P        P PP  + K   
Sbjct: 271 HPPAEAPV---PIPPSPDTKDRW 290

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  155 bits (394), Expect = 2e-44
 Identities = 75/297 (25%), Positives = 130/297 (43%), Gaps = 43/297 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMD-HPNVISL 92
            + ++ +G GSF I  +    ++ +  A+ K++  R   N  +E+  ++L + HPN++ L
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQKEITALKLCEGHPNIVKL 71

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGL 148
              F      D+L   LVME +   E   R+ K  H+S                ++   +
Sbjct: 72  HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAV 119

Query: 149 AYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISYIC-SRYYRAP 205
           +++H V GV HRD+KP+NLL  D   + ++K+ DFG A++       +   C + +Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E +     Y  S D+WS G +L  +L GQ  F   +        ++++     ++I+   
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG- 231

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
               DF F       W  V       EA DL   LL   P+ R        + +  +
Sbjct: 232 ----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  151 bits (384), Expect = 4e-43
 Identities = 69/308 (22%), Positives = 121/308 (39%), Gaps = 50/308 (16%)

Query: 37  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDH-PNV 89
           +  + +G G F +V Q     TG+  A K + + RR ++       E+ ++ L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFR 146
           I+L   +     ++   + L++EY    E     L +    +++      V     QI  
Sbjct: 92  INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----VIRLIKQILE 142

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAKVLVKGEANISYIC-SRYYR 203
           G+ Y+H    + H D+KPQN+L+  +     +K+ DFG ++ +      +  I  +  Y 
Sbjct: 143 GVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           APE I      TT+ D+W+ G +   LL     F GE+  +  + I +V           
Sbjct: 201 APE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV----------- 248

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
                 +  +       +  V        A D    LL  +P  R TA    +H +  + 
Sbjct: 249 ------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294

Query: 324 REPNARLP 331
              N   P
Sbjct: 295 DFENLFHP 302

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  152 bits (385), Expect = 6e-43
 Identities = 74/311 (23%), Positives = 122/311 (39%), Gaps = 47/311 (15%)

Query: 20  STTIGGKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRY 73
             T G  +         Y   + +G+G+FG+    +   T E VA+K       + +   
Sbjct: 5   PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64

Query: 74  KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQR 131
             RE+   R + HPN++  K       +   L   ++MEY    E   R+         R
Sbjct: 65  --REIINHRSLRHPNIVRFKEVI---LTPTHLA--IIMEYASGGELYERICNA-----GR 112

Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVLVKG 190
                 + +  Q+  G++Y H++  +CHRD+K +N L+D     ++K+CDFG +K  V  
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171

Query: 191 EANISYICSRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
               S + +  Y APE++    EY     D+WS G  L  +L+G   F            
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------- 222

Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
                  T + I  +      +  P             R+ PE   L SR+    P+ R 
Sbjct: 223 EPRDYRKTIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRI 267

Query: 310 TALEACAHPFF 320
           +  E   H +F
Sbjct: 268 SIPEIKTHSWF 278

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  150 bits (380), Expect = 1e-42
 Identities = 72/311 (23%), Positives = 115/311 (36%), Gaps = 58/311 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM-RLMDHPNVISLK 93
           E V+G G+   V     L T +  A+K    +    R    RE++++ +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 94  HCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGLA 149
             F     ++E    LV E +     +  + K  H++ +   +           +   L 
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALD 125

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYICSR---- 200
           ++H   G+ HRD+KP+N+L     H      VK+CDF     +                 
Sbjct: 126 FLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 201 ----YYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
                Y APE++      A+ Y    D+WS G +L  LL G P F G    D   +  + 
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241

Query: 253 LGTPTR---EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
                    E I+        + FP      W  +        A DL S+LL      R 
Sbjct: 242 CPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRL 288

Query: 310 TALEACAHPFF 320
           +A +   HP+ 
Sbjct: 289 SAAQVLQHPWV 299

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  150 bits (380), Expect = 3e-42
 Identities = 76/330 (23%), Positives = 132/330 (40%), Gaps = 34/330 (10%)

Query: 22  TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNR 76
           T   K GE K    +     +G G+ G+VF+     +G  +A K +        R    R
Sbjct: 22  TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80

Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLI 135
           ELQ++   + P ++     F+S        +++ ME++   ++ +VLK       R+P  
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLK----KAGRIPEQ 131

Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
            +   +  + +GL Y+     + HRDVKP N+LV+    ++KLCDFG +  L+   AN S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189

Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
           ++ +R Y +PE + G   Y+   DIWS G  L E+ +G+   P  +A +  +     +  
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVF---------------HKRMPPEAIDLASRL 300
              E                + + P   +F                     E  D  ++ 
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308

Query: 301 LQYSPSLRCTALEACAHPFFDELREPNARL 330
           L  +P+ R    +   H F           
Sbjct: 309 LIKNPAERADLKQLMVHAFIKRSDAEEVDF 338

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  151 bits (382), Expect = 3e-42
 Identities = 56/356 (15%), Positives = 104/356 (29%), Gaps = 82/356 (23%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----------------- 82
            V+G        +A   ETGE+  +       R  +  ++ M+                 
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 83  ---------------LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSS 127
                                +I ++            FL   M+   +T   VL  +SS
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 128 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 187
            ++ +        T Q+ R LA +H   G+ H  ++P ++++D     V L  F      
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRD 261

Query: 188 VKGEANISYICSRY----YRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPG 239
             G + +S I   +      A  ++       T  T + D W+ G  +  +         
Sbjct: 262 --GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH--KRMPPEAIDLA 297
           + A+                                        +F   K +P     L 
Sbjct: 320 DAALGGS-----------------------------------EWIFRSCKNIPQPVRALL 344

Query: 298 SRLLQYSPSLRCTALEACAHPFFDELRE-PNARLPNGRPFPPLFNFKQELAGASPE 352
              L+Y    R   L+A   P +++LR   +A LP  +               + +
Sbjct: 345 EGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQ 400

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  146 bits (370), Expect = 2e-41
 Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 41/289 (14%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 94
            +G G++G+V + + + +G+ +A+K++      Q+++    +L   MR +D P  ++   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
             F         + + ME +  ++ +  K      Q +P   +      I + L ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG---A 211
             V HRDVKP N+L++    QVK+CDFG +  LV   A       + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
             Y+   DIWS G  + EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
             PQ+ A  +          E +D  S+ L+ +   R T  E   HPFF
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  146 bits (371), Expect = 2e-41
 Identities = 70/332 (21%), Positives = 123/332 (37%), Gaps = 73/332 (21%)

Query: 24  GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--- 75
            G +G+  Q   Y  +  +G GS+G+V  A         A+K     K+++   +     
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 76  ----------------------RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 113
                                 +E+ +++ +DHPNV+ L        ++D L++  V E 
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119

Query: 114 VP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 171
           V     M           + +     + Y   + +G+ Y+H    + HRD+KP NLLV  
Sbjct: 120 VNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE 172

Query: 172 LTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGAT-EYT-TSIDIWSAGCVLA 228
               +K+ DFG +      +A +S    +  + APE +      ++  ++D+W+ G  L 
Sbjct: 173 -DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 229 ELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 288
             + GQ  F  E  +  L   IK                     FP              
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIK----------------SQALEFPD----------QPD 264

Query: 289 MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
           +  +  DL +R+L  +P  R    E   HP+ 
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  145 bits (369), Expect = 2e-41
 Identities = 66/297 (22%), Positives = 122/297 (41%), Gaps = 52/297 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 90
           +   + +G G++G V  A    T E VA+K     + +       +E+ + ++++H NV+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
                       +  +  L +EY    E     L      +  MP    + + +Q+  G+
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRAP 205
            Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 206 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           EL+    E+    +D+WS G VL  +L G+ P     ++  +  +  +            
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                           PW K     +    + L  ++L  +PS R T  +     ++
Sbjct: 224 -----KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  146 bits (371), Expect = 3e-41
 Identities = 80/330 (24%), Positives = 135/330 (40%), Gaps = 53/330 (16%)

Query: 22  TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-N 75
           +I     E     +Y   + +G G+F  V  A+ + TG  VAIK     ++      K  
Sbjct: 3   SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62

Query: 76  RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMP 133
           RE+++M++++HPN++ L        ++  L+  L+MEY    E     +  Y   + RM 
Sbjct: 63  REVRIMKILNHPNIVKLFEVI---ETEKTLY--LIMEYASGGE-----VFDYLVAHGRMK 112

Query: 134 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 193
               +    QI   + Y H    + HRD+K +NLL+D     +K+ DFG +     G   
Sbjct: 113 EKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK- 169

Query: 194 ISYIC-SRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
           +   C +  Y APEL  G  +Y    +D+WS G +L  L+ G   F G+N + +L E + 
Sbjct: 170 LDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL 227

Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
                              +R P      +       M  +  +L  R L  +P  R T 
Sbjct: 228 ----------------RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTL 259

Query: 312 LEACAHPFFDELREPNARLPNGRPFPPLFN 341
            +     + +   E +   P   P   + +
Sbjct: 260 EQIMKDRWINAGHEEDELKPFVEPELDISD 289

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  145 bits (367), Expect = 3e-41
 Identities = 83/307 (27%), Positives = 125/307 (40%), Gaps = 52/307 (16%)

Query: 24  GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 76
           G K+    +   Y+    +G G+FG V   +   TG  VA+K     K+          R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPL 134
           E+Q ++L  HP++I L       ++  + F  +VMEYV   E     L  Y   + R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVI---STPTDFF--MVMEYVSGGE-----LFDYICKHGRVEE 110

Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
           +  +    QI   + Y H    V HRD+KP+N+L+D      K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE-FL 167

Query: 195 SYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
              C S  Y APE+I G       +DIWS G +L  LL G   F  E+ V  L + I+  
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIR-- 224

Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                            F  P      +       +      L   +LQ  P  R T  +
Sbjct: 225 --------------GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258

Query: 314 ACAHPFF 320
              H +F
Sbjct: 259 IREHEWF 265

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  150 bits (381), Expect = 5e-41
 Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 51/297 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 91
           RV+G G FG VF  +   TG+  A K  L  +R K R        E +++  +    ++S
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L + F    +K +L L  VM  +   +  Y  + +    N          YT QI  GL 
Sbjct: 250 LAYAF---ETKTDLCL--VMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           ++H    + +RD+KP+N+L+D   + V++ D G A  L  G+        +  + APEL+
Sbjct: 304 HLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
            G  EY  S+D ++ G  L E++  +  F                     +E+       
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE------------KVENKEL------- 401

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
                 ++        +  +  P + D    LLQ  P  R      +      HP F
Sbjct: 402 ----KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  145 bits (367), Expect = 9e-41
 Identities = 69/318 (21%), Positives = 113/318 (35%), Gaps = 61/318 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRLMD 85
           Y    ++G+G FG V+    +     VAIK     ++       N      E+ L++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 86  H--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
                VI L   F      D   L  ++E         L  + +    +     + + +Q
Sbjct: 105 SGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELARSFFWQ 157

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 202
           +   + + H   GV HRD+K +N+L+D    ++KL DFGS  +L       +    +R Y
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 214

Query: 203 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
             PE I     Y   S  +WS G +L +++ G   F  +       EII+          
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR---------- 257

Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
                      F             +R+  E   L    L   PS R T  E   HP+  
Sbjct: 258 -------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

Query: 322 ELREPNARLP-NGRPFPP 338
           ++  P      +     P
Sbjct: 299 DVLLPQETAEIHLHSLSP 316

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  145 bits (367), Expect = 9e-41
 Identities = 77/308 (25%), Positives = 124/308 (40%), Gaps = 72/308 (23%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 92
           +++G GSF  V  A+ L T    AIK      ++++    Y  RE  +M  +DHP  + L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
              F     +D+  L   + Y    E     L  Y            + YT +I   L Y
Sbjct: 96  YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS---------YICSRY 201
           +H   G+ HRD+KP+N+L++   H +++ DFG+AKVL                 Y+    
Sbjct: 146 LHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
             +PEL+        S D+W+ GC++ +L+ G P F   N    + + I           
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII---------- 245

Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEAC 315
                   ++ FP            ++  P+A DL  +LL    + R             
Sbjct: 246 ------KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287

Query: 316 AHPFFDEL 323
           AHPFF+ +
Sbjct: 288 AHPFFESV 295

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  145 bits (367), Expect = 9e-41
 Identities = 68/314 (21%), Positives = 128/314 (40%), Gaps = 52/314 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 90
           +   + +G G++G V  A    T E VA+K     + +       +E+ + ++++H NV+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
                       +  +  L +EY    E     L      +  MP    + + +Q+  G+
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRAP 205
            Y+H + G+ HRD+KP+NLL+D     +K+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 206 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           EL+    E+    +D+WS G VL  +L G+ P     ++  +  +  +            
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
                           PW K     +    + L  ++L  +PS R T  +     ++++ 
Sbjct: 224 -----KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268

Query: 324 REPNARLPNGRPFP 337
            +  A+ P      
Sbjct: 269 LKKGAKRPRVTSGG 282

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  144 bits (365), Expect = 1e-40
 Identities = 72/295 (24%), Positives = 107/295 (36%), Gaps = 68/295 (23%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKH 94
            +  +V+G G  G V Q     T E  A+ K+LQD     RE++L  R    P+++ +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 95  CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY----VKLYTYQIFRGL 148
             +         L +VME +   E   R+         R    +           I   +
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQD-------RGDQAFTEREASEIMKSIGEAI 130

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYICSRYYR 203
            Y+H++  + HRDVKP+NLL    T +     +KL DFG                     
Sbjct: 131 QYLHSI-NIAHRDVKPENLL---YTSKRPNAILKLTDFG--------------------F 166

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           A E      +Y  S D+WS G ++  LL G P F   + +     +            R 
Sbjct: 167 AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------RI 214

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
               Y +F  P      W +V       E   L   LL+  P+ R T  E   HP
Sbjct: 215 RMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  148 bits (375), Expect = 5e-40
 Identities = 89/342 (26%), Positives = 142/342 (41%), Gaps = 68/342 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 91
           RV+G G FG V   +   TG+  A K  L+ +R K R        E Q++  ++   V+S
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L + +    +KD L L  V+  +   +  + +   Y       P      Y  +I  GL 
Sbjct: 249 LAYAY---ETKDALCL--VLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLE 300

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
            +H    + +RD+KP+N+L+D   H +++ D G A  + +G+     + +  Y APE++ 
Sbjct: 301 DLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
               YT S D W+ GC+L E++ GQ  F                    REE+        
Sbjct: 359 N-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK------------KIKREEV-------- 397

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELR 324
                 +K  P  + + +R  P+A  L S+LL   P+ R      +A E   HP F +L 
Sbjct: 398 ---ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL- 451

Query: 325 EPN-ARLPNGRPFPP------------LFNFKQELAGASPEL 353
             N  RL  G   PP            + + +Q       EL
Sbjct: 452 --NFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVEL 491

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  143 bits (363), Expect = 5e-40
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 49/293 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRLMDHPN 88
           Y+    +G GSFG V  A   +T + VA+K      + +   +    RE+  ++L+ HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +I L       T+  ++   +V+EY    ++     Y    +RM     + +  QI   +
Sbjct: 71  IIKLYDVI---TTPTDIV--MVIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 207
            Y H    + HRD+KP+NLL+D     VK+ DFG + ++  G   +   C S  Y APE+
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEV 178

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           I G       +D+WS G VL  +L+G+  F  E  +  L + +                 
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN---------------- 221

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
              +  P      +       + P A  L  R++   P  R T  E    P+F
Sbjct: 222 SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  147 bits (373), Expect = 2e-39
 Identities = 73/302 (24%), Positives = 121/302 (40%), Gaps = 58/302 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPN 88
           R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           ++ + + F    + D+L    +++ +   +  Y + +H            ++ Y  +I  
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           GL ++H    V +RD+KP N+L+D   H V++ D G A    K + + + + +  Y APE
Sbjct: 304 GLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++     Y +S D +S GC+L +LL G   F      D             + EI     
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFD 321
                                   PE   L   LLQ   + R  C    A E    PFF 
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

Query: 322 EL 323
            L
Sbjct: 455 SL 456

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  141 bits (358), Expect = 3e-39
 Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 39/300 (13%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 94
            +G G++G V +     +G+ +A+K++      ++++    +L  +MR  D P ++    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
             F           + ME +  +  +  K+ YS ++  +P   +   T    + L ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
              + HRD+KP N+L+D  +  +KLCDFG +  LV   A       R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 214 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
              Y    D+WS G  L EL  G+  +P  N+V   +  + V G P              
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247

Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
              PQ+      + F     P  I+  +  L    S R    E   HPF     E    +
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  144 bits (364), Expect = 3e-39
 Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 58/297 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 91
           +++G G+FG V   K   TG   A+K +L+      +        E ++++   HP + +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           LK+ F    + D L    VMEY    E  + +     S  +       + Y  +I   L 
Sbjct: 213 LKYSF---QTHDRLCF--VMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALD 262

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +K  A +   C +  Y APE++
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
               +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I                  
Sbjct: 322 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------M 363

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
            + RFP            + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 364 EEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  140 bits (355), Expect = 4e-39
 Identities = 75/320 (23%), Positives = 116/320 (36%), Gaps = 62/320 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRLMD 85
           Y    ++G G FG VF    L     VAIK     +VL      +      E+ L+  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 86  ----HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
               HP VI L   +F T  ++   L  V+E         L  Y +    +     + + 
Sbjct: 93  AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQD--LFDYITEKGPLGEGPSRCFF 145

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SR 200
            Q+   + + H+  GV HRD+K +N+L+D      KL DFGS  +L       +    +R
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTR 202

Query: 201 YYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            Y  PE I    +Y      +WS G +L +++ G   F  +       EI++        
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------- 248

Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                     +  FP              + P+   L  R L   PS R +  E    P+
Sbjct: 249 ----------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286

Query: 320 FDELREPNARLPNGRPFPPL 339
                E     P+     PL
Sbjct: 287 MQTPAEDVPLNPSKGGPAPL 306

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  141 bits (357), Expect = 6e-39
 Identities = 37/316 (11%), Positives = 95/316 (30%), Gaps = 66/316 (20%)

Query: 35  SYMAERVVGTGSFGIVFQAKC-----LETGETVAIK----KVLQDRRYKNRELQLMRLMD 85
                 ++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
               +           ++   L  V E       +  +  + ++  + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----------VKLCDFGSA---KVLVKG 190
           +   +  +H    + H D+KP N ++     +          + L D G +   K+  KG
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 191 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEI 249
               +   +  ++  E++     +   ID +     +  +L G  +    E    +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
            +                    R P +    W++ FH             +L        
Sbjct: 299 FR--------------------RLPHL--DMWNEFFHV------------MLNIPDCHHL 324

Query: 310 TALEACAHPFFDELRE 325
            +L+          ++
Sbjct: 325 PSLDLLRQKLKKVFQQ 340

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  142 bits (359), Expect = 6e-39
 Identities = 68/298 (22%), Positives = 128/298 (42%), Gaps = 54/298 (18%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 92
           R +G GSFG V   +  +T +  A+K     K ++    R   +ELQ+M+ ++HP +++L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            + F     +DE  + +V++ +   +  Y + +     N       VKL+  ++   L Y
Sbjct: 81  WYSF-----QDEEDMFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDY 130

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF- 209
           +     + HRD+KP N+L+D   H V + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 210 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCMNP 266
                Y+ ++D WS G    ELL G+  +   ++    ++V   +               
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFFDEL 323
             T   +P                 E + L  +LL+ +P  R + L      P+ +++
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  139 bits (353), Expect = 1e-38
 Identities = 67/302 (22%), Positives = 111/302 (36%), Gaps = 48/302 (15%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 94
            +G+G+ G V++ +  +TG  +A+K++      ++ +    +L  +++  D P ++    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 95  CFFSTTSKDELFLNLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F + T      + + ME     M     K    M   +P   +   T  I + L Y+  
Sbjct: 92  TFITNTD-----VFIAMEL----MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI----F 209
             GV HRDVKP N+L+D    Q+KLCDFG +  LV  +A         Y APE I     
Sbjct: 143 KHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNY 268
              +Y    D+WS G  L EL  GQ  +       + L ++++    P            
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------ 247

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                P +         H     +        L      R    +   H F         
Sbjct: 248 -----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295

Query: 329 RL 330
            +
Sbjct: 296 DV 297

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  141 bits (357), Expect = 2e-38
 Identities = 80/330 (24%), Positives = 123/330 (37%), Gaps = 79/330 (23%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 92
           +V+G G+F  V   K  +TG+  A+K + +    K  E+        ++   D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
              F     +DE +L LVMEY    + +       S   +R+P    + Y  +I   +  
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--------YICSRYY 202
           +H + G  HRD+KP N+L+D   H ++L DFGS   L       S        Y+     
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230

Query: 203 RAPELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
            +PE++       G   Y    D W+ G    E+  GQ  F  ++   +    I      
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282

Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALE 313
                  ++        P            + +P EA D   RLL   P  R     A +
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324

Query: 314 ACAHPFF-----DELREPNARLPNGRPFPP 338
              HPFF     D LR+         PF P
Sbjct: 325 FRTHPFFFGLDWDGLRDSVP------PFTP 348

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  139 bits (352), Expect = 3e-38
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 59/297 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 91
           +++G G+FG V   +   TG   A+K +L+      +        E ++++   HP + +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           LK+ F    + D L    VMEY    E  + + +      +       + Y  +I   L 
Sbjct: 70  LKYAF---QTHDRLCF--VMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 208
           Y+H+   V +RD+K +NL++D   H +K+ DFG  K  +   A +   C    Y APE++
Sbjct: 120 YLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
               +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I                  
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------M 219

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
            + RFP            + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 220 EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  141 bits (356), Expect = 4e-38
 Identities = 77/322 (23%), Positives = 125/322 (38%), Gaps = 65/322 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ--DRRYKNRELQLMRLMDHPNVISL 92
           +V+G G+FG V   K     +  A+K     ++L+  +      E  ++   D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            + F     +D+  L LVM+Y    + +       S    R+P    + Y  ++   +  
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRY-YRAPELI 208
           +H +    HRD+KP N+L+D   H ++L DFGS   L++     S        Y +PE++
Sbjct: 191 VHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 209 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
                G   Y    D WS G  + E+L G+  F  E+ + +    I             M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFF- 320
           N     F+FP              +   A DL  RL+  S   R       +   HPFF 
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343

Query: 321 ----DELREPNARLPNGRPFPP 338
               D +R   A      P+ P
Sbjct: 344 GIDWDNIRNCEA------PYIP 359

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  141 bits (356), Expect = 6e-38
 Identities = 87/308 (28%), Positives = 129/308 (41%), Gaps = 55/308 (17%)

Query: 25  GKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 76
            +  + +  I  Y+    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 77  ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPL 134
           E+Q ++L  HP++I L       ++  ++F  +VMEYV   E     L  Y   N R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVI---STPSDIF--MVMEYVSGGE-----LFDYICKNGRLDE 115

Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
              +    QI  G+ Y H    V HRD+KP+N+L+D      K+ DFG + ++  GE  +
Sbjct: 116 KESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE-FL 172

Query: 195 SYIC-SRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
              C S  Y APE+I G   Y    +DIWS+G +L  LL G   F  ++ V  L + I  
Sbjct: 173 RTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC- 229

Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
                             F  P      +       + P  I L   +LQ  P  R T  
Sbjct: 230 ---------------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIK 262

Query: 313 EACAHPFF 320
           +   H +F
Sbjct: 263 DIREHEWF 270

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  138 bits (348), Expect = 7e-38
 Identities = 63/359 (17%), Positives = 125/359 (34%), Gaps = 105/359 (29%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           +   + +G G FG+VF+AK        AIK++    R        RE++ +  ++HP ++
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 91  SLKH----------------------------------------------------CFFS 98
              +                                                        
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 99  TTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 157
             S  +++L + M+    E +   +    S+  R   + + ++  QI   + ++H+  G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS-KGL 185

Query: 158 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-------------VKGEANISYICSRYYRA 204
            HRD+KP N+        VK+ DFG    +                  +   + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE I G   Y+  +DI+S G +L ELL                E ++++      ++R  
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM-------ERVRII-----TDVR-- 287

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
                + +FP +    +         P+   +   +L  SP+ R  A +   +  F+ L
Sbjct: 288 -----NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  136 bits (343), Expect = 4e-37
 Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 60/299 (20%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRL 83
           Y     +G+G+FG V+ A   E  + V +K     KVL+D   ++        E+ ++  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           ++H N+I +   F    ++      LVME     +   L  +   + R+          Q
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQ 138

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 202
           +   + Y+     + HRD+K +N+++      +KL DFGSA  L +G+      C +  Y
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGTIEY 195

Query: 203 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
            APE++ G   Y    +++WS G  L  L+  +  F       +L E ++          
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE---------- 238

Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                       P              +  E + L S LLQ  P  R T  +    P+ 
Sbjct: 239 -------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  136 bits (345), Expect = 6e-37
 Identities = 78/364 (21%), Positives = 136/364 (37%), Gaps = 84/364 (23%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLM-----DHP 87
           Y   R +G G F  V+ +  ++  + VA+K V     Y      E++L++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 88  N---VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
           N   V+ L   F   +  +   + +V E +   + + +   +   Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLV----------------------------------- 169
            +GL Y+HT   + H D+KP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 170 -------------DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 216
                        +    +VK+ D G+A  +   +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 217 SIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKVLGTPTREEIR-------C 263
             DIWS  C+  EL  G  LF   +        D +  II++LG   R+ I         
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLASRLLQYSPSLRCTALEACAH 317
                      ++K     +V  ++            D    +L+  P  R TA E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 318 PFFD 321
           P+ +
Sbjct: 393 PWLN 396

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  135 bits (342), Expect = 1e-36
 Identities = 73/297 (24%), Positives = 121/297 (40%), Gaps = 59/297 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQ--------LMRLMDHPNVI 90
           +V+G GSFG V  A+        A+K VLQ     K +E +        L++ + HP ++
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L   F    + D+L+   V++Y+   E  Y + +      +       + Y  +I   L
Sbjct: 103 GLHFSF---QTADKLYF--VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPEL 207
            Y+H++  + +RD+KP+N+L+D   H + L DFG  K  ++  +  S  C    Y APE+
Sbjct: 153 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +     Y  ++D W  G VL E+L G P F   N   ++ + I                 
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR----CTALEACAHPFF 320
               +                +   A  L   LLQ   + R       +E  +H FF
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  135 bits (341), Expect = 1e-36
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 56/294 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 90
           +++G GSFG VF A+  +T +  AIK  L+       +           L    +HP + 
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            +   F    +K+ LF   VMEY+   + MY +         +  L     Y  +I  GL
Sbjct: 82  HMFCTF---QTKENLFF--VMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 131

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPEL 207
            ++H+  G+ +RD+K  N+L+D   H +K+ DFG  K  + G+A  +  C    Y APE+
Sbjct: 132 QFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           + G  +Y  S+D WS G +L E+L+GQ  F G++  ++L   I+                
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR---------------- 231

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFF 320
             +  +P            + +  EA DL  +L    P  R         HP F
Sbjct: 232 MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  134 bits (339), Expect = 2e-36
 Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 59/298 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
           RV+G GSFG V  A+  ETG+  A+K + +D   ++ +++        L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF    + D LF   VME+V   + M+ + K      +R      + Y  +I   L 
Sbjct: 89  LFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALM 138

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 208
           ++H   G+ +RD+K  N+L+D   H  KL DFG  K  +      +  C    Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                Y  ++D W+ G +L E+L G   F  EN  D L E I                  
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------N 238

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 320
            +  +P              +  +A  +    +  +P++R              HPFF
Sbjct: 239 DEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  133 bits (338), Expect = 2e-36
 Identities = 72/300 (24%), Positives = 131/300 (43%), Gaps = 61/300 (20%)

Query: 40  RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNR---ELQLMRLMDHPN 88
           RV+G G +G VFQ + +    TG+  A+K      ++++ +       E  ++  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           ++ L + F    +  +L+L  ++EY+   E   ++ +                Y  +I  
Sbjct: 83  IVDLIYAF---QTGGKLYL--ILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISM 132

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAP 205
            L ++H   G+ +RD+KP+N++++   H VKL DFG  K  +         C    Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E++   + +  ++D WS G ++ ++L G P F GEN   + ++ I       + ++    
Sbjct: 191 EILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------LKCKL---- 238

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
                   P              +  EA DL  +LL+ + + R       A E  AHPFF
Sbjct: 239 ------NLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  132 bits (335), Expect = 3e-36
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 18/215 (8%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 96
           E VVG G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN++      
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK----- 65

Query: 97  FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--T 153
                 + + L  VMEY    ++Y VL H +         +   +  Q  +G+AY+H   
Sbjct: 66  LYGACLNPVCL--VMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
              + HRD+KP NLL+      +K+CDFG+A          +   S  + APE+  G + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179

Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248
           Y+   D++S G +L E++  +  F         + 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  133 bits (336), Expect = 4e-36
 Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 59/298 (19%)

Query: 40  RVVGTGSFGIVFQAK---CLETGETVAIK-----KVLQDRRYKNR-ELQLMRLMDHPNVI 90
           +V+G GSFG VF  K     +  +  A+K      +    R + + E  ++  ++HP ++
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            L + F    ++ +L+L  +++++   +   R+     S         VK Y  ++   L
Sbjct: 90  KLHYAF---QTEGKLYL--ILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALAL 139

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 207
            ++H++ G+ +RD+KP+N+L+D   H +KL DFG +K  +  E      C +  Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +     +T S D WS G ++ E+L G   F G++   + + +I                 
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
                 PQ             + PEA  L   L + +P+ R         E   H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  134 bits (340), Expect = 5e-36
 Identities = 77/307 (25%), Positives = 124/307 (40%), Gaps = 68/307 (22%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 92
           +V+G G+FG V   +   T +  A+K     ++++     +   E  +M   + P V+ L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            + F     +D+ +L +VMEY+P  + +  ++      N  +P  + + YT ++   L  
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWARFYTAEVVLALDA 183

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--------YICSRYY 202
           IH++ G  HRDVKP N+L+D   H +KL DFG+   + K              YI     
Sbjct: 184 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236

Query: 203 RAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            +PE++    G   Y    D WS G  L E+L+G   F  ++ V             T  
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------TYS 283

Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACA 316
           +I  MN       FP              +  EA +L    L     +R       E   
Sbjct: 284 KI--MNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR 329

Query: 317 HPFFDEL 323
           H FF   
Sbjct: 330 HLFFKND 336

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  133 bits (336), Expect = 6e-36
 Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 58/297 (19%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
            V+G GSFG V  ++   T E  A+K + +D   ++ +++        L      P +  
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF    + D L+   VMEYV   + MY + +       R    +   Y  +I  GL 
Sbjct: 86  LHSCF---QTMDRLYF--VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 135

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 208
           ++ +  G+ +RD+K  N+++D   H +K+ DFG  K  +         C    Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                Y  S+D W+ G +L E+L GQ  F GE+  D+L + I          +       
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 238

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
               +P            K M  EA+ +   L+   P  R         +   H FF
Sbjct: 239 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  131 bits (331), Expect = 1e-35
 Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 52/306 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 87
           Y  + V+G+G+  +V  A C    E VAIK++        + +     +E+Q M    HP
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL---KEIQAMSQCHHP 73

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
           N++S    F     KDEL+  LVM+      V + +  ++      +  +    +     
Sbjct: 74  NIVSYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSR- 200
           ++  GL Y+H   G  HRDVK  N+L+      V++ DFG SA +   G+   +    R 
Sbjct: 129 EVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRK 184

Query: 201 ------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
                  + APE++     Y    DIWS G    EL  G   +     +  L+  ++   
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--- 241

Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
                     N        P ++     K   K+       + S  LQ  P  R TA E 
Sbjct: 242 ----------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285

Query: 315 CAHPFF 320
             H FF
Sbjct: 286 LRHKFF 291

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  130 bits (328), Expect = 2e-35
 Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 30/219 (13%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHP 87
           E+ +G G FG+V + + ++    VAIK ++                  RE+ +M  ++HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           N++      +           +VME+VP   +Y  L         +           I  
Sbjct: 84  NIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIAL 133

Query: 147 GLAYIHTV-PGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
           G+ Y+    P + HRD++  N+ +           K+ DFG ++      +    + +  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 202 YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 239
           + APE I    E YT   D +S   +L  +L G+  F  
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  130 bits (330), Expect = 2e-35
 Identities = 80/303 (26%), Positives = 125/303 (41%), Gaps = 68/303 (22%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 92
           R +GTGSFG V   +    G   A+K      V++ +   + N E  ++ ++ HP +I +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
              F     +D   + ++M+Y+   E    + K     +QR P    K Y  ++   L Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRYYRAP 205
           +H+   + +RD+KP+N+L+D   H +K+ DFG AK  V            YI      AP
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKY-VPDVTYTLCGTPDYI------AP 172

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E++     Y  SID WS G ++ E+L G   F   N   +  E I               
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL-------------- 216

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFF 320
               + RFP                 +  DL SRL+    S R   L     +   HP+F
Sbjct: 217 --NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

Query: 321 DEL 323
            E+
Sbjct: 263 KEV 265

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  131 bits (331), Expect = 3e-35
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 60/299 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K     KV++ +   +   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 93  KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           +  F     KD   L +VMEYV   E    + +       R    + + Y  QI     Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEY 156

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 209
           +H++  + +RD+KP+NLL+D   + +++ DFG AK   + +     +C +    APE+I 
Sbjct: 157 LHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAK---RVKGRTWTLCGTPEALAPEIIL 211

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
               Y  ++D W+ G ++ E+  G P F  +    Q+ E I                   
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV----------------SG 253

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFFDEL 323
             RFP                 +  DL   LLQ   + R   L     +   H +F   
Sbjct: 254 KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  129 bits (327), Expect = 1e-34
 Identities = 68/298 (22%), Positives = 126/298 (42%), Gaps = 50/298 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
           RV+G GS+  V   +  +T    A+K V ++    + ++           +  +HP ++ 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF    ++  LF   V+EYV   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 75  LHSCF---QTESRLF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           Y+H   G+ +RD+K  N+L+D   H +KL D+G  K  ++     S  C +  Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
            G  +Y  S+D W+ G ++ E++ G+  F    + D   +        T + +       
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 227

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 320
               F  I          + +  +A  +    L   P  R          +   HPFF
Sbjct: 228 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  130 bits (327), Expect = 2e-34
 Identities = 62/339 (18%), Positives = 118/339 (34%), Gaps = 44/339 (12%)

Query: 17  HIISTTIGGKNGEPKQTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKV----LQD 70
           H+ +    G +    +   Y    V+G G      V  A+   TGE V ++++      +
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67

Query: 71  RRYKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS 127
                   EL + +L +HPN++  +  F    + +EL+  +V  ++   +   ++  +  
Sbjct: 68  EMVTFLQGELHVSKLFNHPNIVPYRATFI---ADNELW--VVTSFMAYGSAKDLICTH-- 120

Query: 128 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA--- 184
               M  + +      + + L YIH + G  HR VK  ++L+  +  +V L    S    
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSM 178

Query: 185 -----KVLVKGEANISYICSRYYRAPELIF-GATEYTTSIDIWSAGCVLAELLLGQPLFP 238
                +  V  +     +    + +PE++      Y    DI+S G    EL  G   F 
Sbjct: 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238

Query: 239 GENAVDQLVEIIK-----------------VLGTPTREEIRCMNPNYTDFRFPQIKAHPW 281
              A   L+E +                   +          ++ + T            
Sbjct: 239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298

Query: 282 HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
              +H+   P       + LQ +P  R +A     H FF
Sbjct: 299 SHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  133 bits (335), Expect = 3e-34
 Identities = 84/340 (24%), Positives = 134/340 (39%), Gaps = 71/340 (20%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
            V+G GSFG V  ++   T E  A+K + +D   ++ +++        L      P +  
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF    + D L+   VMEYV   + MY + +       R    +   Y  +I  GL 
Sbjct: 407 LHSCF---QTMDRLYF--VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 456

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           ++ +  G+ +RD+K  N+++D   H +K+ DFG  K  +         C +  Y APE+I
Sbjct: 457 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                Y  S+D W+ G +L E+L GQ  F GE+  D+L + I          +       
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 559

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDEL 323
               +P            K M  EA+ +   L+   P  R         +   H FF   
Sbjct: 560 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF--- 601

Query: 324 REPN-ARLPNGR---PFPP------LFNFKQELAGASPEL 353
           R  +  +L       P+ P        NF +      P L
Sbjct: 602 RYIDWEKLERKEIQPPYKPKASGRNAENFDRFFTRHPPVL 641

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  127 bits (322), Expect = 7e-34
 Identities = 76/303 (25%), Positives = 131/303 (43%), Gaps = 59/303 (19%)

Query: 40  RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHP 87
           +V+GTG++G VF  + +   +TG+  A+K + +    +  +           L  +   P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
            +++L + F    ++ +L L  +++Y+   E    +     S  +R     V++Y  +I 
Sbjct: 120 FLVTLHYAF---QTETKLHL--ILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIV 169

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-IC-SRYYR 203
             L ++H + G+ +RD+K +N+L+D   H V L DFG +K  V  E   +Y  C +  Y 
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 204 APELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
           AP+++ G    +  ++D WS G ++ ELL G   F  +   +   EI           I 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL 279

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAH 317
                 ++  +PQ             M   A DL  RLL   P  R       A E   H
Sbjct: 280 -----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322

Query: 318 PFF 320
            FF
Sbjct: 323 LFF 325

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  128 bits (323), Expect = 1e-33
 Identities = 68/298 (22%), Positives = 126/298 (42%), Gaps = 50/298 (16%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 91
           RV+G GS+  V   +  +T    A++ V ++    + ++           +  +HP ++ 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           L  CF    ++  LF   V+EYV   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 118 LHSCF---QTESRLF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 208
           Y+H   G+ +RD+K  N+L+D   H +KL D+G  K  ++     S  C +  Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
            G  +Y  S+D W+ G ++ E++ G+  F    + D   +        T + +       
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 270

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFF 320
               F  I          + +  +A  +    L   P  R  C           HPFF
Sbjct: 271 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  125 bits (317), Expect = 3e-33
 Identities = 78/296 (26%), Positives = 128/296 (43%), Gaps = 53/296 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 88
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ + HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            I  + C+     +   +  LVMEY   +   +L+ +    + +  + +   T+   +GL
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 167

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYRAPE 206
           AY+H+   + HRDVK  N+L   L+    VKL DFGSA ++       S++ + Y+ APE
Sbjct: 168 AYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPE 220

Query: 207 LIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           +I    E  Y   +D+WS G    EL   +P     NA+  L  I +             
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------N 268

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                    P +++  W + F         +     LQ  P  R T+     H F 
Sbjct: 269 ES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFV 309

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  124 bits (314), Expect = 4e-33
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 19/210 (9%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 92
           +  +G GSFG V +A+    G  VA+K +++   +        RE+ +M+ + HPN++  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
                + T    L +  V EY+   ++YR+L H S   +++         Y + +G+ Y+
Sbjct: 100 MG---AVTQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 152 HTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 209
           H   P + HR++K  NLLVD   + VK+CDFG +++      +  S   +  + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
                    D++S G +L EL   Q  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  123 bits (310), Expect = 1e-32
 Identities = 74/306 (24%), Positives = 126/306 (41%), Gaps = 59/306 (19%)

Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 82
            G+PK+   Y     +G G+ G V+ A  + TG+ VAI+++       +     E+ +MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 142
              +PN+++    +      DEL+  +VMEY+       +   + M++      +     
Sbjct: 73  ENKNPNIVNYLDSYL---VGDELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCR 123

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-- 200
           +  + L ++H+   V HRD+K  N+L+  +   VKL DFG         A I+   S+  
Sbjct: 124 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFC-------AQITPEQSKRS 174

Query: 201 ------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
                 Y+ APE++     Y   +DIWS G +  E++ G+P +  EN +  L  I    G
Sbjct: 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G 232

Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
           TP  +                        +F         D  +R L+     R +A E 
Sbjct: 233 TPELQN-----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKEL 267

Query: 315 CAHPFF 320
             H F 
Sbjct: 268 LQHQFL 273

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  122 bits (308), Expect = 1e-32
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 32/219 (14%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHPNVI 90
           E ++G G FG V++A  +  G+ VA+K    D             +E +L  ++ HPN+I
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           +L+          E  L LVME+     + RVL       +R+P   +  +  QI RG+ 
Sbjct: 70  ALRGV-----CLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119

Query: 150 YIH--TVPGVCHRDVKPQNLLVD-------PLTHQVKLCDFGSAKVLVKGEANISYICSR 200
           Y+H   +  + HRD+K  N+L+             +K+ DFG A+   +     S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAY 178

Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
            + APE+I  +  ++   D+WS G +L ELL G+  F G
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  123 bits (310), Expect = 2e-32
 Identities = 74/315 (23%), Positives = 125/315 (39%), Gaps = 58/315 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMR-LMDHPNVIS 91
           +    +VG G++G V++ + ++TG+  AIK +     +     +E+ +++    H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 92  LKHCFF---STTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
               F         D+L+  LVME+        + +  K        +   ++     +I
Sbjct: 86  YYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREI 138

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLV--KGEANISYICSR 200
            RGL+++H    V HRD+K QN+L   LT   +VKL DFG +  L    G  N ++I + 
Sbjct: 139 LRGLSHLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTP 193

Query: 201 YYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           Y+ APE+I         Y    D+WS G    E+  G P     + +  L  I +     
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----- 248

Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                   NP       P++K+  W K F               L  + S R    +   
Sbjct: 249 --------NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMK 286

Query: 317 HPFFDELREPNARLP 331
           HPF  +         
Sbjct: 287 HPFIRDQPNERQVRI 301

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  122 bits (308), Expect = 2e-32
 Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 48/302 (15%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           +     +G GSFG VF+     T + VAIK +  +          +E+ ++   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
                +       +L+  ++MEY+       L     +++      +     +I +GL Y
Sbjct: 84  KYYGSYL---KDTKLW--IIMEYLGGGSALDLLEPGPLDET----QIATILREILKGLDY 134

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISYICSRYYRAPELI 208
           +H+     HRD+K  N+L+     +VKL DFG A  L   + + N +++ + ++ APE+I
Sbjct: 135 LHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEVI 191

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
             +  Y +  DIWS G    EL  G+P     + +  L  I K    PT E         
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG-------- 241

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                       + K           +     L   PS R TA E   H F     +  +
Sbjct: 242 -----------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

Query: 329 RL 330
            L
Sbjct: 283 YL 284

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  122 bits (307), Expect = 6e-32
 Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 34/216 (15%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 94
            + +G G +G V+  K    GE VA+K     +     RE  +    LM H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 95  CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 152
               T S  +L+L  + +Y    ++Y  LK  +      + L Y          GL ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 153 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 200
           T        P + HRD+K +N+LV        + D G A   +     +    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 201 YYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 231
            Y  PE++  +      +     D++S G +L E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  121 bits (305), Expect = 8e-32
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 47/300 (15%)

Query: 27  NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 82
            G+P+      +   +G GS GIV  A+   +G  VA+K +     Q R     E+ +MR
Sbjct: 40  QGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97

Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYT 141
              H NV+ +   +      +EL++  +ME++    +  ++        R+    +    
Sbjct: 98  DYQHFNVVEMYKSYLV---GEELWV--LMEFLQGGALTDIVSQ-----VRLNEEQIATVC 147

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSR 200
             + + LAY+H   GV HRD+K  ++L+  L  +VKL DFG  A++        S + + 
Sbjct: 148 EAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205

Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
           Y+ APE+I   + Y T +DIWS G ++ E++ G+P +  ++ V  +  +      P  + 
Sbjct: 206 YWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN 263

Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                            +H    V          D   R+L   P  R TA E   HPF 
Sbjct: 264 -----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (305), Expect = 9e-32
 Identities = 75/296 (25%), Positives = 119/296 (40%), Gaps = 55/296 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 93
           +     +G GS+G V++A   ETG+ VAIK+V  +   +   +E+ +M+  D P+V+   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 94  HCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
             +F      +L+  +VMEY     V + +          N+ +    +        +GL
Sbjct: 91  GSYF---KNTDLW--IVMEYCGAGSVSDII-------RLRNKTLTEDEIATILQSTLKGL 138

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLV--KGEANISYICSRYYRA 204
            Y+H +    HRD+K  N+L   L      KL DFG A  L     + N + I + ++ A
Sbjct: 139 EYLHFM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMA 193

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE+I     Y    DIWS G    E+  G+P +   + +  +  I      PT  +    
Sbjct: 194 PEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK---- 247

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                           W   F         D   + L  SP  R TA +   HPF 
Sbjct: 248 -------------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFV 282

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  120 bits (303), Expect = 1e-31
 Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 34/216 (15%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 94
              VG G +G V++      GE VA+K    +D +   RE  L    ++ H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 95  CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 152
              S  S  +L+L  +  Y    ++Y  L+  +      + ++        I  GLA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122

Query: 153 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 200
                    P + HRD+K +N+LV     Q  + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 201 YYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 231
            Y APE++         +    +DIW+ G VL E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  120 bits (303), Expect = 1e-31
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 31/229 (13%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMDHPNVISLKH 94
             V+G G FG   +    ETGE + +K++++     +R   +E+++MR ++HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK--- 71

Query: 95  CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
            F     KD+  LN + EY+   T+  ++K   SM+ + P      +   I  G+AY+H+
Sbjct: 72  -FIGVLYKDKR-LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------------- 200
           +  + HRD+   N LV      V + DFG A+++V  +     + S              
Sbjct: 127 M-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 201 --YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
             Y+ APE+I G   Y   +D++S G VL E++      P         
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  120 bits (303), Expect = 2e-31
 Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 45/306 (14%)

Query: 33  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNV 89
           ++      V   G FG V++A+     E VA+K    QD++    E  +  +  M H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 90  IS-LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFR 146
           +  +      T+   +L+L  +  +  + ++   LK    S N+   +         + R
Sbjct: 81  LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132

Query: 147 GLAYIHT---------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           GLAY+H           P + HRD+K +N+L+        + DFG A      EA  S  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKF---EAGKSAG 188

Query: 198 CSRY------YRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
            +        Y APE++ GA     +    ID+++ G VL EL        G      L 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 307
              ++   P+ E+++         + P ++ + W K     M     +       +    
Sbjct: 249 FEEEIGQHPSLEDMQ--EVVVHKKKRPVLRDY-WQKHAGMAM---LCETIEECWDHDAEA 302

Query: 308 RCTALE 313
           R +A  
Sbjct: 303 RLSAGC 308

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  118 bits (298), Expect = 3e-31
 Identities = 36/211 (17%), Positives = 77/211 (36%), Gaps = 22/211 (10%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISL 92
              +     G +++ +    G  + +K +          R  N E   +R+  HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
                   S       L+  ++P  ++Y VL  +   N  +       +   + RG+A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 152 HTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
           HT+ P +    +  +++++D      ++                +      + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182

Query: 211 --ATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
                   S D+WS   +L EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  118 bits (298), Expect = 4e-31
 Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 26/224 (11%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 92
            + +G+GSFG V++ K       VA+K +               E+ ++R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 93  KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F   ++  +L +  V ++    ++Y  L    +   +  +  +     Q  RG+ Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 208
           H    + HRD+K  N+ +    + VK+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 209 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
                  Y+   D+++ G VL EL+ GQ  +   N  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (296), Expect = 1e-30
 Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 64/304 (21%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 88
           +     +G G+FG V++AK  ETG   A K +       L+D      E++++   DHP 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI---VEIEILATCDHPY 77

Query: 89  VISLKHCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
           ++ L   ++      +L+  +++E+     V   M         +++ +    +++   Q
Sbjct: 78  IVKLLGAYY---HDGKLW--IMIEFCPGGAVDAIM-------LELDRGLTEPQIQVVCRQ 125

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSR 200
           +   L ++H+   + HRD+K  N+L   +T    ++L DFG SAK L   +   S+I + 
Sbjct: 126 MLEALNFLHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 181

Query: 201 YYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           Y+ APE++   T     Y    DIWS G  L E+   +P     N +  L++I K    P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPP 240

Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
           T                       W   F         D     L  +P  R +A +   
Sbjct: 241 TLLT-----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLE 275

Query: 317 HPFF 320
           HPF 
Sbjct: 276 HPFV 279

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  117 bits (296), Expect = 2e-30
 Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 34/216 (15%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 94
           +  +G G FG V++ K    GE VA+K    ++ R   RE  +    ++ H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 95  CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 152
                 +  +L+L  V +Y    +++  L  Y+ ++   + L            GLA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156

Query: 153 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 200
                    P + HRD+K +N+LV        + D G A         I    +     +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 201 YYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 231
            Y APE++  +      E     DI++ G V  E+ 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (290), Expect = 8e-30
 Identities = 68/241 (28%), Positives = 110/241 (45%), Gaps = 39/241 (16%)

Query: 17  HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------ 70
           H+I   I  +         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 71  ---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYS 126
              +R++ RE+     + H N++S+         +D+ +  LVMEY+   T    L  Y 
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPT----LSEYI 102

Query: 127 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 186
             +  + +     +T QI  G+ + H +  + HRD+KPQN+L+D     +K+ DFG AK 
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160

Query: 187 LVKGEANISY----ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
           L   E +++     + +  Y +PE   G      + DI+S G VL E+L+G+P F GE A
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETA 217

Query: 243 V 243
           V
Sbjct: 218 V 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  115 bits (291), Expect = 8e-30
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 30/225 (13%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDH 86
           Y    ++G G    V  A+ L     VA+K VL+           R++ RE Q    ++H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFR-REAQNAAALNH 71

Query: 87  PNVISLKHCFFSTTSKDELFLN---LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTY 142
           P ++++    + T   +        +VMEYV   T    L+        M          
Sbjct: 72  PAIVAV----YDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIA 123

Query: 143 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----IC 198
              + L + H   G+ HRDVKP N+++   T+ VK+ DFG A+ +     +++     I 
Sbjct: 124 DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
           +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 182 TAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  115 bits (289), Expect = 1e-29
 Identities = 50/247 (20%), Positives = 96/247 (38%), Gaps = 45/247 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 92
             ++G G FG V+  +       VAI+ +  +R  ++      RE+   R   H NV+  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 93  K-HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
              C     S   L +  +       T+Y V++        + +   +    +I +G+ Y
Sbjct: 95  MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY--------Y 202
           +H   G+ H+D+K +N+  D    +V + DFG     + G         +         +
Sbjct: 146 LHA-KGILHKDLKSKNVFYD--NGKVVITDFGLFS--ISGVLQAGRREDKLRIQNGWLCH 200

Query: 203 RAPELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
            APE+I   +         ++   D+++ G +  EL   +  F  + A      II  +G
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMG 256

Query: 255 TPTREEI 261
           T  +  +
Sbjct: 257 TGMKPNL 263

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  115 bits (289), Expect = 3e-28
 Identities = 61/252 (24%), Positives = 108/252 (42%), Gaps = 32/252 (12%)

Query: 36  YMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD-------RRYKNRELQLMRLMDHP 87
           Y  +  +  G  G ++ A      G  V +K  L               E Q +  + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139

Query: 88  NVISLKHCFFSTTSKDELFLN-LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           +++ +   F   T +    +  +VMEYV  +++ R         Q++P+     Y  +I 
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
             L+Y+H++ G+ + D+KP+N+++     Q+KL D G+   +           +  ++AP
Sbjct: 193 PALSYLHSI-GLVYNDLKPENIMLTE--EQLKLIDLGAVSRI--NSFG-YLYGTPGFQAP 246

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-EEI--R 262
           E++      T + DI++ G  LA L L  P   G   VD L E   VL T      +  R
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR-YVDGLPEDDPVLKTYDSYGRLLRR 303

Query: 263 CMNPNYTDFRFP 274
            ++P+    RF 
Sbjct: 304 AIDPDPRQ-RFT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  111 bits (280), Expect = 4e-28
 Identities = 68/307 (22%), Positives = 118/307 (38%), Gaps = 50/307 (16%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRL--MDHPNVISLKHC 95
             ++G G +G V++         VA+K     +R+    E  + R+  M+H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIHT 153
               T+   +   LVMEY P  ++ + L  ++        L +       + RGLAY+HT
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129

Query: 154 --------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---------ANISY 196
                    P + HRD+  +N+LV        + DFG +  L             A IS 
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 197 ICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVE 248
           + +  Y APE++ GA            +D+++ G +  E+ +    LFPGE+  + Q+  
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 249 IIKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 305
             +V   PT E+++            R P+     W +  +        +          
Sbjct: 249 QTEVGNHPTFEDMQVLVSRE----KQR-PKFPEA-WKE--NSLAVRSLKETIEDCWDQDA 300

Query: 306 SLRCTAL 312
             R TA 
Sbjct: 301 EARLTAQ 307

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (278), Expect = 5e-28
 Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 28/220 (12%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYK---NRELQLMRLMDHP 87
           Y   R+VG G  G V++A+       VA+K ++      D  ++    RE +    +  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           +V+ +          D   L + M  +        L         +          QI  
Sbjct: 95  HVVPI----HDFGEIDGQ-LYVDMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYY 202
            L   H   G  HRDVKP+N+LV        L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
            APE    +   T   DI++  CVL E L G P + G+  
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 90.9 bits (226), Expect = 8e-21
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 40/233 (17%)

Query: 39  ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
            R +G G FG V           TGE VA+K +  D   ++     +E+ ++R + H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           I  K C           L LVMEYVP      L+ Y      + L  + L+  QI  G+A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLP-RHSIGLAQLLLFAQQICEGMA 148

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+H    + HRD+  +N+L+D     VK+ DFG AK + +G          YYR      
Sbjct: 149 YLHAQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--------EYYRVREDGD 198

Query: 204 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 249
                 APE +     +  + D+WS G  L ELL              +L+ I
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 46/231 (19%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
            R++G G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 90  ISLKH-CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKL--YTYQIF 145
             L      S          +++ ++    ++  L           L    L  +   I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 146 RGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 202
            G+ Y+   + +    HRD+  +N ++      V + DFG ++ +  G+         YY
Sbjct: 148 CGMEYLSSRNFI----HRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD---------YY 193

Query: 203 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
           R            A E L      YT   D+W+ G  + E++  GQ  + G
Sbjct: 194 RQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.1 bits (219), Expect = 5e-20
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 40/215 (18%)

Query: 39  ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
            + +G G+FG V   +       TGE VA+KK LQ    ++     RE+++++ + H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 148
           +  K       S     L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+
Sbjct: 74  VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+ T   + HRD+  +N+LV+   ++VK+ DFG  KVL + +         +++     
Sbjct: 128 EYLGTKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKE--------FFKVKEPG 177

Query: 204 -------APELIFGATEYTTSIDIWSAGCVLAELL 231
                  APE +   ++++ + D+WS G VL EL 
Sbjct: 178 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 87.7 bits (218), Expect = 9e-20
 Identities = 47/230 (20%), Positives = 87/230 (37%), Gaps = 45/230 (19%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
            +++G G FG V +    +       VA+K +       ++      E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKL--YTYQIFR 146
           I L       +S+      +++ ++    ++  L +         +    L  +   I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 147 GLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           G+ Y+   + +    HRD+  +N ++      V + DFG +K +  G+         YYR
Sbjct: 159 GMEYLSNRNFL----HRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD---------YYR 204

Query: 204 ------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                       A E L      YT+  D+W+ G  + E+   G   +PG
Sbjct: 205 QGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 38/214 (17%)

Query: 39  ERVVGTGSFGIVFQAKCL----ETGETVAIKK----VLQDRRYKNRELQLMRLMDHPNVI 90
            + +G G+FG V   +       TGE VA+KK      +  R   RE+++++ + H N++
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 149
             K      ++       L+MEY+P   Y  L+ Y   ++ R+  I +  YT QI +G+ 
Sbjct: 106 KYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+ T   + HRD+  +N+LV+   ++VK+ DFG  KVL + +         YY+      
Sbjct: 160 YLGTKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKE--------YYKVKEPGE 209

Query: 204 ------APELIFGATEYTTSIDIWSAGCVLAELL 231
                 APE +   ++++ + D+WS G VL EL 
Sbjct: 210 SPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 39/215 (18%)

Query: 39  ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
            R +G G FG V   +       TGE VA+K +  +    +     +E++++R + H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN-QRMPLIYVKLYTYQIFRGL 148
           +  K     T         L+ME++P      LK Y   N  ++ L     Y  QI +G+
Sbjct: 86  VKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+ +   V HRD+  +N+LV+   HQVK+ DFG  K +   +         YY      
Sbjct: 140 DYLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAIETDKE--------YYTVKDDR 189

Query: 204 -------APELIFGATEYTTSIDIWSAGCVLAELL 231
                  APE +  +  +  + D+WS G  L ELL
Sbjct: 190 DSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 85.7 bits (213), Expect = 5e-19
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 52/238 (21%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRLMDHPNV 89
            +V+G+G+FG V++   +  GE     VAIK  +     +       E  +M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 148
             L            +   L+ + +P   +  L  Y   ++  +   Y+  +  QI +G+
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 149 AYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-- 203
            Y+     V    HRD+  +N+LV      VK+ DFG AK+L   E          Y   
Sbjct: 131 NYLEDRRLV----HRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 204 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 248
                    A E ++     YT   D+WS G  + EL+  G   + G  A +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 59/252 (23%), Positives = 98/252 (38%), Gaps = 56/252 (22%)

Query: 39  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 87
            + +G G+FG V +A        +   TVA+K +     L +R     EL+++  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPL 134
           N+++L       T        ++ EY                 +          +  + L
Sbjct: 88  NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 135 IYVKLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
               L +  YQ+ +G+A++ +     HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDFGLARDIKNDS- 199

Query: 193 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                    Y             APE IF    YT   D+WS G  L EL  LG   +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 240 ENAVDQLVEIIK 251
                +  ++IK
Sbjct: 251 MPVDSKFYKMIK 262

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 37/313 (11%), Positives = 68/313 (21%), Gaps = 76/313 (24%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNR---ELQLMRLMDHPN 88
           Y      G       +QA        VA+  V                    +  +D P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           V  +              L +V E++   ++  V             +        +   
Sbjct: 93  VARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAA 141

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 207
               H   GV      P  + V      V L                             
Sbjct: 142 ADAAHRA-GVALSIDHPSRVRVSI-DGDVVLAYPA-------------------TMPDA- 179

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
                      DI   G  L  LL+ +   P       L    +        E   ++ +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD 231

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
                                +P +   +A+R +Q    +R  +         + +++  
Sbjct: 232 ---------------------IPFQISAVAARSVQGDGGIRSASTLL------NLMQQAT 264

Query: 328 ARLPNGRPFPPLF 340
           A         P+ 
Sbjct: 265 AVADRTEVLGPID 277

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 40/215 (18%)

Query: 39  ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
              +G G+FG V   +       TG  VA+K  LQ           RE+Q+++ +    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 148
           +  +   +    +    L LVMEY+P      L+ +   ++ R+    + LY+ QI +G+
Sbjct: 87  VKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+ +   V HRD+  +N+LV+     VK+ DFG AK+L   +         YY      
Sbjct: 141 EYLGSRRCV-HRDLAARNILVES-EAHVKIADFGLAKLLPLDKD--------YYVVREPG 190

Query: 204 -------APELIFGATEYTTSIDIWSAGCVLAELL 231
                  APE +     ++   D+WS G VL EL 
Sbjct: 191 QSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 27/213 (12%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
           +  +G G +G V++    +   TVA+K + +D        +E  +M+ + HPN++ L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 281

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 153
                +++  F  ++ E++    Y  L  Y     R  +  V L     QI   + Y+  
Sbjct: 282 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 207
                HR++  +N LV    H VK+ DFG ++++        Y      +      APE 
Sbjct: 337 K-NFIHRNLAARNCLVGE-NHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 390

Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
           +     ++   D+W+ G +L E+   G   +PG
Sbjct: 391 LAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 83.0 bits (204), Expect = 7e-18
 Identities = 51/336 (15%), Positives = 91/336 (27%), Gaps = 86/336 (25%)

Query: 42  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRE--------------------LQL 80
           +G G FG VFQ         VAIK + ++     N                      L  
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 81  MRLMDHPNVISLKHCFF---------------------------STTSKDELFLNLVMEY 113
                    I L                                     D+LF+ L  E+
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 114 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 173
               + ++    SS+         K   +Q+   LA         HRD+   N+L+   T
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-T 198

Query: 174 HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 233
              KL    + K                     L     +YT S        V  ++ + 
Sbjct: 199 SLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245

Query: 234 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-------NYTDFRFPQIKAHPW--HKV 284
           + LF G+   D   +I +++           +P       +Y   +  +        +  
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303

Query: 285 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
             K++  +  +    +L +S     +A +       
Sbjct: 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 57/225 (25%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISL- 92
           + ++G G FG V++   L  G  VA+K+   +      E +     L     HP+++SL 
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLI 101

Query: 93  KHCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSM--NQRMPLIYVKLYTYQIF 145
             C      ++E+ L  + +Y+        +Y       SM   QR+          +I 
Sbjct: 102 GFC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EIC 145

Query: 146 ----RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
               RGL Y+HT   + HRDVK  N+L+D      K+ DFG +K   + +   +++ +  
Sbjct: 146 IGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISKKGTELDQ--THLSTVV 201

Query: 202 -----YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 235
                Y  P       EY      T   D++S G VL E+L  + 
Sbjct: 202 KGTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
           E  +G G FG V+      T   VAIK +           +E Q+M+ + H  ++ L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 153
            ++  S++ ++  +V EY+       L  +        L   +L     QI  G+AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 207
           +    HRD++  N+LV       K+ DFG A+++   E    Y   +  +      APE 
Sbjct: 299 M-NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 352

Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                 +T   D+WS G +L EL   G+  +PG
Sbjct: 353 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
           E  +G G FG V+      T   VAIK +           +E Q+M+ + H  ++ L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 153
            ++  S++ ++  +V EY+       L  +        L   +L     QI  G+AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 207
           +    HRD++  N+LV       K+ DFG A+++   E    Y   +  +      APE 
Sbjct: 382 M-NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 435

Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                 +T   D+WS G +L EL   G+  +PG
Sbjct: 436 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 43/225 (19%)

Query: 37  MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKN------RELQLMRLMDHPN 88
           + ++ +G+G+FG V +           VA+K +  +            E  +M+ +D+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           ++ +          +     LVME         L  Y   N+ +    +    +Q+  G+
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+       HRD+  +N+L+    H  K+ DFG +K L   E         YY+     
Sbjct: 131 KYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADEN--------YYKAQTHG 180

Query: 204 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                  APE + +   ++++  D+WS G ++ E    GQ  + G
Sbjct: 181 KWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 33/213 (15%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 96
            + +G G FG V        G  VA+K +  D   +    E  +M  + H N++ L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 79

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTV 154
                +++  L +V EY+       L  Y     R  L    L  ++  +   + Y+   
Sbjct: 80  LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE-L 207
               HRD+  +N+LV    +  K+ DFG  K                 +      APE L
Sbjct: 137 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 186

Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                +++T  D+WS G +L E+   G+  +P 
Sbjct: 187 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 217

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 33/213 (15%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 96
            + +G G FG V        G  VA+K +  D   +    E  +M  + H N++ L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 251

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTV 154
                +++  L +V EY+       L  Y     R  L    L  ++  +   + Y+   
Sbjct: 252 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE-L 207
               HRD+  +N+LV    +  K+ DFG  K                 +      APE L
Sbjct: 309 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 358

Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                +++T  D+WS G +L E+   G+  +P 
Sbjct: 359 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 53/239 (22%)

Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKN---RELQLM 81
           P + +   ++RV+G G FG+V+  + ++  +     AIK    + + +      RE  LM
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 82  RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-- 139
           R ++HPNV++L           E   ++++ Y+    +  L  +   + +       L  
Sbjct: 77  RGLNHPNVLAL----IGIMLPPEGLPHVLLPYMC---HGDLLQF-IRSPQRNPTVKDLIS 128

Query: 140 YTYQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 196
           +  Q+ RG+ Y+     V    HRD+  +N ++D  +  VK+ DFG A+ ++  E     
Sbjct: 129 FGLQVARGMEYLAEQKFV----HRDLAARNCMLDE-SFTVKVADFGLARDILDRE----- 178

Query: 197 ICSRYYR--------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
               YY               A E L      +TT  D+WS G +L ELL  G P +  
Sbjct: 179 ----YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 47/227 (20%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 90
             V+G G FG V+    L+        A+K +     + +      E  +M+   HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGL 148
           SL        S+      +V+ Y+    +  L+++   N+        L  +  Q+ +G+
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM 141

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+ +     HRD+  +N ++D     VK+ DFG A+ +   E         YY      
Sbjct: 142 KYLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---------YYSVHNKT 190

Query: 204 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                    A E L     ++TT  D+WS G +L EL+  G P +P 
Sbjct: 191 GAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 41/221 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLK 93
              +G G+FG VF  +       VA+K   +      +     E ++++   HPN++ L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-YTYQIFRGLAYIH 152
                  ++ +    +VME V          +         +   L        G+ Y+ 
Sbjct: 178 ---IGVCTQKQPIY-IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--------- 203
           +   + HRD+  +N LV    + +K+ DFG ++    G          Y           
Sbjct: 231 SKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGV---------YAASGGLRQVPV 279

Query: 204 ---APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
              APE L +G   Y++  D+WS G +L E   LG   +P 
Sbjct: 280 KWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPN 318

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 44/234 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
            +V+G+G+FG V++   +  GE     VAIK++ +    K       E  +M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 148
             L            +   L+ + +P   +  L  Y   ++  +   Y+  +  QI +G+
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+     V HRD+  +N+LV      VK+ DFG AK+L   E          Y      
Sbjct: 131 NYLEDRRLV-HRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEK--------EYHAEGGK 180

Query: 204 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 248
                 A E I     YT   D+WS G  + EL+  G   + G  A +   ++E
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 58/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)

Query: 40  RVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHPN 88
           + +G G+FG V +A         T  TVA+K +       + R    EL+++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLI 135
           V++L      T     L   +++E+               E +   +         + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 136 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
           ++  Y++Q+ +G+ ++ +     HRD+  +N+L+    + VK+CDFG A+ + K      
Sbjct: 149 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP---- 202

Query: 196 YICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 242
                 Y             APE IF    YT   D+WS G +L E+  LG   +PG   
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 243 VDQLVEIIK 251
            ++    +K
Sbjct: 257 DEEFCRRLK 265

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 78.8 bits (195), Expect = 8e-17
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 29/214 (13%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
           +  +G G +G V++    +   TVA+K + +D        +E  +M+ + HPN++ L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 74

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 153
                +++  F  ++ E++    Y  L  Y     R  +  V L     QI   + Y+  
Sbjct: 75  -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE- 206
                HRD+  +N LV    H VK+ DFG ++++        Y      +      APE 
Sbjct: 130 K-NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 183

Query: 207 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
           L +   +++   D+W+ G +L E+   G   +PG
Sbjct: 184 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 44/234 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRLMDHPNV 89
            +V+G+G FG V +   +  GE     V IK  +    R+        +  +  +DH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 148
           + L            L   LV +Y+P      L  +   ++  +    +  +  QI +G+
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+    G+ HR++  +N+L+     QV++ DFG A +L   +                 
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDK--------QLLYSEAK 178

Query: 204 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 248
                 A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 179 TPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 61/258 (23%), Positives = 99/258 (38%), Gaps = 63/258 (24%)

Query: 39  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 87
            +V+G+G+FG V  A             VA+K +       +R     EL++M +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVP------------------ETMYRVLKHYSSMN 129
           N+++L       T    ++  L+ EY                    E  Y   K      
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 130 QRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 187
               L +  L  + YQ+ +G+ ++       HRD+  +N+LV      VK+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVVKICDFGLARDI 222

Query: 188 VKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLG 233
           +             Y             APE +F    YT   D+WS G +L E+  L  
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272

Query: 234 QPLFPGENAVDQLVEIIK 251
            P +PG        ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 46/250 (18%), Positives = 81/250 (32%), Gaps = 49/250 (19%)

Query: 15  TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK 74
            G ++    G +         ++  + +G+G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 75  N---RELQLMRLMDHPNVISLK--------------HCFFSTTSKDELFLNLVMEYVPET 117
                EL+  + +   + I                 +    T  K   +  +VME     
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER---- 133

Query: 118 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQV 176
           +   L+  S  N       V     ++   L YIH      H D+K  NLL+      QV
Sbjct: 134 LGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 177 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWSAG 224
            L D+G +        +  Y         +   G  E+ TS+            D+   G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 225 CVLAELLLGQ 234
             +   L G+
Sbjct: 248 YCMLRWLCGK 257

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 56/246 (22%)

Query: 40  RVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRLMDHPNV 89
           R +G GSFG+V++       +      VAIK V     +++R     E  +M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--------SSMNQRMPLIYVKL-- 139
           + L        S+ +  L ++ME +       LK Y        ++     P    K+  
Sbjct: 91  VRLLGV----VSQGQPTL-VIMELMT---RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 140 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 199
              +I  G+AY++    V HRD+  +N +V      VK+ DFG  + + + +        
Sbjct: 143 MAGEIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD-------- 192

Query: 200 RYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 245
            YYR            +PE L  G   +TT  D+WS G VL E+  L +  + G +  +Q
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQ 248

Query: 246 LVEIIK 251
           ++  + 
Sbjct: 249 VLRFVM 254

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 41/219 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
              +G G FG V+          VA+K + Q     +    E  LM+ + H  ++ L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 153
            ++  +++ ++  ++ EY+       L  +      + L   KL     QI  G+A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---------- 203
                HRD++  N+LV   T   K+ DFG A+++   E         Y            
Sbjct: 128 R-NYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNE---------YTAREGAKFPIKW 176

Query: 204 -APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            APE + +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 92
           Y   R +G GSFG++F+   L   + VAIK   +         E +  + L     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
            +       ++ L   LV++ +  ++  +L       ++  +  V +   Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 123

Query: 153 TVPGVCHRDVKPQNLLV----DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YR 203
               + +RD+KP N L+        + + + DFG  K          Y          YR
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173

Query: 204 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 234
             + + G   Y  SI            D+ + G V    L G 
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 41/219 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
           E+ +G G FG V+ A   +    VA+K +            E  +M+ + H  ++ L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 153
             +  +K+ ++  ++ E++       L  +   ++       KL  ++ QI  G+A+I  
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---------- 203
                HRD++  N+LV   +   K+ DFG A+V+   E         Y            
Sbjct: 303 R-NYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNE---------YTAREGAKFPIKW 351

Query: 204 -APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            APE + FG   +T   D+WS G +L E++  G+  +PG
Sbjct: 352 TAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 60/252 (23%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLM-RLMDHP 87
            + +G G+FG V +A     G+      VA+K +       ++     EL++M  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY------------SSMNQRMPLI 135
           N+++L       T    +   ++ EY     Y  L ++            +         
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCC---YGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 136 YVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 193
              L  ++ Q+ +G+A++ +     HRDV  +N+L+    H  K+ DFG A+ ++     
Sbjct: 163 TRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDS-- 218

Query: 194 ISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 239
                   Y             APE IF    YT   D+WS G +L E+  LG  P +PG
Sbjct: 219 -------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPG 269

Query: 240 ENAVDQLVEIIK 251
                +  +++K
Sbjct: 270 ILVNSKFYKLVK 281

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 47/227 (20%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 90
             V+G G FG V+    L+        A+K +     + +      E  +M+   HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGL 148
           SL        S+      +V+ Y+    +  L+++   N+        L  +  Q+ +G+
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM 205

Query: 149 AY---IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-- 203
            +      V    HRD+  +N ++D     VK+ DFG A+ +   E +        +   
Sbjct: 206 KFLASKKFV----HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFD------SVHNKT 254

Query: 204 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                    A E L     ++TT  D+WS G +L EL+  G P +P 
Sbjct: 255 GAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 76.1 bits (188), Expect = 7e-16
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 43/225 (19%)

Query: 37  MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRLMDHPNV 89
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q+M  +D+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 148
           + L          + L   LVME         L  +     + +P+  V    +Q+  G+
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+       HRD+  +N+L+    H  K+ DFG +K L   ++        YY      
Sbjct: 124 KYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDS--------YYTARSAG 173

Query: 204 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                  APE + F   ++++  D+WS G  + E L  GQ  +  
Sbjct: 174 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 49/228 (21%)

Query: 37  MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRLMDHPNV 89
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q+M  +D+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 148
           + L          + L   LVME         L  +     + +P+  V    +Q+  G+
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 149 AYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-- 203
            Y+   + V    HR++  +N+L+    H  K+ DFG +K L   ++        YY   
Sbjct: 450 KYLEEKNFV----HRNLAARNVLLVN-RHYAKISDFGLSKALGADDS--------YYTAR 496

Query: 204 ----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                     APE + F   ++++  D+WS G  + E L  GQ  +  
Sbjct: 497 SAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 44/223 (19%), Positives = 82/223 (36%), Gaps = 43/223 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMR-LMDHPNVISL 92
           +   + +G G+FG +   K L T E VAIK   +       + E +  + L     +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
            +           +  +V+E +  ++  +       ++   L  V +   Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 153 TVPGVCHRDVKPQNLLV----DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YR 203
           +   + +RDVKP+N L+    +     + + DF  AK          YI         YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172

Query: 204 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 234
             + + G   Y  SI            D+ + G +    L G 
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
            R +G G FG V Q   +        VAIK          R     E   MR  DHP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 149
            L        +++ ++  ++ME         L+ +  + +  + L  + LY YQ+   LA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+ +   V HRD+  +N+LV      VKL DFG ++ +             YY+      
Sbjct: 506 YLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 554

Query: 204 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                APE + F    +T++ D+W  G  + E+L  G   F G
Sbjct: 555 PIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 57/258 (22%), Positives = 101/258 (39%), Gaps = 64/258 (24%)

Query: 39  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 88
            + +G G FG V +A            TVA+K +       + R    E  +++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVP-------------------ETMYRVLKHYSSMN 129
           VI L       +    L   L++EY                      +            
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 130 QRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 187
               L    L  + +QI +G+ Y+  +  + HRD+  +N+LV     ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSRDV 200

Query: 188 VKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG- 233
            + +          Y             A E +F    YTT  D+WS G +L E++ LG 
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250

Query: 234 QPLFPGENAVDQLVEIIK 251
            P +PG    ++L  ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 39/231 (16%), Positives = 77/231 (33%), Gaps = 52/231 (22%)

Query: 39  ERVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRRYKN----RELQLMRLMDHP 87
              +G G+F  +F+    E G+        V +K + +  R  +        +M  + H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 88  NVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIF 145
           +++     C       DE  L  V E+V    +  L  Y       + +++      Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENIL--VQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 146 RGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQ-------VKLCDFGSAKVLVKGEANIS 195
             + ++     +    H +V  +N+L+     +       +KL D G +  ++  +    
Sbjct: 124 AAMHFLEENTLI----HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175

Query: 196 YICSRYYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                  +       PE I        + D WS G  L E+   G      
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 57/259 (22%), Positives = 102/259 (39%), Gaps = 59/259 (22%)

Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQL 80
            ++ I     R +G G+FG VF A+C           VA+K +    L  R+   RE +L
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 81  MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMN 129
           +  + H +++             +  + +V EY+                 +L       
Sbjct: 71  LTNLQHEHIVKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 130 QRMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 187
            +  L   ++     QI  G+ Y+ +     HRD+  +N LV      VK+ DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDV 183

Query: 188 VKGEANISYICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 233
              +         YYR             PE +++   ++TT  D+WS G +L E+   G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232

Query: 234 -QPLFPGENAVDQLVEIIK 251
            QP +   +   +++E I 
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 74.5 bits (184), Expect = 2e-15
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 50/226 (22%)

Query: 39  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
            R++G G FG V++            VA+K   +D    N+     E  +M+ +DHP+++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 149
            L         ++  +  ++ME  P   Y  L HY       + ++ + LY+ QI + +A
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 150 YI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--- 203
           Y+   + V    HRD+  +N+LV      VKL DFG ++ +   +         YY+   
Sbjct: 128 YLESINCV----HRDIAVRNILVAS-PECVKLGDFGLSRYIEDED---------YYKASV 173

Query: 204 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                   +PE + F    +TT+ D+W     + E+L  G+  F  
Sbjct: 174 TRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 57/252 (22%)

Query: 39  ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 85
            + +G G+FG V  A+ +            VA+K +      +D      E+++M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPL 134
           H N+I+L        ++D     +++EY                     +  S N    L
Sbjct: 134 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 135 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
               L    YQ+ RG+ Y+ +     HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHID- 245

Query: 193 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                   YY+            APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 240 ENAVDQLVEIIK 251
              V++L +++K
Sbjct: 297 VP-VEELFKLLK 307

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 44/223 (19%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
            R +G G FG V Q   +        VAIK          R     E   MR  DHP+++
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 149
            L        +++ ++  ++ME         L+ +  + +  + L  + LY YQ+   LA
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+ +     HRD+  +N+LV      VKL DFG ++ +             YY+      
Sbjct: 131 YLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 179

Query: 204 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                APE + F    +T++ D+W  G  + E+L  G   F G
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 41/223 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           ++VVG G FG V   +     +   +VAIK +      K R     E  +M   DHPN+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 149
            L        +K +  + +V EY+       L  +    + +  +I +      I  G+ 
Sbjct: 110 RL----EGVVTKSKPVM-IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+  + G  HRD+  +N+L++      K+ DFG  +VL              Y       
Sbjct: 162 YLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVLEDDP-------EAAYTTRGGKI 212

Query: 204 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                +PE + +   ++T++ D+WS G VL E++  G+  +  
Sbjct: 213 PIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 41/223 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 90
           E+++G+G  G V   +    G+    VAIK +      + R     E  +M   DHPN+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 149
            L        ++  L + +V EY+       L  +  + + +  ++ +      +  G+ 
Sbjct: 114 RL----EGVVTRGRLAM-IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 203
           Y+  + G  HRD+  +N+LVD      K+ DFG ++VL   E +        Y       
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSRVL---EDDPDA----AYTTTGGKI 216

Query: 204 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                APE + F    ++++ D+WS G V+ E+L  G+  +  
Sbjct: 217 PIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 59/252 (23%), Positives = 107/252 (42%), Gaps = 57/252 (22%)

Query: 39  ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 85
            + +G G FG V  A+ +       +   TVA+K +      +D      E+++M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-----------TMYRVLKHYSSMNQRMPL 134
           H N+I+L       T    L+  +++EY  +                  +  +      +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 135 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            +  L   TYQ+ RG+ Y+ +     HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNID- 257

Query: 193 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 240 ENAVDQLVEIIK 251
              V++L +++K
Sbjct: 309 IP-VEELFKLLK 319

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 50/237 (21%), Positives = 86/237 (36%), Gaps = 59/237 (24%)

Query: 39  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 88
            R +G G+FG V++ +        +   VA+K +      QD      E  ++   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKL--YT 141
           ++         + +      +++E +       LK +        +Q   L  + L    
Sbjct: 136 IVRCIGV----SLQSLPRF-ILLELMA---GGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 142 YQIFRGLAY---IHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY 196
             I  G  Y    H +    HRD+  +N L+         K+ DFG A+ + +       
Sbjct: 188 RDIACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----- 238

Query: 197 ICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
               YYR             PE  + G   +T+  D WS G +L E+  LG   +P 
Sbjct: 239 ----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 56/252 (22%), Positives = 100/252 (39%), Gaps = 62/252 (24%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRLMDHPNV 89
           +  +G G+FG VF A+C           VA+K +       R+   RE +L+ ++ H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-------------SSMNQRMPLIY 136
           +          ++    L +V EY+    +  L  +                    PL  
Sbjct: 106 VRFFGV----CTEGRPLL-MVFEYMR---HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 137 VKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 194
            +L     Q+  G+ Y+  +    HRD+  +N LV      VK+ DFG ++ +   +   
Sbjct: 158 GQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD--- 212

Query: 195 SYICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 239
                 YYR             PE +++   ++TT  D+WS G VL E+   G QP +  
Sbjct: 213 ------YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQ 263

Query: 240 ENAVDQLVEIIK 251
            +   + ++ I 
Sbjct: 264 LS-NTEAIDCIT 274

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 72.6 bits (179), Expect = 9e-15
 Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 39/218 (17%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
            + +G+G FG+V   K       VA+K + +    ++   +E Q M  + HP ++     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF--- 68

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            +   SK+     +V EY+       L +Y  S  + +    +    Y +  G+A++ + 
Sbjct: 69  -YGVCSKEYPIY-IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 203
               HRD+  +N LVD     VK+ DFG  + ++  +         Y             
Sbjct: 124 -QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVKWS 172

Query: 204 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
           APE   +   +Y++  D+W+ G ++ E+  LG+  +  
Sbjct: 173 APEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 72.6 bits (179), Expect = 9e-15
 Identities = 45/218 (20%), Positives = 86/218 (39%), Gaps = 39/218 (17%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
            + +G+G FG+V     L   + VAIK + +    +     E ++M  + HP ++ L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--- 68

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            +    +      LV E++    +   L+    +     L+        +  G+AY+   
Sbjct: 69  -YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLEEA 123

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 203
             V HRD+  +N LV      +K+ DFG  + ++  +         Y             
Sbjct: 124 -CVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKWA 172

Query: 204 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
           +PE   F    Y++  D+WS G ++ E+   G+  +  
Sbjct: 173 SPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.0 bits (180), Expect = 9e-15
 Identities = 54/239 (22%), Positives = 86/239 (35%), Gaps = 57/239 (23%)

Query: 39  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 88
              +G   FG V++         E  + VAIK +        R     E  L   + HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPLIYV 137
           V+ L        +KD+    ++  Y                  V         +  L   
Sbjct: 74  VVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 138 KL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 195
                  QI  G+ Y+ +   V H+D+  +N+LV      VK+ D G  + +   +    
Sbjct: 129 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAAD---- 182

Query: 196 YICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 239
                YY+            APE +++G  +++   DIWS G VL E+   G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCG 233

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 51/237 (21%), Positives = 87/237 (36%), Gaps = 59/237 (24%)

Query: 39  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 88
            R +G G+FG V++ +        +   VA+K +      QD      E  ++   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKL--YT 141
           ++         + +      ++ME +       LK +        +Q   L  + L    
Sbjct: 95  IVRCIGV----SLQSLPRF-ILMELMA---GGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 142 YQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY 196
             I  G  Y+   H +    HRD+  +N L+         K+ DFG A+ + +       
Sbjct: 147 RDIACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----- 197

Query: 197 ICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
               YYR             PE  + G   +T+  D WS G +L E+  LG   +P 
Sbjct: 198 ----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 41/221 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 92
           Y   R +G+GSFG ++    +  GE VAIK      ++     E ++ + +     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           + C       +  +  +VME +  ++  +       +++  L  V L   Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 153 TVPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 205
           +     HRDVKP N L+      + V + DFG AK          Y  +R      YR  
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172

Query: 206 ELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 234
           + + G   Y  SI            D+ S G VL    LG 
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 55/240 (22%), Positives = 100/240 (41%), Gaps = 56/240 (23%)

Query: 39  ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 85
            + +G G+FG V  A+ +       +   TVA+K +      +D      E+++M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-----------TMYRVLKHYSSMNQRMPL 134
           H N+I+L        ++D     +++EY  +                  +  +      +
Sbjct: 100 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 135 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            +  L   TYQ+ RG+ Y+ +     HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNID- 211

Query: 193 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 40/223 (17%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE----TVAIKKV-----LQDRRYKNRELQLMRLMDHPNV 89
           ++V+G G FG V++     +       VAIK +      + R     E  +M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 148
           I L        SK +  + ++ EY+       L  +    +    ++ +      I  G+
Sbjct: 109 IRL----EGVISKYKPMM-IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 203
            Y+  +    HRD+  +N+LV+      K+ DFG ++VL             Y       
Sbjct: 161 KYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEAT------YTTSGGKI 212

Query: 204 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                APE + +    +T++ D+WS G V+ E++  G+  +  
Sbjct: 213 PIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 68/268 (25%)

Query: 30  PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 79
           P+  I Y+  R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 80  LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYS 126
           LM   D+PN++ L        +  +    L+ EY+             P T+  +     
Sbjct: 103 LMAEFDNPNIVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 127 SMNQRMPLIYVKLYT--------YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 178
           S   R+        +         Q+  G+AY+       HRD+  +N LV      VK+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKI 215

Query: 179 CDFGSAKVLVKGEANISYICSRYYR------------APE-LIFGATEYTTSIDIWSAGC 225
            DFG ++ +   +         YY+             PE + +    YTT  D+W+ G 
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264

Query: 226 VLAELL-LG-QPLFPGENAVDQLVEIIK 251
           VL E+   G QP + G    ++++  ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 46/226 (20%)

Query: 39  ERVVGTGSFGIVFQAKC-LETGET--VAIKKVLQDRRYKN-------RELQLMRLMDHPN 88
              +G GSFG+V + +    +G+T  VA+K +  D   +        RE+  M  +DH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRG 147
           +I L    +       +   +V E  P      L      +Q    L  +  Y  Q+  G
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---- 203
           + Y+ +     HRD+  +NLL+      VK+ DFG  + L + +         +Y     
Sbjct: 134 MGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQND--------DHYVMQEH 183

Query: 204 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
                   APE L      ++ + D W  G  L E+   GQ  + G
Sbjct: 184 RKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 92
           +   R +G+GSFG ++    ++T E VAIK      ++     E ++ R L     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           +         +  +  LVM+ +  ++  +       ++++ L  V +   Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 153 TVPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAP 205
           +     HRD+KP N L+      +QV + DFG AK          Y  +       YR  
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170

Query: 206 ELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 234
           + + G   Y  S+            D+ S G VL   L G 
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 42/252 (16%), Positives = 80/252 (31%), Gaps = 50/252 (19%)

Query: 15  TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG--------ETVAIKK 66
           TG +++   G +         +  +      + GI+++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 67  VLQDRRYKNRELQLMRLMDHPNVISLK-----------HCFFSTTSKDELFLNLVMEYVP 115
             +D R  N +    R      V   K            C      +D+    LV+  + 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141

Query: 116 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-H 174
            ++   L         +    V     ++   L ++H      H +V  +N+ VDP    
Sbjct: 142 RSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQS 198

Query: 175 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWS 222
           QV L  +G A        +++Y             G  E+  S+            D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253

Query: 223 AGCVLAELLLGQ 234
            G  + + L G 
Sbjct: 254 LGYCMLKWLYGF 265

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 39/218 (17%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
            + +GTG FG+V   K       VAIK + +    ++    E ++M  + H  ++ L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--- 84

Query: 96  FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 154
            +   +K      ++ EY+    +   L+      Q   L+        +   + Y+ + 
Sbjct: 85  -YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLESK 139

Query: 155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 203
               HRD+  +N LV+     VK+ DFG ++ ++  E         Y             
Sbjct: 140 -QFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDE---------YTSSVGSKFPVRWS 188

Query: 204 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
            PE L++   ++++  DIW+ G ++ E+  LG+  +  
Sbjct: 189 PPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 46/220 (20%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLK 93
           + ++G G FG V++ + L  G  VA+K++ ++R          E++++ +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 94  HCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSMN--QRMPLIYVKLYTYQIF- 145
                 T  + L   LV  Y+        +    +    ++  +R           +I  
Sbjct: 94  GF--CMTPTERL---LVYPYMANGSVASCLRERPESQPPLDWPKRQ----------RIAL 138

Query: 146 ---RGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 200
              RGLAY+H    P + HRDVK  N+L+D    +  + DFG AK++   +   +++ + 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTA 194

Query: 201 Y-----YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 234
                 + APE L  G +  +   D++  G +L EL+ GQ
Sbjct: 195 VRGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 69.5 bits (171), Expect = 1e-13
 Identities = 69/296 (23%), Positives = 117/296 (39%), Gaps = 70/296 (23%)

Query: 41  VVGTGSFGIVFQAKCLETGETVAIKK--------VLQ-DRRYKNRELQLMRLMDHPNVIS 91
            +G G FG+V++   +    TVA+KK          +  +++   E+++M    H N++ 
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVE 94

Query: 92  LK-HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL-------IYVKLYTYQ 143
           L        +  D+L L  V  Y+P     +L   S ++   PL       I        
Sbjct: 95  LLGFS----SDGDDLCL--VYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQG----- 141

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 200
              G+ ++H      HRD+K  N+L+D      K+ DFG A+   K     + + SR   
Sbjct: 142 AANGINFLHENH-HIHRDIKSANILLDE-AFTAKISDFGLARASEKFAQ--TVMTSRIVG 197

Query: 201 -Y-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ------LVEIIKV 252
              Y APE + G  E T   DI+S G VL E++ G P      AVD+      L++I + 
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP------AVDEHREPQLLLDIKEE 249

Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
           +    +     ++    D     ++                  +AS+ L    + R
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVE--------------AMYSVASQCLHEKKNKR 291

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 56/236 (23%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RLMDHPNVI 90
           + V+G G+FG V +A+  + G     AIK++       D R    EL+++ +L  HPN+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPLIYVKL 139
           +L         +  L+  L +EY P             +        + +    L   +L
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 140 --YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
             +   + RG+ Y+       HRD+  +N+LV    +  K+ DFG ++            
Sbjct: 145 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGLSRG----------- 191

Query: 198 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
               Y             A E L +    YTT+ D+WS G +L E++ LG   + G
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 46/251 (18%), Positives = 77/251 (30%), Gaps = 50/251 (19%)

Query: 16  GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQD 70
           G II+               +     +G G FG ++ A     + + +     +K    D
Sbjct: 26  GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76

Query: 71  RRYKNRELQLMRLMDHPNVISLK--------------HCFFSTTSKDELFLNLVMEYVPE 116
                 EL+  +    P  I                           + +  ++M+    
Sbjct: 77  NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136

Query: 117 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQ 175
            +    K Y +  +R     V   + +I   L YIH      H D+K  NLL++     Q
Sbjct: 137 DLQ---KIYEANAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQ 192

Query: 176 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWSA 223
           V L D+G A        + +Y             G  E+ TSI            D+   
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEIL 247

Query: 224 GCVLAELLLGQ 234
           G  + + L G 
Sbjct: 248 GYCMIQWLTGH 258

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 30/196 (15%)

Query: 73  YKNRELQLMRLMDHPNVI--SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 130
           YK +  +  +  D+   I   LK    S TS      +  +E    +     +       
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE-DLY 186

Query: 131 RMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 188
           +  L    L  Y++Q+ +G+ ++ +   + HRD+  +N+L+    + VK+CDFG A+ + 
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIY 244

Query: 189 KGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 235
           K            Y             APE IF    YT   D+WS G +L E+  LG  
Sbjct: 245 KDP---------DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGAS 294

Query: 236 LFPGENAVDQLVEIIK 251
            +PG    ++    +K
Sbjct: 295 PYPGVKIDEEFCRRLK 310

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.4 bits (96), Expect = 5e-04
 Identities = 50/348 (14%), Positives = 100/348 (28%), Gaps = 99/348 (28%)

Query: 58  TGETVAIKKVLQDRRYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLV-MEYV 114
           +G+T     V    + + +       MD   +  ++LK+C     S + +   L  + Y 
Sbjct: 161 SGKTWVALDVCLSYKVQCK-------MDF-KIFWLNLKNC----NSPETVLEMLQKLLYQ 208

Query: 115 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV----- 169
            +  +     +SS N ++ +  ++    ++ +   Y                LLV     
Sbjct: 209 IDPNWTSRSDHSS-NIKLRIHSIQAELRRLLKSKPY-------------ENCLLVLLNVQ 254

Query: 170 DPLTHQVKLCDFGSAKVLV--KGEANISYICSRYYRAPELIFGATEYTT--SIDIWS--A 223
           +         +    K+L+  + +    ++ +       L   +   T      +     
Sbjct: 255 NAKA--WNAFNLSC-KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311

Query: 224 GCVLAEL----LLGQPL-----------FPG--EN----AVDQLVEIIKV-LGTPTREEI 261
            C   +L    L   P                 +N      D+L  II+  L      E 
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY 371

Query: 262 RCMNPNYTDFR-FP---QIKAHP----WHKVFHKRMPPEAIDLASRLLQYS--------- 304
           R     +     FP    I        W  V    +  + + + ++L +YS         
Sbjct: 372 R---KMFDRLSVFPPSAHIPTILLSLIWFDV----IKSDVMVVVNKLHKYSLVEKQPKES 424

Query: 305 ----PSL----RCTALEACA-H-PFFDELREPNARLPNGRPFPPLFNF 342
               PS+    +       A H    D    P     +    P L  +
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	376
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.7
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.96
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.57
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.49
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.31
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.13
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.08
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.07
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.59
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.57
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.39
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.32
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.29
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.1
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.06
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.04
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.01
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.85
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.77
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.75
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.39
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.53
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.99

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.1e-65  Score=451.37  Aligned_cols=252  Identities=28%  Similarity=0.448  Sum_probs=204.0

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||+||+|++..+|+.||||++.+..       ....+|+++++.++|||||++++++     .+
T Consensus        10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~   84 (275)
T 3hyh_A           10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KS   84 (275)
T ss_dssp             ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EE
Confidence            45678999999999999999999999999999999986432       2345799999999999999999998     45


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+|+|||||+|+|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        85 ~~~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~-~~~vkl~DFGl  158 (275)
T 3hyh_A           85 KDEIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDE-HLNVKIADFGL  158 (275)
T ss_dssp             SSEEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TCCEEECCSSC
T ss_pred             CCEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECC-CCCEEEeecCC
Confidence            556999999999998888765    4679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      |+.........+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+....          
T Consensus       159 a~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~----------  228 (275)
T 3hyh_A          159 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----------  228 (275)
T ss_dssp             C---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred             CeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC----------
Confidence            9887666666678999999999999876656789999999999999999999999888777766665421          


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                             +            .+++.+|+++++||.+||++||++|||++|+++||||+.
T Consensus       229 -------~------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          229 -------Y------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -------C------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                   0            134568999999999999999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.9e-65  Score=456.52  Aligned_cols=258  Identities=30%  Similarity=0.529  Sum_probs=224.0

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++++.++|||||+++++|     ++
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~  103 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QD  103 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ee
Confidence            3457899999999999999999999999999999998643       12356899999999999999999999     55


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      +..+|||||||+| +|.+.+..    .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       104 ~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~-~g~vKl~DFG  177 (311)
T 4aw0_A          104 DEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFG  177 (311)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcC-CCCEEEEEcC
Confidence            6669999999995 88777765    3679999999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccC---CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          183 SAKVLVKG---EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       183 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      +|+.....   ....+.+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+.++.+..      
T Consensus       178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------  250 (311)
T 4aw0_A          178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE------  250 (311)
T ss_dssp             TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------
T ss_pred             CceecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------
Confidence            99876433   2344678999999999998754 8999999999999999999999999998888887776621      


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHH------HhCCCccccccCCCCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNAR  329 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------ll~hp~~~~~~~~~~~  329 (376)
                                 +            .+++.+|+++++||.+||++||++|+|++|      +++||||++++|....
T Consensus       251 -----------~------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          251 -----------Y------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             -----------C------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             -----------C------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence                       1            134568999999999999999999999987      5899999999987543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-63  Score=466.82  Aligned_cols=320  Identities=33%  Similarity=0.603  Sum_probs=254.1

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecC-CCCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTT-SKDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~-~~~~~  105 (376)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.....      ...+|+.+|+.++|||||++++++.... ..+..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            3689999999999999999999999999999999965432      2347999999999999999999875432 13445


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|||||||+|+|...+..    .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus       133 ~~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~-~~~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNE-NCELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCB
T ss_pred             EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCC-CCCEEEeecceee
Confidence            6899999999998877754    5789999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccC-----CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          186 VLVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       186 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      .....     ....+.+||++|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+....|.++...
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            65432     2334678999999999998877789999999999999999999999999999999999999999988765


Q ss_pred             HhhcCcCCcC---ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCC
Q 017139          261 IRCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP  337 (376)
Q Consensus       261 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~  337 (376)
                      +.........   ..++.....+|...+ ..++++++|||.+||++||++|||++|+|+||||++..++.....    ..
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~----~~  361 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPD----CA  361 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCC----CS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccC----CC
Confidence            5432211110   123333334444443 368999999999999999999999999999999998876543321    23


Q ss_pred             CCCCchhhhhcCCHHHHhhhcHHHHH
Q 017139          338 PLFNFKQELAGASPELINRLIPEHVR  363 (376)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (376)
                      +.+++.-+....+.+.+.+++.+++.
T Consensus       362 ~~~~~~~~~~~~~~~~~k~~i~~ei~  387 (398)
T 4b99_A          362 PPFDFAFDREALTRERIKEAIVAEIE  387 (398)
T ss_dssp             SCCCCHHHHSCCCHHHHHHHHHHHHH
T ss_pred             CCCCCccchhhcCHHHHHHHHHHHHH
Confidence            34455544555566667766655543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.7e-63  Score=452.09  Aligned_cols=252  Identities=29%  Similarity=0.429  Sum_probs=216.5

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+++.++|||||+++++|.     ++..+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            5699999999999999999999999999999998533    234568999999999999999999994     4455999


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |||||+| +|.+.+..     ..+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECC-CCCEEEecCcCceecC
Confidence            9999996 67666653     569999999999999999999999 79999999999999996 7889999999998765


Q ss_pred             cC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .. ....+.+||+.|||||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......           
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------  289 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------  289 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------
T ss_pred             CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence            44 345577899999999999665 48999999999999999999999999988888777665521100           


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                     ...+..+|+++++||.+||++||++|||++|+|+||||++..
T Consensus       290 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          290 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             ---------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ---------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                           012245899999999999999999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.9e-63  Score=450.98  Aligned_cols=253  Identities=26%  Similarity=0.393  Sum_probs=211.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++....      ....+|+.+++.++|||||++++++     .++.
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~   96 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENG   96 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECC
Confidence            3578999999999999999999999999999999996542      2345799999999999999999999     4455


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+|||||||+| +|.+.+...  .+..+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla  172 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIA  172 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECT-TCCEEECSTTEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCCEEEcccccc
Confidence            69999999985 888877642  24568999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +...... ...+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.++......        
T Consensus       173 ~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------  243 (350)
T 4b9d_A          173 RVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP--------  243 (350)
T ss_dssp             SCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred             eeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------
Confidence            8764432 23456799999999999765 4899999999999999999999999999888888777652110        


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                          .++..+|+++++||.+||++||++|||++|+|+||||++
T Consensus       244 --------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          244 --------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             --------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                                123467999999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-61  Score=453.87  Aligned_cols=252  Identities=29%  Similarity=0.431  Sum_probs=216.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|.     ++..+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEEE
Confidence            5699999999999999999999999999999998543    234568999999999999999999994     4445999


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |||||+| +|.+++..     ..+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~-~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECT-TCCEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEecCccceECC
Confidence            9999996 67666653     569999999999999999999999 79999999999999996 7889999999998765


Q ss_pred             cC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .. ....+.+||+.|||||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+......            
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~------------  365 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------  365 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC------------
T ss_pred             CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC------------
Confidence            43 345578899999999999765 4899999999999999999999999998888877766552110            


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                    ....+..+|+++++||.+||++||++|||++|+|+||||++..
T Consensus       366 --------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          366 --------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             --------------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                          0012346899999999999999999999999999999998743

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.1e-61  Score=454.89  Aligned_cols=342  Identities=67%  Similarity=1.160  Sum_probs=301.0

Q ss_pred             CCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017139           27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL  105 (376)
Q Consensus        27 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~  105 (376)
                      ........+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++||||+++++++..... .+..
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           47 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             SSCCCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             CCCCcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            334456678999999999999999999999999999999998777777789999999999999999998865432 4566


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      ++++||||+++++...+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++.+++.+||+|||+++
T Consensus       127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            788999999999988888777777889999999999999999999999 7999999999999999756789999999998


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++.++++.+|.+..+.+..+.
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            77666666677899999999999776568999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCCchhh
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE  345 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (376)
                      +.+..+.++.+...+|...++..+++++++||.+||++||.+|||+.|+++||||+.+.++....+.....+..++|...
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~  365 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ  365 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHH
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHH
Confidence            99999999999999999999999999999999999999999999999999999999998887776767777888888866


Q ss_pred             hhcCCHHHHhhhcHHHHHhhcCCC
Q 017139          346 LAGASPELINRLIPEHVRRQTGLS  369 (376)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~  369 (376)
                      .....+.+...+++...+.+...+
T Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~  389 (420)
T 1j1b_A          366 ELSSNPPLATILIPPHARIQAAAS  389 (420)
T ss_dssp             HHTTCGGGHHHHSCTTTTCCCCC-
T ss_pred             HhccChhHHHhhCCHhhhhccccC
Confidence            666677776667766655444333

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-62  Score=442.63  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=212.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ..++|++++.||+|+||+||+|++.   .+++.||||++.+.      .....+|+++++.++|||||++++++     .
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~   96 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----Q   96 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----E
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----E
Confidence            3468999999999999999999984   46789999998643      23355799999999999999999999     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ++..+|+|||||+| +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DF  170 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDF  170 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TSCEEEESS
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcC-CCCEEeccc
Confidence            45569999999995 77777765    3679999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |+|+..... ....+.+||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..+.+..       
T Consensus       171 Gla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-------  242 (304)
T 3ubd_A          171 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-------  242 (304)
T ss_dssp             EEEEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             ccceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-------
Confidence            999865433 3445678999999999997654 8999999999999999999999999998888887776521       


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                +            .++..+|+++++||.+||++||++|||     ++|+++||||++++|.
T Consensus       243 ----------~------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          243 ----------L------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             ----------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ----------C------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence                      0            134568999999999999999999998     5899999999998765

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.7e-61  Score=452.32  Aligned_cols=346  Identities=63%  Similarity=1.124  Sum_probs=308.2

Q ss_pred             cceEeeccCCCCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeeccee
Q 017139           16 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHC   95 (376)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~   95 (376)
                      ..+......+..+. ....+|++.+.||+|+||.||+|++..+++ +|+|++..+.....+|+++++.++||||++++++
T Consensus        23 ~~~~~~~~~~~~~~-~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~  100 (394)
T 4e7w_A           23 KVIKVLASDGKTGE-QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAF  100 (394)
T ss_dssp             CCEEEEEEESSSCC-EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceEEEEecCCCCCC-cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEE
Confidence            33334444555555 456789999999999999999999887766 8999888777777789999999999999999999


Q ss_pred             eeecCC-CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC
Q 017139           96 FFSTTS-KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH  174 (376)
Q Consensus        96 ~~~~~~-~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~  174 (376)
                      +..... .+..++++|||||++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++..++
T Consensus       101 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~  179 (394)
T 4e7w_A          101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSG  179 (394)
T ss_dssp             EEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTT
T ss_pred             EEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCC
Confidence            876544 5566789999999999888888777777889999999999999999999999 79999999999999985488


Q ss_pred             cEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          175 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       175 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      .+||+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+++.+|
T Consensus       180 ~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  259 (394)
T 4e7w_A          180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG  259 (394)
T ss_dssp             EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999999998876666667788999999999997766689999999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR  334 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~  334 (376)
                      .+..+.+..+.+.+....++.....++...++..+++++.+||.+||++||++|||+.|+++||||+++++.....+...
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~  339 (394)
T 4e7w_A          260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGR  339 (394)
T ss_dssp             CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSS
T ss_pred             CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCC
Confidence            99999999999988888999999999999999999999999999999999999999999999999999998887777778


Q ss_pred             CCCCCCCchhhhhcCCHHHHhhhcHHHHHh
Q 017139          335 PFPPLFNFKQELAGASPELINRLIPEHVRR  364 (376)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (376)
                      ..+++++|..+.....++++.+++|.....
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (394)
T 4e7w_A          340 ELPPLFNWTKEELSVRPDLISRLVPQHAEA  369 (394)
T ss_dssp             CCCCSCCCCHHHHHTCGGGHHHHSCGGGCS
T ss_pred             CCCCcCCCCHHHhhcCHHHHHhhccHhhhh
Confidence            889999999888888899999999888743

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-61  Score=432.12  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=209.8

Q ss_pred             ce-EeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           35 SY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        35 ~y-~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      +| ++.++||+|+||+||+|.+..+++.||+|++....      ....+|+++++.++|||||+++++|.+.. .++..+
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~  104 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEE
Confidence            45 78889999999999999999999999999986432      23457999999999999999999885432 345678


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--ceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~--ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      |||||||+| +|.+.+..    ...+++..++.|+.||+.||+|||+ +|  |+||||||+|||++..++.+||+|||+|
T Consensus       105 ~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            999999995 77777764    3679999999999999999999999 68  9999999999999854778999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +... .....+.+||+.|||||++.+  .|+.++|||||||++|+|+||++||.+.+....+...+.....+        
T Consensus       180 ~~~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--------  248 (290)
T 3fpq_A          180 TLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------  248 (290)
T ss_dssp             GGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--------
T ss_pred             EeCC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC--------
Confidence            8643 334456789999999999864  48999999999999999999999998766655544433311110        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                        ..++...++++++||.+||++||++|||++|+|+||||++
T Consensus       249 ------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                              1133457899999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.5e-61  Score=439.49  Aligned_cols=257  Identities=26%  Similarity=0.367  Sum_probs=214.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      ..+.|++.++||+|+||+||+|+++.+|+.||||++..+... .+|+.+++.++|||||++++++     .++..+||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ivm  129 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEELVACAGLSSPRIVPLYGAV-----REGPWVNIFM  129 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-THHHHTTTTCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-HHHHHHHHhCCCCCCCcEEEEE-----EECCEEEEEE
Confidence            346799999999999999999999999999999999765443 4799999999999999999998     4455699999


Q ss_pred             ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      |||+| +|.+.+..    .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|+.....
T Consensus       130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            99995 88887765    3579999999999999999999999 799999999999999974447999999999876543


Q ss_pred             CC------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          191 EA------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       191 ~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ..      ....+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+...  .++       
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~-------  274 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP-------  274 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG-------
T ss_pred             CcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC-------
Confidence            22      1235799999999999775 4999999999999999999999999887766666555541  100       


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH-------------hCCCccccccCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-------------CAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el-------------l~hp~~~~~~~~  326 (376)
                                       ...++..+|+++.+||.+||++||++|||+.|+             |+|||+.+...+
T Consensus       275 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          275 -----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             -----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             -----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence                             111445789999999999999999999999997             689999876554

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-60  Score=446.46  Aligned_cols=332  Identities=49%  Similarity=0.945  Sum_probs=285.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCC----------
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS----------  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~----------  101 (376)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++..+.....+|+.+++.++||||+++++++.....          
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            4568999999999999999999999999999999998887777789999999999999999999866443          


Q ss_pred             -----------------------CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCce
Q 017139          102 -----------------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC  158 (376)
Q Consensus       102 -----------------------~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~iv  158 (376)
                                             .+..++++|||||+++|.+.+..+...+..+++..++.++.||+.||.|||+ +||+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~  163 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGIC  163 (383)
T ss_dssp             -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCc
Confidence                                   3456789999999999999998877778899999999999999999999999 7999


Q ss_pred             eccCCCCCeeecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 017139          159 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP  238 (376)
Q Consensus       159 H~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~  238 (376)
                      ||||||+|||++..++.+||+|||+++............||+.|+|||++.+...++.++||||+||++|+|++|..||.
T Consensus       164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  243 (383)
T 3eb0_A          164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS  243 (383)
T ss_dssp             CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence            99999999999855789999999999887666666778889999999999876668999999999999999999999999


Q ss_pred             CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCC
Q 017139          239 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP  318 (376)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  318 (376)
                      +.+..+.+..+++..|.+..+.+..+.+.+....++......|...++..+++++.+||.+||++||.+|||+.|+|+||
T Consensus       244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (383)
T 3eb0_A          244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP  323 (383)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC-------CCCCCCCC--CCCCCCCCchhhhh-cCCHHHHhhhcHHHHHh
Q 017139          319 FFDELRE-------PNARLPNG--RPFPPLFNFKQELA-GASPELINRLIPEHVRR  364 (376)
Q Consensus       319 ~~~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  364 (376)
                      ||+.+..       .....+..  ..++++++|..... ...++...+++|+....
T Consensus       324 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  379 (383)
T 3eb0_A          324 FFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSP  379 (383)
T ss_dssp             GGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC----
T ss_pred             HHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhcc
Confidence            9988755       22233333  56788899885444 45889999999887654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.6e-60  Score=438.69  Aligned_cols=282  Identities=29%  Similarity=0.476  Sum_probs=218.3

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEeccccc--chHHHHHHHHhC-CCCCeeecceeeeecCCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRR--YKNRELQLMRLM-DHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~--~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~  103 (376)
                      |...++|++.+.||+|+||+||+|+++   .+++.||+|++.....  ...+|+++++.+ +||||++++++|     .+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-----RK   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-----EE
Confidence            566788999999999999999999875   4578999999865543  345799999988 699999999998     44


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ..++|+|||||+| +|.+.+.       .+++..++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            5569999999985 6666552       48999999999999999999999 7999999999999998755899999999


Q ss_pred             CccccccCC-----------------------------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhC
Q 017139          183 SAKVLVKGE-----------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG  233 (376)
Q Consensus       183 ~~~~~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg  233 (376)
                      +|+......                             ...+.+||++|+|||++.+...|+.++||||+||++|+|++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            997543321                             123457999999999998776789999999999999999999


Q ss_pred             CCCCC-CCChHHHHHHHHHhcCCCCHHHHhhcCcCC---------------------cCccCCC----CCCCCccccccc
Q 017139          234 QPLFP-GENAVDQLVEIIKVLGTPTREEIRCMNPNY---------------------TDFRFPQ----IKAHPWHKVFHK  287 (376)
Q Consensus       234 ~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~----~~~~~~~~~~~~  287 (376)
                      +.||. +.+..+++..+.+..|.+............                     .....|.    ..........+.
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            99985 567788899998888865443322110000                     0000000    000111112345


Q ss_pred             CCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          288 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       288 ~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                      .+|++++|||++||++||++|+|++|+|+||||++++
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            6899999999999999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-58  Score=417.54  Aligned_cols=261  Identities=22%  Similarity=0.391  Sum_probs=193.5

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC------
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS------  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~------  101 (376)
                      ..+|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+++++.++|||||++++++.....      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            457999999999999999999999999999999986432     234579999999999999999999865432      


Q ss_pred             -CCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          102 -KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       102 -~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                       ....++|+|||||+| +|.+.+.... .....++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~-~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECC-CCcEEEc
Confidence             234568999999985 7777765421 12234566788999999999999999 79999999999999996 7889999


Q ss_pred             ecCCccccccCCC-------------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017139          180 DFGSAKVLVKGEA-------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL  246 (376)
Q Consensus       180 Dfg~~~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~  246 (376)
                      |||+|+.......             ..+.+||+.|||||++.+. .|+.++|||||||++|+|++   ||.+..  +..
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~  234 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERV  234 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHH
Confidence            9999987644321             2345799999999999765 49999999999999999996   776432  222


Q ss_pred             HHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ..+........+.                         .....++.+.+||.+||++||++|||+.|+|+||||++++++
T Consensus       235 ~~~~~~~~~~~p~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          235 RTLTDVRNLKFPP-------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHHHTTCCCH-------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHHHhcCCCCC-------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            2222211111111                         112246788999999999999999999999999999998775


Q ss_pred             C
Q 017139          327 N  327 (376)
Q Consensus       327 ~  327 (376)
                      .
T Consensus       290 ~  290 (299)
T 4g31_A          290 G  290 (299)
T ss_dssp             -
T ss_pred             C
Confidence            4

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.8e-58  Score=445.84  Aligned_cols=258  Identities=25%  Similarity=0.369  Sum_probs=214.2

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHH---HHHHHhCCCCCeeecceeeee
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRE---LQLMRLMDHPNVISLKHCFFS   98 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e---~~~l~~l~h~~Iv~~~~~~~~   98 (376)
                      .+...++|++.++||+|+||+||+|+++.+|+.||||++.+..       ....+|   +.+++.++|||||+++++|  
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--  261 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--  261 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE--
Confidence            4566789999999999999999999999999999999986432       112233   4566677899999999999  


Q ss_pred             cCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139           99 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                         ++...+|||||||+| +|...+..    .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus       262 ---~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~-~G~vK  332 (689)
T 3v5w_A          262 ---HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVR  332 (689)
T ss_dssp             ---ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TSCEE
T ss_pred             ---EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeC-CCCEE
Confidence               556669999999995 77777764    3679999999999999999999999 79999999999999996 78899


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG  254 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~  254 (376)
                      |+|||+|+..... ...+.+||+.|||||++.+...|+.++|||||||++|+|++|.+||.+.+.   ......+...  
T Consensus       333 L~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--  409 (689)
T 3v5w_A          333 ISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--  409 (689)
T ss_dssp             ECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--
T ss_pred             ecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--
Confidence            9999999876543 345678999999999997555699999999999999999999999976432   2222222221  


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCCC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN  327 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~~  327 (376)
                                                 ...++..+|+++++||.+||++||.+|++     ++|+++||||++++|..
T Consensus       410 ---------------------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~  460 (689)
T 3v5w_A          410 ---------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  460 (689)
T ss_dssp             ---------------------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred             ---------------------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence                                       01144578999999999999999999998     79999999999998753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-56  Score=439.92  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=225.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||+|+||.||+|+++.+|+.||+|++....    ....+|+.+|+.++|||||+++++|     .+...+
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~  229 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM  229 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEE
Confidence            3578999999999999999999999999999999986543    2345799999999999999999999     556679


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC-CCcEEEEecCCcc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAK  185 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~-~~~~kl~Dfg~~~  185 (376)
                      |||||||+| +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+
T Consensus       230 ~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~  305 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA  305 (573)
T ss_dssp             EEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred             EEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeecccee
Confidence            999999985 77666643   34679999999999999999999999 799999999999999852 3789999999999


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ...........+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+........        
T Consensus       306 ~~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~--------  376 (573)
T 3uto_A          306 HLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD--------  376 (573)
T ss_dssp             ECCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--------
T ss_pred             EccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC--------
Confidence            88776666778899999999999775 489999999999999999999999999998888887765322211        


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                                       ...+..+|+++++||.+||++||.+|||++|+|+||||+..+++.
T Consensus       377 -----------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          377 -----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             -----------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                             112346899999999999999999999999999999999876653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.5e-56  Score=401.60  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=208.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      .++|.+.+.||+|+||+||+|++.     .+++.||||++....    ..+.+|+++++.++|||||++++++     .+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VE   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ee
Confidence            368999999999999999999875     357889999996542    2345799999999999999999998     44


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYS---------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT  173 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~---------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~  173 (376)
                      ...+|||||||+ |+|.+.+....         .....+++..+..|+.||+.||+|||+ ++|+||||||+|||++. +
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~-~  164 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-N  164 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-G
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECC-C
Confidence            445899999998 58888886532         234579999999999999999999999 79999999999999996 7


Q ss_pred             CcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017139          174 HQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI  249 (376)
Q Consensus       174 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~  249 (376)
                      +.+||+|||+|+.......   .....||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8899999999986543322   22356899999999997654 9999999999999999998 89999998887777666


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                      .+...                            ...+..+|+++.+|+.+||+.||++|||++++  |+|++++.
T Consensus       244 ~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          244 TQGRV----------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             HcCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            54210                            01345689999999999999999999999999  57887653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.4e-55  Score=418.37  Aligned_cols=286  Identities=31%  Similarity=0.565  Sum_probs=229.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~  104 (376)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..... ++.
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            4578999999999999999999999999999999996532      233479999999999999999999854332 234


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+|||||++++...+.      ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       140 ~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~-~~~~kl~DFG~a  211 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA  211 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCCC
T ss_pred             CeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeC-CCCEEEEEEEee
Confidence            5689999999998777664      348999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +............||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+++..+++.+|.+..+.+...
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            877666566678899999999999775 4899999999999999999999999999999999999999999998877654


Q ss_pred             CcCCcCc--cCCCCCCCCcccccccC-----------CChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          265 NPNYTDF--RFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ......+  ..+......+...++..           .++++++||.+||++||++|||++|+|+||||+.+..+
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence            3222111  11111222222222222           15679999999999999999999999999999977654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9e-55  Score=397.62  Aligned_cols=250  Identities=23%  Similarity=0.332  Sum_probs=200.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...+|.+.++||+|+||+||+|++.     .+++.||||++....    ..+.+|+++++.++|||||++++++     .
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~  113 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----T  113 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            3468999999999999999999875     368899999996543    2345799999999999999999998     4


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSS-----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD  170 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~  170 (376)
                      +...+|||||||+ |+|.+++.....           ...++++..+..|+.||+.||.|||+ ++|+||||||+|||++
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEEC
Confidence            4445899999999 588888765321           23569999999999999999999999 7999999999999999


Q ss_pred             CCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017139          171 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL  246 (376)
Q Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  246 (376)
                      . ++.+||+|||+++.......   .....||+.|||||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+
T Consensus       193 ~-~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  270 (329)
T 4aoj_A          193 Q-GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI  270 (329)
T ss_dssp             T-TTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred             C-CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            6 88999999999986543322   2345789999999999765 49999999999999999999 89999998887777


Q ss_pred             HHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ..+.+...                            ...+..+++++.+|+.+||+.||++|||++|++++
T Consensus       271 ~~i~~g~~----------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          271 DCITQGRE----------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHcCCC----------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            66654210                            01345689999999999999999999999999753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-54  Score=413.67  Aligned_cols=323  Identities=31%  Similarity=0.527  Sum_probs=239.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++.....+...
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            3478999999999999999999999999999999986532      2344799999999999999999998665545556


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+||||++++|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus       131 ~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~-~~~~kl~DFGla~  204 (458)
T 3rp9_A          131 ELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQ-DCSVKVCDFGLAR  204 (458)
T ss_dssp             CEEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCB
T ss_pred             eEEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECC-CCCEeecccccch
Confidence            7899999999998877764    4679999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCC----------------------------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-----
Q 017139          186 VLVKGE----------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-----  232 (376)
Q Consensus       186 ~~~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-----  232 (376)
                      ......                            .....+||++|+|||++.....++.++|||||||++|+|++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            754221                            12345789999999987666669999999999999999998     


Q ss_pred             ------CCCCCCCCC--------------------hHHHHHHHHHhcCCCCHHHHhhcCcCCcC---ccCCCCCCCCccc
Q 017139          233 ------GQPLFPGEN--------------------AVDQLVEIIKVLGTPTREEIRCMNPNYTD---FRFPQIKAHPWHK  283 (376)
Q Consensus       233 ------g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  283 (376)
                            |.++|.+.+                    ..+++..+.+.+|.+..+.+.........   ..++......+..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  778887654                    36788889999999998877654321100   0122222233333


Q ss_pred             ccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCCchhhhhcCCHHHHhhhcHHHHH
Q 017139          284 VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR  363 (376)
Q Consensus       284 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (376)
                      .+ ..+++++.+||.+||++||++|||++|+|+||||+++.+.........++.  +.|. +....+.+.+...+.+++.
T Consensus       365 ~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~e~~  440 (458)
T 3rp9_A          365 RF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVR--LPFN-DWMNMDEPQLRYAFVKEIQ  440 (458)
T ss_dssp             GS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCC--CSSC-TTSCCCHHHHHHHHHHHHT
T ss_pred             HC-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCC--CCcc-ccccCCHHHHHHHHHHHHH
Confidence            33 357999999999999999999999999999999999887654322222222  2232 2244567777777777765


Q ss_pred             h
Q 017139          364 R  364 (376)
Q Consensus       364 ~  364 (376)
                      .
T Consensus       441 ~  441 (458)
T 3rp9_A          441 R  441 (458)
T ss_dssp             T
T ss_pred             H
Confidence            4

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-53  Score=406.25  Aligned_cols=341  Identities=28%  Similarity=0.483  Sum_probs=255.6

Q ss_pred             hcCCCCcccceEeeccCCCCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHH
Q 017139            8 IQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLM   81 (376)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l   81 (376)
                      .+|.+...+|..+..        ...++|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.++
T Consensus         8 ~~~~~~~~~Q~~~~~--------~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l   79 (432)
T 3n9x_A            8 SSGRENLYFQGIKNV--------HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITIL   79 (432)
T ss_dssp             ---CCCCCTTCGGGC--------CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHH
T ss_pred             cccchhhhhcCCCcc--------eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHH
Confidence            456666666654322        23457999999999999999999999999999999996532      2345799999


Q ss_pred             HhCCCCCeeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceecc
Q 017139           82 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD  161 (376)
Q Consensus        82 ~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~d  161 (376)
                      +.++||||+++++++..........+|+||||++++|...+..    ...+++..++.++.||+.||+|||+ +||+|||
T Consensus        80 ~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrD  154 (432)
T 3n9x_A           80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRD  154 (432)
T ss_dssp             HHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred             HHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCC
Confidence            9999999999999985543333356899999999998887764    4679999999999999999999999 7999999


Q ss_pred             CCCCCeeecCCCCcEEEEecCCccccccCC-----------------------CcceeeccccccChhhhhCCCCCCccc
Q 017139          162 VKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-----------------------ANISYICSRYYRAPELIFGATEYTTSI  218 (376)
Q Consensus       162 lkp~Nill~~~~~~~kl~Dfg~~~~~~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  218 (376)
                      |||+|||++. ++.+||+|||+++......                       .....+||++|+|||++.....++.++
T Consensus       155 lkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~  233 (432)
T 3n9x_A          155 LKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI  233 (432)
T ss_dssp             CCGGGEEECT-TCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHH
T ss_pred             CCHHHeEECC-CCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCccc
Confidence            9999999996 7889999999998764332                       125678899999999986666799999


Q ss_pred             hhHHHHHHHHHHHh-----------CCCCCCCCC-----------------hHHHHHHHHHhcCCCCHHHHhhcCcCCcC
Q 017139          219 DIWSAGCVLAELLL-----------GQPLFPGEN-----------------AVDQLVEIIKVLGTPTREEIRCMNPNYTD  270 (376)
Q Consensus       219 DiwslG~il~~llt-----------g~~pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      |||||||++|+|++           |.++|.+.+                 ..+++..+...+|.|+.+.+.........
T Consensus       234 DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~  313 (432)
T 3n9x_A          234 DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVI  313 (432)
T ss_dssp             HHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred             ccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHH
Confidence            99999999999998           555565544                 46788899999999998877654321100


Q ss_pred             -c--cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCCchhhhh
Q 017139          271 -F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELA  347 (376)
Q Consensus       271 -~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (376)
                       +  ..+.....++...+ ..+++++.+||.+||++||++|||++|+|+||||+.+.++.........+  ...|+ +..
T Consensus       314 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~--~~~~~-~~~  389 (432)
T 3n9x_A          314 KYIKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKI--ILPFD-DWM  389 (432)
T ss_dssp             HHHHTSCCCCCCCHHHHS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCC--CCSSC-TTC
T ss_pred             HHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCC--CCChh-hcc
Confidence             0  12222222233322 35899999999999999999999999999999999998765432222222  22333 223


Q ss_pred             cCCHHHHhhhcHHHHHhhc
Q 017139          348 GASPELINRLIPEHVRRQT  366 (376)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~  366 (376)
                      ..+.+.+..++.+++..-.
T Consensus       390 ~~~~~~~~~~~~~e~~~~~  408 (432)
T 3n9x_A          390 VLSETQLRYIFLKEVQSFH  408 (432)
T ss_dssp             CCCHHHHHHHHHHHHHHHC
T ss_pred             cCCHHHHHHHHHHHHHHhC
Confidence            4677888888877776543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.8e-54  Score=398.42  Aligned_cols=306  Identities=46%  Similarity=0.870  Sum_probs=250.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHhCCCCCeeecceeeeecCC--CCce
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRLMDHPNVISLKHCFFSTTS--KDEL  105 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~e~~~l~~l~h~~Iv~~~~~~~~~~~--~~~~  105 (376)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++..+...   ..+++..++.++||||+++++++.....  ....
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence            4557899999999999999999999999999999998665433   3356666778899999999999865432  4456


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH--cCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ++++|||||++++...+..+......+++..++.++.|++.||.|||  + +||+||||||+|||++..++.+||+|||+
T Consensus       100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~  178 (360)
T 3e3p_A          100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGS  178 (360)
T ss_dssp             EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence            68899999999988888777667788999999999999999999999  8 79999999999999986578999999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +.............||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+.+..+.+..+.+..
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            98776666666678899999999997766689999999999999999999999999999999999999999999998888


Q ss_pred             cCcCCcCccCCCCCCCCccccccc---CCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP  337 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~  337 (376)
                      ..+......+......+|...++.   ..++++.+||.+||++||.+|||+.|+|+||||+++..+....+....++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~  335 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLP  335 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCC
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCC
Confidence            777666665555555666655544   36789999999999999999999999999999999988766655544444

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-54  Score=390.27  Aligned_cols=248  Identities=23%  Similarity=0.319  Sum_probs=196.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .+++++.+.||+|+||+||+|+..   ..||||++....      ..+.+|+.+++.++|||||++++++.     ++ .
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~-~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-----KD-N  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS-S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----CC-e
Confidence            467889999999999999999853   369999985432      23457999999999999999999762     22 2


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|||||||+ |+|.+.+..   ....+++..+..|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~-~~~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHE-GLTVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEET-TEEEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECC-CCcEEEeeccCce
Confidence            789999999 577777754   24679999999999999999999999 79999999999999996 8899999999998


Q ss_pred             ccccCC---CcceeeccccccChhhhhCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          186 VLVKGE---ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       186 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ......   .....+||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+..++.....+    
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~----  256 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS----  256 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC----
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----
Confidence            654322   23456899999999999643  248999999999999999999999999877766665555421111    


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                   |.      ....+..+++++.+|+.+||+.||++|||+.+++++
T Consensus       257 -------------p~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          257 -------------PD------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             -------------CC------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             -------------CC------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         10      011345689999999999999999999999987543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-54  Score=403.82  Aligned_cols=288  Identities=31%  Similarity=0.636  Sum_probs=224.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.+. ||||+++++++..   .+
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DN   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CC
Confidence            34578999999999999999999999999999999985432      22347899999997 9999999999854   23


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+|+|||||+++|...+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        83 ~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~  155 (388)
T 3oz6_A           83 DRDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNA-ECHVKVADFGL  155 (388)
T ss_dssp             SSCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTT
T ss_pred             CCEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcC-CCCEEecCCcc
Confidence            345889999999998887764     469999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccC----------------------CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 017139          184 AKVLVKG----------------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN  241 (376)
Q Consensus       184 ~~~~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  241 (376)
                      ++.....                      ......+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9765321                      112346789999999999876668999999999999999999999999999


Q ss_pred             hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccC------CCCCCCCccccc------------ccCCChhHHHHHHhhcCC
Q 017139          242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF------PQIKAHPWHKVF------------HKRMPPEAIDLASRLLQY  303 (376)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~  303 (376)
                      ..+++..++...+.|..+.+......+.....      .......+...+            +..+++++.+||.+||++
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            99999999999999998877654332211000      000001111111            126789999999999999


Q ss_pred             CCCCCCCHHHHhCCCccccccCCCC
Q 017139          304 SPSLRCTALEACAHPFFDELREPNA  328 (376)
Q Consensus       304 dP~~R~t~~ell~hp~~~~~~~~~~  328 (376)
                      ||++|||++|+|+||||+.+..+..
T Consensus       316 dP~~R~t~~e~l~Hp~~~~~~~~~~  340 (388)
T 3oz6_A          316 NPNKRISANDALKHPFVSIFHNPNE  340 (388)
T ss_dssp             SGGGSCCHHHHTTSTTTTTTCCGGG
T ss_pred             CcccCCCHHHHhCCHHHHHhcCCcc
Confidence            9999999999999999998766543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-54  Score=392.69  Aligned_cols=250  Identities=22%  Similarity=0.270  Sum_probs=205.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ...++++.+.||+|+||+||+|+..     .+++.||||++....     ..+.+|+.++++++|||||++++++     
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-----   98 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV-----   98 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE-----
Confidence            3467899999999999999999863     467899999986432     2355799999999999999999998     


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCee
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL  168 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nil  168 (376)
                      .++..+|||||||+ |+|.+++....            .....+++..+..|+.||+.||+|||+ ++|+||||||+|||
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NIL  177 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVL  177 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceE
Confidence            34444889999999 58888886532            113568999999999999999999999 79999999999999


Q ss_pred             ecCCCCcEEEEecCCccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 017139          169 VDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD  244 (376)
Q Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  244 (376)
                      ++. ++.+||+|||+++......   ......||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..+
T Consensus       178 l~~-~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~  255 (308)
T 4gt4_A          178 VYD-KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  255 (308)
T ss_dssp             ECG-GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred             ECC-CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            996 7889999999998654322   233567899999999997654 9999999999999999998 899999988877


Q ss_pred             HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .+..+......                            ..+..+|+++.+|+.+||+.||++|||+.|++++
T Consensus       256 ~~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          256 VVEMIRNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            76655432110                            1345679999999999999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-53  Score=385.42  Aligned_cols=281  Identities=34%  Similarity=0.569  Sum_probs=228.8

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||+|+||+||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++.     +...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence            57999999999999999999999999999999986442      23347999999999999999999984     44558


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|||||++++...+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccceec
Confidence            99999999988777654   34679999999999999999999999 79999999999999996 788999999999876


Q ss_pred             ccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .... ......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+....
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            4332 334567899999999997766689999999999999999987666 67778888899999988888776654433


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                      ........+..............+++++++||.+||++||++|||++|+|+||||+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            22111111211111222223446899999999999999999999999999999998753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9e-53  Score=386.55  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=221.0

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .....++|++.+.||+|+||.||+|.+..+|+.||||++.....      ...+|+.+++.++||||+++++++     .
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~   84 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----E   84 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----E
Confidence            34567889999999999999999999999999999999865422      234799999999999999999998     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ....+|+|||||+| +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DF  158 (328)
T 3fe3_A           85 TEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIADF  158 (328)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECST
T ss_pred             ECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcC-CCCEEEeec
Confidence            45568999999974 77777654    3569999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....        
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------  230 (328)
T 3fe3_A          159 GFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--------  230 (328)
T ss_dssp             TCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             cCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Confidence            999877666666677899999999999876645689999999999999999999999988777776665421        


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                               +.            ++..+++++.+||.+||++||.+|||++++++||||+.....
T Consensus       231 ---------~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          231 ---------YR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             ---------CC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             ---------CC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence                     11            233579999999999999999999999999999999876554

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.2e-53  Score=387.21  Aligned_cols=283  Identities=35%  Similarity=0.654  Sum_probs=230.3

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++.+.||+|+||+||+|++. +|+.||+|++....      ....+|+.+++.++||||+++++++     .+.
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~   91 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSE   91 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCS
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccC
Confidence            34578999999999999999999985 58999999986432      2345799999999999999999998     455


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+++|||||+++|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus        92 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a  166 (311)
T 3niz_A           92 RCLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLA  166 (311)
T ss_dssp             SCEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECC-CCCEEEccCcCc
Confidence            56899999999998877765   34569999999999999999999999 79999999999999996 778999999999


Q ss_pred             cccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+..
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred             eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence            876433 2334557899999999997766689999999999999999999999999988889999999888887665543


Q ss_pred             cCcC--CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          264 MNPN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       264 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ....  +....+......++.. +...+++++.+||.+||++||++|||++|+|+||||++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhccchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            3211  1111222222333333 33468899999999999999999999999999999998754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.7e-54  Score=394.20  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=204.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC-----CcEEEEEEecccc-----cchHHHHHHHHhCCC-CCeeecceeeeecCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLMDH-PNVISLKHCFFSTTS  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h-~~Iv~~~~~~~~~~~  101 (376)
                      .++|++.+.||+|+||+||+|.+..+     ++.||||.+....     ....+|+.+++.++| ||||++++++..   
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~---  139 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---  139 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe---
Confidence            36899999999999999999998654     3679999986543     234579999999976 899999998742   


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCee
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL  168 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nil  168 (376)
                       ++..+|||||||+ |+|.++++....            ....+++..+..|+.||+.||+|||+ ++|+||||||+|||
T Consensus       140 -~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NIL  217 (353)
T 4ase_A          140 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  217 (353)
T ss_dssp             -TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             -cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcccee
Confidence             2334789999999 588888875432            13558999999999999999999999 79999999999999


Q ss_pred             ecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 017139          169 VDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD  244 (376)
Q Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  244 (376)
                      ++. ++.+||+|||+|+.......   .....||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..+
T Consensus       218 l~~-~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCC-CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            996 78899999999987644332   23457899999999998754 9999999999999999998 999999876555


Q ss_pred             HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .+...+.....+                           ..+..+++++.+++.+||+.||++|||+.++++|
T Consensus       296 ~~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            554444321111                           1344679999999999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-52  Score=390.67  Aligned_cols=323  Identities=33%  Similarity=0.604  Sum_probs=255.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++|++++.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++..........+
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999999999999999986432     233479999999999999999999865544445568


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+||||++++|.+.+..     ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus       106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred             EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECC-CCCEEEEeCcceEec
Confidence            99999999998888764     569999999999999999999999 79999999999999996 778999999999866


Q ss_pred             ccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          188 VKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       188 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      .....    .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+..
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            43322    23457899999999987666689999999999999999999999999999999999999999999887754


Q ss_pred             cCcCCc---CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCC
Q 017139          264 MNPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF  340 (376)
Q Consensus       264 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~  340 (376)
                      ......   ....+.....+|.. +...+++++.+||.+||++||++|||++++|+||||++...+....    .....+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~  333 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF  333 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred             hhhhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcC
Confidence            321100   01122222233333 2346799999999999999999999999999999999875543221    122345


Q ss_pred             CchhhhhcCCHHHHhhhcHHHHHhhcC
Q 017139          341 NFKQELAGASPELINRLIPEHVRRQTG  367 (376)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (376)
                      .++.+......+.+.+++.++..+-.+
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~e~~~~~~  360 (364)
T 3qyz_A          334 KFDMELDDLPKEKLKELIFEETARFQP  360 (364)
T ss_dssp             CCC-----CCHHHHHHHHHHHTGGGCC
T ss_pred             CcccccccCCHHHHHHHHHHHHHHhhh
Confidence            555566677788888888877766544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-52  Score=389.75  Aligned_cols=318  Identities=32%  Similarity=0.557  Sum_probs=241.8

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~  104 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..... .+.
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            3468999999999999999999999999999999985432      223479999999999999999999854321 122


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+||||++++|...+..     ..+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus       103 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a  175 (367)
T 1cm8_A          103 TDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA  175 (367)
T ss_dssp             CCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred             ceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcC-CCCEEEEeeecc
Confidence            45689999998888877764     569999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +....  ......+|++|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+++..+.+..|.++.+.+...
T Consensus       176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          176 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            87543  2345678999999999987566999999999999999999999999999999999999999999998877654


Q ss_pred             CcCCcC---ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCC
Q 017139          265 NPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN  341 (376)
Q Consensus       265 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~  341 (376)
                      ......   ...+......+... ...+++++.+||.+||+.||++|||++++|+||||+.+.++..... ..    .++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~-~~----~~~  327 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ-VQ----KYD  327 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C-CC----CCC
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHH-CCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCC-CC----CCC
Confidence            321100   01233333334333 3468999999999999999999999999999999998876543211 11    223


Q ss_pred             chhhhhcCCHHHHhhhcHHHHHh
Q 017139          342 FKQELAGASPELINRLIPEHVRR  364 (376)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~  364 (376)
                      +.-+....+.+.+.+++.+++..
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~  350 (367)
T 1cm8_A          328 DSFDDVDRTLDEWKRVTYKEVLS  350 (367)
T ss_dssp             CC-----CCHHHHHHHHHHHHHT
T ss_pred             CChhhhcCCHHHHHHHHHHHHHH
Confidence            33223345666777776666554

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-52  Score=379.20  Aligned_cols=278  Identities=33%  Similarity=0.631  Sum_probs=222.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||+|+||.||+|++ .+|+.||+|++....      ....+|+.+++.++||||+++++++.     +...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence            5799999999999999999998 678999999985432      23457999999999999999999984     34458


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++||||++++|.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus        76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEeECcccccc
Confidence            999999999988877642   3669999999999999999999999 79999999999999996 788999999999765


Q ss_pred             ccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            432 2233457899999999997665689999999999999999999999999999999999988888776554432211


Q ss_pred             CCc-CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ... ...++.....+|. .+...+++++.+||.+||+.||++|||++++++||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccccCccHH-HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            000 0011111122222 2345689999999999999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-53  Score=387.58  Aligned_cols=289  Identities=33%  Similarity=0.628  Sum_probs=230.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ++|++++.||+|+||.||+|++..+++.||+|++.....     ...+|+.+++.++||||+++++++.     +...++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence            679999999999999999999999999999999864322     2236999999999999999999984     444589


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||||+++|.+.+...   ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECT-TCCEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECC-CCCEEEccCccccccc
Confidence            99999999988877653   4569999999999999999999999 79999999999999996 7789999999997654


Q ss_pred             cCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+......
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            332 2334577999999999977666899999999999999999999999999999999999999998877655432211


Q ss_pred             --CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCC
Q 017139          268 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG  333 (376)
Q Consensus       268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~  333 (376)
                        +..+.++......... ....+++++.+||.+||++||++|||++|+|+||||.++.......+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~  298 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDT  298 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTT
T ss_pred             hhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCC
Confidence              1112222222222211 2346899999999999999999999999999999999987765554433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-52  Score=383.94  Aligned_cols=290  Identities=31%  Similarity=0.547  Sum_probs=218.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++     .+...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence            467999999999999999999999999999999986432     2345799999999999999999998     555568


Q ss_pred             EEEeecccchHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          108 NLVMEYVPETMYRVLKHYSS--MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      |+|||||+++|.+.+.....  ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINK-RGQLKLGDFGLAR  156 (317)
T ss_dssp             EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCSSCE
T ss_pred             EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcC-CCCEEECcCccce
Confidence            99999999999888876432  23468999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ..... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+...
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            76433 23345678999999999976556899999999999999999999999999999999999998888776544332


Q ss_pred             CcCCc-CccCCCCCCCCc----ccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCC
Q 017139          265 NPNYT-DFRFPQIKAHPW----HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR  329 (376)
Q Consensus       265 ~~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~  329 (376)
                      ..... ...++......+    .......++.++.+||.+||+.||++|||++|+|+||||++....+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence            11100 000111111111    112234688999999999999999999999999999999998776543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-52  Score=380.45  Aligned_cols=286  Identities=30%  Similarity=0.526  Sum_probs=231.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCC---CCCeeecceeeeec
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMD---HPNVISLKHCFFST   99 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~---h~~Iv~~~~~~~~~   99 (376)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....         ....+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3568999999999999999999999999999999986322         23446777777664   99999999998776


Q ss_pred             CCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          100 TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                      .......+++||||++++|.+.+....  ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECT-TSCEEEC
T ss_pred             CCCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEEe
Confidence            655566789999999999888877532  2449999999999999999999999 79999999999999996 7889999


Q ss_pred             ecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          180 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       180 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      |||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+...
T Consensus       163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eCccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            999998776666666778899999999997654 8999999999999999999999999999999999999988887766


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                      .+...... ....++.....+.. .....+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus       242 ~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          242 DWPRDVSL-PRGAFPPRGPRPVQ-SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TSCSSCSS-CGGGSCCCCCCCHH-HHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hccchhhc-cccccCCCCCCcHH-HhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            54322111 11122222222222 23346899999999999999999999999999999998643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.3e-52  Score=386.23  Aligned_cols=288  Identities=31%  Similarity=0.558  Sum_probs=231.5

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .....++|++.+.||+|+||+||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++.     
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  103 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----  103 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----
Confidence            4466789999999999999999999999999999999986432      23347999999999999999999984     


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC----CCCcEEE
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKL  178 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~----~~~~~kl  178 (376)
                      +...+|+|||||+++|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.    ..+.+||
T Consensus       104 ~~~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl  178 (329)
T 3gbz_A          104 HNHRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKI  178 (329)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred             cCCEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEE
Confidence            4455899999999998888765    4569999999999999999999999 79999999999999953    2456999


Q ss_pred             EecCCccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          179 CDFGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       179 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      +|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+.
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          179 GDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             CCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence            999999765433 2334556799999999997766689999999999999999999999999999999999999888877


Q ss_pred             HHHHhhcCcC-CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          258 REEIRCMNPN-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       258 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ...+...... .....++......+...+...+++++.+||.+||++||++|||++|+|+||||++.++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence            6554432211 01113344444555555666789999999999999999999999999999999987653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-52  Score=389.00  Aligned_cols=321  Identities=32%  Similarity=0.525  Sum_probs=239.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~  104 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..... .+.
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            4478999999999999999999999999999999986532      233479999999999999999999854311 123


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+|||+++++|...+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       107 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kL~DFG~a  179 (367)
T 2fst_X          107 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLA  179 (367)
T ss_dssp             CCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC----
T ss_pred             CeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECC-CCCEEEeecccc
Confidence            45789999998887776653     569999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +....  ......+|++|+|||++.+...++.++|||||||++|+|++|..||.+.+..+++..+.+..|.+..+.+...
T Consensus       180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          180 RHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             ccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            76533  2345678999999999977566899999999999999999999999999999999999999999998877654


Q ss_pred             CcCCcC---ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCC
Q 017139          265 NPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN  341 (376)
Q Consensus       265 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~  341 (376)
                      ......   ...+......+...+ ..+++++.+||.+||++||++|||++++|+||||+.+..+....     ....++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~-----~~~~~~  331 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYD  331 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCC-----CCCCCC
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCC-----CCCCCC
Confidence            321110   012222233333333 35799999999999999999999999999999999887654321     122244


Q ss_pred             chhhhhcCCHHHHhhhcHHHHHhhcC
Q 017139          342 FKQELAGASPELINRLIPEHVRRQTG  367 (376)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (376)
                      +.-+......+.+.+++.+++..-.+
T Consensus       332 ~~~~~~~~~~~~~~~~~~~e~~~~~~  357 (367)
T 2fst_X          332 QSLESRDLLIDEWKSLTYDEVISFVP  357 (367)
T ss_dssp             GGGSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             cchhhccCCHHHHHHHHHHHHHHhcc
Confidence            44344456778888888887776443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.5e-52  Score=386.42  Aligned_cols=259  Identities=26%  Similarity=0.398  Sum_probs=220.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|++....          ....+|+.+++.++||||+++++++    
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~----   84 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY----   84 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE----
Confidence            45678999999999999999999999999999999986542          2345799999999999999999998    


Q ss_pred             CCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC---cE
Q 017139          101 SKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QV  176 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~---~~  176 (376)
                       .+...+|+|||||+ |+|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.   .+
T Consensus        85 -~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~v  158 (361)
T 2yab_A           85 -ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHI  158 (361)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCE
T ss_pred             -EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCE
Confidence             45556899999997 577666643    4679999999999999999999999 79999999999999986332   79


Q ss_pred             EEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          177 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      ||+|||++.............||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+.......
T Consensus       159 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~  237 (361)
T 2yab_A          159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF  237 (361)
T ss_dssp             EECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             EEEecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            99999999887666555677899999999999764 48999999999999999999999999988888777766532222


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ...                         ++..+++++++||.+||..||.+|||++++|+||||+...+
T Consensus       238 ~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          238 DEE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             CHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             Cch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            221                         23467999999999999999999999999999999986543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-52  Score=388.78  Aligned_cols=255  Identities=28%  Similarity=0.476  Sum_probs=212.4

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|++.+.||+|+||+||+|+++.+|+.||+|++.+..       ....+|..+++.+ +||||+++++++     .
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~   94 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q   94 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence            45578999999999999999999999999999999986532       2234688899887 799999999998     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~-~g~ikL~DF  168 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADF  168 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECC-CCCEEEccc
Confidence            55569999999985 77666654    3669999999999999999999999 79999999999999996 788999999


Q ss_pred             CCcccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |+++.... .......+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+....       
T Consensus       169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------  240 (353)
T 3txo_A          169 GMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-------  240 (353)
T ss_dssp             TTCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             cceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------
Confidence            99986433 23344677999999999997654 8999999999999999999999999998888887776521       


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH------HHHhCCCccccccCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~ell~hp~~~~~~~~  326 (376)
                                .            .++..+++++.+||.+||++||.+||++      +++++||||++++|.
T Consensus       241 ----------~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          241 ----------V------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             ----------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             ----------C------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence                      1            1334579999999999999999999998      899999999998765

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.8e-52  Score=390.24  Aligned_cols=322  Identities=30%  Similarity=0.511  Sum_probs=235.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~  104 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... .+.
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            4578999999999999999999999999999999986532      223479999999999999999998854321 223


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+|||||+++|.+.+.      ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       103 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a  174 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA  174 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCCCC-
T ss_pred             cceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEEEeecc
Confidence            4689999999999877764      348999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+++..+.+..+.+..+
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ---------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             cccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            876555445567889999999999765 4899999999999999999999999999999999999999999887766544


Q ss_pred             CcCCcCc--cCCCCCCCCcccccc-----------cCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCC
Q 017139          265 NPNYTDF--RFPQIKAHPWHKVFH-----------KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP  331 (376)
Q Consensus       265 ~~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~  331 (376)
                      .+....+  ..+......+...++           ...++++++||.+||++||++|||++|+|+||||+.+..+.....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~  333 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA  333 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC
Confidence            3211110  011111111111111           112568999999999999999999999999999987655422211


Q ss_pred             CCCCCCCCCCchhhhhcCCHHHHhhhcHHHHHhh
Q 017139          332 NGRPFPPLFNFKQELAGASPELINRLIPEHVRRQ  365 (376)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (376)
                         +.+.......+....+.+.+.+++.+.+.+-
T Consensus       334 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (371)
T 2xrw_A          334 ---PPPKIPDKQLDEREHTIEEWKELIYKEVMDL  364 (371)
T ss_dssp             ---CCCCCCTTTTCCCCCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCChhhccccCcHHHHHHHHHHHHHHH
Confidence               1111112222223456677777777776654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-51  Score=380.71  Aligned_cols=254  Identities=26%  Similarity=0.417  Sum_probs=216.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++     .+.
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~   77 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTH   77 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECS
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeC
Confidence            3578999999999999999999999999999999986431       2345799999999999999999998     445


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DFG~  151 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGL  151 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECC-CCCEEEeeccc
Confidence            568999999986 67666654    3579999999999999999999999 79999999999999996 78899999999


Q ss_pred             cccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          184 AKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       184 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+....         
T Consensus       152 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  221 (337)
T 1o6l_A          152 CKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------  221 (337)
T ss_dssp             CBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             hhhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence            986433 3344567899999999999765 48999999999999999999999999888777666655410         


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                              .            .++..+++++.+||.+||+.||++||     +++++++||||+.+++.
T Consensus       222 --------~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          222 --------I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             --------C------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence                    0            13446899999999999999999999     89999999999988764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.8e-52  Score=387.75  Aligned_cols=259  Identities=24%  Similarity=0.449  Sum_probs=211.3

Q ss_pred             CCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeee
Q 017139           27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFS   98 (376)
Q Consensus        27 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~   98 (376)
                      .......++|++.++||+|+||+||+|+++.+++.||+|++.+..       .....|..+++.+ +||||+++++++  
T Consensus        45 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~--  122 (396)
T 4dc2_A           45 ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF--  122 (396)
T ss_dssp             ----CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             cccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE--
Confidence            334456789999999999999999999999999999999986542       2245788888776 899999999998  


Q ss_pred             cCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139           99 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                         .+...+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus       123 ---~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ik  193 (396)
T 4dc2_A          123 ---QTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIK  193 (396)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEE
T ss_pred             ---EECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECC-CCCEE
Confidence               455569999999986 77666654    3579999999999999999999999 79999999999999996 78899


Q ss_pred             EEecCCccccc-cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh--------HH-HHH
Q 017139          178 LCDFGSAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VD-QLV  247 (376)
Q Consensus       178 l~Dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~-~~~  247 (376)
                      |+|||+++... ........+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.....        .+ ...
T Consensus       194 L~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~  272 (396)
T 4dc2_A          194 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  272 (396)
T ss_dssp             ECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred             EeecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence            99999998633 33445567899999999999765 489999999999999999999999964321        11 222


Q ss_pred             HHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH------HHHhCCCccc
Q 017139          248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFD  321 (376)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~ell~hp~~~  321 (376)
                      .+...                 .            ..++..+++++++||++||++||.+|+++      +++++||||+
T Consensus       273 ~i~~~-----------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~  323 (396)
T 4dc2_A          273 VILEK-----------------Q------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  323 (396)
T ss_dssp             HHHHC-----------------C------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred             HHhcc-----------------c------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence            22220                 0            11445689999999999999999999985      7999999999


Q ss_pred             cccCC
Q 017139          322 ELREP  326 (376)
Q Consensus       322 ~~~~~  326 (376)
                      .++|.
T Consensus       324 ~i~w~  328 (396)
T 4dc2_A          324 NVDWD  328 (396)
T ss_dssp             TCCHH
T ss_pred             CCCHH
Confidence            98775

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-51  Score=380.23  Aligned_cols=285  Identities=34%  Similarity=0.590  Sum_probs=228.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++....         ....+|+.+++.++||||+++++++     
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   81 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----   81 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence            34578999999999999999999999999999999986421         2345799999999999999999998     


Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .+...+++||||++++|...+..   ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus        82 ~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Df  156 (346)
T 1ua2_A           82 GHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADF  156 (346)
T ss_dssp             CCTTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC
T ss_pred             eeCCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcC-CCCEEEEec
Confidence            44455889999999988777654   34568999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....
T Consensus       157 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             GGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence            9998764332 334567899999999997666689999999999999999999999999999999999999888887766


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      +...........+......++.. +...++.++++||.+||+.||++|||++|+|+||||++...+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhhhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            55433222222222222222222 234678999999999999999999999999999999876554

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.8e-51  Score=370.61  Aligned_cols=284  Identities=33%  Similarity=0.601  Sum_probs=222.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....      ...+|+.+++.++||||+++++++.     +...
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence            4679999999999999999999999999999999865432      2347999999999999999999984     4445


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +++|||||+++++..+..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        77 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITK-HSVIKLCDFGFARL  151 (311)
T ss_dssp             EEEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcC-CCCEEEeeCCCchh
Confidence            889999999865544433   34669999999999999999999999 79999999999999996 78899999999987


Q ss_pred             cccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ..... ......+|+.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+....+.+..+...........
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          152 LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             CC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence            65332 23456789999999999876668999999999999999999999999999999988888888777655433221


Q ss_pred             --cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          266 --PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       266 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                        ..+.....+..............+++++.+||.+||++||++|||++++++||||+++.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence              1112222222222222222234689999999999999999999999999999999987654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.9e-51  Score=377.44  Aligned_cols=323  Identities=29%  Similarity=0.571  Sum_probs=248.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++.....     ...+|+.+++.++||||+++++++..........
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            45689999999999999999999999999999999864322     2347999999999999999999875443334466


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|+||||++++|.+.+..     ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        89 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred             EEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcC-CCcEEEEecccccc
Confidence            899999999998887764     569999999999999999999999 79999999999999996 77899999999986


Q ss_pred             cccCCC-----------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          187 LVKGEA-----------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       187 ~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      ......           .....||+.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+.+..+....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            543221           123467999999999876566899999999999999999999999999988888888888777


Q ss_pred             CCHHHHhh-cCcC-CcC--ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCC
Q 017139          256 PTREEIRC-MNPN-YTD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP  331 (376)
Q Consensus       256 ~~~~~~~~-~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~  331 (376)
                      +....... .... ...  ...+.....++. .....+++++.+||.+||+.||++|||++++++||||+.+..+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~  320 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE  320 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCC
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccc
Confidence            65321110 0000 000  001111111121 123468999999999999999999999999999999999887654433


Q ss_pred             CCCCCCCCCCchhhhhcCCHHHHhhhcHHHH
Q 017139          332 NGRPFPPLFNFKQELAGASPELINRLIPEHV  362 (376)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (376)
                      .....+..+.+.......+.+.+.+++.+++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (353)
T 2b9h_A          321 GEPIPPSFFEFDHYKEALTTKDLKKLIWNEI  351 (353)
T ss_dssp             CCCCCGGGGGGGCCSSCCCHHHHHHHHHHHH
T ss_pred             cCCCCcceeeecchhhcCCHHHHHHHHHHHh
Confidence            2222233455665556677888887777665

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.9e-51  Score=379.19  Aligned_cols=321  Identities=28%  Similarity=0.545  Sum_probs=242.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------------cchHHHHHHHHhCCCCCeeecceee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRLMDHPNVISLKHCF   96 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------------~~~~~e~~~l~~l~h~~Iv~~~~~~   96 (376)
                      ..++|++.+.||+|+||.||+|.+.. |+.||||++....               ....+|+.+++.++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            34679999999999999999999755 8999999885421               2345799999999999999999998


Q ss_pred             eecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcE
Q 017139           97 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV  176 (376)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~  176 (376)
                      ..........+|+||||++|+|.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~  173 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLAD-NNDI  173 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCE
T ss_pred             EeccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcC-CCCE
Confidence            7766566678899999999998888764   34579999999999999999999999 79999999999999996 7789


Q ss_pred             EEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          177 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      ||+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            99999999866655555667889999999999775568999999999999999999999999999999999999999998


Q ss_pred             CHHHHhhcCcCC----cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCC
Q 017139          257 TREEIRCMNPNY----TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN  332 (376)
Q Consensus       257 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~  332 (376)
                      ....+.......    ............+.. .....++.+.+||.+||++||++|||++++++||||+.+..+....  
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~--  330 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT--  330 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT--
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc--
Confidence            877654322110    000111111222222 3346789999999999999999999999999999999876543221  


Q ss_pred             CCCCCCCCCchhhhhcCCHHHHhhhcHHHHHh
Q 017139          333 GRPFPPLFNFKQELAGASPELINRLIPEHVRR  364 (376)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (376)
                       ..+...+.+..  ...+...+.+.+..++.+
T Consensus       331 -~~~~~~~~~~~--~~~~~~~~~~~~~~e~~~  359 (362)
T 3pg1_A          331 -EGLSERFHFDE--SVTDVYDMHKIFTAEVER  359 (362)
T ss_dssp             -TTCCCCCCCCT--TCCCHHHHHHHHHHHHHH
T ss_pred             -cccccccChhh--hhhhHHHHHHHHHHHHHH
Confidence             12233333333  334566666666666543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-52  Score=386.77  Aligned_cols=252  Identities=28%  Similarity=0.460  Sum_probs=212.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++     ..
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TT   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ee
Confidence            5667899999999999999999999999999999998542       22456899999999999999999998     34


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+++||||++|+|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~DFG~  154 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDD-NLNVKIADFGL  154 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECT-TCCEEECCSSC
T ss_pred             CCEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcC-CCCEEEEEecc
Confidence            445899999999998887765    3569999999999999999999999 79999999999999996 77899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+........                
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------  218 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------  218 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------
Confidence            9877666556677899999999999776545789999999999999999999997653221110                


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                 .+..  ....++..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus       219 -----------~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          219 -----------KVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             -----------CCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             -----------HHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                       0000  011244568999999999999999999999999999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.4e-51  Score=385.32  Aligned_cols=259  Identities=28%  Similarity=0.454  Sum_probs=218.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecc-------cccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~-------~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|.+.+.||+|+||+||+|++..+++.||+|++.+       ......+|+.+++.++||||+++++++     .+.
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            45789999999999999999999999999999999854       223456899999999999999999998     555


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+|||||+| +|.+.+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECC-CCCEEEeccce
Confidence            669999999975 77776654     468999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCC--cceeeccccccChhhhhCCCC---CCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          184 AKVLVKGEA--NISYICSRYYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      ++.......  ..+.+||+.|+|||++.+...   ++.++|||||||++|+|++|..||.+.+..+....+......   
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---  291 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---  291 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---
Confidence            987654432  235679999999999975432   678999999999999999999999999888888777652110   


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCC--CCCHHHHhCCCccccccCCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN  327 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~~~~~~~~~  327 (376)
                                  ..+|          ....+++++++||.+||+.+|.+  |++++|+++||||++++|..
T Consensus       292 ------------~~~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          292 ------------LTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             ------------CCCC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             ------------ccCC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence                        0111          11257999999999999999998  99999999999999987754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-51  Score=376.14  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=219.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....   ....+|+.+++.++||||+++++++.     +...+|
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~   77 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence            3468999999999999999999999999999999986543   23457999999999999999999983     444589


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC-CCcEEEEecCCccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKV  186 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~-~~~~kl~Dfg~~~~  186 (376)
                      +|||||+| +|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+|||++.. ++.+||+|||++..
T Consensus        78 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            99999986 77666643   23569999999999999999999999 799999999999999853 57899999999988


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...........      
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------  226 (321)
T 1tki_A          154 LKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------  226 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------
T ss_pred             CCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh------
Confidence            7666666677899999999999765 379999999999999999999999999888888777776433333222      


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                         +..+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       227 -------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          227 -------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                               23579999999999999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4e-51  Score=388.44  Aligned_cols=264  Identities=25%  Similarity=0.401  Sum_probs=220.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|++.++||+|+||+||+|++..+++.||+|++.+.       .....+|..++..++||||+++++++     .+.
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  146 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD  146 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence            347899999999999999999999999999999998542       23356899999999999999999998     455


Q ss_pred             eeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+|||||+ |+|...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~-~g~vkL~DFGl  221 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGS  221 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcC-CCCEEEcchhh
Confidence            56999999997 577777764   24679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCc--ceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          184 AKVLVKGEAN--ISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       184 ~~~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      ++........  ...+||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+..+....++.....  
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--  299 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--  299 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc--
Confidence            9766544332  34678999999999862    344899999999999999999999999999888888777642110  


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCC--CCCHHHHhCCCccccccCCCCC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPNAR  329 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~ell~hp~~~~~~~~~~~  329 (376)
                                   +.+|.         ....+++++++||++||+.+|++  |++++|+++||||++++|...+
T Consensus       300 -------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          300 -------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             -------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             -------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence                         01111         11347999999999999999988  9999999999999999987654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.9e-51  Score=380.00  Aligned_cols=318  Identities=33%  Similarity=0.584  Sum_probs=243.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC-Cc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~-~~  104 (376)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...... ..
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3468999999999999999999999999999999996542      2334799999999999999999998543221 11


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+||||+.++|...+.      ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       120 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a  191 (371)
T 4exu_A          120 YDFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLA  191 (371)
T ss_dssp             CCCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECSTTCC
T ss_pred             eeEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECC-CCCEEEEecCcc
Confidence            2348999999998766552      459999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .....  ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+...
T Consensus       192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          192 RHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             ccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            76533  2345678999999999977566899999999999999999999999999999999999999999887766543


Q ss_pred             CcCCcCc---cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCC
Q 017139          265 NPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN  341 (376)
Q Consensus       265 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~  341 (376)
                      .......   ..+......+.. +...+++++.+||.+||++||++|||++++|+||||+.+..+.......+++.... 
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~-  347 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSL-  347 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTT-
T ss_pred             hhhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcch-
Confidence            2211000   111111112221 23467999999999999999999999999999999998876654433333333322 


Q ss_pred             chhhhhcCCHHHHhhhcHHHHHh
Q 017139          342 FKQELAGASPELINRLIPEHVRR  364 (376)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~  364 (376)
                         +......+.+.+.+.+++..
T Consensus       348 ---~~~~~~~~~~~~~~~~~~~~  367 (371)
T 4exu_A          348 ---EHEKLTVDEWKQHIYKEIVN  367 (371)
T ss_dssp             ---SSCCCCHHHHHHHHHHHHHH
T ss_pred             ---hhcccchHHHHHHHHHHHHh
Confidence               22334566666776666554

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-51  Score=371.76  Aligned_cols=252  Identities=28%  Similarity=0.481  Sum_probs=217.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++.+..       ....+|..+++.++||||+++++++     .+.
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~   78 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDA   78 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECS
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeC
Confidence            4578999999999999999999999999999999986431       2345799999999999999999998     455


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+|||||+| +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~Dfg~  152 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGF  152 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSS
T ss_pred             CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcC-CCCEEEeecCc
Confidence            568999999985 77777654    4679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ++....  .....+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+....          
T Consensus       153 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  219 (318)
T 1fot_A          153 AKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------  219 (318)
T ss_dssp             CEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC----------
T ss_pred             ceecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            986533  23456789999999999765 48999999999999999999999999988877777766521          


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                             .            .++..+++++.++|.+||+.||++|+     +++++++||||+++.+.
T Consensus       220 -------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          220 -------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             -------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence                   0            13346799999999999999999999     89999999999988765

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-50  Score=375.18  Aligned_cols=257  Identities=25%  Similarity=0.455  Sum_probs=211.4

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      .+...++|++.+.||+|+||.||+|+++.+++.||+|++.+...       ...+|..+++.+ +||||+++++++    
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~----   79 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF----   79 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE----
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE----
Confidence            34567899999999999999999999999999999999975421       234688888887 899999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                       .+...+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus        80 -~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~  152 (345)
T 3a8x_A           80 -QTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLT  152 (345)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEEC
T ss_pred             -EeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEE
Confidence             445568999999985 77666654    3569999999999999999999999 79999999999999996 7889999


Q ss_pred             ecCCcccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHH
Q 017139          180 DFGSAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQLVEI  249 (376)
Q Consensus       180 Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---------~~~~~~~~  249 (376)
                      |||+++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|..||....         .......+
T Consensus       153 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i  231 (345)
T 3a8x_A          153 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI  231 (345)
T ss_dssp             CGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred             eccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence            9999986432 3344567889999999999765 48999999999999999999999997531         11122222


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH------HHHhCCCccccc
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDEL  323 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~ell~hp~~~~~  323 (376)
                      ...                 .            ..++..+++++++||.+||+.||.+||++      +++++||||+.+
T Consensus       232 ~~~-----------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          232 LEK-----------------Q------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             HHC-----------------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             HcC-----------------C------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            220                 0            01345689999999999999999999995      899999999998


Q ss_pred             cCC
Q 017139          324 REP  326 (376)
Q Consensus       324 ~~~  326 (376)
                      +|.
T Consensus       283 ~w~  285 (345)
T 3a8x_A          283 DWD  285 (345)
T ss_dssp             CHH
T ss_pred             CHH
Confidence            764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.6e-51  Score=377.58  Aligned_cols=261  Identities=26%  Similarity=0.374  Sum_probs=214.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc---------ccchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++...         .....+|+.+++.++||||+++++++.    
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----   96 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS----   96 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            4567899999999999999999999999999999998532         233568999999999999999999984    


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEEE
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKL  178 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~kl  178 (376)
                       +...+|+|||||+ ++|...+......+..+++..++.++.||+.||.|||+ +||+||||||+|||++.+  ...+||
T Consensus        97 -~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl  174 (351)
T 3c0i_A           97 -SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKL  174 (351)
T ss_dssp             -ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred             -eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEE
Confidence             4455899999999 57877776655556679999999999999999999999 799999999999999752  234999


Q ss_pred             EecCCccccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          179 CDFGSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       179 ~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      +|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ......+........
T Consensus       175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~  252 (351)
T 3c0i_A          175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN  252 (351)
T ss_dssp             CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC
T ss_pred             ecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC
Confidence            99999987654432 3456789999999999765 48999999999999999999999998753 344444443221111


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                      ..                         .+..+++++++||.+||+.||++|||+.++|+||||+...
T Consensus       253 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          253 PR-------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             cc-------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            11                         1235799999999999999999999999999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.2e-51  Score=378.35  Aligned_cols=255  Identities=28%  Similarity=0.483  Sum_probs=215.4

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|.+.+.||+|+||+||+|+++.+|+.||+|++.+..       .....|..+++.+ +||||+++++++     .
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~   88 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q   88 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence            45678999999999999999999999999999999986532       2234688888866 999999999998     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DF  162 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADF  162 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECC-CCCEEEeEC
Confidence            45568999999985 77777654    3569999999999999999999999 79999999999999996 778999999


Q ss_pred             CCcccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |+++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....       
T Consensus       163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------  234 (345)
T 1xjd_A          163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-------  234 (345)
T ss_dssp             TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             hhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-------
Confidence            99986433 2334567889999999999765 48999999999999999999999999988877776665421       


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHH-HHhCCCccccccCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-ell~hp~~~~~~~~  326 (376)
                                            ..++..+++++++||.+||+.||++||++. ++++||||+.++|.
T Consensus       235 ----------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          235 ----------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence                                  013345799999999999999999999998 99999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4e-51  Score=378.89  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=215.8

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      ....++|++.+.||+|+||+||+|++..+|+.||+|++.+..       .....|..++..+ +||||+++++++     
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----   90 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----   90 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----
Confidence            345678999999999999999999999999999999986532       2234688888877 799999999998     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+...+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~D  164 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIAD  164 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcC-CCcEEEEe
Confidence            455569999999985 77777664    2569999999999999999999999 79999999999999996 78899999


Q ss_pred             cCCcccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          181 FGSAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       181 fg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ||+++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....      
T Consensus       165 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------  237 (353)
T 2i0e_A          165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------  237 (353)
T ss_dssp             CTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------
T ss_pred             CCcccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC------
Confidence            999986432 3334567899999999999765 48999999999999999999999999988887777766521      


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                 .            .++..+++++.+||.+||+.||.+||+     ++++++||||+.++|.
T Consensus       238 -----------~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          238 -----------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             -----------C------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             -----------C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence                       0            134568999999999999999999994     6999999999988775

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.3e-50  Score=374.46  Aligned_cols=294  Identities=28%  Similarity=0.462  Sum_probs=229.3

Q ss_pred             CCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        27 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      .+.....++|++.+.||+|+||.||+|++..+|+.||+|++.....      ...+|+.+++.++||||+++++++....
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           10 CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             CTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             ccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            3344567899999999999999999999999999999999854321      2347999999999999999999885532


Q ss_pred             C---CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139          101 S---KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus       101 ~---~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                      .   .....+|+|||||++++...+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+|
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~-~~~~k  164 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLK  164 (351)
T ss_dssp             -------CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEE
T ss_pred             cccccCCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCCEE
Confidence            1   124568899999999888777653   3569999999999999999999999 79999999999999996 77899


Q ss_pred             EEecCCccccccC-----CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 017139          178 LCDFGSAKVLVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV  252 (376)
Q Consensus       178 l~Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  252 (376)
                      |+|||++......     .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  244 (351)
T 3mi9_A          165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL  244 (351)
T ss_dssp             ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            9999999765422     22234567999999999977666899999999999999999999999999999999999888


Q ss_pred             cCCCCHHHHhhcCcC--CcCccCCCCCCCCccccc-ccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          253 LGTPTREEIRCMNPN--YTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      .+.+....+......  +................+ ....++++.+||.+||++||++|||++|+|+||||+....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            887776544332111  000000000000000000 0123778999999999999999999999999999986433

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-50  Score=367.22  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=213.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++..     ...+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEE
Confidence            4568999999999999999999999999999999985432    234579999999999999999999844     3448


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+|||||+| +|.+.+..     ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~  165 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ  165 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECC-CCCEEEeeCCCcee
Confidence            999999974 77776654     469999999999999999999999 79999999999999996 77899999999876


Q ss_pred             cccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.......         
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------  235 (297)
T 3fxz_A          166 ITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE---------  235 (297)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC---------
T ss_pred             cCCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence            65433 334567899999999997654 8999999999999999999999999888776666554421110         


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                       ...+..+++.+.+||.+||+.||++|||++++++||||+..
T Consensus       236 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          236 -----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             -----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -----------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                             01234578999999999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=370.88  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=217.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|++....          ....+|+.+++.++||||+++++++    
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----   83 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY----   83 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence            34578999999999999999999999999999999986432          2345799999999999999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC----c
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----Q  175 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~----~  175 (376)
                       .+...+++|||||++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++    .
T Consensus        84 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~-~~~~~~~  156 (326)
T 2y0a_A           84 -ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD-RNVPKPR  156 (326)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESC-SSSSSCC
T ss_pred             -EeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEec-CCCCCCC
Confidence             445568999999975 77766643    4679999999999999999999999 79999999999999986 44    7


Q ss_pred             EEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          176 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       176 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      +||+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus       157 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  235 (326)
T 2y0a_A          157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE  235 (326)
T ss_dssp             EEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred             EEEEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence            999999999877655555567899999999999654 4899999999999999999999999998887777766553222


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                      ....                         .+..+++.+.+||.+||+.||++|||++++|+||||+...
T Consensus       236 ~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          236 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             CCHH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cCcc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            2211                         2245789999999999999999999999999999998643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=380.74  Aligned_cols=263  Identities=28%  Similarity=0.449  Sum_probs=218.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++.+.       .....+|..++..++||||+++++++     .+.
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence            457899999999999999999999999999999998642       23456799999999999999999998     555


Q ss_pred             eeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+|||||+ |+|...+...   +..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~-~g~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDR-CGHIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecC-CCCEEEeechh
Confidence            66999999997 5777777642   3579999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCC--cceeeccccccChhhhhC------CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          184 AKVLVKGEA--NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       184 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      ++.......  ....+||+.|+|||++..      ...++.++|+|||||++|+|++|..||.+.+..+...++......
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  288 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH  288 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            987654433  234578999999999863      234899999999999999999999999998888877776642100


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCC---CCHHHHhCCCccccccCCCCC
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDELREPNAR  329 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~t~~ell~hp~~~~~~~~~~~  329 (376)
                                     ..+|.         ++..+|+++++||++||+ +|.+|   ++++|+++||||+.++|...+
T Consensus       289 ---------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          289 ---------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             ---------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             ---------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence                           00110         124589999999999999 99998   599999999999999988654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.3e-50  Score=383.90  Aligned_cols=281  Identities=31%  Similarity=0.554  Sum_probs=228.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhC------CCCCeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLM------DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l------~h~~Iv~~~~~~~~~~~  101 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++.....   ...+|+.+++.+      +|+||+++++++.    
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~----  169 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT----  169 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE----
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc----
Confidence            345689999999999999999999999999999999976532   334688888776      5779999999884    


Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc--EEEE
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLC  179 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~--~kl~  179 (376)
                       ....+|+||||++++|.+.+....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.  +||+
T Consensus       170 -~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~-~~~~~vkL~  244 (429)
T 3kvw_A          170 -FRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQ-QGRSGIKVI  244 (429)
T ss_dssp             -ETTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESS-TTSCCEEEC
T ss_pred             -cCCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcc-CCCcceEEe
Confidence             344589999999999988887632  3459999999999999999999999 79999999999999996 554  9999


Q ss_pred             ecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          180 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       180 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      |||++.....  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++..
T Consensus       245 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          245 DFGSSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             CCTTCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecccceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            9999976432  334567899999999998754 8999999999999999999999999999999999999999999887


Q ss_pred             HHhhcCcC--------CcCc----------------------cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC
Q 017139          260 EIRCMNPN--------YTDF----------------------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC  309 (376)
Q Consensus       260 ~~~~~~~~--------~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  309 (376)
                      .+......        +..+                      .........|...+....++++.+||.+||++||++||
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence            66533211        0000                      00011223344445556788999999999999999999


Q ss_pred             CHHHHhCCCccccc
Q 017139          310 TALEACAHPFFDEL  323 (376)
Q Consensus       310 t~~ell~hp~~~~~  323 (376)
                      |++|+|+||||++.
T Consensus       402 ta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          402 TPGQALRHPWLRRR  415 (429)
T ss_dssp             CHHHHHTSTTTC--
T ss_pred             CHHHHhCChhhccC
Confidence            99999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=385.79  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=215.4

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.+|+|++....      ....+|+.+++.++||||+++++++     .+.
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence            45678999999999999999999999999999999986543      2345799999999999999999998     555


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEec
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDF  181 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Df  181 (376)
                      ..+|+|||||.| +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.  .++.+||+||
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             CEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccC
Confidence            668999999985 77666654    4679999999999999999999999 79999999999999974  2567999999


Q ss_pred             CCccccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.......+.. 
T Consensus       158 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-  235 (444)
T 3soa_A          158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP-  235 (444)
T ss_dssp             SSCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT-
T ss_pred             ceeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc-
Confidence            99976654332 3456789999999999764 48999999999999999999999999988887777766532211110 


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                              .+..+++++++||.+||+.||++|||+.|+|+||||+..
T Consensus       236 ------------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          236 ------------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ------------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                                    123579999999999999999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.9e-50  Score=374.29  Aligned_cols=255  Identities=27%  Similarity=0.422  Sum_probs=218.8

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      .+...++|++.+.||+|+||.||+|++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++     
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----  110 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----  110 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence            3456789999999999999999999999999999999985432       2344699999999999999999988     


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+...+|+|||||+ |+|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~D  184 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTD  184 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECC
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECC-CCCEEEcc
Confidence            44556899999997 577777765    2569999999999999999999999 79999999999999996 78899999


Q ss_pred             cCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          181 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       181 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ||+++....  .....+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....       
T Consensus       185 Fg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------  254 (350)
T 1rdq_E          185 FGFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-------  254 (350)
T ss_dssp             CTTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             cccceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-------
Confidence            999986543  23456889999999999765 48999999999999999999999999988877777666521       


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                .            .++..+++++.++|.+||+.||.+||+     ++++++||||+.++|.
T Consensus       255 ----------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          255 ----------V------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             ----------C------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             ----------C------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence                      0            134467999999999999999999998     9999999999988764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-50  Score=371.76  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=209.8

Q ss_pred             CCCccccceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceee
Q 017139           28 GEPKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCF   96 (376)
Q Consensus        28 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~~Iv~~~~~~   96 (376)
                      ......++|++.+.||+|+||.||+|++.   .+|+.||+|++.+..        ....+|+.+++.++||||+++++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            34456689999999999999999999985   689999999986532        2344699999999999999999998


Q ss_pred             eecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc
Q 017139           97 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ  175 (376)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~  175 (376)
                      .     ....+|+|||||+| +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.
T Consensus        91 ~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~-~~~  159 (327)
T 3a62_A           91 Q-----TGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNH-QGH  159 (327)
T ss_dssp             E-----CSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TSC
T ss_pred             E-----cCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECC-CCc
Confidence            4     44458999999984 77766654    3568999999999999999999999 79999999999999996 788


Q ss_pred             EEEEecCCccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          176 VKLCDFGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       176 ~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      +||+|||+++..... .......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  238 (327)
T 3a62_A          160 VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL  238 (327)
T ss_dssp             EEECCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             EEEEeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            999999998754332 223355789999999999765 489999999999999999999999999888777776665211


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                                   .++..+++++.+||.+||..||.+||     +++++++||||+.+++.
T Consensus       239 -----------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          239 -----------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             -----------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             -----------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence                                         12345799999999999999999999     89999999999988764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=378.64  Aligned_cols=257  Identities=24%  Similarity=0.392  Sum_probs=215.0

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++     .
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~   85 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----Q   85 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            355689999999999999999999999999999999985432       2345799999999999999999998     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|||||.| +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DF  159 (384)
T 4fr4_A           86 DEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDE-HGHVHITDF  159 (384)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECC-CCCEEEecc
Confidence            45568999999985 66666553    4679999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTP  256 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~~  256 (376)
                      |++.............||+.|+|||++.+.  ..++.++|||||||++|+|++|..||.....   ......+...    
T Consensus       160 G~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----  235 (384)
T 4fr4_A          160 NIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT----  235 (384)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC----
T ss_pred             ceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc----
Confidence            999887666666778899999999998642  3478999999999999999999999975432   2222222221    


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-HHHHhCCCccccccCC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDELREP  326 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~ell~hp~~~~~~~~  326 (376)
                                               ...++..+++++.+||.+||+.||.+||+ ++++++||||+.++|.
T Consensus       236 -------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          236 -------------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             -------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             -------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence                                     01134567999999999999999999998 8999999999998764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.8e-51  Score=378.89  Aligned_cols=257  Identities=25%  Similarity=0.417  Sum_probs=213.4

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc-------hHHHHHH-HHhCCCCCeeecceeeeecC
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQL-MRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~e~~~-l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      .....++|++.+.||+|+||+||+|+++.+++.||+|++.+....       ..+|..+ ++.++||||+++++++    
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~----  108 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF----  108 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE----
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE----
Confidence            345668999999999999999999999999999999999654321       2234444 4668999999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                       .+...+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus       109 -~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~ikL~  181 (373)
T 2r5t_A          109 -QTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLT  181 (373)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEEC
T ss_pred             -EeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEe
Confidence             445569999999986 77666654    3568999999999999999999999 79999999999999996 7889999


Q ss_pred             ecCCcccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          180 DFGSAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       180 Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      |||+++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....     
T Consensus       182 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-----  255 (373)
T 2r5t_A          182 DFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-----  255 (373)
T ss_dssp             CCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-----
T ss_pred             eCccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----
Confidence            9999986433 3344567899999999999765 48999999999999999999999999988887777766521     


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH----HHHhCCCccccccCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP  326 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~ell~hp~~~~~~~~  326 (376)
                                              ..++..+++++++||.+||+.||.+|+++    +++++||||+.++|.
T Consensus       256 ------------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          256 ------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             ------------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             ------------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence                                    01334689999999999999999999986    699999999998775

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-50  Score=377.06  Aligned_cols=257  Identities=28%  Similarity=0.411  Sum_probs=216.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     .+.
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~  100 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE  100 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence            45678999999999999999999999999999999996543      2345799999999999999999998     455


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEEEEec
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDF  181 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~kl~Df  181 (376)
                      ..+|+|||||.| +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+  ++.+||+||
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeec
Confidence            568999999986 76666643    4679999999999999999999999 799999999999999753  346999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |++.............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+.......+.   
T Consensus       176 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---  251 (362)
T 2bdw_A          176 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---  251 (362)
T ss_dssp             TTCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             CcceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc---
Confidence            999877655555567899999999999764 4899999999999999999999999998877777666553211111   


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                            ..+..+++++++||.+||+.||++|||+.++|+||||+..
T Consensus       252 ----------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          252 ----------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ----------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ----------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                                  0123579999999999999999999999999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-50  Score=362.74  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=210.6

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ...++|.+.+.||+|+||.||+|.+..+++.+|+|++....     ....+|+++++.++||||+++++++     .+..
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   93 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYH   93 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCC
Confidence            45578999999999999999999999999999999986543     2345799999999999999999998     4455


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEecC
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFG  182 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Dfg  182 (376)
                      .+|+|||||++ +|.+.+.........+++..++.++.|++.||+|||+ +||+||||||+||+++.  .++.+||+|||
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            58999999985 8888887766667889999999999999999999999 79999999999999953  24679999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++.............+++.|+|||++.+  .++.++|+|||||++|+|++|..||.+.+..+....+........     
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----  245 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-----  245 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred             cceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-----
Confidence            9987666555566778999999999853  489999999999999999999999998876665544433111000     


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                           .....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       246 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          246 ---------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ---------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ---------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                                 011246899999999999999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=382.22  Aligned_cols=291  Identities=31%  Similarity=0.515  Sum_probs=214.1

Q ss_pred             cccceEe-eeeeccCCceEEEEEEEc--CCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMA-ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~-~~~Lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..+.|.+ +++||+|+||.||+|++.  .+++.||||++....  ....+|+.+++.++||||+++++++..   .....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~   94 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRK   94 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence            4467887 568999999999999976  568899999997543  235589999999999999999999865   33456


Q ss_pred             EEEEeecccchHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec---CCCCcEEE
Q 017139          107 LNLVMEYVPETMYRVLKHYSSM-----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKL  178 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~---~~~~~~kl  178 (376)
                      +|+||||++++|.+.+......     ...+++..++.++.||+.||.|||+ +||+||||||+|||+.   ..++.+||
T Consensus        95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            8999999999998888654322     2359999999999999999999999 7999999999999993   23678999


Q ss_pred             EecCCccccccC----CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh---------HHH
Q 017139          179 CDFGSAKVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQ  245 (376)
Q Consensus       179 ~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~  245 (376)
                      +|||+++.....    .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...         .++
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999999876432    2234567899999999998766689999999999999999999999976654         478


Q ss_pred             HHHHHHhcCCCCHHHHhhcCcCCc---------CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          246 LVEIIKVLGTPTREEIRCMNPNYT---------DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      +..+...+|.+....|........         ...+.......+........++++.+||.+||++||.+|||++|+|+
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            888999999888665543221100         00000000000111112234789999999999999999999999999


Q ss_pred             CCccccccCC
Q 017139          317 HPFFDELREP  326 (376)
Q Consensus       317 hp~~~~~~~~  326 (376)
                      ||||++...+
T Consensus       334 hp~f~~~~~~  343 (405)
T 3rgf_A          334 DPYFLEDPLP  343 (405)
T ss_dssp             SGGGTSSSCC
T ss_pred             ChhhccCCCC
Confidence            9999876554

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-50  Score=374.29  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=213.4

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++.+......+|++++.++ +||||+++++++     .+...+|+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~l   93 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYV   93 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEE
Confidence            456789999999999999999999999999999999988777777899988887 799999999998     55566899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC---CcEEEEecCCcc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAK  185 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~---~~~kl~Dfg~~~  185 (376)
                      |||||.| +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||+...+   +.+||+|||++.
T Consensus        94 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           94 VTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            9999985 77766654    4679999999999999999999999 7999999999999985433   359999999998


Q ss_pred             ccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCCHHHH
Q 017139          186 VLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       186 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      ..... ......+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.   +..+....+....        
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~--------  239 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--------  239 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC--------
T ss_pred             cCcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC--------
Confidence            66443 3344567899999999997644 889999999999999999999999863   3333444333210        


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                               +.+        ...++..+++++++||.+||+.||++|||++++++||||.++..
T Consensus       240 ---------~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          240 ---------FSL--------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             ---------CCC--------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             ---------ccc--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence                     000        11123468999999999999999999999999999999987543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.7e-50  Score=370.12  Aligned_cols=283  Identities=34%  Similarity=0.617  Sum_probs=228.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++.....      ...+|+.+++.++||||+++++++     .+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~   96 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKK   96 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ecC
Confidence            456789999999999999999999999999999999865432      234799999999999999999998     444


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+||||++++++..+..   ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcC-CCcEEEEeCCCc
Confidence            55899999999876555533   34679999999999999999999999 79999999999999996 778999999999


Q ss_pred             cccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ...... .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.........
T Consensus       172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            765433 2234567899999999997765689999999999999999999999999999999999988888777654432


Q ss_pred             c--CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          264 M--NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       264 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      .  .+.+.....+..............+++++.+||.+||++||++|||++|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            2  22233344444444444444445789999999999999999999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.5e-51  Score=369.30  Aligned_cols=253  Identities=19%  Similarity=0.227  Sum_probs=186.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc-h--HHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-K--NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~--~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++...... .  +.|+..+..++|||||++++++.... .....+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            5799999999999999999987  6899999999654321 2  23555556789999999999986533 223458899


Q ss_pred             eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC--------CceeccCCCCCeeecCCCCcEEEEec
Q 017139          111 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--------GVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       111 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--------~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ||||+ |+|.+.+..     ..+++..+..++.|++.||+|||+ +        +|+||||||+|||++. ++.+||+||
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~-~~~~Ki~DF  152 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL  152 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECCC
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECC-CCCEEEEeC
Confidence            99999 588777764     568999999999999999999997 5        8999999999999996 888999999


Q ss_pred             CCccccccCCC-----cceeeccccccChhhhhCCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCh---------
Q 017139          182 GSAKVLVKGEA-----NISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENA---------  242 (376)
Q Consensus       182 g~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~---------  242 (376)
                      |+++.......     ....+||+.|||||++.+..     .++.++|||||||++|||+||.+||.....         
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            99987654332     22457999999999996542     256789999999999999999877643221         


Q ss_pred             -----HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          243 -----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       243 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                           .+.+...+...+.              +-.+|.       .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~--------------rp~~p~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQKL--------------RPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCC--------------CCCCCG-------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHhcccC--------------CCCCCc-------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 1111111110000              000000       00001123568899999999999999999999753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.8e-49  Score=363.24  Aligned_cols=293  Identities=33%  Similarity=0.548  Sum_probs=236.0

Q ss_pred             CCCccccceEeeeeeccCCceEEEEEEEc-CCCcEEEEEEecccc------cchHHHHHHHHhC---CCCCeeecceeee
Q 017139           28 GEPKQTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFF   97 (376)
Q Consensus        28 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~~Iv~~~~~~~   97 (376)
                      +.....++|++.+.||+|+||.||+|.+. .+|+.||+|++....      ....+|+.+++.+   +||||+++++++.
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A            5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            33455688999999999999999999995 678999999885322      2345688777766   8999999999886


Q ss_pred             ecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139           98 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                      .........+++||||++|+|.+.+....  ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~-~~~~k  160 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIK  160 (326)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEE
T ss_pred             ecccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcC-CCCEE
Confidence            44434667789999999999888877532  3458999999999999999999999 79999999999999996 77899


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |+|||++.............+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....+.+.
T Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            9999999876544444566789999999999765 489999999999999999999999999999999999998888877


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                      ...+....... ...+...... ....+...+++++.+||.+||+.||++|||+.++++||||+++....
T Consensus       240 ~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          240 EEDWPRDVALP-RQAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             GGGSCTTCSSC-GGGSCCCCCC-CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             cccCccccccc-hhhhcccCcc-hhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            66554221110 0111111111 12234457899999999999999999999999999999999876653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=366.39  Aligned_cols=258  Identities=25%  Similarity=0.413  Sum_probs=206.3

Q ss_pred             CCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------------------------------cchHHH
Q 017139           28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRE   77 (376)
Q Consensus        28 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------------------------~~~~~e   77 (376)
                      +.....++|++.+.||+|+||.||+|++..+++.||+|++....                              ....+|
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A            7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            44456788999999999999999999999999999999986432                              234579


Q ss_pred             HHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 017139           78 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG  156 (376)
Q Consensus        78 ~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~  156 (376)
                      +.+++.++||||+++++++..   .....+|+||||+++ +|.+.     .....+++..++.++.||+.||.|||+ +|
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~  157 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-QK  157 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            999999999999999998843   234568999999986 43221     124579999999999999999999999 79


Q ss_pred             ceeccCCCCCeeecCCCCcEEEEecCCccccccCC-CcceeeccccccChhhhhCCCC--CCccchhHHHHHHHHHHHhC
Q 017139          157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLG  233 (376)
Q Consensus       157 ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg  233 (376)
                      |+||||||+|||++. ++.+||+|||++....... ......||+.|+|||++.+...  ++.++|||||||++|+|++|
T Consensus       158 ivH~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGE-DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             EECCCCCGGGEEECT-TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             eeccCCCHHHEEECC-CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            999999999999996 7789999999998765432 2335678999999999865432  37789999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHH
Q 017139          234 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE  313 (376)
Q Consensus       234 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  313 (376)
                      ..||.+.+.......+.....                 .++          ....+++++.+||.+||+.||++|||+.|
T Consensus       237 ~~pf~~~~~~~~~~~~~~~~~-----------------~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e  289 (298)
T 2zv2_A          237 QCPFMDERIMCLHSKIKSQAL-----------------EFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPE  289 (298)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCC-----------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             CCCCCCccHHHHHHHHhcccC-----------------CCC----------CccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence            999988776655544433110                 011          11357899999999999999999999999


Q ss_pred             HhCCCcccc
Q 017139          314 ACAHPFFDE  322 (376)
Q Consensus       314 ll~hp~~~~  322 (376)
                      +++||||++
T Consensus       290 ~l~hp~~~~  298 (298)
T 2zv2_A          290 IKLHPWVTR  298 (298)
T ss_dssp             HTTCHHHHC
T ss_pred             HhcCccccC
Confidence            999999963

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-50  Score=376.09  Aligned_cols=259  Identities=26%  Similarity=0.447  Sum_probs=197.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...++|++++.||+|+||.||+|++..+++.||+|++....   ....+|+.+++.++||||+++++++.     +...+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~   91 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHL   91 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEE
Confidence            45678999999999999999999999999999999996543   33558999999999999999999984     44558


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC--cEEEEecCCc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSA  184 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~--~~kl~Dfg~~  184 (376)
                      |+|||||++ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++  .+||+|||++
T Consensus        92 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           92 AIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDG-SPAPRLKICDFGYS  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECS-SSSCCEEECCCCCC
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCceEEEeecCcc
Confidence            999999975 77776654    3569999999999999999999999 79999999999999985 43  4999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +............||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........++.....         
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~---------  236 (361)
T 3uc3_A          166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS---------  236 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT---------
T ss_pred             ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc---------
Confidence            86555555556789999999999987653445599999999999999999999875443222222221100         


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                          ..+.++          ....+++++.+||.+||+.||.+|||++++++||||.+.
T Consensus       237 ----~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          237 ----VKYSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             ----TCCCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             ----CCCCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                000111          112478999999999999999999999999999999664

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=369.88  Aligned_cols=317  Identities=33%  Similarity=0.588  Sum_probs=240.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC-Cce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~-~~~  105 (376)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...... ...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999999999999999986532      2234799999999999999999998433211 112


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+||||+.++|.+.+      ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus       103 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TCCEEECSTTCTT
T ss_pred             eEEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECC-CCcEEEeeccccc
Confidence            35899999998765443      2459999999999999999999999 79999999999999996 7789999999997


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      .....  .....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+....
T Consensus       175 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          175 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            64322  3356789999999999775568999999999999999999999999999999999999999988877665433


Q ss_pred             cCCcCc---cCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCCc
Q 017139          266 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF  342 (376)
Q Consensus       266 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~  342 (376)
                      ......   ..+......+.. ....+++++.+||.+||+.||++|||++++++||||+.+..+........++    +.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~----~~  327 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPF----DD  327 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCC----CC
T ss_pred             hHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCC----cc
Confidence            211000   111111111111 2346799999999999999999999999999999999877654332222222    22


Q ss_pred             hhhhhcCCHHHHhhhcHHHHHh
Q 017139          343 KQELAGASPELINRLIPEHVRR  364 (376)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~  364 (376)
                      ..+....+.+.+.+.+.+++..
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~  349 (353)
T 3coi_A          328 SLEHEKLTVDEWKQHIYKEIVN  349 (353)
T ss_dssp             TTTTCCCCHHHHHHHHHHHHHT
T ss_pred             chhhccCCHHHHHHHHHHHHHh
Confidence            2233445666777777666554

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.4e-50  Score=366.74  Aligned_cols=258  Identities=25%  Similarity=0.352  Sum_probs=208.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++     .+..
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~   78 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGN   78 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence            35678999999999999999999999999999999985432     3456899999999999999999988     4555


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..|+|||||+| +|.+.+    .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~Dfg~a  152 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLA  152 (323)
T ss_dssp             EEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTC
T ss_pred             eEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeC-CCCEEEEEeecc
Confidence            68999999986 544443    345679999999999999999999999 79999999999999996 778999999999


Q ss_pred             cccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          185 KVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       185 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      .......   ......||+.|+|||++.+...++.++|||||||++|+|++|..||...................     
T Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----  227 (323)
T 3tki_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-----  227 (323)
T ss_dssp             EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-----
T ss_pred             ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-----
Confidence            7654322   22356789999999999876645789999999999999999999998765432222211110000     


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                           ......+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       228 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          228 ---------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             ---------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ---------------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                                 0012357899999999999999999999999999999986543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-50  Score=374.39  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=217.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|++....    ....+|+.+++.++||||+++++++     .+...
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  122 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYE  122 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCE
Confidence            34578999999999999999999999999999999986542    2345799999999999999999998     44556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC-CCCcEEEEecCCc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSA  184 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~-~~~~~kl~Dfg~~  184 (376)
                      +++|||||+| +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. .++.+||+|||++
T Consensus       123 ~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a  198 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLA  198 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccc
Confidence            8999999985 66655543   23579999999999999999999999 79999999999999974 2467999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......        
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~--------  269 (387)
T 1kob_A          199 TKLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF--------  269 (387)
T ss_dssp             EECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred             eecCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence            877665555567889999999999764 48999999999999999999999999988877776665421110        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                       .......+++++.+||.+||+.||++|||++++|+||||+...
T Consensus       270 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          270 -----------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             -----------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -----------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                             0112235799999999999999999999999999999998643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.8e-49  Score=357.45  Aligned_cols=263  Identities=27%  Similarity=0.401  Sum_probs=219.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++     .+..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   78 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence            4568999999999999999999999999999999986543      2344799999999999999999998     4555


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEEEEecC
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFG  182 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~kl~Dfg  182 (376)
                      ..++||||+.+ +|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++.+  ++.+||+|||
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            68899999986 66666654    3569999999999999999999999 799999999999999752  2349999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++.............|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......+.    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  228 (284)
T 3kk8_A          154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----  228 (284)
T ss_dssp             TCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----
T ss_pred             eeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----
Confidence            99877666555667889999999999765 4899999999999999999999999988877777666553221110    


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL  330 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~  330 (376)
                                           .....+++++.+||.+||+.||++|||++++++||||++........
T Consensus       229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~  275 (284)
T 3kk8_A          229 ---------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI  275 (284)
T ss_dssp             ---------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSC
T ss_pred             ---------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHh
Confidence                                 01235789999999999999999999999999999998866554443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-49  Score=369.34  Aligned_cols=280  Identities=25%  Similarity=0.438  Sum_probs=223.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCC-----CCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----HPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~-----h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|.+.+.||+|+||.||+|++..+++.||||++....   .....|+.+++.+.     ||||+++++++..    
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~----  107 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY----  107 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE----
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE----
Confidence            34578999999999999999999999999999999986533   23446899999986     9999999999843    


Q ss_pred             CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC-----------
Q 017139          103 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-----------  171 (376)
Q Consensus       103 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~-----------  171 (376)
                       ...+|+|||||+++|.+.+....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.           
T Consensus       108 -~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          108 -YDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             -TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             -CCeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchh
Confidence             34589999999889988887532  2459999999999999999999999 79999999999999973           


Q ss_pred             -------------CCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 017139          172 -------------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP  238 (376)
Q Consensus       172 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~  238 (376)
                                   .++.+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCC
Confidence                         267899999999986433  234567899999999997654 8999999999999999999999999


Q ss_pred             CCChHHHHHHHHHhcCCCCHHHHhhcCcCCc-Cc--------cCCCCCCC--------CcccccccCCChhHHHHHHhhc
Q 017139          239 GENAVDQLVEIIKVLGTPTREEIRCMNPNYT-DF--------RFPQIKAH--------PWHKVFHKRMPPEAIDLASRLL  301 (376)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L  301 (376)
                      +.+..+.+..+....+..+...+........ .+        .++.....        .....+....++.+.+||.+||
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            9999999998888888877665543221110 00        00100000        0000111223578889999999


Q ss_pred             CCCCCCCCCHHHHhCCCccc
Q 017139          302 QYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       302 ~~dP~~R~t~~ell~hp~~~  321 (376)
                      ++||++|||++|+|+||||+
T Consensus       341 ~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          341 QIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CSSGGGSCCHHHHTTSGGGC
T ss_pred             cCChhhCCCHHHHhcCcccC
Confidence            99999999999999999995

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1e-49  Score=369.70  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=199.0

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ....++|++.+.||+|+||.||+|++..+++.||||++....  ....+|+.+++.++||||+++++++     .+...+
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~  123 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEI  123 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeE
Confidence            356678999999999999999999999999999999986542  3455799999999999999999998     444558


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEecCCc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSA  184 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Dfg~~  184 (376)
                      ++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.  .++.+||+|||++
T Consensus       124 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             EEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            999999985 77666653    4669999999999999999999999 79999999999999973  3678999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  263 (376)
                      .............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..... ....+.......       
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~-------  270 (349)
T 2w4o_A          199 KIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF-------  270 (349)
T ss_dssp             --------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-------
T ss_pred             cccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-------
Confidence            876555445567789999999999765 48999999999999999999999998766554 333333311100       


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                        .......++.++.+||.+||+.||++|||+.++|+||||+...
T Consensus       271 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          271 ------------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             ------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             ------------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                              0012345799999999999999999999999999999998643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-50  Score=384.46  Aligned_cols=253  Identities=30%  Similarity=0.444  Sum_probs=216.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|.+++.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++     ..
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~   87 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----ST   87 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence            56788999999999999999999999999999999986432       2345799999999999999999998     34


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+|||||+| +|.+.+.    .+..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~-~~~vkL~DFG  161 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADFG  161 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECT-TCCEEECCCS
T ss_pred             CCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEec-CCCeEEEecc
Confidence            4558999999975 6666554    35679999999999999999999999 79999999999999996 7789999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....        
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------  233 (476)
T 2y94_A          162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--------  233 (476)
T ss_dssp             SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--------
T ss_pred             chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--------
Confidence            998876655556778999999999998765457899999999999999999999998877766666544210        


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                           ..+..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       234 ---------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          234 ---------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ---------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                                 0234578999999999999999999999999999999863

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.3e-49  Score=362.26  Aligned_cols=258  Identities=26%  Similarity=0.378  Sum_probs=217.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....          ....+|+.+++.++||||+++++++     
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   84 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----   84 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence            4578999999999999999999999999999999986532          2245799999999999999999998     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC---cEE
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVK  177 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~---~~k  177 (376)
                      .+...+++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.   .+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEE
Confidence            445568999999974 77777654    4679999999999999999999999 79999999999999986332   799


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |+|||++.............||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+........
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD  238 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence            9999999877665555567789999999999764 489999999999999999999999999888777766654322221


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      .                         .++..+++.+.+||.+||+.||++|||++++++||||+...+
T Consensus       239 ~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          239 E-------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             H-------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             h-------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            1                         123457899999999999999999999999999999987644

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.2e-49  Score=364.61  Aligned_cols=284  Identities=30%  Similarity=0.519  Sum_probs=220.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++ ||||+++++++..   ......+
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~  109 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  109 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEE
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceE
Confidence            4567899999999999999999999999999999998644 344568999999997 9999999998853   2245588


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|...+.       .+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||++...
T Consensus       110 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999996 4444332       38899999999999999999999 799999999999999974558999999999877


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCHHHHh-hcC
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIR-CMN  265 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~  265 (376)
                      ..........+++.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+....+.+...... ...
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            666666667889999999999775668999999999999999999999984 455666676666665543322111 100


Q ss_pred             cCCcCc---cCCCCCCCCcccc----cccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          266 PNYTDF---RFPQIKAHPWHKV----FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       266 ~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ......   .........|...    ....+++++.+||.+||++||.+|||++|+|+||||+.+.+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            000000   0000111111111    22347999999999999999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.8e-50  Score=360.53  Aligned_cols=259  Identities=25%  Similarity=0.375  Sum_probs=201.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc------hHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++......      ..++...++.++||||+++++++..     ..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EG   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cC
Confidence            457899999999999999999999999999999998654221      1234445778899999999999843     34


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~-~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+++||||++|+|.+.+.........+++..++.++.|++.||.|||+ + ||+||||||+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~  157 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKMCDFGIS  157 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECT-TCCEEBCCC---
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecCCc
Confidence            488999999999988888776677889999999999999999999999 7 9999999999999996 778999999999


Q ss_pred             cccccCCCcceeeccccccChhhh---hCCCCCCccchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHH
Q 017139          185 KVLVKGEANISYICSRYYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~  260 (376)
                      .............||+.|+|||++   .....++.++|+|||||++|+|++|..||... .....+.........     
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  232 (290)
T 3fme_A          158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-----  232 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC-----
T ss_pred             ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC-----
Confidence            877665555566789999999997   23445889999999999999999999999864 344444443331110     


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                            ......+++++.++|.+||+.||++|||++++++||||+...
T Consensus       233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          233 ----------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             ----------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ----------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                                  001235789999999999999999999999999999998643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7e-50  Score=382.88  Aligned_cols=256  Identities=27%  Similarity=0.394  Sum_probs=209.6

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.     +
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~  219 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----T  219 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----E
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----e
Confidence            34578999999999999999999999999999999986431       22346888899999999999999984     4


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~-~~~~kl~DFG  294 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFG  294 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS-SSCEEECCCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC-CCCEEEccCC
Confidence            4458999999986 66666654    3579999999999999999999996249999999999999996 7889999999


Q ss_pred             CccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          183 SAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       183 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      +++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....        
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  365 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------  365 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------
Confidence            99764332 334457789999999999765 48999999999999999999999999888777766665421        


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                               .            .++..+++++.+||.+||++||.+||     +++++++||||+.+++.
T Consensus       366 ---------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          366 ---------I------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             ---------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------C------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                     0            13346799999999999999999999     99999999999998764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=362.87  Aligned_cols=247  Identities=27%  Similarity=0.375  Sum_probs=199.1

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccch------HHHHH-HHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQ-LMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~e~~-~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ++|++.++||+|+||+||+|++..+|+.||||++.......      ..|.. +.+..+||||+++++++     .+...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence            78999999999999999999999999999999986543221      12333 33445899999999998     44556


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|+|||||+++|.+.+...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECG-GGCEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEccceeeee
Confidence            8999999999988877653   4579999999999999999999999 79999999999999986 78899999999987


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......   +..  +..          
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~----------  269 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYL----------  269 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCC----------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCC----------
Confidence            765555556678999999999865  489999999999999999999777655432221   111  111          


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                     ...++..+++++.+||.+||++||++|||++++|+||||++
T Consensus       270 ---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          270 ---------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ---------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                           11133467999999999999999999999999999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-49  Score=384.38  Aligned_cols=260  Identities=26%  Similarity=0.400  Sum_probs=216.3

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      +...++|.+.+.||+|+||+||+|+++.+|+.||+|++.+..       ....+|+.+++.++||||+++++++     .
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~  255 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----E  255 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----e
Confidence            345689999999999999999999999999999999985432       2344799999999999999999988     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|||||+| +|...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus       256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~-~g~vkL~DF  333 (543)
T 3c4z_A          256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDL  333 (543)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCC
T ss_pred             eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeC-CCCEEEeec
Confidence            45568999999985 7777776654445679999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCC
Q 017139          182 GSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGTP  256 (376)
Q Consensus       182 g~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~~~~~~~~  256 (376)
                      |+++....... ....+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+    ..+....+....   
T Consensus       334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~---  409 (543)
T 3c4z_A          334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA---  409 (543)
T ss_dssp             TTCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC---
T ss_pred             ceeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc---
Confidence            99987654433 3345899999999999765 48999999999999999999999998753    233333333210   


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                                ..++..+++++++||.+||++||++||+     ++++++||||+.++|.
T Consensus       410 --------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          410 --------------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             --------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             --------------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence                                      0134568999999999999999999996     5899999999998764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-49  Score=383.79  Aligned_cols=258  Identities=29%  Similarity=0.474  Sum_probs=216.3

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++++.||+|+||+||+|++..+++.||||++...      .....+|+.+++.++||||+++++++     .+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcC
Confidence            4568999999999999999999999999999999998532      23355799999999999999999998     455


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEec
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDF  181 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Df  181 (376)
                      ..+|+|||||.| +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.  .++.+||+||
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             CEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            568999999985 77666654    2569999999999999999999999 79999999999999963  2457999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.........   
T Consensus       169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---  243 (486)
T 3mwu_A          169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---  243 (486)
T ss_dssp             SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS---
T ss_pred             CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence            99987766555566789999999999865  4899999999999999999999999999888877776653211111   


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                            ..+..+|+++++||.+||++||.+|||+.++|+||||+....
T Consensus       244 ----------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          244 ----------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             ----------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             ----------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                                  122457999999999999999999999999999999987644

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.5e-49  Score=372.63  Aligned_cols=286  Identities=21%  Similarity=0.326  Sum_probs=209.0

Q ss_pred             ccccceEeeeeeccC--CceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|++++.||+|  +||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++.     
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----   96 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----   96 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----
Confidence            456789999999999  99999999999999999999996543      23446999999999999999999984     


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|||||++ +|.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~df  172 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGL  172 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCG
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEccc
Confidence            34458999999984 777776643  23569999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCC--------CcceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 017139          182 GSAKVLVKGE--------ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV  252 (376)
Q Consensus       182 g~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  252 (376)
                      |.+.......        ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            9876543221        12234678999999999763 45899999999999999999999999887665554443321


Q ss_pred             cCCCC-------HHHHhhc-C-----cCCcC-----ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          253 LGTPT-------REEIRCM-N-----PNYTD-----FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       253 ~~~~~-------~~~~~~~-~-----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                      .....       .+.+... .     .....     ...+. ........++..+++++.+||.+||++||++|||++|+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            10000       0000000 0     00000     00000 00011122455689999999999999999999999999


Q ss_pred             hCCCccccccCC
Q 017139          315 CAHPFFDELREP  326 (376)
Q Consensus       315 l~hp~~~~~~~~  326 (376)
                      |+||||+.+.+.
T Consensus       332 l~hp~f~~~~~~  343 (389)
T 3gni_B          332 LNHSFFKQIKRR  343 (389)
T ss_dssp             TTSGGGGGC---
T ss_pred             hcCHHHHHHhhc
Confidence            999999988764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4e-49  Score=383.22  Aligned_cols=258  Identities=28%  Similarity=0.478  Sum_probs=217.3

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----------------cchHHHHHHHHhCCCCCeeecc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRLMDHPNVISLK   93 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------------~~~~~e~~~l~~l~h~~Iv~~~   93 (376)
                      ...++|.+++.||+|+||+||+|++..+++.||+|++....                 ....+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            45678999999999999999999999999999999986432                 2245799999999999999999


Q ss_pred             eeeeecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC
Q 017139           94 HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL  172 (376)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~  172 (376)
                      +++     .+...+|+|||||+| +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+
T Consensus       113 ~~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~  182 (504)
T 3q5i_A          113 DVF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENK  182 (504)
T ss_dssp             EEE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESST
T ss_pred             EEE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecC
Confidence            998     555668999999985 77776654    3569999999999999999999999 799999999999999863


Q ss_pred             C--CcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017139          173 T--HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  250 (376)
Q Consensus       173 ~--~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  250 (376)
                      +  ..+||+|||++.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+.
T Consensus       183 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  260 (504)
T 3q5i_A          183 NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE  260 (504)
T ss_dssp             TCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3  2699999999988766656667789999999999863  48999999999999999999999999998888877776


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ..........                         +..+++++++||.+||++||.+|||++++|+||||++...
T Consensus       261 ~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          261 KGKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HCCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             cCCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            6322222221                         2357999999999999999999999999999999987544

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=362.29  Aligned_cols=288  Identities=29%  Similarity=0.510  Sum_probs=221.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecC-------
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTT-------  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~-------  100 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++....       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            3467999999999999999999999999999999986543    23457999999999999999998873221       


Q ss_pred             --CCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          101 --SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       101 --~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                        ..+...+|+||||++|+|.+.+..     ..+++..++.++.|++.||+|||+ +||+||||||+||+++..++.+||
T Consensus        89 ~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             --CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEE
Confidence              134466889999999988877753     569999999999999999999999 799999999999999865778999


Q ss_pred             EecCCccccccC----CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          179 CDFGSAKVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       179 ~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      +|||++......    .......+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999865432    1223445689999999987656689999999999999999999999999998888888888776


Q ss_pred             CCCHHHHhhcCcCCcCccCC--CCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          255 TPTREEIRCMNPNYTDFRFP--QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ....+...........+...  .....+ ...+...+++++.+||.+||+.||++|||++++++||||+....+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKP-LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCC-HHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCC-hhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            66655443321111100000  000011 112334689999999999999999999999999999999976654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.3e-49  Score=353.23  Aligned_cols=257  Identities=30%  Similarity=0.448  Sum_probs=218.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ...++|++.+.||+|+||.||+|.+..++..+|+|++....    ....+|+++++.++||||+++++++     .+...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   80 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTD   80 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCe
Confidence            34578999999999999999999999999999999986532    3355799999999999999999998     44556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee---cCCCCcEEEEecC
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFG  182 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill---~~~~~~~kl~Dfg  182 (376)
                      +++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||++   +. ++.+||+|||
T Consensus        81 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~~~~l~Dfg  154 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSP-DSPLKLIDFG  154 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSST-TCCEEECCCT
T ss_pred             EEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCC-CCcEEEEecc
Confidence            8999999985 77666654    3569999999999999999999999 799999999999999   53 6789999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++.............+|+.|+|||++.+  .++.++|+|||||++|+|++|..||.+.+..+....+.......+...+ 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  231 (277)
T 3f3z_A          155 LAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-  231 (277)
T ss_dssp             TCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH-
T ss_pred             cceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh-
Confidence            9987766666667789999999999864  3899999999999999999999999998888777776664333322221 


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                              ..+++++.++|.+||+.||++|||+.++|+||||++...
T Consensus       232 ------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          232 ------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             ------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             ------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence                                    247899999999999999999999999999999987543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6e-50  Score=389.46  Aligned_cols=259  Identities=28%  Similarity=0.448  Sum_probs=215.3

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      +...++|.+.+.||+|+||.||+|++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++     .
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~  254 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----E  254 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----e
Confidence            456678999999999999999999999999999999985431       2245799999999999999999988     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|||||+| +|...+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~-~g~vKL~DF  330 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDD-HGHIRISDL  330 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeC-CCCeEEEec
Confidence            45569999999975 776666542  23459999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPTR  258 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~~~~  258 (376)
                      |++............+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+.   ...+...+...     
T Consensus       331 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-----  404 (576)
T 2acx_A          331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----  404 (576)
T ss_dssp             TTCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----
T ss_pred             ccceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----
Confidence            9998776655556678999999999997654 89999999999999999999999987542   22222222210     


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                             ...++..+++++++||.+||+.||.+||     +++|+++||||+.++|.
T Consensus       405 -----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          405 -----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             -----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             -----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                                   0113456899999999999999999999     89999999999998764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-49  Score=384.13  Aligned_cols=259  Identities=31%  Similarity=0.510  Sum_probs=219.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++     .+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   97 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED   97 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            45678999999999999999999999999999999985432       2345799999999999999999998     45


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEe
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCD  180 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~D  180 (376)
                      ...+|+|||||.| +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.  .++.+||+|
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            5668999999985 66666654    4679999999999999999999999 79999999999999952  367899999


Q ss_pred             cCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          181 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       181 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.........  
T Consensus       173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  248 (484)
T 3nyv_A          173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL--  248 (484)
T ss_dssp             TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--
T ss_pred             eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence            999987766666667789999999999975  4899999999999999999999999999888877776653211110  


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                                             ..+..+++++++||.+||++||.+|||+.++|+||||+.....
T Consensus       249 -----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          249 -----------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             -----------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             -----------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence                                   1223579999999999999999999999999999999886553

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-49  Score=368.11  Aligned_cols=279  Identities=29%  Similarity=0.452  Sum_probs=217.2

Q ss_pred             ccceEeeccCCCCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCC
Q 017139           15 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMD   85 (376)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~   85 (376)
                      ++...++.++|..  ....++|++.+.||+|+||.||+|.+..+++.||+|++....         ....+|+.+++.++
T Consensus         9 ~~~~~~~~q~~~~--~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   86 (345)
T 3hko_A            9 SGRENLYFQGGSL--LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH   86 (345)
T ss_dssp             -----CCCCCBCH--HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC
T ss_pred             CCCccccccCchh--hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC
Confidence            3444556666642  235578999999999999999999999999999999985431         23457999999999


Q ss_pred             CCCeeecceeeeecCCCCceeEEEEeecccc-hHHHHHHhhhhc------------------------------------
Q 017139           86 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSM------------------------------------  128 (376)
Q Consensus        86 h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~------------------------------------  128 (376)
                      ||||+++++++     .+...+++|||||+| +|.+.+..+...                                    
T Consensus        87 hpniv~~~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (345)
T 3hko_A           87 HPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL  161 (345)
T ss_dssp             CTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred             CCCcceeehhh-----ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            99999999998     445568999999974 776666421111                                    


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC-CcEEEEecCCccccccCC-----Ccceeeccccc
Q 017139          129 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQVKLCDFGSAKVLVKGE-----ANISYICSRYY  202 (376)
Q Consensus       129 ~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~-~~~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y  202 (376)
                      ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ ..+||+|||++.......     ......||+.|
T Consensus       162 ~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y  240 (345)
T 3hko_A          162 DFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF  240 (345)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence            2235788899999999999999999 7999999999999998522 279999999998653322     12356789999


Q ss_pred             cChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCc
Q 017139          203 RAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW  281 (376)
Q Consensus       203 ~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      +|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+.........                       
T Consensus       241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------------------  297 (345)
T 3hko_A          241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-----------------------  297 (345)
T ss_dssp             CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-----------------------
T ss_pred             cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-----------------------
Confidence            999998642 45899999999999999999999999999888877776653221111                       


Q ss_pred             ccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          282 HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       282 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                        .....+++++.+||.+||+.||.+|||+.++|+||||+++.+.
T Consensus       298 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          298 --PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             --GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             --cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence              0123478999999999999999999999999999999987654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.4e-49  Score=393.24  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=217.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|++.+.||+|+||+||+|++..+++.||||++.+..       .....|..++..+ +||||+.+++++     .
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~  412 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q  412 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----B
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----E
Confidence            35678999999999999999999999999999999986431       2234688888876 799999999988     5


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+||||++| +|...+..    ...+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~-~g~ikL~DF  486 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADF  486 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECS-SSCEEECCC
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcC-CCcEEEeec
Confidence            55669999999985 77766664    3569999999999999999999999 79999999999999996 788999999


Q ss_pred             CCcccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....       
T Consensus       487 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------  558 (674)
T 3pfq_A          487 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------  558 (674)
T ss_dssp             TTCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-------
T ss_pred             ceeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-------
Confidence            99986432 3344567899999999999765 48999999999999999999999999998888877776521       


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH-----HHHhCCCccccccCCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN  327 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~hp~~~~~~~~~  327 (376)
                                            ..++..+++++++||.+||++||++|+++     +++++||||+.++|..
T Consensus       559 ----------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          559 ----------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence                                  11445689999999999999999999997     9999999999988753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=369.58  Aligned_cols=255  Identities=27%  Similarity=0.385  Sum_probs=209.0

Q ss_pred             ceEe--eeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           35 SYMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        35 ~y~~--~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .|.+  .+.||+|+||.||+|.+..+|+.||+|++....    ....+|+.+++.++||||+++++++     .+...++
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~  162 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIV  162 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            4554  678999999999999999999999999986542    3445799999999999999999998     4445589


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec-CCCCcEEEEecCCccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKV  186 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~-~~~~~~kl~Dfg~~~~  186 (376)
                      +|||||++ +|.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+|||+. ..++.+||+|||+++.
T Consensus       163 lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARR  238 (373)
T ss_dssp             EEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence            99999985 77666654   23468999999999999999999999 7999999999999983 2367899999999988


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........        
T Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------  309 (373)
T 2x4f_A          239 YKPREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED--------  309 (373)
T ss_dssp             CCTTCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS--------
T ss_pred             cCCccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh--------
Confidence            7666555667799999999998654 4899999999999999999999999999888888777663221111        


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                       .....+++++++||.+||+.||.+|||++++|+||||++..
T Consensus       310 -----------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 -----------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             -----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             -----------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                             11235799999999999999999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.6e-49  Score=381.27  Aligned_cols=257  Identities=28%  Similarity=0.464  Sum_probs=214.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++++.||+|+||+||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++     .+.
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~  108 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDK  108 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence            35568999999999999999999999999999999986432      2345799999999999999999998     445


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEEEEec
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDF  181 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~kl~Df  181 (376)
                      ..+|+|||||.| +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++..  ++.+||+||
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  183 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDF  183 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEEC
Confidence            568999999985 77666654    3569999999999999999999999 799999999999999742  345999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |++.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+..........  
T Consensus       184 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  259 (494)
T 3lij_A          184 GLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP--  259 (494)
T ss_dssp             TTCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG--
T ss_pred             CCCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch--
Confidence            99988766655667789999999999853  48999999999999999999999999998888777766532221111  


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                             .+..+++++++||.+||++||.+|||+.++|+||||++..
T Consensus       260 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          260 -----------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             -----------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             -----------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                                   2245799999999999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-48  Score=362.46  Aligned_cols=250  Identities=29%  Similarity=0.436  Sum_probs=211.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence            357999999999999999999999999999999986432       224479999999999999999999844     34


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      ..++|||||.|++.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus       128 ~~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~  202 (348)
T 1u5q_A          128 TAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSAS  202 (348)
T ss_dssp             EEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCB
T ss_pred             eEEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEeeccCce
Confidence            58899999999988877542   4679999999999999999999999 79999999999999996 7899999999997


Q ss_pred             ccccCCCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          186 VLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ....   .....||+.|+|||++.+  ...++.++|||||||++|+|++|..||.+.+....+..+.......       
T Consensus       203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------  272 (348)
T 1u5q_A          203 IMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------  272 (348)
T ss_dssp             SSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------
T ss_pred             ecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence            6533   235678999999999853  3458999999999999999999999999888777666554421100       


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                          .....+++.+.+||.+||+.||++|||++++++||||..
T Consensus       273 --------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          273 --------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence                                012356889999999999999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.8e-48  Score=362.17  Aligned_cols=253  Identities=28%  Similarity=0.459  Sum_probs=213.7

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      ++|.+.+.||+|+||.||+|.+..+|+.||||++....            ....+|+.+++.+ +||||+++++++    
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----  169 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY----  169 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence            68999999999999999999999999999999986542            2234688999998 799999999988    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                       ......|+||||++| +|.+.+..    ...+++..++.++.||+.||.|||+ .||+|+||||+||+++. ++.+||+
T Consensus       170 -~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~-~~~ikl~  242 (365)
T 2y7j_A          170 -ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDD-NMQIRLS  242 (365)
T ss_dssp             -EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEEC
T ss_pred             -eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEE
Confidence             445568999999986 77776654    3569999999999999999999999 79999999999999996 7889999


Q ss_pred             ecCCccccccCCCcceeeccccccChhhhhCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          180 DFGSAKVLVKGEANISYICSRYYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       180 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      |||++.............||+.|+|||++.+.     ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999877665555667899999999998632     2478899999999999999999999998887776666655322


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      ......                         +..++.++.++|.+||+.||++|||++++|+||||++
T Consensus       323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            222111                         1357889999999999999999999999999999973

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-48  Score=351.73  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=212.6

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....          ....+|+.+++.++||||+++++++     .
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~   78 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----E   78 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----c
Confidence            467999999999999999999999999999999986432          2345799999999999999999998     3


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC----cEE
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVK  177 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~----~~k  177 (376)
                      +...+++||||++ ++|.+.+..    ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++    .+|
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~~~~k  152 (283)
T 3bhy_A           79 NKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLD-KNVPNPRIK  152 (283)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESC-SSSSSCCEE
T ss_pred             CCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEec-CCCCCCceE
Confidence            4455899999997 577777754    3569999999999999999999999 79999999999999986 44    799


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |+|||++.............+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+........
T Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  231 (283)
T 3bhy_A          153 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD  231 (283)
T ss_dssp             ECCCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred             EEecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc
Confidence            9999999876555555566789999999998654 489999999999999999999999998887776666544322111


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                      .                         .....+++.+.++|.+||+.||++|||+.++++||||+.+....
T Consensus       232 ~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          232 E-------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             H-------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             c-------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            1                         12245789999999999999999999999999999999876654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.2e-49  Score=369.87  Aligned_cols=262  Identities=26%  Similarity=0.365  Sum_probs=201.3

Q ss_pred             ccccceEee-eeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHH-HhCCCCCeeecceeeeecCCCCceeEE
Q 017139           31 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        31 ~~~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l-~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ...++|.+. +.||.|+||+||+|.+..+|+.||||++... ....+|+.++ +..+||||+++++++.... .+..++|
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~  135 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL  135 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEE
Confidence            355788887 7999999999999999999999999998644 3455688876 5568999999999874322 3466789


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEEEEecCCcc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAK  185 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~kl~Dfg~~~  185 (376)
                      +|||||+| +|.+.+...  ....+++..++.++.||+.||.|||+ +||+||||||+|||++..  ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            99999985 777777642  23469999999999999999999999 799999999999999853  5789999999998


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCCHHHH
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPTREEI  261 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~  261 (376)
                      ...........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+...    ....+...         
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~---------  282 (400)
T 1nxk_A          213 ETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------  282 (400)
T ss_dssp             ECC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT---------
T ss_pred             ccCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC---------
Confidence            76655555677889999999998654 58999999999999999999999997754321    11222110         


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                              .+.++.        ..+..+++++++||.+||+.||++|||++++++||||.+.
T Consensus       283 --------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          283 --------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             --------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             --------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                    011110        0123579999999999999999999999999999999764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-48  Score=350.27  Aligned_cols=253  Identities=28%  Similarity=0.456  Sum_probs=210.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++     .+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   80 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD   80 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence            4568899999999999999999999999999999998543       22345799999999999999999998     44


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+++||||+++ +|.+.+...    ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~l~Dfg  154 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFG  154 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECT-TSCEEECSCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcC-CCCEEEEecc
Confidence            4568999999985 777766543    569999999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++...... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+.....        
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  224 (279)
T 3fdn_A          155 WSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------  224 (279)
T ss_dssp             EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------
T ss_pred             ccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------
Confidence            88654332 23456789999999999764 489999999999999999999999998887776666544211        


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                           .++..+++++.+||.+||+.||.+|||++++++||||+....
T Consensus       225 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          225 ---------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                                 123457899999999999999999999999999999987544

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.5e-48  Score=351.86  Aligned_cols=257  Identities=28%  Similarity=0.437  Sum_probs=214.8

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      |...++|.+.+.||+|+||.||+|.+..+++.+|+|++....       ....+|+.+++.++||||+++++++     .
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~   85 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----E   85 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----c
Confidence            456678999999999999999999999999999999986542       2234699999999999999999998     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~df  159 (294)
T 2rku_A           86 DNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDF  159 (294)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCC
T ss_pred             cCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcC-CCCEEEEec
Confidence            45568999999995 66665554    3579999999999999999999999 79999999999999996 778999999


Q ss_pred             CCccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |++...... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+....       
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------  231 (294)
T 2rku_A          160 GLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-------  231 (294)
T ss_dssp             TTCEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------
T ss_pred             cCceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-------
Confidence            999876433 233455689999999999664 48999999999999999999999999887766555443310       


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                                .            .++..+++++.++|.+||+.||++|||++++++||||+....+.
T Consensus       232 ----------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          232 ----------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             ----------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             ----------C------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence                      0            12345789999999999999999999999999999998765443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-48  Score=359.38  Aligned_cols=256  Identities=26%  Similarity=0.403  Sum_probs=189.9

Q ss_pred             cccceEee---eeeccCCceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHhCC-CCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAE---RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~---~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|.+.   +.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+. ||||+++++++     .+...
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~   80 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLH   80 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCE
Confidence            34678875   78999999999999999999999999996543 34567999999997 99999999998     45556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC--CcEEEEecCC
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGS  183 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~--~~~kl~Dfg~  183 (376)
                      +|+|||||+| +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++  ..+||+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             EEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence            8999999986 77777764    4679999999999999999999999 7999999999999997522  2799999999


Q ss_pred             ccccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCC
Q 017139          184 AKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-------VDQLVEIIKVLGT  255 (376)
Q Consensus       184 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-------~~~~~~~~~~~~~  255 (376)
                      +....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.       .+....+......
T Consensus       156 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~  234 (325)
T 3kn6_A          156 ARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS  234 (325)
T ss_dssp             CEECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred             ceecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence            98654432 23456779999999999765 489999999999999999999999986543       2222222221100


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                               +....+..+++++++||.+||+.||.+|||++++++||||++.
T Consensus       235 -------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          235 -------------------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             -------------------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             -------------------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                                     1111224579999999999999999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-48  Score=366.21  Aligned_cols=284  Identities=31%  Similarity=0.524  Sum_probs=219.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCC-CC-----CeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMD-HP-----NVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~-h~-----~Iv~~~~~~~~~~~  101 (376)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++.....   ....|+.+++.++ |+     +|+++++++..   
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~---  127 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF---  127 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE---
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc---
Confidence            346799999999999999999999999999999999975532   2345788888775 44     48888888843   


Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CCceeccCCCCCeeecC-CCCcEEEE
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDP-LTHQVKLC  179 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-~~ivH~dlkp~Nill~~-~~~~~kl~  179 (376)
                        ...+|+||||++++|.+.+....  ...+++..++.++.|++.||.|||+. .||+||||||+|||++. .++.+||+
T Consensus       128 --~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          128 --RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             --TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             --CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence              34589999999999988887632  24589999999999999999999941 58999999999999952 36679999


Q ss_pred             ecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          180 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       180 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      |||++.....  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++..
T Consensus       204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CCTTCEETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eccCceeccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999987543  234567899999999997654 8999999999999999999999999999999999999999988876


Q ss_pred             HHhhcCcC------C--cCcc----------CCCCCCCCccccccc-----------------CCChhHHHHHHhhcCCC
Q 017139          260 EIRCMNPN------Y--TDFR----------FPQIKAHPWHKVFHK-----------------RMPPEAIDLASRLLQYS  304 (376)
Q Consensus       260 ~~~~~~~~------~--~~~~----------~~~~~~~~~~~~~~~-----------------~~~~~~~~li~~~L~~d  304 (376)
                      .+......      .  ..+.          +.......+...+..                 ..++++++||.+||++|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence            65432110      0  0000          000000000000000                 00137899999999999


Q ss_pred             CCCCCCHHHHhCCCcccccc
Q 017139          305 PSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       305 P~~R~t~~ell~hp~~~~~~  324 (376)
                      |++|||++|+|+||||++..
T Consensus       361 P~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          361 PKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTTSCCHHHHTTSGGGCC--
T ss_pred             hhhCCCHHHHhcCcccccCC
Confidence            99999999999999998753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6e-49  Score=373.12  Aligned_cols=256  Identities=27%  Similarity=0.461  Sum_probs=198.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....            ....+|+.+++.++||||+++++++    
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~----  209 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF----  209 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE----
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            578999999999999999999999999999999986432            2346799999999999999999987    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVK  177 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~k  177 (376)
                       ..+. +|+|||||++ +|.+.+    .....+++..++.++.|++.||+|||+ +||+||||||+|||++..  +..+|
T Consensus       210 -~~~~-~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          210 -DAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             -ESSE-EEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             -ecCc-eEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence             2222 6899999986 543333    345779999999999999999999999 799999999999999742  34599


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      |+|||+++............||+.|+|||++.+  ...++.++|||||||++|+|++|..||........+...+.....
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999988766555566789999999999853  345788999999999999999999999876543333332221111


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ..                        ....+..+++++.+||.+||++||++|||++++|+||||++.
T Consensus       363 ~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CC------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            00                        011224579999999999999999999999999999999764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.3e-48  Score=354.17  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=211.5

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .+.....|...+.||+|+||.||+|++..+|+.||||++.....    ...+|+.+++.++||||+++++++..     .
T Consensus        40 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~  114 (321)
T 2c30_A           40 QGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----G  114 (321)
T ss_dssp             SSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred             CCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----C
Confidence            33444568999999999999999999999999999999864432    24579999999999999999999844     3


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++||||++| +|.+.+.     ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus       115 ~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~  187 (321)
T 2c30_A          115 EELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTL-DGRVKLSDFGF  187 (321)
T ss_dssp             TEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCcEEEeeeee
Confidence            348899999986 6655543     2569999999999999999999999 79999999999999996 77899999999


Q ss_pred             ccccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          184 AKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       184 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      +....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......      
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------  260 (321)
T 2c30_A          188 CAQISKDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK------  260 (321)
T ss_dssp             CEECCSSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC------
T ss_pred             eeecccCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC------
Confidence            87664432 33456789999999999664 48999999999999999999999999887776665554321100      


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                          ......+++++.++|.+||+.||++|||++++++||||.+..
T Consensus       261 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          261 --------------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             --------------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             --------------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                                001234789999999999999999999999999999998643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.1e-49  Score=361.24  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=208.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFS   98 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~Iv~~~~~~~~   98 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++  
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--   98 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--   98 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence            34578999999999999999999999999999999986542            2344799999999999999999998  


Q ss_pred             cCCCCceeEEEEeeccc-c-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcE
Q 017139           99 TTSKDELFLNLVMEYVP-E-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV  176 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~-g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~  176 (376)
                         .+...+++||||+. | +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+
T Consensus        99 ---~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~  169 (335)
T 3dls_A           99 ---ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAE-DFTI  169 (335)
T ss_dssp             ---ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCE
T ss_pred             ---eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcC-CCcE
Confidence               45556899999986 4 66666653    4679999999999999999999999 79999999999999996 7889


Q ss_pred             EEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          177 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      ||+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||......      ..     
T Consensus       170 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-----  238 (335)
T 3dls_A          170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-----  238 (335)
T ss_dssp             EECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-----
T ss_pred             EEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-----
Confidence            9999999988766666667789999999999977654588999999999999999999999652210      00     


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                  .            ....+..+++++.+||.+||+.||++|||++++++||||++
T Consensus       239 ------------~------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          239 ------------A------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             ------------T------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             ------------h------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence                        0            00122347899999999999999999999999999999976

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.9e-48  Score=349.99  Aligned_cols=260  Identities=27%  Similarity=0.388  Sum_probs=215.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------------cchHHHHHHHHhCC-CCCeeecceee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMD-HPNVISLKHCF   96 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------------~~~~~e~~~l~~l~-h~~Iv~~~~~~   96 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++....             ....+|+.+++.+. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            45578999999999999999999999999999999986432             22346889999995 99999999998


Q ss_pred             eecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc
Q 017139           97 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ  175 (376)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~  175 (376)
                           .....+++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ +|++|+||||+||+++. ++.
T Consensus        94 -----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~  162 (298)
T 1phk_A           94 -----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMN  162 (298)
T ss_dssp             -----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCC
T ss_pred             -----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcC-CCc
Confidence                 455668999999984 77777764    3569999999999999999999999 79999999999999996 778


Q ss_pred             EEEEecCCccccccCCCcceeeccccccChhhhh-----CCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017139          176 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  250 (376)
Q Consensus       176 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  250 (376)
                      +||+|||++.............+++.|+|||++.     ....++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  242 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM  242 (298)
T ss_dssp             EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence            9999999998776655556677899999999985     23447889999999999999999999999888776666555


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ........                         .....++.++.++|.+||+.||.+|||++++++||||++....
T Consensus       243 ~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          243 SGNYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             HTCCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cCCcccCc-------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            42111110                         0123578999999999999999999999999999999986554

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.3e-48  Score=366.64  Aligned_cols=284  Identities=27%  Similarity=0.397  Sum_probs=221.8

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCC--------CCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD--------HPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~--------h~~Iv~~~~~~~~~~  100 (376)
                      ..++|++.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.+.        |+||+++++++....
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            3478999999999999999999999999999999997543   23447899998885        788999999885332


Q ss_pred             CCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CceeccCCCCCeeecCCC------
Q 017139          101 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLT------  173 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~-~ivH~dlkp~Nill~~~~------  173 (376)
                       .+...+|+||||+++++.+.+...  ....+++..++.++.||+.||.|||+ + ||+||||||+|||++.++      
T Consensus       115 -~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 -VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             -TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             -CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhh
Confidence             256678999999999888877653  23569999999999999999999999 8 999999999999998532      


Q ss_pred             ------------------------------------------CcEEEEecCCccccccCCCcceeeccccccChhhhhCC
Q 017139          174 ------------------------------------------HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA  211 (376)
Q Consensus       174 ------------------------------------------~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  211 (376)
                                                                ..+||+|||++......  .....||+.|+|||++.+.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTS
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCC
Confidence                                                      27999999999865433  3456789999999999875


Q ss_pred             CCCCccchhHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCHHHHhhcCcCCcCc-------cCCCCCC
Q 017139          212 TEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKA  278 (376)
Q Consensus       212 ~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~  278 (376)
                      . ++.++|||||||++|+|++|..||.+.+      ..+.+..+.+..+.++...+.........+       .+.....
T Consensus       269 ~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          269 G-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             C-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             C-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            4 8999999999999999999999998654      567778888888888776553222110000       0000000


Q ss_pred             CCccc------ccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          279 HPWHK------VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       279 ~~~~~------~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      .....      .++...++++.+||.+||++||++|||++|+|+||||+.
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            00000      012234567899999999999999999999999999973

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.7e-48  Score=347.83  Aligned_cols=254  Identities=26%  Similarity=0.431  Sum_probs=214.0

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++     .
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~   84 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----H   84 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----E
Confidence            34568899999999999999999999999999999998543       12345799999999999999999998     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+||||+++ +|.+.+...    ..+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Df  158 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGY-KGELKIADF  158 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TCCEEECCC
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcC-CCCEEEecc
Confidence            44568999999985 777777652    568999999999999999999999 79999999999999996 778999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |++...... ......|++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+....        
T Consensus       159 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------  228 (284)
T 2vgo_A          159 GWSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--------  228 (284)
T ss_dssp             TTCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------
T ss_pred             cccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--------
Confidence            998765432 23456789999999999765 48999999999999999999999999887766655544310        


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                           ..++..++.++.++|.+||+.||.+|||++++++||||+....
T Consensus       229 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          229 ---------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             ---------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence                                 0133457899999999999999999999999999999987543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.1e-48  Score=355.88  Aligned_cols=264  Identities=24%  Similarity=0.348  Sum_probs=212.7

Q ss_pred             ccccceEee-eeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCC
Q 017139           31 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|.+. +.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.+. ||||+++++++     .
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~   99 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----E   99 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence            345679888 89999999999999999999999999986532      23457889999885 69999999998     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEE
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLC  179 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~  179 (376)
                      +...+++|||||.+ +|.+.+..  .....+++..++.++.|++.||+|||+ +||+||||||+||+++.  .++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEe
Confidence            55568999999986 55444432  224679999999999999999999999 79999999999999984  25689999


Q ss_pred             ecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          180 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       180 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      |||++.............||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+......... 
T Consensus       177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-  254 (327)
T 3lm5_A          177 DFGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-  254 (327)
T ss_dssp             CGGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred             eCccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-
Confidence            99999877655555567899999999999765 4899999999999999999999999998887777766553222111 


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA  328 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~  328 (376)
                                              .....+++.+.+||.+||+.||.+|||++++|+||||+++++...
T Consensus       255 ------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          255 ------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             ------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             ------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence                                    122357899999999999999999999999999999999877654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.9e-48  Score=356.00  Aligned_cols=256  Identities=28%  Similarity=0.439  Sum_probs=215.3

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      +...++|.+.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++     .
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  111 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----E  111 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence            455679999999999999999999999999999999986542       2345799999999999999999998     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|||||++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Df  185 (335)
T 2owb_A          112 DNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDF  185 (335)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCC
T ss_pred             cCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcC-CCCEEEeec
Confidence            45568999999995 77666554    3579999999999999999999999 79999999999999996 778999999


Q ss_pred             CCccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          182 GSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       182 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |++...... .......|++.|+|||++.+. .++.++|||||||++|+|++|..||......+....+....       
T Consensus       186 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------  257 (335)
T 2owb_A          186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-------  257 (335)
T ss_dssp             TTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------
T ss_pred             cCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-------
Confidence            999876433 233456789999999999765 48999999999999999999999999887766655544310       


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                                +            .++..+++++.+||.+||+.||++|||++++++||||+....+
T Consensus       258 ----------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          258 ----------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             ----------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ----------C------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence                      0            1234578999999999999999999999999999999876544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.6e-48  Score=357.45  Aligned_cols=258  Identities=22%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC-----
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS-----  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-----  101 (376)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....     ....+|+.+++.++||||+++++++.....     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999999999999999986432     234579999999999999999998865432     


Q ss_pred             -----------------------------------------------CCceeEEEEeecccc-hHHHHHHhhhhcCCCCC
Q 017139          102 -----------------------------------------------KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMP  133 (376)
Q Consensus       102 -----------------------------------------------~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~  133 (376)
                                                                     ....++++|||||+| +|.+.+.... .....+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~  162 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE  162 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence                                                           223458999999986 7766665532 233456


Q ss_pred             HHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCC-------------Ccceeeccc
Q 017139          134 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-------------ANISYICSR  200 (376)
Q Consensus       134 ~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~t~  200 (376)
                      +..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.......             ......||+
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hHHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeC-CCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            67789999999999999999 79999999999999996 7789999999998765432             223456899


Q ss_pred             cccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCC
Q 017139          201 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP  280 (376)
Q Consensus       201 ~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      .|+|||++.+. .++.++|||||||++|+|++|..|+...  ......+..  +..+.                      
T Consensus       241 ~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~--~~~~~----------------------  293 (332)
T 3qd2_B          241 LYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN--LKFPL----------------------  293 (332)
T ss_dssp             GGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT--TCCCH----------------------
T ss_pred             CccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc--cCCCc----------------------
Confidence            99999999765 4899999999999999999987764211  111111111  11110                      


Q ss_pred             cccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          281 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       281 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                          .....++++.+||.+||+.||++|||++++++||||+++
T Consensus       294 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ----LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ----HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ----ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence                112347788999999999999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.4e-47  Score=344.77  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=210.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .....|.+.+.||+|+||.||+|.+..++..||+|++....      ....+|+.+++.++||||+++++++.... .+.
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~  101 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK  101 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence            34456999999999999999999999999999999986432      22457999999999999999999875443 456


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--ceeccCCCCCeeecCCCCcEEEEec
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~--ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ..+++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ +|  |+||||||+||+++..++.+||+||
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             ceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            778999999975 77777764    3568999999999999999999999 78  9999999999999844788999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |++..... .......|++.|+|||++.+  .++.++|+|||||++|+|++|..||..................      
T Consensus       177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  247 (290)
T 1t4h_A          177 GLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------  247 (290)
T ss_dssp             TGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------
T ss_pred             CCcccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC------
Confidence            99975433 33345678999999998864  4899999999999999999999999886655444433321111      


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                          ...++...++++.++|.+||+.||++|||++++++||||++
T Consensus       248 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 --------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             --------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             --------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                11133456889999999999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=349.57  Aligned_cols=252  Identities=28%  Similarity=0.481  Sum_probs=186.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|.+.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     .+.
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   83 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDS   83 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECS
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccC
Confidence            4578999999999999999999999999999999985432       3345799999999999999999998     445


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~  158 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTR-NMNIKIADFGL  158 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECT-TCCEEECCCTT
T ss_pred             CeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEEeecc
Confidence            568999999975 77666654   23679999999999999999999999 79999999999999996 77899999999


Q ss_pred             ccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          184 AKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       184 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      +...... .......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+....+..           
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------  226 (278)
T 3cok_A          159 ATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----------  226 (278)
T ss_dssp             CEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------
T ss_pred             eeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------
Confidence            9865432 223356789999999998764 489999999999999999999999987654332221110           


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                            ..            ...+..++.++.++|.+||+.||++|||++++++||||...
T Consensus       227 ------~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          227 ------AD------------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             ------SC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             ------cc------------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence                  00            01234578999999999999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-48  Score=351.21  Aligned_cols=260  Identities=28%  Similarity=0.435  Sum_probs=212.8

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....        ....+|+.+++.++||||+++++++..   .+
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   79 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EE   79 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C-
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CC
Confidence            3567999999999999999999999999999999985431        334579999999999999999998753   33


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+|+|||||++++.+.+....  ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus        80 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~-~~~~kl~dfg~  155 (305)
T 2wtk_C           80 KQKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTT-GGTLKISALGV  155 (305)
T ss_dssp             --CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTT
T ss_pred             CCeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcC-CCcEEeecccc
Confidence            44588999999998877776532  4679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCC---CcceeeccccccChhhhhCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          184 AKVLVKGE---ANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       184 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      +.......   ......+++.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+....      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~------  229 (305)
T 2wtk_C          156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS------  229 (305)
T ss_dssp             CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC------
T ss_pred             ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC------
Confidence            98654322   223456899999999986533 24779999999999999999999999887766665554310      


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  327 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~  327 (376)
                                 +            .++..+++++.++|.+||+.||++|||++++++||||++...+.
T Consensus       230 -----------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          230 -----------Y------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             -----------C------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             -----------C------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence                       0            12345789999999999999999999999999999998765543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-48  Score=357.13  Aligned_cols=254  Identities=24%  Similarity=0.327  Sum_probs=201.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCC--CCeeecceeeeecCCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDH--PNVISLKHCFFSTTSKD  103 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h--~~Iv~~~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++....      ....+|+.+++.++|  |||+++++++     .+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~   80 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----IT   80 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----ee
Confidence            345799999999999999999987 468999999986442      223479999999987  9999999988     44


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+|+|||+++++|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++  ++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~--~~~~kl~DFG~  153 (343)
T 3dbq_A           81 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGI  153 (343)
T ss_dssp             SSEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred             CCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE--CCcEEEeeccc
Confidence            556899999888898888765    4679999999999999999999999 7999999999999997  56799999999


Q ss_pred             ccccccCCC---cceeeccccccChhhhhC----------CCCCCccchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 017139          184 AKVLVKGEA---NISYICSRYYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEI  249 (376)
Q Consensus       184 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~  249 (376)
                      +........   .....||+.|+|||++.+          ...++.++|||||||++|+|++|..||...... ..+..+
T Consensus       154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  233 (343)
T 3dbq_A          154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  233 (343)
T ss_dssp             SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence            987644322   235678999999999864          235889999999999999999999999875432 223222


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ....                           ....++...+.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       234 ~~~~---------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          234 IDPN---------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             HCTT---------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             hcCC---------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            2210                           011133456789999999999999999999999999999986433

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5e-48  Score=346.58  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=204.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     ..
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   82 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----ST   82 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ec
Confidence            45678999999999999999999999999999999985432       2345799999999999999999988     34


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg  156 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADFG  156 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECT-TSCEEECCCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECC-CCCEEEeecc
Confidence            4558999999975 88777764    2568999999999999999999999 79999999999999996 7789999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++.............+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+.....        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  228 (276)
T 2h6d_A          157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF--------  228 (276)
T ss_dssp             GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred             cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--------
Confidence            998766555455667899999999997655447899999999999999999999988776665555443110        


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                           .++..++.++.++|.+||+.||++|||++++++||||++
T Consensus       229 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          229 ---------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ---------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence                                 023457899999999999999999999999999999976

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.2e-48  Score=352.05  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=198.3

Q ss_pred             ccccceEee-eeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHh-CCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~-l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|.+. +.||+|+||.||+|.+..+++.||||++....    ....+|+.+++. ++||||+++++++.     +.
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~   83 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EE   83 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eC
Confidence            345679995 78999999999999999999999999986543    234578999988 47999999999984     34


Q ss_pred             eeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC--cEEEEec
Q 017139          105 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDF  181 (376)
Q Consensus       105 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~--~~kl~Df  181 (376)
                      ..+|+|||||+ ++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++.  .+||+||
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             CEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence            45899999998 577777765    2568999999999999999999999 79999999999999986332  3999999


Q ss_pred             CCccccccCC--------CcceeeccccccChhhhhCC----CCCCccchhHHHHHHHHHHHhCCCCCCCCCh-------
Q 017139          182 GSAKVLVKGE--------ANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-------  242 (376)
Q Consensus       182 g~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~-------  242 (376)
                      |++.......        ......||+.|+|||++.+.    ..++.++|||||||++|+|++|..||.+...       
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence            9987653221        12244589999999998641    2378999999999999999999999987542       


Q ss_pred             --------HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          243 --------VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       243 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                              ......+.......+.                         .....+++++++||.+||+.||++|||++|+
T Consensus       239 ~~~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~  293 (316)
T 2ac3_A          239 GEACPACQNMLFESIQEGKYEFPD-------------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQV  293 (316)
T ss_dssp             --CCHHHHHHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             cccchhHHHHHHHHHhccCcccCc-------------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence                    1122222221111110                         0113578999999999999999999999999


Q ss_pred             hCCCccccccC
Q 017139          315 CAHPFFDELRE  325 (376)
Q Consensus       315 l~hp~~~~~~~  325 (376)
                      ++||||++...
T Consensus       294 l~hp~~~~~~~  304 (316)
T 2ac3_A          294 LQHPWVQGCAP  304 (316)
T ss_dssp             HHSTTCC----
T ss_pred             hcChhhcCCCC
Confidence            99999987644

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-49  Score=359.43  Aligned_cols=278  Identities=20%  Similarity=0.298  Sum_probs=209.8

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+++++.++||||+++++++..   .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~   83 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRH   83 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCce
Confidence            3468999999999999999999999999999999986432     234579999999999999999998753   23345


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee----cCCCCcEEEEec
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV----DPLTHQVKLCDF  181 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill----~~~~~~~kl~Df  181 (376)
                      +|+|||||+ ++|.+.+.... ....+++..++.++.||+.||.|||+ +||+||||||+|||+    +. ++.+||+||
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~Df  160 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDF  160 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTS-CEEEEECCC
T ss_pred             EEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCC-CceEEEccC
Confidence            789999998 57777776532 23449999999999999999999999 799999999999998    53 667999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhC-------CCCCCccchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEII  250 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~~  250 (376)
                      |+++............||+.|+|||++..       ...++.++|||||||++|+|++|..||....    ..+....+.
T Consensus       161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            99988766666667789999999999862       2458999999999999999999999997533    233444443


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                      ..........+.........+.    ...+....+...++..+.++|.+||++||++|||++|+|+||-
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWS----GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEE----SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccC----ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            3211111111100000000000    0001111223445678999999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.9e-48  Score=361.40  Aligned_cols=253  Identities=24%  Similarity=0.326  Sum_probs=200.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCC--CCCeeecceeeeecCCCCc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD--HPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~--h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..+|++.+.||+|+||.||+|.+.. ++.||||++....      ....+|+.+++.+.  ||||+++++++.     ..
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~  128 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD  128 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cC
Confidence            3569999999999999999999765 8999999986543      23457999999996  599999999884     34


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+|||+++++|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++  ++.+||+|||++
T Consensus       129 ~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~--~~~~kl~DFG~a  201 (390)
T 2zmd_A          129 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIA  201 (390)
T ss_dssp             SEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES--SSCEEECCCSSS
T ss_pred             CEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE--CCeEEEEecCcc
Confidence            45899999877888888765    3578999999999999999999999 7999999999999996  567999999999


Q ss_pred             cccccCCC---cceeeccccccChhhhhCC----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH
Q 017139          185 KVLVKGEA---NISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEII  250 (376)
Q Consensus       185 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~  250 (376)
                      +.......   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|..||..... ...+..+.
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence            87643322   2356789999999998651          3488999999999999999999999987543 23333332


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ....                           ...++...+.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       282 ~~~~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          282 DPNH---------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CTTS---------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             Cccc---------------------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            2100                           01123345789999999999999999999999999999986443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.6e-47  Score=358.06  Aligned_cols=293  Identities=29%  Similarity=0.493  Sum_probs=225.6

Q ss_pred             CCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCC-----------CCCeeec
Q 017139           27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----------HPNVISL   92 (376)
Q Consensus        27 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~-----------h~~Iv~~   92 (376)
                      .+.+...++|++.+.||+|+||.||+|++..+++.||||++..+.   ....+|+.+++.++           ||||+++
T Consensus        12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           12 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             cCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            455566789999999999999999999999999999999997543   23456888888776           8999999


Q ss_pred             ceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CceeccCCCCCeeecC
Q 017139           93 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDP  171 (376)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~-~ivH~dlkp~Nill~~  171 (376)
                      ++++.... .+...+++||||++++|.+.+....  ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.
T Consensus        92 ~~~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           92 LDHFNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEI  167 (373)
T ss_dssp             CEEEEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEE
T ss_pred             HHHhhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEec
Confidence            99985433 3445789999999889888887643  3559999999999999999999999 8 9999999999999952


Q ss_pred             -----CCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-----
Q 017139          172 -----LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----  241 (376)
Q Consensus       172 -----~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-----  241 (376)
                           ..+.+||+|||++......  .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+     
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence                 2347999999999765432  33457899999999998754 8999999999999999999999998654     


Q ss_pred             -hHHHHHHHHHhcCCCCHHHHhhcCcC-------CcCccCCCCCCCCccc------ccccCCChhHHHHHHhhcCCCCCC
Q 017139          242 -AVDQLVEIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHK------VFHKRMPPEAIDLASRLLQYSPSL  307 (376)
Q Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~  307 (376)
                       ..+.+..+.+.++.++...+......       .....+......+...      .++..+++++.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence             55677888888888776654322110       0000011111111111      123345678999999999999999


Q ss_pred             CCCHHHHhCCCccccccCC
Q 017139          308 RCTALEACAHPFFDELREP  326 (376)
Q Consensus       308 R~t~~ell~hp~~~~~~~~  326 (376)
                      |||++|+|+||||++....
T Consensus       325 Rpt~~ell~hp~f~~~~~~  343 (373)
T 1q8y_A          325 RADAGGLVNHPWLKDTLGM  343 (373)
T ss_dssp             CBCHHHHHTCGGGTTCTTC
T ss_pred             cCCHHHHhhChhhhcccCc
Confidence            9999999999999976443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-47  Score=345.90  Aligned_cols=254  Identities=19%  Similarity=0.239  Sum_probs=206.0

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+..+..+ +||||+++++++.     
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----   81 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----   81 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----
Confidence            355688999999999999999999999999999999986532      2234677888888 9999999999984     


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC----------
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----------  171 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~----------  171 (376)
                      +...+++|||||++ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++.          
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-----------
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccc
Confidence            34458999999975 8888887765556789999999999999999999999 79999999999999974          


Q ss_pred             --------CCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 017139          172 --------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV  243 (376)
Q Consensus       172 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  243 (376)
                              ....+||+|||.+......   ....+|+.|+|||++.+...++.++|||||||++|+|++|.+|+......
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~  237 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW  237 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred             cccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence                    2347999999998876433   23458999999999976655778999999999999999999887554322


Q ss_pred             HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      .   .+...  .                 .         ..++..+++++.++|.+||+.||++|||+.++++||||+..
T Consensus       238 ~---~~~~~--~-----------------~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          238 H---EIRQG--R-----------------L---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             H---HHHTT--C-----------------C---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             H---HHHcC--C-----------------C---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            2   22110  0                 0         11345689999999999999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1e-47  Score=349.55  Aligned_cols=255  Identities=25%  Similarity=0.422  Sum_probs=212.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ...++|.+.+.||+|+||.||+|++..+|+.||+|++....    ....+|+.+++.++||||+++++++     .+...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   80 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTH   80 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCE
Confidence            34568999999999999999999999999999999986542    2345799999999999999999988     44556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee---cCCCCcEEEEecC
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFG  182 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill---~~~~~~~kl~Dfg  182 (376)
                      +|+||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||++   +. ++.+||+|||
T Consensus        81 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~-~~~~kl~Dfg  154 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEE-NSKIMITDFG  154 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSST-TCCEEBCSCS
T ss_pred             EEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCC-CCCEEEccCC
Confidence            8999999985 77777654    3568999999999999999999999 799999999999999   43 7789999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++...... ......|++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+.......      
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------  226 (304)
T 2jam_A          155 LSKMEQNG-IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF------  226 (304)
T ss_dssp             TTCCCCCB-TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC------
T ss_pred             cceecCCC-ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            98754332 33445689999999998664 48999999999999999999999999888777666655421111      


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                         ...++..+++++.++|.+||+.||++|||++++++||||+..
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          227 -------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             -------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             -------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                               111234679999999999999999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-47  Score=344.05  Aligned_cols=260  Identities=26%  Similarity=0.383  Sum_probs=215.3

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      |...++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..   ..
T Consensus         2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~   78 (279)
T 2w5a_A            2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RT   78 (279)
T ss_dssp             -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GG
T ss_pred             CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CC
Confidence            566789999999999999999999999999999999986532      234579999999999999999998754   33


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-----ceeccCCCCCeeecCCCCcEE
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-----VCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~-----ivH~dlkp~Nill~~~~~~~k  177 (376)
                      ...+|+||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +|     |+||||||+||+++. ++.+|
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~-~~~~k  156 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVK  156 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECS-SSCEE
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcC-CCCEE
Confidence            4568899999985 8888887766666779999999999999999999999 68     999999999999996 78899


Q ss_pred             EEecCCccccccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          178 LCDFGSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      |+|||++........ .....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+.....  
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~--  233 (279)
T 2w5a_A          157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--  233 (279)
T ss_dssp             ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred             EecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc--
Confidence            999999876543322 2345679999999999765 489999999999999999999999998877665555443110  


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                                ..++..+++++.++|.+||+.||.+|||++++++|||+.+-
T Consensus       234 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          234 --------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             --------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             --------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                                      01234578999999999999999999999999999999763

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.4e-48  Score=354.31  Aligned_cols=257  Identities=28%  Similarity=0.463  Sum_probs=205.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeec
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFST   99 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~   99 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++.. 
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   86 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-   86 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence            4578999999999999999999999999999999985432            235579999999999999999998732 


Q ss_pred             CCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC--CcE
Q 017139          100 TSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQV  176 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~--~~~  176 (376)
                          .. +|+||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++  ..+
T Consensus        87 ----~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           87 ----ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             ----SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCE
T ss_pred             ----Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeE
Confidence                22 7899999985 76665543    4679999999999999999999999 7999999999999998522  249


Q ss_pred             EEEecCCccccccCCCcceeeccccccChhhhh--CCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          177 KLCDFGSAKVLVKGEANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      ||+|||++.............||+.|+|||++.  +...++.++|||||||++|+|++|..||........+...+....
T Consensus       157 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  236 (322)
T 2ycf_A          157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  236 (322)
T ss_dssp             EECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred             EEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence            999999998765443344567899999999974  234588999999999999999999999976544322222222111


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                      ...                        ....+..+++++.+||.+||+.||++|||++++++||||+..
T Consensus       237 ~~~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          237 YNF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CCC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             ccc------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            000                        011224578999999999999999999999999999999764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-47  Score=344.35  Aligned_cols=255  Identities=24%  Similarity=0.357  Sum_probs=206.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++.     +...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   79 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI   79 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCE
Confidence            4578999999999999999999999999999999986432     23457999999999999999999884     4455


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .|+||||+++ +|.+.+    .....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||.+.
T Consensus        80 ~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~  153 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLAT  153 (276)
T ss_dssp             EEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTCE
T ss_pred             EEEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEcc-CCCEEEeeCCCcc
Confidence            8899999986 554443    335679999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHH
Q 017139          186 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEI  261 (376)
Q Consensus       186 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  261 (376)
                      ......   ......+++.|+|||++.+...++.++|+|||||++|+|++|..||....... ....+......      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  227 (276)
T 2yex_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------  227 (276)
T ss_dssp             ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT------
T ss_pred             ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc------
Confidence            654322   23345689999999999765545788999999999999999999998765432 22222111000      


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                 .          .....+++++.++|.+||+.||++|||++++++||||++..
T Consensus       228 -----------~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          228 -----------L----------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             -----------S----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -----------c----------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                       0          01235789999999999999999999999999999998653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-49  Score=373.01  Aligned_cols=256  Identities=19%  Similarity=0.221  Sum_probs=195.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHH---HHHhCCCCCeeecc-------e
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQ---LMRLMDHPNVISLK-------H   94 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~---~l~~l~h~~Iv~~~-------~   94 (376)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.   +++.++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            3468999999999999999999999999999999986331       23447884   45556899999998       4


Q ss_pred             eeeecC---------CCCce---eEEEEeecccchHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHhHcCCCcee
Q 017139           95 CFFSTT---------SKDEL---FLNLVMEYVPETMYRVLKHYSSM---NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH  159 (376)
Q Consensus        95 ~~~~~~---------~~~~~---~~~lv~e~~~g~l~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH  159 (376)
                      ++....         ..+..   ..|+|||||+|+|.+.+......   ...+++..++.|+.||+.||+|||+ +||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence            432211         01111   37899999999999888764321   1234458888999999999999999 79999


Q ss_pred             ccCCCCCeeecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCC----------CCCCccchhHHHHHHHHH
Q 017139          160 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAE  229 (376)
Q Consensus       160 ~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~  229 (376)
                      |||||+|||++. ++.+||+|||+++...  .......| +.|+|||++.+.          ..++.++|||||||++|+
T Consensus       230 rDikp~NIll~~-~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          230 TYLRPVDIVLDQ-RGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             SCCCGGGEEECT-TCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcC-CCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999996 7889999999998532  23345566 999999999765          148999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC
Q 017139          230 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC  309 (376)
Q Consensus       230 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  309 (376)
                      |++|..||.+.+.......+..                                 ....+++++.+||.+||+.||++||
T Consensus       306 lltg~~Pf~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~li~~~L~~dp~~Rp  352 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWIFR---------------------------------SCKNIPQPVRALLEGFLRYPKEDRL  352 (377)
T ss_dssp             HHHSSCCC------CCSGGGGS---------------------------------SCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred             HHHCCCCCcccccccchhhhhh---------------------------------hccCCCHHHHHHHHHHcCCCchhCC
Confidence            9999999976543211111000                                 1135799999999999999999999


Q ss_pred             CHHHHhCCCccccccC
Q 017139          310 TALEACAHPFFDELRE  325 (376)
Q Consensus       310 t~~ell~hp~~~~~~~  325 (376)
                      |+.++++||||+++..
T Consensus       353 t~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          353 LPLQAMETPEYEQLRT  368 (377)
T ss_dssp             CHHHHHTSHHHHHHHH
T ss_pred             CHHHHhhChHHHHHHH
Confidence            9999999999987643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.3e-48  Score=351.37  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=209.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.....       ...+|+.+++.++||||+++++++.... ..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   87 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA   87 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TT
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CC
Confidence            456789999999999999999999999999999999965421       2347888889999999999999885443 23


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+|||||+ ++|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg  161 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFG  161 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-TSCEEECCCS
T ss_pred             CcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcC-CCCEEEeecc
Confidence            345689999997 477777654    3569999999999999999999999 79999999999999996 7789999999


Q ss_pred             CccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          183 SAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       183 ~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      ++........    .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+...........+..
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS  240 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc
Confidence            9976543322    2245689999999999765 4899999999999999999999999998877776665553222111


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                               .....+++++.++|.+||+.||.+||++.+++.|+|++....
T Consensus       241 -------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          241 -------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             -------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             -------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                                     122457999999999999999999999999999999986544

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3e-47  Score=351.22  Aligned_cols=284  Identities=26%  Similarity=0.463  Sum_probs=221.0

Q ss_pred             ccccceEeeeeeccCCceEEEEEEE-cCCCcEEEEEEecccc---cchHHHHHHHHhCCCC------CeeecceeeeecC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKC-LETGETVAIKKVLQDR---RYKNRELQLMRLMDHP------NVISLKHCFFSTT  100 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~------~Iv~~~~~~~~~~  100 (376)
                      ...++|++.+.||+|+||.||+|.+ ..+++.||+|++....   ....+|+.+++.++|+      +++++++++    
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~----   86 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF----   86 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE----
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc----
Confidence            3456899999999999999999998 5678999999986543   2345788888888765      489998888    


Q ss_pred             CCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--------
Q 017139          101 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--------  172 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--------  172 (376)
                       .....+|+||||++++|.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++..        
T Consensus        87 -~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           87 -EHHGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             -EETTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             -ccCCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCC
Confidence             444468999999988998888653  22468999999999999999999999 799999999999999753        


Q ss_pred             ----------CCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 017139          173 ----------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA  242 (376)
Q Consensus       173 ----------~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  242 (376)
                                ++.+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                      44699999999976433  23456789999999999765 489999999999999999999999999999


Q ss_pred             HHHHHHHHHhcCCCCHHHHhhcCcCCc----CccCCCCC---------CCCcc--cccccCCChhHHHHHHhhcCCCCCC
Q 017139          243 VDQLVEIIKVLGTPTREEIRCMNPNYT----DFRFPQIK---------AHPWH--KVFHKRMPPEAIDLASRLLQYSPSL  307 (376)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~  307 (376)
                      .+....+....+..+...+........    ...+....         ..++.  .......++++.+||.+||+.||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            888888888888777665543221100    00000000         00000  0011223567999999999999999


Q ss_pred             CCCHHHHhCCCccccccC
Q 017139          308 RCTALEACAHPFFDELRE  325 (376)
Q Consensus       308 R~t~~ell~hp~~~~~~~  325 (376)
                      |||++|+++||||+.++.
T Consensus       320 Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          320 RITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SCCHHHHTTSGGGGGGGC
T ss_pred             ccCHHHHhcCHHHHHHhc
Confidence            999999999999998654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3e-48  Score=362.97  Aligned_cols=266  Identities=15%  Similarity=0.133  Sum_probs=190.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhC--CCCCeeecce-------ee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM--DHPNVISLKH-------CF   96 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l--~h~~Iv~~~~-------~~   96 (376)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++.....       ...+|+.+++.+  +||||++++.       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            4459999999999999999999999999999999976432       223564444444  6999888553       33


Q ss_pred             eecCCC------------CceeEEEEeecccchHHHHHHhhhhcCCCCCHHHH------HHHHHHHHHHHHHhHcCCCce
Q 017139           97 FSTTSK------------DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV------KLYTYQIFRGLAYIHTVPGVC  158 (376)
Q Consensus        97 ~~~~~~------------~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~------~~i~~qil~aL~~LH~~~~iv  158 (376)
                      ......            ....+|+|||||+++|.+.+.....   .+++..+      ..++.||+.||+|||+ +||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence            221110            1145899999999999998876422   3344444      5777999999999999 7999


Q ss_pred             eccCCCCCeeecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCC
Q 017139          159 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF  237 (376)
Q Consensus       159 H~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf  237 (376)
                      ||||||+|||++. ++.+||+|||+++....  ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||
T Consensus       217 HrDikp~NIll~~-~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMP-DGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECT-TSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECC-CCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            9999999999996 78899999999986532  22245677999999999651 34899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          238 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .+......                    ..+............+.......+++++.+||.+||+.||++|||++++|+|
T Consensus       294 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGIK--------------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTCT--------------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCcccc--------------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            87642100                    0001111111111111122234689999999999999999999999999999


Q ss_pred             CccccccC
Q 017139          318 PFFDELRE  325 (376)
Q Consensus       318 p~~~~~~~  325 (376)
                      |||+++.+
T Consensus       354 p~f~~~~~  361 (371)
T 3q60_A          354 PEFLQLQN  361 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99988654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-47  Score=345.49  Aligned_cols=257  Identities=29%  Similarity=0.476  Sum_probs=213.5

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++     .+..
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   94 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS   94 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCC
Confidence            3468999999999999999999999999999999985432      2345799999999999999999988     4445


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEEEEecC
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFG  182 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~kl~Dfg  182 (376)
                      .+++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+ +|++|+||||+||+++..  +..+||+|||
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             eEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccC
Confidence            58999999975 77666654    2569999999999999999999999 799999999999999753  3469999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++.............+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+..+....+........     
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  242 (287)
T 2wei_A          170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-----  242 (287)
T ss_dssp             GGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred             cceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence            9987655555555678999999999865  389999999999999999999999998887766665544211100     


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                          ......+++++.++|.+||+.||++|||++++++||||++...
T Consensus       243 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          243 --------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             --------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             --------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                                0012357899999999999999999999999999999987654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-48  Score=359.76  Aligned_cols=257  Identities=28%  Similarity=0.453  Sum_probs=206.4

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEecccc--------cchHHHHHHHHhC-CCCCeeecceeee
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFF   97 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~~Iv~~~~~~~   97 (376)
                      ....++|++.+.||+|+||.||+|++.   .+++.||||++....        ....+|+.+++.+ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            345689999999999999999999985   589999999985421        2334699999999 6999999999884


Q ss_pred             ecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcE
Q 017139           98 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV  176 (376)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~  176 (376)
                           ....+|+|||||++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+
T Consensus       130 -----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~  198 (355)
T 1vzo_A          130 -----TETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHV  198 (355)
T ss_dssp             -----ETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCE
T ss_pred             -----eCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCcE
Confidence                 34458899999985 77777764    2569999999999999999999999 79999999999999996 7889


Q ss_pred             EEEecCCccccccCC--CcceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChH----HHHHHH
Q 017139          177 KLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV----DQLVEI  249 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~~~~  249 (376)
                      ||+|||+++......  ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||......    .....+
T Consensus       199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  278 (355)
T 1vzo_A          199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  278 (355)
T ss_dssp             EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence            999999997653322  22345789999999999753 34789999999999999999999999754322    222222


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCcccccc
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELR  324 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~  324 (376)
                      ...  .                           ..++..++..+.+||.+||..||.+||     |++++++||||+.++
T Consensus       279 ~~~--~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          279 LKS--E---------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             HHC--C---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             hcc--C---------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            210  0                           013346789999999999999999999     999999999999876


Q ss_pred             CC
Q 017139          325 EP  326 (376)
Q Consensus       325 ~~  326 (376)
                      +.
T Consensus       330 ~~  331 (355)
T 1vzo_A          330 WD  331 (355)
T ss_dssp             HH
T ss_pred             hh
Confidence            54

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-47  Score=354.84  Aligned_cols=284  Identities=25%  Similarity=0.427  Sum_probs=220.5

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCC-cEEEEEEecccc---cchHHHHHHHHhCCCCC------eeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR---RYKNRELQLMRLMDHPN------VISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~------Iv~~~~~~~~~~~  101 (376)
                      ..++|++.+.||+|+||+||+|.+..++ +.||+|++....   ....+|+.+++.++|++      ++.+.+++     
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----   91 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----   91 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence            4578999999999999999999998777 689999986543   23446888998887655      78887777     


Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC----------
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----------  171 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~----------  171 (376)
                      .....+|+||||+++++.+.+...  ....+++..++.++.||+.||.|||+ +||+||||||+|||++.          
T Consensus        92 ~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           92 NFHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeCCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccc
Confidence            334458999999999988877653  23569999999999999999999999 79999999999999931          


Q ss_pred             --------CCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 017139          172 --------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV  243 (376)
Q Consensus       172 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  243 (376)
                              .++.+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                    267899999999976433  23456789999999999765 4899999999999999999999999999998


Q ss_pred             HHHHHHHHhcCCCCHHHHhhcCcCCcCc----cCCCCC---------CCCccc--ccccCCChhHHHHHHhhcCCCCCCC
Q 017139          244 DQLVEIIKVLGTPTREEIRCMNPNYTDF----RFPQIK---------AHPWHK--VFHKRMPPEAIDLASRLLQYSPSLR  308 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R  308 (376)
                      +.+..+.+..+..+...+.........+    .++...         ..++..  ......+.++.+||.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            8888888888887776554322110000    000000         000000  0011234578999999999999999


Q ss_pred             CCHHHHhCCCccccccCC
Q 017139          309 CTALEACAHPFFDELREP  326 (376)
Q Consensus       309 ~t~~ell~hp~~~~~~~~  326 (376)
                      ||++++|+||||+++...
T Consensus       326 pt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          326 ITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             CCHHHHTTSGGGGGCCHH
T ss_pred             cCHHHHhcChhhcCCChh
Confidence            999999999999987654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=344.84  Aligned_cols=264  Identities=24%  Similarity=0.385  Sum_probs=208.1

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCCC-C
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK-D  103 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~-~  103 (376)
                      -....++|++.+.||+|+||.||+|++..+|+.||+|++....   ....+|+.+++.+ +||||+++++++...... .
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            3456678999999999999999999999999999999986432   3455799999998 799999999998654321 1


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+||||+++ +|.+.+....  ...+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++.+||+|||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg  174 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFG  174 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCCT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcC-CCCEEEeeCc
Confidence            4568999999986 8887776532  3568999999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCC-CcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          183 SAKVLVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       183 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      ++....... ......+++.|+|||++..    ...++.++|||||||++|+|++|..||.+.+.......+..... + 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-  252 (326)
T 2x7f_A          175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P-  252 (326)
T ss_dssp             TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-
T ss_pred             CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c-
Confidence            987654322 2335578999999999852    23478999999999999999999999988877665554433100 0 


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                               ......+++.+.+||.+||..||.+|||++++++||||++.
T Consensus       253 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          253 -------------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             -------------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             -------------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                                     01123578999999999999999999999999999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.8e-47  Score=343.66  Aligned_cols=259  Identities=24%  Similarity=0.407  Sum_probs=207.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++..     ...
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGK   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCe
Confidence            45578999999999999999999999999999999986432    234479999999999999999999843     345


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +++|||||++ +|...+..   ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        91 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTL-EGDIRLADFGVSA  165 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TSCEEECCCHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECC-CCCEEEEECCCCc
Confidence            8999999986 56555543   24669999999999999999999999 79999999999999996 7789999999875


Q ss_pred             ccccC-CCcceeeccccccChhhhh----CCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          186 VLVKG-EANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       186 ~~~~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ..... .......|++.|+|||++.    ....++.++|+|||||++|+|++|..||...+.......+......     
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  240 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP-----  240 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc-----
Confidence            43211 1223457899999999984    2345889999999999999999999999988877666555442110     


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                           ....+..++.++.++|.+||+.||++|||++++++||||+....
T Consensus       241 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          241 ---------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             ---------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             ---------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                                 00123457899999999999999999999999999999987543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8e-48  Score=358.63  Aligned_cols=283  Identities=25%  Similarity=0.397  Sum_probs=209.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     ..
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~  104 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG  104 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TT
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CC
Confidence            34578999999999999999999999999999999986542     234578999999999999999999843     44


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~-~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      .+|+|||||+| +|.+.+..    ...+++..++.++.|++.||.|||+ + ||+||||||+||+++. ++.+||+|||+
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~  178 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNS-RGEIKLCDFGV  178 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECT-TCCEEECCCCC
T ss_pred             EEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECC-CCCEEEEECCC
Confidence            58999999985 88777765    2569999999999999999999998 5 8999999999999996 77899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-CCHHHHh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT-PTREEIR  262 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~  262 (376)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...... .......
T Consensus       179 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          179 SGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             CHHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             Ccccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            8654322 23356789999999999765 4899999999999999999999999887765543332111110 0000000


Q ss_pred             hcC--cCCcCccCCC------------CCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          263 CMN--PNYTDFRFPQ------------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       263 ~~~--~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ...  .....+....            .............++.++.+||.+||++||++|||++++|+||||+.....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence            000  0000000000            000000111223478899999999999999999999999999999986554

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=342.47  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=206.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|.+....  ....+|+.+++.++||||+++++++..     ...+|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~  100 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLW  100 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence            34568999999999999999999999999999999986543  335579999999999999999999843     34588


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++...
T Consensus       101 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~  175 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNT-EGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred             EEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECC-CCCEEEeecccchhh
Confidence            99999986 77776653   24679999999999999999999999 79999999999999996 778999999999765


Q ss_pred             ccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .... ......+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+......           
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  243 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-----------  243 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------
T ss_pred             hhhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-----------
Confidence            4432 23355789999999999765 4899999999999999999999999887766555443321100           


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                     ....+..++.++.++|.+||..||.+|||+.++++||||+...
T Consensus       244 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          244 ---------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             ---------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             ---------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                           0002334689999999999999999999999999999998643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.6e-47  Score=351.80  Aligned_cols=266  Identities=23%  Similarity=0.358  Sum_probs=187.6

Q ss_pred             ccccceEeee-eeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           31 KQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        31 ~~~~~y~~~~-~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ...++|.+.+ .||+|+||.||+|.+..+|+.||||++........+....++.++||||+++++++.... .+...+++
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l  103 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI  103 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence            4567899965 699999999999999999999999999776555555556678889999999999885432 34666899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEEEEecCCccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKV  186 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~kl~Dfg~~~~  186 (376)
                      |||||+| +|.+.+...  ....+++..++.++.||+.||.|||+ +||+||||||+||+++.+  ++.+||+|||++..
T Consensus       104 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          104 IMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            9999986 887777653  23579999999999999999999999 799999999999999742  34599999999976


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+................           
T Consensus       181 ~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  247 (336)
T 3fhr_A          181 TTQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-----------  247 (336)
T ss_dssp             C-----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred             cccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-----------
Confidence            5432 33456779999999998654 4889999999999999999999999776543322211111000           


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                        ..+.++        ......+++++.+||.+||+.||.+|||++++++||||++.
T Consensus       248 --~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 --GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -----CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             --cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence              000000        01224579999999999999999999999999999999874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-46  Score=341.65  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=209.6

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     ...+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence            467999999999999999999999999999999986432     334579999999999999999998843     3458


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+||||+++ +|.+.+.     ...+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.+||+|||++..
T Consensus        96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQ  168 (303)
T ss_dssp             EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECC-CCCEEEeeccccee
Confidence            999999986 6666554     2579999999999999999999999 79999999999999996 77899999999976


Q ss_pred             cccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ..... ......+++.|+|||++.+. .++.++|+|||||++|+|++|..||...........+.... .          
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~----------  236 (303)
T 3a7i_A          169 LTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-P----------  236 (303)
T ss_dssp             CBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C----------
T ss_pred             cCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-C----------
Confidence            64432 23456789999999999764 48999999999999999999999998877666554443310 0          


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                       ..++..++.++.+||.+||+.||.+|||++++++||||...
T Consensus       237 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          237 -----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             -----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             -----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                             01334678999999999999999999999999999999763

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.6e-48  Score=349.26  Aligned_cols=270  Identities=26%  Similarity=0.384  Sum_probs=193.3

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     ..
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KD   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SS
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cC
Confidence            44578999999999999999999999899999999885432     234478888999999999999998843     33


Q ss_pred             eEEEEeeccc-chHHHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          106 FLNLVMEYVP-ETMYRVLKHYSS----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       106 ~~~lv~e~~~-g~l~~~l~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+++||||++ ++|.+.+.....    ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~d  164 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGE-DGSVQIAD  164 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcC-CCCEEEEe
Confidence            4889999997 478777765322    24569999999999999999999999 79999999999999996 78899999


Q ss_pred             cCCccccccCC------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          181 FGSAKVLVKGE------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       181 fg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      ||++.......      ......|++.|+|||++.+...++.++|+|||||++|+|++|..||.................
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  244 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP  244 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence            99987654321      123456899999999986544589999999999999999999999988776554443332111


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ...                   ............+++++.++|.+||+.||++|||+.++++||||++....
T Consensus       245 ~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          245 PSL-------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             CCT-------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             Ccc-------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            000                   00001112334678999999999999999999999999999999876543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=344.52  Aligned_cols=259  Identities=24%  Similarity=0.346  Sum_probs=191.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++.....      ...++..+++.++||||+++++++.     +.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~   96 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TN   96 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cC
Confidence            456889999999999999999999999999999999865432      1223445678889999999999984     44


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~-~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++||||+++.+..+...   ....+++..++.++.|++.||.|||+ + |++|+||||+||+++. ++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~  171 (318)
T 2dyl_A           97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDE-RGQIKLCDFGI  171 (318)
T ss_dssp             SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECT-TSCEEECCCTT
T ss_pred             CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECC-CCCEEEEECCC
Confidence            46899999997655544433   24679999999999999999999998 5 9999999999999996 77899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCH
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~  258 (376)
                      +.............+++.|+|||++..    ...++.++|||||||++|+|++|..||... ...+.+..+......   
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---  248 (318)
T 2dyl_A          172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP---  248 (318)
T ss_dssp             C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC---
T ss_pred             chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC---
Confidence            977655555556678999999999852    334788999999999999999999999874 344444444431100   


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                   ..+          ....+++++.++|.+||+.||.+|||++++++||||++...
T Consensus       249 -------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          249 -------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             -------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             -------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence                         000          11247899999999999999999999999999999987544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.9e-46  Score=339.57  Aligned_cols=258  Identities=26%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~   82 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EE   82 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----EC
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----ee
Confidence            34568999999999999999999999999999999985432       2345799999999999999999988     55


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+||||++| +|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg  156 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFG  156 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEEeCC
Confidence            5668999999986 77777764    3579999999999999999999999 79999999999999996 7789999999


Q ss_pred             CccccccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          183 SAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       183 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ++........  .....||+.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+............. +.   
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~---  231 (294)
T 4eqm_A          157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PN---  231 (294)
T ss_dssp             SSTTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CC---
T ss_pred             CccccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CC---
Confidence            9986643322  23456899999999997754 89999999999999999999999998887665544433211 11   


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                          .....+..+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus       232 --------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 --------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             --------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             --------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                                11113456899999999999999999999766666677765443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8e-47  Score=346.24  Aligned_cols=249  Identities=26%  Similarity=0.401  Sum_probs=207.0

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhCC--CCCeeecceeeee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD--HPNVISLKHCFFS   98 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~--h~~Iv~~~~~~~~   98 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....          ....+|+.+++.++  ||||+++++++  
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~--  117 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--  117 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE--
Confidence            45678999999999999999999999999999999986432          23447999999996  59999999998  


Q ss_pred             cCCCCceeEEEEeeccc--chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcE
Q 017139           99 TTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV  176 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~--g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~  176 (376)
                         .....+++|||++.  ++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+
T Consensus       118 ---~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          118 ---ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             ---ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEE
T ss_pred             ---ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCE
Confidence               44455889999997  577777765    3578999999999999999999999 7999999999999998557899


Q ss_pred             EEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          177 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      ||+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.....      +...  . 
T Consensus       190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~-  259 (320)
T 3a99_A          190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q-  259 (320)
T ss_dssp             EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C-
T ss_pred             EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c-
Confidence            99999999876433 333567899999999997665457889999999999999999999965321      1110  0 


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                                ..++..+++++.+||.+||+.||++|||++++++||||++...
T Consensus       260 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          260 --------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             --------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             --------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                                      0123467999999999999999999999999999999987543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.9e-46  Score=340.71  Aligned_cols=253  Identities=23%  Similarity=0.365  Sum_probs=197.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|++.+.||+|+||+||+|++  +|+.||+|++.....      ...+|+.+++.++||||+++++++     .+..
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            357899999999999999999987  688999999865432      234799999999999999999998     4444


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--ceeccCCCCCeeecCCCCcEEEEecC
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~--ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      .+++|||||++ +|.+.+.... ....+++..++.++.|++.||+|||+ +|  |+||||||+||+++. ++.+||+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg  184 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK-KYTVKVCDFG  184 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECT-TCCEEECCCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeC-CCcEEECCCC
Confidence            58899999985 7777776421 12348999999999999999999999 79  999999999999996 7889999999


Q ss_pred             CccccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          183 SAKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       183 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      +++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+......      
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------  257 (309)
T 3p86_A          185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------  257 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC------
T ss_pred             CCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------
Confidence            997654332 234567899999999997654 899999999999999999999999988877666554332111      


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC--CCcccc
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE  322 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--hp~~~~  322 (376)
                                           ..++..+++++.+||.+||+.||.+|||++++++  +++++.
T Consensus       258 ---------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 ---------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                 1134568999999999999999999999999986  455543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=338.14  Aligned_cols=257  Identities=25%  Similarity=0.433  Sum_probs=201.2

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      |.....||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++++.     +...+++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEEE
Confidence            444459999999999999999999999999986543    23457999999999999999999984     344588999


Q ss_pred             eccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccC
Q 017139          112 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG  190 (376)
Q Consensus       112 e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~  190 (376)
                      ||++ ++|.+.+... .....+++..++.++.|++.||.|||+ +|++|+||||+||+++..++.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           99 EQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             ECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9997 4777776542 223457789999999999999999999 799999999999999865778999999999765432


Q ss_pred             C-CcceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          191 E-ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       191 ~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      . ......|++.|+|||++.+. ..++.++|+|||||++|+|++|..||..................             
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  243 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-------------  243 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence            2 23345689999999998653 23789999999999999999999999765433222111111000             


Q ss_pred             cCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                   ...++..+++++.++|.+||+.||++|||++++++||||+....
T Consensus       244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                         01134567999999999999999999999999999999986543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.8e-46  Score=338.46  Aligned_cols=258  Identities=25%  Similarity=0.360  Sum_probs=199.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecC--------
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTT--------  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~--------  100 (376)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....   ....+|+.+++.++||||+++++++....        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            4568999999999999999999999999999999986543   23457999999999999999999875432        


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                      ......+|+|||||++ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~-~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcC-CCCEEEe
Confidence            1346678999999985 88877764   23568889999999999999999999 79999999999999996 7789999


Q ss_pred             ecCCccccccC---------------CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh-H
Q 017139          180 DFGSAKVLVKG---------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-V  243 (376)
Q Consensus       180 Dfg~~~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~  243 (376)
                      |||++......               .......|++.|+|||++.+...++.++|+|||||++|+|++   ||..... .
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~  235 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV  235 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence            99998765421               122345689999999999766568999999999999999998   5543322 2


Q ss_pred             HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      +....+.....                 .        +...++...++.+.++|.+||+.||++|||++++++||||+.
T Consensus       236 ~~~~~~~~~~~-----------------~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          236 NILKKLRSVSI-----------------E--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHSTTC-----------------C--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHHhcccccc-----------------c--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            22222221100                 0        011133456788999999999999999999999999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.8e-46  Score=344.88  Aligned_cols=263  Identities=27%  Similarity=0.383  Sum_probs=187.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc-----hHHHHH-HHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQ-LMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~e~~-~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++......     ...|.. +++.++||||+++++++.     ...
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~   94 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REG   94 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSS
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCC
Confidence            447899999999999999999999999999999998654321     123443 667789999999999984     344


Q ss_pred             eEEEEeecccchHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCC-CceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          106 FLNLVMEYVPETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~~-~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..++||||++++|.+.+..... ....+++..++.++.|++.||.|||+ + ||+||||||+||+++. ++.+||+|||+
T Consensus        95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~  172 (327)
T 3aln_A           95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDR-SGNIKLCDFGI  172 (327)
T ss_dssp             EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEET-TTEEEECCCSS
T ss_pred             ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcC-CCCEEEccCCC
Confidence            5889999999988877764332 35779999999999999999999999 8 9999999999999996 88899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhh---CCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHH
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTRE  259 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~  259 (376)
                      +.............|++.|+|||++.   ....++.++|||||||++|+|++|..||.+.... +.+..+..  +     
T Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~-----  245 (327)
T 3aln_A          173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--G-----  245 (327)
T ss_dssp             SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--S-----
T ss_pred             ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--C-----
Confidence            98765554445557899999999983   2334889999999999999999999999765421 11110000  0     


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                  ..     ..+.......+++++.+||.+||+.||++|||+.++++||||.....
T Consensus       246 ------------~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          246 ------------DP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             ------------CC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             ------------CC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence                        00     00111122457899999999999999999999999999999987544

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.9e-46  Score=345.51  Aligned_cols=275  Identities=21%  Similarity=0.335  Sum_probs=208.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------------------cchHHHHHHHHhCCCCCe
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------------RYKNRELQLMRLMDHPNV   89 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------------------~~~~~e~~~l~~l~h~~I   89 (376)
                      ...++|++.+.||+|+||.||+|.+  +|+.||+|++....                     ....+|+.+++.++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            4567899999999999999999998  89999999985431                     445689999999999999


Q ss_pred             eecceeeeecCCCCceeEEEEeecccc-hHHHHHHhh--hhc--CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCC
Q 017139           90 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY--SSM--NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP  164 (376)
Q Consensus        90 v~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~--~~~--~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp  164 (376)
                      +++++++     .+...+|+||||+++ +|.+.+...  ...  ...+++..++.++.|++.||.|||+.+||+||||||
T Consensus       106 ~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p  180 (348)
T 2pml_X          106 LTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP  180 (348)
T ss_dssp             CCCSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred             ceEEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence            9999998     344568999999986 654441110  112  577999999999999999999999723999999999


Q ss_pred             CCeeecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCc-cchhHHHHHHHHHHHhCCCCCCCCCh-
Q 017139          165 QNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENA-  242 (376)
Q Consensus       165 ~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~~lltg~~pf~~~~~-  242 (376)
                      +||+++. ++.+||+|||++...... ......+++.|+|||++.+...++. ++|||||||++|+|++|..||..... 
T Consensus       181 ~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          181 SNILMDK-NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             GGEEECT-TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             HhEEEcC-CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            9999996 778999999999875433 3345678999999999976534555 99999999999999999999988766 


Q ss_pred             HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      .+....+.......+.        ....+..+. . ..........+++++.+||.+||+.||.+|||++++++||||++
T Consensus       259 ~~~~~~i~~~~~~~~~--------~~~~~~~~~-~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          259 VELFNNIRTKNIEYPL--------DRNHFLYPL-T-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             HHHHHHHTSCCCCCCC--------SSSSSTTTT-C-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHhccCcCCcc--------chhhhhccc-c-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            4444444321111000        000000000 0 00011122568999999999999999999999999999999987


Q ss_pred             cc
Q 017139          323 LR  324 (376)
Q Consensus       323 ~~  324 (376)
                      ..
T Consensus       329 ~~  330 (348)
T 2pml_X          329 TN  330 (348)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=335.90  Aligned_cols=255  Identities=26%  Similarity=0.461  Sum_probs=202.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....    ....+|+++++.++||||+++++++.     ++..+
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   82 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRL   82 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCee
Confidence            4578999999999999999999999999999999885432    23457999999999999999999984     34458


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++|||||++ +|.+.+..   ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~  157 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRE-NKNVVVADFGLARL  157 (310)
T ss_dssp             EEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECT-TSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECC-CCCEEEeeccccee
Confidence            899999986 77777765   24679999999999999999999999 79999999999999996 78899999999986


Q ss_pred             cccCCCc---------------ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017139          187 LVKGEAN---------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  251 (376)
Q Consensus       187 ~~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  251 (376)
                      .......               ....||+.|+|||++.+. .++.++|||||||++|+|++|..||..........    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----  232 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----  232 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----
Confidence            6433221               145789999999999764 48999999999999999999999987542210000    


Q ss_pred             hcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                        ......                    ......+..+++++.+++.+||+.||++|||+.++++  |++.+..
T Consensus       233 --~~~~~~--------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~  282 (310)
T 3s95_A          233 --GLNVRG--------------------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM  282 (310)
T ss_dssp             --SBCHHH--------------------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             --hhhhhc--------------------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence              000000                    0011134567899999999999999999999999986  6666543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.4e-45  Score=342.92  Aligned_cols=250  Identities=23%  Similarity=0.346  Sum_probs=202.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-------CCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFS   98 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~   98 (376)
                      ..++|++.+.||+|+||.||+|++.       .++..||+|++.....     ...+|+.+++.+ +||||+++++++  
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence            3579999999999999999999975       3456799999865432     245799999999 899999999998  


Q ss_pred             cCCCCceeEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCC
Q 017139           99 TTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ  165 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~  165 (376)
                         .+...+|+|||||++ +|.+.+.....            ....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus       157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~  232 (370)
T 2psq_A          157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR  232 (370)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred             ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence               444558999999985 88888775421            13468999999999999999999999 79999999999


Q ss_pred             CeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 017139          166 NLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN  241 (376)
Q Consensus       166 Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  241 (376)
                      |||++. ++.+||+|||+++.......   .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       233 NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          233 NVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GEEECT-TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hEEECC-CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999996 78899999999986543322   2234567889999999765 48999999999999999999 999998877


Q ss_pred             hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ..+....+.....                            ...+..+++++.++|.+||+.||++|||+.+++++
T Consensus       311 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          311 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6655544332100                            01234578999999999999999999999998754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-45  Score=339.07  Aligned_cols=250  Identities=18%  Similarity=0.210  Sum_probs=201.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+.+++.+ +||||+++++++.     .....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence            3456799999999999999999999999999999998643  34567899999999 9999999999884     34458


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc-----EEEEecC
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFG  182 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~-----~kl~Dfg  182 (376)
                      ++||||++++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.     +||+|||
T Consensus        81 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~-~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           81 AMVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGR-PGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECC-GGGTCTTSEEECCCT
T ss_pred             EEEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecc-CCCCCCceEEEEEcc
Confidence            999999988888887753   4679999999999999999999999 79999999999999985 555     9999999


Q ss_pred             CccccccCCC--------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHH
Q 017139          183 SAKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIK  251 (376)
Q Consensus       183 ~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~  251 (376)
                      ++........        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.   .+.+..+..
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            9987644322        2456789999999999765 489999999999999999999999987433   333333322


Q ss_pred             hcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .....+.+.                        .....+ ++.+++.+||+.||.+||+++++++
T Consensus       235 ~~~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          235 TKRATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hhccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111111111                        112244 9999999999999999999988764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-46  Score=346.70  Aligned_cols=257  Identities=18%  Similarity=0.205  Sum_probs=207.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEE-----EcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      ...++|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+.+++.++||||+++++++    
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~----  143 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS----  143 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE----
Confidence            345789999999999999999999     45577899999985432     2344799999999999999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CC
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--TH  174 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~  174 (376)
                       .+....|+|||||+| +|.+.+.....   ....+++..++.++.||+.||.|||+ +||+||||||+|||++.+  +.
T Consensus       144 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          144 -LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             -CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTC
T ss_pred             -ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCc
Confidence             444457899999975 88888876432   23568999999999999999999999 799999999999999842  33


Q ss_pred             cEEEEecCCccccccC---CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017139          175 QVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII  250 (376)
Q Consensus       175 ~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  250 (376)
                      .+||+|||+++.....   .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            5999999999754322   2233456789999999997654 8999999999999999998 999999888777666554


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      .....                            ..+..++.++.+||.+||+.||.+|||++++++|.++..
T Consensus       301 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 SGGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            42110                            123457899999999999999999999999999988754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-45  Score=335.45  Aligned_cols=254  Identities=24%  Similarity=0.316  Sum_probs=198.5

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCC--CCCeeecceeeeecCCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD--HPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~--h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....      ....+|+.+++.++  ||||+++++++     .+
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~   99 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----IT   99 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE-----EC
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe-----ec
Confidence            4467999999999999999999975 58899999986432      23357899999997  59999999988     44


Q ss_pred             ceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          104 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       104 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ...+|+|||+++++|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++  ++.+||+|||+
T Consensus       100 ~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~--~~~~kL~Dfg~  172 (313)
T 3cek_A          100 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGI  172 (313)
T ss_dssp             SSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred             CCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE--CCeEEEeeccc
Confidence            456899999888898888765    3578999999999999999999999 7999999999999997  57899999999


Q ss_pred             ccccccCCC---cceeeccccccChhhhhCC----------CCCCccchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 017139          184 AKVLVKGEA---NISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEI  249 (376)
Q Consensus       184 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~  249 (376)
                      +........   .....|++.|+|||++.+.          ..++.++|||||||++|+|++|..||...... ..+..+
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            986543322   2345689999999998641          34788999999999999999999999765432 223222


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ....                           ....++...+.++.++|.+||+.||++|||++++++||||+....
T Consensus       253 ~~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          253 IDPN---------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             HCTT---------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             Hhcc---------------------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            2110                           001133446889999999999999999999999999999986433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5e-45  Score=330.66  Aligned_cols=250  Identities=18%  Similarity=0.233  Sum_probs=203.8

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+|+.+++.+ +|+|++++++++     .+....+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~   82 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNV   82 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeE
Confidence            446799999999999999999999999999999998643  34567899999999 799999999887     4455588


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc-----EEEEecCC
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGS  183 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~-----~kl~Dfg~  183 (376)
                      +||||++++|.+.+...   ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.     +||+|||+
T Consensus        83 lv~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           83 LVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGR-PNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECC-SSSTTTTCEEECCCTT
T ss_pred             EEEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecc-CCCCCCCeEEEEECcc
Confidence            99999988888888653   3569999999999999999999999 79999999999999975 443     99999999


Q ss_pred             ccccccCCC--------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHh
Q 017139          184 AKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKV  252 (376)
Q Consensus       184 ~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---~~~~~~~~~~~~  252 (376)
                      +........        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.   .....+..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            987654322        2355689999999999765 4899999999999999999999999874   333444443332


Q ss_pred             cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ...+....                        +...+++++.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          237 KQSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccCccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            11111111                        22357999999999999999999999999864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.5e-46  Score=334.03  Aligned_cols=254  Identities=24%  Similarity=0.359  Sum_probs=211.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecC----------
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTT----------  100 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~----------  100 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++........+|+++++.++||||+++++++....          
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            3457899999999999999999999999999999999887777889999999999999999999874311          


Q ss_pred             -CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          101 -SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       101 -~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                       ......+++|||||++ +|.+.+....  ...+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl  163 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKI  163 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEE
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcC-CCCEEE
Confidence             1235568999999996 8888776532  3579999999999999999999999 79999999999999996 788999


Q ss_pred             EecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          179 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       179 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +|||++.............+++.|+|||++.+. .++.++|+|||||++|+|++|..||....  .....+..       
T Consensus       164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~-------  233 (284)
T 2a19_B          164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD-------  233 (284)
T ss_dssp             CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT-------
T ss_pred             CcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc-------
Confidence            999999877665555567789999999999765 48999999999999999999998874221  11111110       


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                              ..++..++.++.++|.+||..||.+|||+.++++|++.-.
T Consensus       234 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                    0122357889999999999999999999999999988753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-45  Score=327.21  Aligned_cols=246  Identities=18%  Similarity=0.304  Sum_probs=203.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+|+.+++.++||||+++++++     .+...++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence            4568999999999999999999986 57789999997643   3345799999999999999999998     4455589


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECG-GGCEEECCTTGGGGB
T ss_pred             EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcC-CCCEEeccccccccc
Confidence            99999985 67776654   23568999999999999999999999 79999999999999986 778999999999765


Q ss_pred             ccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....  ......+++.|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+.....          
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------  225 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------  225 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred             cccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence            3321  122344577899999997654 8999999999999999999 9999998887776666544211          


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                        ...+...++++.+++.+||+.||++|||+.++++|
T Consensus       226 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                              11234568999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=336.94  Aligned_cols=247  Identities=23%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|++.+.||+|+||.||+|.+..+++   .||||++....     ....+|+.+++.++||||+++++++     .
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  120 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T  120 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            345789999999999999999999986655   49999986542     2345799999999999999999998     5


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|||||++ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Df  195 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDS-NLVCKVSDF  195 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCC
T ss_pred             eCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECC-CCCEEECCC
Confidence            55568999999975 77777654   24579999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017139          182 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       182 g~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      |++.........    ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-  273 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-  273 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-
Confidence            999876543221    1233467899999997654 8999999999999999999 99999988877766665442111 


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                 ..+..+++++.++|.+||..||++|||+.++++
T Consensus       274 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          274 ---------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                       123457899999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-46  Score=337.83  Aligned_cols=249  Identities=27%  Similarity=0.406  Sum_probs=198.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhC----CCCCeeecceee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLM----DHPNVISLKHCF   96 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l----~h~~Iv~~~~~~   96 (376)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....          ....+|+.+++.+    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34578999999999999999999999999999999985432          2334689999988    899999999988


Q ss_pred             eecCCCCceeEEEEeec-cc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC
Q 017139           97 FSTTSKDELFLNLVMEY-VP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH  174 (376)
Q Consensus        97 ~~~~~~~~~~~~lv~e~-~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~  174 (376)
                           ......++|||+ +. ++|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++..++
T Consensus       108 -----~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          108 -----ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             ----------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT
T ss_pred             -----ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC
Confidence                 444457899998 55 577777765    3569999999999999999999999 79999999999999984478


Q ss_pred             cEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          175 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       175 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      .+||+|||++...... ......+++.|+|||++.+....+.++|||||||++|+|++|..||.....      +...  
T Consensus       178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~--  248 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA--  248 (312)
T ss_dssp             EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--
T ss_pred             eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--
Confidence            8999999999876443 334567899999999987655445689999999999999999999965321      1110  


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                                     .            ..++..++.++.++|.+||+.||++|||++++++||||+....
T Consensus       249 ---------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 ---------------E------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---------------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---------------c------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                           0            0133467999999999999999999999999999999987544

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=352.84  Aligned_cols=255  Identities=26%  Similarity=0.376  Sum_probs=193.0

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEe
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      .+|.+.+.||+|+||+|+. ....+|+.||||++.... ....+|+.+++.+ +||||+++++++     .+...+|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence            4699999999999999764 445689999999986543 4567899999999 799999999988     4555689999


Q ss_pred             ecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC----CCcEEEEecCCcccc
Q 017139          112 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL----THQVKLCDFGSAKVL  187 (376)
Q Consensus       112 e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~----~~~~kl~Dfg~~~~~  187 (376)
                      |||+|+|.+.+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++..    ...+||+|||+++..
T Consensus        98 E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            99999988888753   2334555667899999999999999 799999999999999531    236889999999876


Q ss_pred             ccCC----CcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          188 VKGE----ANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       188 ~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ....    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||......... .+..   ....  
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~---~~~~--  247 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLG---ACSL--  247 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTT---CCCC--
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhc---cCCc--
Confidence            5432    2335678999999999864  2346789999999999999999 99999655433221 1111   1000  


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                   +..       ......+..+.+||.+||+.||.+|||++++++||||..+.
T Consensus       248 -------------~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          248 -------------DCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             -------------TTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             -------------ccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence                         000       00112356689999999999999999999999999997654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-45  Score=341.93  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=202.5

Q ss_pred             cccceEeeeeeccCCceEEEEEE-----EcCCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      ..++|.+.+.||+|+||.||+|+     +..+++.||||++.....     ...+|+.+++.+ +||||+++++++..  
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec--
Confidence            35789999999999999999999     455678999999965432     245799999999 78999999998842  


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhc---------------------------------------------------
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSM---------------------------------------------------  128 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~---------------------------------------------------  128 (376)
                        .+..+++|||||++ +|.+.+......                                                   
T Consensus        98 --~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           98 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             --TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             --CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence              23347899999985 888887654321                                                   


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC---cc
Q 017139          129 -----------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NI  194 (376)
Q Consensus       129 -----------~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~  194 (376)
                                 ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++........   ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCcEEEEeccceeeecccccchhcc
Confidence                       1228999999999999999999999 79999999999999986 77899999999986543322   23


Q ss_pred             eeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccC
Q 017139          195 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF  273 (376)
Q Consensus       195 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ...+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.....+.....+                 
T Consensus       254 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  315 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----------------  315 (359)
T ss_dssp             -CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred             ccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------
Confidence            45678899999999765 48999999999999999998 999998876555544444321111                 


Q ss_pred             CCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                ..+..+++++.++|.+||+.||++|||+.++++|
T Consensus       316 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                      1234578999999999999999999999999876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.7e-45  Score=336.47  Aligned_cols=264  Identities=20%  Similarity=0.261  Sum_probs=190.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCc---EEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ...++|++.+.||+|+||.||+|.+..+++   .||+|++....      ....+|+.+++.++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999999887765   89999986532      234579999999999999999999854332


Q ss_pred             CC-ceeEEEEeecccc-hHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139          102 KD-ELFLNLVMEYVPE-TMYRVLKHYSS--MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus       102 ~~-~~~~~lv~e~~~g-~l~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                      .+ ....++||||+.+ +|.+.+.....  ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+|
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~-~~~~k  177 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAE-DMTVC  177 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcC-CCCEE
Confidence            11 1234899999986 77777765332  22369999999999999999999999 79999999999999996 78899


Q ss_pred             EEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 017139          178 LCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL  253 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  253 (376)
                      |+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            999999976544322   22344577899999997654 8999999999999999999 999999887766665554321


Q ss_pred             CCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-------HHHHhCCCccccccC
Q 017139          254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-------ALEACAHPFFDELRE  325 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~ell~hp~~~~~~~  325 (376)
                      .                            ...+..+++++.++|.+||+.||.+|||       +++++.|||+.....
T Consensus       257 ~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          257 R----------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             C----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             C----------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            1                            0123457899999999999999999999       788999999987543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.2e-45  Score=324.34  Aligned_cols=247  Identities=19%  Similarity=0.275  Sum_probs=203.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++....   ....+|+.+++.++||||+++++++     .+...+
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPI   78 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCce
Confidence            35678999999999999999999875 56789999987543   2345799999999999999999988     455558


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++||||+++ +|.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDR-DLCVKVSDFGMTRY  153 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECT-TCCEEECCTTCEEE
T ss_pred             EEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECC-CCCEEEccCcccee
Confidence            999999975 677777653   3459999999999999999999999 79999999999999996 78899999999986


Q ss_pred             cccCCCc--ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          187 LVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       187 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      .......  ....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+......        
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------  224 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--------  224 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC--------
Confidence            6443321  2234567799999997654 8999999999999999999 99999988877666555432110        


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                          ..+...++++.++|.+||+.||++|||+.++++|
T Consensus       225 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 --------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                1223468899999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-45  Score=341.55  Aligned_cols=258  Identities=16%  Similarity=0.137  Sum_probs=196.8

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCC-----CcEEEEEEecccccchHHHHH---------------HHHhCCCCCeeec
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKNRELQ---------------LMRLMDHPNVISL   92 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~e~~---------------~l~~l~h~~Iv~~   92 (376)
                      .++|++.+.||+|+||.||+|.+..+     ++.||||++........+|++               .++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            34899999999999999999998765     588999998766544333433               4455679999999


Q ss_pred             ceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec--
Q 017139           93 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--  170 (376)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~--  170 (376)
                      ++++.... .+..++|+|||||+++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++  
T Consensus       114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESS
T ss_pred             Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecC
Confidence            99886533 34567899999997788887765   24679999999999999999999999 7999999999999998  


Q ss_pred             CCCCcEEEEecCCccccccCCC--------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 017139          171 PLTHQVKLCDFGSAKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA  242 (376)
Q Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  242 (376)
                      . ++.+||+|||+++.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+...
T Consensus       189 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          189 N-PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             C-TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             C-CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            5 67899999999976543221        13445899999999997654 89999999999999999999999986433


Q ss_pred             HHHHHHHHHh-cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          243 VDQLVEIIKV-LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       243 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .......... ........+....                   ....+++++.+++..||..||.+||+++++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          267 DPKYVRDSKIRYRENIASLMDKCF-------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             CHHHHHHHHHHHHHCHHHHHHHHS-------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHHhhhhHHHHHHHhc-------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2222222211 1111111110000                   01357899999999999999999999998874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.6e-45  Score=349.66  Aligned_cols=259  Identities=29%  Similarity=0.395  Sum_probs=191.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .+.|.+.+.||+|+||+||.+ ...+|+.||||++..+. ....+|+.+++.+ +||||+++++++     .+...+|+|
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv   87 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA   87 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence            356788899999999999875 45679999999986543 2345799999876 899999999887     455668999


Q ss_pred             eecccchHHHHHHhhhhcCCC---CCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC------------CCc
Q 017139          111 MEYVPETMYRVLKHYSSMNQR---MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL------------THQ  175 (376)
Q Consensus       111 ~e~~~g~l~~~l~~~~~~~~~---l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~------------~~~  175 (376)
                      ||||+|+|.+.+.........   .++..++.++.||+.||+|||+ +||+||||||+|||++..            +..
T Consensus        88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceE
Confidence            999999998888754322111   1333457899999999999999 799999999999999742            347


Q ss_pred             EEEEecCCccccccCCC-----cceeeccccccChhhhhC------CCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 017139          176 VKLCDFGSAKVLVKGEA-----NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV  243 (376)
Q Consensus       176 ~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~  243 (376)
                      +||+|||++........     .....||+.|+|||++.+      ...++.++|||||||++|+|++ |..||.+....
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            99999999987654322     224578999999999965      2458999999999999999999 99999765443


Q ss_pred             HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      .  ..+.....                 ..+..     .......+++++.+||.+||+.||++|||+.++++||||..
T Consensus       247 ~--~~i~~~~~-----------------~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 E--SNIIRGIF-----------------SLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             H--HHHHHTCC-----------------CCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             H--HHHhcCCC-----------------Ccccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            2  22222110                 00100     00011235688999999999999999999999999999964

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.7e-45  Score=324.99  Aligned_cols=244  Identities=27%  Similarity=0.422  Sum_probs=190.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||.||+|.+  +++.+|+|++....        ....+|+.+++.++||||+++++++     .+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   77 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LK   77 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred             chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ec
Confidence            346899999999999999999997  48899999985432        2345799999999999999999998     44


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC---ceeccCCCCCeeecC-------C
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG---VCHRDVKPQNLLVDP-------L  172 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~---ivH~dlkp~Nill~~-------~  172 (376)
                      ...+++||||+++ +|.+.+.     ...+++..++.++.|++.||.|||+ +|   |+||||||+||+++.       .
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             CCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEeccccccccc
Confidence            5558899999985 5555543     3679999999999999999999999 78   899999999999974       2


Q ss_pred             CCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 017139          173 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV  252 (376)
Q Consensus       173 ~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  252 (376)
                      ++.+||+|||++....... .....|++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  229 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN  229 (271)
T ss_dssp             SCCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred             CcceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence            5679999999997654332 2356789999999999765 4899999999999999999999999988776655544331


Q ss_pred             cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ..                           ....+..+++++.++|.+||+.||++|||+.++++|
T Consensus       230 ~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 KL---------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC---------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            10                           111335678999999999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.8e-45  Score=336.06  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=204.6

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEE--EEEEeccc-----ccchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETV--AIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~--aiK~~~~~-----~~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      ....++|++.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+.+++.+ +||||+++++++     
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----   95 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----   95 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----
Confidence            345589999999999999999999999888865  99988642     23355799999999 899999999998     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCee
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL  168 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nil  168 (376)
                      .+...+|+||||+++ +|.+.+....            .....+++..++.++.||+.||.|||+ +||+||||||+||+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl  174 (327)
T 1fvr_A           96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNIL  174 (327)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEE
T ss_pred             eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEE
Confidence            344558999999975 8888876542            234579999999999999999999999 79999999999999


Q ss_pred             ecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017139          169 VDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV  247 (376)
Q Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  247 (376)
                      ++. ++.+||+|||++.............+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       175 ~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~  252 (327)
T 1fvr_A          175 VGE-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  252 (327)
T ss_dssp             ECG-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EcC-CCeEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence            986 7789999999997554433444556688999999997654 8999999999999999998 999999887766554


Q ss_pred             HHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .+....                            ....+..+++++.++|.+||+.||.+|||++++++|
T Consensus       253 ~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          253 KLPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HGGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            433210                            001233578999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=337.81  Aligned_cols=250  Identities=22%  Similarity=0.331  Sum_probs=204.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCC-------CcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFS   98 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~   98 (376)
                      ..++|.+.+.||+|+||.||+|++..+       +..||+|++....     ....+|+++++.+ +||||+++++++  
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee--
Confidence            457999999999999999999997543       3579999986543     2244799999999 999999999998  


Q ss_pred             cCCCCceeEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCC
Q 017139           99 TTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ  165 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~  165 (376)
                         .....+++|||||++ +|.+.+.....            ....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus       145 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~  220 (382)
T 3tt0_A          145 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR  220 (382)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGG
T ss_pred             ---ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCcc
Confidence               444558899999985 88888776431            12469999999999999999999999 79999999999


Q ss_pred             CeeecCCCCcEEEEecCCccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 017139          166 NLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN  241 (376)
Q Consensus       166 Nill~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  241 (376)
                      |||++. ++.+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       221 NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          221 NVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GEEECT-TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcC-CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999996 7889999999998664432   22344568899999999765 48999999999999999999 999999887


Q ss_pred             hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ..+....+.....                            ...+..+++++.+||.+||+.||++|||+.+++++
T Consensus       299 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7666554443110                            01234678999999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=352.31  Aligned_cols=272  Identities=21%  Similarity=0.322  Sum_probs=203.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+++++.++||||+++++++..   .+...
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~   83 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRH   83 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCe
Confidence            3468999999999999999999999999999999986432     234479999999999999999998753   23345


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee----cCCCCcEEEEec
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV----DPLTHQVKLCDF  181 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill----~~~~~~~kl~Df  181 (376)
                      +++|||||++ +|.+.+.... ....+++..++.++.||+.||+|||+ +||+||||||+|||+    +. ++.+||+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~DF  160 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDF  160 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTS-CEEEEECCG
T ss_pred             eEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCC-ceeEEEecC
Confidence            7899999985 7777665432 23449999999999999999999999 799999999999998    53 667999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCC-------CCCCccchhHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPGE----NAVDQLVEII  250 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~~~  250 (376)
                      |+++............||+.|+|||++.+.       ..++.++|||||||++|+|++|..||...    ...+.+..+.
T Consensus       161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            999877655555567789999999998641       24678999999999999999999999643    2334444443


Q ss_pred             HhcCCCCHHHHhhc---CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          251 KVLGTPTREEIRCM---NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       251 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ..  .|. ..+...   ......|..    ..+....+...+++.+.++|.+||++||++|||++++++
T Consensus       241 ~~--~p~-~~~~~~~~~~~~~~~~~~----~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          241 TG--KPS-GAISGVQKAENGPIDWSG----DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HS--CCT-TCCEEEECSTTCCEEEES----SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             cC--CCc-ccchhheeccCCCcccCc----cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            32  111 111100   000000000    001111123345678899999999999999999998743

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-45  Score=338.76  Aligned_cols=268  Identities=22%  Similarity=0.252  Sum_probs=197.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|++.  ++.||||++.....   ...+|+.+++.++||||+++++++.... .....++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            4478999999999999999999874  78999999865432   2335788889999999999999986543 2245578


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC----------CceeccCCCCCeeecCCCCcEE
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP----------GVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~----------~ivH~dlkp~Nill~~~~~~~k  177 (376)
                      +|||||++ +|.+.+..     ..+++..++.++.|++.||.|||+ .          ||+||||||+|||++. ++.+|
T Consensus        99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~-~~~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKN-NLTAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECT-TCCEE
T ss_pred             EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECC-CCeEE
Confidence            99999985 88877764     459999999999999999999999 8          9999999999999996 78899


Q ss_pred             EEecCCccccccCCC---cceeeccccccChhhhhCC----CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017139          178 LCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  250 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  250 (376)
                      |+|||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|+|++|..||.+...........
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999976544322   2345789999999999763    235668899999999999999999997654321111111


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCccccc-ccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .....+....+.......  ...+.     +...+ ....++++.+||.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHK--KKRPV-----LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTS--CCCCC-----CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhcc--cCCCC-----ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            112222222221110000  00000     00000 1123456999999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-44  Score=325.46  Aligned_cols=245  Identities=22%  Similarity=0.343  Sum_probs=197.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----------cchHHHHHHHHhCCCCCeeecceeeeec
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKHCFFST   99 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~   99 (376)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....           ....+|+.+++.++||||+++++++   
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---   92 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---   92 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee---
Confidence            44578999999999999999999999999999999985422           2345799999999999999999987   


Q ss_pred             CCCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--ceeccCCCCCeeecCCCCc-
Q 017139          100 TSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQ-  175 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~--ivH~dlkp~Nill~~~~~~-  175 (376)
                        .+..  ++||||++ ++|.+.+..   ....+++..++.++.|++.||.|||+ +|  |+||||||+||+++. ++. 
T Consensus        93 --~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~-~~~~  163 (287)
T 4f0f_A           93 --HNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQS-LDEN  163 (287)
T ss_dssp             --TTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESC-CCTT
T ss_pred             --cCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEec-cCCC
Confidence              3333  59999998 577666654   34579999999999999999999999 79  999999999999985 444 


Q ss_pred             ----EEEEecCCccccccCCCcceeeccccccChhhhhC-CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH--HHH
Q 017139          176 ----VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LVE  248 (376)
Q Consensus       176 ----~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~  248 (376)
                          +||+|||++.....  ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||........  ...
T Consensus       164 ~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  241 (287)
T 4f0f_A          164 APVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM  241 (287)
T ss_dssp             CSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred             CceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence                99999999975432  3345678999999999842 23368899999999999999999999987543322  222


Q ss_pred             HHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      +.. .+.                          ...++..+++++.++|.+||+.||.+|||++++++
T Consensus       242 ~~~-~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          242 IRE-EGL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHH-SCC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hhc-cCC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            222 110                          11134567999999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-44  Score=327.45  Aligned_cols=253  Identities=23%  Similarity=0.254  Sum_probs=202.0

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....  ....+|+.+++.++|++++..+..+..    .....+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~   81 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV   81 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence            45678999999999999999999999999999999886543  345689999999999988777666533    344578


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec--CCCCcEEEEecCCccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKV  186 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~--~~~~~~kl~Dfg~~~~  186 (376)
                      +||||++++|.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+||+++  ..++.+||+|||++..
T Consensus        82 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           82 MVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            99999988888887642   4579999999999999999999999 7999999999999994  2377899999999987


Q ss_pred             cccCCC--------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCC
Q 017139          187 LVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT  255 (376)
Q Consensus       187 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~  255 (376)
                      ......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.   ...+..+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            654332        24567899999999997654 89999999999999999999999986432   2223332221111


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .+..                        .+...+++++.++|.+||+.||++|||++++++
T Consensus       237 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          237 TPIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CchH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1111                        122457899999999999999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-45  Score=337.01  Aligned_cols=249  Identities=25%  Similarity=0.304  Sum_probs=203.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++|++.+.||+|+||.||+|++.     .+++.||+|++....     ....+|+.+++.++||||+++++++     
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----  119 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----  119 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence            4578999999999999999999987     355899999986543     2345799999999999999999998     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCceec
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSSM--------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR  160 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~--------------------~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~  160 (376)
                      .+...+|+|||||++ +|.+.+......                    ...+++..++.++.||+.||.|||+ +||+||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~  198 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR  198 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence            444558899999985 888887663211                    2679999999999999999999999 799999


Q ss_pred             cCCCCCeeecCCCCcEEEEecCCccccccC---CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 017139          161 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL  236 (376)
Q Consensus       161 dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p  236 (376)
                      ||||+||+++. ++.+||+|||++......   .......+++.|+|||++.+.. ++.++|+|||||++|+|++ |..|
T Consensus       199 Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCcceEEECC-CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCc
Confidence            99999999996 778999999998765332   1223456788999999997654 8999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          237 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       237 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      |.+.+..+....+.....                            ..++..+++++.++|.+||+.||++|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            998887766655443100                            0123467899999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.8e-45  Score=332.23  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=202.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++|.+.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.+++.++||||+++++++     
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   95 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----   95 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----
Confidence            4578999999999999999999984     456899999986543     2344799999999999999999998     


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceec
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSS--------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR  160 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~--------------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~  160 (376)
                      .+...+++|||||+ ++|.+.+.....                    ....+++..++.++.||+.||.|||+ +||+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~  174 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR  174 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence            44455889999998 588888776432                    12458999999999999999999999 799999


Q ss_pred             cCCCCCeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 017139          161 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL  236 (376)
Q Consensus       161 dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p  236 (376)
                      ||||+||+++. ++.+||+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..|
T Consensus       175 dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAE-GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEET-TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcC-CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999996 78899999999986544322   22345578899999997654 8999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          237 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       237 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      |.+.+.......+....                            ....+..+++++.++|.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            98877655444333210                            00123467999999999999999999999999986


Q ss_pred             C
Q 017139          317 H  317 (376)
Q Consensus       317 h  317 (376)
                      +
T Consensus       305 ~  305 (314)
T 2ivs_A          305 D  305 (314)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.2e-45  Score=329.76  Aligned_cols=259  Identities=26%  Similarity=0.387  Sum_probs=195.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEE----EcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+.+++.++||||+++++++..   .
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~   83 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---A   83 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---H
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence            456789999999999999999998    56789999999986543    234579999999999999999998743   2


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+++|||||++ +|.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Df  158 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDF  158 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcC-CCeEEEccC
Confidence            23347899999975 888777653   2458999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          182 GSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       182 g~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |++........    .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||......  ....   .+...
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~---~~~~~  232 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRM---IGNDK  232 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHH---HCTTC
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH--HHhh---hcCcc
Confidence            99987644322    22334577899999997654 899999999999999999999998643221  1111   11110


Q ss_pred             H-H-----HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          258 R-E-----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       258 ~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      . .     ........             .....+..+++++.++|.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          233 QGQMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             CTHHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccchhHHHHHHHHhcc-------------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0 0     00000000             001134568999999999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-44  Score=325.28  Aligned_cols=247  Identities=18%  Similarity=0.257  Sum_probs=201.0

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++....   ....+|+.+++.++||||+++++++     .+...+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence            45678999999999999999999875 67789999997543   3345799999999999999999998     455558


Q ss_pred             EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++||||++ ++|.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TSCEEECSTTGGGG
T ss_pred             EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcC-CCCEEEcccccccc
Confidence            99999997 4777777542   3569999999999999999999999 79999999999999996 77899999999976


Q ss_pred             cccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          187 LVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       187 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      .....  ......+++.|+|||++.+.. ++.++|+|||||++|+|++ |..||...+..+....+......        
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------  240 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------  240 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred             ccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence            53321  122334577899999997654 8999999999999999998 99999988877766665542111        


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                          ..+...++.+.++|.+||+.||++|||+.++++|
T Consensus       241 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 --------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                1223568899999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-44  Score=329.73  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=203.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEE-----cCCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      ..++|.+.+.||+|+||.||+|.+     ..+++.||+|++....     ....+|+.+++.+ +||||+++++++    
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----   96 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----   96 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence            346899999999999999999985     4567899999986543     2345799999999 999999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhh--------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCC
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSS--------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ  165 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~  165 (376)
                       .+....++|||||++ +|.+.+.....              ....+++..++.++.|++.||.|||+ +||+||||||+
T Consensus        97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~  174 (313)
T 1t46_A           97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR  174 (313)
T ss_dssp             -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccc
Confidence             444458899999985 88888775421              12358999999999999999999999 79999999999


Q ss_pred             CeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 017139          166 NLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN  241 (376)
Q Consensus       166 Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  241 (376)
                      ||+++. ++.+||+|||++........   .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+..
T Consensus       175 Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          175 NILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             eEEEcC-CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            999996 78899999999987654432   2234567889999998765 48999999999999999998 999998876


Q ss_pred             hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ..............                           ...+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          253 VDSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            65555544432111                           01234578999999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-44  Score=339.62  Aligned_cols=246  Identities=21%  Similarity=0.306  Sum_probs=201.5

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++     .+...
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCCC
Confidence            4578999999999999999999999999999999986542     2345799999999999999999998     44445


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+|||||+ |+|.+.+...   +..+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~-~~~~kl~DfG~s~  261 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTE-KNVLKISDFGMSR  261 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGGGCE
T ss_pred             cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcC-CCcEEECcCCCce
Confidence            889999998 5787777642   3468999999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          186 VLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       186 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      ........   ....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+... ..+     
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-----  334 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRL-----  334 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-CCC-----
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC-----
Confidence            64332111   1223467899999997654 8999999999999999998 99999988776555443321 100     


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                            ..+..+++++.+++.+||+.||++|||++++++
T Consensus       335 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          335 ----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                  123457899999999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.1e-44  Score=326.10  Aligned_cols=252  Identities=23%  Similarity=0.259  Sum_probs=198.3

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...  .....+|+.+++.++|++++..+..+..    .....+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~   81 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV   81 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceE
Confidence            3457899999999999999999999999999999986443  3456789999999999988887776643    344578


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee---cCCCCcEEEEecCCcc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAK  185 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill---~~~~~~~kl~Dfg~~~  185 (376)
                      +||||++++|.+.+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||+   +. ++.+||+|||++.
T Consensus        82 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~-~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           82 MVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKK-GNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGG-TTCEEECCCTTCE
T ss_pred             EEEEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCC-CCeEEEecCccce
Confidence            99999988888887642   4569999999999999999999999 799999999999999   54 7789999999998


Q ss_pred             ccccCCC--------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcC
Q 017139          186 VLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLG  254 (376)
Q Consensus       186 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~~~~~~~  254 (376)
                      .......        .....||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..   .....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            7654322        23557899999999997654 899999999999999999999999864322   22222222111


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ..+.                        ......+++++.++|.+||+.||++|||++++++
T Consensus       236 ~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 STPI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HSCH------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cchh------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            1111                        1122457899999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=333.41  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=186.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCC-CCCeeecceeeeecCC---CCce
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMD-HPNVISLKHCFFSTTS---KDEL  105 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~---~~~~  105 (376)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.+. ||||+++++++.....   ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            48999999999999999999999999999999885443    23347888999996 9999999998854322   4566


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--ceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~--ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      .+++||||++|+|.+.+.... ....+++..++.++.||+.||.|||+ +|  |+||||||+|||++. ++.+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSN-QGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECT-TSCEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECC-CCCEEEecCcc
Confidence            789999999999988887643 34579999999999999999999999 79  999999999999996 77899999999


Q ss_pred             ccccccCCCc-------------ceeeccccccChhhhh--CCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017139          184 AKVLVKGEAN-------------ISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE  248 (376)
Q Consensus       184 ~~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  248 (376)
                      +.........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|..||...........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            9876443221             1445899999999983  233478899999999999999999999976543322111


Q ss_pred             HHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                      ..                     .          .......+..+.+||.+||+.||.+|||+.++++|-+
T Consensus       265 ~~---------------------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          265 KY---------------------S----------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -C---------------------C----------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cc---------------------c----------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            00                     0          0012346788999999999999999999999998744

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=333.93  Aligned_cols=253  Identities=21%  Similarity=0.303  Sum_probs=202.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      ..++|.+.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.+++.+ +||||+++++++    
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence            4578999999999999999999973     456789999986432     2345799999999 899999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCceec
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSM-------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR  160 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~-------------------~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~  160 (376)
                       .....+++|||||++ +|.+.+......                   ...+++..++.++.||+.||.|||+ +||+||
T Consensus       119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~  196 (344)
T 1rjb_A          119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHR  196 (344)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred             -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence             444458899999985 888887653211                   1348999999999999999999999 799999


Q ss_pred             cCCCCCeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 017139          161 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL  236 (376)
Q Consensus       161 dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p  236 (376)
                      ||||+||+++. ++.+||+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..|
T Consensus       197 Dikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          197 DLAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TCSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCChhhEEEcC-CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCC
Confidence            99999999996 78899999999986654332   22345688899999997654 8999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          237 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       237 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      |.+..........+.....                           ...+..+++++.++|.+||+.||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             STTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9887655555444432110                           0123457899999999999999999999999987


Q ss_pred             CCc
Q 017139          317 HPF  319 (376)
Q Consensus       317 hp~  319 (376)
                      |..
T Consensus       328 ~l~  330 (344)
T 1rjb_A          328 FLG  330 (344)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.9e-44  Score=327.29  Aligned_cols=256  Identities=20%  Similarity=0.246  Sum_probs=195.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcC---CCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ...++|.+.+.||+|+||.||+|.+..   +++.||+|++....      ....+|+.+++.++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345789999999999999999998765   45689999986442      224479999999999999999999865443


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                      ......++||||+.+ +|...+....  .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kl  188 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRD-DMTVCV  188 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECT-TSCEEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEE
Confidence            334457899999985 7777775432  234679999999999999999999999 79999999999999996 778999


Q ss_pred             EecCCccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017139          179 CDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       179 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      +|||++.......   ......+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+.......+.....
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            9999997654332   12234567889999999765 48999999999999999999 9999988877665554443110


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                                  ...+..+++++.++|.+||..||.+|||+.+++++
T Consensus       268 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 ----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                        01234678999999999999999999999999854

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-44  Score=325.66  Aligned_cols=248  Identities=21%  Similarity=0.332  Sum_probs=205.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++..+..   ...+|+.+++.++||||+++++++     .+...+
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence            456789999999999999999999999999999999976542   345799999999999999999998     445558


Q ss_pred             EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+||||++ ++|.+.+...  ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECG-GGCEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcC-CCCEEEccCcccee
Confidence            99999999 5887777653  23569999999999999999999999 79999999999999986 77899999999987


Q ss_pred             cccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          187 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       187 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ......  .....+++.|+|||++.+.. ++.++|+||||+++|+|++ |..||.+.+.......+.....         
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------  230 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------  230 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------
T ss_pred             ccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---------
Confidence            654332  22345678899999997654 8999999999999999999 9999988776555444333110         


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                         ...+..+++++.++|.+||..||.+|||++++++
T Consensus       231 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 -------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                               1123467899999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-44  Score=331.59  Aligned_cols=247  Identities=21%  Similarity=0.305  Sum_probs=197.6

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcE----EEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.    +|+|.+....     ....+|+.+++.++||||+++++++     
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----   84 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-----   84 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----
Confidence            4457899999999999999999999888876    6777664321     3345799999999999999999987     


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+ ...++||||+. |+|.+.+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|
T Consensus        85 ~~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~D  158 (325)
T 3kex_A           85 PG-SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKS-PSQVQVAD  158 (325)
T ss_dssp             CB-SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESS-SSCEEECS
T ss_pred             cC-CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECC-CCeEEECC
Confidence            22 23789999998 5777776542   3568999999999999999999999 79999999999999986 78899999


Q ss_pred             cCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017139          181 FGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       181 fg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      ||+++.......   .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....   
T Consensus       159 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---  234 (325)
T 3kex_A          159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---  234 (325)
T ss_dssp             CSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC---
T ss_pred             CCcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---
Confidence            999987644332   23445677999999997654 8999999999999999999 999998877655544433210   


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                               ....+..++.++.++|.+||..||.+|||+.++++|
T Consensus       235 -------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          235 -------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     001233468899999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-44  Score=327.54  Aligned_cols=253  Identities=25%  Similarity=0.289  Sum_probs=191.0

Q ss_pred             CCCCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeee
Q 017139           26 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFS   98 (376)
Q Consensus        26 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~   98 (376)
                      ....+...++|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++. 
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-  104 (309)
T 2h34_A           26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-  104 (309)
T ss_dssp             --------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred             ccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-
Confidence            3344556789999999999999999999999999999999986542       23457999999999999999999984 


Q ss_pred             cCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139           99 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                          .+..+|+||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+|
T Consensus       105 ----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~-~~~~k  174 (309)
T 2h34_A          105 ----IDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSA-DDFAY  174 (309)
T ss_dssp             ----ETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEE
T ss_pred             ----eCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcC-CCCEE
Confidence                34458999999986 77777764    2569999999999999999999999 79999999999999996 77899


Q ss_pred             EEecCCccccccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          178 LCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       178 l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      |+|||++.......  ......+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.. .....+.....
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~  252 (309)
T 2h34_A          175 LVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIP  252 (309)
T ss_dssp             ECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCC
T ss_pred             EecCccCccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCC
Confidence            99999987654432  22345689999999998654 4899999999999999999999999876544 22222221100


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-CHHHHhC
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACA  316 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-t~~ell~  316 (376)
                                               .....+..+++++.++|.+||+.||++|| +++++++
T Consensus       253 -------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 -------------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -------------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -------------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                                     01113456899999999999999999999 7777653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.9e-45  Score=334.59  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=204.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|.+.+.||+|+||.||+|.+ .+|+.||+|++....     ....+|+.+++.++||||+++++++     .....
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~  101 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-----MTPTE  101 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE-----CCSSC
T ss_pred             HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE-----ecCCc
Confidence            457899999999999999999984 468999999986542     2356899999999999999999998     34445


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC---CceeccCCCCCeeecCCCCcEEEEecC
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP---GVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~---~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      .++|||||++ +|.+.+.........+++..++.++.|++.||.|||+ +   ||+||||||+|||++. ++.+||+|||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg  179 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDE-EFEAVVGDFG  179 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECT-TCCEEECCCS
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECC-CCCEEeccCc
Confidence            7899999985 8888887765556679999999999999999999999 8   9999999999999996 7789999999


Q ss_pred             CccccccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCCC
Q 017139          183 SAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE----NAVDQLVEIIKVLGTP  256 (376)
Q Consensus       183 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~~~~~~~~~  256 (376)
                      ++........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...    ............    
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----  254 (326)
T 3uim_A          180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG----  254 (326)
T ss_dssp             SCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT----
T ss_pred             cccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH----
Confidence            9987643322  23445899999999997654 899999999999999999999999521    100001111110    


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                                ..................++...++++.+++.+||+.||.+|||+.++++|-.-.
T Consensus       255 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          255 ----------LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             ----------TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             ----------HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence                      0001111111111222223334457899999999999999999999999886543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=332.66  Aligned_cols=256  Identities=14%  Similarity=0.123  Sum_probs=192.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC---CCcEEEEEEecccccc---------------hHHHHHHHHhCCCCCeeecce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRY---------------KNRELQLMRLMDHPNVISLKH   94 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~---------------~~~e~~~l~~l~h~~Iv~~~~   94 (376)
                      .++|.+.+.||+|+||.||+|.+..   ++..+|+|++......               ..+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3689999999999999999999987   7889999998655322               224667778889999999999


Q ss_pred             eeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC
Q 017139           95 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH  174 (376)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~  174 (376)
                      ++.... .+...+|+|||||+++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++
T Consensus       116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~  188 (345)
T 2v62_A          116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGY-KN  188 (345)
T ss_dssp             EEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEES-SS
T ss_pred             cccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEcc-CC
Confidence            986533 34667899999997787776654    2379999999999999999999999 79999999999999986 44


Q ss_pred             --cEEEEecCCccccccCC--------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC-ChH
Q 017139          175 --QVKLCDFGSAKVLVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAV  243 (376)
Q Consensus       175 --~~kl~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~  243 (376)
                        .+||+|||+++......        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+. ...
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence              89999999997654321        12355789999999999765 4899999999999999999999999652 222


Q ss_pred             HHHHHHHH-hcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          244 DQLVEIIK-VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       244 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ........ .....+...... .                   -...+++++.++|.+||+.||++|||++++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~-~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKW-A-------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHH-S-------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhcccccHHHHhh-c-------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            22222222 111111111110 0                   01257899999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-44  Score=326.30  Aligned_cols=244  Identities=17%  Similarity=0.204  Sum_probs=195.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCC-------cEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeec
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFST   99 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~   99 (376)
                      ...++|++.+.||+|+||.||+|.+..++       ..||+|++....    ....+|+.+++.++||||+++++++.  
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--   82 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV--   82 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC--
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE--
Confidence            34678999999999999999999998877       469999986543    23457999999999999999999983  


Q ss_pred             CCCCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc---
Q 017139          100 TSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ---  175 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~---  175 (376)
                         +....++|||||+ ++|.+.+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.   
T Consensus        83 ---~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~~~  154 (289)
T 4fvq_A           83 ---CGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIR-EEDRKT  154 (289)
T ss_dssp             ---CTTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEE-CCBGGG
T ss_pred             ---eCCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEec-CCcccc
Confidence               3444789999998 5888777652   2348999999999999999999999 79999999999999986 544   


Q ss_pred             -----EEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 017139          176 -----VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEI  249 (376)
Q Consensus       176 -----~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~  249 (376)
                           +||+|||++.....   .....+++.|+|||++.+...++.++|||||||++|+|++| .+||...+...... .
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~  230 (289)
T 4fvq_A          155 GNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-F  230 (289)
T ss_dssp             TBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-H
T ss_pred             cccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-H
Confidence                 99999999865422   23455788999999998745689999999999999999995 55555555443332 2


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ....                             ..++...++++.++|.+||+.||++|||+.++++|
T Consensus       231 ~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          231 YEDR-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHTT-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2210                             01233468899999999999999999999999865

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.1e-45  Score=330.10  Aligned_cols=255  Identities=23%  Similarity=0.322  Sum_probs=195.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHh--CCCCCeeecceeeeecCCCCceeE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~l~~--l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...++|++.+.||+|+||.||+|++  +++.||||++..... ...+|.+++..  ++||||+++++++.... .....+
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~   81 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQL   81 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCcee
Confidence            4567899999999999999999987  789999999865432 23457777776  79999999999875533 445668


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCceeccCCCCCeeecCCCCcEEE
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--------TVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                      ++||||+++ +|.+.+.     ...+++..++.++.|++.||+|||        + +||+||||||+|||++. ++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~-~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKK-NGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECT-TSCEEE
T ss_pred             EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcC-CCCEEE
Confidence            899999985 7777774     357999999999999999999999        8 79999999999999996 788999


Q ss_pred             EecCCccccccCCCc-----ceeeccccccChhhhhCCCC-----CCccchhHHHHHHHHHHHhC----------CCCCC
Q 017139          179 CDFGSAKVLVKGEAN-----ISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFP  238 (376)
Q Consensus       179 ~Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~  238 (376)
                      +|||++.........     ....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999999765443322     23478999999999976532     34689999999999999999          88886


Q ss_pred             CCC----hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          239 GEN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       239 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                      ...    ............+...                 .    .....+....++++.+|+.+||+.||++|||+.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-----------------~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRP-----------------N----IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCC-----------------C----CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCC-----------------C----CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence            532    2222222221111000                 0    00111223356789999999999999999999998


Q ss_pred             hC
Q 017139          315 CA  316 (376)
Q Consensus       315 l~  316 (376)
                      ++
T Consensus       294 ~~  295 (301)
T 3q4u_A          294 KK  295 (301)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.9e-44  Score=329.35  Aligned_cols=260  Identities=23%  Similarity=0.282  Sum_probs=209.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|++.....     ...+|+.+++.++||||+++++++    
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----   97 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----   97 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE----
Confidence            44578999999999999999999876     3578899999865432     234799999999999999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSM------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT  173 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~  173 (376)
                       .+....++|||||++ +|.+.+......      ...+++..++.++.|++.||.|||+ +||+||||||+||+++. +
T Consensus        98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~-~  174 (322)
T 1p4o_A           98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-D  174 (322)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-T
T ss_pred             -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcC-C
Confidence             444458899999985 888887654321      2457899999999999999999999 79999999999999996 7


Q ss_pred             CcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017139          174 HQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI  249 (376)
Q Consensus       174 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~  249 (376)
                      +.+||+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            7899999999876543221   22345688999999997654 8999999999999999999 89999988776665554


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC------Cccccc
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH------PFFDEL  323 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h------p~~~~~  323 (376)
                      .....                            ...+..++.++.++|.+||+.||.+|||+.++++|      |+|+.+
T Consensus       254 ~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          254 MEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             HTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             HcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            43110                            00234578999999999999999999999999876      777665


Q ss_pred             cCC
Q 017139          324 REP  326 (376)
Q Consensus       324 ~~~  326 (376)
                      ...
T Consensus       306 ~~~  308 (322)
T 1p4o_A          306 SFY  308 (322)
T ss_dssp             CST
T ss_pred             ccc
Confidence            544

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.5e-44  Score=328.05  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=201.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEc-------CCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFF   97 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~   97 (376)
                      ...++|++.+.||+|+||.||+|.+.       .+++.||+|++.....     ...+|+.+++.+ +||||+++++++ 
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-  110 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-  110 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence            44589999999999999999999986       4577899999865432     244799999999 899999999988 


Q ss_pred             ecCCCCceeEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCC
Q 017139           98 STTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP  164 (376)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp  164 (376)
                          .+...+|+||||+++ +|.+.+.....            ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus       111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp  185 (334)
T 2pvf_A          111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA  185 (334)
T ss_dssp             ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSG
T ss_pred             ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCcc
Confidence                444558899999985 88888765432            12358999999999999999999999 7999999999


Q ss_pred             CCeeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 017139          165 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE  240 (376)
Q Consensus       165 ~Nill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  240 (376)
                      +||+++. ++.+||+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.
T Consensus       186 ~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          186 RNVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGEEECT-TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcC-CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            9999996 78899999999986644322   22344578899999997654 8999999999999999999 99999988


Q ss_pred             ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          241 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      ...+....+.....                            ...+..++.++.++|.+||+.||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          264 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            77666555443210                            01234578999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.4e-44  Score=321.96  Aligned_cols=247  Identities=27%  Similarity=0.348  Sum_probs=190.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCC---CcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|++.+.||+|+||.||+|.+..+   +..||+|++....     ....+|+.+++.++||||+++++++.     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   86 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----   86 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence            4557899999999999999999998654   4579999886532     23447999999999999999999862     


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      + ..+|+||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus        87 ~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Df  160 (281)
T 1mp8_A           87 E-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDF  160 (281)
T ss_dssp             S-SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC-
T ss_pred             c-CccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECC-CCCEEECcc
Confidence            2 236799999995 77777754   23569999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          182 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       182 g~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      |++........  .....+++.|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.....    
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----  235 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----  235 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred             ccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----
Confidence            99987644322  2234457789999999765 48999999999999999996 9999998877665554433110    


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                              ..++..+++++.++|.+||+.||++|||+.+++++
T Consensus       236 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 ------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    01334679999999999999999999999998753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.9e-44  Score=324.12  Aligned_cols=252  Identities=29%  Similarity=0.456  Sum_probs=191.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++..     
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----  103 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----  103 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence            45678999999999999999999999999999999986421       223479999999999999999999843     


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~-~~~~kl~Dfg  181 (310)
T 2wqm_A          104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLG  181 (310)
T ss_dssp             TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCC-
T ss_pred             CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcC-CCCEEEEecc
Confidence            3458899999986 8888887766667789999999999999999999999 79999999999999996 7789999999


Q ss_pred             CccccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHH
Q 017139          183 SAKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       183 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~  260 (376)
                      ++....... ......+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+... ...+...+.....     
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  255 (310)
T 2wqm_A          182 LGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-----  255 (310)
T ss_dssp             -----------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS-----
T ss_pred             ceeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC-----
Confidence            987654332 22345689999999998764 489999999999999999999999976432 1122222211100     


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                   +        ......+++++.++|.+||..||++|||+.++++
T Consensus       256 -------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          256 -------------P--------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             -------------C--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------C--------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                         0        0012357899999999999999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.9e-44  Score=323.83  Aligned_cols=261  Identities=23%  Similarity=0.360  Sum_probs=195.3

Q ss_pred             ccceEeeeeeccCCceEEEEEE----EcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..+|++.+.||+|+||.||+|+    +..+++.||+|++....     ....+|+.+++.++||||+++++++..   .+
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CC
Confidence            4579999999999999999999    56789999999986442     334579999999999999999998854   22


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+++||||+++ +|.+.+...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg  171 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFG  171 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcC-CCCEEECccc
Confidence            3458899999985 887777542   3569999999999999999999999 79999999999999986 7889999999


Q ss_pred             CccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          183 SAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       183 ~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      ++........    .....+|..|+|||++.+.. ++.++|+|||||++|+|++|..|+....  ....   ...+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~---~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM--ALFL---KMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHHH---HHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh--hHHh---hccCCccc
Confidence            9987654432    22345678899999997654 7899999999999999999998864321  1111   11111110


Q ss_pred             H-HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          259 E-EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       259 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      . ..........         .......+..+++++.++|.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 QMTVTRLVNTLK---------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGHHHHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHh---------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            0 0000000000         00011134568999999999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.7e-44  Score=329.56  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=202.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCc-----EEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      ..++|.+.+.||+|+||.||+|.+..+++     .||+|.+....     ....+|+.+++.+ +||||+++++++    
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----  119 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC----  119 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence            34789999999999999999999977664     79999986543     2345799999999 899999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhh----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSS----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV  169 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~----------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill  169 (376)
                       .+...+|+|||||++ +|.+.+.....          ....+++..++.++.|++.||.|||+ +||+||||||+||++
T Consensus       120 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          120 -THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL  197 (333)
T ss_dssp             -CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred             -ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence             444458899999985 88888765432          14568999999999999999999999 799999999999999


Q ss_pred             cCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 017139          170 DPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ  245 (376)
Q Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~  245 (376)
                      +. ++.+||+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+......
T Consensus       198 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          198 TN-GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EG-GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             CC-CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            96 78899999999986544332   22345678899999987654 8999999999999999998 9999988765555


Q ss_pred             HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ...+......+                           ..+...++++.++|.+||+.||++|||+.++++
T Consensus       276 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 FYKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            54444321110                           122346889999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-45  Score=363.07  Aligned_cols=286  Identities=24%  Similarity=0.319  Sum_probs=207.8

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecC-CCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT-SKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~-~~~~~  105 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++.... .....
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            3468999999999999999999999999999999886542     23446999999999999999988863211 12255


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC--cEEEEecC
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG  182 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~--~~kl~Dfg  182 (376)
                      ..|+|||||+| +|.+.+.... ....+++..++.++.|++.||.|||+ +||+||||||+||+++.++.  .+||+|||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            57899999975 7777776532 23468999999999999999999999 79999999999999985322  48999999


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++.............|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........   .........+.
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~---~i~~~~~~~~~  245 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG---KVREKSNEHIV  245 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST---TCC------CC
T ss_pred             cccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh---hhhcccchhhh
Confidence            99887666666667899999999998654 489999999999999999999999987654322111   11111111110


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ..........+.  ...+....+...+++.+.++|.+||.+||++|||+.++++||||+.+..
T Consensus       246 ~~~~l~g~~~~~--~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          246 VYDDLTGAVKFS--SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             SCCCCSSSCCCC--SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhhhhccccccc--cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            000000111111  1111122234457789999999999999999999999999999987654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-43  Score=321.79  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=191.7

Q ss_pred             CCccccceEee-eeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHH-HhCCCCCeeecceeeeecCCCCcee
Q 017139           29 EPKQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        29 ~~~~~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l-~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .....++|.+. +.||+|+||.||+|.+..+++.||+|++.... ...+|+.++ +.++||||+++++++.... .+...
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~   89 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLY-AGRKC   89 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH-HHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCce
Confidence            34566789887 78999999999999999999999999986543 445688777 6779999999999884422 34667


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC--CCcEEEEecCC
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGS  183 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~--~~~~kl~Dfg~  183 (376)
                      +++|||||++ +|.+.+...  ....+++..++.++.|++.||.|||+ +||+||||||+||+++..  ++.+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            8999999985 888877753  23469999999999999999999999 799999999999999853  56799999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +....                      ...++.++|||||||++|+|++|..||.+.+.......+..            
T Consensus       167 a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~------------  212 (299)
T 3m2w_A          167 AKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------------  212 (299)
T ss_dssp             CEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC------------
T ss_pred             ccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH------------
Confidence            86432                      12378899999999999999999999976654322111000            


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                            ....   ....+.......+++++.+||.+||+.||++|||++++++||||++...
T Consensus       213 ------~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          213 ------RIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             ------SSCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             ------HHhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence                  0000   0001111122468999999999999999999999999999999987543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.9e-44  Score=326.29  Aligned_cols=252  Identities=25%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEE-----cCCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|++.....     ...+|+.+++.+ +||||+++++++..  
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec--
Confidence            457899999999999999999985     35678999999865432     244789999999 68999999998742  


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCe
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYSSM------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL  167 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~------------~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Ni  167 (376)
                        .+..+++|||||++ +|.+.+......            ...+++..++.++.|++.||.|||+ +||+||||||+||
T Consensus       103 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Ni  179 (316)
T 2xir_A          103 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI  179 (316)
T ss_dssp             --TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             --CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceE
Confidence              23447899999985 888777653221            2238999999999999999999999 7999999999999


Q ss_pred             eecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 017139          168 LVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV  243 (376)
Q Consensus       168 ll~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~  243 (376)
                      +++. ++.+||+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....
T Consensus       180 l~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          180 LLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             EECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             EECC-CCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            9985 77899999999986544332   22345688999999997654 8999999999999999998 99999887654


Q ss_pred             HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      +.....+.....+                           ..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       258 ~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444333321110                           1234578999999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-43  Score=316.81  Aligned_cols=246  Identities=18%  Similarity=0.300  Sum_probs=201.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+|+.+++.++||||+++++++     .+...++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC   79 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeE
Confidence            3468999999999999999999986 67889999997653   3345799999999999999999988     4444588


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+++ +|.+.+...   ...+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFV  154 (267)
T ss_dssp             EEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECG-GGCEEECCTTGGGGB
T ss_pred             EEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECC-CCCEEEccccccccc
Confidence            99999985 777777542   3568999999999999999999999 79999999999999986 778999999998765


Q ss_pred             ccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....  ......+++.|+|||++.+.. ++.++|+||||+++|+|++ |..||.+.+..+....+.....          
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----------  223 (267)
T 3t9t_A          155 LDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------  223 (267)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred             ccccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----------
Confidence            3221  112344577899999997654 8999999999999999999 8999998877766655543210          


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                        ...+...++++.+++.+||+.||++|||+.+++++
T Consensus       224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                              01233568899999999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5e-44  Score=328.59  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=201.3

Q ss_pred             CccccceEeeeeeccCCceEEEEEE----EcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      -...++|++.+.||+|+||.||+|+    +..+++.||+|++.....    ...+|+++++.++||||+++++++..   
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   95 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---   95 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---
Confidence            3455789999999999999999999    467899999999865532    24579999999999999999998753   


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+...+|+|||||+ ++|.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~-~~~~kl~D  170 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVES-EAHVKIAD  170 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECC
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECC-CCCEEEcc
Confidence            34566889999996 5777777653   2459999999999999999999999 79999999999999986 78899999


Q ss_pred             cCCccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-
Q 017139          181 FGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT-  255 (376)
Q Consensus       181 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-  255 (376)
                      ||++........    .....+++.|+|||++.+.. ++.++|||||||++|+|++|..||..........  ...... 
T Consensus       171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~  247 (327)
T 3lxl_A          171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGCERDV  247 (327)
T ss_dssp             GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC----C
T ss_pred             cccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--ccccccc
Confidence            999987644332    22345688899999997654 7999999999999999999999996543221110  000000 


Q ss_pred             CCHHHH-hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          256 PTREEI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       256 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      +....+ ......             .....+..+++++.+||.+||+.||++|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          248 PALSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             CHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            000000 000000             0111235689999999999999999999999999643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.3e-45  Score=334.84  Aligned_cols=267  Identities=22%  Similarity=0.243  Sum_probs=200.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ...++|.+.+.||+|+||.||+|.+ .+++.||+|++....    ....+|+.+++.++||||+++++++     .+...
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  109 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERNE  109 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTTC
T ss_pred             HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCe
Confidence            4568999999999999999999996 468999999886543    2345799999999999999999988     44455


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK  187 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECT-TCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECC-CCCEEEeeccccc
Confidence            8899999985 6665554433333469999999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          186 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       186 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+........     ...  
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~--  259 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VES--  259 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHH--
T ss_pred             ccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhc--
Confidence            643221   223456899999999997654 899999999999999999999999765432111000000     000  


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  318 (376)
                      ....     .+...........++...+..+.+++.+||+.||++|||+.++++|.
T Consensus       260 ~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          260 HNNG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             HTTT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cccc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            0000     01111111111223334567899999999999999999999998764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=330.06  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=199.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.++||||+++++++.... .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence            357999999999999999999999999999999885432    23457999999999999999999886432 3455688


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCSSCEES
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcC-CCCEEEEecCcchhc
Confidence            99999996 8888888766667889999999999999999999999 79999999999999986 778999999988754


Q ss_pred             ccCCC----------cceeeccccccChhhhhCCC--CCCccchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcC
Q 017139          188 VKGEA----------NISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLG  254 (376)
Q Consensus       188 ~~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~  254 (376)
                      .....          .....|++.|+|||++.+..  .++.++|||||||++|+|++|..||...... .........  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--  262 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--  262 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence            32111          11335689999999986432  2688999999999999999999999531100 001111110  


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                     ....+          ....+++++.++|.+||+.||.+|||+++++++
T Consensus       263 ---------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 ---------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ---------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                           00001          123578999999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=334.16  Aligned_cols=254  Identities=13%  Similarity=0.126  Sum_probs=197.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC--------CCcEEEEEEecccccchHHHHHHHHhCCCCCeeec------------
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISL------------   92 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~------------   92 (376)
                      .++|++.+.||+|+||.||+|++..        .++.||+|++... ....+|+++++.++||||+++            
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            3689999999999999999999987        4889999998765 456689999999999999984            


Q ss_pred             ---ceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee
Q 017139           93 ---KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV  169 (376)
Q Consensus        93 ---~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill  169 (376)
                         ++++.    .++..+|+|||||+++|.+.+....  ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus       120 ~~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          120 PTCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFV  192 (352)
T ss_dssp             CCCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEE
T ss_pred             cchhhccc----cCCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEE
Confidence               33332    2245688999999779888887532  3679999999999999999999999 799999999999999


Q ss_pred             cCCCC--cEEEEecCCccccccCCC--------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 017139          170 DPLTH--QVKLCDFGSAKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG  239 (376)
Q Consensus       170 ~~~~~--~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  239 (376)
                      +. ++  .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+
T Consensus       193 ~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          193 DP-EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             ET-TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             cC-CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            96 55  899999999976543221        1334789999999999765 489999999999999999999999987


Q ss_pred             CC-hHHHHHHHHHhc-CCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          240 EN-AVDQLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       240 ~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .. ....+....... ..+.            .+..        .......+++++.+||.+||+.||++|||++++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~------------~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPG------------PFVG--------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCC------------CEEC--------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCcCHHHHHHHHHhccCChh------------hhhh--------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            54 333333322211 1000            0000        00012357899999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.4e-44  Score=327.92  Aligned_cols=257  Identities=18%  Similarity=0.202  Sum_probs=202.3

Q ss_pred             ccccceEeeeeeccCCceEEEEEE-----EcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT  100 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~  100 (376)
                      ...++|++.+.||+|+||.||+|+     +..+++.||+|++....     ....+|+.+++.++||||+++++++    
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----  102 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS----  102 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence            456799999999999999999999     55678899999985432     2344699999999999999999998    


Q ss_pred             CCCceeEEEEeeccc-chHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCC
Q 017139          101 SKDELFLNLVMEYVP-ETMYRVLKHYSSM---NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTH  174 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~  174 (376)
                       .+...+|+|||||+ ++|.+.+......   ...+++..++.++.|++.||.|||+ +||+||||||+|||++.  .+.
T Consensus       103 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          103 -LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             -CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTC
T ss_pred             -cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcc
Confidence             44445789999996 5888887764321   2458999999999999999999999 79999999999999983  244


Q ss_pred             cEEEEecCCccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017139          175 QVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII  250 (376)
Q Consensus       175 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  250 (376)
                      .+||+|||++.......   ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            69999999987543322   22234568899999999765 48999999999999999998 999998887766555443


Q ss_pred             HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      ....                            ...+..+++.+.++|.+||+.||.+|||+.++++|+|+-.
T Consensus       260 ~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          260 SGGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            3110                            0123457899999999999999999999999999998754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.5e-45  Score=344.76  Aligned_cols=255  Identities=20%  Similarity=0.208  Sum_probs=193.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCC-CCeeecc---------ee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDH-PNVISLK---------HC   95 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h-~~Iv~~~---------~~   95 (376)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.+.| +|...+.         +.
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            346999999999999999999999999999999986322       234578888888876 3221111         11


Q ss_pred             e------------eecCCCCceeEEEEeecccchHHHHHHhh---hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceec
Q 017139           96 F------------FSTTSKDELFLNLVMEYVPETMYRVLKHY---SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR  160 (376)
Q Consensus        96 ~------------~~~~~~~~~~~~lv~e~~~g~l~~~l~~~---~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~  160 (376)
                      .            ..........++++|+++.++|.+++...   ...+..+++..+..++.|++.||+|||+ +||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence            1            00000112336799999999888887543   2234568888999999999999999999 799999


Q ss_pred             cCCCCCeeecCCCCcEEEEecCCccccccCCCcceeeccccccChhhhh---------CCCCCCccchhHHHHHHHHHHH
Q 017139          161 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF---------GATEYTTSIDIWSAGCVLAELL  231 (376)
Q Consensus       161 dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll  231 (376)
                      ||||+|||++. ++.+||+|||+++.....  .....| +.|+|||++.         ....++.++|||||||++|+|+
T Consensus       236 DiKp~NILl~~-~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQ-RGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECT-TCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEec-CCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            99999999996 778999999998765433  344566 9999999983         3334788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCH
Q 017139          232 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA  311 (376)
Q Consensus       232 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  311 (376)
                      +|+.||.+.+.......+                       ++          ....+|+++.+||.+||+.||++|||+
T Consensus       312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999765432111100                       00          112578999999999999999999999


Q ss_pred             HHHhCCCccccccC
Q 017139          312 LEACAHPFFDELRE  325 (376)
Q Consensus       312 ~ell~hp~~~~~~~  325 (376)
                      .++++||||+.+..
T Consensus       359 ~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          359 LQAMETPEYEQLRT  372 (413)
T ss_dssp             HHHTTSHHHHHHHH
T ss_pred             HHHHhCHHHHHHHH
Confidence            99999999987643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-43  Score=316.04  Aligned_cols=246  Identities=17%  Similarity=0.230  Sum_probs=199.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++.+.||+|+||.||+|++  +++.||+|++....      ....+|+.+++.++||||+++++++..   .+.
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~   81 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPA   81 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTS
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCC
Confidence            4567899999999999999999998  48899999986543      234578889999999999999998843   223


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--ceeccCCCCCeeecCCCCcEEEEec
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~--ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ..+++||||+++ +|.+.+...  ....+++..++.++.|++.||.|||+ +|  ++||||||+||+++. ++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~-~~~~~l~~~  157 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDE-DMTARISMA  157 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECT-TSCEEEEGG
T ss_pred             CCeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcC-CcceeEEec
Confidence            557899999985 888877642  22358999999999999999999999 79  999999999999996 778999998


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCC--CCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      |++.....    ....+|+.|+|||++.+...  ++.++|||||||++|+|++|..||.+.+..+....+......+   
T Consensus       158 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---  230 (271)
T 3kmu_A          158 DVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP---  230 (271)
T ss_dssp             GSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---
T ss_pred             cceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC---
Confidence            88754322    24567999999999976432  2337999999999999999999999888777666554421111   


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                              .++..+++++.++|.+||+.||++|||++++++
T Consensus       231 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 ------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    134568999999999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.9e-44  Score=328.15  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=193.7

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEE----EEEEeccc-----ccchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~-----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ...++|++.+.||+|+||+||+|++..+++.+    |+|.+...     .....+|+.+++.++||||+++++++..   
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   88 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---   88 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---
Confidence            35578999999999999999999998887754    77776432     2234579999999999999999998843   


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                        .. .++|+||+. |+|.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|
T Consensus        89 --~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~D  160 (327)
T 3poz_A           89 --ST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITD  160 (327)
T ss_dssp             --SS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECC
T ss_pred             --CC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECC-CCCEEEcc
Confidence              22 668888888 577777765   24679999999999999999999999 79999999999999996 78899999


Q ss_pred             cCCccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017139          181 FGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       181 fg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      ||+++........   ....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-  238 (327)
T 3poz_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-  238 (327)
T ss_dssp             TTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred             CcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-
Confidence            9999876443322   233457789999999765 48999999999999999999 99999887665544333321100 


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                                 ..+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       239 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 ---------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ---------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                       0233568899999999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.3e-43  Score=337.09  Aligned_cols=264  Identities=21%  Similarity=0.248  Sum_probs=207.0

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +|...++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+++++.+.|++++..+..+.    .....
T Consensus         2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~   77 (483)
T 3sv0_A            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDY   77 (483)
T ss_dssp             CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTE
T ss_pred             CCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCE
Confidence            356678899999999999999999999999999999987543  345678999999998866555555443    23445


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeec--CCCCcEEEEecCCc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSA  184 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~--~~~~~~kl~Dfg~~  184 (376)
                      .++|||||.++|.+++...   ...+++..++.|+.||+.||+|||+ +||+||||||+|||++  ..++.+||+|||++
T Consensus        78 ~~lvme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           78 NVLVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            7899999988988887642   4579999999999999999999999 7999999999999993  23778999999999


Q ss_pred             cccccCCC--------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhc
Q 017139          185 KVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVL  253 (376)
Q Consensus       185 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~  253 (376)
                      +.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+...   ...+..+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence            87654332        22567899999999997654 89999999999999999999999987543   33333333221


Q ss_pred             CCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC----------CCccccc
Q 017139          254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA----------HPFFDEL  323 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~----------hp~~~~~  323 (376)
                      .....+                        .+...+++++.+||.+||+.||++||+++++++          ++|+..+
T Consensus       233 ~~~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~  288 (483)
T 3sv0_A          233 VATSIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVF  288 (483)
T ss_dssp             HHSCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred             ccccHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCc
Confidence            111111                        122457899999999999999999999987643          6666555


Q ss_pred             cC
Q 017139          324 RE  325 (376)
Q Consensus       324 ~~  325 (376)
                      +|
T Consensus       289 dW  290 (483)
T 3sv0_A          289 DW  290 (483)
T ss_dssp             HH
T ss_pred             Cc
Confidence            44

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.2e-44  Score=344.31  Aligned_cols=247  Identities=21%  Similarity=0.336  Sum_probs=203.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ...+|++.+.||+|+||.||+|.+..++..||||++..+.   ....+|+.+++.++||||+++++++     .+...+|
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcEE
Confidence            4568999999999999999999999999999999997653   2345799999999999999999998     4444588


Q ss_pred             EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|||||+ |+|.+.+...  ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus       293 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGE-NHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG-GGCEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECC-CCcEEEeecccceec
Confidence            9999998 5888887653  23568999999999999999999999 79999999999999986 788999999999876


Q ss_pred             ccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .....  .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....           
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------  436 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----------  436 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            43321  12234567899999997654 8999999999999999999 999999887655544333210           


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                       ....+..+++++.+||.+||+.||++|||+.++++
T Consensus       437 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 -----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                             01133467899999999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-43  Score=317.85  Aligned_cols=246  Identities=20%  Similarity=0.307  Sum_probs=194.0

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ....++|++.+.||+|+||.||+|.+  +|+.||+|++....  ....+|+.+++.++||||+++++++..    ....+
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~   90 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL   90 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CC
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCce
Confidence            45568899999999999999999987  58899999987653  234579999999999999999998642    33357


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |+||||+++ +|.+.+....  ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKE  166 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC---
T ss_pred             EEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeC-CCcEEEeecccccc
Confidence            899999986 8888776532  1347899999999999999999999 79999999999999996 77899999999875


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+....            
T Consensus       167 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------  231 (278)
T 1byg_A          167 ASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------  231 (278)
T ss_dssp             -----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC------------
T ss_pred             cccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------
Confidence            4332  2234568899999999765 48999999999999999998 999998876655444332210            


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                      ....+..+++++.++|.+||..||++|||+.++++
T Consensus       232 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 ----------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                            01133467999999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=318.36  Aligned_cols=248  Identities=25%  Similarity=0.300  Sum_probs=200.4

Q ss_pred             cccceEeee-eeccCCceEEEEEEEc--CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           32 QTISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        32 ~~~~y~~~~-~Lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..++|.+.+ .||+|+||.||+|.+.  .+++.||+|++....     ....+|+.+++.++||||+++++++ ..    
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~----   81 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA----   81 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES----
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC----
Confidence            456788877 9999999999999864  467889999997642     2344799999999999999999987 21    


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      + .+++||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        82 ~-~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg  155 (287)
T 1u59_A           82 E-ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFG  155 (287)
T ss_dssp             S-SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCT
T ss_pred             C-CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcC-CCCEEECccc
Confidence            1 27899999986 77666643   34569999999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          183 SAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       183 ~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      ++........    .....+++.|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+.....   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---  231 (287)
T 1u59_A          156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---  231 (287)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---
T ss_pred             ceeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc---
Confidence            9987643322    12334578899999997654 8999999999999999998 9999998877665554433100   


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                                               ..++..+++++.++|.+||+.||++||++.++++|.+
T Consensus       232 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          232 -------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                                     0133467999999999999999999999999987744

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1e-43  Score=332.07  Aligned_cols=247  Identities=23%  Similarity=0.308  Sum_probs=190.3

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|.+.+.||+|+||.||+|++.   .++..||||++....     ....+|+.+++.++||||+++++++     .
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~  116 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----T  116 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence            34568999999999999999999986   467789999986542     2345799999999999999999998     4


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+++|||||+ ++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Df  191 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINS-NLVCKVSDF  191 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC
T ss_pred             eCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcC-CCCEEECcC
Confidence            4455889999997 588777754   24569999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017139          182 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       182 g~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      |+++........    ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-  269 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-  269 (373)
T ss_dssp             ----------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            999876443221    122346789999999765 48999999999999999998 99999988776665554332110 


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                 ..+..++.++.+++.+||+.||.+||++.++++
T Consensus       270 ---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 ---------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                       022357889999999999999999999998875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.9e-43  Score=316.58  Aligned_cols=247  Identities=25%  Similarity=0.328  Sum_probs=196.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCC---CcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|++.+.||+|+||.||+|.+...   +..||+|.+....     ....+|+.+++.++||||+++++++.     
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----   83 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-----   83 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-----
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-----
Confidence            4567899999999999999999987543   4469999986542     23457999999999999999999872     


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      ++ ..|+||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Df  157 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVAS-PECVKLGDF  157 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEE-TTEEEECCC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECC-CCcEEeCcc
Confidence            22 25799999984 77777754   24568999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          182 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       182 g~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      |++........  .....+++.|+|||++.+. .++.++|+|||||++|+|++ |..||......+....+......   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---  233 (281)
T 3cc6_A          158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---  233 (281)
T ss_dssp             CGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---
T ss_pred             CCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---
Confidence            99986544322  2234457889999999765 48999999999999999998 99999877666555444331110   


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                               ..+..+++.+.++|.+||..||++|||+.+++++
T Consensus       234 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 -------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                     0234578999999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.9e-43  Score=319.09  Aligned_cols=249  Identities=23%  Similarity=0.311  Sum_probs=187.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++.+.||+|+||.||+|++.   ..+|+|++....      ....+|+.+++.++||||++++++.     . .
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~-~   91 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-----T-A   91 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C-S
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-----c-C
Confidence            44578999999999999999999853   359999986443      2245799999999999999998854     1 2


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++|||||++ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~  166 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGL  166 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TTEEEECCCC-
T ss_pred             CccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECC-CCCEEEcccee
Confidence            236799999985 66666643   34669999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccC---CCcceeeccccccChhhhhC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          184 AKVLVKG---EANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +......   .......||+.|+|||++..  ...++.++|||||||++|+|++|..||.+....+.+............
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD  246 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence            8755432   22234568999999999852  334788999999999999999999999987776666555543211110


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                             ...+...+++++.+||.+||+.||++|||+.++++
T Consensus       247 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 -----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             -----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                   01123457899999999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.1e-43  Score=335.41  Aligned_cols=245  Identities=21%  Similarity=0.299  Sum_probs=199.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ...++|++.+.||+|+||.||+|.+  .|+.||||++....  ....+|+.+++.++||||+++++++..    ....+|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceE
Confidence            3457899999999999999999987  47899999997653  334589999999999999999998753    223488


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|||||++ +|.+.+...  ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus       264 iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECC-CCCEEEeeCCCcccc
Confidence            99999985 888887653  22347999999999999999999999 79999999999999996 788999999999854


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...  .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+...            
T Consensus       340 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------  404 (450)
T 1k9a_A          340 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------  404 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC------------
T ss_pred             ccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            322  2233568899999999765 48999999999999999998 9999988776655544433100            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                      ...+..+++++.++|.+||+.||++|||+.++++
T Consensus       405 ----------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          405 ----------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            1133567999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.5e-43  Score=316.91  Aligned_cols=244  Identities=23%  Similarity=0.274  Sum_probs=196.3

Q ss_pred             cccceEeee-eeccCCceEEEEEEE--cCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           32 QTISYMAER-VVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        32 ~~~~y~~~~-~Lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ..++|.+.+ .||+|+||.||+|.+  ..+++.||+|++....      ....+|+.+++.++||||+++++++ ..   
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~---   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA---   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES---
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC---
Confidence            346899998 999999999999954  5667899999986542      2345799999999999999999987 21   


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                        ..+++||||++ ++|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus        90 --~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~-~~~~kl~Df  161 (291)
T 1xbb_A           90 --ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDF  161 (291)
T ss_dssp             --SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCC
T ss_pred             --CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeC-CCcEEEccC
Confidence              22789999998 477777754    4569999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017139          182 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       182 g~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      |++.........    ....+++.|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+.... . 
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~-  238 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R-  238 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C-
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C-
Confidence            999876443322    1233568899999997654 7899999999999999999 999999887766554443310 0 


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                ..++..+++++.++|.+||+.||++|||+.++++
T Consensus       239 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 --------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      0123467999999999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-43  Score=322.63  Aligned_cols=248  Identities=21%  Similarity=0.286  Sum_probs=195.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCC----cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ....+|++.+.||+|+||.||+|.+..++    ..||+|++.....     ...+|+.+++.++||||+++++++     
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----  115 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----  115 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            34568999999999999999999987653    3599999865422     234799999999999999999998     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+...+++|||||++ +|.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~D  190 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSD  190 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECC
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECC-CCcEEECC
Confidence            445558999999986 77777654   24679999999999999999999999 79999999999999996 78899999


Q ss_pred             cCCccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017139          181 FGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       181 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      ||++........    .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~  269 (333)
T 1mqb_A          191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL  269 (333)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             CCcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC
Confidence            999987643322    1123457789999999765 48999999999999999998 99999888776665554432110


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                                  ..+..+++++.++|.+||+.||++||++.+++++
T Consensus       270 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 ----------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ----------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                        0223578899999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=324.79  Aligned_cols=246  Identities=23%  Similarity=0.330  Sum_probs=191.9

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEE----EEEEeccc-----ccchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~-----~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.+    |+|.+...     .....+|+.+++.++||||+++++++..   
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   88 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---   88 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES---
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec---
Confidence            34578999999999999999999998888765    66655332     2234579999999999999999998843   


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                        .. .++|+||+. |+|.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|
T Consensus        89 --~~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kL~D  160 (327)
T 3lzb_A           89 --ST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITD  160 (327)
T ss_dssp             --SS-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECC
T ss_pred             --CC-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcC-CCCEEEcc
Confidence              22 668888888 4777777652   4569999999999999999999999 79999999999999986 78899999


Q ss_pred             cCCccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017139          181 FGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       181 fg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      ||++.........   ....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-  238 (327)
T 3lzb_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-  238 (327)
T ss_dssp             TTC----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred             CcceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            9999876433222   2334577899999997654 8999999999999999999 99999887766554443321100 


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                 ..+..++.++.++|.+||..||.+|||+.++++
T Consensus       239 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          239 ---------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ---------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                       123457889999999999999999999999885

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.5e-43  Score=316.87  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=196.1

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCC---cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      ....+|.+.+.||+|+||.||+|.+..++   ..+|+|.+....     ....+|+.+++.++||||+++++++.    .
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~   97 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----R   97 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----C
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----c
Confidence            45568999999999999999999976443   358999886532     23447999999999999999999864    3


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .+...++||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Df  172 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDE-KFTVKVADF  172 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSC
T ss_pred             CCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECC-CCCEEECcc
Confidence            34457899999986 87777754   34668999999999999999999999 79999999999999996 778999999


Q ss_pred             CCccccccCC-----CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017139          182 GSAKVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       182 g~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      |++.......     ......+|+.|+|||.+.+.. ++.++|+|||||++|+|++ |.+||.+.+..+....+..... 
T Consensus       173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-  250 (298)
T 3f66_A          173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-  250 (298)
T ss_dssp             GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-
T ss_pred             cccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-
Confidence            9997654322     123445678899999997654 8999999999999999999 6778877666555544433111 


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                 ...+..++.++.++|.+||+.||++|||+.++++
T Consensus       251 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 ---------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                       0123457889999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.8e-43  Score=335.47  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=200.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|.+.+.||+|+||.||+|.+. ++..||||++....   ....+|+.+++.++||||+++++++.      ...+|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccE
Confidence            4578999999999999999999985 46789999997643   23457999999999999999998872      12378


Q ss_pred             EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|||||. |+|.+.+....  ...+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TCCEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECC-CCcEEEeeCCCceEc
Confidence            9999998 58888876532  2357889999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....  ......++..|+|||++.... ++.++|||||||++|+|++ |..||.+.+..+....+......+        
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------  405 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP--------  405 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--------
T ss_pred             CCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            3321  112234577899999997654 8999999999999999999 999999988777766654421110        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                          .+..+++++.+++.+||+.||++|||++++++
T Consensus       406 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          406 --------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                23457899999999999999999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.9e-43  Score=313.30  Aligned_cols=245  Identities=24%  Similarity=0.323  Sum_probs=199.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+|+++++.++||||+++++++.     ++ ..+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~-~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----CC-CcE
Confidence            4578999999999999999999975 56789999986543   33457999999999999999998872     22 277


Q ss_pred             EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||++ ++|.+.+....  ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus        84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLI  159 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcC-CCCEEECCCcccccc
Confidence            9999997 57777665421  2368999999999999999999999 79999999999999996 788999999999876


Q ss_pred             ccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .....  .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....          
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------  228 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------  228 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             cCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----------
Confidence            44322  12334577899999997654 8999999999999999999 9999998877666655433110          


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                        ...+..+++++.++|.+||..||++|||++++++
T Consensus       229 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                              1123467899999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=314.22  Aligned_cols=249  Identities=22%  Similarity=0.359  Sum_probs=196.3

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      |.....|.+.+.||+|+||.||+|.+..+++   .+|+|++....     ....+|+.+++.++||||+++++++..   
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   93 (298)
T 3pls_A           17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP---   93 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC---
T ss_pred             cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec---
Confidence            4555678899999999999999999766554   79999986533     233479999999999999999998843   


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                       .+...++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|
T Consensus        94 -~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~-~~~~kl~D  167 (298)
T 3pls_A           94 -PEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDE-SFTVKVAD  167 (298)
T ss_dssp             -SSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECC
T ss_pred             -CCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEeCc
Confidence             2233479999997 577777654   34678999999999999999999999 79999999999999996 77899999


Q ss_pred             cCCccccccC-----CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcC
Q 017139          181 FGSAKVLVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       181 fg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      ||++......     .......+++.|+|||.+.+. .++.++|||||||++|+|++| .+||...+..+....+.....
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~  246 (298)
T 3pls_A          168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR  246 (298)
T ss_dssp             TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC
T ss_pred             CCCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC
Confidence            9999754332     122344568899999999765 489999999999999999994 555665555544443333110


Q ss_pred             CCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                  ...+..+++++.+++.+||+.||.+|||+.++++
T Consensus       247 ----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          247 ----------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                        0123457899999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=323.83  Aligned_cols=278  Identities=22%  Similarity=0.299  Sum_probs=193.7

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHH--HHhCCCCCeeecceeeeecCCCCcee
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQL--MRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~--l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ....++|++.+.||+|+||.||+|++  +++.||||++..... ....|.++  +..++||||+++++.+......+...
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            34567899999999999999999976  789999999865432 22234444  44589999999998765555566777


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC---------CceeccCCCCCeeecCCCCcE
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP---------GVCHRDVKPQNLLVDPLTHQV  176 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~---------~ivH~dlkp~Nill~~~~~~~  176 (376)
                      +++|||||++ +|.+.+..     ...++..++.++.||+.||.|||+ +         ||+||||||+|||++. ++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKN-DGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECT-TSCE
T ss_pred             EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcC-CCcE
Confidence            8999999975 88777754     445889999999999999999999 8         9999999999999996 7889


Q ss_pred             EEEecCCccccccCC---------CcceeeccccccChhhhhCC------CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 017139          177 KLCDFGSAKVLVKGE---------ANISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLGQPLFPGEN  241 (376)
Q Consensus       177 kl~Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~lltg~~pf~~~~  241 (376)
                      ||+|||++.......         ......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999997654321         12244689999999999652      235678999999999999999976653322


Q ss_pred             h-HHHHHHHH-HhcCCCCHHHHhhcC-cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh---
Q 017139          242 A-VDQLVEII-KVLGTPTREEIRCMN-PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---  315 (376)
Q Consensus       242 ~-~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell---  315 (376)
                      . .+....+. .....+....+.... .......++..    +  ......++++.+||.+||+.||++|||+.+++   
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L  313 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA----W--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM  313 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT----C--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc----c--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence            1 11000000 011111111111100 00000000000    0  00112345799999999999999999999994   


Q ss_pred             ---CCCcccc
Q 017139          316 ---AHPFFDE  322 (376)
Q Consensus       316 ---~hp~~~~  322 (376)
                         .++|-++
T Consensus       314 ~~ll~~~~~~  323 (336)
T 3g2f_A          314 AELMMIWERN  323 (336)
T ss_dssp             HHHHHCCCC-
T ss_pred             HHHHHHHHhc
Confidence               4666654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.7e-43  Score=317.88  Aligned_cols=244  Identities=28%  Similarity=0.416  Sum_probs=187.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ..++|++.+.||+|+||.||+|++  .++.||+|++....  ....+|+.+++.++||||+++++++.     +.  .++
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~l   76 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCL   76 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEE
Confidence            456899999999999999999987  47899999986543  23457999999999999999998762     22  679


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--CCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ||||+++ +|.+.+.... ....+++..+..++.|++.||.|||+.  +||+||||||+||+++.++..+||+|||++..
T Consensus        77 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999985 7777776421 123478899999999999999999983  38999999999999986444589999999875


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCHHHHhhc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD--QLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.......  ....+..  +.         
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~---------  221 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT---------  221 (307)
T ss_dssp             -----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC---------
T ss_pred             cccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC---------
Confidence            4332  2345689999999999764 48999999999999999999999997643221  1111111  00         


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                       ...+...+++.+.++|.+||+.||++|||++++++
T Consensus       222 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          222 -----------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             -----------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             00123467899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-43  Score=323.28  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=189.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHhC--CCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRLM--DHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~l~~l--~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|++.  ++.||+|++..... ...+|.+++..+  +||||+++++++.... .....+|
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~  111 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLY  111 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceE
Confidence            3468999999999999999999984  89999999865432 223455555544  8999999999886542 2235689


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC--------CceeccCCCCCeeecCCCCcEEEE
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--------GVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~--------~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                      +|||||++ +|.+.+..     ..+++..++.++.|++.||.|||+ +        ||+||||||+|||++. ++.+||+
T Consensus       112 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kl~  184 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIA  184 (337)
T ss_dssp             EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEEC
T ss_pred             EEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECC-CCCEEEE
Confidence            99999985 88887754     469999999999999999999998 7        9999999999999996 7789999


Q ss_pred             ecCCccccccCCCc-----ceeeccccccChhhhhCCCCCCcc------chhHHHHHHHHHHHhC----------CCCCC
Q 017139          180 DFGSAKVLVKGEAN-----ISYICSRYYRAPELIFGATEYTTS------IDIWSAGCVLAELLLG----------QPLFP  238 (376)
Q Consensus       180 Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~~lltg----------~~pf~  238 (376)
                      |||++.........     ....||+.|+|||++.+.. ++..      +|||||||++|+|++|          ..||.
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99999765433222     2457899999999997654 4443      8999999999999999          66775


Q ss_pred             CCC----hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH
Q 017139          239 GEN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  314 (376)
Q Consensus       239 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  314 (376)
                      ...    ................              .++       .......+++++.++|.+||+.||++|||+.++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~--------------~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  322 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLRP--------------SFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRV  322 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCC--------------CCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhcCCCCchhhhHHHHhhhccCc--------------ccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence            432    1222222221100000              000       000112456779999999999999999999999


Q ss_pred             hCC
Q 017139          315 CAH  317 (376)
Q Consensus       315 l~h  317 (376)
                      ++|
T Consensus       323 l~~  325 (337)
T 3mdy_A          323 KKT  325 (337)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            865

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-42  Score=333.33  Aligned_cols=251  Identities=25%  Similarity=0.329  Sum_probs=198.8

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++....   ....+|+.+++.++||||+++++++.     + ..+|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-CceE
Confidence            34789999999999999999999864 4679999997543   23458999999999999999999873     2 2378


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|||||++ +|.+.+....  ...+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus       255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECC-CCCEEECCCccceec
Confidence            99999985 8888776432  3568999999999999999999999 79999999999999985 778999999999865


Q ss_pred             ccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .....  .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......         
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  400 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------  400 (452)
T ss_dssp             ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             CCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            43321  2234457789999999765 48999999999999999999 99999988877766655432110         


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC--CCcccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE  322 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--hp~~~~  322 (376)
                                         ..+..+++++.+++.+||+.||++|||++++++  ..++..
T Consensus       401 -------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                               123457899999999999999999999999875  344443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-43  Score=327.10  Aligned_cols=249  Identities=22%  Similarity=0.326  Sum_probs=188.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCC---cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .....|.+.+.||+|+||.||+|.+..++   ..||+|.+....     ....+|+.+++.++||||+++++++..    
T Consensus        86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----  161 (373)
T 3c1x_A           86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----  161 (373)
T ss_dssp             STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----
T ss_pred             hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----
Confidence            34457999999999999999999976443   468999886432     223468899999999999999998642    


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .+...++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus       162 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DF  236 (373)
T 3c1x_A          162 SEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADF  236 (373)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC
T ss_pred             CCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECC-CCCEEEeec
Confidence            33447899999985 77777754   34568999999999999999999999 79999999999999996 778999999


Q ss_pred             CCccccccCCC-----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017139          182 GSAKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       182 g~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      |+++.......     .....+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+..... 
T Consensus       237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-  314 (373)
T 3c1x_A          237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-  314 (373)
T ss_dssp             ---------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-
T ss_pred             cccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-
Confidence            99976543221     1234567889999999765 48999999999999999999 7888887665544443332100 


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                                 ...+..+++++.+++.+||+.||++|||+.+++++
T Consensus       315 ---------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 ---------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       01234578999999999999999999999998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.3e-43  Score=321.22  Aligned_cols=255  Identities=24%  Similarity=0.323  Sum_probs=194.4

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .|...+.||+|+||.||+|.+  +++.||+|++....        ....+|+.+++.++||||+++++++     .+...
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-----SDGDD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----ecCCc
Confidence            355669999999999999986  68899999985431        2345799999999999999999988     44445


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +++||||++ ++|.+.+... .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~  181 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDE-AFTAKISDFGLAR  181 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred             eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcC-CCcEEEeeccccc
Confidence            889999997 5777777643 234679999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--CCHHH
Q 017139          186 VLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREE  260 (376)
Q Consensus       186 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~  260 (376)
                      .......   .....|++.|+|||.+.+  .++.++|+|||||++|+|++|..||........+..+.+....  .....
T Consensus       182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (307)
T 2nru_A          182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED  259 (307)
T ss_dssp             ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred             ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence            6544322   223568999999999864  3789999999999999999999999876543322222221111  11111


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      +  ..        +..      ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       260 ~--~~--------~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          260 Y--ID--------KKM------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             H--SC--------SSC------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             h--cc--------ccc------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0  00        000      00122346789999999999999999999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.5e-43  Score=319.57  Aligned_cols=257  Identities=27%  Similarity=0.355  Sum_probs=193.5

Q ss_pred             cccce-EeeeeeccCCceEEEEEEE----cCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           32 QTISY-MAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y-~~~~~Lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++| ++++.||+|+||+||++..    ..+++.||+|++....     ....+|+++++.++||||+++++++..   
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---  104 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---  104 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---
Confidence            33455 9999999999999988754    4578899999997653     234579999999999999999998854   


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      .+...+++|||||++ +|.+.+..     ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~-~~~~kl~D  177 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDN-DRLVKIGD  177 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECC
T ss_pred             CCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcC-CCCEEECC
Confidence            234568899999985 77666643     459999999999999999999999 79999999999999996 78899999


Q ss_pred             cCCccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017139          181 FGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       181 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      ||++........    .....+++.|+|||++.+.. ++.++|||||||++|+|++|..||........  .   ..+..
T Consensus       178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~---~~~~~  251 (318)
T 3lxp_A          178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFL--E---LIGIA  251 (318)
T ss_dssp             GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--H---HHCSC
T ss_pred             ccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhh--h---hhccc
Confidence            999987654432    22345688899999997654 78999999999999999999999965422110  0   00000


Q ss_pred             CHH----HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          257 TRE----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       257 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ...    .+......            ......+..+++++.+||.+||+.||.+|||++++++
T Consensus       252 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          252 QGQMTVLRLTELLER------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CHHHHHHHHHHHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchhHHHHHHHHhc------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            000    00000000            0001133467899999999999999999999999973

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.3e-43  Score=315.31  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=190.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-CCc--EEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||.||+|.+.. +++  .||+|++....       ....+|+.+++.++||||+++++++..    
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   92 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   92 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence            4689999999999999999998643 333  68999886432       233479999999999999999998832    


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                       .. .++||||+. ++|.+.+...   ...+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+||
T Consensus        93 -~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Df  165 (291)
T 1u46_A           93 -PP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDF  165 (291)
T ss_dssp             -SS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred             -CC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcC-CCCEEEccc
Confidence             22 679999998 5887777653   3568999999999999999999999 79999999999999986 788999999


Q ss_pred             CCccccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017139          182 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  256 (376)
Q Consensus       182 g~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  256 (376)
                      |++.........    ....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+......+
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL  244 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence            999876543321    2334577899999997654 7899999999999999999 999999888776665554321110


Q ss_pred             CHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                                 ..+..+++++.++|.+||..||.+|||+.++++
T Consensus       245 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          245 ---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                       123457899999999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=318.21  Aligned_cols=266  Identities=24%  Similarity=0.387  Sum_probs=197.5

Q ss_pred             CCCCCCCccccceEeeeeeccCCceEEEEEE----EcCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeeccee
Q 017139           24 GGKNGEPKQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHC   95 (376)
Q Consensus        24 ~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~Iv~~~~~   95 (376)
                      ..........++|++.+.||+|+||.||+|+    +..+++.||+|++.....    ...+|+.+++.++||||++++++
T Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  110 (326)
T 2w1i_A           31 EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV  110 (326)
T ss_dssp             ------CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            3333444566789999999999999999998    456899999999865432    34579999999999999999998


Q ss_pred             eeecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC
Q 017139           96 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH  174 (376)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~  174 (376)
                      +..   .+...+++||||+++ +|.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++
T Consensus       111 ~~~---~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~  182 (326)
T 2w1i_A          111 CYS---AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-EN  182 (326)
T ss_dssp             ECC-------CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TT
T ss_pred             EEe---cCCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcC-CC
Confidence            743   223357899999985 887777652   3569999999999999999999999 79999999999999996 78


Q ss_pred             cEEEEecCCccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017139          175 QVKLCDFGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  250 (376)
Q Consensus       175 ~~kl~Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  250 (376)
                      .+||+|||++........    .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||.....  ...   
T Consensus       183 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~---  256 (326)
T 2w1i_A          183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EFM---  256 (326)
T ss_dssp             EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHH---
T ss_pred             cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHH---
Confidence            899999999987654432    12334577899999997654 89999999999999999999999864311  111   


Q ss_pred             HhcCCCCH-H----HH-hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          251 KVLGTPTR-E----EI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       251 ~~~~~~~~-~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      +..+.... .    .+ ...... .            ....+..+++++.++|.+||+.||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          257 RMIGNDKQGQMIVFHLIELLKNN-G------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHCTTCCTHHHHHHHHHHHHTT-C------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhccccchhhhHHHHHHHhhcC-C------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11111110 0    00 000000 0            00123467899999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=325.86  Aligned_cols=247  Identities=14%  Similarity=0.175  Sum_probs=191.5

Q ss_pred             ccceEeeeeeccCCceEEEEE-----EEcCCCcEEEEEEecccc-cchHHHHHHHHhCC---CCCeeecceeeeecCCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDR-RYKNRELQLMRLMD---HPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~-----~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~---h~~Iv~~~~~~~~~~~~~  103 (376)
                      .++|.+.+.||+|+||.||+|     .+..+++.||+|++.... ....+|..+++.+.   |+||+++++++..     
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-----  138 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-----  138 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-----
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-----
Confidence            468999999999999999999     467789999999997553 33457888888887   8999999999843     


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC---------
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---------  172 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~---------  172 (376)
                      ....|+|||||+ |+|.+.+..... ....+++..++.|+.||+.||+|||+ +||+||||||+|||++..         
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC-----
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCcccccc
Confidence            334889999998 588888876443 35679999999999999999999999 799999999999999741         


Q ss_pred             -CCcEEEEecCCcccccc---CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017139          173 -THQVKLCDFGSAKVLVK---GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE  248 (376)
Q Consensus       173 -~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  248 (376)
                       ++.+||+|||+++....   ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........   
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence             57899999999965432   22334567899999999997754 89999999999999999999999964422100   


Q ss_pred             HHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCc
Q 017139          249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  319 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~  319 (376)
                                    ....     .++.         +  ..++.+.+++.+||+.+|.+|++..+.+.+.+
T Consensus       294 --------------~~~~-----~~~~---------~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          294 --------------KPEG-----LFRR---------L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             --------------EECS-----CCTT---------C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             --------------eech-----hccc---------c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence                          0000     0000         0  13667899999999999999976655555443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.8e-42  Score=314.75  Aligned_cols=252  Identities=20%  Similarity=0.271  Sum_probs=195.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...++|++.+.||+|+||.||+|.+..   .+|+|++....      ....+|+.+++.++||||+++++++..     .
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~  101 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----P  101 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----S
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence            456789999999999999999999754   49999885432      334579999999999999999999843     3


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++||||++| +|.+.+..   ....+++..++.++.||+.||.|||+ +|++||||||+||+++  ++.+||+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~--~~~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD--NGKVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe--CCCEEEeecCC
Confidence            448899999985 76666543   23469999999999999999999999 7999999999999998  56799999999


Q ss_pred             cccccc------CCCcceeeccccccChhhhhC--------CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017139          184 AKVLVK------GEANISYICSRYYRAPELIFG--------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI  249 (376)
Q Consensus       184 ~~~~~~------~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~  249 (376)
                      +.....      ........|++.|+|||++.+        ...++.++|||||||++|+|++|..||.+.........+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            765432      122234458999999999864        234788999999999999999999999988776665554


Q ss_pred             HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      .......                           .....++.++.++|.+||+.||.+|||+.++++  .++.+..
T Consensus       256 ~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~  302 (319)
T 2y4i_B          256 GTGMKPN---------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK  302 (319)
T ss_dssp             HTTCCCC---------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred             ccCCCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence            3311000                           011247889999999999999999999999985  4444433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.2e-42  Score=336.45  Aligned_cols=245  Identities=25%  Similarity=0.326  Sum_probs=200.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++....   ....+|+.+++.++||||+++++++.     + ..+|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-ccce
Confidence            35789999999999999999999865 4679999997543   23567999999999999999999873     2 2378


Q ss_pred             EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          109 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       109 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +|||||.+ +|.+.+....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus       338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcC-CCcEEEcccccceec
Confidence            99999985 8888776432  2458999999999999999999999 79999999999999985 778999999999765


Q ss_pred             ccCC--CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          188 VKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       188 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....  ......++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+.....          
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------  482 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------  482 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            4221  11223456789999999765 48999999999999999999 9999998887776665543110          


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                        ...+..+++++.+||.+||+.||++|||++++++
T Consensus       483 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          483 ------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                              0123457899999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.4e-42  Score=338.21  Aligned_cols=248  Identities=25%  Similarity=0.302  Sum_probs=195.3

Q ss_pred             cceEeee-eeccCCceEEEEEEEcC--CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           34 ISYMAER-VVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        34 ~~y~~~~-~Lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +++.+.+ .||+|+||.||+|.+..  ++..||||++....     ....+|+++++.++||||+++++++..     + 
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~-  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E-  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----S-
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----C-
Confidence            4556655 89999999999998763  56679999986532     234579999999999999999998732     1 


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+++|||||++ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~-~~~vkL~DFGla  483 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVN-RHYAKISDFGLS  483 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCSTT
T ss_pred             CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcC-CCcEEEeeccCc
Confidence            27899999985 67666643   24669999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          185 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       185 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      +........    ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....     
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-----  557 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  557 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            876433221    123346789999999765 48999999999999999998 9999999887776655543110     


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh---CCCccc
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFFD  321 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell---~hp~~~  321 (376)
                                             ..++..+++++.+++.+||+.||++||++.+++   ++.|+.
T Consensus       558 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          558 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                                   013346899999999999999999999999874   454443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.5e-42  Score=338.71  Aligned_cols=237  Identities=23%  Similarity=0.294  Sum_probs=190.8

Q ss_pred             eeeeccCCceEEEEEEE--cCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           39 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .+.||+|+||.||+|.+  ..+++.||||++....      ....+|+.+++.++||||+++++++.     ++ .+++|
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~-~~~lv  447 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-SWMLV  447 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-SEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-CEEEE
Confidence            35899999999999955  4567899999986532      23457999999999999999999872     22 26799


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      ||||.+ +|.+.+..    ...+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus       448 ~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          448 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRA  521 (635)
T ss_dssp             EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCTTHHHHTTC
T ss_pred             EEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeC-CCCEEEEEcCCcccccc
Confidence            999985 77777754    4679999999999999999999999 79999999999999996 78899999999987644


Q ss_pred             CCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          190 GEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       190 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...    .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....          
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----------  590 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----------  590 (635)
T ss_dssp             -------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             CccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            322    22334578899999997654 8999999999999999998 9999999887766655544211          


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                        ...+..+++++.+||.+||+.||++|||++++++
T Consensus       591 ------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          591 ------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                              0133467999999999999999999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2e-44  Score=332.56  Aligned_cols=247  Identities=18%  Similarity=0.164  Sum_probs=184.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhCC---------CCCeee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMD---------HPNVIS   91 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~---------h~~Iv~   91 (376)
                      .++|++.+.||+|+||+||+|++  +|+.||||++....            ....+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            47899999999999999999998  78999999996542            33457999988886         666666


Q ss_pred             cceeeeecC-------------------------CCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHH
Q 017139           92 LKHCFFSTT-------------------------SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF  145 (376)
Q Consensus        92 ~~~~~~~~~-------------------------~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil  145 (376)
                      +.+++....                         ..+...+|+|||||++ ++++.+.     ...+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence            555432110                         0124568999999975 3444442     25689999999999999


Q ss_pred             HHHHHhH-cCCCceeccCCCCCeeecCCCC--------------------cEEEEecCCccccccCCCcceeeccccccC
Q 017139          146 RGLAYIH-TVPGVCHRDVKPQNLLVDPLTH--------------------QVKLCDFGSAKVLVKGEANISYICSRYYRA  204 (376)
Q Consensus       146 ~aL~~LH-~~~~ivH~dlkp~Nill~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~a  204 (376)
                      .||+||| + +||+||||||+|||++. ++                    .+||+|||+++....    ....||+.|+|
T Consensus       172 ~aL~~lH~~-~~ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~a  245 (336)
T 2vuw_A          172 ASLAVAEAS-LRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHHH-HCCBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTC
T ss_pred             HHHHHHHHh-CCEeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccC
Confidence            9999999 8 79999999999999986 44                    899999999987643    25589999999


Q ss_pred             hhhhhCCCCCCccchhHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcc
Q 017139          205 PELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH  282 (376)
Q Consensus       205 PE~~~~~~~~~~~~DiwslG~i-l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ||++.+..  +.++||||+|++ .+++++|..||.+..... ....+........                      ...
T Consensus       246 PE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~  301 (336)
T 2vuw_A          246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT----------------------KCN  301 (336)
T ss_dssp             SGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS----------------------CCC
T ss_pred             hhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc----------------------ccc
Confidence            99997643  889999998777 777888999985421111 1122221110000                      000


Q ss_pred             cccccCCChhHHHHHHhhcCCCCCCCCCHHHHh-CCCccc
Q 017139          283 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFD  321 (376)
Q Consensus       283 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell-~hp~~~  321 (376)
                      ...+..+++++++||.+||++|     |++|+| +||||+
T Consensus       302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            1122357889999999999987     999999 999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.9e-42  Score=317.74  Aligned_cols=254  Identities=20%  Similarity=0.260  Sum_probs=193.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHh--CCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~--l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++.+.||+|+||.||+|++  +|+.||||++.... ....+|.++++.  ++||||+++++++.... .....+|+
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~l  117 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL  117 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEE
Confidence            37899999999999999999998  58999999986543 234568888887  78999999999885432 12235889


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCceeccCCCCCeeecCCCCcEEEEe
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--------TVPGVCHRDVKPQNLLVDPLTHQVKLCD  180 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~~~ivH~dlkp~Nill~~~~~~~kl~D  180 (376)
                      ||||+++ +|.+.+..     ..+++..++.++.|++.||.|||        + +||+||||||+||+++. ++.+||+|
T Consensus       118 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~-~~~~kL~D  190 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKK-NGTCCIAD  190 (342)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECT-TSCEEECC
T ss_pred             EEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECC-CCCEEEEE
Confidence            9999996 88887764     46999999999999999999999        8 79999999999999996 77899999


Q ss_pred             cCCccccccCCC-----cceeeccccccChhhhhCCCC-----CCccchhHHHHHHHHHHHhC----------CCCCCCC
Q 017139          181 FGSAKVLVKGEA-----NISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGE  240 (376)
Q Consensus       181 fg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~~~  240 (376)
                      ||++........     .....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            999976654432     234568999999999976432     23689999999999999999          7888654


Q ss_pred             Ch----HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          241 NA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       241 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ..    ...............              .++       ........+..+.+++.+||+.||++|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~--------------~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          271 VPSDPSVEEMRKVVCEQKLRP--------------NIP-------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCC--------------CCC-------GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcCcccHHHHHHHHHHHHhCC--------------CCc-------ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            21    222222211000000              000       00011134567999999999999999999999986


Q ss_pred             C
Q 017139          317 H  317 (376)
Q Consensus       317 h  317 (376)
                      |
T Consensus       330 ~  330 (342)
T 1b6c_B          330 T  330 (342)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5e-41  Score=334.74  Aligned_cols=245  Identities=27%  Similarity=0.359  Sum_probs=197.9

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCC---CcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||.||+|.+..+   +..+|+|++....     ....+|+.+++.++||||+++++++.     +
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence            457899999999999999999998654   4579999886532     23457999999999999999999872     2


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      + .+|+|||||+ |+|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       463 ~-~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~-~~~vkL~DFG  536 (656)
T 2j0j_A          463 N-PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFG  536 (656)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred             C-ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeC-CCCEEEEecC
Confidence            2 2789999998 577777754   23568999999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCCCc--ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          183 SAKVLVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       183 ~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      +++........  ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......    
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----  611 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----  611 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            99876443221  234457889999999765 48999999999999999997 99999998877776665442110    


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                              .++..+++++.++|.+||..||++|||+.++++
T Consensus       612 ------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                    123467899999999999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7e-41  Score=301.68  Aligned_cols=223  Identities=15%  Similarity=0.051  Sum_probs=174.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++||||+++++++.     +
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~  102 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----T  102 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----E
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----E
Confidence            44578999999999999999999999999999999996543       23457899999999999999999984     3


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+|||||+| +|.+.+..     + .....+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+++|
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~-~g~~kl~~~~  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-DGDVVLAYPA  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEET-TSCEEECSCC
T ss_pred             CCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcC-CCCEEEEecc
Confidence            4458999999985 77666632     2 3556788899999999999999 79999999999999996 7789988443


Q ss_pred             CccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          183 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       183 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                                         |++        .++.++|||||||++|+|++|..||.+.+..+.+....+.          
T Consensus       175 -------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~----------  217 (286)
T 3uqc_A          175 -------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD----------  217 (286)
T ss_dssp             -------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC----------
T ss_pred             -------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH----------
Confidence                               222        2789999999999999999999999876532111000000          


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                  .....+....+...+++++.++|.+||+.||++| |+.++++
T Consensus       218 ------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          218 ------------TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             ------------TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             ------------hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                        0000011112345689999999999999999999 9999876

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-41  Score=341.27  Aligned_cols=243  Identities=23%  Similarity=0.336  Sum_probs=195.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcC-CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      ..++|++.+.||+|+||.||+|.+.. +|+.||||++....     ....+|+.+++.++||||+++++++......+..
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            34799999999999999999999976 78999999886432     2234789999999999999999998765544455


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..|+|||||+| +|.+.+.      ..+++..++.++.||+.||.|||+ +||+||||||+|||++. + .+||+|||++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~-~-~~kl~DFG~a  228 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTE-E-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-S-CEEECCCTTC
T ss_pred             eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeC-C-cEEEEecccc
Confidence            57999999996 4433322      369999999999999999999999 79999999999999985 3 7999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +.....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+....          +.+.       
T Consensus       229 ~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~-------  286 (681)
T 2pzi_A          229 SRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE-------  286 (681)
T ss_dssp             EETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT-------
T ss_pred             hhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------cccc-------
Confidence            865433   456789999999998653  589999999999999999999998652110          0000       


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                        .......++.+.++|.+||++||++||+..+.+.|+|+.-+
T Consensus       287 ------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          287 ------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                              00001246789999999999999999999999999998643

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.8e-33  Score=273.23  Aligned_cols=178  Identities=19%  Similarity=0.107  Sum_probs=124.5

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEecccc--------------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCce
Q 017139           41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        41 ~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      .++.|++|.+..++....|+.|++|++..+.              ....+|+++|+++ .|+||+++++++     +++.
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            4667888888888877889999999996542              2245799999999 699999999998     6777


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+|||||||+| +|.+.+..    ++++++.   .|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~-dg~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDA-RQHARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECT-TSCEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECC-CCCEEEeecccC
Confidence            79999999997 77776654    4567664   478999999999999 79999999999999996 788999999999


Q ss_pred             cccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCC
Q 017139          185 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ  234 (376)
Q Consensus       185 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~  234 (376)
                      +..... ....+.+||+.|+|||++.+  .+...+|+||+|++++.+.++.
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence            876543 33456789999999999965  3678899999999988776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.4e-27  Score=232.51  Aligned_cols=179  Identities=17%  Similarity=0.214  Sum_probs=133.4

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ...+.||+|+||.||+|.  ..++.+++|+.....            ....+|+++++.++||||+++..+......   
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN---  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence            446799999999999994  467889999864321            113579999999999999965555443222   


Q ss_pred             eeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                        .|+|||||+ ++|.+.+..            +..++.|++.||+|||+ +||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence              589999998 577666543            45789999999999999 79999999999999984   899999999


Q ss_pred             ccccccCCC--------cceeeccccccChhhhhCC-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 017139          184 AKVLVKGEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP  238 (376)
Q Consensus       184 ~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~  238 (376)
                      ++.......        .....||+.|+|||++... ..|+..+|+||..+-..+.+.++.+|.
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            987654322        1356789999999999641 237788999999988888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=4.6e-24  Score=191.00  Aligned_cols=136  Identities=17%  Similarity=0.217  Sum_probs=107.7

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------------------cchHHHHHHHHhCCCCCeeeccee
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRLMDHPNVISLKHC   95 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------------------~~~~~e~~~l~~l~h~~Iv~~~~~   95 (376)
                      +.+.||+|+||.||+|.+ .+|+.||+|++....                      ....+|+.+++.++  | +++.++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~  169 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV  169 (282)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred             ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence            339999999999999999 889999999985422                      12457999999999  5 677775


Q ss_pred             eeecCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC
Q 017139           96 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH  174 (376)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~  174 (376)
                      +..      ...|+|||||+| +|.+ +.          ......++.|++.||.|||+ +||+||||||+|||++  ++
T Consensus       170 ~~~------~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~--~~  229 (282)
T 1zar_A          170 YAW------EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS--EE  229 (282)
T ss_dssp             EEE------ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE--TT
T ss_pred             Eec------cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE--CC
Confidence            521      236899999986 5443 21          12245799999999999999 7999999999999999  77


Q ss_pred             cEEEEecCCccccccCCCcceeeccccccChhhhh
Q 017139          175 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF  209 (376)
Q Consensus       175 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~  209 (376)
                      .+||+|||++..            +..+.|||.+.
T Consensus       230 ~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          230 GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            899999999863            44578899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=3.5e-21  Score=170.18  Aligned_cols=135  Identities=19%  Similarity=0.240  Sum_probs=103.0

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcE--EEEEEecccc----------------------------cchHHHHHHHHhC
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR----------------------------RYKNRELQLMRLM   84 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~----------------------------~~~~~e~~~l~~l   84 (376)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998788999  9999864321                            1245799999999


Q ss_pred             CCCCeeecceeeeecCCCCceeEEEEeecccc------hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH-cCCCc
Q 017139           85 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE------TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH-TVPGV  157 (376)
Q Consensus        85 ~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g------~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~~~i  157 (376)
                      .|+++....-+..       ...++||||+++      .|.+....       .++..+..++.|++.+|.||| + .||
T Consensus       128 ~~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~-~gi  192 (258)
T 1zth_A          128 KEAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE-AEL  192 (258)
T ss_dssp             HHTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred             HhCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence            8876532211111       125799999953      44333221       234567889999999999999 8 799


Q ss_pred             eeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          158 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       158 vH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +||||||+|||++.   .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999984   7999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.70  E-value=1.9e-17  Score=152.33  Aligned_cols=134  Identities=15%  Similarity=0.157  Sum_probs=90.9

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc----------c----------------hHHHHHHHHhCCCCC
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----------Y----------------KNRELQLMRLMDHPN   88 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----------~----------------~~~e~~~l~~l~h~~   88 (376)
                      -|.+.+.||+|++|.||+|.+ .+|+.||||++.....          .                ..+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            389999999999999999997 4699999998743210          0                013444455553333


Q ss_pred             eeecceeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCee
Q 017139           89 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL  168 (376)
Q Consensus        89 Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nil  168 (376)
                      +.. ...+..      ...+|||||++|..+   ....      .......++.||+.+|.+||+ +|||||||||.|||
T Consensus       175 v~v-p~p~~~------~~~~LVME~i~G~~L---~~l~------~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          175 FPV-PEPIAQ------SRHTIVMSLVDALPM---RQVS------SVPDPASLYADLIALILRLAK-HGLIHGDFNEFNIL  237 (397)
T ss_dssp             CSC-CCEEEE------ETTEEEEECCSCEEG---GGCC------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEE
T ss_pred             CCC-Ceeeec------cCceEEEEecCCccH---hhhc------ccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEE
Confidence            221 111100      113699999997421   1111      112345788999999999999 79999999999999


Q ss_pred             ecCCCC----------cEEEEecCCcccc
Q 017139          169 VDPLTH----------QVKLCDFGSAKVL  187 (376)
Q Consensus       169 l~~~~~----------~~kl~Dfg~~~~~  187 (376)
                      ++. ++          .+.|+||+-+...
T Consensus       238 l~~-dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IRE-EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEE-EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeC-CCCcccccccccceEEEEeCCcccC
Confidence            975 33          3889999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=6.5e-12  Score=110.77  Aligned_cols=136  Identities=15%  Similarity=0.085  Sum_probs=101.0

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecc----cccchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~~~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      .+.|++...++.|+.+.||++..  .++.+++|+...    ......+|+.+++.+. +..+.+++++..     +....
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~   85 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWS   85 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEE
T ss_pred             hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCce
Confidence            35699999999999999999975  468999999863    3345778999999885 556667776662     33457


Q ss_pred             EEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--------------------------------
Q 017139          108 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--------------------------------  154 (376)
Q Consensus       108 ~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------------------------------  154 (376)
                      |+|||+++|. +...+         .+......++.++..+|..||+.                                
T Consensus        86 ~lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             EEEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            8999999984 33221         01122346778899999999971                                


Q ss_pred             --------------------------CCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          155 --------------------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       155 --------------------------~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                                                ..++|+|++|.||+++. +..+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~  212 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence                                      24899999999999984 5556799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=1.9e-10  Score=101.01  Aligned_cols=134  Identities=16%  Similarity=0.093  Sum_probs=90.5

Q ss_pred             ceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHhCCCCCe--eecceeeeecCCCCceeEEEEe
Q 017139           35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        35 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~h~~I--v~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      .|.+....+.|..+.||++.. .+|+.+++|..... .....+|+.+++.+.+.++  .+++.+..     +....++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEEEE
Confidence            466665555677799999964 56778999987554 2345689999998865443  44555542     223478999


Q ss_pred             ecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC------------------------------------
Q 017139          112 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP------------------------------------  155 (376)
Q Consensus       112 e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~------------------------------------  155 (376)
                      ||++|.... +       ...+   ...++.++...|..||+..                                    
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999984222 1       0111   1245567777777777631                                    


Q ss_pred             ---------------------CceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          156 ---------------------GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       156 ---------------------~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                                           +++|+|++|.||+++. +..+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhccc
Confidence                                 2999999999999984 55567999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.06  E-value=8e-10  Score=101.97  Aligned_cols=141  Identities=16%  Similarity=0.162  Sum_probs=98.6

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEec--cc-----ccchHHHHHHHHhCCC--CCeeecceeeeecCCCCceeE
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QD-----RRYKNRELQLMRLMDH--PNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~--~~-----~~~~~~e~~~l~~l~h--~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ...+.|+.|.++.||++..  .+..+++|+..  ..     .....+|..+++.+..  ..+.+++.++...  ......
T Consensus        41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSC
T ss_pred             ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCe
Confidence            3467889999999999875  34688888775  22     2356689999999874  3455665554221  111346


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC---------------------------------
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------  154 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---------------------------------  154 (376)
                      |+||||++|...   ..  ..-..+++.....++.++...|..||+.                                 
T Consensus       117 ~~vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          117 FYIMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             EEEEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EEEEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            799999998421   11  1123467888888999999999999962                                 


Q ss_pred             ------------------------CCceeccCCCCCeeecCCCC-cEEEEecCCccc
Q 017139          155 ------------------------PGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKV  186 (376)
Q Consensus       155 ------------------------~~ivH~dlkp~Nill~~~~~-~~kl~Dfg~~~~  186 (376)
                                              ..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    36899999999999986332 368999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.96  E-value=4.1e-10  Score=101.42  Aligned_cols=185  Identities=14%  Similarity=0.190  Sum_probs=111.2

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecCC-CCceeEEEEeeccc
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLVMEYVP  115 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~~~~lv~e~~~  115 (376)
                      .+.++.|....||++.     ..+++|+....  .....+|..+++.+.+..-+.+...+..... ......|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999863     46889986543  2345679999988743222222222222111 11223478999999


Q ss_pred             ch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------------------------
Q 017139          116 ET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV----------------------------------------  154 (376)
Q Consensus       116 g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~----------------------------------------  154 (376)
                      |. +.....      ..++......++.++...|..||+.                                        
T Consensus       100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            83 222111      2355666666777777777777741                                        


Q ss_pred             -----------------CCceeccCCCCCeeecCC-CCcEEEEecCCccccccCCCcceeeccccc---cChhhhh----
Q 017139          155 -----------------PGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVLVKGEANISYICSRYY---RAPELIF----  209 (376)
Q Consensus       155 -----------------~~ivH~dlkp~Nill~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y---~aPE~~~----  209 (376)
                                       ..++|+|++|.||+++.+ +..+.|+||+.+........   .......   ..|+...    
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHHH
Confidence                             136999999999999853 34578999998865321100   0000111   2232211    


Q ss_pred             CCCC---------CCccchhHHHHHHHHHHHhCCCCC
Q 017139          210 GATE---------YTTSIDIWSAGCVLAELLLGQPLF  237 (376)
Q Consensus       210 ~~~~---------~~~~~DiwslG~il~~lltg~~pf  237 (376)
                      ....         .....+.|++|.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0000         112368999999999999999776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.49  E-value=9.3e-07  Score=79.45  Aligned_cols=72  Identities=11%  Similarity=0.063  Sum_probs=45.3

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEeecccc
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE  116 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g  116 (376)
                      .+.++.|....||++     |..+++|+....  .....+|..+++.+.+..-+.+........ ......++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEeccCC
Confidence            456789999999988     567888875332  234567999999987532222222221111 123345699999997

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.31  E-value=4e-06  Score=73.66  Aligned_cols=131  Identities=15%  Similarity=0.145  Sum_probs=81.9

Q ss_pred             eccCCc-eEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHhCCC-CCeeecceeeeecCCCCceeEEEEeecccc-h
Q 017139           42 VGTGSF-GIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPE-T  117 (376)
Q Consensus        42 Lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~h-~~Iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~  117 (376)
                      +..|.. +.||+......+..+++|+-.... ....+|...|+.+.. -.+.+++.+.     .+....++|||+++| +
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEeeCCcc
Confidence            344444 479998877778889999865432 235578999888753 2233444444     223346799999997 3


Q ss_pred             HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------------------------------------------
Q 017139          118 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------------------------------------------  154 (376)
Q Consensus       118 l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-------------------------------------------  154 (376)
                      +.+....        .......+..++...|.-||+.                                           
T Consensus       107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            3332221        0111233445555555555542                                           


Q ss_pred             --------------CCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          155 --------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       155 --------------~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                                    ..++|+|+.+.||+++. ++.+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECccccc
Confidence                          01789999999999985 66667999998753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.13  E-value=8e-06  Score=74.25  Aligned_cols=30  Identities=27%  Similarity=0.564  Sum_probs=26.2

Q ss_pred             CCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       155 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+++|+|+++.||+++. ++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~-~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGE-NEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECG-GGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeC-CCcEEEEehhhcc
Confidence            57999999999999975 5679999999774

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.08  E-value=1.9e-05  Score=73.51  Aligned_cols=72  Identities=17%  Similarity=0.204  Sum_probs=44.6

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----------cchHHHHHHHHhCCC--CCee-ecceeeeecCCCC
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDH--PNVI-SLKHCFFSTTSKD  103 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h--~~Iv-~~~~~~~~~~~~~  103 (376)
                      -.+.||.|..+.||++....+++.+++|......           .....|.++++.+..  +..+ +++.+  +   .+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~  108 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TE  108 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CC
Confidence            3568999999999999766567889999754321           123568888887742  3333 33322  2   22


Q ss_pred             ceeEEEEeecccc
Q 017139          104 ELFLNLVMEYVPE  116 (376)
Q Consensus       104 ~~~~~lv~e~~~g  116 (376)
                      .  .++|||+++|
T Consensus       109 ~--~~lvmE~l~g  119 (397)
T 2olc_A          109 M--AVTVMEDLSH  119 (397)
T ss_dssp             T--TEEEECCCTT
T ss_pred             c--cEEEEEeCCC
Confidence            2  4599999976

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.04  E-value=2.2e-05  Score=71.93  Aligned_cols=78  Identities=13%  Similarity=0.087  Sum_probs=49.1

Q ss_pred             Eeeeee-ccCCceEEEEEEEc--C----CCcEEEEEEecccc-------cchHHHHHHHHhCCC---CCeeecceeeeec
Q 017139           37 MAERVV-GTGSFGIVFQAKCL--E----TGETVAIKKVLQDR-------RYKNRELQLMRLMDH---PNVISLKHCFFST   99 (376)
Q Consensus        37 ~~~~~L-g~G~~g~V~~~~~~--~----~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h---~~Iv~~~~~~~~~   99 (376)
                      ...+.| +.|....+|++...  .    +++.+++|+.....       ....+|..+++.+..   -.+.+++.+....
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 88999999988753  1    15678999765432       345689998888743   2344454443111


Q ss_pred             CCCCceeEEEEeecccc
Q 017139          100 TSKDELFLNLVMEYVPE  116 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~g  116 (376)
                        .-....++|||+++|
T Consensus       103 --~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 --DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             --TTTSSCEEEEECCCC
T ss_pred             --CccCCceEEEEecCC
Confidence              111235689999986

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.59  E-value=0.00029  Score=62.80  Aligned_cols=65  Identities=15%  Similarity=0.098  Sum_probs=41.4

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCee-ecceeeeecCCCCceeEEEEeecc
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv-~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      .+.|+.|....+|++      +.+++|+.....   ....+|..+++.+...++. +++...     .+..  ++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~~--~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PATG--VMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTTC--CEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCCC--EEEEeec
Confidence            678999999999998      468888875431   2235688888777533333 333221     2222  3899999


Q ss_pred             -cc
Q 017139          115 -PE  116 (376)
Q Consensus       115 -~g  116 (376)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             65

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.57  E-value=0.0011  Score=55.21  Aligned_cols=100  Identities=18%  Similarity=0.072  Sum_probs=62.7

Q ss_pred             hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCCccee
Q 017139          117 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY  196 (376)
Q Consensus       117 ~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~~~~  196 (376)
                      +|.+.|..+   +.+++|+++|.++.|.+.+|.-+-..+.-..+=+.|..|++.. +|.|.+.+ +.+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~-dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWR-DGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEET-TSCEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEec-CCceeccc-cccc-----------
Confidence            677888764   6889999999999999999877621011123334568888886 66665553 1110           


Q ss_pred             eccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCC
Q 017139          197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ  234 (376)
Q Consensus       197 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~  234 (376)
                      .....+.|||...  ...+.+.=|+|||+++|..+--.
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            1123466888753  23567889999999999988533

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.39  E-value=0.003  Score=55.70  Aligned_cols=73  Identities=14%  Similarity=0.070  Sum_probs=49.1

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEe
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM  111 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv~  111 (376)
                      ..-++.+|.|..+.||++.. .+|+.|++|+-....    .....|...|+.+....-+.+..++...  .    -++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEEE
Confidence            45578899999999999985 578899999865432    2356799999988533222222222211  1    25899


Q ss_pred             eccc
Q 017139          112 EYVP  115 (376)
Q Consensus       112 e~~~  115 (376)
                      |++.
T Consensus        90 e~l~   93 (288)
T 3f7w_A           90 EWVD   93 (288)
T ss_dssp             ECCC
T ss_pred             Eeec
Confidence            9986

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.32  E-value=0.0013  Score=61.54  Aligned_cols=33  Identities=12%  Similarity=0.140  Sum_probs=27.6

Q ss_pred             HcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       152 H~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +. ..++|+|++|.||+++. ++ +.|+||+.+...
T Consensus       230 ~~-~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RA-QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BC-CEEECSCCSGGGEEECS-SC-EEECCCTTCEEE
T ss_pred             CC-CeEEecCCCCCcEEEeC-CC-CEEEeCcccccC
Confidence            45 58999999999999985 44 999999988653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.29  E-value=0.0029  Score=56.70  Aligned_cols=144  Identities=13%  Similarity=0.054  Sum_probs=74.4

Q ss_pred             EeeeeeccCCceEEEEEEEcCCCcEEEEEEecc--cccchHHHHHHHHhCCCCCe--eecceeeeecCC----CCceeEE
Q 017139           37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRLMDHPNV--ISLKHCFFSTTS----KDELFLN  108 (376)
Q Consensus        37 ~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~e~~~l~~l~h~~I--v~~~~~~~~~~~----~~~~~~~  108 (376)
                      .-.+.|+.|....+|++...  +..+++|....  .......|..+++.+....+  .+++..   ...    ......+
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPA   99 (322)
T ss_dssp             EEEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEE
T ss_pred             eEeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEE
Confidence            34567888988999999753  33688998865  33445568888777643222  222211   000    0112357


Q ss_pred             EEeecccchH------------HHH---HHhhhhc-CCC----CCHHHHHHH---------------HHHHHHHHHHhHc
Q 017139          109 LVMEYVPETM------------YRV---LKHYSSM-NQR----MPLIYVKLY---------------TYQIFRGLAYIHT  153 (376)
Q Consensus       109 lv~e~~~g~l------------~~~---l~~~~~~-~~~----l~~~~~~~i---------------~~qil~aL~~LH~  153 (376)
                      ++|++++|..            ...   ++..... ...    .........               ...+...++.+..
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            8999998631            011   1111000 000    111110000               0012333444431


Q ss_pred             ------CCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          154 ------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       154 ------~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                            ..+++|+|+.+.||+++. +..+.|+||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEEeC-CceEEEecchhccC
Confidence                  136899999999999985 54457999998753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.10  E-value=0.0034  Score=56.59  Aligned_cols=32  Identities=41%  Similarity=0.464  Sum_probs=26.7

Q ss_pred             CCceeccCCCCCeeecCC---CCcEEEEecCCccc
Q 017139          155 PGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKV  186 (376)
Q Consensus       155 ~~ivH~dlkp~Nill~~~---~~~~kl~Dfg~~~~  186 (376)
                      ..++|+|+.+.||+++.+   .+.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999852   15799999998864

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.06  E-value=0.0022  Score=57.39  Aligned_cols=71  Identities=14%  Similarity=0.062  Sum_probs=49.9

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHhCCC---CCeeecceeeeecCCCCceeEEEEeecc
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMDH---PNVISLKHCFFSTTSKDELFLNLVMEYV  114 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~h---~~Iv~~~~~~~~~~~~~~~~~~lv~e~~  114 (376)
                      .+.|+.|....+|++..  ++..+++|+..... .....|...|+.+..   ..+.+++...     ......++|||++
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~-----~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIG-----NSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEE-----ECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEe-----ecCCceEEEEEec
Confidence            56789999999999874  56788999875442 335678888887742   4455555543     2223478999999


Q ss_pred             cc
Q 017139          115 PE  116 (376)
Q Consensus       115 ~g  116 (376)
                      +|
T Consensus       114 ~G  115 (312)
T 3jr1_A          114 NK  115 (312)
T ss_dssp             CC
T ss_pred             cC
Confidence            86

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.04  E-value=0.0046  Score=57.95  Aligned_cols=70  Identities=16%  Similarity=0.247  Sum_probs=46.2

Q ss_pred             eeeeeccCCceEEEEEEEcC-------CCcEEEEEEecc-cc-cchHHHHHHHHhCCCCCe-eecceeeeecCCCCceeE
Q 017139           38 AERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQ-DR-RYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~-~~-~~~~~e~~~l~~l~h~~I-v~~~~~~~~~~~~~~~~~  107 (376)
                      -.+.|+.|....||++....       .++.+++|+... .. ....+|..+++.+...++ .++++.+     .+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            35678889999999998643       257899998844 22 234468888888754444 3444433     22    


Q ss_pred             EEEeecccc
Q 017139          108 NLVMEYVPE  116 (376)
Q Consensus       108 ~lv~e~~~g  116 (376)
                      .+|+||++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            278999875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.01  E-value=0.012  Score=55.59  Aligned_cols=70  Identities=13%  Similarity=0.227  Sum_probs=45.5

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCee-ecceeeeecCCCCceeEEEEeec
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEY  113 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv-~~~~~~~~~~~~~~~~~~lv~e~  113 (376)
                      -.+.|+.|-...+|++.....+..+++|+......   ...+|..+++.+...++. ++++.+     .+    .+||||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            35678889999999998754457899998743321   225799999998765554 344433     21    159999


Q ss_pred             ccc
Q 017139          114 VPE  116 (376)
Q Consensus       114 ~~g  116 (376)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.85  E-value=0.0058  Score=54.82  Aligned_cols=73  Identities=14%  Similarity=0.027  Sum_probs=43.0

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHhCCCCC--eeecceeeeecCC--CCceeEEEEee
Q 017139           40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLMDHPN--VISLKHCFFSTTS--KDELFLNLVME  112 (376)
Q Consensus        40 ~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h~~--Iv~~~~~~~~~~~--~~~~~~~lv~e  112 (376)
                      ..|+ |....||++.. .+|+.+++|.....   ......|..+++.+....  +.+++..  ....  ......+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence            4566 78889998764 34667999988633   233456788877764222  3333321  0000  01234578999


Q ss_pred             cccc
Q 017139          113 YVPE  116 (376)
Q Consensus       113 ~~~g  116 (376)
                      +++|
T Consensus       108 ~i~G  111 (328)
T 1zyl_A          108 SVGG  111 (328)
T ss_dssp             CCCC
T ss_pred             ecCC
Confidence            9986

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.77  E-value=0.0061  Score=56.00  Aligned_cols=139  Identities=15%  Similarity=0.226  Sum_probs=75.3

Q ss_pred             eeeeccCCceEEEEEEEcC-------CCcEEEEEEeccc---ccchHHHHHHHHhCCCCCe-eecceeeeecCCCCceeE
Q 017139           39 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD---RRYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h~~I-v~~~~~~~~~~~~~~~~~  107 (376)
                      ++.|..|-...+|++....       +++.+++|+....   .....+|..+++.+...++ .++++.+     .+    
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence            4567778888899988632       3578999986332   2233478888887753333 3333333     22    


Q ss_pred             EEEeecccch-H--------------HHHHHhhhhc----CCCC--CHHHHHHHHHHHHH-------------------H
Q 017139          108 NLVMEYVPET-M--------------YRVLKHYSSM----NQRM--PLIYVKLYTYQIFR-------------------G  147 (376)
Q Consensus       108 ~lv~e~~~g~-l--------------~~~l~~~~~~----~~~l--~~~~~~~i~~qil~-------------------a  147 (376)
                      .+||||++|. +              ...+...-..    ....  -..++..+..++-.                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            1899999852 1              1111111111    1111  13455555544322                   1


Q ss_pred             HHHh----HcC---CCceeccCCCCCeeecCC---CCcEEEEecCCccc
Q 017139          148 LAYI----HTV---PGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKV  186 (376)
Q Consensus       148 L~~L----H~~---~~ivH~dlkp~Nill~~~---~~~~kl~Dfg~~~~  186 (376)
                      +..|    ...   ..++|+|+.+.||+++.+   .+.+.|+||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2222    211   258999999999999863   25799999998754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.75  E-value=0.0039  Score=57.11  Aligned_cols=69  Identities=13%  Similarity=0.130  Sum_probs=40.9

Q ss_pred             eeeeccCCceEEEEEEEcC--------CCcEEEEEEeccccc---chHHHHHHHHhCCCCCe-eecceeeeecCCCCcee
Q 017139           39 ERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELF  106 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~I-v~~~~~~~~~~~~~~~~  106 (376)
                      .+.|+.|....+|++....        .++.+++|+......   ....|..+++.+...++ .++++.+     .    
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~----  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N----  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence            4577888889999998643        136888998754322   23578888887754343 2443322     1    


Q ss_pred             EEEEeecccc
Q 017139          107 LNLVMEYVPE  116 (376)
Q Consensus       107 ~~lv~e~~~g  116 (376)
                      -++||||++|
T Consensus       109 ~~~v~e~i~G  118 (369)
T 3c5i_A          109 GGRIEEWLYG  118 (369)
T ss_dssp             TEEEEECCCS
T ss_pred             CcEEEEEecC
Confidence            1478999876

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.39  E-value=0.011  Score=53.50  Aligned_cols=31  Identities=23%  Similarity=0.486  Sum_probs=26.3

Q ss_pred             CCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       155 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ..++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~-~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGN-EESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECG-GGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeC-CCeEEEEECCCCee
Confidence            36899999999999985 56799999988754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.99  E-value=0.16  Score=47.19  Aligned_cols=70  Identities=11%  Similarity=0.164  Sum_probs=45.0

Q ss_pred             eeeeeccCCceEEEEEEEcCC-------CcEEEEEEecccc---cchHHHHHHHHhCCCCCee-ecceeeeecCCCCcee
Q 017139           38 AERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELF  106 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv-~~~~~~~~~~~~~~~~  106 (376)
                      -++.|..|-...+|++.....       ++.+++++.....   ....+|..+++.+...+++ ++++.+     .    
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence            345677888889999987521       5789999864432   2235788888887533333 333322     1    


Q ss_pred             EEEEeecccc
Q 017139          107 LNLVMEYVPE  116 (376)
Q Consensus       107 ~~lv~e~~~g  116 (376)
                      -+.||||++|
T Consensus       145 ~~~I~efI~G  154 (424)
T 3mes_A          145 EGRIEEFIDG  154 (424)
T ss_dssp             TEEEEECCCS
T ss_pred             CCEEEEEeCC
Confidence            1478999986

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	376
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-125
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-76
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-72
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-70
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-67
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-67
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-67
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-67
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-66
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-66
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-65
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-64
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-63
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-62
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-61
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-60
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-60
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-60
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-58
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-58
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-57
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-53
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-53
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-52
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-52
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-52
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-48
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-44
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-42
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-42
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-40
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-40
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-40
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  363 bits (933), Expect = e-125
 Identities = 230/346 (66%), Positives = 281/346 (81%), Gaps = 3/346 (0%)

Query: 19  ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 78
           +  T G     P Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 79  QLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 137
           Q+MR +DH N++ L++ F+S+   KDE++LNLV++YVPET+YRV +HYS   Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
           KLY YQ+FR LAYIH+  G+CHRD+KPQNLL+DP T  +KLCDFGSAK LV+GE N+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
           CSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
           RE+IR MNPNYT+F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

Query: 318 PFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR 363
            FFDELR+PN +LPNGR  P LFNF  +   ++P L   LIP H R
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (605), Expect = 3e-76
 Identities = 108/341 (31%), Positives = 177/341 (51%), Gaps = 24/341 (7%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKN---RELQLMRLMDHPNVI 90
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++++    H N+I
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            +     + T +    + LV   +   +Y++LK      Q +   ++  + YQI RGL Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPE 206
           IH+   V HRD+KP NLL++  T  +K+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 264
           ++  +  YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 265 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
                     P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 324 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
            +P+            F F  EL     E +  LI E   R
Sbjct: 302 YDPSDE----PIAEAPFKFDMELDDLPKEKLKELIFEETAR 338

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 8e-72
 Identities = 73/305 (23%), Positives = 128/305 (41%), Gaps = 31/305 (10%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           +     +G G+ G+VF+     +G  +A K +  + +        RELQ++   + P ++
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
                F+      +  +++ ME++       L        R+P   +   +  + +GL Y
Sbjct: 68  GFYGAFY-----SDGEISICMEHMDGGS---LDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
           +     + HRDVKP N+LV+    ++KLCDFG +  L+   AN S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 269
            T Y+   DIWS G  L E+ +G+   P  +A   +L+   +V G       R   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 270 DFRF--------------PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
              +                I   P  K+       E  D  ++ L  +P+ R    +  
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 316 AHPFF 320
            H F 
Sbjct: 297 VHAFI 301

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 2e-70
 Identities = 96/304 (31%), Positives = 148/304 (48%), Gaps = 23/304 (7%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVI 90
             +G G F  V++A+   T + VAIKK+    R +          RE++L++ + HPN+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L   F       +  ++LV +++   +          +  +   ++K Y     +GL Y
Sbjct: 64  GLLDAF-----GHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 209
           +H    + HRD+KP NLL+D     +KL DFG AK         ++   +R+YRAPEL+F
Sbjct: 116 LHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
           GA  Y   +D+W+ GC+LAELLL  P  PG++ +DQL  I + LGTPT E+   M     
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR--EPN 327
              F      P H +F      + +DL   L  ++P  R TA +A    +F       P 
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

Query: 328 ARLP 331
            +LP
Sbjct: 293 CQLP 296

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  214 bits (546), Expect = 1e-67
 Identities = 94/300 (31%), Positives = 149/300 (49%), Gaps = 21/300 (7%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLM-RLMDHPNVISLK 93
           Y   R +G G +  VF+A  +   E V +K +   ++ K  RE++++  L   PN+I+L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
                  S+      LV E+V  T ++       + Q +    ++ Y Y+I + L Y H+
Sbjct: 97  DIVKDPVSR---TPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 154 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 213
           + G+ HRDVKP N+++D    +++L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 214 YTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
           Y  S+D+WS GC+LA ++  + P F G +  DQLV I KVLGT    +         D R
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 273 FPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324
           F  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 2e-67
 Identities = 101/336 (30%), Positives = 163/336 (48%), Gaps = 23/336 (6%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 89
           Y     VG+G++G V  A   +TG  VA+KK+      +   +   REL+L++ M H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           I L   F    S +E     ++ ++       +       Q++   +V+   YQI RGL 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 209
           YIH+   + HRD+KP NL V+      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
               Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 270 DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
                   Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 327 NARLPNGRPFPPLFNFKQELAGASPELINRLIPEHV 362
           +       P    ++   E      +    L  + V
Sbjct: 311 DD-----EPVADPYDQSFESRDLLIDEWKSLTYDEV 341

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 5e-67
 Identities = 104/339 (30%), Positives = 174/339 (51%), Gaps = 25/339 (7%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
           Y   + VG+G++G V  A    TG  VAIKK+ +  + +       REL+L++ M H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 90  ISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           I L   F    + D+     LVM ++   + +++KH     +++    ++   YQ+ +GL
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            YIH   G+ HRD+KP NL V+    ++K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 269 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
                   P+++   +  +      P A++L  ++L      R TA EA AHP+F+ L +
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 326 PNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 364
                P  + +   F+        + +   R+  + V  
Sbjct: 310 TE-DEPQVQKYDDSFDDVDR----TLDEWKRVTYKEVLS 343

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 6e-67
 Identities = 100/307 (32%), Positives = 166/307 (54%), Gaps = 21/307 (6%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
           +     +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           + L           E  L LV E++ + + + +    S    +PL  +K Y +Q+ +GLA
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 208
           + H+   V HRD+KPQNLL++     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 267
            G   Y+T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
                FP+     + KV    +  +   L S++L Y P+ R +A  A AHPFF ++ +P 
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292

Query: 328 ARLPNGR 334
             +P+ R
Sbjct: 293 --VPHLR 297

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 2e-66
 Identities = 83/309 (26%), Positives = 146/309 (47%), Gaps = 22/309 (7%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
           Y     +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++L+ H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 90  ISLKHCFFSTTS---KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           ++L     +  S   + +  + LV ++    +       S++  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-----SYICSRY 201
           GL YIH    + HRD+K  N+L+      +KL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           YR PEL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 262 RCMNPNYTDFRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
             ++      +   +K        ++      P A+DL  +LL   P+ R  + +A  H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 319 FFDELREPN 327
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  211 bits (537), Expect = 5e-66
 Identities = 67/309 (21%), Positives = 124/309 (40%), Gaps = 41/309 (13%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVIS 91
           Y     +GTG+FG+V +     TG   A K V+     D+    +E+Q M ++ HP +++
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   F     +D+  + ++ E++      + +  +  + +M       Y  Q+ +GL ++
Sbjct: 88  LHDAF-----EDDNEMVMIYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 152 HTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
           H      H D+KP+N++     ++++KL DFG    L   ++      +  + APE+  G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
                   D+WS G +   LL G   F GEN  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248

Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NA 328
                             +  +  D   +LL   P+ R T  +A  HP+      P  ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 329 RLPNGRPFP 337
           ++P+ R   
Sbjct: 294 QIPSSRYTK 302

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (526), Expect = 6e-65
 Identities = 96/299 (32%), Positives = 155/299 (51%), Gaps = 17/299 (5%)

Query: 36  YMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDRRYKN------RELQLMRLM---D 85
           Y     +G G++G VF+A+ L+  G  VA+K+V      +       RE+ ++R +   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           HPNV+ L      + +  E  L LV E+V + +   L         +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLL 126

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
           RGL ++H+   V HRD+KPQN+LV   + Q+KL DFG A++     A  S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E++   + Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-PRD 242

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324
                  F    A P  K     +     DL  + L ++P+ R +A  A +HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 2e-64
 Identities = 100/299 (33%), Positives = 156/299 (52%), Gaps = 18/299 (6%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
           Y     +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           + L           +  L LV E+       + K++ S N  +    VK + +Q+ +GL 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 208
           + H+   V HRD+KPQNLL++    ++KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 209 FGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           FGA  Y+TSID+WSAGC+ AEL    +PLFPG +  DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
                +P   A         ++     DL   LL+ +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  202 bits (513), Expect = 2e-63
 Identities = 92/295 (31%), Positives = 156/295 (52%), Gaps = 20/295 (6%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 89
           Y     +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           + L           +  L LV E++ + + ++L         +  +  K +  Q+  G+A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIA 114

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 208
           Y H    V HRD+KPQNLL++    ++K+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 267
            G+ +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +         
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
             D  F   +  PW     K +    IDL S++L+  P+ R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  201 bits (513), Expect = 2e-62
 Identities = 71/318 (22%), Positives = 126/318 (39%), Gaps = 40/318 (12%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVIS 91
           Y     +G+G+FG+V +     TG     K +      D+     E+ +M  + HP +I+
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   F     +D+  + L++E++      +    ++ + +M    V  Y  Q   GL ++
Sbjct: 91  LHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143

Query: 152 HTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
           H    + H D+KP+N++ +      VK+ DFG A  L   E       +  + APE++  
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
                   D+W+ G +   LL G   F GE+ ++ L  + +       +           
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252

Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNAR 329
                             + PEA D    LLQ  P  R T  +A  HP+   +     +R
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296

Query: 330 LPNGRPFPPLFNFKQELA 347
           +P+ R        K++ A
Sbjct: 297 IPSSRYNKIRQKIKEKYA 314

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 5e-62
 Identities = 73/328 (22%), Positives = 130/328 (39%), Gaps = 32/328 (9%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFF 97
            +V+G G  G V Q     T E  A+ K+LQD     RE++L  R    P+++ +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 98  STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
           +  +  +  L +VME +    ++  ++     +Q             I   + Y+H++  
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-N 131

Query: 157 VCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 214
           + HRDVKP+NLL         +KL DFG AK      +  +   + YY APE++    +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190

Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
             S D+WS G ++  LL G P F   + +     +        +  IR     + +  + 
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYEFPNPEWS 242

Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNARLPNG 333
           ++               E   L   LL+  P+ R T  E   HP+     + P   L   
Sbjct: 243 EV-------------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289

Query: 334 RPFPPLFNFKQELAGASPELINRLIPEH 361
           R         +++       +  +  ++
Sbjct: 290 RVLKEDKERWEDVKEEMTSALATMRVDY 317

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 5e-61
 Identities = 63/294 (21%), Positives = 110/294 (37%), Gaps = 44/294 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVIS 91
           +     +G G+FG V++A+  ET    A K +     ++      E+ ++   DHPN++ 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L   F       E  L +++E+              + + +    +++   Q    L Y+
Sbjct: 74  LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFG 210
           H    + HRD+K  N+L       +KL DFG +    +      S+I + Y+ APE++  
Sbjct: 127 HD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 211 AT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
            T     Y    D+WS G  L E+   +P     N +  L++I                 
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                     K+ P       R      D   + L+ +   R T  +   HPF 
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 5e-61
 Identities = 67/301 (22%), Positives = 116/301 (38%), Gaps = 44/301 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           +   + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
                             L +EY               +  MP    + + +Q+  G+ Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPEL 207
           +H   G+ HRD+KP+NLL+D     +K+ DFG A V               +  Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
           +     +   +D+WS G VL  +L G+  +   +   Q     K   T            
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226

Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
                      +PW K+         + L  ++L  +PS R T  +     ++++  +  
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270

Query: 328 A 328
           A
Sbjct: 271 A 271

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (499), Expect = 9e-61
 Identities = 76/305 (24%), Positives = 120/305 (39%), Gaps = 49/305 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 88
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ + HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            I  + C+       E    LVMEY   +            + +  + +   T+   +GL
Sbjct: 77  TIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
           AY+H+   + HRDVK  N+L+      VKL DFGSA ++       S++ + Y+ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 183

Query: 209 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
               E  Y   +D+WS G    EL   +P     NA+  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
                       +    +          +     LQ  P  R T+     H F    R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 327 NARLP 331
              + 
Sbjct: 277 TVIMD 281

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (500), Expect = 1e-60
 Identities = 99/359 (27%), Positives = 177/359 (49%), Gaps = 34/359 (9%)

Query: 26  KNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RE 77
           + G+   T+   Y   + +G+G+ GIV  A        VAIKK+ +  + +       RE
Sbjct: 7   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66

Query: 78  LQLMRLMDHPNVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 136
           L LM+ ++H N+ISL + F    + +E   + LVME +   + +V++      +      
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------ 120

Query: 137 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 196
           +    YQ+  G+ ++H+   + HRD+KP N++V      +K+ DFG A+          Y
Sbjct: 121 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPY 178

Query: 197 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           + +RYYRAPE+I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Query: 257 TREEIRCMNPNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQY 303
             E ++ + P   ++    P+     + K+F           +K    +A DL S++L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

Query: 304 SPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHV 362
            P+ R +  +A  HP+ +   +P        P P +++ + +    + E    LI + V
Sbjct: 298 DPAKRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELIYKEV 353

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 2e-60
 Identities = 61/289 (21%), Positives = 118/289 (40%), Gaps = 40/289 (13%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 92
           +  +G GSF  V++    ET   VA  ++   +  K+       E ++++ + HPN++  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
            +  + +T K +  + LV E +       LK Y    + M +  ++ +  QI +GL ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 153 T-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 211
           T  P + HRD+K  N+ +   T  VK+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
            +Y  S+D+++ G  + E+   +  +       Q+   +     P               
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233

Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
                        F K   PE  ++    ++ +   R +  +   H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 5e-60
 Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 45/296 (15%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRLMDHPNV 89
           Y     +GTGS+G   + +    G+ +  K++        +++    E+ L+R + HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +         T+     L +VMEY     +  V+   +   Q +   +V     Q+   L
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 149 AYIH----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYR 203
              H        V HRD+KP N+ +D     VKL DFG A++L    +   +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           +PE +     Y    DIWS GC+L EL    P F   +  +   +I +            
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 229

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                   +F +I               E  ++ +R+L      R +  E   +P 
Sbjct: 230 --------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 9e-60
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 48/292 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 88
           +   R +G G FG V+ A+  ++   +A+K +               RE+++   + HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           ++ L   F      D   + L++EY P      +        +        Y  ++   L
Sbjct: 68  ILRLYGYF-----HDATRVYLILEYAPLGT---VYRELQKLSKFDEQRTATYITELANAL 119

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
           +Y H+   V HRD+KP+NLL+     ++K+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
            G   +   +D+WS G +  E L+G+P F      +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
            +F FP              +   A DL SRLL+++PS R    E   HP+ 
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  195 bits (495), Expect = 9e-60
 Identities = 97/357 (27%), Positives = 159/357 (44%), Gaps = 49/357 (13%)

Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM 84
           GEP +   Y+  R +G G F  V+ AK +     VA+K V  D+ Y      E++L++ +
Sbjct: 7   GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66

Query: 85  DHPNVISLKH----------CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 134
           +  +                  F+    + + + +V E + E +  ++K Y   ++ +PL
Sbjct: 67  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 124

Query: 135 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLCDFGSAKVLVK 189
           IYVK  + Q+  GL Y+H   G+ H D+KP+N+L++ +       Q+K+ D G+A     
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD- 183

Query: 190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------V 243
            E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  +         
Sbjct: 184 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241

Query: 244 DQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKV------FHKRMP 290
           D + +II++LG      +R      T F          ++K  P   V      F K   
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301

Query: 291 PEAIDLASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPFPPLF 340
            E  D  S +LQ  P  R  A     HP+       +E+R P+  L  +G   P  F
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-59
 Identities = 69/342 (20%), Positives = 128/342 (37%), Gaps = 42/342 (12%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRLMDHPNVISL 92
           YM    +G G FGIV +     + +T   K V     D+    +E+ ++ +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
              F     +    L ++ E++    ++  +    +    +    +  Y +Q+   L ++
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118

Query: 152 HTVPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 210
           H+   + H D++P+N++        +K+ +FG A+ L  G+       +  Y APE+   
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
               +T+ D+WS G ++  LL G   F  E     +  I+    T   E           
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227

Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE--LREPNA 328
                           K +  EA+D   RLL      R TA EA  HP+  +   R    
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

Query: 329 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSM 370
            +   +         ++                +R Q G+S+
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSV 313

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-58
 Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 45/309 (14%)

Query: 28  GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRL 83
           G+PK+   Y     +G G+ G V+ A  + TG+ VAI+++       +     E+ +MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 84  MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
             +PN+++    +          L +VMEY    +             M    +     +
Sbjct: 74  NKNPNIVNYLDSYL-----VGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRE 124

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 202
             + L ++H+   V HRD+K  N+L+      VKL DFG    +   ++  S +  + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
            APE++     Y   +DIWS G +  E++ G+P +  EN +  L  I    GTP      
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234

Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
                  + + P            +++     D  +R L      R +A E   H F   
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Query: 323 LREPNARLP 331
            +  ++  P
Sbjct: 276 AKPLSSLTP 284

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  187 bits (476), Expect = 8e-58
 Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 54/306 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------------LQDRRYKNRELQLMR 82
           Y  + ++G G   +V +     T +  A+K +              + R    +E+ ++R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 83  -LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 141
            +  HPN+I LK  +     +   F  LV + +       L  Y +    +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 201
             +   +  +H    + HRD+KP+N+L+D   + +KL DFG +  L  GE       +  
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174

Query: 202 YRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
           Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I       
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227

Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
                  M+ NY  F  P+                   DL SR L   P  R TA EA A
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

Query: 317 HPFFDE 322
           HPFF +
Sbjct: 270 HPFFQQ 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (473), Expect = 5e-57
 Identities = 67/303 (22%), Positives = 115/303 (37%), Gaps = 42/303 (13%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           Y    V+GTG+F  V  A+   T + VAIK + +            E+ ++  + HPN++
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           +L   +     +    L L+M+ V       L                   +Q+   + Y
Sbjct: 71  ALDDIY-----ESGGHLYLIMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
           +H +  + HRD+KP+NLL   L    ++ + DFG +K+   G    +   +  Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                Y+ ++D WS G +   LL G P F  EN      +I+K                 
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
                           +   +   A D    L++  P  R T  +A  HP+       + 
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 329 RLP 331
            + 
Sbjct: 276 NIH 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 7e-57
 Identities = 83/320 (25%), Positives = 130/320 (40%), Gaps = 59/320 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 88
           +   +++G GSF  V  A+ L T    AIK +            Y  RE  +M  +DHP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
            + L   F     +D+  L   + Y        L  Y            + YT +I   L
Sbjct: 70  FVKLYFTF-----QDDEKLYFGLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAP 205
            Y+H   G+ HRD+KP+N+L++     +++ DFG+AKVL          S++ +  Y +P
Sbjct: 122 EYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           EL+        S D+W+ GC++ +L+ G P F   N      +IIK+             
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC------AHPF 319
               ++ FP+            +  P+A DL  +LL    + R    E        AHPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

Query: 320 FDELREPNARLPNGRPFPPL 339
           F+ +      L    P P L
Sbjct: 270 FESVT--WENLHQQTP-PKL 286

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 1e-53
 Identities = 88/338 (26%), Positives = 140/338 (41%), Gaps = 62/338 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHP 87
           ++  +++G GSFG VF A+  +T +  AIK + +D    + +++        L    +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
            +  +   F     + +  L  VMEY+       L ++     +  L     Y  +I  G
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 206
           L ++H+  G+ +RD+K  N+L+D   H  K+ DFG  K  + G+A  +  C +  Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           ++ G  +Y  S+D WS G +L E+L+GQ  F G++  +                IR  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFDELRE 325
            Y  +                 +  EA DL  +L    P  R         HP F E+  
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263

Query: 326 PNARLPNGR---PFPP-------LFNFKQELAGASPEL 353
               L       PF P         NF +E     P L
Sbjct: 264 --EELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 299

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-53
 Identities = 63/305 (20%), Positives = 119/305 (39%), Gaps = 50/305 (16%)

Query: 31  KQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------REL 78
           ++ +   Y     +G+G F +V + +   TG   A K + + R   +          RE+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 79  QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK 138
            +++ + HPNVI+L   +     +++  + L++E V       L  + +  + +      
Sbjct: 65  SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEAT 116

Query: 139 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKVLVKGEANIS 195
            +  QI  G+ Y+H+   + H D+KP+N+++        ++K+ DFG A  +  G    +
Sbjct: 117 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175

Query: 196 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
              +  + APE++          D+WS G +   LL G   F G+   + L  +  V   
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234

Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
              E                         +       A D   RLL   P  R T  ++ 
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

Query: 316 AHPFF 320
            HP+ 
Sbjct: 270 QHPWI 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-52
 Identities = 66/303 (21%), Positives = 111/303 (36%), Gaps = 56/303 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD 85
           Y    ++G+G FG V+    +     VAIK V +DR               E+ L++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 86  --HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 143
                VI L   F            L++E       + L  + +    +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPE--PVQDLFDFITERGALQEELARSFFWQ 118

Query: 144 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 203
           +   + + H   GV HRD+K +N+L+D    ++KL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
            PE I     +  S  +WS G +L +++ G   F  +  + +                  
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------------ 218

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
                                F +R+  E   L    L   PS R T  E   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 324 REP 326
             P
Sbjct: 262 LLP 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  174 bits (443), Expect = 2e-52
 Identities = 75/300 (25%), Positives = 125/300 (41%), Gaps = 54/300 (18%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 88
           +   R +GTGSFG V   +    G   A+K +       L+   + N E  ++ ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           +I +   F     +D   + ++M+Y+       L      +QR P    K Y  ++   L
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIEGGE---LFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 208
            Y+H+   + +RD+KP+N+L+D   H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
                Y  SID WS G ++ E+L G   F   N +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDEL 323
            + RFP                 +  DL SRL+    S R         +   HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  176 bits (446), Expect = 2e-52
 Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 52/303 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD 85
           +   R++G G FG V+  +  +TG+  A+K + + R            +   L L+   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
            P ++ + + F          L+ +++ +       L ++ S +       ++ Y  +I 
Sbjct: 66  CPFIVCMSYAF-----HTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEII 117

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
            GL ++H    V +RD+KP N+L+D   H V++ D G A    K + + S   +  Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
           E++     Y +S D +S GC+L +LL G   F      D+       L            
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFF 320
                                    PE   L   LLQ   + R       A E    PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

Query: 321 DEL 323
             L
Sbjct: 269 RSL 271

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 4e-49
 Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 51/299 (17%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISL 92
            + +G+GSFG V++ K       VA+K +       Q  +    E+ ++R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 93  KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
                         L +V ++    ++Y  L     +  +  +I +     Q  +G+ Y+
Sbjct: 70  MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 208
           H    + HRD+K  N+ +      VK+ DFG A V  +   +  +     S  + APE+I
Sbjct: 121 HA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 209 FG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
                  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++                
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
               +  P +             P     L +  L+     R    +  A    + L  
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS--IELLAR 272

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  163 bits (414), Expect = 1e-48
 Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 43/295 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 88
           Y    ++G G    V  A+ L     VA+K +  D            RE Q    ++HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 148
           ++++ +      +       +VMEYV       L+        M             + L
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 149 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRA 204
            + H   G+ HRDVKP N+++   T+ VK+ DFG A+ +     ++    + I +  Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           PE   G        D++S GCVL E+L G+P F G++ V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                                H+ +  +   +  + L  +P  R           
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-48
 Identities = 68/311 (21%), Positives = 119/311 (38%), Gaps = 53/311 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 92
           +++G G+FG V   +   TG   A+K + ++             E ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           K+ F     +    L  VMEY        L  + S  +       + Y  +I   L Y+H
Sbjct: 71  KYAF-----QTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           +   V +RD+K +NL++D     +K+ DFG  K  +   A +   C         +    
Sbjct: 123 S-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
           +Y  ++D W  G V+ E++ G+  F  ++       I+                   + R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223

Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELREPN 327
           FP            + + PEA  L + LL+  P  R       A E   H FF  +    
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269

Query: 328 ARLPNGRPFPP 338
             +   +  PP
Sbjct: 270 QDVVQKKLLPP 280

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 3e-45
 Identities = 51/282 (18%), Positives = 102/282 (36%), Gaps = 45/282 (15%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFF 97
           + +G G FG V        G  VA+K +  D   +    E  +M  + H N++ L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 98  STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
               +++  L +V EY+ + ++   L+  S     +    +  ++  +   + Y+     
Sbjct: 71  ----EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN 123

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 216
             HRD+  +N+LV    +  K+ DFG  K         +      + APE +    +++T
Sbjct: 124 FVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179

Query: 217 SIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275
             D+WS G +L E+   G+  +P     D +  + K                   ++   
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------GYKMD- 220

Query: 276 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
                         PP   ++         ++R + L+    
Sbjct: 221 ---------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 1e-44
 Identities = 57/302 (18%), Positives = 103/302 (34%), Gaps = 45/302 (14%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 93
           Y   R +G+GSFG ++    +  GE VAIK      ++     E ++ ++M     I   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
               +    +  +  +VME +  ++      ++  +++  L  V L   Q+   + YIH+
Sbjct: 69  RWCGA----EGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 154 VPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANI--------SYICSRYYR 203
                HRDVKP N L+      + V + DFG AK       +         +   +  Y 
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
           +     G  E +   D+ S G VL    LG   + G  A  +  +  ++        I  
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 320
           +   Y                     P E     +         +       +   + F 
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

Query: 321 DE 322
            +
Sbjct: 279 RQ 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 48/267 (17%), Positives = 95/267 (35%), Gaps = 24/267 (8%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 93
           Y   R +G GSFG++F+   L   + VAIK   +         E +  +L+     I   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 94  HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 153
           + F      + L   LV++ +  ++  +L       ++  +  V +   Q+   +  IH 
Sbjct: 67  YYFGQ----EGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 154 VPGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVLVKGEANI--------SYICSRY 201
              + +RD+KP N L+        + + + DFG  K                 +   +  
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           Y +     G  E +   D+ + G V    L G   + G  A     +  ++        +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKR 288
           R +   + +  F +   +  +  F   
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-42
 Identities = 73/322 (22%), Positives = 125/322 (38%), Gaps = 55/322 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKV--------LQDRRYKNRELQLMRLM 84
           +   +V+GTG++G VF  + +   +TG+  A+K +         +   +   E Q++  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 144
                +   H  F    + E  L+L+++Y        L  + S  +R     V++Y  +I
Sbjct: 86  RQSPFLVTLHYAF----QTETKLHLILDY---INGGELFTHLSQRERFTEHEVQIYVGEI 138

Query: 145 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC---SRY 201
              L ++H   G+ +RD+K +N+L+D     V L DFG +K  V  E   +Y       Y
Sbjct: 139 VLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
                +  G + +  ++D WS G ++ ELL G   F  +   +   EI +          
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 246

Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 316
                       P          + + M   A DL  RLL   P  R       A E   
Sbjct: 247 -----RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291

Query: 317 HPFFDELREPNARLPNGRPFPP 338
           H FF ++      L   +   P
Sbjct: 292 HLFFQKINW--DDLAAKKVPAP 311

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  148 bits (374), Expect = 4e-42
 Identities = 58/295 (19%), Positives = 109/295 (36%), Gaps = 54/295 (18%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISL 92
           + +GTGSFG V   K  E+G   A+K +       L+   +   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
           +  F           + +   +       +  +     R    + + Y  QI     Y+H
Sbjct: 107 EFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 212
           ++  + +RD+KP+NLL+D     +++ DFG AK         +   +    APE+I    
Sbjct: 159 SL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213

Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
            Y  ++D W+ G ++ E+  G P F  +  +    +I                       
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250

Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP-----SLRCTALEACAHPFFDE 322
                       F      +  DL   LLQ        +L+    +   H +F  
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 9e-41
 Identities = 58/300 (19%), Positives = 112/300 (37%), Gaps = 37/300 (12%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRLMDHPNVIS 91
           + + +  +G G FG V++ K    GE VA+K      +   ++  E+    ++ H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 92  LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
                 +  +     L LV +Y    +++  L  Y      + +  +         GLA+
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115

Query: 151 IHTV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----YIC 198
           +H         P + HRD+K +N+LV        + D G A         I       + 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 199 SRYYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
           ++ Y APE++  +      E     DI++ G V  E+     +  G +   QL     V 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233

Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
             P+ EE+R +          +++ +  ++            +       + + R TAL 
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-40
 Identities = 57/293 (19%), Positives = 102/293 (34%), Gaps = 47/293 (16%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISL 92
                 +G G FG V+          VA+K + Q     +    E  LM+ + H  ++ L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 93  KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 152
                   +++ +++  + EY+            S   ++ +  +     QI  G+A+I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126

Query: 153 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFG 210
                 HRD++  N+LV       K+ DFG A+++   E            + APE I  
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 211 ATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
              +T   D+WS G +L E++  G+  +PG    + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFF 320
                      +  V     P E   L     +  P  R T     +    FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-40
 Identities = 64/296 (21%), Positives = 105/296 (35%), Gaps = 47/296 (15%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
           E  +G G FG V+      T   VAIK +           +E Q+M+ + H  ++ L   
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                S++ +++  V EY+ +             + + L  +     QI  G+AY+    
Sbjct: 81  V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATE 213
              HRD++  N+LV       K+ DFG A+++   E  A         + APE       
Sbjct: 133 NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 214 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
           +T   D+WS G +L EL   G+  +PG    + L ++ +    P   E            
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239

Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDELREP 326
                            P    DL  +  +  P  R T     A    +F      
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 3e-40
 Identities = 47/291 (16%), Positives = 100/291 (34%), Gaps = 45/291 (15%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCF 96
           + +G+G FG+V         + VAIK + +    +     E ++M  + HP ++ L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
                 ++  + LV E++      +  +  +         +      +  G+AY+     
Sbjct: 70  L-----EQAPICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFGATEY 214
           V HRD+  +N LV      +K+ DFG  + ++  +   S        + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
           ++  D+WS G ++ E+     +     +  ++VE I                        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216

Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
                 +     +        + +   +  P  R             E+ E
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEIAE 261

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (355), Expect = 7e-40
 Identities = 55/294 (18%), Positives = 112/294 (38%), Gaps = 43/294 (14%)

Query: 39  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 95
           +  +G G +G V++    +   TVA+K + +D        +E  +M+ + HPN++ L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 96  FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 155
                   E    ++ E++               Q +  + +     QI   + Y+    
Sbjct: 82  CT-----REPPFYIITEFMTYGNLLDY-LRECNRQEVSAVVLLYMATQISSAMEYLEK-K 134

Query: 156 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATE 213
              HRD+  +N LV    H VK+ DFG ++++      A+        + APE +    +
Sbjct: 135 NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           ++   D+W+ G +L E+            + Q+ E+++                  D+R 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235

Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
                        +  P +  +L     Q++PS R +  E   H  F+ + + +
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETMFQES 277

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-39
 Identities = 59/303 (19%), Positives = 108/303 (35%), Gaps = 56/303 (18%)

Query: 39  ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 90
           ++ +G+G+FG V +      +  +TVA+K +  +            E  +M+ +D+P ++
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            +     + +        LVME         L  Y   N+ +    +    +Q+  G+ Y
Sbjct: 72  RMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE----ANISYICSRYYRAPE 206
           +       HRD+  +N+L+    H  K+ DFG +K L   E    A         + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 207 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
            I    ++++  D+WS G ++ E    GQ  + G    +    + K              
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDE 322
                 R                 P E  DL +    Y    R           + ++D 
Sbjct: 226 ----GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

Query: 323 LRE 325
           + E
Sbjct: 272 VNE 274

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-39
 Identities = 57/288 (19%), Positives = 102/288 (35%), Gaps = 51/288 (17%)

Query: 40  RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN-------RELQLMRLMDHPNV 89
             +G GSFG+V + +         +VA+K +  D   +        RE+  M  +DH N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 149
           I L     +        + +V E  P  +  +L           L  +  Y  Q+  G+ 
Sbjct: 74  IRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 150 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPE 206
           Y+ +     HRD+  +NLL+      VK+ DFG  + L + + +     +    +     
Sbjct: 126 YLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 207 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
                  ++ + D W  G  L E+   GQ  + G N    L +I K              
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229

Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                 R P+           +  P +  ++  +   + P  R T + 
Sbjct: 230 ---EGERLPRP----------EDCPQDIYNVMVQCWAHKPEDRPTFVA 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 54/309 (17%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDH 86
               E+V+G G FG V        G+    VAIK +      + RR    E  +M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 87  PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 146
           PNVI L+             + ++ E++           +  + +  +I +      I  
Sbjct: 87  PNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139

Query: 147 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------ 200
           G+ Y+       HRD+  +N+LV+      K+ DFG ++ L    ++ +Y  +       
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 201 YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE 259
            + APE I    ++T++ D+WS G V+ E++  G+  +      D +  I +        
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------- 248

Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
                     D+R P               P     L     Q   + R    +      
Sbjct: 249 ----------DYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287

Query: 320 FDELREPNA 328
              +R PN+
Sbjct: 288 DKMIRNPNS 296

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 69/315 (21%), Positives = 118/315 (37%), Gaps = 56/315 (17%)

Query: 40  RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 90
           +V+G+G+FG V++   +  GE     VAIK++ +    K       E  +M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
            L     ++T      + L+ + +P     +L +       +   Y+  +  QI +G+ Y
Sbjct: 75  RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR---YYRAPEL 207
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           I     YT   D+WS G  + EL+  G   + G  A  ++  I++               
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE--------------- 227

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
                R P                 +   +  +        R    E     F    R+P
Sbjct: 228 --KGERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274

Query: 327 NARL---PNGRPFPP 338
              L    + R   P
Sbjct: 275 QRYLVIQGDERMHLP 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-39
 Identities = 59/314 (18%), Positives = 108/314 (34%), Gaps = 70/314 (22%)

Query: 39  ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKN-----RELQLM-RLMDHP 87
            +V+G+G+FG V  A      +T     VA+K + +            EL++M +L  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK-------------------HYSS 127
           N+++L              + L+ EY     +   L+                       
Sbjct: 102 NIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 128 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 187
               +    +  + YQ+ +G+ ++       HRD+  +N+LV      VK+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICDFGLARDI 214

Query: 188 VKGEANISYICSR---YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 243
           +     +    +R    + APE +F    YT   D+WS G +L E+  LG   +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 303
               ++I+                   F+                   E   +      +
Sbjct: 274 ANFYKLIQ-----------------NGFKMD----------QPFYATEEIYIIMQSCWAF 306

Query: 304 SPSLRCTALEACAH 317
               R +     + 
Sbjct: 307 DSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 7e-39
 Identities = 48/284 (16%), Positives = 101/284 (35%), Gaps = 45/284 (15%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCF 96
           + +GTG FG+V   K       VAIK + +    ++    E ++M  + H  ++ L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 97  FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 156
                  +  + ++ EY+      +L +   M  R     +      +   + Y+ +   
Sbjct: 69  T-----KQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120

Query: 157 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--YICSRYYRAPELIFGATEY 214
             HRD+  +N LV+     VK+ DFG ++ ++  E   S        +  PE++   +++
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 215 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
           ++  DIW+ G ++ E+  LG+  +      +    I + L                    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------R 222

Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
           P +               +   +           R T     ++
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 4e-38
 Identities = 63/303 (20%), Positives = 107/303 (35%), Gaps = 54/303 (17%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVIS 91
           +  +G G+FG V Q       +   VAIK + Q     +     RE Q+M  +D+P ++ 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 92  LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 151
           L     +        L LVME        + K      + +P+  V    +Q+  G+ Y+
Sbjct: 74  LIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 152 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR----YYRAPEL 207
                  HRD+  +N+L+    H  K+ DFG +K L   ++  +   +      + APE 
Sbjct: 126 EE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
           I    ++++  D+WS G  + E L  GQ  +      + +  I +        E      
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237

Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDEL 323
                                  PPE   L S    Y    R   L         ++   
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274

Query: 324 REP 326
            + 
Sbjct: 275 SKV 277

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 1e-37
 Identities = 58/293 (19%), Positives = 109/293 (37%), Gaps = 51/293 (17%)

Query: 39  ERVVGTGSFGIVFQAKCLE---TGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 90
             V+G G FG V+    L+        A+K +     + +      E  +M+   HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 150
           SL         + E    +V+ Y+     R             +  +  +  Q+ +G+ +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKF 145

Query: 151 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAP 205
           + +     HRD+  +N ++D     VK+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           E +    ++TT  D+WS G +L EL+  G P +P  N  D  V +++          R +
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLL 254

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
            P Y                     P    ++  +       +R +  E  + 
Sbjct: 255 QPEY--------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-36
 Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 56/300 (18%)

Query: 39  ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RLMDHPNVI 90
           + V+G G+FG V +A+  + G     AIK++       D R    EL+++ +L  HPN+I
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 91  SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLK------------HYSSMNQRMPLIYV 137
           +L             +L L +EY P   +   L+              +S    +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 138 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 197
             +   + RG+ Y+       HRD+  +N+LV    +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 198 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
               + A E +   + YTT+ D+WS G +L E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
                        +R                   E  DL  +  +  P  R +  +    
Sbjct: 241 -----------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-36
 Identities = 64/305 (20%), Positives = 113/305 (37%), Gaps = 65/305 (21%)

Query: 39  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 87
            + +G G+FG V +A        +   TVA+K +     L +R     EL+++  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHY--------------SSMNQRM 132
           N+++L                ++ EY     +   L+                      +
Sbjct: 88  NIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 133 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 192
            L  +  ++YQ+ +G+A++ +     HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200

Query: 193 NISYICSR---YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
            +    +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
           +IK                             +  +  +  P E  D+        P  R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 309 CTALE 313
            T  +
Sbjct: 293 PTFKQ 297

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 7e-36
 Identities = 68/293 (23%), Positives = 100/293 (34%), Gaps = 50/293 (17%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDHP 87
               R +G G FG V Q   +        VAIK          R    +E   MR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 88  NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 147
           +++ L           E  + ++ME       R           + L  + LY YQ+   
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 148 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAP 205
           LAY+ +     HRD+  +N+LV      VKL DFG ++ +       +        + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
           E I     +T++ D+W  G  + E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
                                    PP    L ++   Y PS R    E  A 
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-35
 Identities = 55/292 (18%), Positives = 96/292 (32%), Gaps = 50/292 (17%)

Query: 35  SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMD 85
               ++V+G G FG V++     +       VAIK +      K       E  +M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
           H N+I L+             + ++ EY+        K     +    ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGAL--DKFLREKDGEFSVLQLVGMLRGIA 120

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC----SRY 201
            G+ Y+       HRD+  +N+LV+      K+ DFG ++VL                  
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
           + APE I      + S D+WS G V+ E++        E +  ++++ I           
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
                    FR P               P     L  +  Q   + R    +
Sbjct: 228 -------DGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFAD 262

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 6e-35
 Identities = 67/321 (20%), Positives = 114/321 (35%), Gaps = 64/321 (19%)

Query: 36  YMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD------RRYKNRELQLMRLM 84
               + +G G+FG V +A         T  TVA+K + +       R   +    L+ + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 85  DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY------------SSMNQR 131
            H NV++L              L +++E+     +   L+                    
Sbjct: 75  HHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 191
           + L ++  Y++Q+ +G+ ++ +     HRD+  +N+L+    + VK+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP 188

Query: 192 ANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV 247
             +          + APE IF    YT   D+WS G +L E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 307
             +K                 T  R P                PE            PS 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 308 RCTALEACAHPFFDELREPNA 328
           R T  E   H     L + NA
Sbjct: 281 RPTFSELVEH--LGNLLQANA 299

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (315), Expect = 5e-34
 Identities = 65/321 (20%), Positives = 106/321 (33%), Gaps = 73/321 (22%)

Query: 40  RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 89
           R +G G+FG VFQA+       E    VA+K + ++          RE  LM   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 90  ISLKHCFFSTTSKDELFLNLVMEYVP---------------------ETMYRVLKHYSSM 128
           +              + L  + EY+                        +    +  S  
Sbjct: 79  V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 129 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 188
              +          Q+  G+AY+       HRD+  +N LV      VK+ DFG ++ + 
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIY 191

Query: 189 KGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 244
             +   A+ +      +  PE IF    YTT  D+W+ G VL E+   G   + G    +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
            +  +                          I A P      +  P E  +L        
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282

Query: 305 PSLRCTALEACAHPFFDELRE 325
           P+ R +      H     + E
Sbjct: 283 PADRPSFCS--IHRILQRMCE 301

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 4e-33
 Identities = 59/309 (19%), Positives = 112/309 (36%), Gaps = 66/309 (21%)

Query: 36  YMAERVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQD------RRYKNRELQLMR 82
            +  + +G G+FG V  A+ +   +        VA+K +  D          +    +  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 83  LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY------------SSMN 129
           +  H N+I+L           +  L +++EY  +  +   L+               +  
Sbjct: 75  IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 130 QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 189
           +++    +    YQ+ RG+ Y+ +     HRD+  +N+LV    + +K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHH 187

Query: 190 GEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 245
            +      +      + APE +F    YT   D+WS G +L E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 305
           L +++K                    R                   E   +        P
Sbjct: 246 LFKLLK-----------------EGHRMD----------KPSNCTNELYMMMRDCWHAVP 278

Query: 306 SLRCTALEA 314
           S R T  + 
Sbjct: 279 SQRPTFKQL 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 9e-31
 Identities = 59/312 (18%), Positives = 108/312 (34%), Gaps = 63/312 (20%)

Query: 39  ERVVGTGSFGIVFQAKC-----LETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 88
            R +G GSFG+V++         E    VAIK V     +++R     E  +M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 89  VISLKHCFFSTTSKDELFLNLVMEYVPE-------TMYRVLKHYSSMNQRMPLIYVKLYT 141
           V+ L                ++ME +            R     + +     L  +    
Sbjct: 85  VVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 142 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--- 198
            +I  G+AY++      HRD+  +N +V      VK+ DFG  + + + +          
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 199 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 257
              + +PE +     +TT  D+WS G VL E+  L +  + G +    L  +++      
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250

Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------ 311
                                           P    +L     QY+P +R +       
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

Query: 312 LEACAHPFFDEL 323
           ++    P F E+
Sbjct: 289 IKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.5 bits (203), Expect = 4e-19
 Identities = 32/204 (15%), Positives = 55/204 (26%), Gaps = 32/204 (15%)

Query: 40  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------------RELQLMRLMD 85
           +++G G    VF     E      +K                                 +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 86  HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 145
              +  L+               ++ME             +    R+ +         I 
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 146 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 205
             +A  +   G+ H D+   N+LV      + + DF  +  +  GE     I  R  R  
Sbjct: 114 EEVAKFYH-RGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEV--GEEGWREILERDVRNI 168

Query: 206 ELIFGATEYTTSIDIWSAGCVLAE 229
              F    Y T  DI SA   + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	376
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.34
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.8
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.7
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.69
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.34
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.24

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-65  Score=470.87  Aligned_cols=327  Identities=69%  Similarity=1.203  Sum_probs=290.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCC-CCceeEEEEee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLVME  112 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~~~~lv~e  112 (376)
                      .+|+..++||+|+||+||+|++..+|+.||||++..+.....+|+++++.++||||++++++|..... .+..++|+|||
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            47999999999999999999999999999999998887777789999999999999999999865432 45667899999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccccCCC
Q 017139          113 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA  192 (376)
Q Consensus       113 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~  192 (376)
                      ||++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||++........
T Consensus       100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_         100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            99998888888777777889999999999999999999999 79999999999999997566899999999988776666


Q ss_pred             cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCcc
Q 017139          193 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR  272 (376)
Q Consensus       193 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ..+..|++.|+|||.+.+...++.++||||+||++|+|++|.+||...+..+.+..+.+..|.+..+.+......+....
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~  258 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK  258 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence            67788999999999988776799999999999999999999999999999999999999999999999998888888888


Q ss_pred             CCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCCchhhhhcCCHH
Q 017139          273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPE  352 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (376)
                      ++.....++.......+++++.+||.+||++||++|||+.|+|+||||+++..+..+.+..+..+..+++..+.....++
T Consensus       259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~  338 (350)
T d1q5ka_         259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPP  338 (350)
T ss_dssp             CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCGG
T ss_pred             ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCCcc
Confidence            88888888888888899999999999999999999999999999999999988887777777777888888766667777


Q ss_pred             HHhhhcHHH
Q 017139          353 LINRLIPEH  361 (376)
Q Consensus       353 ~~~~~~~~~  361 (376)
                      +...++|.+
T Consensus       339 ~~~~~~p~~  347 (350)
T d1q5ka_         339 LATILIPPH  347 (350)
T ss_dssp             GHHHHSCTT
T ss_pred             ccccCCCcc
Confidence            766666643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-61  Score=424.53  Aligned_cols=248  Identities=29%  Similarity=0.488  Sum_probs=214.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++.+.       .....+|+++++.++||||+++++++     .++.
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence            57899999999999999999999999999999998532       12345799999999999999999998     4555


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+|+|||||+| +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecC-CCCEeeccccee
Confidence            68999999995 77777664    3579999999999999999999999 79999999999999996 778999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+..           
T Consensus       154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----------  220 (263)
T d2j4za1         154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------  220 (263)
T ss_dssp             SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred             eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            765433 34466799999999999775 48999999999999999999999999988877776655421           


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                            +            .+++.+|+++++||.+||++||++|||++|+|+||||+.
T Consensus       221 ------~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         221 ------F------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ------C------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                  1            134568999999999999999999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-61  Score=428.11  Aligned_cols=254  Identities=25%  Similarity=0.356  Sum_probs=209.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+.+++.++||||+++++++.     ++..
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~   77 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI   77 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCce
Confidence            4678999999999999999999999999999999985432     34568999999999999999999994     4456


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+|||||+| +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus        78 ~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~  151 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLAT  151 (271)
T ss_dssp             EEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred             eEEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECC-CCCEEEccchhhe
Confidence            8999999996 6554443    45689999999999999999999999 79999999999999996 7789999999998


Q ss_pred             ccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          186 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       186 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ......   .....+||+.|+|||++.+...++.++||||+||++|+|++|++||...................      
T Consensus       152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------  225 (271)
T d1nvra_         152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------  225 (271)
T ss_dssp             ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT------
T ss_pred             eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------
Confidence            764332   23456799999999999876645788999999999999999999997765433332222211000      


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                          ...+..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       226 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 --------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             --------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             --------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                                0012457999999999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-61  Score=428.10  Aligned_cols=257  Identities=30%  Similarity=0.531  Sum_probs=217.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+++++.++||||+++++++     .++
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   80 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD   80 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECS
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EEC
Confidence            4478999999999999999999999999999999985321       2345799999999999999999998     455


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+|||||+| +|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~-~~~vkl~DFG~  154 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGT  154 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTT
T ss_pred             CEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCC-CceEEeccccc
Confidence            668999999995 77666654    3679999999999999999999999 79999999999999996 77899999999


Q ss_pred             ccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          184 AKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       184 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      |+......   ...+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+...++.+..       
T Consensus       155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-------  226 (288)
T d1uu3a_         155 AKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-------  226 (288)
T ss_dssp             CEECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-------
T ss_pred             ceecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-------
Confidence            98764332   234567999999999997654 8999999999999999999999999988887777665421       


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHH------HhCCCccccccCCCCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNAR  329 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------ll~hp~~~~~~~~~~~  329 (376)
                                +            .++..+++++++||.+||++||++|||++|      +++||||++++|....
T Consensus       227 ----------~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         227 ----------Y------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  279 (288)
T ss_dssp             ----------C------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             ----------C------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence                      1            134568999999999999999999999987      5899999999876543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-60  Score=426.18  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=213.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....    ....+|+.+++.++||||+++++++.     +...+|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEE
Confidence            47999999999999999999999999999999986432    23458999999999999999999984     4445899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |||||+| +|.+.+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus        95 vmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECC-CCcEeeccchhheeec
Confidence            9999996 66554433     469999999999999999999999 79999999999999996 7889999999998765


Q ss_pred             cC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .. ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+..... +.          
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~----------  235 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE----------  235 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC----------
T ss_pred             cccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC----------
Confidence            43 334566799999999999765 489999999999999999999999999888777766655311 00          


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                     ...+..+|+++++||.+||++||++|||++|+|+||||+.
T Consensus       236 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ---------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ---------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                           0133468999999999999999999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-60  Score=428.60  Aligned_cols=277  Identities=34%  Similarity=0.602  Sum_probs=229.9

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017139           38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+++.++||||+++++++     .++..+|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence            4679999999999999999999999999985432         2345799999999999999999999     4455589


Q ss_pred             EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          109 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       109 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      +|||||.+++...+..   .+..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus        77 ivmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecC-CCccccccCccccccC
Confidence            9999999876555543   45779999999999999999999999 79999999999999996 7889999999998765


Q ss_pred             cCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ... .....+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+++..+.+..+.+..+.+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            433 3445678999999999977666899999999999999999999999999999999999999999887766544333


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      .....+......++...+ ..+++++++||.+||++||++|||++|+|+||||++...
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence            333333333333444333 367999999999999999999999999999999986543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-60  Score=421.84  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=206.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      +.++|++.+.||+|+||+||+|+++.+|+.||+|++....      ....+|+++++.++||||+++++++.+   +.+.
T Consensus         2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~   78 (269)
T d2java1           2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNT   78 (269)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------
T ss_pred             CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCC
Confidence            3578999999999999999999999999999999986543      224479999999999999999998853   3344


Q ss_pred             eEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-----ceeccCCCCCeeecCCCCcEEEE
Q 017139          106 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-----VCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       106 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~-----ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                      .+|+|||||+ |+|.+.+......+..+++..++.++.||+.||+|||+ +|     |+||||||+|||++. ++.+||+
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~-~~~vkl~  156 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVKLG  156 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECT-TSCEEEC
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCC-CCcEEEe
Confidence            5889999998 48888887766667889999999999999999999998 56     999999999999996 7889999


Q ss_pred             ecCCccccccCC-CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          180 DFGSAKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       180 Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      |||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....-    
T Consensus       157 DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~----  231 (269)
T d2java1         157 DFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----  231 (269)
T ss_dssp             CHHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----
T ss_pred             eccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----
Confidence            999998765433 33467889999999999665 489999999999999999999999999888777666654210    


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcc
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  320 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~  320 (376)
                                              ..++..+|+++.+||.+||+.||++|||++|+|+|||+
T Consensus       232 ------------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         232 ------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                    01334689999999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.7e-60  Score=426.05  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=203.1

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++....     ....+|+.+++.++||||+++++++     .++..
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~   81 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH   81 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence            4567999999999999999999999999999999986432     2334799999999999999999998     55566


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEecCC
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGS  183 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Dfg~  183 (376)
                      +|+|||||+ |+|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||+..  .++.+||+|||+
T Consensus        82 ~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccce
Confidence            999999998 577777754    4679999999999999999999999 79999999999999953  367899999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ++.........+.+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.+....+.      
T Consensus       157 a~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------  229 (307)
T d1a06a_         157 SKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------  229 (307)
T ss_dssp             ----------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC------
T ss_pred             eEEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC------
Confidence            9877666666678899999999999765 489999999999999999999999999888777776665321111      


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                         ...+..+|+++++||.+||++||++|||++|+|+||||++
T Consensus       230 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         230 -------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             -------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             -------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                               1133468999999999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-59  Score=430.25  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=223.5

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ...++|++++.||+|+||.||+|+++.+|+.||||++....    ....+|+.+++.++||||+++++++     .++..
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   97 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNE   97 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence            34578999999999999999999999999999999986543    2345799999999999999999998     44556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC-CCCcEEEEecCCc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSA  184 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~-~~~~~kl~Dfg~~  184 (376)
                      +|+|||||+| +|.+.+..   ....+++..++.|+.||+.||+|||+ +||+||||||+|||++. .++.+||+|||++
T Consensus        98 ~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a  173 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLT  173 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchh
Confidence            9999999985 77666643   24579999999999999999999999 79999999999999964 2578999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.........      
T Consensus       174 ~~~~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------  246 (350)
T d1koaa2         174 AHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------  246 (350)
T ss_dssp             EECCTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC------
T ss_pred             eecccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------
Confidence            9877666667788999999999998754 899999999999999999999999999888888877664322111      


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                                         .....+|+++++||.+||++||++|||++|+|+||||+....+
T Consensus       247 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         247 -------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             -------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             -------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                               1224589999999999999999999999999999999987654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-59  Score=420.79  Aligned_cols=288  Identities=33%  Similarity=0.553  Sum_probs=237.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCC-CcEEEEEEeccc------ccchHHHHHHHHhC---CCCCeeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD------RRYKNRELQLMRLM---DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~------~~~~~~e~~~l~~l---~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+++.+   +||||+++++++.....
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            357899999999999999999999765 677999998542      22345788877665   79999999999876655


Q ss_pred             CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          102 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      .....++++||||++++......  .....+++..++.++.|++.||+|||+ +||+||||||+|||++. .+.+||+||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~-~~~~kl~df  160 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADF  160 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECSC
T ss_pred             ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcC-CCCeeecch
Confidence            67788999999999876655443  235679999999999999999999999 79999999999999996 778999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |+++............||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+..+.+..+.+..+.+....+
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            999877666666678899999999999765 4899999999999999999999999999999999999999999887766


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ......... .+..... .....+...+++++++||.+||++||++|||++|+|+||||++++..
T Consensus       240 ~~~~~~~~~-~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         240 PRDVALPRQ-AFHSKSA-QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             CTTCSSCGG-GSCCCCC-CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccchhh-hhccccc-cchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence            432221111 1111111 12223456789999999999999999999999999999999988654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-59  Score=421.83  Aligned_cols=283  Identities=34%  Similarity=0.638  Sum_probs=231.6

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      |+|++++.||+|+||+||+|++..+|+.||||++....      ....+|+++++.++||||+++++++     .+...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence            68999999999999999999999999999999985432      2345799999999999999999999     444559


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+|||||.+++...+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecc-cCcceeccCCcceec
Confidence            999999999877666442  34679999999999999999999999 79999999999999996 778999999999876


Q ss_pred             ccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ... .......||+.|+|||++.....++.++|+||+||++|+|++|+.||.+.+..+.+..+....+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            543 3344567899999999987777678999999999999999999999999999999999998888777554433211


Q ss_pred             CCc-CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          267 NYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       267 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ... ...++......+.. ....+++++++||++||++||++|||++|+|+||||+++..+
T Consensus       233 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            100 11122222222222 223678999999999999999999999999999999987654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-59  Score=426.94  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=218.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++||||+++++++     .+..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence            46899999999999999999999999999999998643       12345799999999999999999999     5666


Q ss_pred             eEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~-~g~vkl~DFG~a  152 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred             ccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecC-CCCEEEeecccc
Confidence            79999999996 66565554    4679999999999999999999999 79999999999999996 788999999999


Q ss_pred             ccccc-CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          185 KVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       185 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +.... .......+||+.|+|||++.+.. |+.++|+|||||++|+|++|.+||.+.+..+....+....          
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~----------  221 (337)
T d1o6la_         153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------  221 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             cccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC----------
Confidence            86544 33445678999999999997654 8999999999999999999999999998877776665521          


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                             +            .+++.+|+++++||++||++||++|++     ++|+++||||+++++.
T Consensus       222 -------~------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~  270 (337)
T d1o6la_         222 -------I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             -------C------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence                   1            144568999999999999999999994     9999999999987653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-59  Score=418.88  Aligned_cols=259  Identities=24%  Similarity=0.384  Sum_probs=219.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTS  101 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~  101 (376)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++.+..          ....+|+.+++.++|||||++++++     
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----   82 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----   82 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            4578999999999999999999999999999999985431          2245799999999999999999998     


Q ss_pred             CCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCC---cEE
Q 017139          102 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVK  177 (376)
Q Consensus       102 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~---~~k  177 (376)
                      .+...+|+|||||+| +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++.   .+|
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceE
Confidence            555669999999995 77777765    3579999999999999999999999 79999999999999986332   599


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      |+|||++.............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+........
T Consensus       158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1jksa_         158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  236 (293)
T ss_dssp             ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             ecchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            9999999887666666677899999999999764 489999999999999999999999999988888777765322222


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      .                         ..+..+|+++++||++||+.||++|||++|+|+||||+..++.
T Consensus       237 ~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  280 (293)
T d1jksa_         237 D-------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ  280 (293)
T ss_dssp             H-------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred             c-------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence            1                         1334689999999999999999999999999999999876554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-59  Score=419.92  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=212.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      +.|++++.||+|+||+||+|++..+|+.||+|++....    ....+|+++++.++|||||++++++.     +...+|+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence            57999999999999999999999999999999986432    34568999999999999999999984     3445899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |||||+| +|...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|....
T Consensus        87 vmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECC-CCCEEEEechhhhccC
Confidence            9999986 66555543   24679999999999999999999999 79999999999999996 7789999999987653


Q ss_pred             cC-CCcceeeccccccChhhhhC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          189 KG-EANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       189 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      .. ....+..||+.|+|||++..    ...|+.++|||||||++|+|++|..||.+.+..+.+.++.+....        
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~--------  233 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP--------  233 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC--------
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            32 12335678999999999842    334789999999999999999999999998887777766652110        


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                        ....+..+|+++++||.+||++||++|||++|+|+||||+.
T Consensus       234 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 ------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                              00123468999999999999999999999999999999973

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-59  Score=411.89  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=207.9

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      |++.++||+|+||+||+|++..+++.||+|++....      ....+|+++++.++||||+++++++.... .++..+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            477889999999999999999999999999986432      23457999999999999999999985543 44567899


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--ceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~--ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      |||||+| +|.+.+..    ...+++..++.++.||+.||+|||+ ++  |+||||||+|||++..++.+||+|||+++.
T Consensus        90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999985 77776654    3679999999999999999999999 68  999999999999975577899999999986


Q ss_pred             cccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ... ....+..||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+.+.+.. +..+         
T Consensus       165 ~~~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~---------  231 (270)
T d1t4ha_         165 KRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP---------  231 (270)
T ss_dssp             CCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC---------
T ss_pred             ccC-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC---------
Confidence            433 33456789999999999864  4899999999999999999999999876655544433321 1110         


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                                      ..++...++++++||.+||++||++|||++|+|+||||+
T Consensus       232 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                            113445789999999999999999999999999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.6e-59  Score=426.88  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=220.3

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ..++|++++.||+|+||+||+|++..+|+.||||++....    ....+|+.+++.++||||++++++|     .++..+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~  101 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEM  101 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            4467999999999999999999999999999999986543    2345799999999999999999998     555668


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC-CCCcEEEEecCCcc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAK  185 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~-~~~~~kl~Dfg~~~  185 (376)
                      |+|||||+| +|.+.+..   ...++++..++.|+.||+.||+|||+ +||+||||||+|||++. .++.+||+|||+|.
T Consensus       102 ~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~  177 (352)
T d1koba_         102 VLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLAT  177 (352)
T ss_dssp             EEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccce
Confidence            999999995 65544432   34579999999999999999999999 79999999999999973 36789999999999


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......++        
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  248 (352)
T d1koba_         178 KLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--------  248 (352)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred             ecCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            88776667778899999999999765 489999999999999999999999999998888877766322211        


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                       ...+..+|+++++||.+||++||.+|||++|+|+||||+..
T Consensus       249 -----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 -----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                             11234689999999999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4e-59  Score=423.01  Aligned_cols=251  Identities=28%  Similarity=0.471  Sum_probs=216.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~  105 (376)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++||||+++++++     .+..
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCC
Confidence            46799999999999999999999999999999998542       12345799999999999999999998     4556


Q ss_pred             eEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          106 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       106 ~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      .+|+|||||.|+ +...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus        78 ~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~-~g~vkL~DFG~a  151 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFA  151 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred             eeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcC-CCCEEEecCccc
Confidence            699999999974 444443    35678999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +....  ...+.+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++.....          
T Consensus       152 ~~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------  218 (316)
T d1fota_         152 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----------  218 (316)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC----------
T ss_pred             eEecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC----------
Confidence            87643  33467899999999999765 489999999999999999999999999988888777765211          


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                         .++..++++++++|.+||++||.+|+     |++++++||||+++++.
T Consensus       219 -------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         219 -------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence                               13346899999999999999999996     89999999999998765

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-59  Score=419.14  Aligned_cols=249  Identities=29%  Similarity=0.440  Sum_probs=211.1

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +.|++.+.||+|+||+||+|++..+|+.||||++.....       ...+|+.+++.++|||||++++++.+     ...
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence            469999999999999999999999999999999865432       24479999999999999999999843     445


Q ss_pred             EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          107 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       107 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      +|+|||||.++++..+..   ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus        90 ~~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECC-CCCEEEeecccccc
Confidence            899999999865544332   34679999999999999999999999 79999999999999996 88999999999986


Q ss_pred             cccCCCcceeeccccccChhhhhCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          187 LVKGEANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       187 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ...   .....||+.|+|||++.+.  ..|+.++|||||||++|+|++|..||.+.+..+.+..+......+        
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------  233 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------  233 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence            543   3456899999999998642  348899999999999999999999999988877777665521110        


Q ss_pred             CcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                         ..+..+|+++++||.+||+.||++|||++|+|+||||.+
T Consensus       234 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         234 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             -------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             -------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                               122357999999999999999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-59  Score=427.55  Aligned_cols=283  Identities=26%  Similarity=0.417  Sum_probs=209.2

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++....     ....+|+.+++.++|||||+++++|     .+...
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~   78 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE   78 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence            4678999999999999999999999999999999986542     2345799999999999999999999     44556


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +|+|||||+| +|.+.+..    ...+++..++.++.|++.||.|||+.+||+||||||+|||++. ++.+||+|||+|+
T Consensus        79 ~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~  153 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSG  153 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCH
T ss_pred             EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC-CCCEEEeeCCCcc
Confidence            8999999995 77777654    3569999999999999999999996138999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHHhhc
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  264 (376)
                      ..... ...+.+||+.|+|||++.+.. |+.++||||+||++|+|++|+.||.+.+..+. ........+.+........
T Consensus       154 ~~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         154 QLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HHHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             ccCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            65433 234678999999999998754 99999999999999999999999987654332 2222222222111100000


Q ss_pred             CcCC--cCc---cCCC---------CCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCC
Q 017139          265 NPNY--TDF---RFPQ---------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  326 (376)
Q Consensus       265 ~~~~--~~~---~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~  326 (376)
                      ....  ...   ..+.         ....+........+|.+++|||.+||++||.+|||++|+|+||||++.++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence            0000  000   0000         000000111122468899999999999999999999999999999876543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.7e-58  Score=406.92  Aligned_cols=254  Identities=27%  Similarity=0.404  Sum_probs=218.1

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-------------chHHHHHHHHhCC-CCCeeecceeeee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------------YKNRELQLMRLMD-HPNVISLKHCFFS   98 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------------~~~~e~~~l~~l~-h~~Iv~~~~~~~~   98 (376)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....             ...+|+.+++.++ ||||+++++++  
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--   79 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence            3689999999999999999999999999999999865421             2347999999997 99999999999  


Q ss_pred             cCCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEE
Q 017139           99 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK  177 (376)
Q Consensus        99 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~k  177 (376)
                         .++..+|+|||||+| +|.+.+..    +..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus        80 ---~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~~k  150 (277)
T d1phka_          80 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNIK  150 (277)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEE
T ss_pred             ---ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcC-CCCeE
Confidence               556669999999985 88888764    3579999999999999999999999 79999999999999996 78899


Q ss_pred             EEecCCccccccCCCcceeeccccccChhhhhC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 017139          178 LCDFGSAKVLVKGEANISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV  252 (376)
Q Consensus       178 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  252 (376)
                      |+|||+++............||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus       151 l~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~  230 (277)
T d1phka_         151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  230 (277)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence            999999988766666667789999999999853     334688999999999999999999999999888877777653


Q ss_pred             cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      ...+.                         .....++|+++++||.+||+.||++|||++|+|+||||++
T Consensus       231 ~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         231 NYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            21111                         0122368999999999999999999999999999999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-58  Score=417.67  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=220.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++++.||+|+||+||+|.++.+|+.||||++.....   ...+|+++|+.++||||++++++|     .++..+|+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence            4789999999999999999999999999999999975432   345899999999999999999999     44556999


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCC-CCcEEEEecCCcccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVL  187 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~-~~~~kl~Dfg~~~~~  187 (376)
                      |||||+| +|.+.+..   .+..+++..++.|+.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||+++..
T Consensus        79 vmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999996 77766653   23479999999999999999999999 799999999999999742 457999999999887


Q ss_pred             ccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          188 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       188 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ..........+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+....++..        
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------  225 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--------  225 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH--------
T ss_pred             ccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh--------
Confidence            6666666778899999999987654 8999999999999999999999999999888888887643333322        


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                                       .+..+|+++++||.+||++||++|||++|+|+||||++
T Consensus       226 -----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         226 -----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -----------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                             22357999999999999999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-57  Score=417.10  Aligned_cols=317  Identities=32%  Similarity=0.558  Sum_probs=240.6

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDE  104 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~  104 (376)
                      ..++|++++.||+|+||+||+|.++.+|+.||||++....      ....+|+++|+.++|||||+++++|..... ...
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3568999999999999999999999999999999996532      223479999999999999999999854332 234


Q ss_pred             eeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCc
Q 017139          105 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA  184 (376)
Q Consensus       105 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~  184 (376)
                      ..+|+|||||+.++....+.     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||++
T Consensus        96 ~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a  168 (346)
T d1cm8a_          96 TDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA  168 (346)
T ss_dssp             CCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred             ceEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccc-ccccccccccce
Confidence            45789999998777666553     579999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Q 017139          185 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  264 (376)
Q Consensus       185 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +....  ......||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.++.+.+...
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         169 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             eccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            87543  3346778999999999987766899999999999999999999999999999999999999999988776543


Q ss_pred             CcCCcC---ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCC
Q 017139          265 NPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN  341 (376)
Q Consensus       265 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~  341 (376)
                      ......   ...+......+.. ....++++++|||.+||++||++|||++|+|+||||+.+.+..... ..+    .++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~-~~~----~~~  320 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP-QVQ----KYD  320 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-------CCC----CCC
T ss_pred             cchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc-cCC----CCC
Confidence            321110   1223333333333 2346899999999999999999999999999999999887654321 111    122


Q ss_pred             chhhhhcCCHHHHhhhcHHHHH
Q 017139          342 FKQELAGASPELINRLIPEHVR  363 (376)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~  363 (376)
                      ...+....+.+.+.+++-+++.
T Consensus       321 ~~~~~~~~~~~e~k~~~~~e~~  342 (346)
T d1cm8a_         321 DSFDDVDRTLDEWKRVTYKEVL  342 (346)
T ss_dssp             CC-----CCHHHHHHHHHHHHH
T ss_pred             CchhhhhcCHHHHHHHHHHHhh
Confidence            2222223456666666666654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.2e-58  Score=409.96  Aligned_cols=277  Identities=33%  Similarity=0.611  Sum_probs=225.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|++.++||+|+||+||+|+++ +|+.||||++....      ....+|+.+++.++||||+++++++.     ++...
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence            68999999999999999999985 78999999985532      23457999999999999999999994     44458


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      +++|||+.++++..+..   ..+.+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||.+...
T Consensus        76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcC-CCCEEecccccceec
Confidence            99999999987666654   35779999999999999999999999 79999999999999996 788999999999876


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..... .....+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+.++....+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            54332 34556899999999998777789999999999999999999999999999999999999888887665543321


Q ss_pred             CCc-CccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          267 NYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       267 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      ... ..........+ ...+...++++++|||++||++||++|||++|+|+||||++
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCC-GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcc-hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            111 11111111122 22344578999999999999999999999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.6e-58  Score=419.79  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=218.2

Q ss_pred             CccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        30 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      +...++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++     .
T Consensus        37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~  111 (350)
T d1rdqe_          37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----K  111 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred             CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----c
Confidence            345689999999999999999999999999999999985421       2245799999999999999999998     4


Q ss_pred             CceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+++|||||.| +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~-~g~ikL~DF  185 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTDF  185 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCC
T ss_pred             cccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCC-CCCEEeeec
Confidence            55568999999995 66666554    3579999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |+|+....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+.....       
T Consensus       186 G~a~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-------  255 (350)
T d1rdqe_         186 GFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-------  255 (350)
T ss_dssp             TTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred             eeeeeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-------
Confidence            99987643  33467899999999999765 489999999999999999999999999888877777765211       


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                                            .++..+++++.+||++||++||.+|+     |++++++||||+.+++.
T Consensus       256 ----------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         256 ----------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             ----------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence                                  13346899999999999999999995     89999999999988764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.6e-58  Score=423.22  Aligned_cols=256  Identities=26%  Similarity=0.373  Sum_probs=209.5

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHH---HHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNR---ELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~---e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.+..       ....+   ++.+++.++||||+++++++     .
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence            468999999999999999999999999999999985432       11223   35666777899999999998     4


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEec
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      +...+|+|||||+ |+|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~-~g~iKl~DF  151 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDL  151 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-SSCEEECCC
T ss_pred             ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcC-CCcEEEeee
Confidence            4556899999999 477777664    3678999999999999999999999 79999999999999996 788999999


Q ss_pred             CCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 017139          182 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  261 (376)
Q Consensus       182 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (376)
                      |+|+..... ......||+.|+|||++.....++.++|||||||++|+|++|..||.+.+..+...........      
T Consensus       152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------  224 (364)
T d1omwa3         152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------  224 (364)
T ss_dssp             TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------
T ss_pred             ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------
Confidence            999876543 3345689999999999976566899999999999999999999999876543322211111000      


Q ss_pred             hhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCC-----HHHHhCCCccccccCC
Q 017139          262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell~hp~~~~~~~~  326 (376)
                                          ...++..+|+++++||.+||++||++|||     ++|+++||||+++++.
T Consensus       225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence                                11134568999999999999999999999     7999999999988754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-58  Score=415.20  Aligned_cols=253  Identities=28%  Similarity=0.502  Sum_probs=213.4

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHH-HhCCCCCeeecceeeeecCCCCc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l-~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.++.       .....|..++ +.++||||+++++++     .++
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~   75 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTK   75 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccC
Confidence            478999999999999999999999999999999996431       1223455554 578999999999998     555


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+|||||+| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~-~~~~kl~DFG~  149 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADFGM  149 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTT
T ss_pred             CceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecC-CCceeccccch
Confidence            669999999995 77766654    4679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccC-CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 017139          184 AKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  262 (376)
Q Consensus       184 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...  .+      
T Consensus       150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~------  220 (320)
T d1xjda_         150 CKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP------  220 (320)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC------
T ss_pred             hhhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC------
Confidence            9865443 334456789999999999765 4899999999999999999999999998887777666541  11      


Q ss_pred             hcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHH-HHhCCCccccccCC
Q 017139          263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP  326 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-ell~hp~~~~~~~~  326 (376)
                                           .+++.+|+++++||.+||++||++|||+. ++++||||+++++.
T Consensus       221 ---------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~  264 (320)
T d1xjda_         221 ---------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  264 (320)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             ---------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence                                 13456899999999999999999999995 89999999987653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=412.51  Aligned_cols=320  Identities=33%  Similarity=0.615  Sum_probs=244.6

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      +.+|++++.||+|+||+||+|+++.+|+.||||++.....     ...+|+.+|+.++||||+++++++..........+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            3579999999999999999999999999999999865432     23479999999999999999999865544445567


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      |+++++++|+|.+.+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECC-CCCEEEcccCceeec
Confidence            78888888899888764     469999999999999999999999 79999999999999996 788999999999765


Q ss_pred             ccCC----CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          188 VKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       188 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ....    .....+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+..+.........+.+.......
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            4332    234567899999999986666689999999999999999999999999999888888888888877665432


Q ss_pred             cCcC---CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCC
Q 017139          264 MNPN---YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF  340 (376)
Q Consensus       264 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~  340 (376)
                      ....   ......+.....++...+ ..+++++++||.+||++||++|||++|+|+||||+....+....    .....+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~----~~~~~~  314 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF  314 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred             hhhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc----cccCcc
Confidence            2110   001123333333443333 46799999999999999999999999999999998765543221    122345


Q ss_pred             CchhhhhcCCHHHHhhhcHHHHHh
Q 017139          341 NFKQELAGASPELINRLIPEHVRR  364 (376)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~  364 (376)
                      +++.+......+.+.+++.++..+
T Consensus       315 ~~~~~~~~~~~~~l~~l~~~e~~~  338 (345)
T d1pmea_         315 KFDMELDDLPKEKLKELIFEETAR  338 (345)
T ss_dssp             --------CCHHHHHHHHHHHSGG
T ss_pred             CCChhhhhCCHHHHHHHHHHHHHh
Confidence            566666677788888777665544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=404.52  Aligned_cols=246  Identities=27%  Similarity=0.417  Sum_probs=206.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHhCC--CCCeeecceeeeecC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD--HPNVISLKHCFFSTT  100 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~--h~~Iv~~~~~~~~~~  100 (376)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+..          ....+|+.+++.++  ||||+++++++    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            467999999999999999999999999999999986432          22347999999987  89999999998    


Q ss_pred             CCCceeEEEEeecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          101 SKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                       .+...+|+||||+.+  ++.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||
T Consensus        79 -~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          79 -ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             -ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEE
T ss_pred             -eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEE
Confidence             455568999999974  55555543    3679999999999999999999999 799999999999999875689999


Q ss_pred             EecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          179 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       179 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      +|||+++.... ....+..||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+      .+.+.      
T Consensus       153 ~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------  219 (273)
T d1xwsa_         153 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------  219 (273)
T ss_dssp             CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC------
T ss_pred             Cccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc------
Confidence            99999986543 334567899999999999876656788999999999999999999997532      12210      


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccccc
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  324 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~  324 (376)
                                 .            ..++..+|+++++||.+||++||++|||++|+|+||||+++.
T Consensus       220 -----------~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 -----------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -----------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -----------c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                       0            013456899999999999999999999999999999998753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-57  Score=414.18  Aligned_cols=267  Identities=25%  Similarity=0.348  Sum_probs=212.4

Q ss_pred             CCccccceEeee-eeccCCceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHH-hCCCCCeeecceeeeecCCCCcee
Q 017139           29 EPKQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        29 ~~~~~~~y~~~~-~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~-~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .....++|.+.+ .||+|+||+||+|++..+++.||||++... ....+|+.++. ..+||||++++++|.+.. ..+.+
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~   83 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC   83 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCE
Confidence            345567899875 699999999999999999999999998654 44567888765 558999999999885432 34567


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEecCC
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGS  183 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Dfg~  183 (376)
                      +|+|||||+| +|.+.+...  ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.  +.+.+||+|||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccce
Confidence            8999999985 888877642  23579999999999999999999999 79999999999999975  245799999999


Q ss_pred             ccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 017139          184 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  263 (376)
Q Consensus       184 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ++............||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+.......+......        
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~--------  231 (335)
T d2ozaa1         161 AKETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--------  231 (335)
T ss_dssp             CEECCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS--------
T ss_pred             eeeccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc--------
Confidence            9887776667778899999999998765 4899999999999999999999999876654444333221110        


Q ss_pred             cCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                           ..+.+|        ......+|+++++||.+||++||++|||++|+|+||||.+
T Consensus       232 -----~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 -----GQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             -----CSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             -----CCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence                 011111        1122357999999999999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=412.37  Aligned_cols=317  Identities=30%  Similarity=0.520  Sum_probs=230.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~  105 (376)
                      .++|+++++||+|+||+||+|++..+|+.||||++....      ....+|+.+++.++||||++++++|..... +...
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999999999999999996542      224579999999999999999999854432 3457


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+|+|||||.++++..+.      ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+|++|||+++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~-~~~~kl~df~~~~  167 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC--
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccc-ccceeeechhhhh
Confidence            799999999998776553      568999999999999999999999 79999999999999996 7789999999998


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ............+|+.|+|||++.+. .+++++||||+||++|+|++|++||.+.+.......++...+.+..+.+....
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             -------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            87776667778899999999999775 58999999999999999999999999999999999999999988887765433


Q ss_pred             cCCcCc--cCCCCCCCCccc-----------ccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCC
Q 017139          266 PNYTDF--RFPQIKAHPWHK-----------VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN  332 (376)
Q Consensus       266 ~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~  332 (376)
                      .....+  ..+......+..           ......++++++||++||++||++||||+|+|+||||+...++....  
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~--  324 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE--  324 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHT--
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccccc--
Confidence            221111  001111111111           11223567899999999999999999999999999999865432221  


Q ss_pred             CCCCCCCCCchhhhhcCCHHHHhhhcHHH
Q 017139          333 GRPFPPLFNFKQELAGASPELINRLIPEH  361 (376)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (376)
                       .+.+..++...+....+.+.+.+++-.+
T Consensus       325 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (355)
T d2b1pa1         325 -APPPQIYDKQLDEREHTIEEWKELIYKE  352 (355)
T ss_dssp             -CCCC-------CCCCCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCcchhhhhcCHHHHHHHHHHH
Confidence             1122334433333444555565554433

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4e-56  Score=407.06  Aligned_cols=284  Identities=30%  Similarity=0.510  Sum_probs=225.0

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ..++|+++++||+|+||+||+|++..+|+.||||++.... ....+|+++|+.++ ||||++++++|..   .....+++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~  109 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPAL  109 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeE
Confidence            4578999999999999999999999999999999987543 34568999999995 9999999998853   34455889


Q ss_pred             EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          110 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       110 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      |||||+++.+   ..   ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+....
T Consensus       110 v~e~~~~~~L---~~---~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         110 VFEHVNNTDF---KQ---LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEECCCSCBG---GG---TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EEeecCCCcH---HH---HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999997532   22   23569999999999999999999999 79999999999999987566799999999988776


Q ss_pred             CCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHHHhhcCcCC
Q 017139          190 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIRCMNPNY  268 (376)
Q Consensus       190 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ........+|+.|+|||.+.+...++.++|+||+||++|+|++|..||... +..++...+.+.+|.+....+.......
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            666777889999999999987766899999999999999999999999754 4556666677766655443332211110


Q ss_pred             cCc----cCCCCCCCCcccc----cccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          269 TDF----RFPQIKAHPWHKV----FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       269 ~~~----~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ...    ..+......+...    ....++++++|||++||++||.+|||++|+|+||||+.+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            000    0111111111111    22357899999999999999999999999999999998765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=396.36  Aligned_cols=282  Identities=33%  Similarity=0.560  Sum_probs=228.3

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      ++|++++.||+|+||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++     .+...+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            58999999999999999999999999999999986442      2235799999999999999999998     445558


Q ss_pred             EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccc
Q 017139          108 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL  187 (376)
Q Consensus       108 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~  187 (376)
                      ++|++++.++++..+..   ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||.++..
T Consensus        77 ~iv~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred             eEEeeeccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCccccccc-CCceeeeecchhhcc
Confidence            89999999865554433   45789999999999999999999999 79999999999999996 778999999999877


Q ss_pred             ccCCC-cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          188 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       188 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ..... .....+++.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+.+..+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            55433 334556889999999977766799999999999999999998874 5667777888888888877765544332


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccC
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~  325 (376)
                      ........+..............+++++.+||.+||++||.+|||++|+|+||||+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence            222222222222223333345578999999999999999999999999999999987543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=405.33  Aligned_cols=318  Identities=32%  Similarity=0.533  Sum_probs=244.1

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL  105 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-~~~~  105 (376)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....      ...+|+++++.++||||+++++++..... ++..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            5789999999999999999999999999999999965432      23479999999999999999998854432 2334


Q ss_pred             eEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          106 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       106 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .+++++++++|+|.+++..     +.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~-~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccc-cccccccccchhc
Confidence            4556666666788776643     579999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          186 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       186 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ...  ....+..|++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+.+..+.+..+......
T Consensus       170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            543  334456789999999998777768999999999999999999999999999999999999998888776554322


Q ss_pred             cCCcC---ccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccccCCCCCCCCCCCCCCCCCc
Q 017139          266 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF  342 (376)
Q Consensus       266 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~  342 (376)
                      .....   ...+......+... ...++++++|||.+||++||.+|||++|+|+||||+++..+...     +....+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~-----~~~~~~~~  321 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-----PVADPYDQ  321 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC-----CCCCCCCC
T ss_pred             chhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC-----CCCCCCCC
Confidence            11100   01222222233322 24689999999999999999999999999999999987654322     22333444


Q ss_pred             hhhhhcCCHHHHhhhcHHHHHhh
Q 017139          343 KQELAGASPELINRLIPEHVRRQ  365 (376)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~  365 (376)
                      ..+......+.+..++.++..+-
T Consensus       322 ~~~~~~~~~~~~k~~~~~e~~~~  344 (348)
T d2gfsa1         322 SFESRDLLIDEWKSLTYDEVISF  344 (348)
T ss_dssp             GGGGCCCCHHHHHHHHHHHHHTC
T ss_pred             cccchhcCHHHHHHHHHHHhhcc
Confidence            44445566677777766665543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=400.77  Aligned_cols=289  Identities=28%  Similarity=0.460  Sum_probs=224.5

Q ss_pred             CCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-
Q 017139           29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-  101 (376)
Q Consensus        29 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~-  101 (376)
                      .-...++|.+++.||+|+||+||+|++..+|+.||||++....      ....+|+++++.++||||+++++++..... 
T Consensus         5 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1           5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             TSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             CCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence            3356789999999999999999999999999999999985432      224579999999999999999998854321 


Q ss_pred             --CCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEE
Q 017139          102 --KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC  179 (376)
Q Consensus       102 --~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~  179 (376)
                        ..+..+|+|||||.+++......   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~-~~~~kl~  159 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLA  159 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEEC
T ss_pred             ccccCceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecC-CCcEEee
Confidence              22456889999999876654433   45679999999999999999999999 79999999999999996 7889999


Q ss_pred             ecCCccccccC-----CCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017139          180 DFGSAKVLVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  254 (376)
Q Consensus       180 Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  254 (376)
                      |||++......     ....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+..+
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999765422     2233467899999999998776789999999999999999999999999999999999999888


Q ss_pred             CCCHHHHhhcCcCCcCccC--CCCCCCCccccc-ccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCcccc
Q 017139          255 TPTREEIRCMNPNYTDFRF--PQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  322 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~  322 (376)
                      .+..+.+...........+  ...........+ ....+++++|||.+||++||++|||++|+|+||||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            8776654433221111111  111111111111 1134778999999999999999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-54  Score=386.23  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=204.8

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ...++|++.+.||+|+||+||+|++..+|+.||||++....       ....+|+++++.++||||+++++++.... ..
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CC
Confidence            34578999999999999999999999999999999986532       12457999999999999999999986543 34


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+|||||+| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~-~~~~~l~d~~  156 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFG  156 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEET-TSCEEECCCT
T ss_pred             CceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCc-cccceeehhh
Confidence            5568899999996 55555543    4679999999999999999999999 79999999999999996 7789999999


Q ss_pred             CccccccCC----CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          183 SAKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       183 ~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      .+.......    ......||+.|+|||++.+. .++.++|||||||++|+|+||.+||.+.+..+.+.+++.....++ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~-  234 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-  234 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG-
T ss_pred             hhhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC-
Confidence            987553322    23456789999999999765 489999999999999999999999999888877777665322111 


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccc
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  321 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~  321 (376)
                                              ......+|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus       235 ------------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 ------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ------------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ------------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                    113346899999999999999999999544445577764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-54  Score=383.60  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=204.6

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++..+..   ...+|+++++.++|||||++++++     .+...+|+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCeeEE
Confidence            4689999999999999999999999999999999876543   345799999999999999999998     44445889


Q ss_pred             Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |||||+ |+|...+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus        91 v~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECC-CCcEEEccccceeecC
Confidence            999999 5777766542  34679999999999999999999999 79999999999999996 7889999999998765


Q ss_pred             cCCCc--ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          189 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       189 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .....  ....|++.|+|||++.+.. ++.++|||||||++|+|++|..||........+.+++....            
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~------------  233 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------  233 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC------------
Confidence            44322  2345788999999997654 89999999999999999997666544444444444433211            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCCccccc
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp~~~~~  323 (376)
                                     ...++..+|+++.+||.+||+.||++|||++++++  +|+.+
T Consensus       234 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         234 ---------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ---------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                           11134568999999999999999999999999964  55543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=387.40  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=203.5

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCc-----EEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      .++|++.+.||+|+||+||+|++..+++     .||+|.+....     ....+|+.++..+ +|||||++++++     
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----  110 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----  110 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence            3689999999999999999999876554     69999885432     2345789999887 899999999998     


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceecc
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSS-------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD  161 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~-------------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~d  161 (376)
                      .+...+|+|||||+ |+|.+.+.....                   ....+++..++.++.||+.||+|||+ +||+|||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD  189 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  189 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence            44555899999998 588888765321                   12458999999999999999999999 7999999


Q ss_pred             CCCCCeeecCCCCcEEEEecCCccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 017139          162 VKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF  237 (376)
Q Consensus       162 lkp~Nill~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf  237 (376)
                      |||+|||++. ++.+||+|||+|+........   ....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||
T Consensus       190 lKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         190 LAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             CSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             Cchhcccccc-CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCC
Confidence            9999999996 889999999999876554432   2456799999999997654 8999999999999999997 89999


Q ss_pred             CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          238 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .+.+....+.+++.....+                           ..+..+|+++++||.+||+.||++|||++|+++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9877666666665521111                           1345679999999999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=373.81  Aligned_cols=244  Identities=18%  Similarity=0.304  Sum_probs=192.2

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ++|++.+.||+|+||+||+|++. +++.||||++..+..   ...+|+++++.++||||+++++++.     .+..+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEEE
Confidence            57999999999999999999975 567899999975432   3457999999999999999999984     34448899


Q ss_pred             eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      ||||++ +|.+.+..   ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus        79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECG-GGCEEECSCC-------
T ss_pred             EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecC-CCCeEecccchheeccC
Confidence            999985 67666654   34668999999999999999999999 79999999999999996 78899999999987654


Q ss_pred             CCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          190 GEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       190 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...  .....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+.....            
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------  220 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------  220 (263)
T ss_dssp             -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------------
T ss_pred             CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            432  2245679999999999765 48999999999999999999 5677777666666655544211            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                      ...+...++++.+|+.+||+.||++|||++++++|
T Consensus       221 ----------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         221 ----------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            11234578999999999999999999999999876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=375.48  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=197.0

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      .++|++.+.||+|+||+||+|+.   +..||||++....      ....+|+.+++.++||||++++++..     + ..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-----~-~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----A-PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-----c-cE
Confidence            46799999999999999999974   3469999985432      23447999999999999999998752     1 22


Q ss_pred             EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +++|||||+ |+|.+.+..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~-~~~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TSSEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcC-CCCEEEcccccee
Confidence            789999999 577777754   24569999999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccCC---CcceeeccccccChhhhhCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          186 VLVKGE---ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       186 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ......   ......||+.|+|||++.+.  ..++.++|||||||++|||+||+.||.+.+....+...+.....++   
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p---  229 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP---  229 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence            764322   22356789999999998643  2478999999999999999999999998877666655554321111   


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                          .....+..+++++.+|+.+||+.||++|||++++++|
T Consensus       230 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 --------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                0111345679999999999999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-53  Score=374.25  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++.+.||+|+||.||+|.++ +++.||||++.....   ...+|+++++.++|||||++++++.     ++ .+|+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~-~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-----cC-CeEE
Confidence            368999999999999999999975 577899999975443   3458999999999999999999762     22 2679


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |||||++ +|.+.+...  ....+++..+..|+.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus        85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLIE  160 (272)
T ss_dssp             EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeec-ccceeeccccceEEcc
Confidence            9999995 665554432  23458999999999999999999999 79999999999999996 8889999999998765


Q ss_pred             cCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          189 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       189 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  .....||+.|+|||++.+.. ++.++|||||||++|||+|| .+||...+..+.+..+....            
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~------------  227 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------  227 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------
Confidence            4332  23456789999999997654 89999999999999999995 56666666655555543311            


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC--CCcccc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE  322 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--hp~~~~  322 (376)
                                      ....+..+++++.+|+.+||+.||++|||++++++  |+||..
T Consensus       228 ----------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         228 ----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                            01133568999999999999999999999999987  888864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=369.84  Aligned_cols=244  Identities=18%  Similarity=0.262  Sum_probs=203.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ++|++.++||+|+||+||+|+++ +++.||||++....   ....+|+.+++.++||||+++++++     .++..+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceEEE
Confidence            57999999999999999999984 77899999997643   3345899999999999999999998     344458999


Q ss_pred             eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcccccc
Q 017139          111 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK  189 (376)
Q Consensus       111 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~~  189 (376)
                      ||||+ |++...+..   ....+++..+++++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECT-TCCEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcC-CCcEEECcchhheeccC
Confidence            99998 465555443   24568899999999999999999999 79999999999999996 78899999999986544


Q ss_pred             CCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc
Q 017139          190 GEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  266 (376)
Q Consensus       190 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ...  .....+|+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+...            
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~------------  219 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------  219 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred             CCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC------------
Confidence            332  22456799999999997654 8999999999999999998 8999999888777665544211            


Q ss_pred             CCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                      ...+...++++.+||.+||+.||++|||++++++|
T Consensus       220 ----------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         220 ----------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            11334578999999999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-52  Score=377.05  Aligned_cols=247  Identities=23%  Similarity=0.306  Sum_probs=191.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||+||+|+++.+++   .||||.+....     ....+|+.+++.++|||||++++++     .+
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~   98 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TK   98 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ee
Confidence            34689999999999999999999987765   58899875432     2345799999999999999999998     34


Q ss_pred             ceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      ...+|+|||||++ +|.+++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFG  173 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFG  173 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC-
T ss_pred             CCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECC-CCcEEECCcc
Confidence            4448899999996 56555543   24569999999999999999999999 79999999999999996 8889999999


Q ss_pred             CccccccCCCc------ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017139          183 SAKVLVKGEAN------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       183 ~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      +++........      ....+|+.|+|||.+.+. .++.++|||||||++|||+| |..||.+.+..+.+..+......
T Consensus       174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~  252 (299)
T d1jpaa_         174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL  252 (299)
T ss_dssp             ----------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             cceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99876543221      124568899999999765 48999999999999999998 89999998887766655432110


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                                  ..+..+++++.+|+.+||+.||++|||+.+++++
T Consensus       253 ----------------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         253 ----------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                        1234579999999999999999999999998754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=385.41  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=208.8

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc---CCCcEEEEEEecccc--------cchHHHHHHHHhCCC-CCeeecceeeeec
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDH-PNVISLKHCFFST   99 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h-~~Iv~~~~~~~~~   99 (376)
                      ..++|++++.||+|+||+||+|++.   .+|+.||||++.+..        ....+|++++++++| |||+++++++   
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---   98 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---   98 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE---
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee---
Confidence            3488999999999999999999984   468999999985421        234479999999977 8999999998   


Q ss_pred             CCCCceeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEE
Q 017139          100 TSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL  178 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl  178 (376)
                        .+...++++||||.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||
T Consensus        99 --~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~vkL  170 (322)
T d1vzoa_          99 --QTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVL  170 (322)
T ss_dssp             --EETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEE
T ss_pred             --ccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecC-CCCEEE
Confidence              445569999999995 67666654    3568899999999999999999999 79999999999999996 788999


Q ss_pred             EecCCccccccCC--CcceeeccccccChhhhhCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017139          179 CDFGSAKVLVKGE--ANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  255 (376)
Q Consensus       179 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  255 (376)
                      +|||+++......  ......|++.|+|||.+.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+....
T Consensus       171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~  250 (322)
T d1vzoa_         171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK  250 (322)
T ss_dssp             SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred             eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence            9999997654332  234567899999999997543 4688999999999999999999999877554444444332100


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCC-----CHHHHhCCCccccccCC
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  326 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~hp~~~~~~~~  326 (376)
                      .                         ...++..+|+++++||++||++||++||     |++|+++||||+++++.
T Consensus       251 ~-------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~  301 (322)
T d1vzoa_         251 S-------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  301 (322)
T ss_dssp             C-------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             C-------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence            0                         0113456899999999999999999999     58999999999987653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=372.98  Aligned_cols=250  Identities=25%  Similarity=0.310  Sum_probs=202.8

Q ss_pred             ccceEeeee-eccCCceEEEEEEEcC--CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           33 TISYMAERV-VGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        33 ~~~y~~~~~-Lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .++|.+.+. ||+|+||+||+|.++.  ++..||||++....     ....+|+++++.++|||||++++++..     +
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----C
Confidence            467888885 9999999999998764  34579999986542     234579999999999999999998732     1


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                       .+|+|||||++ +|.+.+..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        82 -~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGl  155 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGL  155 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTT
T ss_pred             -eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeecc-CCceeeccchh
Confidence             27899999995 66665543   34679999999999999999999999 79999999999999996 88999999999


Q ss_pred             ccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 017139          184 AKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      ++.......    .....||+.|+|||++.+.. ++.++|||||||++|||+| |..||.+.+..+....+.+.. .   
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-~---  230 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-R---  230 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-C---
T ss_pred             hhcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C---
Confidence            987654332    22345788999999997654 8999999999999999998 999999888776665554311 0   


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH---hCCCcccc
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDE  322 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el---l~hp~~~~  322 (376)
                                              ..+++.+|+++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       231 ------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         231 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                                    11345689999999999999999999999877   67888753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=370.86  Aligned_cols=246  Identities=23%  Similarity=0.304  Sum_probs=196.3

Q ss_pred             eEee-eeeccCCceEEEEEEEc--CCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017139           36 YMAE-RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF  106 (376)
Q Consensus        36 y~~~-~~Lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~  106 (376)
                      +.+. ++||+|+||+||+|.+.  .+++.||||++....      ....+|+++++.++|||||++++++.     ++. 
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~~~-   81 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AES-   81 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----SSS-
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----cCC-
Confidence            3443 57999999999999864  356789999985432      23457999999999999999999873     222 


Q ss_pred             EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          107 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       107 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      +++|||||++ +|.+++..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus        82 ~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~-~~~~kl~DFGla~  155 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSK  155 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccc-cCcccccchhhhh
Confidence            6799999985 67666654    4679999999999999999999999 79999999999999996 8899999999998


Q ss_pred             ccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          186 VLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       186 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ........    ....||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.+.  .     
T Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~-----  227 (277)
T d1xbba_         156 ALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--E-----  227 (277)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--C-----
T ss_pred             hccccccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence            76543322    2346789999999997654 8999999999999999998 89999988876655544331  0     


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHH---hCCCcccc
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDE  322 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el---l~hp~~~~  322 (376)
                                           ...++..+|+++.+|+.+||+.||++|||++++   |+|+|+.-
T Consensus       228 ---------------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 ---------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ---------------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                                 011345689999999999999999999999987   56766643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=367.12  Aligned_cols=251  Identities=25%  Similarity=0.329  Sum_probs=197.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      .++|++.+.||+|+||+||+|++..+ +.||||++....   ....+|+.+++.++|||||++++++.     ++. +++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-----~~~-~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----EEP-IYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS-CEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-----cCC-eEE
Confidence            47899999999999999999998655 579999996554   23458999999999999999999872     222 679


Q ss_pred             Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |||||++ ++...+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus        89 v~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~-~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE  164 (285)
T ss_dssp             EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC---
T ss_pred             EEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECC-CCcEEEcccchhhhcc
Confidence            9999996 555555432  23569999999999999999999999 79999999999999996 7889999999998664


Q ss_pred             cCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC
Q 017139          189 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  265 (376)
Q Consensus       189 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ....  .....||+.|+|||++.... ++.++|||||||++|+|++| .+||.+....+.+..+.+....          
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~----------  233 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------  233 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred             CCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence            3332  23456799999999997654 89999999999999999995 5555666665555554432110          


Q ss_pred             cCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC--CCccccc
Q 017139          266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDEL  323 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--hp~~~~~  323 (376)
                                        ..+..+++++++||.+||+.||++|||++++++  |+||+..
T Consensus       234 ------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                              133467999999999999999999999999987  8898764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=364.77  Aligned_cols=245  Identities=27%  Similarity=0.348  Sum_probs=190.6

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCC---cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .++|++++.||+|+||.||+|++..++   ..||||.+....     ....+|+.+++.++||||+++++++.     + 
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~-   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E-   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S-
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c-
Confidence            368999999999999999999987553   468999885432     23457999999999999999999872     2 


Q ss_pred             eeEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+|+|||||++ ++...+..   ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~-~~~~Kl~DfG~  154 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGL  154 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC---
T ss_pred             CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecC-CCcEEEccchh
Confidence            237899999995 55554443   34679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCC--cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          184 AKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       184 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ++.......  .....||+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....      
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~------  227 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------  227 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------
T ss_pred             heeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------
Confidence            987543322  2345678999999999765 48999999999999999998 8999998887776666544210      


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                            ..++..+|+++.+||.+||+.||++|||++|+++|
T Consensus       228 ----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         228 ----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                  01345689999999999999999999999999876

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=361.35  Aligned_cols=244  Identities=20%  Similarity=0.271  Sum_probs=187.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCC----cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      ..|++.+.||+|+||.||+|.++.++    ..||||++....     ....+|+.+++.++|||||++++++     .+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ecC
Confidence            46999999999999999999987654    469999986432     2345799999999999999999998     344


Q ss_pred             eeEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      ..+++|||||.++ +...+..   ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl  156 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGL  156 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC
T ss_pred             CceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECC-CCeEEEcccch
Confidence            4488999999964 4444433   34679999999999999999999999 79999999999999996 88999999999


Q ss_pred             ccccccCCC----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCH
Q 017139          184 AKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTR  258 (376)
Q Consensus       184 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~  258 (376)
                      ++.......    .....||+.|+|||++.+. .++.++|||||||++|||++|. +||...+..+.+..+.... .   
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~---  231 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-R---  231 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-C---
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-C---
Confidence            987644322    2234578999999999765 4899999999999999999965 5555555554444433211 0   


Q ss_pred             HHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                                              ...+..++.++.+||.+||+.||++|||+.++++
T Consensus       232 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 ------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                    1133457899999999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=368.07  Aligned_cols=245  Identities=23%  Similarity=0.327  Sum_probs=195.1

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCc----EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE  104 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~  104 (376)
                      .+|++.+.||+|+||+||+|.+..+|+    .||+|++....     ....+|+.+++.++|||||++++++..     +
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence            569999999999999999999988876    58888775322     234579999999999999999999843     2


Q ss_pred             eeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCC
Q 017139          105 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS  183 (376)
Q Consensus       105 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~  183 (376)
                      . .++++||+. |+|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~-~~~~kl~DFGl  157 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFGL  157 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCCSH
T ss_pred             C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCC-CCCeEeecccc
Confidence            2 456777776 577666554   35679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHH
Q 017139          184 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE  259 (376)
Q Consensus       184 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (376)
                      ++........   ....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+.+.. .+   
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~---  232 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RL---  232 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CC---
T ss_pred             ceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CC---
Confidence            9876543332   2345799999999997754 8999999999999999998 899998877665554443311 10   


Q ss_pred             HHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCCC
Q 017139          260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~hp  318 (376)
                                              ..+..+++++.+|+.+||+.||++|||+.++++|.
T Consensus       233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence                                    12346789999999999999999999999999883

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=364.28  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=190.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTTS  101 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~  101 (376)
                      .++|++.+.||+|+||.||+|.+..     +++.||||++.....     ...+|..++.++ .|+||+.+++++.    
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~----   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec----
Confidence            3689999999999999999999764     456899999865432     223455555555 6899999988764    


Q ss_pred             CCceeEEEEeeccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCee
Q 017139          102 KDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL  168 (376)
Q Consensus       102 ~~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nil  168 (376)
                      .++..+++|||||+ |+|.+.+.....            ....+++..+..++.||+.||+|||+ +||+||||||+|||
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NIL  166 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  166 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcccee
Confidence            33345789999999 578887765432            13458999999999999999999999 79999999999999


Q ss_pred             ecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHH
Q 017139          169 VDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD  244 (376)
Q Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~  244 (376)
                      ++. ++.+||+|||+|+.......   .....||+.|+|||++.+. .++.++|||||||++|+|++| .+||.+.+..+
T Consensus       167 l~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         167 LSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             ECG-GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECC-CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            996 78899999999986544322   2345789999999999775 489999999999999999986 57888776655


Q ss_pred             HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      .+...+.....+                           .++..+++++++++.+||+.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            555544421111                           1334679999999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=365.53  Aligned_cols=251  Identities=22%  Similarity=0.288  Sum_probs=205.2

Q ss_pred             ccccceEeeeeeccCCceEEEEEEEcCCCcE--EEEEEeccc-----ccchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017139           31 KQTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        31 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~-----~~~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~~~  102 (376)
                      ...++|++.++||+|+||.||+|+++.+|..  ||||++...     .....+|+++++.+ +||||+++++++..    
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----   82 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----   82 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec----
Confidence            3557999999999999999999999888874  677876432     23456899999998 79999999999843    


Q ss_pred             CceeEEEEeeccc-chHHHHHHhh------------hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeee
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHY------------SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV  169 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~------------~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill  169 (376)
                       ...+++|||||+ |+|.+.+...            ......+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        83 -~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~  160 (309)
T d1fvra_          83 -RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV  160 (309)
T ss_dssp             -TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             -CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEE
Confidence             445899999999 5888877543            2335779999999999999999999999 799999999999999


Q ss_pred             cCCCCcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCC-CCCCCCChHHHHHH
Q 017139          170 DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVE  248 (376)
Q Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~  248 (376)
                      +. ++.+||+|||+++............||..|+|||.+.+.. ++.++|||||||++|+|++|. +||.+.+..+....
T Consensus       161 ~~-~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~  238 (309)
T d1fvra_         161 GE-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  238 (309)
T ss_dssp             CG-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             cC-CCceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            96 7789999999998766555555667899999999997654 899999999999999999965 67888777766655


Q ss_pred             HHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                      +.+..                            ....+..+++++.+||.+||+.||++|||++++++|
T Consensus       239 i~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         239 LPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43310                            011334679999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=355.48  Aligned_cols=245  Identities=20%  Similarity=0.310  Sum_probs=195.4

Q ss_pred             cccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ..++|++.+.||+|+||.||+|.+  .|+.||||++..+.  ....+|++++++++||||+++++++..    +...+|+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~l   78 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI   78 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEE
Confidence            346899999999999999999998  57899999997653  335589999999999999999998743    2334789


Q ss_pred             Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccccc
Q 017139          110 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       110 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~~~  188 (376)
                      |||||+ |+|.+++....  ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus        79 v~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC-----
T ss_pred             EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecC-CCCEeecccccceecC
Confidence            999998 47777775432  2358999999999999999999999 79999999999999996 7889999999998654


Q ss_pred             cCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC
Q 017139          189 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  267 (376)
Q Consensus       189 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ..  .....++..|+|||++.+. .++.++|||||||++|||+| |.+||...+..+....+.+..              
T Consensus       155 ~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--------------  217 (262)
T d1byga_         155 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------  217 (262)
T ss_dssp             ---------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------------
T ss_pred             CC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            32  3345678899999999765 48999999999999999998 789998877666655543210              


Q ss_pred             CcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                    ...++..+++++.+||++||+.||++|||+.+++++
T Consensus       218 --------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         218 --------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                          111445678999999999999999999999999763

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=357.49  Aligned_cols=243  Identities=25%  Similarity=0.327  Sum_probs=190.7

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCC-C--cEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD  103 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~-~--~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~  103 (376)
                      ++|++.+.||+|+||.||+|+...+ +  ..||||++.++.       ....+|+.+++.++||||+++++++.     +
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----~   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----T   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence            5799999999999999999986533 3  368999885431       23457999999999999999999883     2


Q ss_pred             ceeEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecC
Q 017139          104 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG  182 (376)
Q Consensus       104 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg  182 (376)
                      . .+++|||||+ |++.+.+..   ....+++..+..++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~-~~~vkl~DfG  156 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDFG  156 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCCT
T ss_pred             c-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccc-ccceeeccch
Confidence            2 2679999998 466655544   23569999999999999999999999 79999999999999996 7889999999


Q ss_pred             CccccccCCCc----ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 017139          183 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  257 (376)
Q Consensus       183 ~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  257 (376)
                      +++........    ....++..|+|||++.+.. ++.++|||||||++|||+| |..||.+.+..+....+.+....+ 
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-  234 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-  234 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-
Confidence            99876544332    2334677899999997754 8999999999999999998 899999998888777665421111 


Q ss_pred             HHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                                                ..+..+|+++.+||.+||..||++|||+++++
T Consensus       235 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         235 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             --------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                                      13356899999999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-50  Score=361.96  Aligned_cols=260  Identities=22%  Similarity=0.256  Sum_probs=200.7

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      .++|++++.||+|+||.||+|++..+|+.||||++...  ......|+++++.++|+|++..+..+.    .+....++|
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~iv   81 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVMV   81 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEEE
Confidence            35799999999999999999999999999999987543  345678999999999887766655543    333457899


Q ss_pred             eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC--CCCcEEEEecCCccccc
Q 017139          111 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKVLV  188 (376)
Q Consensus       111 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~--~~~~~kl~Dfg~~~~~~  188 (376)
                      ||||++++...+..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++.  .+..+||+|||+|+...
T Consensus        82 me~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          82 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            99999987766554   35679999999999999999999999 79999999999999863  24579999999998765


Q ss_pred             cCCC--------cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 017139          189 KGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  260 (376)
Q Consensus       189 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (376)
                      ....        .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+......    .
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----~  232 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K  232 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH----H
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc----c
Confidence            4322        23557899999999997654 899999999999999999999999876655443333221100    0


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHH---HHhCCCcccc
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFFDE  322 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~---ell~hp~~~~  322 (376)
                      ..                 .........+|+++.+|+.+||+.||++||+++   ++|+|+|.+.
T Consensus       233 ~~-----------------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         233 MS-----------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HH-----------------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CC-----------------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            00                 001112346899999999999999999999987   5577877643

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=358.40  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=196.1

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCC-------cEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeec
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFST   99 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~   99 (376)
                      .++|++.+.||+|+||.||+|++..++       ..||||++..+..     ...+|...+.++ +|||||++++++   
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~---   88 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC---   88 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc---
Confidence            479999999999999999999986654       3799999866542     223577777777 899999999999   


Q ss_pred             CCCCceeEEEEeeccc-chHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCC
Q 017139          100 TSKDELFLNLVMEYVP-ETMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN  166 (376)
Q Consensus       100 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~N  166 (376)
                        .++..+++|||||+ |+|.+.+....            .....+++..++.++.||+.||+|||+ +||+||||||+|
T Consensus        89 --~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N  165 (299)
T d1fgka_          89 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  165 (299)
T ss_dssp             --CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             --ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence              44555899999999 57777776432            123569999999999999999999999 799999999999


Q ss_pred             eeecCCCCcEEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 017139          167 LLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA  242 (376)
Q Consensus       167 ill~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  242 (376)
                      ||++. ++.+||+|||+++.......   .....+++.|+|||.+.+. .|+.++|||||||++|+|++ |.+||.+.+.
T Consensus       166 iLl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         166 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             EEECT-TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eeecC-CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            99996 78899999999987655432   2345678999999999765 49999999999999999998 7999988877


Q ss_pred             HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ......+... ..+                           .++..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 EELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            6655443321 111                           134568999999999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-49  Score=359.51  Aligned_cols=248  Identities=24%  Similarity=0.286  Sum_probs=201.2

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||+||+|+.+.     +++.||||++....     ....+|+++++.++||||+++++++.     
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----   86 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-----   86 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec-----
Confidence            4689999999999999999999753     56789999986542     23457999999999999999999983     


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceecc
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYS--------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD  161 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~d  161 (376)
                      ....++++||||+ |+|.+.+....                    .....+++..+..|+.|++.||+|||+ ++|+|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD  165 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  165 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence            3444889999998 57877775421                    123458999999999999999999999 7999999


Q ss_pred             CCCCCeeecCCCCcEEEEecCCccccccCC---CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCC-CCC
Q 017139          162 VKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLF  237 (376)
Q Consensus       162 lkp~Nill~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf  237 (376)
                      |||+|||++. ++.+||+|||+++...+..   ...+..+++.|+|||.+.+. .++.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999996 7889999999997654332   22345678999999999765 4899999999999999999985 789


Q ss_pred             CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          238 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      .+.+..+....+.+...                            ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~e~~~~v~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88888877766544210                            0134568999999999999999999999999853

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-49  Score=366.56  Aligned_cols=291  Identities=30%  Similarity=0.479  Sum_probs=214.1

Q ss_pred             CCCccccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHhCC-----------CCCeeecc
Q 017139           28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMD-----------HPNVISLK   93 (376)
Q Consensus        28 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~-----------h~~Iv~~~   93 (376)
                      |++...++|+++++||+|+||+||+|++..+|+.||||++.++..   ...+|+.+++.++           |+||++++
T Consensus         7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_           7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            455555679999999999999999999999999999999976532   3356888887765           57899998


Q ss_pred             eeeeecCCCCceeEEEEeeccc--chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC
Q 017139           94 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP  171 (376)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~--g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~  171 (376)
                      +++....   ....+++++++.  ++......  ......+++..++.++.||+.||+|||+..||+||||||+|||++.
T Consensus        87 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          87 DHFNHKG---PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  161 (362)
T ss_dssp             EEEEEEE---TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             EEeeecc---ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence            8874422   223445555544  44333332  2345778999999999999999999996358999999999999975


Q ss_pred             CCC-----cEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-----
Q 017139          172 LTH-----QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----  241 (376)
Q Consensus       172 ~~~-----~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-----  241 (376)
                      ++.     .++++|||.+.....  ......||+.|+|||++.+.. ++.++|+||+||++++|++|+.||....     
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cCcccccceeeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence            322     499999999876533  334667899999999998654 8999999999999999999999997543     


Q ss_pred             -hHHHHHHHHHhcCCCCHHHHhhcCcC-------CcCccCCCCCCCCcccc------cccCCChhHHHHHHhhcCCCCCC
Q 017139          242 -AVDQLVEIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHKV------FHKRMPPEAIDLASRLLQYSPSL  307 (376)
Q Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~  307 (376)
                       ..+.+......+|.++.+.+......       .....+......++...      +....+++++|||.+||++||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence             34667777888888877665432211       00011122222222111      22345678999999999999999


Q ss_pred             CCCHHHHhCCCccccccCC
Q 017139          308 RCTALEACAHPFFDELREP  326 (376)
Q Consensus       308 R~t~~ell~hp~~~~~~~~  326 (376)
                      |||++|+|+||||++....
T Consensus       319 Rpta~e~L~Hp~f~~~~~~  337 (362)
T d1q8ya_         319 RADAGGLVNHPWLKDTLGM  337 (362)
T ss_dssp             CBCHHHHHTCGGGTTCTTC
T ss_pred             CcCHHHHhcCcccCCCCCc
Confidence            9999999999999976443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=356.68  Aligned_cols=255  Identities=23%  Similarity=0.290  Sum_probs=207.0

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSK  102 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||.||+|.+..     +++.||||++.....     ...+|+++++.++||||+++++++     .
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-----~   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----C
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----e
Confidence            4789999999999999999998853     357899999965432     234799999999999999999998     3


Q ss_pred             CceeEEEEeeccc-chHHHHHHhhh------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCc
Q 017139          103 DELFLNLVMEYVP-ETMYRVLKHYS------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ  175 (376)
Q Consensus       103 ~~~~~~lv~e~~~-g~l~~~l~~~~------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~  175 (376)
                      .+..+++|||||+ |+|.+++....      .....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~-~~~  171 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFT  171 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-TCC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecC-Cce
Confidence            3444889999998 57777665432      122457889999999999999999999 79999999999999996 888


Q ss_pred             EEEEecCCccccccCCC---cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 017139          176 VKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIK  251 (376)
Q Consensus       176 ~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~  251 (376)
                      +||+|||+++.......   .....+|+.|+|||.+.+.. ++.++|||||||++|+|+|| .+||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999986644322   23446799999999997654 89999999999999999998 588988888777766554


Q ss_pred             hcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC------CCccccc
Q 017139          252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDEL  323 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~------hp~~~~~  323 (376)
                      ...                            ...+..+++.+.++|.+||+.||++|||++++++      +|+|+++
T Consensus       251 ~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         251 GGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             CCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            210                            0123467899999999999999999999999987      6777653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=353.64  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=202.7

Q ss_pred             cccceEeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecC
Q 017139           32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTT  100 (376)
Q Consensus        32 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~Iv~~~~~~~~~~  100 (376)
                      ..++|++++.||+|+||.||+|+..     .+++.||||++.....     ...+|+.+++.+ +|||||++++++    
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~----   96 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----   96 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence            3479999999999999999999863     4567899999965432     234688899988 699999999998    


Q ss_pred             CCCceeEEEEeecccc-hHHHHHHhhh--------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCC
Q 017139          101 SKDELFLNLVMEYVPE-TMYRVLKHYS--------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ  165 (376)
Q Consensus       101 ~~~~~~~~lv~e~~~g-~l~~~l~~~~--------------~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~  165 (376)
                       .+...+++|||||++ +|...+....              .....+++..+..++.||+.||+|||+ +|++||||||+
T Consensus        97 -~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~  174 (311)
T d1t46a_          97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR  174 (311)
T ss_dssp             -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             -eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccccc
Confidence             444458899999985 7777776532              123468999999999999999999999 79999999999


Q ss_pred             CeeecCCCCcEEEEecCCccccccCCCc---ceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 017139          166 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN  241 (376)
Q Consensus       166 Nill~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  241 (376)
                      ||+++. ++.+|++|||.++........   ....||+.|+|||++.+. .++.++|||||||++|+|+| |.+||.+.+
T Consensus       175 NIl~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         175 NILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccc-cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            999996 788999999999876544332   245679999999999765 48999999999999999998 677787777


Q ss_pred             hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ..+.+.+++.....+                           ..+...++++.+||.+||+.||++|||++++++
T Consensus       253 ~~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         253 VDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            666666665532111                           133457899999999999999999999999885

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-48  Score=347.68  Aligned_cols=244  Identities=20%  Similarity=0.279  Sum_probs=189.0

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCC---cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL  107 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~  107 (376)
                      +.+.++||+|+||+||+|.+..++   ..||||++....     ....+|++++++++||||+++++++..    .+..+
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCce
Confidence            344689999999999999986653   358999986422     234589999999999999999998753    23348


Q ss_pred             EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCCCcEEEEecCCccc
Q 017139          108 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV  186 (376)
Q Consensus       108 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~~  186 (376)
                      ++|||||++ +|.+++..   ....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.
T Consensus       105 ~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~~  179 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARD  179 (311)
T ss_dssp             EEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSSGGGCC
T ss_pred             EEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECC-CCCEEEecccchhh
Confidence            899999996 55555443   34567888899999999999999999 79999999999999996 78899999999987


Q ss_pred             cccCCC-----cceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHH
Q 017139          187 LVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREE  260 (376)
Q Consensus       187 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~  260 (376)
                      ......     .....||+.|+|||.+.+.. ++.++|||||||++|||++|..||...... +....+...  .     
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~-----  251 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R-----  251 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--C-----
T ss_pred             ccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence            644322     22356789999999987654 899999999999999999987777654333 223222221  0     


Q ss_pred             HhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhCC
Q 017139          261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  317 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  317 (376)
                                           ....+..+++++.+|+.+||..||++|||+.|+++|
T Consensus       252 ---------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 ---------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                 001234578999999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-47  Score=342.60  Aligned_cols=248  Identities=19%  Similarity=0.235  Sum_probs=199.9

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHhCCC-CCeeecceeeeecCCCCceeEEEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLV  110 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h-~~Iv~~~~~~~~~~~~~~~~~~lv  110 (376)
                      ++|++++.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++| +|++.+++++     ......++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEEE
Confidence            5799999999999999999999999999999988543  3456789999999976 8999998887     445558899


Q ss_pred             eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecC----CCCcEEEEecCCccc
Q 017139          111 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKV  186 (376)
Q Consensus       111 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~----~~~~~kl~Dfg~~~~  186 (376)
                      ||||+++|...+..   .+..+++..+..++.|++.||+|||+ +||+||||||+|||++.    .++.+||+|||+|+.
T Consensus        80 me~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99999998877654   34579999999999999999999999 79999999999999963    246799999999987


Q ss_pred             cccCC--------CcceeeccccccChhhhhCCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCC
Q 017139          187 LVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT  255 (376)
Q Consensus       187 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~  255 (376)
                      .....        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...   ......+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            64321        23356799999999999765 489999999999999999999999976543   3333333221111


Q ss_pred             CCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHh
Q 017139          256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  315 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  315 (376)
                      .+...                        +..++|+++.+++..|+..+|++||+.+.+.
T Consensus       235 ~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         235 TPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             SCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             CChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            11111                        2245789999999999999999999987664

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=343.55  Aligned_cols=268  Identities=21%  Similarity=0.213  Sum_probs=187.9

Q ss_pred             ccceEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccccc-hHHH--HHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017139           33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRE--LQLMRLMDHPNVISLKHCFFSTTSKDELFLNL  109 (376)
Q Consensus        33 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~e--~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~l  109 (376)
                      ..+|++.+.||+|+||.||+|+.  +|+.||||++..+... ..+|  +..+..++||||+++++++.... .....+|+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence            35799999999999999999986  6899999998654322 2234  44445779999999999987654 34456899


Q ss_pred             Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------CCceeccCCCCCeeecCCCCcEEEEec
Q 017139          110 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------PGVCHRDVKPQNLLVDPLTHQVKLCDF  181 (376)
Q Consensus       110 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-------~~ivH~dlkp~Nill~~~~~~~kl~Df  181 (376)
                      |||||+ |+|...+..     ..+++..+..++.|++.||.|||+.       +||+||||||+|||++. ++.+||+||
T Consensus        79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DF  152 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL  152 (303)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCC
T ss_pred             EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-CCCeEEEec
Confidence            999998 488777764     4689999999999999999999962       58999999999999996 789999999


Q ss_pred             CCccccccCCC-----cceeeccccccChhhhhCCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017139          182 GSAKVLVKGEA-----NISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  251 (376)
Q Consensus       182 g~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  251 (376)
                      |+++.......     .....||+.|+|||++.+..     .++.++|||||||++|||+||..||............ .
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~  231 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-L  231 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-T
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-c
Confidence            99987654332     23467899999999986532     1467899999999999999999887432211000000 0


Q ss_pred             hcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccccCCChhHHHHHHhhcCCCCCCCCCHHHHhC
Q 017139          252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  316 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  316 (376)
                      ....+..+.+.....  .....|.+    ............+.+|+.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~--~~~~~p~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         232 VPSDPSVEEMRKVVC--EQKLRPNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SCSSCCHHHHHHHHT--TSCCCCCC----CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccccchHHHHHHHHh--ccccCCCC----CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            000011111100000  00000000    000011123356899999999999999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.9e-25  Score=186.60  Aligned_cols=165  Identities=16%  Similarity=0.109  Sum_probs=115.7

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc----------------------cchHHHHHHHHhCCCCCeeecc
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRLMDHPNVISLK   93 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------------------~~~~~e~~~l~~l~h~~Iv~~~   93 (376)
                      |.++++||+|+||+||+|.+. +|+.||||++....                      ....+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            578999999999999999974 68999999864321                      0112477788899999988876


Q ss_pred             eeeeecCCCCceeEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCceeccCCCCCeeecCCC
Q 017139           94 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT  173 (376)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~~~ivH~dlkp~Nill~~~~  173 (376)
                      ++.     .    .+++|||+++...          ..+++.....++.|++.+|+|||+ +||+||||||+|||++. +
T Consensus        81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~-~  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSE-E  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEET-T
T ss_pred             Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeC-C
Confidence            543     2    3599999997411          124445567899999999999999 79999999999999984 4


Q ss_pred             CcEEEEecCCccccccCCCcceeeccccccChhhhhCCCCCCccchhHHHHHH
Q 017139          174 HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV  226 (376)
Q Consensus       174 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  226 (376)
                       .++|+|||.|.....+.... ........-.+.+ . ..|+.++|+||+.--
T Consensus       140 -~~~liDFG~a~~~~~~~~~~-~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~  188 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWRE-ILERDVRNIITYF-S-RTYRTEKDINSAIDR  188 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHH-HHHHHHHHHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHH-HHHHHHHHHHHHH-c-CCCCCcccHHHHHHH
Confidence             49999999987654332211 0000000001222 2 247899999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.34  E-value=1.6e-06  Score=73.73  Aligned_cols=77  Identities=17%  Similarity=0.121  Sum_probs=51.0

Q ss_pred             cceEeeeeeccCCceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEE
Q 017139           34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLN  108 (376)
Q Consensus        34 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~~  108 (376)
                      ..|++++..+.++.+.||++.  .+++.+++|+....    .....+|...++.+. +-.+.+++.+.     .++...+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~   86 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSN   86 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceE
Confidence            467888877667778999886  36667888887543    234567888888774 22233444433     2334577


Q ss_pred             EEeecccch
Q 017139          109 LVMEYVPET  117 (376)
Q Consensus       109 lv~e~~~g~  117 (376)
                      +||++++|.
T Consensus        87 lv~~~l~G~   95 (263)
T d1j7la_          87 LLMSEADGV   95 (263)
T ss_dssp             EEEECCSSE
T ss_pred             EEEEecccc
Confidence            999999974

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.80  E-value=7.4e-05  Score=62.62  Aligned_cols=75  Identities=15%  Similarity=0.071  Sum_probs=45.6

Q ss_pred             eEeeeeeccCCceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHhCCCCCe--eecceeeeecCCCCceeEEEEee
Q 017139           36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVME  112 (376)
Q Consensus        36 y~~~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~h~~I--v~~~~~~~~~~~~~~~~~~lv~e  112 (376)
                      +.....-+..+.+.||++.. .++..+++|...... ....+|...++.+....+  .+++.+.     .+....++||+
T Consensus        13 ~~~~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~   86 (255)
T d1nd4a_          13 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLG   86 (255)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEE
T ss_pred             CceEEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEE
Confidence            34433333333468898874 456678889775443 345678888887754333  3344433     22334779999


Q ss_pred             cccc
Q 017139          113 YVPE  116 (376)
Q Consensus       113 ~~~g  116 (376)
                      +++|
T Consensus        87 ~i~G   90 (255)
T d1nd4a_          87 EVPG   90 (255)
T ss_dssp             CCSS
T ss_pred             eeec
Confidence            9976

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.70  E-value=0.00021  Score=64.06  Aligned_cols=71  Identities=20%  Similarity=0.183  Sum_probs=42.4

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeccc-----------ccchHHHHHHHHhCC-C-C-CeeecceeeeecCCCCc
Q 017139           39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRLMD-H-P-NVISLKHCFFSTTSKDE  104 (376)
Q Consensus        39 ~~~Lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------~~~~~~e~~~l~~l~-h-~-~Iv~~~~~~~~~~~~~~  104 (376)
                      .+.||.|....||++.+..+++.+++|.-...           ......|.+.++.+. + | .+.+++.+  +   .+.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence            45689999999999998777889999964221           112345888887663 2 2 23333322  2   222


Q ss_pred             eeEEEEeecccc
Q 017139          105 LFLNLVMEYVPE  116 (376)
Q Consensus       105 ~~~~lv~e~~~g  116 (376)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              3489999975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.69  E-value=0.0042  Score=55.30  Aligned_cols=70  Identities=16%  Similarity=0.225  Sum_probs=45.6

Q ss_pred             eeeeeccCCceEEEEEEEcC-------CCcEEEEEEeccccc--chHHHHHHHHhCCCCCee-ecceeeeecCCCCceeE
Q 017139           38 AERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR--YKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFL  107 (376)
Q Consensus        38 ~~~~Lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h~~Iv-~~~~~~~~~~~~~~~~~  107 (376)
                      .++.|+.|-.-.+|++....       .++.|.+++......  ...+|..+++.+.-.++. ++++++     .+    
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----
Confidence            34688999999999998653       345677777653322  234688888887544444 444443     22    


Q ss_pred             EEEeecccc
Q 017139          108 NLVMEYVPE  116 (376)
Q Consensus       108 ~lv~e~~~g  116 (376)
                      .+|+||++|
T Consensus       117 g~I~efi~g  125 (395)
T d1nw1a_         117 GRLEEYIPS  125 (395)
T ss_dssp             EEEECCCCE
T ss_pred             ceEEEEecc
Confidence            378999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.34  E-value=0.0094  Score=51.39  Aligned_cols=70  Identities=17%  Similarity=0.001  Sum_probs=39.2

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCe--eecceeeeecCCCCceeEEEEeecccc
Q 017139           46 SFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVMEYVPE  116 (376)
Q Consensus        46 ~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~I--v~~~~~~~~~~~~~~~~~~lv~e~~~g  116 (376)
                      .--.||++.. .+|+.|++|+.....   .....|...+..|....+  +.....--........+.+.++++++|
T Consensus        34 ~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          34 YENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ccceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            3468999985 578889999886543   334567777777643222  111111000000223456788888764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.24  E-value=0.0065  Score=52.05  Aligned_cols=30  Identities=30%  Similarity=0.276  Sum_probs=25.8

Q ss_pred             CCceeccCCCCCeeecCCCCcEEEEecCCcc
Q 017139          155 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK  185 (376)
Q Consensus       155 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~~~  185 (376)
                      .|+||+|+.++||+++. +...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLG-DELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhccc-ccceeEecccccc
Confidence            47999999999999995 5556899999875